Citrus Sinensis ID: 016143

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390----
Protein Sequence
MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGKRICGAINSCFFFPPCC
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccEEEccccccEEEEEEEccccEEEEEEEEEEccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEcccccEEEEEEEEEccccHHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccccccccccccccEEEEcccccEEEcccHHHHHHccccccccccccccccccccccccccccccHHHHHHHHHHHcccccccccccHHHHHHHHHcccccccccccccHHHHHHHHHHcccccccccHHHHHccccccccccccccccccccccccHHHcccccccccccccccccccccccccccccccccccHHHHHHccccccEEEEcEEcccccEEEEEEccccccccccccEEEEEcccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccEEEHEEcccccHHHHEEEEccccccEEEEEEEcHHHHHccHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccccEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccEEEccccHHHEEEEcccccEEEEcccHHHHccccccccEccccccccHHHHHHcccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHcccccccccccccHHHHHHHHHHcccHcccccHHHHHccccHccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccHHHHHHcccccccccEEEEEEEccccccEEEEEEEEccccccccccEEEEccccccc
Coil and Loop (DISEMBL)
mdcgsgftkseteegefsekdpscrygrydeilgkgAFKTVykgfdevdgIEVAWNQVniedvmqspdQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHylhshnppiihrdlkcdnifvngnngevkiGDLGLAIVMqqptarsvigtpefmapelyeEEYNELVDIYSFGMCILEMVtceypynecknpaQIYKKVTsgikpaslskvtdpQVKQFIEKcivpaslrlpalellkdpflvtdnpkdlvcdplrlpnlvpevmnlahsephpmdidlnhkkvsadscaksntgtwfLTLELQRLtenneftlrgekndddtvSLTLRigdksgkricgainscfffppcc
Flexible Loop (DISEMBL)
mdcgsgftkseteegefsekdpscrygrydEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYnswvddtnRTINMITElftsgslrqyrKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPaslskvtdpqvKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNeftlrgekndddtvsltlrigdksgkricGAINSCFFFPPCC
Low Complexity Region (SEG)
MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGKRICGAINSCFFFPPCC
Disordered region (IsUnstruct)
***********************CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLA********************CAKSNTGTWFLTLELQRLTENNEFTLR******DTVSLTLRIGDKSGKRICGAINSCFFFPP**
Disordered Region (DISOPRED)
************************RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI***************EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS**KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTD********************************************************************LRGEKNDDDTVSLTLRIGDKSGKRICGAINSCFFFPPCC
Disordered Region (DISEMBL)
*********************PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGKRICGAINSCFFFPPCC
Disordered Region (DISPRO)
*****************SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGKRICGAINSCFFFPPCC
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGKRICGAINSCFFFPPCC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	394	2.2.26 [Sep-21-2011]
Q944Q0	563	Serine/threonine-protein	yes	no	0.949	0.664	0.685	1e-147
Q6EU49	612	Probable serine/threonine	yes	no	0.941	0.606	0.636	1e-138
Q8RXE5	524	Probable serine/threonine	no	no	0.923	0.694	0.679	1e-136
Q8LST2	557	Probable serine/threonine	no	no	0.908	0.642	0.648	1e-134
Q8S8Y8	567	Probable serine/threonine	no	no	0.911	0.633	0.642	1e-133
Q9CAV6	700	Serine/threonine-protein	no	no	0.934	0.525	0.534	1e-119
Q0D598	704	Probable serine/threonine	no	no	0.908	0.508	0.578	1e-118
A2YMV6	704	Probable serine/threonine	N/A	no	0.908	0.508	0.578	1e-118
Q65X23	621	Probable serine/threonine	no	no	0.906	0.574	0.558	1e-117
Q9STK6	516	Probable serine/threonine	no	no	0.687	0.525	0.713	1e-116

>sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1

 Score =  523 bits (1346), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 274/400 (68%), Positives = 306/400 (76%), Gaps = 26/400 (6%)

Query: 1   MDCGSGFTK--SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV 58
           M  GSGF    S  EE +F+EKDPS RY RYD++LG+GAFKTVYK FDEVDGIEVAWN V
Sbjct: 1   MASGSGFLGQISSMEEADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLV 60

Query: 59  NIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY 118
           +IEDVMQ P QLERLYSEVHLLK+LKHENIIK + SWVD+ N+TINMITELFTSGSLR Y
Sbjct: 61  SIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVY 120

Query: 119 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
           RKKH+ VD KAIKNWARQIL+GL+YLHS NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA
Sbjct: 121 RKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLA 180

Query: 179 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
            V+QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPYNEC+N AQIY
Sbjct: 181 TVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIY 240

Query: 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP-- 296
           KKVTS IKP SL KV DPQV+QFIEKC++PAS R  ALEL KDPFL  D  KD       
Sbjct: 241 KKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSALLASS 300

Query: 297 ------LRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTE 350
                 +R P L          E  PMD+D N  K    S + +    W  T+ELQR+ E
Sbjct: 301 STSSKYVRPPQL----------EHLPMDVDHNENK----SVSSNEDYPWSQTIELQRIAE 346

Query: 351 NNEFTLRGEKNDDDTVSLTLRIGDKSGKRICGAINSCFFF 390
           N EF LRGE++DD T S+ LRI D SGK  C  ++  F+ 
Sbjct: 347 NKEFRLRGERSDDVTASMVLRIADPSGK--CRIVHFAFYL 384

Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC).
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1

 Score =  492 bits (1267), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 243/382 (63%), Positives = 299/382 (78%), Gaps = 11/382 (2%)

Query: 11  ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
           + ++ E  E DP+ RY RY+E+LG+GA KTVYK FDEV+GIEVAW+QV I++VMQSPD L
Sbjct: 9   KVDDAECVEVDPTRRYIRYNEVLGRGAMKTVYKAFDEVEGIEVAWSQVEIDEVMQSPDNL 68

Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
           ERLYSEVHLLKSLKHEN++KFYN WVDD  +TIN+ITELFTSGSLRQYR+KH  VD+KAI
Sbjct: 69  ERLYSEVHLLKSLKHENVMKFYNYWVDDQKKTINVITELFTSGSLRQYRQKHPRVDLKAI 128

Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
           KNWARQ+LRGL YLH+H PPIIHRDLKCDNIFVNGN+GEVKIGDLGLA VM  P A+SVI
Sbjct: 129 KNWARQVLRGLDYLHTHQPPIIHRDLKCDNIFVNGNHGEVKIGDLGLATVMLTPRAKSVI 188

Query: 191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
           GTPEFMAPELY+E Y+ELVDIYSFGMC+LEM T EYPY+EC N AQI+KKV+ G+KPA+L
Sbjct: 189 GTPEFMAPELYDENYDELVDIYSFGMCMLEMFTLEYPYSECTNAAQIFKKVSKGVKPAAL 248

Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLA 310
           +K+T+ Q KQFI+KC+VPAS RL A ELL+DPFL +DN   LV    + P+ +P+ ++++
Sbjct: 249 AKITNIQAKQFIDKCLVPASERLSAKELLQDPFLCSDNSSVLV--GTKFPSSLPKSVDVS 306

Query: 311 HSEPHPMDIDLNHKKVSADSCAKSNTGTWFLT-LELQRLTENNEFTLRGEKNDDDTVSLT 369
               H MD+D N    ++ +C +++ G    + LE  R  +N E  L GEK DD++VSL 
Sbjct: 307 LEALH-MDVDTNESMCTS-TCKRNDLGGPHRSVLEFTRTNKNTELKLTGEKLDDNSVSLV 364

Query: 370 LRIGDKSGKRICG-AINSCFFF 390
           LRI D     +CG A N  F F
Sbjct: 365 LRIAD-----LCGHARNIHFLF 381

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RXE5|WNK10_ARATH Probable serine/threonine-protein kinase WNK10 OS=Arabidopsis thaliana GN=WNK10 PE=2 SV=1

 Score =  484 bits (1247), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 250/368 (67%), Positives = 286/368 (77%), Gaps = 4/368 (1%)

Query: 13  EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
           EE +F +KDP+ RY RY+++LG+GAFKTVYK FDEV+GIEVAWN ++IEDV+Q P QL+R
Sbjct: 2   EEADFVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDR 61

Query: 73  LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN 132
           LYSEVHLL SLKH+NIIK + SWVDD N++INMITELFTSGSL  YRKKH+ VD KAI N
Sbjct: 62  LYSEVHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMN 121

Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
           WARQIL+GLHYLHS  PP+IHRDLKCDNIFVNGN G+VKIGDLGLA VMQQPTARSVIGT
Sbjct: 122 WARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGT 181

Query: 193 PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
           PEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY EC+N AQIYKKVTSGIKP SLSK
Sbjct: 182 PEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSK 241

Query: 253 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 312
           V DPQVKQFIEKC++PA  R  ALELLKD  L  D  KD            P +      
Sbjct: 242 VDDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFKPAMP--PQC 299

Query: 313 EPHPMDIDL-NHKKVSADSCAKSNTGTWFL-TLELQRLTENNEFTLRGEKNDDDTVSLTL 370
           E  PMD++   +  VS  S AKS+     L T+E+QR+ E+ EF L GE+ DD   S+ L
Sbjct: 300 EYRPMDVEYKKNTSVSICSSAKSSQECALLQTMEVQRVAESTEFKLSGERRDDVAASMAL 359

Query: 371 RIGDKSGK 378
           RI   SG+
Sbjct: 360 RIAGSSGQ 367

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1

 Score =  477 bits (1227), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 243/375 (64%), Positives = 295/375 (78%), Gaps = 17/375 (4%)

Query: 16  EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
           E  E DP+CRY RY E++GKGA KTV+KGFDEVDGIEVAWNQV I+D++QSPD LERLYS
Sbjct: 17  EVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYS 76

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           EV LLKSLKH+NII+FYNSW+DD N+T+N+ITELFTSGSLRQYRKKH+ V+MKA+K WAR
Sbjct: 77  EVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAVKCWAR 136

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
           QIL GL YLHS +PPIIHRD+KCDNIF+NGN+GEVKIGDLGLA VM+Q  A+SVIGTPEF
Sbjct: 137 QILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEF 196

Query: 196 MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
           MAPELY+E YNEL DIYSFGMC+LEMVT EYPY EC+N AQIYKKV+SGIKPASLSKV D
Sbjct: 197 MAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKD 256

Query: 256 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVC-DPLRLPNLV-PEVMNLAH-- 311
           P+V +FIEKC++PAS RL A ELL D FL   N   LV  +PL LP++V P+  +     
Sbjct: 257 PEVMKFIEKCLLPASERLSAEELLLDSFL---NVNGLVMNNPLPLPDIVMPKEGSFGERC 313

Query: 312 --SEPHP------MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDD 363
             SE  P      M ++L+         + +N+GT    +E++R    N F L+GE+ND+
Sbjct: 314 LMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSGTN--CIEVRRAKRGNFFVLKGEENDE 371

Query: 364 DTVSLTLRIGDKSGK 378
           ++VSL LRI D++G+
Sbjct: 372 NSVSLILRIVDENGR 386

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1

 Score =  476 bits (1224), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 241/375 (64%), Positives = 289/375 (77%), Gaps = 16/375 (4%)

Query: 16  EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
           E  E DP+ RY RY E++GKGAFKTVYK FDEVDGIEVAWNQV I+DV+QSP+ LERLYS
Sbjct: 17  EVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYS 76

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           EV LLKSLKH NII+FYNSW+DD N+T+N+ITELFTSGSLR YRKKH+ V+MKA+KNWAR
Sbjct: 77  EVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWAR 136

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
           QIL GL YLH   PPIIHRDLKCDNIF+NGN+GEVKIGDLGLA VM+Q  A+SVIGTPEF
Sbjct: 137 QILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEF 196

Query: 196 MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
           MAPELY+E YNEL DIYSFGMC+LEMVT +YPY ECKN AQIYKKV+SGIKPASLS+V D
Sbjct: 197 MAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKD 256

Query: 256 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV-PE--------V 306
           P+VKQFIEKC++PAS RL A ELL DPFL  +     + +PL LP++V P+        +
Sbjct: 257 PEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLT--MNNPLPLPDIVMPKEGAFGDRCL 314

Query: 307 MNLAHSEPHP---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDD 363
           M+       P   + IDL+            N+G+    +E++R    N F L+GE+ND+
Sbjct: 315 MSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSGSR--CIEVRRAKRGNFFVLKGEENDE 372

Query: 364 DTVSLTLRIGDKSGK 378
            +VSL LRI D++G+
Sbjct: 373 QSVSLILRIVDENGR 387

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1

 Score =  427 bits (1099), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 218/408 (53%), Positives = 275/408 (67%), Gaps = 40/408 (9%)

Query: 11  ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
           E +  EF E DP+ RYGRY+E+LGKGA KTVY+ FDE +GIEVAWNQV + D +QSP+ L
Sbjct: 8   EPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL 67

Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
           ERLY E+HLLK+LKH+NI+KFY SWVD  NR IN +TELFTSG+LRQYR +HK V+++A+
Sbjct: 68  ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAM 127

Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
           K+W RQILRGLHYLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++++  A   +
Sbjct: 128 KHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187

Query: 191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
           GTPEFMAPE+YEE YNELVDIYSFGMCILEMVT +YPY+EC +PAQIYKKV SG KP +L
Sbjct: 188 GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDAL 247

Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNP---------KDLVCDPLRLPN 301
            KV DP+VK FIEKC+   SLR+ A ELL DPFL  D+          +D V    R P+
Sbjct: 248 YKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDMEDSVGPLYRQPH 307

Query: 302 LVPEVMNLAHSEP----------HPMD-IDLNHKKVSADSCAKSNTGTWFLT-------- 342
            +P+  N   +            +P +   LN +  +  +        W           
Sbjct: 308 HLPDYYNYPSNSSSLNRQYSNGNYPSNSSSLNRQYSNGYNSHHEYQNGWAYNPAETEETH 367

Query: 343 ------------LELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGK 378
                        E ++ + N + T++G++ DD  + L LRI DK G+
Sbjct: 368 GIELFESRNNDDQEEEKKSGNVDITIKGKRRDDGGLFLRLRIADKEGR 415

Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1

 Score =  426 bits (1095), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 218/377 (57%), Positives = 267/377 (70%), Gaps = 19/377 (5%)

Query: 16  EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
           E++E DP+ RYGRY+++LGKGA KTVY+ FDE  G+EVAWNQV + D +QSP+ LERLY 
Sbjct: 16  EYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYC 75

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           E+HLLK+LKH NI+KFY SWVD + R IN ITE+FTSG+LRQYR+KH  V++ A+K+W R
Sbjct: 76  EIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCR 135

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
           QIL GL YLHSH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA ++++  A   +GTPEF
Sbjct: 136 QILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEF 195

Query: 196 MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
           MAPE+YEEEYNELVDIYSFGMC+LEMVT EYPY+EC +P QIYKKV SG KP +L KV D
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255

Query: 256 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP----------LRLPNLVPE 305
           P V+QF+EKC+  AS RL A ELLKDPFL  D   DLV  P          LR P L   
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFLQVD---DLVFCPGDGDYSLMNYLRQPYLEHA 312

Query: 306 VMNLAH-----SEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEK 360
             N++      SE    D     +    D   K++    F   E + L  N + T++G K
Sbjct: 313 YSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLG-NVDITIKGRK 371

Query: 361 NDDDTVSLTLRIGDKSG 377
           ++D ++ L LRI D  G
Sbjct: 372 SEDGSIFLRLRIADNDG 388

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2

 Score =  426 bits (1094), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 218/377 (57%), Positives = 267/377 (70%), Gaps = 19/377 (5%)

Query: 16  EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
           E++E DP+ RYGRY+++LGKGA KTVY+ FDE  G+EVAWNQV + D +QSP+ LERLY 
Sbjct: 16  EYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYC 75

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           E+HLLK+LKH NI+KFY SWVD + R IN ITE+FTSG+LRQYR+KH  V++ A+K+W R
Sbjct: 76  EIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCR 135

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
           QIL GL YLHSH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA ++++  A   +GTPEF
Sbjct: 136 QILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEF 195

Query: 196 MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
           MAPE+YEEEYNELVDIYSFGMC+LEMVT EYPY+EC +P QIYKKV SG KP +L KV D
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255

Query: 256 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP----------LRLPNLVPE 305
           P V+QF+EKC+  AS RL A ELLKDPFL  D   DLV  P          LR P L   
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFLQVD---DLVFCPGDGDYSLMNYLRQPYLEHA 312

Query: 306 VMNLAH-----SEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEK 360
             N++      SE    D     +    D   K++    F   E + L  N + T++G K
Sbjct: 313 YSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLG-NVDITIKGRK 371

Query: 361 NDDDTVSLTLRIGDKSG 377
           ++D ++ L LRI D  G
Sbjct: 372 SEDGSIFLRLRIADNDG 388

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1

 Score =  421 bits (1082), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 209/374 (55%), Positives = 267/374 (71%), Gaps = 17/374 (4%)

Query: 14  EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL 73
           E EF+E DP+ RYGRY E+LGKGAFKTVYK FD+++G+EVAWNQ+ + D++++ D LERL
Sbjct: 15  EPEFAEVDPTARYGRYTEVLGKGAFKTVYKAFDQLEGLEVAWNQIKVGDILRNNDDLERL 74

Query: 74  YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
            SEV LLK+LKH+NIIKFYNSW+D  N  IN ITE+FTSG+LRQYR KHK VD++A+K W
Sbjct: 75  RSEVRLLKTLKHKNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALKKW 134

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGT 192
           +RQIL GL YLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++    +A S+IGT
Sbjct: 135 SRQILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARSAHSIIGT 194

Query: 193 PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
           PEFMAPELY+EEYNELVDIY+FGMC+LE+VT EYPY EC N AQIYKKV+ G KP+SL+K
Sbjct: 195 PEFMAPELYDEEYNELVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGEKPSSLAK 254

Query: 253 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 312
           + DP+V+ FIEKCI  AS RL A ELL DPFL  D  K  +  PL+      +    ++S
Sbjct: 255 IEDPEVRFFIEKCIAKASQRLSAQELLMDPFLRDDGEK--IFYPLQSNTKASDGAGSSNS 312

Query: 313 EPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNE---------FTLRGEKNDD 363
                 +   + + ++    + +TG++       R   +            T+  +  D 
Sbjct: 313 S-----MGYKYDRDASSMAIREHTGSFAEEHPSDRYIHSTMDPQAAAGRIITVESQMKDL 367

Query: 364 DTVSLTLRIGDKSG 377
           +T+ L LRI D +G
Sbjct: 368 NTIFLKLRIADSTG 381

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1

 Score =  418 bits (1074), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 194/272 (71%), Positives = 231/272 (84%), Gaps = 1/272 (0%)

Query: 14  EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL 73
           E EF E DP+ RYGRY E+LGKGAFK VY+ FD+++GIEVAWNQV ++D   S + L+RL
Sbjct: 9   EEEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRL 68

Query: 74  YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           YSEVHLLK+LKH++IIKFY SW+D  + TIN+ITE+FTSG+LRQYRKKHK VD++A+K W
Sbjct: 69  YSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALKKW 128

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGT 192
           +RQIL GL YLHSH+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++ +  +A SVIGT
Sbjct: 129 SRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVIGT 188

Query: 193 PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
           PEFMAPELYEE+YN LVDIY+FGMC+LE+VT EYPY+EC N AQIY+KVTSGIKPA+L  
Sbjct: 189 PEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAALLN 248

Query: 253 VTDPQVKQFIEKCIVPASLRLPALELLKDPFL 284
           VTDPQV+ FIEKCI   S RL A ELL DPFL
Sbjct: 249 VTDPQVRAFIEKCIAKVSQRLSAKELLDDPFL 280

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	394
255555709	585	kinase, putative [Ricinus communis] gi|2	0.959	0.646	0.783	1e-170
224072272	596	predicted protein [Populus trichocarpa]	0.946	0.625	0.788	1e-164
224058021	571	predicted protein [Populus trichocarpa]	0.946	0.653	0.781	1e-161
359474135	645	PREDICTED: serine/threonine-protein kina	0.939	0.573	0.763	1e-159
449452398	679	PREDICTED: serine/threonine-protein kina	0.959	0.556	0.729	1e-157
357462359	614	Serine/threonine protein kinase WNK8 [Me	0.956	0.614	0.746	1e-155
225470964	625	PREDICTED: probable serine/threonine-pro	0.931	0.587	0.735	1e-151
351724041	618	with no lysine kinase 8 [Glycine max] gi	0.934	0.595	0.737	1e-151
297742418	596	unnamed protein product [Vitis vinifera]	0.862	0.570	0.741	1e-149
449433018	663	PREDICTED: probable serine/threonine-pro	0.916	0.544	0.737	1e-149

>gi|255555709|ref|XP_002518890.1| kinase, putative [Ricinus communis] gi|223541877|gb|EEF43423.1| kinase, putative [Ricinus communis]

 Score =  604 bits (1557), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 301/384 (78%), Positives = 334/384 (86%), Gaps = 6/384 (1%)

Query: 7   FTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS 66
           F   + ++ EF EKDP+ RY RYDE+LGKGAFKTVYK FDE++GIEVAWNQV++EDV+QS
Sbjct: 3   FCSRDDDDSEFEEKDPTGRYVRYDEVLGKGAFKTVYKAFDEINGIEVAWNQVSVEDVLQS 62

Query: 67  PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 126
           PDQLERLYSEVHLLKSLKHENI+KFYNSWVDD N+TINMITELFTSGSLR+YRKKHKNVD
Sbjct: 63  PDQLERLYSEVHLLKSLKHENIMKFYNSWVDDNNKTINMITELFTSGSLRKYRKKHKNVD 122

Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
           +KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN+FVNGNNGEVKIGDLGLA VMQQPTA
Sbjct: 123 IKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNVFVNGNNGEVKIGDLGLATVMQQPTA 182

Query: 187 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
           RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPY+ECKNPAQIYKKVTSGIK
Sbjct: 183 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYSECKNPAQIYKKVTSGIK 242

Query: 247 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
           PASL KV DP VK+FIEKCIVPAS+RLPALELLKDPFL T+NPK+LV   L LP+L+ + 
Sbjct: 243 PASLCKVNDPLVKRFIEKCIVPASMRLPALELLKDPFLATENPKELVFASLHLPDLMLKQ 302

Query: 307 MNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGEKNDDDT 365
           ++   SE +PMDID NHKK+S  SC KS +    F T E QRLT  NEF LRGEKNDD+T
Sbjct: 303 VSRGQSESYPMDIDSNHKKLSVGSCTKSMDESLHFSTSEFQRLTVKNEFRLRGEKNDDNT 362

Query: 366 VSLTLRIGDKSGKRICGAINSCFF 389
           +SLTLRI D+     CG + +  F
Sbjct: 363 ISLTLRIVDR-----CGGVKNIHF 381

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224072272|ref|XP_002303683.1| predicted protein [Populus trichocarpa] gi|222841115|gb|EEE78662.1| predicted protein [Populus trichocarpa]

 Score =  585 bits (1508), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 299/379 (78%), Positives = 324/379 (85%), Gaps = 6/379 (1%)

Query: 1   MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI 60
           MD GS    SE   G F+EKDP+ RY R DE LGKGAFKTVYK FDEVDGIEVAWNQVNI
Sbjct: 1   MDFGS---LSEDGGGVFAEKDPTGRYIRNDEFLGKGAFKTVYKAFDEVDGIEVAWNQVNI 57

Query: 61  EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
           EDV+QS  QLERLYSEVHLLKSLKHENIIKFY+SWVDD N+TIN+ITELFTSGS+RQYRK
Sbjct: 58  EDVLQSSQQLERLYSEVHLLKSLKHENIIKFYSSWVDDKNKTINIITELFTSGSMRQYRK 117

Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
           KHK VDMKAIKNWARQILRGLHYLH+H+PPIIHRDLKCDNIFVNGN GEVKIGDLGLAIV
Sbjct: 118 KHKTVDMKAIKNWARQILRGLHYLHTHSPPIIHRDLKCDNIFVNGNTGEVKIGDLGLAIV 177

Query: 181 MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
           MQQP ARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY+ECKNPAQIYKK
Sbjct: 178 MQQPIARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYSECKNPAQIYKK 237

Query: 241 VTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
           V+SGIKPASL KV+D QVK FIEKC+VPAS RLPA+ELLKDPFL T+N K+LV   L+LP
Sbjct: 238 VSSGIKPASLGKVSDHQVKVFIEKCLVPASTRLPAIELLKDPFLATENSKELVSSSLQLP 297

Query: 301 NLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGE 359
           NL+   ++L  SE H MDID   KK+S  SC KS N    F TLEL R TENNEF LRG 
Sbjct: 298 NLISRQVHLLQSESHLMDIDC--KKLSVGSCTKSINESPQFSTLELSRFTENNEFRLRGA 355

Query: 360 KNDDDTVSLTLRIGDKSGK 378
           KN+D+TVSLTLRI D  G+
Sbjct: 356 KNNDNTVSLTLRIADPCGR 374

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224058021|ref|XP_002299436.1| predicted protein [Populus trichocarpa] gi|222846694|gb|EEE84241.1| predicted protein [Populus trichocarpa]

 Score =  573 bits (1477), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 296/379 (78%), Positives = 324/379 (85%), Gaps = 6/379 (1%)

Query: 1   MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI 60
           MD GS    SE   GEF+EKDP+ RY RYDEILGKGAFKTVYK FDEVDGIEVAWNQV+I
Sbjct: 1   MDFGSF---SEDGCGEFAEKDPTGRYVRYDEILGKGAFKTVYKAFDEVDGIEVAWNQVDI 57

Query: 61  EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
           EDV+QS  QLERLYSEVHLLKSLKHENIIKFYNSWVDD N+TINMITEL TSG+LRQYRK
Sbjct: 58  EDVLQSSQQLERLYSEVHLLKSLKHENIIKFYNSWVDDKNKTINMITELLTSGNLRQYRK 117

Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
           KHK VDMKAIKNWARQILRGL YLH+ +P IIHRDLKCDNI VNGNNGEVKIGDLGLAIV
Sbjct: 118 KHKTVDMKAIKNWARQILRGLQYLHTRSPRIIHRDLKCDNILVNGNNGEVKIGDLGLAIV 177

Query: 181 MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
           MQQP ARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY+ECKNPAQIYKK
Sbjct: 178 MQQPIARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYSECKNPAQIYKK 237

Query: 241 VTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
           VTSGIKPASL KV D QVK+FIEKC+VPAS+RL A++LLKDPFL T+N K++V    +LP
Sbjct: 238 VTSGIKPASLVKVNDLQVKEFIEKCLVPASVRLSAIDLLKDPFLATENSKEVVSSLSQLP 297

Query: 301 NLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGE 359
           N++ + ++L  SE H MDID   K +S  SC KS N    FLTLEL+R TENNEF LR E
Sbjct: 298 NVICKQVHLPQSESHHMDIDC--KMLSLGSCPKSINESPQFLTLELRRFTENNEFRLRAE 355

Query: 360 KNDDDTVSLTLRIGDKSGK 378
           KNDD+TVSLTLRI D  G+
Sbjct: 356 KNDDNTVSLTLRIADPCGR 374

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359474135|ref|XP_002273005.2| PREDICTED: serine/threonine-protein kinase WNK8-like [Vitis vinifera]

 Score =  568 bits (1464), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 288/377 (76%), Positives = 322/377 (85%), Gaps = 7/377 (1%)

Query: 9   KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD 68
           K ET++ +F EKDP+ RY RY+E LGKGAFKTVYK FDEVDGIEVAW QV IED++QSP 
Sbjct: 5   KFETDDSDFEEKDPTGRYVRYNEFLGKGAFKTVYKAFDEVDGIEVAWGQVEIEDLLQSPQ 64

Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           QLERLYSEVHLLKSLKH+NIIKFYNSWVDDTN+TIN+ITELFTSGSLRQYRKKHKNVD+K
Sbjct: 65  QLERLYSEVHLLKSLKHDNIIKFYNSWVDDTNKTINLITELFTSGSLRQYRKKHKNVDLK 124

Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
           AIKNWA+QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS
Sbjct: 125 AIKNWAKQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 184

Query: 189 VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248
           VIGTPEFMAPELYEEEYNELVDIYSFGMCILE+VTCEYPYNECKNPAQIYKKV+SGIKPA
Sbjct: 185 VIGTPEFMAPELYEEEYNELVDIYSFGMCILELVTCEYPYNECKNPAQIYKKVSSGIKPA 244

Query: 249 SLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVC------DPLRLPNL 302
           SL KV+DPQVKQFIEKC+VPASLRL A ELLKD F  T+N K+ V       D L+  N 
Sbjct: 245 SLGKVSDPQVKQFIEKCLVPASLRLSAQELLKDAFFATENSKEPVYNHMHVDDSLQSSNF 304

Query: 303 VPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGT-WFLTLELQRLTENNEFTLRGEKN 361
           +P +MNL   E  PMD+D N+KK+S  +  KS +GT  F  L+ +R  +NN F LRGEK 
Sbjct: 305 MPNLMNLPKPELQPMDMDPNYKKLSVSTHMKSISGTPHFRALQFERFNKNNLFKLRGEKI 364

Query: 362 DDDTVSLTLRIGDKSGK 378
           DD+++S+TL I D  G+
Sbjct: 365 DDNSISMTLHIADPCGR 381

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452398|ref|XP_004143946.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus] gi|449529646|ref|XP_004171809.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus]

 Score =  559 bits (1441), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 280/384 (72%), Positives = 312/384 (81%), Gaps = 6/384 (1%)

Query: 1   MDCGSGFT---KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQ 57
           + CGS       SE ++    EKDPS RY RYDEILGKGAFKTVYK FDEV GIEVAW+Q
Sbjct: 47  LSCGSDLIMSGNSEADDRGIVEKDPSGRYIRYDEILGKGAFKTVYKAFDEVGGIEVAWSQ 106

Query: 58  VNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 117
           V+IEDV+QSP+QL+RLYSEVHLLKSLKHENIIKFY+ WVDD ++TINMITELFTSGSLRQ
Sbjct: 107 VDIEDVLQSPEQLQRLYSEVHLLKSLKHENIIKFYSYWVDDKHKTINMITELFTSGSLRQ 166

Query: 118 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177
           YRKKH+ VD+KA KNWARQILRGL YLH HNPPIIHRDLKCDNIFVNGN GEVKIGDLGL
Sbjct: 167 YRKKHRKVDLKAFKNWARQILRGLTYLHGHNPPIIHRDLKCDNIFVNGNTGEVKIGDLGL 226

Query: 178 AIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237
           AIVMQQPTARSVIGTPEFMAPELY+E+YNELVDIYSFGMC+LE+VTCEYPYNECKN AQI
Sbjct: 227 AIVMQQPTARSVIGTPEFMAPELYDEDYNELVDIYSFGMCMLEIVTCEYPYNECKNSAQI 286

Query: 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPL 297
           +KKVTSGIKPASL KV DPQVKQFIEKC+VPAS RLPA ELLKDPFL  ++PKD   +  
Sbjct: 287 FKKVTSGIKPASLEKVLDPQVKQFIEKCLVPASTRLPASELLKDPFLAAESPKDNSSELS 346

Query: 298 RLPNLVPEVMNLAHSEPHPMDIDLNHKKVSAD--SCAKSNTG-TWFLTLELQRLTENNEF 354
           R  N   + +N      HPM+ D N  K+S    S  KSN G + F T ELQRLTENNE 
Sbjct: 347 RSLNEHFKSVNPPLLGSHPMETDHNCTKLSGSVASSVKSNNGISHFSTQELQRLTENNEL 406

Query: 355 TLRGEKNDDDTVSLTLRIGDKSGK 378
           TL+G+  D +T+S  LRI +  GK
Sbjct: 407 TLKGDMTDHNTMSFHLRIAELYGK 430

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357462359|ref|XP_003601461.1| Serine/threonine protein kinase WNK8 [Medicago truncatula] gi|355490509|gb|AES71712.1| Serine/threonine protein kinase WNK8 [Medicago truncatula]

 Score =  555 bits (1430), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 286/383 (74%), Positives = 320/383 (83%), Gaps = 6/383 (1%)

Query: 10  SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
           SE ++    EKDP+ RY RYDE+LGKGAFKTVYK FDEVDGIEVAWNQ++IEDVMQSP  
Sbjct: 3   SEIDDVGVVEKDPTLRYARYDEMLGKGAFKTVYKAFDEVDGIEVAWNQISIEDVMQSPQN 62

Query: 70  LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA 129
           LE+LYSEVHLLKSLKHENIIK Y+SWVD+ +  INMITELFTSGSLRQYRKKHKNVDMKA
Sbjct: 63  LEKLYSEVHLLKSLKHENIIKMYSSWVDEKSSNINMITELFTSGSLRQYRKKHKNVDMKA 122

Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
           IKNWARQILRGL +LHSHNPP+IHRDLKCDNIFVNGNNG+VKIGDLGLAIVMQQPTARSV
Sbjct: 123 IKNWARQILRGLCFLHSHNPPVIHRDLKCDNIFVNGNNGQVKIGDLGLAIVMQQPTARSV 182

Query: 190 IGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249
           IGTPEFMAPELYEEEYNELVD+YSFGMCILEM+TCEYPY+ECKNPAQIYKKVTSGIKPAS
Sbjct: 183 IGTPEFMAPELYEEEYNELVDVYSFGMCILEMITCEYPYSECKNPAQIYKKVTSGIKPAS 242

Query: 250 LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNL 309
           L++V DP+VKQFIEKC+VPAS+RLPA ELLKDPFL T N K++  D L LPN   + +N 
Sbjct: 243 LARVNDPEVKQFIEKCLVPASMRLPASELLKDPFLATGNTKEIYHDNLLLPNPPSKSLNP 302

Query: 310 AHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTL--ELQRLTENNEFTLRGEKNDDDTVS 367
              EPHPM+ID N K  S  S  + +  T  ++   ++ R TENNEF LRGEKN D T+S
Sbjct: 303 PTCEPHPMEIDSNVKHTSPASTVERDKETSQVSSNHDILRKTENNEFRLRGEKNADRTIS 362

Query: 368 LTLRIGDKSGKRICGAINSCFFF 390
           LTLRI D +G    GA N  F F
Sbjct: 363 LTLRIADANG----GARNIHFPF 381

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225470964|ref|XP_002266888.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Vitis vinifera]

 Score =  541 bits (1395), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 270/367 (73%), Positives = 314/367 (85%)

Query: 11  ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
           + +E  + EKDP+ RY R+ EILGKGAFKTVYK FDEVDGIE+AWNQV I+DV++SP+ L
Sbjct: 6   DEDEAAYVEKDPTGRYVRFKEILGKGAFKTVYKAFDEVDGIEIAWNQVKIDDVLRSPEDL 65

Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
           E+LYSEVHLLKSLKHENIIKFYNSWVDD  +T+NMITELFTSGSLRQYRKKHKNVDMKAI
Sbjct: 66  EKLYSEVHLLKSLKHENIIKFYNSWVDDKKKTVNMITELFTSGSLRQYRKKHKNVDMKAI 125

Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
           KNWARQ+LRGL YLHSHNPPIIHRDLKCDNIFVNGN+GEVKIGDLGLAIVMQQPTARSVI
Sbjct: 126 KNWARQVLRGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIVMQQPTARSVI 185

Query: 191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
           GTPEFMAPELYEEEYNELVDIYSFGMC+LEMVT EYPYNECKNPAQIYKKVTSGIKPASL
Sbjct: 186 GTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTFEYPYNECKNPAQIYKKVTSGIKPASL 245

Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLA 310
            KVTD Q+K+FI KC+ PAS RLPA ELLKDPF  ++NPK+ +  PL+LP+  P+ + L+
Sbjct: 246 CKVTDLQIKEFIVKCLAPASERLPAKELLKDPFFQSENPKEPIRVPLQLPSRSPKSIILS 305

Query: 311 HSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTL 370
            S P  MDID +H ++S+ +  ++N    F  LE QR+ +++EF LR +K +D+++SLTL
Sbjct: 306 KSGPFSMDIDPDHPQLSSSTSTENNGSPDFPVLEFQRMYKSSEFRLRAKKINDNSISLTL 365

Query: 371 RIGDKSG 377
           R  D  G
Sbjct: 366 RTVDSYG 372

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351724041|ref|NP_001236020.1| with no lysine kinase 8 [Glycine max] gi|225348645|gb|ACN87284.1| with no lysine kinase [Glycine max]

 Score =  539 bits (1389), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 275/373 (73%), Positives = 313/373 (83%), Gaps = 5/373 (1%)

Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 78
           EKDP+ RY RYDE+LGKGAFKTVYK FDEVDGIEVAWN++ +EDV+Q+P QL +LYSEVH
Sbjct: 8   EKDPTSRYARYDELLGKGAFKTVYKAFDEVDGIEVAWNRIGVEDVVQTPQQLGKLYSEVH 67

Query: 79  LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
           LLKSLKH+N+IK YNSWVDDT  TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL
Sbjct: 68  LLKSLKHDNVIKLYNSWVDDTAGTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 127

Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAP 198
           RGL +LHS +PPI+HRDLKCDNIFVNGN+G VKIGDLGLAIVMQQPTARSVIGTPEFMAP
Sbjct: 128 RGLCFLHSQSPPIVHRDLKCDNIFVNGNSGLVKIGDLGLAIVMQQPTARSVIGTPEFMAP 187

Query: 199 ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
           ELYEEEYNELVDIYSFGMCILEMVTCEYPY+ECKNPAQIYKKVTSGIKPA+L+KV DP+V
Sbjct: 188 ELYEEEYNELVDIYSFGMCILEMVTCEYPYSECKNPAQIYKKVTSGIKPAALAKVNDPEV 247

Query: 259 KQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMD 318
           KQFIEKC+VPAS+RL A ELLKDPFL T+N K++  D L+LPN   +++NL   EPHPM+
Sbjct: 248 KQFIEKCLVPASMRLSASELLKDPFLATENTKEINHDTLQLPNPHIKLVNLPKCEPHPME 307

Query: 319 IDLNHKKVS-ADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSG 377
           ID   ++ S   S  +    +     +L R+T+NN+  LRGEKN + T+SLTLRI D  G
Sbjct: 308 IDSYSRRTSPGSSMGRIEETSQVSFFDLVRMTDNNKLMLRGEKNAESTISLTLRIPDACG 367

Query: 378 KRICGAINSCFFF 390
               GA N  F F
Sbjct: 368 ----GARNIHFPF 376

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297742418|emb|CBI34567.3| unnamed protein product [Vitis vinifera]

 Score =  535 bits (1379), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 273/368 (74%), Positives = 304/368 (82%), Gaps = 28/368 (7%)

Query: 12  TEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE 71
           T++ +F EKDP+ RY RY+E LGKGAFKTVYK FDEVDGIEVAW QV IED++QSP QLE
Sbjct: 147 TDDSDFEEKDPTGRYVRYNEFLGKGAFKTVYKAFDEVDGIEVAWGQVEIEDLLQSPQQLE 206

Query: 72  RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK 131
           RLYSEVHLLKSLKH+NIIKFYNSWVDDTN+TIN+ITELFTSGSLRQYRKKHKNVD+KAIK
Sbjct: 207 RLYSEVHLLKSLKHDNIIKFYNSWVDDTNKTINLITELFTSGSLRQYRKKHKNVDLKAIK 266

Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 191
           NWA+QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG
Sbjct: 267 NWAKQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 326

Query: 192 TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
           TPEFMAPELYEEEYNELVDIYSFGMCILE+VTCEYPYNECKNPAQIYKKV+SGIKPASL 
Sbjct: 327 TPEFMAPELYEEEYNELVDIYSFGMCILELVTCEYPYNECKNPAQIYKKVSSGIKPASLG 386

Query: 252 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAH 311
           KV+DPQVKQFIEKC+VPASLRL A ELLKD F  T+N K+                    
Sbjct: 387 KVSDPQVKQFIEKCLVPASLRLSAQELLKDAFFATENSKE-------------------- 426

Query: 312 SEPHPMDIDLNHKKVSADSCAKSNTGT-WFLTLELQRLTENNEFTLRGEKNDDDTVSLTL 370
               P+ +   HK +S  +  KS +GT  F  L+ +R  +NN F LRGEK DD+++S+TL
Sbjct: 427 ----PLSVS-THKSMS--THMKSISGTPHFRALQFERFNKNNLFKLRGEKIDDNSISMTL 479

Query: 371 RIGDKSGK 378
            I D  G+
Sbjct: 480 HIADPCGR 487

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449433018|ref|XP_004134295.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Cucumis sativus]

 Score =  535 bits (1377), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 267/362 (73%), Positives = 310/362 (85%), Gaps = 1/362 (0%)

Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
           +EKDP+ RY RYDEILG+GAFKTVYK FDEVDGIEVAWNQV I+  +QSP+ LE+LYSEV
Sbjct: 8   AEKDPTGRYVRYDEILGRGAFKTVYKAFDEVDGIEVAWNQVRIDGFLQSPEDLEKLYSEV 67

Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
           HLLKSLKHENIIKFYNSWVDD  +T+NMITELFTSGSLRQYRKKHK+VDMKAIKNWARQI
Sbjct: 68  HLLKSLKHENIIKFYNSWVDDKKKTVNMITELFTSGSLRQYRKKHKHVDMKAIKNWARQI 127

Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMA 197
           LRGL YLHSH+PPIIHRDLK DNIF+NGN+GEVKIGDLGLAIVMQQPTARSVIGTPEFMA
Sbjct: 128 LRGLVYLHSHDPPIIHRDLKGDNIFINGNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMA 187

Query: 198 PELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
           PELYEEEYNELVD+YSFGMC+LEMVT EYPY+ECKNPAQI++KVTSGIKPASL+KV+DP+
Sbjct: 188 PELYEEEYNELVDVYSFGMCMLEMVTFEYPYSECKNPAQIFRKVTSGIKPASLAKVSDPR 247

Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPM 317
             +FI KC+VP   RL A ELLKD FL  +NPK+   +PL+L N V + +NL  S P  M
Sbjct: 248 TMEFINKCLVPVHERLSAKELLKDSFLQVENPKESARNPLQLSNQVSKSINLPKSGPISM 307

Query: 318 DIDLNHKKVSADSCAKSNTGT-WFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKS 376
           DID++ K  S  + A+SN+G+  F  +E Q + +NNEF LRG KNDD++V+LTLRI D +
Sbjct: 308 DIDIDQKIHSLSTYAESNSGSPRFPVVEFQTMNKNNEFRLRGNKNDDNSVALTLRIADSN 367

Query: 377 GK 378
           G+
Sbjct: 368 GR 369

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	394
TAIR|locus:2165790	563	WNK8 "with no lysine (K) kinas	0.967	0.676	0.695	1.1e-140
TAIR|locus:2019404	524	WNK10 "with no lysine (K) kina	0.923	0.694	0.679	7.3e-130
TAIR|locus:2028521	557	WNK7 [Arabidopsis thaliana (ta	0.921	0.651	0.642	2.7e-123
TAIR|locus:2093994	567	WNK6 "with no lysine (K) kinas	0.923	0.641	0.636	5.7e-123
TAIR|locus:2114845	700	WNK1 "with no lysine (K) kinas	0.715	0.402	0.696	1.6e-113
TAIR|locus:504955638	516	WNK3 "with no lysine (K) kinas	0.697	0.532	0.703	8e-110
TAIR|locus:2182039	492	WNK9 [Arabidopsis thaliana (ta	0.703	0.563	0.678	6.5e-106
TAIR|locus:2098242	549	WNK5 "with no lysine (K) kinas	0.738	0.530	0.641	3.8e-101
TAIR|locus:2161278	571	WNK4 "with no lysine (K) kinas	0.690	0.476	0.633	3.3e-95
TAIR|locus:2176135	314	AT5G55560 [Arabidopsis thalian	0.738	0.926	0.577	8.3e-90

TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1376 (489.4 bits), Expect = 1.1e-140, P = 1.1e-140
 Identities = 272/391 (69%), Positives = 306/391 (78%)

Query:     1 MDCGSGFTK--SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV 58
             M  GSGF    S  EE +F+EKDPS RY RYD++LG+GAFKTVYK FDEVDGIEVAWN V
Sbjct:     1 MASGSGFLGQISSMEEADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLV 60

Query:    59 NIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY 118
             +IEDVMQ P QLERLYSEVHLLK+LKHENIIK + SWVD+ N+TINMITELFTSGSLR Y
Sbjct:    61 SIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVY 120

Query:   119 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
             RKKH+ VD KAIKNWARQIL+GL+YLHS NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA
Sbjct:   121 RKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLA 180

Query:   179 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
              V+QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPYNEC+N AQIY
Sbjct:   181 TVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIY 240

Query:   239 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
             KKVTS IKP SL KV DPQV+QFIEKC++PAS R  ALEL KDPFL  D  KD     L 
Sbjct:   241 KKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSAL--LA 298

Query:   299 LPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRG 358
               +   + +     E  PMD+D N  K    S + +    W  T+ELQR+ EN EF LRG
Sbjct:   299 SSSTSSKYVRPPQLEHLPMDVDHNENK----SVSSNEDYPWSQTIELQRIAENKEFRLRG 354

Query:   359 EKNDDDTVSLTLRIGDKSGKRICGAINSCFF 389
             E++DD T S+ LRI D SGK  C  ++  F+
Sbjct:   355 ERSDDVTASMVLRIADPSGK--CRIVHFAFY 383

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0006468 "protein phosphorylation" evidence=IDA;TAS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0048573 "photoperiodism, flowering" evidence=IMP

GO:0005634 "nucleus" evidence=IDA

GO:0009911 "positive regulation of flower development" evidence=IMP

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA;IMP

GO:0009909 "regulation of flower development" evidence=IMP

GO:0006865 "amino acid transport" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0016926 "protein desumoylation" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0050665 "hydrogen peroxide biosynthetic process" evidence=RCA

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1274 (453.5 bits), Expect = 7.3e-130, P = 7.3e-130
 Identities = 250/368 (67%), Positives = 286/368 (77%)

Query:    13 EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
             EE +F +KDP+ RY RY+++LG+GAFKTVYK FDEV+GIEVAWN ++IEDV+Q P QL+R
Sbjct:     2 EEADFVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDR 61

Query:    73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN 132
             LYSEVHLL SLKH+NIIK + SWVDD N++INMITELFTSGSL  YRKKH+ VD KAI N
Sbjct:    62 LYSEVHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMN 121

Query:   133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
             WARQIL+GLHYLHS  PP+IHRDLKCDNIFVNGN G+VKIGDLGLA VMQQPTARSVIGT
Sbjct:   122 WARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGT 181

Query:   193 PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
             PEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY EC+N AQIYKKVTSGIKP SLSK
Sbjct:   182 PEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSK 241

Query:   253 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 312
             V DPQVKQFIEKC++PA  R  ALELLKD  L  D  KD            P +      
Sbjct:   242 VDDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFKPAMP--PQC 299

Query:   313 EPHPMDIDLN-HKKVSADSCAKSNTGTWFL-TLELQRLTENNEFTLRGEKNDDDTVSLTL 370
             E  PMD++   +  VS  S AKS+     L T+E+QR+ E+ EF L GE+ DD   S+ L
Sbjct:   300 EYRPMDVEYKKNTSVSICSSAKSSQECALLQTMEVQRVAESTEFKLSGERRDDVAASMAL 359

Query:   371 RIGDKSGK 378
             RI   SG+
Sbjct:   360 RIAGSSGQ 367

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0003700 "sequence-specific DNA binding transcription factor activity" evidence=ISS

TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)]

 Score = 1212 (431.7 bits), Expect = 2.7e-123, P = 2.7e-123
 Identities = 244/380 (64%), Positives = 297/380 (78%)

Query:    11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
             E  + E  E DP+CRY RY E++GKGA KTV+KGFDEVDGIEVAWNQV I+D++QSPD L
Sbjct:    12 EPPDPEVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCL 71

Query:    71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
             ERLYSEV LLKSLKH+NII+FYNSW+DD N+T+N+ITELFTSGSLRQYRKKH+ V+MKA+
Sbjct:    72 ERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAV 131

Query:   131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
             K WARQIL GL YLHS +PPIIHRD+KCDNIF+NGN+GEVKIGDLGLA VM+Q  A+SVI
Sbjct:   132 KCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVI 191

Query:   191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
             GTPEFMAPELY+E YNEL DIYSFGMC+LEMVT EYPY EC+N AQIYKKV+SGIKPASL
Sbjct:   192 GTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASL 251

Query:   251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD-PLRLPNLV-PEVMN 308
             SKV DP+V +FIEKC++PAS RL A ELL D FL   N   LV + PL LP++V P+  +
Sbjct:   252 SKVKDPEVMKFIEKCLLPASERLSAEELLLDSFL---NVNGLVMNNPLPLPDIVMPKEGS 308

Query:   309 LAH----SEPHP------MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRG 358
                    SE  P      M ++L+         + +N+GT    +E++R    N F L+G
Sbjct:   309 FGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSGT--NCIEVRRAKRGNFFVLKG 366

Query:   359 EKNDDDTVSLTLRIGDKSGK 378
             E+ND+++VSL LRI D++G+
Sbjct:   367 EENDENSVSLILRIVDENGR 386

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1209 (430.6 bits), Expect = 5.7e-123, P = 5.7e-123
 Identities = 242/380 (63%), Positives = 291/380 (76%)

Query:    11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
             E  + E  E DP+ RY RY E++GKGAFKTVYK FDEVDGIEVAWNQV I+DV+QSP+ L
Sbjct:    12 EPPDPEVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCL 71

Query:    71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
             ERLYSEV LLKSLKH NII+FYNSW+DD N+T+N+ITELFTSGSLR YRKKH+ V+MKA+
Sbjct:    72 ERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAV 131

Query:   131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
             KNWARQIL GL YLH   PPIIHRDLKCDNIF+NGN+GEVKIGDLGLA VM+Q  A+SVI
Sbjct:   132 KNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVI 191

Query:   191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
             GTPEFMAPELY+E YNEL DIYSFGMC+LEMVT +YPY ECKN AQIYKKV+SGIKPASL
Sbjct:   192 GTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASL 251

Query:   251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV-PE---- 305
             S+V DP+VKQFIEKC++PAS RL A ELL DPFL  +     + +PL LP++V P+    
Sbjct:   252 SRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLT--MNNPLPLPDIVMPKEGAF 309

Query:   306 ----VMNLAHSEPHP---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRG 358
                 +M+       P   + IDL+            N+G+    +E++R    N F L+G
Sbjct:   310 GDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSGS--RCIEVRRAKRGNFFVLKG 367

Query:   359 EKNDDDTVSLTLRIGDKSGK 378
             E+ND+ +VSL LRI D++G+
Sbjct:   368 EENDEQSVSLILRIVDENGR 387

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1071 (382.1 bits), Expect = 1.6e-113, Sum P(2) = 1.6e-113
 Identities = 197/283 (69%), Positives = 234/283 (82%)

Query:    11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
             E +  EF E DP+ RYGRY+E+LGKGA KTVY+ FDE +GIEVAWNQV + D +QSP+ L
Sbjct:     8 EPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL 67

Query:    71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
             ERLY E+HLLK+LKH+NI+KFY SWVD  NR IN +TELFTSG+LRQYR +HK V+++A+
Sbjct:    68 ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAM 127

Query:   131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
             K+W RQILRGLHYLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++++  A   +
Sbjct:   128 KHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187

Query:   191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
             GTPEFMAPE+YEE YNELVDIYSFGMCILEMVT +YPY+EC +PAQIYKKV SG KP +L
Sbjct:   188 GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDAL 247

Query:   251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL-VTDNPKDL 292
              KV DP+VK FIEKC+   SLR+ A ELL DPFL + D   DL
Sbjct:   248 YKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDL 290

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007623 "circadian rhythm" evidence=IEP

GO:0016020 "membrane" evidence=IDA

TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1053 (375.7 bits), Expect = 8.0e-110, Sum P(2) = 8.0e-110
 Identities = 195/277 (70%), Positives = 235/277 (84%)

Query:     9 KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD 68
             ++ +EE EF E DP+ RYGRY E+LGKGAFK VY+ FD+++GIEVAWNQV ++D   S +
Sbjct:     5 ENNSEE-EFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSE 63

Query:    69 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
              L+RLYSEVHLLK+LKH++IIKFY SW+D  + TIN+ITE+FTSG+LRQYRKKHK VD++
Sbjct:    64 DLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLR 123

Query:   129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TAR 187
             A+K W+RQIL GL YLHSH+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++ +  +A 
Sbjct:   124 ALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAH 183

Query:   188 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
             SVIGTPEFMAPELYEE+YN LVDIY+FGMC+LE+VT EYPY+EC N AQIY+KVTSGIKP
Sbjct:   184 SVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKP 243

Query:   248 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 284
             A+L  VTDPQV+ FIEKCI   S RL A ELL DPFL
Sbjct:   244 AALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFL 280

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)]

 Score = 1048 (374.0 bits), Expect = 6.5e-106, P = 6.5e-106
 Identities = 188/277 (67%), Positives = 229/277 (82%)

Query:    11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
             E++  E+ E DP+ RYGRY+E+LGKG+ KTVY+GFDE  GIEVAWNQV + D +QSP +L
Sbjct:     9 ESDYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQEL 68

Query:    71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
             ERLY E+HLLK+LKH++I+KFY SWVD  NR IN +TE+FTSG+LRQYR KHK V+++A+
Sbjct:    69 ERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAV 128

Query:   131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
             KNW RQILRGL+YLH+H+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA  +Q   A   +
Sbjct:   129 KNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHCV 188

Query:   191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
             GTPEFMAPE+Y+EEYN+LVDIYSFGMC+LEMVT +YPY+EC +PAQIYK+V SG KP  L
Sbjct:   189 GTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDGL 248

Query:   251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTD 287
              KV DP+V+ FIEKC+   SLRL A ELL D FL  D
Sbjct:   249 DKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCID 285

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1003 (358.1 bits), Expect = 3.8e-101, P = 3.8e-101
 Identities = 190/296 (64%), Positives = 234/296 (79%)

Query:    17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
             + E DPS RYGR+ E+LGKGA KTVYK FD+V G+EVAWNQV + +V +SP+ L+RLYSE
Sbjct:    15 YVETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRSPEPLQRLYSE 74

Query:    77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
             VHLLK+L HE+II++  SW+D   RT N ITELFTSG+LR+YR+K++ VD++AIK+WARQ
Sbjct:    75 VHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQ 134

Query:   137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEF 195
             IL GL YLH H+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA +++    A SVIGTPEF
Sbjct:   135 ILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEF 194

Query:   196 MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
             MAPELYEE+YNELVDIYSFGMC+LEM+T EYPY+EC NPAQIYKKVTSG  P S   +  
Sbjct:   195 MAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQH 254

Query:   256 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLA 310
              + ++F+ KC+   S RLPA ELL DPFL   + +DL   PL RLP  +  + NLA
Sbjct:   255 TEAQRFVGKCLETVSRRLPAKELLADPFLAATDERDLA--PLFRLPQQLA-IQNLA 307

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0043424 "protein histidine kinase binding" evidence=IPI

GO:0048573 "photoperiodism, flowering" evidence=IMP

TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 947 (338.4 bits), Expect = 3.3e-95, P = 3.3e-95
 Identities = 173/273 (63%), Positives = 221/273 (80%)

Query:    16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
             E+ E DP+ RYGR+ EILG+GA KTVYK  DE  GIEVAW+QV +++V++S   L+RLYS
Sbjct:     8 EYVETDPTGRYGRFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYS 67

Query:    76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
             EVHLL +L H++II+FY SW+D  N T+N ITELFTSG+LRQY+ K+  +D++AIK+WAR
Sbjct:    68 EVHLLSTLNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWAR 127

Query:   136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPE 194
             QIL GL YLH H+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA +++   +A S+IGTPE
Sbjct:   128 QILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPE 187

Query:   195 FMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
             FMAPELYEE YNEL+D+YSFGMC LEM+T E+PY+EC +PAQIYKKV  G  P +  +V 
Sbjct:   188 FMAPELYEENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVG 247

Query:   255 DPQVKQFIEKCIVPASLRLPALELLKDPFLVTD 287
             D + ++FI KC+V AS R+ A ELL+DPFL +D
Sbjct:   248 DIEAQRFIGKCLVSASKRVSAKELLQDPFLASD 280

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0010260 "organ senescence" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)]

 Score = 896 (320.5 bits), Expect = 8.3e-90, P = 8.3e-90
 Identities = 172/298 (57%), Positives = 219/298 (73%)

Query:     1 MDCGSGF-TKSETEEGE--FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQ 57
             M C S    +SE ++    F E DP+ RYGRY E+LG GA K VY+ FD+ +GIEVAWNQ
Sbjct:     2 MTCASSDDNESEKDKDSESFVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQ 61

Query:    58 VNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 117
             V +      P   ERLYSEV LLK+LK+ NII  Y  W D+ N T+N ITE+ TSG+LR+
Sbjct:    62 VKLRCFSDDPAMTERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLRE 121

Query:   118 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177
             YRKKH++V M+A+K W++QIL+GL YLH+H+P IIHRDL C NIFVNGN G+VKIGDLGL
Sbjct:   122 YRKKHRHVSMRALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGL 181

Query:   178 A-IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 236
             A IV +   A S++GTPEFMAPELYEE Y E+VDIYS+GMC+LE+V+ E PY+EC + A+
Sbjct:   182 AAIVGKNHLAHSILGTPEFMAPELYEENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAK 241

Query:   237 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPF---LVTDNPKD 291
             IYK+V+ G+KP +L+KV DP+ K FIEKCI     R  A ELL DPF   ++ D+ +D
Sbjct:   242 IYKRVSKGLKPEALNKVNDPEAKAFIEKCIAQPRARPSAAELLCDPFFDGILDDDDED 299

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010260 "organ senescence" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q6EU49	WNK4_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.6361	0.9416	0.6062	yes	no
Q944Q0	WNK8_ARATH	2, ., 7, ., 1, 1, ., 1	0.685	0.9492	0.6642	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00031177 hypothetical protein (596 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	394
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-73
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-71
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-64
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-58
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-56
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-55
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-53
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-52
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-49
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-44
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-44
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-44
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-44
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-41
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-41
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-40
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-40
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-39
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-39
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-38
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-38
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-38
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-38
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-38
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-37
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-37
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-37
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-36
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-36
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-35
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-35
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-34
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-34
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-34
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-34
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-34
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-33
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-33
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-33
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-33
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-32
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-32
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-31
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-31
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-30
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-30
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-30
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-29
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-29
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-29
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-29
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-29
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-29
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-28
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-28
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-27
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-27
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-27
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-27
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-26
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-26
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-26
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-26
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-26
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-26
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-25
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-25
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-24
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-24
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-24
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-24
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-24
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-24
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-24
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-24
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-23
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-23
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-22
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-22
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-22
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-21
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-21
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-21
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-20
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-20
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-20
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-20
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-19
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-19
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-19
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-19
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-19
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-19
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-19
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-19
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-18
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-18
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-18
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-18
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-18
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-18
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-18
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-17
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-17
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-17
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-17
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-17
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-17
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-17
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-16
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-16
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-16
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-15
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-15
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-15
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-15
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-15
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-14
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-14
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-13
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-13
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-09
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-09
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.001

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  229 bits (586), Expect = 2e-73
 Identities = 96/260 (36%), Positives = 141/260 (54%), Gaps = 11/260 (4%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E+LG+G+F +VY   D+  G  +A   V +     S ++LE L  E+ +L SL+H NI++
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSG--DSEEELEALEREIRILSSLQHPNIVR 63

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
           +Y S  D+   T+N+  E  + GSL    KK   +    I+ + RQIL GL YLHS+   
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG-- 121

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEY 205
           I+HRD+K  NI V  ++G VK+ D G A  +          SV GTP +MAPE+   EEY
Sbjct: 122 IVHRDIKGANILV-DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180

Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
               DI+S G  ++EM T + P++E  NP     K+ S  +P  + +    + K F+ KC
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240

Query: 266 IVP-ASLRLPALELLKDPFL 284
           +      R  A ELL+ PFL
Sbjct: 241 LRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  223 bits (570), Expect = 5e-71
 Identities = 87/259 (33%), Positives = 132/259 (50%), Gaps = 14/259 (5%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG+G+F  VY   D+  G  VA   +  + +       ER+  E+ +LK LKH NI++
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI---KKDRERILREIKILKKLKHPNIVR 61

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            Y+ + D+    + ++ E    G L    KK   +     + + RQIL  L YLHS    
Sbjct: 62  LYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG-- 117

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPE-LYEEEYNEL 208
           I+HRDLK +NI ++  +G VK+ D GLA  +       + +GTPE+MAPE L  + Y + 
Sbjct: 118 IVHRDLKPENILLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176

Query: 209 VDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCI 266
           VDI+S G  IL E++T + P+       +++KK+     P    +    P+ K  I K +
Sbjct: 177 VDIWSLG-VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235

Query: 267 VP-ASLRLPALELLKDPFL 284
           V     RL A E L+ PF 
Sbjct: 236 VKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  204 bits (522), Expect = 6e-64
 Identities = 80/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             LG G+F TVYK   +  G  VA   +      +   + +    E+ +L+ L H NI++
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVR 62

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
             +++ D  +  + ++ E    G L  Y  +   +     K  A QILRGL YLHS+   
Sbjct: 63  LIDAFEDKDH--LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG-- 118

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE--LYEEEYN 206
           IIHRDLK +NI ++  NG VKI D GLA  +     +  + +GTP +MAPE  L    Y 
Sbjct: 119 IIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASLSKVTD--PQVKQFI 262
             VD++S G+ + E++T + P++      Q+    ++          K +    + K  I
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237

Query: 263 EKCIVP-ASLRLPALELLKDPFL 284
           +KC+    S R  A E+L+ P+ 
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  189 bits (482), Expect = 2e-58
 Identities = 79/256 (30%), Positives = 122/256 (47%), Gaps = 47/256 (18%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG+G F TVY   D+  G +VA   +  ED   S   LE L  E+ +LK L H NI+K Y
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKED---SSSLLEELLREIEILKKLNHPNIVKLY 57

Query: 93  NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
             + D+ +  + ++ E    GSL+   ++    +    I     QIL GL YLHS+   I
Sbjct: 58  GVFEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--I 113

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNE 207
           IHRDLK +NI ++ +NG+VK+ D GL+ ++       ++++GTP +MAPE+      Y+E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267
             DI+S G+ + E+                                  P++K  I K + 
Sbjct: 174 KSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199

Query: 268 P-ASLRLPALELLKDP 282
                R  A E+L+  
Sbjct: 200 KDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  184 bits (469), Expect = 5e-56
 Identities = 94/262 (35%), Positives = 147/262 (56%), Gaps = 17/262 (6%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-LERLYSEVHLLKSLKHENII 89
           E+LG G+F +VY+G +  DG   A  +V++ D  Q+  + +++L  E+ LL  L+H NI+
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           ++  +  ++ N  + +  EL   GSL +  KK+ +     I+ + RQIL GL YLH  N 
Sbjct: 66  QYLGTEREEDN--LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN- 122

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELY--EEEYN 206
             +HRD+K  NI V+  NG VK+ D G+A  V++   A+S  G+P +MAPE+   +  Y 
Sbjct: 123 -TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIE 263
              DI+S G  +LEM T + P+++ +  A ++K   S   P     LS     + K FI 
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS----DEAKDFIL 236

Query: 264 KCI-VPASLRLPALELLKDPFL 284
           KC+    SLR  A ELL+ PF+
Sbjct: 237 KCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  182 bits (464), Expect = 6e-55
 Identities = 95/282 (33%), Positives = 146/282 (51%), Gaps = 24/282 (8%)

Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
           SE DP   Y    E +G+GA   VYK  D   G EVA  ++ +          E + +E+
Sbjct: 13  SEGDPRELYKNL-EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-----QNKELIINEI 66

Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNW 133
            ++K  KH NI+ +Y+S++      + ++ E    GSL     Q   +     +  +   
Sbjct: 67  LIMKDCKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV--- 121

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
            R++L+GL YLHS N  +IHRD+K DNI ++  +G VK+ D G A  +  ++    SV+G
Sbjct: 122 CREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVG 178

Query: 192 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPAS 249
           TP +MAPE+ + ++Y   VDI+S G+  +EM   E PY   + P + ++   T GI P  
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIPPLK 237

Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
             +   P+ K F+ KC+V     R  A ELL+ PFL    PK
Sbjct: 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  176 bits (450), Expect = 4e-53
 Identities = 80/267 (29%), Positives = 139/267 (52%), Gaps = 19/267 (7%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           +Y+ I  +GKG+F  VY    + DG      ++++ +   S  + E   +EV +LK L H
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNH 58

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGL 141
            NIIK+Y S+ +     + ++ E    G L Q  KK K        + I +W  Q+   L
Sbjct: 59  PNIIKYYESFEEKGK--LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE 199
            YLHS    I+HRD+K  NIF+  +NG VK+GD G++ V+      A++V+GTP +++PE
Sbjct: 117 KYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173

Query: 200 LYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
           L + + YN   DI+S G  + E+ T ++P+ E +N  ++  K+  G +   +      ++
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKG-QYPPIPSQYSSEL 231

Query: 259 KQFIEKCIVP-ASLRLPALELLKDPFL 284
           +  +   +      R    ++L+ PF+
Sbjct: 232 RNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  175 bits (445), Expect = 2e-52
 Identities = 86/257 (33%), Positives = 141/257 (54%), Gaps = 13/257 (5%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +GKG F  VYK   +  G EVA   + +E    S ++ E++ +E+ +LK  KH NI+K
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKIINEIQILKKCKHPNIVK 61

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           +Y S++      I M  E  + GSL+   +  ++ +    I    +++L+GL YLHS+  
Sbjct: 62  YYGSYLKKDELWIVM--EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG- 118

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE-LYEEEYNE 207
            IIHRD+K  NI +  ++GEVK+ D GL+  +    AR +++GTP +MAPE +  + Y+ 
Sbjct: 119 -IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267
             DI+S G+  +E+   + PY+E      ++K  T+G       +    + K F++KC+ 
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236

Query: 268 PA-SLRLPALELLKDPF 283
                R  A +LLK PF
Sbjct: 237 KNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  165 bits (420), Expect = 9e-49
 Identities = 88/258 (34%), Positives = 142/258 (55%), Gaps = 13/258 (5%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G+GAF  VYKG +   G  VA  Q+++E +    + L+ +  E+ LLK+LKH NI+K
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVK 63

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
           +  S   +T+ ++ +I E   +GSLRQ  KK        +  +  Q+L+GL YLH     
Sbjct: 64  YIGSI--ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG-- 119

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYEEE-YNE 207
           +IHRD+K  NI     +G VK+ D G+A  +        SV+GTP +MAPE+ E    + 
Sbjct: 120 VIHRDIKAANILTTK-DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267
             DI+S G  ++E++T   PY +    A +++ V     P  L +   P++K F+ +C  
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCFQ 236

Query: 268 P-ASLRLPALELLKDPFL 284
              +LR  A +LLK P++
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  153 bits (388), Expect = 4e-44
 Identities = 90/264 (34%), Positives = 140/264 (53%), Gaps = 14/264 (5%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHE 86
           R  ++LG+GAF  VY  +D   G E+A  QV  + D  ++  ++  L  E+ LLK+L+HE
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            I+++Y    DD   +I M  E    GS++   K +  +     + + RQIL G+ YLHS
Sbjct: 65  RIVQYYGCLRDDETLSIFM--EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELY 201
           +   I+HRD+K  NI +  + G VK+GD G +     I       +SV GTP +M+PE+ 
Sbjct: 123 NM--IVHRDIKGANI-LRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 202 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
             E Y    D++S G  ++EM+T + P+ E +  A I+K  T    P   S V  P  + 
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV-SPDARN 238

Query: 261 FIEKCIVPASLRLP-ALELLKDPF 283
           F+ +  V  + + P A ELL+  F
Sbjct: 239 FLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  153 bits (388), Expect = 7e-44
 Identities = 82/265 (30%), Positives = 146/265 (55%), Gaps = 16/265 (6%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +GKG+F TV K   + DG  + W +++  + M   ++ ++L SEV++L+ LKH NI++
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEK-QQLVSEVNILRELKHPNIVR 63

Query: 91  FYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           +Y+  +D +N+T+ ++ E    G L    ++ +K+ K ++ + I     Q+L  L+  H+
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 147 HNPP---IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-L 200
            + P   ++HRDLK  NIF++ NN  VK+GD GLA ++   +  A++ +GTP +M+PE L
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182

Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
               Y+E  DI+S G  I E+     P+   +N  Q+  K+  G     +      ++ +
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASKIKEGKFR-RIPYRYSSELNE 240

Query: 261 FIEKCI-VPASLRLPALELLKDPFL 284
            I+  + V    R    ELL+ P +
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  152 bits (387), Expect = 9e-44
 Identities = 74/259 (28%), Positives = 133/259 (51%), Gaps = 15/259 (5%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG+G+   VYK   +  G   A  +++++      +  ++L  E+  L+S +   ++K Y
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDG---DEEFRKQLLRELKTLRSCESPYVVKCY 65

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPI 151
            ++       I+++ E    GSL    KK   +    +   ARQIL+GL YLH+  +  I
Sbjct: 66  GAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--I 121

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE-LYEEEYNEL 208
           IHRD+K  N+ +N + GEVKI D G++ V++       + +GT  +M+PE +  E Y+  
Sbjct: 122 IHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180

Query: 209 VDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266
            DI+S G+ +LE    ++P+      +  ++ + +  G  P+  ++   P+ + FI  C+
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240

Query: 267 VP-ASLRLPALELLKDPFL 284
                 R  A ELL+ PF+
Sbjct: 241 QKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  152 bits (386), Expect = 9e-44
 Identities = 90/267 (33%), Positives = 141/267 (52%), Gaps = 25/267 (9%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G F  VY   +   G  +A  ++ I+D    P  ++ +  E+ +L+ LKH N++K+Y
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQD--NDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
              V      I M  E  + G+L +  +  + +D   I+ +  Q+L GL YLHSH   I+
Sbjct: 66  GVEVHREKVYIFM--EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IV 121

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGTPEFMAPELY----E 202
           HRD+K  NIF+  +NG +K+GD G A+ ++  T        S+ GTP +MAPE+      
Sbjct: 122 HRDIKPANIFL-DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVK 259
           + +    DI+S G  +LEM T + P++E  N  QI   V +G KP    SL     P+ K
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL--SPEGK 238

Query: 260 QFIEKCIV--PASLRLPALELLKDPFL 284
            F+++C+   P   R  A ELL+ PF+
Sbjct: 239 DFLDRCLESDP-KKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  145 bits (367), Expect = 4e-41
 Identities = 90/264 (34%), Positives = 143/264 (54%), Gaps = 11/264 (4%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHE 86
           R  ++LG+GAF  VY  +D   G E+A  QV  + +  ++  ++  L  E+ LLK+L HE
Sbjct: 5   RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            I+++Y    D   RT+++  E    GS++   K +  +     + + RQIL G+ YLHS
Sbjct: 65  RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELY 201
           +   I+HRD+K  NI  + + G VK+GD G +     I +     +SV GTP +M+PE+ 
Sbjct: 125 NM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 202 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
             E Y    DI+S G  ++EM+T + P+ E +  A I+K  T    P     V+D   + 
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRD 240

Query: 261 FIEKCIVPASLRLPALELLKDPFL 284
           F+++  V A LR  A ELL+  F+
Sbjct: 241 FLKRIFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  145 bits (366), Expect = 6e-41
 Identities = 89/263 (33%), Positives = 141/263 (53%), Gaps = 11/263 (4%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHE 86
           R  ++LG+GAF  VY  +D   G E+A  QV  + +  ++  ++  L  E+ LLK+L+HE
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            I+++Y    D   +T+ +  E    GS++   K +  +     + + RQIL G+ YLHS
Sbjct: 65  RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELY 201
           +   I+HRD+K  NI  + + G VK+GD G +     I M     RSV GTP +M+PE+ 
Sbjct: 125 NM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 202 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
             E Y    D++S G  ++EM+T + P+ E +  A I+K  T    P   S +++   + 
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARD 240

Query: 261 FIEKCIVPASLRLPALELLKDPF 283
           F+    V A  R  A ELL+ PF
Sbjct: 241 FLGCIFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  144 bits (366), Expect = 1e-40
 Identities = 78/244 (31%), Positives = 128/244 (52%), Gaps = 14/244 (5%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +GKG F  VYK    +DG  VA  +V I ++M      +    E+ LLK L H N+IK+ 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYL 68

Query: 93  NSWVDDTNRTINMITELFTSGSLRQ----YRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
            S+++  N  +N++ EL  +G L +    ++K+ + +  + I  +  Q+   L ++HS  
Sbjct: 69  ASFIE--NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEY 205
             I+HRD+K  N+F+    G VK+GDLGL       T  A S++GTP +M+PE ++E  Y
Sbjct: 127 --IMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 206 NELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
           N   DI+S G  + EM   + P Y +  N   + KK+     P   +     +++  + +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243

Query: 265 CIVP 268
           CI P
Sbjct: 244 CINP 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  144 bits (366), Expect = 1e-40
 Identities = 85/283 (30%), Positives = 136/283 (48%), Gaps = 31/283 (10%)

Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            +   + I GKG+F  VYK  D+     VA   +++E+   + D++E +  E+  L   +
Sbjct: 2   LFTLLECI-GKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCR 57

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
              I K+Y S++  +   I M  E    GS     K  K +D   I    R++L GL YL
Sbjct: 58  SPYITKYYGSFLKGSKLWIIM--EYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYL 114

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY- 201
           H      IHRD+K  NI ++   G+VK+ D G++  +    ++  + +GTP +MAPE+  
Sbjct: 115 HEEGK--IHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171

Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASL--SKVTDP 256
           +  Y+E  DI+S G+  +E+   E P ++  +P     +V   I    P SL  +K + P
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSD-LHPM----RVLFLIPKNNPPSLEGNKFSKP 226

Query: 257 QVKQFIEKCIV--PASLRLPALELLKDPFL----VTDNPKDLV 293
             K F+  C+   P   R  A ELLK  F+     T     L+
Sbjct: 227 -FKDFVSLCLNKDPKE-RPSAKELLKHKFIKKAKKTSYLTLLI 267

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 6e-39
 Identities = 86/263 (32%), Positives = 141/263 (53%), Gaps = 11/263 (4%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHE 86
           R  ++LG+GAF  VY  +D   G E+A  QV  + D  ++  ++  L  E+ LLK+L+H+
Sbjct: 5   RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            I+++Y    D   + +++  E    GS++   K +  +     + + RQIL+G+ YLHS
Sbjct: 65  RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELY 201
           +   I+HRD+K  NI  + + G VK+GD G +     I M     +SV GTP +M+PE+ 
Sbjct: 125 NM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Query: 202 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
             E Y    D++S    ++EM+T + P+ E +  A I+K  T   KP     V+D   + 
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRD 240

Query: 261 FIEKCIVPASLRLPALELLKDPF 283
           F+++  V    R  A  LL+ PF
Sbjct: 241 FLKQIFVEEKRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  139 bits (352), Expect = 7e-39
 Identities = 79/260 (30%), Positives = 143/260 (55%), Gaps = 15/260 (5%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             +GKG+F  V+K   + D    A  Q+++   M   ++ E +  E  +L  L    II+
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAI-DEARVLAKLDSSYIIR 63

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR--QILRGLHYLHSHN 148
           +Y S++D     +N++ E   +G L +  K  +   +   + W    QIL GL +LHS  
Sbjct: 64  YYESFLDK--GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-Y 205
             I+HRD+K  N+F++  +  VKIGDLG+A ++   T  A +++GTP +++PEL E++ Y
Sbjct: 122 --ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178

Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
           NE  D+++ G+ + E  T ++P+ +  N   +  K+  G+ P  +S++   Q+ Q I++C
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQC 236

Query: 266 IVPASLRLP-ALELLKDPFL 284
           +     + P   +LL++P L
Sbjct: 237 LTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  138 bits (351), Expect = 1e-38
 Identities = 86/265 (32%), Positives = 137/265 (51%), Gaps = 26/265 (9%)

Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
            E LG+G++ +VYK   +  G  VA   V +E+ +Q       +  E+ +LK      I+
Sbjct: 8   LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE------IIKEISILKQCDSPYIV 61

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHN 148
           K+Y S+  +T+  I M  E   +GS+    K  +K +  + I     Q L+GL YLHS+ 
Sbjct: 62  KYYGSYFKNTDLWIVM--EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE-Y 205
              IHRD+K  NI +N   G+ K+ D G++  +    A+  +VIGTP +MAPE+ +E  Y
Sbjct: 120 --KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176

Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PASLSKVTD--PQVKQ 260
           N   DI+S G+  +EM   + PY++      I+      I    P +LS      P+   
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNKPPPTLSDPEKWSPEFND 231

Query: 261 FIEKCIV-PASLRLPALELLKDPFL 284
           F++KC+V     R  A++LL+ PF+
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  138 bits (350), Expect = 2e-38
 Identities = 88/268 (32%), Positives = 142/268 (52%), Gaps = 22/268 (8%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-----LERLYSEVHLLKSLKHE 86
           ++G G+F +VY G +   G  +A  QV +  V  S        L+ L  E+ LLK L+HE
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NI+++  S +D  +  +N+  E    GS+      +   +   ++N+ RQIL+GL+YLH+
Sbjct: 67  NIVQYLGSSLDADH--LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQQPTAR-SVIGTPEFMAP 198
               IIHRD+K  NI V+ N G +KI D G++       +  +   AR S+ G+  +MAP
Sbjct: 125 RG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
           E+ ++  Y    DI+S G  ++EM+T ++P+ +C     I+ K+     P   S ++  +
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASPEIPSNISS-E 239

Query: 258 VKQFIEKCIVP-ASLRLPALELLKDPFL 284
              F+EK      + R  A ELLK PFL
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  137 bits (347), Expect = 3e-38
 Identities = 84/260 (32%), Positives = 131/260 (50%), Gaps = 19/260 (7%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--EVHLLKSLKHENIIK 90
           LGKG++ +VYK     D    A  +V++     S  Q ER  +  E+ +L S+ H NII 
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDL----GSMSQKEREDAVNEIRILASVNHPNIIS 63

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKN-VDMKAIKNWARQILRGLHYLHS 146
           +  +++D     I M  E    G L +    RKK +  +  + I     Q+LRGL  LH 
Sbjct: 64  YKEAFLDGNKLCIVM--EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-Y 205
               I+HRDLK  NI +   N  VKIGDLG++ V+++  A++ IGTP +MAPE+++   Y
Sbjct: 122 QK--ILHRDLKSANILLV-ANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPY 178

Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
           +   DI+S G  + EM T   P+ E ++   +  KV  G  P  +  +    ++ FI   
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPP-IPPIYSQDLQNFIRSM 236

Query: 266 IVP-ASLRLPALELLKDPFL 284
           +     LR    ++L  P +
Sbjct: 237 LQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  137 bits (348), Expect = 3e-38
 Identities = 63/229 (27%), Positives = 99/229 (43%), Gaps = 22/229 (9%)

Query: 28  RYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
              + LG+GAF  VYKG      E    +VA   +       S ++ E    E  ++K L
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA---SEEEREEFLEEASIMKKL 58

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLH 142
            H NI++            + ++TE    G L  + +KH   + +K +   A QI +G+ 
Sbjct: 59  SHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF-----MA 197
           YL S N   +HRDL   N  V   N  VKI D GL+  +                   MA
Sbjct: 117 YLESKN--FVHRDLAARNCLV-TENLVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWMA 172

Query: 198 PELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
           PE  ++ ++    D++SFG+ + E+ T  E PY    N  ++ + +  G
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLELLEDG 220

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  137 bits (347), Expect = 5e-38
 Identities = 70/246 (28%), Positives = 109/246 (44%), Gaps = 20/246 (8%)

Query: 30  DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            + LG+GAF  VYKG          +EVA   V       S  Q+E    E  +++ L H
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVA---VKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYL 144
            N++K      ++    + ++ E    G L  Y RK    + +  + ++A QI RG+ YL
Sbjct: 61  PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE---FMAPE-L 200
            S N   IHRDL   N  V G N  VKI D GL+  +         G      +MAPE L
Sbjct: 119 ESKN--FIHRDLAARNCLV-GENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175

Query: 201 YEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
            E ++    D++SFG+ + E+ T  E PY    N  ++ + + +G +           + 
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLKNGYRLPQPPNCPPE-LY 233

Query: 260 QFIEKC 265
             + +C
Sbjct: 234 DLMLQC 239

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  136 bits (344), Expect = 1e-37
 Identities = 72/247 (29%), Positives = 113/247 (45%), Gaps = 21/247 (8%)

Query: 30  DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            + LG+GAF  VYKG      +   +EVA   V       S  Q+E    E  +++ L H
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVA---VKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHY 143
            NI+K      ++    + ++ E    G L  Y +K++  ++      ++A QI RG+ Y
Sbjct: 61  PNIVKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE---FMAPE- 199
           L S N   IHRDL   N  V G N  VKI D GL+  +       V G      +MAPE 
Sbjct: 119 LESKN--FIHRDLAARNCLV-GENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175

Query: 200 LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
           L E ++    D++SFG+ + E+ T  E PY    N A++ + +  G +           +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLKKGYRLPKPPNCPPE-L 233

Query: 259 KQFIEKC 265
            + + +C
Sbjct: 234 YKLMLQC 240

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  136 bits (343), Expect = 3e-37
 Identities = 88/270 (32%), Positives = 132/270 (48%), Gaps = 25/270 (9%)

Query: 26  YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLK 84
           Y R  E++G+GA+  VY+G     G  VA   +N++    +P D +  +  EV LL  L+
Sbjct: 3   YQRL-ELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLR 57

Query: 85  H---ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
                NI K+Y S++      I M  E    GS+R   K    +  K I    R++L  L
Sbjct: 58  QSQPPNITKYYGSYLKGPRLWIIM--EYAEGGSVRTLMKAGP-IAEKYISVIIREVLVAL 114

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE 199
            Y+H     +IHRD+K  NI V  N G VK+ D G+A ++ Q +++  + +GTP +MAPE
Sbjct: 115 KYIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE 171

Query: 200 LYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-KVTDP 256
           +  E   Y+   DI+S G+ I EM T   PY      A     +    KP  L       
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPY--SDVDAFRAMMLIPKSKPPRLEDNGYSK 229

Query: 257 QVKQFIEKCI--VPASLRLPALELLKDPFL 284
            +++F+  C+   P   RL A ELLK  ++
Sbjct: 230 LLREFVAACLDEEPKE-RLSAEELLKSKWI 258

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  135 bits (342), Expect = 3e-37
 Identities = 78/264 (29%), Positives = 126/264 (47%), Gaps = 16/264 (6%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLKHENI 88
           + LG GAF + Y+  D   G  +A  QV        +  + +E L  E+ L+  L H +I
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I+   +  +D++   N+  E    GS+     K+       I N+  Q+LRGL YLH + 
Sbjct: 66  IRMLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS------VIGTPEFMAPE-LY 201
             IIHRD+K  N+ ++     ++I D G A  +      +      ++GT  FMAPE L 
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYN--ECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
            E+Y    D++S G  I+EM T + P+N  +  N   +  K+ S     S+ +   P ++
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241

Query: 260 QFIEKCI-VPASLRLPALELLKDP 282
               +C+ +    R P+ ELLK P
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  136 bits (342), Expect = 2e-36
 Identities = 86/393 (21%), Positives = 142/393 (36%), Gaps = 38/393 (9%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE- 86
           R    LG+G+F  VY   D      VA   +    +     ++ER   E+ +L SL H  
Sbjct: 3   RILRKLGEGSFGEVYLARDR---KLVALKVLAK-KLESKSKEVERFLREIQILASLNHPP 58

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHY 143
           NI+K Y+ + D+ +  + M  E    GSL    KK      +          QIL  L Y
Sbjct: 59  NIVKLYDFFQDEGSLYLVM--EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--------QQPTARSVIGTPEF 195
           LHS    IIHRD+K +NI ++ +   VK+ D GLA ++              + +GTP +
Sbjct: 117 LHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 196 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPA 248
           MAPE+         +   DI+S G+ + E++T   P+         +Q  K +     P+
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234

Query: 249 SLSKV-------TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
             S +               ++K +      RL +   L    L       L    L   
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL---AHLKLKESDLSDL 291

Query: 301 NLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEK 360
               +   L  S P  ++  ++     A S +         + EL     ++        
Sbjct: 292 LKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSL 351

Query: 361 NDDDTVSLTLRIGDKSGKRICGAINSCFFFPPC 393
                 S    +   S +    +++S       
Sbjct: 352 LLSTASSKRSSLPKISARSSPSSLSSSSRQQAS 384

Length = 384

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  133 bits (335), Expect = 2e-36
 Identities = 91/269 (33%), Positives = 131/269 (48%), Gaps = 31/269 (11%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           +LGKG +  VY   D    + +A  ++   D        + L+ E+ L   LKH NI+++
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV----QPLHEEIALHSYLKHRNIVQY 70

Query: 92  YNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMK--AIKNWARQILRGLHYLHSHN 148
             S  D  N    +  E    GSL    R K   +      I  + +QIL GL YLH + 
Sbjct: 71  LGS--DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLG----LAIVMQQPTARSVIGTPEFMAPELYEE- 203
             I+HRD+K DN+ VN  +G VKI D G    LA +   P   +  GT ++MAPE+ ++ 
Sbjct: 129 --IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDKG 184

Query: 204 --EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYK----KVTSGIKPASLSKVTDP 256
              Y    DI+S G  I+EM T + P+ E   P A ++K    K+   I P SLS     
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI-PESLSA---- 239

Query: 257 QVKQFIEKCIVPASLRLP-ALELLKDPFL 284
           + K FI +C  P   +   A +LL+DPFL
Sbjct: 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  131 bits (331), Expect = 1e-35
 Identities = 79/271 (29%), Positives = 129/271 (47%), Gaps = 29/271 (10%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E++G GA   VY      +  +VA  ++++E   +    ++ L  EV  +    H N++K
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLE---KCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 91  FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           +Y S+V      + M     + GSL    +       +D   I    +++L+GL YLHS+
Sbjct: 64  YYTSFVVGDELWLVM--PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS------VIGTPEFMAPELY 201
               IHRD+K  NI + G +G VKI D G++  +     R+       +GTP +MAPE+ 
Sbjct: 122 G--QIHRDIKAGNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 202 EEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV- 258
           E+   Y+   DI+SFG+  +E+ T   PY++   P ++         P SL    D +  
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQN-DPPSLETGADYKKY 236

Query: 259 ----KQFIEKCIV--PASLRLPALELLKDPF 283
               ++ I  C+   P+  R  A ELLK  F
Sbjct: 237 SKSFRKMISLCLQKDPSK-RPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  129 bits (326), Expect = 9e-35
 Identities = 75/267 (28%), Positives = 126/267 (47%), Gaps = 45/267 (16%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ----LERLYSEVHLLKSLKHE 86
           +I+G+G+F TV    ++    E A   ++   +++        +E+   EV L +   H 
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEK---EV-LTRLNGHP 62

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            IIK Y ++ D+ N  +  + E   +G L QY +K+ ++D K  + +A +IL  L YLHS
Sbjct: 63  GIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----------------------QQP 184
               IIHRDLK +NI ++  +  +KI D G A V+                       + 
Sbjct: 121 KG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 185 TARSVIGTPEFMAPELYEEEY-NELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVT 242
              S +GT E+++PEL  E+   +  D+++ G CI+ +M+T + P+    N    ++K  
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFR-GSNEYLTFQK-- 233

Query: 243 SGIKPASLS--KVTDPQVKQFIEKCIV 267
             I     S      P  K  IEK +V
Sbjct: 234 --ILKLEYSFPPNFPPDAKDLIEKLLV 258

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  129 bits (326), Expect = 1e-34
 Identities = 94/295 (31%), Positives = 134/295 (45%), Gaps = 58/295 (19%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHE 86
           E LG+G +  VYK  D+  G  VA  ++ +++      + E + S    E+ LLK LKH 
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN------EEEGIPSTALREISLLKELKHP 58

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 145
           NI+K  +  V  T R + ++ E +    L++Y  K+   +    IK+   Q+LRGL Y H
Sbjct: 59  NIVKLLD--VIHTERKLYLVFE-YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPELY 201
           SH   I+HRDLK  NI +N  +G +K+ D GLA    I ++  T   V  T  + APE+ 
Sbjct: 116 SHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEIL 170

Query: 202 --EEEYNELVDIYSFGMCILEMVT--------CE------------YPYNE-----CKNP 234
              + Y+  VDI+S G    EM+T         E             P  E      K P
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230

Query: 235 AQIYKKVTSGIKPASLSKVT---DPQVKQFIEK--CIVPASLRLPALELLKDPFL 284
              YK       P  L KV    DP+    + K     PA  R+ A E LK P+ 
Sbjct: 231 D--YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK-RISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  129 bits (325), Expect = 1e-34
 Identities = 86/287 (29%), Positives = 149/287 (51%), Gaps = 25/287 (8%)

Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
              DP      + +I G+G+   V    D+  G +VA  ++++    +   + E L++EV
Sbjct: 13  DPGDPRSYLDNFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDL----RKQQRRELLFNEV 67

Query: 78  HLLKSLKHENIIKFYNSW-VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
            +++  +H NI++ Y+S+ V D    + ++ E    G+L      H  ++ + I      
Sbjct: 68  VIMRDYQHPNIVEMYSSYLVGDE---LWVVMEFLEGGALTDI-VTHTRMNEEQIATVCLA 123

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 194
           +L+ L +LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  +S++GTP 
Sbjct: 124 VLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 180

Query: 195 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKPAS--L 250
           +MAPE+     Y   VDI+S G+ ++EMV  E PY NE   P Q  K++   + P    L
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE--PPLQAMKRIRDNLPPKLKNL 238

Query: 251 SKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 295
            KV+ P+++ F+++ +V  PA  R  A ELL  PFL    P   +  
Sbjct: 239 HKVS-PRLRSFLDRMLVRDPAQ-RATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 3e-34
 Identities = 80/269 (29%), Positives = 127/269 (47%), Gaps = 23/269 (8%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            Y+ I  +G G +  VYK  D   G  VA   + +E      D  E +  E+ +LK  +H
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRH 59

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYL 144
            NI+ ++ S++      I M  E    GSL+  Y+     +    I    R+ L+GL YL
Sbjct: 60  PNIVAYFGSYLRRDKLWIVM--EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYE 202
           H      IHRD+K  NI +   +G+VK+ D G++  +    A+  S IGTP +MAPE+  
Sbjct: 118 HETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174

Query: 203 EE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVT--D 255
            E    Y+   DI++ G+  +E+   + P  +  +P + ++    S   P  L       
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPPPKLKDKEKWS 233

Query: 256 PQVKQFIEKCIVPASLRLP-ALELLKDPF 283
           P    FI+KC+     + P A +LL+ PF
Sbjct: 234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  126 bits (320), Expect = 4e-34
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 28/253 (11%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---SPDQLERLYSEVHLLKSLKHEN 87
           + LG+GAF  VYKG  ++ G +    +V ++  ++   S ++ +    E  ++K L H N
Sbjct: 1   KKLGEGAFGEVYKG--KLKGKDGKTTEVAVK-TLKEDASEEERKDFLKEARVMKKLGHPN 57

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN---------WARQIL 138
           +++     V      + ++ E    G L  Y +K + V     K+         +A QI 
Sbjct: 58  VVRLLG--VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPE--- 194
           +G+ YL S     +HRDL   N  V G +  VKI D GL+  +      R   G      
Sbjct: 116 KGMEYLASKK--FVHRDLAARNCLV-GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172

Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252
           +MAPE L +  +    D++SFG+ + E+ T    PY    N  ++ + +  G +      
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRKGYRLPKPEY 231

Query: 253 VTDPQVKQFIEKC 265
             D ++ + +  C
Sbjct: 232 CPD-ELYELMLSC 243

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  127 bits (321), Expect = 4e-34
 Identities = 92/275 (33%), Positives = 146/275 (53%), Gaps = 19/275 (6%)

Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           DP  +Y R+++I G+GA  TVY   D   G EVA  Q+N++   Q P + E + +E+ ++
Sbjct: 16  DPKKKYTRFEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKK-ELIINEILVM 70

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +  KH NI+ + +S++      + ++ E    GSL     +   +D   I    R+ L+ 
Sbjct: 71  RENKHPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q    +++GTP +MAP
Sbjct: 128 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Query: 199 ELY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGIKPASLSKVTD 255
           E+   + Y   VDI+S G+  +EMV  E PY NE  NP + +Y   T+G       +   
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLS 242

Query: 256 PQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 289
              + F+ +C+ +    R  A ELL+ PFL    P
Sbjct: 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  125 bits (315), Expect = 2e-33
 Identities = 82/262 (31%), Positives = 141/262 (53%), Gaps = 14/262 (5%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           R ++ +G+G F  VY+    +DG+ VA  +V I D+M +  + + +  E+ LLK L H N
Sbjct: 5   RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPN 63

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHY 143
           +IK+Y S+++D    +N++ EL  +G L    + ++K+ + +  K +  +  Q+   L +
Sbjct: 64  VIKYYASFIEDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-L 200
           +HS    ++HRD+K  N+F+    G VK+GDLGL       T  A S++GTP +M+PE +
Sbjct: 122 MHSRR--VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
           +E  YN   DI+S G  + EM   + P Y +  N   + KK+     P   S     +++
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238

Query: 260 QFIEKCIVPASLRLPALELLKD 281
           Q +  CI P   + P +  + D
Sbjct: 239 QLVNMCINPDPEKRPDITYVYD 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  124 bits (315), Expect = 2e-33
 Identities = 62/238 (26%), Positives = 118/238 (49%), Gaps = 12/238 (5%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG+F  V     +  G   A   +  + +++   ++E   +E ++L  + H  I+K +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++  +    + ++ E    G L  +  K      +  + +A +I+  L YLHS    II
Sbjct: 60  YAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--II 115

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 209
           +RDLK +NI ++  +G +K+ D GLA  +  +     +  GTPE++APE L  + Y + V
Sbjct: 116 YRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174

Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267
           D +S G+ + EM+T + P+   ++  +IY+K+     P    +   P+ +  I   + 
Sbjct: 175 DWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQ 229

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  124 bits (313), Expect = 3e-33
 Identities = 79/256 (30%), Positives = 138/256 (53%), Gaps = 13/256 (5%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           ++G+GAF  V+    + D   V   Q+ +E + +  D+     +E  +LK L H NII++
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEY 64

Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNP 149
           Y ++++D    I M  E    G+L +Y +K  N  +D   I ++  QIL  LH++H+   
Sbjct: 65  YENFLEDKALMIVM--EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELYE-EEYNE 207
            I+HRDLK  NI ++ +   VKIGD G++ I+  +  A +V+GTP +++PEL E + YN+
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI- 266
             DI++ G  + E+ + +  +     PA +  K+ SG   A +S    P ++Q I   + 
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMSG-TFAPISDRYSPDLRQLILSMLN 238

Query: 267 VPASLRLPALELLKDP 282
           +  S R    +++  P
Sbjct: 239 LDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  123 bits (311), Expect = 7e-33
 Identities = 85/267 (31%), Positives = 131/267 (49%), Gaps = 20/267 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKHENI 88
           E+LGKGA+ TVY G     G  +A  QV ++  +V+ +  + E+L  EV LLKSLKH NI
Sbjct: 6   EVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +++  + +DD   TI++  E    GS+     +   +       + +QIL G+ YLH++ 
Sbjct: 65  VQYLGTCLDDN--TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--------VMQQPTARSVIGTPEFMAPEL 200
             ++HRD+K +N+ +   NG +K+ D G A                +S+ GTP +MAPE+
Sbjct: 123 --VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 201 YEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQV 258
             E  Y    DI+S G  + EM T + P       A + Y     G+ P  L        
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RLPDSFSAAA 238

Query: 259 KQFIEKCIVPASLRLP-ALELLKDPFL 284
             F+  C+       P AL+LL+  FL
Sbjct: 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  122 bits (306), Expect = 5e-32
 Identities = 92/275 (33%), Positives = 146/275 (53%), Gaps = 19/275 (6%)

Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           DP  +Y RY++I G+GA  TV+   D   G EVA  Q+N    +Q   + E + +E+ ++
Sbjct: 16  DPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQIN----LQKQPKKELIINEILVM 70

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           K LK+ NI+ F +S++      + ++ E    GSL     +   +D   I    R+ L+ 
Sbjct: 71  KELKNPNIVNFLDSFL--VGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQA 127

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L +LH++   +IHRD+K DN+ + G +G VK+ D G    I  +Q    +++GTP +MAP
Sbjct: 128 LEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGIKPASLSKVTD 255
           E+   + Y   VDI+S G+  +EMV  E PY NE  NP + +Y   T+G       +   
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLS 242

Query: 256 PQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 289
           P  + F+ +C+ +    R  A ELL+ PFL    P
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 7e-32
 Identities = 86/279 (30%), Positives = 138/279 (49%), Gaps = 27/279 (9%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG GAF  VYK   +  G+  A   + IE      ++LE    E+ +L   KH NI+  Y
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIES----EEELEDFMVEIDILSECKHPNIVGLY 68

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
            ++  +      ++ E    G+L     +  + +    I+   RQ+L  L++LHSH   +
Sbjct: 69  EAYFYENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--V 124

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE----- 204
           IHRDLK  NI +   +G+VK+ D G++   +    +  + IGTP +MAPE+   E     
Sbjct: 125 IHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183

Query: 205 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQF 261
            Y+   DI+S G+ ++E+   E P++E  NP ++  K+     P     SK +      F
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSS-SFNDF 241

Query: 262 IEKCIVP-ASLRLPALELLKDPFL--VTDNP--KDLVCD 295
           ++ C+V     R  A ELLK PF+   +DN   KDL+ +
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLLAE 280

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  118 bits (297), Expect = 7e-31
 Identities = 76/261 (29%), Positives = 133/261 (50%), Gaps = 19/261 (7%)

Query: 32  ILGKGAF--KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           +LGKGAF   T+Y+  +  D   V W +VN+  +  S  +     +E+ +L  L+H NII
Sbjct: 7   VLGKGAFGEATLYRRTE--DDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNII 62

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +YN ++DD    I M  E    G+L     R+K +  + + +  +  QI+  + Y+H  
Sbjct: 63  AYYNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EE 204
              I+HRD+K  NIF+    G +K+GD G++ ++      A +V+GTP +M+PEL +  +
Sbjct: 121 G--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177

Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
           YN   DI++ G  + E++T +  + +  NP  +  K+  G     +S  +  ++   +  
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPVVSVYSS-ELISLVHS 235

Query: 265 CI-VPASLRLPALELLKDPFL 284
            +      R  A E+L  P L
Sbjct: 236 LLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  119 bits (298), Expect = 8e-31
 Identities = 95/279 (34%), Positives = 149/279 (53%), Gaps = 27/279 (9%)

Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           DP  +Y R+++I G+GA  TVY   D   G EVA  Q+N++   Q P + E + +E+ ++
Sbjct: 16  DPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQ---QQPKK-ELIINEILVM 70

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +  K+ NI+ + +S++      + ++ E    GSL     +   +D   I    R+ L+ 
Sbjct: 71  RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q    +++GTP +MAP
Sbjct: 128 LDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Query: 199 ELY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPASLS 251
           E+   + Y   VDI+S G+  +EMV  E PY NE  NP + +Y   T+G      P  LS
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPERLS 242

Query: 252 KVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 289
            V     + F+ +C+ +    R  A ELL+ PFL    P
Sbjct: 243 AV----FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  119 bits (300), Expect = 1e-30
 Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 30/214 (14%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY+  + +G GA+  V    D+  G +VA     I +V       +R+  E+ LL+ L+H
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRH 58

Query: 86  ENIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           ENII   +     +      + ++TEL  +  L +  K  + +    I+ +  QILRGL 
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLK 117

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM------ 196
           YLHS N  +IHRDLK  NI VN N  ++KI D GLA  +             F+      
Sbjct: 118 YLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDED-----EKGFLTEYVVT 169

Query: 197 ----APE--LYEEEYNELVDIYSFGMCIL-EMVT 223
               APE  L    Y + +DI+S G CI  E++T
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVG-CIFAELLT 202

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  116 bits (291), Expect = 5e-30
 Identities = 73/250 (29%), Positives = 133/250 (53%), Gaps = 14/250 (5%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G+G F  VY+    +D   VA  +V I ++M +  + +    E+ LLK L H N+IK+ 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPNVIKYL 68

Query: 93  NSWVDDTNRTINMITELFTSGSLRQ----YRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +S+++D    +N++ EL  +G L Q    ++K+ + +  + +  +  Q+   + ++HS  
Sbjct: 69  DSFIEDNE--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEY 205
             ++HRD+K  N+F+    G VK+GDLGL       T  A S++GTP +M+PE ++E  Y
Sbjct: 127 --VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 206 NELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
           N   DI+S G  + EM   + P Y +  N   + +K+     P   ++    ++++ +  
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243

Query: 265 CIVPASLRLP 274
           CI P   + P
Sbjct: 244 CIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  115 bits (290), Expect = 9e-30
 Identities = 67/260 (25%), Positives = 124/260 (47%), Gaps = 14/260 (5%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G    V K      G  +A   + +E    +    +++  E+ +L       I+ FY
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLE---INEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
            ++ ++ +  I++  E    GSL +  K+    +  + +   A  +L+GL YLH     I
Sbjct: 66  GAFYNNGD--ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKI 122

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVD 210
           IHRD+K  NI VN + G++K+ D G++  +    A++ +GT  +MAPE +   +Y+   D
Sbjct: 123 IHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSD 181

Query: 211 IYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266
           I+S G+ ++E+ T  +PY           ++ + + +   P   S    P  + F+  C+
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCL 241

Query: 267 VPASLRLPAL-ELLKDPFLV 285
           +      P+  ELL+ PF+ 
Sbjct: 242 IKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  115 bits (289), Expect = 1e-29
 Identities = 63/235 (26%), Positives = 107/235 (45%), Gaps = 9/235 (3%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G F  V     +      A   V  +  +    Q E ++SE  +L+   H  I+K Y
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVK-KRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++ D   + I M+ E    G L    +     D    + +   ++    YLH+    II
Sbjct: 60  RTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--II 115

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE-YNELVD 210
           +RDLK +N+ ++ +NG VK+ D G A  ++      +  GTPE++APE+   + Y+  VD
Sbjct: 116 YRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVD 174

Query: 211 IYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
            +S G+ + E++T   P+ E   +P +IY  +  G          D   K  I++
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ 229

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  115 bits (291), Expect = 2e-29
 Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 17/201 (8%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLK 84
           RY++   LG+G +  VYK  D+  G  VA  ++ + +  ++ D +      E+ LL+ LK
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA-IKNWARQILRGLHY 143
           H NII   + +   +N  IN++ E F    L +  K    V   A IK++    LRGL Y
Sbjct: 61  HPNIIGLLDVFGHKSN--INLVFE-FMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPEL 200
           LHS+   I+HRDLK +N+ +  ++G +K+ D GLA     P  +    V+ T  + APEL
Sbjct: 118 LHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPEL 173

Query: 201 Y--EEEYNELVDIYSFGMCIL 219
                 Y   VD++S G CI 
Sbjct: 174 LFGARHYGVGVDMWSVG-CIF 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 3e-29
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 22/204 (10%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIED-VMQSPDQLERLYSEVHLLKSLKHENII 89
             +G+G +  VYK  ++  G  VA  ++ +E+     P    R   E+ LL+ L+H NI+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR---EIKLLQKLRHPNIV 61

Query: 90  KFYNSWVDDTNRTINMITELFT---SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           +           +I M+ E      +G L     K        IK + +Q+L GL YLHS
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQLLEGLQYLHS 118

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS----VIGTPEFMAPELY- 201
           +   I+HRD+K  NI +N N+G +K+ D GLA    +  +      VI T  +  PEL  
Sbjct: 119 NG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLL 174

Query: 202 -EEEYNELVDIYSFGMCIL-EMVT 223
               Y   VD++S G CIL E+  
Sbjct: 175 GATRYGPEVDMWSVG-CILAELFL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  114 bits (286), Expect = 4e-29
 Identities = 92/279 (32%), Positives = 148/279 (53%), Gaps = 27/279 (9%)

Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           DP  +Y R+++I G+GA  TVY   D   G EVA  Q+N++   Q P + E + +E+ ++
Sbjct: 17  DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 71

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +  K+ NI+ + +S++      + ++ E    GSL     +   +D   I    R+ L+ 
Sbjct: 72  RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 128

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q    +++GTP +MAP
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 199 ELY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPASLS 251
           E+   + Y   VDI+S G+  +EM+  E PY NE  NP + +Y   T+G      P  LS
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLS 243

Query: 252 KVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 289
            +     + F+ +C+ +    R  A ELL+  FL    P
Sbjct: 244 AI----FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  113 bits (284), Expect = 5e-29
 Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 24/271 (8%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLLKSLK 84
           E++GKG +  VY   +   G  +A  QV +          +  D ++ L SE+  LK L 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H NI+++     + T   +++  E    GS+    + +   + + ++ +  Q+L GL YL
Sbjct: 67  HLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----AIVMQQPTARSVIGTPEFMAPE- 199
           HS    I+HRDLK DN+ V+  +G  KI D G+      +       S+ G+  +MAPE 
Sbjct: 125 HSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 200 --LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK----KVTSGIKPASLSKV 253
              Y + Y+  VDI+S G  +LEM     P+++ +  A ++K    +    I P     +
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241

Query: 254 TDPQVKQFIEKCIVPASLRLP-ALELLKDPF 283
           + P    F+  C        P A ELL+ PF
Sbjct: 242 S-PVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  114 bits (286), Expect = 6e-29
 Identities = 87/301 (28%), Positives = 145/301 (48%), Gaps = 20/301 (6%)

Query: 17  FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
           FS+ DP   +    EI G G+F  VY   D      VA  +++     QS ++ + +  E
Sbjct: 8   FSKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKE 65

Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT-SGSLRQYRKKHKNVDMKAIKNWAR 135
           V  L+ L+H N I++   ++ +    + M   L + S  L  ++K  + V++ AI     
Sbjct: 66  VRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI---CH 122

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
             L+GL YLHSH    IHRD+K  NI +    G VK+ D G A ++    A S +GTP +
Sbjct: 123 GALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVS--PANSFVGTPYW 177

Query: 196 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
           MAPE+     E +Y+  VD++S G+  +E+   + P       + +Y    +     +LS
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTLS 235

Query: 252 KVTDPQ-VKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMN 308
                   + F++ C+      R  + ELLK  F++ + P  ++ D + R  + V E+ N
Sbjct: 236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRELDN 295

Query: 309 L 309
           L
Sbjct: 296 L 296

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  111 bits (278), Expect = 5e-28
 Identities = 87/274 (31%), Positives = 141/274 (51%), Gaps = 16/274 (5%)

Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           DP   + + ++I GKG+F  V+KG D      VA   + I D+ ++ D++E +  E+ +L
Sbjct: 1   DPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVL 56

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
                  + K+Y S++ DT   I  I E    GS     +    +D   I    R+IL+G
Sbjct: 57  SQCDSPYVTKYYGSYLKDTKLWI--IMEYLGGGSALDLLEPGP-LDETQIATILREILKG 113

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L YLHS     IHRD+K  N+ ++  +GEVK+ D G+A  +   Q    + +GTP +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
           E+ ++  Y+   DI+S G+  +E+   E P++E  +P ++   +     P      + P 
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNNPPTLEGNYSKP- 228

Query: 258 VKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 290
           +K+F+E C+    S R  A ELLK  F+V    K
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  111 bits (278), Expect = 6e-28
 Identities = 78/236 (33%), Positives = 128/236 (54%), Gaps = 18/236 (7%)

Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
           E L++EV +++  +HEN+++ YNS++      + ++ E    G+L      H  ++ + I
Sbjct: 62  ELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQI 118

Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARS 188
                 +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  +S
Sbjct: 119 AAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKS 175

Query: 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIK 246
           ++GTP +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + 
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLP 233

Query: 247 P--ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
           P   +L KV+ P +K F+++ +V  PA  R  A ELLK PFL    P   +   +R
Sbjct: 234 PKLKNLHKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPSCIVPLMR 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  109 bits (274), Expect = 1e-27
 Identities = 66/267 (24%), Positives = 124/267 (46%), Gaps = 22/267 (8%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           + KGA+  V+    +  G   A   +  +  M   +Q++++ +E  +L   +   ++K Y
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIK-KADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+    N  + ++ E    G L    +   ++D    + +  +I+  L YLHS+   II
Sbjct: 60  YSFQGKKN--LYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--II 115

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGL--------AIVMQQPTARS--VIGTPEFMAPE-LY 201
           HRDLK DNI ++ +NG +K+ D GL         I +         ++GTP+++APE + 
Sbjct: 116 HRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
            + +++ VD +S G  + E +    P++  + P +I++ + +G            +    
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233

Query: 262 IEKCIVPASL-RLPAL---ELLKDPFL 284
           I K +VP    RL A    E+   PF 
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 2e-27
 Identities = 69/238 (28%), Positives = 121/238 (50%), Gaps = 15/238 (6%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G F  V+   D +     A   + I +V+    Q + +++E  +LK + H  II+ +
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLF 67

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            +  D     + M+ E    G L  Y +            +A +I+  L YLHS    I+
Sbjct: 68  WTEHDQRF--LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IV 123

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           +RDLK +NI ++   G +K+ D G A  ++  T  ++ GTPE++APE+ + + +N+ VD 
Sbjct: 124 YRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTW-TLCGTPEYLAPEVIQSKGHNKAVDW 181

Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQFIEKCIV 267
           ++ G+ I EM+    P+ +  NP  IY+K+ +G ++ P  L    D   K  I+K +V
Sbjct: 182 WALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLEFPRHL----DLYAKDLIKKLLV 234

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 4e-27
 Identities = 74/209 (35%), Positives = 108/209 (51%), Gaps = 26/209 (12%)

Query: 29  YDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNI---EDVMQSPDQLERLYSEVHLLKSL 83
           Y+E+  +G+GA+ TVYK  D   G  VA  +V +   E+ +  P    R   E+ LLK L
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI--PLSTLR---EIALLKQL 55

Query: 84  K---HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWAR 135
           +   H NI++  +       D    + ++ E      L  Y  K     +  + IK+  R
Sbjct: 56  ESFEHPNIVRLLDVCHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPPETIKDLMR 114

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPE 194
           Q+LRG+ +LHSH   I+HRDLK  NI V  ++G+VKI D GLA +     A  SV+ T  
Sbjct: 115 QLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLW 171

Query: 195 FMAPE-LYEEEYNELVDIYSFGMCIL-EM 221
           + APE L +  Y   VD++S G CI  E+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVG-CIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 7e-27
 Identities = 80/291 (27%), Positives = 138/291 (47%), Gaps = 43/291 (14%)

Query: 20  KDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
            DP+   G ++  E++G+G +  VYK   +  G  VA   + I D++   D+ E +  E 
Sbjct: 2   PDPT---GIFELVEVIGEGTYGKVYKARHKKTGQLVA---IKIMDII--EDEEEEIKEEY 53

Query: 78  HLLKSL-KHENIIKFYNSWV--DDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKN 132
           ++L+    H NI  FY +++  +       + ++ EL   GS+    K  +    +  + 
Sbjct: 54  NILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEE 113

Query: 133 W----ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR- 187
           W     R+ LRGL YLH +   +IHRD+K  NI +   N EVK+ D G++  +     R 
Sbjct: 114 WIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRR 170

Query: 188 -SVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA----- 235
            + IGTP +MAPE+       +  Y+   D++S G+  +E+   + P   C         
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--CDMHPMRALF 228

Query: 236 QIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 284
           +I +     +K P + SK    +   FI +C++    + P   ELL+ PF+
Sbjct: 229 KIPRNPPPTLKSPENWSK----KFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  107 bits (270), Expect = 8e-27
 Identities = 73/270 (27%), Positives = 133/270 (49%), Gaps = 21/270 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             LG+GA  +V K   +  G+  A   +       +PD  +++  E+ + KS K   I+K
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTIT---TDPNPDLQKQILRELEINKSCKSPYIVK 63

Query: 91  FYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           +Y +++D+++ +I +  E    GSL    ++ +K+   +  K +   A  +L+GL YLHS
Sbjct: 64  YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEY 205
               IIHRD+K  NI +    G+VK+ D G++  +    A +  GT  +MAPE +  + Y
Sbjct: 124 RK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPY 180

Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD-PQV------ 258
           +   D++S G+ +LE+    +P+     P     ++ S I      ++ D P        
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240

Query: 259 --KQFIEKCIVPASLRLPA-LELLKDPFLV 285
             K FI++C+     R P   ++L+ P++ 
Sbjct: 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  106 bits (267), Expect = 1e-26
 Identities = 79/265 (29%), Positives = 134/265 (50%), Gaps = 25/265 (9%)

Query: 33  LGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           LGKG+F TVY    K     + ++V   ++ + ++  +P++  +   E  LL  L H  I
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVL-KEIPVGEL--NPNETVQANQEAQLLSKLDHPAI 64

Query: 89  IKFYNSWVDDTNRTINMITELFTSG-----SLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
           +KF+ S+++     I  ITE +  G      L + +   K +    +  W  Q+L G+HY
Sbjct: 65  VKFHASFLERDAFCI--ITE-YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-L 200
           +H     I+HRDLK  NIF+  N   +KIGD G++ ++      A +  GTP +M+PE L
Sbjct: 122 MHQRR--ILHRDLKAKNIFLKNN--LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177

Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
             + Y+   DI+S G  + EM    + + E +N   +  ++  G  P SL +    Q+  
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP-SLPETYSRQLNS 235

Query: 261 FIEKCIVP-ASLRLPALELLKDPFL 284
            ++  +    SLR  A E+L++PF+
Sbjct: 236 IMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  107 bits (267), Expect = 2e-26
 Identities = 78/273 (28%), Positives = 141/273 (51%), Gaps = 20/273 (7%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G+G+   V    ++  G +VA  +++    ++   + E L++EV +++   HEN++  Y
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMD----LRKQQRRELLFNEVVIMRDYHHENVVDMY 85

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
           NS++      + ++ E    G+L      H  ++ + I      +LR L YLH+    +I
Sbjct: 86  NSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLHNQG--VI 140

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEE-EYNELV 209
           HRD+K D+I +  ++G +K+ D G    +  + P  +S++GTP +MAPE+     Y   V
Sbjct: 141 HRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 210 DIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCI 266
           DI+S G+ ++EM+  E PY NE   P Q  +++   + P      KV+   ++ F++  +
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNE--PPLQAMRRIRDNLPPRVKDSHKVSS-VLRGFLDLML 256

Query: 267 V-PASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
           V   S R  A ELL+ PFL    P   +   +R
Sbjct: 257 VREPSQRATAQELLQHPFLKLAGPPSCIVPLMR 289

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  105 bits (262), Expect = 5e-26
 Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 16/265 (6%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY+  + +G+G+F  +Y    + D       ++++  +     +  +   EV LL  +KH
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMKH 58

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGLHY 143
            NI+ F+ S+ ++    I M  E    G L +   + + V      I +W  QI  GL  
Sbjct: 59  PNIVTFFASFQENGRLFIVM--EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK- 115

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY 201
            H H+  I+HRD+K  NIF++ N    K+GD G+A  +      A + +GTP +++PE+ 
Sbjct: 116 -HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC 174

Query: 202 EEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
           +   YN   DI+S G  + E+ T ++P+ E  N  Q+  K+  G   A +S      ++ 
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQG-YFAPISPNFSRDLRS 232

Query: 261 FIEKCIVPASLRLPAL-ELLKDPFL 284
            I +    +    P++  +LK PFL
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  105 bits (262), Expect = 6e-26
 Identities = 82/269 (30%), Positives = 134/269 (49%), Gaps = 16/269 (5%)

Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           DP   + + + I GKG+F  VYKG D      VA   + I D+ ++ D++E +  E+ +L
Sbjct: 1   DPEELFTKLERI-GKGSFGEVYKGIDNRTKEVVA---IKIIDLEEAEDEIEDIQQEITVL 56

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
                  I ++Y S++  T   I  I E    GS     K    ++   I    R+IL+G
Sbjct: 57  SQCDSPYITRYYGSYLKGTKLWI--IMEYLGGGSALDLLKPGP-LEETYIATILREILKG 113

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L YLHS     IHRD+K  N+ ++   G+VK+ D G+A  +   Q    + +GTP +MAP
Sbjct: 114 LDYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
           E+ ++  Y+   DI+S G+  +E+   E P ++  +P ++   +     P    + + P 
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNSPPTLEGQYSKP- 228

Query: 258 VKQFIEKCI-VPASLRLPALELLKDPFLV 285
            K+F+E C+      R  A ELLK  F+ 
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKFIT 257

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  104 bits (260), Expect = 8e-26
 Identities = 72/262 (27%), Positives = 133/262 (50%), Gaps = 14/262 (5%)

Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           +  ++GKG++  V       DG +    ++N+ +   S  + +    E  LL  LKH NI
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNI 61

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHS 146
           + +  SW +  +  + ++      G L    K+ K   +    +  W  QI   L YLH 
Sbjct: 62  VAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELYEEE 204
            +  I+HRDLK  N+F+   N  +K+GDLG+A V+  Q   A ++IGTP +M+PEL+  +
Sbjct: 121 KH--ILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 205 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263
            YN   D+++ G C+ EM T ++ +N     + +Y+ +   + P  + K   P++ + I 
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--MPKDYSPELGELIA 235

Query: 264 KCIVPASLRLPALE-LLKDPFL 284
             +     + P+++ +L+ P++
Sbjct: 236 TMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  104 bits (261), Expect = 8e-26
 Identities = 83/274 (30%), Positives = 135/274 (49%), Gaps = 16/274 (5%)

Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           DP   + + + I GKG+F  V+KG D      VA   + I D+ ++ D++E +  E+ +L
Sbjct: 1   DPEELFTKLERI-GKGSFGEVFKGIDNRTQQVVA---IKIIDLEEAEDEIEDIQQEITVL 56

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
                  + K+Y S++  T   I  I E    GS     +     D   I    ++IL+G
Sbjct: 57  SQCDSPYVTKYYGSYLKGTKLWI--IMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKG 113

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L YLHS     IHRD+K  N+ ++   G+VK+ D G+A  +   Q    + +GTP +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
           E+ ++  Y+   DI+S G+  +E+   E P N   +P ++   +     P    + +   
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGE-PPNSDMHPMRVLFLIPKNNPPTLTGEFSK-P 228

Query: 258 VKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 290
            K+FI+ C+    S R  A ELLK  F+V +  K
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  103 bits (260), Expect = 2e-25
 Identities = 74/256 (28%), Positives = 131/256 (51%), Gaps = 34/256 (13%)

Query: 31  EILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
           + LG G+F  V    +KG  +      A   ++   +++   Q+E + +E  +L+S++H 
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKY----YALKILSKAKIVKL-KQVEHVLNEKRILQSIRHP 61

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            ++  Y S+ DD+N  + ++ E    G L  + +K         + +A Q++  L YLHS
Sbjct: 62  FLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-Y 205
            +  I++RDLK +N+ +  ++G +KI D G A  ++  T  ++ GTPE++APE+   + Y
Sbjct: 120 LD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGRT-YTLCGTPEYLAPEIILSKGY 175

Query: 206 NELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGIKPASLSKVT-----DPQV 258
            + VD ++ G+ I EM+   YP  +++  NP QIY+K+  G       KV       P  
Sbjct: 176 GKAVDWWALGILIYEML-AGYPPFFDD--NPIQIYEKILEG-------KVRFPSFFSPDA 225

Query: 259 KQFIEK-CIVPASLRL 273
           K  I     V  + RL
Sbjct: 226 KDLIRNLLQVDLTKRL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  103 bits (258), Expect = 2e-25
 Identities = 78/272 (28%), Positives = 139/272 (51%), Gaps = 23/272 (8%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG GAF  VYK  ++  G+  A   ++     +S ++LE    E+ +L S  H NI+K  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVID----TKSEEELEDYMVEIDILASCDHPNIVKLL 68

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           +++  + N  I  + E    G++     +  + +    I+   +Q L  L+YLH +   I
Sbjct: 69  DAFYYENNLWI--LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--I 124

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY------EE 203
           IHRDLK  NI     +G++K+ D G++    +   R  S IGTP +MAPE+       + 
Sbjct: 125 IHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183

Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQF 261
            Y+   D++S G+ ++EM   E P++E  NP ++  K+    +P +L++ +    + K F
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKS-EPPTLAQPSRWSSEFKDF 241

Query: 262 IEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
           ++KC+      R    +LL+ PF+  ++ K +
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  102 bits (254), Expect = 1e-24
 Identities = 83/279 (29%), Positives = 142/279 (50%), Gaps = 18/279 (6%)

Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           DP      Y +I G+G+   V    ++  G +VA   V + D ++   + E L++EV ++
Sbjct: 18  DPRSLLENYIKI-GEGSTGIVCIAREKHSGRQVA---VKMMD-LRKQQRRELLFNEVVIM 72

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +  +H+N+++ Y S++      + ++ E    G+L     + + ++ + I      +L+ 
Sbjct: 73  RDYQHQNVVEMYKSYL--VGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQA 129

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L YLHS    +IHRD+K D+I +   +G VK+ D G    I    P  +S++GTP +MAP
Sbjct: 130 LCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186

Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDP 256
           E+     Y   VDI+S G+ ++EMV  E PY    +P Q  K++     P    +    P
Sbjct: 187 EVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISP 245

Query: 257 QVKQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 293
            ++ F+E+ +      R  A ELL  PFL+ T  P+ LV
Sbjct: 246 VLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLV 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  100 bits (251), Expect = 2e-24
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 8/200 (4%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           ++GKGAF  V            A   +N +  +     +  + +E  +L+ L H  ++  
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPFLVNL 65

Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           + S+ D+ N  + ++ +L   G LR +  +      + +K W  +I+  L YLHS    I
Sbjct: 66  WYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--I 121

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELY-EEEYNELV 209
           IHRD+K DNI ++   G V I D  +A  V       S  GTP +MAPE+   + Y+  V
Sbjct: 122 IHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAV 180

Query: 210 DIYSFGMCILEMVTCEYPYN 229
           D +S G+   E +  + PY 
Sbjct: 181 DWWSLGVTAYECLRGKRPYR 200

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  101 bits (252), Expect = 2e-24
 Identities = 65/201 (32%), Positives = 110/201 (54%), Gaps = 18/201 (8%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG+G + TVYKG +   G  VA  +++++    +P    R   E+ L+K LKHENI++
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVR 62

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSH 147
            ++  V  T   + ++ E +    L++Y   H     +D   +K++  Q+L+G+ + H +
Sbjct: 63  LHD--VIHTENKLMLVFE-YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEE 203
              ++HRDLK  N+ +N   GE+K+ D GLA     P  T  + + T  + AP+  L   
Sbjct: 120 R--VLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176

Query: 204 EYNELVDIYSFGMCIL-EMVT 223
            Y+  +DI+S G CI+ EM+T
Sbjct: 177 TYSTSIDIWSVG-CIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  101 bits (255), Expect = 2e-24
 Identities = 76/211 (36%), Positives = 107/211 (50%), Gaps = 30/211 (14%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM---QSPDQLERLYSEVHLLKS 82
           RY  +  +G GA+  V   FD   G +VA     I+ +    QS    +R Y E+ LLK 
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVA-----IKKLSRPFQSAIHAKRTYRELRLLKH 70

Query: 83  LKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
           + HEN+I   + +   ++    + + ++T L  +  L    K  K  D   I+    QIL
Sbjct: 71  MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDH-IQFLVYQIL 128

Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEF 195
           RGL Y+HS    IIHRDLK  NI VN +  E+KI D GLA    + T   + G   T  +
Sbjct: 129 RGLKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA----RHTDDEMTGYVATRWY 181

Query: 196 MAPE--LYEEEYNELVDIYSFGMCIL-EMVT 223
            APE  L    YN+ VDI+S G CI+ E++T
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVG-CIMAELLT 211

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  100 bits (252), Expect = 3e-24
 Identities = 68/212 (32%), Positives = 110/212 (51%), Gaps = 19/212 (8%)

Query: 24  CRYGRYDEILGKGAFKTVYKG-FDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
            R+ ++ + LG+G F  V    +D +    G +VA   +N     Q     ER   E+ +
Sbjct: 3   KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEI 59

Query: 80  LKSLKHENIIKFYNSWVDDTN-RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQI 137
           L++L HENI+K Y    +    R++ +I E   SGSLR Y ++H+  +++K +  ++ QI
Sbjct: 60  LRTLDHENIVK-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118

Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP 193
            +G+ YL S     IHRDL   NI V  +   VKI D GLA V+ +       +    +P
Sbjct: 119 CKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175

Query: 194 EF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            F  APE L   +++   D++SFG+ + E+ T
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  100 bits (250), Expect = 4e-24
 Identities = 81/269 (30%), Positives = 133/269 (49%), Gaps = 20/269 (7%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +Y EILG G   TVYK +  +    +A   V +  +  + +  +++ SE+ +L       
Sbjct: 4   QYQEILGHGNGGTVYKAYHLLTRRILA---VKVIPLDITVELQKQIMSELEILYKCDSPY 60

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           II FY ++  + NR I++ TE    GSL  YRK  ++V    +   A  +++GL YL S 
Sbjct: 61  IIGFYGAFFVE-NR-ISICTEFMDGGSLDVYRKIPEHV----LGRIAVAVVKGLTYLWSL 114

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYN 206
              I+HRD+K  N+ VN   G+VK+ D G++  +    A++ +GT  +MAPE +  E+Y 
Sbjct: 115 K--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYG 171

Query: 207 ELVDIYSFGMCILEMVTCEYPY-----NECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
              D++S G+  +E+    +PY     N+    P Q+ + +     P         +   
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231

Query: 261 FIEKCIVPASLRLPALELLKD-PFLVTDN 288
           FI +C+       PA E L D PF+V  N
Sbjct: 232 FITQCMRKQPKERPAPENLMDHPFIVQYN 260

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 6e-24
 Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 13/196 (6%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G+G +  VYK  D++ G  VA  ++ +    +S    +    E+ LLK L H NIIK  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
           +  V      + ++ E   +   +  + + + +    IK++  Q+L+GL + HSH   I+
Sbjct: 65  D--VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--IL 120

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELY--EEEYNEL 208
           HRDLK +N+ +N   G +K+ D GLA             + T  + APEL   ++ Y+  
Sbjct: 121 HRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179

Query: 209 VDIYSFGMCIL-EMVT 223
           VDI+S G CI  E+++
Sbjct: 180 VDIWSVG-CIFAELLS 194

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 99.7 bits (248), Expect = 6e-24
 Identities = 82/270 (30%), Positives = 133/270 (49%), Gaps = 25/270 (9%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NII 89
           E++G G +  VYKG     G   A   + + DV +  D+ E +  E+++LK   H  NI 
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTE--DEEEEIKLEINMLKKYSHHRNIA 76

Query: 90  KFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQILRGLHY 143
            +Y +++  +    +  + ++ E   +GS+    K  K   +K   I    R+ILRGL +
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY 201
           LH+H   +IHRD+K  N+ +   N EVK+ D G++  + +   R  + IGTP +MAPE+ 
Sbjct: 137 LHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 202 ------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
                 +  Y+   DI+S G+  +EM     P  +  +P +    +     P   SK   
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPPPKLKSKKWS 252

Query: 256 PQVKQFIEKCIVPASLRLPALE-LLKDPFL 284
            +   FIE C+V   L  P+ E LLK PF+
Sbjct: 253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 99.4 bits (247), Expect = 8e-24
 Identities = 79/270 (29%), Positives = 131/270 (48%), Gaps = 25/270 (9%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENII 89
           E++G G +  VYKG     G   A   + + DV  + D+ E +  E+++LK   H  NI 
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAA---IKVMDV--TGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 90  KFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQILRGLHY 143
            +Y +++       +  + ++ E   +GS+    K  K   +K   I    R+ILRGL +
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY 201
           LH H   +IHRD+K  N+ +   N EVK+ D G++  + +   R  + IGTP +MAPE+ 
Sbjct: 127 LHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 202 ------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
                 +  Y+   D++S G+  +EM     P  +  +P +    +     P   SK   
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKWS 242

Query: 256 PQVKQFIEKCIVPASLRLPALE-LLKDPFL 284
            + + FIE C+V    + P  E L+K PF+
Sbjct: 243 KKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 99.5 bits (249), Expect = 9e-24
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 29/211 (13%)

Query: 29  YDEI--LGKGAFKTVYKGFDEVDGIEVAWNQV-----NIEDVMQSPDQLERLYSEVHLLK 81
           Y  I  LG G F +VY   ++  G  VA  ++     + E+ M           EV  L+
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR--------EVKSLR 52

Query: 82  SLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--KAIKNWARQIL 138
            L  H NI+K    + +  N  +  + E +  G+L Q  K  K        I++   QIL
Sbjct: 53  KLNEHPNIVKLKEVFRE--NDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQIL 109

Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEFMA 197
           +GL ++H H     HRDLK +N+ V+G    VKI D GLA  +  +P     + T  + A
Sbjct: 110 QGLAHIHKHG--FFHRDLKPENLLVSG-PEVVKIADFGLAREIRSRPPYTDYVSTRWYRA 166

Query: 198 PE--LYEEEYNELVDIYSFGMCIL-EMVTCE 225
           PE  L    Y+  VDI++ G CI+ E+ T  
Sbjct: 167 PEILLRSTSYSSPVDIWALG-CIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  100 bits (250), Expect = 9e-24
 Identities = 71/202 (35%), Positives = 108/202 (53%), Gaps = 19/202 (9%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---SPDQLERLYSEVHLLKS 82
           RY ++  +G GAF  V    D++ G  VA     I+ +M+   +P   +R Y E+ LLK 
Sbjct: 11  RYVDLQPVGMGAFGLVCSARDQLTGQNVA-----IKKIMKPFSTPVLAKRTYRELKLLKH 65

Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           L+HENII   + ++      I  +TEL  +   R      + ++ + I+ +  QILRGL 
Sbjct: 66  LRHENIISLSDIFISPLE-DIYFVTELLGTDLHRLL--TSRPLEKQFIQYFLYQILRGLK 122

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--L 200
           Y+HS    ++HRDLK  NI +N  N ++KI D GLA + Q P     + T  + APE  L
Sbjct: 123 YVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARI-QDPQMTGYVSTRYYRAPEIML 178

Query: 201 YEEEYNELVDIYSFGMCILEMV 222
             ++Y+  VDI+S G    EM+
Sbjct: 179 TWQKYDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 99.0 bits (246), Expect = 2e-23
 Identities = 89/302 (29%), Positives = 150/302 (49%), Gaps = 18/302 (5%)

Query: 17  FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
           F + DP   +    EI G G+F  VY   D  +   VA  +++     QS ++ + +  E
Sbjct: 8   FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKE 65

Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWAR 135
           V  L+ L+H N I++   ++ +    + M   L ++  L +  KK  + V++ A+ + A 
Sbjct: 66  VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA- 124

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
             L+GL YLHSHN  +IHRD+K  NI ++   G VK+GD G A +M    A   +GTP +
Sbjct: 125 --LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA--PANXFVGTPYW 177

Query: 196 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
           MAPE+     E +Y+  VD++S G+  +E+   + P       + +Y  +     PA  S
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQS 236

Query: 252 KVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNL 309
                  + F++ C+       P  E LLK  F++ + P  ++ D + R  + V E+ NL
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNL 296

Query: 310 AH 311
            +
Sbjct: 297 QY 298

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 99.4 bits (247), Expect = 2e-23
 Identities = 89/303 (29%), Positives = 152/303 (50%), Gaps = 20/303 (6%)

Query: 17  FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
           F ++DP   +    EI G G+F  VY   D      VA  +++     QS ++ + +  E
Sbjct: 18  FFKEDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKE 75

Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWAR 135
           V  L+ +KH N I++   ++ +    + M   L ++  L +  KK  + V++ AI + A 
Sbjct: 76  VKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA- 134

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
             L+GL YLHSHN  +IHRD+K  NI +    G+VK+ D G A +     A S +GTP +
Sbjct: 135 --LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIAS--PANSFVGTPYW 187

Query: 196 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
           MAPE+     E +Y+  VD++S G+  +E+   + P       + +Y  +     P   S
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPTLQS 246

Query: 252 KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMN 308
                  + F++ C+  +P   R  + ELLK  F++ + P+ ++ D + R  + V E+ N
Sbjct: 247 NEWSDYFRNFVDSCLQKIPQD-RPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELDN 305

Query: 309 LAH 311
           L +
Sbjct: 306 LQY 308

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 98.2 bits (244), Expect = 4e-23
 Identities = 88/302 (29%), Positives = 146/302 (48%), Gaps = 18/302 (5%)

Query: 17  FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
           F + DP   +    EI G G+F  VY   +      VA  +++     Q+ ++ + +  E
Sbjct: 14  FYKDDPEEIFVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMSYSG-KQTNEKWQDIIKE 71

Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWAR 135
           V  L+ LKH N I++   ++ +    + M   L ++  L +  KK  + V++ AI + A 
Sbjct: 72  VKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA- 130

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
             L+GL YLHSHN  +IHRD+K  NI +    G+VK+ D G A       A S +GTP +
Sbjct: 131 --LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSS--PANSFVGTPYW 183

Query: 196 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
           MAPE+     E +Y+  VD++S G+  +E+   + P       + +Y  +     P   S
Sbjct: 184 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQS 242

Query: 252 KVTDPQVKQFIEKCIVPASLRLPA-LELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNL 309
                  + F++ C+       PA  ELL+  F+  D P  ++ D + R  + V E+ NL
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDNL 302

Query: 310 AH 311
            +
Sbjct: 303 QY 304

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 97.7 bits (243), Expect = 4e-23
 Identities = 54/163 (33%), Positives = 92/163 (56%), Gaps = 10/163 (6%)

Query: 68  DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VD 126
           + +  L  E+ +L++L HENI+K+     +D    I +I E   SGSL++Y  ++KN ++
Sbjct: 48  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN 107

Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184
           +K    +A QI +G+ YL S     +HRDL   N+ V  +  +VKIGD GL   ++    
Sbjct: 108 LKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKE 164

Query: 185 --TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
             T +  + +P F  APE L + ++    D++SFG+ + E++T
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 96.8 bits (241), Expect = 8e-23
 Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 18/210 (8%)

Query: 25  RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + L     E+ +L
Sbjct: 4   RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ----HSTAEHLRDFEREIEIL 59

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILR 139
           KSL+H+NI+K+         R + ++ E    GSLR Y +KH+  +D + +  +A QI +
Sbjct: 60  KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119

Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----- 194
           G+ YL S     +HRDL   NI V   N  VKIGD GL  V+ Q      +  P      
Sbjct: 120 GMEYLGSKR--YVHRDLATRNILVESEN-RVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176

Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           + APE L E +++   D++SFG+ + E+ T
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 31/214 (14%)

Query: 34  GKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERL----YSEVHLLKSLKHEN 87
           G+G +  VYK    +  DG E A     I+      +Q   +      E+ LL+ LKHEN
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYA-----IKKFKGDKEQYTGISQSACREIALLRELKHEN 63

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQ-----YRKKHKNVDMKAIKNWARQILRGLH 142
           ++     +++  ++++ ++ + +    L Q      + K  ++    +K+   QIL G+H
Sbjct: 64  VVSLVEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP-----TARSVIGTPE 194
           YLHS+   ++HRDLK  NI V G     G VKIGDLGLA +   P         V+ T  
Sbjct: 123 YLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 195 FMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE 225
           + APEL      Y + +DI++ G CI  E++T E
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 95.5 bits (237), Expect = 3e-22
 Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 23/264 (8%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG GAF  VYK  ++  G   A   +      +S ++LE    E+ +L +  H  I+K  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIE----TKSEEELEDYMVEIEILATCNHPYIVKLL 75

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
            ++  D    I MI E    G++     +  + +    I+   RQ+L  L YLHS    I
Sbjct: 76  GAFYWDGKLWI-MI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--I 131

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE------LYEE 203
           IHRDLK  N+ +   +G++K+ D G++    +   R  S IGTP +MAPE      + + 
Sbjct: 132 IHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190

Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQF 261
            Y+   DI+S G+ ++EM   E P++E  NP ++  K+    +P +LS+ +    + + F
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKS-EPPTLSQPSKWSMEFRDF 248

Query: 262 IEKCIVP-ASLRLPALELLKDPFL 284
           ++  +      R  A +LL+ PF+
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFV 272

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 93.7 bits (233), Expect = 7e-22
 Identities = 72/253 (28%), Positives = 127/253 (50%), Gaps = 21/253 (8%)

Query: 31  EILGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQSPDQLER------LYSEVHLLK-S 82
           E LG GAF  VYK   + +G   +A  ++N+ +     D+ ER      + SEV ++K  
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQIL 138
           L+H NI+++Y ++++  N  + ++ +L     L ++    ++K +    + I N   Q++
Sbjct: 66  LRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFM 196
             L YLH     I+HRDL  +NI + G + +V I D GLA   +QP ++  SV+GT  + 
Sbjct: 124 LALRYLHKEKR-IVHRDLTPNNIML-GEDDKVTITDFGLA-KQKQPESKLTSVVGTILYS 180

Query: 197 APELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
            PE+ + E Y E  D+++FG  + +M T + P+    N   +  K+   +       +  
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYS 239

Query: 256 PQVKQFIEKCIVP 268
             V   I  C+ P
Sbjct: 240 EDVTDVITSCLTP 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 93.0 bits (231), Expect = 1e-21
 Identities = 70/228 (30%), Positives = 116/228 (50%), Gaps = 14/228 (6%)

Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           +Y +  +I G+G+F        + DG +    ++NI  +  SP + E    EV +L ++K
Sbjct: 1   KYVKVKKI-GEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMK 57

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGLH 142
           H NI+++  S+ ++ N  I M  +    G L +     + V      I +W  QI   L 
Sbjct: 58  HPNIVQYQESFEENGNLYIVM--DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPEL 200
             H H+  I+HRD+K  NIF+   +G +K+GD G+A V+      AR+ IGTP +++PE+
Sbjct: 116 --HVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172

Query: 201 YEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
            E   YN   DI++ G  + EM T ++ + E  N   +  K+  G  P
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSYP 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 77/286 (26%), Positives = 131/286 (45%), Gaps = 38/286 (13%)

Query: 30  DEI-----LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           DEI     LGKG + +VYK      G+ +A  ++ +E       +  ++  E+ +L    
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAV 57

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGL 141
              I+ FY ++  +    + M  E   +GSL +        + +    ++     +++GL
Sbjct: 58  SPYIVDFYGAFFIEG--AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL 115

Query: 142 HYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL 200
            +L   HN  IIHRD+K  N+ VNGN G+VK+ D G++  +    A++ IG   +MAPE 
Sbjct: 116 KFLKEEHN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPER 172

Query: 201 YEEE-------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------P 247
            +         Y    D++S G+ ILEM    YPY     P + Y  + + +       P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANIFAQLSAIVDGDP 227

Query: 248 ASLSKVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKD 291
            +L        + F+ KC+  +P + R    +LL+ P+LV     D
Sbjct: 228 PTLPSGYSDDAQDFVAKCLNKIP-NRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 18/206 (8%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 84
           RY  +  +G+GA   V+K  D   G  VA  +V +  +    P+Q  R   E+  L++ +
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR---EIKALQACQ 57

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H  ++K  + +   +     ++ E   S      R + + +    +K++ R +L+G+ Y+
Sbjct: 58  HPYVVKLLDVFPHGSG--FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV---IGTPEFMAPELY 201
           H++   I+HRDLK  N+ +   +G +KI D GLA +  +   R     + T  + APEL 
Sbjct: 116 HANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 202 --EEEYNELVDIYSFGMCIL-EMVTC 224
               +Y+  VD+++ G CI  E++  
Sbjct: 173 YGARKYDPGVDLWAVG-CIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 92.5 bits (230), Expect = 3e-21
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 21/203 (10%)

Query: 32  ILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +LG GAF TVYKG    +G    I VA   +  E    SP   + +  E +++ S+ H +
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE---TSPKANKEILDEAYVMASVDHPH 70

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHS 146
           +++     +   +  + +IT+L   G L  Y + HK N+  + + NW  QI +G+ YL  
Sbjct: 71  VVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT----P-EFMAPE-L 200
               ++HRDL   N+ V      VKI D GLA  +     +         P ++MA E +
Sbjct: 128 KR--LVHRDLAARNVLVKTPQ-HVKITDFGLA-KLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 201 YEEEYNELVDIYSFGMCILEMVT 223
               Y    D++S+G+ + E++T
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 92.5 bits (230), Expect = 3e-21
 Identities = 63/205 (30%), Positives = 117/205 (57%), Gaps = 23/205 (11%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 84
           +Y+++  +G+G + TV+K  +      VA  +V ++D  +  P    R   E+ LLK LK
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELK 57

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHY 143
           H+NI++ Y+  V  +++ + ++ E +    L++Y    + ++D + +K++  Q+L+GL +
Sbjct: 58  HKNIVRLYD--VLHSDKKLTLVFE-YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPE 199
            HSHN  ++HRDLK  N+ +N  NGE+K+ D GLA    I ++  +A  V  T  +  P+
Sbjct: 115 CHSHN--VLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPD 169

Query: 200 --LYEEEYNELVDIYSFGMCIL-EM 221
                + Y+  +D++S G CI  E+
Sbjct: 170 VLFGAKLYSTSIDMWSAG-CIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 14/198 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+G++ TVYKG  ++ G  VA  ++ +E    +P    R   E  LLK LKH NI+ 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVT 67

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNP 149
            ++  +  T +T+ ++ E +    L+QY       + M  ++ +  Q+LRGL Y H    
Sbjct: 68  LHD--IIHTKKTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR- 123

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEY 205
            ++HRDLK  N+ ++   GE+K+ D GLA     P  T  + + T  +  P+  L   EY
Sbjct: 124 -VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 206 NELVDIYSFGMCILEMVT 223
           +  +D++  G    EM T
Sbjct: 182 STSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 66/196 (33%), Positives = 102/196 (52%), Gaps = 14/196 (7%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG+G + TV+KG  ++    VA  ++ +E    +P    R   EV LLK+LKH NI+  +
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKNLKHANIVTLH 69

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPI 151
           +  +  T R + ++ E   S  L+QY     N+  M  +K +  Q+LRGL Y H     I
Sbjct: 70  D--IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--I 124

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEYNE 207
           +HRDLK  N+ +N   GE+K+ D GLA     PT    + + T  +  P+  L   EY+ 
Sbjct: 125 LHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 208 LVDIYSFGMCILEMVT 223
            +D++  G  + EM T
Sbjct: 184 PIDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 89.0 bits (221), Expect = 3e-20
 Identities = 67/238 (28%), Positives = 104/238 (43%), Gaps = 52/238 (21%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYS----EVHLL 80
           + LG G+F  V +G          W+      V+         D+L  +      E  ++
Sbjct: 1   KKLGDGSFGVVRRG---------EWSTSG-GKVIPVAVKCLKSDKLSDIMDDFLKEAAIM 50

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQIL 138
            SL HEN+I+ Y   +      + M+TEL   GSL    +K       +  + ++A QI 
Sbjct: 51  HSLDHENLIRLYGVVLTH---PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA 107

Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------IVMQQ----PT 185
            G+ YL S     IHRDL   NI +  ++ +VKIGD GL           VM++    P 
Sbjct: 108 NGMRYLESKR--FIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164

Query: 186 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241
           A        + APE L    ++   D++ FG+ + EM T  E P+    + +QI KK+
Sbjct: 165 A--------WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 89.0 bits (220), Expect = 4e-20
 Identities = 72/261 (27%), Positives = 122/261 (46%), Gaps = 20/261 (7%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G +  VYK  +   G   A   + +E      +    +  E+ ++K  KH NI+ ++
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLE----PGEDFAVVQQEIIMMKDCKHSNIVAYF 72

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S++      I M  E    GSL+        +    I   +R+ L+GL+YLHS     +
Sbjct: 73  GSYLRRDKLWICM--EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--M 128

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE----YN 206
           HRD+K  NI +  +NG VK+ D G++  +    A+  S IGTP +MAPE+   E    YN
Sbjct: 129 HRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187

Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS---KVTDPQVKQFIE 263
           +L DI++ G+  +E+   + P  +      ++    S  +P  L    K ++     F++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN-SFHHFVK 246

Query: 264 KCIVPASLRLPALE-LLKDPF 283
             +     + P  E LL+ PF
Sbjct: 247 MALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 89.0 bits (221), Expect = 5e-20
 Identities = 75/267 (28%), Positives = 131/267 (49%), Gaps = 20/267 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENII 89
           E LG+GA+  V K      G  +A  +  I   + S +Q +RL  ++ + ++S+     +
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKR--IRATVNSQEQ-KRLLMDLDISMRSVDCPYTV 63

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK----AIKNWARQILRGLHYLH 145
            FY +   + +  I M  E+  + SL ++ KK  +  +      +   A  I++ L YLH
Sbjct: 64  TFYGALFREGDVWICM--EVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYEEE 204
           S    +IHRD+K  N+ +N  NG+VK+ D G++  +    A+++  G   +MAPE    E
Sbjct: 121 S-KLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPE 178

Query: 205 -----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
                Y+   D++S G+ ++E+ T  +PY+  K P Q  K+V     P   ++   P+ +
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQ 238

Query: 260 QFIEKCIVPASLRLPAL-ELLKDPFLV 285
            F+ KC+       P   ELL+ PF  
Sbjct: 239 DFVNKCLKKNYKERPNYPELLQHPFFE 265

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 88.9 bits (220), Expect = 6e-20
 Identities = 63/196 (32%), Positives = 103/196 (52%), Gaps = 14/196 (7%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG+G + TVYKG  ++    VA  ++ +E    +P    R   EV LLK LKH NI+  +
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVTLH 70

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPI 151
           +  +  T +++ ++ E +    L+QY     N ++M  +K +  Q+LRGL+Y H     +
Sbjct: 71  D--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--V 125

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEYNE 207
           +HRDLK  N+ +N   GE+K+ D GLA     PT    + + T  +  P+  L   +Y+ 
Sbjct: 126 LHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184

Query: 208 LVDIYSFGMCILEMVT 223
            +D++  G    EM T
Sbjct: 185 QIDMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 24/275 (8%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G   +V K      G  +A   V+I        Q+ R   E+ ++   +   I+ FY
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR---ELQIMHECRSPYIVSFY 69

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPI 151
            +++++ N  I M  E    GSL +  KK   + ++ +   A  ++ GL YL++ H   I
Sbjct: 70  GAFLNENN--ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--I 125

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVD 210
           +HRD+K  NI VN   G++K+ D G++  +    A + +GT  +M+PE +   +Y    D
Sbjct: 126 MHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184

Query: 211 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------KPASLSKVTDPQV-K 259
           ++S G+ I+E+   ++P+    N     +    GI           P  L     P+  +
Sbjct: 185 VWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243

Query: 260 QFIEKCIV--PASLRLPALELLKDPFLVTDNPKDL 292
            F++ C++  P     P       PF+      ++
Sbjct: 244 DFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 87.6 bits (217), Expect = 1e-19
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 16/200 (8%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 62

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 63  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEE 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE  L  +
Sbjct: 120 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176

Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 177 YYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 17/255 (6%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G +  VYK  +   G   A   + +E      D    +  E+ ++K  KH NI+ ++
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLE----PGDDFSLIQQEIFMVKECKHCNIVAYF 72

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S++      I M  E    GSL+        +    I    R+ L+GL YLHS     +
Sbjct: 73  GSYLSREKLWICM--EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--M 128

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE----YN 206
           HRD+K  NI +  +NG+VK+ D G+A  +    A+  S IGTP +MAPE+   E    YN
Sbjct: 129 HRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187

Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQFIEK 264
           +L DI++ G+  +E+   + P  +      ++    S  +P  L   T        F++ 
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKI 247

Query: 265 CIVPASLRLPALELL 279
            +     + P  E L
Sbjct: 248 SLTKNPKKRPTAERL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 32/269 (11%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQV--NIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
            +G GA  TVYK      G   A   +  N ED ++   Q+ R   E+ +L+ + H N++
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR--QICR---EIEILRDVNHPNVV 135

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           K ++ +  D N  I ++ E    GSL       +    + + + ARQIL G+ YLH  + 
Sbjct: 136 KCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADE----QFLADVARQILSGIAYLHRRH- 188

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---PTARSVIGTPEFMAPELYEEEYN 206
            I+HRD+K  N+ +N     VKI D G++ ++ Q   P   SV GT  +M+PE    + N
Sbjct: 189 -IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLN 245

Query: 207 ELV------DIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSGIKPASLSKVTDPQV 258
                    DI+S G+ ILE     +P+   +    A +   +     P + +  +  + 
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS-REF 304

Query: 259 KQFIEKCIV--PASLRLPALELLKDPFLV 285
           + FI  C+   PA  R  A++LL+ PF++
Sbjct: 305 RHFISCCLQREPAK-RWSAMQLLQHPFIL 332

Length = 353

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 64/255 (25%), Positives = 125/255 (49%), Gaps = 18/255 (7%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G F  V++G  + + + VA   +  +D+++     +    EV  LK L+H+++I  +
Sbjct: 14  LGSGYFGEVWEGLWK-NRVRVAIKILKSDDLLK----QQDFQKEVQALKRLRHKHLISLF 68

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V      + +ITEL   GSL  + +  + + + + ++ + A Q+  G+ YL   N  
Sbjct: 69  A--VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN-- 124

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNE 207
            IHRDL   NI V G +   K+ D GLA ++++    +       ++ APE      ++ 
Sbjct: 125 SIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST 183

Query: 208 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266
             D++SFG+ + EM T  + PY    N  ++Y ++T+G +    +K    ++ + + +C 
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGYRMPCPAKCP-QEIYKIMLECW 241

Query: 267 VPASLRLPALELLKD 281
                  P+ + L++
Sbjct: 242 AAEPEDRPSFKALRE 256

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 22/203 (10%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  D++ G  VA  ++ +E   +  P    R   E+ LLK L H NI+
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIV 61

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           +  +    +    + ++ E F    L++Y        +D   IK++  Q+L+G+ Y HSH
Sbjct: 62  RLLDVVHSENK--LYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPE--LY 201
              ++HRDLK  N+ ++   G +K+ D GLA    + ++  T   V  T  + APE  L 
Sbjct: 119 R--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 173

Query: 202 EEEYNELVDIYSFGMCIL-EMVT 223
             +Y+  VDI+S G CI  EMV 
Sbjct: 174 SRQYSTPVDIWSIG-CIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 87.1 bits (215), Expect = 3e-19
 Identities = 65/197 (32%), Positives = 106/197 (53%), Gaps = 14/197 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG+G++ TVYKG  +V+G  VA   + +++   +P    R   E  LLK LKH NI+ 
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLKGLKHANIVL 67

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNP 149
            ++  +  T  T+ ++ E +    L QY  KH   +  + +K +  Q+LRGL Y+H    
Sbjct: 68  LHD--IIHTKETLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY- 123

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEY 205
            I+HRDLK  N+ ++ + GE+K+ D GLA     P  T  + + T  +  P+  L   EY
Sbjct: 124 -ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 206 NELVDIYSFGMCILEMV 222
           +  +D++  G   +EM+
Sbjct: 182 STCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 75/249 (30%), Positives = 121/249 (48%), Gaps = 24/249 (9%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 75

Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 76  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 133

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAP 198
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA    + T   + G   T  + AP
Sbjct: 134 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA----RHTDDEMTGYVATRWYRAP 186

Query: 199 ELYEE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVT 254
           E+      YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246

Query: 255 DPQVKQFIE 263
               + +I+
Sbjct: 247 SESARNYIQ 255

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 18/208 (8%)

Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHE 86
           +LGKG+F  V     KG +E   I+     V +ED     D +E    E  +L  + +H 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED-----DDVECTMVERRVLALAWEHP 56

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            +   + ++   T   +  + E    G L  + +     D    + +A +I+ GL +LH 
Sbjct: 57  FLTHLFCTF--QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-E 203
               II+RDLK DN+ ++  +G +KI D G+    +  +  A +  GTP+++APE+ + +
Sbjct: 115 KG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171

Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNEC 231
           +YNE VD +SFG+ + EM+  + P++  
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 85.8 bits (212), Expect = 4e-19
 Identities = 59/177 (33%), Positives = 86/177 (48%), Gaps = 10/177 (5%)

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNW 133
           E  LL  +KH NI+ F  S+  D +  I M  E    G L Q  K  +        I  W
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVM--EYCDGGDLMQKIKLQRGKLFPEDTILQW 105

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IG 191
             Q+  G+   H H   ++HRD+K  NIF+   NG+VK+GD G A ++  P A +   +G
Sbjct: 106 FVQMCLGVQ--HIHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVG 162

Query: 192 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
           TP ++ PE++E   YN   DI+S G  + E+ T ++P+        I K      KP
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 86.6 bits (214), Expect = 4e-19
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 14/198 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG+G + TV+KG  ++    VA  ++ +E    +P    R   EV LLK LKH NI+ 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNP 149
            ++  +  T++++ ++ E +    L+QY     N+  M  +K +  QILRGL Y H    
Sbjct: 69  LHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEY 205
            ++HRDLK  N+ +N   GE+K+ D GLA     PT    + + T  +  P+  L   EY
Sbjct: 125 -VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 206 NELVDIYSFGMCILEMVT 223
           +  +D++  G    EM +
Sbjct: 183 STQIDMWGVGCIFFEMAS 200

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 85.2 bits (211), Expect = 8e-19
 Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 36/263 (13%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQ---VNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           LG G F  V++G          WN    V ++ +       +   +E  ++K L+H  +I
Sbjct: 14  LGAGQFGEVWEGL---------WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLI 64

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           + Y   V      I ++TEL   GSL +Y      + + +  + + A Q+  G+ YL + 
Sbjct: 65  QLYA--VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPELYEEE 204
           N   IHRDL   N+ V G N   K+ D GLA V+++    AR     P ++ APE     
Sbjct: 123 N--YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE--AAL 177

Query: 205 YNELV---DIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---PASLSKVTDPQ 257
           YN      D++SFG+ + E+VT    PY    N A++ ++V  G +   P         +
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQGYRMPCPPG----CPKE 232

Query: 258 VKQFIEKCIVPASLRLPALELLK 280
           +   +  C        P  E L+
Sbjct: 233 LYDIMLDCWKEDPDDRPTFETLQ 255

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.3 bits (211), Expect = 8e-19
 Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 21/211 (9%)

Query: 25  RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           RY +   +LG+G F  V    Y   ++  G  VA   +  E              E+++L
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINIL 60

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           K+L HENI+K+     +   + + +I E    GSLR Y  KH  +++  +  +A+QI  G
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEG 119

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------RSVIGTPE 194
           + YLHS +   IHRDL   N+ ++ N+  VKIGD GLA  +  P        R    +P 
Sbjct: 120 MAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAV--PEGHEYYRVREDGDSPV 174

Query: 195 F-MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           F  A E L E +++   D++SFG+ + E++T
Sbjct: 175 FWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 9e-19
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 30/215 (13%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQL--ERLYSEVHLLK 81
           RY     +G+GA+  V     +  G++VA  ++       SP   Q   +R   E+ +L+
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFEHQTFCQRTLREIKILR 58

Query: 82  SLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
             KHENII   +     +  + N   ++ EL  +   +  + +H + D   I+ +  QIL
Sbjct: 59  RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH--IQYFLYQIL 116

Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTP 193
           RGL Y+HS N  ++HRDLK  N+ +N  N ++KI D GLA +       +      + T 
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 194 EFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTCE 225
            + APE  L  + Y + +DI+S G CIL EM++  
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVG-CILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 33/290 (11%)

Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           RY +  E++GKG++  V    D   G +VA  ++N  DV +      R+  E+ LL+ L+
Sbjct: 1   RY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN--DVFEHVSDATRILREIKLLRLLR 57

Query: 85  HENIIKFYNSWVDDTNRT---INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           H +I++  +  +  + R    I ++ EL  S  L Q  K + ++  +  + +  Q+LR L
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-----IGTPEFM 196
            Y+H+ N  + HRDLK  NI  N  + ++KI D GLA V    T  ++     + T  + 
Sbjct: 117 KYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 197 APEL---YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASL 250
           APEL   +  +Y   +DI+S G CI   V    P    KN       +T  +    P ++
Sbjct: 174 APELCGSFFSKYTPAIDIWSIG-CIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232

Query: 251 SKVTDPQVKQFI----EKCIVPASLRLP-----ALELLKDPFLVTDNPKD 291
           S+V + + ++++    +K  VP S + P     AL LL+   L+  +PKD
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLER--LLAFDPKD 280

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 50/141 (35%), Positives = 73/141 (51%), Gaps = 5/141 (3%)

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           I+ FY ++  D   +I M  E    GSL Q  KK   +    +   +  +LRGL YL   
Sbjct: 61  IVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE- 117

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYN 206
              I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M+PE L    Y 
Sbjct: 118 KHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYT 176

Query: 207 ELVDIYSFGMCILEMVTCEYP 227
              DI+S G+ ++EM    YP
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 25/212 (11%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
           +Y+ +  LGKGA+  V+K  D      VA  +  I D  ++    +R + E+  L+ L  
Sbjct: 8   KYEILQKLGKGAYGIVWKAIDRRTKEVVALKK--IFDAFRNATDAQRTFREIMFLQELGD 65

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           H NI+K  N    + ++ I ++ E   +  L    + +  ++V  + I     Q+L+ L 
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYI---MYQLLKALK 121

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQQPTARSVIGTPEF 195
           Y+HS N  +IHRDLK  NI +N ++  VK+ D GLA          + P     + T  +
Sbjct: 122 YIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178

Query: 196 MAPE--LYEEEYNELVDIYSFGMCIL-EMVTC 224
            APE  L    Y + VD++S G CIL EM+  
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVG-CILGEMLLG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 30/210 (14%)

Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQV-NIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
            E +G GA+  V    D   G +VA  ++ +  DV       +R   E+ +L+  KH+NI
Sbjct: 10  IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA---KRTLRELKILRHFKHDNI 66

Query: 89  IKFYNSWVDDTNRT-------INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           I      + D  R        + ++ +L  S  L       + +  + I+ +  Q+LRGL
Sbjct: 67  IA-----IRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGL 120

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSV-----IGTPEF 195
            Y+HS N  +IHRDLK  N+ VN  + E++IGD G+A  +   PT         + T  +
Sbjct: 121 KYIHSAN--VIHRDLKPSNLLVNE-DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177

Query: 196 MAPELY--EEEYNELVDIYSFGMCIL-EMV 222
            APEL     EY   +D++S G CI  EM+
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVG-CIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 76/340 (22%), Positives = 142/340 (41%), Gaps = 58/340 (17%)

Query: 27  GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            RY ++  LG G+   V+   D      VA  ++    V+  P  ++    E+ +++ L 
Sbjct: 5   SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI----VLTDPQSVKHALREIKIIRRLD 60

Query: 85  HENIIKFYNSWVD---DTNRTINMITELFTSGSLRQYRK-------KHKNVDMKAIKNWA 134
           H+NI+K Y        D    +  +TEL +   +++Y +       +   +  +  + + 
Sbjct: 61  HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM 120

Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----V 189
            Q+LRGL Y+HS N  ++HRDLK  N+F+N  +  +KIGD GLA ++    +        
Sbjct: 121 YQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178

Query: 190 IGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTC---------------------- 224
           + T  + +P   L    Y + +D+++ G CI  EM+T                       
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKPLFAGAHELEQMQLILESVPV 237

Query: 225 --EYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIVPASL-RLPALEL 278
             E   NE  N    + +   G     L  +    +P+   F+E+ +    + RL A E 
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA 297

Query: 279 LKDPFL-VTDNPKD--LVCDPLRLPNLVPEVMNLAHSEPH 315
           L  P++     P D  +   P  + + + +++ +      
Sbjct: 298 LMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSI 337

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 14/199 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
            ++G+GA+  V K  ++  G  VA  +    +     D  +    EV +L+ L+HENI+ 
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLRHENIVN 64

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              ++       + ++ E      L         +   A++++  Q+L+ + Y HSHN  
Sbjct: 65  LKEAFRRK--GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN-- 120

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELY--EEEY 205
           IIHRD+K +NI V+  +G +K+ D G A  ++   A      + T  + APEL   +  Y
Sbjct: 121 IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179

Query: 206 NELVDIYSFGMCIL-EMVT 223
            + VD+++ G CI+ E++ 
Sbjct: 180 GKPVDVWAIG-CIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 5e-18
 Identities = 58/262 (22%), Positives = 110/262 (41%), Gaps = 17/262 (6%)

Query: 35  KGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYN 93
           KGAF +VY       G   A   +   D M + +Q+  + +E  ++        + K Y 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSD-MIAKNQVTNVKAERAIMMIQGESPYVAKLY- 63

Query: 94  SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153
            +   +   + ++ E    G      K    +     K +  +++ G+  LH     IIH
Sbjct: 64  -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIH 120

Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIY 212
           RD+K +N+ ++   G +K+ D GL+    +   +  +GTP+++APE       +++ D +
Sbjct: 121 RDIKPENLLID-QTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETILGVGDDKMSDWW 177

Query: 213 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVP-A 269
           S G  I E +   YP    + P  ++  + S     P  + +   P+    I + +    
Sbjct: 178 SLGCVIFEFLF-GYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236

Query: 270 SLRLPA---LELLKDPFLVTDN 288
           + RL A    E+   PF  + N
Sbjct: 237 AKRLGANGYQEIKSHPFFKSIN 258

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 15/197 (7%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKF 91
           +G+G F  V K      G   A   +      +S +Q+  L  E+  L+ L  H NI++ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMK--KHFKSLEQVNNL-REIQALRRLSPHPNILRL 63

Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPP 150
                D     + ++ EL    +L +  K  K  +  K +K++  Q+L+ L ++H +   
Sbjct: 64  IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE--LYEEEYN 206
           I HRD+K +NI +  +   +K+ D G    I  + P     I T  + APE  L +  Y 
Sbjct: 121 IFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYT-EYISTRWYRAPECLLTDGYYG 177

Query: 207 ELVDIYSFGMCILEMVT 223
             +DI++ G    E+++
Sbjct: 178 PKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 23/201 (11%)

Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D  +G GAF  V+   D  DG  VA  +  + +V Q+    +R++ E+ +L   KH+N++
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKK--MPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62

Query: 90  KFYNSWVD-------DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
               S +D       D    I ++TEL  S  L +     + +    +K +  QILRGL 
Sbjct: 63  ----SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLK 117

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV---IGTPEFMAPE 199
           YLHS    I+HRD+K  N+ VN +N  +KI D GLA V +   ++ +   + T  + APE
Sbjct: 118 YLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174

Query: 200 LY--EEEYNELVDIYSFGMCI 218
           +      Y   VDI+S G CI
Sbjct: 175 ILMGSRHYTSAVDIWSVG-CI 194

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 82.7 bits (204), Expect = 9e-18
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 14/197 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG+G++ TVYKG   ++G  VA   ++++     P    R   E  LLK LKH NI+ 
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVL 67

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNP 149
            ++  +  T  T+  + E +    L QY  +H   +    ++ +  Q+LRGL Y+H  + 
Sbjct: 68  LHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH- 123

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEY 205
            I+HRDLK  N+ ++   GE+K+ D GLA     P  T  S + T  +  P+  L   +Y
Sbjct: 124 -ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181

Query: 206 NELVDIYSFGMCILEMV 222
           +  +DI+  G   +EM+
Sbjct: 182 SSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 82.2 bits (203), Expect = 9e-18
 Identities = 41/99 (41%), Positives = 63/99 (63%), Gaps = 6/99 (6%)

Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 190
           +  QI+ GL +LH     II+RDLK +N+ ++ N+G V+I DLGLA+ ++  Q   +   
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158

Query: 191 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPY 228
           GTP FMAPEL + EEY+  VD ++ G+ + EM+    P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 78/276 (28%), Positives = 130/276 (47%), Gaps = 35/276 (12%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENII 89
           E +GKG +  VYK  ++ DG   A   V I D +   D  E + +E ++L+SL  H N++
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAA---VKILDPISDVD--EEIEAEYNILQSLPNHPNVV 82

Query: 90  KFYNSWVDDTNRT---INMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLH 142
           KFY  +          + ++ EL   GS+ +  K      + +D   I       L GL 
Sbjct: 83  KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 200
           +LH  N  IIHRD+K +NI +    G VK+ D G++  +     R  + +GTP +MAPE+
Sbjct: 143 HLH--NNRIIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 199

Query: 201 ------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
                 Y+  Y+   D++S G+  +E+   + P  +  +P +   K+     P  L    
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVKTLFKIPRNPPPTLL---- 254

Query: 255 DPQ-----VKQFIEKCIVPASLRLPAL-ELLKDPFL 284
            P+        FI +C++      P++  LL+ PF+
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 84.8 bits (209), Expect = 1e-17
 Identities = 58/202 (28%), Positives = 108/202 (53%), Gaps = 29/202 (14%)

Query: 72  RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RQYRKKHK---NVDM 127
           +L  EV++++ LKH+NI+++ + +++  N+ + ++ E   +G L R  +K +K    ++ 
Sbjct: 58  QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117

Query: 128 KAIKNWARQILRGLHYLHS-----HNPPIIHRDLKCDNIFV--------------NGNNG 168
            AI +  RQ+L  L Y H+     +   ++HRDLK  NIF+              N  NG
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177

Query: 169 E--VKIGDLGLAI-VMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMV 222
               KIGD GL+  +  +  A S +GTP + +PEL   E   Y++  D+++ G  I E+ 
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 223 TCEYPYNECKNPAQIYKKVTSG 244
           + + P+++  N +Q+  ++  G
Sbjct: 238 SGKTPFHKANNFSQLISELKRG 259

Length = 1021

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 66/227 (29%), Positives = 99/227 (43%), Gaps = 42/227 (18%)

Query: 27  GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYSEVHLLK 81
             Y+ +  LG+G F  VYK      G  VA  ++   N +D    P    R   E+ +LK
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PITALR---EIKILK 62

Query: 82  SLKHENIIKFYNSWVDDTNRTINMITELFT---------SGSLRQYRKKHKNVDMKAIKN 132
            LKH N++   +  V+  +++      ++          SG L     K   +    IK 
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKC 119

Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARS 188
           +  Q+L G++YLH ++  I+HRD+K  NI ++ N G +KI D GLA         P    
Sbjct: 120 YMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 189 VIGTPEFM---------APELY--EEEYNELVDIYSFGMCIL-EMVT 223
             GT ++           PEL   E  Y   VDI+  G C+  EM T
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 35/228 (15%)

Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--- 75
               S RY +    LG+G +  V K +D + G  VA  +V I ++     +  +L     
Sbjct: 3   SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62

Query: 76  -------EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
                  E+ ++  +KHENI+   + +V+     IN++ ++  +  L++   +   +   
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYVEGD--FINLVMDIM-ASDLKKVVDRKIRLTES 119

Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------- 178
            +K    QIL GL+ LH      +HRDL   NIF+N + G  KI D GLA          
Sbjct: 120 QVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSD 176

Query: 179 -IVMQQPTARSVIGTPE-----FMAPELY--EEEYNELVDIYSFGMCI 218
            +   +   R    T +     + APEL    E+Y+  VD++S G CI
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG-CI 223

Length = 335

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 32  ILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK---SLK 84
           +LG+G F  V    YK   E+  I+     +   D++ + D++E L  E  + +   S +
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKA----LKKGDII-ARDEVESLMCEKRIFETANSER 60

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHY 143
           H  ++  +  +   T   +  + E    G L      H +V        +A  ++ GL Y
Sbjct: 61  HPFLVNLFACF--QTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQY 116

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPE-L 200
           LH +   I++RDLK DN+ ++   G VKI D GL         R+    GTPEF+APE L
Sbjct: 117 LHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL 173

Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            E  Y   VD +  G+ I EM+  E P+
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  D V    +A  ++ +E   +  P    R   E+ LLK ++H NI+
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR---EISLLKEMQHGNIV 64

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV------DMKAIKNWARQILRGLHY 143
           +  +  V  + + + ++ E      L    KKH +       + + IK +  QILRG+ Y
Sbjct: 65  RLQD--VVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-- 199
            HSH   ++HRDLK  N+ ++     +K+ D GLA     P  T    + T  + APE  
Sbjct: 118 CHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175

Query: 200 LYEEEYNELVDIYSFGMCILEMVT 223
           L    Y+  VDI+S G    EMV 
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 16/204 (7%)

Query: 28  RYDEIL--GKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY ++   G GA+ TV    D   G +VA  +  +    QS    +R Y E+ LLK +KH
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHMKH 73

Query: 86  ENIIKFYNSWVDDTNRTINMITELFT----SGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +  D +  ++   + +      G+      KH+ +    I+    Q+L+GL
Sbjct: 74  ENVIGLLDVFTPDLS--LDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-- 199
            Y+H+    IIHRDLK  N+ VN  + E+KI D GLA          V+ T  + APE  
Sbjct: 132 KYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSEMTGYVV-TRWYRAPEVI 187

Query: 200 LYEEEYNELVDIYSFGMCILEMVT 223
           L    Y + VDI+S G  + EM+T
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLT 211

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 40/216 (18%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIK 90
            +G+G +  VYK  D+  G  VA  +V +++  +  P    R   E+ +L+ L H NI+ 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIVN 70

Query: 91  FYNSWVDDTN--------RTINMITE--------LFTSGSLRQYRKKHKNVDMKAIKNWA 134
                 D  +            ++ E        L  SG L  + + H       IK++ 
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDH-------IKSFM 122

Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVI 190
           +Q+L GL+Y H  N   +HRD+KC NI +N N G++K+ D GLA +      +P    VI
Sbjct: 123 KQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 191 GTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 223
            T  +  PEL   EE Y   +D++S G CIL E+ T
Sbjct: 180 -TLWYRPPELLLGEERYGPAIDVWSCG-CILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 17/200 (8%)

Query: 30  DEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
              +G+G F  VY+G     E + I VA           SP   E+   E ++++   H 
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHP 67

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLH 145
           +I+K      ++    + ++ EL   G LR Y + +K  +D+ ++  ++ Q+   L YL 
Sbjct: 68  HIVKLIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTP-EFMAPE-LY 201
           S     +HRD+   N+ V+  +  VK+GD GL+  ++  +    S    P ++MAPE + 
Sbjct: 125 SKR--FVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181

Query: 202 EEEYNELVDIYSFGMCILEM 221
              +    D++ FG+C+ E+
Sbjct: 182 FRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 67/203 (33%), Positives = 106/203 (52%), Gaps = 21/203 (10%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYKG ++  G  VA  ++ +E   +  P    R   E+ LLK L+H NI+
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR---EISLLKELQHPNIV 62

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYR---KKHKNVDMKAIKNWARQILRGLHYLHS 146
              +  + + +R + +I E F S  L++Y     K + +D + +K++  QIL+G+ + HS
Sbjct: 63  CLQDVLMQE-SR-LYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPE--L 200
               ++HRDLK  N+ ++ N G +K+ D GLA     P    T   V  T  + APE  L
Sbjct: 120 RR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLL 174

Query: 201 YEEEYNELVDIYSFGMCILEMVT 223
               Y+  VDI+S G    EM T
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 80.3 bits (198), Expect = 7e-17
 Identities = 68/244 (27%), Positives = 118/244 (48%), Gaps = 21/244 (8%)

Query: 31  EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKH 85
           ++LGKG+F  V     KG DEV  I+V    V ++D     D ++   +E  +L  + KH
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD-----DDVDCTMTEKRILALAAKH 55

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
             +   +  +   T   +  + E    G L    ++ +  D    + +A ++   L +LH
Sbjct: 56  PFLTALHCCF--QTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYE 202
            H   +I+RDLK DNI ++   G  K+ D G+    ++   T  +  GTP+++APE L E
Sbjct: 114 RHG--VIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE 170

Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQ 260
            EY   VD ++ G+ + EM+  + P+ E  N   +++ +     + P  LSK     +K 
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKA 229

Query: 261 FIEK 264
           F+ K
Sbjct: 230 FMTK 233

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 79.9 bits (197), Expect = 8e-17
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 18/206 (8%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHEN-I 88
           E +G+G +  VYK  D+  G  VA  +  +E D    P    R   E+ LL+ L     I
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR---EISLLQMLSESIYI 63

Query: 89  IKFYN-SWVDDTNRTINM-ITELFTSGSLRQY-----RKKHKNVDMKAIKNWARQILRGL 141
           ++  +   V++ N   ++ +   +    L+++     R   + +  K IK++  Q+L+G+
Sbjct: 64  VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IGTPEFMAPE 199
            + H H   ++HRDLK  N+ V+   G +KI DLGL      P       I T  + APE
Sbjct: 124 AHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181

Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             L    Y+  VDI+S G    EM  
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSR 207

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 18/205 (8%)

Query: 32  ILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHE 86
           +LGKG+F  V     KG DE+  ++V    V ++D     D +E   +E  +L  + KH 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD-----DDVECTMTEKRVLALAGKHP 56

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            + + ++ +   T   +  + E    G L  + ++    D    + +A +I+ GL +LH 
Sbjct: 57  FLTQLHSCF--QTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEE 203
               II+RDLK DN+ ++   G +KI D G+    ++   T  +  GTP+++APE L  +
Sbjct: 115 RG--IIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171

Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y   VD ++ G+ + EM+  + P+
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 72/276 (26%), Positives = 130/276 (47%), Gaps = 35/276 (12%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 89
           E +GKG +  V+K  ++ +G + A   V I D +   D  E + +E ++LK+L  H N++
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAA---VKILDPIHDID--EEIEAEYNILKALSDHPNVV 78

Query: 90  KFYNSWVDDTNRT---INMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLH 142
           KFY  +     +    + ++ EL   GS+    + + K+ + ++   I     + L GL 
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 200
           +LH      IHRD+K +NI +    G VK+ D G++  +     R  + +GTP +MAPE+
Sbjct: 139 HLH--VNKTIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195

Query: 201 YEEE------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
              E      Y+   D++S G+  +E+   + P  +  +P +   K+     P     + 
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPRNPPP----TLH 250

Query: 255 DPQV-----KQFIEKCIVPA-SLRLPALELLKDPFL 284
            P++       FI KC+      R    +LL+  F+
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 66/256 (25%), Positives = 116/256 (45%), Gaps = 25/256 (9%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G F  V+ G      I+VA   +  E  M   D +E    E  ++  L H N+++ Y
Sbjct: 12  LGSGQFGVVHLGKWR-GKIDVAIKMIR-EGAMSEDDFIE----EAKVMMKLSHPNLVQLY 65

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPI 151
              V    R I ++TE   +G L  Y ++ K     + + +    +   + YL S+    
Sbjct: 66  G--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--F 121

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP-EFMAPELYE-EEYNE 207
           IHRDL   N  V G +  VK+ D GLA  ++  Q T+      P ++  PE+++   ++ 
Sbjct: 122 IHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 208 LVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIE 263
             D++SFG+ + E+ +  + PY    N +++ + V++G    +P    K+   +V   + 
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSAGYRLYRP----KLAPTEVYTIMY 235

Query: 264 KCIVPASLRLPALELL 279
            C        PA + L
Sbjct: 236 SCWHEKPEDRPAFKKL 251

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 77/328 (23%), Positives = 138/328 (42%), Gaps = 49/328 (14%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G+GA+  V    +     +VA  +  I +   +    +R   E+ LL+ L HEN+I   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKK--IANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 93  NSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           +          N   ++ EL  +  L Q  +  + +     + +  Q+LRGL Y+HS N 
Sbjct: 71  DIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN- 128

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----------APE 199
            ++HRDLK  N+ +N N  ++KI D GL        AR+     +FM          APE
Sbjct: 129 -VLHRDLKPSNLLLNANC-DLKICDFGL--------ARTTSEKGDFMTEYVVTRWYRAPE 178

Query: 200 LY--EEEYNELVDIYSFGMCIL-EMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVT 254
           L     EY   +D++S G CI  E++  +  +P  +  +  ++  ++        L  + 
Sbjct: 179 LLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237

Query: 255 DPQVKQFIEKCIVPASLRLP-----------ALELLKDPFLVTDNPKDL-VCDPLRLPNL 302
           + + +++I    +P + R             A++LL +  LV D  K + V + L  P L
Sbjct: 238 NEKARRYIRS--LPYTPRQSFARLFPHANPLAIDLL-EKMLVFDPSKRITVEEALAHPYL 294

Query: 303 VP-EVMNLAHSEPHPMDIDLNHKKVSAD 329
                 +       P   D     ++ +
Sbjct: 295 ASLHDPSDEPVCQTPFSFDFEEDALTEE 322

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 39/207 (18%)

Query: 36  GAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNS 94
           G +  VY+  D+  G  VA  ++ +E   +  P    R   E+++L  L+H NI+     
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR---EINILLKLQHPNIVTVKEV 72

Query: 95  WVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA-------------IKNWARQILRGL 141
            V      I M+ E            +H   D+K+             +K    Q+L G+
Sbjct: 73  VVGSNLDKIYMVMEYV----------EH---DLKSLMETMKQPFLQSEVKCLMLQLLSGV 119

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE 199
            +LH +   I+HRDLK  N+ +N N G +KI D GLA     P      ++ T  + APE
Sbjct: 120 AHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPE 176

Query: 200 LY--EEEYNELVDIYSFGMCIL-EMVT 223
           L    +EY+  +D++S G CI  E++T
Sbjct: 177 LLLGAKEYSTAIDMWSVG-CIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 34/204 (16%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--EVHLLKSLKHENII 89
            +G+G +  VY+  D   G  VA  +V ++      D +  + S  E+ LL +L+H NI+
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMD---NERDGIP-ISSLREITLLLNLRHPNIV 69

Query: 90  KFYNSWVDDTNRTINMITELFTS--GSLRQYRKKHKNVDMKA------IKNWARQILRGL 141
           +     V     +I ++ E       SL          +M        +K    Q+LRGL
Sbjct: 70  ELKEVVVGKHLDSIFLVMEYCEQDLASLLD--------NMPTPFSESQVKCLMLQLLRGL 121

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMA 197
            YLH +   IIHRDLK  N+ +    G +KI D GLA     P    T + V  T  + A
Sbjct: 122 QYLHENF--IIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRA 176

Query: 198 PELY--EEEYNELVDIYSFGMCIL 219
           PEL      Y   +D+++ G CIL
Sbjct: 177 PELLLGCTTYTTAIDMWAVG-CIL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 55/205 (26%), Positives = 103/205 (50%), Gaps = 19/205 (9%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD--QLERL-YSEVHLLKS 82
           +Y+++  +G+G++  V+K  +   G  VA     I+  ++S D   ++++   E+ +LK 
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVA-----IKKFVESEDDPVIKKIALREIRMLKQ 56

Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           LKH N++      V    R ++++ E      L +  K  + V    IK    Q L+ ++
Sbjct: 57  LKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 200
           + H HN   IHRD+K +NI +    G++K+ D G A ++  P       + T  + APEL
Sbjct: 115 FCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL 171

Query: 201 Y--EEEYNELVDIYSFGMCILEMVT 223
              + +Y   VD+++ G    E++T
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 8/196 (4%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G    V+K   +  G+ +A   +++E     P    ++  E+ +L       I+ FY
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 69

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++  D   +I M  E    GSL Q  KK   +  + +   +  +++GL YL   +  I+
Sbjct: 70  GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 126

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M+PE L    Y+   DI
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185

Query: 212 YSFGMCILEMVTCEYP 227
           +S G+ ++EM    YP
Sbjct: 186 WSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 8/196 (4%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G    V K   +  G+ +A   +++E     P    ++  E+ +L       I+ FY
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 69

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++  D   +I M  E    GSL Q  K+ K +  + +   +  +LRGL YL   +  I+
Sbjct: 70  GAFYSDGEISICM--EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ-IM 126

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M+PE L    Y+   DI
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185

Query: 212 YSFGMCILEMVTCEYP 227
           +S G+ ++E+    YP
Sbjct: 186 WSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 20/222 (9%)

Query: 33  LGKGAFKTVYKG-FDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           LG G F +V KG +    G  +EVA   +  E +     +  R   E  ++  L H  I+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPCIV 59

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           +       +    + ++ EL   G L +Y KK + + +  +K  A Q+  G+ YL S + 
Sbjct: 60  RLIGVCKGEP---LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH- 115

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTP-EFMAPE-LYEE 203
             +HRDL   N+ +  N  + KI D G++  +        A +    P ++ APE +   
Sbjct: 116 -FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173

Query: 204 EYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           +++   D++S+G+ + E  +    PY E K   ++   + SG
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLESG 214

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 28/208 (13%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           LG G F  V+ G          WN   +V ++ +       E    E  ++K L+H+ ++
Sbjct: 14  LGAGQFGEVWMGT---------WNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLV 64

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH 147
           + Y   V      I ++TE  + GSL  + K    K + +  + + A QI  G+ YL S 
Sbjct: 65  QLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE--LYE 202
           N   IHRDL   NI V G N   KI D GLA +++    TAR     P ++ APE   Y 
Sbjct: 123 N--YIHRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY- 178

Query: 203 EEYNELVDIYSFGMCILEMVT---CEYP 227
             +    D++SFG+ + E+VT     YP
Sbjct: 179 GRFTIKSDVWSFGILLTEIVTYGRVPYP 206

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 75/208 (36%), Positives = 105/208 (50%), Gaps = 22/208 (10%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 84
           +Y+ +  +G GA+ TVYK  D   G  VA   V ++      P    R   EV LLK L+
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR---EVALLKRLE 57

Query: 85  ---HENIIKFYNSWVDDTNRTIN--MITELF--TSGSLRQYRKK--HKNVDMKAIKNWAR 135
              H NI++  +  V  T+RT     +T +F      LR Y  K     +  + IK+  R
Sbjct: 58  AFDHPNIVRLMD--VCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMR 115

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPE 194
           Q LRGL +LH++   I+HRDLK +NI V  + G+VK+ D GLA I   Q     V+ T  
Sbjct: 116 QFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLW 172

Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEM 221
           + APE L +  Y   VD++S G    EM
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 69/265 (26%), Positives = 119/265 (44%), Gaps = 21/265 (7%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G+GAF TV K   +  G  +A  ++      +   +L  +  +V +++S     I+KFY
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRL-LMDLDV-VMRSSDCPYIVKFY 69

Query: 93  NSWVDDTNRTINMITELFTSGSL-----RQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +   + +  I M  EL    SL       Y      +  + +   A   ++ L+YL   
Sbjct: 70  GALFREGDCWICM--ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE- 125

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYEEE-- 204
              IIHRD+K  NI ++  NG +K+ D G++  +    A++   G   +MAPE  +    
Sbjct: 126 ELKIIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAR 184

Query: 205 --YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQVK 259
             Y+   D++S G+ + E+ T ++PY +  +      +V  G   I   S  +   P   
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFV 244

Query: 260 QFIEKCIVP-ASLRLPALELLKDPF 283
            FI  C++   S R    ELL+ PF
Sbjct: 245 NFINLCLIKDESKRPKYKELLEHPF 269

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 52/154 (33%), Positives = 83/154 (53%), Gaps = 9/154 (5%)

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           E  LL+++ H ++I+  ++ V  +     M+   ++S       K+ + + +       +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPE 194
           QIL GL YLH+    IIHRD+K +NIF+N  + +V IGDLG A   +  P    + GT E
Sbjct: 165 QILEGLRYLHAQR--IIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVE 221

Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
             APE L  ++YN   DI+S G+ + EM+   YP
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLA--YP 253

Length = 357

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 79.5 bits (196), Expect = 4e-16
 Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 43/240 (17%)

Query: 16  EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
           E + K+ + +Y     +LG GA  TV       DG   A   V++E +  S     R  +
Sbjct: 24  EATAKEQAKKY-WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQA 80

Query: 76  EVHLLKSLKHENIIKFYNSWV--DDTN----RTINMITELFTSGSLRQYRKKHKNVDMKA 129
           EV  L +    +I+K +  +   D  N      I ++ +   +G LRQ            
Sbjct: 81  EVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQ-----------E 129

Query: 130 IKNWAR---------------QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174
           IK+ A+               Q+L  +H++HS +  +IHRD+K  NI +  +NG VK+GD
Sbjct: 130 IKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILL-CSNGLVKLGD 186

Query: 175 LGL----AIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYN 229
            G     A  +     R+  GTP ++APE++  + Y++  D++S G+ + E++T + P++
Sbjct: 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 78.6 bits (193), Expect = 4e-16
 Identities = 71/239 (29%), Positives = 116/239 (48%), Gaps = 16/239 (6%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G GA+ +V   +D     +VA  +++     QS     R Y E+ LLK +KHEN+I   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLS--RPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 93  NSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           + +   T+      + ++T L     L    K  K  D + ++    Q+LRGL Y+HS  
Sbjct: 81  DVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSD-EHVQFLIYQLLRGLKYIHSAG 138

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYN 206
             IIHRDLK  N+ VN  + E++I D GLA           + T  + APE  L    YN
Sbjct: 139 --IIHRDLKPSNVAVN-EDCELRILDFGLARQADDEMT-GYVATRWYRAPEIMLNWMHYN 194

Query: 207 ELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263
           + VDI+S G  + E++  +  +P N+  +  +   +V     P  L K++    +++I+
Sbjct: 195 QTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.4 bits (191), Expect = 5e-16
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 17/202 (8%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER---LYSEVHLLKSLKHEN 87
            ++G+G++  V K   +  G  VA     I+  ++S D          E+ +LK L+HEN
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVA-----IKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           ++      V    + + ++ E      L    K    +D   ++ +  QILRG+ + HSH
Sbjct: 62  LVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY--EE 203
           N  IIHRD+K +NI V+  +G VK+ D G A  +  P       + T  + APEL   + 
Sbjct: 120 N--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 204 EYNELVDIYSFGMCILEMVTCE 225
           +Y   VDI++ G  + EM+T E
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 13/198 (6%)

Query: 33  LGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIK 90
           +G+GA+  V+K  D  +G   VA  +V ++   +  P    R  + +  L++ +H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 91  FYN-SWVDDTNRTINMITELF--TSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLH 145
            ++   V  T+R   + T +F      L  Y  K     V  + IK+   Q+LRGL +LH
Sbjct: 69  LFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPE-LYEE 203
           SH   ++HRDLK  NI V  ++G++K+ D GLA I   Q    SV+ T  + APE L + 
Sbjct: 128 SHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 184

Query: 204 EYNELVDIYSFGMCILEM 221
            Y   VD++S G    EM
Sbjct: 185 SYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)

Query: 31  EILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
           ++LG GAF TVYKG      E   I VA   + I +    P        E  ++ S+ H 
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 69

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLH 145
           ++++     +   + TI ++T+L   G L  Y  +HK N+  + + NW  QI +G+ YL 
Sbjct: 70  HLVRLLGVCL---SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPE-L 200
                ++HRDL   N+ V   N  VKI D GLA +++    +  A       ++MA E +
Sbjct: 127 ERR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 201 YEEEYNELVDIYSFGMCILEMVT 223
           +  ++    D++S+G+ I E++T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 77.0 bits (190), Expect = 7e-16
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 33/219 (15%)

Query: 33  LGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           LG+G+F  VY+G             VA   VN    M+  +++E   +E  ++K     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIE-FLNEASVMKEFNCHH 70

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA----------IKNWARQI 137
           +++     V     T+ ++ EL   G L+ Y +  +                    A +I
Sbjct: 71  VVRLLGV-VSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ---QPTARSVIGT 192
             G+ YL +     +HRDL   N  V   +  VKIGD G+   I      +   + ++  
Sbjct: 129 ADGMAYLAAKK--FVHRDLAARNCMVAE-DLTVKIGDFGMTRDIYETDYYRKGGKGLL-- 183

Query: 193 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPY 228
           P  +MAPE L +  +    D++SFG+ + EM T  E PY
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 19/204 (9%)

Query: 30  DEILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKH 85
            ++LG GAF TVYKG    E + +++    V I+++ +  SP   + +  E +++ S+ +
Sbjct: 12  IKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 144
            ++ +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL
Sbjct: 69  PHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE- 199
                 ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E 
Sbjct: 126 EERR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182

Query: 200 LYEEEYNELVDIYSFGMCILEMVT 223
           +    Y    D++S+G+ + E++T
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 22/220 (10%)

Query: 53  VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112
           VA  ++N++    S + L+ L  E+   + L+H NI+ +  S++ D+   + +++ L   
Sbjct: 28  VAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAY 83

Query: 113 GSLRQYRKKHKNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170
           GS     K H    +   AI    + +L  L Y+HS     IHR +K  +I ++G +G+V
Sbjct: 84  GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSG-DGKV 140

Query: 171 KIGDLGLAIVM--QQPTARSVIGTPEF-------MAPELYEEE---YNELVDIYSFGMCI 218
            +  L  ++ M       R V   P+        ++PE+ ++    YNE  DIYS G+  
Sbjct: 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITA 200

Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
            E+     P+ +     Q+  +   G  P  L K T P  
Sbjct: 201 CELANGHVPFKDMP-ATQMLLEKVRGTVPCLLDKSTYPLY 239

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 94/334 (28%), Positives = 146/334 (43%), Gaps = 51/334 (15%)

Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           RY    ++ G GA+ +V    D+  G +VA  +++     QS    +R Y E+ LLK ++
Sbjct: 16  RYTSLKQV-GSGAYGSVCSAIDKRTGEKVAIKKLS--RPFQSEIFAKRAYRELTLLKHMQ 72

Query: 85  HENIIKFYNSWV-----DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILR 139
           HEN+I   + +      D+      ++  + T   L++      + D   ++    Q+L 
Sbjct: 73  HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSED--KVQYLVYQMLC 128

Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE 199
           GL Y+HS    IIHRDLK  N+ VN  + E+KI D GLA          V+ T  + APE
Sbjct: 129 GLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGYVV-TRWYRAPE 184

Query: 200 --LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASLSKVTD 255
             L    YN+ VDI+S G  + EM+T +  +       Q+ +  KVT    P  + K+ D
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244

Query: 256 PQVKQFIEKCIVPA------SLRLP-----ALELLKDPFLVTDNPKDLVC---------D 295
              K +I+   +P       S   P     A++LL +  L  D  K L           D
Sbjct: 245 KAAKSYIKS--LPKYPRKDFSTLFPKASPQAVDLL-EKMLELDVDKRLTATEALEHPYFD 301

Query: 296 PLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSAD 329
             R  +           E  P D  L ++K+S D
Sbjct: 302 SFRDADEET--------EQQPYDDSLENEKLSVD 327

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 50/291 (17%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           ++G+GAF  V+   D+  G   A   +   D+++   Q+  + +E  +L       I+K 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN-QIAHVRAERDILADADSPWIVKL 66

Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           Y S+ D+ +  + ++ E    G L     +      +  + +  +++  L  +H      
Sbjct: 67  YYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--F 122

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----------------------------Q 182
           IHRD+K DNI +   +G +K+ D GL   M                             +
Sbjct: 123 IHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181

Query: 183 QPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQI 237
           Q    A S +GTP+++APE L    Y    D +S G+ + EM+   +P  Y++     + 
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY-GFPPFYSD--TLQET 238

Query: 238 YKKVTSGIKPASLSKVTDPQV----KQFIEKCIVPASLRL-PALELLKDPF 283
           Y K+ +  +  SL    DP V       I + +     RL    E+   PF
Sbjct: 239 YNKIINWKE--SLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 66/249 (26%), Positives = 120/249 (48%), Gaps = 24/249 (9%)

Query: 1   MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWN 56
           M     FTK +T   + S+ +         E LG G+F  V    +KG  E   I+    
Sbjct: 1   MKAAYMFTKPDTSSWKLSDFE-------MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK 53

Query: 57  QVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR 116
           +  ++  M+   Q++ +  E  +L  L H  I+    S+ D+    +  + E    G L 
Sbjct: 54  REILK--MK---QVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELF 106

Query: 117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
            + +K         K +  +++    YLHS +  II+RDLK +N+ ++ N G VK+ D G
Sbjct: 107 THLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFG 163

Query: 177 LAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPA 235
            A  +   T  ++ GTPE++APE+ + + + + VD ++ G+ + E +    P+ +   P 
Sbjct: 164 FAKKVPDRTF-TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPF 221

Query: 236 QIYKKVTSG 244
           +IY+K+ +G
Sbjct: 222 RIYEKILAG 230

Length = 329

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 12/164 (7%)

Query: 137 ILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPE 194
           I++ LHYL   H   +IHRD+K  NI ++  +G VK+ D G++  +    A++   G   
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179

Query: 195 FMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA- 248
           +MAPE  +      +Y+   D++S G+ ++E+ T ++PY  CK   ++  K+     P+ 
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239

Query: 249 SLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKD 291
             ++   P    F++ C+     + P   ELL+ PF+      +
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 66/239 (27%), Positives = 113/239 (47%), Gaps = 35/239 (14%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           LG G F  V+ G          WN   +V ++ +       E    E  ++K L+H+ ++
Sbjct: 14  LGNGQFGEVWMG---------TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSH 147
           + Y      +   I ++TE  + GSL  + K  + + + +  + + A Q+  G+ Y+   
Sbjct: 65  QLYAVV---SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE--LYE 202
           N   IHRDL+  NI V G+    KI D GLA +++  + TAR     P ++ APE  LY 
Sbjct: 122 N--YIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY- 177

Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK-------PASLSKV 253
             +    D++SFG+ + E+VT    PY    N  ++ ++V  G +       P SL ++
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISLHEL 235

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 38/103 (36%), Positives = 61/103 (59%), Gaps = 7/103 (6%)

Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVI 190
           +A QI+ GL +LH     I++RDLK +N+ ++ ++G V+I DLGLA+ +   +       
Sbjct: 100 YAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRA- 155

Query: 191 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
           GTP +MAPE L  E Y+  VD ++ G  + EM+    P+ + K
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 50/201 (24%), Positives = 101/201 (50%), Gaps = 9/201 (4%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           ++LGKG F  V    ++  G   A   +  E V+ + D++    +E  +L++ +H  +  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
               +   T+  +  + E    G L  +  + +    +  + +  +I+  L YLHS +  
Sbjct: 60  L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 115

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 207
           +++RD+K +N+ ++  +G +KI D GL    +    T ++  GTPE++APE+ E+ +Y  
Sbjct: 116 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 208 LVDIYSFGMCILEMVTCEYPY 228
            VD +  G+ + EM+    P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 64/262 (24%), Positives = 127/262 (48%), Gaps = 14/262 (5%)

Query: 9   KSETEEGEFSEKDPSCRYGRYDEI--LGKGAF-KTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
           K +++  +  ++    +Y  ++ I  LG G+F + +   +   D   VA  +     +++
Sbjct: 12  KKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK 71

Query: 66  SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
              Q++ ++SE  +L  + H   +  Y S+ D++   + ++ E    G    + +++K  
Sbjct: 72  Q-KQVDHVFSERKILNYINHPFCVNLYGSFKDES--YLYLVLEFVIGGEFFTFLRRNKRF 128

Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185
                  +A QI+    YL S N  I++RDLK +N+ ++  +G +K+ D G A V+   T
Sbjct: 129 PNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDTRT 185

Query: 186 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
             ++ GTPE++APE L    + +  D ++ G+ I E++    P+     P  IY+K+  G
Sbjct: 186 -YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF-YANEPLLIYQKILEG 243

Query: 245 IKPASLSKVTDPQVKQFIEKCI 266
           I      K  D   K  ++K +
Sbjct: 244 I--IYFPKFLDNNCKHLMKKLL 263

Length = 340

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 74.2 bits (182), Expect = 9e-15
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 18/207 (8%)

Query: 31  EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKH 85
           ++LGKG+F  V+    KG ++   I+        +DV+   D +E    E  +L  + +H
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKAL-----KKDVVLMDDDVECTMVEKRVLSLAWEH 55

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
             +   Y ++   T   +  + E    G L  + +     D+     +A +I+ GL +LH
Sbjct: 56  PFLTHLYCTF--QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYE 202
           S    I++RDLK DNI ++  +G +KI D G+    ++      +  GTP+++APE L  
Sbjct: 114 SKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYN 229
           ++YN  VD +SFG+ + EM+  + P++
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 74.3 bits (182), Expect = 9e-15
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 29/220 (13%)

Query: 33  LGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +G+G +  VYK    D  D  E A  Q+    +  S  +      E+ LL+ LKH N+I 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR------EIALLRELKHPNVIA 62

Query: 91  FYNSWVDDTNRTINMITE--------LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
               ++  ++R + ++ +        +       +  KK   +    +K+   QIL G+H
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-----RSVIGTPE 194
           YLH++   ++HRDLK  NI V G     G VKI D+G A +   P         V+ T  
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 195 FMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
           + APEL      Y + +DI++ G    E++T E P   C+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 74.3 bits (182), Expect = 9e-15
 Identities = 53/201 (26%), Positives = 101/201 (50%), Gaps = 9/201 (4%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           ++LGKG F  V    ++  G   A  ++  ++V+ + D++    +E  +LK+ +H  +  
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAM-KILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              S+   T   +  + E    G L  +  + +       + +  +I+  L YLHS    
Sbjct: 60  LKYSF--QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-- 115

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 207
           I++RDLK +N+ ++  +G +KI D GL    +    T ++  GTPE++APE+ E+ +Y  
Sbjct: 116 IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 208 LVDIYSFGMCILEMVTCEYPY 228
            VD +  G+ + EM+    P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 58/214 (27%), Positives = 110/214 (51%), Gaps = 9/214 (4%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++GKG+F  V     ++DG   A   +  + V+   +Q   +     LLK++KH  ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            + S+   T   +  + +    G L  + ++ ++      + +A +I   L YLHS N  
Sbjct: 61  LHYSF--QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN-- 116

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNE 207
           I++RDLK +NI ++ + G V + D GL    + Q  T  +  GTPE++APE + ++ Y+ 
Sbjct: 117 IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
            VD +  G  + EM+    P+  C++ A++Y  +
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPF-YCRDVAEMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G F  V+ G+           +V I+ + Q     E   +E +L+K L+H  +++ Y
Sbjct: 14  LGAGQFGEVWMGYYNGH------TKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY 67

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHNPP 150
                 T   I +ITE   +GSL  + K  + + +   K  + A QI  G+ ++   N  
Sbjct: 68  AVV---TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN-- 122

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP-EFMAPE-LYEEEYN 206
            IHRDL+  NI V+      KI D GLA  I   + TAR     P ++ APE +    + 
Sbjct: 123 YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181

Query: 207 ELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 237
              D++SFG+ + E+VT    PY    NP  I
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 26/206 (12%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 9   RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 59

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y    ++    I ++TE  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 60  HEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 117 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173

Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 174 AALY-GRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 22/175 (12%)

Query: 61  EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT---SGSLRQ 117
           E V+    Q     +E H+L+++ H +II+   ++      T N  T L        L  
Sbjct: 118 EHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTF------TYNKFTCLILPRYKTDLYC 171

Query: 118 YRKKHKNV---DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174
           Y    +N+   D+ AI+   R +LR + YLH     IIHRD+K +NIF+N + G+V +GD
Sbjct: 172 YLAAKRNIAICDILAIE---RSVLRAIQYLH--ENRIIHRDIKAENIFIN-HPGDVCLGD 225

Query: 175 LGLA---IVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCE 225
            G A   + +         GT    APEL   + Y   VDI+S G+ + EM TC 
Sbjct: 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 38/226 (16%)

Query: 30  DEILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHE 86
            + LG+G F  V K     + G    +  V ++ + +  S  +L  L SE +LLK + H 
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGR-AGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD-------------------- 126
           ++IK Y +   D    + +I E    GSLR + ++ + V                     
Sbjct: 64  HVIKLYGACSQD--GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121

Query: 127 ----MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
               M  + ++A QI RG+ YL      ++HRDL   N+ V     ++KI D GL+  + 
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLV-AEGRKMKISDFGLSRDVY 178

Query: 183 QPTA---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           +  +   RS    P ++MA E L++  Y    D++SFG+ + E+VT
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 78/280 (27%), Positives = 118/280 (42%), Gaps = 52/280 (18%)

Query: 27  GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            RYD I  +GKG    VY  +D V    VA  ++  ED+ ++P   +R   E  +   L 
Sbjct: 2   QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLI 60

Query: 85  HENIIKFYN--SWVDDTNRTINMITELFTSGS-LRQYRKK-------HKNVDMKAIKNWA 134
           H  I+  Y+  S  D    T+  I E +T  S L+   +K        +   + A  +  
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYI-EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----------P 184
            +I   + Y+HS    ++HRDLK DNI + G  GEV I D G AI  +            
Sbjct: 120 HKICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 185 TARS----------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKN 233
                         ++GTP++MAPE L     +E  DIY+ G+ + +M+T  +PY   K 
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236

Query: 234 PAQIYKKVTSGIK--------PASLSKV------TDPQVK 259
               Y+ V             P  LS++       DP  +
Sbjct: 237 RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276

Length = 932

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 72.3 bits (177), Expect = 5e-14
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 9/216 (4%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++GKG+F  V     + DG   A   +  + +++  +Q   +     LLK+LKH  ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            + S+   T   +  + +    G L  + ++ +       + +A ++   + YLHS N  
Sbjct: 61  LHYSF--QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN-- 116

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNE 207
           II+RDLK +NI ++ + G V + D GL     +P  T  +  GTPE++APE L +E Y+ 
Sbjct: 117 IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243
            VD +  G  + EM+    P+   ++ +Q+Y  +  
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILH 210

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 57/236 (24%), Positives = 114/236 (48%), Gaps = 11/236 (4%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++GKG+F  V     + +    A   +  + +++  ++   +     LLK++KH  ++ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            + S+   T   +  + +    G L  + ++ +       + +A +I   L YLHS N  
Sbjct: 61  LHFSF--QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN-- 116

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNE 207
           I++RDLK +NI ++ + G + + D GL     +   T  +  GTPE++APE L+++ Y+ 
Sbjct: 117 IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263
            VD +  G  + EM+    P+   +N A++Y  + +  KP  L        +  +E
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILN--KPLQLKPNITNSARHLLE 228

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 16/206 (7%)

Query: 31  EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
           ++LGKG+F  V     KG  E   ++        +DV+   D +E    E  +L +L  E
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKAL-----KKDVVLIDDDVECTMVEKRVL-ALAWE 54

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           N    +      T   +  + E    G L  + +     D+     +A +I+ GL +LHS
Sbjct: 55  NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS 114

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-E 203
               II+RDLK DN+ ++  +G +KI D G+    V     A +  GTP+++APE+ +  
Sbjct: 115 KG--IIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171

Query: 204 EYNELVDIYSFGMCILEMVTCEYPYN 229
           +Y   VD +SFG+ + EM+  + P++
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 71.1 bits (174), Expect = 7e-14
 Identities = 59/205 (28%), Positives = 108/205 (52%), Gaps = 23/205 (11%)

Query: 31  EILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV--HLLK--SLK 84
           ++LG G F TV+KG    E D I++      I+D  +S  Q    + E+  H+L   SL 
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQT---FQEITDHMLAMGSLD 67

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHY 143
           H  I++           ++ ++T+L   GSL  + ++H+ ++D + + NW  QI +G++Y
Sbjct: 68  HAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTP-EFMAPE 199
           L  H   ++HR+L   NI +  ++  V+I D G+A ++     +   S   TP ++MA E
Sbjct: 125 LEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 200 -LYEEEYNELVDIYSFGMCILEMVT 223
            +    Y    D++S+G+ + EM++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 68/243 (27%), Positives = 119/243 (48%), Gaps = 21/243 (8%)

Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +LGKG+F  V     KG DE+  I++    V I+D     D +E    E  +L       
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD-----DDVECTMVEKRVLALPGKPP 61

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLR-QYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            +   +S     +R +  + E    G L    ++  K  +  A+  +A +I  GL +LHS
Sbjct: 62  FLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGKFKEPHAV-FYAAEIAIGLFFLHS 119

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-E 203
               II+RDLK DN+ ++   G +KI D G+    +    T R+  GTP+++APE+   +
Sbjct: 120 KG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQ 176

Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--SGIKPASLSKVTDPQVKQF 261
            Y + VD ++FG+ + EM+  + P+ + ++  ++++ +   +   P SLSK      K  
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235

Query: 262 IEK 264
           + K
Sbjct: 236 LTK 238

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 29/220 (13%)

Query: 33  LGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +G+G +  VYK    D  D  + A  Q+    +  S  +      E+ LL+ LKH N+I 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR------EIALLRELKHPNVIS 62

Query: 91  FYNSWVDDTNRTINMITE--------LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
               ++   +R + ++ +        +       +  KK   +    +K+   QIL G+H
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-----RSVIGTPE 194
           YLH++   ++HRDLK  NI V G     G VKI D+G A +   P         V+ T  
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 195 FMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
           + APEL      Y + +DI++ G    E++T E P   C+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 70.5 bits (172), Expect = 8e-14
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 26/206 (12%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R D  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 9   RLDVKLGQGCFGEVWMG---------TWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLR 59

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           H+ ++  Y    ++    I ++TE    GSL  + K+   K + +  + + A QI  G+ 
Sbjct: 60  HDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   IHRDL+  NI V G+N   KI D GLA +++  + TAR     P ++ APE
Sbjct: 117 YIERMN--YIHRDLRAANILV-GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173

Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+VT
Sbjct: 174 AALY-GRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 79/311 (25%), Positives = 126/311 (40%), Gaps = 75/311 (24%)

Query: 13  EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLE 71
           ++ EF   D   +Y +  +I G+G F  V+K   +     VA  +V +E+  +  P    
Sbjct: 1   DQYEFPFCDEVSKYEKLAKI-GQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL 59

Query: 72  RLYSEVHLLKSLKHENIIKFY---NSWVDDTNR---TINMITELFT---SGSLRQYRKKH 122
           R   E+ +L+ LKHEN++       +     NR   +  ++ E      +G L       
Sbjct: 60  R---EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN----- 111

Query: 123 KNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
           KNV      IK   + +L GL+Y+H +   I+HRD+K  NI +   +G +K+ D GLA  
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLARA 168

Query: 181 MQQP--------TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT------ 223
                       T R V  T  +  PEL   E +Y   +D++  G CI+ EM T      
Sbjct: 169 FSLSKNSKPNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWTRSPIMQ 225

Query: 224 --------------C------------EYP-YNECKNPAQIYKKVTSGIKPASLSKVTDP 256
                         C            +   + + + P    +KV   +KP     V DP
Sbjct: 226 GNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP----YVKDP 281

Query: 257 QVKQFIEKCIV 267
                I+K +V
Sbjct: 282 HALDLIDKLLV 292

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 26/208 (12%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V G  VA  +  +    Q+    +R Y E+ L+K + H
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKK--LSRPFQNVTHAKRAYRELVLMKLVNH 74

Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL  + +L Q      ++D + +     Q+L G+
Sbjct: 75  KNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQV--IQMDLDHERMSYLLYQMLCGI 131

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 132 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 184

Query: 197 APE-LYEEEYNELVDIYSFGMCIL-EMV 222
           APE +    Y E VDI+S G CI+ EM+
Sbjct: 185 APEVILGMGYKENVDIWSVG-CIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 47/182 (25%), Positives = 88/182 (48%), Gaps = 12/182 (6%)

Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKA 129
           +    E  ++  L HE +++ Y   V    R I ++TE  ++G L  Y ++H K      
Sbjct: 44  DEFIEEAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ 101

Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
           +    + +  G+ YL S     IHRDL   N  V+ + G VK+ D GL+  +      S 
Sbjct: 102 LLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSS 158

Query: 190 IGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           +G+     +  PE L   +++   D+++FG+ + E+ +  + PY    N ++  +KV+ G
Sbjct: 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQG 217

Query: 245 IK 246
           ++
Sbjct: 218 LR 219

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 62/206 (30%), Positives = 88/206 (42%), Gaps = 18/206 (8%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +GKG F  VYKG  +    EVA            PD   +   E  +LK   H NI+K
Sbjct: 1   EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVK 56

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
                V    + I ++ EL   GSL  + RKK   + +K +   +     G+ YL S N 
Sbjct: 57  LIGVCVQ--KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN- 113

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEEE 204
             IHRDL   N  V G N  +KI D G++   +        G  +    + APE L    
Sbjct: 114 -CIHRDLAARNCLV-GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 205 YNELVDIYSFGMCILEMVT---CEYP 227
           Y    D++S+G+ + E  +     YP
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYP 197

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 78/294 (26%), Positives = 138/294 (46%), Gaps = 20/294 (6%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           ++GKG+F  V     + DG   A   +  + +++  +Q   +     LLK++KH  ++  
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           + S+   T   +  + +    G L  + ++ ++      + +A +I   L YLHS N  I
Sbjct: 62  HYSF--QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--I 117

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNEL 208
           I+RDLK +NI ++ + G V + D GL    +    T  +  GTPE++APE L ++ Y+  
Sbjct: 118 IYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176

Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 268
           VD +  G  + EM+    P+   ++ A++Y  + +  KP  L        +  +E  +  
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF-YSRDTAEMYDNILN--KPLRLKPNISVSARHLLEGLLQK 233

Query: 269 -ASLRLPA----LELLKDPFLVTDNPKDLVCDPLRLPNLVPEV---MNLAHSEP 314
             + RL A    LE+    F  + N  DLV   +  P   P V   M+L H +P
Sbjct: 234 DRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPP-FNPNVSGPMDLKHFDP 286

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 78/277 (28%), Positives = 123/277 (44%), Gaps = 27/277 (9%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY ++  +G GA   V   FD V GI VA  +++     Q+    +R Y E+ LLK + H
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS--RPFQNQTHAKRAYRELVLLKCVNH 79

Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL  +   +     H  +D + +     Q+L G+
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGI 136

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV-----MQQPTARSVIGTPEFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA       M  P     + T  + 
Sbjct: 137 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTACTNFMMTP----YVVTRYYR 189

Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + E+V     +    +  Q  K +   G   A      
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249

Query: 255 DPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD 291
            P V+ ++E    P    +   EL  D    +++ +D
Sbjct: 250 QPTVRNYVEN--RPQYPGISFEELFPDWIFPSESERD 284

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 24/217 (11%)

Query: 32  ILGKGAFKTVYKG-FDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
            LG GAF  VY+G   ++ G      +V ++ + +     E+     E HL+ +  H NI
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-------VDMKAIKNWARQILRGL 141
           +K     +   N    +I EL   G L  Y +  +        + +K + +    + +G 
Sbjct: 62  VKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIVMQQPTARSVIGTP---- 193
            YL   +   IHRDL   N  V+    +    VKIGD GLA  + +       G      
Sbjct: 120 VYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPY 228
            +MAPE L + ++    D++SFG+ + E++T  + PY
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 9/204 (4%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           ++LGKG F  V    ++  G   A   +  E V+ + D++    +E  +L++ +H  +  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKE-VIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              S+   T+  +  + E    G L  +  + +       + +  +I+  L YLHS    
Sbjct: 60  LKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN- 116

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 207
           +++RDLK +N+ ++  +G +KI D GL    +    T ++  GTPE++APE+ E+ +Y  
Sbjct: 117 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 208 LVDIYSFGMCILEMVTCEYP-YNE 230
            VD +  G+ + EM+    P YN+
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQ 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 63/240 (26%), Positives = 114/240 (47%), Gaps = 13/240 (5%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENII 89
            +LGKG+F  V     +  G  +   +V  +DV+   D +E   +E  +L  +  H  + 
Sbjct: 1   RVLGKGSFGKVMLARLKESG-RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           + Y  +   T   +  + E    G L  + +K +  D    + +A +I   L +LH    
Sbjct: 60  QLYCCF--QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYN 206
            II+RDLK DN+ ++ + G  K+ D G+    +    T  +  GTP+++APE L E  Y 
Sbjct: 117 -IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQFIEK 264
             VD ++ G+ + EM+    P+ E +N   +++ + +   + P  LS+     +K F+ K
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK 233

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 35/221 (15%)

Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER----LYSEVHLLKSL-K 84
            + LG+GAF  V K   E  G++       +   M   D  E+    L SE+ ++K + K
Sbjct: 17  GKPLGEGAFGQVVKA--EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----------------K 128
           H+NII      V      + ++ E    G+LR + +  +                    K
Sbjct: 75  HKNIINLLG--VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQ 183
            + ++A Q+ RG+ +L S     IHRDL   N+ V  ++  +KI D GLA     I   +
Sbjct: 133 DLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDH-VMKIADFGLARDIHHIDYYR 189

Query: 184 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            T    +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 190 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 56/181 (30%), Positives = 92/181 (50%), Gaps = 19/181 (10%)

Query: 75  SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAI 130
           SE+H L +  H  I+K ++ +  D    + +I E  + G L    +Q  K+H       +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171

Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----A 186
                QI+  L  +HS    ++HRDLK  NIF+    G +K+GD G +           A
Sbjct: 172 GLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSDSVSLDVA 228

Query: 187 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ--IYKKVTS 243
            S  GTP ++APEL+E + Y++  D++S G+ + E++T   P+   K P+Q  I ++V  
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLY 285

Query: 244 G 244
           G
Sbjct: 286 G 286

Length = 478

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 30/214 (14%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKHENIIK 90
           LGKG       GF EV  +     QV     M +  +L+  RL  +     +L  + I++
Sbjct: 1   LGKG-------GFGEVCAV-----QVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILE 48

Query: 91  FYNS-------WVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGL 141
             NS       +  ++   + ++  L   G L+   Y    + ++M+ + +++ QI  G+
Sbjct: 49  KVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI 108

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE 199
             LH H+  I++RD+K +N+ ++ + G  ++ DLGLA+ ++  +   +   GT  +MAPE
Sbjct: 109 --LHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPE 164

Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
            L EE Y+  VD ++ G  I EMV    P+ + K
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 70.1 bits (171), Expect = 5e-13
 Identities = 88/340 (25%), Positives = 146/340 (42%), Gaps = 61/340 (17%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII-- 89
           I+G G+F  VY+    +D  E    +V I+ V+Q P    R   E+ ++K+L H NII  
Sbjct: 73  IIGNGSFGVVYEAIC-IDTSE----KVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFL 124

Query: 90  --KFYNSWV--DDTNRTINMITELF---TSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
              +Y      ++ N  +N++ E         ++ Y + +  + +  +K ++ Q+ R L 
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEFMAPELY 201
           Y+HS    I HRDLK  N+ ++ N   +K+ D G A  ++    + S I +  + APEL 
Sbjct: 185 YIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELM 242

Query: 202 --EEEYNELVDIYSFGMCILEMVTCEYPYNECKN--------------PAQIYKKVTS-- 243
                Y   +D++S G  I EM+   YP    ++              P +   K  +  
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPN 301

Query: 244 -------GIKPASLSKV----TDPQVKQFIEKCIVPASL-RLPALELLKDPFLVTDNPKD 291
                   +KP  L KV    T      FI + +    L RL  +E L DPF       D
Sbjct: 302 YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF------D 355

Query: 292 LVCDP-LRLPNLV---PEVMNLAHSEPHPMDIDLNHKKVS 327
            + DP ++LP  +   P++ N   +E   M      K + 
Sbjct: 356 DLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIP 395

Length = 440

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 67.7 bits (165), Expect = 6e-13
 Identities = 73/245 (29%), Positives = 111/245 (45%), Gaps = 25/245 (10%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE-RLYSEVHLLKSLKHENII 89
           E+LGKG F  V+KG  + D   VA      ED+   P +L+ +  SE  +LK   H NI+
Sbjct: 1   ELLGKGNFGEVFKGTLK-DKTPVAVKTCK-EDL---PQELKIKFLSEARILKQYDHPNIV 55

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           K     V    + I ++ EL   G    + RKK   +  K +  +A     G+ YL S N
Sbjct: 56  KLIG--VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEE 203
              IHRDL   N  V G N  +KI D G++   +     S  G  +    + APE L   
Sbjct: 114 --CIHRDLAARNCLV-GENNVLKISDFGMS-RQEDDGIYSSSGLKQIPIKWTAPEALNYG 169

Query: 204 EYNELVDIYSFGMCILEMVT---CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
            Y+   D++S+G+ + E  +   C YP        Q  ++V  G + +   K  D  V +
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYP---GMTNQQAREQVEKGYRMSCPQKCPD-DVYK 225

Query: 261 FIEKC 265
            +++C
Sbjct: 226 VMQRC 230

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 16/205 (7%)

Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +LGKG+F  V     KG DE+  I++    V I+D     D +E    E  +L       
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALQDKPP 61

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +   +S     +R +  + E    G L  + ++           +A +I  GL +LH  
Sbjct: 62  FLTQLHSCFQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-EE 204
              II+RDLK DN+ ++ + G +KI D G+    ++   T R+  GTP+++APE+   + 
Sbjct: 121 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177

Query: 205 YNELVDIYSFGMCILEMVTCEYPYN 229
           Y + VD +++G+ + EM+  + P++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 68.0 bits (167), Expect = 7e-13
 Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 23/197 (11%)

Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
           VH L    + N IK Y S    T +   +I +    G L    KK   +    +K   RQ
Sbjct: 61  VHQLMK-DNPNFIKLYYSV--TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ 117

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 196
           ++  L+ LH HN  IIH D+K +N+  +     + + D GL  ++  P+     GT ++ 
Sbjct: 118 LVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--GTLDYF 173

Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPY----NECKNPAQ----IYKKVTSGIKP 247
           +PE +    Y+   D ++ G+   E++T ++P+    +E  +         KK+      
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP----- 228

Query: 248 ASLSKVTDPQVKQFIEK 264
               K        F++ 
Sbjct: 229 --FIKNVSKNANDFVQS 243

Length = 267

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 67.6 bits (165), Expect = 8e-13
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 22/223 (9%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 68

Query: 93  NSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y      + V+   +   A QI   + YL   N  
Sbjct: 69  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 125 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183

Query: 207 ELVDIYSFGMCILEMVT---CEYPYNECKNPAQIYKKVTSGIK 246
              D+++FG+ + E+ T     YP  +    +Q+Y+ +  G +
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKGYR 223

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 63/230 (27%), Positives = 112/230 (48%), Gaps = 19/230 (8%)

Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +LGKG+F  V     KG DE+  I++    V I+D     D +E    E  +L       
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALSGKPP 61

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +   +S     +R +  + E    G L    ++           +A +I  GL +LHS 
Sbjct: 62  FLTQLHSCFQTMDR-LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-EE 204
              II+RDLK DN+ ++ + G +KI D G+    +    T ++  GTP+++APE+   + 
Sbjct: 121 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177

Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSK 252
           Y + VD ++FG+ + EM+  + P+ E ++  ++++ +       P S+SK
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSK 226

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 37/210 (17%)

Query: 33  LGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           +G+G +  V+    K   E+    VA  ++  + ++   +++  + +E  +L + K E +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEI----VALKRMK-KSLLFKLNEVRHVLTERDILTTTKSEWL 63

Query: 89  IKFYNSWVDDTNRTINM--------ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +K   ++ DD    + M         T L   G L +   +    +M    +        
Sbjct: 64  VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD-------A 116

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           LH L       IHRDLK +N F+   +G +K+ D GL+  IV     A SV+G+P++MAP
Sbjct: 117 LHELG-----YIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTY---ANSVVGSPDYMAP 167

Query: 199 E-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
           E L  + Y+  VD +S G C+L    C +P
Sbjct: 168 EVLRGKGYDFTVDYWSLG-CMLYEFLCGFP 196

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 17/197 (8%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G F  V+ G+           +V ++ +      ++    E +L+K+L+H+ +++ Y
Sbjct: 14  LGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 67

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPP 150
              V      I +ITE    GSL  + K  +   V +  + +++ QI  G+ Y+   N  
Sbjct: 68  A--VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 123

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPELYE-EEYN 206
            IHRDL+  N+ V+  +   KI D GLA V++  + TAR     P ++ APE      + 
Sbjct: 124 YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182

Query: 207 ELVDIYSFGMCILEMVT 223
              D++SFG+ + E+VT
Sbjct: 183 IKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 65/277 (23%), Positives = 130/277 (46%), Gaps = 38/277 (13%)

Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHE 86
           ++G+G++  V     K  + +  ++V   ++  +D     + ++ + +E H+  ++  H 
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNHP 56

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            ++  ++ +   T   +  + E    G L  + ++ + +  +  + ++ +I   L+YLH 
Sbjct: 57  FLVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-E 203
               II+RDLK DN+ ++ + G +K+ D G+     +P  T  +  GTP ++APE+   E
Sbjct: 115 RG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 171

Query: 204 EYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
           +Y   VD ++ G+ + EM+    P++      NP Q                  D   + 
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDYLFQV 216

Query: 261 FIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 296
            +EK I +P SL + A  +LK  FL  D  + L C P
Sbjct: 217 ILEKQIRIPRSLSVKAASVLKS-FLNKDPKERLGCHP 252

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 58/231 (25%), Positives = 107/231 (46%), Gaps = 17/231 (7%)

Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
            +++G G F  V++G  ++ G +     +       +  Q +   SE  ++    H NII
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSH 147
           +     V    +   +ITE   +G+L +Y + H   +  + +     R I  G+ YL   
Sbjct: 70  RLEG--VVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDM 126

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFMAPE-LY 201
           N   +HRDL   NI VN +N E K+ D GL+ V++     +   +       + APE + 
Sbjct: 127 N--YVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 202 EEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK-PASL 250
             ++    D++SFG+ + E+++  E PY +  N  ++ K +  G + PA +
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPM 233

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 28/218 (12%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKH 85
           R+  +LGKG F             EV   QV     M +  +LE  R+        +L  
Sbjct: 3   RHYRVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 50

Query: 86  ENIIKFYNS-------WVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWARQ 136
           + I++  NS       +  +T   + ++  L   G L+   Y   +   D +    +A +
Sbjct: 51  KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE 110

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEF 195
           I  GL  LH     I++RDLK +NI ++ + G ++I DLGLA+ + +  T R  +GT  +
Sbjct: 111 ITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGY 167

Query: 196 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK 232
           MAPE+ + E Y    D +  G  I EM+  + P+ + K
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 39/129 (30%), Positives = 69/129 (53%), Gaps = 5/129 (3%)

Query: 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165
           I +L   G L  +  +H     K ++ +A +I+ GL   H HN  +++RDLK  NI ++ 
Sbjct: 75  ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLD- 131

Query: 166 NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 223
            +G V+I DLGLA    +    + +GT  +MAPE+ ++   Y+   D +S G  + +++ 
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191

Query: 224 CEYPYNECK 232
              P+ + K
Sbjct: 192 GHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 51/201 (25%), Positives = 103/201 (51%), Gaps = 9/201 (4%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           ++LGKG F  V    ++  G   A  ++  ++V+ + D++    +E  +L++ +H  +  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAM-KILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              S+   T+  +  + E    G L  +  + +       + +  +I+  L YLHS +  
Sbjct: 60  LKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 207
           +++RDLK +N+ ++  +G +KI D GL    +    T ++  GTPE++APE+ E+ +Y  
Sbjct: 116 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 208 LVDIYSFGMCILEMVTCEYPY 228
            VD +  G+ + EM+    P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 61/230 (26%), Positives = 108/230 (46%), Gaps = 18/230 (7%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSL-KHENI 88
            LG GAF  V +          A  +V ++ +  +    ER  L SE+ ++  L  HENI
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHS 146
           +    +        I +ITE    G L  +  RK+   + ++ + +++ Q+ +G+ +L S
Sbjct: 102 VNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEV-KIGDLGLAIVMQQPTARSVIGTP----EFMAPE-L 200
            N   IHRDL   N+ +   +G++ KI D GLA  +   +   V G      ++MAPE +
Sbjct: 160 KN--CIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215

Query: 201 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 249
           +   Y    D++S+G+ + E+ +    PY      ++ YK +  G + A 
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 40/210 (19%)

Query: 33  LGKGAFKTV--YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 89
           LG+GA+  V   +  +  +   VA  +  I +V       +R   E+ LL+  + H+NI 
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKK--ITNVFSKKILAKRALRELKLLRHFRGHKNIT 65

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI------------KNWARQI 137
             Y    D          EL+    L +        D+  I            +++  QI
Sbjct: 66  CLY----DMDIVFPGNFNELYLYEELMEA-------DLHQIIRSGQPLTDAHFQSFIYQI 114

Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA------IVMQQPTARSVIG 191
           L GL Y+HS N  ++HRDLK  N+ VN  + E+KI D GLA                 + 
Sbjct: 115 LCGLKYIHSAN--VLHRDLKPGNLLVNA-DCELKICDFGLARGFSENPGENAGFMTEYVA 171

Query: 192 TPEFMAPE--LYEEEYNELVDIYSFGMCIL 219
           T  + APE  L  + Y + +D++S G CIL
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 37/235 (15%)

Query: 20  KDPSCRYGRYDEILGK----GAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLE 71
           +DP   + R    LGK    G F  V      G D+    E     V +     +   L 
Sbjct: 6   EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS 65

Query: 72  RLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
            L SE+ ++K + KH+NII    +   D    + +I E  + G+LR+Y +  +   M+  
Sbjct: 66  DLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYS 123

Query: 131 KNWAR----------------QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174
            + AR                Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D
Sbjct: 124 YDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIAD 180

Query: 175 LGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            GLA     I   + T    +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 181 FGLARDVNNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 19/202 (9%)

Query: 32  ILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +LG GAF TVYKG    DG    I VA   + +     SP   + +  E +++  +    
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVA---IKVLRENTSPKANKEILDEAYVMAGVGSPY 70

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHS 146
           + +     +     T+ ++T+L   G L  Y +++K+ +  + + NW  QI +G+ YL  
Sbjct: 71  VCRLLGICL---TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTP---EFMAPE-LY 201
               ++HRDL   N+ V   N  VKI D GLA ++    T     G     ++MA E + 
Sbjct: 128 VR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 202 EEEYNELVDIYSFGMCILEMVT 223
              +    D++S+G+ + E++T
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 65.9 bits (160), Expect = 1e-11
 Identities = 51/180 (28%), Positives = 93/180 (51%), Gaps = 17/180 (9%)

Query: 73  LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT-----ELFTSGSLRQYRKKHKNVDM 127
           L +E+  L  L HENI+K       + N    MIT     +L++      +  K + + +
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTY--MITQKYDFDLYSFMYDEAFDWKDRPL-L 266

Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TA 186
           K  +   +Q+L  + Y+H     +IHRD+K +NIF+N  +G++ +GD G A+  ++   A
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNC-DGKIVLGDFGTAMPFEKEREA 323

Query: 187 RSV--IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY-PYNE-CKNPAQIYKKV 241
                +GT    +PE L  + Y E+ DI+S G+ +L+M++ ++ P  +    P +   K+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383

Length = 501

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 38/129 (29%), Positives = 68/129 (52%), Gaps = 5/129 (3%)

Query: 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165
           I +L   G L  +  +H       ++ +A +I+ GL   H HN  +++RDLK  NI ++ 
Sbjct: 75  ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD- 131

Query: 166 NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 223
            +G V+I DLGLA    +    + +GT  +MAPE+ ++   Y+   D +S G  + +++ 
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191

Query: 224 CEYPYNECK 232
              P+ + K
Sbjct: 192 GHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 66/241 (27%), Positives = 98/241 (40%), Gaps = 36/241 (14%)

Query: 31  EILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
             LG+GAF  V+ G       E D   VA   V       S D  +    E  LL + +H
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVA---VKTLKETASNDARKDFEREAELLTNFQH 67

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN------------- 132
           ENI+KFY    +       M+ E    G L ++ + H                       
Sbjct: 68  ENIVKFYGVCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 133 -WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 191
             A QI  G+ YL S +   +HRDL   N  V G +  VKIGD G++  +       V G
Sbjct: 126 QIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDVYTTDYYRVGG 182

Query: 192 TP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
                  +M PE  +Y +   E  D++SFG+ + E+ T  + P+    N  ++ + +T G
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIECITQG 240

Query: 245 I 245
            
Sbjct: 241 R 241

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)

Query: 76  EVHLLKSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           E+  L+ +   NI+K Y   +D  D    +++I E  T G LR+   K K++  K   + 
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127

Query: 134 ARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
           A    +GL+ L+   N P  +++L   +  V   N ++KI   GL  ++  P  ++V   
Sbjct: 128 AIDCCKGLYNLYKYTNKP--YKNLTSVSFLVT-ENYKLKIICHGLEKILSSPPFKNV--- 181

Query: 193 PEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
             FM    Y+       EY    DIYS G+ + E+ T + P+       +IY  + +   
Sbjct: 182 -NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYDLIINKNN 239

Query: 247 PASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
              L      ++K  +E C    S++ P +
Sbjct: 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269

Length = 283

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 20/196 (10%)

Query: 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164
            + E  + G L  + ++ + +  +  + ++ +I   L++LH     II+RDLK DN+ ++
Sbjct: 73  FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD 130

Query: 165 GNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 221
              G +K+ D G+     +P  T  +  GTP ++APE L  E+Y   VD ++ G+ + EM
Sbjct: 131 A-EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189

Query: 222 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLK 280
           +    P++              G+         D   +  +EK I +P SL + A  +LK
Sbjct: 190 MAGRSPFD------------IVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237

Query: 281 DPFLVTDNPKDLVCDP 296
             FL  D  + L C P
Sbjct: 238 G-FLNKDPKERLGCHP 252

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 64/273 (23%), Positives = 126/273 (46%), Gaps = 32/273 (11%)

Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++G+G++  V     K  D++  ++V   ++  +D     + ++ + +E H+ +      
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD-----EDIDWVQTEKHVFEQASSNP 56

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +   +S    T+R   ++ E    G L  + ++ + +  +  + +A +I   L++LH  
Sbjct: 57  FLVGLHSCFQTTSRLF-LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE 204
              II+RDLK DN+ ++  +G +K+ D G+      P  T  +  GTP ++APE+   EE
Sbjct: 116 G--IIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE 172

Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
           Y   VD ++ G+ + EM+    P++   +   +                 D   +  +EK
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM--------------NTEDYLFQVILEK 218

Query: 265 CI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 296
            I +P  L + A  +LK  FL  D  + L C P
Sbjct: 219 PIRIPRFLSVKASHVLKG-FLNKDPKERLGCQP 250

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 71/268 (26%), Positives = 119/268 (44%), Gaps = 39/268 (14%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKH 85
           R   +LGKG F             EV   QV     M +  +LE  R+        +L  
Sbjct: 3   RQYRVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGESMALNE 50

Query: 86  ENIIKFYNS-------WVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWARQ 136
           + I++  NS       +  +T   + ++  L   G L+   Y       +      +A +
Sbjct: 51  KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE 110

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEF 195
           I  GL  LH     I++RDLK +NI ++ ++G ++I DLGLA+ V +  T +  +GT  +
Sbjct: 111 ICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 167

Query: 196 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
           MAPE+ + E Y    D ++ G  + EM+  + P+ + K      KK    IK   + ++ 
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK------KK----IKREEVERLV 217

Query: 255 DPQVKQFIEKCIVPASLRLPALELLKDP 282
               +++ EK   P +  L  + L KDP
Sbjct: 218 KEVQEEYSEK-FSPDARSLCKMLLCKDP 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 33/218 (15%)

Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+G F  V      G D+     V    V +     +   L  L SE+ ++K + KH+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y +  +                 +  K + 
Sbjct: 86  IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T 
Sbjct: 144 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 200

Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 201 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 17/223 (7%)

Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           D SC   + +E++G G F  V +G  ++ G    +  +       +  Q     SE  ++
Sbjct: 2   DVSCV--KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 59

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILR 139
               H NII      V   +R + +ITE   +G+L  + R+      +  +    R I  
Sbjct: 60  GQFDHPNIIHLEG--VVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAA 117

Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTP-- 193
           G+ YL   N   +HRDL   NI VN +N   K+ D GL+  ++     PT  S +G    
Sbjct: 118 GMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174

Query: 194 -EFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKN 233
             + APE +   ++    D++S+G+ + E M   E PY +  N
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 8/150 (5%)

Query: 99  TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
           T+  + ++T+  + G L  + +K         K +  +++  L +LH ++  I++RDLK 
Sbjct: 67  TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKP 124

Query: 159 DNIFVNGNNGEVKIGDLGL--AIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSF 214
           +NI ++   G + + D GL  A +    T  +  GT E++APE+  +E  Y + VD +S 
Sbjct: 125 ENILLDA-TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL 183

Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           G+ + EM     P+   ++  Q+Y+ +  G
Sbjct: 184 GVLVFEMCCGWSPF-YAEDTQQMYRNIAFG 212

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 13/175 (7%)

Query: 70  LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDM 127
           +E   +E +++K+L+H+ ++K  ++ V  T   I +ITE    GSL  + K  +     +
Sbjct: 45  VEAFLAEANVMKTLQHDKLVKL-HAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL 101

Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPT 185
             + +++ QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA V++  + T
Sbjct: 102 PKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT 158

Query: 186 ARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 237
           AR     P ++ APE +    +    D++SFG+ ++E+VT    PY    NP  I
Sbjct: 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 59/259 (22%), Positives = 116/259 (44%), Gaps = 27/259 (10%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + +GKG F  V  G  +  G +VA   +  +   Q+        +E  ++  L+H N+++
Sbjct: 12  QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQ 63

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV-DMKAIKNWARQILRGLHYLHSHN 148
                V++    + ++TE    GSL  Y R + ++V     +  ++  +   + YL ++N
Sbjct: 64  LLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEY 205
              +HRDL   N+ V+ +N   K+ D GL       Q T +  +   ++ APE L E+++
Sbjct: 123 --FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKF 176

Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQVKQFI 262
           +   D++SFG+ + E+    Y +     P    K V   ++        D   P V   +
Sbjct: 177 STKSDVWSFGILLWEI----YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM 232

Query: 263 EKCIVPASLRLPALELLKD 281
           ++C    +   P+   L++
Sbjct: 233 KQCWHLDAATRPSFLQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 37/220 (16%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQ------VNIEDVMQSPDQLERLYSEVHLLKSL-KH 85
           LG+G F  V +   E  GI+ +         V +     +   L  L SE+ L+K + KH
Sbjct: 20  LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKA 129
           +NII        +    + +I E    G+LR++                +   + +  K 
Sbjct: 78  KNIINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQP 184
           + + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + 
Sbjct: 136 LVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMKIADFGLARGVHDIDYYKK 192

Query: 185 TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           T+   +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 193 TSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 20/166 (12%)

Query: 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167
           ELFT    R++  +        ++ +  +I+  L +LH     II+RD+K +NI ++   
Sbjct: 91  ELFTHLYQREHFTES------EVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDS-E 141

Query: 168 GEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEM 221
           G V + D GL+          A S  GT E+MAPE+       +++ VD +S G+   E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201

Query: 222 VTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
           +T   P+    E  + ++I +++     P    K    + + FI+K
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQK 245

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKH 85
           R   +LGKG F             EV   QV     M +  +LE  R+        +L  
Sbjct: 3   RQYRVLGKGGFG------------EVCACQVRATGKMYACKRLEKKRIKKRKGESMALNE 50

Query: 86  ENIIKFYNS-------WVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWARQ 136
           + I++  NS       +  +T   + ++  +   G L+   Y   +   + +    +A +
Sbjct: 51  KQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE 110

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEF 195
           IL GL  LH  N   ++RDLK +NI ++ + G ++I DLGLA+ + +  + R  +GT  +
Sbjct: 111 ILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGY 167

Query: 196 MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 228
           MAPE L  + Y    D +  G  I EM+  + P+
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 22/207 (10%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G F  V+ G+           +V I+ + +     E    E  ++  L H  +++ Y
Sbjct: 12  IGSGQFGLVWLGYWLEK------RKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 93  NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
              V      I ++ E    G L  Y R +      + +      +  G+ YL S N  +
Sbjct: 66  G--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--V 121

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPELYE-EEYNE 207
           IHRDL   N  V G N  VK+ D G+   +      S  GT    ++ +PE++   +Y+ 
Sbjct: 122 IHRDLAARNCLV-GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNP 234
             D++SFG+ + E+      ++E K P
Sbjct: 181 KSDVWSFGVLMWEV------FSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 38/132 (28%), Positives = 72/132 (54%), Gaps = 7/132 (5%)

Query: 113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172
           G L  + ++    D+   + +  ++L  L  LH  N  +I+RDLK +NI ++   G + +
Sbjct: 78  GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIAL 134

Query: 173 GDLGLAIVMQQPTARS--VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN 229
            D GL  +  +   ++    GTPE++APEL     Y + VD ++ G+ + EM+T   P+ 
Sbjct: 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194

Query: 230 ECKNPAQIYKKV 241
           + +N  ++Y+K+
Sbjct: 195 D-ENVNEMYRKI 205

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSV 189
           ARQ+L  + Y+H     IIHRD+K +N+ VNG   ++ +GD G A   +     P    +
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGI 322

Query: 190 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 220
            GT +  APE L  + Y   VDI+S G+ I E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 67/291 (23%), Positives = 133/291 (45%), Gaps = 30/291 (10%)

Query: 31  EILGKGAFKTVY-----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           ++LG GA+  V+      G D   G   A   +    ++Q     E   +E  +L+ ++ 
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDS--GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63

Query: 86  EN-IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
              ++  + ++  DT   +++I +    G L  +  + +    + ++ ++ +I+  L +L
Sbjct: 64  SPFLVTLHYAFQTDTK--LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELY 201
           H     II+RD+K +NI ++ +NG V + D GL+      +   A S  GT E+MAP++ 
Sbjct: 122 HKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 202 ---EEEYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTD 255
              +  +++ VD +S G+ + E++T   P+    E  + A+I +++     P    +   
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMS 236

Query: 256 PQVKQFIEKCIVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 300
              K  I++ ++     RL      A E+ K PF    N  DL    +  P
Sbjct: 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAP 287

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 36/223 (16%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV--MQSPDQLERLYSEVHLLKSLKH 85
           R+ E LG+ AF  +YKG   + G++ A   V I+ +  + +P Q      E  L+  L H
Sbjct: 8   RFMEELGECAFGKIYKGHLYLPGMDHA-QLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNV--------------DMK 128
            NI+        +  + + M+ E    G L ++   R  H +V              D  
Sbjct: 67  PNIVCLLGVVTQE--QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124

Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ------ 182
              + A QI  G+ YL SH    +H+DL   NI + G    VKI DLGL+  +       
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHVKISDLGLSREIYSADYYR 181

Query: 183 -QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            QP +   I    +M PE +   +++   DI+SFG+ + E+ +
Sbjct: 182 VQPKSLLPI---RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 58.7 bits (142), Expect = 7e-10
 Identities = 56/218 (25%), Positives = 107/218 (49%), Gaps = 18/218 (8%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G F  V+ G      I+VA   +N E  M   D +E    E  ++  L H  +++ Y
Sbjct: 12  LGSGQFGVVHLG-KWRAQIKVAIKAIN-EGAMSEEDFIE----EAKVMMKLSHPKLVQLY 65

Query: 93  NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
              V    + + ++TE   +G L  Y R++   +    + +  + +  G+ YL  ++   
Sbjct: 66  G--VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--F 121

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP-EFMAPELYE-EEYNE 207
           IHRDL   N  V+ + G VK+ D G+   ++  + T+ S    P ++  PE++   +Y+ 
Sbjct: 122 IHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180

Query: 208 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
             D++SFG+ + E+ T  + P+ E K+  ++ + ++ G
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRG 217

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 50/196 (25%), Positives = 92/196 (46%), Gaps = 20/196 (10%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             +GKG F  V  G  +  G +VA     ++D   +        +E  ++ +L+H N+++
Sbjct: 12  ATIGKGEFGDVMLG--DYRGQKVAVK--CLKDDSTAAQAF---LAEASVMTTLRHPNLVQ 64

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKA-IKNWARQILRGLHYLHSHN 148
                +      + ++TE    GSL  Y R + + V   A    +A  +  G+ YL   N
Sbjct: 65  LLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEY 205
              +HRDL   N+ V+  +   K+ D GLA      Q + +  +   ++ APE L E+++
Sbjct: 123 --FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKKF 176

Query: 206 NELVDIYSFGMCILEM 221
           +   D++SFG+ + E+
Sbjct: 177 STKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 36/237 (15%)

Query: 33  LGKGAFKTV-----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHE 86
           LG+GAF  V     Y    E D I VA     ++ +  + D   +  + E  LL +L+HE
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVA-----VKTLKDASDNARKDFHREAELLTNLQHE 67

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-------------KNVDMKAIKNW 133
           +I+KFY   V+     + M+ E    G L ++ + H               +    + + 
Sbjct: 68  HIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
           A+QI  G+ YL S +   +HRDL   N  V G N  VKIGD G++  +       V G  
Sbjct: 126 AQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGMSRDVYSTDYYRVGGHT 182

Query: 194 ----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
                +M PE +   ++    D++S G+ + E+ T  + P+ +  N  ++ + +T G
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQG 238

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 29/177 (16%)

Query: 70  LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM- 127
           L  L SE+ ++K + KH+NII    +   D    + ++ E  + G+LR+Y +  +   M 
Sbjct: 61  LSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVLVEYASKGNLREYLRARRPPGMD 118

Query: 128 ---------------KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172
                          K + + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDN-VMKI 175

Query: 173 GDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            D GLA     I   + T    +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 21/234 (8%)

Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEV 77
           DPS      ++++G G F  V +G  ++ G   I+VA     ++       +L+ L +E 
Sbjct: 2   DPSYV--TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKAGSSDKQRLDFL-TEA 56

Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++    H NII+     V   +R + +ITE   +GSL ++ R+      +  +    R 
Sbjct: 57  SIMGQFDHPNIIRLEG--VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRG 114

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGT 192
           I  G+ YL   N   +HRDL   NI VN +N   K+ D GL+  ++      T +     
Sbjct: 115 IASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171

Query: 193 PEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKNPAQIYKKVTSG 244
             + APE +   ++    D++SFG+ + E M   E PY +  N   + K V  G
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 57/249 (22%), Positives = 110/249 (44%), Gaps = 45/249 (18%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G+GAF  V     +  G   A   +   D+++  +Q+  + +E  +L       ++K
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-EQVGHIRAERDILVEADSLWVVK 65

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            + S+ D  N  + +I E    G +     K   +  +  + +  + +  +  +H     
Sbjct: 66  MFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG-- 121

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------------PT----------- 185
            IHRD+K DN+ ++ + G VK+ D GL   +++              P+           
Sbjct: 122 FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 186 ------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 232
                       A S +GTP+++APE++ +  YN+L D +S G+ + EM+   YP    +
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPPFCSE 239

Query: 233 NPAQIYKKV 241
            P + YKKV
Sbjct: 240 TPQETYKKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 43/221 (19%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-------QSPDQLER--LYSEVHLLKSL 83
           LG+GAF  V+        +   +N    +D M       + P    R     E  LL +L
Sbjct: 13  LGEGAFGKVF--------LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 64

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDM 127
           +HE+I+KFY    D     + M+ E    G L ++ + H                  + +
Sbjct: 65  QHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
             + + A QI  G+ YL S +   +HRDL   N  V G N  VKIGD G++  +      
Sbjct: 123 SQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSRDVYSTDYY 179

Query: 188 SVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            V G       +M PE +   ++    D++SFG+ + E+ T
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 58.6 bits (141), Expect = 2e-09
 Identities = 73/262 (27%), Positives = 116/262 (44%), Gaps = 25/262 (9%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 75

Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 132

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 133 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 185

Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKL 267

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 4/87 (4%)

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE 202
           H H+  II+RDLK +NI ++   G +K+ D GL+   +  +  A S  GT E+MAPE+  
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171

Query: 203 EE-YNELVDIYSFGMCILEMVTCEYPY 228
              + +  D +SFG+ + EM+T   P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 57/249 (22%), Positives = 110/249 (44%), Gaps = 45/249 (18%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G+GAF  V     +  G   A   +   D+++  +Q+  + +E  +L       ++K
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-EQVAHIRAERDILVEADGAWVVK 65

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            + S+ D   R + +I E    G +     K   +  +A + +  + +  +  +H     
Sbjct: 66  MFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG-- 121

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------------PT----------- 185
            IHRD+K DN+ ++   G VK+ D GL   +++              P+           
Sbjct: 122 FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 186 ------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 232
                       A S +GTP+++APE++ +  YN+L D +S G+ + EM+   YP    +
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPPFCSE 239

Query: 233 NPAQIYKKV 241
            P + Y+KV
Sbjct: 240 TPQETYRKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 24/207 (11%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 82

Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 139

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192

Query: 197 APE-LYEEEYNELVDIYSFGMCILEMV 222
           APE +    Y E VDI+S G  + EM+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 62/218 (28%), Positives = 90/218 (41%), Gaps = 30/218 (13%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKH 85
           R+ E LG+GAF  VYKG        ++   V I+ + +   P   +    E  L+  L+H
Sbjct: 8   RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNV-------------DMKA 129
            NI+      V    +   M+ E    G L ++      H +V             D   
Sbjct: 68  PNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125

Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
             + A QI  G+ YL SH+   +HRDL   N  V G    VKI D GL+  +       V
Sbjct: 126 FLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYYRV 182

Query: 190 IGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEM 221
                    +M PE  LY +   E  DI+SFG+ + E+
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 21/218 (9%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLYSEVHLLKSLKHENII 89
            LG+G F  V+    +    E     V ++ + ++ D+        E+ + + L H+N++
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQY---------RKKHKNVDMKAIKNWARQILRG 140
           +      +       MI E    G L+Q+         + K   +  K       QI  G
Sbjct: 72  RLLGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQP--TARSVIGTPEFMA 197
           + +L +     +HRDL   N  V+    EVK+  L L+  V        R+ +    ++A
Sbjct: 130 MDHLSNAR--FVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186

Query: 198 PE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKN 233
           PE + E++++   D++SFG+ + E+ T  E P+    +
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)

Query: 75  SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 134
            E+ +LK++ H  II   +++      T+ M+   +    L  Y  +   + ++      
Sbjct: 135 REIDILKTISHRAIINLIHAY--RWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQ 191

Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVI 190
           R++L  L YLH     IIHRD+K +NIF++       +GD G A  +      P      
Sbjct: 192 RRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 191 GTPEFMAPELYE-EEYNELVDIYSFGMCILEM 221
           GT E  +PEL   + Y    DI+S G+ + EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 49/192 (25%), Positives = 74/192 (38%), Gaps = 16/192 (8%)

Query: 61  EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
            D  +   Q  R   E  L   L H NI+   +S           + E     +LR+   
Sbjct: 13  TDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLF-AVFEYVPGRTLREVLA 71

Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGL- 177
               +          Q+L  L    +HN  I+HRDLK  NI V+        K+ D G+ 
Sbjct: 72  ADGALPAGETGRLMLQVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129

Query: 178 --------AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 228
                   A V        V+GTP + APE L  E      D+Y++G+  LE +T +   
Sbjct: 130 TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-RV 188

Query: 229 NECKNPAQIYKK 240
            +  + A+I  +
Sbjct: 189 VQGASVAEILYQ 200

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 28/218 (12%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKH 85
           R+  +LGKG F             EV   QV     M +  +LE  R+        +L  
Sbjct: 3   RHYRVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 50

Query: 86  ENIIKFYNS-------WVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWARQ 136
           + I++  NS       +  +T   + ++  +   G L+   Y   +   D +    +A +
Sbjct: 51  KRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE 110

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEF 195
           +  GL  L      I++RDLK +NI ++ + G ++I DLGLA+ + +  T R  +GT  +
Sbjct: 111 LCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGY 167

Query: 196 MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
           MAPE +  E+Y    D +  G  I EM+  + P+ + K
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 55.9 bits (135), Expect = 6e-09
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 26/208 (12%)

Query: 31  EILGKGAFKTVYKG-FDEVDGIEV--AWNQVN-IEDVMQSPDQLERLYSEVHLLKSLKHE 86
            ++GKG F  VY G   + DG ++  A   +N I D+    +++E+   E  ++K   H 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL----EEVEQFLKEGIIMKDFSHP 56

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 145
           N++      +      + ++      G LR + R +  N  +K +  +  Q+ +G+ YL 
Sbjct: 57  NVLSLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA 115

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------IVMQQPTARSVIGTPEFM 196
           S     +HRDL   N  ++  +  VK+ D GLA          V     A+  +   ++M
Sbjct: 116 SKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWM 169

Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVT 223
           A E L  +++    D++SFG+ + E++T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 6e-09
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 52/232 (22%)

Query: 31  EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
           ++LGKG    V+    KG  ++  ++V       +  M   ++++R+ +E  +L +L H 
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVL-----DKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSG----SLRQYRKKHKNVDMKAIKNWARQILRGLH 142
            +   Y      T   + ++ + +  G     L Q R+  K +  +  + +A ++L  L 
Sbjct: 62  FLPTLY--ASFQTETYLCLVMD-YCPGGELFRLLQ-RQPGKCLSEEVARFYAAEVLLALE 117

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA------------------------ 178
           YLH     I++RDLK +NI ++  +G + + D  L+                        
Sbjct: 118 YLH--LLGIVYRDLKPENILLHE-SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174

Query: 179 -----IVMQQPTAR--SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMV 222
                   ++P+ R  S +GT E++APE+   + +   VD ++ G+ + EM+
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 36/217 (16%)

Query: 33  LGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           LG+GAF  V+         E D + VA     +++  +S  Q      E  LL  L+H++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQ--DFQREAELLTVLQHQH 68

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------KNVDMKAIKN 132
           I++FY    +   R + M+ E    G L ++ + H                 + +  +  
Sbjct: 69  IVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126

Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
            A QI  G+ YL S +   +HRDL   N  V G    VKIGD G++  +       V G 
Sbjct: 127 IASQIASGMVYLASLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRVGGR 183

Query: 193 P----EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 223
                 +M PE  LY +   E  DI+SFG+ + E+ T
Sbjct: 184 TMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 55.7 bits (134), Expect = 8e-09
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 22/219 (10%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           EI+G+G F  V +G  E  G +VA   +  +   Q+         E  ++  L H+N+++
Sbjct: 12  EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQA------FLEETAVMTKLHHKNLVR 63

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHN 148
                +   +  + ++ EL + G+L  + +      V +  +  ++  +  G+ YL S  
Sbjct: 64  LLGVIL---HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNE 207
             ++HRDL   NI V+  +G  K+ D GLA V       S +   ++ APE L  ++++ 
Sbjct: 121 --LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPV-KWTAPEALKHKKFSS 176

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
             D++S+G+ + E+    + Y     P    K+V   ++
Sbjct: 177 KSDVWSYGVLLWEV----FSYGRAPYPKMSLKEVKECVE 211

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 60/231 (25%), Positives = 93/231 (40%), Gaps = 36/231 (15%)

Query: 31  EILGKGAFKTVY-------KGFDEVDGIEVAWNQVNIEDVMQSP------DQLERLYSEV 77
           E LG+G F  V+       + F E    E       +   ++        +  E    EV
Sbjct: 11  EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70

Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-----------KNVD 126
            +L  L   NI +       D    + MI E   +G L Q+ +KH           K++ 
Sbjct: 71  KILSRLSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128

Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
              +   A QI  G+ YL S N   +HRDL   N  V G N  +KI D G++  +     
Sbjct: 129 FSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLYSSDY 185

Query: 187 RSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C-EYPYNE 230
             V G       +MA E +   ++    D+++FG+ + E++T C E PY  
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 60/239 (25%), Positives = 105/239 (43%), Gaps = 42/239 (17%)

Query: 33  LGKGAFKTVYKG-FDEVDGIEVAWNQVNIEDVMQSP---DQLERLYSEVHLLKSLKHENI 88
           LG GAF  VY+G +   DG  V   QV ++ + +S    D+ + L  E  ++    H+NI
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVEL-QVAVKTLPESCSEQDESDFL-MEALIMSKFNHQNI 71

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-------VDMKAIKNWARQILRGL 141
           ++      +   R I  + EL   G L+ + ++++        + MK +   AR + +G 
Sbjct: 72  VRLIGVSFERLPRFI--LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 142 HYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP------ 193
            YL  ++   IHRD+   N  +   G     KI D G+        AR +          
Sbjct: 130 KYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGM--------ARDIYRASYYRKGG 179

Query: 194 ------EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSG 244
                 ++M PE + +  +    D++SFG+ + E+ +  Y PY    N  ++ + VT G
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGG 237

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.5 bits (133), Expect = 1e-08
 Identities = 41/146 (28%), Positives = 77/146 (52%), Gaps = 21/146 (14%)

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 197
           +H LH      +HRD+K DNI ++  NG +++ D G  + +M+  T +S   +GTP++++
Sbjct: 118 VHQLH-----YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 198 PELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----P 247
           PE+ +       +Y    D +S G+C+ EM+  E P+   ++  + Y K+ +  +    P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFP 230

Query: 248 ASLSKVTDPQVKQFIEKCIVPASLRL 273
           A ++ V++   K  I + I     RL
Sbjct: 231 AQVTDVSE-DAKDLIRRLICSREHRL 255

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL--YSEVHLLKSLKHENIIK 90
           LG+G+F  VY+G  +    +    +V I+ V ++    ER+   +E  ++K     ++++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKN------VDMKAIKNWARQILRG 140
                V    +   +I EL T G L+ Y    R + +N        +K +   A +I  G
Sbjct: 74  LLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP----EFM 196
           + YL+++    +HRDL   N  V   +  VKIGD G+   + +       G       +M
Sbjct: 132 MAYLNANK--FVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
           +PE L +  +    D++SFG+ + E+ T  E PY    N  Q+ + V  G
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLRFVMEG 237

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 40/144 (27%), Positives = 78/144 (54%), Gaps = 17/144 (11%)

Query: 144 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS--VIGTPEFMAPE 199
           +HS H    +HRD+K DN+ ++  NG +++ D G  + M Q  T +S   +GTP++++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 200 LYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----PAS 249
           + +       +Y    D +S G+C+ EM+  E P+   ++  + Y K+ +  +    P+ 
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHEERFQFPSH 232

Query: 250 LSKVTDPQVKQFIEKCIVPASLRL 273
           ++ V++ + K  I++ I     RL
Sbjct: 233 ITDVSE-EAKDLIQRLICSRERRL 255

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 45/196 (22%), Positives = 96/196 (48%), Gaps = 26/196 (13%)

Query: 68  DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
           +Q+++++ E  +L   ++  ++  + S+  +T R + M+ E    G      K    + +
Sbjct: 43  NQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLCMVMEYVEGGDCATLLKNIGALPV 100

Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV------- 180
              + +  + +  L YLH++   I+HRDLK DN+ +  + G +K+ D GL+ +       
Sbjct: 101 DMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTT 157

Query: 181 ----------MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPY 228
                      ++   + V GTPE++APE +  + Y + VD ++ G+ + E +V C   +
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217

Query: 229 NECKNPAQIYKKVTSG 244
            +   P +++ +V S 
Sbjct: 218 GD--TPEELFGQVISD 231

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 39/234 (16%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLER---------LY 74
           R  E LG+G F  V+    E +G+         + + + V+ +   L             
Sbjct: 8   RLKEKLGEGQFGEVH--LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65

Query: 75  SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---------NV 125
            E+ ++  LK+ NII+     V D    + MITE   +G L Q+  + +         N+
Sbjct: 66  KEIKIMSRLKNPNIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNI 123

Query: 126 DMKAIKN---WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
              +I N    A QI  G+ YL S N   +HRDL   N  V GN+  +KI D G++  + 
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV-GNHYTIKIADFGMSRNLY 180

Query: 183 QPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C-EYPYN 229
                 + G       +MA E +   ++    D+++FG+ + EM T C E PY+
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 23/214 (10%)

Query: 33  LGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +G+G     +VY       G  V     ++E+   + + L+ L +EV L    +H NI+ 
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMT 63

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQILRGLHYLHSHN 148
            +   V  T   + +I+     GS     K +    M    I N     LRGL+YLH + 
Sbjct: 64  SWT--VFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLG--LAIVMQQPTARSVIGTPEF-------MAPE 199
              IHR++K  +I ++G+ G V +  L    ++V     A+ V   P+F       ++PE
Sbjct: 122 --YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178

Query: 200 LYEEE---YNELVDIYSFGMCILEMVTCEYPYNE 230
           L  ++   YN   DIYS G+   E+ T   P+ +
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 35/135 (25%), Positives = 72/135 (53%), Gaps = 8/135 (5%)

Query: 99  TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
           T   +++I +  + G +  +  +  N     ++ ++ +I+  L +LH     I++RD+K 
Sbjct: 76  TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKL 133

Query: 159 DNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYS 213
           +NI ++ + G V + D GL+   +  ++    S  GT E+MAPE+   +  + + VD +S
Sbjct: 134 ENILLD-SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWS 192

Query: 214 FGMCILEMVTCEYPY 228
            G+ I E++T   P+
Sbjct: 193 LGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 15/221 (6%)

Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           D SC   + ++++G G F  V  G  ++ G       +       +  Q     SE  ++
Sbjct: 2   DASCI--KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIM 59

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILR 139
               H NII      V   ++ + ++TE   +GSL  + +KH     +  +    R I  
Sbjct: 60  GQFDHPNIIHLEG--VVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIAS 117

Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPE 194
           G+ YL       +HRDL   NI VN +N   K+ D GL+ V++       T R       
Sbjct: 118 GMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174

Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKN 233
           + APE +   ++    D++S+G+ + E M   E PY E  N
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 29/220 (13%)

Query: 31  EILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHE 86
           ++L +G F  ++ G   DE  G E    +V ++ V    S  Q+  L  E  LL  L H+
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKE---EEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQ 68

Query: 87  NIIKFYNSWVDDTNRTINMITELFTS-GSLRQYRKKHKNVDM---KAIK-----NWARQI 137
           NI+   +  ++D       +   + + G+L+ + ++ +  +    +A+      + A QI
Sbjct: 69  NILPILHVCIEDGEPP--FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126

Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE--- 194
             G+ YLH     +IH+D+   N  ++    +VKI D  L+  +  P     +G  E   
Sbjct: 127 ACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNALSRDLF-PMDYHCLGDNENRP 182

Query: 195 --FMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNE 230
             +MA E L  +EY+   D++SFG+ + E++T  + PY E
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 36/149 (24%), Positives = 77/149 (51%), Gaps = 14/149 (9%)

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           +++ + ++ DD  + + M+ E    G L      + +V  K  K +  +++  L  +HS 
Sbjct: 105 VVQLFCAFQDD--KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM 161

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEEE 204
              +IHRD+K DN+ ++  +G +K+ D G  + M +       + +GTP++++PE+ + +
Sbjct: 162 G--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 205 -----YNELVDIYSFGMCILEMVTCEYPY 228
                Y    D +S G+ + EM+  + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.4 bits (128), Expect = 6e-08
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 23/173 (13%)

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------N 124
           E+ ++  LK  NII+     +      + MITE   +G L Q+  +H+            
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126

Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
           +    +   A QI  G+ YL S N   +HRDL   N  V G N  +KI D G++  +   
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLYSG 183

Query: 185 -----TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT-C-EYPYNE 230
                  R+V+         +   ++    D+++FG+ + E++T C E PY++
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 15/135 (11%)

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL---AIVMQQPTARSVIGT 192
           +I   L +LH     II+RDLK +NI ++   G VK+ D GL   +I     T  +  GT
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVT-HTFCGT 163

Query: 193 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPAS 249
            E+MAPE L    + + VD +S G  + +M+T   P+   +N  +   K+  G    P  
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPY 222

Query: 250 LSKVTDPQVKQFIEK 264
           L+    P+ +  ++K
Sbjct: 223 LT----PEARDLLKK 233

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 52.7 bits (126), Expect = 7e-08
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 16/223 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +G+G F  V+ G    D   VA    +  + +  PD   +   E  +LK   H NI++
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVK--SCRETL-PPDLKAKFLQEARILKQYSHPNIVR 57

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
                V    + I ++ EL   G    + R +   + +K +         G+ YL S + 
Sbjct: 58  LIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH- 114

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEEE 204
             IHRDL   N  V   N  +KI D G++   +     S  G  +    + APE L    
Sbjct: 115 -CIHRDLAARNCLVTEKNV-LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 246
           Y+   D++SFG+ + E  +    PY    N  Q  + +  G++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSN-QQTREAIEQGVR 214

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 8e-08
 Identities = 47/219 (21%), Positives = 90/219 (41%), Gaps = 47/219 (21%)

Query: 64  MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
           M   +Q+  + +E  +L    +  ++K Y S+ D+    + +I E    G +     K  
Sbjct: 39  MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY--LYLIMEYLPGGDMMTLLMKKD 96

Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL------ 177
               +  + +  + +  +  +H      IHRD+K DN+ ++   G +K+ D GL      
Sbjct: 97  TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKK 153

Query: 178 ------------------AIVMQQPT----------------ARSVIGTPEFMAPELYEE 203
                                + +P                 A S +GTP+++APE++ +
Sbjct: 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ 213

Query: 204 E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
             YN+  D +S G+ + EM+   YP     NP + Y+K+
Sbjct: 214 TGYNKECDWWSLGVIMYEMLV-GYPPFCSDNPQETYRKI 251

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 36/149 (24%), Positives = 76/149 (51%), Gaps = 14/149 (9%)

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           +++ + ++ DD  R + M+ E    G L      + +V  K  + +  +++  L  +HS 
Sbjct: 105 VVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM 161

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEEE 204
               IHRD+K DN+ ++  +G +K+ D G  + M +       + +GTP++++PE+ + +
Sbjct: 162 G--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 205 -----YNELVDIYSFGMCILEMVTCEYPY 228
                Y    D +S G+ + EM+  + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 64/273 (23%), Positives = 94/273 (34%), Gaps = 79/273 (28%)

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------------------------- 181
           H    IHRD+K DNI ++  +G +K+ D GL                             
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 182 --------------------QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 220
                               Q+  A S++GTP ++APE+     Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Query: 221 MVTCEYPYNECKNPAQIYKKV-----TSGIKP-ASLSKVTDPQVKQFIEKCIVPASLRL- 273
           M+  + P+     PA+   KV     T  I   A LS     +    I +    A  RL 
Sbjct: 237 MLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLS----REASDLILRLCCGAEDRLG 291

Query: 274 --PALELLKDPFLVTDNPKDLVCDPLRLP-NLVPEVMNLAHSEPHPMDIDLNHKKVSADS 330
              A E+   PF       D      R     +P++        HP D   N   V  + 
Sbjct: 292 KNGADEIKAHPFFKG---IDFASLIRRQKAPYIPKIT-------HPTDTS-NFDPVDPEK 340

Query: 331 CAKSNTG---TWFLTLELQR-LTENN--EFTLR 357
               ++G            R  TE+   EFT R
Sbjct: 341 LRSDDSGESSPDRNVKPNNRKRTEHAFYEFTFR 373

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 33/182 (18%)

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD--------- 126
           EV +L  LK  NII+     VD+    + MITE   +G L Q+   H   D         
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 127 ----------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
                       ++ + A QI  G+ YL S N   +HRDL   N  V G N  +KI D G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLV-GENLTIKIADFG 183

Query: 177 LAIVM-----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE--MVTCEYPY 228
           ++  +      +   R+V+    +MA E +   ++    D+++FG+ + E  M+  E PY
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPI-RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242

Query: 229 NE 230
            E
Sbjct: 243 GE 244

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 28/232 (12%)

Query: 33  LGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERL--YSEVHLLKSLKHENI 88
           LG+G+F  VY+G   D + G   A  +V ++ V +S    ER+   +E  ++K     ++
Sbjct: 14  LGQGSFGMVYEGNARDIIKG--EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKN------VDMKAIKNWARQIL 138
           ++     V    +   ++ EL   G L+ Y    R + +N        ++ +   A +I 
Sbjct: 72  VRLLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP----E 194
            G+ YL++     +HRDL   N  V  +   VKIGD G+   + +       G       
Sbjct: 130 DGMAYLNAKK--FVHRDLAARNCMVAHDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
           +MAPE L +  +    D++SFG+ + E+ +  E PY    N  Q+ K V  G
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFVMDG 237

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 19/155 (12%)

Query: 144 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTPEFMAPE 199
           +HS H    +HRD+K +N+ ++   G +K+ D G A  +   +   ++  +GTP+++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173

Query: 200 LYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
           +           Y    D +S G+   EM+    P++E    A+ Y  + +      L  
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMN--FQRFLKF 230

Query: 253 VTDPQV----KQFIEKCIVPASLRLPALELLKDPF 283
             DP+V       I+  +     RL    L   PF
Sbjct: 231 PEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 43/136 (31%), Positives = 69/136 (50%), Gaps = 10/136 (7%)

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGT-- 192
           Q+  G+ +L S N   +HRDL   N+ +      VKI D GLA  +M+     S   T  
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 193 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 249
           P ++MAPE ++   Y  L D++SFG+ + E+ T    PY E     Q Y  +  G + A 
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK 363

Query: 250 LSKVTDPQVKQFIEKC 265
            +  +D ++ + ++KC
Sbjct: 364 PAHASD-EIYEIMQKC 378

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 30/108 (27%), Positives = 56/108 (51%), Gaps = 15/108 (13%)

Query: 133 WAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ---QPT 185
           WAR    +++  L  +HS     IHRD+K DN+ ++  +G +K+ D G  + M       
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVR 199

Query: 186 ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPY 228
             + +GTP++++PE+ +       Y    D +S G+ + EM+  + P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 63/260 (24%), Positives = 116/260 (44%), Gaps = 32/260 (12%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHE 86
           ++++++G+G F  V +   + DG+++      +++     D  +    E+ +L  L  H 
Sbjct: 5   KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-FAGELEVLCKLGHHP 63

Query: 87  NIIKFYNSWVDDTNRTINMIT-ELFTSGSLRQYRKKHKNVDM---------KAIKNWARQ 136
           NII    +     NR    I  E    G+L  + +K + ++           A    ++Q
Sbjct: 64  NIINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 137 ILR-------GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
           +L+       G+ YL       IHRDL   N+ V G N   KI D GL+   +    +++
Sbjct: 121 LLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVKKTM 177

Query: 190 IGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGI 245
              P  +MA E L    Y    D++SFG+ + E+V+    PY  C    A++Y+K+  G 
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGY 235

Query: 246 KPASLSKVTDPQVKQFIEKC 265
           +     +  D +V + + +C
Sbjct: 236 R-MEKPRNCDDEVYELMRQC 254

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 26/201 (12%)

Query: 33  LGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           LG G F TV KG  ++   E  VA   +  ++    P   + L  E ++++ L +  I++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVR 60

Query: 91  FY-----NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
                   SW+        ++ EL   G L ++ +K+K+V  K I     Q+  G+ YL 
Sbjct: 61  MIGICEAESWM--------LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE- 199
             N   +HRDL   N+ +   +   KI D GL+  +        A++    P ++ APE 
Sbjct: 113 ETN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169

Query: 200 LYEEEYNELVDIYSFGMCILE 220
           +   +++   D++SFG+ + E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 45/192 (23%), Positives = 98/192 (51%), Gaps = 12/192 (6%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           ++G+GA+  V K   +     VA  +   +D  ++ +  E    E+ +L++LK ENI++ 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKK--FKDSEENEEVKETTLRELKMLRTLKQENIVEL 65

Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
             ++       + ++ E      L    +    V  + ++++  Q+++ +H+ H ++  I
Sbjct: 66  KEAF--RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--I 121

Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIGTPEFMAPE-LYEEEYNE 207
           +HRD+K +N+ ++ N+  +K+ D G A  + + +  +    + T  + +PE L    Y +
Sbjct: 122 VHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180

Query: 208 LVDIYSFGMCIL 219
            VD++S G CIL
Sbjct: 181 AVDMWSVG-CIL 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 31/230 (13%)

Query: 33  LGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENII 89
           +G G F  V  G  E   G+  A  +V ++++  S  PD+      EV   + L H N++
Sbjct: 3   IGNGWFGKVLLG--EAHRGMSKA--RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKA----IKNWARQILRGLHYL 144
           +     ++       ++ E    G L+ Y R     V   A    ++  A ++  GL +L
Sbjct: 59  QCLGQCIESI--PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPEL 200
           H  +   IH DL   N  +  +   VKIGD GLA+         T         ++APEL
Sbjct: 117 HQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173

Query: 201 YEEEYNELV--------DIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241
            E    +L+        +I+S G+ + E+ T  + PY +  +  Q+ K+V
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQV 222

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 21/146 (14%)

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 197
           +H L       +HRD+K DN+ ++  NG +++ D G  + ++   T +S   +GTP++++
Sbjct: 118 VHQLG-----YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171

Query: 198 PELYEE------EYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASL 250
           PE+ +        Y    D +S G+C+ EM+  E P Y E  +  + Y K+ +  +    
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQF 229

Query: 251 -SKVTD--PQVKQFIEKCIVPASLRL 273
              VTD   + K  I + I     RL
Sbjct: 230 PPDVTDVSEEAKDLIRRLICSPETRL 255

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 39/173 (22%), Positives = 62/173 (35%), Gaps = 22/173 (12%)

Query: 133 WA--RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
           WA   Q L  L  LH          L   +  +   +G V            +   +S  
Sbjct: 20  WAVCLQCLGALRELHRQAKS--GNILLTWDGLLK-LDGSV----------AFKTPEQS-R 65

Query: 191 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249
             P FMAPE+ +   Y E  DIYS G+ + E +  E PYNE +  + I + + +G    +
Sbjct: 66  PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG--MPA 123

Query: 250 LSKVTDPQVKQFIEKCIVPASLRLPALELLK---DPFLVTDNPKDLVCDPLRL 299
                   ++           +RL A  L +          + + L  + L L
Sbjct: 124 DDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 193
           Q+ RG+ +L S N   +HRDL   N+ +      VKI D GLA  +   +     G+   
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 194 --EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 249
             ++MAPE +++  Y  L D++S+G+ + E+ +    PY      +  Y K+ SG + A 
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK 361

Query: 250 LSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
               T  +V   + KC      + P+   L D
Sbjct: 362 PDHATQ-EVYDIMVKCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
           Q+ RG+ +L S     IHRDL   NI ++ NN  VKI D GL        AR +   P++
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 229

Query: 196 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
                       MAPE ++++ Y    D++SFG+ + E+ +
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 29/209 (13%)

Query: 33  LGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLY--SEVHLLKSLKHENII 89
           +G G F  V  G  EV+ G   A  QV ++++  S    E++    E    +SL+H N++
Sbjct: 3   IGNGWFGKVILG--EVNSGYTPA--QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-----DMKAIKNWARQILRGLHYL 144
           +      + T   + M  E    G L+ Y +  +       D   ++  A +I  GL +L
Sbjct: 59  QCLGQCTEVTPYLLVM--EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPEL 200
           H +N   IH DL   N  +  +   VKIGD GL+    +     T   +     ++APEL
Sbjct: 117 HKNN--FIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173

Query: 201 YEEEYNELV--------DIYSFGMCILEM 221
            +E +  L+        +++S G+ I E+
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 36/262 (13%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHE 86
           ++ +++G+G F  V K   + DG+ +      +++   S D       E+ +L  L  H 
Sbjct: 10  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHP 68

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK---AIKN----------- 132
           NII    +   +    + +  E    G+L  + +K + ++     AI N           
Sbjct: 69  NIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 133 --WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
             +A  + RG+ YL       IHRDL   NI V G N   KI D GL+   +    +++ 
Sbjct: 127 LHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMG 183

Query: 191 GTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGI- 245
             P  +MA E L    Y    D++S+G+ + E+V+    PY  C    A++Y+K+  G  
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYR 241

Query: 246 --KPASLSKVTDPQVKQFIEKC 265
             KP +     D +V   + +C
Sbjct: 242 LEKPLN----CDDEVYDLMRQC 259

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 46.8 bits (111), Expect = 7e-06
 Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 42/277 (15%)

Query: 32  ILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           +LGKG F +V +     ++    +VA   +   D+  S D +E    E   +K   H N+
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSD-IEEFLREAACMKEFDHPNV 63

Query: 89  IKFYNSWVDDTNRT-----INMITELFTS-GSLRQYRKKHK------NVDMKAIKNWARQ 136
           IK     V   +R      I M+   F   G L  +    +       + ++ +  +   
Sbjct: 64  IKLIG--VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------QQPTARSVI 190
           I  G+ YL S N   IHRDL   N  +N  N  V + D GL+  +      +Q  A  + 
Sbjct: 122 IASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVADFGLSKKIYSGDYYRQGCASKL- 177

Query: 191 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK-- 246
              +++A E L +  Y    D+++FG+ + E++T  + PY   +N ++IY  +  G +  
Sbjct: 178 -PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIKGNRLK 235

Query: 247 --PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
             P  L  V +      + +C  P     P+ + L+D
Sbjct: 236 QPPDCLEDVYE-----LMCQCWSPEPKCRPSFQHLRD 267

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
           Q+ RG+ +L S     IHRDL   NI ++ NN  VKI D GL        AR +   P++
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 230

Query: 196 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
                       MAPE ++++ Y    D++SFG+ + E+ +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 26/144 (18%)

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
           Q+ +G+ +L S     IHRDL   NI ++ NN  VKI D GL        AR +   P++
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 235

Query: 196 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 241
                       MAPE +++  Y    D++SFG+ + E+ +    PY   K   +  +++
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295

Query: 242 TSGIKPASLSKVTDPQVKQFIEKC 265
             G +  +    T P++ Q +  C
Sbjct: 296 KEGTRMRA-PDYTTPEMYQTMLDC 318

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 30/220 (13%)

Query: 28  RYDEILGKGAFKTVYKG--FDEVDGIEVAWNQV-NIEDVMQSPDQLERLYSEVHLLKSLK 84
           R+ E LG+  F  VYKG  F    G +     +  ++D  + P + E    E  +   L+
Sbjct: 8   RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR-EEFKHEAMMRSRLQ 66

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNV----DMKAIKNW---- 133
           H NI+        +  + ++MI    +   L ++   R  H +V    D K +K+     
Sbjct: 67  HPNIVCLLGVVTKE--QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124

Query: 134 -----ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
                  QI  G+ +L SH+  ++H+DL   N+ V  +   VKI DLGL   +       
Sbjct: 125 DFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-DKLNVKISDLGLFREVYAADYYK 181

Query: 189 VIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           ++G       +M+PE +   +++   DI+S+G+ + E+ +
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)

Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181
           D+  IK   RQ+L GL  LH     I+HRD+K +N+ V   +G+VKI D G A+ M
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDM 359

Length = 507

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)

Query: 31  EILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSE-----VHLLKSL 83
           E LG+G F  ++KG   +  D  E+   +V    +++  D+  R YSE       ++  L
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEV----LLKVLDKSHRNYSESFFEAASMMSQL 56

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK-NWARQILRGLH 142
            H++++  Y   V        M+ E    GSL  Y KK+KN+   + K   A+Q+   LH
Sbjct: 57  SHKHLVLNYGVCVCGDESI--MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALH 114

Query: 143 YLHSHNPPIIHRDLKCDNIFV-------NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
           +L      + H ++   N+ +        GN   +K+ D G++I +  P    +   P +
Sbjct: 115 FLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV-LPKEILLERIP-W 170

Query: 196 MAPELYEEEYNELV--DIYSFGMCILEM 221
           + PE  E   N  +  D +SFG  + E+
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEI 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 61/256 (23%), Positives = 109/256 (42%), Gaps = 30/256 (11%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NII 89
           +++G+G F  V K   + DG+ +      +++     D  +    E+ +L  L H  NII
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 59

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM---------KAIKNWARQILR- 139
               +   +    + +  E    G+L  + +K + ++           A    ++Q+L  
Sbjct: 60  NLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 140 ------GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
                 G+ YL       IHRDL   NI V G N   KI D GL+   +    +++   P
Sbjct: 118 AADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMGRLP 174

Query: 194 -EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGIKPAS 249
             +MA E L    Y    D++S+G+ + E+V+    PY  C    A++Y+K+  G +   
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYR-LE 231

Query: 250 LSKVTDPQVKQFIEKC 265
                D +V   + +C
Sbjct: 232 KPLNCDDEVYDLMRQC 247

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 54/238 (22%), Positives = 102/238 (42%), Gaps = 35/238 (14%)

Query: 31  EILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +ILG+G F +V +G    D+   ++VA   + ++    S  ++E   SE   +K   H N
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS--EIEEFLSEAACMKDFDHPN 62

Query: 88  IIKFYNSWVDDTNRTIN------MITELFTSGSLRQY------RKKHKNVDMKAIKNWAR 135
           ++K     V     ++       +I      G L  +          + + ++ +  +  
Sbjct: 63  VMKLIG--VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------QQPTARS 188
            I  G+ YL + N   IHRDL   N  +   +  V + D GL+  +       Q   A+ 
Sbjct: 121 DIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177

Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
            +   +++A E L +  Y    D+++FG+ + E+ T  + PY   +N  +IY  +  G
Sbjct: 178 PV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLRHG 231

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 36/129 (27%), Positives = 67/129 (51%), Gaps = 11/129 (8%)

Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV-KIGDLGLAIVMQQ 183
           +D + + +++ Q+ +G+ +L S N   IHRDL   NI +   +G + KI D GLA  ++ 
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRN 266

Query: 184 PTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 237
            +   V G      ++MAPE ++   Y    D++S+G+ + E+ +    PY      ++ 
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326

Query: 238 YKKVTSGIK 246
           YK +  G +
Sbjct: 327 YKMIKEGYR 335

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 85/388 (21%), Positives = 146/388 (37%), Gaps = 81/388 (20%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG GAF  V            A   +  +DV+   +Q+  + +E  +L    +E ++K Y
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR-NQVAHVKAERDILAEADNEWVVKLY 67

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+ D  N  +  + +    G +     + +       + +  ++   +  +H      I
Sbjct: 68  YSFQDKDN--LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FI 123

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-------------------QPT-------- 185
           HRD+K DNI ++  +G +K+ D GL    +                   +P+        
Sbjct: 124 HRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 186 ----------------------ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 222
                                 A S++GTP ++APE L  + Y +L D +S G+ + EM+
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 223 TCEYPYNECKNPAQIYKKVT---SGIKPASLSKVTDPQVKQFIEKCIVPASLRL---PAL 276
             + P+     P +   KV    + +      K++ P+    I K    A  RL    A 
Sbjct: 243 VGQPPF-LAPTPTETQLKVINWENTLHIPPQVKLS-PEAVDLITKLCCSAEERLGRNGAD 300

Query: 277 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADS----CA 332
           ++   PF    +  D   D    P   P V  ++    HPMD   N   V  +S     +
Sbjct: 301 DIKAHPFF---SEVDFSSDIRTQP--APYVPKIS----HPMDTS-NFDPVEEESPWNDAS 350

Query: 333 KSNTGTW-FLTLELQRLTENN--EFTLR 357
             +T TW  L     +  E+   EFT R
Sbjct: 351 GDSTRTWDTLCSPNGKHPEHAFYEFTFR 378

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 52/261 (19%), Positives = 105/261 (40%), Gaps = 57/261 (21%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++GKGAF  V +   + D  ++   +  ++  M   DQL  + +E  +L       ++ 
Sbjct: 7   KVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            Y S+ D   + + +I E    G L     K+        + +  + +  +  +H     
Sbjct: 66  LYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG-- 121

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI-------------VMQQPTAR---------- 187
            IHRD+K DNI ++   G +K+ D GL+              ++Q  + +          
Sbjct: 122 FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 188 --------------------------SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 220
                                     S +GTP+++APE++ ++ Y +  D +S G  + E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Query: 221 MVTCEYPYNECKNPAQIYKKV 241
            +   +P    +N  + Y+K+
Sbjct: 241 CL-IGWPPFCSENSHETYRKI 260

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 37/123 (30%), Positives = 52/123 (42%), Gaps = 32/123 (26%)

Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----- 182
           K I+   RQIL  L  LHS    I+HRD+K  NI  +  +G  KI DLG A  ++     
Sbjct: 255 KIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY 312

Query: 183 QPTARSVIGTPEFMAPE-----------------------LYEEEYNELVDIYSFGMCIL 219
            P  +  +  P + APE                       L++    +  DIYS G+  L
Sbjct: 313 IP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370

Query: 220 EMV 222
           +M 
Sbjct: 371 QMA 373

Length = 566

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 21/40 (52%), Positives = 27/40 (67%), Gaps = 3/40 (7%)

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
           L YLH H   IIHRDLK DN+ ++ N G +K+ D GL+ V
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 54/239 (22%), Positives = 105/239 (43%), Gaps = 34/239 (14%)

Query: 43  KGFDEV----------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +GF+++           G  V   ++N+E    + + +  L  E+H+ K   H NI+ + 
Sbjct: 8   RGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYR 65

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK--AIKNWARQILRGLHYLHSHNPP 150
            +++ D    + ++T     GS +     H    M   AI    + +L+ L Y+H     
Sbjct: 66  ATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG-- 121

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDL--GLAIVMQQPTARSVIGTPEF-------MAPELY 201
            +HR +K  +I ++  +G+V +  L   L+++      R V   P++       ++PE+ 
Sbjct: 122 YVHRSVKASHILISV-DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVL 180

Query: 202 EEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKKVTSGIKPASLSKVTDP 256
           ++    Y+   DIYS G+   E+     P+ +   PA Q+  +  +G  P  L   T P
Sbjct: 181 QQNLQGYDAKSDIYSVGITACELANGHVPFKDM--PATQMLLEKLNGTVPCLLDTTTIP 237

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 33/132 (25%), Positives = 51/132 (38%), Gaps = 51/132 (38%)

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----------------------------- 177
           H    IHRD+K DNI ++  +G +K+ D GL                             
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 178 --------------------AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 216
                               A   Q+  A S++GTP ++APE L    Y +L D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236

Query: 217 CILEMVTCEYPY 228
            + EM+  + P+
Sbjct: 237 ILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 30/233 (12%)

Query: 33  LGKGAFKTVYKG-FDEVDGI-EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           LG+G F +V +G  ++ D I +VA   + I    +S  ++E   SE   +K   H N+++
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS--EMEDFLSEAVCMKEFDHPNVMR 64

Query: 91  FYNSWVDDTNR----TINMITELFTSGSLRQYRKKHKNVDM------KAIKNWARQILRG 140
                +         +  +I      G L  +    +  D       + +  +   I  G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------QQPTARSVIGTP 193
           + YL S +   IHRDL   N  +N  N  V + D GL+  +       Q   A+  +   
Sbjct: 125 MEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV--- 178

Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
           +++A E L +  Y    D++SFG+ + E+ T  + PY   +N ++IY  +  G
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDYLRQG 230

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 37/168 (22%), Positives = 72/168 (42%), Gaps = 22/168 (13%)

Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQIL 138
           L+H NI++     V+       ++ E    G L+ Y  +     +N  +  ++  A +I 
Sbjct: 52  LQHPNILQCLGQCVEAI--PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIA 109

Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPE 194
            G+ ++H HN   +H DL   N F+  +   VK+GD G+     +     T         
Sbjct: 110 AGVTHMHKHN--FLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166

Query: 195 FMAPELYEEEYNELV--------DIYSFGMCILEMVTC-EYPYNECKN 233
           ++APEL  E +  L+        ++++ G+ + E+      PY+   +
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 49/225 (21%), Positives = 94/225 (41%), Gaps = 26/225 (11%)

Query: 5   SGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
           S  +KS T     S         + + ++ +G     YKG    +G++    ++N  DV 
Sbjct: 677 SKVSKSITINDILSSL-------KEENVISRGKKGASYKGKSIKNGMQFVVKEIN--DVN 727

Query: 65  QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 124
             P       SE+  +  L+H NI+K        + +   +I E     +L +  +   N
Sbjct: 728 SIPS------SEIADMGKLQHPNIVKLIGLC--RSEKGAYLIHEYIEGKNLSEVLR---N 776

Query: 125 VDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
           +  +  +  A  I + L +LH   +P ++  +L  + I ++G +       L   +    
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDT 836

Query: 184 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYP 227
               S      ++APE  E ++  E  DIY FG+ ++E++T + P
Sbjct: 837 KCFIS----SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	394
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
PRK10345	210	hypothetical protein; Provisional	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.84
smart00090	237	RIO RIO-like kinase.	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.61
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.57
KOG1243	690	consensus Protein kinase [General function predict	99.49
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.41
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.38
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
KOG3087	229	consensus Serine/threonine protein kinase [General	99.27
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.25
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.23
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.17
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.01
COG4248	637	Uncharacterized protein with protein kinase and he	98.98
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.92
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.82
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.77
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.77
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.74
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.56
PRK09902	216	hypothetical protein; Provisional	98.52
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.49
PF01636	239	APH: Phosphotransferase enzyme family This family	98.37
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.29
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.24
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.21
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.17
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.12
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.12
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.08
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.04
PLN02876	822	acyl-CoA dehydrogenase	98.02
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.93
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.83
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.76
PRK10593	297	hypothetical protein; Provisional	97.71
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.7
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.61
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.4
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.23
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.22
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.16
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.07
KOG2270	520	consensus Serine/threonine protein kinase involved	97.06
PRK05231	319	homoserine kinase; Provisional	96.85
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.83
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.82
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.7
PRK12396	409	5-methylribose kinase; Reviewed	96.65
PLN02236	344	choline kinase	96.61
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.49
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.31
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.27
PLN02756	418	S-methyl-5-thioribose kinase	95.82
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.71
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.6
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.04
PTZ00384	383	choline kinase; Provisional	94.97
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.63
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	93.76
PRK06148	1013	hypothetical protein; Provisional	93.52
PRK10271	188	thiK thiamine kinase; Provisional	92.37
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	92.35
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	92.35
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	92.16

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-79  Score=597.17  Aligned_cols=377  Identities=61%  Similarity=1.000  Sum_probs=321.1

Q ss_pred             CCCCCCccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCcee
Q 016143           11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK   90 (394)
Q Consensus        11 ~~~~~~~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~   90 (394)
                      ++.+.++++.+|+|||.|+.++||+|+|.+||+|+|..+|.+|||..++..++.++++.+++|++|+++|+.|+|||||+
T Consensus        26 e~~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIir  105 (632)
T KOG0584|consen   26 EPDESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIR  105 (632)
T ss_pred             ccccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceee
Confidence            35678899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE
Q 016143           91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV  170 (394)
Q Consensus        91 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~  170 (394)
                      +|++|++..+.++.+|+|++.+|+|+.|+++++.++.+.++.|++||+.||.|||++.|||+|||||++||||+++.|.|
T Consensus       106 fy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~V  185 (632)
T KOG0584|consen  106 FYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEV  185 (632)
T ss_pred             eeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCce
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEcccceeeeecCCCCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 016143          171 KIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL  250 (394)
Q Consensus       171 kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~  250 (394)
                      ||+|+|||+..+.+.+.+++|||+|||||++...|++.+|||||||||+||+|+++||++|.+++|+|+++.+|.+|..+
T Consensus       186 KIGDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl  265 (632)
T KOG0584|consen  186 KIGDLGLATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL  265 (632)
T ss_pred             eecchhHHHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHcCCCCCCCCCHHHHhcCCccccCCCC-------CcccCCC--CCCCCchhhcccCCCCCCCCCccc
Q 016143          251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPK-------DLVCDPL--RLPNLVPEVMNLAHSEPHPMDIDL  321 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~~p~~R~s~~elL~~p~~~~~~~~-------~~~~~~~--~~p~~~~~~~~~~~~~~~~~~~~~  321 (394)
                      .++-+|++++||++||...+.|+|+.|||.||||..+.-.       ......+  ......+...........+++.+.
T Consensus       266 ~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g~~~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~  345 (632)
T KOG0584|consen  266 SKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDEDGGIVELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNL  345 (632)
T ss_pred             hccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccccccccccchhhcccccccccccccchhhcCCcccccccceeec
Confidence            9999999999999999999999999999999999986431       0000000  011000000000001111222222


Q ss_pred             cCccccc--ccccccCCCCcchhhhhhhhcCCceEEEeceecCCC-ceEEEEEeeCCCCceecccccceeecC
Q 016143          322 NHKKVSA--DSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDD-TVSLTLRIGDKSGKRICGAINSCFFFP  391 (394)
Q Consensus       322 ~~~~~~~--~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (394)
                      +......  .....++........+++|..+.+.+.++|++.++. .++|.|||+|.+|++    .++||-|.
T Consensus       346 ~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~----r~i~fpf~  414 (632)
T KOG0584|consen  346 NTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLV----RNIHFPFD  414 (632)
T ss_pred             CCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCc----ccccCCCc
Confidence            2211110  001111222334468999999999999999999987 999999999999984    45577664

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-58  Score=447.09  Aligned_cols=262  Identities=33%  Similarity=0.530  Sum_probs=236.0

Q ss_pred             CccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeE
Q 016143           16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW   95 (394)
Q Consensus        16 ~~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~   95 (394)
                      .....|+..++|..++.||+|||++||.+.+..+|+.||+|+|.+..+ ..+...+++.+||+++++|+|||||++|++|
T Consensus         9 p~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l-~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F   87 (592)
T KOG0575|consen    9 PEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL-KKPKQREKVLNEIEIHRSLKHPNIVQFYHFF   87 (592)
T ss_pred             CCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh-cCcchHHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence            345566666777889999999999999999999999999999986554 4567889999999999999999999999999


Q ss_pred             EcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143           96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus        96 ~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                      .|.  .++|||.|+|..++|..++++.+.++|.+++.+++||+.||.|||+++  |+|||||..|+|++ ++.+|||+||
T Consensus        88 EDs--~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~-~~~~VKIgDF  162 (592)
T KOG0575|consen   88 EDS--NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLN-ENMNVKIGDF  162 (592)
T ss_pred             ecC--CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeec-CcCcEEeccc
Confidence            654  579999999999999999999999999999999999999999999999  99999999999999 7889999999


Q ss_pred             ceeeeecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 016143          176 GLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK  252 (394)
Q Consensus       176 gla~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  252 (394)
                      |||+.+..+  ...+.||||.|+|||++.+ .++..+||||+||+||.||+|++||.. .+..+.+.+|....+  .+|.
T Consensus       163 GLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y--~~P~  239 (592)
T KOG0575|consen  163 GLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEY--SMPS  239 (592)
T ss_pred             ceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCc--cccc
Confidence            999988755  4567899999999998875 589999999999999999999999976 778889999987643  2456


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      ..++++++||.++|. +|.+|||++++|.|+||+.
T Consensus       240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence            788999999999998 9999999999999999943

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-59  Score=435.29  Aligned_cols=262  Identities=26%  Similarity=0.377  Sum_probs=227.1

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCH---HHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP---DQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~---~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      ...||-+.+.||+|+||.|-+|+.+.||+.||||+++........   .....+.+|+++|++|+|||||+++++|..+ 
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-  248 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-  248 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-
Confidence            455667889999999999999999999999999999876654322   1223467899999999999999999998544 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEcccce
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGL  177 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~--~~~~kl~Dfgl  177 (394)
                       .+.||||||++||+|++.+-.++.+.+...+.+++||+.|+.|||++|  |+||||||+|||++.+  .-.+||+|||+
T Consensus       249 -ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  249 -DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             -CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccch
Confidence             567999999999999999999999999999999999999999999999  9999999999999732  25799999999


Q ss_pred             eeeecC-CCCcccccCCcccCccccccc----CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC--CC
Q 016143          178 AIVMQQ-PTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SL  250 (394)
Q Consensus       178 a~~~~~-~~~~~~~gt~~y~aPE~l~~~----~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~--~~  250 (394)
                      |+.... +.+++.||||.|.|||++.+.    |..++||||+||+||.+++|.+||++......+.+.|.+|.++.  ..
T Consensus       326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~  405 (475)
T KOG0615|consen  326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ  405 (475)
T ss_pred             hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence            987754 357889999999999988653    45699999999999999999999999777666888898885532  34


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +..++.++++||.+||+ +|+.||+++|+|+||||+...
T Consensus       406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            55678999999999998 999999999999999998653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-57  Score=418.17  Aligned_cols=253  Identities=29%  Similarity=0.492  Sum_probs=230.6

Q ss_pred             ccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEc
Q 016143           29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        29 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      ....||+|+.|+||++.|+.|++.+|+|.|....   ++....++.+|++++++.+|||||++|++|..+.. .+.++||
T Consensus        83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~---~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mE  158 (364)
T KOG0581|consen   83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI---DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICME  158 (364)
T ss_pred             hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC---CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehh
Confidence            3478999999999999999999999999995432   46778889999999999999999999999987765 6899999


Q ss_pred             ccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCc
Q 016143          109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR  187 (394)
Q Consensus       109 ~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~  187 (394)
                      ||++|+|.++++..++++|..+..++.++++||.|||. ++  |+||||||+|||+| ..|.+||+|||.+..+.++.+.
T Consensus       159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvN-skGeVKicDFGVS~~lvnS~a~  235 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVN-SKGEVKICDFGVSGILVNSIAN  235 (364)
T ss_pred             hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeec-cCCCEEeccccccHHhhhhhcc
Confidence            99999999999999999999999999999999999995 77  99999999999999 7899999999999998888889


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCC----CCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNE----CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~----~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      +++||..|||||.+.+ .|+.++||||||+.++||.+|++||..    ..+..+++..|..+..|......+++++++||
T Consensus       236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV  315 (364)
T KOG0581|consen  236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFV  315 (364)
T ss_pred             cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence            9999999999998887 599999999999999999999999976    35778889999988766544445999999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          263 EKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ..||. +|++|+++.|+|+|||++...
T Consensus       316 ~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  316 SCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             HHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            99998 999999999999999998654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-56  Score=410.97  Aligned_cols=266  Identities=25%  Similarity=0.441  Sum_probs=236.8

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +.+.++||+|+||+||+++.+.|++.+|+|++++..... ....+....|..+|.+++||.||+++.+|++.  ..+|+|
T Consensus        27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~--~kLylV  103 (357)
T KOG0598|consen   27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPFIVKLIYSFQTE--EKLYLV  103 (357)
T ss_pred             eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCcEeeeEEecccC--CeEEEE
Confidence            467899999999999999999999999999998776544 35678899999999999999999999999655  569999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      +||+.||+|+..+++.+.+++..++.|+..|+.||.|||++|  |+||||||+|||+| .+|+++|+|||+++..-..  
T Consensus       104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhcccCCC
Confidence            999999999999999999999999999999999999999999  99999999999999 8999999999999754333  


Q ss_pred             CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          185 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                      ...+.|||++|||||++. ..|+..+|+||||+++|||++|.+||.+ .+...++++|..+.. ...+...+.+++++++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~-~~~p~~ls~~ardll~  258 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKL-PLPPGYLSEEARDLLK  258 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcC-CCCCccCCHHHHHHHH
Confidence            456689999999999765 5699999999999999999999999987 778889999988752 2356668899999999


Q ss_pred             HcCC-CCCCCC----CHHHHhcCCccccCCCCCcccCCCCCC
Q 016143          264 KCIV-PASLRL----PALELLKDPFLVTDNPKDLVCDPLRLP  300 (394)
Q Consensus       264 ~~L~-~p~~R~----s~~elL~~p~~~~~~~~~~~~~~~~~p  300 (394)
                      ++|. +|.+|.    ++.++-+||||...+|+.+....+..|
T Consensus       259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~Pp  300 (357)
T KOG0598|consen  259 KLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPP  300 (357)
T ss_pred             HHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCC
Confidence            9998 999996    688999999999999988766655443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-55  Score=392.08  Aligned_cols=266  Identities=27%  Similarity=0.464  Sum_probs=239.9

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ...+.||.|+||+|.+++++.+|..+|+|++++.++.+ ..+.+...+|.++|+.+.||+++++++.|.|.  ..+||||
T Consensus        47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~--~~lymvm  123 (355)
T KOG0616|consen   47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN--SNLYMVM  123 (355)
T ss_pred             hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEeeccC--CeEEEEE
Confidence            34588999999999999999999999999998877654 56778899999999999999999999998654  5799999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCc
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR  187 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~  187 (394)
                      ||.+||.|+.++++.+++++..++.++.||+.||+|||+++  |++|||||+|||+| .+|.+||+|||+|+..... ..
T Consensus       124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~r-T~  199 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGR-TW  199 (355)
T ss_pred             eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEecCc-EE
Confidence            99999999999999999999999999999999999999999  99999999999999 7999999999999988877 56


Q ss_pred             ccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      +.||||.|+|||++. +.|+.++|+|||||++|||+.|.+||.. .++.+++.+|..+..  .+|...++++++||+++|
T Consensus       200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL  276 (355)
T KOG0616|consen  200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKLL  276 (355)
T ss_pred             EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCcc--cCCcccCHHHHHHHHHHH
Confidence            789999999999776 5699999999999999999999999987 677999999998843  467788899999999999


Q ss_pred             C-CCCCCC-----CHHHHhcCCccccCCCCCcccCCCCCCCCc
Q 016143          267 V-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPNLV  303 (394)
Q Consensus       267 ~-~p~~R~-----s~~elL~~p~~~~~~~~~~~~~~~~~p~~~  303 (394)
                      + |-.+|.     ...++..||||+...|..+....+..|..+
T Consensus       277 ~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p  319 (355)
T KOG0616|consen  277 QVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP  319 (355)
T ss_pred             hhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence            7 877773     578999999999999988877766666654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-54  Score=403.74  Aligned_cols=259  Identities=27%  Similarity=0.516  Sum_probs=225.7

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      ..+.| -+.+.||+|+||+||+|+++.++..||||.|.....  .++..+.+..|+.+|+.++|||||+++++..+  .+
T Consensus         8 ~~~~y-~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~   82 (429)
T KOG0595|consen    8 VVGDY-ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIED--DD   82 (429)
T ss_pred             ccccc-eehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CC
Confidence            34555 566779999999999999999999999999986653  46778889999999999999999999998744  45


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--C---CcEEEcccc
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--N---GEVKIGDLG  176 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~--~---~~~kl~Dfg  176 (394)
                      ++|+|||||.||+|.+|+++++.+++..++.++.||+.||++||+++  ||||||||+|||++..  +   -.+||+|||
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            89999999999999999999999999999999999999999999999  9999999999999842  1   468999999


Q ss_pred             eeeeecCCC-CcccccCCcccCcccc-cccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCC
Q 016143          177 LAIVMQQPT-ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKV  253 (394)
Q Consensus       177 la~~~~~~~-~~~~~gt~~y~aPE~l-~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~-~~~~~~~  253 (394)
                      +|+.+.... +.+.||+|.|||||++ ..+|+.|+|+||+|+|+|+|++|+.||.. .+..+++..+..+.. ...++..
T Consensus       161 fAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~  239 (429)
T KOG0595|consen  161 FARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAE  239 (429)
T ss_pred             hhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhh
Confidence            999887664 6778999999999988 46799999999999999999999999987 667777777776633 3345556


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .++.+.+++-..|. ++.+|.+..+-+.|+++....
T Consensus       240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             ccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            67777888888787 899999999999999998754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-56  Score=395.72  Aligned_cols=246  Identities=31%  Similarity=0.498  Sum_probs=221.0

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||.||++.+..+|..||+|.++...+  +.+..+.+..|+.+|++|+|||||++|+.-+.+++..+++|
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4788999999999999999999999999999985543  46778889999999999999999999995555666779999


Q ss_pred             EcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          107 TELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPP--IIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~--ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ||||.+|+|.++|+.    ++.+++..++.++.|++.||.++|++-+.  |+||||||.|||++ .+|.+||+|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhHhH
Confidence            999999999999874    35699999999999999999999995455  99999999999999 789999999999998


Q ss_pred             ecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          181 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       181 ~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      +...  .+.+.+|||.||+||++.+ +|+.++||||+||++|||+.-+.||.+ .+..++.++|..+..|+-+...+|..
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS~~  256 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYSTD  256 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhhhH
Confidence            8766  3678899999999997765 699999999999999999999999988 58999999999997776555788999


Q ss_pred             HHHHHHHcCC-CCCCCCCHH
Q 016143          258 VKQFIEKCIV-PASLRLPAL  276 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~  276 (394)
                      +..+|..|+. ++..||+..
T Consensus       257 l~~li~~ci~vd~~~RP~t~  276 (375)
T KOG0591|consen  257 LRELINMCIAVDPEQRPDTV  276 (375)
T ss_pred             HHHHHHHHccCCcccCCCcc
Confidence            9999999998 999999873

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-53  Score=410.52  Aligned_cols=259  Identities=27%  Similarity=0.540  Sum_probs=226.0

Q ss_pred             CCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCH-HHHHHHHHHHHHHHcCC-CCCceeEeeeEEcC
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLK-HENIIKFYNSWVDD   98 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~-~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~   98 (394)
                      ...++| ++++.||+|+||+|++|.+..+|..||+|+++........ ...+.+.+|+.+++.++ ||||+++++++...
T Consensus        14 ~~~g~y-~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   14 LSIGKY-ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             cccCce-eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            344566 8899999999999999999999999999988765332122 34556778999999999 99999999998655


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      .  .+++|||||.||+|.+++.+.+++.+..++.+|+||++|++|||++|  |+||||||+|||++.+.+++||+|||++
T Consensus        93 ~--~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   93 T--KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             C--eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            4  49999999999999999999999999999999999999999999999  9999999999999944399999999999


Q ss_pred             eee--cCCCCcccccCCcccCcccccc-c-CC-CcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 016143          179 IVM--QQPTARSVIGTPEFMAPELYEE-E-YN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       179 ~~~--~~~~~~~~~gt~~y~aPE~l~~-~-~~-~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      ...  ......+.+|||.|+|||++.+ . |+ .++||||+|++||.|++|+.||.+ .+...++.++..+...  ++..
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~--~p~~  245 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFK--IPSY  245 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCcc--CCCC
Confidence            888  3456788999999999998876 4 64 899999999999999999999988 6777777778777433  4555


Q ss_pred             C-CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          254 T-DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       254 ~-~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      . +++++.|+++||. +|.+|+++.+++.||||+..
T Consensus       246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  246 LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence            5 8999999999998 99999999999999999974

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-53  Score=408.91  Aligned_cols=260  Identities=27%  Similarity=0.468  Sum_probs=229.8

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ..+.++++||+|+|++|++|.++.++++||||++.+.-+.+ ++...-+..|-..|..| .||.|+++|..|.|+.  .+
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~--sL  149 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE--SL  149 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc--ce
Confidence            34578999999999999999999999999999987655433 34445577799999999 8999999999997764  69


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      |+|+||+++|+|.++|++.+.|++..++.++.||+.||+|||++|  ||||||||+|||+| .+|++||+|||.|..+..
T Consensus       150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd-~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLD-KDGHIKITDFGSAKILSP  226 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEc-CCCcEEEeeccccccCCh
Confidence            999999999999999999999999999999999999999999999  99999999999999 789999999999976643


Q ss_pred             C-------------CC--cccccCCcccCccccccc-CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q 016143          184 P-------------TA--RSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP  247 (394)
Q Consensus       184 ~-------------~~--~~~~gt~~y~aPE~l~~~-~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~  247 (394)
                      .             ..  .+++||..|.+||+|... .+..+|||+||||||.|+.|.+||.+ .++-.++++|..-.  
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l~--  303 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQALD--  303 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHhc--
Confidence            2             11  458999999999988765 68999999999999999999999987 77788888887653  


Q ss_pred             CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCCCcc
Q 016143          248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV  293 (394)
Q Consensus       248 ~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~~~~  293 (394)
                      -.++...++.+++||+++|+ +|++|+++.+|..||||...+|+.+-
T Consensus       304 y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw  350 (604)
T KOG0592|consen  304 YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW  350 (604)
T ss_pred             ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence            34677778999999999998 99999999999999999999987743

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-52  Score=393.09  Aligned_cols=256  Identities=33%  Similarity=0.547  Sum_probs=218.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +..++.||+|+||+||++.++.+|...|+|.+...+   .+. .+.+.+|+.+|++|+|||||++++.........+++.
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            467899999999999999999999999999987653   222 7789999999999999999999996432322478999


Q ss_pred             EcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--
Q 016143          107 TELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--  183 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--  183 (394)
                      |||+++|+|.+++++.+ ++++..++.+.+||++||+|||++|  ++||||||+|||++..++.+||+|||++.....  
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            99999999999999987 7999999999999999999999999  999999999999994378999999999987663  


Q ss_pred             ---CCCcccccCCcccCcccccccCC--CcCcchhhhhHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          184 ---PTARSVIGTPEFMAPELYEEEYN--ELVDIYSFGMCILEMVTCEYPYNEC-KNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       184 ---~~~~~~~gt~~y~aPE~l~~~~~--~~~DIwSlG~il~elltg~~Pf~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                         .......|||.|||||++...+.  .++|||||||++.||+||+.||.+. .....++........| .++...+++
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~~  251 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSDE  251 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCHH
Confidence               22446789999999998874432  4999999999999999999999873 3344445544444334 688889999


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +++|+.+|++ +|.+||||+++|.|||++....
T Consensus       252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  252 AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999998 9999999999999999987644

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-52  Score=409.16  Aligned_cols=255  Identities=24%  Similarity=0.461  Sum_probs=230.0

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      -|++++.||.|+.|.|.+|++..||+.+|||+|.+.. ..+......+-+|+-+|+.+.|||++++|++|  +++..+|+
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~-~~s~s~~~~IerEIviMkLi~HpnVl~LydVw--e~~~~lyl   89 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS-ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW--ENKQHLYL   89 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeecccc-ccccccccchhhhhHHHHHhcCCCeeeeeeee--ccCceEEE
Confidence            3599999999999999999999999999999997653 22344556677899999999999999999999  55568999


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee-cCC
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-QQP  184 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~-~~~  184 (394)
                      |.||++||.|++|+-+++++++.++..+++||+.|+.|+|..+  |+||||||+|+|++ ..+++||+|||+|... ...
T Consensus        90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd-~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLD-VKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhh-cccCEeeeccceeecccCCc
Confidence            9999999999999999999999999999999999999999999  99999999999999 5667999999999754 445


Q ss_pred             CCcccccCCcccCccccccc-C-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          185 TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~~~-~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      ...+.||+|.|.|||+..+. | +.++||||+|||||.||||++||++ .|...++.++++|...  ++..+++++++||
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~eaQdLL  243 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISSEAQDLL  243 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCHHHHHHH
Confidence            67889999999999988874 6 5899999999999999999999986 8899999999999654  5688899999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          263 EKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      .+||. ||++|.+..|+++|||+.....
T Consensus       244 r~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  244 RRMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             HHHhccCccccccHHHHhhCchhhcCCC
Confidence            99997 9999999999999999987643

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-52  Score=402.48  Aligned_cols=261  Identities=32%  Similarity=0.570  Sum_probs=230.0

Q ss_pred             cccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEc
Q 016143           18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD   97 (394)
Q Consensus        18 ~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~   97 (394)
                      ...||..+|-. .+.||+|+.|.||.|....++..||||.+++..    +...+-+++|+.+|+.++|+|||.++++|..
T Consensus       267 ~~~dP~~~y~~-~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~----Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv  341 (550)
T KOG0578|consen  267 SQGDPRSKYTD-FKKIGQGATGGVYVARKISTKQEVAIKRMDLRK----QPKKELLLNEILVMRDLHHPNIVNFLDSYLV  341 (550)
T ss_pred             cCCChhhhhcc-hhhhccccccceeeeeeccCCceEEEEEEEecc----CCchhhhHHHHHHHHhccchHHHHHHHHhcc
Confidence            44788888844 477999999999999999999999999998765    3445678999999999999999999999876


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                      .  ..+|+||||++||+|.+.+.... ++|.++..+.+.++.||+|||.++  |+|||||.+|||++ .+|.+||+|||+
T Consensus       342 ~--deLWVVMEym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGF  415 (550)
T KOG0578|consen  342 G--DELWVVMEYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGF  415 (550)
T ss_pred             c--ceeEEEEeecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeee
Confidence            6  46899999999999999998876 999999999999999999999999  99999999999998 789999999999


Q ss_pred             eeeecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          178 AIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       178 a~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      +..+...  ...+.+|||+|||||+... .|+.++||||||++++||+-|++||-.......++.....|......+...
T Consensus       416 caqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~kl  495 (550)
T KOG0578|consen  416 CAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKL  495 (550)
T ss_pred             eeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCcccc
Confidence            9877554  4567899999999998765 699999999999999999999999976444455666666776666677788


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      ++++++|+.+||+ |+.+|++|.|||.||||+...+
T Consensus       496 S~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  496 SPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             CHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence            9999999999998 9999999999999999976543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.5e-52  Score=375.07  Aligned_cols=255  Identities=26%  Similarity=0.466  Sum_probs=217.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      .+|.++ -++|+|+||+||+|+++.||+.||||++.-+  ..++...+-.++|+++|++|+|+|+|.++++|  .....+
T Consensus         2 ekYE~L-gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrkl   76 (396)
T KOG0593|consen    2 EKYEKL-GKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKL   76 (396)
T ss_pred             cHHhhh-hccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHH--Hhccee
Confidence            356544 4599999999999999999999999998533  34566677789999999999999999999988  556789


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++|+|||+..-|..+-....+++.+.++.+++|++.|+.|+|+++  ++||||||+|||++ .+|.+||||||+|+.+..
T Consensus        77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEe-cCCcEEeccchhhHhhcC
Confidence            999999988777776666678999999999999999999999999  99999999999999 789999999999987764


Q ss_pred             C--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc----------------
Q 016143          184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----------------  243 (394)
Q Consensus       184 ~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~----------------  243 (394)
                      +  ..+.++.|.+|.|||++-+  +|+..+||||+||++.||++|++.|.+.++.+|++.....                
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            3  4567889999999998876  5999999999999999999999999999999998876542                


Q ss_pred             ---CCC---C---CCC---CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          244 ---GIK---P---ASL---SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       244 ---~~~---~---~~~---~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                         |..   |   +.+   ....+..+.+|+++||. ||.+|++.+++|.||||..
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence               110   0   111   11234578999999998 9999999999999999954

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.5e-51  Score=394.48  Aligned_cols=261  Identities=23%  Similarity=0.403  Sum_probs=226.4

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+...||+|+||.||+|..+.||..+|+|+++++... ..++.+.+..|-.+|...++|+||++|.+|++.  .++|+||
T Consensus       144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~--~~LYLiM  220 (550)
T KOG0605|consen  144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK--EYLYLIM  220 (550)
T ss_pred             hhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC--CeeEEEE
Confidence            4568899999999999999999999999999877654 367788899999999999999999999999655  5799999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC----
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----  183 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~----  183 (394)
                      ||++||++..++.+.+.|+++.++.++.+++.|+..||++|  +|||||||+|+||| ..|++||+||||++-+..    
T Consensus       221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccchhhhhhhh
Confidence            99999999999999999999999999999999999999999  99999999999999 799999999999842210    


Q ss_pred             -----------C---------C-------------------------CcccccCCcccCcccccc-cCCCcCcchhhhhH
Q 016143          184 -----------P---------T-------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMC  217 (394)
Q Consensus       184 -----------~---------~-------------------------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~i  217 (394)
                                 .         .                         +.+.+|||.|||||++.+ .|+..+|+||||||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                       0         0                         113569999999997765 59999999999999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCCCHHHHHHHHHcCCCCCCCCC---HHHHhcCCccccCCCCCc
Q 016143          218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       218 l~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~~li~~~L~~p~~R~s---~~elL~~p~~~~~~~~~~  292 (394)
                      |||||.|.+||.. .++.+.+.+|........+  ....++++++||.+||.+|.+|..   +.||.+||||+..+|..+
T Consensus       378 myEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l  456 (550)
T KOG0605|consen  378 MYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHL  456 (550)
T ss_pred             HHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchh
Confidence            9999999999987 8888888888764322112  223468999999999999999985   899999999999999887


Q ss_pred             ccC
Q 016143          293 VCD  295 (394)
Q Consensus       293 ~~~  295 (394)
                      ...
T Consensus       457 ~~~  459 (550)
T KOG0605|consen  457 REM  459 (550)
T ss_pred             hcC
Confidence            543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-50  Score=386.57  Aligned_cols=264  Identities=28%  Similarity=0.388  Sum_probs=221.2

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      .++||+|.||.||+|++..+|+.||+|+|..+..  .++......+||.+|++|+|||||++.+...+.....+|||+||
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeY  199 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEY  199 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEec
Confidence            4789999999999999999999999999987653  34556677899999999999999999998877766799999999


Q ss_pred             cCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC---
Q 016143          110 FTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---  185 (394)
Q Consensus       110 ~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~---  185 (394)
                      ++. +|.-++... -.|++.+++.+++||+.||+|||++|  |+|||||+.||||| ++|.+||+|||||+.+....   
T Consensus       200 Mdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~~~  275 (560)
T KOG0600|consen  200 MDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFYTPSGSAP  275 (560)
T ss_pred             ccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeeccCCCCcc
Confidence            965 888888764 57999999999999999999999999  99999999999999 89999999999999776543   


Q ss_pred             CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-C-CCCCCC-----------
Q 016143          186 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G-IKPASL-----------  250 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~-~~~~~~-----------  250 (394)
                      .+..+-|.+|.|||+|-+  .|+.++|+||.||||.||++|++.|.+..+.+|+-+.+.- | +....|           
T Consensus       276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~  355 (560)
T KOG0600|consen  276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF  355 (560)
T ss_pred             cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence            566778999999998765  5999999999999999999999999997777777555432 1 111111           


Q ss_pred             -------------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCCCcccCCCCCCCC
Q 016143          251 -------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL  302 (394)
Q Consensus       251 -------------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~~~~~~~~~~p~~  302 (394)
                                   .+..++.+.+|+..+|. +|.+|.||.++|.++||...   .+.+++..+|..
T Consensus       356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~---p~~~~p~~Lp~y  418 (560)
T KOG0600|consen  356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE---PLPCDPSSLPKY  418 (560)
T ss_pred             CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC---CCCCCcccCCCC
Confidence                         13346788999999998 99999999999999999443   334455555543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3e-51  Score=394.45  Aligned_cols=251  Identities=30%  Similarity=0.518  Sum_probs=224.0

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +| -+-+.||+|+||.||+|+.+.+.+.||+|.+.+..  ...+++..+.+|+++++.|+|||||.++++|  ++...++
T Consensus         3 ~y-hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~   77 (808)
T KOG0597|consen    3 QY-HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLW   77 (808)
T ss_pred             ch-hHHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEE
Confidence            44 45689999999999999999999999999987543  4567888999999999999999999999999  5556799


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      +|+|||.| +|+.++...+.++|+.++.++.|++.||.|||+++  |.|||+||+|||+. .+|.+|++|||+|+.+...
T Consensus        78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhcccC
Confidence            99999976 99999999999999999999999999999999999  99999999999998 7899999999999877655


Q ss_pred             C--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          185 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       185 ~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                      .  .++.-|||.|||||++.+ .|+..+|+||+|||+|||++|++||.. ....++.+.|...  |..++...+..+++|
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d--~v~~p~~~S~~f~nf  230 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKD--PVKPPSTASSSFVNF  230 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcC--CCCCcccccHHHHHH
Confidence            3  566789999999998876 599999999999999999999999976 5566777777765  334555778899999


Q ss_pred             HHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          262 IEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ++.+|. ||.+|.+..+++.|||++..
T Consensus       231 l~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  231 LQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HHHHhhcChhhcccHHHHhcChHHhhh
Confidence            999998 99999999999999999864

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=375.17  Aligned_cols=263  Identities=27%  Similarity=0.443  Sum_probs=224.1

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +....|.+.+.||.|..++||+|....+++.||||+++.++.   ....+.+.+|+..|+.++||||++++.+|+.++  
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc---~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~--   97 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC---NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS--   97 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh---hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc--
Confidence            344556888999999999999999999999999999998764   345788999999999999999999999998764  


Q ss_pred             eEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          102 TINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      .+|+||.|+.+|++.++++..  .+++|..+..+.++++.||.|||++|  .||||||+.||||+ .+|.|||+|||.+.
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKLADFGVSA  174 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEEcCceeee
Confidence            699999999999999999875  45999999999999999999999999  99999999999999 79999999999986


Q ss_pred             eecCCC------CcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC----
Q 016143          180 VMQQPT------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----  246 (394)
Q Consensus       180 ~~~~~~------~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~----  246 (394)
                      .+....      ....+|||.|||||++..   .|+.|+||||||++..||.+|..||........+..+++..++    
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t  254 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT  254 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence            554331      155689999999998653   5999999999999999999999999986555555555544332    


Q ss_pred             ---CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCCCc
Q 016143          247 ---PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       247 ---~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~~~  292 (394)
                         +.+-.+..+..++.+|..||+ ||.+||||+++|+|+||+....+..
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~  304 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY  304 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence               111223356689999999998 9999999999999999998776543

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.1e-51  Score=365.26  Aligned_cols=252  Identities=25%  Similarity=0.462  Sum_probs=221.4

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCH----HHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEE
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP----DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +++||+|..++|.++.++.+|.++|+|++.......+.    +..+.-.+|+.+|+++ .||||+++.++|  ++..+++
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--es~sF~F   99 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--ESDAFVF   99 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--cCcchhh
Confidence            58999999999999999999999999999875543332    3445566899999999 699999999998  5567899


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      +|+|.|+.|.|++|+...-.++++..+.+++||+.|++|||.++  |+||||||+|||++ ++.++||+|||+|+.+...
T Consensus       100 lVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILld-dn~~i~isDFGFa~~l~~G  176 (411)
T KOG0599|consen  100 LVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLD-DNMNIKISDFGFACQLEPG  176 (411)
T ss_pred             hhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeec-cccceEEeccceeeccCCc
Confidence            99999999999999999999999999999999999999999999  99999999999999 7899999999999988765


Q ss_pred             -CCcccccCCcccCccccc-------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCC
Q 016143          185 -TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVT  254 (394)
Q Consensus       185 -~~~~~~gt~~y~aPE~l~-------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~  254 (394)
                       ..+..||||+|+|||.+.       ..|+..+|+|++|+|||.|+.|.+||+. .....+...|.+|...-  .-+..+
T Consensus       177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~speWadi  255 (411)
T KOG0599|consen  177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRSPEWADI  255 (411)
T ss_pred             hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCCcchhhc
Confidence             577889999999999764       2488999999999999999999999987 55667778888885532  223445


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      +..+++||.+||+ ||.+|.|+.|+|.||||...
T Consensus       256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             cccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            6799999999998 99999999999999999654

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-50  Score=397.52  Aligned_cols=265  Identities=24%  Similarity=0.431  Sum_probs=233.7

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      .++.++||+|+||+|++|..+.+++.+|||.+++..+.+ .++.+..+.|.+++.... ||.++.++.+|+.  ..++|+
T Consensus       370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~~~l~f  446 (694)
T KOG0694|consen  370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQT--KEHLFF  446 (694)
T ss_pred             eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeeccccccc--CCeEEE
Confidence            466789999999999999999999999999999887766 467788999999998885 9999999999954  468999


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee--cC
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQ  183 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~--~~  183 (394)
                      ||||+.||++. .++..+.+++..++.|+..|+.||.|||++|  |||||||.+|||+| ..|++||+|||+++..  ..
T Consensus       447 vmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  447 VMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             EEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEecccccccccCCCC
Confidence            99999999944 4445567999999999999999999999999  99999999999999 7899999999999754  34


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      ..+.+.||||.|||||++.+ .|+.++|+|||||+|||||.|+.||.+ .++++++..|...  ...+|...+.+..+++
T Consensus       523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d--~~~yP~~ls~ea~~il  599 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVND--EVRYPRFLSKEAIAIM  599 (694)
T ss_pred             CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC--CCCCCCcccHHHHHHH
Confidence            45678999999999998876 599999999999999999999999987 7888999988765  2336777889999999


Q ss_pred             HHcCC-CCCCCCC-----HHHHhcCCccccCCCCCcccCCCCCCC
Q 016143          263 EKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPN  301 (394)
Q Consensus       263 ~~~L~-~p~~R~s-----~~elL~~p~~~~~~~~~~~~~~~~~p~  301 (394)
                      +++|. +|.+|+-     +.++..||||+..+|..+....++.|.
T Consensus       600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf  644 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPF  644 (694)
T ss_pred             HHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCC
Confidence            99998 8999996     578999999999999988777666543

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-51  Score=360.08  Aligned_cols=253  Identities=26%  Similarity=0.482  Sum_probs=223.2

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|.|+.||++.+..+|+.+|+|+++......  ...+.+.+|+++.+.|+||||+++.+.+  .+..+.|||+
T Consensus        14 ~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti--~~~~~~ylvF   89 (355)
T KOG0033|consen   14 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSI--QEESFHYLVF   89 (355)
T ss_pred             hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhh--cccceeEEEE
Confidence            67799999999999999999999999999998776644  3667888999999999999999999987  4556899999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEcccceeeeecCCC
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |+++|++|..-|-++.-+++..+..+++||+.+|.|+|.++  |+|||+||+|+++-.  +..-+||+|||+|..++...
T Consensus        90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~  167 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE  167 (355)
T ss_pred             ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence            99999999887777677899999999999999999999999  999999999999953  33469999999999887543


Q ss_pred             -CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCHHHHHH
Q 016143          186 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQF  261 (394)
Q Consensus       186 -~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~l  261 (394)
                       .....|||.|||||++.+ +|+..+|||+.|+|||-|+.|.+||++ .+...++..|..+..  +......+++++++|
T Consensus       168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L  246 (355)
T KOG0033|consen  168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL  246 (355)
T ss_pred             ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence             456789999999998875 599999999999999999999999998 677899999988743  333455667999999


Q ss_pred             HHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          262 IEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      |++||. +|.+|.|+.|.|+|||+.+.
T Consensus       247 vrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  247 IRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHhccChhhhccHHHHhCCchhcch
Confidence            999998 99999999999999999864

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-50  Score=383.42  Aligned_cols=261  Identities=28%  Similarity=0.373  Sum_probs=219.9

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDD   98 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~   98 (394)
                      +....|| .+.+.||.|+||.||+|..+.+|..||||.++.+-.  +-++. .-++|++.|++|+ |||||++++++.+.
T Consensus         6 ~~~m~RY-~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~--s~ee~-~nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    6 VIFMDRY-TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY--SWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             hhHHHHH-HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc--cHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            3445677 778999999999999999999999999999864332  21221 2357999999998 99999999998876


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143           99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                      .. .+++||||++ .+|.++++.+ +.+++..++.|++||+.||+|+|++|  +.||||||+|||+.+ +..+||+|||+
T Consensus        82 ~~-~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~-~~~iKiaDFGL  156 (538)
T KOG0661|consen   82 DR-ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISG-NDVIKIADFGL  156 (538)
T ss_pred             Cc-eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecc-cceeEeccccc
Confidence            64 8999999996 5899999876 45999999999999999999999999  999999999999984 67999999999


Q ss_pred             eeeecCC-CCcccccCCcccCcccc-c-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--------
Q 016143          178 AIVMQQP-TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--------  246 (394)
Q Consensus       178 a~~~~~~-~~~~~~gt~~y~aPE~l-~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--------  246 (394)
                      |+...+. ..+.++.|.+|.|||++ + +-|+.++|||++|||++|+.+-++.|.+..+.+|+++...---.        
T Consensus       157 ARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  157 AREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             ccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            9877665 56778999999999965 3 45999999999999999999999999998888898887531000        


Q ss_pred             ----------------C---CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          247 ----------------P---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       247 ----------------~---~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                                      +   ..+....++++.++|.+||. ||.+||+|.++|+||||+....
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence                            0   11123367899999999999 9999999999999999987544

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.8e-49  Score=378.51  Aligned_cols=255  Identities=24%  Similarity=0.438  Sum_probs=218.7

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      +.||+|+||+||+|.++.+|+.||+|++..... ........+.+|+.++++++||||+++++++.+.  ..+++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e~~   77 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEeCC
Confidence            469999999999999999999999999875432 2234556788999999999999999999988544  5789999999


Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--CCCcc
Q 016143          111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARS  188 (394)
Q Consensus       111 ~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--~~~~~  188 (394)
                      ++|+|.+++...+.+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++.....  .....
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccc
Confidence            99999999998888999999999999999999999999  99999999999998 788999999999865322  23345


Q ss_pred             cccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC
Q 016143          189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  267 (394)
Q Consensus       189 ~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~  267 (394)
                      .+||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+...+...+..+.  ..++...++++++||++||.
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~  231 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHcc
Confidence            679999999998765 589999999999999999999999976 55566666665542  33556778999999999998


Q ss_pred             -CCCCCC-----CHHHHhcCCccccCCCCCccc
Q 016143          268 -PASLRL-----PALELLKDPFLVTDNPKDLVC  294 (394)
Q Consensus       268 -~p~~R~-----s~~elL~~p~~~~~~~~~~~~  294 (394)
                       +|.+||     ++.++++||||...++..+..
T Consensus       232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~  264 (323)
T cd05571         232 KDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQ  264 (323)
T ss_pred             CCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence             999999     899999999999877665543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-49  Score=374.29  Aligned_cols=254  Identities=28%  Similarity=0.441  Sum_probs=219.8

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|+||+||+|.++.+|+.||+|++...... .....+.+.+|+.++++++||||+++++++.+  ...+++||
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~   80 (291)
T cd05612           4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYMLM   80 (291)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEEEE
Confidence            6789999999999999999999999999998754321 23455678899999999999999999998754  45789999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCc
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR  187 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~  187 (394)
                      ||+.+|+|.+++...+.+++..+..++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++...... ..
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~-~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR-TW  156 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC-cc
Confidence            99999999999999888999999999999999999999999  99999999999998 7889999999999766443 23


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+.  ..++...++.++++|++||
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l  233 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGK--LEFPRHLDLYAKDLIKKLL  233 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--cCCCccCCHHHHHHHHHHc
Confidence            4579999999998765 488999999999999999999999987 56667777776653  2355667899999999999


Q ss_pred             C-CCCCCCC-----HHHHhcCCccccCCCCC
Q 016143          267 V-PASLRLP-----ALELLKDPFLVTDNPKD  291 (394)
Q Consensus       267 ~-~p~~R~s-----~~elL~~p~~~~~~~~~  291 (394)
                      . +|.+|++     +.++++||||....+..
T Consensus       234 ~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~  264 (291)
T cd05612         234 VVDRTRRLGNMKNGADDVKNHRWFKSVDWDD  264 (291)
T ss_pred             CCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence            8 9999995     99999999998766544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-49  Score=367.11  Aligned_cols=256  Identities=30%  Similarity=0.453  Sum_probs=217.2

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEc---CCCce
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD---DTNRT  102 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~---~~~~~  102 (394)
                      ||...+.||+|+||.|+.|.++.+|+.||||++.  +..+..-..++.++|+++|+.++|+||+.+++.+..   +.-+-
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            3344688999999999999999999999999985  223456678899999999999999999999998865   33457


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +|+|+|++ +.+|.+.++.+..++.+.++.+++||+.||+|+||.|  |+||||||.|+|+| .+..+||+|||+|+...
T Consensus       101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n-~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLN-ADCDLKICDFGLARYLD  176 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeec-cCCCEEeccccceeecc
Confidence            99999999 6799999999999999999999999999999999999  99999999999999 68899999999998885


Q ss_pred             ----CCCCcccccCCcccCccccc--ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHh--------------
Q 016143          183 ----QPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--------------  242 (394)
Q Consensus       183 ----~~~~~~~~gt~~y~aPE~l~--~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~--------------  242 (394)
                          ....+.++.|.+|.|||++.  .+|+.++||||+|||+.||++|++.|.+.....|+...+.              
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence                44567788999999999664  4699999999999999999999999988655544432221              


Q ss_pred             ---------c-CCCC----CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          243 ---------S-GIKP----ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       243 ---------~-~~~~----~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                               + ...|    ..+-...++.+.+|+++||+ ||.+|+|++|+|.||||...
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence                     1 1111    11223568899999999999 99999999999999999864

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9e-49  Score=378.16  Aligned_cols=256  Identities=25%  Similarity=0.430  Sum_probs=222.4

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|+||+||+|.++.+++.||+|++...... .....+.+.+|+.+++.++||||+++++++.++  ..+++||
T Consensus        21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~   97 (329)
T PTZ00263         21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLL   97 (329)
T ss_pred             EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEEEEEE
Confidence            7889999999999999999999999999998754322 234567788999999999999999999988654  5789999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCc
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR  187 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~  187 (394)
                      ||+.+|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++....... .
T Consensus        98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~-~  173 (329)
T PTZ00263         98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRT-F  173 (329)
T ss_pred             cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCceEcCCCc-c
Confidence            99999999999999888999999999999999999999999  99999999999998 78899999999997665433 3


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ...||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+.+..+..+..  .++...+..+++||++||
T Consensus       174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L  250 (329)
T PTZ00263        174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRL--KFPNWFDGRARDLVKGLL  250 (329)
T ss_pred             eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCc--CCCCCCCHHHHHHHHHHh
Confidence            4579999999998765 488999999999999999999999976 566677777776632  345667899999999999


Q ss_pred             C-CCCCCCC-----HHHHhcCCccccCCCCCcc
Q 016143          267 V-PASLRLP-----ALELLKDPFLVTDNPKDLV  293 (394)
Q Consensus       267 ~-~p~~R~s-----~~elL~~p~~~~~~~~~~~  293 (394)
                      . +|.+|++     +.+++.||||....+..+.
T Consensus       251 ~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~  283 (329)
T PTZ00263        251 QTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY  283 (329)
T ss_pred             hcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence            8 9999997     7999999999987665443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-48  Score=376.58  Aligned_cols=243  Identities=36%  Similarity=0.621  Sum_probs=207.6

Q ss_pred             ccceecccCceEEEEEEEccCCeE-EEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           29 YDEILGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        29 ~~~~LG~G~~g~Vy~a~~~~~~~~-vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +.+.||+|+||+||+|...  |.. ||+|.+.....  +....+.|.+|+.+|.+|+|||||+|++++.++.. .+.+||
T Consensus        45 ~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVt  119 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDF--DDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVT  119 (362)
T ss_pred             hhhhcccCCceeEEEEEeC--CceeEEEEEecchhc--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEE
Confidence            4466999999999999876  455 99999876543  22337889999999999999999999998865432 688999


Q ss_pred             cccCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC-cEEEcccceeeeecCC
Q 016143          108 ELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQP  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~--~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~-~~kl~Dfgla~~~~~~  184 (394)
                      ||+++|+|.+++..  .+.++...+..|+.||+.||.|||++++ ||||||||+|||++ .++ ++||+|||+++.....
T Consensus       120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~-~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVD-LKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEc-CCCCEEEECCCccceeeccc
Confidence            99999999999988  5779999999999999999999999986 99999999999999 565 9999999999877653


Q ss_pred             --CCcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCCHHH
Q 016143          185 --TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-SGIKPASLSKVTDPQV  258 (394)
Q Consensus       185 --~~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~  258 (394)
                        ......||+.|||||++.+   .|+.++||||||++||||+||+.||.+... .+....+. .+..| .++...++.+
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp-~~p~~~~~~l  275 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRP-PIPKECPPHL  275 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCC-CCCccCCHHH
Confidence              4445789999999999985   399999999999999999999999998666 55555554 45444 4566688999


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhc
Q 016143          259 KQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..++++||. +|..||+..+++.
T Consensus       276 ~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  276 SSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHhCCCCCCcCCCHHHHHH
Confidence            999999998 9999999998775

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.4e-49  Score=348.91  Aligned_cols=254  Identities=26%  Similarity=0.411  Sum_probs=214.7

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      ||. ..+.||+|.||.||+|.+..+|+.||||+|+..+..  ...-....+|++.|+.++|+||+.+.++|.  +...+.
T Consensus         3 rY~-~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k--dGi~~talREIK~Lqel~h~nIi~LiD~F~--~~~~l~   77 (318)
T KOG0659|consen    3 RYE-KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK--DGINRTALREIKLLQELKHPNIIELIDVFP--HKSNLS   77 (318)
T ss_pred             hhh-hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc--cCccHHHHHHHHHHHHccCcchhhhhhhcc--CCCceE
Confidence            563 357899999999999999999999999999877542  233456789999999999999999999994  445688


Q ss_pred             EEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +|+||++ .+|...++.. ..++..+++.|+.++++||+|||++.  |+||||||.|+|++ .+|.+||+|||+|+.+..
T Consensus        78 lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   78 LVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFGS  153 (318)
T ss_pred             EEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccCC
Confidence            8999995 6999988865 45999999999999999999999999  99999999999998 789999999999998876


Q ss_pred             CCC--cccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC--CCCCCCC------
Q 016143          184 PTA--RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLS------  251 (394)
Q Consensus       184 ~~~--~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~--~~~~~~~------  251 (394)
                      +..  ...+-|.+|.|||++-|  .|+..+||||.|||+.||+-|.+-|.+.++.+|+...+..-  +.+..|+      
T Consensus       154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            642  23368999999998765  59999999999999999999999999988888886665421  1111121      


Q ss_pred             -----------------CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          252 -----------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       252 -----------------~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                       ...+..+.+|+.++|. +|-+|+++.|+|+|+||++.
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence                             2235577999999999 99999999999999999873

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-49  Score=381.37  Aligned_cols=255  Identities=31%  Similarity=0.560  Sum_probs=227.7

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      .| -+.+.+|+|+||.++++.++.++..|++|.+.....  +....+...+|+.++++++|||||.++++|++++ ..++
T Consensus         5 ~Y-e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~--t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l~   80 (426)
T KOG0589|consen    5 NY-EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL--TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLLC   80 (426)
T ss_pred             hh-hhhhhcCccccchhhhhhhccCCceEEEEEEecccc--CchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceEE
Confidence            44 567999999999999999999999999999988764  3445557889999999999999999999997654 4699


Q ss_pred             EEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          105 MITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      |||+||+||+|.+.+++.+  .++++.+..|+.||+.|+.|||++.  |+|||||+.|||++ .++.|||+|||+|+.+.
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLT-KDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcc-ccCceeecchhhhhhcC
Confidence            9999999999999998764  5999999999999999999999998  99999999999999 67788999999999988


Q ss_pred             CC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          183 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       183 ~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ..  .+.+++|||.||.||++.+ +|+.++|||||||++|||++-+.+|.+ .+...+..+|..+. ...++..++.+++
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~-~~Plp~~ys~el~  235 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGL-YSPLPSMYSSELR  235 (426)
T ss_pred             CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhcc-CCCCCccccHHHH
Confidence            77  5678899999999999987 699999999999999999999999987 77777777777765 3346778889999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          260 QFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .+|+.||. +|..||++.++|.+|.++...
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            99999998 899999999999999988543

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.6e-48  Score=379.97  Aligned_cols=262  Identities=23%  Similarity=0.394  Sum_probs=217.3

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|+||+||+|.++.++..||+|++...... .......+.+|+.++..++||||+++++.+.+.  ..+++||
T Consensus         4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~~~lv~   80 (363)
T cd05628           4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LNLYLIM   80 (363)
T ss_pred             eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CeEEEEE
Confidence            6779999999999999999999999999999754322 234556788899999999999999999988654  5789999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC--
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~--  185 (394)
                      ||+++|+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCCEEEeeccCcccccccccc
Confidence            99999999999998889999999999999999999999999  99999999999998 68899999999986442210  


Q ss_pred             -----------------------------------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCC
Q 016143          186 -----------------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYN  229 (394)
Q Consensus       186 -----------------------------------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~  229 (394)
                                                         ....+||+.|+|||++.+ .++.++|||||||++|||++|..||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                               123579999999998754 58999999999999999999999997


Q ss_pred             CCCCHHHHHHHHhcCCCCCCCC--CCCCHHHHHHHHHcCCCC---CCCCCHHHHhcCCccccCCCCCcccCC
Q 016143          230 ECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPA---SLRLPALELLKDPFLVTDNPKDLVCDP  296 (394)
Q Consensus       230 ~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~L~~p---~~R~s~~elL~~p~~~~~~~~~~~~~~  296 (394)
                      + .+....+..+........++  ...+++++++|.+++.++   ..||++.|+++||||+..++..+...+
T Consensus       238 ~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~  308 (363)
T cd05628         238 S-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRERP  308 (363)
T ss_pred             C-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCC
Confidence            6 55666677666532222222  235789999999977643   457899999999999998776654433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=380.81  Aligned_cols=261  Identities=31%  Similarity=0.544  Sum_probs=228.1

Q ss_pred             ccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEE
Q 016143           17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV   96 (394)
Q Consensus        17 ~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~   96 (394)
                      ....++...| +-.+.||+|+||.||+|.+..+++.||+|+++...   ....++.+.+|+.+|.+++++||.++|++|+
T Consensus         6 ~~~~~~~~~~-~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl   81 (467)
T KOG0201|consen    6 VLKIDPELLY-TKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYL   81 (467)
T ss_pred             hhcCCccccc-ccchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhhee
Confidence            3455666777 44599999999999999999999999999998765   4667888999999999999999999999998


Q ss_pred             cCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccc
Q 016143           97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG  176 (394)
Q Consensus        97 ~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfg  176 (394)
                      ...  .++++||||.||++.++++....+++..+..++++++.||.|||+++  .+|||||+.|||+. .+|.+||+|||
T Consensus        82 ~g~--~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s-~~g~vkl~Dfg  156 (467)
T KOG0201|consen   82 KGT--KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLS-ESGDVKLADFG  156 (467)
T ss_pred             ecc--cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEe-ccCcEEEEecc
Confidence            764  68889999999999999999987899999999999999999999999  99999999999999 66999999999


Q ss_pred             eeeeecCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 016143          177 LAIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       177 la~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      .+.++....  ..+++|||.|||||++.. .|+.++||||||++.|||++|++|+.+... ......|.+ ..|+.+...
T Consensus       157 Va~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrvlflIpk-~~PP~L~~~  234 (467)
T KOG0201|consen  157 VAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRVLFLIPK-SAPPRLDGD  234 (467)
T ss_pred             eeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceEEEeccC-CCCCccccc
Confidence            998887653  367899999999998776 699999999999999999999999988443 222222222 235667778


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +++.+++||+.||. +|..||+|.+||+|+|++...
T Consensus       235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  235 FSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            99999999999998 999999999999999999854

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4e-48  Score=375.32  Aligned_cols=263  Identities=24%  Similarity=0.433  Sum_probs=223.2

Q ss_pred             cccccccceecccCceEEEEEEEccCC-eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      ..| .+.+.||+|+||.||+|.++.++ ..||+|.+...... .....+.+.+|+.+++.++||||+++++++.++  ..
T Consensus        30 ~~y-~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~  105 (340)
T PTZ00426         30 EDF-NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--SY  105 (340)
T ss_pred             hhc-EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--CE
Confidence            344 77899999999999999876655 78999998754432 234566788999999999999999999998654  57


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||+.+|+|.+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++....
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeecC
Confidence            8999999999999999999889999999999999999999999999  99999999999998 78899999999997664


Q ss_pred             CCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       183 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                      .. .....||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+...++..+..+..  .++...++.++++
T Consensus       183 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l  258 (340)
T PTZ00426        183 TR-TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKHL  258 (340)
T ss_pred             CC-cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHH
Confidence            43 345679999999998765 488999999999999999999999986 566677777776642  3456678999999


Q ss_pred             HHHcCC-CCCCCC-----CHHHHhcCCccccCCCCCcccCCC
Q 016143          262 IEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL  297 (394)
Q Consensus       262 i~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~~~~~~  297 (394)
                      |++||. +|.+|+     ++.++++||||...++.......+
T Consensus       259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~  300 (340)
T PTZ00426        259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNV  300 (340)
T ss_pred             HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence            999998 899995     899999999999877655444333

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-48  Score=376.86  Aligned_cols=258  Identities=23%  Similarity=0.432  Sum_probs=216.8

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+|+.||+|++...... .......+.+|+.+|+.++||||++++++|.+.  ..+++|
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv   79 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDE--NYLYLI   79 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CeEEEE
Confidence            36789999999999999999999999999999754332 234556788899999999999999999988654  578999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      |||+++|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++..+.... 
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceecccccc
Confidence            999999999999998888999999999999999999999999  99999999999998 78999999999986543211 


Q ss_pred             ---------------------------------------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcC
Q 016143          186 ---------------------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCE  225 (394)
Q Consensus       186 ---------------------------------------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~  225 (394)
                                                             ....+||+.|+|||++.+ .++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                   113469999999997754 5899999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhcCCCCCCCC--CCCCHHHHHHHHHcCCCCCCCCC---HHHHhcCCccccCCCCC
Q 016143          226 YPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKD  291 (394)
Q Consensus       226 ~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~L~~p~~R~s---~~elL~~p~~~~~~~~~  291 (394)
                      .||.. .+..+.+..+.........+  ...++++++||++||.+|.+|++   +.++|.||||+...+..
T Consensus       237 ~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~  306 (364)
T cd05599         237 PPFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEH  306 (364)
T ss_pred             CCCCC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence            99987 44555666655433222222  24578999999999999999998   99999999999876543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-49  Score=366.76  Aligned_cols=252  Identities=23%  Similarity=0.489  Sum_probs=225.2

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      .|| .+.+.||+|.||+|-+|.+...|+.||||.|+++.+ ++++++-.+.+|+++|..|+||||+++|.+|  ++...+
T Consensus        53 HRy-E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI-kdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKI  128 (668)
T KOG0611|consen   53 HRY-EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI-KDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKI  128 (668)
T ss_pred             hHH-HHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc-ccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceE
Confidence            344 677999999999999999999999999999986664 5678888899999999999999999999998  555679


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      .+||||..+|+|.+|+...+.|++.+++.+|+||++|+.|+|+++  ++|||||.+|||+| .++++||+|||++..+..
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD-~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLD-QNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeec-CCCCeeeeccchhhhhcc
Confidence            999999999999999999999999999999999999999999999  99999999999999 789999999999987766


Q ss_pred             C-CCcccccCCcccCccccccc-C-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          184 P-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       184 ~-~~~~~~gt~~y~aPE~l~~~-~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      . ..+++||+|-|.+||+.++. | ++.+|-||||++||.|+.|..||++ .+-..+++.|.+|.+.+.   ..+..+.-
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP---~~PSdA~g  281 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREP---ETPSDASG  281 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCC---CCCchHHH
Confidence            5 46889999999999999875 5 5899999999999999999999988 666778888888855331   22357889


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          261 FIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      ||+.||. +|.+|-|+.++-.|.|+.-
T Consensus       282 LIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  282 LIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             HHHHHHhcCcccchhHHHHhhhheeec
Confidence            9999996 9999999999999999853

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-47  Score=367.35  Aligned_cols=250  Identities=24%  Similarity=0.405  Sum_probs=214.9

Q ss_pred             ecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCC
Q 016143           33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS  112 (394)
Q Consensus        33 LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~  112 (394)
                      ||+|+||+||+|.++.+++.||+|.+..... ........+.+|+.++++++||||+++++++.++  ..+++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~   77 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFING   77 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCC
Confidence            7999999999999999999999999875432 2344567788999999999999999999988543  578999999999


Q ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--CCcccc
Q 016143          113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVI  190 (394)
Q Consensus       113 gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~~~~~~  190 (394)
                      |+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++......  .....+
T Consensus        78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCcccccc
Confidence            999999998888999999999999999999999999  99999999999998 7889999999999754322  234467


Q ss_pred             cCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-C
Q 016143          191 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P  268 (394)
Q Consensus       191 gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~  268 (394)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+++..+..+  +..++...+++++++|.+||. +
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~d  231 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCC
Confidence            9999999998765 589999999999999999999999987 4556666666654  334566788999999999998 9


Q ss_pred             CCCCC---CHHHHhcCCccccCCCCC
Q 016143          269 ASLRL---PALELLKDPFLVTDNPKD  291 (394)
Q Consensus       269 p~~R~---s~~elL~~p~~~~~~~~~  291 (394)
                      |.+|+   ++.++|+||||....+..
T Consensus       232 p~~R~~~~~~~e~l~hp~~~~~~~~~  257 (312)
T cd05585         232 PTRRLGYNGAQEIKNHPFFSQLSWKK  257 (312)
T ss_pred             HHHcCCCCCHHHHHcCCCcCCCCHHH
Confidence            99997   589999999999865443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.9e-48  Score=353.88  Aligned_cols=252  Identities=25%  Similarity=0.325  Sum_probs=216.2

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ...|++|+||.||+|+|+.|++.||+|.++.+..  ....--..++|+.+|.+++|||||.+-.+.+..+.+.+||||||
T Consensus        81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke--k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~  158 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE--KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY  158 (419)
T ss_pred             HhhcccCcceeEEEeccCCcceeEEeeecccccc--cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence            3569999999999999999999999999987652  22233456789999999999999999999988888889999999


Q ss_pred             cCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--CC
Q 016143          110 FTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA  186 (394)
Q Consensus       110 ~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~~  186 (394)
                      |+. +|..++..-+ ++...+++.++.|++.||+|||.+.  |+||||||+|+|++ +.|.+||+|||+|+.+..+  ..
T Consensus       159 ~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~k~~  234 (419)
T KOG0663|consen  159 VEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREYGSPLKPY  234 (419)
T ss_pred             HHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhhcCCcccC
Confidence            964 8999998765 7999999999999999999999999  99999999999999 8999999999999988876  35


Q ss_pred             cccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCC------------
Q 016143          187 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASL------------  250 (394)
Q Consensus       187 ~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~------------  250 (394)
                      +..+-|.+|.|||++-+  .|+.++|+||+|||+.||+++++.|.+....+|+.+.+..--.|  ..|            
T Consensus       235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~  314 (419)
T KOG0663|consen  235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM  314 (419)
T ss_pred             cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence            66778999999997654  59999999999999999999999999988888877766421111  000            


Q ss_pred             --------------CCC-CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          251 --------------SKV-TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       251 --------------~~~-~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                    ... .+....+|+..+|. ||.+|.||.|.|+|.||...
T Consensus       315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                          111 34677899999998 99999999999999999864

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9e-49  Score=362.34  Aligned_cols=252  Identities=29%  Similarity=0.434  Sum_probs=213.2

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc---e
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR---T  102 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~---~  102 (394)
                      .++-.+++|+|+||+||+|....+++.||||++-.+...+        .+|+.+|+.++|||||++..+|......   +
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            3466799999999999999999999999999986544222        2499999999999999999888755444   7


Q ss_pred             EEEEEcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          103 INMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      +.+||||++ .+|.++++.    +.+++.-.++-+..||++||.|||++|  |+||||||+|+|+|.++|.+||+|||.|
T Consensus        97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcc
Confidence            788999996 588888874    567999999999999999999999999  9999999999999988999999999999


Q ss_pred             eeecCC-CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-C----------
Q 016143          179 IVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G----------  244 (394)
Q Consensus       179 ~~~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~----------  244 (394)
                      +.+... ...++..|..|.|||++-+  +|+.++||||.||++.||+-|++-|.+....+|+...+.- |          
T Consensus       174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            877554 4567889999999997754  6999999999999999999999999997776666555431 0          


Q ss_pred             -----------CCCCC----CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          245 -----------IKPAS----LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       245 -----------~~~~~----~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                 .++..    +.+..++++.+|+.++|+ +|.+|.++.|+|.||||....
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence                       01111    345568999999999999 999999999999999998753

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-47  Score=369.33  Aligned_cols=253  Identities=24%  Similarity=0.449  Sum_probs=215.9

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      ++||+|+||+||+|.++.+|..||+|++..... ........+.+|+.+++.++||||+++++++.++  ..+++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~Ey~   77 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVMEYV   77 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEeCC
Confidence            469999999999999999999999999875432 2345567788999999999999999999988544  5789999999


Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--CCCcc
Q 016143          111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARS  188 (394)
Q Consensus       111 ~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--~~~~~  188 (394)
                      ++|+|..++...+.+++.+++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.....  .....
T Consensus        78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCccccccc
Confidence            99999999998888999999999999999999999999  99999999999998 788999999999875332  22345


Q ss_pred             cccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC
Q 016143          189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  267 (394)
Q Consensus       189 ~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~  267 (394)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+..+  ...++...++++.+||++||.
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~  231 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME--DIKFPRTLSADAKSLLSGLLI  231 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccC--CccCCCCCCHHHHHHHHHHcC
Confidence            679999999998764 589999999999999999999999976 4455555555443  233566778999999999998


Q ss_pred             -CCCCCC-----CHHHHhcCCccccCCCCCc
Q 016143          268 -PASLRL-----PALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       268 -~p~~R~-----s~~elL~~p~~~~~~~~~~  292 (394)
                       +|.+|+     ++.++++||||....+...
T Consensus       232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~  262 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQDV  262 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence             999997     8999999999988765543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=369.97  Aligned_cols=256  Identities=27%  Similarity=0.454  Sum_probs=223.3

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +|.+.+.||+|.||+||+|.++.+|..+|+|.+.+..... ....+.+.+|+.+|++|. |||||+++++|.+.  ..++
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~~~~  112 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--DSVY  112 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--CeEE
Confidence            4588899999999999999999999999999998765433 345678899999999998 99999999999655  4799


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC---CCcEEEcccceeeee
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVM  181 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~---~~~~kl~Dfgla~~~  181 (394)
                      +|||+|.||+|++.+.+. .+++..+..+++||+.+++|||+.|  |+||||||+|+|+...   ++.+|++|||+|...
T Consensus       113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            999999999999999887 4999999999999999999999999  9999999999999743   248999999999877


Q ss_pred             cCC-CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCHH
Q 016143          182 QQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQ  257 (394)
Q Consensus       182 ~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~  257 (394)
                      ... .....+|||+|+|||++. ..|+..+||||+|+++|.|+.|..||.+ .+.......+..+..  +.......+..
T Consensus       190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~~is~~  268 (382)
T KOG0032|consen  190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWDDISES  268 (382)
T ss_pred             cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCccccCHH
Confidence            763 466789999999999888 6799999999999999999999999988 444555556766633  33445556899


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +++||.++|. +|.+|+++.++|+|||++...
T Consensus       269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence            9999999998 999999999999999998753

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-47  Score=374.53  Aligned_cols=257  Identities=23%  Similarity=0.387  Sum_probs=213.2

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|+||+||+|.++.+++.||+|.+...... .....+.+.+|+.+++.++||||++++++|.+.  ..+++||
T Consensus         4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~   80 (377)
T cd05629           4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA--QYLYLIM   80 (377)
T ss_pred             eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CeeEEEE
Confidence            6789999999999999999999999999998654322 234567788999999999999999999998654  5789999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC---
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~---  184 (394)
                      ||+++|+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+++.....   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeeccccccccccccc
Confidence            99999999999998888999999999999999999999999  99999999999998 7889999999998532110   


Q ss_pred             ----------------------------------------------CCcccccCCcccCcccccc-cCCCcCcchhhhhH
Q 016143          185 ----------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMC  217 (394)
Q Consensus       185 ----------------------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~i  217 (394)
                                                                    .....+||+.|+|||++.+ .++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                          0012469999999997764 58999999999999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC--CCCHHHHHHHHHcCCCCCC---CCCHHHHhcCCccccCCCCC
Q 016143          218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNPKD  291 (394)
Q Consensus       218 l~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~li~~~L~~p~~---R~s~~elL~~p~~~~~~~~~  291 (394)
                      +|||++|..||.. .+....+..+........++.  ..++++++||.+||.+|.+   |+++.+++.||||...++..
T Consensus       238 l~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~~  315 (377)
T cd05629         238 MFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDT  315 (377)
T ss_pred             hhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence            9999999999976 445555666654322222222  4678999999999986655   56999999999998765433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-47  Score=370.13  Aligned_cols=257  Identities=20%  Similarity=0.349  Sum_probs=216.8

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||.||+|.+..+++.||+|++..... ........+.+|+.+++.++||||+++++++.+  ...+++|
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv   79 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYLA   79 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEEE
Confidence            3788999999999999999999999999999875432 223455678899999999999999999998854  4578999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA  186 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~  186 (394)
                      |||+++|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++..... ..
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~-~~  155 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT-YA  155 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc-cc
Confidence            999999999999998888999999999999999999999999  99999999999998 788999999999976544 33


Q ss_pred             cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC---CCC---CCCCCHHHH
Q 016143          187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---ASL---SKVTDPQVK  259 (394)
Q Consensus       187 ~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~---~~~---~~~~~~~~~  259 (394)
                      ....||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+..+.+..+......   +..   ....++++.
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~  234 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEAW  234 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence            45679999999997765 589999999999999999999999987 5555555555432111   111   124578999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhcCCccccCCCCC
Q 016143          260 QFIEKCIV-PASLRLPALELLKDPFLVTDNPKD  291 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~~  291 (394)
                      +||.+||. +|.+||++.++++||||....+..
T Consensus       235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~  267 (333)
T cd05600         235 DLITKLINDPSRRFGSLEDIKNHPFFKEVDWNE  267 (333)
T ss_pred             HHHHHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence            99999998 788999999999999999765443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.7e-47  Score=360.32  Aligned_cols=261  Identities=22%  Similarity=0.353  Sum_probs=215.8

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |+..+.||+|+||+||+|.+..+|..||+|.+....... ......+.+|+.++++++|+||+++++++.++  ..+++|
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv   78 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLV   78 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEE
Confidence            467789999999999999999999999999987544322 23345678899999999999999999988544  478999


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+++|+|..++...  ..+++..+..++.||+.||.|||+++  |+||||||+|||++ +++.+||+|||++......
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCC
Confidence            9999999999887643  35899999999999999999999999  99999999999998 7889999999999765433


Q ss_pred             -CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          185 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       185 -~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                       ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......   ..+...+...  ...++...++++.
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~  233 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--QEEYSEKFSEDAK  233 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--cccCCccCCHHHH
Confidence             2345679999999998764 6899999999999999999999999864332   2233333222  2335556789999


Q ss_pred             HHHHHcCC-CCCCCCC-----HHHHhcCCccccCCCCCcccC
Q 016143          260 QFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCD  295 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s-----~~elL~~p~~~~~~~~~~~~~  295 (394)
                      +|+++||. +|.+|++     ++++++||||...+++.+...
T Consensus       234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~  275 (285)
T cd05631         234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN  275 (285)
T ss_pred             HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence            99999998 9999997     899999999999877665443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-47  Score=356.99  Aligned_cols=257  Identities=28%  Similarity=0.415  Sum_probs=222.8

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      .++.+.||.|..|+||+|....++..+|+|++.+.... ..+.+.+...|-.||+.++||.++.+|..|  +...+++++
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~-~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~~cl~  155 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA-SRKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKYSCLV  155 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh-hhhHHHHHHHHHHHHHhcCCCccchhhhee--eccceeEEE
Confidence            46678999999999999999999999999999876543 356777888999999999999999999998  555789999


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee---
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---  181 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~---  181 (394)
                      ||||.||+|..+++++  +.+++..++.++..++.||+|||..|  ||+|||||+||||- ++|++-|+||.|+...   
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccCCCC
Confidence            9999999999999876  45999999999999999999999999  99999999999998 8999999999987321   


Q ss_pred             ----cC----------------------------C-----------------------CCcccccCCcccCccccccc-C
Q 016143          182 ----QQ----------------------------P-----------------------TARSVIGTPEFMAPELYEEE-Y  205 (394)
Q Consensus       182 ----~~----------------------------~-----------------------~~~~~~gt~~y~aPE~l~~~-~  205 (394)
                          ..                            .                       ...+++||-+|+|||++.++ .
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                00                            0                       01235799999999999875 8


Q ss_pred             CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCC----HHHHhc
Q 016143          206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP----ALELLK  280 (394)
Q Consensus       206 ~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s----~~elL~  280 (394)
                      +.++|+|+|||.+|||+.|..||.+..+.+.+...+.+...-+..+ ..+..+++||+++|+ ||.+|..    |.||-+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            9999999999999999999999999888777777776654333222 456799999999998 9999998    999999


Q ss_pred             CCccccCCCC
Q 016143          281 DPFLVTDNPK  290 (394)
Q Consensus       281 ~p~~~~~~~~  290 (394)
                      ||||+..+|.
T Consensus       392 HpFF~gVnWa  401 (459)
T KOG0610|consen  392 HPFFEGVNWA  401 (459)
T ss_pred             CccccCCChh
Confidence            9999999997

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.2e-47  Score=367.55  Aligned_cols=253  Identities=23%  Similarity=0.440  Sum_probs=215.6

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      ++||+|+||+||+|.++.+|..||+|++..... ........+.+|+.+++.++||||++++++|.++  ..+++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~   77 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCC
Confidence            479999999999999999999999999875432 2244566788899999999999999999988644  5789999999


Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--CCcc
Q 016143          111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARS  188 (394)
Q Consensus       111 ~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~~~~  188 (394)
                      ++|+|..++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++ +++.+||+|||++......  ....
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCcccc
Confidence            99999999998888999999999999999999999999  99999999999998 7889999999998653222  2345


Q ss_pred             cccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC
Q 016143          189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  267 (394)
Q Consensus       189 ~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~  267 (394)
                      ..||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+....  ..++...+++++++|++||.
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~  231 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcc
Confidence            679999999998764 589999999999999999999999976 45555555555432  23456778999999999998


Q ss_pred             -CCCCCC-----CHHHHhcCCccccCCCCCc
Q 016143          268 -PASLRL-----PALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       268 -~p~~R~-----s~~elL~~p~~~~~~~~~~  292 (394)
                       +|.+|+     ++.++++||||....+...
T Consensus       232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~  262 (323)
T cd05595         232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDV  262 (323)
T ss_pred             CCHHHhCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence             999998     8999999999998765543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.5e-47  Score=366.03  Aligned_cols=256  Identities=26%  Similarity=0.434  Sum_probs=213.4

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHH-HHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~-~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ++||+|+||+||+|.++.+|+.||+|++....... ......+..|.. +++.++||||+++++.+.+.  ..+++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e~   77 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVLDY   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEEcC
Confidence            47999999999999999999999999987554322 223344555544 56889999999999988544  578999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--CCCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--~~~~  187 (394)
                      +++|+|..++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.....  ....
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCccc
Confidence            999999999998888999999999999999999999999  99999999999998 788999999999865322  2334


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+.  ..++...++.+.++|++||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l  231 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKP--LRLKPNISVSARHLLEGLL  231 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHh
Confidence            5679999999997765 589999999999999999999999976 56667777776553  2344556899999999999


Q ss_pred             C-CCCCCCCH----HHHhcCCccccCCCCCcccC
Q 016143          267 V-PASLRLPA----LELLKDPFLVTDNPKDLVCD  295 (394)
Q Consensus       267 ~-~p~~R~s~----~elL~~p~~~~~~~~~~~~~  295 (394)
                      . +|.+||++    .++++||||....+..+...
T Consensus       232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~  265 (323)
T cd05575         232 QKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNK  265 (323)
T ss_pred             hcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhc
Confidence            8 99999987    69999999988766554433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-48  Score=366.95  Aligned_cols=258  Identities=22%  Similarity=0.421  Sum_probs=217.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC----------HHHHHHHHHHHHHHHcCCCCCceeEeeeEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----------PDQLERLYSEVHLLKSLKHENIIKFYNSWV   96 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~----------~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~   96 (394)
                      |++.+.||+|.||+|.+|.+..+++.||||++.+......          -..+++.++|+.+|++|.|||||+++++.-
T Consensus        99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD  178 (576)
T KOG0585|consen   99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD  178 (576)
T ss_pred             eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence            3667889999999999999999999999999987553221          123578999999999999999999999987


Q ss_pred             cCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccc
Q 016143           97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG  176 (394)
Q Consensus        97 ~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfg  176 (394)
                      |.....+|||+|||..|.+...-.....+++.+++.+++.++.||.|||.+|  |+||||||+|+|++ .+|++||+|||
T Consensus       179 DP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~-~~g~VKIsDFG  255 (576)
T KOG0585|consen  179 DPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLS-SDGTVKISDFG  255 (576)
T ss_pred             CcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEc-CCCcEEeeccc
Confidence            7788899999999999988655444344999999999999999999999999  99999999999998 67999999999


Q ss_pred             eeeeecCC-------CCcccccCCcccCccccccc-----CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 016143          177 LAIVMQQP-------TARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG  244 (394)
Q Consensus       177 la~~~~~~-------~~~~~~gt~~y~aPE~l~~~-----~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~  244 (394)
                      .+......       .....+|||.|+|||++.++     -+.+.||||+||+||.|+.|+.||-+ .....++++|...
T Consensus       256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn~  334 (576)
T KOG0585|consen  256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVND  334 (576)
T ss_pred             eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhcC
Confidence            99766322       23346899999999987652     25789999999999999999999987 6667788888775


Q ss_pred             CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       245 ~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .............++++|+++|. ||.+|.+..++..|||.....
T Consensus       335 pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  335 PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            33222223357899999999998 999999999999999997653

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-47  Score=374.52  Aligned_cols=265  Identities=23%  Similarity=0.411  Sum_probs=219.5

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||+||+|.++.++..||+|++...... ..+....+.+|+.++..++||||+++++.|.+.  ..+++|
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv   79 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RNLYLI   79 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEE
Confidence            36779999999999999999999999999998754322 234567788999999999999999999988544  578999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      |||+++|+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++......  
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCcccccccc
Confidence            999999999999998888999999999999999999999999  99999999999998 7899999999998643211  


Q ss_pred             -----------------------------------CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCC
Q 016143          185 -----------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY  228 (394)
Q Consensus       185 -----------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf  228 (394)
                                                         .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                               0123579999999998764 5899999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhcCCCCCCCC--CCCCHHHHHHHHHcCCCCCCCC---CHHHHhcCCccccCCCCCcccCCCC
Q 016143          229 NECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKDLVCDPLR  298 (394)
Q Consensus       229 ~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~L~~p~~R~---s~~elL~~p~~~~~~~~~~~~~~~~  298 (394)
                      .+ .++...+..+........++  ...+++++++|.+++.+|.+|+   ++.++++||||+..++..+...+..
T Consensus       237 ~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~  310 (360)
T cd05627         237 CS-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAA  310 (360)
T ss_pred             CC-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCC
Confidence            76 55566666665432222222  2367899999999888888888   4799999999999887765444333

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8e-47  Score=371.78  Aligned_cols=258  Identities=22%  Similarity=0.351  Sum_probs=211.7

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +.+.+.||+|+||+||+|.++.++..||+|++...... .....+.+.+|+.+++.++||||+++++++.+.  ..+++|
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~lv   79 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFV   79 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEEEEE
Confidence            36778999999999999999999999999999765432 245567789999999999999999999998654  578999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      |||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++++||+|||++......  
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCcccccccc
Confidence            999999999999999888999999999999999999999999  99999999999998 6889999999997532100  


Q ss_pred             -----------------------------------------------CCcccccCCcccCcccccc-cCCCcCcchhhhh
Q 016143          185 -----------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGM  216 (394)
Q Consensus       185 -----------------------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~  216 (394)
                                                                     ...+.+||+.|+|||++.+ .++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                           0124579999999997764 5899999999999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCCCHHHHHHHHHcCC---CCCCCCCHHHHhcCCccccCCCCC
Q 016143          217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV---PASLRLPALELLKDPFLVTDNPKD  291 (394)
Q Consensus       217 il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~~li~~~L~---~p~~R~s~~elL~~p~~~~~~~~~  291 (394)
                      ++|||++|..||.... .......+........+  ....++++++||.+++.   ++..|+++.++++||||....+..
T Consensus       237 il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~  315 (381)
T cd05626         237 ILFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS  315 (381)
T ss_pred             HHHHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhH
Confidence            9999999999998744 33333344322111112  23467899999999654   455699999999999998876543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.7e-47  Score=366.53  Aligned_cols=253  Identities=23%  Similarity=0.416  Sum_probs=215.7

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ++||+|+||+||+|.++.++..||+|++...... .....+.+..|..++..+ +||||+++++++.+.  ..+++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey   77 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEF   77 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcC
Confidence            4799999999999999999999999998754322 234556778898998877 699999999988544  578999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec--CCCCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~--~~~~~  187 (394)
                      +++|+|..++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++....  .....
T Consensus        78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCccc
Confidence            999999999998888999999999999999999999999  99999999999998 78899999999987542  22334


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ...||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+..  .++...+++++++|++||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L  231 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFM  231 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence            5679999999998765 588999999999999999999999976 566677777766532  345567899999999999


Q ss_pred             C-CCCCCCCH------HHHhcCCccccCCCCCc
Q 016143          267 V-PASLRLPA------LELLKDPFLVTDNPKDL  292 (394)
Q Consensus       267 ~-~p~~R~s~------~elL~~p~~~~~~~~~~  292 (394)
                      . +|.+|+++      .++++||||....+..+
T Consensus       232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~  264 (320)
T cd05590         232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL  264 (320)
T ss_pred             ccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence            8 99999998      89999999998766544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.4e-47  Score=374.71  Aligned_cols=258  Identities=23%  Similarity=0.337  Sum_probs=213.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+++.||+|++...... .......+.+|+.+|+.++||||+++++.|.++  ..+++|
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv   79 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFV   79 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CEEEEE
Confidence            47889999999999999999999999999998654321 233456788899999999999999999988654  579999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      |||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+|..+...  
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCcccccccc
Confidence            999999999999998888999999999999999999999999  99999999999998 7889999999997432100  


Q ss_pred             -------------------------------------------CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHH
Q 016143          185 -------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILE  220 (394)
Q Consensus       185 -------------------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~e  220 (394)
                                                                 .....+||+.|+|||++.+ .++.++|||||||++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                       0123579999999998765 58999999999999999


Q ss_pred             HHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHcCCCCCCCC---CHHHHhcCCccccCCCCC
Q 016143          221 MVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKD  291 (394)
Q Consensus       221 lltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li~~~L~~p~~R~---s~~elL~~p~~~~~~~~~  291 (394)
                      |++|+.||.+. +.......+.....  ........++++.++|.+|+.+|.+|+   ++.++++||||+......
T Consensus       237 ll~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~  311 (376)
T cd05598         237 MLVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFAS  311 (376)
T ss_pred             hhhCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHH
Confidence            99999999874 44444444433211  111223467899999999888999999   999999999999765433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-47  Score=371.30  Aligned_cols=256  Identities=23%  Similarity=0.411  Sum_probs=216.8

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|+||+||+|.+..+|+.||+|++...... .......+.+|+.++..++||||+++++++.++  ..+++||
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~   80 (350)
T cd05573           4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDE--EHLYLVM   80 (350)
T ss_pred             eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecC--CeEEEEE
Confidence            7789999999999999999999999999998754432 234556788999999999999999999988544  5789999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC--
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~--  185 (394)
                      ||+.+++|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.......  
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCcccCcc
Confidence            99999999999998888999999999999999999999999  99999999999998 78899999999997554332  


Q ss_pred             -----------------------------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHH
Q 016143          186 -----------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA  235 (394)
Q Consensus       186 -----------------------------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~  235 (394)
                                                   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||... +..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~~~  236 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD-TLQ  236 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC-CHH
Confidence                                         234569999999997765 5899999999999999999999999874 455


Q ss_pred             HHHHHHhcCCCCCCC--CCCCCHHHHHHHHHcCCCCCCCCC-HHHHhcCCccccCCCC
Q 016143          236 QIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDNPK  290 (394)
Q Consensus       236 ~~~~~i~~~~~~~~~--~~~~~~~~~~li~~~L~~p~~R~s-~~elL~~p~~~~~~~~  290 (394)
                      ..+..+........+  ....++++++||.+||.+|.+|++ +.++|+||||+...+.
T Consensus       237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~  294 (350)
T cd05573         237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWE  294 (350)
T ss_pred             HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHH
Confidence            555555542111112  223589999999999999999999 9999999999876554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.6e-47  Score=374.34  Aligned_cols=257  Identities=23%  Similarity=0.350  Sum_probs=213.4

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +.+.+.||+|+||+||+|.++.++..||+|++..... ......+.+.+|+.+++.++||||+++++.|.++  ..+++|
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~lv   79 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFV   79 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEEEE
Confidence            3677999999999999999999999999999875442 2245567788999999999999999999998654  579999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      |||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++......  
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCcccccccc
Confidence            999999999999998888999999999999999999999999  99999999999998 7899999999997432100  


Q ss_pred             -----------------------------------------------CCcccccCCcccCcccccc-cCCCcCcchhhhh
Q 016143          185 -----------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGM  216 (394)
Q Consensus       185 -----------------------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~  216 (394)
                                                                     .....+||+.|+|||++.+ .|+.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                           0123579999999997754 6999999999999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHcCCCCCCCCC---HHHHhcCCccccCCCC
Q 016143          217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPK  290 (394)
Q Consensus       217 il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~~li~~~L~~p~~R~s---~~elL~~p~~~~~~~~  290 (394)
                      ++|||++|+.||.. .++.+....+........  .....+++++++|.+++.+|.+|++   +.++++||||+...+.
T Consensus       237 il~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~  314 (382)
T cd05625         237 ILYEMLVGQPPFLA-QTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFS  314 (382)
T ss_pred             HHHHHHhCCCCCCC-CCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence            99999999999987 444444444443222111  2234678999999998889999987   9999999999886554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.4e-47  Score=366.48  Aligned_cols=252  Identities=23%  Similarity=0.438  Sum_probs=214.6

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      +.||+|+||+||+|.++.+|..||+|++..... ........+.+|+.+++.++||||+++++++.++  ..+++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~   77 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYA   77 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence            469999999999999999999999999875432 2344566778899999999999999999988544  5789999999


Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--CCCc
Q 016143          111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR  187 (394)
Q Consensus       111 ~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--~~~~  187 (394)
                      ++|+|..++...+.+++..++.++.||+.||.|||+ ++  |+||||||+|||++ .++.+||+|||++.....  ....
T Consensus        78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccc
Confidence            999999999988889999999999999999999997 68  99999999999998 788999999999875432  2334


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ...||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...+...+...  ...++...++++.++|++||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L  231 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME--EIRFPRTLSPEAKSLLSGLL  231 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHh
Confidence            5679999999998764 589999999999999999999999976 4555566665543  22355667899999999999


Q ss_pred             C-CCCCCC-----CHHHHhcCCccccCCCCC
Q 016143          267 V-PASLRL-----PALELLKDPFLVTDNPKD  291 (394)
Q Consensus       267 ~-~p~~R~-----s~~elL~~p~~~~~~~~~  291 (394)
                      . +|.+|+     ++.++++||||....+..
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~  262 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVWQD  262 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcCCCCHHH
Confidence            8 999997     899999999999765543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-46  Score=369.07  Aligned_cols=256  Identities=20%  Similarity=0.364  Sum_probs=214.0

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.++..||+|++...... .....+.+.+|+.+++.++||||+++++++.+  ...+++|
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~~lv  121 (370)
T cd05596          45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYLYMV  121 (370)
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEEEEE
Confidence            36779999999999999999999999999998754322 22344557789999999999999999998854  4579999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      |||+++|+|.+++... .+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++....... 
T Consensus       122 ~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         122 MEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceeeccCCCc
Confidence            9999999999998765 5899999999999999999999999  99999999999998 78999999999997664432 


Q ss_pred             --CcccccCCcccCcccccc-----cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC--CCCH
Q 016143          186 --ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDP  256 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~~-----~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~--~~~~  256 (394)
                        ....+||+.|+|||++.+     .++.++|||||||++|||++|+.||.. .+....+..+........++.  ..+.
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDIEISK  276 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence              234679999999998753     378899999999999999999999987 455566666665433323333  4688


Q ss_pred             HHHHHHHHcCC-CCCC--CCCHHHHhcCCccccCCCC
Q 016143          257 QVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPK  290 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~--R~s~~elL~~p~~~~~~~~  290 (394)
                      ++++||++||. +|.+  |+++.++++||||+...+.
T Consensus       277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~  313 (370)
T cd05596         277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT  313 (370)
T ss_pred             HHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence            99999999998 5665  9999999999999986554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.5e-46  Score=361.84  Aligned_cols=256  Identities=25%  Similarity=0.426  Sum_probs=213.0

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHH---HcCCCCCceeEeeeEEcCCCceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL---KSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l---~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      |++.+.||+|+||+||+|.++.+|..||+|.++..... .....+.+.+|++++   +.++||||+++++++.+.  ..+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~   77 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHV   77 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEE
Confidence            36789999999999999999999999999999754422 233456677776665   566899999999988544  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+++++|..++.. +.+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++.....
T Consensus        78 ~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          78 CFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCC
Confidence            999999999999988865 45999999999999999999999999  99999999999998 788999999999864322


Q ss_pred             --CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          184 --PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       184 --~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                        ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+ .+..+....+..+..  .++...++.+.+
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~  230 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAIS  230 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHH
Confidence              23345679999999997765 588999999999999999999999986 455666666655422  245567899999


Q ss_pred             HHHHcCC-CCCCCC-----CHHHHhcCCccccCCCCCc
Q 016143          261 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       261 li~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~  292 (394)
                      +|.+||. +|.+||     ++.++++||||+...+...
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~  268 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL  268 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHH
Confidence            9999998 999999     6999999999988665443

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.4e-47  Score=363.09  Aligned_cols=253  Identities=22%  Similarity=0.358  Sum_probs=215.9

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ++||+|+||+||+|.++.+++.||+|++..... ......+.+..|..++..+ +||||++++++|.++  ..+++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~   77 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEY   77 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeC
Confidence            469999999999999999999999999875432 2244556778899999876 799999999998654  578999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--CCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~~~  187 (394)
                      +++|+|..++...+.+++..+..++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++......  ...
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccCCcccc
Confidence            999999999998888999999999999999999999999  99999999999998 7889999999999754322  234


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ...||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+..+..  ..+...++++.++|.+||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L  231 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSILKAFM  231 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence            5679999999998765 589999999999999999999999987 556667777765532  244557899999999999


Q ss_pred             C-CCCCCC-------CHHHHhcCCccccCCCCCc
Q 016143          267 V-PASLRL-------PALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       267 ~-~p~~R~-------s~~elL~~p~~~~~~~~~~  292 (394)
                      . +|.+|+       ++.++++||||....+..+
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~  265 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL  265 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHH
Confidence            8 999999       8999999999988766544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-46  Score=362.67  Aligned_cols=254  Identities=25%  Similarity=0.392  Sum_probs=214.9

Q ss_pred             ceecccCceEEEEEEEc---cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           31 EILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +.||+|+||+||+|.+.   .+++.||+|.+..............+.+|+.+|+.++||||++++++|.++  ..+++||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~   79 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL   79 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence            67999999999999863   578899999987654333344556678899999999999999999988654  5789999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--C
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~  185 (394)
                      ||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++......  .
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCc
Confidence            99999999999998888999999999999999999999999  99999999999998 7889999999998654322  2


Q ss_pred             CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK  264 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  264 (394)
                      .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.. .+.......+..+.  ..++...++.+++||++
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~  233 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGK--LNLPPYLTPEARDLLKK  233 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence            344679999999998765 588999999999999999999999987 44555566665553  23556678999999999


Q ss_pred             cCC-CCCCCC-----CHHHHhcCCccccCCCCCc
Q 016143          265 CIV-PASLRL-----PALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       265 ~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~  292 (394)
                      ||. +|.+|+     ++.+++.||||....+...
T Consensus       234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~  267 (323)
T cd05584         234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL  267 (323)
T ss_pred             HcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence            998 999999     8999999999987665443

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-46  Score=363.59  Aligned_cols=253  Identities=18%  Similarity=0.362  Sum_probs=212.0

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ++||+|+||+||+|.++.++..||+|+++.... ........+.+|..+++.+ +||||++++++|.++  ..+++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~   77 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEF   77 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeC
Confidence            479999999999999999999999999975432 2344566788899999999 799999999988544  578999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec--CCCCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~--~~~~~  187 (394)
                      +++|+|..++.+.+.+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++....  .....
T Consensus        78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccCCCccc
Confidence            999999999988888999999999999999999999999  99999999999998 68899999999986432  22334


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC--------CCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~--------~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...        .....+...+...  ...++...++.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~  232 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKA  232 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCCCCCCHHH
Confidence            5679999999998765 5889999999999999999999999631        1223344445443  233556678999


Q ss_pred             HHHHHHcCC-CCCCCCC------HHHHhcCCccccCCCCC
Q 016143          259 KQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPKD  291 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s------~~elL~~p~~~~~~~~~  291 (394)
                      .++|.+||. +|.+|++      +.++++||||....+..
T Consensus       233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~  272 (329)
T cd05588         233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL  272 (329)
T ss_pred             HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHH
Confidence            999999998 9999987      78999999998765543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-48  Score=337.95  Aligned_cols=251  Identities=24%  Similarity=0.458  Sum_probs=224.6

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+++.||+|-||.||+|+.++++-.||+|++.++...+ .+.-.++.+|+++-..|+||||+++|++|.|+  ..+|+++
T Consensus        25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--~riyLil  101 (281)
T KOG0580|consen   25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--KRIYLIL  101 (281)
T ss_pred             cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhheecc--ceeEEEE
Confidence            56899999999999999999999999999998776433 34456788999999999999999999999766  4688999


Q ss_pred             cccCCCcHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          108 ELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       108 e~~~~gsL~~~i~--~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      ||...|+|...++  ...++++.....+++|++.||.|+|.++  |+||||||+|+|++ ..+.+||+|||-+.......
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p~~k  178 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSNK  178 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccC-CCCCeeccCCCceeecCCCC
Confidence            9999999999999  6677999999999999999999999999  99999999999998 78999999999998877777


Q ss_pred             CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK  264 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  264 (394)
                      ..+.|||..|.|||+.++ .++..+|+|++|++.||++.|.+||.. .+..+.+++|.+-.  ..++..++..++++|.+
T Consensus       179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes-~~~~etYkrI~k~~--~~~p~~is~~a~dlI~~  255 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES-QSHSETYKRIRKVD--LKFPSTISGGAADLISR  255 (281)
T ss_pred             ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh-hhhHHHHHHHHHcc--ccCCcccChhHHHHHHH
Confidence            788999999999998876 589999999999999999999999976 44788888887642  23456778999999999


Q ss_pred             cCC-CCCCCCCHHHHhcCCccccC
Q 016143          265 CIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       265 ~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ||. +|.+|++..|++.|||+...
T Consensus       256 ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  256 LLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HhccCccccccHHHHhhhHHHHhc
Confidence            998 99999999999999998753

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-46  Score=363.67  Aligned_cols=259  Identities=21%  Similarity=0.357  Sum_probs=215.2

Q ss_pred             ccccceecccCceEEEEEEEc---cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCce
Q 016143           27 GRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~  102 (394)
                      |++.+.||+|+||+||+|.+.   .++..||+|++............+.+.+|+.+++.+ +||||+++++++.+  ...
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~   79 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EAK   79 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CCE
Confidence            367899999999999998763   578999999987554433445567788999999999 59999999998854  357


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||+.+|+|.+++.+...+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++....
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEEC-CCCCEEEeeCcCCcccc
Confidence            8899999999999999998888999999999999999999999999  99999999999998 68899999999997543


Q ss_pred             CC---CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCC---CCHHHHHHHHhcCCCCCCCCCCC
Q 016143          183 QP---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC---KNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       183 ~~---~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~---~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      ..   ......||+.|+|||++.+  .++.++|||||||++|||++|..||...   .....+...+....  ..++...
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~  234 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFI  234 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCC
Confidence            32   2234579999999998765  3788999999999999999999999642   23344444444432  2355667


Q ss_pred             CHHHHHHHHHcCC-CCCCCC-----CHHHHhcCCccccCCCCCc
Q 016143          255 DPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~  292 (394)
                      ++.+++++.+||. +|.+|+     ++.++++||||+...+...
T Consensus       235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~  278 (332)
T cd05614         235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEAL  278 (332)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence            8999999999998 999999     7889999999987655443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.2e-46  Score=367.24  Aligned_cols=257  Identities=21%  Similarity=0.385  Sum_probs=212.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.++..||+|++...... .....+.+.+|+.+++.++||||+++++++.++  ..+
T Consensus        43 ~~y-~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~  118 (370)
T cd05621          43 EDY-DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD--KYL  118 (370)
T ss_pred             HHC-eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEE
Confidence            344 7889999999999999999999999999998653322 233445678899999999999999999988544  579


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+++|+|.+++... .+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.....
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceeccc
Confidence            9999999999999999765 5899999999999999999999999  99999999999998 789999999999987643


Q ss_pred             CC---CcccccCCcccCcccccc-----cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC--C
Q 016143          184 PT---ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--V  253 (394)
Q Consensus       184 ~~---~~~~~gt~~y~aPE~l~~-----~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~--~  253 (394)
                      ..   ....+||+.|+|||++.+     .++.++|||||||++|+|++|+.||.. .+....+..+........++.  .
T Consensus       195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~  273 (370)
T cd05621         195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDVE  273 (370)
T ss_pred             CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCccc
Confidence            32   235679999999998753     278899999999999999999999986 445555666654332222322  4


Q ss_pred             CCHHHHHHHHHcCCCC---CCCCCHHHHhcCCccccCCC
Q 016143          254 TDPQVKQFIEKCIVPA---SLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       254 ~~~~~~~li~~~L~~p---~~R~s~~elL~~p~~~~~~~  289 (394)
                      .+..+++++.+||.++   ..|+++.++++||||+...+
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             CCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence            5789999999999843   34889999999999987654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.6e-46  Score=362.37  Aligned_cols=259  Identities=19%  Similarity=0.324  Sum_probs=217.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |.+.+.||+|+||+||+|.++.+|..||+|.++.... ...+..+.+.+|+.+++.++||||+++++++.+.  ..+++|
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~lv   79 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYLV   79 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEEEE
Confidence            3778999999999999999999999999999975432 2234556788899999999999999999988544  578999


Q ss_pred             EcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCCCC
Confidence            9999999999999886 67999999999999999999999999  99999999999998 78999999999997665432


Q ss_pred             ---CcccccCCcccCccccc-------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC--CC
Q 016143          186 ---ARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KV  253 (394)
Q Consensus       186 ---~~~~~gt~~y~aPE~l~-------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~  253 (394)
                         .....||+.|+|||++.       ..++.++|||||||++|+|++|..||... +....+..+........++  ..
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~  235 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQRFLKFPEDPK  235 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCCccCCCCCCC
Confidence               22346999999999875       34788999999999999999999999874 4455555555433222222  24


Q ss_pred             CCHHHHHHHHHcCCCCCCCCCHHHHhcCCccccCCCCCc
Q 016143          254 TDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       254 ~~~~~~~li~~~L~~p~~R~s~~elL~~p~~~~~~~~~~  292 (394)
                      .++++++||.+||.+|.+|+++.++++||||+...+..+
T Consensus       236 ~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~~~  274 (330)
T cd05601         236 VSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNI  274 (330)
T ss_pred             CCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHHHH
Confidence            678999999999999999999999999999998665443

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.1e-46  Score=360.82  Aligned_cols=257  Identities=22%  Similarity=0.345  Sum_probs=217.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCC-CceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hp-nIv~~~~~~~~~~~~~~~l  105 (394)
                      |++.+.||+|+||.||+|.++.++..||+|++..... ......+.+..|+.++..++|+ +|+++++++.+.  ..+++
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF   78 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence            3678999999999999999999999999999875432 2234567788899999999765 577888887543  57899


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec--C
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--Q  183 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~--~  183 (394)
                      ||||+++|+|.+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++....  .
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCCC
Confidence            9999999999999998888999999999999999999999999  99999999999998 68899999999986432  2


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      ......+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+ .+..+++..+....  ..++...++++.+++
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li  232 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSIC  232 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Confidence            23445679999999998765 589999999999999999999999986 55666677776543  235567789999999


Q ss_pred             HHcCC-CCCCCCCH-----HHHhcCCccccCCCCCc
Q 016143          263 EKCIV-PASLRLPA-----LELLKDPFLVTDNPKDL  292 (394)
Q Consensus       263 ~~~L~-~p~~R~s~-----~elL~~p~~~~~~~~~~  292 (394)
                      .+||. +|.+|+++     .++++||||+..++..+
T Consensus       233 ~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~  268 (324)
T cd05587         233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKL  268 (324)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence            99998 99999986     89999999998766543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4e-46  Score=359.93  Aligned_cols=255  Identities=26%  Similarity=0.452  Sum_probs=213.5

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||.||+|.++.+|..||+|.+....   .....+++.+|+.+|++++||||+++++++.++  ..+
T Consensus         5 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   78 (331)
T cd06649           5 DDF-ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI   78 (331)
T ss_pred             ccc-eEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence            344 67789999999999999999999999999987532   345567899999999999999999999988654  468


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~-~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+. +  |+||||||+||+++ .++.+||+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEc-CCCcEEEccCccccccc
Confidence            89999999999999999888899999999999999999999985 5  99999999999998 78899999999997665


Q ss_pred             CCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHH--------------------
Q 016143          183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV--------------------  241 (394)
Q Consensus       183 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i--------------------  241 (394)
                      ........||+.|+|||++.+ .++.++|||||||++|+|++|+.||... +..++...+                    
T Consensus       156 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCcccc
Confidence            555556779999999998765 5899999999999999999999999653 222222211                    


Q ss_pred             --------------------------hcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          242 --------------------------TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       242 --------------------------~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                                .....+.......++++++||.+||. +|.+||++.++|+||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                      11111111223467899999999998 999999999999999998654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.9e-46  Score=354.12  Aligned_cols=250  Identities=20%  Similarity=0.338  Sum_probs=205.6

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|+||+||+|.++.++..||+|.+.....  .....+.+.+|+.+++.++||||+++++++..  ...+++||
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~   79 (287)
T cd07848           4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLVF   79 (287)
T ss_pred             eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEEE
Confidence            788999999999999999999999999999875432  23445678889999999999999999998854  45789999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC---
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~---  184 (394)
                      ||+++++|..+......+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++......   
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCcccccccccc
Confidence            99999888877766677999999999999999999999999  99999999999998 7889999999999765432   


Q ss_pred             CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CC-----------------
Q 016143          185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI-----------------  245 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~-----------------  245 (394)
                      ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............... +.                 
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            2234579999999997754 5899999999999999999999999874443332221110 00                 


Q ss_pred             --CCC---------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          246 --KPA---------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       246 --~~~---------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                        .+.         ......+.++++||++||. +|.+|||++++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence              000         0112357789999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.1e-46  Score=357.68  Aligned_cols=252  Identities=24%  Similarity=0.427  Sum_probs=211.6

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      +.||+|+||+||+|.+..+++.||+|.++..... .....+.+..|..++..+ +||||+++++++..  ...+++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~   77 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEY   77 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcC
Confidence            4699999999999999999999999998754322 233445566677777654 89999999998854  3579999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--CCCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--~~~~  187 (394)
                      +++|+|..++...+.+++..+..++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++.....  ....
T Consensus        78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCccc
Confidence            999999999998888999999999999999999999999  99999999999998 788999999999975432  2334


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+ .+..+++..+....  ..++...+.++.+++++||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~ll~~~l  231 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDR--PHFPRWISKEAKDCLSKLF  231 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHc
Confidence            5679999999998765 589999999999999999999999987 55566666665542  2345667889999999999


Q ss_pred             C-CCCCCCCH-HHHhcCCccccCCCCC
Q 016143          267 V-PASLRLPA-LELLKDPFLVTDNPKD  291 (394)
Q Consensus       267 ~-~p~~R~s~-~elL~~p~~~~~~~~~  291 (394)
                      . +|.+|+++ .+++.||||....+..
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~  258 (316)
T cd05592         232 ERDPTKRLGVDGDIRQHPFFRGIDWER  258 (316)
T ss_pred             cCCHHHcCCChHHHHcCcccCCCCHHH
Confidence            8 89999986 4889999999876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-46  Score=361.24  Aligned_cols=256  Identities=27%  Similarity=0.412  Sum_probs=206.4

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC---ceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~---~~~  103 (394)
                      |++.+.||+|+||.||+|.++.+|..||+|.+....  .......++.+|+.+++.++||||+++++++.....   ..+
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            378899999999999999999999999999886322  123344578899999999999999999998765432   358


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+. ++|.+++.....+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.....
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCcccccccc
Confidence            99999994 799999998888999999999999999999999999  99999999999998 788999999999975432


Q ss_pred             CC-----CcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHH--------------HHH
Q 016143          184 PT-----ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY--------------KKV  241 (394)
Q Consensus       184 ~~-----~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~--------------~~i  241 (394)
                      ..     .....||+.|+|||++.+   .++.++|||||||++|+|++|+.||.+.....++.              ..+
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            21     234579999999998754   58899999999999999999999997643322111              000


Q ss_pred             h-----------cCCCCCC---CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          242 T-----------SGIKPAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       242 ~-----------~~~~~~~---~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .           ....+..   .....++.+.+++.+||. +|.+||++.|+|+||||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence            0           0000110   112356789999999998 999999999999999998654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-46  Score=357.38  Aligned_cols=255  Identities=27%  Similarity=0.418  Sum_probs=204.8

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.++..||+|++.....   ......+.+|+.+++.++||||+++++++.++  ..+
T Consensus         5 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~   78 (303)
T cd07869           5 DSY-EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTK--ETL   78 (303)
T ss_pred             ccc-eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecC--CeE
Confidence            345 678999999999999999999999999999865432   22234567899999999999999999988654  578


Q ss_pred             EEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+. ++|.+++... +.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++....
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKS  154 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceecc
Confidence            99999995 6777776654 56999999999999999999999999  99999999999998 78899999999997543


Q ss_pred             CC--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC--C-----------
Q 016143          183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I-----------  245 (394)
Q Consensus       183 ~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~--~-----------  245 (394)
                      ..  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+..+.......+...  .           
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            32  2344578999999998754  47899999999999999999999998765554433333210  0           


Q ss_pred             ----CCCCCC-------------CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          246 ----KPASLS-------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       246 ----~~~~~~-------------~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                          .+..+.             ...++.+++|+.+||. +|.+|+|+.|+|+||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence                000000             0134678999999998 999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.1e-46  Score=359.47  Aligned_cols=262  Identities=21%  Similarity=0.331  Sum_probs=220.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      |++.+.||+|+||+||+|.++.++..||+|++..... ......+.+..|..++..+ +|++|+++++++.+.  ..+++
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF   78 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence            3678999999999999999999999999999875432 2234455677788888887 589999999988543  57899


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--  183 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--  183 (394)
                      ||||+++|+|.+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.....  
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCCC
Confidence            9999999999999998888999999999999999999999999  99999999999998 788999999999975432  


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      ......+||+.|+|||++.+ .++.++|||||||++|||+||+.||.+ .+...++..+....  ..++...+.++++++
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~li  232 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN--VAYPKSMSKEAVAIC  232 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCcCCHHHHHHH
Confidence            23445679999999997764 589999999999999999999999987 55666777776543  235567789999999


Q ss_pred             HHcCC-CCCCCCCH-----HHHhcCCccccCCCCCcccCCC
Q 016143          263 EKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPL  297 (394)
Q Consensus       263 ~~~L~-~p~~R~s~-----~elL~~p~~~~~~~~~~~~~~~  297 (394)
                      .+||. +|.+|+++     .+++.||||+..++........
T Consensus       233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~  273 (323)
T cd05616         233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEV  273 (323)
T ss_pred             HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCC
Confidence            99998 99999984     8999999999877665544433

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.6e-46  Score=358.99  Aligned_cols=252  Identities=25%  Similarity=0.426  Sum_probs=212.4

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      +.||+|+||+||+|.++.+|..||+|.+...... .....+.+..|..++..+ +||||+++++++.+.  ..+++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~   77 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEF   77 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECC
Confidence            4699999999999999999999999998754321 123445667788888765 899999999988544  579999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec--CCCCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~--~~~~~  187 (394)
                      +.+|+|..++...+.+++..+..++.||+.||+|||+++  |+||||||+||+++ .++.+||+|||++....  .....
T Consensus        78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCcee
Confidence            999999999998888999999999999999999999999  99999999999998 68899999999986432  22344


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++...+....  ..++...+.+++++|++||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l  231 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDILEKLF  231 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHc
Confidence            5679999999998765 589999999999999999999999976 55566666665542  2345567899999999999


Q ss_pred             C-CCCCCCCH-HHHhcCCccccCCCCC
Q 016143          267 V-PASLRLPA-LELLKDPFLVTDNPKD  291 (394)
Q Consensus       267 ~-~p~~R~s~-~elL~~p~~~~~~~~~  291 (394)
                      . +|.+|+++ .++++||||+...+..
T Consensus       232 ~~dP~~R~~~~~~~~~h~~f~~~~~~~  258 (316)
T cd05620         232 ERDPTRRLGVVGNIRGHPFFKTINWTA  258 (316)
T ss_pred             cCCHHHcCCChHHHHcCCCcCCCCHHH
Confidence            8 99999998 5889999998876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.1e-46  Score=358.21  Aligned_cols=254  Identities=26%  Similarity=0.409  Sum_probs=211.8

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHH-HHHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV-HLLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~-~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ++||+|+||+||+|.++.+|..||+|++....... ......+..|. .+++.++||||+++++++.+.  ..+++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~   77 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVLDY   77 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEEcC
Confidence            47999999999999999999999999987544322 23334455555 468889999999999988544  578999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--CCCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--~~~~  187 (394)
                      +++++|..++.....+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++.....  ....
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccc
Confidence            999999999988888999999999999999999999999  99999999999998 788999999999875322  2234


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ..+||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+..+++..+...  +..++...+..+.++|.+||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l  231 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLL  231 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHc
Confidence            5679999999998765 589999999999999999999999987 5666777777654  33455667889999999999


Q ss_pred             C-CCCCCCCH----HHHhcCCccccCCCCCcc
Q 016143          267 V-PASLRLPA----LELLKDPFLVTDNPKDLV  293 (394)
Q Consensus       267 ~-~p~~R~s~----~elL~~p~~~~~~~~~~~  293 (394)
                      . +|.+|+++    .++++|+||....+..+.
T Consensus       232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T cd05603         232 HKDQRRRLGAKADFLEIKNHVFFSPINWDDLY  263 (321)
T ss_pred             cCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHh
Confidence            8 89999976    499999999876655443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-47  Score=372.27  Aligned_cols=251  Identities=31%  Similarity=0.546  Sum_probs=222.7

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      -+||+|.||+||.|+|..+....|||.|..++    ....+-+.+|+.+.++|+|.|||++++++  ..++++-|.||-+
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqV  654 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD----SREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQV  654 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccccc----chhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecC
Confidence            37999999999999999999999999987543    45667788999999999999999999987  4556888999999


Q ss_pred             CCCcHHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--CC
Q 016143          111 TSGSLRQYRKK-HKNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PT  185 (394)
Q Consensus       111 ~~gsL~~~i~~-~~~l--~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--~~  185 (394)
                      +||+|..+++. .+++  ++..+-.+.+||++||+|||.+.  |||||||-+|||||...|.+||+|||.++.+..  +.
T Consensus       655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence            99999999875 4777  89999999999999999999999  999999999999998999999999999976653  45


Q ss_pred             CcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      ..++.||..|||||++..   .|+.++|||||||++.||.||++||.+..++...+.++---...+.++...+.+++.||
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi  812 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI  812 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence            677889999999998863   49999999999999999999999999988887666666554556667888899999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          263 EKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      .+|+. +|.+||+|.++|.+||++..+.
T Consensus       813 lrcFepd~~~R~sA~~LL~DpFlq~~~k  840 (1226)
T KOG4279|consen  813 LRCFEPDPCDRPSAKDLLQDPFLQHNNK  840 (1226)
T ss_pred             HHHcCCCcccCccHHHhccCcccccCCC
Confidence            99999 8999999999999999997643

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.3e-46  Score=360.71  Aligned_cols=254  Identities=25%  Similarity=0.418  Sum_probs=211.2

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHH-HHHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV-HLLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~-~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      +.||+|+||+||+|.++.++..||+|++......... ....+..|. .+++.++||||+++++++.+.  ..+++||||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~   77 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK-EEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDY   77 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhh-HHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeC
Confidence            4699999999999999999999999998754432222 223344444 457889999999999988544  578999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--CCCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--~~~~  187 (394)
                      +.+|+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.....  ....
T Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcc
Confidence            999999999998888999999999999999999999999  99999999999998 788999999999965422  2344


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+...  +..+....++.++++|++||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l  231 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNK--PLQLKPNITNSARHLLEGLL  231 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHc
Confidence            5679999999997765 588999999999999999999999986 5566666666554  23344567889999999999


Q ss_pred             C-CCCCCCCHH----HHhcCCccccCCCCCcc
Q 016143          267 V-PASLRLPAL----ELLKDPFLVTDNPKDLV  293 (394)
Q Consensus       267 ~-~p~~R~s~~----elL~~p~~~~~~~~~~~  293 (394)
                      + +|.+|+++.    ++++|+||....+..+.
T Consensus       232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~  263 (325)
T cd05602         232 QKDRTKRLGAKDDFMEIKNHIFFSPINWDDLI  263 (325)
T ss_pred             ccCHHHCCCCCCCHHHHhcCcccCCCCHHHHH
Confidence            8 899999876    89999999887765543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3e-46  Score=358.83  Aligned_cols=252  Identities=22%  Similarity=0.387  Sum_probs=215.0

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      +.||+|+||+||+|.++.++..||+|++..... ........+.+|..+++.+ +||||+++++++.+.  ..+++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~   77 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEY   77 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence            469999999999999999999999999875432 2234556778899999888 699999999988544  578999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--CCCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--~~~~  187 (394)
                      +.+|+|..++.+.+.+++..+..++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++.....  ....
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCccc
Confidence            999999999998888999999999999999999999999  99999999999998 788999999999865322  2334


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+....  ..++...+..+++||++||
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l  231 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDE--VRYPRWLSKEAKSILKSFL  231 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCC--CCCCCcCCHHHHHHHHHHc
Confidence            4579999999998765 589999999999999999999999976 55666666665542  2345667899999999999


Q ss_pred             C-CCCCCCCH-----HHHhcCCccccCCCCC
Q 016143          267 V-PASLRLPA-----LELLKDPFLVTDNPKD  291 (394)
Q Consensus       267 ~-~p~~R~s~-----~elL~~p~~~~~~~~~  291 (394)
                      . +|.+||++     .+++.||||+...+..
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~  262 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKGHPFFREIDWDK  262 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence            8 99999999     9999999998876543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.1e-46  Score=352.73  Aligned_cols=249  Identities=27%  Similarity=0.424  Sum_probs=202.3

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +| ++.+.||+|+||+||+|.++.++..||+|.+.....   ......+.+|+.+++.++||||+++++++.++  ..++
T Consensus         6 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~   79 (288)
T cd07871           6 TY-VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCLT   79 (288)
T ss_pred             cc-eEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEE
Confidence            44 677999999999999999999999999999865432   22334577899999999999999999988543  5788


Q ss_pred             EEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          105 MITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +||||+.+ +|.+++...+ .+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.....
T Consensus        80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSV  155 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeeccC
Confidence            99999974 8999887654 4899999999999999999999999  99999999999998 788999999999976543


Q ss_pred             C--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC--CCC-C--------
Q 016143          184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP-A--------  248 (394)
Q Consensus       184 ~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~--~~~-~--------  248 (394)
                      .  ......||+.|+|||++.+  .++.++||||+||++|+|++|+.||.+...... ...+...  ..+ .        
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccc
Confidence            3  2334578999999997754  488999999999999999999999987443333 2222110  000 0        


Q ss_pred             -----------------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          249 -----------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       249 -----------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                       ......++++++||++||. +|.+|+|+.|+|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                             0012346789999999998 99999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.2e-46  Score=358.93  Aligned_cols=252  Identities=19%  Similarity=0.376  Sum_probs=211.1

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ++||+|+||+||+|.++.+++.||+|++..... ........+.+|+.++.++ +||||+++++++.++  ..+++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~   77 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEY   77 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeC
Confidence            479999999999999999999999999975432 2345566788899998877 899999999988654  578999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--CCCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--~~~~  187 (394)
                      +++|+|..++...+.+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++.....  ....
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCccc
Confidence            999999999988888999999999999999999999999  99999999999998 788999999999965322  2234


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC--------CCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~--------~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                      ...||+.|+|||++.+ .++.++|||||||++|+|++|+.||...        .....+...+...  ...++...+..+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~  232 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKA  232 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCCCCCHHH
Confidence            5679999999997765 5889999999999999999999999521        1223344444443  223566778999


Q ss_pred             HHHHHHcCC-CCCCCCC------HHHHhcCCccccCCCC
Q 016143          259 KQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPK  290 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s------~~elL~~p~~~~~~~~  290 (394)
                      +++|++||. +|.+|++      ..++++||||+..++.
T Consensus       233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~  271 (329)
T cd05618         233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  271 (329)
T ss_pred             HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence            999999998 9999998      4799999999887654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.5e-46  Score=351.01  Aligned_cols=253  Identities=26%  Similarity=0.423  Sum_probs=208.5

Q ss_pred             ecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCC
Q 016143           33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS  112 (394)
Q Consensus        33 LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~  112 (394)
                      ||+|+||+||+|.++.+++.||+|.+..... ......+.+..|+.+++.++||||+++++++..  ...+++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNG   77 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCC
Confidence            7999999999999999999999999875432 223345677889999999999999999998754  3568999999999


Q ss_pred             CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC--C
Q 016143          113 GSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--A  186 (394)
Q Consensus       113 gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~--~  186 (394)
                      |+|..++..    ...+++..++.++.||+.||.|||+++  |+||||||+||+++ +++.+||+|||++.......  .
T Consensus        78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~  154 (280)
T cd05608          78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKT  154 (280)
T ss_pred             CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccc
Confidence            999988743    346999999999999999999999999  99999999999998 68899999999997654432  3


Q ss_pred             cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       187 ~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      ....||+.|+|||.+.+ .++.++|||||||++|+|++|+.||......   ..+...+...  +..++...++.+++++
T Consensus       155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li  232 (280)
T cd05608         155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFC  232 (280)
T ss_pred             cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHH
Confidence            34579999999997764 5889999999999999999999999763322   2223333222  2334556788999999


Q ss_pred             HHcCC-CCCCCC-----CHHHHhcCCccccCCCCCcc
Q 016143          263 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDLV  293 (394)
Q Consensus       263 ~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~~  293 (394)
                      .+||. +|.+|+     +++++++||||+...+..+.
T Consensus       233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~  269 (280)
T cd05608         233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLE  269 (280)
T ss_pred             HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHh
Confidence            99998 999999     88999999999987665543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-45  Score=361.45  Aligned_cols=256  Identities=20%  Similarity=0.365  Sum_probs=214.0

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      -|++.+.||+|+||+||+|.++.+++.||+|++...... .......+.+|+.+++.++||||+++++.+.+  ...+++
T Consensus        44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~l  120 (371)
T cd05622          44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLYM  120 (371)
T ss_pred             hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEEE
Confidence            347889999999999999999999999999998754322 23345567889999999999999999998854  457999


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      ||||+++|+|.+++... .+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.......
T Consensus       121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCcCC
Confidence            99999999999999765 4899999999999999999999999  99999999999998 78899999999998765432


Q ss_pred             ---CcccccCCcccCcccccc-----cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCCC
Q 016143          186 ---ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTD  255 (394)
Q Consensus       186 ---~~~~~gt~~y~aPE~l~~-----~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~--~~~~~  255 (394)
                         ....+||+.|+|||++.+     .++.++|||||||++|||++|..||.. .+....+..+........+  ....+
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDIS  275 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcCCCC
Confidence               235679999999998753     278899999999999999999999976 5666677777654322222  23568


Q ss_pred             HHHHHHHHHcCCCCCC---CCCHHHHhcCCccccCCC
Q 016143          256 PQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNP  289 (394)
Q Consensus       256 ~~~~~li~~~L~~p~~---R~s~~elL~~p~~~~~~~  289 (394)
                      .+++++|.+||.+|..   |+++.++++||||+...+
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence            8999999999985443   789999999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.2e-46  Score=345.51  Aligned_cols=253  Identities=28%  Similarity=0.426  Sum_probs=212.0

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCC-ceeEeeeEEcCC----CceEE
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDT----NRTIN  104 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpn-Iv~~~~~~~~~~----~~~~~  104 (394)
                      .++||+|+||+||+|.++.+|..||+|++......  +..-....+|+.+|+.|+|+| |+.+++++...+    ...++
T Consensus        16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~   93 (323)
T KOG0594|consen   16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY   93 (323)
T ss_pred             HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence            36699999999999999999999999999876431  223345678999999999999 999999886544    24789


Q ss_pred             EEEcccCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          105 MITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~----~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      +|+||. ..+|.+|+....    +++...++.+++||+.||.|||+++  |+||||||+||+|+ +.|.+||+|||+|+.
T Consensus        94 lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   94 LVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLIS-SSGVLKLADFGLARA  169 (323)
T ss_pred             EEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEEC-CCCcEeeeccchHHH
Confidence            999999 469999998765    6888999999999999999999999  99999999999999 699999999999986


Q ss_pred             ecCC--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCCC---
Q 016143          181 MQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLS---  251 (394)
Q Consensus       181 ~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~---  251 (394)
                      ..-+  .....++|.+|.|||++-+  .|+..+||||+|||++||++++..|.+..+.+|+.+....--.|  ..|+   
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~  249 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS  249 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence            6533  4667789999999997765  49999999999999999999999999988877777665421001  1111   


Q ss_pred             ----------------------CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          252 ----------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       252 ----------------------~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                            +..++...+++.+||. +|.+|.||..+|.||||....
T Consensus       250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence                                  1123578999999999 999999999999999998764

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.3e-46  Score=373.78  Aligned_cols=253  Identities=26%  Similarity=0.395  Sum_probs=203.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC-----
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD-----   98 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~-----   98 (394)
                      .+| ++.+.||+|+||+||+|.+..+++.||+|++....        ....+|+.+|+.++||||++++++|...     
T Consensus        66 ~~y-~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         66 KSY-KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CeE-EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            444 88999999999999999999999999999885321        1234699999999999999999877542     


Q ss_pred             -CCceEEEEEcccCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143           99 -TNRTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus        99 -~~~~~~lV~e~~~~gsL~~~i~----~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                       ...++++||||+.+ +|.+++.    ....+++..++.++.||+.||.|||+++  |+||||||+|||++.+++.+||+
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeee
Confidence             23467899999974 6766654    3467999999999999999999999999  99999999999998555689999


Q ss_pred             ccceeeeecCC-CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC----
Q 016143          174 DLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----  246 (394)
Q Consensus       174 Dfgla~~~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~----  246 (394)
                      |||+|+..... ......||+.|+|||++.+  .|+.++|||||||++|||++|.+||.+.....++...+.....    
T Consensus       214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            99999765433 3345678999999997654  5899999999999999999999999886555554444321100    


Q ss_pred             --------------C--------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          247 --------------P--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       247 --------------~--------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                    +        ..++...++++++||.+||. +|.+|+++.|+|.||||....
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                          0        01223456799999999998 999999999999999998643

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.9e-46  Score=359.05  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=210.3

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHH-HHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~-~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      +.||+|+||+||+|.++.+|..||+|++....... ......+..|.. +++.++||||+++++++..+  ..+++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~e~   77 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVLDF   77 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEEcC
Confidence            46999999999999999999999999987543322 233445555554 57889999999999988544  578999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec--CCCCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~--~~~~~  187 (394)
                      +.+|+|..++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ +++.+||+|||++....  .....
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcc
Confidence            999999999998888999999999999999999999999  99999999999998 78899999999986532  22334


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+....  ..+....+..+.++|.+||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll  231 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKP--LVLRPGASLTAWSILEELL  231 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHh
Confidence            5679999999998765 588999999999999999999999976 55666666666542  2234457789999999999


Q ss_pred             C-CCCCCCCH----HHHhcCCccccCCCCCc
Q 016143          267 V-PASLRLPA----LELLKDPFLVTDNPKDL  292 (394)
Q Consensus       267 ~-~p~~R~s~----~elL~~p~~~~~~~~~~  292 (394)
                      . +|.+||++    .+++.||||....+..+
T Consensus       232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~  262 (325)
T cd05604         232 EKDRQRRLGAKEDFLEIQEHPFFESLSWTDL  262 (325)
T ss_pred             ccCHHhcCCCCCCHHHHhcCCCcCCCCHHHH
Confidence            8 89999876    58999999997665443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.3e-46  Score=355.94  Aligned_cols=253  Identities=25%  Similarity=0.437  Sum_probs=212.3

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      +.||+|+||+||+|.++.++..||+|.+...... .....+....|..++..+ +||||+++++++.+.  ..+++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey   77 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEY   77 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeC
Confidence            4699999999999999999999999998754321 123345566788888764 899999999988654  578999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec--CCCCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~--~~~~~  187 (394)
                      +++|+|.+++.....+++.++..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++....  .....
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCcee
Confidence            999999999998888999999999999999999999999  99999999999998 68899999999986532  22334


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ...||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+....  ..++...+.+++++|.+||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l  231 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDN--PCYPRWLTREAKDILVKLF  231 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHh
Confidence            5679999999998765 589999999999999999999999976 45566666665442  2245567889999999999


Q ss_pred             C-CCCCCCCHH-HHhcCCccccCCCCCc
Q 016143          267 V-PASLRLPAL-ELLKDPFLVTDNPKDL  292 (394)
Q Consensus       267 ~-~p~~R~s~~-elL~~p~~~~~~~~~~  292 (394)
                      . +|.+|+++. ++++||||+...+..+
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~~  259 (316)
T cd05619         232 VREPERRLGVKGDIRQHPFFREIDWSAL  259 (316)
T ss_pred             ccCHhhcCCChHHHHcCcccCCCCHHHH
Confidence            8 999999996 8999999998766543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-47  Score=359.82  Aligned_cols=255  Identities=24%  Similarity=0.414  Sum_probs=222.5

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      -|.+.+.||+|-|+.|-+|+|.-||+.||+|+|.+.+.  +.-....+++|++.|+.++|||||++|++.  +.+..+|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyL   94 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYL   94 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEE
Confidence            34788999999999999999999999999999987765  334456789999999999999999999965  66678999


Q ss_pred             EEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          106 ITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |+|+-.+|+|++||-++ .+++++.++.+|.||+.|+.|+|+..  +|||||||+||.+-..-|-+||.|||++..+...
T Consensus        95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999999999998877 57999999999999999999999999  9999999999998878899999999999766654


Q ss_pred             -CCcccccCCcccCcccccc-cCC-CcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          185 -TARSVIGTPEFMAPELYEE-EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       185 -~~~~~~gt~~y~aPE~l~~-~~~-~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                       ...+.||+..|-|||++-+ .|+ +++||||||+|||.|++|++||.+..+.+.+. +|....+  ..+...+.++++|
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT-mImDCKY--tvPshvS~eCrdL  249 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT-MIMDCKY--TVPSHVSKECRDL  249 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh-hhhcccc--cCchhhhHHHHHH
Confidence             5788899999999997765 576 79999999999999999999999866555443 4443322  2466778999999


Q ss_pred             HHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          262 IEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      |..||+ +|.+|-+.++|..++|++..+.
T Consensus       250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  250 IQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHHHHhcCchhhccHHHHhccccccCCCC
Confidence            999999 9999999999999999998664

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.2e-45  Score=356.08  Aligned_cols=254  Identities=19%  Similarity=0.367  Sum_probs=213.8

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      +.||+|+||+||+|.++.++..||+|++..... ...+..+.+.+|+.++.++ +||||+++++++.+.  ..+++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~   77 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEY   77 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeC
Confidence            479999999999999999999999999975432 2345567788999999988 699999999988544  578999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--CCCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--~~~~  187 (394)
                      +++|+|..++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.....  ....
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCcee
Confidence            999999999998888999999999999999999999999  99999999999998 788999999999975322  2334


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC------CCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC------KNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|..||...      .....+...+...  +..++...+..+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~  232 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASH  232 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHH
Confidence            5679999999997764 5899999999999999999999999532      2233445555443  33466678899999


Q ss_pred             HHHHcCC-CCCCCCC------HHHHhcCCccccCCCCCc
Q 016143          261 FIEKCIV-PASLRLP------ALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       261 li~~~L~-~p~~R~s------~~elL~~p~~~~~~~~~~  292 (394)
                      ++.+||. +|.+|++      ..+++.||||...++..+
T Consensus       233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~  271 (327)
T cd05617         233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL  271 (327)
T ss_pred             HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHH
Confidence            9999998 9999998      469999999998776543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.3e-46  Score=357.00  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=212.2

Q ss_pred             ceecccCceEEEEEEE---ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           31 EILGKGAFKTVYKGFD---EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~---~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +.||+|+||+||++.+   +.+|..||+|++.....  ......++.+|+.+|++++||||+++++++.++  ..+++||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~   77 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLIL   77 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEE
Confidence            6799999999999876   45789999999875432  123445677899999999999999999988544  5789999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--C
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~  185 (394)
                      ||+++|+|.+++.+...+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++......  .
T Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCc
Confidence            99999999999988888999999999999999999999999  99999999999998 7889999999999765433  2


Q ss_pred             CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK  264 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  264 (394)
                      .....||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.. .+..+....+....  ..++...++.++++|++
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~  231 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAK--LGMPQFLSPEAQSLLRA  231 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence            345679999999998765 588999999999999999999999986 45555666665542  23455678999999999


Q ss_pred             cCC-CCCCCCC-----HHHHhcCCccccCCCCC
Q 016143          265 CIV-PASLRLP-----ALELLKDPFLVTDNPKD  291 (394)
Q Consensus       265 ~L~-~p~~R~s-----~~elL~~p~~~~~~~~~  291 (394)
                      ||. +|.+||+     ..+++.||||+...+..
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~  264 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNK  264 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHH
Confidence            998 9999999     67799999998865543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2e-45  Score=353.90  Aligned_cols=258  Identities=22%  Similarity=0.350  Sum_probs=216.7

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      ++.+.||+|+||+||+|.++.+|..||+|++...... .....+.+..|..+++.+. |++|+++++++.++  ..+++|
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv   79 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYFV   79 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEEE
Confidence            5678999999999999999999999999998754322 2345566788999998886 56788888887544  478999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      |||+++|+|.+++...+.+++.+++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++......  
T Consensus        80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCCCc
Confidence            999999999999999888999999999999999999999999  99999999999998 7889999999998754322  


Q ss_pred             CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                      ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+ .+...+...+....  ..++...+.++++++.
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~  233 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSICK  233 (323)
T ss_pred             cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHHH
Confidence            2345679999999997764 589999999999999999999999977 55666666666543  2355667889999999


Q ss_pred             HcCC-CCCCCCC-----HHHHhcCCccccCCCCCccc
Q 016143          264 KCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVC  294 (394)
Q Consensus       264 ~~L~-~p~~R~s-----~~elL~~p~~~~~~~~~~~~  294 (394)
                      +||. +|.+|++     ..++++||||+..++..+..
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~  270 (323)
T cd05615         234 GLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLEN  270 (323)
T ss_pred             HHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhc
Confidence            9998 9999997     47899999999877654433

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-45  Score=351.65  Aligned_cols=258  Identities=19%  Similarity=0.349  Sum_probs=211.5

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.++..||+|++...... .....+.+.+|+.+++.++|+||+++++++.++  ..+++|
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv   79 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLYLV   79 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEEEE
Confidence            37789999999999999999999999999998754322 234456688899999999999999999988544  579999


Q ss_pred             EcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCCCC
Confidence            999999999999986 457999999999999999999999999  99999999999998 78899999999997654332


Q ss_pred             ---CcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC---CCCCCC
Q 016143          186 ---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---ASLSKV  253 (394)
Q Consensus       186 ---~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~---~~~~~~  253 (394)
                         .....||+.|+|||++.      +.++.++|||||||++|+|++|+.||.. .+..+.+..+......   ......
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~  235 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDVTD  235 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCccCC
Confidence               22346999999999875      2478899999999999999999999976 4455555555443211   111234


Q ss_pred             CCHHHHHHHHHcCCC---CCCCCCHHHHhcCCccccCCCCC
Q 016143          254 TDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKD  291 (394)
Q Consensus       254 ~~~~~~~li~~~L~~---p~~R~s~~elL~~p~~~~~~~~~  291 (394)
                      .+..++++|++||..   +..|+++.++|+||||....+..
T Consensus       236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~  276 (331)
T cd05597         236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN  276 (331)
T ss_pred             CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence            678999999998863   34478999999999998766543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.5e-45  Score=354.72  Aligned_cols=254  Identities=26%  Similarity=0.453  Sum_probs=211.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||.||+|.++.++..+|+|.+....   .....+.+.+|++++++++||||+++++++.++  ..+
T Consensus         5 ~~y-~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   78 (333)
T cd06650           5 DDF-EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI   78 (333)
T ss_pred             hhh-heeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEE
Confidence            445 77899999999999999999999999999886532   344567789999999999999999999998654  478


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~-~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+.+++|.+++...+.+++..+..++.||+.||.|||+. +  |+||||||+|||++ +++.+||+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhhh
Confidence            99999999999999999888899999999999999999999974 6  99999999999998 68899999999997665


Q ss_pred             CCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHH-----------------------
Q 016143          183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY-----------------------  238 (394)
Q Consensus       183 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~-----------------------  238 (394)
                      ........||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... .++.                       
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA-KELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             hhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch-hHHHHHhcCcccCCccccccCcccCCc
Confidence            544455679999999998765 588999999999999999999999975322 2111                       


Q ss_pred             ---------------------HHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          239 ---------------------KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       239 ---------------------~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                           ..+.....+.......+.++++||.+||. +|.+||++.|++.||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                 11111111111122356889999999998 99999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=356.54  Aligned_cols=251  Identities=24%  Similarity=0.387  Sum_probs=209.3

Q ss_pred             ecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC---CCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        33 LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L---~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ||+|+||+||+|.++.+|..||+|++....... .........|..++..+   +||||+++++.|.+.  ..+++||||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~   77 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDY   77 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcC
Confidence            799999999999999999999999987544322 23444556677777665   699999999988544  578999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--CCCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--~~~~  187 (394)
                      +.+|+|..++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.....  ....
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCcc
Confidence            999999999998888999999999999999999999999  99999999999998 788999999999865322  2344


Q ss_pred             ccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHc
Q 016143          188 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC  265 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~  265 (394)
                      ..+||+.|+|||++.+  .++.++|||||||++|+|++|..||.. .+..+++..+..+.... .....++++++||++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~  232 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGL  232 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHH
Confidence            5679999999998754  478999999999999999999999976 56667777776653321 1234678999999999


Q ss_pred             CC-CCCCCC----CHHHHhcCCccccCCCCC
Q 016143          266 IV-PASLRL----PALELLKDPFLVTDNPKD  291 (394)
Q Consensus       266 L~-~p~~R~----s~~elL~~p~~~~~~~~~  291 (394)
                      |. +|.+||    ++.++++||||....+..
T Consensus       233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~  263 (330)
T cd05586         233 LNRNPQHRLGAHRDAVELKEHPFFADIDWDL  263 (330)
T ss_pred             cCCCHHHCCCCCCCHHHHhcCccccCCCHHH
Confidence            98 899998    689999999998765443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-45  Score=345.80  Aligned_cols=259  Identities=24%  Similarity=0.387  Sum_probs=213.2

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.++||+|+||+||+|.+..++..||+|++...... .......+.+|+.+++.++||||+++++.+.++  ..+++||
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~   79 (285)
T cd05605           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVL   79 (285)
T ss_pred             eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEEE
Confidence            6678999999999999999999999999998654332 223345677899999999999999999988543  5789999


Q ss_pred             cccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      ||+++|+|..++...  ..+++..+..++.||+.||.|||+++  ++||||||+||+++ +++.++|+|||++...... 
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCCCC
Confidence            999999999887653  45999999999999999999999999  99999999999998 6789999999999765433 


Q ss_pred             CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHH---HHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      ......|++.|+|||++.+ .++.++||||+||++|+|++|+.||.+.....   .+...+...  +...+...++.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  234 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAARS  234 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHHH
Confidence            2344579999999997754 58899999999999999999999998643322   222222222  23345567889999


Q ss_pred             HHHHcCC-CCCCCC-----CHHHHhcCCccccCCCCCccc
Q 016143          261 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVC  294 (394)
Q Consensus       261 li~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~~~  294 (394)
                      ||.+||. +|.+||     ++.++++||||...+++.+..
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  274 (285)
T cd05605         235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA  274 (285)
T ss_pred             HHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhh
Confidence            9999998 999999     899999999999877665543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.8e-45  Score=368.96  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=221.2

Q ss_pred             cccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEc
Q 016143           18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD   97 (394)
Q Consensus        18 ~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~   97 (394)
                      ......++| ++.+.||+|+||+||+|.+..+|+.||+|.+.....  +......+.+|+.++..++|+||+++++.+..
T Consensus        26 ~~~~~~~rY-~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~  102 (496)
T PTZ00283         26 TAKEQAKKY-WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK  102 (496)
T ss_pred             cccccCCCE-EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence            334445666 889999999999999999999999999999876543  35566778899999999999999999887653


Q ss_pred             CCC------ceEEEEEcccCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 016143           98 DTN------RTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN  167 (394)
Q Consensus        98 ~~~------~~~~lV~e~~~~gsL~~~i~~~----~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~  167 (394)
                      ...      ..+++||||+.+|+|.+++...    ..+++..+..++.||+.||.|||+++  |+||||||+|||++ .+
T Consensus       103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~-~~  179 (496)
T PTZ00283        103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLC-SN  179 (496)
T ss_pred             ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEe-CC
Confidence            321      2478999999999999998753    45899999999999999999999999  99999999999998 68


Q ss_pred             CcEEEcccceeeeecCC----CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 016143          168 GEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT  242 (394)
Q Consensus       168 ~~~kl~Dfgla~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~  242 (394)
                      +.+||+|||+++.....    .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+...++..+.
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~  258 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTL  258 (496)
T ss_pred             CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHh
Confidence            89999999999765432    2345679999999998765 589999999999999999999999976 56666666666


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      .+..+ .++...++++++++.+||. +|.+||++.++|+|||++..
T Consensus       259 ~~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        259 AGRYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             cCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            65433 3556678999999999998 99999999999999998753

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-44  Score=342.34  Aligned_cols=252  Identities=28%  Similarity=0.424  Sum_probs=199.3

Q ss_pred             ccccceecccCceEEEEEEEcc-CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC---CCCCceeEeeeEEc---CC
Q 016143           27 GRYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVD---DT   99 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L---~hpnIv~~~~~~~~---~~   99 (394)
                      |++.+.||+|+||+||+|.+.. ++..||+|.+......  ......+.+|+.+++.+   +||||+++++++..   +.
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3778999999999999999854 4788999998754322  12223455677776665   69999999998753   23


Q ss_pred             CceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143          100 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                      ...+++||||+. ++|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEccccc
Confidence            456899999996 6899998764  45899999999999999999999999  99999999999998 688999999999


Q ss_pred             eeeecCC-CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC--CCCCC----
Q 016143          178 AIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPAS----  249 (394)
Q Consensus       178 a~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~--~~~~~----  249 (394)
                      +...... ......||+.|+|||++. ..++.++|||||||++|||++|.+||.+......+...+...  ..+..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            9766543 234567999999999775 468999999999999999999999998755444333332110  00000    


Q ss_pred             ------------------CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          250 ------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       250 ------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                        +....++.+++++.+||+ +|.+||++.++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              112357788999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-44  Score=349.48  Aligned_cols=259  Identities=19%  Similarity=0.355  Sum_probs=212.5

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+++.||+|.+...... .....+.+.+|+.++..++|+||+++++++.++  ..+++|
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~lv   79 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDE--NYLYLV   79 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEE
Confidence            37789999999999999999999999999998753321 234455678899999999999999999988544  578999


Q ss_pred             EcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccCCC
Confidence            999999999999987 467999999999999999999999999  99999999999998 78899999999997665432


Q ss_pred             C---cccccCCcccCcccccc------cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC---CC
Q 016143          186 A---RSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS---KV  253 (394)
Q Consensus       186 ~---~~~~gt~~y~aPE~l~~------~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~---~~  253 (394)
                      .   ....||+.|+|||++.+      .++.++|||||||++|+|++|+.||.. .+..+.+..+........++   ..
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~  235 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHITD  235 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCcccc
Confidence            2   23569999999998763      478899999999999999999999976 45555666655432211122   23


Q ss_pred             CCHHHHHHHHHcCCCCCC---CCCHHHHhcCCccccCCCCCc
Q 016143          254 TDPQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       254 ~~~~~~~li~~~L~~p~~---R~s~~elL~~p~~~~~~~~~~  292 (394)
                      .+.+++++|.+||..+.+   |+++.++++||||+...+...
T Consensus       236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~  277 (331)
T cd05624         236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI  277 (331)
T ss_pred             CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence            578999999999984333   568999999999998766543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3e-44  Score=349.85  Aligned_cols=248  Identities=27%  Similarity=0.476  Sum_probs=203.6

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|+||+||+|.+..+++.||+|++....   .....+.+.+|+.+++.++|+||+++++++.+  ...+++||
T Consensus        77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~  151 (353)
T PLN00034         77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLL  151 (353)
T ss_pred             hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEEEE
Confidence            55688999999999999999999999999985432   34556778999999999999999999998844  45788999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--C
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~  185 (394)
                      ||+++++|...    ...++..+..++.||+.||.|||+++  |+||||||+|||++ +++.+||+|||++......  .
T Consensus       152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceeccccccc
Confidence            99999998643    34678889999999999999999999  99999999999998 7889999999999766543  2


Q ss_pred             CcccccCCcccCcccccc-----c-CCCcCcchhhhhHHHHHHhcCCCCCCCC--CHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          186 ARSVIGTPEFMAPELYEE-----E-YNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~-----~-~~~~~DIwSlG~il~elltg~~Pf~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      .....||+.|+|||.+..     . .+.++|||||||++|||++|+.||....  +.......+.... +...+...+.+
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  303 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPATASRE  303 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCCccCHH
Confidence            345679999999998743     2 3468999999999999999999997422  2223333333322 23345567889


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +++||.+||. +|.+||++.|+|+||||....
T Consensus       304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            9999999998 999999999999999998753

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-44  Score=353.63  Aligned_cols=255  Identities=30%  Similarity=0.423  Sum_probs=203.9

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC--
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--  100 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~--  100 (394)
                      ..+| ++.+.||+|+||+||+|.+..+|..||+|++....  .......++.+|+.+++.++||||+++++++.....  
T Consensus        20 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          20 LKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhce-EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            4566 77899999999999999999999999999986442  234455678899999999999999999998864432  


Q ss_pred             --ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          101 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       101 --~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                        ..+++||||+.+ +|.+.+.  ..+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~a  170 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA  170 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCCc
Confidence              357899999965 5666654  34899999999999999999999999  99999999999998 7889999999999


Q ss_pred             eeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-------------
Q 016143          179 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------  243 (394)
Q Consensus       179 ~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-------------  243 (394)
                      ...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+..             
T Consensus       171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            755333 3345678999999998765 5899999999999999999999999875433222111100             


Q ss_pred             --------C--CCC----------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          244 --------G--IKP----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       244 --------~--~~~----------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                              .  ..+                .......++++++||.+||. +|.+|||+.|+|+||||..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                    0  000                00112345789999999998 9999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-46  Score=338.24  Aligned_cols=264  Identities=23%  Similarity=0.435  Sum_probs=230.2

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.++||+|.||+|-+++.+.+|+.+|+|++++.-+.. .+....-+.|-++|+..+||.+..+..+|+  .+..+++||
T Consensus       171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ--t~drlCFVM  247 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-KDEVAHTLTENRVLQNCRHPFLTSLKYSFQ--TQDRLCFVM  247 (516)
T ss_pred             hHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-hHHhhhhhhHHHHHHhccCcHHHHhhhhhc--cCceEEEEE
Confidence            45689999999999999999999999999997655444 455666778999999999999999998884  456899999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee--cCCC
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPT  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~--~~~~  185 (394)
                      ||..||.|+-.+.+.+.++++..+.+...|++||.|||+++  ||+||||.+|.|+| .+|++||+|||+++..  ....
T Consensus       248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhcccccce
Confidence            99999999999999999999999999999999999999999  99999999999999 7899999999999644  3445


Q ss_pred             CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK  264 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  264 (394)
                      ..++||||+|+|||++.. .|+.++|+|.+|++||||++|++||.. .+-..++..|..+  ...++...+++++.|+..
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~e--d~kFPr~ls~eAktLLsG  401 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILME--DLKFPRTLSPEAKTLLSG  401 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhh--hccCCccCCHHHHHHHHH
Confidence            778999999999999875 699999999999999999999999987 4445556555543  344677889999999999


Q ss_pred             cCC-CCCCCCC-----HHHHhcCCccccCCCCCcccCCCCCC
Q 016143          265 CIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP  300 (394)
Q Consensus       265 ~L~-~p~~R~s-----~~elL~~p~~~~~~~~~~~~~~~~~p  300 (394)
                      +|. +|.+|+.     |.|+.+|+||...+|.....+.+..|
T Consensus       402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PP  443 (516)
T KOG0690|consen  402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPP  443 (516)
T ss_pred             HhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCC
Confidence            998 8999984     88999999999999988776655444

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.8e-44  Score=348.53  Aligned_cols=259  Identities=18%  Similarity=0.348  Sum_probs=212.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||++.++.++..||+|.+...... .......+.+|+.++..++|+||+++++.+.++  ..+++|
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv   79 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYLV   79 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEEE
Confidence            36789999999999999999999999999998643322 233445678899999999999999999988544  578999


Q ss_pred             EcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheecccCC
Confidence            999999999999987 467999999999999999999999999  99999999999998 78899999999997543321


Q ss_pred             ---CcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC---CCC
Q 016143          186 ---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL---SKV  253 (394)
Q Consensus       186 ---~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~---~~~  253 (394)
                         ....+||+.|+|||++.      +.++.++|||||||++|||++|+.||.. .+..+.+..+........+   ...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~  235 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVTD  235 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCcccc
Confidence               22357999999999774      3478999999999999999999999987 4555666666543221112   234


Q ss_pred             CCHHHHHHHHHcCCC---CCCCCCHHHHhcCCccccCCCCCc
Q 016143          254 TDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       254 ~~~~~~~li~~~L~~---p~~R~s~~elL~~p~~~~~~~~~~  292 (394)
                      .++++++|+++||..   +..|+++.++++||||....+..+
T Consensus       236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~  277 (332)
T cd05623         236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI  277 (332)
T ss_pred             CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHH
Confidence            688999999999973   334689999999999998765543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-44  Score=364.64  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=214.6

Q ss_pred             CCCcccccccceecccCceEEEEEEEccC-CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      +|...-|.+.+.||+|+||.||+|.+..+ +..||+|.+...    .......+.+|+.+|+.++||||+++++++..+ 
T Consensus        63 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-  137 (478)
T PTZ00267         63 NPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSD-  137 (478)
T ss_pred             CCcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-
Confidence            33344468889999999999999998887 788999876433    344556778899999999999999999998654 


Q ss_pred             CceEEEEEcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143          100 NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                       ..+++||||+++|+|.+++..    ...+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+||
T Consensus       138 -~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DF  213 (478)
T PTZ00267        138 -DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDF  213 (478)
T ss_pred             -CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeC
Confidence             578999999999999987754    346899999999999999999999999  99999999999998 7889999999


Q ss_pred             ceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 016143          176 GLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL  250 (394)
Q Consensus       176 gla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~  250 (394)
                      |++.......    ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+..+ .+
T Consensus       214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~-~~  291 (478)
T PTZ00267        214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYD-PF  291 (478)
T ss_pred             cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC-CC
Confidence            9998664432    345679999999998765 589999999999999999999999976 4556666666555332 24


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      +...++.++++|.+||. +|.+||++.++|.|+|++.
T Consensus       292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            45677899999999998 9999999999999999864

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-44  Score=332.68  Aligned_cols=251  Identities=34%  Similarity=0.586  Sum_probs=212.9

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccC-CHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      .+.+.||+|++|.||+|.+..++..||+|.+....... .......+.+|+.++++++||||+++++++.++  ..+++|
T Consensus         5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v   82 (263)
T cd06625           5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETLSIF   82 (263)
T ss_pred             cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeEEEE
Confidence            67899999999999999999999999999987543211 123456788999999999999999999998654  489999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA  186 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~  186 (394)
                      +||+++++|.+++...+.+++..++.++.||+.||.|||+.+  ++||||+|+||+++ +++.++|+|||++........
T Consensus        83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecccccc
Confidence            999999999999998888999999999999999999999999  99999999999998 788999999999975543211


Q ss_pred             -----cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          187 -----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       187 -----~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                           ....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........... +........++...+..+.+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  238 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPQLPSHVSPDARN  238 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH-HhccCCCCCCCccCCHHHHH
Confidence                 33568899999998765 488999999999999999999999987544444433 33333344466778899999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          261 FIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      +|.+||. +|.+||++.++|+||||
T Consensus       239 li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         239 FLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHhhcCcccCCCHHHHhhCCCC
Confidence            9999998 89999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.6e-44  Score=338.49  Aligned_cols=253  Identities=23%  Similarity=0.354  Sum_probs=204.7

Q ss_pred             ecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCC
Q 016143           33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS  112 (394)
Q Consensus        33 LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~  112 (394)
                      ||+|+||+||++.++.+|..||+|.+....... ......+..|+.++++++||||+++++++.+  ...+++||||+.+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g   77 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNG   77 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence            799999999999999999999999986543321 2223445679999999999999999998854  4578999999999


Q ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-Cccc
Q 016143          113 GSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSV  189 (394)
Q Consensus       113 gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-~~~~  189 (394)
                      ++|.+++....  .+++..+..++.||+.||.|||+++  ++||||||+||+++ +++.++|+|||++....... ....
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~  154 (277)
T cd05607          78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQR  154 (277)
T ss_pred             CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeecc
Confidence            99998886543  5899999999999999999999999  99999999999998 78899999999997665432 2345


Q ss_pred             ccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHc
Q 016143          190 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC  265 (394)
Q Consensus       190 ~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~  265 (394)
                      .|++.|+|||.+.+ .++.++|||||||++|+|++|..||.....   ..++.........+. .....++++++++.+|
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~  233 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF  233 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHH
Confidence            68999999997754 589999999999999999999999975332   233333333322211 1235678999999999


Q ss_pred             CC-CCCCCCCH----HHHhcCCccccCCCCCc
Q 016143          266 IV-PASLRLPA----LELLKDPFLVTDNPKDL  292 (394)
Q Consensus       266 L~-~p~~R~s~----~elL~~p~~~~~~~~~~  292 (394)
                      |. +|.+||++    .+++.||||+..++..+
T Consensus       234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~  265 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPRKHEFFKTINFPRL  265 (277)
T ss_pred             hccCHhhCCCCccchhhhhcChhhcCCCHHHH
Confidence            98 99999999    67889999988665443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-46  Score=358.99  Aligned_cols=265  Identities=30%  Similarity=0.511  Sum_probs=227.0

Q ss_pred             CCccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeee
Q 016143           15 GEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS   94 (394)
Q Consensus        15 ~~~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~   94 (394)
                      ..|...||..+|.-+ +-||+|+||.||-|.+..+.+.||||++..+. .++.+..+.+..||+.|++|+|||+|.+.++
T Consensus        17 ~LF~k~DPEklf~dL-rEIGHGSFGAVYfArd~~n~evVAIKKMsySG-KQs~EKWqDIlKEVrFL~~l~HPntieYkgC   94 (948)
T KOG0577|consen   17 DLFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDILKEVRFLRQLRHPNTIEYKGC   94 (948)
T ss_pred             HHHccCCHHHHHHHH-HHhcCCccceeEEeeccCccceeeeeeccccc-cccHHHHHHHHHHHHHHHhccCCCcccccce
Confidence            457778888888655 56999999999999999999999999997654 4556778899999999999999999999999


Q ss_pred             EEcCCCceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143           95 WVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus        95 ~~~~~~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                      |+-++  +.|+||||| -|+-.+++.-+ +++-+-++..|..+.+.||+|||+++  .||||||..|||++ +.|.|||+
T Consensus        95 yLre~--TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKLa  168 (948)
T KOG0577|consen   95 YLREH--TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKLA  168 (948)
T ss_pred             eeccc--hHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeeec
Confidence            98664  678899999 56888888765 46999999999999999999999999  99999999999998 89999999


Q ss_pred             ccceeeeecCCCCcccccCCcccCcccc----cccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 016143          174 DLGLAIVMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS  249 (394)
Q Consensus       174 Dfgla~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~  249 (394)
                      |||.|.....  +.+++|||+|||||++    .|.|+-++||||||++..||...++|+-.......+|. |..+..|.-
T Consensus       169 DFGSAsi~~P--AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-IAQNesPtL  245 (948)
T KOG0577|consen  169 DFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPTL  245 (948)
T ss_pred             cccchhhcCc--hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-HHhcCCCCC
Confidence            9999966543  5678999999999954    36799999999999999999999999866444444444 444444544


Q ss_pred             CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCC
Q 016143          250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK  290 (394)
Q Consensus       250 ~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~  290 (394)
                      ....|+..+++||..||. .|.+|||++++|+|+|.....+.
T Consensus       246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~  287 (948)
T KOG0577|consen  246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPP  287 (948)
T ss_pred             CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence            566788999999999998 78999999999999999876664

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.7e-44  Score=338.72  Aligned_cols=257  Identities=27%  Similarity=0.465  Sum_probs=220.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|++|+||+|.+..+++.||+|.+..... ......+.+.+|+.++++++||||+++++++.+.  ..+++|
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v   79 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLYLV   79 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEEEE
Confidence            4778999999999999999999999999999865433 2234567789999999999999999999988544  578999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA  186 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~  186 (394)
                      |||+.+++|.+++...+.+++..+..++.||+.||.|||+++  ++|+||+|+||+++ .++.+||+|||++...... .
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~-~  155 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR-T  155 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC-C
Confidence            999999999999998888999999999999999999999999  99999999999998 6889999999999766554 3


Q ss_pred             cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHc
Q 016143          187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC  265 (394)
Q Consensus       187 ~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~  265 (394)
                      ....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.. .+.......+..+.  ..++...++.++++|++|
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~  232 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD-DNPIQIYEKILEGK--VRFPSFFSPDAKDLIRNL  232 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC--ccCCccCCHHHHHHHHHH
Confidence            34568999999997654 578899999999999999999999976 44555666665543  234556689999999999


Q ss_pred             CC-CCCCCC-----CHHHHhcCCccccCCCCCcc
Q 016143          266 IV-PASLRL-----PALELLKDPFLVTDNPKDLV  293 (394)
Q Consensus       266 L~-~p~~R~-----s~~elL~~p~~~~~~~~~~~  293 (394)
                      |. +|.+|+     ++.++++||||....+..+.
T Consensus       233 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~  266 (290)
T cd05580         233 LQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALL  266 (290)
T ss_pred             ccCCHHHccCcccCCHHHHHcCcccccCCHHHHh
Confidence            98 899999     89999999999887665543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.2e-44  Score=332.64  Aligned_cols=255  Identities=34%  Similarity=0.570  Sum_probs=214.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeecccc-CCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      |++.+.||+|+||+||+|.+..+|..||+|.+...... ......+.+.+|+.++++++||||+++++++.+.....+++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            36789999999999999999999999999988654322 22345678899999999999999999999887665668889


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      +|||+++++|.+++.+...+++..+..++.|++.||.|||+++  ++|+||||+||+++ .++.++|+|||++...... 
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          84 FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCcccccccccc
Confidence            9999999999999998888999999999999999999999999  99999999999998 7889999999999754321 


Q ss_pred             ----CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          185 ----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       185 ----~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                          ......|+..|+|||.+.+ .++.++|||||||++|+|++|+.||........+.. ..........+...+..+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPVLPPHVSDHCR  239 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH-HhcCCCCCCCchhhCHHHH
Confidence                2334568999999997754 588999999999999999999999987544444433 3333223334556678899


Q ss_pred             HHHHHcCCCCCCCCCHHHHhcCCccc
Q 016143          260 QFIEKCIVPASLRLPALELLKDPFLV  285 (394)
Q Consensus       260 ~li~~~L~~p~~R~s~~elL~~p~~~  285 (394)
                      ++|.+|+.+|.+||+++++++|||+.
T Consensus       240 ~~i~~~l~~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         240 DFLKRIFVEAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHhcChhhCCCHHHHhcCcccC
Confidence            99999999999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.4e-44  Score=377.59  Aligned_cols=261  Identities=25%  Similarity=0.459  Sum_probs=220.1

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.++..||+|.+.....  .......+..|+.+|+.|+|||||+++++|.+.....+
T Consensus        13 ~~Y-eIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         13 NEY-EVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             CCE-EEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            344 788999999999999999999999999999875543  34556778999999999999999999999987777789


Q ss_pred             EEEEcccCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeEecCCCCCcEEEeC---------
Q 016143          104 NMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHN-----PPIIHRDLKCDNIFVNG---------  165 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~----~~l~~~~~~~i~~qil~~L~~LH~~~-----~~ivHrDLkp~NIll~~---------  165 (394)
                      +|||||+.+|+|.+++...    +.+++..++.|+.||+.||.|||+.+     .+|+||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999998753    56999999999999999999999854     24999999999999962         


Q ss_pred             -------CCCcEEEcccceeeeecCC-CCcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCH
Q 016143          166 -------NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNP  234 (394)
Q Consensus       166 -------~~~~~kl~Dfgla~~~~~~-~~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~  234 (394)
                             ..+.+||+|||++...... ......||+.|+|||++.+   .++.++||||||||||+|++|..||....+.
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~  249 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF  249 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence                   1235899999999766443 2345679999999998743   4789999999999999999999999877777


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       235 ~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      .++...+..+...  .....++++.+||..||. +|.+||++.++|.|||++...+
T Consensus       250 ~qli~~lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        250 SQLISELKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             HHHHHHHhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            7777777665322  223457899999999998 9999999999999999986543

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-44  Score=355.83  Aligned_cols=247  Identities=27%  Similarity=0.376  Sum_probs=198.5

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| .+.+.||+|+||.||+|.+..+++.||+|...          ...+.+|+.+|++|+||||++++++|..+  ...
T Consensus        92 ~~y-~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~  158 (391)
T PHA03212         92 AGF-SILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYN--KFT  158 (391)
T ss_pred             CCc-EEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC--Cee
Confidence            344 78899999999999999999999999999643          13467899999999999999999988654  468


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++|+|++. ++|..++.....+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+|.....
T Consensus       159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCccccccc
Confidence            88999994 789999988888999999999999999999999999  99999999999998 788999999999965332


Q ss_pred             ---CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCC-------CHHHHHHHHhc-CCC-----
Q 016143          184 ---PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-------NPAQIYKKVTS-GIK-----  246 (394)
Q Consensus       184 ---~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~-------~~~~~~~~i~~-~~~-----  246 (394)
                         .......||+.|+|||++.+ .|+.++|||||||++|||++|..||.+..       ...++...+.. +..     
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence               22334679999999997764 58999999999999999999998874321       11111111110 000     


Q ss_pred             ---------------------CCCCC-----CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          247 ---------------------PASLS-----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       247 ---------------------~~~~~-----~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                           +...+     ...+.++.+||.+||. +|.+|||+.|+|+||||+..
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                                 00000     1134578999999998 99999999999999999864

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.9e-45  Score=339.10  Aligned_cols=251  Identities=32%  Similarity=0.587  Sum_probs=207.8

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.++..||+|.+.....  .........+|+.++++++||||+++++++.+  ...+++|
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v   76 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIV   76 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhccccccccccccccccccc--ccccccc
Confidence            4789999999999999999999999999999986543  12233345669999999999999999999866  4578899


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee--cCC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~--~~~  184 (394)
                      |||+.+++|.+++...+.+++..+..++.||+.||.+||+++  ++|+||||+||+++ +++.++|+|||++...  ...
T Consensus        77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccccccccccccccccccccc
Confidence            999999999999998788999999999999999999999999  99999999999999 7899999999999763  233


Q ss_pred             CCcccccCCcccCccccc--ccCCCcCcchhhhhHHHHHHhcCCCCCCCC--CHHHHHHHHhcCCCCCCCC--CCCCHHH
Q 016143          185 TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLS--KVTDPQV  258 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~--~~~~~~~DIwSlG~il~elltg~~Pf~~~~--~~~~~~~~i~~~~~~~~~~--~~~~~~~  258 (394)
                      ......+++.|+|||++.  ..++.++||||||+++|+|++|..||....  +.............+....  ...+.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL  233 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence            345567899999999887  458899999999999999999999998752  2223333222211111111  1123799


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          259 KQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .++|++||. +|.+||++.++++||||
T Consensus       234 ~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  234 RDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            999999998 99999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-43  Score=331.69  Aligned_cols=254  Identities=34%  Similarity=0.571  Sum_probs=213.2

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeecccc-CCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      ++.+.||+|+||.||+|.+..++..||+|.+...... ...+..+.+.+|+.+++.++||||+++++++.+.....++++
T Consensus         5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~   84 (266)
T cd06651           5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF   84 (266)
T ss_pred             cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence            6779999999999999999999999999988654321 123456778899999999999999999998876666788999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      +||+.+++|.+++...+.+++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++......  
T Consensus        85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCCCccccccccc
Confidence            999999999999998888999999999999999999999999  99999999999998 6889999999998755321  


Q ss_pred             ---CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          185 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       185 ---~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                         ......++..|+|||.+.+ .++.++|||||||++|+|++|+.||........+.+..... ....++...++.+++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  240 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-TNPQLPSHISEHARD  240 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-CCCCCchhcCHHHHH
Confidence               1233458899999997765 47899999999999999999999998755544444433332 234456667889999


Q ss_pred             HHHHcCCCCCCCCCHHHHhcCCccc
Q 016143          261 FIEKCIVPASLRLPALELLKDPFLV  285 (394)
Q Consensus       261 li~~~L~~p~~R~s~~elL~~p~~~  285 (394)
                      ++..|+.+|.+||++.|+++||||+
T Consensus       241 li~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         241 FLGCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHhcCChhhCcCHHHHhcCcccc
Confidence            9965455999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.4e-44  Score=351.90  Aligned_cols=254  Identities=29%  Similarity=0.430  Sum_probs=207.5

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC---ceEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTIN  104 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~---~~~~  104 (394)
                      .+.+.||+|+||+||+|.+..+|..||+|.+...  ........++.+|+.+++.++||||+++++++.+...   ..++
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            5678999999999999999999999999987532  1233455678899999999999999999998865431   2688


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      +||||+. ++|.+++.....+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++......
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeecccC
Confidence            9999996 689998888888999999999999999999999999  99999999999998 7889999999999765433


Q ss_pred             C---CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc----------------
Q 016143          185 T---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----------------  243 (394)
Q Consensus       185 ~---~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~----------------  243 (394)
                      .   .....+|+.|+|||++.+  .++.++|||||||++|||++|+.||.+.. ..+....+..                
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS-PIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            2   234568999999998765  37899999999999999999999997743 3322222211                


Q ss_pred             --------CCCCC------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          244 --------GIKPA------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       244 --------~~~~~------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                              ...+.      .+....++++.+||.+||. +|.+||++.|+|.||||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                    11111      1223457899999999998 999999999999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.3e-44  Score=348.31  Aligned_cols=248  Identities=24%  Similarity=0.403  Sum_probs=202.4

Q ss_pred             cccccccceecccCceEEEEEEE-----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD   97 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~   97 (394)
                      +|| ++.+.||+|+||+||+|.+     ..++..||+|++....   .......+.+|+.+|+.+ +||||+++++++..
T Consensus         7 ~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           7 DRL-RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             hHc-eeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            455 8889999999999999975     3456789999886322   244556789999999999 89999999998754


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhC-------------------------------------------------------
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKH-------------------------------------------------------  122 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~-------------------------------------------------------  122 (394)
                      . +..+++||||+++|+|.+++...                                                       
T Consensus        83 ~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          83 P-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             C-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            3 34688999999999999998753                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC----Cccccc
Q 016143          123 -------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIG  191 (394)
Q Consensus       123 -------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~g  191 (394)
                             ..+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+++......    .....+
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCCCC
Confidence                   23778899999999999999999999  99999999999998 68899999999997653321    123346


Q ss_pred             CCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-C
Q 016143          192 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P  268 (394)
Q Consensus       192 t~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~  268 (394)
                      ++.|+|||++. ..++.++|||||||++|||++ |..||.+......+...+..+..+ ..+...++.+.+++.+||. +
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~d  317 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQGD  317 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHccCC
Confidence            78899999765 458999999999999999997 999998755445555555555332 2455678899999999998 9


Q ss_pred             CCCCCCHHHHhc
Q 016143          269 ASLRLPALELLK  280 (394)
Q Consensus       269 p~~R~s~~elL~  280 (394)
                      |.+||++.++++
T Consensus       318 p~~RPs~~el~~  329 (338)
T cd05102         318 PKERPTFSALVE  329 (338)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.7e-44  Score=337.55  Aligned_cols=242  Identities=22%  Similarity=0.318  Sum_probs=206.3

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEc--CCCceEEEEEc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD--DTNRTINMITE  108 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~--~~~~~~~lV~e  108 (394)
                      ..||+|+++.||+|.+  +|..||+|.+..... ......+.+.+|+.+|++++||||+++++++.+  +....+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            5699999999999986  689999999875432 233446778899999999999999999999876  44567899999


Q ss_pred             ccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCc
Q 016143          109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR  187 (394)
Q Consensus       109 ~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~-~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~  187 (394)
                      |+++|+|.+++.+.+.+++.....++.|++.||.|||+. +  ++||||||+||+++ +++.+||+|||++....... .
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~~-~  178 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSPP-F  178 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhcccc-c
Confidence            999999999999888899999999999999999999985 7  88999999999998 78999999999997654432 3


Q ss_pred             ccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 016143          188 SVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK  264 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  264 (394)
                      ...||+.|+|||++.+   .|+.++|||||||++|||++|+.||.+ .+..+++..+..+.....++...++++++|+.+
T Consensus       179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~  257 (283)
T PHA02988        179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA  257 (283)
T ss_pred             cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence            4568999999998764   689999999999999999999999987 455666666654433344555678899999999


Q ss_pred             cCC-CCCCCCCHHHHhc
Q 016143          265 CIV-PASLRLPALELLK  280 (394)
Q Consensus       265 ~L~-~p~~R~s~~elL~  280 (394)
                      ||+ +|.+||++.+++.
T Consensus       258 cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        258 CTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HhcCCcccCcCHHHHHH
Confidence            998 9999999999986

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.3e-44  Score=338.02  Aligned_cols=251  Identities=29%  Similarity=0.409  Sum_probs=199.0

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC---CCCCceeEeeeEEcC---CCc
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDD---TNR  101 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L---~hpnIv~~~~~~~~~---~~~  101 (394)
                      ++.+.||+|+||+||+|.++.+|..||+|.+.......  .....+.+|+.+++.+   +||||+++++++.+.   ...
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            67899999999999999999999999999987543211  1122345566666655   799999999987643   235


Q ss_pred             eEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          102 TINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      .+++|+||+. ++|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+||+++ +++.+||+|||++.
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccCccc
Confidence            6889999997 5898888764  34899999999999999999999999  99999999999998 78899999999997


Q ss_pred             eecCCC-CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC--CCC--------
Q 016143          180 VMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP--------  247 (394)
Q Consensus       180 ~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~--~~~--------  247 (394)
                      ...... .....||+.|+|||++. ..++.++|||||||++|+|++|.+||........+.+.+...  ...        
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            665432 34467899999999775 468999999999999999999999997754443333322110  000        


Q ss_pred             --------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          248 --------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       248 --------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                    .......+..++++|.+||. +|.+||++.++|.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                          01112356788999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.2e-44  Score=333.93  Aligned_cols=255  Identities=29%  Similarity=0.539  Sum_probs=210.9

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD   98 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~   98 (394)
                      .+|.|+| ++.+.||+|+||.||+|.+..+++.||+|.+....     .....+.+|+.+++.+ +|+||+++++++...
T Consensus         2 ~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (272)
T cd06637           2 RDPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   75 (272)
T ss_pred             CChhhhh-hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence            3678888 77899999999999999999999999999986432     2235677899999999 799999999988754


Q ss_pred             C----CceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 016143           99 T----NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI  172 (394)
Q Consensus        99 ~----~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl  172 (394)
                      .    ...+++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+++  |+||||||+||+++ +++.+||
T Consensus        76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~-~~~~~~l  152 (272)
T cd06637          76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKL  152 (272)
T ss_pred             CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEEC-CCCCEEE
Confidence            2    24688999999999999998864  35899999999999999999999999  99999999999998 7889999


Q ss_pred             cccceeeeecCC--CCcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 016143          173 GDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG  244 (394)
Q Consensus       173 ~Dfgla~~~~~~--~~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~  244 (394)
                      +|||++......  ......|++.|+|||++.      ..++.++|||||||++|+|++|..||..... ......+...
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-~~~~~~~~~~  231 (272)
T cd06637         153 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-MRALFLIPRN  231 (272)
T ss_pred             ccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-HHHHHHHhcC
Confidence            999999765432  234467899999999774      2478899999999999999999999976443 3333333333


Q ss_pred             CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       245 ~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      ..+.......+..+++|+.+||. +|.+||++.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            22333344567899999999998 99999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.2e-44  Score=333.24  Aligned_cols=252  Identities=27%  Similarity=0.489  Sum_probs=209.1

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +.++| ++.+.||+|+||.||+|.+..++..||+|.++...    ......+.+|+.+++.++||||+++++++.+.  .
T Consensus         7 ~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~   79 (267)
T cd06645           7 PQEDF-ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--D   79 (267)
T ss_pred             cHHHH-HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--C
Confidence            33455 77899999999999999999999999999986542    23445678899999999999999999988654  5


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .+++||||+++++|.+++...+.+++.+++.++.||+.||.|||++|  ++|+||||+||+++ .++.+||+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~  156 (267)
T cd06645          80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVSAQI  156 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceeeeEc
Confidence            78899999999999999998889999999999999999999999999  99999999999998 6889999999999765


Q ss_pred             cCCC--CcccccCCcccCccccc----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC--CC
Q 016143          182 QQPT--ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KV  253 (394)
Q Consensus       182 ~~~~--~~~~~gt~~y~aPE~l~----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~  253 (394)
                      ....  .....|++.|+|||.+.    +.++.++|||||||++|+|++|..||..................+..+.  ..
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06645         157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK  236 (267)
T ss_pred             cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCC
Confidence            4332  23457999999999763    3488899999999999999999999976443333333333332222222  23


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCc
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPF  283 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~  283 (394)
                      ++..++++|.+||. +|.+||++.+++.|||
T Consensus       237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         237 WSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            56789999999998 8999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-47  Score=341.84  Aligned_cols=252  Identities=28%  Similarity=0.514  Sum_probs=217.7

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.++||+|+||.||+|.|+.+|..+|||++..+      ..++.+.+|+.+|++++.|++|++|++|+...  -+|+||
T Consensus        36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--DLWIVM  107 (502)
T KOG0574|consen   36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--DLWIVM  107 (502)
T ss_pred             HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCC--ceEeeh
Confidence            5668899999999999999999999999998753      36678899999999999999999999987654  588999


Q ss_pred             cccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          108 ELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      |||..|+..+.++. ++.|+++++..+++.-+.||+|||...  -+|||||..|||++ .+|..||+|||.|.++.... 
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLN-TDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEc-ccchhhhhhccccchhhhhHH
Confidence            99999999998875 467999999999999999999999988  89999999999999 78999999999998887663 


Q ss_pred             -CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCCHHHHHHH
Q 016143          186 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFI  262 (394)
Q Consensus       186 -~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~li  262 (394)
                       ..+++|||.|||||++.. .|+.++||||||++..||..|++||.+ ..+......|-..++| ..-+..++.+.-+||
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD-IHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD-IHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI  263 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc-ccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence             457899999999998876 699999999999999999999999987 4444333333333222 223456788999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCccccCCCCC
Q 016143          263 EKCIV-PASLRLPALELLKDPFLVTDNPKD  291 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~~~~~~~~  291 (394)
                      ++||. +|.+|-+|.++++|||+++...-.
T Consensus       264 ~~CLiK~PE~R~TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  264 RSCLIKKPEERKTALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             HHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence            99998 899999999999999999876543

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.9e-44  Score=350.11  Aligned_cols=255  Identities=29%  Similarity=0.399  Sum_probs=204.3

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC---
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---   99 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~---   99 (394)
                      .++| ++.+.||+|+||+||+|.+..++..||+|.+....  .......++.+|+.+++.++||||++++++|....   
T Consensus        16 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          16 LKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhce-eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            4566 77899999999999999999999999999886432  23445677889999999999999999999886432   


Q ss_pred             -CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 -NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 -~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                       ...+++||||+.+ +|.+.+..  .+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~~  166 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA  166 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCccc
Confidence             2357899999965 67666653  4899999999999999999999999  99999999999998 7889999999999


Q ss_pred             eeecCCC-CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-------------
Q 016143          179 IVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------  243 (394)
Q Consensus       179 ~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-------------  243 (394)
                      ....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+..             
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence            7654442 345679999999998765 5899999999999999999999999864332222111110             


Q ss_pred             ---------CCC------C-----------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          244 ---------GIK------P-----------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       244 ---------~~~------~-----------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                               ...      +           .......+.++++||.+||. +|.+|||+.|+|+||||..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence                     000      0           01112235678999999998 9999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.7e-44  Score=349.30  Aligned_cols=254  Identities=29%  Similarity=0.410  Sum_probs=204.4

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC---
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---   99 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~---   99 (394)
                      .++| ++.+.||+|+||+||+|.+..++..||+|++....  ........+.+|+.+++.++||||+++++++....   
T Consensus        23 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          23 LKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hcce-eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence            4566 77899999999999999999999999999986432  23445567889999999999999999999875432   


Q ss_pred             -CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 -NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 -~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                       ...+++||||+. ++|.+++..  .+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a  173 (364)
T cd07875         100 EFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA  173 (364)
T ss_pred             ccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCCc
Confidence             246899999996 477777754  4889999999999999999999999  99999999999998 7889999999999


Q ss_pred             eeecCCC-CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC----------
Q 016143          179 IVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----------  246 (394)
Q Consensus       179 ~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~----------  246 (394)
                      ....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..... .+..+.....          
T Consensus       174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhh
Confidence            7654432 345679999999997765 58999999999999999999999998744333 2222211000          


Q ss_pred             -----------C-------------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          247 -----------P-------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       247 -----------~-------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                                 +                   .......+.++++||.+||. +|.+|||+.++|+||||..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                       0                   00111234678999999998 9999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.6e-44  Score=342.30  Aligned_cols=246  Identities=26%  Similarity=0.425  Sum_probs=193.4

Q ss_pred             cceecccCceEEEEEEEc--cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           30 DEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +++||+|+||+||+|.++  .++..||+|.+.....      ...+.+|+.+|++++||||++++++|.......++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            468999999999999865  4678999998864321      23467899999999999999999999877777899999


Q ss_pred             cccCCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe---CCCCcEEEccc
Q 016143          108 ELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDL  175 (394)
Q Consensus       108 e~~~~gsL~~~i~~~---------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~---~~~~~~kl~Df  175 (394)
                      ||+. ++|..++...         ..+++..++.++.||+.||.|||+++  |+||||||+|||++   ..++.+||+||
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            9985 5888887632         24899999999999999999999999  99999999999994   24578999999


Q ss_pred             ceeeeecCC-----CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCH---------HHHHH
Q 016143          176 GLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------AQIYK  239 (394)
Q Consensus       176 gla~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~---------~~~~~  239 (394)
                      |++......     ......||+.|+|||++.+  .++.++||||+||++|+|++|++||....+.         .++..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            999765433     2335678999999997754  4889999999999999999999999643211         11111


Q ss_pred             HHhcCCCC-----------------------------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCc
Q 016143          240 KVTSGIKP-----------------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  283 (394)
Q Consensus       240 ~i~~~~~~-----------------------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~  283 (394)
                      .+.....+                                   .......+..+.+||.+||. ||.+|+|+.|+|+|||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~  316 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  316 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            11100000                                   00011235678999999998 9999999999999999


Q ss_pred             c
Q 016143          284 L  284 (394)
Q Consensus       284 ~  284 (394)
                      |
T Consensus       317 f  317 (317)
T cd07868         317 F  317 (317)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.8e-44  Score=345.79  Aligned_cols=255  Identities=29%  Similarity=0.436  Sum_probs=205.1

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC---
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---   99 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~---   99 (394)
                      ..+| ++.+.||+|+||+||+|.+..++..||+|++....  ......+.+.+|+.+|++++||||++++++|....   
T Consensus        14 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          14 PERY-QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhh-hhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            3566 67799999999999999999999999999986432  12334566788999999999999999999875432   


Q ss_pred             -CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 -NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 -~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                       ...++++++++ +++|.++++. ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~  165 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLA  165 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcCCccc
Confidence             23578999988 7899888765 45999999999999999999999999  99999999999998 7889999999999


Q ss_pred             eeecCCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC--CC--------
Q 016143          179 IVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IK--------  246 (394)
Q Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~--~~--------  246 (394)
                      ...... .....||+.|+|||++.+  .++.++|||||||++|+|++|..||.+..... ....+...  ..        
T Consensus       166 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         166 RQADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             eecCCC-cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhc
Confidence            766543 345679999999998765  48899999999999999999999997643322 22222110  00        


Q ss_pred             ---------------C-C---CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          247 ---------------P-A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       247 ---------------~-~---~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                     + .   ......++.+.+||.+||. +|.+|||+.|+|.||||...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence                           0 0   0012345678999999998 99999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.9e-44  Score=336.70  Aligned_cols=256  Identities=22%  Similarity=0.374  Sum_probs=209.8

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +..+.||+|+||+||+|.+..+++.||+|.+..... ........+.+|+.+++.++|+||+++++.+.+.  ..+++||
T Consensus         3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~   79 (285)
T cd05630           3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVL   79 (285)
T ss_pred             eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc-cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEEE
Confidence            456889999999999999999999999999875433 2233445677899999999999999999988544  5789999


Q ss_pred             cccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      ||+.+++|.+++...  ..+++.++..++.|++.||.|||+++  |+||||||+||+++ .++.++|+|||++...... 
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecCCCc
Confidence            999999999988654  35999999999999999999999999  99999999999998 6789999999999765432 


Q ss_pred             CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHH--HHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA--QIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                      ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.......  .....+.... +...+...++++++|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  235 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-QEEYSEKFSPDARSL  235 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-hhhcCccCCHHHHHH
Confidence            2334579999999997764 58899999999999999999999997643321  1122222211 223455678899999


Q ss_pred             HHHcCC-CCCCCCC-----HHHHhcCCccccCCCC
Q 016143          262 IEKCIV-PASLRLP-----ALELLKDPFLVTDNPK  290 (394)
Q Consensus       262 i~~~L~-~p~~R~s-----~~elL~~p~~~~~~~~  290 (394)
                      +.+||+ +|.+|++     +.|+++||||+.....
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence            999998 9999999     9999999999876544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-44  Score=334.59  Aligned_cols=256  Identities=31%  Similarity=0.556  Sum_probs=215.7

Q ss_pred             CCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      +|..+| .+.+.||+|++|+||+|.+..++..||+|.+...    .....+.+.+|+.++++++||||+++++.+.++  
T Consensus         2 ~~~~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   74 (280)
T cd06611           2 NPNDIW-EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE--   74 (280)
T ss_pred             CchhHH-HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--
Confidence            567777 7888999999999999999889999999998643    345667788999999999999999999988643  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ..+++||||+++++|..++.+. ..+++..++.++.|++.||.|||+++  |+|+||||+||+++ .++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~~  151 (280)
T cd06611          75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSA  151 (280)
T ss_pred             CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEC-CCCCEEEccCccch
Confidence            5789999999999999998774 46999999999999999999999999  99999999999998 78899999999986


Q ss_pred             eecCC--CCcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CCC
Q 016143          180 VMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASL  250 (394)
Q Consensus       180 ~~~~~--~~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-~~~  250 (394)
                      .....  ......|++.|+|||.+.      ..++.++||||||+++|+|++|+.||... +.......+..+..+ ...
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~  230 (280)
T cd06611         152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQ  230 (280)
T ss_pred             hhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCC
Confidence            54432  223456899999999764      23677999999999999999999999774 444555555554332 223


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      +..++.++.++|.+||. +|.+||++.++|+||||...
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            44577899999999998 89999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.2e-43  Score=334.48  Aligned_cols=253  Identities=23%  Similarity=0.377  Sum_probs=203.9

Q ss_pred             eecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHH---HHcCCCCCceeEeeeEEcCCCceEEEEEc
Q 016143           32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL---LKSLKHENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        32 ~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~---l~~L~hpnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      +||+|+||.||+|.+..++..||+|.+........ .......+|..+   +...+||||+.+++++..+  ...++|||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e   77 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILD   77 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEe
Confidence            48999999999999999999999999875443222 222223444433   4445799999999988544  46889999


Q ss_pred             ccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCcc
Q 016143          109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS  188 (394)
Q Consensus       109 ~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~  188 (394)
                      |+.+++|.+++..++.+++..+..++.||+.||.|||+++  ++||||||+||+++ .++.++|+|||++..........
T Consensus        78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~  154 (279)
T cd05633          78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA  154 (279)
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccCccC
Confidence            9999999999998888999999999999999999999999  99999999999998 78899999999997665444445


Q ss_pred             cccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCC--HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 016143          189 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIEK  264 (394)
Q Consensus       189 ~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  264 (394)
                      ..||+.|+|||.+.+  .++.++||||+||++|+|++|..||.....  ...+.....  ..+..++...+++++++|++
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~  232 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TVNVELPDSFSPELKSLLEG  232 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--cCCcCCccccCHHHHHHHHH
Confidence            579999999997753  478999999999999999999999975332  222222211  12334556678999999999


Q ss_pred             cCC-CCCCCC-----CHHHHhcCCccccCCCCCc
Q 016143          265 CIV-PASLRL-----PALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       265 ~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~  292 (394)
                      ||. +|.+|+     ++.++++||||+..++...
T Consensus       233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~  266 (279)
T cd05633         233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV  266 (279)
T ss_pred             HhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence            998 999999     6999999999998776544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.9e-43  Score=337.80  Aligned_cols=252  Identities=28%  Similarity=0.448  Sum_probs=210.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||.||+|.+..++..+|+|.+....   ......++.+|+.++++++||||+++++++.++  ..+++|
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv   77 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISIC   77 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEEE
Confidence            477899999999999999999999999999886432   245566788999999999999999999998654  578999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |||+++++|.+++.+.+.+++..+..++.||+.||.|||+ ++  ++||||||+||+++ .++.+||+|||++.......
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEe-cCCcEEEccCCCcccccccc
Confidence            9999999999999988889999999999999999999997 57  99999999999998 68899999999997665554


Q ss_pred             CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc---------------------
Q 016143          186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---------------------  243 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~---------------------  243 (394)
                      .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... .......+..                     
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            556779999999998765 48899999999999999999999996532 2222222211                     


Q ss_pred             ---------------CCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          244 ---------------GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       244 ---------------~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                     ...+.......+.++++|+.+||. +|++||++.++++||||...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                           111111112357789999999998 99999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.3e-44  Score=350.48  Aligned_cols=249  Identities=27%  Similarity=0.463  Sum_probs=207.6

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CC-----CceeEeeeEEcCCCc
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HE-----NIIKFYNSWVDDTNR  101 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hp-----nIv~~~~~~~~~~~~  101 (394)
                      -+.++||+|+||.|-+|.+..|++.||||+++..     .....+...|+++|..|+ |.     |+|+++++|...  +
T Consensus       189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr--~  261 (586)
T KOG0667|consen  189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR--N  261 (586)
T ss_pred             EEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--c
Confidence            5589999999999999999999999999999743     456677788999999997 43     899999999554  5


Q ss_pred             eEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEccccee
Q 016143          102 TINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLA  178 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~-~~~~~kl~Dfgla  178 (394)
                      +++||+|.+ +.+|.++++.+  .+++...++.++.||+.||.+||+.+  |||+||||+||||.. ....+||+|||.|
T Consensus       262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccc
Confidence            799999999 67999999976  46999999999999999999999999  999999999999962 2347999999999


Q ss_pred             eeecCCCCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCC--------
Q 016143          179 IVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA--------  248 (394)
Q Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~~~~--------  248 (394)
                      +....... +++-+..|.|||++- .+|+.++||||||||++||++|.+.|.+....+|+...+.- |.+|.        
T Consensus       339 c~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  339 CFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             cccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            87776655 788899999999655 57999999999999999999999999986666666544320 11110        


Q ss_pred             --------------------------------------------C-------CCCCCCHHHHHHHHHcCC-CCCCCCCHH
Q 016143          249 --------------------------------------------S-------LSKVTDPQVKQFIEKCIV-PASLRLPAL  276 (394)
Q Consensus       249 --------------------------------------------~-------~~~~~~~~~~~li~~~L~-~p~~R~s~~  276 (394)
                                                                  .       +....+..+.+||++||. ||.+|+|+.
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence                                                        0       001123467999999998 999999999


Q ss_pred             HHhcCCccccC
Q 016143          277 ELLKDPFLVTD  287 (394)
Q Consensus       277 elL~~p~~~~~  287 (394)
                      ++|+||||...
T Consensus       498 qal~Hpfl~~~  508 (586)
T KOG0667|consen  498 QALNHPFLTGT  508 (586)
T ss_pred             HHhcCcccccc
Confidence            99999999853

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7.1e-44  Score=359.90  Aligned_cols=255  Identities=20%  Similarity=0.325  Sum_probs=197.1

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC------CCceeEeeeEEc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH------ENIIKFYNSWVD   97 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h------pnIv~~~~~~~~   97 (394)
                      ++| ++.+.||+|+||+||+|.+..++..||+|+++..     .........|+.+++.++|      .++++++++|..
T Consensus       129 ~~y-~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        129 QRF-KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             CcE-EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            444 7889999999999999999999999999998632     1223344556777666654      568889888765


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCC---------
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNN---------  167 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~---------  167 (394)
                      + ...+++|||++ +++|.+++.+++.+++..++.++.||+.||.|||+ .|  |+||||||+|||++..+         
T Consensus       203 ~-~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        203 E-TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             C-CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccccccc
Confidence            4 34788999988 78999999888889999999999999999999998 48  99999999999998322         


Q ss_pred             ------CcEEEcccceeeeecCCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHH
Q 016143          168 ------GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK  240 (394)
Q Consensus       168 ------~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~  240 (394)
                            +.+||+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+..+...+...
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  357 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM  357 (467)
T ss_pred             ccCCCCceEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence                  1599999998854332 2345679999999997765 5999999999999999999999999875443322211


Q ss_pred             Hhc-CCCCCCC--------------------------------------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          241 VTS-GIKPASL--------------------------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       241 i~~-~~~~~~~--------------------------------------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ... +..|..+                                      ....++.+.+||.+||. ||.+||++.|+|+
T Consensus       358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            110 1000000                                      01124567899999998 9999999999999


Q ss_pred             CCccccCCC
Q 016143          281 DPFLVTDNP  289 (394)
Q Consensus       281 ~p~~~~~~~  289 (394)
                      ||||....+
T Consensus       438 Hp~~~~~~~  446 (467)
T PTZ00284        438 HPYVLKYYP  446 (467)
T ss_pred             CccccccCC
Confidence            999987543

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.5e-43  Score=332.93  Aligned_cols=258  Identities=29%  Similarity=0.492  Sum_probs=214.5

Q ss_pred             CCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      +|.+.| ++.+.||+|+||.||+|.+..++..||+|.+...    .....+.+.+|+.+++.++||||+++++.+..+  
T Consensus         9 ~~~~~y-~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   81 (292)
T cd06644           9 DPNEVW-EIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD--   81 (292)
T ss_pred             Ccchhh-hhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--
Confidence            444555 8899999999999999999999999999998643    355677888999999999999999999988654  


Q ss_pred             ceEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          101 RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ..+++||||+++++|..++.+ ...+++..+..++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++.
T Consensus        82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~  158 (292)
T cd06644          82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSA  158 (292)
T ss_pred             CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEc-CCCCEEEccCccce
Confidence            478899999999999988764 456899999999999999999999999  99999999999998 68899999999986


Q ss_pred             eecCC--CCcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CCC
Q 016143          180 VMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASL  250 (394)
Q Consensus       180 ~~~~~--~~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-~~~  250 (394)
                      .....  ......+++.|+|||.+.      ..++.++|||||||++|+|++|..||... +....+..+.....+ ...
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~  237 (292)
T cd06644         159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLSQ  237 (292)
T ss_pred             eccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhcCCCccCCC
Confidence            54332  223456899999999763      23678999999999999999999999763 344444444443322 233


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +...+.++.++|.+||. +|.+||++.++++||||....+
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            45567899999999998 9999999999999999987554

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.9e-44  Score=339.97  Aligned_cols=254  Identities=27%  Similarity=0.422  Sum_probs=203.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      .+| ++.+.||+|+||+||+|.++.++..||+|.+.....   ......+.+|+.++++++||||+++++++.++  ...
T Consensus         6 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   79 (309)
T cd07872           6 ETY-IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSL   79 (309)
T ss_pred             Cce-EEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeE
Confidence            445 778999999999999999999999999999875432   22234567899999999999999999988654  468


Q ss_pred             EEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++....
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          80 TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKS  155 (309)
T ss_pred             EEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECccccceecC
Confidence            899999975 888877654 45899999999999999999999999  99999999999998 68899999999997654


Q ss_pred             CC--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC---CC---------
Q 016143          183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IK---------  246 (394)
Q Consensus       183 ~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~---~~---------  246 (394)
                      ..  ......+|+.|+|||++.+  .++.++|||||||++|+|+||+.||.+....+. ...+...   ..         
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcc
Confidence            33  2234568999999997754  478999999999999999999999977443322 2211110   00         


Q ss_pred             ---------CC-------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          247 ---------PA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       247 ---------~~-------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                               +.       ......+++++++|.+||. +|.+|+|+.|+|+||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                     00       0112357789999999998 999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.9e-43  Score=335.91  Aligned_cols=261  Identities=30%  Similarity=0.513  Sum_probs=217.5

Q ss_pred             ccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEE
Q 016143           17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV   96 (394)
Q Consensus        17 ~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~   96 (394)
                      ....++..+| ++.+.||+|++|.||+|.+..++..||+|.+.....    ...+.+.+|+.+++.++||||+++++.+.
T Consensus        13 ~~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~   87 (296)
T cd06654          13 VSVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYL   87 (296)
T ss_pred             cccCCcccce-eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4556777777 677899999999999999999999999999875432    33467889999999999999999999886


Q ss_pred             cCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccc
Q 016143           97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG  176 (394)
Q Consensus        97 ~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfg  176 (394)
                      +.  ...++||||+++++|.+++... .+++.++..++.|++.||.|||+++  |+||||||+||+++ .++.+||+|||
T Consensus        88 ~~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~dfg  161 (296)
T cd06654          88 VG--DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFG  161 (296)
T ss_pred             eC--CEEEEeecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECccc
Confidence            54  4789999999999999998754 5899999999999999999999999  99999999999998 78899999999


Q ss_pred             eeeeecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 016143          177 LAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       177 la~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      ++......  ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||...............+..+...+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T cd06654         162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK  241 (296)
T ss_pred             cchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence            98654332  2234568999999997765 47899999999999999999999997744434444443333333334455


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .++.+.+++.+||. +|.+||++.++++||||....
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence            77899999999998 999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.7e-43  Score=324.49  Aligned_cols=250  Identities=28%  Similarity=0.552  Sum_probs=211.8

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|++|.||+|.++.+++.||+|.+.....  .....+.+.+|+.++++++|+|++++++.+.. ....++++
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv   78 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIV   78 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEE
Confidence            3788999999999999999999999999999865432  23455678899999999999999999997743 33578899


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      +||+++++|.+++...  ..+++.+++.++.|++.||.|||+++  ++||||||+||+++ .++.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEeccc
Confidence            9999999999998763  45899999999999999999999999  99999999999998 7889999999999766433


Q ss_pred             --CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          185 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       185 --~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                        ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+..+..+ ..+...++++.++
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  233 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEGKLP-PMPKDYSPELGEL  233 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCC-CCccccCHHHHHH
Confidence              2334568999999997764 588999999999999999999999976 4444555555555433 2455678999999


Q ss_pred             HHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          262 IEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      +.+||. +|.+||++.++++||||
T Consensus       234 i~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         234 IATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHhccCcccCCCHHHHhcCCCC
Confidence            999998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=357.46  Aligned_cols=253  Identities=28%  Similarity=0.467  Sum_probs=215.2

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+..-||-|+||+||+|..+.++..-|-|+|..    ++.+.++.++-|+.||..++||+||++++.|+.++  .++|+.
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~en--kLwili  108 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN--KLWILI  108 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--ceEEEE
Confidence            344558899999999999999988888888863    35788999999999999999999999999876654  588889


Q ss_pred             cccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          108 ELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      |||.||-....+-. ...|++.++..+++|++.||.|||+++  |||||||..|||++ -+|.++|+|||.+......  
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeecccccccchhHHh
Confidence            99999999987654 567999999999999999999999999  99999999999999 7899999999998655433  


Q ss_pred             CCcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          185 TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                      ...+++|||+|||||+..      .+|+.++||||||++|.||..+++|..+......+++...+.++...-+..|+..+
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence            456789999999999653      35999999999999999999999999884443444444444443344567788999


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          259 KQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      ++|+.+||+ +|..||++++||+|||+++...
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence            999999998 9999999999999999996544

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.2e-43  Score=331.15  Aligned_cols=250  Identities=28%  Similarity=0.514  Sum_probs=208.4

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.++||+|+||+||+|.+..++..||+|.+....   .......+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv   77 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISIC   77 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEE
Confidence            367799999999999999999999999999986432   244556788999999999999999999988654  467899


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA  186 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~  186 (394)
                      |||+++++|..+    ..+++..+..++.||+.||.|||+++  |+|+||||+||+++ .++.++|+|||++........
T Consensus        78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~~  150 (279)
T cd06619          78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIA  150 (279)
T ss_pred             EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceecccccc
Confidence            999999999765    34789999999999999999999999  99999999999998 789999999999987766555


Q ss_pred             cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCC------HHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN------PAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       187 ~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ....||+.|+|||.+.+ .++.++|||||||++|+|++|..||.....      .......+.....+.......+++++
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV  230 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence            66789999999997764 588999999999999999999999964221      12333333333222222344678999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          260 QFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ++|.+||. +|.+||++.++++||||+..+
T Consensus       231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         231 HFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            99999998 899999999999999998654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.2e-43  Score=331.25  Aligned_cols=253  Identities=23%  Similarity=0.397  Sum_probs=205.4

Q ss_pred             eecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHH---HHHHHcCCCCCceeEeeeEEcCCCceEEEEEc
Q 016143           32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE---VHLLKSLKHENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        32 ~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E---~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      +||+|+||+||+|.+..+++.||+|.+......... ......+|   +.+++...||||+++++.+.++  ..+++|||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e   77 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILD   77 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch-hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEe
Confidence            489999999999999999999999998765432221 11223333   3455556899999999988544  57889999


Q ss_pred             ccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCcc
Q 016143          109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS  188 (394)
Q Consensus       109 ~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~  188 (394)
                      |+.|++|..++.+.+.+++..++.|+.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++..........
T Consensus        78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~  154 (278)
T cd05606          78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA  154 (278)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC-CCCCEEEccCcCccccCccCCcC
Confidence            9999999999988888999999999999999999999999  99999999999998 67899999999997665544455


Q ss_pred             cccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCC--CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 016143          189 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK  264 (394)
Q Consensus       189 ~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  264 (394)
                      ..|++.|+|||.+.+  .++.++||||+||++|+|++|+.||....  ...........  .+..++...++++.+++.+
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~  232 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEG  232 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHH
Confidence            679999999998763  48899999999999999999999997642  22222222222  1333555678999999999


Q ss_pred             cCC-CCCCCC-----CHHHHhcCCccccCCCCCc
Q 016143          265 CIV-PASLRL-----PALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       265 ~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~  292 (394)
                      ||. +|.+|+     ++.++++||||+...+...
T Consensus       233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~  266 (278)
T cd05606         233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV  266 (278)
T ss_pred             HhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence            998 899999     9999999999998766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-43  Score=326.51  Aligned_cols=254  Identities=31%  Similarity=0.550  Sum_probs=216.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeecccc-CCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      |++.+.||+|+||.||+|.+..++..||+|.+...... ........+.+|+.++++++|+||+++++++.+.....+++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI   83 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence            37889999999999999999999999999987643321 23455678889999999999999999999987766678889


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      ++||+++++|.+++...+.+++..++.++.||+.||.|||+++  ++|+||||+||+++ .++.++|+|||++...... 
T Consensus        84 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          84 FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcccccccccccc
Confidence            9999999999999998888999999999999999999999999  99999999999998 6889999999999765332 


Q ss_pred             ----CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          185 ----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       185 ----~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                          ......|+..|+|||.+.+ .++.++|+|||||++|+|++|+.||.+......+.+... ...+..++...+.+++
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~  239 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT-QPTKPMLPDGVSDACR  239 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc-CCCCCCCCcccCHHHH
Confidence                2234568999999997765 478999999999999999999999987555555544333 3333456677889999


Q ss_pred             HHHHHcCCCCCCCCCHHHHhcCCcc
Q 016143          260 QFIEKCIVPASLRLPALELLKDPFL  284 (394)
Q Consensus       260 ~li~~~L~~p~~R~s~~elL~~p~~  284 (394)
                      ++|.+||+++..||++.+++.|||.
T Consensus       240 ~~i~~~l~~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         240 DFLKQIFVEEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHhcCcccCccHHHHhcCCCC
Confidence            9999999989999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-44  Score=351.26  Aligned_cols=258  Identities=29%  Similarity=0.486  Sum_probs=225.5

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      ..+.| .+...||+|.|++|.+|.+..++.+||||+++++..  .....+.+.+|+++|+.|+|||||++|.+.  +...
T Consensus        54 ~vg~y-~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~--~t~~  128 (596)
T KOG0586|consen   54 SVGLY-VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVI--ETEA  128 (596)
T ss_pred             cccce-eeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeee--eecc
Confidence            33444 788999999999999999999999999999876553  445666799999999999999999999977  4456


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .+|+||||+.+|.+++|+.+++...+..++.++.|+++|++|||+++  |+|||||.+|||++ .+.++||+|||++..+
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~-~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLD-ENMNIKIADFGFSTFF  205 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccc-cccceeeeccccceee
Confidence            89999999999999999999999999999999999999999999999  99999999999999 6788999999999877


Q ss_pred             cCC-CCcccccCCcccCccccccc-C-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          182 QQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       182 ~~~-~~~~~~gt~~y~aPE~l~~~-~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                      ... ...+.+|+|.|.|||++.+. | ++.+|+||+|+++|.|+.|.+||++ .+...+..++..+...  ++...+-++
T Consensus       206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~r--Ip~~ms~dc  282 (596)
T KOG0586|consen  206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYR--IPFYMSCDC  282 (596)
T ss_pred             cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeec--ccceeechh
Confidence            654 57889999999999999874 5 5899999999999999999999987 5555666666665443  345567799


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcCCccccCCCC
Q 016143          259 KQFIEKCIV-PASLRLPALELLKDPFLVTDNPK  290 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~  290 (394)
                      .++|.++|+ +|++|.+.++++.|.|.......
T Consensus       283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            999999998 99999999999999998765443

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.2e-43  Score=329.93  Aligned_cols=252  Identities=28%  Similarity=0.511  Sum_probs=210.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||.||+|.+..++..+++|.+...    .....+.+.+|+.+++.++||||+++++.+...  ...++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v   80 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWIL   80 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEE
Confidence            47778899999999999999999999999988533    345667788999999999999999999988654  478899


Q ss_pred             EcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          107 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      +||+.+++|..++.+ ...+++..+..++.||+.||.|||+.+  ++||||||+||+++ .++.+||+|||++...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEccccccccccccc
Confidence            999999999988765 456999999999999999999999999  99999999999998 7889999999998654332 


Q ss_pred             -CCcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCCCH
Q 016143          185 -TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDP  256 (394)
Q Consensus       185 -~~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~-~~~~~~~~~~  256 (394)
                       ......|++.|+|||++.      ..++.++|||||||++|+|++|..||.... .......+..... ....+..++.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSS  236 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCH
Confidence             233456899999999873      236789999999999999999999997743 4444444433322 2233455778


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ++++||.+||. +|.+||++.++++||||....
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence            99999999998 899999999999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.3e-43  Score=327.98  Aligned_cols=252  Identities=32%  Similarity=0.518  Sum_probs=209.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeecccc--CCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      |++.+.||+|+||+||+|.+ .+|..+|+|.+......  ........+.+|+.++++++|+||+++++++.+.  ..++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   78 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTIS   78 (265)
T ss_pred             ccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEE
Confidence            47789999999999999976 57889999998754321  1234456788999999999999999999988654  6789


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC-
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-  183 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~-  183 (394)
                      +|+||+++++|.+++.+...+++..+..++.||+.||.|||+.+  ++|+||+|+||+++ .++.++|+|||++..... 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhc
Confidence            99999999999999998888999999999999999999999999  99999999999998 788999999999865421 


Q ss_pred             -------CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          184 -------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       184 -------~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                             .......|++.|+|||.+.+ .++.++|||||||++|+|++|..||...................+.++...+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS  235 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence                   11234568999999998765 4789999999999999999999999765444433332222112233556678


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .++.++|.+||. +|.+||++.++|+||||
T Consensus       236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         236 AAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999998 89999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.7e-43  Score=327.78  Aligned_cols=254  Identities=30%  Similarity=0.508  Sum_probs=210.4

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccC--CHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      +..+.||+|++|.||+|.+..++..||+|.+.......  .....+.+.+|+.++++++|+||+++++++.+.  ..+++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~   80 (268)
T cd06630           3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED--SHFNL   80 (268)
T ss_pred             cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--CeEEE
Confidence            66789999999999999999999999999987543211  123567889999999999999999999988544  57889


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |+||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++  ++|+||+|+||+++.++..+||+|||++.......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            9999999999999998888999999999999999999999999  99999999999998544579999999996654331


Q ss_pred             ------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCC--HHHHHHHHhcCCCCCCCCCCCCH
Q 016143          186 ------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       186 ------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~--~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                            .....|+..|+|||.+.+ .++.++||||+|+++|+|++|..||.....  .......+.........+...++
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP  238 (268)
T ss_pred             ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence                  123468899999997764 588999999999999999999999965332  22223233223334455666789


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcCCccc
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKDPFLV  285 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~p~~~  285 (394)
                      ++.+++.+||. +|.+||++.++++||||+
T Consensus       239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999999998 999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-45  Score=373.56  Aligned_cols=259  Identities=21%  Similarity=0.378  Sum_probs=226.4

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +.+.++||+|+||.|.+++++.+++.||+|++++-.+.+. ....-|..|-.+|..-+.+-|++++..|.|+  .++|||
T Consensus        77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr-~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~--~~LYlV  153 (1317)
T KOG0612|consen   77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR-AETACFREERDIMVFGNSEWIVQLHYAFQDE--RYLYLV  153 (1317)
T ss_pred             hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc-hhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc--cceEEE
Confidence            3567899999999999999999999999999987555443 3345688899999999999999999999665  589999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      |||++||+|-.++.+..+++++-++.|+..|+.||.-||+.|  +|||||||+|||+| ..|++||+|||.+..+.... 
T Consensus       154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcCCCCc
Confidence            999999999999999999999999999999999999999999  99999999999999 79999999999997776443 


Q ss_pred             --CcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC--CCCC
Q 016143          186 --ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTD  255 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~  255 (394)
                        ....+|||.|+|||++.      +.|+..+|+||+||++|||+.|..||.. .+...-|.+|..-.....+|  ..+|
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VS  309 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVS  309 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccC
Confidence              34568999999999884      3599999999999999999999999987 66677788887643333333  3378


Q ss_pred             HHHHHHHHHcCCCCCCCCC---HHHHhcCCccccCCCCCc
Q 016143          256 PQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       256 ~~~~~li~~~L~~p~~R~s---~~elL~~p~~~~~~~~~~  292 (394)
                      .++++||++.+.+|+.|..   +.++-+||||.+..|..+
T Consensus       310 eeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~i  349 (1317)
T KOG0612|consen  310 EEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNI  349 (1317)
T ss_pred             HHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhh
Confidence            9999999999999999998   999999999999999654

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.6e-43  Score=323.24  Aligned_cols=248  Identities=31%  Similarity=0.577  Sum_probs=212.9

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|++|.||+|.++.++..|++|.+.....  .....+.+.+|+.+++.++||||+++++++.+.  ...++||
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~   78 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVM   78 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEE
Confidence            567899999999999999999999999999875543  245667789999999999999999999988654  5789999


Q ss_pred             cccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      ||+++++|.+++...  ..+++..+..++.||+.||.|||+++  ++|+||||+||+++ .++.++|+|||++.......
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEe-CCCCEEEcccccceeccCcc
Confidence            999999999999874  56999999999999999999999999  99999999999998 67899999999987664432


Q ss_pred             --CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          186 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                        .....|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.. .+.......+..+..+. .+...+..+.+++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i  233 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFPP-VSQMYSQQLAQLI  233 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHHH
Confidence              234568999999997764 588999999999999999999999976 44566666666654333 4446788999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCcc
Q 016143          263 EKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .+||+ +|++||++.+++.|||+
T Consensus       234 ~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         234 DQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHccCCcccCcCHHHHhhCCCC
Confidence            99998 89999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.5e-43  Score=332.16  Aligned_cols=256  Identities=23%  Similarity=0.381  Sum_probs=210.3

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +..+.||+|+||+||+|.+..+++.||+|.+..... ........+.+|+.+|+.++|+||+++++.+.++  ..+++||
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~   79 (285)
T cd05632           3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI-KKRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLVL   79 (285)
T ss_pred             eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh-hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEEE
Confidence            456889999999999999999999999999865433 2233445678899999999999999999988544  5789999


Q ss_pred             cccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      ||+.+++|..++...  ..+++..+..++.|++.||.|||+++  |+||||||+||+++ +++.+||+|||++...... 
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEC-CCCCEEEecCCcceecCCCC
Confidence            999999999888653  36999999999999999999999999  99999999999998 6789999999999765432 


Q ss_pred             CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHH---HHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          185 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      ......|++.|+|||.+. ..++.++|||||||++|+|++|..||.......   .+...+...  ...++...++++.+
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  234 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAKS  234 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHHH
Confidence            234567999999999775 458899999999999999999999998743322   222222222  22344557789999


Q ss_pred             HHHHcCC-CCCCCCC-----HHHHhcCCccccCCCCC
Q 016143          261 FIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKD  291 (394)
Q Consensus       261 li~~~L~-~p~~R~s-----~~elL~~p~~~~~~~~~  291 (394)
                      |+.+||+ +|.+||+     +.+++.|+||.....+.
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05632         235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR  271 (285)
T ss_pred             HHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHH
Confidence            9999998 9999999     88999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7e-43  Score=324.34  Aligned_cols=250  Identities=31%  Similarity=0.544  Sum_probs=217.1

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|+||+||+|.+..++..||+|.+.....  .....+++.+|+.+++.++||||+++++.+....+..++++|
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            667899999999999999999999999999875433  345667889999999999999999999988877777899999


Q ss_pred             cccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          108 ELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLH-----SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       108 e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH-----~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ||+++++|.+++..    ...+++..++.++.||+.||.|||     +.+  ++|+||+|+||+++ +++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEeccccc
Confidence            99999999999876    356999999999999999999999     777  99999999999998 7899999999999


Q ss_pred             eeecCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          179 IVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       179 ~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      .......  .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||... +...+...+..+.. ..++...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~  235 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKF-RRIPYRYS  235 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCC-CCCccccC
Confidence            8765543  344578999999997764 5789999999999999999999999874 46666666666543 34566778


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      ..+.+++.+||. +|.+||++.++|+|||+
T Consensus       236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            899999999998 99999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.4e-43  Score=329.22  Aligned_cols=254  Identities=28%  Similarity=0.480  Sum_probs=207.7

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      ..+...| ++.+.||+|+||.||+|.++.++..||+|++....    ......+.+|+.++++++||||+++++++..+ 
T Consensus         5 ~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-   78 (267)
T cd06646           5 RNPQHDY-ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-   78 (267)
T ss_pred             cCchhhc-chhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Confidence            3444455 78899999999999999999999999999986432    23345677899999999999999999998654 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                       ..+++||||+.+++|.+++...+.+++..+..++.|++.||.|||+++  |+||||||+||+++ .++.+||+|||++.
T Consensus        79 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~  154 (267)
T cd06646          79 -EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFGVAA  154 (267)
T ss_pred             -CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCccce
Confidence             478899999999999999988888999999999999999999999999  99999999999998 78899999999997


Q ss_pred             eecCCC--CcccccCCcccCccccc----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--C
Q 016143          180 VMQQPT--ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--S  251 (394)
Q Consensus       180 ~~~~~~--~~~~~gt~~y~aPE~l~----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~--~  251 (394)
                      ......  .....|++.|+|||.+.    ..++.++|||||||++|+|++|..||..................+..+  .
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06646         155 KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK  234 (267)
T ss_pred             eecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccc
Confidence            664332  23456899999999763    337789999999999999999999996543222222222222222222  2


Q ss_pred             CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCc
Q 016143          252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  283 (394)
Q Consensus       252 ~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~  283 (394)
                      ..++..+.+||.+||. +|.+||+++++|+|+|
T Consensus       235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             cccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            3457899999999998 9999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-43  Score=328.24  Aligned_cols=254  Identities=29%  Similarity=0.525  Sum_probs=209.8

Q ss_pred             CCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCC
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT   99 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~   99 (394)
                      +++++| ++.+.||+|++|+||+|.++.++..|++|.+....     ...+.+.+|+.+++++ +|+||+++++++.+..
T Consensus         3 ~~~~~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           3 DPTGIF-ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             Cchhhe-eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            567888 78899999999999999999999999999886432     2346688999999999 7999999999987643


Q ss_pred             ----CceEEEEEcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEE
Q 016143          100 ----NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK  171 (394)
Q Consensus       100 ----~~~~~lV~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~k  171 (394)
                          ...+++||||+++++|.+++..    ...+++..++.++.|++.||.|||+++  ++|+||+|+||+++ .++.+|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~-~~~~~~  153 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVK  153 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEc-cCCeEE
Confidence                4568999999999999998865    346999999999999999999999999  99999999999998 678999


Q ss_pred             EcccceeeeecCC--CCcccccCCcccCcccccc------cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 016143          172 IGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS  243 (394)
Q Consensus       172 l~Dfgla~~~~~~--~~~~~~gt~~y~aPE~l~~------~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~  243 (394)
                      |+|||++......  ......|++.|+|||.+..      .++.++|||||||++|+|++|..||........ ...+..
T Consensus       154 l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~  232 (275)
T cd06608         154 LVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LFKIPR  232 (275)
T ss_pred             ECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HHHhhc
Confidence            9999998765433  2234568999999997642      367889999999999999999999976433333 333444


Q ss_pred             CCCCC-CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          244 GIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       244 ~~~~~-~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      ...+. ..+..++..++++|++||. +|.+||++.+++.|||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            32222 1122367799999999998 99999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.1e-43  Score=335.80  Aligned_cols=261  Identities=31%  Similarity=0.524  Sum_probs=216.6

Q ss_pred             ccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEE
Q 016143           17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV   96 (394)
Q Consensus        17 ~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~   96 (394)
                      ....|+..+| ++.+.||+|++|.||+|.+..++..||+|.+....    ....+.+.+|+.+++.++|+||+++++++.
T Consensus        12 ~~~~~~~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (297)
T cd06656          12 VSVGDPKKKY-TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYL   86 (297)
T ss_pred             cccCChhhhc-eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4456777777 77899999999999999999999999999986543    233466888999999999999999999886


Q ss_pred             cCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccc
Q 016143           97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG  176 (394)
Q Consensus        97 ~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfg  176 (394)
                      ..  ...++||||+++++|.+++.+. .+++.++..++.|++.||.|||+.+  ++||||||+||+++ .++.++|+|||
T Consensus        87 ~~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Dfg  160 (297)
T cd06656          87 VG--DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFG  160 (297)
T ss_pred             cC--CEEEEeecccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcCc
Confidence            44  5788999999999999998764 4899999999999999999999999  99999999999998 78899999999


Q ss_pred             eeeeecCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 016143          177 LAIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       177 la~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      ++.......  .....|++.|+|||.+.+ .++.++|||||||++|+|++|..||........+......+..+...+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (297)
T cd06656         161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER  240 (297)
T ss_pred             cceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccc
Confidence            997654332  234568999999997765 48899999999999999999999997644333333322223323334556


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .+..+++|+.+||. +|.+||++.++|+||||+...
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            77899999999998 899999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.5e-43  Score=330.99  Aligned_cols=254  Identities=30%  Similarity=0.534  Sum_probs=210.2

Q ss_pred             CCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcC-
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD-   98 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~-   98 (394)
                      ++.++| ++.+.||+|+||+||+|.+..++..||+|.+...     ......+..|+.+++++ +|+||++++++|... 
T Consensus        13 ~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636          13 DPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             Chhhhh-hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            466777 7789999999999999999999999999987643     23445678899999999 699999999988643 


Q ss_pred             ---CCceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143           99 ---TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus        99 ---~~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                         ....++++|||+.+|+|.+++...  ..+++..+..++.||+.||.|||+++  ++|+||+|+||+++ +++.++|+
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l~  163 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKLV  163 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEe
Confidence               346789999999999999999764  35889999999999999999999999  99999999999998 78899999


Q ss_pred             ccceeeeecCC--CCcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q 016143          174 DLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI  245 (394)
Q Consensus       174 Dfgla~~~~~~--~~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~  245 (394)
                      |||++......  ......|++.|+|||.+.      ..++.++|||||||++|+|++|..||........+. .+....
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~  242 (282)
T cd06636         164 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNP  242 (282)
T ss_pred             eCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-hHhhCC
Confidence            99998655332  234467899999999764      347889999999999999999999997744333333 333333


Q ss_pred             CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       246 ~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .+.......+.++.+||.+||. +|.+||++.|+|+||||
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         243 PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            3333344578899999999998 99999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.7e-43  Score=326.05  Aligned_cols=250  Identities=34%  Similarity=0.582  Sum_probs=210.1

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC-----HHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .+...||+|++|.||+|.+..++..||+|.+........     .+..+.+.+|+.++++++||||+++++++.++  ..
T Consensus         3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~   80 (267)
T cd06628           3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--DH   80 (267)
T ss_pred             cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--Cc
Confidence            678899999999999999999999999998865433221     23346788999999999999999999988654  46


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      .++|+||+++++|.+++...+.+++..+..++.|++.||.|||+++  ++||||+|+||+++ +++.++|+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLE  157 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccCCCcccc
Confidence            7889999999999999999888999999999999999999999999  99999999999998 78899999999997664


Q ss_pred             CCC--------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 016143          183 QPT--------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       183 ~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      ...        .....|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+......+ ..+.... ...++..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~-~~~~~~~  235 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGENA-SPEIPSN  235 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHhccC-CCcCCcc
Confidence            221        123458899999997764 5888999999999999999999999875544433 3333332 2334556


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .+..++++|++||. +|.+||++.++++||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         236 ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            78899999999998 89999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.6e-43  Score=325.41  Aligned_cols=251  Identities=26%  Similarity=0.422  Sum_probs=214.3

Q ss_pred             ecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCC
Q 016143           33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS  112 (394)
Q Consensus        33 LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~  112 (394)
                      ||.|++|.||+|.+..++..||+|.+..... ......+.+.+|+.+++.++||||+++++.+.++  ..+++|+||+++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLG   77 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcc-hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCC
Confidence            7999999999999999999999999875443 2234557799999999999999999999987544  468899999999


Q ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-Cccccc
Q 016143          113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIG  191 (394)
Q Consensus       113 gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-~~~~~g  191 (394)
                      ++|.+++.+...+++..+..++.||+.||.|||+++  ++|+||+|+||+++ .++.++|+|||++....... .....|
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~  154 (262)
T cd05572          78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCG  154 (262)
T ss_pred             CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccC
Confidence            999999998888999999999999999999999999  99999999999998 68899999999997665542 334568


Q ss_pred             CCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCC-CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-C
Q 016143          192 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P  268 (394)
Q Consensus       192 t~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~  268 (394)
                      ++.|+|||.+.+ .++.++|+||||+++|+|++|..||.... +....+..+..+......+...+++++++|.+||. +
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence            999999997654 58899999999999999999999997644 25566666664433444555568899999999998 9


Q ss_pred             CCCCCC-----HHHHhcCCccccCCC
Q 016143          269 ASLRLP-----ALELLKDPFLVTDNP  289 (394)
Q Consensus       269 p~~R~s-----~~elL~~p~~~~~~~  289 (394)
                      |.+|++     +.|+++||||+...+
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhhhCCCC
Confidence            999999     999999999987654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.1e-43  Score=333.04  Aligned_cols=258  Identities=31%  Similarity=0.550  Sum_probs=214.4

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      .++..+| ++.+.||.|++|+||+|.+..+|+.||+|.+....    ....+.+.+|+.+++.++||||+++++++.+. 
T Consensus        15 ~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-   88 (296)
T cd06655          15 GDPKKKY-TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLVG-   88 (296)
T ss_pred             CCCcceE-EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEecC-
Confidence            3455566 67789999999999999999999999999986433    23446788999999999999999999988644 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                       ..+++|+||+.+++|..++... .+++.++..++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++.
T Consensus        89 -~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~  163 (296)
T cd06655          89 -DELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFGFCA  163 (296)
T ss_pred             -ceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccch
Confidence             5788999999999999998765 5899999999999999999999999  99999999999998 78899999999987


Q ss_pred             eecCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          180 VMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       180 ~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      ......  .....|++.|+|||.+.+ .++.++|||||||++|+|++|..||........+.........+...+...++
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T cd06655         164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSP  243 (296)
T ss_pred             hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCH
Confidence            554332  234568999999997765 48899999999999999999999998754434433333333323334556788


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .++++|++||. +|.+||++.+++.||||+...
T Consensus       244 ~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            99999999998 899999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.4e-43  Score=338.84  Aligned_cols=251  Identities=22%  Similarity=0.436  Sum_probs=202.0

Q ss_pred             ccceeccc--CceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           29 YDEILGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        29 ~~~~LG~G--~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +.++||+|  +|++||++.++.+|+.||+|.++....  .....+.+.+|+.+++.++||||++++++|..+  ..+++|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv   77 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVV   77 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEE
Confidence            46789999  789999999999999999999875432  234556788899999999999999999998655  468899


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+++|+|.+++..+  ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.++++||+.+......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhccccc
Confidence            9999999999999764  45999999999999999999999999  99999999999998 6789999999875432211


Q ss_pred             ---------CCcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-----
Q 016143          185 ---------TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-----  247 (394)
Q Consensus       185 ---------~~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-----  247 (394)
                               ......++..|+|||.+.+   .|+.++|||||||++|+|++|..||............+. +..+     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~  233 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCLLDT  233 (327)
T ss_pred             cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-CCccccccc
Confidence                     1122356788999998764   488999999999999999999999986443333322221 1111     


Q ss_pred             ---------------------------------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          248 ---------------------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       248 ---------------------------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                                             .......++++++||++||. +|.+|||+.++|+||||+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                                   00112346789999999998 99999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-43  Score=327.20  Aligned_cols=254  Identities=29%  Similarity=0.516  Sum_probs=215.3

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +| ++.+.||.|++|.||+|.+..++..||+|.+....   .......+.+|+.+++.++|+||+++++++.++  ..++
T Consensus         2 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~   75 (274)
T cd06609           2 LF-TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLW   75 (274)
T ss_pred             hh-hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEE
Confidence            44 67789999999999999999999999999987543   234556688999999999999999999988655  5789


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      +|+||+.+++|.+++... .+++..++.++.||+.||.|||+++  ++|+||+|+||+++ +++.++|+|||++......
T Consensus        76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEcccccceeeccc
Confidence            999999999999999876 7999999999999999999999999  99999999999998 6889999999999777654


Q ss_pred             --CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          185 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       185 --~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                        ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||.. .++......+..+..+.......++.+.++
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD-LHPMRVLFLIPKNNPPSLEGNKFSKPFKDF  230 (274)
T ss_pred             ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc-CchHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence              2334568999999997764 589999999999999999999999976 345555555555443332222277899999


Q ss_pred             HHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          262 IEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +.+||. +|.+||++.++++||||+....
T Consensus       231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         231 VSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             HHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence            999997 9999999999999999987643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.8e-43  Score=328.00  Aligned_cols=252  Identities=27%  Similarity=0.491  Sum_probs=214.0

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|++|.||+|.++.++..||+|.+....   .......+.+|+.+++.++||||+++++.+...  ..+++++
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~   78 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICM   78 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEE
Confidence            66789999999999999999999999999887543   235556788999999999999999999988655  5789999


Q ss_pred             cccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      ||+.+++|.+++... ..+++..+..++.||+.||.|||+ .+  ++|+||||+||+++ +++.++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhHHHH
Confidence            999999999999876 779999999999999999999999 88  99999999999998 68899999999987654443


Q ss_pred             CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC----CCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      .....|+..|+|||.+.+ .++.++||||||+++|+|++|..||...    .......+.+.....+.......++++++
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06605         156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD  235 (265)
T ss_pred             hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence            333678999999997765 5889999999999999999999999764    23444555555544333223337889999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          261 FIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      +|.+||. +|.+||++.+++.||||+..
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            9999998 99999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-43  Score=333.57  Aligned_cols=258  Identities=22%  Similarity=0.370  Sum_probs=212.0

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|++|+||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++.+.+  ....++|
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv   79 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCLV   79 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEEE
Confidence            36778999999999999999999999999999765432 23456778999999999999999999998754  4578999


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+.+++|.+++...  ..+++..++.++.||+.||.|||+++  ++|+||||+||+++ .++.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc-CCCCEEEeecchhhccccc
Confidence            9999999999998864  46999999999999999999999999  99999999999998 6889999999998543221


Q ss_pred             -------------------------------CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCC
Q 016143          185 -------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK  232 (394)
Q Consensus       185 -------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~  232 (394)
                                                     ......||..|+|||++.+ .++.++||||||+++|+|++|..||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence                                           1123468999999997764 58899999999999999999999998754


Q ss_pred             CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCC----HHHHhcCCccccCCCCC
Q 016143          233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP----ALELLKDPFLVTDNPKD  291 (394)
Q Consensus       233 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s----~~elL~~p~~~~~~~~~  291 (394)
                      .... +..+.............+.+++++|++||. +|.+||+    +.++|.||||+...+..
T Consensus       237 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~  299 (316)
T cd05574         237 RDET-FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL  299 (316)
T ss_pred             hHHH-HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence            4443 333333222211222367899999999998 9999999    99999999999866543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.7e-43  Score=333.22  Aligned_cols=249  Identities=27%  Similarity=0.471  Sum_probs=201.0

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|+||+||+|.++.+|..||+|.+.....  .......+.+|+.++++++||||+++++++.+.  ..+++|+
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv~   78 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLTLVF   78 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceEEEE
Confidence            667899999999999999999999999999875432  222335577899999999999999999988654  4688999


Q ss_pred             cccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          108 ELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      ||+. ++|.+++.. .+.+++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++......  
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          79 EYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEc-CCCcEEECccchhhccCCCCC
Confidence            9996 578777764 567999999999999999999999999  99999999999998 6889999999999755432  


Q ss_pred             CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC----------------
Q 016143          185 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----------------  246 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~----------------  246 (394)
                      ......+++.|+|||.+.+  .++.++|||||||++|+|+||..||....+....+..+.....                
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            2234567899999997754  3789999999999999999999886554444443333321100                


Q ss_pred             ---C--------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          247 ---P--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       247 ---~--------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                         +        .......+++++++|.+||. +|.+|||+.++|.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence               0        01112356889999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=325.07  Aligned_cols=261  Identities=21%  Similarity=0.317  Sum_probs=216.2

Q ss_pred             ccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeE
Q 016143           17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW   95 (394)
Q Consensus        17 ~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~   95 (394)
                      +.+...+.-|.--.++||-|-.|+|-.++++.||+.+|+|++.-     +    .+..+|+++.-.. .|||||.++++|
T Consensus        54 ~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s----~KARrEVeLHw~~s~h~~iV~IidVy  124 (400)
T KOG0604|consen   54 FKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----S----PKARREVELHWMASGHPHIVSIIDVY  124 (400)
T ss_pred             hhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----C----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence            44445556664445899999999999999999999999998641     2    3355688887666 699999999988


Q ss_pred             Ec--CCCceEEEEEcccCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCc
Q 016143           96 VD--DTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGE  169 (394)
Q Consensus        96 ~~--~~~~~~~lV~e~~~~gsL~~~i~~~~~--l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--~~~~  169 (394)
                      ..  .....+.+|||.++||+|+..++.++.  ++|.++..+++||..|+.|||+.+  |.||||||+|+|..+  .+..
T Consensus       125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~  202 (400)
T KOG0604|consen  125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAP  202 (400)
T ss_pred             hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcc
Confidence            43  235678999999999999999998875  999999999999999999999999  999999999999963  3457


Q ss_pred             EEEcccceeeeecC-CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCC---CHHHHHHHHhcC
Q 016143          170 VKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSG  244 (394)
Q Consensus       170 ~kl~Dfgla~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~---~~~~~~~~i~~~  244 (394)
                      +||+|||+|+.... ....+.+-||+|.|||++.. +|+..+|+||+||+||-|+.|.+||....   -.-.+..+|..|
T Consensus       203 lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g  282 (400)
T KOG0604|consen  203 LKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG  282 (400)
T ss_pred             eEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence            99999999987764 45677789999999998875 59999999999999999999999996532   223556677766


Q ss_pred             CC--CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          245 IK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       245 ~~--~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .+  |..-+...|..++++|+++|. +|++|.++.++++|||+....
T Consensus       283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            43  333344567899999999997 999999999999999998653

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-42  Score=320.84  Aligned_cols=251  Identities=35%  Similarity=0.589  Sum_probs=212.5

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeecccc-CCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +..+.||+|++|+||+|.+..++..|++|.+...... ...+..+.+.+|+.+++.++|+||+++++++.+.  ..++++
T Consensus         3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv   80 (258)
T cd06632           3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLYIF   80 (258)
T ss_pred             cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEEEE
Confidence            6789999999999999999889999999998764422 2345667899999999999999999999987543  578899


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      +||+++++|.+++.+...+++..+..++.||+.||.|||+++  ++|+||+|+||+++ .++.+||+|||++....... 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~~~  157 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSF  157 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccceecccccc
Confidence            999999999999998888999999999999999999999999  99999999999998 68899999999997654443 


Q ss_pred             CcccccCCcccCcccccc-c-CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~-~-~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                      .....|++.|+|||.+.. . ++.++|+||||+++|+|++|+.||........... +.........+...++.++++++
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~  236 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELPPIPDHLSDEAKDFIL  236 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HHhcccCCCcCCCcCHHHHHHHH
Confidence            345668999999997653 3 78999999999999999999999987553333333 33322233455667899999999


Q ss_pred             HcCC-CCCCCCCHHHHhcCCcc
Q 016143          264 KCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       264 ~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      +||. +|.+||++.++|.|||+
T Consensus       237 ~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         237 KCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHhhcCcccCcCHHHHhcCCCC
Confidence            9998 99999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=323.29  Aligned_cols=252  Identities=29%  Similarity=0.523  Sum_probs=210.4

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      |..+| .+.+.||+|+||.||+|.+..++..+++|.+....    .+..+.+.+|+.++++++||||+++++++.+.  .
T Consensus         1 ~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~   73 (262)
T cd06613           1 PQEDY-ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR--D   73 (262)
T ss_pred             Cccce-EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC--C
Confidence            45566 67899999999999999999999999999987543    23567788999999999999999999988654  4


Q ss_pred             eEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      .++++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++  ++|+||+|+||+++ +++.+||+|||++..
T Consensus        74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~  150 (262)
T cd06613          74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQ  150 (262)
T ss_pred             EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchh
Confidence            789999999999999999876 78999999999999999999999999  99999999999999 788999999999976


Q ss_pred             ecCC--CCcccccCCcccCcccccc----cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC--CCC
Q 016143          181 MQQP--TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSK  252 (394)
Q Consensus       181 ~~~~--~~~~~~gt~~y~aPE~l~~----~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~--~~~  252 (394)
                      ....  ......++..|+|||.+.+    .++.++|||||||++|+|++|..||.+................+..  ...
T Consensus       151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (262)
T cd06613         151 LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKE  230 (262)
T ss_pred             hhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchh
Confidence            5433  2334568999999997653    5788999999999999999999999875544444333333222222  123


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCc
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPF  283 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~  283 (394)
                      ..+.++++++++||. +|..||++.+++.|+|
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             hhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            346789999999998 8999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.3e-43  Score=328.53  Aligned_cols=250  Identities=28%  Similarity=0.445  Sum_probs=202.8

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|++|+||+|.+..++..||+|.+.....  .......+.+|+.++++++||||+++++++.++  ..+++|
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v   77 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLYLI   77 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEEEE
Confidence            3677899999999999999999999999999865432  223345678899999999999999999998654  578999


Q ss_pred             EcccCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          107 TELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~---~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      |||+. ++|.+++...   ..+++..++.++.||+.||.|||+++  ++||||||+||+++ +++.+||+|||++.....
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGI  153 (285)
T ss_pred             EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeecCC
Confidence            99997 6888887653   45899999999999999999999999  99999999999998 789999999999976543


Q ss_pred             CC--CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC------------
Q 016143          184 PT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------  247 (394)
Q Consensus       184 ~~--~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~------------  247 (394)
                      ..  .....+++.|+|||.+.+  .++.++|||||||++|+|+||+.||.+................+            
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence            32  233467899999997754  47889999999999999999999998754444333322110000            


Q ss_pred             --------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          248 --------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       248 --------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                    .......+++++++|++||. +|.+||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                          01123467899999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.7e-43  Score=333.74  Aligned_cols=246  Identities=28%  Similarity=0.439  Sum_probs=192.1

Q ss_pred             cceecccCceEEEEEEEcc--CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           30 DEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +.+||+|+||+||+|.++.  ++..||+|.+....      ....+.+|+.+++.++||||+++++++.......+++|+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            4689999999999998653  66889999876432      123467899999999999999999998877777899999


Q ss_pred             cccCCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe---CCCCcEEEccc
Q 016143          108 ELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDL  175 (394)
Q Consensus       108 e~~~~gsL~~~i~~~---------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~---~~~~~~kl~Df  175 (394)
                      ||+. ++|.+++...         ..+++..++.++.||+.||.|||+++  |+||||||+||++.   ..++.+||+||
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9986 5787776532         24889999999999999999999999  99999999999994   25678999999


Q ss_pred             ceeeeecCCC-----CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCH---------HHHHH
Q 016143          176 GLAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------AQIYK  239 (394)
Q Consensus       176 gla~~~~~~~-----~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~---------~~~~~  239 (394)
                      |++.......     .....||+.|+|||++.+  .++.++|||||||++|||+||++||....+.         .++..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            9997664432     234578999999998754  4789999999999999999999999642211         11111


Q ss_pred             HHhc-CCC---------------------------C-------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCc
Q 016143          240 KVTS-GIK---------------------------P-------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  283 (394)
Q Consensus       240 ~i~~-~~~---------------------------~-------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~  283 (394)
                      .+.. +..                           .       .......+..+++++.+||. +|.+|||+.|+|+|||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~  316 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY  316 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            1100 000                           0       00011235678899999998 9999999999999999


Q ss_pred             c
Q 016143          284 L  284 (394)
Q Consensus       284 ~  284 (394)
                      |
T Consensus       317 f  317 (317)
T cd07867         317 F  317 (317)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.8e-43  Score=331.76  Aligned_cols=253  Identities=27%  Similarity=0.438  Sum_probs=204.2

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +| ++.+.||+|+||.||+|.++.++..||+|.+.....   ......+.+|+.+++.++||||+++++++.++  ..++
T Consensus         7 ~y-~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~   80 (301)
T cd07873           7 TY-IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLT   80 (301)
T ss_pred             ce-EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeEE
Confidence            44 778999999999999999999999999999875432   22234567899999999999999999998544  5789


Q ss_pred             EEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +||||+. ++|.+++... ..+++..++.++.||+.||.|||+++  ++|+||||+||+++ +++.+||+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSI  156 (301)
T ss_pred             EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccCC
Confidence            9999996 5888887754 56899999999999999999999999  99999999999998 788999999999965433


Q ss_pred             C--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC---CC----------
Q 016143          184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IK----------  246 (394)
Q Consensus       184 ~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~---~~----------  246 (394)
                      .  ......+++.|+|||.+.+  .++.++|||||||++|+|++|++||.......+ ...+...   ..          
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhcc
Confidence            2  2234467899999997754  478899999999999999999999987443332 2222110   00          


Q ss_pred             --------C-------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          247 --------P-------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       247 --------~-------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                              +       .......++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                    0       00112457789999999998 999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-42  Score=328.29  Aligned_cols=252  Identities=29%  Similarity=0.528  Sum_probs=211.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +.+.+.||+|+||+||+|.+..+|..||+|.+....   .......+.+|+.++++++||||+++++.+..+  ..+++|
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv   77 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYMC   77 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEEE
Confidence            367899999999999999999999999999886432   344557889999999999999999999988653  578999


Q ss_pred             EcccCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          107 TELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~---~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      |||+++++|..++...   ..+++..+..++.||+.||.|||+ ++  ++||||||+||+++ .++.+||+|||++....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEEC-CCCCEEEeecCCccccc
Confidence            9999999999998874   369999999999999999999996 57  99999999999998 68899999999997765


Q ss_pred             CCCCcccccCCcccCcccccc-------cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHH---HHHhcCCCCCCCCC
Q 016143          183 QPTARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY---KKVTSGIKPASLSK  252 (394)
Q Consensus       183 ~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~---~~i~~~~~~~~~~~  252 (394)
                      ........|++.|+|||.+.+       .++.++|||||||++|+|++|..||.... .....   ..+..+. +..++.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~-~~~~~~  232 (286)
T cd06622         155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGD-PPTLPS  232 (286)
T ss_pred             CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcC-CCCCCc
Confidence            555555678999999998743       25789999999999999999999997533 22222   2333333 334455


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ..+.++.+||++||. +|.+||++.+++.||||....
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             ccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            578999999999998 899999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8e-43  Score=324.10  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=212.9

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||.|+||.||+|.++.++..||+|.+..... ......+.+.+|+.++++++||||+++++.+.  ....+++|+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   79 (258)
T cd05578           3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLVV   79 (258)
T ss_pred             eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEEEE
Confidence            678999999999999999999999999999875442 22345678999999999999999999999874  345789999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-CC
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TA  186 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-~~  186 (394)
                      ||+.+++|.+++.....+++..+..++.||+.||.|||+++  ++|+||+|+||+++ +++.++|+|||++...... ..
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCccc
Confidence            99999999999998878999999999999999999999999  99999999999998 7889999999999766544 23


Q ss_pred             cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCC--HHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       187 ~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                      ....|+..|+|||.+.. .++.++|+||||+++|+|++|..||.....  ..++......  .....+...+..+.++|+
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~  234 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAIN  234 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHH
Confidence            34568899999997765 478999999999999999999999987543  4444444432  223345567789999999


Q ss_pred             HcCC-CCCCCCCH--HHHhcCCcc
Q 016143          264 KCIV-PASLRLPA--LELLKDPFL  284 (394)
Q Consensus       264 ~~L~-~p~~R~s~--~elL~~p~~  284 (394)
                      +||. +|.+||++  .|+++||||
T Consensus       235 ~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         235 KLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHccCChhHcCCccHHHHhcCCCC
Confidence            9998 99999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3e-42  Score=326.23  Aligned_cols=256  Identities=28%  Similarity=0.461  Sum_probs=208.1

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD   98 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~   98 (394)
                      .+++++| .+.+.||+|+||.||+|.++.++..+|+|.+....     .....+.+|+.+++++ +|||++++++++...
T Consensus        18 ~~~~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          18 GDPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             CCCCCCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            3567777 77889999999999999999999999999875321     2335577899999999 899999999988654


Q ss_pred             C---CceEEEEEcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEE
Q 016143           99 T---NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK  171 (394)
Q Consensus        99 ~---~~~~~lV~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~k  171 (394)
                      +   ...+++||||+++++|.++++.    ...+++..++.++.|++.||.|||+++  ++||||||+||+++ .++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEE
Confidence            3   2468999999999999998763    456899999999999999999999999  99999999999998 688999


Q ss_pred             EcccceeeeecCCC--CcccccCCcccCcccccc------cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 016143          172 IGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS  243 (394)
Q Consensus       172 l~Dfgla~~~~~~~--~~~~~gt~~y~aPE~l~~------~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~  243 (394)
                      |+|||++.......  .....|++.|+|||.+..      .++.++|||||||++|+|++|+.||........ ...+..
T Consensus       169 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~~~~  247 (291)
T cd06639         169 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFKIPR  247 (291)
T ss_pred             EeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHHHhc
Confidence            99999987554322  234568999999998753      257899999999999999999999987433333 333433


Q ss_pred             CCCC-CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccc
Q 016143          244 GIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  285 (394)
Q Consensus       244 ~~~~-~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~  285 (394)
                      +..+ ...+...+..++++|.+||. +|.+||++.+++.||||+
T Consensus       248 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            3222 11233456789999999998 899999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3e-42  Score=322.18  Aligned_cols=246  Identities=32%  Similarity=0.518  Sum_probs=204.3

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      ..||+|+||+||+|.+..++..||+|.+....    ....+.+.+|+.+++.++|+||+++++++.++  ..+++|+||+
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~   87 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIFMEQV   87 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEEEecC
Confidence            57999999999999999999999999876432    34566788999999999999999999987544  5788999999


Q ss_pred             CCCcHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--C
Q 016143          111 TSGSLRQYRKKH-KNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T  185 (394)
Q Consensus       111 ~~gsL~~~i~~~-~~l--~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~  185 (394)
                      ++++|.+++... ..+  ++..+..++.||+.||.|||+++  |+||||||+||+++..++.++|+|||++......  .
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence            999999998865 445  88999999999999999999999  9999999999999855789999999999765432  2


Q ss_pred             CcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      .....|++.|+|||.+.+   .++.++||||||+++|+|++|..||.....................++...++++++|+
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  245 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI  245 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence            233468999999998753   37899999999999999999999997654433332222211123345666788999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCcc
Q 016143          263 EKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .+||. +|.+||++.+++.||||
T Consensus       246 ~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         246 LRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHcCCCchhCCCHHHHHhCCCC
Confidence            99998 89999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=338.92  Aligned_cols=240  Identities=26%  Similarity=0.435  Sum_probs=203.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      .++.+.||+|-||.||+|..+ ....||+|.++....     ..+.|.+|+.+|++|+|+|||++++++..+  ..++||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~--~piyIV  279 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQ--EPIYIV  279 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEc-CCCcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEecC--CceEEE
Confidence            466789999999999999875 334799999875432     225577899999999999999999987543  479999


Q ss_pred             EcccCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~--~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||++.|+|.+|++.  +..++..+...++.||++|++||++++  +|||||...||||+ ++..+||+|||+|+.....
T Consensus       280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEcccccccccCCC
Confidence            999999999999997  456999999999999999999999999  99999999999998 7889999999999955544


Q ss_pred             CCccccc---CCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          185 TARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       185 ~~~~~~g---t~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ......|   +..|.|||.+. +.++.++|||||||+||||+| |+.||.+ .+..+.+..+.+|.+-+ -|..+++++.
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyRlp-~P~~CP~~vY  434 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYRLP-RPEGCPDEVY  434 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCcCC-CCCCCCHHHH
Confidence            3332222   45799999765 679999999999999999999 9999987 66678888999986644 3556889999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHh
Q 016143          260 QFIEKCIV-PASLRLPALELL  279 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL  279 (394)
                      +++..||. +|.+|||...+.
T Consensus       435 ~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  435 ELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHHHHhhCCcccCCCHHHHH
Confidence            99999998 999999988554

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-43  Score=340.59  Aligned_cols=253  Identities=26%  Similarity=0.413  Sum_probs=209.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~  102 (394)
                      ||-|.+.+.||+||.+.||++.. .+...||+|.+....  .+...+.-+.+|+.+|.+|+ |.+||++|++-+.  +.+
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~  434 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGY  434 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--Cce
Confidence            66667778999999999999975 456678888775443  35678888999999999996 9999999997654  468


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCH-HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDM-KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~-~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      +||||||- ..+|.+++++.....+ -.++.++.|++.++.++|++|  |||-||||.|+|+-  .|.+||+|||+|...
T Consensus       435 lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFGIANAI  509 (677)
T ss_pred             EEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeechhccc
Confidence            99999997 4699999998765333 589999999999999999999  99999999999996  689999999999887


Q ss_pred             cCCCC----cccccCCcccCcccccc------------cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q 016143          182 QQPTA----RSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI  245 (394)
Q Consensus       182 ~~~~~----~~~~gt~~y~aPE~l~~------------~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~  245 (394)
                      .....    .+.+||+.|||||.+..            +.+.++||||||||||+|+.|+.||....+...-+..|+..-
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~  589 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN  589 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence            76643    35689999999997631            145789999999999999999999987666666666666543


Q ss_pred             CCCCCCCCCCHH-HHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          246 KPASLSKVTDPQ-VKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       246 ~~~~~~~~~~~~-~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      -...++...++. +.++++.||+ ||.+||+..+||+|||++.
T Consensus       590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            333455554444 9999999998 9999999999999999986

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.5e-42  Score=325.67  Aligned_cols=256  Identities=26%  Similarity=0.472  Sum_probs=208.1

Q ss_pred             ccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEc
Q 016143           19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD   97 (394)
Q Consensus        19 ~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~   97 (394)
                      ..++..+| .+.+.||+|+||+||+|.++.++..+|+|++....     .....+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          13 FPDPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             CCCcccce-eeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            34566777 67899999999999999999999999999875321     2235577899999999 69999999998753


Q ss_pred             ---CCCceEEEEEcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE
Q 016143           98 ---DTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV  170 (394)
Q Consensus        98 ---~~~~~~~lV~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~  170 (394)
                         .....+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+++  ++||||||+||+++ .++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC-CCCCE
Confidence               234578999999999999998753    346899999999999999999999999  99999999999998 67889


Q ss_pred             EEcccceeeeecCC--CCcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 016143          171 KIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT  242 (394)
Q Consensus       171 kl~Dfgla~~~~~~--~~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~  242 (394)
                      ||+|||++......  ......|++.|+|||.+.      ..++.++|||||||++|+|++|+.||........+. .+.
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-~~~  242 (286)
T cd06638         164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-KIP  242 (286)
T ss_pred             EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-hcc
Confidence            99999999766433  223456999999999774      237889999999999999999999998754433333 222


Q ss_pred             cCC-CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          243 SGI-KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       243 ~~~-~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      ... .....+...+..+.++|.+||. +|.+||++.++|.|+||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            222 1222344567889999999998 99999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.5e-42  Score=321.28  Aligned_cols=250  Identities=32%  Similarity=0.563  Sum_probs=208.0

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      |.++| .+.+.||+|+||.||+|.+..++..|++|.+....      ..+.+.+|+.++++++||||+++++.+.+.  .
T Consensus         1 ~~~~y-~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~   71 (256)
T cd06612           1 PEEVF-DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKN--T   71 (256)
T ss_pred             Ccccc-hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--C
Confidence            34556 77899999999999999999889999999986432      257788999999999999999999988655  5


Q ss_pred             eEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          102 TINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      .+++++||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+  ++|+||+|+||+++ .++.++|+|||++..
T Consensus        72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~  148 (256)
T cd06612          72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQ  148 (256)
T ss_pred             cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEC-CCCcEEEcccccchh
Confidence            78899999999999999976 456899999999999999999999999  99999999999998 688999999999976


Q ss_pred             ecCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCCH
Q 016143          181 MQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKPASLSKVTDP  256 (394)
Q Consensus       181 ~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~-~~~~~~~~~~~~  256 (394)
                      .....  .....|+..|+|||.+.+ .++.++||||||+++|+|++|+.||........ ...+... ......+...+.
T Consensus       149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd06612         149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-IFMIPNKPPPTLSDPEKWSP  227 (256)
T ss_pred             cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-hhhhccCCCCCCCchhhcCH
Confidence            55432  234558999999998765 588999999999999999999999976433322 2222221 112223345678


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .+.++|.+||. +|.+||++.++|.||||
T Consensus       228 ~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            99999999998 99999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.1e-42  Score=316.81  Aligned_cols=252  Identities=38%  Similarity=0.624  Sum_probs=219.4

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|++|.||+|.+..++..|++|.+.....  .....+.+.+|+.++++++||||+++++.+.+.....+++++
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             eeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            677899999999999999999999999999875542  245678899999999999999999999988765446889999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC--
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~--  185 (394)
                      ||+.+++|.+++.+...+++..+..++.|++.||.|||+++  ++|+||+|+||+++ .++.++|+|||.+.......  
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEcccccEEeccccccc
Confidence            99999999999998888999999999999999999999999  99999999999998 68899999999998776553  


Q ss_pred             --CcccccCCcccCccccccc-CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          186 --ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~~~-~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                        .....++..|+|||.+.+. ++.++||||||+++|+|++|..||....+.......+........++...+..++++|
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i  237 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL  237 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence              3445789999999977654 8899999999999999999999998766555555555543344456667789999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCcc
Q 016143          263 EKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .+||. +|.+||++.+++.||||
T Consensus       238 ~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         238 RKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHhCcCChhhCCCHHHHhhCCCC
Confidence            99998 89999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-42  Score=325.60  Aligned_cols=254  Identities=24%  Similarity=0.421  Sum_probs=211.6

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      -+++.+.||+|+||+||+|.+..+|..||+|++....   .....+.+.+|+.+++.++||||+++++++.+.  ..+++
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l   80 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICM   80 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEE
Confidence            3478899999999999999999999999999886432   244567789999999999999999999998655  57899


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      ||||+++++|..++.+.+.+++..+..++.|++.||.|||+ ++  ++||||||+||+++ +++.++|+|||++......
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchhhh
Confidence            99999999999999988889999999999999999999997 57  99999999999998 7889999999998765444


Q ss_pred             CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCH----------HHHHHHHhcCCCCCCCCCC
Q 016143          185 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP----------AQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~----------~~~~~~i~~~~~~~~~~~~  253 (394)
                      ......|+..|+|||.+. +.++.++|||||||++|+|++|..||......          ......+.....+......
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD  237 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence            445567999999999764 56889999999999999999999999753321          1222333322222211223


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      .+..+.+|+.+||. +|.+||++.|+++|+||...
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            67789999999998 89999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.1e-42  Score=324.93  Aligned_cols=256  Identities=27%  Similarity=0.472  Sum_probs=211.9

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +..+.||.|++|.||+|.++.++..||+|.+....   ......++.+|+.+++.++||||++++++|.+.....+++||
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            56688999999999999999999999999887543   234567789999999999999999999998877777899999


Q ss_pred             cccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          108 ELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       108 e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ||+++++|.+++..    ...+++..+..++.||+.||.|||+.+  ++|+||+|+||+++ .++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-cCCeEEEeeccccccccc
Confidence            99999999988653    345899999999999999999999999  99999999999998 678999999999876554


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC----CCHHHHHHHHhcCCCCC---CCC--CC
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPA---SLS--KV  253 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~----~~~~~~~~~i~~~~~~~---~~~--~~  253 (394)
                      .......++..|+|||.+.+ .++.++|||||||++|+|++|..||...    ....+....+.....+.   ...  ..
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd06621         158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK  237 (287)
T ss_pred             cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence            44445568899999997654 5889999999999999999999999764    23344444444322111   111  23


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +++.+++||.+||. +|.+||++.|++.||||+....
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             hHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            46789999999998 9999999999999999976543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.1e-42  Score=317.15  Aligned_cols=248  Identities=29%  Similarity=0.499  Sum_probs=212.9

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|+||.||.+.+..++..+++|.+.....  +.....++.+|+.++++++|+||+++++++.++  ..++++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~~~   78 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLIEM   78 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEEEE
Confidence            778999999999999999999999999999875543  345566788999999999999999999998654  5789999


Q ss_pred             cccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      ||+++++|.+++...  ..+++.++..++.|++.||.|||+.+  ++|+||+|+||+++ .++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEccccc
Confidence            999999999999875  45899999999999999999999999  99999999999998 68899999999997664432


Q ss_pred             --CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          186 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                        .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.. .+..+....+..+..+. .....+.++.+++
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i  233 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELISLV  233 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHHH
Confidence              344568999999997765 478899999999999999999999976 45556666665553332 3355678999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCcc
Q 016143          263 EKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .+||. +|.+||++.++|+|||+
T Consensus       234 ~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         234 HSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHcccCcccCCCHHHHhhCcCC
Confidence            99998 89999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-44  Score=337.00  Aligned_cols=271  Identities=25%  Similarity=0.400  Sum_probs=228.5

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      +++.-++||+||||.||-+.-+.||+.||+|.+.++.+.+ ...-...++|-.+|.+++.+.||.+-..|  ++...+++
T Consensus       186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd~LCl  262 (591)
T KOG0986|consen  186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAF--ETKDALCL  262 (591)
T ss_pred             ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCCceEE
Confidence            4456689999999999999999999999999987655433 23334567899999999999999998888  45567999


Q ss_pred             EEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          106 ITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      |+..+.||+|.-+|-+.+  ++++..++.++.+|+.||.+||+.+  ||+|||||+|||+| +.|+++|+|+|+|..+..
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEecCC
Confidence            999999999999998876  7999999999999999999999999  99999999999999 899999999999987765


Q ss_pred             C-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          184 P-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       184 ~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                      . ..+..+||.+|||||++.+ .|+..+|+|||||++|||+.|+.||......   +++-+++..  .+..++...++++
T Consensus       340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~ea  417 (591)
T KOG0986|consen  340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEEA  417 (591)
T ss_pred             CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHHH
Confidence            5 4455589999999998875 4999999999999999999999999753322   233333333  2556778889999


Q ss_pred             HHHHHHcCC-CCCCCC-----CHHHHhcCCccccCCCCCcccCCCCCCCCch
Q 016143          259 KQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPNLVP  304 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~~~~~~~~p~~~~  304 (394)
                      +++.+.+|. +|++|+     .+.++-.||||+..+++.+....+..|..++
T Consensus       418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPd  469 (591)
T KOG0986|consen  418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPD  469 (591)
T ss_pred             HHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCC
Confidence            999999998 899887     4789999999999999987777666665443

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.2e-42  Score=328.64  Aligned_cols=259  Identities=22%  Similarity=0.389  Sum_probs=214.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |.+.+.||+|+||.||+|.++.++..||+|.+..... ........+.+|+.+++.++||||+++++.+..  +..+++|
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv   79 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCMV   79 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEEE
Confidence            3677999999999999999999999999998875432 223456678899999999999999999998854  4578999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      |||++|++|.++++..+.+++..+..++.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++......  
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcCcc
Confidence            999999999999998888999999999999999999999999  99999999999998 7889999999998532111  


Q ss_pred             ---------------CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-
Q 016143          185 ---------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-  247 (394)
Q Consensus       185 ---------------~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-  247 (394)
                                     ......|++.|+|||.+. ..++.++|||||||++|+|++|..||.+ .+..++...+..+..+ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~~~  235 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEW  235 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCC
Confidence                           011235788999999765 4688999999999999999999999986 4556666666554221 


Q ss_pred             CCCCCCCCHHHHHHHHHcCC-CCCCCCC---HHHHhcCCccccCCCCCc
Q 016143          248 ASLSKVTDPQVKQFIEKCIV-PASLRLP---ALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       248 ~~~~~~~~~~~~~li~~~L~-~p~~R~s---~~elL~~p~~~~~~~~~~  292 (394)
                      .......+.+++++|++||+ +|.+||+   +.++|+||||....+...
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~  284 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL  284 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHH
Confidence            22223567899999999998 8999998   799999999987665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-44  Score=323.66  Aligned_cols=253  Identities=26%  Similarity=0.436  Sum_probs=214.7

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEEEEc
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      .++||+|+|+.|-.+....+|.+||+|+|.+..    .-...++++|++++.+.+ |+||++++++|.++  ...|+|||
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~----gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd--~~FYLVfE  156 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP----GHSRSRVFREVETFYQCQGHKNILQLIEFFEDD--TRFYLVFE  156 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCC----chHHHHHHHHHHHHHHhcCCccHHHHHHHhccc--ceEEEEEe
Confidence            478999999999999999999999999997543    345678999999999995 99999999999665  46889999


Q ss_pred             ccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEcccceeeeecCC--
Q 016143          109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       109 ~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~--~~~kl~Dfgla~~~~~~--  184 (394)
                      -+.||+|...|+++..+++.++.++.+.|+.||.|||.+|  |.||||||+|||....+  .-+||+||.+.......  
T Consensus       157 Km~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~  234 (463)
T KOG0607|consen  157 KMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND  234 (463)
T ss_pred             cccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence            9999999999999999999999999999999999999999  99999999999997332  23899999998533211  


Q ss_pred             -------CCcccccCCcccCccccc---c---cCCCcCcchhhhhHHHHHHhcCCCCCCCC--------------CHHHH
Q 016143          185 -------TARSVIGTPEFMAPELYE---E---EYNELVDIYSFGMCILEMVTCEYPYNECK--------------NPAQI  237 (394)
Q Consensus       185 -------~~~~~~gt~~y~aPE~l~---~---~~~~~~DIwSlG~il~elltg~~Pf~~~~--------------~~~~~  237 (394)
                             ...+.+|+.+|||||+..   +   .|+.++|.||||||||-|+.|.+||.+.-              -...+
T Consensus       235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L  314 (463)
T KOG0607|consen  235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL  314 (463)
T ss_pred             CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence                   233567889999999643   3   48999999999999999999999996521              12577


Q ss_pred             HHHHhcCCC--CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCC
Q 016143          238 YKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK  290 (394)
Q Consensus       238 ~~~i~~~~~--~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~  290 (394)
                      +..|+.|.+  |..-+..++.+.+++|+.+|+ ++.+|.++.++|+|||++...+.
T Consensus       315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            889998855  444445678899999999998 99999999999999999876554

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3e-42  Score=324.71  Aligned_cols=250  Identities=25%  Similarity=0.436  Sum_probs=205.5

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|++|.||+|.++.+|..||+|.+.....  .....+.+.+|+.++++++||||+++++++.+.  ..+++||
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v~   79 (286)
T cd07847           4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLHLVF   79 (286)
T ss_pred             eeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEEEEE
Confidence            677899999999999999999999999998864432  222335577899999999999999999988654  5788999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC--
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~--  185 (394)
                      ||+++++|..++.....+++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++.......  
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCCccc
Confidence            99999999998887778999999999999999999999999  99999999999998 67899999999997665432  


Q ss_pred             CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc--C-----------------
Q 016143          186 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--G-----------------  244 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~--~-----------------  244 (394)
                      .....++..|+|||.+.+  .++.++||||||+++|+|++|+.||.+..+.+.+......  .                 
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            234568899999997754  4789999999999999999999999875554444332210  0                 


Q ss_pred             CC-CC--------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          245 IK-PA--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       245 ~~-~~--------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .. +.        ......+..+.+|+.+||. +|.+||++.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00 00        0012346789999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.9e-42  Score=318.70  Aligned_cols=249  Identities=33%  Similarity=0.614  Sum_probs=211.4

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|+||.||+|.+..++..||+|.+.....  .+...+.+.+|+.+++.++|+||+++++.+.  ....+++|+
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~lv~   78 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEV--HREKVYIFM   78 (264)
T ss_pred             eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEe--cCCEEEEEE
Confidence            678999999999999999999999999999876543  2457788999999999999999999999764  345788999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC-
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-  186 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~-  186 (394)
                      ||+++++|.+++.....+++..++.++.|++.||.|||+++  ++|+||+|+||+++ +++.+||+|||++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEcccccccccCCCCCc
Confidence            99999999999998878999999999999999999999999  99999999999998 688999999999976644321 


Q ss_pred             -----cccccCCcccCcccccc-c---CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC--CC
Q 016143          187 -----RSVIGTPEFMAPELYEE-E---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV--TD  255 (394)
Q Consensus       187 -----~~~~gt~~y~aPE~l~~-~---~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~--~~  255 (394)
                           ....+++.|+|||.+.+ .   ++.++||||||+++|+|++|..||....+.......+..+. ...++..  .+
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQLS  234 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC-CCCCCcccccC
Confidence                 13457899999998764 2   68899999999999999999999977555555544444432 2223333  47


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      +.+.++|.+||. +|.+||++.+++.|||+
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            899999999998 89999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.7e-42  Score=317.37  Aligned_cols=249  Identities=29%  Similarity=0.504  Sum_probs=211.0

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|++|.||+|.+..++..+|+|.+.....  .......+.+|+.+++.++||||+++++.+..  ...+++||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~   78 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM   78 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence            678999999999999999999999999999875443  33456789999999999999999999998754  45789999


Q ss_pred             cccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            999999999999864  34899999999999999999999999  99999999999998566678999999997665432


Q ss_pred             -CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          186 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       186 -~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                       .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||... +.......+..+... .++...++.+++++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~  234 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-NLPALVLKIMSGTFA-PISDRYSPDLRQLIL  234 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-chHHHHHHHHhcCCC-CCCCCcCHHHHHHHH
Confidence             334568999999998765 4788999999999999999999999774 444455555444322 344557889999999


Q ss_pred             HcCC-CCCCCCCHHHHhcCCcc
Q 016143          264 KCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       264 ~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      +||. +|.+||++.++|+||||
T Consensus       235 ~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         235 SMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHccCChhhCCCHHHHhhCCCC
Confidence            9998 99999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=320.88  Aligned_cols=250  Identities=23%  Similarity=0.420  Sum_probs=204.7

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHH-HHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~-l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      +.||+|+||.||+|.+..+|+.||+|.+....... ......+..|..+ ...++|+||+++++++..  ...+++|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~   78 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEY   78 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEec
Confidence            56999999999999999999999999986543211 2223344455544 445589999999998854  4578999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCccc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV  189 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~~  189 (394)
                      +.+++|.++++..+.+++..+..++.||+.||.|||+++  ++||||+|+||+++ +++.+||+|||++.....  ....
T Consensus        79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~--~~~~  153 (260)
T cd05611          79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE--NKKF  153 (260)
T ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEeecccceeccc--cccC
Confidence            999999999998888999999999999999999999999  99999999999998 688999999999875443  2334


Q ss_pred             ccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHcC
Q 016143          190 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       190 ~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~li~~~L  266 (394)
                      .|++.|+|||.+.+ .++.++||||||+++|+|++|..||.. .+..+.+..+..+.  .+.......++.+.+++++||
T Consensus       154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  232 (260)
T cd05611         154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL  232 (260)
T ss_pred             CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence            68899999997765 478999999999999999999999976 45555655554432  233344457889999999999


Q ss_pred             C-CCCCCCCH---HHHhcCCccccCCC
Q 016143          267 V-PASLRLPA---LELLKDPFLVTDNP  289 (394)
Q Consensus       267 ~-~p~~R~s~---~elL~~p~~~~~~~  289 (394)
                      . +|.+||++   .|+|.||||+..+|
T Consensus       233 ~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         233 CMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             cCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            8 99999955   79999999987654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.4e-42  Score=324.80  Aligned_cols=252  Identities=24%  Similarity=0.394  Sum_probs=208.0

Q ss_pred             ecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCC
Q 016143           33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS  112 (394)
Q Consensus        33 LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~  112 (394)
                      ||+|+||+||+|.+..+|+.||+|.+...... .......+.+|+.+|+.++||||+++++.+..  ...+++||||+++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNG   77 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCC
Confidence            69999999999999999999999998754322 22345567789999999999999999998854  3578999999999


Q ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-CCccc
Q 016143          113 GSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSV  189 (394)
Q Consensus       113 gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-~~~~~  189 (394)
                      ++|.+++.+..  .+++..+..++.|++.||.|||+++  ++||||+|+||+++ +++.++|+|||++...... .....
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~  154 (277)
T cd05577          78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGR  154 (277)
T ss_pred             CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccc
Confidence            99999998765  6999999999999999999999999  99999999999998 7889999999998655432 23345


Q ss_pred             ccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHc
Q 016143          190 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC  265 (394)
Q Consensus       190 ~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~  265 (394)
                      .++..|+|||.+.+ .++.++||||||+++|+|++|+.||.....   ...+...+..  .+...+...++.+.++|++|
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~  232 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL  232 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence            68889999997654 588999999999999999999999976432   2233332222  23345566789999999999


Q ss_pred             CC-CCCCCC-----CHHHHhcCCccccCCCCCc
Q 016143          266 IV-PASLRL-----PALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       266 L~-~p~~R~-----s~~elL~~p~~~~~~~~~~  292 (394)
                      |. +|.+||     ++.+++.||||...++...
T Consensus       233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~  265 (277)
T cd05577         233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL  265 (277)
T ss_pred             ccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence            98 999999     8999999999988766544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-45  Score=377.97  Aligned_cols=252  Identities=30%  Similarity=0.532  Sum_probs=223.2

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ..+-.||.|.||.||.|.+..+|+..|+|.++..+..  ......+.+|+.++..|+|||+|++|++=++.  ..++|.|
T Consensus      1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--ekv~IFM 1313 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--EKVYIFM 1313 (1509)
T ss_pred             ccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecH--HHHHHHH
Confidence            4567899999999999999999999999998876643  34455677899999999999999999965544  4567788


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC--
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~--  185 (394)
                      |||++|+|.++++.++-.++...+.+..|++.|+.|||++|  ||||||||.|||++ .+|.+|++|||.|....+..  
T Consensus      1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee-cCCcEEeecccceeEecCchhc
Confidence            99999999999999888899999999999999999999999  99999999999999 78899999999997766542  


Q ss_pred             ----CcccccCCcccCcccccc----cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          186 ----ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       186 ----~~~~~gt~~y~aPE~l~~----~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                          .+...|||.|||||++.+    ....+.|||||||++.||+||+.||....+..+++.++..|.+|. +|...+++
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq-~P~~ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ-IPERLSSE 1469 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC-CchhhhHh
Confidence                346789999999998865    356799999999999999999999999999999999999998776 45558899


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          258 VKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      -++||+.||. ||..|.++.|||.|.|-+..
T Consensus      1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             HHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            9999999998 99999999999999987654

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.3e-42  Score=317.53  Aligned_cols=248  Identities=27%  Similarity=0.496  Sum_probs=211.2

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|+||+||++.+..+|..||+|.+.....  .......+.+|+.++++++||||+++++++.+  ....++|+
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~   78 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM   78 (256)
T ss_pred             eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence            778999999999999999999999999999875433  23445678899999999999999999998844  45789999


Q ss_pred             cccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          108 ELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      ||+.+++|.+++....  .+++.++..|+.|++.||.|||+++  ++|+||+|+||+++ .++.++|+|||++.......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecCcch
Confidence            9999999999987643  5899999999999999999999999  99999999999998 67899999999997664432


Q ss_pred             --CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          186 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                        .....|++.|+|||.+.+ .++.++|+|||||++|+|++|..||.. .+...+...+..+..+. .+...+..+.++|
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li  233 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPP-VSSHYSYDLRNLV  233 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCCCC-CcccCCHHHHHHH
Confidence              234568999999997764 578899999999999999999999976 45555666665554332 3456678999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCcc
Q 016143          263 EKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .+||. +|.+||++.++|.||||
T Consensus       234 ~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         234 SQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHhhCChhhCcCHHHHhhCcCC
Confidence            99998 89999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-44  Score=344.24  Aligned_cols=233  Identities=32%  Similarity=0.489  Sum_probs=197.6

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      +.||+|+.|.||+|..+  ++.||||+++--+        +   .+++-|++|+|||||.|.+++  ...-.++||||||
T Consensus       130 eWlGSGaQGAVF~Grl~--netVAVKKV~elk--------E---TdIKHLRkLkH~NII~FkGVC--tqsPcyCIiMEfC  194 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH--NETVAVKKVRELK--------E---TDIKHLRKLKHPNIITFKGVC--TQSPCYCIIMEFC  194 (904)
T ss_pred             hhhccCcccceeeeecc--CceehhHHHhhhh--------h---hhHHHHHhccCcceeeEeeee--cCCceeEEeeecc
Confidence            56999999999999754  8899999875211        1   278899999999999999987  4445789999999


Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-CCccc
Q 016143          111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSV  189 (394)
Q Consensus       111 ~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-~~~~~  189 (394)
                      ..|-|...++....++......|..+|+.|+.|||.+.  |||||||.-||||+ .+..|||+|||.++..... ..-++
T Consensus       195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs-~~d~VKIsDFGTS~e~~~~STkMSF  271 (904)
T KOG4721|consen  195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILIS-YDDVVKISDFGTSKELSDKSTKMSF  271 (904)
T ss_pred             ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEee-ccceEEeccccchHhhhhhhhhhhh
Confidence            99999999999999999999999999999999999999  99999999999998 6779999999999766544 45578


Q ss_pred             ccCCcccCccccccc-CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-
Q 016143          190 IGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-  267 (394)
Q Consensus       190 ~gt~~y~aPE~l~~~-~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-  267 (394)
                      +||..|||||++.++ .++++|||||||+|||||||+.||.+-...+.++ -+-.+......+...+.-++-||+.||. 
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-GVGsNsL~LpvPstcP~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-GVGSNSLHLPVPSTCPDGFKLLLKQCWNS  350 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-eccCCcccccCcccCchHHHHHHHHHHhc
Confidence            999999999988765 7999999999999999999999997633322222 2222222334566778899999999998 


Q ss_pred             CCCCCCCHHHHhcCC
Q 016143          268 PASLRLPALELLKDP  282 (394)
Q Consensus       268 ~p~~R~s~~elL~~p  282 (394)
                      +|..||+..++|.|-
T Consensus       351 KpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  351 KPRNRPSFRQILLHL  365 (904)
T ss_pred             CCCCCccHHHHHHHH
Confidence            999999999999983

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.1e-42  Score=327.72  Aligned_cols=258  Identities=23%  Similarity=0.338  Sum_probs=207.9

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +..+| ++.+.||+|+||.||+|.++.+|..||+|.+......  ......+.+|+.++++++|+||+++++++.+....
T Consensus         5 ~~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           5 SVTEF-EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             cccce-eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            44555 7788999999999999999999999999998754421  12223456799999999999999999998776666


Q ss_pred             eEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      .+++||||+. ++|.+++... ..+++.++..++.||+.||.|||+++  ++||||||+||+++ +++.+||+|||++..
T Consensus        82 ~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~~  157 (309)
T cd07845          82 SIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLART  157 (309)
T ss_pred             eEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceeee
Confidence            7899999996 5888887763 56999999999999999999999999  99999999999998 788999999999977


Q ss_pred             ecCC--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-C--------
Q 016143          181 MQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P--------  247 (394)
Q Consensus       181 ~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~-~--------  247 (394)
                      ....  ......+++.|+|||.+.+  .++.++|||||||++|+|++|+.||.... ..+.+..+..... +        
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-EIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCChhhchhh
Confidence            6543  2233456889999998754  47899999999999999999999998744 3433333322100 0        


Q ss_pred             -------------CCC------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          248 -------------ASL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       248 -------------~~~------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                   ..+      ....++.+.++|.+||. +|.+||++.++|.||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence                         000      01247889999999998 99999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-43  Score=354.10  Aligned_cols=246  Identities=21%  Similarity=0.386  Sum_probs=202.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEee-eEEcC---C-C
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYN-SWVDD---T-N  100 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~-~~~~~---~-~  100 (394)
                      +++.+.|.+|||+.||+|.+...|..||+|.+...    ++..++.+.+||.+|+.|+ |+|||.|++ +....   . .
T Consensus        39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            47789999999999999999888899999987644    4788899999999999997 999999999 33322   1 2


Q ss_pred             ceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          101 RTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ..+++.||||.||.|-+++..+  .+|++.++++|++|+++|+.+||...|||||||||-+||||+ .+|+.||||||.|
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCccccc
Confidence            3578999999999999998843  459999999999999999999999999999999999999998 7889999999999


Q ss_pred             eeecCCC--Cc---------ccccCCcccCccccc---c-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 016143          179 IVMQQPT--AR---------SVIGTPEFMAPELYE---E-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS  243 (394)
Q Consensus       179 ~~~~~~~--~~---------~~~gt~~y~aPE~l~---~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~  243 (394)
                      +......  ..         ....|+.|+|||++.   + ..++|+|||+|||+||-||....||.+....     .|..
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----aIln  268 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----AILN  268 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----eEEe
Confidence            5332221  11         123699999999764   3 4899999999999999999999999874332     2333


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCC
Q 016143          244 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  282 (394)
Q Consensus       244 ~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p  282 (394)
                      +.+.......++..+++||..||+ +|.+||.+.+++.+-
T Consensus       269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence            333222234567899999999998 999999999988753

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-42  Score=337.54  Aligned_cols=244  Identities=25%  Similarity=0.378  Sum_probs=192.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.+..++..||+|+....          ....|+.++++++||||+++++++...  ...++|
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv  135 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSG--AITCMV  135 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeC--CeeEEE
Confidence            47889999999999999999999999999974321          134599999999999999999988654  467889


Q ss_pred             EcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          107 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      +||+. ++|.+++.. ...+++..++.|+.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++...... 
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEecCccccccccCc
Confidence            99995 578877765 466999999999999999999999999  99999999999998 7889999999999654332 


Q ss_pred             CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCC-CCCCC---------HHHHHHHHhc-CCCCCCCC-
Q 016143          185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKN---------PAQIYKKVTS-GIKPASLS-  251 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf-~~~~~---------~~~~~~~i~~-~~~~~~~~-  251 (394)
                      ......||+.|+|||++.+ .++.++|||||||++|||+++..|+ .....         ...+...+.. +..+..++ 
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            3345679999999997764 5899999999999999999865444 32111         1122222111 11111111 


Q ss_pred             -----------------------------CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          252 -----------------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       252 -----------------------------~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                                                   ...+..+.+||.+||. +|.+|||+.|+|+||||+.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                         1235567789999998 9999999999999999975

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-42  Score=341.60  Aligned_cols=249  Identities=22%  Similarity=0.324  Sum_probs=198.9

Q ss_pred             ccccceecccCceEEEEEEEc--cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      |++.+.||+|+||+||+|...  .++..||+|.+...         ....+|+.+|++|+||||++++++|..+  ..++
T Consensus        94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~  162 (392)
T PHA03207         94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWK--STVC  162 (392)
T ss_pred             eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeC--CEEE
Confidence            478899999999999999753  45688999987532         1245699999999999999999988544  5788


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      +|||++. ++|.+++.....+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++......
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCccccccCcc
Confidence            9999995 789999987788999999999999999999999999  99999999999998 7889999999999765433


Q ss_pred             C----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCC---HHHHHHHHh---c----------
Q 016143          185 T----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVT---S----------  243 (394)
Q Consensus       185 ~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~---~~~~~~~i~---~----------  243 (394)
                      .    .....||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+...   ..++...+.   .          
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            2    234579999999998765 589999999999999999999999966332   112211111   0          


Q ss_pred             ------------CCCC-CCC-----CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCC
Q 016143          244 ------------GIKP-ASL-----SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK  290 (394)
Q Consensus       244 ------------~~~~-~~~-----~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~  290 (394)
                                  ...+ ..+     ....+.++++||++||. +|.+||++.++|.||||+...+.
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~  384 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN  384 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence                        0000 000     12345688999999998 99999999999999999875443

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.8e-42  Score=319.62  Aligned_cols=248  Identities=31%  Similarity=0.526  Sum_probs=206.8

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||.|+||+||+|....++..+|+|.+.....   ......+.+|+.+++.++|+||+++++.+.+.  ...++|
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv   77 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELWLV   77 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEEEE
Confidence            4788999999999999999988999999998864432   23567789999999999999999999988654  578899


Q ss_pred             EcccCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          107 TELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~---~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +|++++++|.+++...   ..+++..+..++.||+.||.|||+++  ++||||+|+||+++ +++.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLG-EDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccchHHHhcc
Confidence            9999999999999864   45899999999999999999999999  99999999999998 678999999999865543


Q ss_pred             CC------CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC----
Q 016143          184 PT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS----  251 (394)
Q Consensus       184 ~~------~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~----  251 (394)
                      ..      .....|++.|+|||.+..  .++.++|+||||+++|+|++|+.||....... .+........+ .+.    
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~  232 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPP-SLETGAD  232 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCC-CcCCccc
Confidence            32      133568999999997764  47899999999999999999999998754433 33333333211 111    


Q ss_pred             -CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          252 -KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       252 -~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                       ...++.+++++.+||. +|.+||++.+++.||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence             2457899999999998 89999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.6e-42  Score=325.65  Aligned_cols=261  Identities=28%  Similarity=0.467  Sum_probs=213.8

Q ss_pred             ccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEE
Q 016143           17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV   96 (394)
Q Consensus        17 ~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~   96 (394)
                      +...+|..+| +..+.||+|+||+||+|.+..+|..||+|.+..... ...+....+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~   85 (307)
T cd06607           8 FSKDDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL   85 (307)
T ss_pred             hcCCCcchhh-hhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence            4456777776 677999999999999999999999999999864432 23455667889999999999999999999987


Q ss_pred             cCCCceEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143           97 DDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus        97 ~~~~~~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                      +.  ...++|+||+. |+|.+++.. ...+++..+..++.||+.||.|||+++  ++||||+|+||+++ +++.++|+||
T Consensus        86 ~~--~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~-~~~~~kL~df  159 (307)
T cd06607          86 RE--HTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADF  159 (307)
T ss_pred             eC--CeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEC-CCCCEEEeec
Confidence            54  46789999996 567676654 456999999999999999999999999  99999999999998 7889999999


Q ss_pred             ceeeeecCCCCcccccCCcccCccccc----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 016143          176 GLAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS  251 (394)
Q Consensus       176 gla~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~  251 (394)
                      |++......  ....|++.|+|||.+.    +.++.++||||||+++|+|++|..||... +.......+.....+....
T Consensus       160 g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~  236 (307)
T cd06607         160 GSASLVSPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDSPTLSS  236 (307)
T ss_pred             CcceecCCC--CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCCCCCCCc
Confidence            998655433  3456889999999763    35788999999999999999999999764 3333333444333333334


Q ss_pred             CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       252 ~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ..++..++++|.+||. +|.+||++.+++.||||....
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            4567899999999998 899999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.1e-42  Score=338.51  Aligned_cols=246  Identities=23%  Similarity=0.369  Sum_probs=202.4

Q ss_pred             ccccceecccCceEEEEEEE-----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCC
Q 016143           27 GRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN  100 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~  100 (394)
                      +++.+.||+|+||+||+|.+     ..++..||+|+++...   .....+.+.+|+.+|+.+ +||||+++++++.+.  
T Consensus        37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--  111 (375)
T cd05104          37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTVG--  111 (375)
T ss_pred             eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence            37899999999999999964     4567789999886432   234456788999999999 899999999988554  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCC---------------------------------------------------------
Q 016143          101 RTINMITELFTSGSLRQYRKKHK---------------------------------------------------------  123 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~---------------------------------------------------------  123 (394)
                      ...++||||+++|+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            46889999999999999986432                                                         


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          124 ------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       124 ------------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                                        .+++..+..++.||+.||.|||+++  |+||||||+|||++ +++.+||+|||++.......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEE-CCCcEEEecCccceeccCcc
Confidence                              3788899999999999999999999  99999999999998 68899999999997664432


Q ss_pred             Cc----ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          186 AR----SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       186 ~~----~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ..    ...+++.|+|||.+.+ .++.++|||||||++|||++ |..||..........+.+..+..+. .+...+.+++
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~  347 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-SPECAPSEMY  347 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-CCCCCCHHHH
Confidence            21    2234568999997754 58999999999999999998 8999987666666677776664332 3445678999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhcC
Q 016143          260 QFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +++.+||. +|.+||++.++++.
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHHH
Confidence            99999998 99999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.1e-42  Score=322.80  Aligned_cols=253  Identities=28%  Similarity=0.468  Sum_probs=202.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHH-HHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~-l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      +++.+.||+|+||.||+|.++.+|..||+|.++....  .... .++..|+.+ ++.++||||+++++++..+  ..+++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~l   77 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWI   77 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEE
Confidence            3677899999999999999999999999999865422  2222 345556554 6777999999999988654  46889


Q ss_pred             EEcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          106 ITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~-~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      +|||++ |+|.+++..    ...+++..++.++.||+.||.|||++ +  ++||||||+||+++ .++.+||+|||++..
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~~~  153 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGISGY  153 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecccccc
Confidence            999996 688777654    24689999999999999999999997 7  99999999999998 688999999999976


Q ss_pred             ecCCCC-cccccCCcccCcccccc-----cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          181 MQQPTA-RSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       181 ~~~~~~-~~~~gt~~y~aPE~l~~-----~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      ...... ....|+..|+|||.+.+     .++.++|+|||||++|+|++|+.||....+..+....+..+..+.......
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd06617         154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF  233 (283)
T ss_pred             cccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence            544332 23568999999998753     367899999999999999999999976444333333433433333223456


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +.++.++|.+||. +|.+||++.+++.||||+...
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            7899999999998 999999999999999999764

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.3e-42  Score=317.86  Aligned_cols=251  Identities=29%  Similarity=0.541  Sum_probs=216.9

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|++|.||+|.+..++..|++|++.....   ......+.+|+..+.+++|+||+++++++...  ..+++|+
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~   78 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVL   78 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEE
Confidence            567999999999999999999999999999875432   24567789999999999999999999988654  5789999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA  186 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~  186 (394)
                      ||+++++|.+++.....+++..+..++.||+.||.|||+ ++  ++||||+|+||+++ .++.++|+|||++........
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEEC-CCCCEEEccCccceecccCCC
Confidence            999999999999988889999999999999999999999 99  99999999999998 688999999999976654432


Q ss_pred             c--ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCC--CHHHHHHHHhcCCCCCCCCCC-CCHHHHH
Q 016143          187 R--SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLSKV-TDPQVKQ  260 (394)
Q Consensus       187 ~--~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~--~~~~~~~~i~~~~~~~~~~~~-~~~~~~~  260 (394)
                      .  ...++..|+|||.+.+ .++.++|+||||+++|+|++|..||....  ...+....+.....+. ++.. .+..+.+
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~  234 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS-LPAEEFSPEFRD  234 (264)
T ss_pred             cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC-CCcccCCHHHHH
Confidence            2  4568999999997765 47889999999999999999999998764  5566666666544333 3444 7789999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          261 FIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      +|.+||. +|.+||++.+++.|||++..
T Consensus       235 li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         235 FISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            9999998 89999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=343.91  Aligned_cols=265  Identities=23%  Similarity=0.386  Sum_probs=239.3

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ...||-||||.|-++..+.....+|+|++++..+.+ ..+.+.++.|-++|..++.|.||++|..|-  +.+++||+||-
T Consensus       425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfr--d~kyvYmLmEa  501 (732)
T KOG0614|consen  425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFR--DSKYVYMLMEA  501 (732)
T ss_pred             hhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhc--cchhhhhhHHh
Confidence            357999999999999877666679999998777655 456688999999999999999999999984  45789999999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-CCcc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS  188 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-~~~~  188 (394)
                      |-||.|+..++..+.++...++.++..+++|+.|||++|  ||+|||||+|.+++ .+|-+||.|||+|+..... ...+
T Consensus       502 ClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~KTwT  578 (732)
T KOG0614|consen  502 CLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGRKTWT  578 (732)
T ss_pred             hcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhccCCceee
Confidence            999999999999999999999999999999999999999  99999999999999 8999999999999877654 5778


Q ss_pred             cccCCcccCcc-cccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC
Q 016143          189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  267 (394)
Q Consensus       189 ~~gt~~y~aPE-~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~  267 (394)
                      +||||+|.||| ++++..+.++|.||||+++|||++|.+||++ .++...|..|.+|+.-..+|+.+...+.++|+++..
T Consensus       579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr  657 (732)
T KOG0614|consen  579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCR  657 (732)
T ss_pred             ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHh
Confidence            99999999999 5677899999999999999999999999988 889999999999988888999999999999998776


Q ss_pred             -CCCCCCC-----HHHHhcCCccccCCCCCcccCCCCCCC
Q 016143          268 -PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPN  301 (394)
Q Consensus       268 -~p~~R~s-----~~elL~~p~~~~~~~~~~~~~~~~~p~  301 (394)
                       .|.+|+.     +.++-+|.||...+|..+....++.|.
T Consensus       658 ~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi  697 (732)
T KOG0614|consen  658 DNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPI  697 (732)
T ss_pred             cCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCc
Confidence             8999886     889999999999999988776665554

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.9e-42  Score=322.65  Aligned_cols=250  Identities=23%  Similarity=0.410  Sum_probs=205.1

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|++|.||+|.++.+|..||+|.+.....  .......+.+|+.+++.++||||+++++++.+  ...+++|+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~   78 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM   78 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence            788999999999999999999999999999876542  23345678899999999999999999998865  45789999


Q ss_pred             cccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      ||+ +++|.+++... ..+++.+++.++.||+.||.|||+++  ++|+||||+||+++ .++.++|+|||++....... 
T Consensus        79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEc-CCCcEEEeeeeecccccCCCC
Confidence            999 99999998653 56999999999999999999999999  99999999999998 68899999999997665443 


Q ss_pred             --CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--------------
Q 016143          186 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--------------  247 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--------------  247 (394)
                        .....|+..|+|||.+.+  .++.++||||+||++|+|++|.+||....+.......+.....+              
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence              334568999999997753  36899999999999999999988887644433332222110000              


Q ss_pred             -------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccc
Q 016143          248 -------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  285 (394)
Q Consensus       248 -------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~  285 (394)
                                   .......+..+.++|++||. +|.+||++.++|+||||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                         00112346789999999998 999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.2e-42  Score=319.75  Aligned_cols=244  Identities=20%  Similarity=0.333  Sum_probs=202.1

Q ss_pred             ccccceecccCceEEEEEEEc---cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      +++.++||+|+||.||+|.++   ..+..||+|.++...   +....+.+.+|+.+++.++||||+++++++..  ...+
T Consensus         7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   81 (266)
T cd05064           7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNTM   81 (266)
T ss_pred             eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCCc
Confidence            478899999999999999765   456789999886432   34455678899999999999999999998854  3568


Q ss_pred             EEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+++  ++||||||+||+++ .++.+|++|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~-~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVN-SDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEc-CCCcEEECCCccccccc
Confidence            8999999999999999874 56899999999999999999999999  99999999999998 68899999999875543


Q ss_pred             CCC---CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          183 QPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       183 ~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      ...   .....+++.|+|||.+. +.++.++|||||||++|||++ |+.||.+ .+...+.+.+..+..++ .+...+..
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~  236 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD-MSGQDVIKAVEDGFRLP-APRNCPNL  236 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHCCCCCC-CCCCCCHH
Confidence            221   11233567899999765 468999999999999999775 9999987 44555666666654333 45667889


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          258 VKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +.+++.+||. +|.+||++.++++
T Consensus       237 ~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         237 LHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHcCCCchhCCCHHHHHH
Confidence            9999999998 8999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9e-42  Score=329.77  Aligned_cols=263  Identities=26%  Similarity=0.373  Sum_probs=210.6

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHH----------HHHHHHHHHHHHHcCCCCCce
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD----------QLERLYSEVHLLKSLKHENII   89 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~----------~~~~~~~E~~~l~~L~hpnIv   89 (394)
                      .+..+||..+.+.||+|+||+||+|.++.+++.||+|++..........          ....+.+|+.++++++||||+
T Consensus         4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   83 (335)
T PTZ00024          4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM   83 (335)
T ss_pred             cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence            3567899888899999999999999999999999999986543221110          012467899999999999999


Q ss_pred             eEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 016143           90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE  169 (394)
Q Consensus        90 ~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~  169 (394)
                      ++++++..+  ..+++||||+. |+|.+++.....+++..+..++.||+.||.|||+++  ++|+||+|+||+++ .++.
T Consensus        84 ~~~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~~  157 (335)
T PTZ00024         84 GLVDVYVEG--DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGI  157 (335)
T ss_pred             eeeEEEecC--CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCCC
Confidence            999988644  57889999996 699999988888999999999999999999999999  99999999999998 7889


Q ss_pred             EEEcccceeeeecCC----------------CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCC
Q 016143          170 VKIGDLGLAIVMQQP----------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC  231 (394)
Q Consensus       170 ~kl~Dfgla~~~~~~----------------~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~  231 (394)
                      ++|+|||++.....+                ......+++.|+|||.+.+  .++.++|||||||++|+|++|..||...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999765411                1223356889999997754  3688999999999999999999999875


Q ss_pred             CCHHHHHHHHhc--CCCCC-----------------------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccc
Q 016143          232 KNPAQIYKKVTS--GIKPA-----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  285 (394)
Q Consensus       232 ~~~~~~~~~i~~--~~~~~-----------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~  285 (394)
                      .....+......  ...+.                       ......+.++.++|.+||. +|.+||+++++|.||||+
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~  317 (335)
T PTZ00024        238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK  317 (335)
T ss_pred             CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence            444333222111  00000                       0012346789999999998 999999999999999998


Q ss_pred             cCC
Q 016143          286 TDN  288 (394)
Q Consensus       286 ~~~  288 (394)
                      ...
T Consensus       318 ~~~  320 (335)
T PTZ00024        318 SDP  320 (335)
T ss_pred             CCC
Confidence            653

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.9e-42  Score=326.36  Aligned_cols=261  Identities=32%  Similarity=0.541  Sum_probs=213.7

Q ss_pred             cccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEc
Q 016143           18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD   97 (394)
Q Consensus        18 ~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~   97 (394)
                      ...++.++| .+.+.||+|+||+||+|.+..++..||+|.+....    ....+.+.+|+.+++.++||||+++++.+.+
T Consensus        13 ~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~   87 (293)
T cd06647          13 SVGDPKKKY-TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLV   87 (293)
T ss_pred             eccCchhhc-eeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeee
Confidence            345666777 67799999999999999998899999999986432    2344678899999999999999999998865


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                      .  ...++|+||+++++|.+++.+. .+++..+..++.|++.||.|||+++  ++|+||||+||+++ .++.++|+|||+
T Consensus        88 ~--~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg~  161 (293)
T cd06647          88 G--DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGF  161 (293)
T ss_pred             C--CcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCcc
Confidence            4  4688999999999999998765 4889999999999999999999999  99999999999998 688999999999


Q ss_pred             eeeecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          178 AIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       178 a~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      +......  ......|++.|+|||.+.. .++.++|+||||+++|+|++|+.||.......++......+......+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd06647         162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL  241 (293)
T ss_pred             eecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCcccc
Confidence            8655433  2234568999999997654 588999999999999999999999976443333322222222222233445


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +..++++|++||. +|.+||++.+++.||||+...+
T Consensus       242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence            7889999999998 8999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=341.68  Aligned_cols=241  Identities=34%  Similarity=0.529  Sum_probs=208.1

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|+||+||+|++-.   .||||+++....  +++..+.|.+||.++++-+|.||+=|.+++...   .+.||+
T Consensus       395 ~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p---~~AIiT  466 (678)
T KOG0193|consen  395 LLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP---PLAIIT  466 (678)
T ss_pred             hccceeccccccceeeccccc---ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC---ceeeee
Confidence            567889999999999998864   599999987764  567999999999999999999999999988543   348999


Q ss_pred             cccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec----
Q 016143          108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----  182 (394)
Q Consensus       108 e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~----  182 (394)
                      .+|+|.+|..++.-. .+|++.+.+.|++||+.|+.|||.++  |||||||..|||+. ++++|||+|||++..-.    
T Consensus       467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTRWSG  543 (678)
T ss_pred             hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCCcEEEecccceeeeeeecc
Confidence            999999999998754 46999999999999999999999999  99999999999998 67999999999995432    


Q ss_pred             CCCCcccccCCcccCcccccc----cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCC
Q 016143          183 QPTARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PASLSKVTD  255 (394)
Q Consensus       183 ~~~~~~~~gt~~y~aPE~l~~----~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~---~~~~~~~~~  255 (394)
                      ........|...|||||++..    +|+..+||||||+++|||+||..||. ..+.++++-.+.+|..   ........+
T Consensus       544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~p  622 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCP  622 (678)
T ss_pred             ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCH
Confidence            223344557889999997753    58999999999999999999999999 6899999999999843   333344566


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .++++|+..||. ++.+||...+||.
T Consensus       623 k~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  623 KAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHHhcCcccCccHHHHHH
Confidence            799999999999 9999999999887

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.8e-42  Score=318.21  Aligned_cols=249  Identities=26%  Similarity=0.464  Sum_probs=209.3

Q ss_pred             ecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCC
Q 016143           33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS  112 (394)
Q Consensus        33 LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~  112 (394)
                      ||+|+||+||+|.+..+|..||+|.+..... ......+.+.+|+.++++++||||+++++.+..  ...+++++||+.+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPG   77 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCC
Confidence            6899999999999999999999999865432 224566788999999999999999999998754  4578999999999


Q ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--------
Q 016143          113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--------  184 (394)
Q Consensus       113 gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--------  184 (394)
                      ++|.+++.+.+.+++..+..++.||+.||.|||+++  ++|+||+|+||+++ +++.++|+|||++......        
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc-CCCCEEEEecccchhcccCcccccccc
Confidence            999999998888999999999999999999999999  99999999999998 6889999999998654333        


Q ss_pred             --CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          185 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       185 --~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                        ......+++.|+|||.+.. .++.++||||||+++|+|++|..||.. ......+..+..+..+.......+..+.++
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL  233 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence              2233568889999997654 578899999999999999999999976 455666666655432221122247899999


Q ss_pred             HHHcCC-CCCCCCCH---HHHhcCCccccCC
Q 016143          262 IEKCIV-PASLRLPA---LELLKDPFLVTDN  288 (394)
Q Consensus       262 i~~~L~-~p~~R~s~---~elL~~p~~~~~~  288 (394)
                      +++||. +|.+||++   .++|+||||+..+
T Consensus       234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             HHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence            999998 89999999   9999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.2e-42  Score=321.51  Aligned_cols=256  Identities=30%  Similarity=0.555  Sum_probs=213.8

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +.+.| +..+.||+|+||.||+|.+..++..||+|.+....   .......+.+|+.++++++||||+++++++.+.  .
T Consensus         2 ~~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~   75 (277)
T cd06640           2 PEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--T   75 (277)
T ss_pred             hHHhh-hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--C
Confidence            34455 55678999999999999999999999999887543   245567889999999999999999999988654  5


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .+++||||+++++|.+++... .+++.++..++.|++.||.|||+++  ++|+||+|+||+++ .++.++|+|||++...
T Consensus        76 ~~~lv~e~~~~~~L~~~i~~~-~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~  151 (277)
T cd06640          76 KLWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQL  151 (277)
T ss_pred             EEEEEEecCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEcccccceec
Confidence            789999999999999998764 5899999999999999999999999  99999999999998 7889999999999765


Q ss_pred             cCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          182 QQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       182 ~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                      ....  .....++..|+|||.+.+ .++.++|+|||||++|+|++|..||.+. ++......+..+. ++.+....+..+
T Consensus       152 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~  229 (277)
T cd06640         152 TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIPKNN-PPTLTGEFSKPF  229 (277)
T ss_pred             cCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc-ChHhHhhhhhcCC-CCCCchhhhHHH
Confidence            4432  233468899999997754 5789999999999999999999999874 3444444443332 334455667899


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          259 KQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      .+++.+||. +|.+||++.++++||||.....
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         230 KEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             HHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence            999999998 8999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-42  Score=344.53  Aligned_cols=244  Identities=23%  Similarity=0.324  Sum_probs=196.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||.||+|.+..+++.||+|....          ..+.+|+++|++|+|+|||++++++...  ...++|
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~lv  238 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLTCLV  238 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEEE
Confidence            4788999999999999999999999999996431          2345799999999999999999987654  467889


Q ss_pred             EcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      ||++. ++|..++... ..+++.+++.|+.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+++......
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVN-GPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEEC-CCCCEEEcccCCceeccccc
Confidence            99995 6888887664 46999999999999999999999999  99999999999998 67899999999997654332


Q ss_pred             ----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCC-C------CCHHHHHHHHhcCCCC-CC---
Q 016143          186 ----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNE-C------KNPAQIYKKVTSGIKP-AS---  249 (394)
Q Consensus       186 ----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~-~------~~~~~~~~~i~~~~~~-~~---  249 (394)
                          .....||+.|+|||++.+ .++.++|||||||+||||++|..|+.. .      ....++...+...... ..   
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence                223569999999998765 589999999999999999998765422 1      1123444444332110 00   


Q ss_pred             --------------------------CC--CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          250 --------------------------LS--KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       250 --------------------------~~--~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                                                |.  ...+..+.+||.+||. ||.+|||+.|+|+||||+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                      10  1235689999999999 9999999999999999974

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=311.34  Aligned_cols=253  Identities=23%  Similarity=0.295  Sum_probs=202.8

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC---CC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD---TN  100 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~---~~  100 (394)
                      +..||+.+.||+|||+.||++....++..||+|++....    .+..+..++|++..++++|||+++++++.+.+   ..
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            344499999999999999999999999999999987543    57788899999999999999999999876543   23


Q ss_pred             ceEEEEEcccCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccc
Q 016143          101 RTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG  176 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~----~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfg  176 (394)
                      ...|++++|+..|+|.+.++..    ..+++.++..|+.+|++||++||+..+|+.||||||.||++. +.+.++|.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-DSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec-CCCceEEEecc
Confidence            5689999999999999998753    359999999999999999999999999999999999999998 68999999999


Q ss_pred             eeeeecCC-----CC------cccccCCcccCccccccc----CCCcCcchhhhhHHHHHHhcCCCCCCCCCH-HHHHHH
Q 016143          177 LAIVMQQP-----TA------RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYKK  240 (394)
Q Consensus       177 la~~~~~~-----~~------~~~~gt~~y~aPE~l~~~----~~~~~DIwSlG~il~elltg~~Pf~~~~~~-~~~~~~  240 (394)
                      .++.....     .+      .....|..|.|||++.-+    .++++|||||||+||+|+.|..||...... ..+.-.
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA  254 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA  254 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence            98654321     10      112368899999998743    679999999999999999999999541100 000011


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       241 i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +..+.....-...++..+.++|+.||+ ||.+||++.+++.+
T Consensus       255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            112111111123378899999999998 99999999999874

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.3e-42  Score=323.08  Aligned_cols=250  Identities=26%  Similarity=0.453  Sum_probs=202.9

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |+..+.||+|++|.||+|.++.+|..||+|.+.....  .......+.+|+.++++++||||+++++++.+  ...+++|
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v   77 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV   77 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEE
Confidence            3677899999999999999999999999998865432  22344568889999999999999999998754  4578899


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+. ++|..++...  ..+++..++.++.||+.||.|||+++  ++|+||+|+||+++ .++.+||+|||++......
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEeeccchhhcccC
Confidence            99995 6898888653  56899999999999999999999999  99999999999998 7889999999998755433


Q ss_pred             --CCcccccCCcccCcccccc-c-CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC------------
Q 016143          185 --TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA------------  248 (394)
Q Consensus       185 --~~~~~~gt~~y~aPE~l~~-~-~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~------------  248 (394)
                        ......+++.|+|||.+.+ . ++.++|||||||++|+|+||+.||..........+.+.....+.            
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence              2233457889999997764 2 68899999999999999999999987554444433332111000            


Q ss_pred             --------------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          249 --------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       249 --------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                    ......+++++++|.+||. +|.+||++.++|.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                          1122457889999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.4e-41  Score=322.59  Aligned_cols=253  Identities=26%  Similarity=0.418  Sum_probs=206.5

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccC-CHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      .+.+.||+|++|.||+|.+..+|..||+|.+....... .......+.+|+.+++.++|+||+++++++.+  ...+++|
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv   80 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNINLV   80 (298)
T ss_pred             eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEEEE
Confidence            56788999999999999999999999999987654321 12234557789999999999999999999865  4578999


Q ss_pred             EcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          107 TELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      |||+ +++|.+++.... .+++..+..++.||+.||.|||+++  ++|+||+|+||+++ .++.++|+|||++...... 
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEc-CCCCEEEccceeeeeccCCC
Confidence            9999 899999998776 7999999999999999999999999  99999999999999 6889999999999776543 


Q ss_pred             -CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CC-------------
Q 016143          185 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-KP-------------  247 (394)
Q Consensus       185 -~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~-~~-------------  247 (394)
                       ......+++.|+|||.+.+  .++.++|||||||++|+|++|.+||.+...... +.++.... .+             
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-LGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-HHHHHHHcCCCchhhhhhcccccc
Confidence             2233457889999997753  478999999999999999999888876444333 22222110 00             


Q ss_pred             ------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          248 ------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       248 ------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                  .......+..+.++|.+||. +|.+||++.++|.||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~  288 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND  288 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence                        00113346789999999998 99999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-41  Score=324.27  Aligned_cols=247  Identities=24%  Similarity=0.345  Sum_probs=195.3

Q ss_pred             cccccccceecccCceEEEEEEEcc----------------CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEV----------------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN   87 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpn   87 (394)
                      ++| ++.+.||+|+||.||+|.+..                ++..||+|.+....   .......+.+|+.+|++++|||
T Consensus         5 ~~~-~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           5 GHL-LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             hhC-eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCC
Confidence            455 789999999999999997532                34579999886432   3445667899999999999999


Q ss_pred             ceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 016143           88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------------------NVDMKAIKNWARQILRGLHYLHSHN  148 (394)
Q Consensus        88 Iv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~-------------------~l~~~~~~~i~~qil~~L~~LH~~~  148 (394)
                      |+++++++.+.  ...++||||+.+|+|.+++....                   .+++..+..++.||+.||.|||+++
T Consensus        81 iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~  158 (304)
T cd05096          81 IIRLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN  158 (304)
T ss_pred             eeEEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999998655  45889999999999999986532                   3677889999999999999999999


Q ss_pred             CCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh
Q 016143          149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT  223 (394)
Q Consensus       149 ~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt  223 (394)
                        |+||||||+|||++ .++.+||+|||++.......    .....+++.|+|||.+. +.++.++|||||||++|+|++
T Consensus       159 --ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         159 --FVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             --ccccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence              99999999999998 78899999999997654332    12234578999999765 568999999999999999987


Q ss_pred             --cCCCCCCCCCHHHHHHHHhc----C--CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          224 --CEYPYNECKNPAQIYKKVTS----G--IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       224 --g~~Pf~~~~~~~~~~~~i~~----~--~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                        +..||.+... .+....+..    .  ......+...+..+.+++.+||. +|.+||++.++..
T Consensus       236 ~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         236 LCKEQPYGELTD-EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             ccCCCCCCcCCH-HHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence              6688876433 333332221    1  11111234567899999999998 9999999999843

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.2e-41  Score=322.53  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=205.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||.||+|.++.++..+|+|.++.....  ......+.+|+.++++++||||+++++++.+.+...+++|
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            36779999999999999999999999999998755432  2333456789999999999999999999877665789999


Q ss_pred             EcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          107 TELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      |||+. ++|.+++.... .+++..++.++.||+.||.|||+++  ++|+||||+||+++ +++.+||+|||++...... 
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCcEEEeecCceeeccCCc
Confidence            99997 59999887654 5999999999999999999999999  99999999999998 7899999999999766543 


Q ss_pred             -CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---------------
Q 016143          185 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---------------  246 (394)
Q Consensus       185 -~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~---------------  246 (394)
                       ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||......... .++.....               
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL-NKIFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCchHHHHHhhccch
Confidence             2334568899999998764  3688999999999999999999999874443322 22211000               


Q ss_pred             --------------CCCCCCC-CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          247 --------------PASLSKV-TDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       247 --------------~~~~~~~-~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                    ...++.. .++.++++|++||+ +|++||++.|+|.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                          0112222 47789999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=7e-42  Score=335.82  Aligned_cols=245  Identities=24%  Similarity=0.394  Sum_probs=199.7

Q ss_pred             ccccceecccCceEEEEEEEccC-----CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCC
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN  100 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~  100 (394)
                      +.+.+.||+|+||.||+|.+..+     +..||+|.+....   .....+.+.+|+.+++.+ +|+||+++++++.+.  
T Consensus        40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~--  114 (374)
T cd05106          40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACTHG--  114 (374)
T ss_pred             ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence            37889999999999999986443     3579999986432   244567788999999999 899999999988544  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhC----------------------------------------------------------
Q 016143          101 RTINMITELFTSGSLRQYRKKH----------------------------------------------------------  122 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~----------------------------------------------------------  122 (394)
                      ..+++||||+.+|+|.+++...                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            4688999999999999988642                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCc---
Q 016143          123 ------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---  187 (394)
Q Consensus       123 ------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~---  187 (394)
                                  ..+++.+++.++.||+.||.|||+++  |+||||||+||+++ +++.+||+|||+++........   
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccCCcceeec
Confidence                        23788899999999999999999999  99999999999998 7889999999999765433221   


Q ss_pred             -ccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 016143          188 -SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK  264 (394)
Q Consensus       188 -~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  264 (394)
                       ...+++.|+|||++. ..++.++|||||||++|+|++ |+.||............+..+..+ ..+...++++++++.+
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~  350 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-SRPDFAPPEIYSIMKM  350 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-cCCCCCCHHHHHHHHH
Confidence             223456899999765 568999999999999999997 999998755444455555544322 3445567999999999


Q ss_pred             cCC-CCCCCCCHHHHhc
Q 016143          265 CIV-PASLRLPALELLK  280 (394)
Q Consensus       265 ~L~-~p~~R~s~~elL~  280 (394)
                      ||. +|.+||++.++++
T Consensus       351 cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         351 CWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            998 9999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.2e-42  Score=325.45  Aligned_cols=248  Identities=29%  Similarity=0.557  Sum_probs=207.1

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ...||+|+||.||++.+..++..||+|.+....    ....+.+.+|+.+++.++|+||+++++.+...  ...++||||
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~lv~e~  100 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELWVVMEF  100 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEEEEEeC
Confidence            467999999999999999999999999886432    34566788999999999999999999988654  578899999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--CCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~~~  187 (394)
                      +++++|.+++... .+++.++..++.||+.||.|||+++  ++||||||+||+++ +++.++|+|||++......  ...
T Consensus       101 ~~~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~  176 (292)
T cd06658         101 LEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRK  176 (292)
T ss_pred             CCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEccCcchhhcccccccCc
Confidence            9999999988654 5999999999999999999999999  99999999999998 6789999999998654332  223


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCCCHHHHHHHHHc
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKC  265 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~li~~~  265 (394)
                      ...|++.|+|||.+.+ .++.++||||||+++|||++|..||.. .+....+..+.....+. ......+..+++++.+|
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  255 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM  255 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence            4578999999997764 588999999999999999999999976 34444444444432221 12234678999999999


Q ss_pred             CC-CCCCCCCHHHHhcCCccccCC
Q 016143          266 IV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       266 L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      |. +|.+||++.++|+||||+...
T Consensus       256 l~~~P~~Rpt~~~il~~~~~~~~~  279 (292)
T cd06658         256 LVREPSQRATAQELLQHPFLKLAG  279 (292)
T ss_pred             ccCChhHCcCHHHHhhChhhhccC
Confidence            98 999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-41  Score=318.12  Aligned_cols=253  Identities=30%  Similarity=0.503  Sum_probs=207.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccC------CHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~------~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      |.+.+.||+|+||+||+|.+..+|..||+|.+.......      .....+.+.+|+.+++.++||||+++++++..  .
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   80 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--E   80 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--C
Confidence            367899999999999999999999999999886532211      12234568889999999999999999998754  4


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ..+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++  ++||||+|+||+++ .++.++|+|||++..
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~~~~~~  157 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKK  157 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeecccccc
Confidence            578899999999999999998888999999999999999999999999  99999999999998 789999999999975


Q ss_pred             ecCC----CCcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC---CCCCC
Q 016143          181 MQQP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASL  250 (394)
Q Consensus       181 ~~~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~---~~~~~  250 (394)
                      ....    ......|+..|+|||.+..   .++.++|+||||+++|+|++|..||.................   .+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            5432    1233468899999997754   278899999999999999999999976444433333222221   12223


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      ....+..++++|.+||. +|.+||++.++|+|||+
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            34467899999999998 99999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.1e-41  Score=315.99  Aligned_cols=248  Identities=29%  Similarity=0.487  Sum_probs=207.8

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|+||.||+|.++.++..||+|.+..... ........+.+|+.+++.++||||+++++++.+.  ..+++|+
T Consensus         5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~   81 (267)
T cd08228           5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNIVL   81 (267)
T ss_pred             eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEEEE
Confidence            788999999999999999999999999998865432 2345567788999999999999999999988654  4688999


Q ss_pred             cccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          108 ELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       108 e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ||+++++|.+++..    ...+++..+..++.||+.||.|||+++  ++|+||||+||+++ .++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc-CCCCEEECccccceeccc
Confidence            99999999988753    344899999999999999999999999  99999999999998 688999999999976654


Q ss_pred             CC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCC-CHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          184 PT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       184 ~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ..  .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.... +...+...+.....+.......+..+.
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR  238 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence            32  234568999999997754 58889999999999999999999996533 344555666554444444455678999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhcC
Q 016143          260 QFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +++.+||. +|++||++.++++.
T Consensus       239 ~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         239 ELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHCCCCcccCcCHHHHHHH
Confidence            99999998 99999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.6e-41  Score=318.25  Aligned_cols=245  Identities=24%  Similarity=0.374  Sum_probs=205.4

Q ss_pred             ccccceecccCceEEEEEEEccCC-----eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +++.+.||+|+||.||+|.+...+     ..||+|.+....   .......+.+|+.+++.++||||+++++++.+.  .
T Consensus         7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~   81 (283)
T cd05048           7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--Q   81 (283)
T ss_pred             cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--C
Confidence            377899999999999999876555     789999876332   345567789999999999999999999988544  4


Q ss_pred             eEEEEEcccCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 016143          102 TINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG  165 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~----------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~  165 (394)
                      ..+++|||+++++|.+++...                ..+++..+..++.||+.||.|||+++  ++||||||+||+++ 
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~-  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG-  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc-
Confidence            688999999999999999765                45888999999999999999999999  99999999999998 


Q ss_pred             CCCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHH
Q 016143          166 NNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK  239 (394)
Q Consensus       166 ~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~  239 (394)
                      +++.+||+|||++.......    .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ .+..++..
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~  237 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIE  237 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence            78899999999997553321    22345688999999665 568999999999999999998 9999987 45566777


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       240 ~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+..+..+. .+...++++.+++.+||. +|.+||++.+++++
T Consensus       238 ~i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            776654433 455678999999999998 89999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2e-41  Score=329.94  Aligned_cols=253  Identities=29%  Similarity=0.425  Sum_probs=203.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC----
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~----   99 (394)
                      .+| ++.+.||+|+||+||+|.+..+|..||+|.+....  ........+.+|+.+++.++||||++++++|....    
T Consensus        16 ~~y-~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          16 KRY-QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             cce-EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            455 77799999999999999999999999999875332  23445567888999999999999999999886442    


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ....++||||+. ++|.+++...  +++..+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~  166 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR  166 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccce
Confidence            235789999995 5888887654  899999999999999999999999  99999999999998 68899999999997


Q ss_pred             eecCCC-CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-----------
Q 016143          180 VMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-----------  246 (394)
Q Consensus       180 ~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~-----------  246 (394)
                      ...... .....|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.......+ +..+.....           
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHhh
Confidence            665442 234568999999997754 589999999999999999999999976433222 222111000           


Q ss_pred             ----------C------------C--------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          247 ----------P------------A--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       247 ----------~------------~--------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                                +            .        ......++.++++|.+||. +|.+||++.|+|.||||+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                      0            0        0012345678999999998 9999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-41  Score=321.70  Aligned_cols=252  Identities=27%  Similarity=0.453  Sum_probs=199.7

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      +++| ++.+.||+|+||.||+|.+..+|..||+|.+.....   ......+.+|+.+++.++|+||+++++++.++  ..
T Consensus         4 ~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~   77 (291)
T cd07870           4 ATSY-LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTK--ET   77 (291)
T ss_pred             ccee-EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC--Ce
Confidence            3455 788999999999999999999999999999865432   12223567899999999999999999988543  57


Q ss_pred             EEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .++|+||+. ++|..++.. ...+++..++.++.||+.||.|||+++  ++|+||||+||+++ .++.+||+|||++...
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAK  153 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEecccccccc
Confidence            889999996 666666554 456889999999999999999999999  99999999999998 7889999999999754


Q ss_pred             cCC--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc--CCC---------
Q 016143          182 QQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIK---------  246 (394)
Q Consensus       182 ~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~--~~~---------  246 (394)
                      ...  ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||....+..+....+..  +..         
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            332  2334467999999998754  4788999999999999999999999875544333333211  000         


Q ss_pred             --------------CCCC-----CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          247 --------------PASL-----SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       247 --------------~~~~-----~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                    +..+     ....++.+.+++.+||. +|.+|||+.++|.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                          0000     00125688999999998 99999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=318.56  Aligned_cols=251  Identities=33%  Similarity=0.561  Sum_probs=208.5

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC---CCCceeEeeeEEcCCCceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~---hpnIv~~~~~~~~~~~~~~  103 (394)
                      |++.+.||+|+||.||+|.+..++..||+|.+....   .......+.+|+.+++.++   |||++++++++.+.  ...
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~~   77 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PRL   77 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CEE
Confidence            467789999999999999999999999999886432   2345567888999999997   99999999988644  478


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+++++|.++++.. .+++..+..++.||+.||.|||+.+  ++|+||+|+||+++ .++.++|+|||++.....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             EEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEc-CCCCEEEccCCceeecCC
Confidence            8999999999999998765 6999999999999999999999999  99999999999998 688999999999976654


Q ss_pred             CC--CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC-CCCHHH
Q 016143          184 PT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK-VTDPQV  258 (394)
Q Consensus       184 ~~--~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~  258 (394)
                      ..  .....|+..|+|||.+.+  .++.++|+||||+++|+|++|..||.+.. .......+... .+..+.. ..+.++
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (277)
T cd06917         154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIPKS-KPPRLEDNGYSKLL  231 (277)
T ss_pred             CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhccccC-CCCCCCcccCCHHH
Confidence            32  234568999999997754  36889999999999999999999997643 33333333222 2233333 367899


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          259 KQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .+++.+||. +|.+||++.+++.||||+...
T Consensus       232 ~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         232 REFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            999999998 899999999999999997643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.1e-41  Score=320.72  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=201.6

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCC---ceE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN---RTI  103 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~---~~~  103 (394)
                      ++.+.||+|+||+||+|.+..+|..||+|.+.....  .......+.+|+.+++.+. ||||+++++++.....   ..+
T Consensus         4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            677899999999999999999999999998765432  2233456788999999995 6999999998765432   247


Q ss_pred             EEEEcccCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          104 NMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~-----~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ++||||+.+ +|.+++...     ..+++..++.++.||+.||.|||+++  ++||||||+||+++.+++.+||+|||++
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccc
Confidence            899999975 788887642     35899999999999999999999999  9999999999999944889999999999


Q ss_pred             eeecCC--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-------
Q 016143          179 IVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------  247 (394)
Q Consensus       179 ~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-------  247 (394)
                      ......  ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||.......+..+.......+       
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            755432  2233457899999997653  47899999999999999999999998755544443322210000       


Q ss_pred             ------------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccc
Q 016143          248 ------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  285 (394)
Q Consensus       248 ------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~  285 (394)
                                        .......++++.+||.+||. +|.+||++.++|.||||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                              00113467889999999998 999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.8e-41  Score=318.70  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=199.0

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      |++.+.||+|+||.||+|.++.++..||+|.+.....  +... ....+|+.+++++. |+||+++++++.+.....+++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence            3678899999999999999999999999998764321  2222 23457899999885 999999999988765568999


Q ss_pred             EEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          106 ITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      ||||+. ++|.+.+.. ...+++.+++.++.||+.||.|||+++  ++||||+|+||+++ . +.+||+|||++......
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~-~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIK-D-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEc-C-CCeEEEecccccccccC
Confidence            999997 577777765 456899999999999999999999999  99999999999998 4 99999999999766443


Q ss_pred             C-CcccccCCcccCccccc--ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC--C--------------
Q 016143          185 T-ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I--------------  245 (394)
Q Consensus       185 ~-~~~~~gt~~y~aPE~l~--~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~--~--------------  245 (394)
                      . .....+++.|+|||.+.  +.++.++|||||||++|||++|..||... +....+..+...  .              
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT-NELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC-CHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            2 23456899999999654  34688999999999999999999999763 333332222210  0              


Q ss_pred             CCCC-----------CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          246 KPAS-----------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       246 ~~~~-----------~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      ....           +....+..++++|.+||. +|.+||++.++|+||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            0000           112356899999999999 99999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.6e-42  Score=321.59  Aligned_cols=250  Identities=30%  Similarity=0.545  Sum_probs=208.9

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +..+.||+|+||.||+|.+..++..||+|.+....   .....+.+.+|+.++++++||||+++++++.++  ..+++||
T Consensus         7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~   81 (277)
T cd06642           7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKLWIIM   81 (277)
T ss_pred             HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccC--CceEEEE
Confidence            55688999999999999999999999999886443   234567788999999999999999999988654  4688999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC--
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~--  185 (394)
                      ||+.+++|.+++.. ..+++..++.++.||+.||.|||+++  ++|+||+|+||+++ +++.++|+|||++.......  
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEccccccccccCcchh
Confidence            99999999999875 45899999999999999999999999  99999999999998 78899999999997654432  


Q ss_pred             CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK  264 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  264 (394)
                      .....|+..|+|||.+.+ .++.++|||||||++|+|++|..||... .+......+..+. +..+....+.++.++|.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~  235 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLEGQYSKPFKEFVEA  235 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCC-CCCCCcccCHHHHHHHHH
Confidence            223468899999998765 5788999999999999999999999763 3333333333332 333455567899999999


Q ss_pred             cCC-CCCCCCCHHHHhcCCccccCC
Q 016143          265 CIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       265 ~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ||. +|.+||++.++++||||....
T Consensus       236 ~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         236 CLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HccCCcccCcCHHHHHHhHHHHHHh
Confidence            998 999999999999999997643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7e-41  Score=309.42  Aligned_cols=248  Identities=31%  Similarity=0.562  Sum_probs=213.8

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|++|.||+|.+..++..||+|.+.....  .......+.+|+++++.++|||++++++.+.+.  ...++|+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~   78 (258)
T cd08215           3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM   78 (258)
T ss_pred             eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence            677999999999999999999999999999875442  345667788999999999999999999988655  5788999


Q ss_pred             cccCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          108 ELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       108 e~~~~gsL~~~i~~~----~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ||+++++|.+++...    ..+++..+..++.||+.||.|||+++  ++|+||+|+||+++ +++.++|+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceeeccc
Confidence            999999999999874    67999999999999999999999999  99999999999998 688999999999976654


Q ss_pred             C--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          184 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       184 ~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      .  ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.. .+...+........ ...++...+..+.+
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  233 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKGQ-YPPIPSQYSSELRN  233 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC-CcHHHHHHHHhcCC-CCCCCCCCCHHHHH
Confidence            4  2334578999999997654 588999999999999999999999976 44556666655543 33355577889999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          261 FIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      ++.+||. +|.+||++.++|.||||
T Consensus       234 ~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         234 LVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHcCCChhhCcCHHHHhcCCCC
Confidence            9999998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-41  Score=329.55  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=205.2

Q ss_pred             CCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      +..+|| ++.+.||+|+||+||+|.++.+|..||+|++.....    ...+.+.+|+.+++.++||||+++++++.....
T Consensus         2 ~~~~~y-~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   76 (342)
T cd07854           2 DLGSRY-MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS   76 (342)
T ss_pred             CcCcce-EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence            345666 778999999999999999999999999999875542    445668889999999999999999987654432


Q ss_pred             ------------ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 016143          101 ------------RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG  168 (394)
Q Consensus       101 ------------~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~  168 (394)
                                  ..+++|+||+. ++|.+++... .+++..++.++.||+.||.|||++|  ++||||||+||+++..++
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~  152 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG-PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccccccccccceEEEEeeccc-ccHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCc
Confidence                        35789999996 5898888654 5999999999999999999999999  999999999999986677


Q ss_pred             cEEEcccceeeeecCCC-----CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHH
Q 016143          169 EVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV  241 (394)
Q Consensus       169 ~~kl~Dfgla~~~~~~~-----~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i  241 (394)
                      .+||+|||++.......     .....|+..|+|||.+..  .++.++|||||||++|+|++|+.||............+
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            89999999997654321     122357889999996543  47889999999999999999999997644333222221


Q ss_pred             hcC-----------------------CCC----CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          242 TSG-----------------------IKP----ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       242 ~~~-----------------------~~~----~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      ...                       ..+    ..+....+.++++||.+||. +|.+||++.++|.||||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            110                       000    00122456789999999998 9999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.6e-41  Score=311.76  Aligned_cols=245  Identities=27%  Similarity=0.458  Sum_probs=208.2

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|+||.||++.++.++..||+|.++...   .....+.+.+|+.+++.++|+||+++++.+.++  ..++++|
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~   77 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIVM   77 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEE
Confidence            67899999999999999999999999999986543   234567788899999999999999999988544  5789999


Q ss_pred             cccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      ||+++++|.+++...  ..+++..++.|+.||+.||.|||+++  ++|+||||+||+++ +++.++|+|||++.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeecccc
Confidence            999999999988653  45899999999999999999999999  99999999999998 78899999999997665432


Q ss_pred             --CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          186 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                        .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..+..+ ..+...+..++++|
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li  232 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYK-PLPSHYSYELRSLI  232 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCC-CCCcccCHHHHHHH
Confidence              234568999999998765 488999999999999999999999976 5555555555555332 24556778999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCC
Q 016143          263 EKCIV-PASLRLPALELLKDP  282 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p  282 (394)
                      .+||. +|.+||++.+++.--
T Consensus       233 ~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         233 KQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             HHHHhCCcccCCCHHHHhhcc
Confidence            99998 999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.5e-41  Score=313.21  Aligned_cols=249  Identities=27%  Similarity=0.493  Sum_probs=207.6

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|+||.||+|.++.+|..||+|.+.....  .....+.+.+|+.+++.++|+||+++++.+.+  ...+++|+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~   78 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM   78 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence            678899999999999999999999999999876432  22345667889999999999999999998754  45789999


Q ss_pred             cccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          108 ELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+++  ++|+||||+||+++.++..+||+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999999987654  4799999999999999999999999  99999999999998544567999999997665432


Q ss_pred             --CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          186 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                        .....|++.|+|||.+.. .++.++|+||||+++|+|++|..||... +..+....+..+..+ ......+.+++++|
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i  234 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFA-PISPNFSRDLRSLI  234 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCC-CCCCCCCHHHHHHH
Confidence              233468999999997754 5889999999999999999999999763 444444444444322 23345678999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCcc
Q 016143          263 EKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .+||. +|++||++.++++||||
T Consensus       235 ~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         235 SQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHhccChhhCcCHHHHhhCCCC
Confidence            99998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-41  Score=323.31  Aligned_cols=251  Identities=28%  Similarity=0.541  Sum_probs=208.1

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      ++.....||+|+||.||+|.+..++..||+|.+.....    ...+.+.+|+.+++.++||||+++++.+..+  ..+++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~i   95 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWV   95 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEE
Confidence            33455689999999999999999999999999865432    2345688899999999999999999988654  57889


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      |+||+++++|..++.. ..+++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++...... 
T Consensus        96 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          96 LMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             EEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhccccc
Confidence            9999999999998765 45899999999999999999999999  99999999999998 7889999999998654433 


Q ss_pred             -CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCCHHHHHH
Q 016143          185 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQF  261 (394)
Q Consensus       185 -~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~l  261 (394)
                       ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.. .+.......+.....+ .......+..+.++
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  250 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISPVLRDF  250 (297)
T ss_pred             ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCccccCCCCHHHHHH
Confidence             2334678999999997764 588999999999999999999999976 3444444444433221 12233467899999


Q ss_pred             HHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          262 IEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      |.+||. +|.+||++.++++||||...
T Consensus       251 i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         251 LERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             HHHHhcCCcccCcCHHHHhhChhhccC
Confidence            999998 99999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.5e-41  Score=316.78  Aligned_cols=257  Identities=35%  Similarity=0.609  Sum_probs=214.2

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      .++...| ...+.||+|++|.||+|.+..++..|++|.+.....     ..+.+.+|+.+++.++|+||+++++.+..+ 
T Consensus        15 ~~~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-   87 (286)
T cd06614          15 GDPRELY-KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVG-   87 (286)
T ss_pred             CCccccc-hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-
Confidence            4555555 677899999999999999998999999999864431     456688899999999999999999998765 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                       ..+++|+||+++++|.+++.... .+++..+..++.||+.||.|||++|  ++|+||+|+||+++ .++.++|+|||++
T Consensus        88 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d~~~~  163 (286)
T cd06614          88 -DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFA  163 (286)
T ss_pred             -CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECccchh
Confidence             57889999999999999999886 7999999999999999999999999  99999999999998 7889999999998


Q ss_pred             eeecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCC
Q 016143          179 IVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT  254 (394)
Q Consensus       179 ~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~~~~~~~~~~  254 (394)
                      ......  ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||... +.......+.. ...+......+
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~  242 (286)
T cd06614         164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEKW  242 (286)
T ss_pred             hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchhhC
Confidence            654332  2233458899999997654 5889999999999999999999999764 44333333333 22222223336


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +..++++|++||. +|.+||++.++|.|+||+...
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence            7899999999998 899999999999999999744

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=319.58  Aligned_cols=250  Identities=25%  Similarity=0.432  Sum_probs=206.7

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|++|.||+|.++.++..||+|.++....  .....+.+.+|+.+++.++|+||+++++.+.+  ...+++|+
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~   79 (288)
T cd07833           4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLVF   79 (288)
T ss_pred             eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEEE
Confidence            788999999999999999999999999998865432  23455778899999999999999999999865  45789999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC--
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~--  185 (394)
                      ||+.++.|..+..+...+++..+..++.||+.||.|||+++  ++|+||+|+||+++ +++.+||+|||++.......  
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEEeeecccccCCCccc
Confidence            99999888877777777999999999999999999999999  99999999999998 68999999999997665432  


Q ss_pred             -CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-------------------
Q 016143          186 -ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------------  243 (394)
Q Consensus       186 -~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-------------------  243 (394)
                       .....+++.|+|||.+.+  .++.++||||||+++|+|++|..||........+......                   
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence             334568899999997654  4789999999999999999999999875444433322110                   


Q ss_pred             C--CCC--------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          244 G--IKP--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       244 ~--~~~--------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      +  ..+        ..++...+.++++||++||. +|.+||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0  000        01223347889999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=332.95  Aligned_cols=261  Identities=28%  Similarity=0.460  Sum_probs=216.4

Q ss_pred             ccCCCcccccc-cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEc
Q 016143           19 EKDPSCRYGRY-DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD   97 (394)
Q Consensus        19 ~~~~~~ry~r~-~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~   97 (394)
                      ..|.+.-|.-+ .++||+|-||+||-|++.++|+.||||+|.+......  .-..+.+|+.+|+++.||.||.+...|  
T Consensus       557 ~vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k--qesqlR~EVaILq~l~HPGiV~le~M~--  632 (888)
T KOG4236|consen  557 NVDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK--QESQLRNEVAILQNLHHPGIVNLECMF--  632 (888)
T ss_pred             hhhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc--hHHHHHHHHHHHHhcCCCCeeEEEEee--
Confidence            34444555433 4899999999999999999999999999987665433  337788999999999999999999887  


Q ss_pred             CCCceEEEEEcccCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEcc
Q 016143           98 DTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGD  174 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~-~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~--~~~~kl~D  174 (394)
                      ++...+++|||-+.|.-|.-.+. ..++|++...+.++.||+.||.|||-+|  |+|.||||+|||+...  --++||+|
T Consensus       633 ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCD  710 (888)
T KOG4236|consen  633 ETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCD  710 (888)
T ss_pred             cCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeecc
Confidence            45567999999996544444444 3467999999999999999999999999  9999999999999732  34799999


Q ss_pred             cceeeeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC--CCCCCC
Q 016143          175 LGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL  250 (394)
Q Consensus       175 fgla~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~--~~~~~~  250 (394)
                      ||+|+..... ..++++|||.|+|||++.. .|+..-|+||.|+|+|.-+.|..||.+..+   +...|+..  .+|+..
T Consensus       711 FGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---IndQIQNAaFMyPp~P  787 (888)
T KOG4236|consen  711 FGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---INDQIQNAAFMYPPNP  787 (888)
T ss_pred             ccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---hhHHhhccccccCCCc
Confidence            9999987655 4678899999999998765 599999999999999999999999987544   33444432  345556


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ++.+++++.+||..+|+ +-.+|-|.+..|.|||++...
T Consensus       788 W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            66778999999999998 889999999999999999753

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.3e-41  Score=311.37  Aligned_cols=240  Identities=23%  Similarity=0.404  Sum_probs=197.9

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      +.||+|+||+||+|.++.++..||+|.+....   ..+....+.+|+.+++.++||||+++++++.+.  ..+++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeec
Confidence            46999999999999999999999999875321   345567789999999999999999999988544  4688999999


Q ss_pred             CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCccc
Q 016143          111 TSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV  189 (394)
Q Consensus       111 ~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~~  189 (394)
                      .+++|.+++... ..+++..++.++.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++...........
T Consensus        76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCccccccccccc
Confidence            999999999764 45899999999999999999999999  99999999999998 688999999999875443221111


Q ss_pred             ----ccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          190 ----IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       190 ----~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                          .++..|+|||.+.+ .++.++|||||||++|+|++ |..||.. .........+...... ..+...+..+.+++.
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~  230 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN-LSNQQTREAIEQGVRL-PCPELCPDAVYRLME  230 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc-cCHHHHHHHHHcCCCC-CCcccCCHHHHHHHH
Confidence                23457999997754 58899999999999999998 8999976 3444455555444322 345567889999999


Q ss_pred             HcCC-CCCCCCCHHHHhc
Q 016143          264 KCIV-PASLRLPALELLK  280 (394)
Q Consensus       264 ~~L~-~p~~R~s~~elL~  280 (394)
                      +||. +|.+||++.++++
T Consensus       231 ~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         231 RCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            9998 8999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.9e-41  Score=320.75  Aligned_cols=260  Identities=25%  Similarity=0.381  Sum_probs=203.0

Q ss_pred             ccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEE
Q 016143           17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV   96 (394)
Q Consensus        17 ~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~   96 (394)
                      +...+..++| ++.+.||+|+||+||+|.++.++..||+|.+.....  .......+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   81 (310)
T cd07865           5 FPFCDEVSKY-EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICR   81 (310)
T ss_pred             Ccccchhhhe-EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence            3345556677 678999999999999999999999999999865432  1222345668999999999999999999876


Q ss_pred             cCC------CceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 016143           97 DDT------NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE  169 (394)
Q Consensus        97 ~~~------~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~  169 (394)
                      +..      ....++||||+. ++|.+++... ..+++.+++.++.||+.||.|||+++  ++|+||||+||+++ .++.
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~  157 (310)
T cd07865          82 TKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGI  157 (310)
T ss_pred             cccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCc
Confidence            543      245789999996 5788777654 36999999999999999999999999  99999999999998 7889


Q ss_pred             EEEcccceeeeecCCC------CcccccCCcccCccccccc--CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHH
Q 016143          170 VKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV  241 (394)
Q Consensus       170 ~kl~Dfgla~~~~~~~------~~~~~gt~~y~aPE~l~~~--~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i  241 (394)
                      +||+|||++.......      .....++..|+|||.+.+.  ++.++||||||+++|+|++|..||..... ......+
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-~~~~~~~  236 (310)
T cd07865         158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-QHQLTLI  236 (310)
T ss_pred             EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence            9999999997553321      1234578899999977543  68899999999999999999999976433 2222111


Q ss_pred             hc---CCCCC---------------------------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          242 TS---GIKPA---------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       242 ~~---~~~~~---------------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      ..   ...+.                           ......+..++++|.+||. +|.+||+++++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            11   10000                           0011235678899999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=318.89  Aligned_cols=248  Identities=27%  Similarity=0.453  Sum_probs=198.1

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|++|+||+|.++.++..||+|.+.....   ......+.+|+.+++.++||||+++++++.+  ....++||
T Consensus         8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   82 (291)
T cd07844           8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE---EGAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTLVF   82 (291)
T ss_pred             eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc---cCCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEEEE
Confidence            678999999999999999999999999999875432   1122346679999999999999999998854  35789999


Q ss_pred             cccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      ||+. ++|.+++... ..+++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++......  
T Consensus        83 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          83 EYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             ecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEc-CCCCEEECccccccccCCCCc
Confidence            9997 4899988764 46899999999999999999999999  99999999999998 7889999999998654322  


Q ss_pred             CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC---CC------------
Q 016143          185 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KP------------  247 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~---~~------------  247 (394)
                      ......+++.|+|||.+.+  .++.++||||+|+++|+|++|+.||.+.....+....+....   .+            
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            2223357889999998754  478999999999999999999999976553333332221100   00            


Q ss_pred             ----------CC---CCCCCC--HHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          248 ----------AS---LSKVTD--PQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       248 ----------~~---~~~~~~--~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                ..   .....+  ..+.+++.+||. +|.+||++.++|.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                      00   001123  788999999998 89999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.9e-41  Score=318.48  Aligned_cols=259  Identities=23%  Similarity=0.374  Sum_probs=212.6

Q ss_pred             ccccceecccCceEEEEEEEc---cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCce
Q 016143           27 GRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~  102 (394)
                      |++.+.||+|+||.||+|.+.   .+|..||+|.+............+.+.+|+.+++.+ +|+||+++++.+..  +..
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~   79 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DTK   79 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CCe
Confidence            367899999999999999874   478999999987544333334556788899999999 59999999998754  357


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||+++++|.+++.....+++..+..++.||+.||.|||+++  ++||||+|+||+++ .++.+||+|||++....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEC-CCCCEEEeeCccceecc
Confidence            8899999999999999998888999999999999999999999999  99999999999998 68899999999997654


Q ss_pred             CCC---CcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCC---CHHHHHHHHhcCCCCCCCCCC
Q 016143          183 QPT---ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       183 ~~~---~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~---~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      ...   .....|+..|+|||.+..   .++.++||||||+++|+|++|..||....   ....+...+.....  .++..
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~  234 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQE  234 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCcc
Confidence            322   234568999999997753   46789999999999999999999996422   22333344433322  24556


Q ss_pred             CCHHHHHHHHHcCC-CCCCCC-----CHHHHhcCCccccCCCCCc
Q 016143          254 TDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~  292 (394)
                      .++.+.+++++||. +|.+|+     ++.+++.||||+..++..+
T Consensus       235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~  279 (290)
T cd05613         235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL  279 (290)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence            78899999999998 899997     8999999999998876443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.9e-41  Score=319.37  Aligned_cols=250  Identities=27%  Similarity=0.442  Sum_probs=204.1

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|+||.||+|.++.++..||+|.+.....  .....+.+.+|+.+++.++||||+++++++.+  ....++|+
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   79 (286)
T cd07846           4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLVF   79 (286)
T ss_pred             eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEEE
Confidence            677999999999999999998999999998764332  22345567889999999999999999998854  45789999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--C
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~  185 (394)
                      ||+++++|..+......+++.+++.++.||+.||.|||+++  ++|+||+|+||+++ +++.++|+|||++......  .
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCCccc
Confidence            99999999998877777999999999999999999999999  99999999999998 7889999999999765443  2


Q ss_pred             CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-------------------C
Q 016143          186 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------------G  244 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-------------------~  244 (394)
                      .....++..|+|||.+.+  .++.++||||||+++|+|++|+.||...............                   +
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            334568899999997764  3678999999999999999999999764433322221110                   0


Q ss_pred             CC-CC--------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          245 IK-PA--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       245 ~~-~~--------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .. +.        ......+..+.+|+.+||. +|.+||++.++|.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            00 00        0122456789999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.5e-41  Score=316.06  Aligned_cols=250  Identities=32%  Similarity=0.563  Sum_probs=210.9

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +..+.||+|+||.||+|.+..++..||+|.+....   .......+.+|+.++++++||||+++++++.++  ...++||
T Consensus         7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~   81 (277)
T cd06641           7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIM   81 (277)
T ss_pred             hhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEE
Confidence            56788999999999999999999999999876433   234556788999999999999999999998654  4788999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC--
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~--  185 (394)
                      ||+.+++|.+++... .+++..+..++.|++.||.|||+++  ++|+||+|+||+++ +++.++|+|||++.......  
T Consensus        82 e~~~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          82 EYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EeCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecccchhh
Confidence            999999999998764 5899999999999999999999999  99999999999998 68899999999987654432  


Q ss_pred             CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK  264 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  264 (394)
                      .....|+..|+|||.+.+ .++.++|+|||||++|+|++|..||.. .+.......+..+. +..+....+.++.+++.+
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~  235 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEA  235 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhcCC-CCCCCcccCHHHHHHHHH
Confidence            233568899999997764 478899999999999999999999976 44444444444432 334556678899999999


Q ss_pred             cCC-CCCCCCCHHHHhcCCccccCC
Q 016143          265 CIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       265 ~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ||. +|.+||++.++++||||....
T Consensus       236 ~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         236 CLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             HccCChhhCcCHHHHHhCHHHhhhh
Confidence            998 899999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-40  Score=315.22  Aligned_cols=248  Identities=29%  Similarity=0.567  Sum_probs=208.5

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      .+.||+|++|.||+|.++.++..|++|.+....    ....+.+.+|+.+++.++||||+++++++...  ...++++||
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~--~~~~~v~e~   97 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG--DELWVVMEF   97 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--CeEEEEEec
Confidence            378999999999999999999999999876432    33456688999999999999999999988654  468899999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--CCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~~~  187 (394)
                      +.+++|.+++.. .++++..+..++.||+.||.|||+++  ++||||+|+||+++ .++.++|+|||++......  ...
T Consensus        98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~~~~~~~  173 (285)
T cd06648          98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRK  173 (285)
T ss_pred             cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc-CCCcEEEcccccchhhccCCcccc
Confidence            999999999988 56999999999999999999999999  99999999999998 7889999999988654332  223


Q ss_pred             ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC-CCCCCCHHHHHHHHHc
Q 016143          188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTDPQVKQFIEKC  265 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~li~~~  265 (394)
                      ...|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.. .++......+.....+.. .....+..+.+|+.+|
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM  252 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence            4568999999997764 588999999999999999999999976 455555556655432221 1223678999999999


Q ss_pred             CC-CCCCCCCHHHHhcCCccccCC
Q 016143          266 IV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       266 L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      |. +|.+||++.+++.||||+...
T Consensus       253 l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         253 LVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             cccChhhCcCHHHHccCcccccCC
Confidence            98 899999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.4e-41  Score=327.46  Aligned_cols=249  Identities=23%  Similarity=0.388  Sum_probs=201.8

Q ss_pred             cccccccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD   97 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~   97 (394)
                      .|| ++.+.||+|+||.||+|.+.     .+++.||+|++....   .....+.+.+|+.+++++ +|+||+++++++..
T Consensus         7 ~~~-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           7 DRL-KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             HHh-hhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            345 88999999999999999743     345789999886332   234556788999999999 89999999998764


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhC-------------------------------------------------------
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKH-------------------------------------------------------  122 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~-------------------------------------------------------  122 (394)
                      . ...+++++||+.+++|.+++...                                                       
T Consensus        83 ~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          83 P-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             C-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            4 34788999999999999998642                                                       


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC----CcccccC
Q 016143          123 ------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGT  192 (394)
Q Consensus       123 ------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt  192 (394)
                            ..+++..+..++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++..+....    .....++
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                  25789999999999999999999999  99999999999999 68899999999997653321    1233467


Q ss_pred             CcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CC
Q 016143          193 PEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PA  269 (394)
Q Consensus       193 ~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p  269 (394)
                      ..|+|||.+. ..++.++|||||||++|||++ |..||.+......+...+..+..+ ..+...++++.+++.+||+ +|
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p  317 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNP  317 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccCCh
Confidence            7899999665 569999999999999999998 999997744434444555544333 2345667899999999998 99


Q ss_pred             CCCCCHHHHhcC
Q 016143          270 SLRLPALELLKD  281 (394)
Q Consensus       270 ~~R~s~~elL~~  281 (394)
                      .+||++.++++|
T Consensus       318 ~~RPs~~ell~~  329 (337)
T cd05054         318 EDRPTFSELVEI  329 (337)
T ss_pred             hhCcCHHHHHHH
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.1e-41  Score=316.03  Aligned_cols=250  Identities=27%  Similarity=0.416  Sum_probs=201.3

Q ss_pred             CcccccccceecccCceEEEEEE----EccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      .+||+++.+.||+|+||+||++.    ...++..||+|.+....   .......+.+|+.+|++++||||+++++++...
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ   78 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            47898999999999999998864    34578899999886432   234456788999999999999999999988766


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ....+++||||+.+++|.+++... .+++.+++.++.|++.||.|||+++  ++||||||+||+++ +++.+||+|||++
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~  154 (283)
T cd05080          79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLA  154 (283)
T ss_pred             CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEc-CCCcEEEeecccc
Confidence            666889999999999999999875 4999999999999999999999999  99999999999998 6789999999999


Q ss_pred             eeecCCC-----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHH--------------HHH
Q 016143          179 IVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------------QIY  238 (394)
Q Consensus       179 ~~~~~~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~--------------~~~  238 (394)
                      .......     .....++..|+|||.+. ..++.++||||||+++|+|+||..||.......              .+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence            7654322     12234567799999775 458899999999999999999999986532211              111


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       239 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+..+.. ...+...+.++.+++.+||. +|++||++.+++.
T Consensus       235 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         235 ELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11111111 12345567899999999998 9999999999885

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-40  Score=310.45  Aligned_cols=250  Identities=30%  Similarity=0.517  Sum_probs=208.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|++|.||+|.+..+|..||+|.++.... ......+++.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~   77 (267)
T cd08224           2 GNF-KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NEL   77 (267)
T ss_pred             Cce-eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeE
Confidence            345 788999999999999999999999999999875443 2244567889999999999999999999998654  468


Q ss_pred             EEEEcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          104 NMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ++||||+++++|..++..    ...+++.++..++.||+.||.|||+++  ++||||+|+||+++ .++.++|+|||++.
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~  154 (267)
T cd08224          78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC-CCCcEEEeccceee
Confidence            899999999999999864    245899999999999999999999999  99999999999998 68899999999987


Q ss_pred             eecCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          180 VMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC-KNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       180 ~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~-~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      ......  .....|++.|+|||.+.+ .++.++|||||||++|+|++|..||... .+.......+..+..++......+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS  234 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence            654432  234568999999997654 5889999999999999999999999653 334455555555544443333677


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..++++|.+||. +|.+||++.+++.
T Consensus       235 ~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         235 EELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            899999999998 8999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=307.69  Aligned_cols=248  Identities=35%  Similarity=0.615  Sum_probs=213.0

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|++|.||+|.+..++..||+|.+.....  .....+.+.+|+.++++++|||++++++++.+.  ..++++|
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~   78 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL   78 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence            678999999999999999999999999999875542  245667899999999999999999999987554  5788999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC-
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-  186 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~-  186 (394)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+++  ++||||+|+||+++ .++.++|+|||++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTT-KDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEC-CCCCEEEeccccceecCCCccc
Confidence            99999999999998888999999999999999999999999  99999999999998 688999999999976655432 


Q ss_pred             -cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 016143          187 -RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK  264 (394)
Q Consensus       187 -~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  264 (394)
                       ....|+..|+|||.+.+ .++.++||||+|+++|+|++|..||................  ...++...+..+++++.+
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~  233 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--HPPLPEGISPELKDFLMQ  233 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC--CCCCCCCCCHHHHHHHHH
Confidence             34568999999997754 47889999999999999999999998755434444433222  233556678899999999


Q ss_pred             cCC-CCCCCCCHHHHhcCCcc
Q 016143          265 CIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       265 ~L~-~p~~R~s~~elL~~p~~  284 (394)
                      ||. +|.+||++.+++.||||
T Consensus       234 ~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         234 CFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHhCChhhCcCHHHHhcCCCC
Confidence            998 99999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-41  Score=325.58  Aligned_cols=255  Identities=27%  Similarity=0.417  Sum_probs=202.1

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC---C
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---N  100 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~---~  100 (394)
                      ++| ++.+.||+|+||+||+|.+..+|..||+|.+....   ......++.+|+.++++++||||+++++++....   .
T Consensus         5 ~~y-~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           5 PRY-QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             cce-EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            455 78899999999999999999999999999986322   2345567888999999999999999999765432   2


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ..+++|+||+. ++|.+++.. ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++..
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~  155 (336)
T cd07849          81 NDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARI  155 (336)
T ss_pred             ceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECcccceee
Confidence            45889999996 588888765 45999999999999999999999999  99999999999998 788999999999976


Q ss_pred             ecCCC-----CcccccCCcccCccccc--ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHH------------
Q 016143          181 MQQPT-----ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV------------  241 (394)
Q Consensus       181 ~~~~~-----~~~~~gt~~y~aPE~l~--~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i------------  241 (394)
                      .....     .....||+.|+|||.+.  ..++.++|||||||++|+|++|+.||.+......+....            
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            54321     22356899999999754  358899999999999999999999997633222111110            


Q ss_pred             --hc---------CCC--CC---CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          242 --TS---------GIK--PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       242 --~~---------~~~--~~---~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                        ..         ...  ..   ......++++.+++.+||. +|.+||++.+++.||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence              00         000  00   0112346789999999998 99999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.1e-41  Score=317.73  Aligned_cols=253  Identities=25%  Similarity=0.405  Sum_probs=203.1

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|++|+||+|.++.+|+.||+|.+.....  .....+.+.+|+.++++++||||+++++++.+.  ..+++||
T Consensus         5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~   80 (294)
T PLN00009          5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLYLVF   80 (294)
T ss_pred             EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEEEEE
Confidence            677899999999999999999999999998865432  223445678899999999999999999998644  5789999


Q ss_pred             cccCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          108 ELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~--l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      ||+. ++|.+++.....  +++..++.++.||+.||.|||+++  ++||||+|+||+++..++.+||+|||++...... 
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9995 588888765443  588899999999999999999999  9999999999999855678999999999755332 


Q ss_pred             -CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--------------
Q 016143          185 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--------------  247 (394)
Q Consensus       185 -~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--------------  247 (394)
                       ......+++.|+|||.+.+  .++.++|||||||++|+|+||..||........+.+.+.....+              
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY  237 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence             2234467899999997754  47889999999999999999999997754444443332110000              


Q ss_pred             ---------C---CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          248 ---------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       248 ---------~---~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                               .   ......++.+.+++.+||. +|.+||++.++|.||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence                     0   0112356789999999998 89999999999999999864

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.3e-41  Score=312.75  Aligned_cols=236  Identities=23%  Similarity=0.381  Sum_probs=192.4

Q ss_pred             ecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEEcccC
Q 016143           33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFT  111 (394)
Q Consensus        33 LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~e~~~  111 (394)
                      ||+|+||+||++.++.++..+|+|.+.......    .     |+.....+ +||||+++++.|..+  ..+++||||++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~-----e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv~e~~~   92 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I-----EPMVHQLMKDNPNFIKLYYSVTTL--KGHVLIMDYIK   92 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h-----hHHHHHHhhcCCCEEEEEEEEecC--CeeEEEEEcCC
Confidence            599999999999999999999999986543211    1     22222222 799999999998654  47899999999


Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCccccc
Q 016143          112 SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG  191 (394)
Q Consensus       112 ~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~~~g  191 (394)
                      +++|.+++.....+++.+++.++.||+.||.|||+.+  ++||||||+||+++.+++.++|+|||++.......  ...|
T Consensus        93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~  168 (267)
T PHA03390         93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS--CYDG  168 (267)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc--cCCC
Confidence            9999999998888999999999999999999999999  99999999999999433399999999997664432  3468


Q ss_pred             CCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCH----HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcC
Q 016143          192 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP----AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       192 t~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  266 (394)
                      ++.|+|||.+.+ .++.++||||||+++|+|++|..||......    ..+....   ..+....+..++.+++||.+||
T Consensus       169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l  245 (267)
T PHA03390        169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNANDFVQSML  245 (267)
T ss_pred             CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCCcccccCHHHHHHHHHHh
Confidence            999999998764 5889999999999999999999999753322    1222222   2233445578899999999999


Q ss_pred             C-CCCCCCC-HHHHhcCCcccc
Q 016143          267 V-PASLRLP-ALELLKDPFLVT  286 (394)
Q Consensus       267 ~-~p~~R~s-~~elL~~p~~~~  286 (394)
                      . +|.+|++ .+++|+||||+.
T Consensus       246 ~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        246 KYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             ccChhhCCchHHHHhcCCcccC
Confidence            8 8999996 599999999973

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-41  Score=321.65  Aligned_cols=252  Identities=29%  Similarity=0.472  Sum_probs=199.4

Q ss_pred             cccceecccCceEEEEEEEcc--CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      ++.+.||+|++|.||+|.++.  ++..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.....+++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            677889999999999999988  899999999875431 12233466788999999999999999999998776678999


Q ss_pred             EEcccCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC----CCcEEEcccc
Q 016143          106 ITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----NGEVKIGDLG  176 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~-----~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~----~~~~kl~Dfg  176 (394)
                      ||||+++ +|.+++...     ..+++..++.++.||+.||.|||+++  ++||||||+||+++ .    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~-~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVM-GEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEc-CCCCccceEEECCCc
Confidence            9999964 677766432     26899999999999999999999999  99999999999998 5    7899999999


Q ss_pred             eeeeecCCC-----CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHH--------HHHHHH
Q 016143          177 LAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------QIYKKV  241 (394)
Q Consensus       177 la~~~~~~~-----~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~--------~~~~~i  241 (394)
                      ++.......     .....+|+.|+|||.+.+  .++.++|||||||++|+|++|+.||.......        .....+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            997654332     234568899999997654  47899999999999999999999997533211        000000


Q ss_pred             hc------------------------CCCCCCCC-----------CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          242 TS------------------------GIKPASLS-----------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       242 ~~------------------------~~~~~~~~-----------~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      ..                        .......+           ...+..+.+++.+||. +|.+||++.|++.||||
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            00                        00000001           1456789999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.3e-41  Score=319.96  Aligned_cols=262  Identities=28%  Similarity=0.471  Sum_probs=213.3

Q ss_pred             CccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeE
Q 016143           16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW   95 (394)
Q Consensus        16 ~~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~   95 (394)
                      -+...++...| ...+.||+|+||+||+|.+..+|..||+|.+..... ......+.+.+|+.+++.++|||++++++++
T Consensus        13 ~~~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   90 (313)
T cd06633          13 LFYKDDPEEIF-VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY   90 (313)
T ss_pred             HhccCCHHHHh-hcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            34556666666 445779999999999999999999999999875432 2345567788999999999999999999988


Q ss_pred             EcCCCceEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcc
Q 016143           96 VDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD  174 (394)
Q Consensus        96 ~~~~~~~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~D  174 (394)
                      .+.  ...++||||+. ++|.+++.. ...+++.++..++.||+.||.|||+++  ++|+||+|+||+++ .++.+||+|
T Consensus        91 ~~~--~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~d  164 (313)
T cd06633          91 LKE--HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLAD  164 (313)
T ss_pred             EeC--CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEee
Confidence            654  56889999996 577776654 456999999999999999999999999  99999999999998 688999999


Q ss_pred             cceeeeecCCCCcccccCCcccCccccc----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 016143          175 LGLAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL  250 (394)
Q Consensus       175 fgla~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~  250 (394)
                      ||++.....  .....|+..|+|||.+.    +.++.++|||||||++|+|++|..||.......... .+.....+...
T Consensus       165 fg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~  241 (313)
T cd06633         165 FGSASKSSP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQ  241 (313)
T ss_pred             cCCCcccCC--CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCC
Confidence            999854322  23456899999999763    357889999999999999999999997754444444 33333334334


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ...++..+++|+.+||. +|.+||++.+++.||||....
T Consensus       242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            45567789999999998 899999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.3e-41  Score=317.70  Aligned_cols=252  Identities=25%  Similarity=0.420  Sum_probs=201.3

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      ...+.||+|+||.||++.+..++..||+|.+.....   ......+.+|+.++.++. |+||+++++++.++  ...+++
T Consensus         7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~   81 (288)
T cd06616           7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWIC   81 (288)
T ss_pred             HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEE
Confidence            345789999999999999999999999999875432   245567889999999996 99999999988654  456789


Q ss_pred             EcccCCCcHHHHH---H--hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          107 TELFTSGSLRQYR---K--KHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       107 ~e~~~~gsL~~~i---~--~~~~l~~~~~~~i~~qil~~L~~LH~~-~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      |||+. ++|.++.   .  ....+++..+..++.|++.||+|||+. +  ++||||||+||+++ .++.+||+|||++..
T Consensus        82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~  157 (288)
T cd06616          82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGISGQ  157 (288)
T ss_pred             Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchhHH
Confidence            99985 4554432   2  235699999999999999999999974 7  99999999999998 688999999999965


Q ss_pred             ecCCC-CcccccCCcccCcccccc----cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC---CCCC
Q 016143          181 MQQPT-ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSK  252 (394)
Q Consensus       181 ~~~~~-~~~~~gt~~y~aPE~l~~----~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~---~~~~  252 (394)
                      ..... .....|++.|+|||.+.+    .++.++|||||||++|+|++|+.||.......+....+..+..+.   ....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd06616         158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER  237 (288)
T ss_pred             hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence            54332 233468999999998764    478999999999999999999999976553333333333332222   1123


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ..+.++.+||++||. +|.+||++.+++.||||+...
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            467899999999998 899999999999999998643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-41  Score=316.75  Aligned_cols=249  Identities=27%  Similarity=0.448  Sum_probs=202.9

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|++|+||+|.++.+|..||+|.+.....  .......+.+|+.+++.++||||+++++++.+.  ...++++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~   77 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVF   77 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEE
Confidence            567899999999999999999999999999875432  223345678899999999999999999988544  5788999


Q ss_pred             cccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          108 ELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      ||+. ++|.+++....  .+++..+..++.||+.||.|||+++  ++||||+|+||+++ .++.++|+|||++...... 
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPV  153 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCcEEEeecccccccCCCc
Confidence            9995 69999998766  6999999999999999999999999  99999999999998 6899999999999755432 


Q ss_pred             -CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---------------
Q 016143          185 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---------------  246 (394)
Q Consensus       185 -~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~---------------  246 (394)
                       ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||.......+..+.......               
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence             2233457899999997654  4688999999999999999999999875443333332211000               


Q ss_pred             -----------CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          247 -----------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       247 -----------~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                 ........+..+.++|.+||. +|.+||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                       011123456789999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=310.82  Aligned_cols=247  Identities=21%  Similarity=0.366  Sum_probs=202.7

Q ss_pred             cccceecccCceEEEEEEEccC---CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC----
Q 016143           28 RYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----  100 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~----  100 (394)
                      ++.+.||+|+||.||+|.+..+   +..||+|.+.....  .....+.+.+|+.+++.++||||+++++.+.....    
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            6789999999999999987654   47899999865332  34556788999999999999999999997754332    


Q ss_pred             ceEEEEEcccCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcc
Q 016143          101 RTINMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD  174 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~D  174 (394)
                      ...++++||+++|+|..++...      ..+++..+..++.||+.||.|||+++  ++||||||+||+++ +++.+||+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEEC-CCCeEEECC
Confidence            3478999999999999988543      35899999999999999999999999  99999999999998 688999999


Q ss_pred             cceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCC
Q 016143          175 LGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA  248 (394)
Q Consensus       175 fgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~  248 (394)
                      ||++.......    .....++..|+|||.+.+ .++.++|||||||++|||++ |..||.+ .+..++++.+..+..+ 
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-  234 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRL-  234 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-
Confidence            99997664432    112235678999997764 58899999999999999999 8999976 4455666666655433 


Q ss_pred             CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       249 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..+...+..+.+++.+||+ +|.+||++.+++.+
T Consensus       235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3455678899999999998 89999999998864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-40  Score=305.45  Aligned_cols=248  Identities=33%  Similarity=0.587  Sum_probs=207.5

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |.+.+.||+|++|.||+|.+..++..+++|.+.....    .....+.+|+.+++.++|+||+++++.+...  ...+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~   75 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIV   75 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEE
Confidence            4677899999999999999998999999999865432    3557788999999999999999999988655  568899


Q ss_pred             EcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      +||+.+++|.+++... ..+++..+..++.|++.||.|||+++  ++||||+|+||+++ +++.++|+|||++.......
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc-cCCeEEEeeccccccccccc
Confidence            9999999999999886 67999999999999999999999999  99999999999998 68899999999997665543


Q ss_pred             -CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          186 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       186 -~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                       .....|+..|+|||.+.+ .++.++|+||||+++|+|++|+.||........+................++..+.++|.
T Consensus       153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  232 (253)
T cd05122         153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK  232 (253)
T ss_pred             cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence             345678999999997764 478899999999999999999999987433333333332221111122223789999999


Q ss_pred             HcCC-CCCCCCCHHHHhcCCc
Q 016143          264 KCIV-PASLRLPALELLKDPF  283 (394)
Q Consensus       264 ~~L~-~p~~R~s~~elL~~p~  283 (394)
                      +||. +|.+||++.++|.|||
T Consensus       233 ~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHccCChhhCCCHHHHhcCCC
Confidence            9998 9999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-40  Score=309.55  Aligned_cols=239  Identities=23%  Similarity=0.372  Sum_probs=200.5

Q ss_pred             eecccCceEEEEEEE--ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           32 ILGKGAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        32 ~LG~G~~g~Vy~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      .||+|+||+||+|.+  +.++..||+|++....  ......+.+.+|+.+++.++||||+++++++.+   ...++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEec
Confidence            589999999999964  5678999999876432  234566778999999999999999999997632   356789999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC---
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---  186 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~---  186 (394)
                      +.+++|.+++.....+++..+..++.||+.||.|||+++  ++||||||+||+++ +++.+||+|||++........   
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc-CCCeEEECCCccccccCCCCCeee
Confidence            999999999998888999999999999999999999999  99999999999998 678999999999976543321   


Q ss_pred             --cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          187 --RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       187 --~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                        ....+++.|+|||.+.. .++.++|||||||++|||++ |..||.. .+...+...+..+..+ ..+...++++.++|
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li  231 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERM-ECPQRCPPEMYDLM  231 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence              12234679999997764 58889999999999999998 9999976 4556677777766543 35566789999999


Q ss_pred             HHcCC-CCCCCCCHHHHhc
Q 016143          263 EKCIV-PASLRLPALELLK  280 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~  280 (394)
                      ++||. +|.+||++.++..
T Consensus       232 ~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         232 KLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHhccCchhCcCHHHHHH
Confidence            99998 9999999998754

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=324.45  Aligned_cols=265  Identities=22%  Similarity=0.389  Sum_probs=229.8

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      .+..+||+|+||+|.+|..+.+.+.+|||+++++-+.++ +..+--+.|-++|... +-|.+++++.+|+.-  ..+|+|
T Consensus       352 nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTm--DRLyFV  428 (683)
T KOG0696|consen  352 NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTM--DRLYFV  428 (683)
T ss_pred             ceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhh--hheeeE
Confidence            346789999999999999999999999999987666553 4556667788888877 578899999988544  569999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee--eecCC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~--~~~~~  184 (394)
                      |||+.||+|...|++-+++.+..+..++..|+-||-|||++|  |++||||.+||+++ ..|++||+|||+++  .....
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd-~eGHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEec-cCCceEeeecccccccccCCc
Confidence            999999999999999999999999999999999999999999  99999999999999 68999999999996  44555


Q ss_pred             CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          185 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                      ..++++|||.|+|||++. .+|+.++|+||+|++||||+.|++||++ .+.++++..|...  ...+++..+.++.++++
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~eh--nvsyPKslSkEAv~ick  582 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEH--NVSYPKSLSKEAVAICK  582 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHc--cCcCcccccHHHHHHHH
Confidence            678899999999999665 6799999999999999999999999987 7788888888764  34577888999999999


Q ss_pred             HcCC-CCCCCCCH-----HHHhcCCccccCCCCCcccCCCCCCC
Q 016143          264 KCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLRLPN  301 (394)
Q Consensus       264 ~~L~-~p~~R~s~-----~elL~~p~~~~~~~~~~~~~~~~~p~  301 (394)
                      ..|. .|.+|+..     .++-.||||+..+|..+....++.|.
T Consensus       583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPf  626 (683)
T KOG0696|consen  583 GLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPF  626 (683)
T ss_pred             HHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCC
Confidence            9997 79998853     57899999999999876655555443

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=308.50  Aligned_cols=241  Identities=24%  Similarity=0.421  Sum_probs=206.3

Q ss_pred             ceecccCceEEEEEEEccC---CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           31 EILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +.||+|+||.||+|.+...   +..||+|.+.....   ....+.+.+|+.+++.++|+||+++++++.+  ...+++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence            4799999999999998866   89999999865432   2256788999999999999999999998865  46789999


Q ss_pred             cccCCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          108 ELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       108 e~~~~gsL~~~i~~~---------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ||+++++|.+++...         ..+++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~-~~~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVG-EDLVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEEC-CCCcEEEcccccc
Confidence            999999999999886         67999999999999999999999999  99999999999998 6799999999999


Q ss_pred             eeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 016143          179 IVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK  252 (394)
Q Consensus       179 ~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  252 (394)
                      .......    .....+++.|+|||.+.. .++.++|||||||++|+|++ |..||... ...++...+..+... ..+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~  230 (262)
T cd00192         153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-PKPE  230 (262)
T ss_pred             cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCc
Confidence            7665432    334567889999997765 58899999999999999999 69999874 566777777665433 3455


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..++++.+++.+||. +|.+||++.+++++
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         231 YCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            568899999999998 89999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.1e-41  Score=352.24  Aligned_cols=251  Identities=27%  Similarity=0.414  Sum_probs=199.7

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      +|| ++.+.||+|+||+||+|.+..+|+.||+|++.... ...+...+++.+|+.++++++||||+++++++.+.  ...
T Consensus         2 grY-eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~l   77 (932)
T PRK13184          2 QRY-DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPV   77 (932)
T ss_pred             CCe-EEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEE
Confidence            566 78899999999999999999999999999986432 23345567899999999999999999999987543  578


Q ss_pred             EEEEcccCCCcHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 016143          104 NMITELFTSGSLRQYRKKH-----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI  172 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~-----------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl  172 (394)
                      ++||||++|++|.+++...           ..++...+..++.||+.||.|||+++  |+||||||+||+++ .++.+||
T Consensus        78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKL  154 (932)
T PRK13184         78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVI  154 (932)
T ss_pred             EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEE
Confidence            9999999999999998642           23566788999999999999999999  99999999999998 7889999


Q ss_pred             cccceeeeecCC--------------------CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC
Q 016143          173 GDLGLAIVMQQP--------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC  231 (394)
Q Consensus       173 ~Dfgla~~~~~~--------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~  231 (394)
                      +|||++......                    .....+||+.|+|||.+.+ .++.++|||||||++|||+||..||...
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            999999765211                    1113469999999997764 5899999999999999999999999763


Q ss_pred             CCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          232 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       232 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .......................++.+.+++.+||. +|.+|+++.+.|.+
T Consensus       235 ~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             chhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            332222222111111111123467899999999998 99999887665543

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-40  Score=313.32  Aligned_cols=244  Identities=25%  Similarity=0.382  Sum_probs=202.8

Q ss_pred             ccccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           27 GRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +.+.+.||+|+||+||+|.+.     .++..||+|.+....   ..+..+.+.+|+.+|+.++||||+++++++...  .
T Consensus         7 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~   81 (280)
T cd05049           7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG--D   81 (280)
T ss_pred             hhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--C
Confidence            367899999999999999874     346889999886432   233557889999999999999999999988654  5


Q ss_pred             eEEEEEcccCCCcHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 016143          102 TINMITELFTSGSLRQYRKKHK--------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN  167 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~--------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~  167 (394)
                      ..++||||+++++|.+++...+              .+++.++..++.||+.||.|||+++  ++||||||+||+++ .+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG-YD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc-CC
Confidence            6899999999999999997642              3788999999999999999999999  99999999999998 67


Q ss_pred             CcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHH
Q 016143          168 GEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV  241 (394)
Q Consensus       168 ~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i  241 (394)
                      +.+||+|||++.......    .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||... +.......+
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~~~~  237 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIECI  237 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHH
Confidence            999999999997543321    223446789999997764 58999999999999999998 99999774 455566666


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+..+. .+...+..+++++.+||. +|.+||++.|++.
T Consensus       238 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            6654332 345678899999999998 8999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.4e-41  Score=320.51  Aligned_cols=244  Identities=27%  Similarity=0.455  Sum_probs=200.8

Q ss_pred             ccccceecccCceEEEEEEEccCCeE----EEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIE----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      |+..+.||+|+||+||+|.+..++..    ||+|.+...   ......+++.+|+.+++.++||||+++++++...   .
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---~   82 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T   82 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---C
Confidence            47789999999999999988666654    899987532   2345567788999999999999999999988643   3


Q ss_pred             EEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||+++  |+||||||+||+++ +++.+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEccccccccc
Confidence            56899999999999999875 45899999999999999999999999  99999999999998 7889999999999766


Q ss_pred             cCCCC----cccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          182 QQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       182 ~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      .....    ....++..|+|||.+. ..++.++|||||||++|||++ |..||.+ ....++...+..+..+. .+...+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~  237 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPICT  237 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCCC-CCCCCC
Confidence            53321    1223467899999765 458999999999999999998 9999976 44555555555543332 344567


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..+.+++.+||. +|.+||++.+++.+
T Consensus       238 ~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         238 IDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            899999999998 99999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.3e-41  Score=330.12  Aligned_cols=244  Identities=27%  Similarity=0.416  Sum_probs=200.0

Q ss_pred             cccceecccCceEEEEEEEcc-----CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCc
Q 016143           28 RYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNR  101 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~  101 (394)
                      ++.++||+|+||+||+|.+..     ++..||+|.+....   .....+.+.+|+.+|++++ ||||+++++++.+.  .
T Consensus        40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~--~  114 (400)
T cd05105          40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS--G  114 (400)
T ss_pred             ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC--C
Confidence            678999999999999998643     34579999886432   3445677999999999996 99999999998543  5


Q ss_pred             eEEEEEcccCCCcHHHHHHhC-----------------------------------------------------------
Q 016143          102 TINMITELFTSGSLRQYRKKH-----------------------------------------------------------  122 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~-----------------------------------------------------------  122 (394)
                      .+++||||+++|+|.+++.+.                                                           
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            789999999999999987642                                                           


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 016143          123 -------------------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG  165 (394)
Q Consensus       123 -------------------------------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~  165 (394)
                                                           ..+++..+..++.||+.||.|||+++  |+||||||+||+++ 
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~-  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLA-  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEe-
Confidence                                                 24778889999999999999999999  99999999999998 


Q ss_pred             CCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHH
Q 016143          166 NNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK  239 (394)
Q Consensus       166 ~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~  239 (394)
                      .++.+||+|||++.......    .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||........++.
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            68899999999997654322    223456789999997654 58999999999999999997 9999987555555666


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       240 ~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .+..+..+ ..+...+..+++++.+||. +|.+||++.++.+
T Consensus       352 ~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         352 KIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            66665433 2445677899999999998 9999999988765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.8e-41  Score=315.31  Aligned_cols=248  Identities=28%  Similarity=0.497  Sum_probs=200.8

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|++|+||+|.+..+|..||+|.+.....   ....+.+.+|+.+++.++||||+++++++.+.  ...++||
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~   77 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVF   77 (284)
T ss_pred             eEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEE
Confidence            677899999999999999999999999999875432   22335567899999999999999999998655  4678999


Q ss_pred             cccCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          108 ELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~~---~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      ||+.+ +|.+++...   ..+++..+..++.||+.||.|||+++  ++||||||+||+++ +++.++|+|||++......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhcCC
Confidence            99974 888888754   35899999999999999999999999  99999999999998 7889999999999655432


Q ss_pred             --CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-------------
Q 016143          185 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------------  247 (394)
Q Consensus       185 --~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-------------  247 (394)
                        ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+................|             
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence              2234567899999997754  36889999999999999999999998755443332222110000             


Q ss_pred             --C-----------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          248 --A-----------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       248 --~-----------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                        .           .+....++.++++|.+||+ +|.+||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence              0           0112346789999999998 99999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.4e-40  Score=307.81  Aligned_cols=248  Identities=31%  Similarity=0.515  Sum_probs=212.5

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|++|.||++.++.++..+|+|.+.....  .......+.+|+.+++.++|+||+++++++.+.  ...++|+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~   78 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM   78 (256)
T ss_pred             eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence            677899999999999999999999999999875442  245567788999999999999999999988654  5788999


Q ss_pred             cccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          108 ELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       108 e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ||+++++|.+++.+    ...+++..+..++.|++.||.|||+++  ++|+||+|+||+++ +++.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLV-ANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEe-cCCcEEEeeccchhhhcc
Confidence            99999999999876    356899999999999999999999999  99999999999999 688999999999977665


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      .......|++.|+|||.+.+ .++.++|+||||+++|+|++|+.||.. .+...+...+..+..+. .+...+.++++++
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li  233 (256)
T cd08530         156 NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQRGKYPP-IPPIYSQDLQNFI  233 (256)
T ss_pred             CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCC-CchhhCHHHHHHH
Confidence            54445668999999997755 478899999999999999999999977 44555555555554333 3446788999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCcc
Q 016143          263 EKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      .+||. +|.+||++.++|+||++
T Consensus       234 ~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         234 RSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHcCCCcccCCCHHHHhcCCCC
Confidence            99998 89999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.3e-41  Score=325.12  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=206.4

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC--CCceEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TNRTIN  104 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~--~~~~~~  104 (394)
                      |.+.+.||+|++|.||+|.++.+|..||+|.+.....  .......+.+|+.+|++++||||+++++++...  ....++
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            3678999999999999999999999999999864322  223456678899999999999999999977543  335789


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      +|+||+. ++|.+++...+.+++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++......
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEecccccceeeccc
Confidence            9999995 689999988888999999999999999999999999  99999999999998 7899999999999765432


Q ss_pred             C------CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHh--------------
Q 016143          185 T------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--------------  242 (394)
Q Consensus       185 ~------~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~--------------  242 (394)
                      .      .....|+..|+|||.+.+  .++.++|||||||++|+|++|+.||.+.....++.....              
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            1      123468999999997754  488999999999999999999999976433222211110              


Q ss_pred             ---------cCCC--CC---CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          243 ---------SGIK--PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       243 ---------~~~~--~~---~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                               ....  +.   .+....++.++++|++||. +|.+||++.+++.||||....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence                     0000  00   0113357899999999998 999999999999999998643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-40  Score=312.20  Aligned_cols=245  Identities=24%  Similarity=0.407  Sum_probs=198.9

Q ss_pred             ccccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           27 GRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +++.+.||+|+||+||+|.++     .++..||+|.+....   .......+.+|+.+++.++||||+++++++.+  ..
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~   82 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--GQ   82 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CC
Confidence            488899999999999999864     345789999875322   23445678899999999999999999998743  35


Q ss_pred             eEEEEEcccCCCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEE
Q 016143          102 TINMITELFTSGSLRQYRKKHK----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK  171 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~----------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~k  171 (394)
                      ..++||||+.+++|.+++....          .+++..+..++.|++.||.|||+++  ++||||||+||+++ .++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~-~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc-CCCCEE
Confidence            6889999999999999987632          2577889999999999999999999  99999999999998 688999


Q ss_pred             EcccceeeeecCCCC----cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCC
Q 016143          172 IGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI  245 (394)
Q Consensus       172 l~Dfgla~~~~~~~~----~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~  245 (394)
                      |+|||++........    ....+++.|+|||.+.+ .++.++|||||||++|||++ |..||.+ .+.....+.+..+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~  238 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFVMEGG  238 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCC
Confidence            999999865533221    12345788999998764 58999999999999999999 7899976 44555555555443


Q ss_pred             CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       246 ~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+ ..+...+..+++++.+||. +|.+||++.|++++
T Consensus       239 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 LL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22 3445667899999999998 99999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.2e-40  Score=308.92  Aligned_cols=242  Identities=26%  Similarity=0.413  Sum_probs=204.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +.+.+.||+|++|.||+|.++.++..||+|.+...     ......+.+|+.+++.++||||+++++++..+  ..+++|
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   80 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII   80 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEE
Confidence            46788999999999999999999999999987532     23346688999999999999999999987543  467899


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+++++|.+++...  ..+++..++.++.|++.||.|||+++  ++||||||+||+++ +++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCccccccccc
Confidence            9999999999998764  35899999999999999999999999  99999999999998 7889999999999766544


Q ss_pred             CCc---ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          185 TAR---SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       185 ~~~---~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ...   ...+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+ .+.......+..+..+ ..+...++++.
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~  235 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKVY  235 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHH
Confidence            222   1234668999997664 58899999999999999998 9999976 5666777777665443 34566789999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhc
Q 016143          260 QFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ++|.+||. +|++||++.++++
T Consensus       236 ~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         236 ELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHccCCcccCCCHHHHHH
Confidence            99999998 9999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.1e-41  Score=325.06  Aligned_cols=256  Identities=27%  Similarity=0.391  Sum_probs=205.8

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC---
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---  100 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~---  100 (394)
                      .+| ++.+.||+|+||+||+|.+..++..||+|.+....  ........+.+|+.+++.++|+||+++++++.....   
T Consensus         5 ~~y-~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           5 TKY-VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             cce-eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            344 77889999999999999999999999999986432  123334567789999999999999999998764432   


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ..+++|+||+. ++|.+++...+.+++..+..++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++..
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~  157 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLART  157 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcCccccc
Confidence            35899999995 789999998888999999999999999999999999  99999999999998 678999999999976


Q ss_pred             ecCC--CCcccccCCcccCccccc--ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-------------
Q 016143          181 MQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------  243 (394)
Q Consensus       181 ~~~~--~~~~~~gt~~y~aPE~l~--~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-------------  243 (394)
                      ....  ......++..|+|||.+.  ..++.++|||||||++|+|++|+.||.+... ......+..             
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhhc
Confidence            5443  233456899999999765  3588999999999999999999999976322 111111100             


Q ss_pred             -----------C---CCC--CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          244 -----------G---IKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       244 -----------~---~~~--~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                 .   ..+  .......+++++++|++||. +|.+||++.++|+||||...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                       0   000  01123467889999999998 99999999999999999764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9e-41  Score=323.16  Aligned_cols=256  Identities=26%  Similarity=0.380  Sum_probs=207.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++| .+.+.||+|+||.||+|.+..+|..||+|.+....  ........+.+|+.+++++ +||||+++++++...+...
T Consensus         7 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           7 RKY-EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hHH-HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            444 77899999999999999999999999999875322  1233445677899999999 9999999999887666667


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||+. ++|..++... .+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++....
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchhccc
Confidence            899999996 5999998876 7899999999999999999999999  99999999999998 78999999999996553


Q ss_pred             CC-------CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------
Q 016143          183 QP-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--------  245 (394)
Q Consensus       183 ~~-------~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~--------  245 (394)
                      ..       ......||+.|+|||.+.+  .++.++||||||+++|+|++|+.||..........+......        
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32       2234568999999997643  478899999999999999999999976544433222111100        


Q ss_pred             --------------------CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          246 --------------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       246 --------------------~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                          .........+.++.++|.+||. +|.+||++.++++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                                0111222357899999999998 99999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=285.23  Aligned_cols=250  Identities=25%  Similarity=0.433  Sum_probs=204.8

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      .++||+|.||+||+|+...+++.||+|.++.++-  ++..-....+|+-+|+.|+|.|||++++..  .+.+.+-+|+||
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvl--hsdkkltlvfe~   82 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKLTLVFEF   82 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhh--ccCceeEEeHHH
Confidence            4789999999999999999999999999987753  334456678899999999999999999976  344567889999


Q ss_pred             cCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC--C
Q 016143          110 FTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--A  186 (394)
Q Consensus       110 ~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~--~  186 (394)
                      |. .+|.+|... ++.++.+.++.++.|+++||.|+|+++  +.||||||+|.+++ .+|.+|++|||+++.+.-+.  .
T Consensus        83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin-~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEec-cCCcEEecccchhhhcCCceEee
Confidence            94 689998876 467999999999999999999999999  99999999999999 79999999999998877653  3


Q ss_pred             cccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhc-CCC-CCCCCC---------
Q 016143          187 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS-GIK-PASLSK---------  252 (394)
Q Consensus       187 ~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~-~~~-~~~~~~---------  252 (394)
                      ...+-|.+|.+|.++-+  -|+.+.|+||.|||+.|+.. |++.|.+..-.+|+.+.... |.. ...|+.         
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            44567999999997765  39999999999999999986 88888885555555444321 110 111110         


Q ss_pred             ---------------CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          253 ---------------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       253 ---------------~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                     ..+..-+++++++|. +|.+|.+|++.|+||||...
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                           112345899999998 99999999999999999754

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.8e-40  Score=310.44  Aligned_cols=247  Identities=22%  Similarity=0.351  Sum_probs=201.8

Q ss_pred             cccceecccCceEEEEEEEccCCe--EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC----Cc
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NR  101 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~----~~  101 (394)
                      .+++.||+|+||.||+|.+..++.  .||+|.++...  .+....+.+.+|+.+++.++||||+++++.+....    ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            467899999999999999877765  68999876532  24556778899999999999999999998764322    23


Q ss_pred             eEEEEEcccCCCcHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143          102 TINMITELFTSGSLRQYRKK------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~------~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                      ..++++||+.+|+|.+++..      ...+++..+..++.||+.||.|||+++  |+||||||+||+++ .++.+||+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCC
Confidence            56889999999999998742      234899999999999999999999999  99999999999998 7889999999


Q ss_pred             ceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCC
Q 016143          176 GLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS  249 (394)
Q Consensus       176 gla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~  249 (394)
                      |++.......    .....+++.|+|||.+.+ .++.++|||||||++|+|++ |+.||.. ....++...+..+..+. 
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-  234 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK-  234 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-
Confidence            9997664332    122346778999997764 58999999999999999999 8999976 45567777777664432 


Q ss_pred             CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       250 ~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+...+..++++|.+||. +|.+||++.+++++
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            334567889999999998 99999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.7e-40  Score=312.72  Aligned_cols=254  Identities=23%  Similarity=0.385  Sum_probs=203.6

Q ss_pred             cccccccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      .+| ++.+.||+|+||.||+|.++     ..+..||+|.++...   .......+.+|+.+++.++||||+++++++.+.
T Consensus         6 ~~~-~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           6 EKI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             HHc-eeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            344 77899999999999999764     235689999875332   233445688899999999999999999987544


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHK----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG  168 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~----------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~  168 (394)
                        ...++||||+.+|+|.+++...+          .++...+..++.||+.||.|||+++  |+||||||+||+++ .++
T Consensus        82 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~-~~~  156 (288)
T cd05061          82 --QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA-HDF  156 (288)
T ss_pred             --CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc-CCC
Confidence              46889999999999999997532          3466788999999999999999999  99999999999998 688


Q ss_pred             cEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHh
Q 016143          169 EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT  242 (394)
Q Consensus       169 ~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~  242 (394)
                      .++|+|||+++......    .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+ ....+..+.+.
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~  235 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVM  235 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence            99999999987543322    11234577899999775 458999999999999999998 7899976 45556666665


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc------CCccccCC
Q 016143          243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK------DPFLVTDN  288 (394)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~------~p~~~~~~  288 (394)
                      .+..+. .+...++.+++++.+||. +|.+||++.++++      ||||....
T Consensus       236 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         236 DGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             cCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            543322 344557899999999998 9999999999987      88887654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-40  Score=310.54  Aligned_cols=247  Identities=32%  Similarity=0.537  Sum_probs=205.9

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|++|.||+|.++.++..||+|.+..... ........+.+|+.+++.++||||+++++++.++  ..++++|
T Consensus         5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v~   81 (267)
T cd08229           5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNIVL   81 (267)
T ss_pred             hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEEEE
Confidence            678999999999999999999999999998875442 2244557788999999999999999999988654  4788999


Q ss_pred             cccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          108 ELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       108 e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ||+++++|.+++..    ...+++..++.++.||+.||.|||+++  ++|+||||+||+++ .++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhcccc
Confidence            99999999998874    345899999999999999999999999  99999999999998 688999999999876543


Q ss_pred             CC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCC-CHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          184 PT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       184 ~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ..  .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.... +.....+.+.....+.......+..++
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR  238 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence            32  234568999999997754 58889999999999999999999996533 234455555544444434456788999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhc
Q 016143          260 QFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +++.+||. +|.+||++.++++
T Consensus       239 ~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         239 QLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHhcCCCcccCCCHHHHHH
Confidence            99999998 9999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=301.09  Aligned_cols=250  Identities=24%  Similarity=0.447  Sum_probs=211.0

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ..||+|+-|+|+++..+.+|...|+|.+....   ..++..+++..++++..- +.|+||+.|++|+.+..  +++.||.
T Consensus        98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V~IcMel  172 (391)
T KOG0983|consen   98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--VFICMEL  172 (391)
T ss_pred             HhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--HHHHHHH
Confidence            56999999999999999999999999997654   467778888888887666 49999999999987765  5567798


Q ss_pred             cCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC-c
Q 016143          110 FTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-R  187 (394)
Q Consensus       110 ~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~-~  187 (394)
                      + +.-+.+++++ .++++|..+-.+...++.||.||..+. +|+|||+||+|||+| +.|++||+|||++-.+-.+.+ .
T Consensus       173 M-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSkAht  249 (391)
T KOG0983|consen  173 M-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKAHT  249 (391)
T ss_pred             H-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-cCCCEEeecccccceeecccccc
Confidence            8 4456666654 356999999999999999999996543 399999999999999 899999999999976655544 3


Q ss_pred             ccccCCcccCcccccc----cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC--CCCHHHHHH
Q 016143          188 SVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQF  261 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~----~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~l  261 (394)
                      ...|-+.|||||.+.-    .|+-.+||||||++++||.||++||.++....+...++....+| .++.  ..++...+|
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP-~L~~~~gFSp~F~~f  328 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP-LLPGHMGFSPDFQSF  328 (391)
T ss_pred             cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC-CCCcccCcCHHHHHH
Confidence            4569999999998753    48999999999999999999999999998888888888775443 3332  378999999


Q ss_pred             HHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          262 IEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +..||. |+.+||...+||+|||+....+
T Consensus       329 v~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  329 VKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             HHHHhhcCcccCcchHHHhcCcceeecch
Confidence            999998 9999999999999999987654

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-40  Score=323.56  Aligned_cols=250  Identities=25%  Similarity=0.388  Sum_probs=202.5

Q ss_pred             CcccccccceecccCceEEEEEEE-----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEE
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV   96 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~   96 (394)
                      .+|| ++.+.||+|+||+||+|.+     ..+++.||+|.++...   .......+.+|+.+|.++ +||||+++++++.
T Consensus         6 ~~~~-~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           6 RDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             hhHh-cccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            3455 8999999999999999974     3567899999986432   234556788999999999 6899999999876


Q ss_pred             cCCCceEEEEEcccCCCcHHHHHHhC------------------------------------------------------
Q 016143           97 DDTNRTINMITELFTSGSLRQYRKKH------------------------------------------------------  122 (394)
Q Consensus        97 ~~~~~~~~lV~e~~~~gsL~~~i~~~------------------------------------------------------  122 (394)
                      ... ..+++||||+++|+|.+++...                                                      
T Consensus        82 ~~~-~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          82 KPG-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             cCC-CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            443 4688999999999999998643                                                      


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC----
Q 016143          123 -------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----  185 (394)
Q Consensus       123 -------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~----  185 (394)
                                   ..+++..+..++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++.......    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~  237 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVR  237 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEc-CCCcEEEEecccccccccCcchhh
Confidence                         13678888999999999999999999  99999999999998 78899999999997653321    


Q ss_pred             CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                      .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||........+...+..+..+ ..+...++.+.+++.
T Consensus       238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  316 (343)
T cd05103         238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTML  316 (343)
T ss_pred             cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHHH
Confidence            11233567899999765 458999999999999999997 999998755555555555555433 234456789999999


Q ss_pred             HcCC-CCCCCCCHHHHhcC
Q 016143          264 KCIV-PASLRLPALELLKD  281 (394)
Q Consensus       264 ~~L~-~p~~R~s~~elL~~  281 (394)
                      +||. +|.+||++.++++|
T Consensus       317 ~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         317 DCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHccCChhhCcCHHHHHHH
Confidence            9998 99999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.6e-40  Score=312.77  Aligned_cols=243  Identities=26%  Similarity=0.409  Sum_probs=201.7

Q ss_pred             ccccceecccCceEEEEEEE-----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           27 GRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +++.+.||+|+||+||++.+     ..++..+|+|.+...    .......+.+|+.++++++||||+++++++...  .
T Consensus         7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~   80 (288)
T cd05093           7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--D   80 (288)
T ss_pred             eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence            47789999999999999975     345677999987532    244566789999999999999999999988644  5


Q ss_pred             eEEEEEcccCCCcHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 016143          102 TINMITELFTSGSLRQYRKKHK-------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG  168 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~-------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~  168 (394)
                      .+++||||+++++|.+++...+             .+++.++..++.||+.||+|||+++  ++||||||+||+++ +++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~-~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCC
Confidence            6889999999999999997553             3899999999999999999999999  99999999999998 788


Q ss_pred             cEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHh
Q 016143          169 EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT  242 (394)
Q Consensus       169 ~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~  242 (394)
                      .+||+|||++.......    .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.. .+.......+.
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~-~~~~~~~~~i~  236 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIECIT  236 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence            99999999997553322    223345778999997764 58899999999999999998 9999976 44556666776


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .+..+ ..+...++++.+++.+||. +|.+||++.+++.
T Consensus       237 ~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         237 QGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            66433 2445677899999999998 8999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1e-40  Score=312.85  Aligned_cols=248  Identities=31%  Similarity=0.500  Sum_probs=209.5

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      .+.+.||+|++|.||+|.+..+|..||+|++..... ........+.+|+.++++++ ||||+++++++.+  ...+++|
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv   80 (280)
T cd05581           4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLYFV   80 (280)
T ss_pred             eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEEEE
Confidence            678899999999999999999999999999875433 22344567889999999998 9999999998744  4578999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      |||+++++|.+++.+.+.+++..++.++.|++.||.|||+++  ++|+||+|+||+++ .++.++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCCccc
Confidence            999999999999999888999999999999999999999999  99999999999998 78899999999997554322 


Q ss_pred             ---------------------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 016143          186 ---------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS  243 (394)
Q Consensus       186 ---------------------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~  243 (394)
                                           .....|+..|+|||.+.. .++.++||||||+++++|++|..||.... ....+..+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~  236 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKILK  236 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHh
Confidence                                 123457899999997654 57889999999999999999999998744 3444444443


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCH----HHHhcCCcc
Q 016143          244 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELLKDPFL  284 (394)
Q Consensus       244 ~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~----~elL~~p~~  284 (394)
                      .  ...++...++.+.+||++||. +|.+||++    .++|+||||
T Consensus       237 ~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         237 L--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             c--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            2  223445568899999999998 89999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7e-41  Score=322.82  Aligned_cols=251  Identities=24%  Similarity=0.406  Sum_probs=200.0

Q ss_pred             ceeccc--CceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEc
Q 016143           31 EILGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        31 ~~LG~G--~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      +.||+|  +||+||+|.+..+|..||+|++.....  ..+..+.+.+|+.+++.++||||++++++|..+  ..+++|+|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~e   79 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISP   79 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEEe
Confidence            456776  999999999999999999999875432  345567889999999999999999999998654  46889999


Q ss_pred             ccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          109 LFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       109 ~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      |+.+++|.+++.+.  ..+++..+..++.||+.||.|||+++  ++||||||+||+++ .++.++++||+.+......  
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCc
Confidence            99999999998875  35899999999999999999999999  99999999999998 6789999999865322111  


Q ss_pred             C-------CcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-C------
Q 016143          185 T-------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P------  247 (394)
Q Consensus       185 ~-------~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~-~------  247 (394)
                      .       .....++..|+|||++.+   .++.++|||||||++|+|++|..||............+..... +      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence            0       111235667999998764   3689999999999999999999999875544444333321110 0      


Q ss_pred             -------------------------------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          248 -------------------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       248 -------------------------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                                           .......++.+++|+.+||. +|.+|||+.++|+||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                                 00112245678999999998 999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1e-40  Score=318.04  Aligned_cols=254  Identities=26%  Similarity=0.393  Sum_probs=199.1

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC--
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--  100 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~--  100 (394)
                      .++| ++.+.||+|+||.||+|.++.++..||+|.+......  ......+.+|+.+++.++||||+++++.+.+...  
T Consensus         7 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDY-EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            4566 7889999999999999999999999999998654321  1223456789999999999999999998765432  


Q ss_pred             ----ceEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143          101 ----RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus       101 ----~~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                          ..+++|+||+.+ +|...+.. ...+++.+++.++.||+.||.|||+++  ++|+||||+||+++ +++.+||+||
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~df  159 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADF  159 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECcC
Confidence                357899999965 66666554 457999999999999999999999999  99999999999998 7899999999


Q ss_pred             ceeeeecCCC-------------CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHH
Q 016143          176 GLAIVMQQPT-------------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK  240 (394)
Q Consensus       176 gla~~~~~~~-------------~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~  240 (394)
                      |++.......             .....|++.|+|||.+.+  .++.++|||||||++|+|++|++||.+...... ...
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~  238 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHL  238 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence            9996543221             123457889999997654  478999999999999999999999976443332 222


Q ss_pred             Hhc---CCCCCC------------------C-------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          241 VTS---GIKPAS------------------L-------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       241 i~~---~~~~~~------------------~-------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      +..   ...+..                  .       ....++.+.+||.+||. +|.+||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            211   000000                  0       01234678899999998 99999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=311.84  Aligned_cols=250  Identities=25%  Similarity=0.400  Sum_probs=204.4

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.+.||+|++|.||+|.+..+|..+|+|.+....  ........+.+|+.+++.++|||++++++++.+.....+++|+
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            56788999999999999999999999999997653  2234446678899999999999999999998765346899999


Q ss_pred             cccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      ||+. ++|..++... ..+++..++.++.||+.||+|||+++  ++|+||+|+||+++ +++.+||+|||++....... 
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc-CCCCEEEccccceeeccCCCc
Confidence            9997 5899888765 57999999999999999999999999  99999999999998 78999999999997665543 


Q ss_pred             --CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC---CCC----------
Q 016143          186 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPA----------  248 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~---~~~----------  248 (394)
                        .....++..|+|||.+.+  .++.++||||||+++|+|++|+.||....... ....+....   .+.          
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhccccccchh
Confidence              233457889999997654  47899999999999999999999998744333 333222110   000          


Q ss_pred             ----------------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          249 ----------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       249 ----------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                      .+....++.+.+++++||. +|.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                            0111237789999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.7e-41  Score=313.35  Aligned_cols=242  Identities=28%  Similarity=0.513  Sum_probs=198.0

Q ss_pred             ccceecccCceEEEEEEEc----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           29 YDEILGKGAFKTVYKGFDE----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        29 ~~~~LG~G~~g~Vy~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +.+.||.|+||.||+|...    ..+..|+||.++..   ...+..+.+.+|++.+++++||||+++++++...  ..++
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~--~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN--EPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS--SSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeeccccccccccccccccccccccc--cccc
Confidence            4688999999999999887    45688999998532   2455678899999999999999999999998733  3488


Q ss_pred             EEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          105 MITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +|+||+++|+|.+++...  ..+++..+..|+.||+.||.|||+++  ++|++|+++||+++ .++.+||+|||++....
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~-~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLD-SNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEE-TTTEEEEESTTTGEETT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccccccccccccccccc
Confidence            999999999999999987  67999999999999999999999999  99999999999999 68899999999997763


Q ss_pred             CCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          183 QPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       183 ~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      ...    .....+...|+|||.+.. .++.++||||||+++|||++ |+.||.+. +..++...+..+..+. .+...+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~  232 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNCPK  232 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTSBH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccce-eccchhH
Confidence            221    223446778999998765 58999999999999999999 78999874 6677777776664433 4556788


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .+.++|.+||. +|.+||++.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            99999999998 9999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.7e-40  Score=310.79  Aligned_cols=247  Identities=22%  Similarity=0.362  Sum_probs=200.8

Q ss_pred             cccccceecccCceEEEEEEEcc-----CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      .+++.+.||+|++|.||+|.+..     ++..||+|.+....   .......+.+|+.+++.++|+||+++++++.+.  
T Consensus         7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--   81 (277)
T cd05036           7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--   81 (277)
T ss_pred             HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--
Confidence            34778999999999999999877     77899999875332   234446688999999999999999999987654  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEE
Q 016143          101 RTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVK  171 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~-------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~--~~~~k  171 (394)
                      ...++||||+.+++|.+++...+       .+++.++..++.||+.||.|||+++  ++||||||+||+++.+  +..+|
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceE
Confidence            35678999999999999997653       4899999999999999999999999  9999999999999832  23699


Q ss_pred             EcccceeeeecCCCC----cccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCC
Q 016143          172 IGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI  245 (394)
Q Consensus       172 l~Dfgla~~~~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~  245 (394)
                      |+|||++........    .....++.|+|||.+. ..++.++|||||||++|+|++ |..||.+. +...+...+....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~~~~~~~~~~  238 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEFVTGGG  238 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCC
Confidence            999999976543221    1223356899999775 458999999999999999997 99999874 4445555555443


Q ss_pred             CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       246 ~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+ ..+...+..+.+++.+||. +|.+||++.++|+|
T Consensus       239 ~~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 RL-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            32 3455667899999999998 89999999999976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.4e-40  Score=315.25  Aligned_cols=257  Identities=29%  Similarity=0.488  Sum_probs=210.1

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      .++..+| ...+.||+|+||+||+|.++.++..||+|.+..... .......++.+|+.+++.++|+|++++++++... 
T Consensus        11 ~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   87 (308)
T cd06634          11 DDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-   87 (308)
T ss_pred             CCcHHHH-HHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-
Confidence            4455555 556889999999999999999999999999864332 2344556788999999999999999999988654 


Q ss_pred             CceEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 NRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                       ...++|+||+. |+|.+++.. ...+++..+..++.|++.||.|||+++  ++||||+|+||+++ .++.++|+|||++
T Consensus        88 -~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~  162 (308)
T cd06634          88 -HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSA  162 (308)
T ss_pred             -CeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC-CCCcEEECCcccc
Confidence             46889999996 577776654 456899999999999999999999999  99999999999998 6789999999998


Q ss_pred             eeecCCCCcccccCCcccCccccc----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          179 IVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      ......  ....|++.|+|||.+.    +.++.++|||||||++|+|++|..||.......... .+..+..+.......
T Consensus       163 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~  239 (308)
T cd06634         163 SIMAPA--NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHW  239 (308)
T ss_pred             eeecCc--ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-HHhhcCCCCcCcccc
Confidence            765433  3456899999999763    357889999999999999999999997644333333 343443344344567


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      +..++++|++||. +|.+||++.+++.|||+...
T Consensus       240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             cHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            7899999999998 89999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.6e-41  Score=351.28  Aligned_cols=247  Identities=32%  Similarity=0.566  Sum_probs=208.8

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEc------------
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD------------   97 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~------------   97 (394)
                      .++||+||||.||+++.+-+|+.||||+|....   +.....++.+|+.+|.+|+|||||++|.+|++            
T Consensus       484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~  560 (1351)
T KOG1035|consen  484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVA  560 (1351)
T ss_pred             HHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccc
Confidence            368999999999999999999999999998664   45667789999999999999999999988863            


Q ss_pred             ----------------------------------------------------------------C---------------
Q 016143           98 ----------------------------------------------------------------D---------------   98 (394)
Q Consensus        98 ----------------------------------------------------------------~---------------   98 (394)
                                                                                      +               
T Consensus       561 ~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~  640 (1351)
T KOG1035|consen  561 SDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSV  640 (1351)
T ss_pred             cchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcc
Confidence                                                                            0               


Q ss_pred             ------------------CC--------ceEEEEEcccCCCcHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCe
Q 016143           99 ------------------TN--------RTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPI  151 (394)
Q Consensus        99 ------------------~~--------~~~~lV~e~~~~gsL~~~i~~~~~l-~~~~~~~i~~qil~~L~~LH~~~~~i  151 (394)
                                        .+        ..+||=||||+..+|.+++..+... ....++++|+||++||.|+|++|  |
T Consensus       641 ~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--i  718 (1351)
T KOG1035|consen  641 ILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--I  718 (1351)
T ss_pred             ccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--e
Confidence                              00        3588999999999999988877644 57889999999999999999999  9


Q ss_pred             EecCCCCCcEEEeCCCCcEEEcccceeeeec----------C----------CCCcccccCCcccCcccccc----cCCC
Q 016143          152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----------Q----------PTARSVIGTPEFMAPELYEE----EYNE  207 (394)
Q Consensus       152 vHrDLkp~NIll~~~~~~~kl~Dfgla~~~~----------~----------~~~~~~~gt~~y~aPE~l~~----~~~~  207 (394)
                      |||||||.|||++ .++.|||+|||+|+...          .          ...++.+||.-|+|||++.+    .|+.
T Consensus       719 IHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999999 78899999999997621          0          02345689999999999864    5999


Q ss_pred             cCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC---CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCc
Q 016143          208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  283 (394)
Q Consensus       208 ~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~  283 (394)
                      |+|+|||||+++||+.   ||........+...+.++..|..   +.+.. +.-+.+|++||+ ||++||||.|+|++.|
T Consensus       798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~-~~e~slI~~Ll~hdP~kRPtA~eLL~s~l  873 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEH-PEEASLIRWLLSHDPSKRPTATELLNSEL  873 (1351)
T ss_pred             hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccc-hHHHHHHHHHhcCCCccCCCHHHHhhccC
Confidence            9999999999999985   68776777777777777766655   23333 466889999998 9999999999999999


Q ss_pred             ccc
Q 016143          284 LVT  286 (394)
Q Consensus       284 ~~~  286 (394)
                      |..
T Consensus       874 lpp  876 (1351)
T KOG1035|consen  874 LPP  876 (1351)
T ss_pred             CCc
Confidence            984

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-40  Score=320.52  Aligned_cols=255  Identities=29%  Similarity=0.413  Sum_probs=209.7

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC---CceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---NRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~---~~~~  103 (394)
                      |++.+.||+|++|.||+|.+..++..||+|.+....  ......+.+.+|+.+++.++||||+++++++.+..   ...+
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            378899999999999999999899999999886432  12345567889999999999999999999876553   2368


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+. ++|.+++.+...+++..++.++.||+.||.|||++|  ++||||||+||+++ .++.++|+|||++.....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~-~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVN-SNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccCceEeecc
Confidence            99999997 589999988888999999999999999999999999  99999999999998 679999999999987655


Q ss_pred             CC-----CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--C-C-----
Q 016143          184 PT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P-A-----  248 (394)
Q Consensus       184 ~~-----~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~-~-----  248 (394)
                      ..     .....+++.|+|||.+.+  .++.++||||||+++|+|++|..||.... ....+..+.....  + .     
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHhhhc
Confidence            43     334568999999997764  47899999999999999999999998744 3333333322110  0 0     


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          249 ---------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       249 ---------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                           ......++.+.++|.+||. +|.+||++.++|.||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                                 0112246789999999998 999999999999999998643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.9e-40  Score=305.88  Aligned_cols=241  Identities=22%  Similarity=0.419  Sum_probs=199.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||.||+|..+ ++..+|+|.+.....     ..+.+.+|+.+|+.++||||+++++++.+  ...+++|
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv   77 (256)
T cd05114           6 LTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIV   77 (256)
T ss_pred             cEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEE
Confidence            367789999999999999764 456899998753321     23567889999999999999999998754  3568899


Q ss_pred             EcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |||+++|+|.+++... ..+++..+..++.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEc-CCCeEEECCCCCccccCCCc
Confidence            9999999999998754 45899999999999999999999999  99999999999998 68899999999997554332


Q ss_pred             C---cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          186 A---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       186 ~---~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      .   ....++..|+|||.+.+ .++.++||||||+++|+|++ |+.||.. .+..+....+..+..+. .+...+..+.+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~  232 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRLY-RPKLASMTVYE  232 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHHH
Confidence            1   12235668999998764 58899999999999999999 9999976 45566677776654332 34556789999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhc
Q 016143          261 FIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~  280 (394)
                      ++.+||. +|.+||++.++++
T Consensus       233 li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         233 VMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            9999998 8999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.7e-40  Score=313.74  Aligned_cols=261  Identities=23%  Similarity=0.362  Sum_probs=211.3

Q ss_pred             ccccceecccCceEEEEEEEc---cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCce
Q 016143           27 GRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~  102 (394)
                      |++.+.||+|++|+||+|.+.   .++..||+|.+............+.+.+|+.++.++ +||||+++++.+..  ...
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~~   79 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DTK   79 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CCE
Confidence            367789999999999999753   467899999987544333344556788999999999 59999999998743  457


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||+.+++|.+++.....+++..++.++.|++.||.|||+.+  ++||||+|+||+++ .++.++|+|||++....
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLD-SEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEEECccccccc
Confidence            8899999999999999988788999999999999999999999998  99999999999998 67899999999987654


Q ss_pred             CCC---CcccccCCcccCccccccc---CCCcCcchhhhhHHHHHHhcCCCCCCCC---CHHHHHHHHhcCCCCCCCCCC
Q 016143          183 QPT---ARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       183 ~~~---~~~~~gt~~y~aPE~l~~~---~~~~~DIwSlG~il~elltg~~Pf~~~~---~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      ...   .....|++.|+|||.+.+.   .+.++||||||+++|+|++|..||....   ....+.+.+.....  ..+..
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~  234 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKT  234 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcc
Confidence            332   2234689999999977543   6789999999999999999999996422   22333344433322  24455


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCC---HHHHhcCCccccCCCCCccc
Q 016143          254 TDPQVKQFIEKCIV-PASLRLP---ALELLKDPFLVTDNPKDLVC  294 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s---~~elL~~p~~~~~~~~~~~~  294 (394)
                      .++.+++++.+||. +|++||+   +.++|+||||+...+..+..
T Consensus       235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~  279 (288)
T cd05583         235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAA  279 (288)
T ss_pred             cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhh
Confidence            77899999999998 9999998   57889999999887655433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-40  Score=305.13  Aligned_cols=239  Identities=24%  Similarity=0.408  Sum_probs=199.0

Q ss_pred             ceecccCceEEEEEEEccCC---eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           31 EILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +.||+|+||.||+|++..++   ..||+|.+.....   ....+.+.+|+.+++.++||||+++++++..   ...++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEE
Confidence            46999999999999876655   7899998865432   2455678899999999999999999997642   3578999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC-
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-  186 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~-  186 (394)
                      ||+.+++|.+++.....+++..+..++.|++.||.|||+++  ++|+||||+||+++ .++.+||+|||++........ 
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecCCcc
Confidence            99999999999998888999999999999999999999999  99999999999998 788999999999976543321 


Q ss_pred             -c---ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          187 -R---SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       187 -~---~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                       .   ...++..|+|||.+.+ .++.++|||||||++|+|++ |..||.. .+..++...+..+.. ...+...++.+++
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  229 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE-MKGAEVIAMLESGER-LPRPEECPQEIYS  229 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCc-CCCCCCCCHHHHH
Confidence             1   1123467999997654 58899999999999999998 9999977 445666666666543 3345567789999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhc
Q 016143          261 FIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~  280 (394)
                      +|.+||. +|.+||++.++++
T Consensus       230 li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         230 IMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHhcCChhhCcCHHHHHH
Confidence            9999998 8999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-40  Score=304.46  Aligned_cols=243  Identities=28%  Similarity=0.480  Sum_probs=209.4

Q ss_pred             ecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCC
Q 016143           33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS  112 (394)
Q Consensus        33 LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~  112 (394)
                      ||+|+||.||++.+..++..||+|.+..... ......+.+.+|+.+++.++||||+++++.+.  .+..+++||||+.+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~   77 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPG   77 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCC
Confidence            6999999999999998999999999875543 23446678899999999999999999999874  44678999999999


Q ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--CCcccc
Q 016143          113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVI  190 (394)
Q Consensus       113 gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~~~~~~  190 (394)
                      ++|.+++.....+++..+..++.||+.||.|||+.+  ++|+||+|+||+++ .++.++|+|||++......  ......
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCc
Confidence            999999998888999999999999999999999999  99999999999998 6889999999999766543  344566


Q ss_pred             cCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-C
Q 016143          191 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P  268 (394)
Q Consensus       191 gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~  268 (394)
                      ++..|+|||...+ ..+.++|+||||+++|+|++|..||.. .+.......+...  ...++...+..+.+++++||. +
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~--~~~~~~~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKD--PLRFPEFLSPEARDLISGLLQKD  231 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhcCC
Confidence            8999999997765 478899999999999999999999976 4445566666553  233556668899999999998 9


Q ss_pred             CCCCCCH---HHHhcCCcc
Q 016143          269 ASLRLPA---LELLKDPFL  284 (394)
Q Consensus       269 p~~R~s~---~elL~~p~~  284 (394)
                      |.+||++   .++++||||
T Consensus       232 p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         232 PTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HhhCCCcccHHHHHhCCCC
Confidence            9999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.8e-40  Score=310.56  Aligned_cols=245  Identities=25%  Similarity=0.373  Sum_probs=201.3

Q ss_pred             ccccceecccCceEEEEEEE----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           27 GRYDEILGKGAFKTVYKGFD----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      +++.+.||+|+||+||+|..    ..++..||+|.+....   ..+....+.+|+.+++.++||||+++++++...  ..
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~   81 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QP   81 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cc
Confidence            47889999999999999985    3456789999886322   344556788999999999999999999987554  46


Q ss_pred             EEEEEcccCCCcHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 016143          103 INMITELFTSGSLRQYRKKH-----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG  165 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-----------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~  165 (394)
                      .++||||+.+++|.+++...                 ..+++.++..++.||+.||.|||+++  ++||||||+||+++ 
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~-  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG-  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc-
Confidence            88999999999999998532                 23788999999999999999999999  99999999999998 


Q ss_pred             CCCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHH
Q 016143          166 NNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK  239 (394)
Q Consensus       166 ~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~  239 (394)
                      +++.+||+|||+++......    .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+ .+...+..
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~  237 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIE  237 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence            67899999999997654321    22344677899999765 458999999999999999998 9999976 44555566


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       240 ~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+.....+ ..+...++.+++++.+||+ +|.+||++.+++++
T Consensus       238 ~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 MVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            66554333 3456678999999999998 99999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-40  Score=306.50  Aligned_cols=242  Identities=23%  Similarity=0.404  Sum_probs=200.0

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||.||+|.++ ++..+|+|.+.....     ..+.+.+|+.+++.++||||+++++++.+  ....++|
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv   77 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIV   77 (256)
T ss_pred             cchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEE
Confidence            478899999999999999875 567899998753322     22457789999999999999999998743  3578899


Q ss_pred             EcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |||+++++|.+++... ..+++..+..++.||+.||.|||+++  ++||||||+||+++ +++.+||+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceeccccc
Confidence            9999999999998764 46899999999999999999999999  99999999999998 78899999999997654433


Q ss_pred             Ccccc---cCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          186 ARSVI---GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       186 ~~~~~---gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      .....   ++..|+|||.+. ..++.++||||||+++|+|++ |..||.. .+..+....+..+..+ ..+...+.++.+
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  232 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER-FSNSEVVESVSAGYRL-YRPKLAPTEVYT  232 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHcCCcC-CCCCCCCHHHHH
Confidence            22222   345799999776 468899999999999999999 8999976 4455666666655433 344567899999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcC
Q 016143          261 FIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++.+||. +|.+||++.++++.
T Consensus       233 li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         233 IMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHHH
Confidence            9999998 89999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.9e-40  Score=314.89  Aligned_cols=262  Identities=28%  Similarity=0.466  Sum_probs=212.7

Q ss_pred             cccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEc
Q 016143           18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD   97 (394)
Q Consensus        18 ~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~   97 (394)
                      ...++...| ...+.||+|+||+||+|.+..++..||+|.+..... ...+....+.+|+.+++.++|||++++++++.+
T Consensus        19 ~~~~~~~~f-~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (317)
T cd06635          19 FKEDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR   96 (317)
T ss_pred             cCCCchhhh-hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            445555554 677889999999999999999999999999875432 234556778999999999999999999998865


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccc
Q 016143           98 DTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG  176 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfg  176 (394)
                      +  ...++||||+.+ +|.+++.. ...+++.++..++.||+.||.|||+++  ++||||+|+||+++ .++.+||+|||
T Consensus        97 ~--~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~dfg  170 (317)
T cd06635          97 E--HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFG  170 (317)
T ss_pred             C--CeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEecCC
Confidence            4  467899999975 77776654 456999999999999999999999999  99999999999998 68899999999


Q ss_pred             eeeeecCCCCcccccCCcccCccccc----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 016143          177 LAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK  252 (394)
Q Consensus       177 la~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  252 (394)
                      ++.....  .....|++.|+|||.+.    +.++.++|||||||++|+|++|..||......... ..+..+..+.....
T Consensus       171 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~  247 (317)
T cd06635         171 SASIASP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNESPTLQSN  247 (317)
T ss_pred             CccccCC--cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHHhccCCCCCCc
Confidence            9865433  23456899999999763    35788999999999999999999999774433333 34433333333345


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCC
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK  290 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~  290 (394)
                      ..++.+++++.+||. +|.+||++.++++|+|+....+.
T Consensus       248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  286 (317)
T cd06635         248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE  286 (317)
T ss_pred             cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence            567899999999998 89999999999999999765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-40  Score=320.11  Aligned_cols=258  Identities=30%  Similarity=0.429  Sum_probs=207.8

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC-
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-  100 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~-  100 (394)
                      ..+|| ++.+.||+|+||+||+|.+..+|..||+|.+....  ........+.+|+.+|+.++||||+++++++..... 
T Consensus        13 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          13 VPDRY-RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             cccce-EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            44566 67789999999999999999999999999885432  233445678899999999999999999998865432 


Q ss_pred             ---ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143          101 ---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus       101 ---~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                         ..+++||||+ +++|..++.. ..+++..++.++.||+.||.|||+++  |+||||||+||+++ +++.+||+|||+
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~kl~dfg~  164 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGL  164 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeccc
Confidence               2468999999 7899988875 46999999999999999999999999  99999999999998 688999999999


Q ss_pred             eeeecCCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC----------
Q 016143          178 AIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------  245 (394)
Q Consensus       178 a~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~----------  245 (394)
                      +...... .....+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.................          
T Consensus       165 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         165 ARQTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             ccccccC-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            9765433 234567999999997764  478899999999999999999999987544333222211100          


Q ss_pred             ---------------CC---CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          246 ---------------KP---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       246 ---------------~~---~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                     .+   ..+....++++.++|.+||. +|.+||++.+++.||||+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence                           00   01123456789999999998 999999999999999998753

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.3e-40  Score=314.61  Aligned_cols=245  Identities=24%  Similarity=0.392  Sum_probs=198.0

Q ss_pred             ccccceecccCceEEEEEEEccCCeEE--EEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEV--AWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~v--aiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~  103 (394)
                      +.+.+.||+|+||+||+|.++.++..+  |+|.+...   ........+.+|+.++.++ +||||+++++++.+  ...+
T Consensus         9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~   83 (303)
T cd05088           9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL   83 (303)
T ss_pred             ceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCc
Confidence            377899999999999999988777654  66654321   2345567788999999999 89999999998754  4568


Q ss_pred             EEEEcccCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 016143          104 NMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN  167 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~----------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~  167 (394)
                      ++||||+++++|.+++.+.+                .+++.+++.++.||+.||+|||+++  ++||||||+||+++ .+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~-~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-EN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec-CC
Confidence            99999999999999997543                4789999999999999999999999  99999999999998 68


Q ss_pred             CcEEEcccceeeeecCCC-CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcC
Q 016143          168 GEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG  244 (394)
Q Consensus       168 ~~~kl~Dfgla~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~  244 (394)
                      +.+||+|||++....... .....++..|+|||.+.+ .++.++|||||||++|+|+| |..||.. .+..+....+..+
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~  239 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQG  239 (303)
T ss_pred             CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhcC
Confidence            899999999986432211 111224668999997765 47899999999999999998 9999976 4455666666554


Q ss_pred             CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       245 ~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..+. .+...++.+.+++.+||+ +|.+||++.++|.+
T Consensus       240 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         240 YRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3322 334467899999999998 89999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.5e-40  Score=305.05  Aligned_cols=243  Identities=24%  Similarity=0.419  Sum_probs=200.4

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      ..+++.+.||+|+||+||+|.+. ++..||+|.+....     ...+.+.+|+.+++.++|+||+++++.+.+  ....+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~   77 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIY   77 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcE
Confidence            34588899999999999999864 56789999875432     235678899999999999999999998754  35688


Q ss_pred             EEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          105 MITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++|||+++++|.+++...  ..+++..+..++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++....
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIE  154 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCccceecC
Confidence            999999999999998753  46899999999999999999999999  99999999999998 78899999999997665


Q ss_pred             CCC---CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          183 QPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       183 ~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      ...   .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.. .+.......+..+...+ .....+.+
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~  232 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRMP-RMENCPDE  232 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHH
Confidence            432   12234567899999775 458889999999999999998 9999976 44555666666554333 33456789


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          258 VKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +.+++.+||. +|.+||+++++++
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         233 LYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            9999999998 8999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.8e-40  Score=312.77  Aligned_cols=247  Identities=30%  Similarity=0.555  Sum_probs=206.0

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      .+||+|+||.||+|..+.+|..||+|++...    .......+.+|+.+++.++|+||+++++.+.+.  ...++||||+
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~   99 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVMEFL   99 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEecC
Confidence            6799999999999999999999999987532    234556788999999999999999999988654  5788999999


Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC--Ccc
Q 016143          111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARS  188 (394)
Q Consensus       111 ~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~--~~~  188 (394)
                      ++++|.+++... .+++..+..++.|++.||+|||+++  ++|+||+|+||+++ .++.++|+|||++.......  ...
T Consensus       100 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657         100 EGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             CCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEcccccceecccccccccc
Confidence            999999987654 5899999999999999999999999  99999999999998 67899999999986554322  234


Q ss_pred             cccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCCCHHHHHHHHHcC
Q 016143          189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCI  266 (394)
Q Consensus       189 ~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~li~~~L  266 (394)
                      ..|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.. .........+.....+. ......++.+.+++.+||
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL  254 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence            568999999997654 578999999999999999999999976 44444444444433221 122346789999999999


Q ss_pred             C-CCCCCCCHHHHhcCCccccCC
Q 016143          267 V-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       267 ~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      . +|.+||++.++|.||||....
T Consensus       255 ~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         255 VRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             hCCcccCcCHHHHhcChHHhccC
Confidence            8 999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.5e-40  Score=304.17  Aligned_cols=240  Identities=28%  Similarity=0.447  Sum_probs=198.5

Q ss_pred             ceecccCceEEEEEEEcc-CC--eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           31 EILGKGAFKTVYKGFDEV-DG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~-~~--~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +.||+|++|+||+|.+.. .+  ..||+|.+.....   ....+.+.+|+.++++++||||+++++.+.+   ..+++|+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL---SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc---HHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence            468999999999998765 23  3699999875442   1566789999999999999999999998865   5788999


Q ss_pred             cccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          108 ELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      ||+++++|.+++....  .+++..++.++.||+.||.|||+++  ++|+||||+||+++ .++.+||+|||++.......
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~  151 (257)
T cd05040          75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNE  151 (257)
T ss_pred             EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEe-cCCEEEeccccccccccccc
Confidence            9999999999998764  6899999999999999999999999  99999999999998 67899999999997664421


Q ss_pred             -----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          186 -----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       186 -----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                           .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||... +..++.+.+.........+...+..+
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (257)
T cd05040         152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDI  230 (257)
T ss_pred             cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHH
Confidence                 112346789999997764 58899999999999999998 99999764 44555555543222223344567899


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhc
Q 016143          259 KQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .+++.+||. +|.+||++.+++.
T Consensus       231 ~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         231 YNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHHCCCCcccCCCHHHHHH
Confidence            999999998 8999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-40  Score=321.88  Aligned_cols=257  Identities=31%  Similarity=0.461  Sum_probs=208.0

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC-
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-  100 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~-  100 (394)
                      ..++| .+.+.||+|++|+||+|.+..++..||+|.+....  .+......+.+|+.+++.++||||+++++++...+. 
T Consensus        13 ~~~~y-~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          13 VPDRY-QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             ccCce-EEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            44566 67899999999999999999999999999876432  223455668889999999999999999987754332 


Q ss_pred             ---ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143          101 ---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus       101 ---~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                         ..+++|+||+ +++|.+++... .+++..++.++.||+.||.|||+++  |+||||||+||+++ +++.+||+|||+
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~~-~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~  164 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGL  164 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEccccc
Confidence               3588999999 67999998764 5999999999999999999999999  99999999999998 688999999999


Q ss_pred             eeeecCCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CC-----
Q 016143          178 AIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PA-----  248 (394)
Q Consensus       178 a~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~-----  248 (394)
                      +...... .....+++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+.... ..+..+.....  ++     
T Consensus       165 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         165 ARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             ccccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhh
Confidence            9766443 344568999999997754  4788999999999999999999999874433 33333322110  00     


Q ss_pred             ----------------------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          249 ----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       249 ----------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                            ......++.+.+||++||. +|.+||++.++|.||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~  305 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH  305 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence                                  0112347899999999998 899999999999999998654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.9e-40  Score=307.79  Aligned_cols=245  Identities=25%  Similarity=0.419  Sum_probs=201.4

Q ss_pred             ccccccceecccCceEEEEEEEccCCe----EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      ..+++.+.||+|+||+||+|.+..++.    .||+|.+....   .....+.+.+|+.+++.++||||+++++++...  
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--   81 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--   81 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--
Confidence            345778999999999999999877776    48999875432   345567788999999999999999999987543  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                       ..++++||+++|+|.+++... +.+++..+..++.||+.||.|||+++  ++||||||+||+++ +++.+||+|||++.
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~~~  157 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGLAR  157 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCcee
Confidence             466899999999999999774 46999999999999999999999999  99999999999998 67899999999998


Q ss_pred             eecCCCC----cccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 016143          180 VMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       180 ~~~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      .......    ....+++.|+|||.+. ..++.++|||||||++|||++ |..||.. .....+...+..+..+. .+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~  235 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP-QPPI  235 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCcc
Confidence            7654322    1223467899999765 458999999999999999998 8999976 44555556665554332 3455


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .+..+.+++.+||. +|.+||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            67899999999998 9999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.1e-40  Score=308.65  Aligned_cols=251  Identities=27%  Similarity=0.427  Sum_probs=202.3

Q ss_pred             cccccccceecccCceEEEEEEE----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFD----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      +|++++.+.||+|+||.||+|..    +.++..||+|.++...   .......+.+|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   79 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            56778889999999999999974    4678899999986432   2445677899999999999999999999887765


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ...+++||||+++++|.+++.+.. .+++..+..++.||+.||.|||+++  ++||||||+||+++ .++.++|+|||++
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~~  156 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLT  156 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCccc
Confidence            667899999999999999997653 5899999999999999999999999  99999999999998 6889999999999


Q ss_pred             eeecCCC-----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCC--------------CHHHHH
Q 016143          179 IVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--------------NPAQIY  238 (394)
Q Consensus       179 ~~~~~~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~--------------~~~~~~  238 (394)
                      .......     .....|+..|+|||.+. ..++.++|||||||++|+|+++..|+....              ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence            7654332     12345677899999765 458899999999999999999877653211              112222


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       239 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..+..+... ..+...+..+.+|+.+||. +|.+||++.++++.
T Consensus       237 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         237 RVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            233333222 2344567899999999998 99999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.8e-40  Score=312.44  Aligned_cols=245  Identities=23%  Similarity=0.401  Sum_probs=199.3

Q ss_pred             ccccceecccCceEEEEEEEccCCe--EEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~  103 (394)
                      +++.+.||+|+||.||+|.++.++.  .+++|.++..   ......+.+.+|+.++.++ +||||+++++++.+.  ..+
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~   78 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYL   78 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccc
Confidence            3788999999999999999877765  4677776521   2344567788999999999 799999999987543  468


Q ss_pred             EEEEcccCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 016143          104 NMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN  167 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~----------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~  167 (394)
                      ++|+||+++++|.+++....                .+++..++.++.||+.||+|||+++  ++||||||+||+++ .+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~  155 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG-EN  155 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-CC
Confidence            89999999999999997542                4888999999999999999999999  99999999999998 68


Q ss_pred             CcEEEcccceeeeecCCCCcc-cccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcC
Q 016143          168 GEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG  244 (394)
Q Consensus       168 ~~~kl~Dfgla~~~~~~~~~~-~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~  244 (394)
                      +.+||+|||++.......... ...+..|+|||.+.+ .++.++|||||||++|||++ |..||.. .+.......+..+
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~  234 (297)
T cd05089         156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQG  234 (297)
T ss_pred             CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcC
Confidence            899999999986433221111 223457999997654 58999999999999999997 9999976 5556666666665


Q ss_pred             CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       245 ~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..+ ..+...+..+++|+.+||. +|.+||+++++++.
T Consensus       235 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         235 YRM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            433 2445678899999999998 89999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-40  Score=304.91  Aligned_cols=245  Identities=24%  Similarity=0.402  Sum_probs=201.7

Q ss_pred             ccccceecccCceEEEEEEEccC---CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      +++.+.||+|+||+||+|.++.+   ...||+|.+....   .......+.+|+.+++.++||||+++++++..  ...+
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   80 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPV   80 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCce
Confidence            37889999999999999988644   4679999876432   34456678899999999999999999998754  3568


Q ss_pred             EEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+++++|.+++... +.+++.++..++.|++.||.|||+++  |+|+||||+||+++ .++.++|+|||++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCCEEECccchhhccc
Confidence            8999999999999999765 46899999999999999999999999  99999999999998 68899999999997664


Q ss_pred             CC--CC--cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          183 QP--TA--RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       183 ~~--~~--~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      ..  ..  ....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.... ..+....+..+...+ .+...+.
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~  235 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-NQDVIKAVEDGYRLP-PPMDCPS  235 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHcCCCCC-CCCCCCH
Confidence            22  11  12234678999997764 58899999999999999998 999997744 455566665553322 3445678


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+.+++.+||. +|.+||++.+++++
T Consensus       236 ~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         236 ALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999998 99999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=8.9e-40  Score=309.71  Aligned_cols=247  Identities=24%  Similarity=0.314  Sum_probs=200.5

Q ss_pred             cccccccceecccCceEEEEEEEccCC----------------eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDG----------------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN   87 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~----------------~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpn   87 (394)
                      ++| ++.+.||+|+||.||+|.+..++                ..||+|.+....   .....+.+.+|+.++++++|||
T Consensus         5 ~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           5 QPL-NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             hhC-cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCC
Confidence            455 88899999999999999876544                568999876443   2456677889999999999999


Q ss_pred             ceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC
Q 016143           88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL  156 (394)
Q Consensus        88 Iv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~-----------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDL  156 (394)
                      |+++++++.++  ...+++|||+.+++|.+++....           .+++..++.++.|++.||.|||+++  ++||||
T Consensus        81 i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dl  156 (296)
T cd05051          81 IARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDL  156 (296)
T ss_pred             EeEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccc
Confidence            99999988654  46889999999999999998765           6899999999999999999999999  999999


Q ss_pred             CCCcEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh--cCCCCC
Q 016143          157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT--CEYPYN  229 (394)
Q Consensus       157 kp~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt--g~~Pf~  229 (394)
                      ||+||+++ +++.++|+|||++.......    .....+++.|+|||.+.+ .++.++|||||||++|+|++  +..||.
T Consensus       157 kp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         157 ATRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             chhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            99999998 67899999999997654332    223456789999997654 68999999999999999998  778887


Q ss_pred             CCCCHHHHHHHHhcC------CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          230 ECKNPAQIYKKVTSG------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       230 ~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ... ..+.+..+...      ......+...+.++.+++.+||+ +|.+||++.++++
T Consensus       236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         236 HLT-DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CcC-hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            643 34444444322      11112234456899999999998 9999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.1e-40  Score=311.54  Aligned_cols=245  Identities=23%  Similarity=0.384  Sum_probs=201.9

Q ss_pred             ccccceecccCceEEEEEEE-----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCC
Q 016143           27 GRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN  100 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~  100 (394)
                      +.+.+.||+|+||.||+|.+     ..++..||+|.++...   .....+.+.+|+.+++++ +||||+++++++.+.  
T Consensus        37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--  111 (302)
T cd05055          37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTIG--  111 (302)
T ss_pred             eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence            47789999999999999975     3456789999876432   244567789999999999 799999999988544  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          101 RTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ..+++||||+.+|+|.+++....  .+++.++..++.||+.||.|||+++  ++|+||||+||+++ .++.++|+|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeEEECCCccc
Confidence            46889999999999999997643  3899999999999999999999999  99999999999998 7889999999999


Q ss_pred             eeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 016143          179 IVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK  252 (394)
Q Consensus       179 ~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  252 (394)
                      .......    .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||............+..+..+ ..+.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~  267 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPE  267 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCC
Confidence            7554322    11234678899999765 458899999999999999998 999998755555555555555433 2345


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..++++.+++.+||. +|.+||++.+++.
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            567899999999998 8999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-40  Score=306.47  Aligned_cols=243  Identities=24%  Similarity=0.415  Sum_probs=200.6

Q ss_pred             cccceecccCceEEEEEEEccC-----CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           28 RYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++.+.||+|+||.||+|.++..     +..||+|.+....   .......+.+|+.+++.++||||+++++++.+.  ..
T Consensus         9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~   83 (277)
T cd05032           9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--QP   83 (277)
T ss_pred             eEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--CC
Confidence            6789999999999999987643     4889999975332   234456788999999999999999999988544  56


Q ss_pred             EEEEEcccCCCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 016143          103 INMITELFTSGSLRQYRKKHK----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI  172 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~----------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl  172 (394)
                      .++||||+++++|.+++....          .+++..+..++.||+.||.|||+++  ++||||||+||+++ .++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~-~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA-EDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc-CCCCEEE
Confidence            888999999999999986532          3678899999999999999999999  99999999999998 7899999


Q ss_pred             cccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCC
Q 016143          173 GDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK  246 (394)
Q Consensus       173 ~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~  246 (394)
                      +|||+++......    .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+ .+.....+.+..+..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~  239 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVIDGGH  239 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHhcCCC
Confidence            9999997554332    22344678999999765 458899999999999999998 9999976 455666666665433


Q ss_pred             CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          247 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       247 ~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      + ..+...+.++.+++.+||. +|.+||++.+++.
T Consensus       240 ~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         240 L-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             C-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            2 3445568899999999998 9999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.9e-40  Score=311.85  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=200.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC-------
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-------   99 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~-------   99 (394)
                      |.+.+.||+|+||+||+|.++.+|+.||+|.++.....  ......+.+|+.+++.++||||+++++++.+..       
T Consensus         9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            36789999999999999999999999999998754321  223345678999999999999999999886543       


Q ss_pred             -CceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143          100 -NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus       100 -~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                       ...+++|+||+++ +|..++... ..+++..++.++.||+.||.|||+++  |+|+||||+||+++ +++.+||+|||+
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~  162 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGL  162 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEEeCcccc
Confidence             3478999999976 676766654 46999999999999999999999999  99999999999998 788999999999


Q ss_pred             eeeecCCC---CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc---CCCCCC
Q 016143          178 AIVMQQPT---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKPAS  249 (394)
Q Consensus       178 a~~~~~~~---~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~---~~~~~~  249 (394)
                      +.......   .....+++.|+|||.+.+  .++.++|||||||++|+|++|++||....... ....+..   ...+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~  241 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELISRLCGSPCPAV  241 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhh
Confidence            97654432   122346888999997754  36889999999999999999999997644332 2222221   111110


Q ss_pred             -------------------------CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          250 -------------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       250 -------------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                               .....+..+.+++.+||. +|.+||++.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                     112357899999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.2e-40  Score=304.12  Aligned_cols=242  Identities=24%  Similarity=0.423  Sum_probs=199.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||+||+|.+. .+..||+|.+.....     ..+.+.+|+.++++++||||+++++++.+.  ..+++|
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   77 (256)
T cd05113           6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIV   77 (256)
T ss_pred             eEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcEEE
Confidence            377889999999999999764 345699998764321     235688899999999999999999987543  467899


Q ss_pred             EcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |||+.+|+|.+++... ..+++.+++.++.||+.||.|||+++  ++|+||||+||+++ .++.+||+|||++.......
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecCCCc
Confidence            9999999999999764 46899999999999999999999999  99999999999998 68899999999987654432


Q ss_pred             Ccc---cccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          186 ARS---VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       186 ~~~---~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      ...   ..++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .+.......+..+..+. .+...+..+++
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  232 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER-FNNSETVEKVSQGLRLY-RPHLASEKVYA  232 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHhcCCCCC-CCCCCCHHHHH
Confidence            222   23556899999876 468899999999999999998 9999976 44455666666554332 34456789999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcC
Q 016143          261 FIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++.+||. +|.+||++.+++.+
T Consensus       233 li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         233 IMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHHHh
Confidence            9999998 89999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-39  Score=305.33  Aligned_cols=242  Identities=22%  Similarity=0.331  Sum_probs=190.8

Q ss_pred             ceecccCceEEEEEEEc--cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEc
Q 016143           31 EILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      +.||+|+||.||+|...  .++..+|+|.+....   .......+.+|+.+++.++||||+++++++.+.  ..+++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEE
Confidence            46899999999999754  456789999876443   233445688899999999999999999987544  46789999


Q ss_pred             ccCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          109 LFTSGSLRQYRKKHK-----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       109 ~~~~gsL~~~i~~~~-----~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      |+++|+|.+++....     ..++..++.++.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~  152 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYK  152 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEECCccccccccC
Confidence            999999999987532     3567788899999999999999999  99999999999998 688999999999965433


Q ss_pred             CC----CcccccCCcccCcccccc--------cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCC---CC
Q 016143          184 PT----ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI---KP  247 (394)
Q Consensus       184 ~~----~~~~~gt~~y~aPE~l~~--------~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~---~~  247 (394)
                      ..    .....|++.|+|||++.+        .++.++||||||+++|||++ |+.||............+....   ..
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T cd05087         153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK  232 (269)
T ss_pred             cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence            21    223457889999998753        25789999999999999996 9999987554444333333221   12


Q ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCHHHHhc
Q 016143          248 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLK  280 (394)
Q Consensus       248 ~~~~~~~~~~~~~li~~~L~~p~~R~s~~elL~  280 (394)
                      +.+....+..+.+++++|+.+|.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~  265 (269)
T cd05087         233 PRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL  265 (269)
T ss_pred             CccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence            223334677899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.5e-40  Score=305.97  Aligned_cols=242  Identities=25%  Similarity=0.422  Sum_probs=202.4

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++. +..+|+|.+....    ....+.+.+|+.+++.++||||+++++++.+.  ...++|
T Consensus         8 y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv   80 (261)
T cd05148           8 FTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVYII   80 (261)
T ss_pred             HHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeEEE
Confidence            4788999999999999999877 8899999986443    33456688899999999999999999987544  468899


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+++++|.+++...  ..+++.++..++.||+.||.|||+++  ++|+||||+||+++ +++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLARLIKED  157 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchhhcCCc
Confidence            9999999999999863  45899999999999999999999999  99999999999998 7889999999999765433


Q ss_pred             C--CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          185 T--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       185 ~--~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      .  .....++..|+|||.+. +.++.++||||||+++|+|++ |+.||.. .+..+.+..+..+..+ ..+...++.+.+
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  235 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQEIYK  235 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCHHHHH
Confidence            2  22334567899999765 458899999999999999998 8999976 4455566666655333 234567789999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhc
Q 016143          261 FIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~  280 (394)
                      ++.+||. +|.+||++.++++
T Consensus       236 ~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         236 IMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHcCCCchhCcCHHHHHH
Confidence            9999998 9999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=326.74  Aligned_cols=245  Identities=26%  Similarity=0.404  Sum_probs=205.0

Q ss_pred             ccceecccCceEEEEEEEccCCe---E-EEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           29 YDEILGKGAFKTVYKGFDEVDGI---E-VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        29 ~~~~LG~G~~g~Vy~a~~~~~~~---~-vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +.++||+|+||.||+|..+..+.   . ||+|....+. ....+.+..+++|.++|++++|||||++|++..++  ..++
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~--~Pl~  237 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE--EPLM  237 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CccE
Confidence            45899999999999998765432   3 8999886422 23477889999999999999999999999987655  5799


Q ss_pred             EEEcccCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          105 MITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~-l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +|||+|.||+|.+|+++.+. ++..+...++.+.+.||+|||+++  ++||||-.+|+|++ .++.+||+|||+++....
T Consensus       238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~-~~~~vKISDFGLs~~~~~  314 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS-KKGVVKISDFGLSRAGSQ  314 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec-CCCeEEeCccccccCCcc
Confidence            99999999999999999875 999999999999999999999999  99999999999998 677889999999865542


Q ss_pred             CCC-c-ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          184 PTA-R-SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       184 ~~~-~-~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      -.. . ..--...|+|||.+.. .|+.++|||||||++||+.+ |..||.+ ....++..++.....+...+...+.++.
T Consensus       315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p~~~~  393 (474)
T KOG0194|consen  315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTPKELA  393 (474)
T ss_pred             eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence            211 1 1224568999998875 59999999999999999998 8899988 5556777777443344445667788999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhc
Q 016143          260 QFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .++++|+. +|.+||++.++.+
T Consensus       394 ~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  394 KVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHhccCChhhccCHHHHHH
Confidence            99999998 9999999998766

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1e-39  Score=309.10  Aligned_cols=244  Identities=26%  Similarity=0.391  Sum_probs=200.1

Q ss_pred             cccccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           26 YGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      -+.+.+.||+|+||.||+|.+.     .++..+++|.+...    .......+.+|+.++++++||||+++++++..  .
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   79 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGD--G   79 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--C
Confidence            3467899999999999999753     34567888887532    23445668899999999999999999998854  3


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 016143          101 RTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN  164 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~----------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~  164 (394)
                      ...++||||+++++|.+++..++                .+++..++.++.||+.||.|||+++  ++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~  157 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG  157 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence            56889999999999999997643                3889999999999999999999999  99999999999998


Q ss_pred             CCCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHH
Q 016143          165 GNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY  238 (394)
Q Consensus       165 ~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~  238 (394)
                       .++.++|+|||++.......    .....+++.|+|||.+.+ .++.++|||||||++|+|+| |..||.. .+.....
T Consensus       158 -~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~  235 (291)
T cd05094         158 -ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTEVI  235 (291)
T ss_pred             -cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHH
Confidence             68899999999997554322    223456889999997654 58899999999999999999 9999976 3445555


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       239 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+..+..+ ..+...+..+.+++.+||. +|.+||++.++++
T Consensus       236 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         236 ECITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            556555433 2445567899999999998 9999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.2e-39  Score=302.56  Aligned_cols=240  Identities=23%  Similarity=0.407  Sum_probs=200.5

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      .+++.+.||+|+||.||+|...  |..||+|.+...      ...+.+.+|+.+++.++|+|++++++++... ...+++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~l   77 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI   77 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEE
Confidence            3477899999999999999754  788999987532      2345688899999999999999999976543 346889


Q ss_pred             EEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          106 ITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      |+||+++++|.+++.+..  .+++..+..++.||+.||.|||+++  ++||||||+||+++ +++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCccceeccc
Confidence            999999999999998654  3889999999999999999999999  99999999999998 788999999999875543


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                      .. ....++..|+|||.+.+ .++.++|||||||++|+|++ |+.||.. .+..++...+..+..+ ..+...++.++++
T Consensus       155 ~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  231 (256)
T cd05082         155 TQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYDV  231 (256)
T ss_pred             cC-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHH
Confidence            32 23345678999997765 58899999999999999997 9999976 5566677777665443 3456678999999


Q ss_pred             HHHcCC-CCCCCCCHHHHhc
Q 016143          262 IEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL~  280 (394)
                      +.+||. +|.+||++.++++
T Consensus       232 i~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         232 MKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            999998 9999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.3e-40  Score=313.61  Aligned_cols=247  Identities=27%  Similarity=0.423  Sum_probs=202.4

Q ss_pred             cccccccceecccCceEEEEEEEcc-------CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW   95 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~   95 (394)
                      ++| .+.+.||+|+||+||+|.+..       ++..+|+|.+....   .......+.+|+.+++.+ +||||+++++++
T Consensus        18 ~~~-~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          18 DRL-VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             HHe-EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            455 788999999999999997643       33579999886432   244566788999999999 799999999988


Q ss_pred             EcCCCceEEEEEcccCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 016143           96 VDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD  159 (394)
Q Consensus        96 ~~~~~~~~~lV~e~~~~gsL~~~i~~~~----------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~  159 (394)
                      .+.  ..+++||||+.+|+|.+++...+                .+++.++..++.||+.||+|||+++  ++||||||+
T Consensus        94 ~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~  169 (307)
T cd05098          94 TQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAAR  169 (307)
T ss_pred             ecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHH
Confidence            544  46889999999999999997642                4888999999999999999999999  999999999


Q ss_pred             cEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCC
Q 016143          160 NIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKN  233 (394)
Q Consensus       160 NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~  233 (394)
                      ||+++ .++.+||+|||++.......    .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+ .+
T Consensus       170 Nill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~  247 (307)
T cd05098         170 NVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VP  247 (307)
T ss_pred             heEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CC
Confidence            99998 67899999999987554321    111234578999997654 58899999999999999998 8899976 56


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       234 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..++...+..+..+ ..+...+.++++++.+||. +|.+||++.+++.+
T Consensus       248 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         248 VEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            67777777665433 3455678899999999998 89999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.3e-40  Score=309.32  Aligned_cols=245  Identities=26%  Similarity=0.404  Sum_probs=201.8

Q ss_pred             ccccceecccCceEEEEEEEccC-----CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCC
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN  100 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~  100 (394)
                      +++.+.||+|+||.||+|.+...     ...+|+|.+....   .......+.+|+.+++.+ +|+||+++++++..  .
T Consensus        14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~   88 (293)
T cd05053          14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--E   88 (293)
T ss_pred             eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--C
Confidence            37789999999999999987643     3789999876432   344556788999999999 89999999998754  3


Q ss_pred             ceEEEEEcccCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 016143          101 RTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN  164 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~----------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~  164 (394)
                      ..++++|||+.+|+|..++...                ..+++..+..++.||+.||.|||+++  |+||||||+||+++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~  166 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVT  166 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEc
Confidence            5689999999999999998642                45899999999999999999999999  99999999999998


Q ss_pred             CCCCcEEEcccceeeeecCCCC----cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHH
Q 016143          165 GNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY  238 (394)
Q Consensus       165 ~~~~~~kl~Dfgla~~~~~~~~----~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~  238 (394)
                       +++.+||+|||++........    ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.. .+..+.+
T Consensus       167 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~  244 (293)
T cd05053         167 -EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELF  244 (293)
T ss_pred             -CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCHHHHH
Confidence             788999999999976544321    11234568999997654 58899999999999999997 9999976 5556666


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       239 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..+..+..+. .+...+..+.+|+.+||. +|.+|||+.+++++
T Consensus       245 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         245 KLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            7666654433 344567899999999998 89999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.5e-39  Score=306.36  Aligned_cols=243  Identities=25%  Similarity=0.418  Sum_probs=198.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeE----EEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIE----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      +++.+.||+|+||+||+|.+..++..    |++|.+...   ........+..|+..+++++||||+++++++..   ..
T Consensus         9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~   82 (279)
T cd05111           9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---AS   82 (279)
T ss_pred             ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Cc
Confidence            36778999999999999998777764    666665321   123445678889999999999999999998642   34


Q ss_pred             EEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .++++||+.+|+|.+++... +.+++..+..|+.||+.||.|||+++  ++||||||+||+++ +++.+||+|||++...
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLL  159 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEEcCCccceec
Confidence            67899999999999999764 56899999999999999999999999  99999999999998 7889999999999765


Q ss_pred             cCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          182 QQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       182 ~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      ....    .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+ .....+.+.+..+..+. .+...+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~  237 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG-MRPHEVPDLLEKGERLA-QPQICT  237 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCCCCC
Confidence            3321    22344677899999775 568999999999999999998 9999976 45555556666554332 344567


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+.+++.+|+. +|.+||++.|+++
T Consensus       238 ~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         238 IDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            789999999998 9999999999877

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.7e-40  Score=305.72  Aligned_cols=242  Identities=22%  Similarity=0.354  Sum_probs=190.7

Q ss_pred             ceecccCceEEEEEEEcc--CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEc
Q 016143           31 EILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      +.||+|+||+||+|....  ....+|+|.+....   .......+.+|+.+++.++||||+++++.+.+.  ..+++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEE
Confidence            358999999999996432  34568888764322   344556788999999999999999999988543  56889999


Q ss_pred             ccCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          109 LFTSGSLRQYRKKHK-----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       109 ~~~~gsL~~~i~~~~-----~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      |+++|+|.+++....     ..++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~  152 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLT-ADLSVKIGDYGLALEQYP  152 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEec-CCCcEEEecccccccccc
Confidence            999999999997653     2467888999999999999999999  99999999999998 688999999999864322


Q ss_pred             CC----CcccccCCcccCcccccc--------cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCC---C
Q 016143          184 PT----ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---P  247 (394)
Q Consensus       184 ~~----~~~~~gt~~y~aPE~l~~--------~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~---~  247 (394)
                      ..    .....+++.|+|||++..        .++.++|||||||++|||++ |..||....+...+...+.....   .
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T cd05042         153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK  232 (269)
T ss_pred             chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC
Confidence            21    122346778999997642        36789999999999999999 88999875555444444443321   2


Q ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCHHHHhc
Q 016143          248 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLK  280 (394)
Q Consensus       248 ~~~~~~~~~~~~~li~~~L~~p~~R~s~~elL~  280 (394)
                      +.+....+..+.+++..|+.+|.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~  265 (269)
T cd05042         233 PQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE  265 (269)
T ss_pred             CcccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence            234456778899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=302.89  Aligned_cols=241  Identities=25%  Similarity=0.412  Sum_probs=199.7

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|++|.||+|.+. ++..||+|.+.....     ..+.+.+|+.++++++||||+++++++...  ...++|
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   79 (261)
T cd05068           8 IQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYIV   79 (261)
T ss_pred             eeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecC--CCeeee
Confidence            488899999999999999875 457899999864332     235578899999999999999999987543  468899


Q ss_pred             EcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+.+++|.+++....  .+++..+..++.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGLARVIKED  156 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEc-CCCCEEECCcceEEEccCC
Confidence            99999999999997654  6999999999999999999999999  99999999999998 7889999999999876544


Q ss_pred             CCccccc---CCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          185 TARSVIG---TPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       185 ~~~~~~g---t~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ......|   +..|+|||.+.+ .++.++||||||+++|+|++ |+.||.+ .+.......+...... ..+...+..+.
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-MTNAEVLQQVDQGYRM-PCPPGCPKELY  234 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCcCCHHHH
Confidence            3322233   357999997664 58899999999999999999 9999976 4555566666554332 23455678999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhc
Q 016143          260 QFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +++.+||. +|.+||++.+++.
T Consensus       235 ~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         235 DIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHhhcCcccCCCHHHHHH
Confidence            99999998 9999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-39  Score=316.48  Aligned_cols=257  Identities=30%  Similarity=0.429  Sum_probs=204.4

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC--
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--   99 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~--   99 (394)
                      ...+| .+.+.||+|+||.||+|.+..+|..||+|.+....  ......+.+.+|+.++++++||||+++++++....  
T Consensus        15 ~~~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          15 VPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             ccCce-EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            33566 67799999999999999999999999999886432  22334567889999999999999999999875432  


Q ss_pred             --CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143          100 --NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus       100 --~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                        ...++++++++ +++|.++++.. .+++..++.++.||+.||.|||+++  |+||||||+||+++ +++.+||+|||+
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg~  166 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGL  166 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEecccc
Confidence              23477888887 78998888754 5999999999999999999999999  99999999999998 688999999999


Q ss_pred             eeeecCCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC--C--------
Q 016143          178 AIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I--------  245 (394)
Q Consensus       178 a~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~--~--------  245 (394)
                      +...... .....|++.|+|||.+.+  .++.++|||||||++|+|++|+.||....... ....+...  .        
T Consensus       167 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         167 ARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKK  244 (345)
T ss_pred             ccccccc-ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhh
Confidence            8765432 334568999999997754  47889999999999999999999997633322 22221110  0        


Q ss_pred             ----------------CC---CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          246 ----------------KP---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       246 ----------------~~---~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                      ..   .......+++++++|.+||. +|.+|+++.++|.||||+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence                            00   00112357789999999998 999999999999999998643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.3e-40  Score=314.80  Aligned_cols=250  Identities=24%  Similarity=0.422  Sum_probs=197.5

Q ss_pred             ccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEc
Q 016143           29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        29 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      +++.+|  ++|.||++.++.++..||+|.+.....  ..+..+.+.+|+.+++.++|+||++++++|.++  ...+++||
T Consensus         6 i~~~~~--~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e   79 (314)
T cd08216           6 IGKCFE--DLMIVHLAKHKPTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSP   79 (314)
T ss_pred             hhHhhc--CCceEEEEEecCCCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEe
Confidence            444444  445566666667999999999875432  345677899999999999999999999998654  46889999


Q ss_pred             ccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          109 LFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       109 ~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      |+.+++|.+++...  ..+++..+..++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||.+......  
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeeccccc
Confidence            99999999999864  45899999999999999999999999  99999999999998 7889999999998644321  


Q ss_pred             -------CCcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-------
Q 016143          185 -------TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------  247 (394)
Q Consensus       185 -------~~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-------  247 (394)
                             ......++..|+|||++..   .++.++|||||||++|+|++|..||............+......       
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence                   1223457789999998764   37899999999999999999999998755444444433211100       


Q ss_pred             ------------------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          248 ------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       248 ------------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                              .......+.++.+|+.+||. +|.+||++.++|+||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence                                    00111224578899999998 99999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2e-41  Score=306.50  Aligned_cols=256  Identities=29%  Similarity=0.457  Sum_probs=202.0

Q ss_pred             ccccceecccCceEEEEEEEccCCe----EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      |.....||+|.||.||+|..+.++.    .+|||+++-.+-  ........-+|+.+++.|+|||++.+..+|+.. ...
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~  102 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK  102 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence            4556789999999999997766654    789999875431  122335567899999999999999999998865 578


Q ss_pred             EEEEEcccCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC---CCcEEEcc
Q 016143          103 INMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGD  174 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-----~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~---~~~~kl~D  174 (394)
                      ++|++||.+. +|.+.|+-+     +.++...++.++.||+.|+.|||++.  |+||||||.||||.++   .|.+||+|
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeec
Confidence            9999999964 899988754     35999999999999999999999999  9999999999999843   38999999


Q ss_pred             cceeeeecCCC-----CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCC------CH---HHHH
Q 016143          175 LGLAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECK------NP---AQIY  238 (394)
Q Consensus       175 fgla~~~~~~~-----~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~------~~---~~~~  238 (394)
                      ||+++.+.++.     ...++-|.+|.|||++-+  .|+.++|||++|||+.||+|-++.|.+..      ++   +|+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999887763     345667999999997765  59999999999999999999999886421      11   2222


Q ss_pred             HHHhc-CC-CCCCC--------------------------------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCc
Q 016143          239 KKVTS-GI-KPASL--------------------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  283 (394)
Q Consensus       239 ~~i~~-~~-~~~~~--------------------------------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~  283 (394)
                      +.+.- |. ....|                                .+.-++...+|+.++|. ||-+|.+++++|+|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            11110 10 00000                                12335668899999998 9999999999999999


Q ss_pred             cccCC
Q 016143          284 LVTDN  288 (394)
Q Consensus       284 ~~~~~  288 (394)
                      |..+.
T Consensus       340 F~~d~  344 (438)
T KOG0666|consen  340 FTEDP  344 (438)
T ss_pred             cccCC
Confidence            98764

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.8e-39  Score=302.19  Aligned_cols=237  Identities=19%  Similarity=0.379  Sum_probs=195.1

Q ss_pred             ecccCceEEEEEEEc--cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           33 LGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        33 LG~G~~g~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      ||+|+||.||+|.+.  .++..||+|++....   .....+.+.+|+.++++++||||+++++++..   ...++||||+
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~   76 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMA   76 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeC
Confidence            899999999999764  456679999876432   34556778999999999999999999997632   3578999999


Q ss_pred             CCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC----
Q 016143          111 TSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----  185 (394)
Q Consensus       111 ~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~----  185 (394)
                      ++++|.+++.. ...+++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++.......    
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccCCcccee
Confidence            99999999875 456999999999999999999999999  99999999999998 78899999999997543321    


Q ss_pred             -CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          186 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       186 -~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                       .....+++.|+|||.+.. .++.++|||||||++|+|++ |..||.+. ........+..+..+ ..+...++++.+++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li  231 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYALM  231 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence             111223578999997764 58899999999999999996 99999874 445566666665433 35566789999999


Q ss_pred             HHcCC-CCCCCCCHHHHhc
Q 016143          263 EKCIV-PASLRLPALELLK  280 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~  280 (394)
                      .+||. +|.+||++.++.+
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            99998 8999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=302.21  Aligned_cols=242  Identities=22%  Similarity=0.396  Sum_probs=204.1

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      .+.+++.+.||+|+||.||+|...  |..||+|.+....     ...+++.+|+.+++.++|+||+++++++.+  ....
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   75 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPL   75 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCe
Confidence            345588899999999999999864  8899999986432     245778999999999999999999998865  4568


Q ss_pred             EEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          104 NMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      ++||||+++++|.++++...  .+++..+..++.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~  152 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEA  152 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEccccccccc
Confidence            89999999999999998765  6999999999999999999999999  99999999999998 7889999999999766


Q ss_pred             cCCCCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          182 QQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       182 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ..... ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...++.+.
T Consensus       153 ~~~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~  229 (256)
T cd05039         153 SQGQD-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVY  229 (256)
T ss_pred             ccccc-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHH
Confidence            43322 334566899999765 468899999999999999997 9999976 4566666666665433 34556789999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhc
Q 016143          260 QFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ++|++||. +|.+||++.+++.
T Consensus       230 ~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         230 KVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHhccChhhCcCHHHHHH
Confidence            99999998 9999999999886

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-39  Score=306.34  Aligned_cols=243  Identities=25%  Similarity=0.406  Sum_probs=199.3

Q ss_pred             ccccceecccCceEEEEEEE-----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           27 GRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +++.+.||+|+||+||+|..     ..++..+|+|.+...    .....+.+.+|+.+++.++|+||+++++++.+.  .
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~   80 (280)
T cd05092           7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--R   80 (280)
T ss_pred             ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--C
Confidence            46789999999999999964     345778999886532    345567789999999999999999999988654  4


Q ss_pred             eEEEEEcccCCCcHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 016143          102 TINMITELFTSGSLRQYRKKHK---------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN  166 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~---------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~  166 (394)
                      ..+++|||+.+++|.+++...+               .+++..+..++.||+.||+|||+++  ++||||||+|||++ +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~-~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVG-Q  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEc-C
Confidence            6889999999999999997653               4889999999999999999999999  99999999999998 6


Q ss_pred             CCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHH
Q 016143          167 NGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK  240 (394)
Q Consensus       167 ~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~  240 (394)
                      ++.+||+|||++.......    .....+++.|+|||.+. ..++.++|||||||++|+|++ |.+||.... .......
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~  236 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-NTEAIEC  236 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC-HHHHHHH
Confidence            8899999999997554322    12234578899999765 458999999999999999998 999997643 4445555


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       241 i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +..+..+ ..+...++.+.+++.+||. +|.+||++.+++.
T Consensus       237 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         237 ITQGREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHcCccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            5554333 2345677899999999998 9999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-39  Score=307.73  Aligned_cols=244  Identities=26%  Similarity=0.411  Sum_probs=199.7

Q ss_pred             ccccceecccCceEEEEEEEcc-----CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           27 GRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +++.+.||+|+||+||+|.+..     ....+|+|.+....   .....+++.+|+.+++.++||||+++++.+..+  .
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~   76 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--G   76 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--C
Confidence            3678999999999999998743     23568888775332   234567789999999999999999999987544  4


Q ss_pred             eEEEEEcccCCCcHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCC
Q 016143          102 TINMITELFTSGSLRQYRKKH------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK  157 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~------------------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLk  157 (394)
                      ..++++||+.+++|.+++...                        ..+++..+..++.|++.||.|||+++  ++|||||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dik  154 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLA  154 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhh
Confidence            578899999999999998653                        24788999999999999999999999  9999999


Q ss_pred             CCcEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCC
Q 016143          158 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNEC  231 (394)
Q Consensus       158 p~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~  231 (394)
                      |+||+++ +++.+||+|||++.......    .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+ 
T Consensus       155 p~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-  232 (290)
T cd05045         155 ARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-  232 (290)
T ss_pred             hheEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-
Confidence            9999998 78899999999997553321    12234567899999665 458899999999999999998 9999976 


Q ss_pred             CCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          232 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       232 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+..+...+..+..+. .+...+..+.+|+.+||. +|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         233 IAPERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            56677777776654333 345677899999999998 9999999999876

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.3e-40  Score=317.29  Aligned_cols=255  Identities=28%  Similarity=0.406  Sum_probs=202.3

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC---
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---  100 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~---  100 (394)
                      .+| ...+.||+|+||+||+|.++.+|..||+|.+.....  .......+.+|+.+++.++||||+++++++.....   
T Consensus        15 ~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          15 ERY-TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             cce-EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            555 677999999999999999999999999998864321  23344567889999999999999999998764322   


Q ss_pred             -ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 -~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                       ..+++|+||+. .+|..++.  ..+++..+..++.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++.
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~-~~~~~kL~dfg~~~  165 (342)
T cd07879          92 FQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLAR  165 (342)
T ss_pred             CceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCCCCc
Confidence             35689999995 47777653  45899999999999999999999999  99999999999998 68899999999986


Q ss_pred             eecCCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC--C---------
Q 016143          180 VMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--K---------  246 (394)
Q Consensus       180 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~--~---------  246 (394)
                      ..... .....+++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+.. ....+..+....  .         
T Consensus       166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         166 HADAE-MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-YLDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             CCCCC-CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHHHhc
Confidence            54332 234568899999997754  47899999999999999999999998743 222222222100  0         


Q ss_pred             -----------C----CC---CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          247 -----------P----AS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       247 -----------~----~~---~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                                 +    ..   .....++.+.+||++||. +|.+||++.++|.||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                       0    00   012356789999999998 9999999999999999987643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-41  Score=314.71  Aligned_cols=263  Identities=27%  Similarity=0.421  Sum_probs=215.7

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeecccc---CCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM---QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~---~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      +..|.+..+||+|||+.||+|+|...++.||+|+-...+.-   +.+.......+|.++.+.|+||-||++|++|.-++ 
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt-  540 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT-  540 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc-
Confidence            33336779999999999999999999999999986554321   11234455778999999999999999999986554 


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEccccee
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLA  178 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--~~~~~kl~Dfgla  178 (394)
                      ..++-|+|||+|.+|.-|++.++.+++++++.|+.||+.||.||.+..|||+|-||||.|||+-.  .-|.+||+|||++
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            36778999999999999999999999999999999999999999999999999999999999952  2367999999999


Q ss_pred             eeecCCCCc---------ccccCCcccCccccc-c----cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 016143          179 IVMQQPTAR---------SVIGTPEFMAPELYE-E----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG  244 (394)
Q Consensus       179 ~~~~~~~~~---------~~~gt~~y~aPE~l~-~----~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~  244 (394)
                      +.+......         ...||-+|++||.+. +    +.+.++||||+|||+|..+.|+.||........+....+--
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            988765332         346899999999653 2    36789999999999999999999998766665555443211


Q ss_pred             ---CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          245 ---IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       245 ---~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                         ..........++++++||++||+ .-.+|....+|-.||+|...
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence               11112345678899999999999 78899999999999999864

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.6e-39  Score=303.17  Aligned_cols=243  Identities=24%  Similarity=0.391  Sum_probs=198.0

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .++| ++.+.||+|+||+||+|.+..+ ..||+|++.....     ..+.+.+|+.+++.++||||+++++.+.+   ..
T Consensus         5 ~~~~-~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~   74 (262)
T cd05071           5 RESL-RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EP   74 (262)
T ss_pred             hHHe-eEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC---CC
Confidence            3455 8999999999999999988655 4699998864332     12467889999999999999999987632   34


Q ss_pred             EEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          103 INMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      .++||||+.+|+|.+++...  ..+++..+..++.|++.||.|||+++  ++||||||+||+++ +++.+||+|||++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~~~~  151 (262)
T cd05071          75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARL  151 (262)
T ss_pred             cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCceee
Confidence            68999999999999999864  35899999999999999999999999  99999999999998 688999999999976


Q ss_pred             ecCCCC---cccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          181 MQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       181 ~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      ......   ....++..|+|||... +.++.++|||||||++|+|+| |..||.+. ....+...+..+... ......+
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~  229 (262)
T cd05071         152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPECP  229 (262)
T ss_pred             ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCC-CCccccC
Confidence            644322   2234667899999765 468999999999999999999 88899764 445555555554322 2344567


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+.+++.+|+. +|.+||++.+++.
T Consensus       230 ~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         230 ESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHHH
Confidence            899999999998 8999999998765

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.5e-39  Score=306.39  Aligned_cols=245  Identities=21%  Similarity=0.296  Sum_probs=201.6

Q ss_pred             ccccceecccCceEEEEEEEcc-----CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           27 GRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +++.+.||+|+||+||+|.+..     ++..||+|.++...   .....+.+.+|+.++..++||||+++++++.+.  .
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~   81 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--Q   81 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--C
Confidence            4788999999999999998754     35789999986432   234557788999999999999999999987544  4


Q ss_pred             eEEEEEcccCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 016143          102 TINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG  165 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~----------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~  165 (394)
                      .+++++||+.+++|.+++...                ..+++..+..++.|++.||.|||+++  |+||||||+||+++ 
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~-  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec-
Confidence            688899999999999998532                24788899999999999999999999  99999999999998 


Q ss_pred             CCCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHH
Q 016143          166 NNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK  239 (394)
Q Consensus       166 ~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~  239 (394)
                      +++.+||+|||++.......    .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ ....++..
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~  237 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIE  237 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence            67899999999987554322    12334678999999764 568999999999999999998 8889876 45566777


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       240 ~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+..+... ..+...+..+.+++.+||+ +|.+||++.+++..
T Consensus       238 ~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         238 MIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            77665432 2455678899999999998 99999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-40  Score=307.03  Aligned_cols=249  Identities=28%  Similarity=0.446  Sum_probs=203.6

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|++|.||+|.+..+|..+++|.+.....  .+.....+.+|+.+++.++|+||+++++++.++  ..+++|+
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~   77 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVF   77 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEE
Confidence            567889999999999999999999999999865432  224456788899999999999999999987554  5788999


Q ss_pred             cccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      ||+.+ +|.+++... ..+++..+..++.||+.||.|||+++  ++|+||||+||+++ .++.++|+|||.+....... 
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCcc
Confidence            99975 888877664 57999999999999999999999999  99999999999998 68899999999997665543 


Q ss_pred             -CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--C-------------
Q 016143          186 -ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P-------------  247 (394)
Q Consensus       186 -~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~-------------  247 (394)
                       .....++..|+|||.+.+  .++.++||||||+++|+|++|+.||.......++.+.......  +             
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence             233468889999997654  4789999999999999999999999875554443333221100  0             


Q ss_pred             ------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          248 ------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       248 ------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                  .......+.++++||.+||. +|.+||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                        01112356789999999998 99999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-39  Score=304.86  Aligned_cols=247  Identities=27%  Similarity=0.422  Sum_probs=196.9

Q ss_pred             cccccceecccCceEEEEEE----EccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           26 YGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      .+++.+.||+|+||+||+|.    +..++..||+|.+...    .....+.+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            34788999999999999987    4567899999997643    245567788999999999999999999987666556


Q ss_pred             eEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      .+++|+||+++++|.+++... ..+++..+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++..
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~  157 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKV  157 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCccccc
Confidence            789999999999999999765 45899999999999999999999999  99999999999998 688999999999976


Q ss_pred             ecCCCC-----cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCH---------------HHHHH
Q 016143          181 MQQPTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------------AQIYK  239 (394)
Q Consensus       181 ~~~~~~-----~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~---------------~~~~~  239 (394)
                      ......     ....++..|+|||.+.+ .++.++|||||||++|||++|..|+......               ..+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            543321     11223456999997764 5889999999999999999988776432111               01112


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       240 ~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .+..+.. ...+...+.++.+++.+||. +|.+|||+.+++.
T Consensus       238 ~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         238 LLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2222221 12334567899999999998 9999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.4e-39  Score=340.90  Aligned_cols=149  Identities=26%  Similarity=0.415  Sum_probs=133.5

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      .+| ++.+.||+|+||+||+|.+..+++.||+|++..... ........+..|+.+++.++||||+++++++...  ..+
T Consensus         4 ~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~   79 (669)
T cd05610           4 EEF-VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQSA--NNV   79 (669)
T ss_pred             CCE-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--CEE
Confidence            344 788999999999999999999999999999875543 2345567788999999999999999999887543  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+++
T Consensus        80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~-~~g~vkL~DFGls~  152 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence            999999999999999998888999999999999999999999999  99999999999998 68899999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.5e-39  Score=304.40  Aligned_cols=246  Identities=23%  Similarity=0.333  Sum_probs=203.9

Q ss_pred             cccccceecccCceEEEEEEEcc----CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      -+++.++||+|+||.||+|.+..    ++..|++|.+...   ......+.+.+|+.+++.++||||+++++++... +.
T Consensus         7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~   82 (280)
T cd05043           7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE   82 (280)
T ss_pred             heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence            34788999999999999999875    3688999887522   2355677889999999999999999999987654 34


Q ss_pred             eEEEEEcccCCCcHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143          102 TINMITELFTSGSLRQYRKKH--------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~--------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                      ..+++++|+.+++|.+++...        ..+++..+..++.||+.||.|||+++  ++||||||+||+++ +++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEc-CCCcEEEC
Confidence            678899999999999998764        34899999999999999999999999  99999999999998 67899999


Q ss_pred             ccceeeeecCCCC----cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCC
Q 016143          174 DLGLAIVMQQPTA----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP  247 (394)
Q Consensus       174 Dfgla~~~~~~~~----~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~  247 (394)
                      |||+++.+.....    ....++..|+|||.+.+ .++.++|||||||++|+|++ |+.||.. .++..+...+..+..+
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~  238 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDGYRL  238 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHcCCCC
Confidence            9999976543321    22345678999997764 58899999999999999999 9999977 4666777777666443


Q ss_pred             CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       248 ~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      . .+...++++.+++.+||. +|++||++.+++.
T Consensus       239 ~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 A-QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             C-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3 334467899999999998 9999999999885

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.6e-39  Score=308.96  Aligned_cols=248  Identities=26%  Similarity=0.421  Sum_probs=201.3

Q ss_pred             CCcccccccceecccCceEEEEEEEc-------cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEee
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN   93 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~   93 (394)
                      +.++| .+.+.||+|+||.||+|.+.       .....||+|.+....   .......+.+|+.+++.+ +||||+++++
T Consensus        10 ~~~~~-~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099          10 PRDRL-VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cHHHe-eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            33555 68899999999999999763       235579999876332   245567788999999999 6999999999


Q ss_pred             eEEcCCCceEEEEEcccCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCC
Q 016143           94 SWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK  157 (394)
Q Consensus        94 ~~~~~~~~~~~lV~e~~~~gsL~~~i~~~----------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLk  157 (394)
                      ++.+.  ..+++||||+.+|+|.+++...                ..+++.++..++.||+.||.|||++|  ++|||||
T Consensus        86 ~~~~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlk  161 (314)
T cd05099          86 VCTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLA  161 (314)
T ss_pred             EEccC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecccc
Confidence            88543  4688999999999999999763                24888999999999999999999999  9999999


Q ss_pred             CCcEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCC
Q 016143          158 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNEC  231 (394)
Q Consensus       158 p~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~  231 (394)
                      |+||+++ +++.+||+|||++.......    .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.. 
T Consensus       162 p~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-  239 (314)
T cd05099         162 ARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-  239 (314)
T ss_pred             ceeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-
Confidence            9999998 78899999999997554321    112234568999997654 58899999999999999999 8999976 


Q ss_pred             CCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          232 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       232 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .+...++..+..+..+ ..+...+.++++++.+||. +|.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         240 IPVEELFKLLREGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            5566677776665432 2345567899999999998 8999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3e-39  Score=307.84  Aligned_cols=249  Identities=27%  Similarity=0.415  Sum_probs=203.2

Q ss_pred             CcccccccceecccCceEEEEEEEc-------cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeee
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS   94 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~   94 (394)
                      ...-+.+.+.||+|+||.||+|.+.       .++..||+|.+....   .......+.+|+.+++.+ +||||++++++
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            3444478899999999999999742       245679999875321   244567789999999999 89999999998


Q ss_pred             EEcCCCceEEEEEcccCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 016143           95 WVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC  158 (394)
Q Consensus        95 ~~~~~~~~~~lV~e~~~~gsL~~~i~~~----------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp  158 (394)
                      +...  ..+++||||+.+|+|.+++.+.                ..++..++..++.||+.||.|||++|  ++||||||
T Consensus        90 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp  165 (304)
T cd05101          90 CTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA  165 (304)
T ss_pred             EecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence            8544  4688999999999999999764                23778889999999999999999999  99999999


Q ss_pred             CcEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCC
Q 016143          159 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECK  232 (394)
Q Consensus       159 ~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~  232 (394)
                      +||+++ .++.+||+|||++.......    .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+ .
T Consensus       166 ~Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~  243 (304)
T cd05101         166 RNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-I  243 (304)
T ss_pred             ceEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-C
Confidence            999998 68899999999997664322    122345678999997754 58999999999999999998 8889976 4


Q ss_pred             CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       233 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +..++...+..+... ..+...+.++++|+.+||. +|.+||++.++++.
T Consensus       244 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         244 PVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            566777777665433 2345677899999999998 89999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=307.91  Aligned_cols=247  Identities=25%  Similarity=0.352  Sum_probs=195.6

Q ss_pred             cccccccceecccCceEEEEEEEccCC--------------eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDG--------------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII   89 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~--------------~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv   89 (394)
                      .+| ++.+.||+|+||.||+|.+..++              ..||+|.+....   .....+.+.+|++++++++||||+
T Consensus         5 ~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           5 QQL-RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             HhC-eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            455 88899999999999999875432              358999886432   345566789999999999999999


Q ss_pred             eEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCC
Q 016143           90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK  157 (394)
Q Consensus        90 ~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLk  157 (394)
                      ++++++...  ..+++||||+.+++|.+++....            .+++..+..++.||+.||.|||+++  ++|||||
T Consensus        81 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlk  156 (295)
T cd05097          81 RLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLA  156 (295)
T ss_pred             eEEEEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccC
Confidence            999988544  46889999999999999986542            3688899999999999999999999  9999999


Q ss_pred             CCcEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh--cCCCCCC
Q 016143          158 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--CEYPYNE  230 (394)
Q Consensus       158 p~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt--g~~Pf~~  230 (394)
                      |+||+++ +++.+||+|||++.......    .....+++.|+|||.+. +.++.++|||||||++|+|++  +..||..
T Consensus       157 p~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         157 TRNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             hhhEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            9999998 68899999999997553322    12234567899999665 568999999999999999988  6788876


Q ss_pred             CCCHHHHHHHHhc------CCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          231 CKNPAQIYKKVTS------GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       231 ~~~~~~~~~~i~~------~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .. ..+....+..      .......+...++.+++|+.+||. +|.+||++.++++
T Consensus       236 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         236 LS-DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             cC-hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            43 3433333221      111122344567899999999998 8999999999865

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=305.08  Aligned_cols=249  Identities=28%  Similarity=0.392  Sum_probs=201.4

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      |++.+.||+|++|+||+|....+++.||+|.+.....  . .......+|+..+++++ ||||+++++++.+  +...++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEE
Confidence            3678899999999999999998999999998764321  1 12233457999999999 9999999998865  457889


Q ss_pred             EEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          106 ITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ||||+ +|+|.+++....  .+++..+..++.|++.+|.|||+++  ++|+||+|+||+++ .++.++|+|||++.....
T Consensus        76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS-GPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCCEEEeecccceeccC
Confidence            99999 789999887764  7899999999999999999999999  99999999999998 789999999999976654


Q ss_pred             CC-CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-------------
Q 016143          184 PT-ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------------  247 (394)
Q Consensus       184 ~~-~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-------------  247 (394)
                      .. .....|+..|+|||.+.+  .++.++|+||||+++++|++|+.||..........+.......+             
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            32 334568999999997743  47899999999999999999999997755444433322110000             


Q ss_pred             -----------C---CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          248 -----------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       248 -----------~---~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                 .   ......+..++++|++||. +|.+||++.|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                       0   0011225789999999998 99999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.1e-39  Score=303.28  Aligned_cols=249  Identities=31%  Similarity=0.515  Sum_probs=203.4

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccC-CHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      .+.+.||+|+||+||+|.+..++..+++|.++...... .......+..|+.+++.++||||+++++++.+.  ...++|
T Consensus         3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   80 (260)
T cd08222           3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER--DAFCII   80 (260)
T ss_pred             eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--CceEEE
Confidence            67899999999999999998877777777655322211 223445577899999999999999999988654  457889


Q ss_pred             EcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          107 TELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +||+++++|.+++..    ...+++..++.++.|++.||.|||+++  ++|+||+|+||+++  ++.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~--~~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLK--NNLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEee--cCCEeecccCceeecC
Confidence            999999999998764    356999999999999999999999999  99999999999997  3579999999997654


Q ss_pred             CCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          183 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       183 ~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ...  .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.. .+.......+..+..+ ..+...+.++.
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTP-SLPETYSRQLN  234 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCC-CCcchhcHHHH
Confidence            332  234568999999997654 478899999999999999999999976 4444455555444333 35567788999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          260 QFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      ++|.+||. +|.+||++.++++||||
T Consensus       235 ~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         235 SIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            99999998 89999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=304.32  Aligned_cols=251  Identities=29%  Similarity=0.423  Sum_probs=198.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC---CCCCceeEeeeEEcCCC---
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDDTN---  100 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L---~hpnIv~~~~~~~~~~~---  100 (394)
                      |++.+.||+|+||.||+|.++.++..||+|.+.....  .......+.+|+.+++++   +||||+++++++.+...   
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence            3677899999999999999988999999999875432  222334566787777666   69999999999875532   


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          101 RTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ..++++|||+. ++|.+++....  .+++..++.++.||+.||.|||+++  ++|+||+|+||+++ .++.+||+|||++
T Consensus        79 ~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~-~~~~~~l~dfg~~  154 (287)
T cd07838          79 LKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLA  154 (287)
T ss_pred             ceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEc-cCCCEEEeccCcc
Confidence            24889999997 58998887643  4999999999999999999999999  99999999999999 6799999999999


Q ss_pred             eeecCCC-CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CC--------
Q 016143          179 IVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-KP--------  247 (394)
Q Consensus       179 ~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~-~~--------  247 (394)
                      ....... .....+++.|+|||.+.+ .++.++|||||||++|+|++|.+||......+ ...++.... .+        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCCC
Confidence            7764432 334458899999997764 58899999999999999999999998744433 333332110 00        


Q ss_pred             ----------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          248 ----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       248 ----------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                                      .......++.+.++|.+||. +|.+||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                            00011235678999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.3e-39  Score=320.19  Aligned_cols=245  Identities=26%  Similarity=0.415  Sum_probs=201.6

Q ss_pred             cccceecccCceEEEEEEE-----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCc
Q 016143           28 RYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNR  101 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~  101 (394)
                      .+.+.||+|+||.||+|.+     ..++..||+|+++...   .....+.+.+|+.+|.++. ||||+++++++..+  .
T Consensus        40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~--~  114 (401)
T cd05107          40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG--G  114 (401)
T ss_pred             ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--C
Confidence            4578999999999999985     3456789999986432   2344567889999999997 99999999988654  4


Q ss_pred             eEEEEEcccCCCcHHHHHHhCC----------------------------------------------------------
Q 016143          102 TINMITELFTSGSLRQYRKKHK----------------------------------------------------------  123 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~----------------------------------------------------------  123 (394)
                      .+++||||+.+|+|.+++.+.+                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            6889999999999999986532                                                          


Q ss_pred             ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 016143          124 ----------------------------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV  163 (394)
Q Consensus       124 ----------------------------------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll  163 (394)
                                                              .+++..+..++.||+.||.|||+++  ++||||||+|||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl  272 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLI  272 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEE
Confidence                                                    3567788999999999999999998  9999999999999


Q ss_pred             eCCCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHH
Q 016143          164 NGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI  237 (394)
Q Consensus       164 ~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~  237 (394)
                      + +++.+||+|||++.......    .....+++.|+|||.+.+ .++.++|||||||++|||++ |..||.........
T Consensus       273 ~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         273 C-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             e-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            8 68899999999997653221    223457889999997754 58899999999999999998 89999876666666


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       238 ~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ...+..+..+. .+...+.++.+++.+||. +|.+||++.+++..
T Consensus       352 ~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         352 YNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            66666664332 445578899999999998 99999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.5e-39  Score=300.17  Aligned_cols=240  Identities=24%  Similarity=0.404  Sum_probs=197.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||+||+|.++ ++..||+|.+.....     ..+.+.+|+.++++++|+||+++++++..   ...+++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv   78 (260)
T cd05070           8 LQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIV   78 (260)
T ss_pred             hhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEE
Confidence            378899999999999999765 667799998864332     12457889999999999999999997632   347899


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+.+++|.+++...  ..+++.+++.++.||+.||.|||+++  ++||||||+||+++ +++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVG-DGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEe-CCceEEeCCceeeeeccCc
Confidence            9999999999999764  35899999999999999999999999  99999999999998 6889999999999766443


Q ss_pred             CC---cccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          185 TA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       185 ~~---~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ..   ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+ .+.......+..+..+ ..+...+..++
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQVERGYRM-PCPQDCPISLH  233 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCcCCHHHH
Confidence            21   2233566899999765 458899999999999999999 8999976 4445555666554333 34556778999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhc
Q 016143          260 QFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +++.+||. +|.+||++.+++.
T Consensus       234 ~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         234 ELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHcccCcccCcCHHHHHH
Confidence            99999998 8999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.8e-39  Score=299.83  Aligned_cols=242  Identities=22%  Similarity=0.377  Sum_probs=195.0

Q ss_pred             ceecccCceEEEEEEEcc---CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           31 EILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +.||+|+||+||+|.+..   ++..||+|.+...   ......+.+.+|+.+++.++||||+++++++...+ ...++|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEE
Confidence            468999999999998643   3467999987432   23455678889999999999999999999765433 3577899


Q ss_pred             cccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      ||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++  ++||||||+||+++ +++.+||+|||++....... 
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCccccccccCCcc
Confidence            999999999999764 44788888999999999999999999  99999999999998 68899999999997553321 


Q ss_pred             -----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhc-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          186 -----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       186 -----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg-~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                           .....+++.|+|||.+. ..++.++|||||||++|||++| .+||.. .+...+...+..+..+. .+...+..+
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~  231 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLL-QPEYCPDPL  231 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHH
Confidence                 12334677899999765 4688999999999999999995 566654 55666666666654332 344567899


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          259 KQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+++.+||. +|.+||++.+++..
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999998 99999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.4e-39  Score=300.35  Aligned_cols=242  Identities=25%  Similarity=0.396  Sum_probs=197.3

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|++|+||+|.+..+ ..+|+|.+....     ...+.+.+|+.+++.++|||++++++++..   ...
T Consensus         6 ~~~-~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   75 (260)
T cd05069           6 ESL-RLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPI   75 (260)
T ss_pred             HHe-eeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCc
Confidence            344 7889999999999999987654 468999875432     123567889999999999999999987632   347


Q ss_pred             EEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          104 NMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      +++|||+.+++|.+++....  .+++..+..++.||+.||.|||+++  ++|+||||+||+++ +++.++|+|||++...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~  152 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGLARLI  152 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCccceEc
Confidence            79999999999999997643  4899999999999999999999999  99999999999998 7889999999999766


Q ss_pred             cCCCC---cccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          182 QQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       182 ~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      .....   ....++..|+|||... +.++.++||||||+++|+|++ |..||.+ .........+..+..+ ..+...+.
T Consensus       153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~  230 (260)
T cd05069         153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MVNREVLEQVERGYRM-PCPQGCPE  230 (260)
T ss_pred             cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCH
Confidence            44321   2234567899999765 458899999999999999999 9999987 4444555566555333 23456778


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .+++++++||. +|.+||++.++++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         231 SLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHH
Confidence            99999999998 9999999998875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.4e-39  Score=312.37  Aligned_cols=255  Identities=31%  Similarity=0.474  Sum_probs=203.8

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .++| .+.+.||+|+||.||+|.++.++..||+|.+.....  .....+.+.+|+.+++.++||||++++++|.... ..
T Consensus         9 ~~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~   84 (328)
T cd07856           9 TNRY-VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-ED   84 (328)
T ss_pred             ccce-EEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-Cc
Confidence            3454 788999999999999999999999999998764321  2334566788999999999999999999886543 46


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      .++|+||+ +++|..+++.. .+++..+..++.||+.||.|||+++  ++||||+|+||+++ +++.++|+|||++....
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCccccccccC
Confidence            78999998 67898888754 5889999999999999999999999  99999999999998 78899999999997543


Q ss_pred             CCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-----------------
Q 016143          183 QPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-----------------  243 (394)
Q Consensus       183 ~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-----------------  243 (394)
                      .. .....+++.|+|||.+.+  .++.++|||||||++|+|++|+.||.... .......+..                 
T Consensus       160 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd07856         160 PQ-MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD-HVNQFSIITDLLGTPPDDVINTICSEN  237 (328)
T ss_pred             CC-cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhccchh
Confidence            32 234567899999997654  58899999999999999999999997633 2111111100                 


Q ss_pred             -------C----CCC-CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          244 -------G----IKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       244 -------~----~~~-~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                             .    ..+ .......++.++++|++||. +|.+||++.+++.||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence                   0    000 01123456899999999998 999999999999999997643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3e-39  Score=302.54  Aligned_cols=240  Identities=25%  Similarity=0.398  Sum_probs=194.2

Q ss_pred             ceecccCceEEEEEEEccCCe--EEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++||+|+||.||+|.++.++.  .+|+|.+...   ......+.+.+|+.++.++ +||||+++++++...  ..+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEE
Confidence            469999999999999988776  4577776522   1245556788999999999 899999999988543  4688999


Q ss_pred             cccCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEE
Q 016143          108 ELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK  171 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~----------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~k  171 (394)
                      ||+++|+|.+++....                .+++.+++.++.|++.||+|||+++  ++||||||+||+++ .++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCCeEE
Confidence            9999999999987543                4789999999999999999999999  99999999999998 788999


Q ss_pred             EcccceeeeecCCCCc-ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCC
Q 016143          172 IGDLGLAIVMQQPTAR-SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA  248 (394)
Q Consensus       172 l~Dfgla~~~~~~~~~-~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~  248 (394)
                      |+|||++......... ....+..|+|||.+.. .++.++|||||||++|||++ |..||.+ .+....+..+..+... 
T Consensus       153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~-  230 (270)
T cd05047         153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL-  230 (270)
T ss_pred             ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCC-
Confidence            9999998533222111 1223567999997754 58899999999999999997 9999976 4555666666555333 


Q ss_pred             CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       249 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+...+.++.+++.+||. +|.+||++.+++.
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            2344567899999999998 8999999999886

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.9e-39  Score=300.34  Aligned_cols=244  Identities=25%  Similarity=0.426  Sum_probs=200.0

Q ss_pred             ccccceecccCceEEEEEEEccCCe---EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++..+.||+|+||.||+|.++.++.   .+|+|.+....   .....+.+.+|+.+++.++||||+++++++.+.  ...
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   81 (268)
T cd05063           7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KPA   81 (268)
T ss_pred             ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CCc
Confidence            3677999999999999999876654   78999875432   244567788999999999999999999988544  467


Q ss_pred             EEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+++++|.+++... +.+++.++..++.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCccceecc
Confidence            8999999999999999764 56899999999999999999999999  99999999999998 68899999999997664


Q ss_pred             CCCCc-----ccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          183 QPTAR-----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       183 ~~~~~-----~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      .....     ....++.|+|||.+. ..++.++|||||||++|||++ |..||.. .+.......+..+...+ .....+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~  236 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD-MSNHEVMKAINDGFRLP-APMDCP  236 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc-CCHHHHHHHHhcCCCCC-CCCCCC
Confidence            33211     112345799999776 458899999999999999997 9999976 34455666666543322 334467


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+.+++.+||. +|.+||++.++++
T Consensus       237 ~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         237 SAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            899999999998 9999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.2e-39  Score=296.37  Aligned_cols=240  Identities=27%  Similarity=0.405  Sum_probs=197.4

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      ++||+|+||.||+|.. .++..||+|.+....   .......+.+|+.+++.++||||+++++++...  ...++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECC
Confidence            4799999999999986 478899999876332   244456788999999999999999999988544  4688999999


Q ss_pred             CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC---
Q 016143          111 TSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---  186 (394)
Q Consensus       111 ~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~---  186 (394)
                      ++++|.+++... ..+++..+..++.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++........   
T Consensus        75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~  151 (250)
T cd05085          75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSS  151 (250)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccccccccC
Confidence            999999998754 45899999999999999999999999  99999999999998 788999999999975443321   


Q ss_pred             cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 016143          187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK  264 (394)
Q Consensus       187 ~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  264 (394)
                      ....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||... +.......+..+... ..+...+..+.+++.+
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~  229 (250)
T cd05085         152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQR  229 (250)
T ss_pred             CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence            12234668999997764 58899999999999999998 99999874 455555666555433 3345567899999999


Q ss_pred             cCC-CCCCCCCHHHHhcC
Q 016143          265 CIV-PASLRLPALELLKD  281 (394)
Q Consensus       265 ~L~-~p~~R~s~~elL~~  281 (394)
                      ||. +|.+||++.++++.
T Consensus       230 ~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         230 CWDYKPENRPKFSELQKE  247 (250)
T ss_pred             HcccCcccCCCHHHHHHH
Confidence            998 99999999998763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.5e-40  Score=332.78  Aligned_cols=257  Identities=25%  Similarity=0.364  Sum_probs=188.6

Q ss_pred             ccccceecccCceEEEEEEEccCC-eEEEEEEee-------------eccccCCHHHHHHHHHHHHHHHcCCCCCceeEe
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVN-------------IEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY   92 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~-~~vaiK~i~-------------~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~   92 (394)
                      |++.+.||+|+||+||+|..+... ..++.|.++             .............+.+|+.+|++++||||++++
T Consensus       150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  229 (501)
T PHA03210        150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE  229 (501)
T ss_pred             cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence            478899999999999998764332 222222111             011112233456688999999999999999999


Q ss_pred             eeEEcCCCceEEEEEcccCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 016143           93 NSWVDDTNRTINMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN  167 (394)
Q Consensus        93 ~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~-----~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~  167 (394)
                      +++.++  ...++|++++. ++|..++...     .......++.++.||+.||.|||+++  |+||||||+|||++ .+
T Consensus       230 ~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~-~~  303 (501)
T PHA03210        230 EILRSE--ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN-CD  303 (501)
T ss_pred             EEEEEC--CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CC
Confidence            988654  46788999984 5777766432     23456788899999999999999999  99999999999998 68


Q ss_pred             CcEEEcccceeeeecCCC---CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCC-CCCC-CCH-HHHHHH
Q 016143          168 GEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP-YNEC-KNP-AQIYKK  240 (394)
Q Consensus       168 ~~~kl~Dfgla~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~P-f~~~-~~~-~~~~~~  240 (394)
                      +.+||+|||++.......   ....+||+.|+|||++.+ .|+.++|||||||++|||++|..+ |... .++ .++.+.
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            899999999998765432   234579999999998765 589999999999999999998864 4322 122 233332


Q ss_pred             HhcCC-CCCCC----------------------------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          241 VTSGI-KPASL----------------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       241 i~~~~-~~~~~----------------------------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +.... ....+                            ....+..+.++|.+||. ||.+||++.|+|.||||.....
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~  462 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE  462 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence            22100 00000                            01234567788999998 9999999999999999987543

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3e-39  Score=306.72  Aligned_cols=254  Identities=24%  Similarity=0.439  Sum_probs=203.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      +++.+.||+|++|.||+|.++.++..||+|.+.....   ......+.+|+.++..+ .||||+++++++.+.  ..+++
T Consensus        17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~   91 (296)
T cd06618          17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVFI   91 (296)
T ss_pred             heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEEE
Confidence            3778999999999999999998999999999865432   23445566677766666 499999999998654  46889


Q ss_pred             EEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          106 ITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ||||+. ++|..++.. ...+++..+..++.||+.||.|||+ ++  |+||||+|+||+++ +++.+||+|||++.....
T Consensus        92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEECccccchhccC
Confidence            999985 577777765 4569999999999999999999997 57  99999999999998 788999999999865543


Q ss_pred             CC-CcccccCCcccCccccccc-----CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCCH
Q 016143          184 PT-ARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDP  256 (394)
Q Consensus       184 ~~-~~~~~gt~~y~aPE~l~~~-----~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-~~~~~~~~~  256 (394)
                      .. .....+++.|+|||.+.+.     ++.++||||||+++|+|++|+.||.......+....+.....+ .......+.
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence            32 2234578899999987633     7889999999999999999999997644444445444443222 122234678


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      ++++|+.+||. +|.+||++.+++.||||.....
T Consensus       248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            99999999998 9999999999999999986543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.2e-39  Score=299.59  Aligned_cols=240  Identities=24%  Similarity=0.401  Sum_probs=198.7

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.++||+|+||+||+|.. .++..||+|.+.....     ..+.+.+|+.++++++|+||+++++++.+   ..++++
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v   78 (260)
T cd05067           8 LKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYII   78 (260)
T ss_pred             ceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEE
Confidence            47889999999999999986 4678899998864332     23567889999999999999999997632   357899


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+.+++|.+++...  ..+++.++..++.|++.||.|||+++  ++||||||+||+++ +++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcceeecCCC
Confidence            9999999999998754  35899999999999999999999999  99999999999998 7889999999999766533


Q ss_pred             CC---cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          185 TA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       185 ~~---~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ..   ....++..|+|||.+.. .++.++||||||+++|+|++ |+.||.+. +.......+..+..+ ..+...+.++.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCPEELY  233 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence            22   22345678999997764 58899999999999999999 99999874 445556666555433 34455678999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhc
Q 016143          260 QFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +++.+||. +|.+||++++++.
T Consensus       234 ~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         234 ELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHccCChhhCCCHHHHHH
Confidence            99999998 9999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.4e-39  Score=300.77  Aligned_cols=243  Identities=24%  Similarity=0.422  Sum_probs=199.8

Q ss_pred             cccceecccCceEEEEEEEccCC---eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      ++.+.||+|+||.||+|.++.++   ..+|+|.++...   .....+.+.+|+.+++.++||||+++++++.+  ...++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~   81 (267)
T cd05066           7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPVM   81 (267)
T ss_pred             EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCccE
Confidence            78899999999999999876444   479999875432   24456778999999999999999999998754  35788


Q ss_pred             EEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +||||+++++|.+++... +.+++.++..++.|++.||.|||+++  ++||||||+||+++ .++.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEEC-CCCeEEeCCCCccccccc
Confidence            999999999999999765 45899999999999999999999999  99999999999998 688999999999976543


Q ss_pred             CCC-----cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          184 PTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       184 ~~~-----~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      ...     ....++..|+|||.+.+ .++.++|+|||||++|+|++ |..||.+. +..+....+..+..++ .+...++
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~  236 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRLP-APMDCPA  236 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcCC-CCCCCCH
Confidence            321     11223568999998764 68999999999999999886 99999774 4455666666654332 3345678


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .+.+++.+||. +|.+||++.++++
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         237 ALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHHcccCchhCCCHHHHHH
Confidence            99999999998 8999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.5e-39  Score=296.77  Aligned_cols=243  Identities=28%  Similarity=0.473  Sum_probs=204.6

Q ss_pred             cccceecccCceEEEEEEEccCC----eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      .+.+.||+|+||.||+|.+...+    ..||+|.+....   ..+....+.+|+.+++.++|+||+++++++.+.  ...
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--Cee
Confidence            46788999999999999998766    899999986432   233567888999999999999999999988654  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          104 NMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~--l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      +++|||+++++|.+++.....  +++.++..++.||+.||.|||+++  ++|+||||+||+++ +++.++|+|||++...
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~  153 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDL  153 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCceec
Confidence            899999999999999987654  999999999999999999999999  99999999999998 7889999999999766


Q ss_pred             cCCCCc---ccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          182 QQPTAR---SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       182 ~~~~~~---~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      ......   ...+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.. .+...+...+..+..+. .+...+.
T Consensus       154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~  231 (258)
T smart00219      154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPP  231 (258)
T ss_pred             ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCH
Confidence            543211   1236789999997754 58899999999999999998 8888876 56666677776654433 3445788


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ++.+++.+||. +|.+||++.++++
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      232 EIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHHh
Confidence            99999999998 9999999999886

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.6e-39  Score=312.40  Aligned_cols=254  Identities=24%  Similarity=0.356  Sum_probs=201.7

Q ss_pred             ccccceecccCceEEEEEEEccC--CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEc--CCCc
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVD--GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD--DTNR  101 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~--~~~~  101 (394)
                      |++.+.||+|+||.||+|.+..+  +..||+|.+....  ........+.+|+.+++++ +||||+++++.+..  ....
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            47789999999999999999888  8999999876322  1233456678899999999 59999999986532  2234


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .++++++|+. ++|.+++.....+++..++.++.||+.||.|||+++  ++||||||+|||++ .++.+||+|||++...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVN-ADCELKICDFGLARGF  155 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEc-CCCCEEeCcCCCceec
Confidence            6788999985 699999988888999999999999999999999999  99999999999998 6889999999999755


Q ss_pred             cCC------CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc----------
Q 016143          182 QQP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----------  243 (394)
Q Consensus       182 ~~~------~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~----------  243 (394)
                      ...      ......||+.|+|||.+.+  .++.++||||||+++|+|++|..||....... ....+..          
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL  234 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence            432      1233578999999997654  58899999999999999999999997633221 1111110          


Q ss_pred             ----------------CCCC---CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          244 ----------------GIKP---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       244 ----------------~~~~---~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                      ....   .......+..+++|+.+||. +|.+||++.+++.||||+.-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence                            0000   11122347899999999998 99999999999999999653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.4e-39  Score=300.35  Aligned_cols=245  Identities=23%  Similarity=0.396  Sum_probs=200.1

Q ss_pred             cccccceecccCceEEEEEEEccCCe---EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++++.+.||+|+||.||+|.++.++.   .||+|.+...   ........+..|+.+++.++||||+++++++.+  ...
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~   79 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRP   79 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCc
Confidence            35889999999999999999877664   5999987643   235566789999999999999999999998754  346


Q ss_pred             EEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      +++||||+.+++|.+++... +.+++.+++.++.|++.||.|||+++  ++|+||||+||+++ .++.+||+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~~  156 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFL  156 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEc-CCCcEEECCCcccccc
Confidence            88999999999999998764 56899999999999999999999999  99999999999998 6789999999998655


Q ss_pred             cCCCC----cc-cc--cCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 016143          182 QQPTA----RS-VI--GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK  252 (394)
Q Consensus       182 ~~~~~----~~-~~--gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  252 (394)
                      .....    .. ..  ++..|+|||.+. ..++.++|||||||++|||++ |..||.. .+.......+...... ..+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~  234 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIEQDYRL-PPPM  234 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcCCcC-CCcc
Confidence            43211    11 11  245799999776 468999999999999999886 9999977 4445556666544322 2334


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+..+.+++.+||. +|.+||++.+++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            567899999999998 8999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.1e-39  Score=301.97  Aligned_cols=245  Identities=20%  Similarity=0.350  Sum_probs=200.6

Q ss_pred             cccceecccCceEEEEEEEcc-----CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           28 RYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++.+.||+|+||+||+|..+.     +...|++|.+....   .....+.+.+|+.++++++|+||+++++++.+  ...
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~   82 (275)
T cd05046           8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AEP   82 (275)
T ss_pred             eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CCc
Confidence            677889999999999998754     34678888765322   23356778999999999999999999998744  356


Q ss_pred             EEEEEcccCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143          103 INMITELFTSGSLRQYRKKHK---------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~---------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                      .++||||+++|+|.+++....         .+++..+..++.||+.||.|||+++  |+||||||+||+++ .++.++|+
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEe-CCCcEEEc
Confidence            889999999999999998765         6899999999999999999999999  99999999999998 68899999


Q ss_pred             ccceeeeecCC---CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCC
Q 016143          174 DLGLAIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA  248 (394)
Q Consensus       174 Dfgla~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~  248 (394)
                      |||++......   ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ........+..+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~~~~~~  238 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAGKLEL  238 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHcCCcCC
Confidence            99998644322   223345678899999765 457889999999999999998 88999763 3445555555444333


Q ss_pred             CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       249 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..+...+..+.+++.+||. +|.+||++.+++..
T Consensus       239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            3445677899999999998 99999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.3e-39  Score=305.65  Aligned_cols=249  Identities=24%  Similarity=0.368  Sum_probs=195.2

Q ss_pred             CCcccccccceecccCceEEEEEEEcc----------------CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEV----------------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH   85 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h   85 (394)
                      |.++| ++.+.||+|+||+||+|.+..                ++..||+|.+....   .....+.+.+|+.+++.++|
T Consensus         3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~   78 (296)
T cd05095           3 PRKRL-TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKD   78 (296)
T ss_pred             Chhhc-eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCC
Confidence            44565 889999999999999985432                34578999876432   34456778899999999999


Q ss_pred             CCceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 016143           86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR  154 (394)
Q Consensus        86 pnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~-----------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHr  154 (394)
                      +||+++++++.+.  ..+++||||+.+++|.+++....           .+++.++..++.||+.||.|||+++  ++||
T Consensus        79 ~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~  154 (296)
T cd05095          79 PNIIRLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHR  154 (296)
T ss_pred             CCcceEEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence            9999999988654  46889999999999999987643           3677899999999999999999999  9999


Q ss_pred             CCCCCcEEEeCCCCcEEEcccceeeeecCCCC----cccccCCcccCcccc-cccCCCcCcchhhhhHHHHHHh--cCCC
Q 016143          155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT--CEYP  227 (394)
Q Consensus       155 DLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~----~~~~gt~~y~aPE~l-~~~~~~~~DIwSlG~il~ellt--g~~P  227 (394)
                      ||||+||+++ .++.++|+|||++........    ....+++.|+|||.. .+.++.++|||||||++|||++  |..|
T Consensus       155 dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p  233 (296)
T cd05095         155 DLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP  233 (296)
T ss_pred             cCChheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence            9999999998 688999999999976543321    123346789999954 4568999999999999999998  7799


Q ss_pred             CCCCCCHHHHHHHHhc----C--CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          228 YNECKNPAQIYKKVTS----G--IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       228 f~~~~~~~~~~~~i~~----~--~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      |.... ..+.......    .  ......+...++.+.+|+.+||. +|.+||++.++++
T Consensus       234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         234 YSQLS-DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ccccC-hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            97633 3333322211    0  01111234456899999999998 9999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.2e-39  Score=310.03  Aligned_cols=248  Identities=26%  Similarity=0.408  Sum_probs=202.0

Q ss_pred             cccccccceecccCceEEEEEEEcc-------CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW   95 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~   95 (394)
                      ...|++.+.||+|+||.||+|.+..       .+..||+|.+...   ......+.+.+|+.+++++ +||||+++++++
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            3445889999999999999997643       2347899987632   2345567889999999999 799999999988


Q ss_pred             EcCCCceEEEEEcccCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 016143           96 VDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD  159 (394)
Q Consensus        96 ~~~~~~~~~lV~e~~~~gsL~~~i~~~~----------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~  159 (394)
                      ..+  ..+++++||+.+|+|.+++.+..                .++..++..++.||+.||.|||+++  ++||||||+
T Consensus        88 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~  163 (334)
T cd05100          88 TQD--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAAR  163 (334)
T ss_pred             ccC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccc
Confidence            543  46889999999999999987532                3778899999999999999999999  999999999


Q ss_pred             cEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCC
Q 016143          160 NIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKN  233 (394)
Q Consensus       160 NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~  233 (394)
                      ||+++ .++.+||+|||+++......    .....++..|+|||.+.+ .++.++|||||||++|||++ |..||.+ .+
T Consensus       164 Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~  241 (334)
T cd05100         164 NVLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IP  241 (334)
T ss_pred             eEEEc-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CC
Confidence            99998 67899999999997654322    112234568999997754 58899999999999999998 8899976 55


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       234 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .......+..+..+. .+...+.++.+++.+||. +|.+||++.+++.+
T Consensus       242 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         242 VEELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            666777776654332 344567899999999998 99999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.6e-39  Score=299.51  Aligned_cols=244  Identities=25%  Similarity=0.445  Sum_probs=199.2

Q ss_pred             ccccceecccCceEEEEEEEccC---CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      +.+.+.||+|+||.||+|.+...   ...||+|......   ..+..+.+.+|+.+++.++||||+++++++.++   ..
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~   81 (270)
T cd05056           8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PV   81 (270)
T ss_pred             ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---Cc
Confidence            46789999999999999987544   3568999875432   245667889999999999999999999987542   46


Q ss_pred             EEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+++++|.+++.... .+++..+..++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS-SPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe-cCCCeEEccCceeeecc
Confidence            78999999999999998754 5899999999999999999999999  99999999999998 68899999999997654


Q ss_pred             CCCC---cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          183 QPTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       183 ~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      ....   ....+++.|+|||.+.. .++.++||||||+++|+|++ |..||..... ......+..+..+ ..+...+.+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~~~~~  236 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERL-PMPPNCPPT  236 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCcC-CCCCCCCHH
Confidence            4321   12234568999997654 58899999999999999996 9999987544 4444555554333 344567889


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          258 VKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +.+++.+|+. +|.+||++.+++..
T Consensus       237 ~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         237 LYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999998 99999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-39  Score=296.56  Aligned_cols=239  Identities=26%  Similarity=0.429  Sum_probs=197.4

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      ++||+|+||.||+|.+.. +..||+|.+.....   .+..+.+.+|+.++++++|+||+++++++.+.  ...++|+||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcC
Confidence            479999999999999877 99999998865432   34567789999999999999999999987654  4688899999


Q ss_pred             CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC---
Q 016143          111 TSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---  186 (394)
Q Consensus       111 ~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~---  186 (394)
                      .+++|.+++... ..+++..+..++.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++........   
T Consensus        75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~  151 (251)
T cd05041          75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVS  151 (251)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcceec
Confidence            999999998764 56899999999999999999999999  99999999999998 788999999999975542211   


Q ss_pred             -cccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          187 -RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       187 -~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                       ....++..|+|||.+. +.++.++||||||+++|+|++ |..||... ........+..+.. ...+...+.++.+++.
T Consensus       152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~  229 (251)
T cd05041         152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGYR-MPAPQLCPEEIYRLML  229 (251)
T ss_pred             cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCCC-CCCCccCCHHHHHHHH
Confidence             1122356799999765 458899999999999999999 88999763 44555555554432 2234567789999999


Q ss_pred             HcCC-CCCCCCCHHHHhc
Q 016143          264 KCIV-PASLRLPALELLK  280 (394)
Q Consensus       264 ~~L~-~p~~R~s~~elL~  280 (394)
                      +||. +|.+||++.|+|+
T Consensus       230 ~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         230 QCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHhccChhhCcCHHHHHH
Confidence            9998 8999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.1e-40  Score=333.66  Aligned_cols=242  Identities=25%  Similarity=0.390  Sum_probs=205.4

Q ss_pred             cccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           28 RYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++.+.||+|+||+||+|.-.     .+...||||.++...   +.+..+.|.+|+.+|..|+|||||++++++.  .++.
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~--~~~P  563 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCR--EGDP  563 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEc--cCCe
Confidence            56789999999999999643     344679999886433   3557788999999999999999999999884  4568


Q ss_pred             EEEEEcccCCCcHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 016143          103 INMITELFTSGSLRQYRKKHK----------N----VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG  168 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~----------~----l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~  168 (394)
                      ++||+||+..|||.+++..+.          .    |+..+.+.++.||+.|+.||-++.  +|||||...|+||+ ++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg-e~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG-ENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec-cce
Confidence            999999999999999987542          2    788999999999999999999999  99999999999998 889


Q ss_pred             cEEEcccceeeeecCCCCccc----ccCCcccCcc-cccccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHh
Q 016143          169 EVKIGDLGLAIVMQQPTARSV----IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT  242 (394)
Q Consensus       169 ~~kl~Dfgla~~~~~~~~~~~----~gt~~y~aPE-~l~~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~  242 (394)
                      .|||+|||+++..-+......    .-..+||||| ++.++|+.++||||+||+|||+++ |.-||.+..+ ++.+..+.
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-~EVIe~i~  719 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-QEVIECIR  719 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-HHHHHHHH
Confidence            999999999976655432222    2356999999 778999999999999999999998 9999988555 56667777


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHh
Q 016143          243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  279 (394)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL  279 (394)
                      .|.. .+-+...+.++.+|+..||+ .|.+||+.+||-
T Consensus       720 ~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  720 AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            7754 45678899999999999998 899999999864

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-39  Score=300.34  Aligned_cols=244  Identities=27%  Similarity=0.449  Sum_probs=202.3

Q ss_pred             cccccceecccCceEEEEEEEccCCe----EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      .+++.+.||+|+||+||+|.++.+|.    .||+|......   .......+.+|+.++++++||||+++++++..   .
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~   81 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS---S   81 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence            34788999999999999999877665    58888765432   24566778899999999999999999998865   4


Q ss_pred             eEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ..++|+||+.+|+|.+++... ..+++..+..++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++..
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg~~~~  158 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGLAKL  158 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCccccc
Confidence            678899999999999998875 46999999999999999999999998  99999999999998 688999999999976


Q ss_pred             ecCCCC----cccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          181 MQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       181 ~~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      ......    ....++..|+|||.+. ..++.++||||||+++|||++ |..||.. ....++...+..+.. ...+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~  236 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGER-LPQPPIC  236 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhCCCC-CCCCCCC
Confidence            543321    1122356899999765 468899999999999999998 9999977 456666666766533 2334557


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +..+.+++.+||. +|..||++.++++
T Consensus       237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         237 TIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            7899999999998 9999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.2e-39  Score=303.10  Aligned_cols=244  Identities=22%  Similarity=0.319  Sum_probs=199.3

Q ss_pred             ccccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           27 GRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +++.+.||+|+||.||+|.+.     .++..||+|.+....   .......+.+|+.++++++||||+++++++.+.  .
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--~   81 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVG--K   81 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--C
Confidence            377899999999999999874     367899999876432   244556788999999999999999999987544  4


Q ss_pred             eEEEEEcccCCCcHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 016143          102 TINMITELFTSGSLRQYRKKHK----------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD  159 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~----------------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~  159 (394)
                      .+++|+||+.+++|.+++....                      .+++.++..++.||+.||.|||+++  ++||||||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~  159 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATR  159 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHh
Confidence            6789999999999999987532                      3788899999999999999999999  999999999


Q ss_pred             cEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCC
Q 016143          160 NIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKN  233 (394)
Q Consensus       160 NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~  233 (394)
                      ||+++ .++.++|+|||++.......    .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+ .+
T Consensus       160 nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~-~~  237 (288)
T cd05050         160 NCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG-MA  237 (288)
T ss_pred             heEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CC
Confidence            99998 68899999999987553321    12233567899999765 468999999999999999997 8889976 45


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       234 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+....+..+... ..+...+.++.+|+.+||. +|.+||++.|+++
T Consensus       238 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         238 HEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            56666666655432 2344567899999999998 9999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.1e-39  Score=299.45  Aligned_cols=242  Identities=20%  Similarity=0.328  Sum_probs=187.7

Q ss_pred             ceecccCceEEEEEEEccC--CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEc
Q 016143           31 EILGKGAFKTVYKGFDEVD--GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      +.||+|+||+||+|....+  ...+++|.+...   ......+.+.+|+.+++.++||||+++++.+.+.  ..+++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC---CChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEe
Confidence            3599999999999975332  234556655432   2344567899999999999999999999988644  46889999


Q ss_pred             ccCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          109 LFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       109 ~~~~gsL~~~i~~~----~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |+++|+|.+++.+.    ..+++..++.++.||+.||.|||+++  ++||||||+|||++ .++.+||+|||++......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~  152 (268)
T cd05086          76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKE  152 (268)
T ss_pred             cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc-CCccEEecccccccccCcc
Confidence            99999999998764    34677788999999999999999999  99999999999998 6889999999998543221


Q ss_pred             ----CCcccccCCcccCcccccc--------cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCC---CCC
Q 016143          185 ----TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI---KPA  248 (394)
Q Consensus       185 ----~~~~~~gt~~y~aPE~l~~--------~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~---~~~  248 (394)
                          ......|++.|+|||++..        .++.++|||||||++|||++ |..||........+...+....   ..+
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  232 (268)
T cd05086         153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKP  232 (268)
T ss_pred             hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCC
Confidence                1234568899999997642        35678999999999999997 5778876444333333333221   123


Q ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCCCHHHHhc
Q 016143          249 SLSKVTDPQVKQFIEKCIVPASLRLPALELLK  280 (394)
Q Consensus       249 ~~~~~~~~~~~~li~~~L~~p~~R~s~~elL~  280 (394)
                      .+....++.+.+++..|+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~  264 (268)
T cd05086         233 QLELPYSERWYEVLQFCWLSPEKRATAEEVHR  264 (268)
T ss_pred             ccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence            34445678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-39  Score=302.34  Aligned_cols=237  Identities=21%  Similarity=0.376  Sum_probs=188.3

Q ss_pred             ceecccCceEEEEEEEccCCe-------EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           31 EILGKGAFKTVYKGFDEVDGI-------EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~-------~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      +.||+|+||+||+|.++.++.       .||+|.+...    .....+.+.+|+.+++.++||||+++++++....  ..
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~   74 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ES   74 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--Cc
Confidence            469999999999998865544       3888776432    2345567889999999999999999999987643  57


Q ss_pred             EEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC-------cEEEccc
Q 016143          104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-------EVKIGDL  175 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~-------~~kl~Df  175 (394)
                      ++||||+.+|+|..++...+ .+++..+..++.||+.||.|||+++  |+||||||+||+++.++.       .++++||
T Consensus        75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccc
Confidence            78999999999999998654 5899999999999999999999999  999999999999984332       2799999


Q ss_pred             ceeeeecCCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhc-CCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 016143          176 GLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLSK  252 (394)
Q Consensus       176 gla~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg-~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  252 (394)
                      |++......  ....+++.|+|||.+.+  .++.++|||||||++|+|++| ..||.. .+..........   ...++.
T Consensus       153 g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~~~---~~~~~~  226 (258)
T cd05078         153 GISITVLPK--EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFYED---RHQLPA  226 (258)
T ss_pred             ccccccCCc--hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHHHc---cccCCC
Confidence            998655432  23568899999998865  478999999999999999998 466655 333322222222   122344


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..+.++.+++.+||. +|.+||++.++++.
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         227 PKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            456789999999998 99999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.5e-39  Score=297.87  Aligned_cols=233  Identities=23%  Similarity=0.411  Sum_probs=187.8

Q ss_pred             ceecccCceEEEEEEEccCC----------eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           31 EILGKGAFKTVYKGFDEVDG----------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~----------~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      +.||+|+||.||+|.+..++          ..|++|.+....     .....+.+|+.+++.++||||+++++++..   
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   72 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR---   72 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence            46999999999999998776          457777665332     115778899999999999999999998865   


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC-------cEEE
Q 016143          101 RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-------EVKI  172 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~-------~~kl  172 (394)
                      ...++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++  |+||||||+||+++ ..+       .+||
T Consensus        73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~-~~~~~~~~~~~~kl  149 (259)
T cd05037          73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVA-RYGLNEGYVPFIKL  149 (259)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEe-cCccccCCceeEEe
Confidence            34678999999999999998766 7999999999999999999999999  99999999999998 455       7999


Q ss_pred             cccceeeeecCCCCcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCC
Q 016143          173 GDLGLAIVMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA  248 (394)
Q Consensus       173 ~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~  248 (394)
                      +|||++.....  .....++..|+|||.+.+   .++.++||||||+++|+|++ |..||.... ...........   .
T Consensus       150 ~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~---~  223 (259)
T cd05037         150 SDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQ---H  223 (259)
T ss_pred             CCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcC---C
Confidence            99999976544  223457788999998765   47899999999999999999 688887643 22222222221   1


Q ss_pred             CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       249 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+......+.+++.+||. +|.+||++.++++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1122223789999999998 9999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-39  Score=302.95  Aligned_cols=249  Identities=31%  Similarity=0.470  Sum_probs=201.9

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|++|.||+|.+..+++.||+|.+....  ......+.+.+|+.+++.++|+||+++++++.+.  ..+++|+
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~   77 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVF   77 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEe
Confidence            56788999999999999999999999999987653  1233446677899999999999999999988544  5788999


Q ss_pred             cccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      ||+. ++|.+++.+. ..+++..+..++.|++.||.|||+++  |+||||+|+||+++ +++.++|+|||++....... 
T Consensus        78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc-CCCCEEEecCCcccccCCCcc
Confidence            9997 5999999887 57999999999999999999999999  99999999999998 68999999999997654432 


Q ss_pred             -CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC------------------
Q 016143          186 -ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG------------------  244 (394)
Q Consensus       186 -~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~------------------  244 (394)
                       .....++..|+|||.+.+  .++.++|||||||++|+|++|..||........+.+.....                  
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence             233456788999997653  57889999999999999999999997744333322211100                  


Q ss_pred             -CCCC-------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          245 -IKPA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       245 -~~~~-------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                       ..+.       ......+..+.++|++||. +|.+||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence             0000       0011236789999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=322.31  Aligned_cols=239  Identities=23%  Similarity=0.408  Sum_probs=205.6

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      .+...+|.|+|+.|-.+.+..++...++|++....        ....+|+.++... +||||+++++.+.  .+..+|+|
T Consensus       325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~niv~~~~v~~--~~~~~~~v  394 (612)
T KOG0603|consen  325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPNIVKSHDVYE--DGKEIYLV  394 (612)
T ss_pred             ccccccCCCCccceeeeeccccccchhheeccccc--------cccccccchhhhhcCCCcceeecceec--CCceeeee
Confidence            45667999999999999999999999999987542        1123466565555 7999999999884  45678999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA  186 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~  186 (394)
                      ||++.|+.|.+.+...+.+. ..+..|++||+.|+.|||++|  |+||||||+|||++++.|+++|+|||.++..... .
T Consensus       395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~  470 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-C  470 (612)
T ss_pred             ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh-h
Confidence            99999999988887776555 788899999999999999999  9999999999999547889999999999888777 3


Q ss_pred             cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHc
Q 016143          187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC  265 (394)
Q Consensus       187 ~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~  265 (394)
                      .+.+-|..|.|||++.. +|++++||||||++||+|++|+.||....+..+++.++..+.    +....|.++++||++|
T Consensus       471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~----~s~~vS~~AKdLl~~L  546 (612)
T KOG0603|consen  471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK----FSECVSDEAKDLLQQL  546 (612)
T ss_pred             cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc----cccccCHHHHHHHHHh
Confidence            33456889999998875 599999999999999999999999988777778888887653    3477889999999999


Q ss_pred             CC-CCCCCCCHHHHhcCCcc
Q 016143          266 IV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       266 L~-~p~~R~s~~elL~~p~~  284 (394)
                      |+ +|.+|+++.+++.||||
T Consensus       547 L~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  547 LQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ccCChhhCcChhhhccCcch
Confidence            98 99999999999999999

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.3e-38  Score=295.23  Aligned_cols=242  Identities=21%  Similarity=0.416  Sum_probs=199.9

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||.||+|.+. .+..+|+|.+.....     ....+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         6 ~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v   77 (256)
T cd05112           6 LTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPICLV   77 (256)
T ss_pred             eEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceEEE
Confidence            367899999999999999875 467899998764332     124578899999999999999999987544  468899


Q ss_pred             EcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      +||+++++|.+++... ..++++.++.++.|++.||.|||+++  ++|+||||+||+++ .++.+||+|||++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeecccCc
Confidence            9999999999998765 45899999999999999999999999  99999999999998 78899999999997654432


Q ss_pred             Cc---ccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          186 AR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       186 ~~---~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      ..   ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .....+...+..+..+. .+...+..+.+
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  232 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRLY-KPRLASQSVYE  232 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCCC-CCCCCCHHHHH
Confidence            22   223456899999776 458899999999999999998 9999976 45566666666554332 34556789999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcC
Q 016143          261 FIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++.+||. +|.+||++.++++.
T Consensus       233 l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         233 LMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHcccChhhCCCHHHHHHh
Confidence            9999998 89999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.1e-39  Score=297.05  Aligned_cols=227  Identities=17%  Similarity=0.252  Sum_probs=187.5

Q ss_pred             cCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCCCcH
Q 016143           36 GAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL  115 (394)
Q Consensus        36 G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL  115 (394)
                      |.+|+||+|.++.+++.||+|.+.....         ..+|...+....||||+++++++.+.  ..+++||||+++|+|
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---------~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---------YSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh---------hhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCH
Confidence            8999999999999999999999864321         22345555666799999999988644  578999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCcccccCCcc
Q 016143          116 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF  195 (394)
Q Consensus       116 ~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y  195 (394)
                      .+++.+...+++..+..++.||+.||.|||+++  ++||||||+||+++ .++.++++|||++....... ....+++.|
T Consensus        73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~~-~~~~~~~~y  148 (237)
T cd05576          73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDSC-DGEAVENMY  148 (237)
T ss_pred             HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEecccchhcccccc-ccCCcCccc
Confidence            999988888999999999999999999999999  99999999999998 67899999999886554432 234567889


Q ss_pred             cCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCC
Q 016143          196 MAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL  273 (394)
Q Consensus       196 ~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~  273 (394)
                      +|||.+.+ .++.++||||+|+++|+|++|..||......      +. ......++...++.++++|++||. +|.+|+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  221 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------IN-THTTLNIPEWVSEEARSLLQQLLQFNPTERL  221 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cc-cccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence            99998764 5889999999999999999999988642211      11 111123455678899999999998 899999


Q ss_pred             CH-----HHHhcCCcc
Q 016143          274 PA-----LELLKDPFL  284 (394)
Q Consensus       274 s~-----~elL~~p~~  284 (394)
                      ++     .++++||||
T Consensus       222 ~~~~~~~~~~~~h~~~  237 (237)
T cd05576         222 GAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCCccchHHHHcCCCC
Confidence            86     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-39  Score=310.53  Aligned_cols=243  Identities=28%  Similarity=0.467  Sum_probs=188.8

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      .+||+|+||+||+|... +|..||||.+.....   .. ..+|.+|+.++.+++|||+|++++++.+.+. ...+|+||+
T Consensus        81 ~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~---~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEym  154 (361)
T KOG1187|consen   81 NLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSG---QG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEYM  154 (361)
T ss_pred             cceecCCCeEEEEEEEC-CCCEEEEEEecCCCC---cc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEcc
Confidence            58999999999999764 458999997654321   11 3449999999999999999999999976653 578899999


Q ss_pred             CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC-CCC
Q 016143          111 TSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTA  186 (394)
Q Consensus       111 ~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~-~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~-~~~  186 (394)
                      +.|+|.+++....  .++|....+|+.+++.||+|||+. .|+|+|||||+.|||+| .+.+.||+|||+|..... ...
T Consensus       155 ~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~~~~  233 (361)
T KOG1187|consen  155 PNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEGDTS  233 (361)
T ss_pred             CCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCccccc
Confidence            9999999988765  799999999999999999999995 45899999999999999 899999999999965554 322


Q ss_pred             -ccc-ccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCC--CH---HHH-HHHHhcCC----CCCCCC-C
Q 016143          187 -RSV-IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--NP---AQI-YKKVTSGI----KPASLS-K  252 (394)
Q Consensus       187 -~~~-~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~--~~---~~~-~~~i~~~~----~~~~~~-~  252 (394)
                       ... .||.+|+|||.+. +..+.++||||||++|.||+||+.|.+...  ..   ... ...+..+.    ..+.+. .
T Consensus       234 ~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~  313 (361)
T KOG1187|consen  234 VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG  313 (361)
T ss_pred             eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence             222 7999999999765 678999999999999999999998887532  11   111 12222221    112222 2


Q ss_pred             CCC--HHH---HHHHHHcCC-CCCCCCCHHHHhc
Q 016143          253 VTD--PQV---KQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       253 ~~~--~~~---~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+  .++   ..+..+|+. +|..||+..|+++
T Consensus       314 ~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  314 EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            222  233   455678998 7899999999754

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=295.75  Aligned_cols=241  Identities=25%  Similarity=0.410  Sum_probs=198.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||+||+|.++ ++..||+|.+.....     ..+.+.+|+.++++++|+||+++++++.+  ...+++|
T Consensus         8 ~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v   79 (261)
T cd05034           8 LKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYIV   79 (261)
T ss_pred             eeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEEE
Confidence            478899999999999999875 567899998864332     23567889999999999999999998754  3468999


Q ss_pred             EcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+++++|.+++....  .+++..+..++.||+.||.|||+++  ++|+||||+||+++ +++.+||+|||++......
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVG-ENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEc-CCCCEEECccccceeccch
Confidence            99999999999997653  6899999999999999999999999  99999999999998 7899999999999766533


Q ss_pred             CC---cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          185 TA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       185 ~~---~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ..   ....++..|+|||.+.+ .++.++||||||+++|+|++ |+.||.+ .+.......+..+... ..+...+.++.
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG-MTNREVLEQVERGYRM-PRPPNCPEELY  234 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence            21   12234678999997764 58899999999999999998 9999976 4445555666554332 23344578999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhc
Q 016143          260 QFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +++.+||. +|.+||++.+++.
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         235 DLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHcccCcccCCCHHHHHH
Confidence            99999998 8999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-38  Score=299.88  Aligned_cols=250  Identities=26%  Similarity=0.424  Sum_probs=201.8

Q ss_pred             cccccccceecccCceEEEEEEEc----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDE----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      .+++++.+.||+|+||+||+|...    .++..||+|.+.....   ....+.+.+|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            466788899999999999999854    3588999999864432   245677899999999999999999999887766


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ....++||||+++++|.+++.... .+++..+..++.||+.||.|||+++  ++|+||||+||+++ .++.++|+|||++
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~  156 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLA  156 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccccc
Confidence            678899999999999999998765 6999999999999999999999999  99999999999998 6789999999999


Q ss_pred             eeecCCCC-----cccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCH--------------HHHH
Q 016143          179 IVMQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP--------------AQIY  238 (394)
Q Consensus       179 ~~~~~~~~-----~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~--------------~~~~  238 (394)
                      ........     ....++..|+|||.+. ..++.++||||||+++|+|++|..||......              ..+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            76653211     1223456799999665 46889999999999999999999998653221              1122


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       239 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+..+... ..+...+.++.+++.+||. +|.+||++.+++.
T Consensus       237 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         237 ELLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            223332221 2234456899999999998 9999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-38  Score=293.74  Aligned_cols=237  Identities=22%  Similarity=0.416  Sum_probs=197.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||.||++.  .++..||+|.+....      ..+.+.+|+.+++.++||||+++++++..+   ..++|
T Consensus         8 ~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~v   76 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLYIV   76 (254)
T ss_pred             ceeeeeeccCCCCceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcEEE
Confidence            3788999999999999986  478899999875321      235688899999999999999999987543   36889


Q ss_pred             EcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+.+++|.+++....  .+++..+..++.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCcEEECCCccceecccc
Confidence            99999999999998653  4899999999999999999999999  99999999999998 6889999999999764432


Q ss_pred             CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          185 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                       ......+..|+|||.+. +.++.++|+|||||++|+|++ |..||.. .+.......+..+..+. .+...+..+.+++
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li  230 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK-MSLKEVKECVEKGYRME-PPEGCPADVYVLM  230 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhCCCCCC-CCCcCCHHHHHHH
Confidence             22233467899999765 468899999999999999997 9999977 44555666666664433 3456778999999


Q ss_pred             HHcCC-CCCCCCCHHHHhc
Q 016143          263 EKCIV-PASLRLPALELLK  280 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~  280 (394)
                      .+||. +|..||++.+++.
T Consensus       231 ~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         231 TSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            99998 8999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.5e-38  Score=294.73  Aligned_cols=249  Identities=26%  Similarity=0.444  Sum_probs=203.3

Q ss_pred             ccccceecccCceEEEEEEEcc-CCeEEEEEEeeecccc------CCHHHHHHHHHHHHHHHc-CCCCCceeEeeeEEcC
Q 016143           27 GRYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVM------QSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDD   98 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~-~~~~vaiK~i~~~~~~------~~~~~~~~~~~E~~~l~~-L~hpnIv~~~~~~~~~   98 (394)
                      |.+.+.||+|+||.||+|.++. ++..+|+|.+......      .......++.+|+.++.+ ++||||+++++++.+ 
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-   80 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE-   80 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc-
Confidence            4677899999999999999987 6889999988654321      223456678889998875 799999999998854 


Q ss_pred             CCceEEEEEcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143           99 TNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                       ....++||||+++++|.+++..    ...+++..++.++.|++.||.|||+ .+  ++|+||+|+||+++ .++.+||+
T Consensus        81 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~  156 (269)
T cd08528          81 -NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTIT  156 (269)
T ss_pred             -CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEEe
Confidence             3578999999999999988743    3469999999999999999999996 66  99999999999998 78899999


Q ss_pred             ccceeeeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 016143          174 DLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS  251 (394)
Q Consensus       174 Dfgla~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~  251 (394)
                      |||++...... ......|+..|+|||.+.+ .++.++||||||+++|+|++|+.||.. .+.......+..+...+...
T Consensus       157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd08528         157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPE  235 (269)
T ss_pred             cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCc
Confidence            99999766544 3345568999999997764 588999999999999999999999976 44455555555544333333


Q ss_pred             CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          252 KVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       252 ~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ...++.+.++|.+||. +|.+||++.|+..+
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            4577899999999998 99999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-38  Score=296.94  Aligned_cols=240  Identities=27%  Similarity=0.432  Sum_probs=193.9

Q ss_pred             ceecccCceEEEEEEEccCC------eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           31 EILGKGAFKTVYKGFDEVDG------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~------~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +.||+|+||.||+|.++...      ..+|+|.+....   .......+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeE
Confidence            46999999999999876544      789999875332   234456788999999999999999999988654  4688


Q ss_pred             EEEcccCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC-----cEEE
Q 016143          105 MITELFTSGSLRQYRKKH-------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-----EVKI  172 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~-------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~-----~~kl  172 (394)
                      +||||+++++|.+++...       ..+++.++..++.||+.||.|||+.+  ++|+||||+||+++ .++     .++|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVS-EKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEe-cCCCCCCcceEE
Confidence            999999999999998743       34788999999999999999999999  99999999999998 455     8999


Q ss_pred             cccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCC
Q 016143          173 GDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK  246 (394)
Q Consensus       173 ~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~  246 (394)
                      +|||++.......    .....++..|+|||.+. +.++.++|||||||++|+|++ |..||... +..+....+..+..
T Consensus       153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~  231 (269)
T cd05044         153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAGGR  231 (269)
T ss_pred             CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-CHHHHHHHHhcCCc
Confidence            9999996553321    11234578899999765 458899999999999999998 99999763 44555555554432


Q ss_pred             CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          247 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       247 ~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      + ..+...+..+.++|.+||. +|.+||++.++++
T Consensus       232 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 L-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             c-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2 2344567899999999998 8999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.1e-38  Score=295.52  Aligned_cols=248  Identities=22%  Similarity=0.324  Sum_probs=199.1

Q ss_pred             ccccceecccCceEEEEEEEc---cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC---
Q 016143           27 GRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---  100 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~---  100 (394)
                      |++.+.||+|+||+||+|.++   .++..||+|.+....  ......+++.+|+.+++.++||||+++++++.....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence            367889999999999999864   357899999986432  234556778999999999999999999998765432   


Q ss_pred             -ceEEEEEcccCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143          101 -RTINMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus       101 -~~~~lV~e~~~~gsL~~~i~~~------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                       ...+++++|+.+|+|..++...      ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEEC
Confidence             2346789999999999887532      24789999999999999999999999  99999999999998 78899999


Q ss_pred             ccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCC
Q 016143          174 DLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP  247 (394)
Q Consensus       174 Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~  247 (394)
                      |||++.......    .....+++.|++||.+.+ .++.++|||||||++|+|++ |..||.. .+...++..+..+...
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~  234 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL  234 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC
Confidence            999997654321    122345678999997654 57899999999999999999 8999976 4555566666554322


Q ss_pred             CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       248 ~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                       ..+...+..+.+++.+||. +|.+||++.+++..
T Consensus       235 -~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         235 -KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             2334567899999999998 89999999998863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.5e-38  Score=292.85  Aligned_cols=241  Identities=23%  Similarity=0.390  Sum_probs=197.6

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      .+++.+.||+|+||.||+|.+. .+..+|+|.+...     ....+.+.+|+.+++.++|+||+++++.+.+   ...++
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~   77 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI   77 (260)
T ss_pred             ceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence            3488999999999999999754 5567999987532     2345678889999999999999999998754   46789


Q ss_pred             EEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          106 ITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +|||+++++|.+++...  ..+++..+..++.||+.||.|||+++  ++|+||||+||+++ .++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARVIED  154 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCcceeeccC
Confidence            99999999999999764  35788999999999999999999999  99999999999998 688999999999976543


Q ss_pred             CCC---cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          184 PTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       184 ~~~---~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                      ...   ....++..|+|||.+.. .++.++|||||||++|+|++ |..||.. .+...+...+..+... ......+.++
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~  232 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRM-PRPENCPEEL  232 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCCC-CCcccCCHHH
Confidence            321   12335678999997764 58889999999999999999 9999987 4444555555555433 2345677899


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhc
Q 016143          259 KQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .+++.+||. +|.+||++.+++.
T Consensus       233 ~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         233 YNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHcccCcccCcCHHHHHH
Confidence            999999998 8999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-38  Score=298.92  Aligned_cols=236  Identities=20%  Similarity=0.313  Sum_probs=185.2

Q ss_pred             eecccCceEEEEEEEccC------------------------CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCC
Q 016143           32 ILGKGAFKTVYKGFDEVD------------------------GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN   87 (394)
Q Consensus        32 ~LG~G~~g~Vy~a~~~~~------------------------~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpn   87 (394)
                      .||+|+||.||+|....+                        ...||+|.+....    ......+.+|+.+++.++|||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence            599999999999975322                        2458888775322    344567889999999999999


Q ss_pred             ceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 016143           88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN  166 (394)
Q Consensus        88 Iv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~  166 (394)
                      |+++++++.+.  ...++||||+++|+|..++.+ .+.+++..+..++.||+.||.|||+++  |+||||||+||+++..
T Consensus        78 iv~~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~  153 (274)
T cd05076          78 LAFVHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL  153 (274)
T ss_pred             eeeEEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence            99999988654  467889999999999999875 456899999999999999999999998  9999999999999732


Q ss_pred             ------CCcEEEcccceeeeecCCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHH-hcCCCCCCCCCHHHH
Q 016143          167 ------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQI  237 (394)
Q Consensus       167 ------~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~ell-tg~~Pf~~~~~~~~~  237 (394)
                            ...+|++|||++......  ....+++.|+|||.+.+  .++.++|||||||++|||+ +|..||..... .+.
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~  230 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-SEK  230 (274)
T ss_pred             CcccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-HHH
Confidence                  224899999998544322  22357889999997754  4789999999999999995 69999976433 332


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       238 ~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ........   ..+...++.+.++|.+||. +|.+||++.++|++
T Consensus       231 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         231 ERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            22222211   1223345789999999998 89999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2e-38  Score=301.21  Aligned_cols=253  Identities=21%  Similarity=0.241  Sum_probs=188.9

Q ss_pred             CCCcccccccceecccCceEEEEEEEccC---CeEEEEEEeeeccccCCHHH-------HHHHHHHHHHHHcCCCCCcee
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQ-------LERLYSEVHLLKSLKHENIIK   90 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~-------~~~~~~E~~~l~~L~hpnIv~   90 (394)
                      |..++.|++.++||+|+||+||+|.+..+   +..+|+|+..........+.       ......+...+..++|+||++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            34445558999999999999999998777   66777776443321100000       011233445567789999999


Q ss_pred             EeeeEEcCCC--ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 016143           91 FYNSWVDDTN--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG  168 (394)
Q Consensus        91 ~~~~~~~~~~--~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~  168 (394)
                      ++++......  .+.+++++++. .++.+.++.....++..++.++.||+.||.|||+++  |+||||||+|||++ .++
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~-~~~  163 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD-GNN  163 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCC
Confidence            9987654432  24567888874 577777777666789999999999999999999999  99999999999998 678


Q ss_pred             cEEEcccceeeeecCC---------CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHH-
Q 016143          169 EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-  237 (394)
Q Consensus       169 ~~kl~Dfgla~~~~~~---------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~-  237 (394)
                      .++|+|||+|+.....         ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+......+ 
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999765321         1223469999999997765 5899999999999999999999999875333222 


Q ss_pred             -------HHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          238 -------YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       238 -------~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                             .+.+..+..   .....++++.++++.|+. +|.+||+..++++
T Consensus       244 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                   222332211   123346899999999998 9999999999875

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-38  Score=295.48  Aligned_cols=236  Identities=20%  Similarity=0.367  Sum_probs=185.1

Q ss_pred             ceecccCceEEEEEEEcc------------CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           31 EILGKGAFKTVYKGFDEV------------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~------------~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      +.||+|+||+||+|....            ....||+|.+...    .......+.+|+.+++.++||||+++++++.++
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            468999999999997432            2335888876532    234456788899999999999999999988654


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc-------E
Q 016143           99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-------V  170 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~-------~  170 (394)
                      .  ..++||||+++++|..++... ..+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.       +
T Consensus        77 ~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~~~~~~~~  151 (262)
T cd05077          77 V--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLA-REGIDGECGPFI  151 (262)
T ss_pred             C--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEe-cCCccCCCCcee
Confidence            3  567899999999999998764 56999999999999999999999999  99999999999997 3443       8


Q ss_pred             EEcccceeeeecCCCCcccccCCcccCccccc--ccCCCcCcchhhhhHHHHHH-hcCCCCCCCCCHHHHHHHHhcCCCC
Q 016143          171 KIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQIYKKVTSGIKP  247 (394)
Q Consensus       171 kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DIwSlG~il~ell-tg~~Pf~~~~~~~~~~~~i~~~~~~  247 (394)
                      +++|||++......  ....|+..|+|||.+.  ..++.++|||||||++|+|+ +|..||... ...+.. ....+...
T Consensus       152 ~l~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~-~~~~~~~~  227 (262)
T cd05077         152 KLSDPGIPITVLSR--QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-RFYEGQCM  227 (262)
T ss_pred             EeCCCCCCccccCc--ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHH-HHHhcCcc
Confidence            99999998654322  2346888999999775  35889999999999999998 588998753 222222 22222111


Q ss_pred             CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       248 ~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                        .....+.++++++.+||. +|.+||+..++|.+
T Consensus       228 --~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         228 --LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             --CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence              122235789999999998 99999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.1e-38  Score=301.01  Aligned_cols=244  Identities=28%  Similarity=0.466  Sum_probs=197.8

Q ss_pred             ccccceecccCceEEEEEEEccCCe----EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++..+.||+|+||.||+|.+..+|.    .||+|.+....   .......+.+|+.+++.++||||+++++++...   .
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~   82 (303)
T cd05110           9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---T   82 (303)
T ss_pred             ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---C
Confidence            3667899999999999999877776    46888765322   234445688999999999999999999987543   3


Q ss_pred             EEEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .++++||+++|+|.+++..+. .+++..+..++.||+.||.|||+++  |+||||||+||+++ +++.+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLL  159 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEccccccccc
Confidence            568999999999999988754 5899999999999999999999999  99999999999998 6789999999999765


Q ss_pred             cCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          182 QQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       182 ~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      ....    .....++..|+|||.+.+ .++.++|||||||++|||++ |..||.+ .........+..+..+. .+...+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~  237 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG-IPTREIPDLLEKGERLP-QPPICT  237 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCC
Confidence            4322    122345778999997764 58899999999999999997 9999976 34455555555443332 344567


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..+.+++.+|+. +|.+||++.+++..
T Consensus       238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         238 IDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999998 99999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=296.61  Aligned_cols=264  Identities=17%  Similarity=0.319  Sum_probs=222.0

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      +++.++||+|+|++|-++.+++|.+.+|+|++++.- .+..+.++-...|-.+..+- +||.+|.++.+|..+  ..+++
T Consensus       252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel-~nddedidwvqtek~vfe~asn~pflvglhscfqte--srlff  328 (593)
T KOG0695|consen  252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKEL-VNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE--SRLFF  328 (593)
T ss_pred             ceeeeeecCcchhhhhheehcccceeeehhhHHHHh-cCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc--ceEEE
Confidence            477899999999999999999999999999997544 44556777788888888777 799999999999655  46889


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--  183 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--  183 (394)
                      |.||.+||+|.-.+++.++++++.++.+...|+.||.|||++|  |++||||.+|+|++ ..|++||+|+|+.+.--.  
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlld-aeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEc-cCCceeecccchhhcCCCCC
Confidence            9999999999999999999999999999999999999999999  99999999999999 689999999999965433  


Q ss_pred             CCCcccccCCcccCccccccc-CCCcCcchhhhhHHHHHHhcCCCCCC-------CCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          184 PTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNE-------CKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~~-~~~~~DIwSlG~il~elltg~~Pf~~-------~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      ....++||||.|+|||++.++ |+.++|+|+||++|+||+.|+.||+-       ..+.+.++..|...  ...++...+
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--qiriprsls  483 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--QIRIPRSLS  483 (593)
T ss_pred             cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh--cccccceee
Confidence            356678999999999999874 99999999999999999999999952       23445566666553  233455556


Q ss_pred             HHHHHHHHHcCC-CCCCCCC------HHHHhcCCccccCCCCCcccCCCC
Q 016143          256 PQVKQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPKDLVCDPLR  298 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s------~~elL~~p~~~~~~~~~~~~~~~~  298 (394)
                      -.+..+++.-|. ||.+|+.      ..++-.|+||+..+|..+..+...
T Consensus       484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~  533 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVL  533 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccC
Confidence            666777777776 8888764      678999999999888766555443

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.3e-41  Score=294.36  Aligned_cols=264  Identities=23%  Similarity=0.367  Sum_probs=208.9

Q ss_pred             ccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEE
Q 016143           17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV   96 (394)
Q Consensus        17 ~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~   96 (394)
                      +.-.+..+.|.++ .+||+|.||.||+|..+.+|+.||+|++.....  ....-....+|+++|..|+|+|++.+++.+-
T Consensus        10 ~P~~~~~~~yek~-~kigqGtfgeVFkAr~~n~~kkvalkkvlmene--KeGfpitalreikiL~~lkHenv~nliEic~   86 (376)
T KOG0669|consen   10 EPFCDEVSKYEKL-AKIGQGTFGEVFKARSKNTGKKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICR   86 (376)
T ss_pred             CCceecchHHHHH-HhcCCchHHHHHHHhhcCccchhHHHHHHHhcc--ccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence            3345556677554 679999999999999999999999998765432  1233456778999999999999999877542


Q ss_pred             c------CCCceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 016143           97 D------DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE  169 (394)
Q Consensus        97 ~------~~~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~  169 (394)
                      .      .....+|+|+.+|+ -+|.-++... .+++..+++.++.+++.||.|+|++.  |+|||+|+.|+|++ .+|.
T Consensus        87 tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt-~dgi  162 (376)
T KOG0669|consen   87 TKATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLIT-KDGI  162 (376)
T ss_pred             hccCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEc-CCce
Confidence            1      12346999999996 4898888876 67999999999999999999999999  99999999999999 6899


Q ss_pred             EEEcccceeeeecCCCC------cccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHH-
Q 016143          170 VKIGDLGLAIVMQQPTA------RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK-  240 (394)
Q Consensus       170 ~kl~Dfgla~~~~~~~~------~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~-  240 (394)
                      +||+|||+++.+..+..      +..+-|.+|.+||++-+  +|+++.|||..||||.||.|+.+-+.+..+..++... 
T Consensus       163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is  242 (376)
T KOG0669|consen  163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS  242 (376)
T ss_pred             EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence            99999999976654422      22345999999997654  5999999999999999999999999886665544221 


Q ss_pred             -HhcCCCCCCC------------------------------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          241 -VTSGIKPASL------------------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       241 -i~~~~~~~~~------------------------------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                       +.-...++.|                              +...++++.+|++++|. ||.+|+.++++|+|.||..+
T Consensus       243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence             1111111111                              12336688999999999 99999999999999999765

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=321.91  Aligned_cols=199  Identities=34%  Similarity=0.541  Sum_probs=171.9

Q ss_pred             ccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC----CceEE
Q 016143           29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NRTIN  104 (394)
Q Consensus        29 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~----~~~~~  104 (394)
                      ..+.||+||||.||+++++.+|+.||||.++...   .....++..+|+++|++|+|+|||+++++=.+..    ...-.
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3588999999999999999999999999987644   3456677889999999999999999999643333    23456


Q ss_pred             EEEcccCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe-CCCC--cEEEccccee
Q 016143          105 MITELFTSGSLRQYRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNG--EVKIGDLGLA  178 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~---~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~-~~~~--~~kl~Dfgla  178 (394)
                      +|||||.||||+.++++   ..+|++.+++.+...+..||.|||++|  |+||||||.||++- +.+|  .-||+|||.|
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            89999999999999975   457999999999999999999999999  99999999999985 2223  3699999999


Q ss_pred             eeecCC-CCcccccCCcccCccccc--ccCCCcCcchhhhhHHHHHHhcCCCCCCCC
Q 016143          179 IVMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECK  232 (394)
Q Consensus       179 ~~~~~~-~~~~~~gt~~y~aPE~l~--~~~~~~~DIwSlG~il~elltg~~Pf~~~~  232 (394)
                      +.+... ...+.+||+.|++||++.  +.|+..+|.|||||++|+.+||..||-...
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            877655 567889999999999998  569999999999999999999999995533

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=317.46  Aligned_cols=260  Identities=28%  Similarity=0.490  Sum_probs=219.4

Q ss_pred             cccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEE
Q 016143           18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV   96 (394)
Q Consensus        18 ~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~   96 (394)
                      ...||+... -+.+.||.|.+|+||+++++.+++.+|+|+......     .-+.+..|.++|+.+ .|||++.+|++|.
T Consensus        13 ~lpdp~d~~-ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-----~deEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen   13 SLPDPADIF-EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-----EEEEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             hCCCCCCcc-EEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-----ccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            344566655 577999999999999999999999999998865432     223445588999988 5999999999886


Q ss_pred             cC---CCceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEE
Q 016143           97 DD---TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK  171 (394)
Q Consensus        97 ~~---~~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~k  171 (394)
                      ..   ..+.+|+|||||.|||..+++++.  .++.|..+..|++.++.||.+||.+.  ++|||+|-.|||++ .++.||
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT-~e~~VK  163 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT-ENAEVK  163 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe-ccCcEE
Confidence            33   346799999999999999999865  56999999999999999999999999  99999999999999 789999


Q ss_pred             EcccceeeeecCCC--CcccccCCcccCcccccc------cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 016143          172 IGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS  243 (394)
Q Consensus       172 l~Dfgla~~~~~~~--~~~~~gt~~y~aPE~l~~------~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~  243 (394)
                      |+|||.+.++....  ..+.+|||.|||||++..      .|+..+|+||||++..||.-|.+|+.+ ..+...+-.|.+
T Consensus       164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D-mHPmraLF~IpR  242 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPR  242 (953)
T ss_pred             EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC-cchhhhhccCCC
Confidence            99999998887663  456789999999998752      377899999999999999999999977 556655555656


Q ss_pred             CCCCCCC-CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          244 GIKPASL-SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       244 ~~~~~~~-~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      +++|... ++.++.++-+||+.||. +-.+||+..++|.|||+...
T Consensus       243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            5544433 56788999999999998 89999999999999999854

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=329.05  Aligned_cols=243  Identities=23%  Similarity=0.401  Sum_probs=201.6

Q ss_pred             cccceecccCceEEEEEEEccC-C----eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           28 RYDEILGKGAFKTVYKGFDEVD-G----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~-~----~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .+.+.||+|+||.||.|..... |    ..||+|.+...   .+.+....|++|..+|++++|||||+++++.++.  ..
T Consensus       695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--~~  769 (1025)
T KOG1095|consen  695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--GP  769 (1025)
T ss_pred             EeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--CC
Confidence            4568999999999999976432 2    34888887543   2477888999999999999999999999998874  45


Q ss_pred             EEEEEcccCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143          103 INMITELFTSGSLRQYRKKH-------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                      .++++||++||+|..++++.       ..++...+..++.||+.|++||++++  +|||||..+|+|++ ....+||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~-~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLD-ERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeec-ccCcEEEccc
Confidence            77899999999999999876       34999999999999999999999999  99999999999999 6689999999


Q ss_pred             ceeeeecCCCCccc----ccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCC
Q 016143          176 GLAIVMQQPTARSV----IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS  249 (394)
Q Consensus       176 gla~~~~~~~~~~~----~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~  249 (394)
                      |+|+..........    .-...|||||.+. +.++.++|||||||+|||++| |..||.+..+.+.+......|  ...
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--RL~  924 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--RLD  924 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--ccC
Confidence            99984443322221    2246899999776 679999999999999999999 999998855555444455555  333


Q ss_pred             CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       250 ~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .+..++..+.+++..||. +|.+||+...|++
T Consensus       925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            566778889999999998 9999999999987

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-39  Score=312.06  Aligned_cols=256  Identities=22%  Similarity=0.371  Sum_probs=211.8

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      +.||-|+||.|.++....|...||+|-+.+.++.. .++......|-.||..-+.+-||++|.+|.|.+  .+|+||+|+
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDkd--nLYFVMdYI  711 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYFVMDYI  711 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--ceEEEEecc
Confidence            57999999999999988899999999988877655 456667788999999999999999999997664  699999999


Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC------
Q 016143          111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------  184 (394)
Q Consensus       111 ~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~------  184 (394)
                      +||++..++-+-+-|.|+.++.++..+..|+++.|..|  +|||||||+||||| .+|++||+||||++-+.-.      
T Consensus       712 PGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  712 PGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             CCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeeccccccceeccccccc
Confidence            99999999988888999999999999999999999999  99999999999999 7999999999998533100      


Q ss_pred             --------------------------------------CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcC
Q 016143          185 --------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE  225 (394)
Q Consensus       185 --------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~  225 (394)
                                                            .+.+.+||+.|+|||++. ..|+..+|+||.|||||||+.|+
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence                                                  012356999999999765 56999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhc-CCCCCCCCCCCCHHHHHHHHHcCCCCCCCCC---HHHHhcCCccccCCCCCc
Q 016143          226 YPYNECKNPAQIYKKVTS-GIKPASLSKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       226 ~Pf~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~li~~~L~~p~~R~s---~~elL~~p~~~~~~~~~~  292 (394)
                      +||-...-....++.+.- .......-...++++.++|.++...++.|+.   ++++-.||||+..++..+
T Consensus       869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfssl  939 (1034)
T KOG0608|consen  869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSL  939 (1034)
T ss_pred             CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhh
Confidence            999764332222222211 1112223445689999999998888888774   778999999999887653

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.1e-37  Score=319.48  Aligned_cols=252  Identities=21%  Similarity=0.273  Sum_probs=176.7

Q ss_pred             ccccceecccCceEEEEEEEccC----CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEE----cC
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVD----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV----DD   98 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~----~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~----~~   98 (394)
                      |.+.+.||+|+||+||+|.+..+    +..||+|.+....      ..+....|  .++...+.++..+...|.    ..
T Consensus       134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            36789999999999999999988    9999999875321      11111111  122222333333332221    13


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHKN--------------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC  158 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~~--------------------l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp  158 (394)
                      ....+++|+||+.+++|.+++.....                    .....+..++.||+.||.|||+++  |+||||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP  283 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKP  283 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCH
Confidence            44578899999999999999875421                    123457789999999999999999  99999999


Q ss_pred             CcEEEeCCCCcEEEcccceeeeecCC---CCcccccCCcccCcccccc-----------------------cCCCcCcch
Q 016143          159 DNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE-----------------------EYNELVDIY  212 (394)
Q Consensus       159 ~NIll~~~~~~~kl~Dfgla~~~~~~---~~~~~~gt~~y~aPE~l~~-----------------------~~~~~~DIw  212 (394)
                      +|||++.+++.+||+|||+|+.+...   .....+||+.|+|||.+..                       .++.++|||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            99999855689999999999765432   2345679999999996531                       234567999


Q ss_pred             hhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-------------CCCC------CCCCCCHHHHHHHHHcCC-CCCCC
Q 016143          213 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-------------KPAS------LSKVTDPQVKQFIEKCIV-PASLR  272 (394)
Q Consensus       213 SlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~-------------~~~~------~~~~~~~~~~~li~~~L~-~p~~R  272 (394)
                      ||||+||||+++..|+..  +..++...+....             ....      .....+....+||.+||. +|.+|
T Consensus       364 SlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            999999999998777643  2222222222110             0000      011122345689999998 99999


Q ss_pred             CCHHHHhcCCccccCCCC
Q 016143          273 LPALELLKDPFLVTDNPK  290 (394)
Q Consensus       273 ~s~~elL~~p~~~~~~~~  290 (394)
                      ||+.++|+||||+.....
T Consensus       442 ~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        442 ISAKAALAHPYFDREGLL  459 (566)
T ss_pred             CCHHHHhCCcCcCCCCcc
Confidence            999999999999886553

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=293.53  Aligned_cols=258  Identities=21%  Similarity=0.375  Sum_probs=205.2

Q ss_pred             ccccCC-CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC--C----Cce
Q 016143           17 FSEKDP-SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--E----NII   89 (394)
Q Consensus        17 ~~~~~~-~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h--p----nIv   89 (394)
                      +...|. ++|| .+..+||+|.||+|-.+.+..++..||+|+++.  +   ....+..+-|+++|.+|.+  |    -+|
T Consensus        81 ~~~gD~l~~Ry-~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~--V---~kYreAa~iEi~vLqki~~~DP~g~~rcv  154 (415)
T KOG0671|consen   81 YQVGDILTNRY-EIVDLLGEGTFGKVVECWDRETKEHVALKIIKN--V---DKYREAALIEIEVLQKINESDPNGKFRCV  154 (415)
T ss_pred             EEeccccccce-ehhhhhcCCcccceEEEeecCCCceehHHHHHH--H---HHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence            455565 5666 678999999999999999999999999999852  2   3455667779999999942  2    266


Q ss_pred             eEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--
Q 016143           90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--  165 (394)
Q Consensus        90 ~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--  165 (394)
                      ++.++|  +-.+.+++|+|.+ |-++++.++++.  +++...++.+++||+.+++|||+.+  ++|.||||+|||+..  
T Consensus       155 ~m~~wF--dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~  229 (415)
T KOG0671|consen  155 QMRDWF--DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSE  229 (415)
T ss_pred             eeehhh--hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccc
Confidence            777766  4456899999999 779999999864  5899999999999999999999999  999999999999831  


Q ss_pred             -----------------CCCcEEEcccceeeeecCCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCC
Q 016143          166 -----------------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP  227 (394)
Q Consensus       166 -----------------~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~P  227 (394)
                                       .+..++++|||.|+...... ...+.|..|.|||++-+ .++..+||||+||||+||+||...
T Consensus       230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence                             13368999999997665544 56678999999997665 799999999999999999999999


Q ss_pred             CCCCCCHHHH--HHHHhcCCCCC-----------------CCCCC----------------------C---CHHHHHHHH
Q 016143          228 YNECKNPAQI--YKKVTSGIKPA-----------------SLSKV----------------------T---DPQVKQFIE  263 (394)
Q Consensus       228 f~~~~~~~~~--~~~i~~~~~~~-----------------~~~~~----------------------~---~~~~~~li~  263 (394)
                      |....+.+.+  +.+|.. +.|.                 .|+..                      .   ..++.+|++
T Consensus       309 FqtHen~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~  387 (415)
T KOG0671|consen  309 FQTHENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR  387 (415)
T ss_pred             cccCCcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence            9887766533  333322 1110                 01000                      0   126789999


Q ss_pred             HcCC-CCCCCCCHHHHhcCCccccC
Q 016143          264 KCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       264 ~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      +||. ||.+|+|+.|+|.||||+..
T Consensus       388 ~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  388 RMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             HHHccCccccccHHHHhcCHHhhcC
Confidence            9999 99999999999999999864

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.2e-38  Score=274.11  Aligned_cols=248  Identities=22%  Similarity=0.408  Sum_probs=208.7

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      .+.+++|+|-++.||.|....+++.++||+++       +-....+.+|+.+|+.|. ||||+++++...|...+...+|
T Consensus        41 eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   41 EIVRKVGRGKYSEVFEGINITNNEKCVIKILK-------PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             HHHHHHcCccHhhHhcccccCCCceEEEeeec-------hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            67789999999999999999999999999875       334467889999999997 9999999999988888888999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      +||+...+...+-   ..++...++.++.||+.||.|+||.|  |+|||+||.|+++|.....++|+|+|+|....... 
T Consensus       114 FE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e  188 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  188 (338)
T ss_pred             hhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence            9999888776654   44788899999999999999999999  99999999999999888899999999997776553 


Q ss_pred             CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCC-CCCCCHHHHHHHHhc---------------CCCC
Q 016143          186 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTS---------------GIKP  247 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf-~~~~~~~~~~~~i~~---------------~~~~  247 (394)
                      ....+.+..|--||++..  .|+.+-|+|||||++..|+..+.|| .+..|.+|+.+...-               ...|
T Consensus       189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp  268 (338)
T KOG0668|consen  189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP  268 (338)
T ss_pred             eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence            344567889999998864  5899999999999999999999887 455777777665420               0000


Q ss_pred             -------------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          248 -------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       248 -------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                         ..-....++++.+|+.++|. |-.+|+||.|++.||||...
T Consensus       269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                               11112246899999999999 99999999999999999864

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-39  Score=285.26  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=206.5

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHc-CCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~-L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ..||.|+||+|++-.++.+|+..|+|.+.....   .....+++.|.....+ =+.||||++|+..+.+.  -.||.||+
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--dcWiCMEL  144 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--DCWICMEL  144 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--ceeeeHHH
Confidence            469999999999999999999999999986543   4556678888876544 47999999999876554  47789999


Q ss_pred             cCCCcHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          110 FTSGSLRQYRK-----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       110 ~~~gsL~~~i~-----~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      + ..+|..+-+     +...++|+-+-.+....+.||.||-..- .|+|||+||+|||++ ..|.+||+|||++-.+..+
T Consensus       145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILld-r~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLD-RHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEe-cCCCEeeecccchHhHHHH
Confidence            9 467766432     3456999999999999999999996542 399999999999999 7899999999999888776


Q ss_pred             CCcc-cccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC-C---CCCH
Q 016143          185 TARS-VIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-K---VTDP  256 (394)
Q Consensus       185 ~~~~-~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~-~---~~~~  256 (394)
                      .+.+ -.|-..|||||.+..   .|+-++|+||||++|||+.||..||.+..+..+....+..|-+|.... .   ..+.
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~  301 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF  301 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence            5443 368889999998753   499999999999999999999999998777766677777776554322 2   2578


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .+..||..||. +.+.||...+|+++||++...
T Consensus       302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             HHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence            99999999998 899999999999999998754

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.9e-36  Score=276.28  Aligned_cols=240  Identities=34%  Similarity=0.593  Sum_probs=205.4

Q ss_pred             CceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCCCcHH
Q 016143           37 AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR  116 (394)
Q Consensus        37 ~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~  116 (394)
                      +||.||+|.+..+|..+|+|++.....   ....+.+.+|+..+++++|+||+++++.+...  ...++++||+.+++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKI---KKKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccc---ccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHH
Confidence            689999999998999999999875432   11157888999999999999999999988654  5788999999999999


Q ss_pred             HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-CCcccccCCcc
Q 016143          117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEF  195 (394)
Q Consensus       117 ~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-~~~~~~gt~~y  195 (394)
                      .++.....++...+..++.|++.++.|||+.+  ++|+||+|+||+++ +++.++|+|||.+...... ......++..|
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T smart00220       76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLD-EDGHVKLADFGLARQLDPGGLLTTFVGTPEY  152 (244)
T ss_pred             HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEEC-CCCcEEEccccceeeeccccccccccCCcCC
Confidence            99988777999999999999999999999999  99999999999998 6789999999999776654 34556789999


Q ss_pred             cCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC-CCHHHHHHHHHcCC-CCCCC
Q 016143          196 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV-TDPQVKQFIEKCIV-PASLR  272 (394)
Q Consensus       196 ~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~li~~~L~-~p~~R  272 (394)
                      +|||.+. ..++.++||||||+++|+|++|..||....+...+...+..+......... .+.++.+++.+||. +|.+|
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  232 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR  232 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence            9999775 458889999999999999999999998766667777777665443322222 67899999999998 99999


Q ss_pred             CCHHHHhcCCcc
Q 016143          273 LPALELLKDPFL  284 (394)
Q Consensus       273 ~s~~elL~~p~~  284 (394)
                      |++.++++||||
T Consensus       233 p~~~~~~~~~~~  244 (244)
T smart00220      233 LTAEEALQHPFF  244 (244)
T ss_pred             cCHHHHhhCCCC
Confidence            999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=302.51  Aligned_cols=251  Identities=25%  Similarity=0.479  Sum_probs=207.4

Q ss_pred             ccccCCCcccccc-------cceecccCceEEEEEEEc----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC
Q 016143           17 FSEKDPSCRYGRY-------DEILGKGAFKTVYKGFDE----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH   85 (394)
Q Consensus        17 ~~~~~~~~ry~r~-------~~~LG~G~~g~Vy~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h   85 (394)
                      ..-..|++|-|++       .++||.|-||.||+|...    .....||||..+.+.   .++..+.|+.|..+|+.++|
T Consensus       374 ety~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdH  450 (974)
T KOG4257|consen  374 ETYSTPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDH  450 (974)
T ss_pred             ccccCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCC
Confidence            3445677776655       478999999999999753    335679999886544   46668999999999999999


Q ss_pred             CCceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 016143           86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN  164 (394)
Q Consensus        86 pnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~  164 (394)
                      ||||++++.+.+   ...|+|||.++-|.|+.|++.++ .++......++.||+.||.|||+.+  +|||||...||||.
T Consensus       451 phIikLIGv~~e---~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVs  525 (974)
T KOG4257|consen  451 PHIIKLIGVCVE---QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVS  525 (974)
T ss_pred             cchhheeeeeec---cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeec
Confidence            999999998854   36899999999999999999875 5999999999999999999999999  99999999999998


Q ss_pred             CCCCcEEEcccceeeeecCCCC-cccc--cCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHH
Q 016143          165 GNNGEVKIGDLGLAIVMQQPTA-RSVI--GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK  239 (394)
Q Consensus       165 ~~~~~~kl~Dfgla~~~~~~~~-~~~~--gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~  239 (394)
                       ....+||+|||+++.+..... ....  -..-|||||-++ ..++.++|||.||+||||++. |..||.+-.|.+. ..
T Consensus       526 -Sp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-I~  603 (974)
T KOG4257|consen  526 -SPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-IG  603 (974)
T ss_pred             -CcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-EE
Confidence             677999999999987776532 1112  245799999665 679999999999999999876 9999998666544 34


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHH
Q 016143          240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  278 (394)
Q Consensus       240 ~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~el  278 (394)
                      .+..|..++ .+..+++.+..++.+||+ +|++||...++
T Consensus       604 ~iEnGeRlP-~P~nCPp~LYslmskcWayeP~kRPrftei  642 (974)
T KOG4257|consen  604 HIENGERLP-CPPNCPPALYSLMSKCWAYEPSKRPRFTEI  642 (974)
T ss_pred             EecCCCCCC-CCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence            455554433 567788999999999999 99999987654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.2e-37  Score=296.12  Aligned_cols=247  Identities=24%  Similarity=0.402  Sum_probs=202.5

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC------CCCceeEeeeEEcCCCceE
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK------HENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~------hpnIv~~~~~~~~~~~~~~  103 (394)
                      .-..|+|-|++|.+|.+..-|.+||||+|....++.     ..=+.|+.+|++|+      --|+++++..|  ...+++
T Consensus       437 ~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F--~hknHL  509 (752)
T KOG0670|consen  437 QGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-----KTGLKELEILKKLNDADPEDKFHCLRLFRHF--KHKNHL  509 (752)
T ss_pred             EeccccceeeeeeeccccCCCCeeEEEEeecchHHh-----hhhhHHHHHHHHhhccCchhhhHHHHHHHHh--hhccee
Confidence            345799999999999999999999999998655433     33456999999995      34899999988  455689


Q ss_pred             EEEEcccCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          104 NMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~---~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      +||+|.+ ..+|.+.+++.+   +|...+++.|+.|++.||..|-..|  |+|.||||+|||||.....+||||||.|..
T Consensus       510 ClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~  586 (752)
T KOG0670|consen  510 CLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSASF  586 (752)
T ss_pred             EEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCccccc
Confidence            9999999 689999999865   5999999999999999999999999  999999999999997777899999999988


Q ss_pred             ecCCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHH-HHHhcCCCCCCC--------
Q 016143          181 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY-KKVTSGIKPASL--------  250 (394)
Q Consensus       181 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~-~~i~~~~~~~~~--------  250 (394)
                      ......+.+.-+..|.|||++-+ .|+...|+||.||+||||.||+..|.+.+|...+. .+-..|..|..+        
T Consensus       587 ~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~d  666 (752)
T KOG0670|consen  587 ASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKD  666 (752)
T ss_pred             cccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhh
Confidence            87777777777889999997665 69999999999999999999999999866654331 122222222100        


Q ss_pred             ---------------------------------------------CCC---CCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          251 ---------------------------------------------SKV---TDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       251 ---------------------------------------------~~~---~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                                                                   +..   .-.++++|+.+||. ||.+|.|..++|.|
T Consensus       667 qHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  667 QHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             hhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence                                                         000   01267899999998 99999999999999


Q ss_pred             Ccccc
Q 016143          282 PFLVT  286 (394)
Q Consensus       282 p~~~~  286 (394)
                      |||..
T Consensus       747 pFi~~  751 (752)
T KOG0670|consen  747 PFITE  751 (752)
T ss_pred             CcccC
Confidence            99974

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=279.63  Aligned_cols=253  Identities=29%  Similarity=0.411  Sum_probs=206.3

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC---
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---   99 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~---   99 (394)
                      ..||.. ...+|.|+- .|..|+|..+++.||+|++...  ........+.++|..++..++|+||++++.+|....   
T Consensus        16 ~~Ry~n-L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   16 PKRYVN-LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeee-ecccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            356643 377899998 8899999999999999988654  223455677899999999999999999999885432   


Q ss_pred             -CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 -NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 -~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                       -..+|+|||++ ..+|.+.+.  -.++-+.+..++.|++.|++|||+.+  |+||||||+||+++ ....+||.|||+|
T Consensus        92 ~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~-~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   92 EFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDFGLA  165 (369)
T ss_pred             HHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceec-chhheeeccchhh
Confidence             23578899999 568988887  44788999999999999999999999  99999999999998 7899999999999


Q ss_pred             eeecCC-CCcccccCCcccCcccc-cccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC------------
Q 016143          179 IVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG------------  244 (394)
Q Consensus       179 ~~~~~~-~~~~~~gt~~y~aPE~l-~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~------------  244 (394)
                      +..... ..+.++.|..|.|||++ .-.|.+.+||||+||++.||++|...|.+....++..+.+..-            
T Consensus       166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            877666 56778899999999955 4469999999999999999999999998755555544443210            


Q ss_pred             --------------------CCC-CCC------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccc
Q 016143          245 --------------------IKP-ASL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  285 (394)
Q Consensus       245 --------------------~~~-~~~------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~  285 (394)
                                          ..| ..+      ++.....+++++.+||+ +|++|.++.++|+|||++
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                000 001      12234578999999998 999999999999999998

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.3e-35  Score=296.25  Aligned_cols=257  Identities=23%  Similarity=0.306  Sum_probs=182.2

Q ss_pred             ccccceecccCceEEEEEEEc----------------cCCeEEEEEEeeeccccCCHH----------HHHHHHHHHHHH
Q 016143           27 GRYDEILGKGAFKTVYKGFDE----------------VDGIEVAWNQVNIEDVMQSPD----------QLERLYSEVHLL   80 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~----------------~~~~~vaiK~i~~~~~~~~~~----------~~~~~~~E~~~l   80 (394)
                      +++.++||+|+||+||+|.+.                ..++.||+|.+.........+          ..+....|+.++
T Consensus       147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l  226 (507)
T PLN03224        147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC  226 (507)
T ss_pred             ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence            377899999999999999752                345679999986432110000          112233477778


Q ss_pred             HcCCCCCc-----eeEeeeEEcC------CCceEEEEEcccCCCcHHHHHHhCC------------------------CC
Q 016143           81 KSLKHENI-----IKFYNSWVDD------TNRTINMITELFTSGSLRQYRKKHK------------------------NV  125 (394)
Q Consensus        81 ~~L~hpnI-----v~~~~~~~~~------~~~~~~lV~e~~~~gsL~~~i~~~~------------------------~l  125 (394)
                      .+++|.++     ++++++|...      .....++|+||+.+++|.+++....                        .+
T Consensus       227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~  306 (507)
T PLN03224        227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR  306 (507)
T ss_pred             HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence            88876654     5666665432      1245789999999999999886421                        24


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-Cc--ccccCCcccCccccc
Q 016143          126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-AR--SVIGTPEFMAPELYE  202 (394)
Q Consensus       126 ~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-~~--~~~gt~~y~aPE~l~  202 (394)
                      ++..++.++.|++.||.|||+++  |+||||||+||+++ .++.+||+|||++....... ..  ...+|+.|+|||++.
T Consensus       307 ~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence            56788999999999999999999  99999999999998 67899999999996554321 12  223589999999764


Q ss_pred             cc---------------------CC--CcCcchhhhhHHHHHHhcCC-CCCCCCCH----------HHHHHHHhcCCCCC
Q 016143          203 EE---------------------YN--ELVDIYSFGMCILEMVTCEY-PYNECKNP----------AQIYKKVTSGIKPA  248 (394)
Q Consensus       203 ~~---------------------~~--~~~DIwSlG~il~elltg~~-Pf~~~~~~----------~~~~~~i~~~~~~~  248 (394)
                      ..                     |+  .++||||+||++|+|++|.. ||......          ...+..+.......
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~  463 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF  463 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence            21                     22  35799999999999999986 77542111          11112222222222


Q ss_pred             CCCCCCCHHHHHHHHHcCC-CC---CCCCCHHHHhcCCcccc
Q 016143          249 SLSKVTDPQVKQFIEKCIV-PA---SLRLPALELLKDPFLVT  286 (394)
Q Consensus       249 ~~~~~~~~~~~~li~~~L~-~p---~~R~s~~elL~~p~~~~  286 (394)
                      ......++..++|+.++|. +|   .+|+|+.|+|+||||..
T Consensus       464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            2334467899999999997 44   68999999999999964

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=291.23  Aligned_cols=243  Identities=24%  Similarity=0.378  Sum_probs=200.0

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +++++||+|-||.|.+|.-. .+..||+|..+...   .......|.+|+++|.+|+|||||.++++++.+  +.++||+
T Consensus       541 ~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D--ePicmI~  614 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQD--DPLCMIT  614 (807)
T ss_pred             ehhhhhcCcccceeEEEEec-CceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeecC--CchHHHH
Confidence            57899999999999999754 36899999987543   245567899999999999999999999998755  4789999


Q ss_pred             cccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          108 ELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      ||++.|+|.+++.++.  .+.......++.||++|++||.+.+  +|||||.+.|+|++ .++++||+|||+++-+-...
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~-~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVD-GEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeec-CcccEEecCcccccccccCC
Confidence            9999999999999984  3455667789999999999999999  99999999999999 68899999999998665543


Q ss_pred             Ccc----cccCCcccCcc-cccccCCCcCcchhhhhHHHHHHh--cCCCCCCCCCHHHHHHHHhcCCC------CCCCCC
Q 016143          186 ARS----VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTSGIK------PASLSK  252 (394)
Q Consensus       186 ~~~----~~gt~~y~aPE-~l~~~~~~~~DIwSlG~il~ellt--g~~Pf~~~~~~~~~~~~i~~~~~------~~~~~~  252 (394)
                      ...    .+-..+||||| ++.++++.++|+|+||++|||+++  .+.||+...+ +++......-..      ....+.
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~~~~~l~~P~  770 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQGRQVVLSRPP  770 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCCcceeccCCC
Confidence            332    23467999999 788999999999999999999876  6799987444 455444432111      123466


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .++..+.+++.+||. +..+|||.+++-.
T Consensus       771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  771 ACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             cCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            778899999999998 8999999998754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=304.38  Aligned_cols=240  Identities=28%  Similarity=0.419  Sum_probs=189.1

Q ss_pred             cceecccCceE-EEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEE
Q 016143           30 DEILGKGAFKT-VYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        30 ~~~LG~G~~g~-Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+++|.|+-|+ ||+|..  .|+.||||.+-       .+......+|+.+|+.- +|||||++|+  .+.+..++|+..
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll-------~e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIal  582 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY--EGREVAVKRLL-------EEFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIAL  582 (903)
T ss_pred             HHHcccCCCCcEEEEEee--CCceehHHHHh-------hHhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEe
Confidence            57899999986 799985  58899998764       33445677899999998 5999999999  456778999999


Q ss_pred             cccCCCcHHHHHHhCC-CC---CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC----CCcEEEcccceee
Q 016143          108 ELFTSGSLRQYRKKHK-NV---DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----NGEVKIGDLGLAI  179 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~-~l---~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~----~~~~kl~Dfgla~  179 (394)
                      |.|. .+|.++++... .+   .....+.+..|+++||++||+.+  ||||||||+||||+..    ..+++|+|||+++
T Consensus       583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            9995 59999999852 11   11345788999999999999999  9999999999999852    2578999999998


Q ss_pred             eecCCC-----CcccccCCcccCccccccc-CCCcCcchhhhhHHHHHHhc-CCCCCCCCCHHHHHHHHhcCCCC-CCCC
Q 016143          180 VMQQPT-----ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKP-ASLS  251 (394)
Q Consensus       180 ~~~~~~-----~~~~~gt~~y~aPE~l~~~-~~~~~DIwSlG~il~elltg-~~Pf~~~~~~~~~~~~i~~~~~~-~~~~  251 (394)
                      .+....     .....||-+|+|||++.+. -+.++||+||||++|..++| ..||.+..   +.-..|..+.+. ..+.
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~---~R~~NIl~~~~~L~~L~  736 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL---ERQANILTGNYTLVHLE  736 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH---HhhhhhhcCccceeeec
Confidence            775442     3356799999999988765 56799999999999998885 99997532   222334443322 2222


Q ss_pred             CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       252 ~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      ...+.++++||++|+. +|..||+|.++|.||||=.
T Consensus       737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence            2223389999999999 9999999999999999954

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=301.85  Aligned_cols=247  Identities=24%  Similarity=0.436  Sum_probs=209.7

Q ss_pred             ccccccceecccCceEEEEEEEccCC---eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      .|.++.++||.|.||.||+|..+..|   ..||||-++..   ..+++...|+.|+.||-+++||||+++.++.  ...+
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G---ytekqrrdFL~EAsIMGQFdHPNIIrLEGVV--Tks~  703 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG---YTEKQRRDFLSEASIMGQFDHPNIIRLEGVV--TKSK  703 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC---ccHHHHhhhhhhhhhcccCCCCcEEEEEEEE--ecCc
Confidence            35678899999999999999988776   46999987643   3577888899999999999999999999975  4557


Q ss_pred             eEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      .++||+||++.|+|+.+++++ +.++.-++..+++.|+.|++||-+.|  +|||||...||||| .+-..|++|||+++.
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVN-snLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRV  780 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeec-cceEEEeccccceee
Confidence            899999999999999998876 56999999999999999999999999  99999999999999 788999999999998


Q ss_pred             ecCCCC--ccccc---CCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 016143          181 MQQPTA--RSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       181 ~~~~~~--~~~~g---t~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      ++....  .+..|   ..+|.|||.+. .+++.++||||+|++|||.+. |+.||++..| .+.++.|..+..-+ .+-.
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~gyRLP-pPmD  858 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQGYRLP-PPMD  858 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhccCCC-CCCC
Confidence            866542  12222   46899999654 679999999999999999665 9999999555 56667777775533 2445


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++..+.+|+..||+ +-..||...+|+.+
T Consensus       859 CP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  859 CPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             CcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            67899999999998 88999999998874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=275.81  Aligned_cols=254  Identities=27%  Similarity=0.456  Sum_probs=205.2

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC---ceEEEE
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINMI  106 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~---~~~~lV  106 (394)
                      .+.||-|+||.||.+.|..+|+.||+|++.  .+.++-....++++|+.+|..++|.|++..++.....+-   ..+|++
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            378999999999999999999999999863  333444556789999999999999999998886544332   236788


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      +|.+ ..+|.+.|-.-..++.+.++-+.+||++||+|||+.+  |.||||||.|.|+| .+-.+||+|||+|+..+... 
T Consensus       136 TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVN-SNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEec-cCceEEecccccccccchhhh
Confidence            9998 4689999988888999999999999999999999999  99999999999999 78899999999998776553 


Q ss_pred             --CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHh-------------------
Q 016143          186 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-------------------  242 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~-------------------  242 (394)
                        .+..+-|.+|.|||++.+  .|+.++||||.|||+.||+..+..|.. .++.+....|.                   
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA-q~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA-AGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc-cChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence              444567899999998876  499999999999999999999999976 33333322222                   


Q ss_pred             -----cCCCCCCCC--------CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCC
Q 016143          243 -----SGIKPASLS--------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK  290 (394)
Q Consensus       243 -----~~~~~~~~~--------~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~  290 (394)
                           .+.++++++        .....+...++.++|. +|.+|.+..+.+.|+++......
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r  352 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLR  352 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccccee
Confidence                 122333322        1223466778888888 99999999999999999876543

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-36  Score=294.22  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=208.1

Q ss_pred             cccceecccCceEEEEEEEccCC---eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      ++.|+||+|+||.|++|.++..+   ..||||.+......   .....|++|+.+|.+|+|+|+|++|+...+   ..+.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~m  186 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAM  186 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeecc---chhh
Confidence            56699999999999999876433   57999998755432   267889999999999999999999998876   3688


Q ss_pred             EEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          105 MITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ||||++++|+|.+.+.+.  ..|....+..++.||+.|+.||.+++  +|||||...|+|+- ....+||+||||.+.+.
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNllla-sprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLA-SPRTVKICDFGLMRALG  263 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheec-ccceeeeecccceeccC
Confidence            999999999999988873  45888999999999999999999999  99999999999997 57799999999998776


Q ss_pred             CCCCcccc-----cCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          183 QPTARSVI-----GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       183 ~~~~~~~~-----gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      .....-..     -...|+|||.++ ..++.++|+|++||++|||++ |+.||.+ .+..++.+.|..+..- .-++.++
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G-~~g~qIL~~iD~~erL-pRPk~cs  341 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG-CRGIQILKNIDAGERL-PRPKYCS  341 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC-CCHHHHHHhccccccC-CCCCCCh
Confidence            55322222     245799999665 679999999999999999998 8999988 5678888888765432 2466788


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ..+.+++..||+ .|.+||+...|...-++...
T Consensus       342 edIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  342 EDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             HHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence            999999999999 89999999998766555543

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=286.06  Aligned_cols=240  Identities=26%  Similarity=0.421  Sum_probs=210.0

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ....+||-|-||.||.|.+++-...||+|-++-+     .-..+.|+.|..+|+.++|||+|++++++.  .+-..|||+
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLkEAAvMKeikHpNLVqLLGVCT--~EpPFYIiT  342 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--HEPPFYIIT  342 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHHHHHHHHhhcCccHHHHhhhhc--cCCCeEEEE
Confidence            3568899999999999999999999999987632     356788999999999999999999999874  445789999


Q ss_pred             cccCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          108 ELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~--l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      ||+..|+|.+|+++..+  ++.-.++.++.||.+|++||..++  +|||||...|.||. ++..+|++|||+++.+....
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVg-EnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccc-ccceEEeeccchhhhhcCCc
Confidence            99999999999987643  777778899999999999999999  99999999999997 78899999999999998887


Q ss_pred             Cccccc---CCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          186 ARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       186 ~~~~~g---t~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      .+...|   ..-|.|||-+. +.++.++|||+||++|||+.| |-.||.+ .+..+.|..+..+.... -+..+++.+.+
T Consensus       420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM~-~PeGCPpkVYe  497 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRMD-GPEGCPPKVYE  497 (1157)
T ss_pred             eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhcccccc-CCCCCCHHHHH
Confidence            666555   45799999554 668999999999999999998 8899987 78889999998886544 45677899999


Q ss_pred             HHHHcCC-CCCCCCCHHHHh
Q 016143          261 FIEKCIV-PASLRLPALELL  279 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL  279 (394)
                      |+..||. .|++||+..|+-
T Consensus       498 LMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  498 LMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHhcCCcccCccHHHHH
Confidence            9999999 999999988754

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-35  Score=250.73  Aligned_cols=210  Identities=27%  Similarity=0.464  Sum_probs=178.9

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      +.||+|++|.|-+-++..+|...|+|.+...-  . .+...++++|+.+..+. ..|.+|.||+.+..+.  -+++.||.
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tv--n-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg--dvwIcME~  126 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--N-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG--DVWICMEL  126 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhc--C-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc--cEEEeHHH
Confidence            56999999999999999999999999987543  2 34556678888876555 7999999999887664  47888999


Q ss_pred             cCCCcHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          110 FTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       110 ~~~gsL~~~----i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      +. .+|..+    +++++.++|..+-+++..++.||.|||++- .++|||+||.|||+| ..|++|+||||++-.+.++-
T Consensus       127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILIN-YDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEc-cCCcEEEcccccceeehhhh
Confidence            94 677664    556778999999999999999999999973 599999999999999 78999999999998888876


Q ss_pred             Ccc-cccCCcccCcccccc-----cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 016143          186 ARS-VIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA  248 (394)
Q Consensus       186 ~~~-~~gt~~y~aPE~l~~-----~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~  248 (394)
                      +.+ -.|--.|||||.+..     .|+-++||||||+++.||.++++||....++.+..+.+.....|.
T Consensus       204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~  272 (282)
T KOG0984|consen  204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ  272 (282)
T ss_pred             HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence            655 468889999998753     488899999999999999999999999999998888888765443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=294.16  Aligned_cols=265  Identities=28%  Similarity=0.497  Sum_probs=227.5

Q ss_pred             CCccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeee
Q 016143           15 GEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS   94 (394)
Q Consensus        15 ~~~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~   94 (394)
                      .+....+|...|+ +...+|+|++|.||+|+++.+++..|+|+|+....    +...-+.+|+-+++..+|||||.+++.
T Consensus         6 ~disrrnP~ddye-llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~----dd~~~iqqei~~~~dc~h~nivay~gs   80 (829)
T KOG0576|consen    6 SDISRRNPQDDYE-LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG----DDFSGIQQEIGMLRDCRHPNIVAYFGS   80 (829)
T ss_pred             chhhhcCCccchh-heeeecCCcccchhhhcccccCchhhheeeeccCC----ccccccccceeeeecCCCcChHHHHhh
Confidence            3445558888885 45779999999999999999999999999987653    344557779999999999999999999


Q ss_pred             EEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcc
Q 016143           95 WVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD  174 (394)
Q Consensus        95 ~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~D  174 (394)
                      |.-..  .++++||||.||+|.+.-.-.+.+++.++....+..+.||+|||+.+  =+|||||-.||+++ +.|.+|++|
T Consensus        81 ylr~d--klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvklaD  155 (829)
T KOG0576|consen   81 YLRRD--KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLAD  155 (829)
T ss_pred             hhhhc--CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeecc
Confidence            96554  57889999999999998888889999999999999999999999999  89999999999999 889999999


Q ss_pred             cceeeeecCC--CCcccccCCcccCcccc----cccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 016143          175 LGLAIVMQQP--TARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA  248 (394)
Q Consensus       175 fgla~~~~~~--~~~~~~gt~~y~aPE~l----~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~  248 (394)
                      ||.+......  ...+++|||+|||||+-    .+.|+.++|||++|+...|+--.++|-.+.-....++...+++..|+
T Consensus       156 fgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp  235 (829)
T KOG0576|consen  156 FGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP  235 (829)
T ss_pred             cCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC
Confidence            9999877665  35678999999999964    35699999999999999999999988766444455566667777776


Q ss_pred             CCC--CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          249 SLS--KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       249 ~~~--~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      .+.  ..+++.+-+|++.+|. +|.+||+++.+|.|||......
T Consensus       236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~  279 (829)
T KOG0576|consen  236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLS  279 (829)
T ss_pred             cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchh
Confidence            653  3478899999999997 8999999999999999976543

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-34  Score=272.73  Aligned_cols=238  Identities=29%  Similarity=0.453  Sum_probs=186.6

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC--CCCCceeEeeeEEcCC--CceE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL--KHENIIKFYNSWVDDT--NRTI  103 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L--~hpnIv~~~~~~~~~~--~~~~  103 (394)
                      .+.++||+|.||.||+|..  +++.||||++.       .+..+.+.+|-++.+..  +|+||++|++.=.-.+  ...+
T Consensus       213 ~l~eli~~Grfg~V~KaqL--~~~~VAVKifp-------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQL--DNRLVAVKIFP-------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             hhHHHhhcCccceeehhhc--cCceeEEEecC-------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            5668999999999999974  57999999986       45567788888877655  8999999998532111  3368


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-------CCCCeEecCCCCCcEEEeCCCCcEEEcccc
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLG  176 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~-------~~~~ivHrDLkp~NIll~~~~~~~kl~Dfg  176 (394)
                      ++|++|.+.|+|.+|++.+- +++....+++.-+++||+|||+       +.|+|+|||||..||||. ++++..|+|||
T Consensus       284 wLVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDFG  361 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADFG  361 (534)
T ss_pred             eEEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeeccc
Confidence            99999999999999999986 9999999999999999999996       346799999999999997 89999999999


Q ss_pred             eeeeecCCC----CcccccCCcccCcccccccCC-------CcCcchhhhhHHHHHHhcC------------CCCCC---
Q 016143          177 LAIVMQQPT----ARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVTCE------------YPYNE---  230 (394)
Q Consensus       177 la~~~~~~~----~~~~~gt~~y~aPE~l~~~~~-------~~~DIwSlG~il~elltg~------------~Pf~~---  230 (394)
                      +|..+....    ....+||.+|||||++.+..+       .+.||||+|.+||||++..            .||..   
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            998776442    334689999999999987533       3689999999999998743            23321   


Q ss_pred             -CCCHHHHHHHHhcCCCCC----CCCCCC-CHHHHHHHHHcCC-CCCCCCCHH
Q 016143          231 -CKNPAQIYKKVTSGIKPA----SLSKVT-DPQVKQFIEKCIV-PASLRLPAL  276 (394)
Q Consensus       231 -~~~~~~~~~~i~~~~~~~----~~~~~~-~~~~~~li~~~L~-~p~~R~s~~  276 (394)
                       ....+++...+.+....+    .|.+.. -..+++.++.||. |+..|+||.
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence             223355555554433322    233322 3467999999998 999999975

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.6e-34  Score=314.26  Aligned_cols=237  Identities=20%  Similarity=0.324  Sum_probs=178.1

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +..++||+|+||.||+|.++.++..||+|.+.....        ....|+..+++++|||||++++++.++  ...++||
T Consensus       693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~~lv~  762 (968)
T PLN00113        693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSE--KGAYLIH  762 (968)
T ss_pred             CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcC--CCCEEEE
Confidence            345689999999999999999999999998753221        112368899999999999999998655  4578899


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA  186 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~-~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~  186 (394)
                      ||+++|+|.++++.   +++..+..++.||+.||+|||.+ .++|+||||||+||+++ .++..++. ||.+......  
T Consensus       763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~~--  835 (968)
T PLN00113        763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLCTD--  835 (968)
T ss_pred             eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC-CCCceEEE-eccccccccC--
Confidence            99999999999963   88999999999999999999944 23399999999999998 56666664 5554332222  


Q ss_pred             cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCC----HHHHHHHHhcC-----CCCCCCCC----
Q 016143          187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN----PAQIYKKVTSG-----IKPASLSK----  252 (394)
Q Consensus       187 ~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~----~~~~~~~i~~~-----~~~~~~~~----  252 (394)
                      ....||+.|+|||++.+ .|+.++|||||||++|||+||+.||.....    ...........     ...+.+..    
T Consensus       836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (968)
T PLN00113        836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV  915 (968)
T ss_pred             CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence            23368999999997764 599999999999999999999999854211    11111111110     00011111    


Q ss_pred             --CCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          253 --VTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       253 --~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                        ....++.+++.+||. +|.+||++.|+++.
T Consensus       916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence              111256788999998 99999999999875

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=290.91  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=207.1

Q ss_pred             ccccCCCcccccccceecccCceEEEEEEEc---c----CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCc
Q 016143           17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDE---V----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENI   88 (394)
Q Consensus        17 ~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~---~----~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnI   88 (394)
                      ..+.+..+.  .+.+.||+|+||+|++|.-.   .    ....||+|..+...   ...+.+.+..|+.+|+.+ +|+||
T Consensus       290 ~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~ni  364 (609)
T KOG0200|consen  290 KWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNI  364 (609)
T ss_pred             ceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcch
Confidence            344444433  45679999999999999632   1    25679999875433   236778899999999999 69999


Q ss_pred             eeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 016143           89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPII  152 (394)
Q Consensus        89 v~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~----------------~l~~~~~~~i~~qil~~L~~LH~~~~~iv  152 (394)
                      +.+.+++..  ...+++|+||+..|+|..+++..+                .++...+..++.||+.|++||++..  ++
T Consensus       365 v~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~v  440 (609)
T KOG0200|consen  365 VNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CV  440 (609)
T ss_pred             hhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--cc
Confidence            999998755  567899999999999999998766                3889999999999999999999998  99


Q ss_pred             ecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCcc---ccc--CCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cC
Q 016143          153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIG--TPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CE  225 (394)
Q Consensus       153 HrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~---~~g--t~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~  225 (394)
                      ||||...|||++ .+..+||+|||+|+.........   ..|  ...|||||.+.. .|+.++||||||++|||+++ |.
T Consensus       441 HRDLAaRNVLi~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~  519 (609)
T KOG0200|consen  441 HRDLAARNVLIT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG  519 (609)
T ss_pred             chhhhhhhEEec-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC
Confidence            999999999998 67899999999998655443222   222  335999997665 69999999999999999998 89


Q ss_pred             CCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          226 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       226 ~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .||.+......++..+..|.+.. .+...++++.++++.||. +|.+||+..++..
T Consensus       520 ~PYp~~~~~~~l~~~l~~G~r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  520 TPYPGIPPTEELLEFLKEGNRME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             CCCCCCCcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            99988554667788888887654 455668999999999998 9999999998765

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=269.62  Aligned_cols=250  Identities=30%  Similarity=0.502  Sum_probs=192.5

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC--CCCCceeEeeeEEc
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL--KHENIIKFYNSWVD   97 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L--~hpnIv~~~~~~~~   97 (394)
                      +-...|-.++.+.||+|.||.||+|.+.  |+.||||++...+       -+..++|.++.+..  +|+||+.|+.+=..
T Consensus       206 QRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd-------E~SWfrEtEIYqTvmLRHENILgFIaaD~~  276 (513)
T KOG2052|consen  206 QRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD-------ERSWFRETEIYQTVMLRHENILGFIAADNK  276 (513)
T ss_pred             HHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc-------hhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence            3344666678899999999999999876  8899999987433       14466777777665  99999999885322


Q ss_pred             C--CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------CCCCeEecCCCCCcEEEeCCCCc
Q 016143           98 D--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGE  169 (394)
Q Consensus        98 ~--~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~------~~~~ivHrDLkp~NIll~~~~~~  169 (394)
                      +  .-..+++|++|.+.|||++|+.+ ..++.+...+++..++.||+|||.      ..|.|.|||||..||||. ++|.
T Consensus       277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~  354 (513)
T KOG2052|consen  277 DNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGT  354 (513)
T ss_pred             CCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCc
Confidence            2  23468999999999999999998 459999999999999999999994      346699999999999998 8999


Q ss_pred             EEEcccceeeeecCC------CCcccccCCcccCcccccccCC-------CcCcchhhhhHHHHHHh----------cCC
Q 016143          170 VKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVT----------CEY  226 (394)
Q Consensus       170 ~kl~Dfgla~~~~~~------~~~~~~gt~~y~aPE~l~~~~~-------~~~DIwSlG~il~ellt----------g~~  226 (394)
                      .-|+|+|||......      ..+..+||-+|||||++....+       ..+||||||.++||++.          -++
T Consensus       355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            999999999655443      2456789999999999986533       46899999999999974          257


Q ss_pred             CCCCC----CCHHHHHHHHhcCCCCCCCCCCC--CH---HHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          227 PYNEC----KNPAQIYKKVTSGIKPASLSKVT--DP---QVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       227 Pf~~~----~~~~~~~~~i~~~~~~~~~~~~~--~~---~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ||.+.    .+-+++.+.+......+.++..+  ++   .+..+++.||. +|..|.||--+-+
T Consensus       435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            88652    34456666654432222233322  23   34667899997 9999999875543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-34  Score=270.72  Aligned_cols=132  Identities=27%  Similarity=0.483  Sum_probs=114.2

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-----C---CCceeEeeeE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----H---ENIIKFYNSW   95 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-----h---pnIv~~~~~~   95 (394)
                      +|| -+.++||-|-|+|||+|.|..+.+.||+|+++-.     +...+..+.|+++|++++     |   .+||++++.|
T Consensus        78 gRY-~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   78 GRY-HVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ceE-EEEEeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            455 6789999999999999999999999999998632     345677888999999984     2   3799999998


Q ss_pred             EcC--CCceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 016143           96 VDD--TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV  163 (394)
Q Consensus        96 ~~~--~~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll  163 (394)
                      ...  ++.+++||+|++ |.+|..+|+..  ++++...+++|++||+.||.|||..- +|||-||||+|||+
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL  221 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence            643  567899999999 77888888764  67999999999999999999999873 49999999999999

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-35  Score=281.86  Aligned_cols=198  Identities=28%  Similarity=0.446  Sum_probs=176.0

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHH----HHHHHHHHHHHHHcCC---CCCceeEeeeEEcCCC
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD----QLERLYSEVHLLKSLK---HENIIKFYNSWVDDTN  100 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~----~~~~~~~E~~~l~~L~---hpnIv~~~~~~~~~~~  100 (394)
                      ...+.||+|+||.|++|.++.+..+|++|.|.+..+.-+.-    .+-.+-.|+.+|..|+   |+||++++++|.+  +
T Consensus       564 ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd--d  641 (772)
T KOG1152|consen  564 TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED--D  641 (772)
T ss_pred             eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec--C
Confidence            44578999999999999999999999999998766543211    1223567999999997   9999999999954  4


Q ss_pred             ceEEEEEccc-CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          101 RTINMITELF-TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 ~~~~lV~e~~-~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      .++|++||-. +|.+|+++|..+..++|.+++.+++|++.|+++||++|  |+|||||-+||.++ .+|-+||+|||.|.
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd-~~g~~klidfgsaa  718 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVD-SNGFVKLIDFGSAA  718 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEe-cCCeEEEeeccchh
Confidence            6899999986 56799999999999999999999999999999999999  99999999999999 68999999999999


Q ss_pred             eecCCCCcccccCCcccCccccccc-C-CCcCcchhhhhHHHHHHhcCCCCCC
Q 016143          180 VMQQPTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNE  230 (394)
Q Consensus       180 ~~~~~~~~~~~gt~~y~aPE~l~~~-~-~~~~DIwSlG~il~elltg~~Pf~~  230 (394)
                      ...+.....++||..|.|||++.++ | +..-|||+||++||.++..+.||..
T Consensus       719 ~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  719 YTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            8888888999999999999999875 4 6889999999999999999999863

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-33  Score=280.05  Aligned_cols=241  Identities=30%  Similarity=0.482  Sum_probs=200.9

Q ss_pred             ccceecccCceEEEEEEEccCCe----EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           29 YDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        29 ~~~~LG~G~~g~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      ..++||+|+||+||+|.+-..|+    +||+|++....   .++....+++|+-+|.+|+|||+++++++....   .+.
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~q  773 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQ  773 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHH
Confidence            35789999999999998865554    57888765332   355667899999999999999999999987544   377


Q ss_pred             EEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          105 MITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +|++|++.|+|.+|++.++ .+-.+..+.|..||++||.|||.+.  ++||||-..||||. .-..+||.|||+|..+..
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVk-sP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVK-SPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeec-CCCeEEEEecchhhccCc
Confidence            8999999999999999874 6999999999999999999999998  99999999999998 677999999999987765


Q ss_pred             CCCc----ccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          184 PTAR----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       184 ~~~~----~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      ....    ...-.+-|||=|.+. ..|+.++|||||||++||++| |..||.+ ...+++-+.+..|.+ .+-+...+..
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCtiD  928 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTID  928 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccHH
Confidence            5322    112245788888554 569999999999999999998 8999987 666777777777765 4456778889


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          258 VKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +-.++.+||. |+..||+++++-.
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHHH
Confidence            9999999998 8999999887644

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=7.4e-33  Score=260.35  Aligned_cols=251  Identities=26%  Similarity=0.432  Sum_probs=198.8

Q ss_pred             cccccccceecccCceEEEEEEEcc---CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDT   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~   99 (394)
                      ..+++..++||+|+|++||+|++..   .++.||+|.+....      ...++..|+++|..+. +.||+++.+++  ..
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~--rn  106 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCF--RN  106 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhh--cc
Confidence            4566889999999999999999877   78899999987543      2356888999999995 99999999988  55


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      +..+.+|+||++..+-.++...   ++...++.+++.++.||.++|++|  ||||||||.|++.+...++-.|.|||+|.
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHH
Confidence            5678899999999888887654   678999999999999999999999  99999999999999889999999999985


Q ss_pred             eec---------C------CC----------------C---------------cccccCCcccCcccccc--cCCCcCcc
Q 016143          180 VMQ---------Q------PT----------------A---------------RSVIGTPEFMAPELYEE--EYNELVDI  211 (394)
Q Consensus       180 ~~~---------~------~~----------------~---------------~~~~gt~~y~aPE~l~~--~~~~~~DI  211 (394)
                      ..+         .      ..                .               ....|||+|.|||++.+  .-++++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            110         0      00                0               01248999999997764  46789999


Q ss_pred             hhhhhHHHHHHhcCCCCCCCCCH----HHHHHHH----------hcCC--------------------------------
Q 016143          212 YSFGMCILEMVTCEYPYNECKNP----AQIYKKV----------TSGI--------------------------------  245 (394)
Q Consensus       212 wSlG~il~elltg~~Pf~~~~~~----~~~~~~i----------~~~~--------------------------------  245 (394)
                      ||.|+|+.-++++++||-...+.    .++....          ..|.                                
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            99999999999999999543322    1111000          0000                                


Q ss_pred             ---CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          246 ---KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       246 ---~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                         ....+....+..+.+|+.+||. +|.+|.+|+++|+||||...
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence               0112233445688999999998 99999999999999999854

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=3.7e-31  Score=235.19  Aligned_cols=209  Identities=38%  Similarity=0.652  Sum_probs=183.9

Q ss_pred             ecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCC
Q 016143           33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS  112 (394)
Q Consensus        33 LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~  112 (394)
                      ||+|++|.||++.+..++..+++|.+.....   ....+.+.+|+..++.++|++|+++++++...  ...++++||+.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS---SSLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccc---hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCC
Confidence            6899999999999988899999999875432   11457788999999999999999999988554  578899999999


Q ss_pred             CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC--Cccc
Q 016143          113 GSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSV  189 (394)
Q Consensus       113 gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~--~~~~  189 (394)
                      ++|.+++... ..++...+..++.+++.+|.+||+++  ++|+||+|.||+++..++.++|+|||.+.......  ....
T Consensus        76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            9999999876 56999999999999999999999999  99999999999998327899999999998776654  4456


Q ss_pred             ccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC
Q 016143          190 IGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  267 (394)
Q Consensus       190 ~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~  267 (394)
                      .+...|++||.+..  .++.++|+|++|+++++|                                  ..+.+++.+|+.
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhh
Confidence            68899999998776  678899999999999999                                  588999999998


Q ss_pred             -CCCCCCCHHHHhcCC
Q 016143          268 -PASLRLPALELLKDP  282 (394)
Q Consensus       268 -~p~~R~s~~elL~~p  282 (394)
                       +|.+||++.++++++
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence             999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.98  E-value=4.2e-31  Score=238.94  Aligned_cols=211  Identities=34%  Similarity=0.548  Sum_probs=181.8

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|++|+||+|.+..++..+|+|.+......   ...+.+.+|+..++.++|+|++++++++...  ...+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEE
Confidence            36778999999999999999988999999998754321   2567888999999999999999999987554  468889


Q ss_pred             EcccCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          107 TELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~-l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      +||+.+++|.+++..... +++..+..++.|++.+|.+||+++  ++|+||+|.||+++ .++.++|+|||++...... 
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLG-MDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeCceeeEecCcc
Confidence            999999999999998777 899999999999999999999998  99999999999998 6789999999999876554 


Q ss_pred             --CCcccccCCcccCcccc-c-ccCCCcCcchhhhhHHHHHHhcCCCCCC-CCCHHHHHHHHhcCC
Q 016143          185 --TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTCEYPYNE-CKNPAQIYKKVTSGI  245 (394)
Q Consensus       185 --~~~~~~gt~~y~aPE~l-~-~~~~~~~DIwSlG~il~elltg~~Pf~~-~~~~~~~~~~i~~~~  245 (394)
                        ......++..|++||.+ . ..++.++|+||||+++++|++|+.||.. ..+...+.+.+..+.
T Consensus       153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence              23445688899999987 3 3467799999999999999999999977 566667888887764

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4e-31  Score=235.75  Aligned_cols=254  Identities=21%  Similarity=0.308  Sum_probs=194.2

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCC
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN  100 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~  100 (394)
                      ...-| .+.+.||+|-||++-+|.|+.++..+++|.+...-     -....|.+|.+.--.| .|.||+.-|+.-+. +.
T Consensus        22 l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq-t~   94 (378)
T KOG1345|consen   22 LEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ-TS   94 (378)
T ss_pred             hhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhh-cC
Confidence            33444 78899999999999999999999999999987442     3456789999888888 49999999886443 34


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe-CCCCcEEEcccceee
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~-~~~~~~kl~Dfgla~  179 (394)
                      +.+++++||++.|+|..-+...+ +-|...+.++.|+++|+.|||+++  +||||||.+||||- .+..++||+|||+++
T Consensus        95 d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             ceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeeccccc
Confidence            58889999999999998887754 999999999999999999999999  99999999999994 445689999999986


Q ss_pred             eecCCCCcccccCCcccCcccccc----c--CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHH---HHHhcCCCC--C
Q 016143          180 VMQQPTARSVIGTPEFMAPELYEE----E--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY---KKVTSGIKP--A  248 (394)
Q Consensus       180 ~~~~~~~~~~~gt~~y~aPE~l~~----~--~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~---~~i~~~~~~--~  248 (394)
                      ....... ..-.+..|.+||++..    .  .++.+|||.||+++|..+||.+||......++-+   .....+..+  +
T Consensus       172 k~g~tV~-~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P  250 (378)
T KOG1345|consen  172 KVGTTVK-YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP  250 (378)
T ss_pred             ccCceeh-hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence            5443321 2224667999997642    2  4688999999999999999999997533222222   222222222  2


Q ss_pred             CCCCCCCHHHHHHHHHcCC-CCCCC---CCHHHHhcCCcccc
Q 016143          249 SLSKVTDPQVKQFIEKCIV-PASLR---LPALELLKDPFLVT  286 (394)
Q Consensus       249 ~~~~~~~~~~~~li~~~L~-~p~~R---~s~~elL~~p~~~~  286 (394)
                      ..-+..++.+..+.++-|. ++.+|   .++.......|...
T Consensus       251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            2234456788889999998 67777   56666666666643

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.1e-30  Score=277.42  Aligned_cols=198  Identities=19%  Similarity=0.225  Sum_probs=146.1

Q ss_pred             cCCC-CCceeEeeeEE----cC-CCceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 016143           82 SLKH-ENIIKFYNSWV----DD-TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHR  154 (394)
Q Consensus        82 ~L~h-pnIv~~~~~~~----~~-~~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHr  154 (394)
                      .+.| +||.+++++|.    +. ....++.++||+ +++|.+++... ..+++..++.+++||+.||.|||++|  |+||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHr  104 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVH  104 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence            3445 57777777661    11 123567788887 67999999763 46999999999999999999999999  9999


Q ss_pred             CCCCCcEEEeC------------------CCCcEEEcccceeeeecCC------------------CCcccccCCcccCc
Q 016143          155 DLKCDNIFVNG------------------NNGEVKIGDLGLAIVMQQP------------------TARSVIGTPEFMAP  198 (394)
Q Consensus       155 DLkp~NIll~~------------------~~~~~kl~Dfgla~~~~~~------------------~~~~~~gt~~y~aP  198 (394)
                      ||||+||||+.                  .++.+|++|||+++.....                  .....+||+.||||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999951                  3456778888877542110                  00124689999999


Q ss_pred             cccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHH
Q 016143          199 ELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL  276 (394)
Q Consensus       199 E~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~  276 (394)
                      |++. ..|+.++|||||||+||||++|..|+...   ......+.....+..... ..+...+++.+||. +|.+||++.
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~L~~~P~~Rps~~  260 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQILL-NWPKEASFCLWLLHPEPSCRPSMS  260 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChhhhh-cCHHHHHHHHHhCCCChhhCcChH
Confidence            9765 46999999999999999999999887542   222222222222222111 23567889999998 899999999


Q ss_pred             HHhcCCcccc
Q 016143          277 ELLKDPFLVT  286 (394)
Q Consensus       277 elL~~p~~~~  286 (394)
                      |+|+||||..
T Consensus       261 eil~h~~~~~  270 (793)
T PLN00181        261 ELLQSEFINE  270 (793)
T ss_pred             HHhhchhhhh
Confidence            9999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.8e-29  Score=221.09  Aligned_cols=160  Identities=26%  Similarity=0.350  Sum_probs=129.1

Q ss_pred             CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCccccc
Q 016143          113 GSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG  191 (394)
Q Consensus       113 gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~~~g  191 (394)
                      |+|.+++... ..+++.+++.++.||+.||.|||+++        ||+|||++ .++.+|+  ||++.......   ..|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~~---~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPEQ---SRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeecccc---CCC
Confidence            7899999874 45999999999999999999999886        99999998 7889999  99997665432   268


Q ss_pred             CCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC-----CCCCCCH--HHHHHHH
Q 016143          192 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-----LSKVTDP--QVKQFIE  263 (394)
Q Consensus       192 t~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~--~~~~li~  263 (394)
                      |+.|||||++.+ .|+.++|||||||++|||+||+.||............+.....+..     .....+.  ++++++.
T Consensus        67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  146 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR  146 (176)
T ss_pred             cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence            999999997765 5899999999999999999999999765544444544443322221     1111222  6999999


Q ss_pred             HcCC-CCCCCCCHHHHhcCCcccc
Q 016143          264 KCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       264 ~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      +||. +|.+||++.+++.|+|+..
T Consensus       147 ~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      147 VCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHhcccccccCHHHHHHHHHHHH
Confidence            9998 9999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=8e-29  Score=230.68  Aligned_cols=244  Identities=22%  Similarity=0.323  Sum_probs=200.1

Q ss_pred             cccceecccCceEEEEEEEccCCe-----EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGI-----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      |+.-++-+|.||.||.|.+.....     .|-+|-++..   .++-+...++.|.-++..+.|||+.++.++.+++. ..
T Consensus       287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~-~~  362 (563)
T KOG1024|consen  287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY-AT  362 (563)
T ss_pred             echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc-Cc
Confidence            455678899999999997654433     2333433211   24556778999999999999999999999877654 46


Q ss_pred             EEEEEcccCCCcHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcc
Q 016143          103 INMITELFTSGSLRQYRKKH--------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD  174 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~--------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~D  174 (394)
                      .++++.+..-|+|..++...        +.++..++..++.|++.|++|||+++  |+|.||...|.+++ +.-++||+|
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVkltD  439 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVKLTD  439 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEEecc
Confidence            67788999899999999833        23777888999999999999999999  99999999999999 789999999


Q ss_pred             cceeeeecCCCCcc----cccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCC
Q 016143          175 LGLAIVMQQPTARS----VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA  248 (394)
Q Consensus       175 fgla~~~~~~~~~~----~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~  248 (394)
                      =.+++.+.......    .--+..|||||.+. ..|+.++|+||||++||||+| |+.||.+ .++.++...++.|.+-.
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyRla  518 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYRLA  518 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhccceec
Confidence            99998776553321    12245799999766 569999999999999999998 9999987 89999999999997543


Q ss_pred             CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       249 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                       .+..++.++..++..||+ .|.+||+.+|+..
T Consensus       519 -QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  519 -QPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             -CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence             466788999999999998 9999999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=5.6e-29  Score=255.10  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=204.6

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeec--cccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      +..|++..+++|.|++|.|+.+.........++|.+...  ...........+..|+-+-.+|+|||++.....+.+...
T Consensus       316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG  395 (601)
T ss_pred             ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence            355878889999999999999988888877777766532  111122233337789999999999999887775544332


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                        ..-+||||++ +|+.++...+.++..++..+++||+.||+|||+.|  |.|||||++|++++ .+|.+||+|||.+..
T Consensus       396 --~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~-~~g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 --ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVT-ENGILKIIDFGAASV  469 (601)
T ss_pred             --chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEe-cCCceEEeecCccee
Confidence              2234899999 99999999888999999999999999999999999  99999999999999 788999999999977


Q ss_pred             ecCCC------CcccccCCcccCcccccc-cCC-CcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-C-----CC
Q 016143          181 MQQPT------ARSVIGTPEFMAPELYEE-EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G-----IK  246 (394)
Q Consensus       181 ~~~~~------~~~~~gt~~y~aPE~l~~-~~~-~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~-----~~  246 (394)
                      .....      ....+|+..|+|||++.+ +|+ ..+||||.|+++..|++|+.||.-....++.+..... .     ..
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~  549 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG  549 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC
Confidence            75542      345689999999998875 576 5799999999999999999999764444333211111 0     11


Q ss_pred             CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          247 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       247 ~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +..+....+...+.+|.++|+ +|.+|.++.++++++||+...-
T Consensus       550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            222334456688999999998 9999999999999999997643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=1.4e-25  Score=211.39  Aligned_cols=252  Identities=30%  Similarity=0.445  Sum_probs=204.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCC-CceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hp-nIv~~~~~~~~~~~~~~~l  105 (394)
                      |++.+.||.|+||.||++.+.   ..+++|.+...... .......+.+|+.+++.+.|+ +|+++++.+..  ....++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~   75 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLES-KSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYL   75 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhcc-chhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEE
Confidence            467889999999999999887   78899988755432 223577899999999999988 79999998843  344789


Q ss_pred             EEcccCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC-cEEEcccceeeee
Q 016143          106 ITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVM  181 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~---~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~-~~kl~Dfgla~~~  181 (394)
                      +++++.+++|.+++....   .++...+..++.|++.++.|+|+.+  ++|||+||+||+++ ..+ .++++|||++...
T Consensus        76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~-~~~~~~~l~dfg~~~~~  152 (384)
T COG0515          76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLD-RDGRVVKLIDFGLAKLL  152 (384)
T ss_pred             EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-CCCCeEEEeccCcceec
Confidence            999999999998888775   7999999999999999999999999  99999999999998 455 7999999999755


Q ss_pred             cCCC--------CcccccCCcccCcccccc----cCCCcCcchhhhhHHHHHHhcCCCCCCCCC---HHHHHHHHhcCCC
Q 016143          182 QQPT--------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIK  246 (394)
Q Consensus       182 ~~~~--------~~~~~gt~~y~aPE~l~~----~~~~~~DIwSlG~il~elltg~~Pf~~~~~---~~~~~~~i~~~~~  246 (394)
                      ....        .....||+.|+|||.+.+    .+...+|+||+|++++++++|..||.....   ..+....+.....
T Consensus       153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  232 (384)
T COG0515         153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT  232 (384)
T ss_pred             CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence            4432        356789999999997764    578899999999999999999999877554   4566666655433


Q ss_pred             C-CCCCCCC------CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          247 P-ASLSKVT------DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       247 ~-~~~~~~~------~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      + .......      ...+.+++.+++. +|..|.+..+...++|....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            3 1111111      1478999999998 89999999998888766554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=7.3e-26  Score=218.74  Aligned_cols=171  Identities=21%  Similarity=0.240  Sum_probs=131.3

Q ss_pred             cccccceecccCceEEEEEEEcc-CCeEEEEEEeeeccc-cCCHHHHHHHHHHHHHHHcCCCCCcee-EeeeEEcCCCce
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDV-MQSPDQLERLYSEVHLLKSLKHENIIK-FYNSWVDDTNRT  102 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~-~~~~vaiK~i~~~~~-~~~~~~~~~~~~E~~~l~~L~hpnIv~-~~~~~~~~~~~~  102 (394)
                      .|++.+.||+|+||+||+|.++. ++..||+|.+..... .......+.+.+|+++|++|+|+||+. +++ +     ..
T Consensus        19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~-----~~   92 (365)
T PRK09188         19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T-----GK   92 (365)
T ss_pred             CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c-----CC
Confidence            34889999999999999998876 678889998652211 012345667899999999999999985 443 2     23


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC-CCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL-KCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDL-kp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .++||||++|++|... ...+      ...++.|++.||.|||++|  |+|||| ||+|||++ .++.+||+|||+|...
T Consensus        93 ~~LVmE~~~G~~L~~~-~~~~------~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-RPHG------DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQLASVF  162 (365)
T ss_pred             cEEEEEccCCCCHHHh-Cccc------hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEECccceec
Confidence            6899999999999732 2111      2568899999999999999  999999 99999997 6789999999999866


Q ss_pred             cCCC----------CcccccCCcccCccccccc-------CCCcCcch
Q 016143          182 QQPT----------ARSVIGTPEFMAPELYEEE-------YNELVDIY  212 (394)
Q Consensus       182 ~~~~----------~~~~~gt~~y~aPE~l~~~-------~~~~~DIw  212 (394)
                      ....          .....+++.|+|||.+..+       .+..+|-|
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            5432          1345688899999988642       23456777

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.7e-27  Score=231.54  Aligned_cols=250  Identities=19%  Similarity=0.281  Sum_probs=204.2

Q ss_pred             eecccCceEEEEEE---EccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEEEE
Q 016143           32 ILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        32 ~LG~G~~g~Vy~a~---~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+|+|+||.|+++.   -...|..+|+|+.+..........  .-..|..++...+ ||.+++++..|..+.  .+++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~l~l   76 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDG--KLYLIL   76 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeecccc--chhHhh
Confidence            47999999999763   234577789988766544332222  4556888899887 999999999886554  577788


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCc
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR  187 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~  187 (394)
                      ++..||+|...+.+...+++...+.+...++.++.++|+.+  ++|||+|++||+++ .+|++++.|||+++..-.....
T Consensus        77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeec-ccCccccCCchhhhHhHhhhhc
Confidence            99999999999999999999999999999999999999999  99999999999999 7899999999999766544433


Q ss_pred             ccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC
Q 016143          188 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  267 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~  267 (394)
                        |||..|||||+.+ .+...+|.||||++++||+||..||..     ++.+.|....  ...+...+..+++++..++.
T Consensus       154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~  223 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE--LEMPRELSAEARSLFRQLFK  223 (612)
T ss_pred             --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHh
Confidence              8999999999988 677899999999999999999999976     4555554432  22456667889999999887


Q ss_pred             -CCCCCCC-----HHHHhcCCccccCCCCCcccCCCC
Q 016143          268 -PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLR  298 (394)
Q Consensus       268 -~p~~R~s-----~~elL~~p~~~~~~~~~~~~~~~~  298 (394)
                       +|..|.-     +.++++|+||+..++..+.....+
T Consensus       224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~  260 (612)
T KOG0603|consen  224 RNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRP  260 (612)
T ss_pred             hCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCC
Confidence             7877775     579999999999998866544433

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=5.4e-24  Score=204.82  Aligned_cols=247  Identities=21%  Similarity=0.243  Sum_probs=183.0

Q ss_pred             ccccccceecccCceEEEEEEEccCC-eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC----CCceeEeeeEEcCC
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH----ENIIKFYNSWVDDT   99 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h----pnIv~~~~~~~~~~   99 (394)
                      +| ++.+.||+|+||.||++.+..++ ..+|+|..........    ..+..|+.++..+..    +++..+++... ..
T Consensus        19 ~~-~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~   92 (322)
T KOG1164|consen   19 RY-KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-ST   92 (322)
T ss_pred             ce-EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CC
Confidence            45 88999999999999999987775 6889988765432111    146678899988863    68889988764 34


Q ss_pred             CceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC----CcEEEc
Q 016143          100 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN----GEVKIG  173 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~----~~~kl~  173 (394)
                      ..+-+|||+.+ |-+|.++....  +.++...+..++.|++.+|++||+.|  ++||||||+|+.+....    ..+.|.
T Consensus        93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEE
Confidence            56788899998 88999998655  47999999999999999999999999  99999999999997432    469999


Q ss_pred             ccceee--eecCC---------C-CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHH--HH
Q 016143          174 DLGLAI--VMQQP---------T-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ--IY  238 (394)
Q Consensus       174 Dfgla~--~~~~~---------~-~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~--~~  238 (394)
                      |||+++  .....         . .....||..|+++....+ +.+.+-|+||++.++.+|+.|..||........  .+
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~  249 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF  249 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence            999998  32111         1 123459999999997655 588999999999999999999999976553322  22


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       239 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ................+.++..+...+-. +...+|....+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            22222211111223344566666655544 6677777666544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=7.8e-24  Score=191.24  Aligned_cols=175  Identities=16%  Similarity=0.135  Sum_probs=134.3

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHH------HHHHHHHHHcCCCCCceeEeeeEE
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER------LYSEVHLLKSLKHENIIKFYNSWV   96 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~------~~~E~~~l~~L~hpnIv~~~~~~~   96 (394)
                      .+|| |..++||.|+||.||++.+  ++..+|+|++.... ...+...++      +.+|+..+.++.|++|..+.+++.
T Consensus        30 ~~~y-~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~-~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         30 SYNI-KTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKV-KRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             hCce-EEEEEecCCCceEEEEEec--CCCcEEEEEechhc-CchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            4566 8999999999999999754  57789999986433 233444444      568999999999999999999877


Q ss_pred             cCCC------ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE
Q 016143           97 DDTN------RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV  170 (394)
Q Consensus        97 ~~~~------~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~  170 (394)
                      +...      ...++||||++|.+|.++..    +++    ....+++.+|..||++|  ++|||+||.||+++ .+| +
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~-~~g-i  173 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVS-KNG-L  173 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEe-CCC-E
Confidence            5432      34789999999999988732    333    34569999999999999  99999999999998 566 9


Q ss_pred             EEcccceeeeecCCCCcccccCCcccCcccccccCCCcCcchhhhhHHHHHH
Q 016143          171 KIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV  222 (394)
Q Consensus       171 kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~ell  222 (394)
                      +|+|||.........+...         =++...|+.++||||||+++....
T Consensus       174 ~liDfg~~~~~~e~~a~d~---------~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAKDR---------IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhHHH---------HHHHhHhcccccccceeEeehHHH
Confidence            9999998755433222111         023445778999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=2.3e-23  Score=185.05  Aligned_cols=146  Identities=16%  Similarity=0.184  Sum_probs=112.8

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHH----------------------HHHHHHHHHHHHHcCCCCC
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD----------------------QLERLYSEVHLLKSLKHEN   87 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~----------------------~~~~~~~E~~~l~~L~hpn   87 (394)
                      ...||+|+||+||+|.+. +|+.||+|+++.........                      ......+|+.++.+|.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999986 89999999997643211000                      0122345999999998887


Q ss_pred             ceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEecCCCCCcEEEeCC
Q 016143           88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGN  166 (394)
Q Consensus        88 Iv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~L-H~~~~~ivHrDLkp~NIll~~~  166 (394)
                      +...+....  ..  .+|||||++|++|...+...+.+++..+..++.||+.+|.++ |+.|  |+||||||+||+++  
T Consensus        81 v~~p~~~~~--~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~--  152 (190)
T cd05147          81 IPCPEPILL--KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH--  152 (190)
T ss_pred             CCCCcEEEe--cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE--
Confidence            644333221  12  268999999988876655556799999999999999999999 7999  99999999999998  


Q ss_pred             CCcEEEcccceeeeecCC
Q 016143          167 NGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       167 ~~~~kl~Dfgla~~~~~~  184 (394)
                      ++.++|+|||+|.....+
T Consensus       153 ~~~v~LiDFG~a~~~~~~  170 (190)
T cd05147         153 DGKLYIIDVSQSVEHDHP  170 (190)
T ss_pred             CCcEEEEEccccccCCCc
Confidence            378999999999755443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=4.2e-23  Score=189.30  Aligned_cols=211  Identities=21%  Similarity=0.329  Sum_probs=171.6

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCC
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN  100 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~  100 (394)
                      ..|-.||++++||+|+||..+.|....+++.||||.-..+.      ..-++..|.+..+.|. .++|..+|.+-  ..+
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS------~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG   96 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS------EAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEG   96 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccC------CcchHHHHHHHHHHHcCCCCCCceeeec--ccc
Confidence            44556799999999999999999999999999999865432      2234566888888884 78888887643  555


Q ss_pred             ceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC----CCCcEEEccc
Q 016143          101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDL  175 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~----~~~~~kl~Df  175 (394)
                      .+-.||+|++ |-+|.++..-. ++++.+.+.-++.|++.-++|+|+++  +|.|||||+|+||..    +...+.|+||
T Consensus        97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDF  173 (449)
T KOG1165|consen   97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDF  173 (449)
T ss_pred             chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEec
Confidence            5666899999 88999998865 56999999999999999999999999  999999999999952    3346999999


Q ss_pred             ceeeeecCCC---------CcccccCCcccCccc-ccccCCCcCcchhhhhHHHHHHhcCCCCCCCC--CHHHHHHHHhc
Q 016143          176 GLAIVMQQPT---------ARSVIGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTS  243 (394)
Q Consensus       176 gla~~~~~~~---------~~~~~gt~~y~aPE~-l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~--~~~~~~~~i~~  243 (394)
                      |+|+....+.         ..+..||.+||+--. +..+-+..-|+-|||.++...|-|.+||.+..  +..+-+.+|-.
T Consensus       174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe  253 (449)
T KOG1165|consen  174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE  253 (449)
T ss_pred             cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence            9998776553         235679999999874 44567788999999999999999999998753  44566777644

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=2.1e-23  Score=183.68  Aligned_cols=233  Identities=21%  Similarity=0.289  Sum_probs=178.5

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC-CCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h-pnIv~~~~~~~~~~~~~  102 (394)
                      +.-|++.+.||+|+||.+|+|....+|++||||.-.... ..     -.+..|.++.+.|++ ..|..+..+.  .+..+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~h-----pqL~yEskvY~iL~~g~GiP~i~~y~--~e~~y   85 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KH-----PQLLYESKVYRILQGGVGIPHIRHYG--TEKDY   85 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CC-----cchhHHHHHHHHhccCCCCchhhhhc--ccccc
Confidence            334499999999999999999999999999999865322 11     236678899999974 5555565544  33456


Q ss_pred             EEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEcccceee
Q 016143          103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAI  179 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~--~~~~~~kl~Dfgla~  179 (394)
                      -.+||+.. |-+|.++..-. +.++.++++-++-|++.-++|+|.++  .+||||||+|+|..  ....++.++|||+|+
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchh
Confidence            67899999 88999998854 56999999999999999999999999  99999999999984  234579999999997


Q ss_pred             eecCCC---------CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCC--CHHHHHHHHhcCC--
Q 016143          180 VMQQPT---------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGI--  245 (394)
Q Consensus       180 ~~~~~~---------~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~--~~~~~~~~i~~~~--  245 (394)
                      ......         .+...||..|.+--..- .+-+..-|+-|+|.+|....-|.+||.+..  +..|-+.+|.+..  
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s  242 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS  242 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence            664432         23456999999877443 345778899999999999999999998843  3456666665432  


Q ss_pred             -CCCCCCCCCCHHHHHHHHHcCC
Q 016143          246 -KPASLSKVTDPQVKQFIEKCIV  267 (394)
Q Consensus       246 -~~~~~~~~~~~~~~~li~~~L~  267 (394)
                       .++.+-+..+.+..-.+.-|-.
T Consensus       243 ~~ie~LC~G~P~EF~myl~Y~R~  265 (341)
T KOG1163|consen  243 TPIEVLCKGFPAEFAMYLNYCRG  265 (341)
T ss_pred             CCHHHHhCCCcHHHHHHHHHHhh
Confidence             2333455567777777776654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.6e-22  Score=179.91  Aligned_cols=146  Identities=18%  Similarity=0.216  Sum_probs=114.2

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccC--------------------CH--HHHHHHHHHHHHHHcCCCCC
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--------------------SP--DQLERLYSEVHLLKSLKHEN   87 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~--------------------~~--~~~~~~~~E~~~l~~L~hpn   87 (394)
                      .+.||+|++|+||+|.+. +|+.||+|+++......                    ..  .....+..|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 89999999987642110                    00  01223467999999999998


Q ss_pred             ceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCC
Q 016143           88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGN  166 (394)
Q Consensus        88 Iv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~  166 (394)
                      |.....++...    .++||||++|+++.........++...+..++.|++.+|.+||+ +|  |+||||||+||+++  
T Consensus        81 i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~--  152 (190)
T cd05145          81 VPVPEPILLKK----NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH--  152 (190)
T ss_pred             CCCceEEEecC----CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--
Confidence            75544433322    36899999988665443344568899999999999999999999 89  99999999999997  


Q ss_pred             CCcEEEcccceeeeecCC
Q 016143          167 NGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       167 ~~~~kl~Dfgla~~~~~~  184 (394)
                      ++.++|+|||++......
T Consensus       153 ~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         153 DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             CCCEEEEEcccceecCCC
Confidence            579999999999776543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=3.6e-23  Score=213.46  Aligned_cols=219  Identities=26%  Similarity=0.470  Sum_probs=166.6

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ...++|..|++|.||...|+.+.+.+|+ +++....               +|+.     |..+-+    +    .+.| 
T Consensus        86 ~~IklisngAygavylvrh~~trqrfa~-kiNkq~l---------------ilRn-----ilt~a~----n----pfvv-  135 (1205)
T KOG0606|consen   86 NTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL---------------ILRN-----ILTFAG----N----PFVV-  135 (1205)
T ss_pred             ceeEeeccCCCCceeeeeccccccchhh-cccccch---------------hhhc-----cccccC----C----ccee-
Confidence            4458899999999999999999999998 4443221               1211     222211    1    1122 


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC---
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~---  184 (394)
                           |+-...++.-+.++.+.        +.+++|||+.+  |+|||+||+|.+|+ .-|++|++|||++...-..   
T Consensus       136 -----gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             -----chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhhhhhhhhccc
Confidence                 66666677766666544        78999999998  99999999999999 7899999999998432111   


Q ss_pred             --------------CCcccccCCcccCcccc-cccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC-C-CC
Q 016143          185 --------------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-I-KP  247 (394)
Q Consensus       185 --------------~~~~~~gt~~y~aPE~l-~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~-~-~~  247 (394)
                                    ..+.++|||+|.|||++ ...|+..+|+|++|+|+||.+.|+.||.+ .++++++..+... + .|
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~wp  278 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWP  278 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhcccc
Confidence                          12346899999999954 56799999999999999999999999987 7788888777653 2 23


Q ss_pred             CCCCCCCCHHHHHHHHHcCC-CCCCCC---CHHHHhcCCccccCCCCCccc
Q 016143          248 ASLSKVTDPQVKQFIEKCIV-PASLRL---PALELLKDPFLVTDNPKDLVC  294 (394)
Q Consensus       248 ~~~~~~~~~~~~~li~~~L~-~p~~R~---s~~elL~~p~~~~~~~~~~~~  294 (394)
                      +. ..-..++++++|+++|. .|..|.   .+.++.+|+||+..+++.+..
T Consensus       279 E~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llR  328 (1205)
T KOG0606|consen  279 EE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLR  328 (1205)
T ss_pred             cc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhh
Confidence            33 45567899999999997 787776   577899999999998885443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=3.1e-22  Score=177.37  Aligned_cols=184  Identities=15%  Similarity=0.098  Sum_probs=138.0

Q ss_pred             ccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEEEE
Q 016143           29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        29 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ....|++|+||+||.+..  .+..++.+.+.....-...-....+.+|+++|++|. |++|++++++      ...+++|
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm   77 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR   77 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence            457899999999998754  677777665543322111112235788999999995 5889999884      1357899


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC-CCCcEEEeCCCCcEEEcccceeeeecCCCC
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL-KCDNIFVNGNNGEVKIGDLGLAIVMQQPTA  186 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDL-kp~NIll~~~~~~~kl~Dfgla~~~~~~~~  186 (394)
                      ||+.|.+|.+.+..       ....++.|++.+|.++|++|  |+|||| ||+|||++ .++.++|+|||+|........
T Consensus        78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcch
Confidence            99999999764322       12457899999999999999  999999 79999998 678999999999975543321


Q ss_pred             -----c----------ccccCCcccCccccc--ccCC-CcCcchhhhhHHHHHHhcCCCCCC
Q 016143          187 -----R----------SVIGTPEFMAPELYE--EEYN-ELVDIYSFGMCILEMVTCEYPYNE  230 (394)
Q Consensus       187 -----~----------~~~gt~~y~aPE~l~--~~~~-~~~DIwSlG~il~elltg~~Pf~~  230 (394)
                           .          ...+++.|++|+.-.  ...+ ...++++.|+-+|.++|+..|+.+
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                 0          113688999998432  2334 567888999999999999998765

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=2e-22  Score=187.41  Aligned_cols=231  Identities=18%  Similarity=0.213  Sum_probs=148.8

Q ss_pred             ccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC----------CCceeEeeeEE--
Q 016143           29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH----------ENIIKFYNSWV--   96 (394)
Q Consensus        29 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h----------pnIv~~~~~~~--   96 (394)
                      .++.||.|+++.||.+.|..||+.+|+|++.... .......+.+.+|......+.+          -.++.-++...  
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            4689999999999999999999999999987665 3344567778777766655433          11222122111  


Q ss_pred             -------cCCC-c-----eEEEEEcccCCCcHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC
Q 016143           97 -------DDTN-R-----TINMITELFTSGSLRQYRKK---HKN----VDMKAIKNWARQILRGLHYLHSHNPPIIHRDL  156 (394)
Q Consensus        97 -------~~~~-~-----~~~lV~e~~~~gsL~~~i~~---~~~----l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDL  156 (394)
                             -..+ .     ..+++|+-+ .++|.+++..   ...    +.......+..|++..+++||++|  ++|+||
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi  171 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDI  171 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEeccc
Confidence                   1111 1     135567766 5788887542   221    333344566699999999999999  999999


Q ss_pred             CCCcEEEeCCCCcEEEcccceeeeecCCCCcccccCCcccCcccccc---------cCCCcCcchhhhhHHHHHHhcCCC
Q 016143          157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE---------EYNELVDIYSFGMCILEMVTCEYP  227 (394)
Q Consensus       157 kp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~---------~~~~~~DIwSlG~il~elltg~~P  227 (394)
                      +|+|+|++ .+|.++|+||+........... ...+..|.+||+...         .++.+.|.|+||+++|.|.+|+.|
T Consensus       172 ~~~nfll~-~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  172 KPENFLLD-QDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             SGGGEEE--TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             ceeeEEEc-CCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            99999999 7899999999887655543322 345678999996632         367899999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCC
Q 016143          228 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLR  272 (394)
Q Consensus       228 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R  272 (394)
                      |....... ....     .-..-. ..+..++.||..+|. +|.+|
T Consensus       250 f~~~~~~~-~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEA-DPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGS-TSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccc-cccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            97532110 0000     011122 567899999999998 77766

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.8e-21  Score=174.98  Aligned_cols=137  Identities=19%  Similarity=0.247  Sum_probs=108.2

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-----CCCCceeEeeeEEcCCC-ceE
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-----KHENIIKFYNSWVDDTN-RTI  103 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-----~hpnIv~~~~~~~~~~~-~~~  103 (394)
                      .+.||+|+||.||.  +..++.. +||++.....    ...+.+.+|+.+++.|     +||||+++|+++.++.+ ..+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            37899999999995  7767666 6898865432    2346689999999999     57999999999876642 343


Q ss_pred             E-EEEcc--cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeEecCCCCCcEEEeC---CCCcEEEcccc
Q 016143          104 N-MITEL--FTSGSLRQYRKKHKNVDMKAIKNWARQILRGL-HYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLG  176 (394)
Q Consensus       104 ~-lV~e~--~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L-~~LH~~~~~ivHrDLkp~NIll~~---~~~~~kl~Dfg  176 (394)
                      + +|+||  +.+++|.+++++. .+++.  ..++.|++.++ +|||+++  |+||||||+|||++.   .++.++|+||+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            4 78999  5579999999775 46666  46788888888 8999999  999999999999973   23479999954


Q ss_pred             ee
Q 016143          177 LA  178 (394)
Q Consensus       177 la  178 (394)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=4e-22  Score=178.39  Aligned_cols=237  Identities=18%  Similarity=0.284  Sum_probs=186.2

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ..+|.+.-.|..|+|++..  ..++.|+++..+.  +....+.|..|.-.|+-+.||||+.+++.+..  .-.+.+|..|
T Consensus       195 ~tkl~e~hsgelwrgrwqg--ndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgacns--ppnlv~isq~  268 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQG--NDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGACNS--PPNLVIISQY  268 (448)
T ss_pred             hhhhccCCCcccccccccC--cchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhccC--CCCceEeeee
Confidence            3568888999999998764  3455677766554  23445668889999999999999999998844  3568889999


Q ss_pred             cCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE--cccceeeeecCCC
Q 016143          110 FTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI--GDLGLAIVMQQPT  185 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~--l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl--~Dfgla~~~~~~~  185 (394)
                      ++-|+|...+.....  ++..++.+++.+|++|++|||+..|-|.--.|....+++| ++.+.+|  +|--++.+...  
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid-edltarismad~kfsfqe~g--  345 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFSFQEVG--  345 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceeeeeccc--
Confidence            999999999987654  6788999999999999999999985555567999999998 6665554  45444433222  


Q ss_pred             CcccccCCcccCccccccc---C-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYEEE---Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~~---~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                         ....|.||+||.++..   . -.++|+|||++++|||.|.+.||.+....+--++....|..+. ++..++..+..+
T Consensus       346 ---r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~-ippgis~hm~kl  421 (448)
T KOG0195|consen  346 ---RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH-IPPGISRHMNKL  421 (448)
T ss_pred             ---cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc-CCCCccHHHHHH
Confidence               2357899999988753   2 2689999999999999999999999777666677777776554 566677899999


Q ss_pred             HHHcCC-CCCCCCCHHHHh
Q 016143          262 IEKCIV-PASLRLPALELL  279 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL  279 (394)
                      +.-|+. ||.+||..+.++
T Consensus       422 m~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  422 MNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHhcCCCCcCCCcceeh
Confidence            999998 999999877643

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=2.8e-22  Score=207.11  Aligned_cols=241  Identities=21%  Similarity=0.276  Sum_probs=177.1

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      -+.+-||++.|=+|.+|++. .|. |++|++-+.+-.-+-....+...|++ ...+++||.+.+.-+-  ..++..|||-
T Consensus        26 ~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAAylvR  100 (1431)
T KOG1240|consen   26 HYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAAYLVR  100 (1431)
T ss_pred             eeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHHHHHH
Confidence            57899999999999999874 455 88888755442222334444555666 6777999999987753  4445678899


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee---cCC
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQP  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~---~~~  184 (394)
                      +|+. -+|.+.+.-+.-+..-+.+.|+.||+.||.-+|..|  |+|||||.+||||+ .-+-+.|+||..-+-.   ...
T Consensus       101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEe-eechhhhhcccccCCccCCCCC
Confidence            9995 589999988888888999999999999999999999  99999999999998 5567899999765211   111


Q ss_pred             C--CcccccC----CcccCcccccc-----------c-CCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCC
Q 016143          185 T--ARSVIGT----PEFMAPELYEE-----------E-YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI  245 (394)
Q Consensus       185 ~--~~~~~gt----~~y~aPE~l~~-----------~-~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~  245 (394)
                      .  ..-+..|    ..|+|||.+..           . .+++-||||+||+++||++ |++||.-    .|++..-..+.
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~  252 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNA  252 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCc
Confidence            1  1112222    36999997642           1 3467899999999999988 7888842    34333322211


Q ss_pred             -CC-CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          246 -KP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       246 -~~-~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                       .+ ..+.++-+..++.+|..|++ +|++|.+|++.|+.
T Consensus       253 ~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  253 DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence             01 11234445689999999998 99999999999985

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.5e-20  Score=176.14  Aligned_cols=197  Identities=20%  Similarity=0.339  Sum_probs=146.9

Q ss_pred             CCCCceeEeeeEEc-------------------------CCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHH
Q 016143           84 KHENIIKFYNSWVD-------------------------DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL  138 (394)
Q Consensus        84 ~hpnIv~~~~~~~~-------------------------~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil  138 (394)
                      +|||||+++.+|.+                         .+..++|+||.-.. .+|+.|+-.+. .+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence            69999999998865                         23467899999885 59999987654 77788888999999


Q ss_pred             HHHHHHHhCCCCeEecCCCCCcEEEeCC-C--CcEEEcccceeeeecCCC--------CcccccCCcccCcccccccC--
Q 016143          139 RGLHYLHSHNPPIIHRDLKCDNIFVNGN-N--GEVKIGDLGLAIVMQQPT--------ARSVIGTPEFMAPELYEEEY--  205 (394)
Q Consensus       139 ~~L~~LH~~~~~ivHrDLkp~NIll~~~-~--~~~kl~Dfgla~~~~~~~--------~~~~~gt~~y~aPE~l~~~~--  205 (394)
                      +|+.|||++|  |.|||||.+|||+.-+ +  -.+.|+|||.+-....-.        .-..-|.-.-||||+...-.  
T Consensus       352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp  429 (598)
T KOG4158|consen  352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP  429 (598)
T ss_pred             HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence            9999999999  9999999999999522 2  358999999985443311        11233677899999886421  


Q ss_pred             -----CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCH---H
Q 016143          206 -----NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA---L  276 (394)
Q Consensus       206 -----~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~---~  276 (394)
                           -.++|.|+.|.+.||+++...||........-....++. .-+.++...++.+++++..+|. +|++|+++   .
T Consensus       430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~-qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA  508 (598)
T KOG4158|consen  430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES-QLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA  508 (598)
T ss_pred             ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh-hCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence                 258999999999999999999997622211111111221 2334677888999999999998 99999984   4


Q ss_pred             HHhcCCccc
Q 016143          277 ELLKDPFLV  285 (394)
Q Consensus       277 elL~~p~~~  285 (394)
                      .+|+-..+.
T Consensus       509 Nvl~LsLw~  517 (598)
T KOG4158|consen  509 NVLNLSLWR  517 (598)
T ss_pred             hHHHHHHhc
Confidence            555544343

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=2.1e-20  Score=171.66  Aligned_cols=151  Identities=19%  Similarity=0.160  Sum_probs=116.8

Q ss_pred             cccccccceecccCceEEEEEE-EccCCeEEEEEEeeeccccC------------------CH--HHHHHHHHHHHHHHc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGF-DEVDGIEVAWNQVNIEDVMQ------------------SP--DQLERLYSEVHLLKS   82 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~-~~~~~~~vaiK~i~~~~~~~------------------~~--~~~~~~~~E~~~l~~   82 (394)
                      |+-|++.+.||+|++|.||+|. +..+|+.||+|.+.......                  ..  .....+.+|+.++++
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            4456888999999999999998 77899999999987543110                  00  012346689999999


Q ss_pred             CCCC--CceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCc
Q 016143           83 LKHE--NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN  160 (394)
Q Consensus        83 L~hp--nIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~N  160 (394)
                      +.+.  .+.++++.   .   ..++||||+.|++|..+......+...++..++.||+.+|.+||++| +++||||||+|
T Consensus       107 L~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~N  179 (237)
T smart00090      107 LYEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYN  179 (237)
T ss_pred             HHhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhh
Confidence            9753  33444432   1   23689999999888776645556777788999999999999999986 59999999999


Q ss_pred             EEEeCCCCcEEEcccceeeeecC
Q 016143          161 IFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       161 Ill~~~~~~~kl~Dfgla~~~~~  183 (394)
                      |+++  ++.++|+|||.+.....
T Consensus       180 Ili~--~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      180 ILVH--DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EEEE--CCCEEEEEChhhhccCC
Confidence            9998  67899999999865444

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=2.6e-21  Score=187.75  Aligned_cols=173  Identities=24%  Similarity=0.474  Sum_probs=137.1

Q ss_pred             ceEEEEEcccCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143          101 RTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~---~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                      .++|+.|++|+..+|.+++....   ..+....+.|+.|+..|+.|   ++  .+|||+||.||+.. .+..+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~-~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS-DDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc-cchhhhhhhhhh
Confidence            36899999999999999997543   46778899999999999999   67  99999999999997 677999999999


Q ss_pred             eeeecCCC--------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCC
Q 016143          178 AIVMQQPT--------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP  247 (394)
Q Consensus       178 a~~~~~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~  247 (394)
                      .+......        .+...||..||+||.+.+ .|+.++||||||++|+||+. ...+|..    ...+..+..+..|
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip  478 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIP  478 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCC
Confidence            97664433        234579999999998875 59999999999999999998 4444432    2233445555555


Q ss_pred             CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       248 ~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      +.+.... |+-..|+.++|. .|.+||++.+.-.|+|+
T Consensus       479 ~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  479 PEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            4333332 566789999998 89999988887777765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=1.5e-21  Score=200.37  Aligned_cols=253  Identities=24%  Similarity=0.338  Sum_probs=203.4

Q ss_pred             ccccceecccCceEEEEEEEc-cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +++.+.||+|+|+.|-.+... .....+|.|.+....  ++....++...|..+-+.+. |+|++.+++..  .+....+
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~~   97 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSYL   97 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCcc--CCCcccc
Confidence            377788999999999988663 334557777665543  44566677777999999997 99999999977  4445778


Q ss_pred             EEEcccCCCcHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCeEecCCCCCcEEEeCCCC-cEEEcccceeee
Q 016143          105 MITELFTSGSLRQYR-KKHK-NVDMKAIKNWARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIV  180 (394)
Q Consensus       105 lV~e~~~~gsL~~~i-~~~~-~l~~~~~~~i~~qil~~L~~LH-~~~~~ivHrDLkp~NIll~~~~~-~~kl~Dfgla~~  180 (394)
                      ++++|..|++++.-+ .... ..+...+..++.|+..++.|+| ..+  +.|||+||+|.+++ ..+ .++++|||+|+.
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~-~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLD-ESGSALKIADFGLATA  174 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhc-cCCCcccCCCchhhcc
Confidence            899999999999998 5555 6888899999999999999999 888  99999999999999 667 999999999987


Q ss_pred             ecC-CC----Cccccc-CCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCC
Q 016143          181 MQQ-PT----ARSVIG-TPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASL  250 (394)
Q Consensus       181 ~~~-~~----~~~~~g-t~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~  250 (394)
                      ... ..    ....+| ++.|+|||.+.+  ...+..|+||+|+++..|++|..|+.........+........  ....
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP  254 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence            766 32    234578 999999998876  3578999999999999999999999765444443333333211  1334


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      ....+....+++.+++. +|+.|.+..++-.+||+..
T Consensus       255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccCChhhhhcccccccCCchhccccccccccccccc
Confidence            45567789999999996 9999999999999999987

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=6.3e-21  Score=174.93  Aligned_cols=269  Identities=33%  Similarity=0.557  Sum_probs=189.4

Q ss_pred             CCCCccccCCCcccccccceeccc---CceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCce
Q 016143           13 EEGEFSEKDPSCRYGRYDEILGKG---AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII   89 (394)
Q Consensus        13 ~~~~~~~~~~~~ry~r~~~~LG~G---~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv   89 (394)
                      .+.+..+..|-+|..+-.+..|+.   +.-.||++-+...|.+|.|..+.......-..+-+....-...|-.+.|.|||
T Consensus        51 ~~~eIleesp~~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlv  130 (458)
T KOG1266|consen   51 DESEILEESPCGRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLV  130 (458)
T ss_pred             chhhhhccCchhhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHH
Confidence            345677777888887666667753   23468999999999999998775433222112222222234456667899999


Q ss_pred             eEeeeEEcCC---CceEEEEEcccCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEE
Q 016143           90 KFYNSWVDDT---NRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF  162 (394)
Q Consensus        90 ~~~~~~~~~~---~~~~~lV~e~~~~gsL~~~i~~~----~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIl  162 (394)
                      +++.+|.+..   ...+.+++||+..|+|.+++++.    ..+.....++|.-||+.||.|||+..|+|+|+++.++-|+
T Consensus       131 kfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tif  210 (458)
T KOG1266|consen  131 KFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIF  210 (458)
T ss_pred             HHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhhee
Confidence            9999996543   23577899999999999998764    4588999999999999999999999999999999999999


Q ss_pred             EeCCCCcEEEcccceeeeecC------CCCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHH
Q 016143          163 VNGNNGEVKIGDLGLAIVMQQ------PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA  235 (394)
Q Consensus       163 l~~~~~~~kl~Dfgla~~~~~------~~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~  235 (394)
                      +. .+|-+|++--.....-..      .......|-++|.|||--. ...+..+|||+||++..+|..++.--.......
T Consensus       211 iq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~  289 (458)
T KOG1266|consen  211 IQ-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKV  289 (458)
T ss_pred             ec-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCccee
Confidence            98 788888865332211100      0111234678999999433 346678999999999999999886644433221


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       236 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ..-..+..-     .-...+..-+.++.+||. .|..||++.++|.||.+-+.
T Consensus       290 ~~ee~ia~~-----i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  290 EVEENIANV-----IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             ehhhhhhhh-----eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence            111111111     011112345788999999 89999999999999987653

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=7.4e-19  Score=173.46  Aligned_cols=195  Identities=27%  Similarity=0.427  Sum_probs=153.4

Q ss_pred             HHcCCCCCceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCe-EecCCC
Q 016143           80 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPI-IHRDLK  157 (394)
Q Consensus        80 l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~i-vHrDLk  157 (394)
                      |+.+.|.|+.+|++..++.  ...++|.+||..|+|.+.+... ..++..-...+++.|+.||.|||+..  | .|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            4678999999999998877  4677899999999999999884 56888889999999999999999875  5 999999


Q ss_pred             CCcEEEeCCCCcEEEcccceeeeecCC----CCcccccCCcccCccccccc--------CCCcCcchhhhhHHHHHHhcC
Q 016143          158 CDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEEE--------YNELVDIYSFGMCILEMVTCE  225 (394)
Q Consensus       158 p~NIll~~~~~~~kl~Dfgla~~~~~~----~~~~~~gt~~y~aPE~l~~~--------~~~~~DIwSlG~il~elltg~  225 (394)
                      +.|.+++ ....+||+|||+.......    ......-..-|.|||++...        .+.+.||||+|++++|+++..
T Consensus        77 s~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   77 SSNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             cccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            9999999 7899999999998665431    11111234469999988753        356799999999999999999


Q ss_pred             CCCCCC---CCHHHHHHHHhc-CCC---CCCCCC-CCCHHHHHHHHHcCC-CCCCCCCHHHHh
Q 016143          226 YPYNEC---KNPAQIYKKVTS-GIK---PASLSK-VTDPQVKQFIEKCIV-PASLRLPALELL  279 (394)
Q Consensus       226 ~Pf~~~---~~~~~~~~~i~~-~~~---~~~~~~-~~~~~~~~li~~~L~-~p~~R~s~~elL  279 (394)
                      .||...   ..++++..++.. +..   |.-... ...+++..++..||. +|..||++.++-
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence            999762   233566666666 321   221111 344579999999998 899999988753

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=2.7e-19  Score=188.02  Aligned_cols=188  Identities=22%  Similarity=0.301  Sum_probs=148.8

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC---CCCceeEeeeEEcCCCceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~---hpnIv~~~~~~~~~~~~~~  103 (394)
                      +-+.+.||+|+||+||+|.+.. |+.||+|+-+....  .+     ++-=.+++.+|+   -+.|+.+...++-.+.  -
T Consensus       700 ~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~--S  769 (974)
T KOG1166|consen  700 FCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--WE-----FYICLQVMERLKPQMLPSIMHISSAHVFQNA--S  769 (974)
T ss_pred             EEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--ee-----eeehHHHHHhhchhhhcchHHHHHHHccCCc--c
Confidence            3567889999999999999866 99999998653321  11     111224455555   3445556665554443  4


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe------CCCCcEEEcccce
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------GNNGEVKIGDLGL  177 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~------~~~~~~kl~Dfgl  177 (394)
                      ++|+||.+.|+|.+++...+..++..+..++.|++..+++||..+  |||+||||+|++|.      .+..-++|+|||-
T Consensus       770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            469999999999999998888999999999999999999999999  99999999999994      2344699999999


Q ss_pred             eeeec---CC-CCcccccCCcccCccccccc-CCCcCcchhhhhHHHHHHhcCC
Q 016143          178 AIVMQ---QP-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEY  226 (394)
Q Consensus       178 a~~~~---~~-~~~~~~gt~~y~aPE~l~~~-~~~~~DIwSlG~il~elltg~~  226 (394)
                      +..+.   .. .....++|-.+--+|+..|. ++..+|.|.|+.+++.||+|++
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            96442   22 45567789999999988874 8999999999999999999964

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=3.4e-18  Score=154.24  Aligned_cols=138  Identities=22%  Similarity=0.264  Sum_probs=111.3

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCC----HHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~----~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +.||+|++|.||+|.+  +|..|++|+.........    .....++.+|+.++..+.|++|.....++.+..  ..+++
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv   77 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIV   77 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEE
Confidence            5799999999999986  678899997643221111    112346788999999999998877666555443  45679


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      |||++|++|.+++.....    ....++.+++.+|.+||+++  ++|+|++|.||+++  ++.++|+|||++..
T Consensus        78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~  143 (211)
T PRK14879         78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence            999999999999876542    88899999999999999999  99999999999998  57899999998854

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=2.1e-18  Score=154.37  Aligned_cols=142  Identities=23%  Similarity=0.211  Sum_probs=109.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC------------------HHHHHHHHHHHHHHHcCCCCC-
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS------------------PDQLERLYSEVHLLKSLKHEN-   87 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~------------------~~~~~~~~~E~~~l~~L~hpn-   87 (394)
                      +.+.+.||+|+||.||+|... +|+.||+|.+........                  .........|..++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            577899999999999999874 899999998765321000                  011123667999999998874 


Q ss_pred             -ceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 016143           88 -IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN  166 (394)
Q Consensus        88 -Iv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~  166 (394)
                       +...++    .  ...++||||++|++|..+...      .....++.+|+.++.++|+++  ++||||||+||+++ .
T Consensus        96 ~v~~~~~----~--~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~-~  160 (198)
T cd05144          96 PVPKPID----W--NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVD-D  160 (198)
T ss_pred             CCCceee----c--CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEc-C
Confidence             444443    1  234789999999999775431      346788999999999999999  99999999999998 6


Q ss_pred             CCcEEEcccceeeeecCC
Q 016143          167 NGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       167 ~~~~kl~Dfgla~~~~~~  184 (394)
                      ++.++|+|||++......
T Consensus       161 ~~~~~liDfg~~~~~~~~  178 (198)
T cd05144         161 DEKIYIIDWPQMVSTDHP  178 (198)
T ss_pred             CCcEEEEECCccccCCCc
Confidence            889999999999665554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=1.1e-17  Score=149.65  Aligned_cols=134  Identities=22%  Similarity=0.284  Sum_probs=104.7

Q ss_pred             eecccCceEEEEEEEccCCeEEEEEEeeeccccCC----HHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        32 ~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~----~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .||+|+||+||+|.  .+|..|++|..........    ....+++.+|+.+++.+.|+++....-++.++.  ..++||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~   76 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVM   76 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEE
Confidence            48999999999997  4678899998543321111    123467888999999999886544433334343  356899


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ||++|++|.+++.....       .++.|++.+|.+||+.+  ++|+|++|.||+++  ++.++++|||++..
T Consensus        77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~  138 (199)
T TIGR03724        77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence            99999999998765431       88999999999999999  99999999999998  68999999998854

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=2.1e-17  Score=169.61  Aligned_cols=137  Identities=21%  Similarity=0.236  Sum_probs=107.7

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccC----CHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~----~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ...+.||+|+||+||+|.+.  +..+++|+........    .....+++.+|+.+++.++|++++..+.++.+..  ..
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~  411 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--EK  411 (535)
T ss_pred             CccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CC
Confidence            55789999999999999764  3344554432221111    1123467889999999999999988766655443  35


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ++||||++|++|.+++.        ....++.|++.+|.+||+++  ++||||||+||+++  ++.++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCccccc
Confidence            68999999999999886        45789999999999999999  99999999999995  67899999999855

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=4.6e-17  Score=143.99  Aligned_cols=142  Identities=23%  Similarity=0.229  Sum_probs=99.8

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHH--------------------HHHHHHHHHHHcCCCCC--
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL--------------------ERLYSEVHLLKSLKHEN--   87 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~--------------------~~~~~E~~~l~~L~hpn--   87 (394)
                      .+.||+|+||+||+|.+. +|+.||+|++............                    .....|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999876 8999999988653321111000                    01135666676665443  


Q ss_pred             ceeEeeeEEcCCCceEEEEEcccCCCcHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeC
Q 016143           88 IIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNG  165 (394)
Q Consensus        88 Iv~~~~~~~~~~~~~~~lV~e~~~~gsL~~-~i~~~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~  165 (394)
                      +.+.+...      ..++||||++++++.. .+.... .. .+++.++.|++.++.++|+ ++  |+||||||+||+++ 
T Consensus        81 ~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-  149 (187)
T cd05119          81 VPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-  149 (187)
T ss_pred             CCceEecC------CCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-
Confidence            44444421      2478999999854321 111111 11 6788999999999999999 88  99999999999998 


Q ss_pred             CCCcEEEcccceeeeecCC
Q 016143          166 NNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       166 ~~~~~kl~Dfgla~~~~~~  184 (394)
                       ++.++|+|||.+.....+
T Consensus       150 -~~~~~liDfg~a~~~~~~  167 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDHP  167 (187)
T ss_pred             -CCcEEEEECcccccccCc
Confidence             679999999999665553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2.2e-16  Score=145.26  Aligned_cols=141  Identities=14%  Similarity=0.188  Sum_probs=107.2

Q ss_pred             cceec-ccCceEEEEEEEccCCeEEEEEEeeeccc----cC-----CHHHHHHHHHHHHHHHcCCCCCc--eeEeeeEEc
Q 016143           30 DEILG-KGAFKTVYKGFDEVDGIEVAWNQVNIEDV----MQ-----SPDQLERLYSEVHLLKSLKHENI--IKFYNSWVD   97 (394)
Q Consensus        30 ~~~LG-~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~----~~-----~~~~~~~~~~E~~~l~~L~hpnI--v~~~~~~~~   97 (394)
                      ..+|| .||.|+||.+...  +..+++|.+....+    ..     +.....++.+|+.++..|+|++|  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            46788 8999999998753  78899998864321    01     12334578889999999998875  666665433


Q ss_pred             CCCc--eEEEEEcccCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcc
Q 016143           98 DTNR--TINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD  174 (394)
Q Consensus        98 ~~~~--~~~lV~e~~~~-gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~D  174 (394)
                      +...  ..++|||+++| .+|.+++... .+++..    +.||+.+|.+||++|  |+||||||.|||++ .++.++|+|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~-~~~~v~LID  185 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLD-PDGKFWLID  185 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEc-CCCCEEEEE
Confidence            3221  23589999997 6999988764 466543    578999999999999  99999999999998 567999999


Q ss_pred             cceeee
Q 016143          175 LGLAIV  180 (394)
Q Consensus       175 fgla~~  180 (394)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998855

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=2.8e-15  Score=126.50  Aligned_cols=132  Identities=20%  Similarity=0.115  Sum_probs=106.9

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC--CCceeEeeeEEcCCCceEEEEE
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h--pnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      .+.||+|.++.||++....  ..+++|.+.....      ...+.+|+.+++.++|  .++++++.+...  ....++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~   72 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLM   72 (155)
T ss_pred             ceecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEE
Confidence            4679999999999998743  7889998753321      4567889999999976  588888886643  35688999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~-~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ||+.++++..+       +......++.+++.+|.+||... .+++|+|++|.||+++ +.+.++++|||.+.
T Consensus        73 e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~  137 (155)
T cd05120          73 EWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAG  137 (155)
T ss_pred             EecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-CCcEEEEEeccccc
Confidence            99998888654       55677888999999999999852 2399999999999998 57899999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=9.7e-16  Score=151.68  Aligned_cols=249  Identities=24%  Similarity=0.279  Sum_probs=192.6

Q ss_pred             cceecc--cCceEEEEEEE--ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEE
Q 016143           30 DEILGK--GAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        30 ~~~LG~--G~~g~Vy~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~  104 (394)
                      .+.+|+  |.+|.||.+..  ..++..+|+|.-+...  ..+....+=++|+...+.++ |+|.++.+..|.  ....++
T Consensus       119 ~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~--s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e--~~~~lf  194 (524)
T KOG0601|consen  119 SSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF--SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE--GSGILF  194 (524)
T ss_pred             ccccccCCCCCceeecccCCcccCCcccccccccCCC--CCccccccccchhhcccccCccccccccCcccc--cCCcce
Confidence            467999  99999999988  8889999998733221  12233344456888888885 999999999884  445788


Q ss_pred             EEEcccCCCcHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          105 MITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILR----GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~-l~~~~~~~i~~qil~----~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      +-+|+| +.+|..+...... ++...++..+.+...    ||.++|+.+  ++|-|+||+||+...+....+++|||+..
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~  271 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVS  271 (524)
T ss_pred             eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeE
Confidence            899999 5788888776655 899999999999999    999999999  99999999999998443889999999998


Q ss_pred             eecCCCCcc-------cccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 016143          180 VMQQPTARS-------VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK  252 (394)
Q Consensus       180 ~~~~~~~~~-------~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  252 (394)
                      .+.......       ..|...|++||+.++-++...|||++|.+..+-.++..++....+..  +..+..+..+..+-.
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--W~~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--WSQLRQGYIPLEFCE  349 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC--ccccccccCchhhhc
Confidence            776654221       24777899999999999999999999999999999887765432111  111222223444444


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ..+..+...+..++. ++..|+++..+++++++...
T Consensus       350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             CcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            455677778888887 88999999999999998754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.57  E-value=8.3e-16  Score=159.57  Aligned_cols=257  Identities=19%  Similarity=0.326  Sum_probs=200.6

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      .+-+-+|+++.++.+.-..+|...++|......... ....+....+-.++-...+|.++...-.+  ......+++++|
T Consensus       809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~-~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L~~~~  885 (1205)
T KOG0606|consen  809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR-TNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPLVGHY  885 (1205)
T ss_pred             cccccCCCCcccccCCccccccccchhhhccchhhc-cccccccCCccCccccCCCCceecccCCC--CCCCCcchhhHH
Confidence            356788999999999877777666666554433222 22344455565666666778888776654  334568889999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec-------
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-------  182 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~-------  182 (394)
                      ..+++|...+.+-+..+++.++.++..+..+++|||+..  +.|||++|+|++.. .++..++.|||......       
T Consensus       886 ~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  886 LNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             hccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCccccccccccccCcCC
Confidence            999999999999888999999999999999999999987  99999999999998 88999999998431110       


Q ss_pred             C------------------C--------CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHH
Q 016143          183 Q------------------P--------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA  235 (394)
Q Consensus       183 ~------------------~--------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~  235 (394)
                      .                  .        ......||+.|.+||.+.+ .....+|+|+.|++++|.++|..||.. ..+.
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~tpq 1041 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-ETPQ 1041 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-cchh
Confidence            0                  0        0113468999999996654 578999999999999999999999987 7778


Q ss_pred             HHHHHHhcCCC-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHH---HHhcCCccccCCCCCcc
Q 016143          236 QIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPAL---ELLKDPFLVTDNPKDLV  293 (394)
Q Consensus       236 ~~~~~i~~~~~-~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~---elL~~p~~~~~~~~~~~  293 (394)
                      +++..+..+.. .+.-+...++++++++.+.|. ++.+|..+.   ++-.|+||+...|..+.
T Consensus      1042 ~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred             hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccc
Confidence            88877766533 333445568899999999998 899999987   89999999998876543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.49  E-value=8.1e-13  Score=132.42  Aligned_cols=169  Identities=25%  Similarity=0.315  Sum_probs=128.2

Q ss_pred             EEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhC
Q 016143           43 KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH  122 (394)
Q Consensus        43 ~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~  122 (394)
                      .|..+.++.+|.+...+....    +..+...+-++.|+.|+||||+++++.+..  ...+|+|+|-+.  .|..++++.
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~--Pl~~~lk~l  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVR--PLETVLKEL  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccc--cHHHHHHHh
Confidence            467778899999888765432    445667778899999999999999998854  458999999985  688888775


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC--cccccCCcccCccc
Q 016143          123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPEL  200 (394)
Q Consensus       123 ~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~--~~~~gt~~y~aPE~  200 (394)
                      +   ...+..-+.||+.||.|||..+ .++|++|.-+.|+|+ ..|..||++|.++........  ....---.|..|+.
T Consensus       102 ~---~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~  176 (690)
T KOG1243|consen  102 G---KEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE  176 (690)
T ss_pred             H---HHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence            4   6667778899999999998443 399999999999999 789999999998865444331  22222223555553


Q ss_pred             ccccCCCcCcchhhhhHHHHHHhcC
Q 016143          201 YEEEYNELVDIYSFGMCILEMVTCE  225 (394)
Q Consensus       201 l~~~~~~~~DIwSlG~il~elltg~  225 (394)
                      .... .-..|.|-|||++++++.|.
T Consensus       177 ~~~s-~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  177 IDPS-EWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cCcc-ccchhhhhHHHHHHHHhCcc
Confidence            3221 13579999999999999993

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.47  E-value=7.4e-14  Score=141.32  Aligned_cols=142  Identities=14%  Similarity=0.158  Sum_probs=94.3

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeecccc--------------------------CCH----HHHHHHHH-----
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--------------------------QSP----DQLERLYS-----   75 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~--------------------------~~~----~~~~~~~~-----   75 (394)
                      +.||+|++|+||+|..+.+|+.||||+.+..-..                          +-.    +..+.+.+     
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            6899999999999999888999999998643100                          000    11222333     


Q ss_pred             -HHHHHHcCC----CCCceeEeeeEEcCCCceEEEEEcccCCCcHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHH
Q 016143           76 -EVHLLKSLK----HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHK----NVDMKAIKNWARQILRGLHYL  144 (394)
Q Consensus        76 -E~~~l~~L~----hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~--i~~~~----~l~~~~~~~i~~qil~~L~~L  144 (394)
                       |+..+.+++    +.+.+.+-..|.+-. ...++||||++|+++.++  +...+    .+.+..+..++.|++      
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s-t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYC-SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccC-CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH------
Confidence             443443332    333333333332212 235689999999999874  33333    255555666667765      


Q ss_pred             HhCCCCeEecCCCCCcEEEeCCCC----cEEEcccceeeeecC
Q 016143          145 HSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVMQQ  183 (394)
Q Consensus       145 H~~~~~ivHrDLkp~NIll~~~~~----~~kl~Dfgla~~~~~  183 (394)
                       ..|  ++|+|+||.||+++ .+|    +++++|||++..+..
T Consensus       278 -~~G--ffHaDpHPGNIlv~-~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -RDG--FFHADMHPGNIFVS-YDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -hCC--eeeCCCChHHeEEe-cCCCCCCeEEEEecceEEECCH
Confidence             367  99999999999998 555    999999999976644

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=5.2e-13  Score=133.32  Aligned_cols=145  Identities=21%  Similarity=0.198  Sum_probs=96.9

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCH--------------------------H----HHH------HHH
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--------------------------D----QLE------RLY   74 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~--------------------------~----~~~------~~~   74 (394)
                      +.||+|++|.||+|.. .+|+.||||+.+..-...-.                          +    ...      .+.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5799999999999986 47999999987543100000                          0    000      234


Q ss_pred             HHHHHHHcC----CCCCceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 016143           75 SEVHLLKSL----KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILR-GLHYLHSHN  148 (394)
Q Consensus        75 ~E~~~l~~L----~hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~-~L~~LH~~~  148 (394)
                      +|.+.+.++    +|.+-+.+-..+.+-. ..-++||||++|++|.++.... ...+   ...++.+++. .+..+|..|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence            456555555    2333344333332222 2357899999999998876532 1232   3445566655 467789999


Q ss_pred             CCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       149 ~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                        ++|+|+||.||+++ .+++++++|||++..+..
T Consensus       278 --~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       278 --FFHADLHPGNIFVL-KDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             --ceeCCCCcccEEEC-CCCcEEEEeCCCeeECCH
Confidence              99999999999998 678999999999866543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.41  E-value=3.8e-12  Score=112.78  Aligned_cols=144  Identities=16%  Similarity=0.156  Sum_probs=103.3

Q ss_pred             ceecccCceEEEEEEEcc------CCeEEEEEEeeeccc--cC-------C---------HHHHHHHH----HHHHHHHc
Q 016143           31 EILGKGAFKTVYKGFDEV------DGIEVAWNQVNIEDV--MQ-------S---------PDQLERLY----SEVHLLKS   82 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~------~~~~vaiK~i~~~~~--~~-------~---------~~~~~~~~----~E~~~l~~   82 (394)
                      ..||.|--+.||.|....      .+..+|+|+.+....  .+       +         ......+.    +|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999997643      357999998764321  00       0         11222333    79999999


Q ss_pred             CC--CCCceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEecCCCCC
Q 016143           83 LK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCD  159 (394)
Q Consensus        83 L~--hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~L-H~~~~~ivHrDLkp~  159 (394)
                      |.  .-++.+.+++    ..  -++||||+.++.+..-.-+...++..++..+..|++.+|..| |+.|  ++|+||++.
T Consensus        83 l~~~Gv~vP~pi~~----~~--~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~  154 (197)
T cd05146          83 MQKAGIPCPEVVVL----KK--HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY  154 (197)
T ss_pred             HHHcCCCCCeEEEe----cC--CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence            95  3566677763    12  346999997654432222223466677888899999999998 8999  999999999


Q ss_pred             cEEEeCCCCcEEEcccceeeeecCC
Q 016143          160 NIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       160 NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      ||+++  ++.+.|+|||.+.....+
T Consensus       155 NIL~~--~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         155 NMLWH--DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             HEEEE--CCcEEEEECCCceeCCCC
Confidence            99997  468999999988766554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.38  E-value=1.8e-12  Score=112.46  Aligned_cols=128  Identities=20%  Similarity=0.054  Sum_probs=93.1

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCce-eEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII-KFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv-~~~~~~~~~~~~~~~lV~e~  109 (394)
                      +.|+.|.++.||++...  +..|++|.......     ....+..|+.+++.+.+.+++ +++...  ...  -++||||
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~--~~lv~e~   72 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFD--PET--GVLITEF   72 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCC--CeEEEEe
Confidence            56889999999999754  78899998643221     112356799999988655544 454432  322  3579999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP---PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~---~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ++|.++...        ......++.+++.+|..||+.+.   .++|+|++|.||+++  ++.++++|||.+.
T Consensus        73 i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~  135 (170)
T cd05151          73 IEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG  135 (170)
T ss_pred             cCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence            999888643        11123567899999999999871   149999999999998  4689999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=6.5e-13  Score=131.76  Aligned_cols=244  Identities=20%  Similarity=0.169  Sum_probs=172.7

Q ss_pred             ccceecccCceEEEEEEEc-cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEEE
Q 016143           29 YDEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        29 ~~~~LG~G~~g~Vy~a~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      ....||.|.|+.|+..... .++..|++|.....- .. ......-+.|+.+...+ -|.+++.++..|....+  .|+=
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~-~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--~~ip  344 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-AT-FASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--GYIP  344 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhccc-cc-hHhhhcchhhhhHhhHhhcccccCCCCCCcccccc--ccCc
Confidence            3577999999999987644 677888888764322 22 22223345688888777 49999999999865544  4467


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA  186 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~  186 (394)
                      .|||+++++...+.--..+++...+.+..|++.++.++|+..  ++|+|+||+||++..+++..+++|||.++.+.-...
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~  422 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG  422 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccceecc
Confidence            799999998887755566889999999999999999999999  999999999999983347889999999965322211


Q ss_pred             cccccCCccc-Ccccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          187 RSVIGTPEFM-APELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       187 ~~~~gt~~y~-aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                       ...++-+++ .+|++..  .+..++|++|||..+++..++...-..    .+....+.++..+. .+... .++..+.+
T Consensus       423 -~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----~~~~~~i~~~~~p~-~~~~~-~~~q~~~k  495 (524)
T KOG0601|consen  423 -VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----GVQSLTIRSGDTPN-LPGLK-LQLQVLLK  495 (524)
T ss_pred             -cccccccccccchhhccccccccccccccccccccccccCcccCcc----cccceeeecccccC-CCchH-Hhhhhhhh
Confidence             122334445 3555544  367899999999999999998743322    11223333443332 22222 56677777


Q ss_pred             HcCC-CCCCCCCHHHHhcCCccc
Q 016143          264 KCIV-PASLRLPALELLKDPFLV  285 (394)
Q Consensus       264 ~~L~-~p~~R~s~~elL~~p~~~  285 (394)
                      .++. ++..|+.+.++..|.-|.
T Consensus       496 v~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  496 VMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhcCCccccchhhhhhcccchhh
Confidence            7776 777888888888776554

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.27  E-value=5.6e-11  Score=102.03  Aligned_cols=146  Identities=21%  Similarity=0.250  Sum_probs=106.8

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccC----CHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~----~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      ..+|-+|+-+.|+++.+  .|+.+.||.=..+....    ..-...+..+|+++|.++.--.|.--.-+|+|...+.+  
T Consensus        12 l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i--   87 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI--   87 (229)
T ss_pred             ceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE--
Confidence            46788999999999975  58888887543332211    12234567889999999864444443334566766666  


Q ss_pred             EEcccCC-CcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE--EEcccceeee
Q 016143          106 ITELFTS-GSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV--KIGDLGLAIV  180 (394)
Q Consensus       106 V~e~~~~-gsL~~~i~~~~~--l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~--kl~Dfgla~~  180 (394)
                      +|||++| .++.+++.....  ........++++|-..+.-||.++  |+|+||..+||++..+++.+  .++|||++..
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence            6699976 478888876532  333334789999999999999999  99999999999998666655  8999999854


Q ss_pred             e
Q 016143          181 M  181 (394)
Q Consensus       181 ~  181 (394)
                      .
T Consensus       166 s  166 (229)
T KOG3087|consen  166 S  166 (229)
T ss_pred             c
Confidence            3

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=1.2e-10  Score=100.36  Aligned_cols=132  Identities=23%  Similarity=0.357  Sum_probs=95.4

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHH-----HHHHHHHHHHHHHcCCCC--CceeEeeeEEcCCCceE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD-----QLERLYSEVHLLKSLKHE--NIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~-----~~~~~~~E~~~l~~L~hp--nIv~~~~~~~~~~~~~~  103 (394)
                      ..+++|+-+.+|.+..  -|..+++|. .+.+....++     ..++..+|++++.+++--  +...+|+  +|..+.. 
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d--vD~~~~~-   75 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD--VDPDNGL-   75 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE--EcCCCCE-
Confidence            4678999999999854  355555554 3333333333     234567799999998644  3344555  5565544 


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                       |+|||++|-.|.+++...   .    ..+++.+-.-+.-||..|  |+|+||.++||++.  ++.+.++|||++..
T Consensus        76 -I~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~--~~~i~~IDfGLg~~  140 (204)
T COG3642          76 -IVMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAG--IVHGDLTTSNIILS--GGRIYFIDFGLGEF  140 (204)
T ss_pred             -EEEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcC--eecCCCccceEEEe--CCcEEEEECCcccc
Confidence             588999999999898876   2    445566666677799999  99999999999997  45699999999953

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.23  E-value=2.7e-10  Score=111.36  Aligned_cols=214  Identities=18%  Similarity=0.251  Sum_probs=153.3

Q ss_pred             CceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC--CCceEEEEEcccCC-C
Q 016143           37 AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TNRTINMITELFTS-G  113 (394)
Q Consensus        37 ~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~--~~~~~~lV~e~~~~-g  113 (394)
                      --.+.|+|+...+|..|++|.++..... ..   .....-++.++++.|+|+|++.++|...  ....+.+|++|.++ +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQ-ST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeecccccc-Cc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            3457899999999999999998543321 11   1233468899999999999999988633  34579999999875 5


Q ss_pred             cHHHHH---------------HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          114 SLRQYR---------------KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       114 sL~~~i---------------~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      +|.++-               ..+.+.++..+|.++.||..||.++|+.|  +.-+-|.|.+|++++ +.+++|...|+.
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G-~~RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTG-KMRIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeC-cceEEEecccce
Confidence            776652               12345889999999999999999999999  888999999999994 459999999988


Q ss_pred             eeecCCCCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHH-HHHHhcCCCCCCCCCCCCHH
Q 016143          179 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~  257 (394)
                      -++.......            ++  --.+-|.=.||.+++.|.||..--.......+. .+.+.         ..++.+
T Consensus       441 Dvl~~d~~~~------------le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~---------~~yS~D  497 (655)
T KOG3741|consen  441 DVLQEDPTEP------------LE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT---------TTYSTD  497 (655)
T ss_pred             eeecCCCCcc------------hh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh---------hhhhHH
Confidence            7666554111            11  124568889999999999996442222222222 22332         234567


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          258 VKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++++|.-... .+.+ .++.++|.+
T Consensus       498 ~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  498 LRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHhcCccc-ccHHHHHHH
Confidence            8888887666 3443 677777654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.17  E-value=1.8e-10  Score=104.09  Aligned_cols=144  Identities=19%  Similarity=0.204  Sum_probs=105.2

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCC--CceeEeeeEEcCC-CceEEEEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNSWVDDT-NRTINMIT  107 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hp--nIv~~~~~~~~~~-~~~~~lV~  107 (394)
                      +.|+.|.++.||++... +|..+++|........   .....+.+|+.+++.+.+.  ++.+++.+..... ....++||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            66899999999999764 3688999987543321   1334677899999999753  4566666542211 12467999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN---------------------------------------  148 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~---------------------------------------  148 (394)
                      ||++|.++...+.. ..+++.+...++.+++.+|..||+..                                       
T Consensus        80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99999988776542 45778888888888888888888521                                       


Q ss_pred             ---------------CCeEecCCCCCcEEEeCC-CCcEEEcccceee
Q 016143          149 ---------------PPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAI  179 (394)
Q Consensus       149 ---------------~~ivHrDLkp~NIll~~~-~~~~kl~Dfgla~  179 (394)
                                     ..++|+|++|.||+++.+ ++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                           236999999999999843 4668999998774

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=4.4e-09  Score=92.85  Aligned_cols=132  Identities=27%  Similarity=0.299  Sum_probs=85.7

Q ss_pred             EEEEEEEccCCeEEEEEEeeeccccC----------------------CHHHHHHHHHHHHHHHcCCCC--CceeEeeeE
Q 016143           40 TVYKGFDEVDGIEVAWNQVNIEDVMQ----------------------SPDQLERLYSEVHLLKSLKHE--NIIKFYNSW   95 (394)
Q Consensus        40 ~Vy~a~~~~~~~~vaiK~i~~~~~~~----------------------~~~~~~~~~~E~~~l~~L~hp--nIv~~~~~~   95 (394)
                      .||.|.. .+|..+|+|+.+.....-                      .........+|.+.|.++..-  ++.+.+++-
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899976 578899999876531100                      011234567899999999755  566777532


Q ss_pred             EcCCCceEEEEEcccC--CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 016143           96 VDDTNRTINMITELFT--SGSLRQYRKKHKNVDMKAIKNWARQILRGLHY-LHSHNPPIIHRDLKCDNIFVNGNNGEVKI  172 (394)
Q Consensus        96 ~~~~~~~~~lV~e~~~--~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~-LH~~~~~ivHrDLkp~NIll~~~~~~~kl  172 (394)
                        +  .  .+||||++  |..+..+....  ++.+....++.+++..+.. +|+.|  |+|+||.+.||+++ + +.+.|
T Consensus        80 --~--~--~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~-~-~~~~i  147 (188)
T PF01163_consen   80 --R--N--VIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVD-D-GKVYI  147 (188)
T ss_dssp             --T--T--EEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEE-T-TCEEE
T ss_pred             --C--C--EEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEee-c-ceEEE
Confidence              2  2  36999998  66666554432  2245567788888886655 57999  99999999999998 3 49999


Q ss_pred             cccceeeeecCC
Q 016143          173 GDLGLAIVMQQP  184 (394)
Q Consensus       173 ~Dfgla~~~~~~  184 (394)
                      +|||.+.....+
T Consensus       148 IDf~qav~~~~p  159 (188)
T PF01163_consen  148 IDFGQAVDSSHP  159 (188)
T ss_dssp             --GTTEEETTST
T ss_pred             EecCcceecCCc
Confidence            999988765543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.98  E-value=1.4e-08  Score=97.38  Aligned_cols=243  Identities=19%  Similarity=0.238  Sum_probs=154.5

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeE---
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW---   95 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~---   95 (394)
                      .|++|--...++.||+|+-+.+|..-.  -+..|| |+......    ....+   .+..|... .||-+-. --.|   
T Consensus         6 ~~~~ge~i~~gr~LgqGgea~ly~l~e--~~d~VA-KIYh~Ppp----a~~aq---k~a~la~~p~~p~~~~-rvaWPqa   74 (637)
T COG4248           6 YDVYGEPIPPGRPLGQGGEADLYTLGE--VRDQVA-KIYHAPPP----AAQAQ---KVAELAATPDAPLLNY-RVAWPQA   74 (637)
T ss_pred             ccccCcccCCCccccCCccceeeecch--hhchhh-eeecCCCc----hHHHH---HHHHhccCCCCcchhh-hhcccHH
Confidence            344444445678899999999997532  233344 66654332    11111   22333333 4664322 1111   


Q ss_pred             ---EcCCCceEEEEEcccCCCcH-------HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 016143           96 ---VDDTNRTINMITELFTSGSL-------RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG  165 (394)
Q Consensus        96 ---~~~~~~~~~lV~e~~~~gsL-------~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~  165 (394)
                         -.+....+.++|..+.|..-       ....+.....++.-+.+.++.|+.+.+.||.+|  .+-+|+.++|+||+ 
T Consensus        75 ~L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-  151 (637)
T COG4248          75 TLHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-  151 (637)
T ss_pred             HhhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-
Confidence               11233347788888876421       111223345888999999999999999999999  99999999999998 


Q ss_pred             CCCcEEEcccceeeeecCC-CCcccccCCcccCccccc-c-----cCCCcCcchhhhhHHHHHHhc-CCCCCCCC-----
Q 016143          166 NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-E-----EYNELVDIYSFGMCILEMVTC-EYPYNECK-----  232 (394)
Q Consensus       166 ~~~~~kl~Dfgla~~~~~~-~~~~~~gt~~y~aPE~l~-~-----~~~~~~DIwSlG~il~elltg-~~Pf~~~~-----  232 (394)
                      +++.+.|.|=..-....+. .....+|.++|.+||+-. +     +-+...|-|-||+++++++.| +.||++-.     
T Consensus       152 d~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a  231 (637)
T COG4248         152 DDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA  231 (637)
T ss_pred             cCceEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence            7889999886544333222 334457999999999644 2     346789999999999999986 99997621     


Q ss_pred             -CHHH--H------H-HHHhcCCCC--CCC-CCCCCHHHHHHHHHcCCC---CCCCCCHH
Q 016143          233 -NPAQ--I------Y-KKVTSGIKP--ASL-SKVTDPQVKQFIEKCIVP---ASLRLPAL  276 (394)
Q Consensus       233 -~~~~--~------~-~~i~~~~~~--~~~-~~~~~~~~~~li~~~L~~---p~~R~s~~  276 (394)
                       ++-+  +      + ..-..+.+|  .++ ....++.+..++.+|+.+   +.-||++.
T Consensus       232 p~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         232 PNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             CCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence             1111  1      0 011122222  222 234578999999999974   55899865

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.92  E-value=4.1e-08  Score=91.70  Aligned_cols=137  Identities=15%  Similarity=0.073  Sum_probs=92.1

Q ss_pred             eEEEEEEEccCCeEEEEEEeeecccc---CC----HHHHHHHHHHHHHHHcCCCCCc--eeEeeeEEcCC---CceEEEE
Q 016143           39 KTVYKGFDEVDGIEVAWNQVNIEDVM---QS----PDQLERLYSEVHLLKSLKHENI--IKFYNSWVDDT---NRTINMI  106 (394)
Q Consensus        39 g~Vy~a~~~~~~~~vaiK~i~~~~~~---~~----~~~~~~~~~E~~~l~~L~hpnI--v~~~~~~~~~~---~~~~~lV  106 (394)
                      ..|.+..  ..|+.|.+|........   +.    ......+.+|+..+..|..-+|  .+...+.....   ...-++|
T Consensus        36 rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         36 RRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             ceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            3355542  35677888865322210   00    0011136788888888843222  23333332211   2346789


Q ss_pred             EcccCCC-cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC------CCCcEEEcccce
Q 016143          107 TELFTSG-SLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------NNGEVKIGDLGL  177 (394)
Q Consensus       107 ~e~~~~g-sL~~~i~~--~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~------~~~~~kl~Dfgl  177 (394)
                      ||++++. +|.+++..  ....+......++.+++..+.-||.+|  |+|+||++.|||++.      ++..+.++||+.
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            9999876 89999864  244667788899999999999999999  999999999999973      246899999998


Q ss_pred             ee
Q 016143          178 AI  179 (394)
Q Consensus       178 a~  179 (394)
                      +.
T Consensus       192 ~~  193 (268)
T PRK15123        192 AQ  193 (268)
T ss_pred             cc
Confidence            74

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.82  E-value=2.7e-09  Score=107.88  Aligned_cols=151  Identities=19%  Similarity=0.297  Sum_probs=108.1

Q ss_pred             HHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC-----------cccccCCcccCccccccc-C
Q 016143          138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----------RSVIGTPEFMAPELYEEE-Y  205 (394)
Q Consensus       138 l~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~-----------~~~~gt~~y~aPE~l~~~-~  205 (394)
                      ..||.|+|.+- ++||+.|.|++|.++ .++.+||+.|+++.......-           ....-...|.|||.+... .
T Consensus       109 ~dgl~flh~sA-k~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  109 ADGLAFLHRSA-KVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cchhhhhccCc-ceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            38999999873 699999999999999 789999999999854444210           011234589999976654 6


Q ss_pred             CCcCcchhhhhHHHHHH-hcCCCCCCCCCHHHH-HHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCC
Q 016143          206 NELVDIYSFGMCILEMV-TCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  282 (394)
Q Consensus       206 ~~~~DIwSlG~il~ell-tg~~Pf~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p  282 (394)
                      +.++|++|+|+++|.+. .|+.-+........- ......+..........++++++-+.+++. ++..||++.+++..|
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~  266 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP  266 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence            78999999999999998 555555442221111 111111111222346677899999999997 899999999999999


Q ss_pred             ccccCCCC
Q 016143          283 FLVTDNPK  290 (394)
Q Consensus       283 ~~~~~~~~  290 (394)
                      ||.....+
T Consensus       267 ff~D~~~~  274 (700)
T KOG2137|consen  267 FFSDPGLK  274 (700)
T ss_pred             ccCCchhh
Confidence            99875443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.77  E-value=1.2e-07  Score=85.20  Aligned_cols=109  Identities=21%  Similarity=0.208  Sum_probs=83.4

Q ss_pred             HHHHHHHHHHHHcCCCCC--ceeEeeeEEcCC--CceEEEEEcccCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 016143           70 LERLYSEVHLLKSLKHEN--IIKFYNSWVDDT--NRTINMITELFTSG-SLRQYRKKHKNVDMKAIKNWARQILRGLHYL  144 (394)
Q Consensus        70 ~~~~~~E~~~l~~L~hpn--Iv~~~~~~~~~~--~~~~~lV~e~~~~g-sL~~~i~~~~~l~~~~~~~i~~qil~~L~~L  144 (394)
                      ..+..+|...+..|..-.  ..+.+.+.....  ....++|||++++. +|.+++......+......++.++...+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            345777888888775322  333444333221  23457899999874 8999998866678888999999999999999


Q ss_pred             HhCCCCeEecCCCCCcEEEeCCCC---cEEEcccceeeee
Q 016143          145 HSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDLGLAIVM  181 (394)
Q Consensus       145 H~~~~~ivHrDLkp~NIll~~~~~---~~kl~Dfgla~~~  181 (394)
                      |.+|  |+|+|+++.|||++ .++   .+.++||+-+...
T Consensus       135 H~~g--i~H~Dl~~~NILv~-~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAG--IYHGDLNPSNILVD-PDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCc--CCCCCCCcccEEEe-CCCCceeEEEEcchhceeC
Confidence            9999  99999999999998 444   7999999977543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.77  E-value=2.6e-09  Score=106.91  Aligned_cols=237  Identities=19%  Similarity=0.242  Sum_probs=157.3

Q ss_pred             ccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCC-ceeEeeeEEcCCCceEEEEE
Q 016143           29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        29 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpn-Iv~~~~~~~~~~~~~~~lV~  107 (394)
                      +-.-+++|+++++++++...+...+ .+++...         ....-++++|.+++||| .+..++.+  +.+.+.++++
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i~~  313 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWIPM  313 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--Ccccccchhh
Confidence            3355889999999999877666555 5655422         23344889999999999 55555544  4456888999


Q ss_pred             cccCCC-cHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          108 ELFTSG-SLRQYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       108 e~~~~g-sL~~~i-~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      +++.++ +-...+ .....+..-+.....+.-.++|+++|+..  =+|||    ||+..  .+..+.+||+.+..+... 
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s--~~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGS--EEEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccccc--ccccccccccCCcccCccc
Confidence            999877 221111 11112334445556666778899999874  58888    88775  578999999998766655 


Q ss_pred             CCcccccCCcccCcccc-cccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CCCCCC-CCCCHHH-HH
Q 016143          185 TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-KPASLS-KVTDPQV-KQ  260 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l-~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~-~~~~~~-~~~~~~~-~~  260 (394)
                      ..++..+|+.++|||+. .+.+....|.|++|.--.+|.-|.+|-..   +......+-.+. .+.... ..+++.. ++
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~  462 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVLPMIGNGPNSPMLTDKSAWSPVFHRD  462 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC---CccccCCCCCCCCccccchhhhcCcccccC
Confidence            45667899999999955 45699999999999988888888877543   110001111111 000000 0111111 24


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          261 FIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +...|+. .|..++....++.|.+|..-.
T Consensus       463 ~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  463 FPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             CcccccCCCCCCCcchhhHHHHHHhccCc
Confidence            6677887 788899999999998887643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.74  E-value=4.2e-08  Score=89.64  Aligned_cols=139  Identities=22%  Similarity=0.223  Sum_probs=99.8

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccc-----cC-----------C--HHHHHHHHHHHHHHHcCCCC-
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV-----MQ-----------S--PDQLERLYSEVHLLKSLKHE-   86 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~-----~~-----------~--~~~~~~~~~E~~~l~~L~hp-   86 (394)
                      ...++..||-|--+.||.|.+. .|.++|+|.-+....     ..           +  .-......+|..+|..|.-. 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            3467789999999999999875 789999996433210     00           0  01233466899999999654 


Q ss_pred             -CceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 016143           87 -NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG  165 (394)
Q Consensus        87 -nIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~  165 (394)
                       .+.+.+++      +.-.+||||++|-.|....     ++.+....++..|+.-+.-+-..|  ++|+|+++-||+++ 
T Consensus       171 ~~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~-  236 (304)
T COG0478         171 VKVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVT-  236 (304)
T ss_pred             CCCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEe-
Confidence             67777662      1335799999998876543     234455566666666666666677  99999999999999 


Q ss_pred             CCCcEEEcccceee
Q 016143          166 NNGEVKIGDLGLAI  179 (394)
Q Consensus       166 ~~~~~kl~Dfgla~  179 (394)
                      ++|.+.++||--+.
T Consensus       237 ~dg~~~vIDwPQ~v  250 (304)
T COG0478         237 EDGDIVVIDWPQAV  250 (304)
T ss_pred             cCCCEEEEeCcccc
Confidence            78899999996553

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.56  E-value=2e-07  Score=99.32  Aligned_cols=205  Identities=22%  Similarity=0.353  Sum_probs=146.0

Q ss_pred             HHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce--EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 016143           68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT--INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH  145 (394)
Q Consensus        68 ~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~--~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH  145 (394)
                      ..+....-|...+.++.|+|++.++.+-.......  +.+..++|...++...++.-+.++.+.++.+..++++||.|+|
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            34444556778888889999999998776543222  3356789999999999999999999999999999999999999


Q ss_pred             hCCCCeEecCCCCC---cEEEeCCCCcEEEc--ccceeeeecCCC-CcccccCCcccCccccccc-C--CCcCcchhhhh
Q 016143          146 SHNPPIIHRDLKCD---NIFVNGNNGEVKIG--DLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE-Y--NELVDIYSFGM  216 (394)
Q Consensus       146 ~~~~~ivHrDLkp~---NIll~~~~~~~kl~--Dfgla~~~~~~~-~~~~~gt~~y~aPE~l~~~-~--~~~~DIwSlG~  216 (394)
                      +..  ..|.-|...   +.-.+ ..+.+.++  ||+.+..+.... .....-+..+.|||.+... +  ....|+|++|.
T Consensus       304 ~~~--l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  304 SLS--LEHVVLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             Hhc--cceeEEecccccccccC-ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence            986  666555444   33333 23456666  888776554443 2233446678888876644 3  34579999999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC-CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       217 il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ....+..|..+-.....             +..+ +.....+..++..+|+. ++++|+++.++|.|+|.+...
T Consensus       381 l~~~~~~~~~i~~~~~~-------------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAV-------------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             HHhhhhhcCcccccccc-------------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence            99999988655322111             1111 11122267888999997 899999999999999998654

>PRK09902 hypothetical protein; Provisional

Probab=98.52  E-value=2.4e-06  Score=76.30  Aligned_cols=141  Identities=15%  Similarity=0.152  Sum_probs=97.3

Q ss_pred             cccCceEEEEEEEccCCeEEEEEEee--eccccCCHHHHHHHHHHHHHHHcCCCC--CceeEe--eeEEcCCCceEEEEE
Q 016143           34 GKGAFKTVYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFY--NSWVDDTNRTINMIT  107 (394)
Q Consensus        34 G~G~~g~Vy~a~~~~~~~~vaiK~i~--~~~~~~~~~~~~~~~~E~~~l~~L~hp--nIv~~~--~~~~~~~~~~~~lV~  107 (394)
                      |+||-+.|+....  .|..+-+|.-.  ......-+.-...+.+|+..++.|..-  .+.+..  +.-.......-++|+
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            4688888988653  34467777642  111111133456788999999998532  233333  111122233467899


Q ss_pred             cccCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc--EEEcccceee
Q 016143          108 ELFTS-GSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAI  179 (394)
Q Consensus       108 e~~~~-gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~--~kl~Dfgla~  179 (394)
                      |-+.+ -+|.+++...  .+.+......++.++...+.-||+.|  +.|+|+.+.||+++ .+|.  ++++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~-~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVK-TEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeec-CCCCeeEEEEEhhccc
Confidence            97643 6899888764  34577788899999999999999999  99999999999997 3456  9999997553

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.49  E-value=7.7e-07  Score=90.03  Aligned_cols=145  Identities=14%  Similarity=0.144  Sum_probs=90.8

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeecccc--------------------------CCHHH----HHH------HH
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--------------------------QSPDQ----LER------LY   74 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~--------------------------~~~~~----~~~------~~   74 (394)
                      +.|+.++-|.||+|..+ +|+.||||+.+..-..                          .-.+.    .++      +.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67999999999999875 5999999976532100                          00011    111      23


Q ss_pred             HHHHHHHcCC-----CCCceeEeeeEEcCCCceEEEEEcccCCCcHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 016143           75 SEVHLLKSLK-----HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSH  147 (394)
Q Consensus        75 ~E~~~l~~L~-----hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~--i~~~~~l~~~~~~~i~~qil~~L~~LH~~  147 (394)
                      +|...+.+++     .++ +.+=..|.+-+. .-.++|||++|..+.+.  ++. .+++.+.+.....++..---+-  .
T Consensus       210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~-~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~~--d  284 (517)
T COG0661         210 REAANAERFRENFKDDPD-VYVPKVYWEYTT-RRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLLR--D  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCC-eEeceeehhccC-CcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHHh--c
Confidence            3444454442     233 222222222122 24579999999999887  444 4466555544444433322222  4


Q ss_pred             CCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       148 ~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |  ++|.|.+|.||+++ .+|++.+.|||+...+...
T Consensus       285 g--ffHaDpHpGNi~v~-~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 G--FFHADPHPGNILVR-SDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             C--ccccCCCccceEEe-cCCcEEEEcCcceecCCHH
Confidence            7  99999999999999 6799999999998665543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.37  E-value=1.1e-05  Score=73.00  Aligned_cols=140  Identities=22%  Similarity=0.258  Sum_probs=80.3

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCC--CceeEeeeEEcC-CCceEEEEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNSWVDD-TNRTINMIT  107 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hp--nIv~~~~~~~~~-~~~~~~lV~  107 (394)
                      +.|+.|..+.||+.....  ..+++|....      ......+.+|..+++.|...  .+.+++...... .....+++|
T Consensus         3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRP------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEESSSSEEEEEEETT--SEEEEEEESS------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC--cEEEEEEeCC------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            578999999999997654  4888888642      23456677898998888533  345666533222 234578999


Q ss_pred             cccCCCcHHH----------------HHH---hC----CCCCHHH---------HHHH------------HHHHHH-HHH
Q 016143          108 ELFTSGSLRQ----------------YRK---KH----KNVDMKA---------IKNW------------ARQILR-GLH  142 (394)
Q Consensus       108 e~~~~gsL~~----------------~i~---~~----~~l~~~~---------~~~i------------~~qil~-~L~  142 (394)
                      ++++|.++..                .+.   ..    ..+....         ....            ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999988877                111   11    1111000         0000            011111 222


Q ss_pred             HHHh-----CCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          143 YLHS-----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       143 ~LH~-----~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      .+++     ....++|+|+.|.||+++..++.+-|+||+.+
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a  195 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA  195 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence            3322     22349999999999999855667789999866

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.29  E-value=7.2e-06  Score=74.86  Aligned_cols=135  Identities=13%  Similarity=0.126  Sum_probs=77.5

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCC--ceeEeeeEEcCCCceEEEEEc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpn--Iv~~~~~~~~~~~~~~~lV~e  108 (394)
                      +.||+|..+.||+.    .|..+++|......      ....+.+|.++++.+..-.  +.+.+.+.  +......+|||
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeee
Confidence            57899999999984    24567788764211      1234577999998886433  35556544  23345678999


Q ss_pred             ccCCCc-HH--------------HHHHh-----CC----CCCHHH-HHHHHHH----------HHHH-HHHH--HhCCCC
Q 016143          109 LFTSGS-LR--------------QYRKK-----HK----NVDMKA-IKNWARQ----------ILRG-LHYL--HSHNPP  150 (394)
Q Consensus       109 ~~~~gs-L~--------------~~i~~-----~~----~l~~~~-~~~i~~q----------il~~-L~~L--H~~~~~  150 (394)
                      +++|.+ +.              ..+.+     |.    ..+... ...+..+          +... ..+|  +...+.
T Consensus        75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            999863 11              11110     10    111111 0111111          1111 1112  222334


Q ss_pred             eEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       151 ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ++|+|+.|.||+++ +++ +.|+||+.+.
T Consensus       155 ~~HgD~~~~Nii~~-~~~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITS-GKG-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEc-CCC-cEEEechhcC
Confidence            78999999999998 555 9999998773

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.24  E-value=9.9e-06  Score=72.66  Aligned_cols=67  Identities=22%  Similarity=0.346  Sum_probs=52.3

Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ..+|+|||++|..|.++..    +++    .+...|..++.-||+.|  +.|+|.+|.|++++  ++.++++||+....
T Consensus       117 ~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~--~~~i~iID~~~k~~  183 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS--NNGIRIIDTQGKRM  183 (229)
T ss_pred             EEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE--CCcEEEEECccccc
Confidence            4568999999988876532    232    24456777889999999  99999999999997  45699999976543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.21  E-value=1.3e-05  Score=72.87  Aligned_cols=142  Identities=19%  Similarity=0.199  Sum_probs=94.4

Q ss_pred             eecccCceEEEEEEEccCCeEEEEEEeeeccccCC------------------HHHH--HHHHHHHHHHHcCC--CCCce
Q 016143           32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS------------------PDQL--ERLYSEVHLLKSLK--HENII   89 (394)
Q Consensus        32 ~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~------------------~~~~--~~~~~E~~~l~~L~--hpnIv   89 (394)
                      .|++|--++||+|.. .++..+|+|++........                  ...+  .-..+|+..|+++.  +=.+.
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            566777889999965 5788999998865432110                  0000  11335888888874  44444


Q ss_pred             eEeeeEEcCCCceEEEEEcccCCCcHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCC
Q 016143           90 KFYNSWVDDTNRTINMITELFTSGSLR-QYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNN  167 (394)
Q Consensus        90 ~~~~~~~~~~~~~~~lV~e~~~~gsL~-~~i~~~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~  167 (394)
                      +-+.+.  +    -.+||||+....+. -.++. -++..+++..+..+++..+.-|-. .+  +||+||+.-|||+.  .
T Consensus       134 ~Pi~~~--~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~--~  202 (268)
T COG1718         134 EPIAFR--N----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH--D  202 (268)
T ss_pred             Cceeec--C----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE--C
Confidence            555543  1    24689999543111 11111 123444788888999999988866 67  99999999999997  6


Q ss_pred             CcEEEcccceeeeecCCC
Q 016143          168 GEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       168 ~~~kl~Dfgla~~~~~~~  185 (394)
                      +.+.|+|||-|.....+.
T Consensus       203 ~~p~iID~~QaV~~~hp~  220 (268)
T COG1718         203 GEPYIIDVSQAVTIDHPN  220 (268)
T ss_pred             CeEEEEECccccccCCCc
Confidence            799999999887665543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.17  E-value=1.9e-05  Score=72.72  Aligned_cols=78  Identities=15%  Similarity=0.100  Sum_probs=49.1

Q ss_pred             cccceecccCc-eEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEE
Q 016143           28 RYDEILGKGAF-KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        28 r~~~~LG~G~~-g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      |+.. |..|.. +.||+....  +..+.+|......       ...+.+|+++++.+. +--+.+++.+....  ..-++
T Consensus         2 ~~~~-~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~l   69 (244)
T cd05150           2 RWER-VTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWL   69 (244)
T ss_pred             ccee-cCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEE
Confidence            4433 444555 789998643  4567777654221       234567888888884 44455677655333  35678


Q ss_pred             EEcccCCCcHHH
Q 016143          106 ITELFTSGSLRQ  117 (394)
Q Consensus       106 V~e~~~~gsL~~  117 (394)
                      |||+++|.+|..
T Consensus        70 v~e~i~G~~l~~   81 (244)
T cd05150          70 LTSAVPGVPAAA   81 (244)
T ss_pred             EEEeeCCccHhH
Confidence            999999877764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.12  E-value=2.4e-07  Score=100.76  Aligned_cols=216  Identities=13%  Similarity=0.026  Sum_probs=146.9

Q ss_pred             HHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHH
Q 016143           68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHY  143 (394)
Q Consensus        68 ~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~----~~l~~~~~~~i~~qil~~L~~  143 (394)
                      ...+.+..|...++..+|+++...+.-..+.+....+..++|+.+|.++..+-++    ..++..-+.....+.+.+..-
T Consensus      1271 Plkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1271 PLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred             HHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccch
Confidence            3455667788888888999999888766555666678899999999999998765    345555666666666777777


Q ss_pred             HHhCC---CCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhH
Q 016143          144 LHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMC  217 (394)
Q Consensus       144 LH~~~---~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~i  217 (394)
                      +|+..   --.+|++||+-|.++. .+..+|++++|+.+.....  ......++|.|++|++.+. +++.++|||+.|+-
T Consensus      1351 ~ls~tnlg~T~v~~~Lkf~lpmIV-tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIV-TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred             hhhcccCCccchhhhhhhhcccee-cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence            66542   1268999999999998 5668999999999844433  2345678999999998876 57888999999999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCHHHHhcCCcccc
Q 016143          218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVT  286 (394)
Q Consensus       218 l~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~-L~~p~~R~s~~elL~~p~~~~  286 (394)
                      +|++..|..+|-.-  ..-..+.+......-.++...+.+.-.....+ +..-..||+-...+.-+.+..
T Consensus      1430 ly~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred             HHHHhcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence            99999998887431  11111222222122223333222222222222 235566788777777776654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.12  E-value=1.9e-05  Score=79.92  Aligned_cols=143  Identities=17%  Similarity=0.151  Sum_probs=92.4

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCC----------------------------HHHHHHHHH------H
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----------------------------PDQLERLYS------E   76 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~----------------------------~~~~~~~~~------E   76 (394)
                      +.||.-+.|.|++|..+. |+.||+|+-+.. +.+.                            .+..+.+..      |
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            689999999999998765 999999964321 1100                            111222333      3


Q ss_pred             HHHHH----cCCCCC------ceeEeeeEEcCCCceEEEEEcccCCCcHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHH
Q 016143           77 VHLLK----SLKHEN------IIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYL  144 (394)
Q Consensus        77 ~~~l~----~L~hpn------Iv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~--i~~~~~l~~~~~~~i~~qil~~L~~L  144 (394)
                      .+...    .++|-+      |.++|-.+   + ..-.++|||++|..+.+.  +++.+ ++...+..-+.+...-+-+.
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---s-t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDL---S-TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYLEQIFK  319 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhc---C-cceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHHHHHHh
Confidence            33332    234555      44444432   1 245689999999877654  44544 77776665555554444444


Q ss_pred             HhCCCCeEecCCCCCcEEEeC---CCCcEEEcccceeeeecCC
Q 016143          145 HSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       145 H~~~~~ivHrDLkp~NIll~~---~~~~~kl~Dfgla~~~~~~  184 (394)
                      |  |  .+|.|=+|.||+++.   .++.+.+.|||+.......
T Consensus       320 ~--G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  320 T--G--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             c--C--CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            4  7  999999999999983   3678999999998665544

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.08  E-value=2.3e-05  Score=67.57  Aligned_cols=130  Identities=24%  Similarity=0.231  Sum_probs=89.7

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +..+.||+|.+|.||++..  .|..+|+|+-..      +.....+..|+++|..++-.++..-.-.| ++    .++.|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~------ds~r~~l~kEakiLeil~g~~~~p~vy~y-g~----~~i~m   91 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRR------DSPRRNLEKEAKILEILAGEGVTPEVYFY-GE----DFIRM   91 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecC------CcchhhHHHHHHHHHHhhhcCCCceEEEe-ch----hhhhh
Confidence            4568899999999999975  467899987542      23456688899999999877776543322 12    23459


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC--CcEEEeCCCCcEEEcccceeeee
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC--DNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp--~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      ||+.|-.|.+.-...   +    +.-...+++.---|-..|  |-|..|+-  .||+++  ++.+.|+||.-|+.-
T Consensus        92 e~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~--~~~~~iIDFd~At~k  156 (201)
T COG2112          92 EYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVN--DRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhc--cchhhhcCCceeEEec--CCcEEEEEccchhhc
Confidence            999988887654422   2    223334445544466667  99988864  367775  459999999988743

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.04  E-value=2.8e-05  Score=71.35  Aligned_cols=75  Identities=8%  Similarity=0.009  Sum_probs=44.0

Q ss_pred             ceecccCce-EEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCC---CceeEeeeEEcCC-CceEEE
Q 016143           31 EILGKGAFK-TVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE---NIIKFYNSWVDDT-NRTINM  105 (394)
Q Consensus        31 ~~LG~G~~g-~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hp---nIv~~~~~~~~~~-~~~~~l  105 (394)
                      +.|+.|+.. .||+.     +..+++|....      ......+.+|..+|+.|...   .+.+++......+ ....++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~------~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSA------AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCc------cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            567777776 48875     23466775432      11234678899999888532   3344444222111 124478


Q ss_pred             EEcccCCCcHH
Q 016143          106 ITELFTSGSLR  116 (394)
Q Consensus       106 V~e~~~~gsL~  116 (394)
                      +|++++|.++.
T Consensus        72 l~~~i~G~~l~   82 (235)
T cd05155          72 VYRWLEGETAT   82 (235)
T ss_pred             EEEeecCCCCC
Confidence            99999986663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.02  E-value=7.3e-05  Score=80.97  Aligned_cols=149  Identities=19%  Similarity=0.285  Sum_probs=88.6

Q ss_pred             cceecccCceEEEEEEEccCC--eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCc--eeEeeeEEcCC-CceE
Q 016143           30 DEILGKGAFKTVYKGFDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENI--IKFYNSWVDDT-NRTI  103 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~--~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnI--v~~~~~~~~~~-~~~~  103 (394)
                      .+.|+.|.+..+|+......+  ..+++|+........   ....+.+|+++|+.|. |.++  .+++.++.+.. ....
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~---~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ---SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc---cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            366888999999987654322  467777654322211   2245778999999995 6664  66676554332 2356


Q ss_pred             EEEEcccCCCcHHH--------------------HHHh-CC------CC---------CHHHHHHHHHHH----------
Q 016143          104 NMITELFTSGSLRQ--------------------YRKK-HK------NV---------DMKAIKNWARQI----------  137 (394)
Q Consensus       104 ~lV~e~~~~gsL~~--------------------~i~~-~~------~l---------~~~~~~~i~~qi----------  137 (394)
                      |+||||++|..+.+                    .+.. |.      ++         ...++..|..|.          
T Consensus       120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~  199 (822)
T PLN02876        120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP  199 (822)
T ss_pred             eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence            78999998764321                    1110 00      01         112344433332          


Q ss_pred             -----HHHHHHHHhCCC---------CeEecCCCCCcEEEeCCCCc-EEEcccceeeee
Q 016143          138 -----LRGLHYLHSHNP---------PIIHRDLKCDNIFVNGNNGE-VKIGDLGLAIVM  181 (394)
Q Consensus       138 -----l~~L~~LH~~~~---------~ivHrDLkp~NIll~~~~~~-~kl~Dfgla~~~  181 (394)
                           ...+.+|..+-|         .++|+|+++.||+++.+++. .-|.||.+++.-
T Consensus       200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence                 223556644322         39999999999999843444 579999987543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.93  E-value=0.00024  Score=63.36  Aligned_cols=132  Identities=20%  Similarity=0.321  Sum_probs=86.5

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccC------------CHHHHHHHHHHHHHHHcCC------CCCceeEe
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------------SPDQLERLYSEVHLLKSLK------HENIIKFY   92 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~------------~~~~~~~~~~E~~~l~~L~------hpnIv~~~   92 (394)
                      ..||+|+.=.||.-   ..+....||+........            .........+|+.....+.      +.+|.++|
T Consensus         7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            67999999999974   344456688876544000            0112344555666655555      88999999


Q ss_pred             eeEEcCCCceEEEEEcccCC------CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 016143           93 NSWVDDTNRTINMITELFTS------GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN  166 (394)
Q Consensus        93 ~~~~~~~~~~~~lV~e~~~~------gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~  166 (394)
                      ++..  ++..+.+|+|.+..      -+|.++++... ++. ++...+.   .-..||-+++  |+.+||+|.||++...
T Consensus        84 G~ve--T~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~~~L~---~f~~~l~~~~--Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   84 GFVE--TNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-ELRQALD---EFKRYLLDHH--IVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEEe--cCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHHHHHH---HHHHHHHHcC--CeecCCCcccEEEEec
Confidence            9764  44456778888742      47888986554 666 4444444   4445666777  9999999999999632


Q ss_pred             C--C-cEEEcc
Q 016143          167 N--G-EVKIGD  174 (394)
Q Consensus       167 ~--~-~~kl~D  174 (394)
                      +  . .+.|+|
T Consensus       155 ~~~~~~lvlID  165 (199)
T PF10707_consen  155 DSGEFRLVLID  165 (199)
T ss_pred             CCCceEEEEEe
Confidence            2  2 466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.83  E-value=6.2e-05  Score=66.61  Aligned_cols=101  Identities=26%  Similarity=0.186  Sum_probs=78.6

Q ss_pred             HHHHHHHHcCCC-CCceeEeeeEEcCCCceEEEEEcccCCCcHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 016143           74 YSEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP  149 (394)
Q Consensus        74 ~~E~~~l~~L~h-pnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~---~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~  149 (394)
                      ..|.-+|+.+.+ +++.++++++  .    -++|+||...+++..   .+...-.-++....+++.+++..+.+|+....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C--G----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC--G----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC--C----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            348889999976 6999999987  2    235889998776642   12233347899999999999999999986321


Q ss_pred             -CeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          150 -PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       150 -~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                       .+.-.|++++|+-++ +++++|++|...+...
T Consensus        81 ~~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVN-DDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CcEEEeecchHHeEEe-CCCcEEEEechhcchh
Confidence             278899999999999 7889999999877433

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.76  E-value=0.00027  Score=64.54  Aligned_cols=74  Identities=15%  Similarity=0.143  Sum_probs=44.9

Q ss_pred             ceecccCceEEEEEEEcc-CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCC-CceeEeeeEEcCCCceEEEEEc
Q 016143           31 EILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hp-nIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      +.|..|-...+|+..... .+..|++|+.....    . ......+|+.+++.+... -..+++..+  +.    .+|||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~----~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e   72 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT----E-LIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYE   72 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc----c-ceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEE
Confidence            457778888999986432 35688888654221    1 111223588888888533 344455432  22    26999


Q ss_pred             ccCCCcH
Q 016143          109 LFTSGSL  115 (394)
Q Consensus       109 ~~~~gsL  115 (394)
                      |++|.++
T Consensus        73 ~i~G~~l   79 (235)
T cd05157          73 FIPGRTL   79 (235)
T ss_pred             eeCCCcC
Confidence            9998665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.71  E-value=0.00058  Score=65.00  Aligned_cols=77  Identities=12%  Similarity=0.110  Sum_probs=51.3

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC---CCceeEeeeEEcC-CCceEEEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDD-TNRTINMI  106 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h---pnIv~~~~~~~~~-~~~~~~lV  106 (394)
                      +.||.|..+.||.... .++ .+.+|..+ ..     .....+..|...|+.|.-   -.+.++++.+.++ ....-++|
T Consensus        20 ~~i~~G~~~~vy~~~~-~~~-~~~~k~~~-~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         20 ECISEQPYAALWALYD-SQG-NPMPLMAR-SF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             eecCCccceeEEEEEc-CCC-CEEEEEec-cc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            6799999999999853 223 45566632 11     012457779999988853   3577788765433 23457889


Q ss_pred             EcccCCCcH
Q 016143          107 TELFTSGSL  115 (394)
Q Consensus       107 ~e~~~~gsL  115 (394)
                      ||+++|.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.70  E-value=0.00095  Score=59.31  Aligned_cols=132  Identities=20%  Similarity=0.240  Sum_probs=89.0

Q ss_pred             cccccccceecccCc-eEEEEEEEccCCeEEEEEEeee---ccc-------cCCH-------HHHHHHHHHHHHHHcCC-
Q 016143           24 CRYGRYDEILGKGAF-KTVYKGFDEVDGIEVAWNQVNI---EDV-------MQSP-------DQLERLYSEVHLLKSLK-   84 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~-g~Vy~a~~~~~~~~vaiK~i~~---~~~-------~~~~-------~~~~~~~~E~~~l~~L~-   84 (394)
                      +.-..+.+.||.|+- |.||++.  ..|..+|+|++..   ...       ....       ....-|..|.+...+|+ 
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            344567799999999 9999996  5688999999322   110       0000       22345778888877774 


Q ss_pred             --CCCc--eeEeeeEEcCC----------------CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 016143           85 --HENI--IKFYNSWVDDT----------------NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL  144 (394)
Q Consensus        85 --hpnI--v~~~~~~~~~~----------------~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~L  144 (394)
                        +.++  |+.+++..-..                .....||-||.....         .+..    .-+.+|++-|..+
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~  180 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKIL  180 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHH
Confidence              5566  88888763220                112457778776543         2233    3456677788889


Q ss_pred             HhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       145 H~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      |+.|  |+-+|+++.|.. +     -||+|||.+
T Consensus       181 ~k~g--I~~~Dv~~~ny~-~-----G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLG--IVPRDVKPRNYR-G-----GKLVDFSSS  206 (207)
T ss_pred             HHCC--eeeccCcccccc-C-----CEEEecccC
Confidence            9999  999999999974 2     289999854

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.61  E-value=0.0021  Score=63.39  Aligned_cols=80  Identities=21%  Similarity=0.217  Sum_probs=53.5

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeecccc--C-CHHHHHHHHHHHHHHHcCC---CCCceeEeeeEEcCCCceEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--Q-SPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~--~-~~~~~~~~~~E~~~l~~L~---hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +.||.|.+..||++.+...++.|+||+-......  . .+-..++...|.+.|+.+.   -.++.+++.+  +++  .-+
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~--~~~  107 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEE--LAV  107 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCC--CCE
Confidence            5789999999999987543368999985421110  1 1234567778888888873   3457777774  343  345


Q ss_pred             EEEcccCCCc
Q 016143          105 MITELFTSGS  114 (394)
Q Consensus       105 lV~e~~~~gs  114 (394)
                      +||||+++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            7999998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.40  E-value=0.00067  Score=62.96  Aligned_cols=134  Identities=19%  Similarity=0.202  Sum_probs=73.8

Q ss_pred             eecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCc-eeEeeeEEcCCCceEEEEEccc
Q 016143           32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        32 ~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnI-v~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      .+..|-...+|+..  .++..+++|......    ....-...+|..+++.+....+ .+++..  ++  .  ++|+||+
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~----~~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~--~--~~v~e~i   70 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVC----KALGVDRQREYQILQALSALGLAPKPILV--NE--H--WLLVEWL   70 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCccc----ccccCcHHHHHHHHHHHHhcCCCCceEEE--eC--C--EEEEEec
Confidence            35567788899885  456778888643221    1110123568888888864333 333332  22  1  4689999


Q ss_pred             CCCcHHH--------------HHHh-C------CCCCH-HHHHHHHHHH---------HHHHHHHHhC------CCCeEe
Q 016143          111 TSGSLRQ--------------YRKK-H------KNVDM-KAIKNWARQI---------LRGLHYLHSH------NPPIIH  153 (394)
Q Consensus       111 ~~gsL~~--------------~i~~-~------~~l~~-~~~~~i~~qi---------l~~L~~LH~~------~~~ivH  153 (394)
                      +|..+..              .+.+ |      ..++. ..+..+..++         ...+..+-..      .+.++|
T Consensus        71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H  150 (256)
T TIGR02721        71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH  150 (256)
T ss_pred             cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence            9866532              1111 1      11221 1222332222         1112222211      123899


Q ss_pred             cCCCCCcEEEeCCCCcEEEcccceee
Q 016143          154 RDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       154 rDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      +|+.|.||+++ +++ +.|+||..|.
T Consensus       151 ~Dl~~~Nil~~-~~~-~~lIDwE~a~  174 (256)
T TIGR02721       151 MDVHAYNLVVT-PQG-LKLIDWEYAS  174 (256)
T ss_pred             CCCCcCcEEEe-CCC-CEEEeccccC
Confidence            99999999998 444 7899998773

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.23  E-value=0.002  Score=61.33  Aligned_cols=75  Identities=20%  Similarity=0.197  Sum_probs=44.7

Q ss_pred             ceecccCceEEEEEEEcc------CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCc-eeEeeeEEcCCCceE
Q 016143           31 EILGKGAFKTVYKGFDEV------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTI  103 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnI-v~~~~~~~~~~~~~~  103 (394)
                      +.|..|-...+|+.....      ++..+++|+.....     .......+|..+++.+....+ .+++.++  +.    
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~----   72 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIF--PN----   72 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEe--CC----
Confidence            345556677899886432      25788888854321     122335668888888853333 3455543  22    


Q ss_pred             EEEEcccCCCcHH
Q 016143          104 NMITELFTSGSLR  116 (394)
Q Consensus       104 ~lV~e~~~~gsL~  116 (394)
                      .+|+||++|.++.
T Consensus        73 ~~v~e~i~G~~l~   85 (302)
T cd05156          73 GRIEEFIPSRTLT   85 (302)
T ss_pred             CchhheeCCCcCC
Confidence            1478999887654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.22  E-value=0.0007  Score=67.45  Aligned_cols=163  Identities=20%  Similarity=0.273  Sum_probs=101.7

Q ss_pred             HHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 016143           72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI  151 (394)
Q Consensus        72 ~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~i  151 (394)
                      ++.-...+++++.|+|..+++++-.. ......+|+|++ +.+|.++...+. +-.....              .++  +
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~-~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~--~   88 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRG-KHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHG--V   88 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecC-ccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccc--c
Confidence            35566789999999999999886443 344578999999 679999887765 2111111              122  2


Q ss_pred             EecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCC
Q 016143          152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNEC  231 (394)
Q Consensus       152 vHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~  231 (394)
                      .|-             +.++++| .++   ...  .+..|               +++||||+|.++.++.-|...+...
T Consensus        89 ~~~-------------~~~~~td-~~~---t~~--~~~~~---------------pKsdVwsl~~i~~el~L~~~l~~~~  134 (725)
T KOG1093|consen   89 LHL-------------NIIYITD-HFL---TKY--PSPIG---------------PKSDVWSLGFIILELYLGISLEAEL  134 (725)
T ss_pred             cee-------------hhhhccc-ccc---ccC--CCCCC---------------cchhhhhHHHHHHHHHHhhHHHHHH
Confidence            221             2233333 111   000  11112               4999999999999999998887664


Q ss_pred             CCHHHHHHHHhcCCCCCCC---------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          232 KNPAQIYKKVTSGIKPASL---------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       232 ~~~~~~~~~i~~~~~~~~~---------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      .+..+.....+-...+.+.         ....+....++.++|+. .|..||...++++++-|.+.
T Consensus       135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            4444333322222212111         11235566788889997 89999999999999888653

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.16  E-value=0.0025  Score=60.35  Aligned_cols=138  Identities=17%  Similarity=0.131  Sum_probs=76.6

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCC--CceeEeee----EEcCCCceEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNS----WVDDTNRTIN  104 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hp--nIv~~~~~----~~~~~~~~~~  104 (394)
                      +.|..|....+|+...  ++..+++|+...    ..   .+.+..|+.++..|.+.  .+.+++..    +.....+..+
T Consensus        20 ~~i~~G~~n~~y~v~~--~~~~~vLr~~~~----~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          20 EGISAGIENTNYFVTT--DSGRYVLTLFEK----VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             ecccCccccceEEEEe--CCCcEEEEEcCC----CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            5677788889998753  345788887642    11   23456688888777432  24444331    1111123567


Q ss_pred             EEEcccCCCcHHH--------H---HHh-C---CCC----------CHHHH----------HHHHHHHHHHHHHHHh---
Q 016143          105 MITELFTSGSLRQ--------Y---RKK-H---KNV----------DMKAI----------KNWARQILRGLHYLHS---  146 (394)
Q Consensus       105 lV~e~~~~gsL~~--------~---i~~-~---~~l----------~~~~~----------~~i~~qil~~L~~LH~---  146 (394)
                      +|++|++|.++..        +   +.+ +   ..+          .+...          ......+..++.++.+   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            8999998866421        1   000 0   000          00000          0011112233444433   


Q ss_pred             --CCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          147 --HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       147 --~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                        ....++|+|+.|.||+++ +++.+.|+||+.+
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~-~~~~~~iIDfe~a  203 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFD-GDELSGVIDFYFA  203 (296)
T ss_pred             hcCCCcCCccCcCcccEEEe-CCceEEEeehhhh
Confidence              112399999999999998 5556689999876

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.07  E-value=0.00067  Score=64.08  Aligned_cols=138  Identities=19%  Similarity=0.204  Sum_probs=92.3

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeecc-----ccCCH---------HH----HHHHHHHHHHHHcCC-C-CC
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIED-----VMQSP---------DQ----LERLYSEVHLLKSLK-H-EN   87 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~-----~~~~~---------~~----~~~~~~E~~~l~~L~-h-pn   87 (394)
                      -++..||-|--+.||.+-+ ..|.+.++|+-....     +....         .+    .-...+|...|+.|. | --
T Consensus        95 svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   95 SVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            4567899999999999976 468888888543221     10000         11    123557999999884 2 33


Q ss_pred             ceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 016143           88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN  167 (394)
Q Consensus        88 Iv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~  167 (394)
                      +.+.+++    +  .-++|||++.|..|.+...-   .+   +..+...++.-+.-|..+|  +||+|..--||+++ ++
T Consensus       174 VPkpiD~----~--RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~-dd  238 (465)
T KOG2268|consen  174 VPKPIDH----N--RHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVK-DD  238 (465)
T ss_pred             CCCcccc----c--ceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcC--ceecccchheeEEe-cC
Confidence            4444442    1  34579999999888765322   12   3344455555566677889  99999999999998 78


Q ss_pred             CcEEEcccceeeee
Q 016143          168 GEVKIGDLGLAIVM  181 (394)
Q Consensus       168 ~~~kl~Dfgla~~~  181 (394)
                      +.++++||--....
T Consensus       239 ~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  239 DKIVVIDFPQMVST  252 (465)
T ss_pred             CCEEEeechHhhcc
Confidence            89999999655333

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.06  E-value=0.0048  Score=59.40  Aligned_cols=145  Identities=19%  Similarity=0.233  Sum_probs=94.3

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccC--------------------CHHHHH--HHHHHHHHHHcCCCCCc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--------------------SPDQLE--RLYSEVHLLKSLKHENI   88 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~--------------------~~~~~~--~~~~E~~~l~~L~hpnI   88 (394)
                      -.|..|--+.||.|. ..+|..+|||+++-+-...                    .+...-  -.-.|++-|++|+...|
T Consensus       150 GCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  150 GCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             cccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            347778888999986 4688899999875432110                    011111  12358888888865443


Q ss_pred             eeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEecCCCCCcEEEeCCC
Q 016143           89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNN  167 (394)
Q Consensus        89 v~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH-~~~~~ivHrDLkp~NIll~~~~  167 (394)
                      .----..+-    .-.+||+++.......-.-+.-.++...+..+-.|++.-+.-|- ..+  +||.||.--|+|+.  +
T Consensus       229 P~PePIlLk----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh--d  300 (520)
T KOG2270|consen  229 PCPEPILLK----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH--D  300 (520)
T ss_pred             CCCCceeee----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE--C
Confidence            321111121    12479999953322222223344778889999999998888874 445  99999999999995  7


Q ss_pred             CcEEEcccceeeeecCC
Q 016143          168 GEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       168 ~~~kl~Dfgla~~~~~~  184 (394)
                      |.+.|+|.+-+.....+
T Consensus       301 G~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             CEEEEEEccccccCCCh
Confidence            89999999877554443

>PRK05231 homoserine kinase; Provisional

Probab=96.85  E-value=0.017  Score=55.24  Aligned_cols=28  Identities=29%  Similarity=0.347  Sum_probs=23.6

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       150 ~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      +++|+|++|.||+++ .+...-|+||+.+
T Consensus       188 ~liHgD~~~~Nil~~-~~~~~~iIDf~~~  215 (319)
T PRK05231        188 GVIHADLFRDNVLFE-GDRLSGFIDFYFA  215 (319)
T ss_pred             ccCCCCCCCCcEEEE-CCceEEEEecccc
Confidence            499999999999998 4444589999877

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.83  E-value=0.014  Score=56.64  Aligned_cols=77  Identities=16%  Similarity=0.134  Sum_probs=49.6

Q ss_pred             eecccCceEEEEEEEccCCeEEEEEEeeeccc---cCCHHHHHHHHHHHHHHHcCC--CC-CceeEeeeEEcCCCceEEE
Q 016143           32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV---MQSPDQLERLYSEVHLLKSLK--HE-NIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        32 ~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~---~~~~~~~~~~~~E~~~l~~L~--hp-nIv~~~~~~~~~~~~~~~l  105 (394)
                      -||-|....||++.+...+..|+||+-...-.   ...+-..++..-|...|+...  -| .+.++|.  .++.  ...+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e--~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE--MAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc--ccee
Confidence            47889999999998754346899997532111   112344566777888887774  34 4555665  3343  3447


Q ss_pred             EEcccCC
Q 016143          106 ITELFTS  112 (394)
Q Consensus       106 V~e~~~~  112 (394)
                      |||+++.
T Consensus        78 vMEdL~~   84 (370)
T TIGR01767        78 VMEDLSH   84 (370)
T ss_pred             hHhhCcc
Confidence            8999954

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.82  E-value=0.011  Score=55.57  Aligned_cols=30  Identities=23%  Similarity=0.367  Sum_probs=24.1

Q ss_pred             CeEecCCCCCcEEEeCCCCc-EEEcccceeee
Q 016143          150 PIIHRDLKCDNIFVNGNNGE-VKIGDLGLAIV  180 (394)
Q Consensus       150 ~ivHrDLkp~NIll~~~~~~-~kl~Dfgla~~  180 (394)
                      .++|+|++|.||+++ +++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~-~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILID-EDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEe-CCCCEEEEECcHhccc
Confidence            489999999999998 4344 56999997743

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.70  E-value=0.0097  Score=56.80  Aligned_cols=139  Identities=17%  Similarity=0.130  Sum_probs=74.8

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCC--CceeEeee----EEcCCCceEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNS----WVDDTNRTIN  104 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hp--nIv~~~~~----~~~~~~~~~~  104 (394)
                      +.++.|....+|+...  ++..+++|+.....   ..   +.+..|+.++..|...  .+.+++..    +.....+..+
T Consensus        28 ~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~---~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        28 KGIAEGVENSNYLLTT--DVGRYILTLYEKRV---KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             cccCCccccceEEEEe--CCCcEEEEEecCCC---CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            5677777789998753  34467788764311   12   2344567777776422  23343331    1111234568


Q ss_pred             EEEcccCCCcHH-----H------HHHh-C---CCCC--------HH---H--HH----------HHHHHHHHHHHHHHh
Q 016143          105 MITELFTSGSLR-----Q------YRKK-H---KNVD--------MK---A--IK----------NWARQILRGLHYLHS  146 (394)
Q Consensus       105 lV~e~~~~gsL~-----~------~i~~-~---~~l~--------~~---~--~~----------~i~~qil~~L~~LH~  146 (394)
                      ++++|++|.++.     .      .+.+ +   ..++        ..   .  ..          .....+...+.++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            899999885431     1      1110 0   1110        00   0  00          001112334444432


Q ss_pred             -----CCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          147 -----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       147 -----~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                           ....++|+|+++.||+++ .++...|+||+.+
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~-~~~~~~vIDfd~~  215 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFD-GDSVKGVIDFYFA  215 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEE-CCceEEEeecccc
Confidence                 223499999999999998 4566689999876

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.65  E-value=0.01  Score=58.21  Aligned_cols=86  Identities=20%  Similarity=0.200  Sum_probs=55.1

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeecc-c-cCCHHHHHHHHHHHHHHHcCC--CC-CceeEeeeEEcCCCceEE
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIED-V-MQSPDQLERLYSEVHLLKSLK--HE-NIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~-~-~~~~~~~~~~~~E~~~l~~L~--hp-nIv~~~~~~~~~~~~~~~  104 (394)
                      .+.||-|....||++.+...+..|+||+-...- + ...+-..++..-|...|+.+.  -| .+.++|.  .|+.  ...
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e--~~~  109 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSV--MNC  109 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcH--Hhh
Confidence            367899999999999875445679999743211 1 112445677788999998874  34 4556665  3343  345


Q ss_pred             EEEcccCCC-cHHHHH
Q 016143          105 MITELFTSG-SLRQYR  119 (394)
Q Consensus       105 lV~e~~~~g-sL~~~i  119 (394)
                      +|||+++.. .|++.+
T Consensus       110 ~vMEdL~~~~ilR~~L  125 (409)
T PRK12396        110 CVMEDLSDHTILRTAL  125 (409)
T ss_pred             HHHHhCcccHHHHHHH
Confidence            689999543 344443

>PLN02236 choline kinase

Probab=96.61  E-value=0.014  Score=56.80  Aligned_cols=137  Identities=15%  Similarity=0.203  Sum_probs=76.9

Q ss_pred             ceecccCceEEEEEEEcc----CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCc-eeEeeeEEcCCCceEEE
Q 016143           31 EILGKGAFKTVYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINM  105 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnI-v~~~~~~~~~~~~~~~l  105 (394)
                      +.|-.|-.-.+|++....    .+..|++|+.....    ...+++ .+|..+++.+..-++ .++++.+  +.+    .
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~idR-~~E~~~~~~l~~~gl~P~~~~~~--~~g----~  110 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFDR-DDEIRTFECMSRHGQGPRLLGRF--PNG----R  110 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeech-HHHHHHHHHHHHcCCCCceEEEE--CCc----e
Confidence            345447778899986422    34678888764321    122222 568888888854333 3455544  322    3


Q ss_pred             EEcccCCCcHHHH--------------HHh-C--C------CCCHHHHHHHHHHHH-----------------HHHHH--
Q 016143          106 ITELFTSGSLRQY--------------RKK-H--K------NVDMKAIKNWARQIL-----------------RGLHY--  143 (394)
Q Consensus       106 V~e~~~~gsL~~~--------------i~~-~--~------~l~~~~~~~i~~qil-----------------~~L~~--  143 (394)
                      |++|+++-+|...              +.+ |  .      ....+.+..|..++.                 ..+..  
T Consensus       111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~  190 (344)
T PLN02236        111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE  190 (344)
T ss_pred             EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence            7899887665321              111 1  0      111234444443321                 11111  


Q ss_pred             --HHh--CCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          144 --LHS--HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       144 --LH~--~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                        +.+  ....++|+|+++.||+++..++.+.++||..+
T Consensus       191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya  229 (344)
T PLN02236        191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYA  229 (344)
T ss_pred             HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhc
Confidence              221  11238999999999999854578999999877

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.49  E-value=0.02  Score=55.33  Aligned_cols=28  Identities=25%  Similarity=0.475  Sum_probs=25.0

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          151 IIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       151 ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ++|.|+.+.||+++.+++.++++||..|
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYa  211 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYG  211 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEccccc
Confidence            6899999999999755678999999877

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.31  E-value=0.026  Score=53.97  Aligned_cols=28  Identities=11%  Similarity=0.150  Sum_probs=24.8

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       150 ~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      .++|+|+.++||+++ .++.+.++||..+
T Consensus       197 ~lcHgD~~~~Nvl~~-~~~~~~iIDfd~~  224 (309)
T TIGR02904       197 VLVHGKLSLSHFLYD-ETRGGYFINFEKA  224 (309)
T ss_pred             eeeCCCCcHHhEEEc-CCCCEEEEEhhhc
Confidence            499999999999998 5678999999876

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.27  E-value=0.041  Score=52.61  Aligned_cols=141  Identities=13%  Similarity=0.208  Sum_probs=76.6

Q ss_pred             ccCce-EEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC--CCceeEeeeEEcCCCceEEEEEcccC
Q 016143           35 KGAFK-TVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFT  111 (394)
Q Consensus        35 ~G~~g-~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h--pnIv~~~~~~~~~~~~~~~lV~e~~~  111 (394)
                      +||++ .+|...+.  ++.+++. .. . ............+|..+++.+.-  --+...+..+.++.....+.||+|++
T Consensus        34 ~~G~sn~t~~~~~~--~~~~vlR-~P-~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve  108 (321)
T COG3173          34 SGGWSNDTFRLGDT--GQKYVLR-KP-P-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE  108 (321)
T ss_pred             cCCcccceEEEecC--CceEEEe-cC-C-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence            34443 34544433  7778776 22 1 11223445566778888888743  22233444443333246788999998


Q ss_pred             CCcH---------H-HHHH--------h-C-------------CCCCHHHHHHHHHHH--------------HHHHHHHH
Q 016143          112 SGSL---------R-QYRK--------K-H-------------KNVDMKAIKNWARQI--------------LRGLHYLH  145 (394)
Q Consensus       112 ~gsL---------~-~~i~--------~-~-------------~~l~~~~~~~i~~qi--------------l~~L~~LH  145 (394)
                      |..+         . ++..        . |             ......++..|..+.              ..-..+|+
T Consensus       109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~  188 (321)
T COG3173         109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE  188 (321)
T ss_pred             ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence            8322         1 1111        0 0             001122233333332              22234454


Q ss_pred             hCCC------CeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          146 SHNP------PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       146 ~~~~------~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .+-+      .++|+|+.+.||+++ +++-+=+.||+++..-
T Consensus       189 ~~~p~~~~~~~lvHGD~~~gNlii~-~~~~~gVlDwe~~~lG  229 (321)
T COG3173         189 ANRPPWAGPPVLVHGDYRPGNLIID-PGRPTGVLDWELATLG  229 (321)
T ss_pred             hcCCCcCCCceeeeCCcccCCEEEe-CCCeeEEEeccccccC
Confidence            4432      489999999999999 4556899999988543

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.82  E-value=0.15  Score=50.56  Aligned_cols=77  Identities=17%  Similarity=0.096  Sum_probs=49.2

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCC---HHHHHHHHHHHHHHHcCC---CCCceeEeeeEEcCCCceE
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS---PDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~~E~~~l~~L~---hpnIv~~~~~~~~~~~~~~  103 (394)
                      .+.||.|....||+..+  .+..++||+-.......+   +-..++...|...|+.+.   ..++.++|.+.  ++.  -
T Consensus        37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--ed~--~  110 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--RTM--A  110 (418)
T ss_pred             EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--CCC--C
Confidence            36789999999999876  345688887542111111   123455666777777764   24777788743  332  4


Q ss_pred             EEEEcccCC
Q 016143          104 NMITELFTS  112 (394)
Q Consensus       104 ~lV~e~~~~  112 (394)
                      +++|||+++
T Consensus       111 vlvME~L~~  119 (418)
T PLN02756        111 LIGMRYLEP  119 (418)
T ss_pred             EEEEeecCC
Confidence            568999976

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.71  E-value=0.052  Score=48.91  Aligned_cols=85  Identities=22%  Similarity=0.333  Sum_probs=57.8

Q ss_pred             HHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 016143           72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI  151 (394)
Q Consensus        72 ~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~i  151 (394)
                      -++.+.+++.++.  .|+++..    +++..+.+|.|+|..-..            . ...++..=+.+|.-.|+.+...
T Consensus       104 ~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i------------~-~~N~i~agi~~L~~fH~~~~~~  164 (308)
T PF07387_consen  104 LYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKI------------N-FSNFITAGIKDLMDFHSENQHC  164 (308)
T ss_pred             hhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCccc------------c-hhHHHHHhHHHHHHhhccCCCe
Confidence            3567888888764  4666664    344567789999953111            0 1112222245566779776679


Q ss_pred             EecCCCCCcEEEeCCCCcEEEcccc
Q 016143          152 IHRDLKCDNIFVNGNNGEVKIGDLG  176 (394)
Q Consensus       152 vHrDLkp~NIll~~~~~~~kl~Dfg  176 (394)
                      +|+|-.|+||+-| ..|.+||.|=+
T Consensus       165 lHGD~np~NiM~D-~~G~lKlVDP~  188 (308)
T PF07387_consen  165 LHGDCNPDNIMCD-KFGYLKLVDPV  188 (308)
T ss_pred             ecCCCChhheeec-CCCCEEecChh
Confidence            9999999999999 78999999965

The function of this family is unknown.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.60  E-value=0.072  Score=51.45  Aligned_cols=105  Identities=18%  Similarity=0.238  Sum_probs=69.7

Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      +..+.|++|++- |+++.- +   .....+++..++.+.+..+.-+..+ .+.-||++..+||+++  .|++.|+||-++
T Consensus       297 e~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId--~GnvtLIDfkls  368 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID--EGNVTLIDFKLS  368 (488)
T ss_pred             CceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee--cCceEEEEeeee
Confidence            445788888886 555432 2   2245678888888888777766554 4789999999999997  789999999999


Q ss_pred             eeecCCCCcccccCCcccCcccccccCCCcCcchhh
Q 016143          179 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSF  214 (394)
Q Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DIwSl  214 (394)
                      +.-.....   +--...--|-.+.|.-+..-+||-+
T Consensus       369 Rl~~~q~~---isy~rldhp~lF~G~dd~QFeIYrl  401 (488)
T COG5072         369 RLSYSQGI---ISYNRLDHPDLFNGVDDYQFEIYRL  401 (488)
T ss_pred             ecccCCce---eeccccCchhhhcCccceeeeHHHH
Confidence            73322211   1112233455555544556666653

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.04  E-value=0.082  Score=49.99  Aligned_cols=73  Identities=19%  Similarity=0.128  Sum_probs=41.6

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC---CCCceeEeeeEEcCCCceEEEE
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~---hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      .+.|+.|....+|+..  .++..+-+|.-. ..      ....+..|..-|+.|.   --.+.+++.+....+.  -++|
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~fLl   90 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS-ES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--AFLL   90 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEE-GG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--CEEE
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecC-hh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--ceEE
Confidence            3668889999999976  677788888754 11      1234566888887773   3446677776544433  3689


Q ss_pred             EcccCCC
Q 016143          107 TELFTSG  113 (394)
Q Consensus       107 ~e~~~~g  113 (394)
                      +||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9999766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PTZ00384 choline kinase; Provisional

Probab=94.97  E-value=0.15  Score=50.37  Aligned_cols=26  Identities=31%  Similarity=0.326  Sum_probs=22.7

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          151 IIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       151 ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      .+|.|+-+.||+.+  ++.+.++||..|
T Consensus       229 fCHNDL~~gNIL~~--~~~l~lID~EYA  254 (383)
T PTZ00384        229 FCHNDLFFTNILDF--NQGIYFIDFDFA  254 (383)
T ss_pred             eeeccCCcccEEec--CCCEEEEEeccc
Confidence            79999999999986  457999999866

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.63  E-value=0.14  Score=50.22  Aligned_cols=62  Identities=18%  Similarity=0.199  Sum_probs=43.5

Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEecCCCCCcEEEeCCC
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNN  167 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~L-H~~~~~ivHrDLkp~NIll~~~~  167 (394)
                      ..|+-+|..|.++..+++..+ .+++..+.++.--..||--+ --.|  .+|.|++|.||++-..+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNK  382 (565)
T ss_pred             ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecC
Confidence            457778888989988887654 55555566665555555433 3336  99999999999996433

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=93.76  E-value=0.46  Score=43.20  Aligned_cols=74  Identities=19%  Similarity=0.228  Sum_probs=44.8

Q ss_pred             ceecccCceEEEEEEEccCC-eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC---CCceeEeeeEEcCCCceEEEE
Q 016143           31 EILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h---pnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +.+.-|..-..|...   +| .++-+|.       +..+....+..|+.-|..|.-   -++.+++.  ....+.+.|+|
T Consensus        22 ~~v~gG~inea~~v~---dg~~~~FvK~-------n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~--~G~~~~~sylV   89 (286)
T COG3001          22 EEVSGGDINEAWRLR---DGTDPFFVKC-------NQREQLSMFTAEADGLELLARSNTITVPKVIA--VGASRDHSYLV   89 (286)
T ss_pred             cccCCccccceeEee---cCCcceEEEe-------cchhhHHHHHHHHHHHHHHHhcCCccccceEE--ecCCCCeeEEE
Confidence            344445555555543   33 3455553       124455667778888877744   34556666  34566788999


Q ss_pred             EcccCCCcHH
Q 016143          107 TELFTSGSLR  116 (394)
Q Consensus       107 ~e~~~~gsL~  116 (394)
                      +||.+-+.+.
T Consensus        90 le~L~~~~~d   99 (286)
T COG3001          90 LEYLPTGPLD   99 (286)
T ss_pred             EeeccCCCCC
Confidence            9999876554

>PRK06148 hypothetical protein; Provisional

Probab=93.52  E-value=1.8  Score=48.41  Aligned_cols=30  Identities=30%  Similarity=0.531  Sum_probs=23.9

Q ss_pred             CeEecCCCCCcEEEeCCC-CcEE-Ecccceee
Q 016143          150 PIIHRDLKCDNIFVNGNN-GEVK-IGDLGLAI  179 (394)
Q Consensus       150 ~ivHrDLkp~NIll~~~~-~~~k-l~Dfgla~  179 (394)
                      .+||+|+.+.||+++++. +++. |+|||-+.
T Consensus       204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        204 QVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             ceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            499999999999998432 1555 99999873

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.37  E-value=0.11  Score=45.69  Aligned_cols=28  Identities=21%  Similarity=0.311  Sum_probs=24.0

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       151 ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      .+|+|+.|.||+++ +++ ++++||+.|..
T Consensus        79 p~H~D~~~~N~~~~-~~~-~~lIDwe~a~~  106 (188)
T PRK10271         79 PLHMDVHAGNLVHS-ASG-LRLIDWEYAGD  106 (188)
T ss_pred             eecCCCCCccEEEE-CCC-EEEEeCCcccC
Confidence            69999999999997 455 99999998843

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=92.35  E-value=0.029  Score=56.01  Aligned_cols=67  Identities=21%  Similarity=0.517  Sum_probs=57.0

Q ss_pred             ccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        29 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      .+..+|.|+||+|+.+..+.++-.+|||.+....   ......+..+|+.-+..+-|++|++++..|...
T Consensus        53 ~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn---~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~  119 (516)
T KOG1033|consen   53 PGQCLGRGGFGVVFSAQNKADENKYAVKRITLKN---REESRSRVLREVSSLAEFEHPGIKRYFHAWYER  119 (516)
T ss_pred             ccccccccCccccCCccccccchhhHHHHhcccc---hhhhhhhhhccccchhhhcccchhhheeceecC
Confidence            3578999999999999998888899999887654   355667788899999999999999999988643

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=92.35  E-value=0.29  Score=46.47  Aligned_cols=27  Identities=26%  Similarity=0.443  Sum_probs=23.5

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       150 ~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      .++|+|+.+.||+++ . +.+.|+||+.+
T Consensus       188 ~liHgD~~~~Nil~~-~-~~i~lIDfd~~  214 (313)
T TIGR02906       188 GFCHQDYAYHNILLK-D-NEVYVIDFDYC  214 (313)
T ss_pred             ceEcCCCCcccEEEe-C-CcEEEEECccc
Confidence            499999999999998 3 57899999855

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=92.16  E-value=0.19  Score=48.23  Aligned_cols=54  Identities=24%  Similarity=0.236  Sum_probs=34.6

Q ss_pred             HHHHHHHHHHHHHHHHHH---H-hCCCCeEecCCCCCcEEEeCCC-----------------CcEEEcccceeeeec
Q 016143          127 MKAIKNWARQILRGLHYL---H-SHNPPIIHRDLKCDNIFVNGNN-----------------GEVKIGDLGLAIVMQ  182 (394)
Q Consensus       127 ~~~~~~i~~qil~~L~~L---H-~~~~~ivHrDLkp~NIll~~~~-----------------~~~kl~Dfgla~~~~  182 (394)
                      .+-++.++.||+.-.--+   - ..+  .+|-||||+|||+-+..                 -..+|.||.+|...+
T Consensus       274 ~~YvkfifLQiaLLyikIYelp~c~n--F~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~  348 (434)
T PF05445_consen  274 VEYVKFIFLQIALLYIKIYELPCCTN--FLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN  348 (434)
T ss_pred             HHHHHHHHHHHHHHHeeeecCCCcce--eeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence            455677778876654222   1 234  89999999999994221                 135677777775443

; GO: 0004672 protein kinase activity, 0005524 ATP binding

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	394
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-75
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-30
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-30
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-29
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-27
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-26
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-26
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-26
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-26
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-25
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-25
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-25
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-24
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-24
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-24
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-24
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-24
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-24
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-24
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-24
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-23
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-23
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-23
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-23
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-23
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-23
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-23
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-23
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-23
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-22
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-22
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-22
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-22
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-22
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-22
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-22
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-22
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-22
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-22
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-22
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-22
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-22
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-22
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-22
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-22
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-22
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-22
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-22
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-22
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-22
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-22
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-22
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-22
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-22
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-22
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-22
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-21
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-21
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-21
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-21
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-21
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-21
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-21
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-21
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-21
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-21
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-21
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-21
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-20
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-20
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-20
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-20
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-20
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-20
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-19
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-19
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-19
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-19
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-19
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-19
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-19
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-18
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-18
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-18
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-18
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-18
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-18
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-18
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-18
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-18
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-18
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-18
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-18
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-18
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-18
3soa_A	444	Full-Length Human Camkii Length = 444		8e-18
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-17
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-17
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-17
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-17
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-17
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-17
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-17
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-17
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-17
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-17
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-17
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-17
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-17
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-17
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-17
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-17
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-17
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-17
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-17
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-17
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-17
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-17
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-17
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-17
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-17
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-17
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-17
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-17
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-17
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-17
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-17
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-17
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-17
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-17
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-17
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-17
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-17
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-17
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-17
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-17
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-17
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-16
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-16
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-16
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-16
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-16
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-16
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-16
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-16
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-16
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-16
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-16
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-16
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-16
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-16
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-16
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-16
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-16
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-16
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-16
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-16
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-16
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-16
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-16
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-16
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-16
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-16
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-16
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-16
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-16
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-16
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-16
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-16
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-16
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-16
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-16
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-16
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-16
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-16
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-16
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-16
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-16
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-16
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-16
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-16
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-16
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-16
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-16
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-16
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-16
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-16
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-16
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-16
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-16
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-16
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-16
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-16
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-16
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-16
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-16
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-16
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-15
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-15
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-15
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-15
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-15
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-15
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-15
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-15
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-15
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-15
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-15
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-15
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-15
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-15
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-15
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-15
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-15
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-15
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-15
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-15
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-15
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-15
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-15
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-15
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-15
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-15
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-15
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-15
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-15
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-15
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-15
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-15
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-15
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-15
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-15
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-15
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-14
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-14
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-14
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-14
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-14
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-14
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-14
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-14
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-14
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-14
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-14
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-14
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-14
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-14
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-14
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-14
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-13
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-13
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-13
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-13
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-12
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-12
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-12
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		9e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-11
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-11
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-11
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-11
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-11
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-11
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-11
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-11
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-11
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-11
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-11
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		7e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		8e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-10
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-10
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-09
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		9e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-08
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		9e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		6e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-07
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-07
3gni_B	389	Structure Of Strad And Mo25 Length = 389		8e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-06
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-06
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		8e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-05
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-05
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-05
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-05
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-05
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-05
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-05
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-05
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-05
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-05
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-04
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-04
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-04
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-04
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-04
2lav_A	361	Nmr Solution Structure Of Human Vaccinia-Related Ki		2e-04
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-04
2kty_A	368	Solution Structure Of Human Vaccinia Related Kinase		2e-04
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-04
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-04
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-04
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-04
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-04
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-04
3op5_A	364	Human Vaccinia-Related Kinase 1 Length = 364		2e-04

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  277 bits (709), Expect = 6e-75,   Method: Compositional matrix adjust.
 Identities = 129/244 (52%), Positives = 173/244 (70%), Gaps = 4/244 (1%)
Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R+ ++D  +G+G+FKTVYKG D    +EVAW ++    + +S  Q  R   E   LK L+
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ--RFKEEAEXLKGLQ 83
Query: 85  HENIIKFYNSWVDDTN--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           H NI++FY+SW       + I ++TEL TSG+L+ Y K+ K   +K +++W RQIL+GL 
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQ 143
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE 202
           +LH+  PPIIHRDLKCDNIF+ G  G VKIGDLGLA + +   A++VIGTPEF APE YE
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXYE 203
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           E+Y+E VD+Y+FG C LE  T EYPY+EC+N AQIY++VTSG+KPAS  KV  P+VK+ I
Sbjct: 204 EKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263
Query: 263 EKCI 266
           E CI
Sbjct: 264 EGCI 267

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 140/262 (53%), Gaps = 24/262 (9%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL---YSEVHLLKSLKHEN 87
           E +G G+F TV++   E  G +VA     ++ +M+     ER+     EV ++K L+H N
Sbjct: 43  EKIGAGSFGTVHRA--EWHGSDVA-----VKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-----VDMKAIKNWARQILRGLH 142
           I+ F  +     N +I  +TE  + GSL  YR  HK+     +D +   + A  + +G++
Sbjct: 96  IVLFMGAVTQPPNLSI--VTEYLSRGSL--YRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE- 199
           YLH+ NPPI+HR+LK  N+ V+     VK+ D GL+ +      +++S  GTPE+MAPE 
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
           L +E  NE  D+YSFG+ + E+ T + P+    NPAQ+   V    K   + +  +PQV 
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKCKRLEIPRNLNPQVA 269
Query: 260 QFIEKCIVPASLRLPALELLKD 281
             IE C      + P+   + D
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMD 291

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 141/262 (53%), Gaps = 14/262 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           R ++ +G+G F  VY+    +DG+ VA  +V I D+M +  + + +  E+ LLK L H N
Sbjct: 35  RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPN 93
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHY 143
           +IK+Y S+++D    +N++ EL  +G L    + ++K+ + +  + +  +  Q+   L +
Sbjct: 94  VIKYYASFIEDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-L 200
           +HS    ++HRD+K  N+F+    G VK+GDLGL       T  A S++GTP +M+PE +
Sbjct: 152 MHSRR--VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
           +E  YN   DI+S G  + EM   + P Y +  N   + KK+     P   S     +++
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 268
Query: 260 QFIEKCIVPASLRLPALELLKD 281
           Q +  CI P   + P +  + D
Sbjct: 269 QLVNMCINPDPEKRPDVTYVYD 290

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 138/262 (52%), Gaps = 24/262 (9%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL---YSEVHLLKSLKHEN 87
           E +G G+F TV++   E  G +VA     ++ +M+     ER+     EV ++K L+H N
Sbjct: 43  EKIGAGSFGTVHRA--EWHGSDVA-----VKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-----VDMKAIKNWARQILRGLH 142
           I+ F  +     N +I  +TE  + GSL  YR  HK+     +D +   + A  + +G++
Sbjct: 96  IVLFMGAVTQPPNLSI--VTEYLSRGSL--YRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE- 199
           YLH+ NPPI+HRDLK  N+ V+     VK+ D GL+ +       ++   GTPE+MAPE 
Sbjct: 152 YLHNRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEV 210
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
           L +E  NE  D+YSFG+ + E+ T + P+    NPAQ+   V    K   + +  +PQV 
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKCKRLEIPRNLNPQVA 269
Query: 260 QFIEKCIVPASLRLPALELLKD 281
             IE C      + P+   + D
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMD 291

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 140/277 (50%), Gaps = 24/277 (8%)
Query: 29  YDE-----ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
           YDE     +LGKG +  VY G D  + + +A  ++   D   S    + L+ E+ L K L
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS----QPLHEEIALHKHL 76
Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV--DMKAIKNWARQILRG 140
           KH+NI+++  S+ +  N  I +  E    GSL    R K   +  + + I  + +QIL G
Sbjct: 77  KHKNIVQYLGSFSE--NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 134
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L YLH +   I+HRD+K DN+ +N  +G +KI D G +  +    P   +  GT ++MAP
Sbjct: 135 LKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192
Query: 199 ELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYKKVTSGIKPASLSKVT 254
           E+ ++    Y +  DI+S G  I+EM T + P+ E   P A ++K     + P  + +  
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP-EIPESM 251
Query: 255 DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
             + K FI KC  P    R  A +LL D FL   + K
Sbjct: 252 SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 138/271 (50%), Gaps = 24/271 (8%)
Query: 29  YDE-----ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
           YDE     +LGKG +  VY G D  + + +A  ++   D   S    + L+ E+ L K L
Sbjct: 7   YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS----QPLHEEIALHKHL 62
Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV--DMKAIKNWARQILRG 140
           KH+NI+++  S+ +  N  I +  E    GSL    R K   +  + + I  + +QIL G
Sbjct: 63  KHKNIVQYLGSFSE--NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 120
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L YLH +   I+HRD+K DN+ +N  +G +KI D G +  +    P   +  GT ++MAP
Sbjct: 121 LKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 178
Query: 199 ELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYKKVTSGIKPASLSKVT 254
           E+ ++    Y +  DI+S G  I+EM T + P+ E   P A ++K     + P  + +  
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP-EIPESM 237
Query: 255 DPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
             + K FI KC  P    R  A +LL D FL
Sbjct: 238 SAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 93/282 (32%), Positives = 149/282 (52%), Gaps = 27/282 (9%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
           S  DP  +Y R+++I G+GA  TVY   D   G EVA  Q+N++   Q P + E + +E+
Sbjct: 14  SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEI 68
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
            +++  K+ NI+ + +S++      + ++ E    GSL     +   +D   I    R+ 
Sbjct: 69  LVMRENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCREC 125
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL--AIVMQQPTARSVIGTPEF 195
           L+ L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q    +++GTP +
Sbjct: 126 LQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 196 MAPELY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPA 248
           MAPE+   + Y   VDI+S G+  +EM+  E PY NE  NP + +Y   T+G      P 
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQNPE 240
Query: 249 SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 289
            LS +     + F+ +C+ +    R  A ELL+  FL    P
Sbjct: 241 KLSAI----FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 93/282 (32%), Positives = 148/282 (52%), Gaps = 27/282 (9%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
           S  DP  +Y R+++I G+GA  TVY   D   G EVA  Q+N++   Q P + E + +E+
Sbjct: 14  SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEI 68
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
            +++  K+ NI+ + +S++      + ++ E    GSL     +   +D   I    R+ 
Sbjct: 69  LVMRENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCREC 125
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL--AIVMQQPTARSVIGTPEF 195
           L+ L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q     ++GTP +
Sbjct: 126 LQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYW 182
Query: 196 MAPELY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPA 248
           MAPE+   + Y   VDI+S G+  +EM+  E PY NE  NP + +Y   T+G      P 
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQNPE 240
Query: 249 SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 289
            LS +     + F+ +C+ +    R  A ELL+  FL    P
Sbjct: 241 KLSAI----FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 93/282 (32%), Positives = 148/282 (52%), Gaps = 27/282 (9%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
           S  DP  +Y R+++I G+GA  TVY   D   G EVA  Q+N++   Q P + E + +E+
Sbjct: 14  SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEI 68
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
            +++  K+ NI+ + +S++      + ++ E    GSL     +   +D   I    R+ 
Sbjct: 69  LVMRENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCREC 125
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL--AIVMQQPTARSVIGTPEF 195
           L+ L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q     ++GTP +
Sbjct: 126 LQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 182
Query: 196 MAPELY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPA 248
           MAPE+   + Y   VDI+S G+  +EM+  E PY NE  NP + +Y   T+G      P 
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQNPE 240
Query: 249 SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 289
            LS +     + F+ +C+ +    R  A ELL+  FL    P
Sbjct: 241 KLSAI----FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 92/282 (32%), Positives = 148/282 (52%), Gaps = 27/282 (9%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
           S  DP  +Y R+++I G+GA  TVY   D   G EVA  Q+N++   Q P + E + +E+
Sbjct: 15  SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEI 69
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
            +++  K+ NI+ + +S++      + ++ E    GSL     +   +D   I    R+ 
Sbjct: 70  LVMRENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCREC 126
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL--AIVMQQPTARSVIGTPEF 195
           L+ L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q     ++GTP +
Sbjct: 127 LQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 183
Query: 196 MAPELY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPA 248
           MAPE+   + Y   VDI+S G+  +EM+  E PY NE  NP + +Y   T+G      P 
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQNPE 241
Query: 249 SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 289
            LS +     + F+ +C+ +    R  A EL++  FL    P
Sbjct: 242 KLSAI----FRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKP 279

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 91/282 (32%), Positives = 149/282 (52%), Gaps = 27/282 (9%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
           S  DP  +Y R+++I G+GA  TVY   D   G EVA  Q+N++   Q P + E + +E+
Sbjct: 15  SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEI 69
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
            +++  K+ NI+ + +S++      + ++ E    GSL     +   +D   I    R+ 
Sbjct: 70  LVMRENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCREC 126
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL--AIVMQQPTARSVIGTPEF 195
           L+ L +LHS+   +IHR++K DNI + G +G VK+ D G    I  +Q    +++GTP +
Sbjct: 127 LQALEFLHSNQ--VIHRNIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 183
Query: 196 MAPELY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPA 248
           MAPE+   + Y   VDI+S G+  +EM+  E PY NE  NP + +Y   T+G      P 
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQNPE 241
Query: 249 SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 289
            LS +     + F+ +C+ +    R  A EL++  FL    P
Sbjct: 242 KLSAI----FRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKP 279

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/246 (32%), Positives = 130/246 (52%), Gaps = 23/246 (9%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   +N+     +P QL+   +EV +L+  +H NI+ F 
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 93  NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
                 T   + ++T+     SL  +        +MK + + ARQ  RG+ YLH+ +  I
Sbjct: 75  GY---STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--I 129
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE--- 204
           IHRDLK +NIF++ +N  VKIGD GLA V  + +       + G+  +MAPE+   +   
Sbjct: 130 IHRDLKSNNIFLHEDN-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 205 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQVKQ 260
            Y+   D+Y+FG+ + E++T + PY+   N  QI + V  G     LSKV      ++K+
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 248
Query: 261 FIEKCI 266
            + +C+
Sbjct: 249 LMAECL 254

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/246 (32%), Positives = 129/246 (52%), Gaps = 23/246 (9%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   +N+     +P QL+   +EV +L+  +H NI+ F 
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 93  NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
                 T   + ++T+     SL  +        +MK + + ARQ  RG+ YLH+ +  I
Sbjct: 87  GY---STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--I 141
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE--- 204
           IHRDLK +NIF++ +N  VKIGD GLA    + +       + G+  +MAPE+   +   
Sbjct: 142 IHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 205 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQVKQ 260
            Y+   D+Y+FG+ + E++T + PY+   N  QI + V  G     LSKV      ++K+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260
Query: 261 FIEKCI 266
            + +C+
Sbjct: 261 LMAECL 266

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 80/246 (32%), Positives = 129/246 (52%), Gaps = 23/246 (9%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   +N+     +P QL+   +EV +L+  +H NI+ F 
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 93  NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
                 T   + ++T+     SL  +        +MK + + ARQ  RG+ YLH+ +  I
Sbjct: 87  GY---STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--I 141
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE--- 204
           IHRDLK +NIF++ +N  VKIGD GLA    + +       + G+  +MAPE+   +   
Sbjct: 142 IHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 205 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQVKQ 260
            Y+   D+Y+FG+ + E++T + PY+   N  QI + V  G     LSKV      ++K+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260
Query: 261 FIEKCI 266
            + +C+
Sbjct: 261 LMAECL 266

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 127/236 (53%), Gaps = 18/236 (7%)
Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
           E L++EV +++  +HEN+++ YNS++      + ++ E    G+L      H  ++ + I
Sbjct: 193 ELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQI 249
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL--AIVMQQPTARS 188
                 +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  + 
Sbjct: 250 AAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKX 306
Query: 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIK 246
           ++GTP +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + 
Sbjct: 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLP 364
Query: 247 P--ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
           P   +L KV+ P +K F+++ +V  PA  R  A ELLK PFL    P   +   +R
Sbjct: 365 PRLKNLHKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPASIVPLMR 418

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 127/236 (53%), Gaps = 18/236 (7%)
Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
           E L++EV +++  +HEN+++ YNS++      + ++ E    G+L      H  ++ + I
Sbjct: 116 ELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQI 172
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL--AIVMQQPTARS 188
                 +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  + 
Sbjct: 173 AAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKX 229
Query: 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIK 246
           ++GTP +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + 
Sbjct: 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLP 287
Query: 247 P--ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
           P   +L KV+ P +K F+++ +V  PA  R  A ELLK PFL    P   +   +R
Sbjct: 288 PRLKNLHKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPASIVPLMR 341

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 127/236 (53%), Gaps = 18/236 (7%)
Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
           E L++EV +++  +HEN+++ YNS++      + ++ E    G+L      H  ++ + I
Sbjct: 66  ELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQI 122
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL--AIVMQQPTARS 188
                 +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  + 
Sbjct: 123 AAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKX 179
Query: 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIK 246
           ++GTP +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + 
Sbjct: 180 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLP 237
Query: 247 P--ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
           P   +L KV+ P +K F+++ +V  PA  R  A ELLK PFL    P   +   +R
Sbjct: 238 PRLKNLHKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPASIVPLMR 291

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 127/236 (53%), Gaps = 18/236 (7%)
Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
           E L++EV +++  +HEN+++ YNS++      + ++ E    G+L      H  ++ + I
Sbjct: 73  ELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQI 129
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL--AIVMQQPTARS 188
                 +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  + 
Sbjct: 130 AAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKX 186
Query: 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIK 246
           ++GTP +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + 
Sbjct: 187 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLP 244
Query: 247 P--ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
           P   +L KV+ P +K F+++ +V  PA  R  A ELLK PFL    P   +   +R
Sbjct: 245 PRLKNLHKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPASIVPLMR 298

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 127/236 (53%), Gaps = 18/236 (7%)
Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
           E L++EV +++  +HEN+++ YNS++      + ++ E    G+L      H  ++ + I
Sbjct: 71  ELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQI 127
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL--AIVMQQPTARS 188
                 +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  + 
Sbjct: 128 AAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKX 184
Query: 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIK 246
           ++GTP +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + 
Sbjct: 185 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLP 242
Query: 247 P--ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
           P   +L KV+ P +K F+++ +V  PA  R  A ELLK PFL    P   +   +R
Sbjct: 243 PRLKNLHKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPASIVPLMR 296

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 127/236 (53%), Gaps = 18/236 (7%)
Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
           E L++EV +++  +HEN+++ YNS++      + ++ E    G+L      H  ++ + I
Sbjct: 62  ELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQI 118
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL--AIVMQQPTARS 188
                 +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  + 
Sbjct: 119 AAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKX 175
Query: 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIK 246
           ++GTP +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + 
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLP 233
Query: 247 P--ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
           P   +L KV+ P +K F+++ +V  PA  R  A ELLK PFL    P   +   +R
Sbjct: 234 PRLKNLHKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPASIVPLMR 287

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 144/281 (51%), Gaps = 20/281 (7%)
Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           RY R    LGKG F   Y+   ++D  EV   +V  + ++  P Q E++ +E+ + KSL 
Sbjct: 43  RYMR-GRFLGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           + +++ F+  + DD    + ++ E+    SL +  K+ K V     + + RQ ++G+ YL
Sbjct: 101 NPHVVGFHGFFEDDD--FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LY 201
           H++   +IHRDLK  N+F+N ++ +VKIGD GLA  I       +++ GTP ++APE L 
Sbjct: 159 HNNR--VIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLC 215
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
           ++ ++  VDI+S G CIL  +    P  E     + Y ++       S+ +  +P     
Sbjct: 216 KKGHSFEVDIWSLG-CILYTLLVGKPPFETSCLKETYIRIKKN--EYSVPRHINPVASAL 272
Query: 262 IEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
           I + +    +LR    ELL D F  +         P+RLP 
Sbjct: 273 IRRMLHADPTLRPSVAELLTDEFFTSGY------APMRLPT 307

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 89/283 (31%), Positives = 145/283 (51%), Gaps = 16/283 (5%)
Query: 12  TEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE 71
           TE   F   DP   + + ++I GKG+F  V+KG D      VA   + I D+ ++ D++E
Sbjct: 15  TENLYFQSMDPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIE 70
Query: 72  RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK 131
            +  E+ +L       + K+Y S++ DT   I  I E    GS     +    +D   I 
Sbjct: 71  DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI--IMEYLGGGSALDLLEPGP-LDETQIA 127
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSV 189
              R+IL+GL YLHS     IHRD+K  N+ ++  +GEVK+ D G+A  +   Q    + 
Sbjct: 128 TILREILKGLDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTF 184
Query: 190 IGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248
           +GTP +MAPE+ ++  Y+   DI+S G+  +E+   E P++E  +P ++   +     P 
Sbjct: 185 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNPPT 243
Query: 249 SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 290
                + P +K+F+E C+    S R  A ELLK  F++ +  K
Sbjct: 244 LEGNYSKP-LKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 285

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 144/281 (51%), Gaps = 20/281 (7%)
Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           RY R    LGKG F   Y+   ++D  EV   +V  + ++  P Q E++ +E+ + KSL 
Sbjct: 43  RYMR-GRFLGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           + +++ F+  + DD    + ++ E+    SL +  K+ K V     + + RQ ++G+ YL
Sbjct: 101 NPHVVGFHGFFEDDD--FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPE-LY 201
           H++   +IHRDLK  N+F+N ++ +VKIGD GLA  ++    R   + GTP ++APE L 
Sbjct: 159 HNNR--VIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLC 215
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
           ++ ++  VDI+S G CIL  +    P  E     + Y ++       S+ +  +P     
Sbjct: 216 KKGHSFEVDIWSLG-CILYTLLVGKPPFETSCLKETYIRIKKN--EYSVPRHINPVASAL 272
Query: 262 IEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
           I + +    +LR    ELL D F  +         P+RLP 
Sbjct: 273 IRRMLHADPTLRPSVAELLTDEFFTSGY------APMRLPT 307

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 144/281 (51%), Gaps = 20/281 (7%)
Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           RY R    LGKG F   Y+   ++D  EV   +V  + ++  P Q E++ +E+ + KSL 
Sbjct: 27  RYMR-GRFLGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 84
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           + +++ F+  + DD    + ++ E+    SL +  K+ K V     + + RQ ++G+ YL
Sbjct: 85  NPHVVGFHGFFEDDD--FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPE-LY 201
           H++   +IHRDLK  N+F+N ++ +VKIGD GLA  ++    R   + GTP ++APE L 
Sbjct: 143 HNNR--VIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLC 199
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
           ++ ++  VDI+S G CIL  +    P  E     + Y ++       S+ +  +P     
Sbjct: 200 KKGHSFEVDIWSLG-CILYTLLVGKPPFETSCLKETYIRIKKN--EYSVPRHINPVASAL 256
Query: 262 IEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
           I + +    +LR    ELL D F  +         P+RLP 
Sbjct: 257 IRRMLHADPTLRPSVAELLTDEFFTSGYA------PMRLPT 291

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 144/281 (51%), Gaps = 20/281 (7%)
Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           RY R    LGKG F   Y+   ++D  EV   +V  + ++  P Q E++ +E+ + KSL 
Sbjct: 43  RYMR-GRFLGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           + +++ F+  + DD    + ++ E+    SL +  K+ K V     + + RQ ++G+ YL
Sbjct: 101 NPHVVGFHGFFEDDD--FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPE-LY 201
           H++   +IHRDLK  N+F+N ++ +VKIGD GLA  ++    R   + GTP ++APE L 
Sbjct: 159 HNNR--VIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLC 215
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
           ++ ++  VDI+S G CIL  +    P  E     + Y ++       S+ +  +P     
Sbjct: 216 KKGHSFEVDIWSLG-CILYTLLVGKPPFETSCLKETYIRIKKN--EYSVPRHINPVASAL 272
Query: 262 IEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
           I + +    +LR    ELL D F  +         P+RLP 
Sbjct: 273 IRRMLHADPTLRPSVAELLTDEFFTSGY------APMRLPT 307

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 131/259 (50%), Gaps = 16/259 (6%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG+G++ +VYK   +  G  VA  QV +E        L+ +  E+ +++     +++K
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVE------SDLQEIIKEISIMQQCDSPHVVK 88
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           +Y S+  +T+  I M  E   +GS+    R ++K +    I    +  L+GL YLH    
Sbjct: 89  YYGSYFKNTDLWIVM--EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEE-EYN 206
             IHRD+K  NI +N   G  K+ D G+A  +    A+   VIGTP +MAPE+ +E  YN
Sbjct: 147 --IHRDIKAGNILLN-TEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266
            + DI+S G+  +EM   + PY +      I+   T+        ++       F+++C+
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCL 263
Query: 267 VPA-SLRLPALELLKDPFL 284
           V +   R  A +LL+ PF+
Sbjct: 264 VKSPEQRATATQLLQHPFV 282

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 150/302 (49%), Gaps = 18/302 (5%)
Query: 17  FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
           F + DP   +    EI G G+F  VY   D  +   VA  +++     QS ++ + +  E
Sbjct: 47  FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKE 104
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWAR 135
           V  L+ L+H N I++   ++ +    + M   L ++  L +  KK  + V++ A+ + A 
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA- 163
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
             L+GL YLHSHN  +IHRD+K  NI ++   G VK+GD G A +M    A   +GTP +
Sbjct: 164 --LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA--PANXFVGTPYW 216
Query: 196 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
           MAPE+     E +Y+  VD++S G+  +E+   + P       + +Y  +     PA  S
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQS 275
Query: 252 KVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNL 309
                  + F++ C+       P  E LLK  F++ + P  ++ D + R  + V E+ NL
Sbjct: 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNL 335
Query: 310 AH 311
            +
Sbjct: 336 QY 337

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 142/274 (51%), Gaps = 16/274 (5%)
Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           DP   + + ++I GKG+F  V+KG D      VA   + I D+ ++ D++E +  E+ +L
Sbjct: 4   DPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVL 59
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
                  + K+Y S++ DT   I  I E    GS     +    +D   I    R+IL+G
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWI--IMEYLGGGSALDLLEPGP-LDETQIATILREILKG 116
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L YLHS     IHRD+K  N+ ++  +GEVK+ D G+A  +   Q    + +GTP +MAP
Sbjct: 117 LDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 173
Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
           E+ ++  Y+   DI+S G+  +E+   E P++E  +P ++   +     P      + P 
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNPPTLEGNYSKP- 231
Query: 258 VKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 290
           +K+F+E C+    S R  A ELLK  F++ +  K
Sbjct: 232 LKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 265

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 150/302 (49%), Gaps = 18/302 (5%)
Query: 17  FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
           F + DP   +    EI G G+F  VY   D  +   VA  +++     QS ++ + +  E
Sbjct: 8   FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKE 65
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWAR 135
           V  L+ L+H N I++   ++ +    + M   L ++  L +  KK  + V++ A+ + A 
Sbjct: 66  VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA- 124
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
             L+GL YLHSHN  +IHRD+K  NI ++   G VK+GD G A +M    A   +GTP +
Sbjct: 125 --LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIM--APANXFVGTPYW 177
Query: 196 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
           MAPE+     E +Y+  VD++S G+  +E+   + P       + +Y  +     PA  S
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQS 236
Query: 252 KVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNL 309
                  + F++ C+       P  E LLK  F++ + P  ++ D + R  + V E+ NL
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNL 296
Query: 310 AH 311
            +
Sbjct: 297 QY 298

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 147/307 (47%), Gaps = 25/307 (8%)
Query: 15  GEFSEKDPSCRYGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
           G F +   +    RY    +LGKG+F  V    D++ G E A   ++   V Q  D+ E 
Sbjct: 37  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK-ES 95
Query: 73  LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKA 129
           L  EV LLK L H NI+K Y  + D       ++ E++T G L      RK+   VD   
Sbjct: 96  LLREVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 153
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA- 186
           I    RQ+L G+ Y+H +   I+HRDLK +N+ +     +  ++I D GL+   +     
Sbjct: 154 I---IRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 208
Query: 187 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
           +  IGT  ++APE+    Y+E  D++S G+ +  +++   P+N   N   I KKV  G  
Sbjct: 209 KDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKVEKGKY 267
Query: 247 PASLS--KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
              L   K      K  I K +  VP S+R+ A + L   ++ T   + +  D   +P+L
Sbjct: 268 TFELPQWKKVSESAKDLIRKMLTYVP-SMRISARDALDHEWIQTYTKEQISVD---VPSL 323
Query: 303 VPEVMNL 309
              ++N+
Sbjct: 324 DNAILNI 330

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 147/307 (47%), Gaps = 25/307 (8%)
Query: 15  GEFSEKDPSCRYGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
           G F +   +    RY    +LGKG+F  V    D++ G E A   ++   V Q  D+ E 
Sbjct: 38  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK-ES 96
Query: 73  LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKA 129
           L  EV LLK L H NI+K Y  + D       ++ E++T G L      RK+   VD   
Sbjct: 97  LLREVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 154
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ-QPTA 186
           I    RQ+L G+ Y+H +   I+HRDLK +N+ +     +  ++I D GL+   +     
Sbjct: 155 I---IRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 209
Query: 187 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
           +  IGT  ++APE+    Y+E  D++S G+ +  +++   P+N   N   I KKV  G  
Sbjct: 210 KDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKVEKGKY 268
Query: 247 PASLS--KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
              L   K      K  I K +  VP S+R+ A + L   ++ T   + +  D   +P+L
Sbjct: 269 TFELPQWKKVSESAKDLIRKMLTYVP-SMRISARDALDHEWIQTYTKEQISVD---VPSL 324
Query: 303 VPEVMNL 309
              ++N+
Sbjct: 325 DNAILNI 331

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 136/273 (49%), Gaps = 19/273 (6%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
            LGKG F   ++   + D  EV   ++  + ++  P Q E++  E+ + +SL H++++ F
Sbjct: 24  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           +  + D  N  + ++ EL    SL +  K+ K +     + + RQI+ G  YLH +   +
Sbjct: 83  HGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 138
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEEYNEL- 208
           IHRDLK  N+F+N  + EVKIGD GLA  ++    R  ++ GTP ++APE+  ++ +   
Sbjct: 139 IHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 268
           VD++S G CI+  +    P  E     + Y ++       S+ K  +P     I+K +  
Sbjct: 198 VDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKMLQT 254
Query: 269 ASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLP 300
                P + ELL D F  +         P RLP
Sbjct: 255 DPTARPTINELLNDEFFTSGY------IPARLP 281

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 146/291 (50%), Gaps = 17/291 (5%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
            LGKG F   ++   + D  EV   ++  + ++  P Q E++  E+ + +SL H++++ F
Sbjct: 24  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           +  + D  N  + ++ EL    SL +  K+ K +     + + RQI+ G  YLH +   +
Sbjct: 83  HGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 138
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEEYNEL- 208
           IHRDLK  N+F+N  + EVKIGD GLA  ++    R  ++ GTP ++APE+  ++ +   
Sbjct: 139 IHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 268
           VD++S G CI+  +    P  E     + Y ++       S+ K  +P     I+K +  
Sbjct: 198 VDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKMLQT 254
Query: 269 ASLRLPAL-ELLKDPFLVTDN-PKDLVCDPLRLP---NLVPEVMNLAHSEP 314
                P + ELL D F  +   P  L    L +P   ++ P  ++ ++ +P
Sbjct: 255 DPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKP 305

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 132/259 (50%), Gaps = 13/259 (5%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
            LGKG F   ++   + D  EV   ++  + ++  P Q E++  E+ + +SL H++++ F
Sbjct: 28  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           +  + D  N  + ++ EL    SL +  K+ K +     + + RQI+ G  YLH +   +
Sbjct: 87  HGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 142
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEEYNEL- 208
           IHRDLK  N+F+N  + EVKIGD GLA  ++    R  ++ GTP ++APE+  ++ +   
Sbjct: 143 IHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 201
Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 268
           VD++S G CI+  +    P  E     + Y ++       S+ K  +P     I+K +  
Sbjct: 202 VDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKMLQT 258
Query: 269 ASLRLPAL-ELLKDPFLVT 286
                P + ELL D F  +
Sbjct: 259 DPTARPTINELLNDEFFTS 277

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 131/259 (50%), Gaps = 13/259 (5%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
            LGKG F   ++   + D  EV   ++  + ++  P Q E++  E+ + +SL H++++ F
Sbjct: 48  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           +  + D  N  + ++ EL    SL +  K+ K +     + + RQI+ G  YLH +   +
Sbjct: 107 HGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 162
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI--GTPEFMAPELYEEEYNEL- 208
           IHRDLK  N+F+N  + EVKIGD GLA  ++    R  +  GTP ++APE+  ++ +   
Sbjct: 163 IHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 268
           VD++S G CI+  +    P  E     + Y ++       S+ K  +P     I+K +  
Sbjct: 222 VDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKMLQT 278
Query: 269 ASLRLPAL-ELLKDPFLVT 286
                P + ELL D F  +
Sbjct: 279 DPTARPTINELLNDEFFTS 297

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 131/259 (50%), Gaps = 13/259 (5%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
            LGKG F   ++   + D  EV   ++  + ++  P Q E++  E+ + +SL H++++ F
Sbjct: 46  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           +  + D  N  + ++ EL    SL +  K+ K +     + + RQI+ G  YLH +   +
Sbjct: 105 HGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 160
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI--GTPEFMAPELYEEEYNEL- 208
           IHRDLK  N+F+N  + EVKIGD GLA  ++    R  +  GTP ++APE+  ++ +   
Sbjct: 161 IHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 268
           VD++S G CI+  +    P  E     + Y ++       S+ K  +P     I+K +  
Sbjct: 220 VDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKMLQT 276
Query: 269 ASLRLPAL-ELLKDPFLVT 286
                P + ELL D F  +
Sbjct: 277 DPTARPTINELLNDEFFTS 295

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 147/307 (47%), Gaps = 25/307 (8%)
Query: 15  GEFSEKDPSCRYGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
           G F +   +    RY    +LGKG+F  V    D++ G E A   ++   V Q  D+ E 
Sbjct: 14  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK-ES 72
Query: 73  LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKA 129
           L  EV LLK L H NI+K Y  + D       ++ E++T G L      RK+   VD   
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 130
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ-QPTA 186
           I    RQ+L G+ Y+H +   I+HRDLK +N+ +     +  ++I D GL+   +     
Sbjct: 131 I---IRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 187 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
           +  IGT  ++APE+    Y+E  D++S G+ +  +++   P+N   N   I KKV  G  
Sbjct: 186 KDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKVEKGKY 244
Query: 247 PASLS--KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
              L   K      K  I K +  VP S+R+ A + L   ++ T   + +  D   +P+L
Sbjct: 245 TFELPQWKKVSESAKDLIRKMLTYVP-SMRISARDALDHEWIQTYTKEQISVD---VPSL 300
Query: 303 VPEVMNL 309
              ++N+
Sbjct: 301 DNAILNI 307

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 141/274 (51%), Gaps = 16/274 (5%)
Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           DP   + + ++I GKG+F  V+KG D      VA   + I D+ ++ D++E +  E+ +L
Sbjct: 19  DPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVL 74
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
                  + K+Y S++ DT   I  I E    GS     +    +D   I    R+IL+G
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWI--IMEYLGGGSALDLLEPGP-LDETQIATILREILKG 131
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L YLHS     IHRD+K  N+ ++  +GEVK+ D G+A  +   Q      +GTP +MAP
Sbjct: 132 LDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 188
Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
           E+ ++  Y+   DI+S G+  +E+   E P++E  +P ++   +     P      + P 
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNPPTLEGNYSKP- 246
Query: 258 VKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 290
           +K+F+E C+    S R  A ELLK  F++ +  K
Sbjct: 247 LKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 280

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 141/274 (51%), Gaps = 16/274 (5%)
Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           DP   + + ++I GKG+F  V+KG D      VA   + I D+ ++ D++E +  E+ +L
Sbjct: 4   DPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVL 59
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
                  + K+Y S++ DT   I  I E    GS     +    +D   I    R+IL+G
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWI--IMEYLGGGSALDLLEPGP-LDETQIATILREILKG 116
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L YLHS     IHRD+K  N+ ++  +GEVK+ D G+A  +   Q      +GTP +MAP
Sbjct: 117 LDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 173
Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
           E+ ++  Y+   DI+S G+  +E+   E P++E  +P ++   +     P      + P 
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNPPTLEGNYSKP- 231
Query: 258 VKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 290
           +K+F+E C+    S R  A ELLK  F++ +  K
Sbjct: 232 LKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 265

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 135/273 (49%), Gaps = 19/273 (6%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
            LGKG F   ++   + D  EV   ++  + ++  P Q E++  E+ + +SL H++++ F
Sbjct: 22  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           +  + D  N  + ++ EL    SL +  K+ K +     + + RQI+ G  YLH +   +
Sbjct: 81  HGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 136
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI--GTPEFMAPELYEEEYNEL- 208
           IHRDLK  N+F+N  + EVKIGD GLA  ++    R  +  GTP ++APE+  ++ +   
Sbjct: 137 IHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 268
           VD++S G CI+  +    P  E     + Y ++       S+ K  +P     I+K +  
Sbjct: 196 VDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKMLQT 252
Query: 269 ASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLP 300
                P + ELL D F  +         P RLP
Sbjct: 253 DPTARPTINELLNDEFFTSGY------IPARLP 279

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 127/248 (51%), Gaps = 27/248 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   +N+     +P QL+   +EV +L+  +H NI+ F 
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNP 149
                 T   + ++T+     SL  Y   H      +M  + + ARQ  +G+ YLH+ + 
Sbjct: 99  GY---STKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS- 152
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE- 204
            IIHRDLK +NIF++  +  VKIGD GLA V  + +       + G+  +MAPE+   + 
Sbjct: 153 -IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 205 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQV 258
              Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G     LSKV       +
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 270
Query: 259 KQFIEKCI 266
           K+ + +C+
Sbjct: 271 KRLMAECL 278

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 127/248 (51%), Gaps = 27/248 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   +N+     +P QL+   +EV +L+  +H NI+ F 
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNP 149
                 T   + ++T+     SL  Y   H      +M  + + ARQ  +G+ YLH+ + 
Sbjct: 76  GY---STKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS- 129
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE- 204
            IIHRDLK +NIF++  +  VKIGD GLA V  + +       + G+  +MAPE+   + 
Sbjct: 130 -IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 205 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQV 258
              Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G     LSKV       +
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 247
Query: 259 KQFIEKCI 266
           K+ + +C+
Sbjct: 248 KRLMAECL 255

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 127/248 (51%), Gaps = 27/248 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   +N+     +P QL+   +EV +L+  +H NI+ F 
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNP 149
                 T   + ++T+     SL  Y   H      +M  + + ARQ  +G+ YLH+ + 
Sbjct: 98  GY---STKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS- 151
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE- 204
            IIHRDLK +NIF++  +  VKIGD GLA V  + +       + G+  +MAPE+   + 
Sbjct: 152 -IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 205 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQV 258
              Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G     LSKV       +
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 269
Query: 259 KQFIEKCI 266
           K+ + +C+
Sbjct: 270 KRLMAECL 277

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 127/248 (51%), Gaps = 27/248 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   +N+     +P QL+   +EV +L+  +H NI+ F 
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNP 149
                 T   + ++T+     SL  Y   H      +M  + + ARQ  +G+ YLH+ + 
Sbjct: 76  GY---STKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS- 129
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE- 204
            IIHRDLK +NIF++  +  VKIGD GLA V  + +       + G+  +MAPE+   + 
Sbjct: 130 -IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 205 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQV 258
              Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G     LSKV       +
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 247
Query: 259 KQFIEKCI 266
           K+ + +C+
Sbjct: 248 KRLMAECL 255

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 127/248 (51%), Gaps = 27/248 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   +N+     +P QL+   +EV +L+  +H NI+ F 
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNP 149
                 T   + ++T+     SL  Y   H      +M  + + ARQ  +G+ YLH+ + 
Sbjct: 73  GY---STKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS- 126
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE- 204
            IIHRDLK +NIF++  +  VKIGD GLA V  + +       + G+  +MAPE+   + 
Sbjct: 127 -IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 205 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQV 258
              Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G     LSKV       +
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 244
Query: 259 KQFIEKCI 266
           K+ + +C+
Sbjct: 245 KRLMAECL 252

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 138/273 (50%), Gaps = 21/273 (7%)
Query: 23  SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
           S RY R  + LG GA+  V    D++ G E A   +    V  + +    L  EV +LK 
Sbjct: 3   SDRYQRVKK-LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNS-GALLDEVAVLKQ 60
Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKAIKNWARQILR 139
           L H NI+K Y  + D   R   ++ E++  G L      R+K   VD   I    +Q+L 
Sbjct: 61  LDHPNIMKLYEFFED--KRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVLS 115
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQ-QPTARSVIGTPEFM 196
           G  YLH HN  I+HRDLK +N+ +   + +  +KI D GL+   +     +  +GT  ++
Sbjct: 116 GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 173
Query: 197 APELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKV 253
           APE+  ++Y+E  D++S G+ IL ++ C YP    +   +I K+V  G     P   ++V
Sbjct: 174 APEVLRKKYDEKCDVWSCGV-ILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQV 232
Query: 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285
           +D + KQ ++  +    S R+ A E L  P++V
Sbjct: 233 SD-EAKQLVKLMLTYEPSKRISAEEALNHPWIV 264

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 127/248 (51%), Gaps = 27/248 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   +N+     +P QL+   +EV +L+  +H NI+ F 
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNP 149
                 T   + ++T+     SL  Y   H      +M  + + ARQ  +G+ YLH+ + 
Sbjct: 71  GY---STKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE- 204
            IIHRDLK +NIF++  +  VKIGD GLA V  + +       + G+  +MAPE+   + 
Sbjct: 125 -IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 205 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQV 258
              Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G     LSKV       +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 259 KQFIEKCI 266
           K+ + +C+
Sbjct: 243 KRLMAECL 250

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 125/251 (49%), Gaps = 33/251 (13%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   + + D   +P+Q +   +EV +L+  +H NI+ F 
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFM 98
Query: 93  NSWVDDTNRTINMITELFTSGSL-RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
                D    + ++T+     SL +    +     M  + + ARQ  +G+ YLH+ N  I
Sbjct: 99  GYMTKDN---LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--I 153
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIV---------MQQPTARSVIGTPEFMAPELYE 202
           IHRD+K +NIF++     VKIGD GLA V         ++QPT     G+  +MAPE+  
Sbjct: 154 IHRDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSGSQQVEQPT-----GSVLWMAPEVIR 207
Query: 203 EEYNE----LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD--- 255
            + N       D+YS+G+ + E++T E PY+   N  QI   V  G     LSK+     
Sbjct: 208 MQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267
Query: 256 PQVKQFIEKCI 266
             +K+ +  C+
Sbjct: 268 KAMKRLVADCV 278

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 138/273 (50%), Gaps = 21/273 (7%)
Query: 23  SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
           S RY R  + LG GA+  V    D++ G E A   +    V  + +    L  EV +LK 
Sbjct: 20  SDRYQRVKK-LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNS-GALLDEVAVLKQ 77
Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKAIKNWARQILR 139
           L H NI+K Y  + D   R   ++ E++  G L      R+K   VD   I    +Q+L 
Sbjct: 78  LDHPNIMKLYEFFED--KRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVLS 132
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQ-QPTARSVIGTPEFM 196
           G  YLH HN  I+HRDLK +N+ +   + +  +KI D GL+   +     +  +GT  ++
Sbjct: 133 GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 190
Query: 197 APELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKV 253
           APE+  ++Y+E  D++S G+ IL ++ C YP    +   +I K+V  G     P   ++V
Sbjct: 191 APEVLRKKYDEKCDVWSCGV-ILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQV 249
Query: 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285
           +D + KQ ++  +    S R+ A E L  P++V
Sbjct: 250 SD-EAKQLVKLMLTYEPSKRISAEEALNHPWIV 281

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 127/248 (51%), Gaps = 27/248 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   +N+     +P QL+   +EV +L+  +H NI+ F 
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNP 149
                 T   + ++T+     SL  Y   H      +M  + + ARQ  +G+ YLH+ + 
Sbjct: 71  GY---STAPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE- 204
            IIHRDLK +NIF++  +  VKIGD GLA V  + +       + G+  +MAPE+   + 
Sbjct: 125 -IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 205 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQV 258
              Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G     LSKV       +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 259 KQFIEKCI 266
           K+ + +C+
Sbjct: 243 KRLMAECL 250

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 140/273 (51%), Gaps = 20/273 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G+G+   V    ++  G +VA  +++    ++   + E L++EV +++   H+N++  Y
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMD----LRKQQRRELLFNEVVIMRDYHHDNVVDMY 108
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
           +S++      + ++ E    G+L      H  ++ + I      +LR L YLH  N  +I
Sbjct: 109 SSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLH--NQGVI 163
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGL--AIVMQQPTARSVIGTPEFMAPELYEE-EYNELV 209
           HRD+K D+I +  ++G +K+ D G    +  + P  + ++GTP +MAPE+     Y   V
Sbjct: 164 HRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 210 DIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCI 266
           DI+S G+ ++EM+  E PY NE   P Q  +++   + P    L KV+   ++ F++  +
Sbjct: 223 DIWSLGIMVIEMIDGEPPYFNE--PPLQAMRRIRDSLPPRVKDLHKVSS-VLRGFLDLML 279
Query: 267 V-PASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
           V   S R  A ELL  PFL    P   +   +R
Sbjct: 280 VREPSQRATAQELLGHPFLKLAGPPSCIVPLMR 312

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 135/277 (48%), Gaps = 26/277 (9%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENII 89
           E++G G +  VYKG     G   A   + + DV  + D+ E +  E+++LK   H  NI 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAA---IKVMDV--TGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 90  KFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQILRGLHY 143
            +Y +++       +  + ++ E   +GS+    K  K   +K   I    R+ILRGL +
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY 201
           LH H   +IHRD+K  N+ +   N EVK+ D G++  + +   R  + IGTP +MAPE+ 
Sbjct: 145 LHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 202 ------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
                 +  Y+   D++S G+  +EM     P  +  +P +    +     P   SK   
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPAPRLKSKKWS 260
Query: 256 PQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKD 291
            + + FIE C+V    + PA E L+K PF + D P +
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQLMKHPF-IRDQPNE 296

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 123/259 (47%), Gaps = 13/259 (5%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           +LGKG+F  V K  D +   E A   +N             +  EV LLK L H NI+K 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVIN--KASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           +    D +  +  ++ EL+T G L     K K           +Q+  G+ Y+H HN  I
Sbjct: 87  FEILEDSS--SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--I 142
Query: 152 IHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEEYNEL 208
           +HRDLK +NI +     +  +KI D GL+   QQ T  +  IGT  ++APE+    Y+E 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEK 202
Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCI 266
            D++S G+ +  +++   P+   KN   I K+V +G     L   +      K  I K +
Sbjct: 203 CDVWSAGVILYILLSGTPPFY-GKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 267 V-PASLRLPALELLKDPFL 284
               SLR+ A + L+ P++
Sbjct: 262 TFHPSLRITATQCLEHPWI 280

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 67/178 (37%), Positives = 101/178 (56%), Gaps = 10/178 (5%)
Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RQYRKKHKNVDMKA 129
           E +Y+E+ LLKSL H NIIK ++ + D   +   ++TE +  G L  Q   +HK  D   
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFED--KKYFYLVTEFYEGGELFEQIINRHK-FDECD 147
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQP-TA 186
             N  +QIL G+ YLH HN  I+HRD+K +NI +   N    +KI D GL+    +    
Sbjct: 148 AANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 187 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           R  +GT  ++APE+ +++YNE  D++S G+ I+ ++ C YP    +N   I KKV  G
Sbjct: 206 RDRLGTAYYIAPEVLKKKYNEKCDVWSCGV-IMYILLCGYPPFGGQNDQDIIKKVEKG 262

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 124/259 (47%), Gaps = 13/259 (5%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           +LGKG+F  V K  D +   E A   +N             +  EV LLK L H NI+K 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVIN--KASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           +    D +  +  ++ EL+T G L     K K           +Q+  G+ Y+H HN  I
Sbjct: 87  FEILEDSS--SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--I 142
Query: 152 IHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEEYNEL 208
           +HRDLK +NI +     + ++KI D GL+   QQ T  +  IGT  ++APE+    Y+E 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEK 202
Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCI 266
            D++S G+ +  +++   P+   KN   I K+V +G     L   +      K  I K +
Sbjct: 203 CDVWSAGVILYILLSGTPPFY-GKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 267 V-PASLRLPALELLKDPFL 284
               SLR+ A + L+ P++
Sbjct: 262 TFHPSLRITATQCLEHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 124/259 (47%), Gaps = 13/259 (5%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           +LGKG+F  V K  D +   E A   +N             +  EV LLK L H NI+K 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVIN--KASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           +    D +  +  ++ EL+T G L     K K           +Q+  G+ Y+H HN  I
Sbjct: 87  FEILEDSS--SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--I 142
Query: 152 IHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEEYNEL 208
           +HRDLK +NI +     + ++KI D GL+   QQ T  +  IGT  ++APE+    Y+E 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEK 202
Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCI 266
            D++S G+ +  +++   P+   KN   I K+V +G     L   +      K  I K +
Sbjct: 203 CDVWSAGVILYILLSGTPPFY-GKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 267 V-PASLRLPALELLKDPFL 284
               SLR+ A + L+ P++
Sbjct: 262 TFHPSLRITATQCLEHPWI 280

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 144/307 (46%), Gaps = 25/307 (8%)
Query: 15  GEFSEKDPSCRYGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
           G F +   +    RY    +LGKG+F  V    D++ G E A   ++   V Q  D+ E 
Sbjct: 14  GXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK-ES 72
Query: 73  LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKA 129
           L  EV LLK L H NI K Y  + D       ++ E++T G L      RK+   VD   
Sbjct: 73  LLREVQLLKQLDHPNIXKLYEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 130
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ-QPTA 186
           I    RQ+L G+ Y H +   I+HRDLK +N+ +     +  ++I D GL+   +     
Sbjct: 131 I---IRQVLSGITYXHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKX 185
Query: 187 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
           +  IGT  ++APE+    Y+E  D++S G+ +  +++   P+N   N   I KKV  G  
Sbjct: 186 KDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKVEKGKY 244
Query: 247 PASLS--KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
              L   K      K  I K +  VP S R+ A + L   ++ T   + +  D   +P+L
Sbjct: 245 TFELPQWKKVSESAKDLIRKXLTYVP-SXRISARDALDHEWIQTYTKEQISVD---VPSL 300
Query: 303 VPEVMNL 309
              ++N+
Sbjct: 301 DNAILNI 307

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 134/267 (50%), Gaps = 22/267 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G++    K   + DG  + W +++   + ++  Q+  L SEV+LL+ LKH NI+++Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM--LVSEVNLLRELKHPNIVRYY 71
Query: 93  NSWVDDTNRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +  +D TN T+ ++ E    G L        K+ + +D + +     Q+   L   H  +
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 149 P---PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYE 202
                ++HRDLK  N+F++G    VK+GD GLA ++   T  A++ +GTP +M+PE +  
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 190
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVK 259
             YNE  DI+S G  + E+     P+          K++   I+     ++      ++ 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIREGKFRRIPYRYSDELN 245
Query: 260 QFIEKCIVPASLRLPAL-ELLKDPFLV 285
           + I + +       P++ E+L++P ++
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 134/267 (50%), Gaps = 22/267 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G++    K   + DG  + W +++   + ++  Q+  L SEV+LL+ LKH NI+++Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM--LVSEVNLLRELKHPNIVRYY 71
Query: 93  NSWVDDTNRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +  +D TN T+ ++ E    G L        K+ + +D + +     Q+   L   H  +
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 149 P---PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYE 202
                ++HRDLK  N+F++G    VK+GD GLA ++   T  A++ +GTP +M+PE +  
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVK 259
             YNE  DI+S G  + E+     P+          K++   I+     ++      ++ 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIREGKFRRIPYRYSDELN 245
Query: 260 QFIEKCIVPASLRLPAL-ELLKDPFLV 285
           + I + +       P++ E+L++P ++
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 126/248 (50%), Gaps = 27/248 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   +N+     +P QL+   +EV +L+  +H NI+ F 
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNP 149
                 T   + ++T+     SL  Y   H      +M  + + ARQ  +G+ YLH+ + 
Sbjct: 91  GY---STKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS- 144
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE- 204
            IIHRDLK +NIF++  +  VKIGD GLA    + +       + G+  +MAPE+   + 
Sbjct: 145 -IIHRDLKSNNIFLH-EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 205 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQV 258
              Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G     LSKV       +
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 262
Query: 259 KQFIEKCI 266
           K+ + +C+
Sbjct: 263 KRLMAECL 270

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 126/248 (50%), Gaps = 27/248 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   +N+     +P QL+   +EV +L+  +H NI+ F 
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNP 149
                 T   + ++T+     SL  Y   H      +M  + + ARQ  +G+ YLH+ + 
Sbjct: 99  GY---STKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS- 152
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE- 204
            IIHRDLK +NIF++  +  VKIGD GLA    + +       + G+  +MAPE+   + 
Sbjct: 153 -IIHRDLKSNNIFLH-EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 205 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQV 258
              Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G     LSKV       +
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 270
Query: 259 KQFIEKCI 266
           K+ + +C+
Sbjct: 271 KRLMAECL 278

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 126/248 (50%), Gaps = 27/248 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G+F TVYKG    D   VA   +N+     +P QL+   +EV +L+  +H NI+ F 
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNP 149
                 T   + ++T+     SL  Y   H      +M  + + ARQ  +G+ YLH+ + 
Sbjct: 71  GY---STKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE- 204
            IIHRDLK +NIF++  +  VKIGD GLA    + +       + G+  +MAPE+   + 
Sbjct: 125 -IIHRDLKSNNIFLH-EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 205 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQV 258
              Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G     LSKV       +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 259 KQFIEKCI 266
           K+ + +C+
Sbjct: 243 KRLMAECL 250

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 136/284 (47%), Gaps = 22/284 (7%)
Query: 15  GEFSEKDPSCRYGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
           G F +   +    RY    +LGKG+F  V    D++ G E A   ++   V Q  D+ E 
Sbjct: 20  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK-ES 78
Query: 73  LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKA 129
           L  EV LLK L H NI+K Y  + D       ++ E++T G L      RK+   VD   
Sbjct: 79  LLREVQLLKQLDHPNIMKLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAAR 136
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ-QPTA 186
           I    RQ+L G+ Y+H +   I+HRDLK +N+ +     +  ++I D GL+   +     
Sbjct: 137 I---IRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 191
Query: 187 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
           +  IGT  ++APE+    Y+E  D++S G+ +  +++   P+N   N   I KKV  G  
Sbjct: 192 KDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKVEKGKY 250
Query: 247 PASLS--KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVT 286
              L   K      K  I K +  VP S+R+ A + L   ++ T
Sbjct: 251 TFELPQWKKVSESAKDLIRKMLTYVP-SMRISARDALDHEWIQT 293

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 109/203 (53%), Gaps = 19/203 (9%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G + TVYKG ++  G+ VA  +V ++    +P    R   E+ L+K LKHENI++
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKELKHENIVR 67
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHYL 144
            Y+  V  T   + ++ E F    L++Y          + +++  +K +  Q+L+GL + 
Sbjct: 68  LYD--VIHTENKLTLVFE-FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY- 201
           H +   I+HRDLK  N+ +N   G++K+GD GLA     P  T  S + T  + AP++  
Sbjct: 125 HENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181
Query: 202 -EEEYNELVDIYSFGMCILEMVT 223
               Y+  +DI+S G  + EM+T
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMIT 204

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 136/270 (50%), Gaps = 23/270 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG GAF  VYK  ++   +  A   ++     +S ++LE    E+ +L S  H NI+K  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVID----TKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           +++  + N  I  + E    G++     +  + +    I+   +Q L  L+YLH +   I
Sbjct: 101 DAFYYENNLWI--LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--I 156
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY------EE 203
           IHRDLK  NI     +G++K+ D G++    +   R  S IGTP +MAPE+       + 
Sbjct: 157 IHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQF 261
            Y+   D++S G+ ++EM   E P++E  NP ++  K+    +P +L++ +      K F
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKS-EPPTLAQPSRWSSNFKDF 273
Query: 262 IEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
           ++KC+      R    +LL+ PF+  D+ K
Sbjct: 274 LKKCLEKNVDARWTTSQLLQHPFVTVDSNK 303

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 136/270 (50%), Gaps = 23/270 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG GAF  VYK  ++   +  A   ++     +S ++LE    E+ +L S  H NI+K  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVID----TKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           +++  + N  I  + E    G++     +  + +    I+   +Q L  L+YLH +   I
Sbjct: 101 DAFYYENNLWI--LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--I 156
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY------EE 203
           IHRDLK  NI     +G++K+ D G++    +   R  S IGTP +MAPE+       + 
Sbjct: 157 IHRDLKAGNILFTL-DGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQF 261
            Y+   D++S G+ ++EM   E P++E  NP ++  K+    +P +L++ +      K F
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKS-EPPTLAQPSRWSSNFKDF 273
Query: 262 IEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
           ++KC+      R    +LL+ PF+  D+ K
Sbjct: 274 LKKCLEKNVDARWTTSQLLQHPFVTVDSNK 303

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/249 (31%), Positives = 118/249 (47%), Gaps = 17/249 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEV-AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           +EI+G G F  VY+ F   D + V A      ED+ Q+   +E +  E  L   LKH NI
Sbjct: 12  EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQT---IENVRQEAKLFAMLKHPNI 68
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I      + + N  + ++ E    G L +     K +    + NWA QI RG++YLH   
Sbjct: 69  IALRGVCLKEPN--LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 149 -PPIIHRDLKCDNIFV-----NGN--NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL 200
             PIIHRDLK  NI +     NG+  N  +KI D GLA    + T  S  G   +MAPE+
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEV 185
Query: 201 YEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
                +++  D++S+G+ + E++T E P+      A  Y    + +     S   +P  K
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAK 245
Query: 260 QFIEKCIVP 268
             +E C  P
Sbjct: 246 -LMEDCWNP 253

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 82/256 (32%), Positives = 127/256 (49%), Gaps = 48/256 (18%)
Query: 23  SCRYGR-YDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
           S RY   ++EI  LG+GAF  V K  + +D    A     I+ +  + ++L  + SEV L
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYA-----IKKIRHTEEKLSTILSEVML 55
Query: 80  LKSLKHENIIKFYNSWVDDTN-----------RTINMITELFTSGSLRQYRKKH-KNVDM 127
           L SL H+ ++++Y +W++  N            T+ +  E   +G+L  Y   H +N++ 
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL--YDLIHSENLNQ 113
Query: 128 KAIKNWA--RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184
           +  + W   RQIL  L Y+HS    IIHRDLK  NIF++ +   VKIGD GLA  + +  
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSL 170
Query: 185 ---------------TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYP 227
                             S IGT  ++A E+ +    YNE +D+YS G+   EM+   YP
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YP 227
Query: 228 YNECKNPAQIYKKVTS 243
           ++       I KK+ S
Sbjct: 228 FSTGMERVNILKKLRS 243

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 143/282 (50%), Gaps = 20/282 (7%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 78
           + DP      Y +I G+G+   V    ++  G +VA   ++    ++   + E L++EV 
Sbjct: 40  QGDPRLLLDSYVKI-GEGSTGIVCLAREKHSGRQVAVKMMD----LRKQQRRELLFNEVV 94
Query: 79  LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
           +++  +H N+++ Y S++      + ++ E    G+L     + + ++ + I      +L
Sbjct: 95  IMRDYQHFNVVEMYKSYL--VGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVL 151
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFM 196
           + L YLH+    +IHRD+K D+I +   +G VK+ D G    + +  P  + ++GTP +M
Sbjct: 152 QALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWM 208
Query: 197 APELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVT 254
           APE+     Y   VDI+S G+ ++EMV  E PY    +P Q  K++     P    S   
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF-SDSPVQAMKRLRDSPPPKLKNSHKV 267
Query: 255 DPQVKQFIEKCIV--PASLRLPALELLKDPFLV-TDNPKDLV 293
            P ++ F+E+ +V  P   R  A ELL  PFL+ T  P+ LV
Sbjct: 268 SPVLRDFLERMLVRDPQE-RATAQELLDHPFLLQTGLPECLV 308

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 111/223 (49%), Gaps = 21/223 (9%)
Query: 15  GEFSEKDPSC---RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSP 67
           G F ++DP+    R+ ++ + LGKG F +V    Y    +  G  VA  ++       + 
Sbjct: 4   GAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTE 59
Query: 68  DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVD 126
           + L     E+ +LKSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D
Sbjct: 60  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 119
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
              +  +  QI +G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q   
Sbjct: 120 HIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKE 176
Query: 187 RSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +  P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 177 XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 138/289 (47%), Gaps = 35/289 (12%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E++G GA   V   +      +VA  ++N+E    S D+L +   E+  +    H NI+ 
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK---EIQAMSQCHHPNIVS 77
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRK------KHKN--VDMKAIKNWARQILRGLH 142
           +Y S+V      + ++ +L + GS+    K      +HK+  +D   I    R++L GL 
Sbjct: 78  YYTSFV--VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-------VMQQPTARSVIGTPEF 195
           YLH +    IHRD+K  NI + G +G V+I D G++        + +    ++ +GTP +
Sbjct: 136 YLHKNGQ--IHRDVKAGNILL-GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 196 MAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--------KVTSGI 245
           MAPE+ E+   Y+   DI+SFG+  +E+ T   PY++   P ++           + +G+
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP-PMKVLMLTLQNDPPSLETGV 251
Query: 246 KPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDNPKDLV 293
           +   + K      ++ I  C+     + P A ELL+  F      K+ +
Sbjct: 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFL 300

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 111/223 (49%), Gaps = 21/223 (9%)
Query: 15  GEFSEKDPSC---RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSP 67
           G F ++DP+    R+ ++ + LGKG F +V    Y    +  G  VA  ++       + 
Sbjct: 2   GAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTE 57
Query: 68  DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVD 126
           + L     E+ +LKSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D
Sbjct: 58  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 117
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
              +  +  QI +G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q   
Sbjct: 118 HIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKE 174
Query: 187 RSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +  P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 175 XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 133/267 (49%), Gaps = 22/267 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G++    K   + DG  + W +++   + ++  Q+  L SEV+LL+ LKH NI+++Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM--LVSEVNLLRELKHPNIVRYY 71
Query: 93  NSWVDDTNRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +  +D TN T+ ++ E    G L        K+ + +D + +     Q+   L   H  +
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 149 P---PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE-LYE 202
                ++HRDLK  N+F++G    VK+GD GLA ++   +  A+  +GTP +M+PE +  
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNR 190
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVK 259
             YNE  DI+S G  + E+     P+          K++   I+     ++      ++ 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIREGKFRRIPYRYSDELN 245
Query: 260 QFIEKCIVPASLRLPAL-ELLKDPFLV 285
           + I + +       P++ E+L++P ++
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 135/280 (48%), Gaps = 35/280 (12%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E++G GA   V   +      +VA  ++N+E    S D+L +   E+  +    H NI+ 
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK---EIQAMSQCHHPNIVS 72
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRK------KHKN--VDMKAIKNWARQILRGLH 142
           +Y S+V      + ++ +L + GS+    K      +HK+  +D   I    R++L GL 
Sbjct: 73  YYTSFV--VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 130
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-------VMQQPTARSVIGTPEF 195
           YLH +    IHRD+K  NI + G +G V+I D G++        + +    ++ +GTP +
Sbjct: 131 YLHKNGQ--IHRDVKAGNILL-GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 196 MAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--------KVTSGI 245
           MAPE+ E+   Y+   DI+SFG+  +E+ T   PY++   P ++           + +G+
Sbjct: 188 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP-PMKVLMLTLQNDPPSLETGV 246
Query: 246 KPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 284
           +   + K      ++ I  C+     + P A ELL+  F 
Sbjct: 247 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 286

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 124/254 (48%), Gaps = 44/254 (17%)
Query: 23  SCRYGR-YDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
           S RY   ++EI  LG+GAF  V K  + +D    A     I+ +  + ++L  + SEV L
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYA-----IKKIRHTEEKLSTILSEVML 55
Query: 80  LKSLKHENIIKFYNSWVDDTN-----RTINMITELFTSGSLRQYRKKH-----KNVDMKA 129
           L SL H+ ++++Y +W++  N       +   + LF      + R  +     +N++ + 
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQR 115
Query: 130 IKNWA--RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 184
            + W   RQIL  L Y+HS    IIHRDLK  NIF++ +   VKIGD GLA  + +    
Sbjct: 116 DEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDI 172
Query: 185 -------------TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYN 229
                           S IGT  ++A E+ +    YNE +D+YS G+   EM+   YP++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFS 229
Query: 230 ECKNPAQIYKKVTS 243
                  I KK+ S
Sbjct: 230 TGMERVNILKKLRS 243

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG GAF  VYK  ++   +  A   ++     +S ++LE    E+ +L S  H NI+K  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVID----TKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
           +++  + N  I  + E    G++     +  + +    I+   +Q L  L+YLH +   I
Sbjct: 101 DAFYYENNLWI--LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--I 156
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY------EE 203
           IHRDLK  NI     +G++K+ D G++    +   R    IGTP +MAPE+       + 
Sbjct: 157 IHRDLKAGNILFTL-DGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQF 261
            Y+   D++S G+ ++EM   E P++E  NP ++  K+    +P +L++ +      K F
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKS-EPPTLAQPSRWSSNFKDF 273
Query: 262 IEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
           ++KC+      R    +LL+ PF+  D+ K
Sbjct: 274 LKKCLEKNVDARWTTSQLLQHPFVTVDSNK 303

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 113/218 (51%), Gaps = 16/218 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG GA+  V    D+V  +E A   +    V  S +   +L  EV +LK L H NI+K Y
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS--KLLEEVAVLKLLDHPNIMKLY 102
Query: 93  NSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           + + D   R   ++ E +  G L     +R K   VD   I    +Q+L G+ YLH HN 
Sbjct: 103 DFFED--KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI---IKQVLSGVTYLHKHN- 156
Query: 150 PIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQ-QPTARSVIGTPEFMAPELYEEEYN 206
            I+HRDLK +N+ +     +  +KI D GL+ V + Q   +  +GT  ++APE+  ++Y+
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYD 215
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           E  D++S G+ IL ++   YP    +   +I +KV  G
Sbjct: 216 EKCDVWSIGV-ILFILLAGYPPFGGQTDQEILRKVEKG 252

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 17  FSEKDPSC---RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
           F ++DP+    R+ ++   LGKG F +V    Y    +  G  VA  ++       + + 
Sbjct: 2   FEDRDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEH 57
Query: 70  LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMK 128
           L     E+ +LKSL+H+NI+K+         R + +I E    GSLR+Y +KHK  +D  
Sbjct: 58  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHI 117
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
            +  +  QI +G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q     
Sbjct: 118 KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXX 174
Query: 189 VIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            +  P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 136/274 (49%), Gaps = 16/274 (5%)
Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           DP   + + + I GKG+F  V+KG D      VA   + I D+ ++ D++E +  E+ +L
Sbjct: 20  DPEELFTKLERI-GKGSFGEVFKGIDNRTQQVVA---IKIIDLEEAEDEIEDIQQEITVL 75
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
                  + K+Y S++  +   I  I E    GS     +     D   I    ++IL+G
Sbjct: 76  SQCDSSYVTKYYGSYLKGSKLWI--IMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKG 132
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           L YLHS     IHRD+K  N+ ++   G+VK+ D G+A  +   Q    + +GTP +MAP
Sbjct: 133 LDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 189
Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
           E+ ++  Y+   DI+S G+  +E+   E P N   +P ++   +     P  +   T   
Sbjct: 190 EVIQQSAYDSKADIWSLGITAIELAKGE-PPNSDMHPMRVLFLIPKNNPPTLVGDFTK-S 247
Query: 258 VKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 290
            K+FI+ C+    S R  A ELLK  F+V ++ K
Sbjct: 248 FKEFIDACLNKDPSFRPTAKELLKHKFIVKNSKK 281

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 17  FSEKDPSC---RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
           F ++DP+    R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + 
Sbjct: 30  FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEH 85
Query: 70  LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMK 128
           L     E+ +LKSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D  
Sbjct: 86  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 145
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
            +  +  QI +G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q     
Sbjct: 146 KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXX 202
Query: 189 VIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            +  P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 203 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 17  FSEKDPSC---RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
           F ++DP+    R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + 
Sbjct: 3   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEH 58
Query: 70  LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMK 128
           L     E+ +LKSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D  
Sbjct: 59  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 118
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
            +  +  QI +G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q     
Sbjct: 119 KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXX 175
Query: 189 VIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            +  P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 176 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 132/258 (51%), Gaps = 14/258 (5%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           +LGKG+F  VY+      G+EVA   ++ +  M     ++R+ +EV +   LKH +I++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMID-KKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPP 150
           YN + +D+N  + ++ E+  +G + +Y K   K       +++  QI+ G+ YLHSH   
Sbjct: 77  YN-YFEDSN-YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEEYNEL 208
           I+HRDL   N+ +   N  +KI D GLA  ++ P  +  ++ GTP +++PE+     + L
Sbjct: 133 ILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL 191
Query: 209 -VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCI 266
             D++S G     ++    P++       + K V +  + P+ LS      + Q + +  
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRN- 250
Query: 267 VPASLRLPALELLKDPFL 284
            PA  RL    +L  PF+
Sbjct: 251 -PAD-RLSLSSVLDHPFM 266

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 17  FSEKDPSC---RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
           F ++DP+    R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + 
Sbjct: 5   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEH 60
Query: 70  LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMK 128
           L     E+ +LKSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D  
Sbjct: 61  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 120
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
            +  +  QI +G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q     
Sbjct: 121 KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXX 177
Query: 189 VIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            +  P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 178 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 11/209 (5%)
Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           RY   D+ LG G   TVY   D +  I+VA   + I    +  + L+R   EVH    L 
Sbjct: 12  RYKIVDK-LGGGGMSTVYLAEDTILNIKVAIKAIFIPP-REKEETLKRFEREVHNSSQLS 69
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H+NI+   +  VD+ +    ++ E     +L +Y + H  + +    N+  QIL G+   
Sbjct: 70  HQNIVSMID--VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK-- 125
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY 201
           H+H+  I+HRD+K  NI ++ N   +KI D G+A  + + +      V+GT ++ +PE  
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKT-LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 202 E-EEYNELVDIYSFGMCILEMVTCEYPYN 229
           + E  +E  DIYS G+ + EM+  E P+N
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 122/254 (48%), Gaps = 44/254 (17%)
Query: 23  SCRYGR-YDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
           S RY   ++EI  LG+GAF  V K  + +D    A     I+ +  + ++L  + SEV L
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYA-----IKKIRHTEEKLSTILSEVXL 55
Query: 80  LKSLKHENIIKFYNSWVDDTN-----RTINMITELFTSGSLRQYRKKH-----KNVDMKA 129
           L SL H+ ++++Y +W++  N       +   + LF      + R  +     +N++ + 
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQR 115
Query: 130 IKNWA--RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 184
            + W   RQIL  L Y+HS    IIHR+LK  NIF++ +   VKIGD GLA  + +    
Sbjct: 116 DEYWRLFRQILEALSYIHSQG--IIHRNLKPXNIFIDESRN-VKIGDFGLAKNVHRSLDI 172
Query: 185 -------------TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYN 229
                           S IGT  ++A E+ +    YNE +D YS G+   E +   YP++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFS 229
Query: 230 ECKNPAQIYKKVTS 243
                  I KK+ S
Sbjct: 230 TGXERVNILKKLRS 243

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 109/219 (49%), Gaps = 21/219 (9%)
Query: 19  EKDPSC---RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLE 71
           ++DP+    R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + L 
Sbjct: 4   DRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLR 59
Query: 72  RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAI 130
               E+ +LKSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D   +
Sbjct: 60  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 119
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
             +  QI +G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q      +
Sbjct: 120 LQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 191 GTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
             P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 177 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 137/291 (47%), Gaps = 26/291 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD-QLERLYSEVHLLKSLKHENII 89
           E++GKGAF  V +  +   G + A   V++     SP    E L  E  +   LKH +I+
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGLHYLH 145
           +   ++  D    + M+ E      L     K  +           ++ RQIL  L Y H
Sbjct: 90  ELLETYSSDG--MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 146 SHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY 201
            +N  IIHRD+K +N+ +    N+  VK+GD G+AI + +    A   +GTP FMAPE+ 
Sbjct: 148 DNN--IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 202 EEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQ 257
           + E Y + VD++  G+ +  +++   P+   K   ++++ +  G   + P   S +++  
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYKMNPRQWSHISE-S 262
Query: 258 VKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
            K  + + ++  PA  R+   E L  P+L     +D     + LP  V ++
Sbjct: 263 AKDLVRRMLMLDPAE-RITVYEALNHPWL---KERDRYAYKIHLPETVEQL 309

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 20  KDPSC---RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
           +DP+    R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + L  
Sbjct: 2   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRD 57
Query: 73  LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIK 131
              E+ +LKSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D   + 
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 191
            +  QI +G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q      + 
Sbjct: 118 QYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVK 174
Query: 192 TPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 20  KDPSC---RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
           +DP+    R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + L  
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRD 56
Query: 73  LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIK 131
              E+ +LKSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D   + 
Sbjct: 57  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 116
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 191
            +  QI +G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q      + 
Sbjct: 117 QYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVK 173
Query: 192 TPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 174 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 135/274 (49%), Gaps = 16/274 (5%)
Query: 16  EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
           + S  DP   + + D I GKG+F  VYKG D      VA   + I D+ ++ D++E +  
Sbjct: 11  QHSRVDPEELFTKLDRI-GKGSFGEVYKGIDNHTKEVVA---IKIIDLEEAEDEIEDIQQ 66
Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           E+ +L       I +++ S++  T   + +I E    GS     K    ++   I    R
Sbjct: 67  EITVLSQCDSPYITRYFGSYLKSTK--LWIIMEYLGGGSALDLLKP-GPLEETYIATILR 123
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
           +IL+GL YLHS     IHRD+K  N+ ++   G+VK+ D G+A  +   Q      +GTP
Sbjct: 124 EILKGLDYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNXFVGTP 180
Query: 194 EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
            +MAPE+ ++  Y+   DI+S G+  +E+   E P N   +P ++   +     P    +
Sbjct: 181 FWMAPEVIKQSAYDFKADIWSLGITAIELAKGE-PPNSDLHPMRVLFLIPKNSPPTLEGQ 239
Query: 253 VTDPQVKQFIEKCI-VPASLRLPALELLKDPFLV 285
            + P  K+F+E C+      R  A ELLK  F+ 
Sbjct: 240 HSKP-FKEFVEACLNKDPRFRPTAKELLKHKFIT 272

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 25  RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + L     E+ +L
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRDFEREIEIL 65
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILR 139
           KSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D   +  +  QI +
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----- 194
           G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q      +  P      
Sbjct: 126 GMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           + APE L E +++   D++SFG+ + E+ T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 25  RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + L     E+ +L
Sbjct: 8   RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRDFEREIEIL 63
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILR 139
           KSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D   +  +  QI +
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 123
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----- 194
           G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q      +  P      
Sbjct: 124 GMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 180
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           + APE L E +++   D++SFG+ + E+ T
Sbjct: 181 WYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 117/231 (50%), Gaps = 13/231 (5%)
Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           +Y R  +I G+G+F          DG +    ++NI  +  S  + E    EV +L ++K
Sbjct: 25  KYVRLQKI-GEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMK 81
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK--AIKNWARQILRGLH 142
           H NI+++  S+  + N ++ ++ +    G L +     K V  +   I +W  QI   L 
Sbjct: 82  HPNIVQYRESF--EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPEL 200
             H H+  I+HRD+K  NIF+   +G V++GD G+A V+      AR+ IGTP +++PE+
Sbjct: 140 --HVHDRKILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196
Query: 201 YEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
            E + YN   DI++ G  + E+ T ++ +        + K ++    P SL
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSL 247

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 117/236 (49%), Gaps = 12/236 (5%)
Query: 15  GEFSEKDPSCRYGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
            E  + D   + G Y   + LG G F  V  G  E+ G +VA   +N + + +S D + +
Sbjct: 4   AEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-RSLDVVGK 62
Query: 73  LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN 132
           +  E+  LK  +H +IIK Y   V  T   I M+ E  + G L  Y  K+  +D K  + 
Sbjct: 63  IRREIQNLKLFRHPHIIKLYQ--VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRR 120
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIG 191
             +QIL G+ Y H H   ++HRDLK +N+ ++ +    KI D GL+ +M      R   G
Sbjct: 121 LFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRXSCG 177
Query: 192 TPEFMAPELYEEEY--NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245
           +P + APE+          VDI+S G+ +  ++    P+++   P  ++KK+  GI
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKICDGI 232

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 120/231 (51%), Gaps = 13/231 (5%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSE 76
           +++ P     R  + +GKG F  V      + G EVA   V I D  Q +P  L++L+ E
Sbjct: 8   TDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVA---VKIIDKTQLNPTSLQKLFRE 64
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
           V ++K L H NI+K +   V +T +T+ ++ E  + G +  Y   H  +  K  +   RQ
Sbjct: 65  VRIMKILNHPNIVKLFE--VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 122
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-GTPEF 195
           I+  + Y H     I+HRDLK +N+ ++G+   +KI D G +             G+P +
Sbjct: 123 IVSAVQYCHQKY--IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPY 179
Query: 196 MAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
            APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRG 229

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 109/221 (49%), Gaps = 21/221 (9%)
Query: 17  FSEKDPSC---RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
           F ++DP+    R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + 
Sbjct: 2   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEH 57
Query: 70  LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMK 128
           L     E+ +LKSL+H+NI+K+         R + +I E    GSLR Y + H + +D  
Sbjct: 58  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHI 117
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
            +  +  QI +G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q     
Sbjct: 118 KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXX 174
Query: 189 VIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            +  P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 25  RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + L     E+ +L
Sbjct: 28  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRDFEREIEIL 83
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILR 139
           KSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D   +  +  QI +
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----- 194
           G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q      +  P      
Sbjct: 144 GMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           + APE L E +++   D++SFG+ + E+ T
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 25  RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + L     E+ +L
Sbjct: 28  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRDFEREIEIL 83
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILR 139
           KSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D   +  +  QI +
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----- 194
           G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q      +  P      
Sbjct: 144 GMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           + APE L E +++   D++SFG+ + E+ T
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 25  RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + L     E+ +L
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRDFEREIEIL 65
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILR 139
           KSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D   +  +  QI +
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----- 194
           G+ YL +     IHRDL   NI V  N   VKIGD GL  V+ Q      +  P      
Sbjct: 126 GMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           + APE L E +++   D++SFG+ + E+ T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 120/231 (51%), Gaps = 13/231 (5%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSE 76
           S++ P     R  + +GKG F  V      + G EVA   + I D  Q +P  L++L+ E
Sbjct: 5   SDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVA---IKIIDKTQLNPTSLQKLFRE 61
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
           V ++K L H NI+K +   V +T +T+ +I E  + G +  Y   H  +  K  ++  RQ
Sbjct: 62  VRIMKILNHPNIVKLFE--VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 119
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-GTPEF 195
           I+  + Y H     I+HRDLK +N+ ++ +   +KI D G +             G+P +
Sbjct: 120 IVSAVQYCHQKR--IVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDTFCGSPPY 176
Query: 196 MAPELYE-EEYNE-LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
            APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G
Sbjct: 177 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRG 226

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 122/262 (46%), Gaps = 43/262 (16%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS---EVHLLKSLKH 85
           Y++ +GKG F  V+KG    D   VA   + + D     + +E+      EV ++ +L H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ------ILR 139
            NI+K Y       +    M+ E    G L      H+ +D      W+ +      I  
Sbjct: 83  PNIVKLYGL----MHNPPRMVMEFVPCGDLY-----HRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEV--KIGDLGLAIVMQQP--TARSVIGTP 193
           G+ Y+ + NPPI+HRDL+  NIF+     N  V  K+ D GL+   QQ   +   ++G  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS---QQSVHSVSGLLGNF 190
Query: 194 EFMAPELY---EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-------S 243
           ++MAPE     EE Y E  D YSF M +  ++T E P++E       Y K+         
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-----YGKIKFINMIREE 245
Query: 244 GIKPASLSKVTDPQVKQFIEKC 265
           G++P ++ +   P+++  IE C
Sbjct: 246 GLRP-TIPEDCPPRLRNVIELC 266

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 135/265 (50%), Gaps = 21/265 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LGKGAF  V +    + G E A   +N + +  S    ++L  E  + + LKH NI++
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKL--SARDHQKLEREARICRLLKHPNIVR 85
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            ++S  ++ +    +I +L T G L +    R+ +   D     +  +QIL  +  LH H
Sbjct: 86  LHDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAV--LHCH 138
Query: 148 NPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDLK +N+ +        VK+ D GLAI +  +Q       GTP +++PE L +
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 198
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQ 260
           + Y + VD+++ G+ IL ++   YP    ++  ++Y+++ +G    P+       P+ K 
Sbjct: 199 DPYGKPVDLWACGV-ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 257
Query: 261 FIEKCI-VPASLRLPALELLKDPFL 284
            I K + +  S R+ A E LK P++
Sbjct: 258 LINKMLTINPSKRITAAEALKHPWI 282

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 20  KDPSC---RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
           +DP+    R+ ++ + LGKG F +V    Y    +  G  VA  ++       + + L  
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRD 58
Query: 73  LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIK 131
              E+ +LKSL+H+NI+K+         R + +I E    GSLR Y +KHK  +D   + 
Sbjct: 59  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 118
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 191
            +  QI +G+ YL +     IHR+L   NI V  N   VKIGD GL  V+ Q      + 
Sbjct: 119 QYTSQICKGMEYLGTKR--YIHRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVK 175
Query: 192 TPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 176 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 134/265 (50%), Gaps = 14/265 (5%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG+G+F  V   +    G +VA   +N + V+   D   R+  E+  L+ L+H +IIK Y
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIIN-KKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 74
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
           +  V  +   I M+ E +    L  Y  +   +  +  + + +QI+  + Y H H   I+
Sbjct: 75  D--VIKSKDEIIMVIE-YAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IV 129
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEEY--NELV 209
           HRDLK +N+ ++  +  VKI D GL+ +M      ++  G+P + APE+   +      V
Sbjct: 130 HRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 188
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPA 269
           D++S G+ +  M+    P+++   P  ++K +++G+   +L K   P     I++ ++  
Sbjct: 189 DVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGV--YTLPKFLSPGAAGLIKRMLIVN 245
Query: 270 SL-RLPALELLKDPFLVTDNPKDLV 293
            L R+   E+++D +   D P+ L+
Sbjct: 246 PLNRISIHEIMQDDWFKVDLPEYLL 270

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 134/265 (50%), Gaps = 14/265 (5%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG+G+F  V   +    G +VA   +N + V+   D   R+  E+  L+ L+H +IIK Y
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIIN-KKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 80
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
           +  V  +   I M+ E +    L  Y  +   +  +  + + +QI+  + Y H H   I+
Sbjct: 81  D--VIKSKDEIIMVIE-YAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IV 135
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEEY--NELV 209
           HRDLK +N+ ++  +  VKI D GL+ +M      ++  G+P + APE+   +      V
Sbjct: 136 HRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 194
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPA 269
           D++S G+ +  M+    P+++   P  ++K +++G+   +L K   P     I++ ++  
Sbjct: 195 DVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGV--YTLPKFLSPGAAGLIKRMLIVN 251
Query: 270 SL-RLPALELLKDPFLVTDNPKDLV 293
            L R+   E+++D +   D P+ L+
Sbjct: 252 PLNRISIHEIMQDDWFKVDLPEYLL 276

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 134/265 (50%), Gaps = 14/265 (5%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG+G+F  V   +    G +VA   +N + V+   D   R+  E+  L+ L+H +IIK Y
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIIN-KKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 79
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
           +  V  +   I M+ E +    L  Y  +   +  +  + + +QI+  + Y H H   I+
Sbjct: 80  D--VIKSKDEIIMVIE-YAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IV 134
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEEY--NELV 209
           HRDLK +N+ ++  +  VKI D GL+ +M      ++  G+P + APE+   +      V
Sbjct: 135 HRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 193
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPA 269
           D++S G+ +  M+    P+++   P  ++K +++G+   +L K   P     I++ ++  
Sbjct: 194 DVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGV--YTLPKFLSPGAAGLIKRMLIVN 250
Query: 270 SL-RLPALELLKDPFLVTDNPKDLV 293
            L R+   E+++D +   D P+ L+
Sbjct: 251 PLNRISIHEIMQDDWFKVDLPEYLL 275

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 119/231 (51%), Gaps = 13/231 (5%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSE 76
           +++ P     R  + +GKG F  V      + G EVA   + I D  Q +P  L++L+ E
Sbjct: 8   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVA---IKIIDKTQLNPTSLQKLFRE 64
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
           V ++K L H NI+K +   V +T +T+ +I E  + G +  Y   H  +  K  ++  RQ
Sbjct: 65  VRIMKILNHPNIVKLFE--VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 122
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-GTPEF 195
           I+  + Y H     I+HRDLK +N+ ++ +   +KI D G +             G P +
Sbjct: 123 IVSAVQYCHQKR--IVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPY 179
Query: 196 MAPELYE-EEYNE-LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
            APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRG 229

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 136/271 (50%), Gaps = 24/271 (8%)
Query: 26  YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           Y  Y++I GKGAF  V +      G E A   +N + +  S    ++L  E  + + LKH
Sbjct: 6   YQLYEDI-GKGAFSVVRRCVKLCTGHEYAAKIINTKKL--SARDHQKLEREARICRLLKH 62
Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKAIKNWARQILRGLH 142
            NI++ ++S  ++      ++ +L T G L +    R+ +   D     +  +QIL  + 
Sbjct: 63  SNIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAV- 116
Query: 143 YLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAP 198
            LH H   ++HRDLK +N+ +        VK+ D GLAI +Q  Q       GTP +++P
Sbjct: 117 -LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 199 E-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD 255
           E L +E Y + VDI++ G+ IL ++   YP    ++  ++Y+++ +G    P+       
Sbjct: 176 EVLRKEAYGKPVDIWACGV-ILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVT 234
Query: 256 PQVKQFIEKCIV--PASLRLPALELLKDPFL 284
           P+ K  I + +   PA  R+ A E LK P++
Sbjct: 235 PEAKNLINQMLTINPAK-RITAHEALKHPWV 264

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 134/265 (50%), Gaps = 14/265 (5%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG+G+F  V   +    G +VA   +N + V+   D   R+  E+  L+ L+H +IIK Y
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIIN-KKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 70
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
           +  V  +   I M+ E +    L  Y  +   +  +  + + +QI+  + Y H H   I+
Sbjct: 71  D--VIKSKDEIIMVIE-YAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IV 125
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEEY--NELV 209
           HRDLK +N+ ++  +  VKI D GL+ +M      ++  G+P + APE+   +      V
Sbjct: 126 HRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 184
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPA 269
           D++S G+ +  M+    P+++   P  ++K +++G+   +L K   P     I++ ++  
Sbjct: 185 DVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGV--YTLPKFLSPGAAGLIKRMLIVN 241
Query: 270 SL-RLPALELLKDPFLVTDNPKDLV 293
            L R+   E+++D +   D P+ L+
Sbjct: 242 PLNRISIHEIMQDDWFKVDLPEYLL 266

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 124/254 (48%), Gaps = 20/254 (7%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           +E++G+GAF  V K   +    +VA  Q+      +S  + +    E+  L  + H NI+
Sbjct: 14  EEVVGRGAFGVVCKA--KWRAKDVAIKQI------ESESERKAFIVELRQLSRVNHPNIV 65
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN---WARQILRGLHYLHS 146
           K Y + ++     + ++ E    GSL       + +      +   W  Q  +G+ YLHS
Sbjct: 66  KLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 121
Query: 147 HNP-PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EE 204
             P  +IHRDLK  N+ +      +KI D G A  +Q     +  G+  +MAPE++E   
Sbjct: 122 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-GSAAWMAPEVFEGSN 180
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKKVTSGIKPASLSKVTDPQVKQFIE 263
           Y+E  D++S+G+ + E++T   P++E   PA +I   V +G +P  +  +  P ++  + 
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP-IESLMT 239
Query: 264 KCIVPASLRLPALE 277
           +C      + P++E
Sbjct: 240 RCWSKDPSQRPSME 253

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 124/254 (48%), Gaps = 20/254 (7%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           +E++G+GAF  V K   +    +VA  Q+      +S  + +    E+  L  + H NI+
Sbjct: 13  EEVVGRGAFGVVCKA--KWRAKDVAIKQI------ESESERKAFIVELRQLSRVNHPNIV 64
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN---WARQILRGLHYLHS 146
           K Y + ++     + ++ E    GSL       + +      +   W  Q  +G+ YLHS
Sbjct: 65  KLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 147 HNP-PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EE 204
             P  +IHRDLK  N+ +      +KI D G A  +Q     +  G+  +MAPE++E   
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-GSAAWMAPEVFEGSN 179
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKKVTSGIKPASLSKVTDPQVKQFIE 263
           Y+E  D++S+G+ + E++T   P++E   PA +I   V +G +P  +  +  P ++  + 
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP-IESLMT 238
Query: 264 KCIVPASLRLPALE 277
           +C      + P++E
Sbjct: 239 RCWSKDPSQRPSME 252

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 114/239 (47%), Gaps = 11/239 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G    V+K   +  G+ +A   +++E     P    ++  E+ +L       I+ FY
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 89
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++  D   +I M  E    GSL Q  KK   +  + +   +  +++GL YL   +  I+
Sbjct: 90  GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 146
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M+PE L    Y+   DI
Sbjct: 147 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 205
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PASLSKVTDPQVKQFIEKCIV 267
           +S G+ ++EM    YP         I++ +   +    P   S V   + + F+ KC++
Sbjct: 206 WSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 264

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 115/233 (49%), Gaps = 12/233 (5%)
Query: 18  SEKDPSCRYGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
           S+ D   + G Y   + LG G F  V  G  ++ G +VA   +N + + +S D + ++  
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIKR 60
Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           E+  LK  +H +IIK Y   V  T     M+ E  + G L  Y  KH  V+    +   +
Sbjct: 61  EIQNLKLFRHPHIIKLYQ--VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ 118
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPE 194
           QIL  + Y H H   ++HRDLK +N+ ++ +    KI D GL+ +M      R+  G+P 
Sbjct: 119 QILSAVDYCHRHM--VVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPN 175
Query: 195 FMAPELYEEEY--NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245
           + APE+          VDI+S G+ +  ++    P+++   P  ++KK+  G+
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-LFKKIRGGV 227

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 121/262 (46%), Gaps = 43/262 (16%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS---EVHLLKSLKH 85
           Y++ +GKG F  V+KG    D   VA   + + D     + +E+      EV ++ +L H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ------ILR 139
            NI+K Y       +    M+ E    G L      H+ +D      W+ +      I  
Sbjct: 83  PNIVKLYGL----MHNPPRMVMEFVPCGDLY-----HRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEV--KIGDLGLAIVMQQP--TARSVIGTP 193
           G+ Y+ + NPPI+HRDL+  NIF+     N  V  K+ D G +   QQ   +   ++G  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS---QQSVHSVSGLLGNF 190
Query: 194 EFMAPELY---EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-------S 243
           ++MAPE     EE Y E  D YSF M +  ++T E P++E       Y K+         
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-----YGKIKFINMIREE 245
Query: 244 GIKPASLSKVTDPQVKQFIEKC 265
           G++P ++ +   P+++  IE C
Sbjct: 246 GLRP-TIPEDCPPRLRNVIELC 266

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 133/261 (50%), Gaps = 14/261 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LGKGAF  V +   +  G+E A   +N + +  S    ++L  E  + + L+H NI++
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVR 92
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            ++S  +++     ++ +L T G L +     +        +  +QIL  + Y HS+   
Sbjct: 93  LHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG-- 148
Query: 151 IIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE-YN 206
           I+HR+LK +N+ +        VK+ D GLAI +    A     GTP +++PE+ +++ Y+
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 208
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEK 264
           + VDI++ G+ IL ++   YP    ++  ++Y ++ +G    P+       P+ K  I+ 
Sbjct: 209 KPVDIWACGV-ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267
Query: 265 CI-VPASLRLPALELLKDPFL 284
            + V    R+ A + LK P++
Sbjct: 268 MLTVNPKKRITADQALKVPWI 288

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 133/261 (50%), Gaps = 14/261 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LGKGAF  V +   +  G+E A   +N + +  S    ++L  E  + + L+H NI++
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVR 69
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            ++S  +++     ++ +L T G L +     +        +  +QIL  + Y HS+   
Sbjct: 70  LHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG-- 125
Query: 151 IIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE-YN 206
           I+HR+LK +N+ +        VK+ D GLAI +    A     GTP +++PE+ +++ Y+
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEK 264
           + VDI++ G+ IL ++   YP    ++  ++Y ++ +G    P+       P+ K  I+ 
Sbjct: 186 KPVDIWACGV-ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244
Query: 265 CI-VPASLRLPALELLKDPFL 284
            + V    R+ A + LK P++
Sbjct: 245 MLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 133/261 (50%), Gaps = 14/261 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LGKGAF  V +   +  G+E A   +N + +  S    ++L  E  + + L+H NI++
Sbjct: 11  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVR 68
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            ++S  +++     ++ +L T G L +     +        +  +QIL  + Y HS+   
Sbjct: 69  LHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG-- 124
Query: 151 IIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE-YN 206
           I+HR+LK +N+ +        VK+ D GLAI +    A     GTP +++PE+ +++ Y+
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 184
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEK 264
           + VDI++ G+ IL ++   YP    ++  ++Y ++ +G    P+       P+ K  I+ 
Sbjct: 185 KPVDIWACGV-ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 243
Query: 265 CI-VPASLRLPALELLKDPFL 284
            + V    R+ A + LK P++
Sbjct: 244 MLTVNPKKRITADQALKVPWI 264

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 133/261 (50%), Gaps = 14/261 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LGKGAF  V +   +  G+E A   +N + +  S    ++L  E  + + L+H NI++
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVR 69
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            ++S  +++     ++ +L T G L +     +        +  +QIL  + Y HS+   
Sbjct: 70  LHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG-- 125
Query: 151 IIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE-YN 206
           I+HR+LK +N+ +        VK+ D GLAI +    A     GTP +++PE+ +++ Y+
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEK 264
           + VDI++ G+ IL ++   YP    ++  ++Y ++ +G    P+       P+ K  I+ 
Sbjct: 186 KPVDIWACGV-ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244
Query: 265 CI-VPASLRLPALELLKDPFL 284
            + V    R+ A + LK P++
Sbjct: 245 MLTVNPKKRITADQALKVPWI 265

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 12/233 (5%)
Query: 18  SEKDPSCRYGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
           S+ D   + G Y   + LG G F  V  G  ++ G +VA   +N + + +S D + ++  
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIKR 60
Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           E+  LK  +H +IIK Y   V  T     M+ E  + G L  Y  KH  V+    +   +
Sbjct: 61  EIQNLKLFRHPHIIKLYQ--VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ 118
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPE 194
           QIL  + Y H H   ++HRDLK +N+ ++ +    KI D GL+ +M      R   G+P 
Sbjct: 119 QILSAVDYCHRHM--VVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRDSCGSPN 175
Query: 195 FMAPELYEEEY--NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245
           + APE+          VDI+S G+ +  ++    P+++   P  ++KK+  G+
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-LFKKIRGGV 227

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 121/262 (46%), Gaps = 43/262 (16%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS---EVHLLKSLKH 85
           Y++ +GKG F  V+KG    D   VA   + + D     + +E+      EV ++ +L H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ------ILR 139
            NI+K Y       +    M+ E    G L      H+ +D      W+ +      I  
Sbjct: 83  PNIVKLYGL----MHNPPRMVMEFVPCGDLY-----HRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEV--KIGDLGLAIVMQQP--TARSVIGTP 193
           G+ Y+ + NPPI+HRDL+  NIF+     N  V  K+ D  L+   QQ   +   ++G  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS---QQSVHSVSGLLGNF 190
Query: 194 EFMAPELY---EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-------S 243
           ++MAPE     EE Y E  D YSF M +  ++T E P++E       Y K+         
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-----YGKIKFINMIREE 245
Query: 244 GIKPASLSKVTDPQVKQFIEKC 265
           G++P ++ +   P+++  IE C
Sbjct: 246 GLRP-TIPEDCPPRLRNVIELC 266

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 135/265 (50%), Gaps = 21/265 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LGKGAF  V +    + G E A   +N + +  S    ++L  E  + + LKH NI++
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVR 74
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            ++S  ++ +    +I +L T G L +    R+ +   D     +  +QIL  +  LH H
Sbjct: 75  LHDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAV--LHCH 127
Query: 148 NPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPE-LYE 202
              ++HR+LK +N+ +        VK+ D GLAI +  +Q       GTP +++PE L +
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQ 260
           + Y + VD+++ G+ IL ++   YP    ++  ++Y+++ +G    P+       P+ K 
Sbjct: 188 DPYGKPVDLWACGV-ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246
Query: 261 FIEKCI-VPASLRLPALELLKDPFL 284
            I K + +  S R+ A E LK P++
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWI 271

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 117/245 (47%), Gaps = 17/245 (6%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G    V+K   +  G+ +A   +++E     P    ++  E+ +L       I+ FY
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++  D   +I M  E    GSL Q  KK   +  + +   +  +++GL YL   +  I+
Sbjct: 71  GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M+PE L    Y+   DI
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 212 YSFGMCILEMVTCEYPY------NECKNPAQIYK---KVTSGIKPASLSKVTDPQVKQFI 262
           +S G+ ++EM    YP        + + P  I++    + +   P   S V   + + F+
Sbjct: 187 WSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 246
Query: 263 EKCIV 267
            KC++
Sbjct: 247 NKCLI 251

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 116/226 (51%), Gaps = 20/226 (8%)
Query: 12  TEEGEFSEKDPSC---RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVM 64
           +E+   +E DP+    R+ +    LG+G F  V    Y    +  G +VA   +  E   
Sbjct: 5   SEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--- 61
Query: 65  QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 124
              + +  L  E+ +L++L HENI+K+     +D    I +I E   SGSL++Y  K+KN
Sbjct: 62  SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN 121
Query: 125 -VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-- 181
            +++K    +A QI +G+ YL S     +HRDL   N+ V   + +VKIGD GL   +  
Sbjct: 122 KINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEH-QVKIGDFGLTKAIET 178
Query: 182 --QQPTARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
             +  T +    +P F  APE L + ++    D++SFG+ + E++T
Sbjct: 179 DKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 17/202 (8%)
Query: 33  LGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           LG+G F  V    Y    +  G +VA   +  E      + +  L  E+ +L++L HENI
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENI 73
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSH 147
           +K+     +D    I +I E   SGSL++Y  K+KN +++K    +A QI +G+ YL S 
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEF-MAPE-LY 201
               +HRDL   N+ V   + +VKIGD GL   +    +  T +    +P F  APE L 
Sbjct: 134 Q--YVHRDLAARNVLVESEH-QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 202 EEEYNELVDIYSFGMCILEMVT 223
           + ++    D++SFG+ + E++T
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 138/273 (50%), Gaps = 18/273 (6%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSE 76
           +++ P     R  + +GKG F  V      + G EVA   V I D  Q +   L++L+ E
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVA---VRIIDKTQLNSSSLQKLFRE 63
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
           V ++K L H NI+K +   V +T +T+ ++ E  + G +  Y   H  +  K  +   RQ
Sbjct: 64  VRIMKVLNHPNIVKLFE--VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-GTPEF 195
           I+  + Y   H   I+HRDLK +N+ ++ +   +KI D G +             G+P +
Sbjct: 122 IVSAVQY--CHQKFIVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPY 178
Query: 196 MAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLS 251
            APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  +S
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRGKYRIPFYMS 237
Query: 252 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 284
              +  +K+F+   I+  S R    +++KD ++
Sbjct: 238 TDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 138/273 (50%), Gaps = 18/273 (6%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSE 76
           +++ P     R  + +GKG F  V      + G EVA   V I D  Q +   L++L+ E
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVA---VKIIDKTQLNSSSLQKLFRE 63
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
           V ++K L H NI+K +   V +T +T+ ++ E  + G +  Y   H  +  K  +   RQ
Sbjct: 64  VRIMKVLNHPNIVKLFE--VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-GTPEF 195
           I+  + Y   H   I+HRDLK +N+ ++ +   +KI D G +             G+P +
Sbjct: 122 IVSAVQY--CHQKFIVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPY 178
Query: 196 MAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLS 251
            APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  +S
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRGKYRIPFYMS 237
Query: 252 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 284
              +  +K+F+   I+  S R    +++KD ++
Sbjct: 238 TDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 115/239 (48%), Gaps = 15/239 (6%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G    V+K   +  G+ +A   +++E     P    ++  E+ +L       I+ FY
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 73
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++  D   +I M  E    GSL Q  KK   +  + +   +  +++GL YL   +  I+
Sbjct: 74  GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 130
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           HRD+K  NI VN + GE+K+ D G++  +    A   +GT  +M+PE L    Y+   DI
Sbjct: 131 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTHYSVQSDI 189
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYK---KVTSGIKPASLSKVTDPQVKQFIEKCIV 267
           +S G+ ++EM    YP    + P  I++    + +   P   S V   + + F+ KC++
Sbjct: 190 WSMGLSLVEMAVGRYP----RPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLI 244

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 138/273 (50%), Gaps = 18/273 (6%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSE 76
           +++ P     R  + +GKG F  V      + G EVA   V I D  Q +   L++L+ E
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVA---VKIIDKTQLNSSSLQKLFRE 63
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
           V ++K L H NI+K +   V +T +T+ ++ E  + G +  Y   H  +  K  +   RQ
Sbjct: 64  VRIMKVLNHPNIVKLFE--VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-GTPEF 195
           I+  + Y   H   I+HRDLK +N+ ++ +   +KI D G +             G+P +
Sbjct: 122 IVSAVQY--CHQKFIVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPY 178
Query: 196 MAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLS 251
            APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  +S
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRGKYRIPFYMS 237
Query: 252 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 284
              +  +K+F+   I+  S R    +++KD ++
Sbjct: 238 TDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 132/263 (50%), Gaps = 17/263 (6%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LGKGAF  V +   +    E A   +N + +  S    ++L  E  + + LKH NI++
Sbjct: 37  EELGKGAFSVVRRCVKKTPTQEYAAKIINTKKL--SARDHQKLEREARICRLLKHPNIVR 94
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            ++S  ++      ++ +L T G L +     +        +   QIL  ++++H H+  
Sbjct: 95  LHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHD-- 150
Query: 151 IIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE-LYEEEY 205
           I+HRDLK +N+ +        VK+ D GLAI +Q  Q       GTP +++PE L ++ Y
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPY 210
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIE 263
            + VDI++ G+ IL ++   YP    ++  ++Y+++ +G    P+       P+ K  I 
Sbjct: 211 GKPVDIWACGV-ILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 269
Query: 264 KCIV--PASLRLPALELLKDPFL 284
           + +   PA  R+ A + LK P++
Sbjct: 270 QMLTINPAK-RITADQALKHPWV 291

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 137/273 (50%), Gaps = 18/273 (6%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSE 76
           +++ P     R  + +GKG F  V      + G EVA   V I D  Q +   L++L+ E
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVA---VKIIDKTQLNSSSLQKLFRE 63
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
           V ++K L H NI+K +   V +T +T+ ++ E  + G +  Y   H  +  K  +   RQ
Sbjct: 64  VRIMKVLNHPNIVKLFE--VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-GTPEF 195
           I+  + Y   H   I+HRDLK +N+ ++ +   +KI D G +             G P +
Sbjct: 122 IVSAVQY--CHQKFIVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAPPY 178
Query: 196 MAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLS 251
            APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  +S
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRGKYRIPFYMS 237
Query: 252 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 284
              +  +K+F+   I+  S R    +++KD ++
Sbjct: 238 TDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 13/223 (5%)
Query: 6   GFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
            F   + + GE  + D    + R  E LG G    V K      G+ +A   +++E    
Sbjct: 2   AFLTQKAKVGELKDDD----FERISE-LGAGNGGVVTKVQHRPSGLIMARKLIHLE---I 53
Query: 66  SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
            P    ++  E+ +L       I+ FY ++  D   +I M  E    GSL Q  K+ K +
Sbjct: 54  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKEAKRI 111
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185
             + +   +  +LRGL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    
Sbjct: 112 PEEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSM 169
Query: 186 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
           A S +GT  +MAPE L    Y+   DI+S G+ ++E+    YP
Sbjct: 170 ANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 133/291 (45%), Gaps = 26/291 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD-QLERLYSEVHLLKSLKHENII 89
           E++GKG F  V +  +   G + A   V++     SP    E L  E  +   LKH +I+
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGLHYLH 145
           +   ++  D    + M+ E      L     K  +           ++ RQIL  L Y H
Sbjct: 92  ELLETYSSDG--MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 149
Query: 146 SHNPPIIHRDLK--CDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY 201
            +N  IIHRD+K  C  +    N+  VK+G  G+AI + +    A   +GTP FMAPE+ 
Sbjct: 150 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 202 EEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQ 257
           + E Y + VD++  G+ +  +++   P+   K   ++++ +  G   + P   S +++  
Sbjct: 208 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYKMNPRQWSHISE-S 264
Query: 258 VKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
            K  + + ++  PA  R+   E L  P+L     +D     + LP  V ++
Sbjct: 265 AKDLVRRMLMLDPAE-RITVYEALNHPWL---KERDRYAYKIHLPETVEQL 311

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDXELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F S  L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 69  KLLD--VIHTENKLYLVFE-FLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK +N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 126 R--VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT 202

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 112/239 (46%), Gaps = 20/239 (8%)
Query: 25  RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           R+ +Y   LGKG F +V    Y    +  G  VA  Q+        PDQ      E+ +L
Sbjct: 10  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREIQIL 65
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILR 139
           K+L  + I+K+         +++ ++ E   SG LR + ++H+  +D   +  ++ QI +
Sbjct: 66  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 125
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----- 194
           G+ YL S     +HRDL   NI V  +   VKI D GLA ++       V+  P      
Sbjct: 126 GMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 182
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
           + APE L +  ++   D++SFG+ + E+ T  Y    C   A+  + + S     +LS+
Sbjct: 183 WYAPESLSDNIFSRQSDVWSFGVVLYELFT--YCDKSCSPSAEFLRMMGSERDVPALSR 239

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/246 (32%), Positives = 123/246 (50%), Gaps = 20/246 (8%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   +D   G+++A  +++     QS    +R Y E+ LLK +KH
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 109
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +   T+      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 167
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-- 199
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE  
Sbjct: 168 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 223
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPAS-LSKVTDP 256
           L    YN  VDI+S G  + E++T    +P  +  N  Q   ++T G  PAS +S++   
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLT-GTPPASVISRMPSH 282
Query: 257 QVKQFI 262
           + + +I
Sbjct: 283 EARNYI 288

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 132/281 (46%), Gaps = 24/281 (8%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 87
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 145
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAP 198
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA    + TA  + G   T  + AP
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA----RHTADEMTGYVATRWYRAP 198
Query: 199 ELYEE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVT 254
           E+      YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 255 DPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
               + +I+       +    + +  +P  V    K LV D
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 299

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 66
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F S  L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 67  KLLD--VIHTENKLYLVFE-FLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK +N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 124 R--VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 181 YYSTAVDIWSLGCIFAEMVT 200

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 133/291 (45%), Gaps = 26/291 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD-QLERLYSEVHLLKSLKHENII 89
           E++GKG F  V +  +   G + A   V++     SP    E L  E  +   LKH +I+
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGLHYLH 145
           +   ++  D    + M+ E      L     K  +           ++ RQIL  L Y H
Sbjct: 90  ELLETYSSDG--MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 146 SHNPPIIHRDLK--CDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY 201
            +N  IIHRD+K  C  +    N+  VK+G  G+AI + +    A   +GTP FMAPE+ 
Sbjct: 148 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 202 EEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQ 257
           + E Y + VD++  G+ +  +++   P+   K   ++++ +  G   + P   S +++  
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYKMNPRQWSHISE-S 262
Query: 258 VKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
            K  + + ++  PA  R+   E L  P+L     +D     + LP  V ++
Sbjct: 263 AKDLVRRMLMLDPAE-RITVYEALNHPWL---KERDRYAYKIHLPETVEQL 309

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 132/281 (46%), Gaps = 24/281 (8%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 87
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 145
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAP 198
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA    + TA  + G   T  + AP
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA----RHTADEMTGYVATRWYRAP 198
Query: 199 ELYEE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVT 254
           E+      YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 255 DPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
               + +I+       +    + +  +P  V    K LV D
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 299

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 140
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVN-EDSELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 196
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 257 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 294

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 132/281 (46%), Gaps = 24/281 (8%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 87
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 145
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAP 198
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA    + TA  + G   T  + AP
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA----RHTADEMTGYVATRWYRAP 198
Query: 199 ELYEE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVT 254
           E+      YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 255 DPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
               + +I+       +    + +  +P  V    K LV D
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 299

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 86
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 144
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVN-EDSELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 200
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 261 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 298

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G    V+K   +  G+ +A   +++E     P    ++  E+ +L       I+ FY
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 132
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++  D   +I M  E    GSL Q  KK   +  + +   +  +++GL YL   +  I+
Sbjct: 133 GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 189
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M+PE L    Y+   DI
Sbjct: 190 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 248
Query: 212 YSFGMCILEMVTCEYP 227
           +S G+ ++EM    YP
Sbjct: 249 WSMGLSLVEMAVGRYP 264

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 138/273 (50%), Gaps = 18/273 (6%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSE 76
           +++ P     R  + +GKG F  V      + G EVA   V I D  Q +   L++L+ E
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVA---VRIIDKTQLNSSSLQKLFRE 63
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
           V ++K L H NI+K +   V +T +T+ ++ E  + G +  Y   H  +  K  +   RQ
Sbjct: 64  VRIMKVLNHPNIVKLFE--VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEF 195
           I+  + Y   H   I+HRDLK +N+ ++ +   +KI D G +             G+P +
Sbjct: 122 IVSAVQY--CHQKFIVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSPPY 178
Query: 196 MAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLS 251
            APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  +S
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRGKYRIPFYMS 237
Query: 252 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 284
              +  +K+F+   I+  S R    +++KD ++
Sbjct: 238 TDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 129/269 (47%), Gaps = 23/269 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG GAF  VYK  ++  G   A   +      +S ++LE    E+ +L +  H  I+K  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIET----KSEEELEDYIVEIEILATCDHPYIVKLL 74
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
            ++  D    I  + E    G++     +  + +    I+   RQ+L  L++LHS    I
Sbjct: 75  GAYYHDGKLWI--MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--I 130
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE------LYEE 203
           IHRDLK  N+ +    G++++ D G++    +   +  S IGTP +MAPE      + + 
Sbjct: 131 IHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFI 262
            Y+   DI+S G+ ++EM   E P++E  NP ++  K+     P  L+      + + F+
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 248
Query: 263 EKCIVP-ASLRLPALELLKDPFL--VTDN 288
           +  +      R  A +LL+ PF+  +T N
Sbjct: 249 KIALDKNPETRPSAAQLLEHPFVSSITSN 277

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 129/269 (47%), Gaps = 23/269 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG GAF  VYK  ++  G   A   +      +S ++LE    E+ +L +  H  I+K  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIET----KSEEELEDYIVEIEILATCDHPYIVKLL 82
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
            ++  D    I  + E    G++     +  + +    I+   RQ+L  L++LHS    I
Sbjct: 83  GAYYHDGKLWI--MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--I 138
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE------LYEE 203
           IHRDLK  N+ +    G++++ D G++    +   +  S IGTP +MAPE      + + 
Sbjct: 139 IHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFI 262
            Y+   DI+S G+ ++EM   E P++E  NP ++  K+     P  L+      + + F+
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256
Query: 263 EKCIVP-ASLRLPALELLKDPFL--VTDN 288
           +  +      R  A +LL+ PF+  +T N
Sbjct: 257 KIALDKNPETRPSAAQLLEHPFVSSITSN 285

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 133/266 (50%), Gaps = 23/266 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LGKGAF  V +      G E A   +N + +  S    ++L  E  + + LKH NI++
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL--SARDHQKLEREARICRLLKHPNIVR 67
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            ++S  ++      ++ +L T G L +    R+ +   D     +  +QIL  ++  H H
Sbjct: 68  LHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESVN--HCH 120
Query: 148 NPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE-LYE 202
              I+HRDLK +N+ +        VK+ D GLAI +Q  Q       GTP +++PE L +
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQ 260
           + Y + VD+++ G+ IL ++   YP    ++  ++Y+++ +G    P+       P+ K 
Sbjct: 181 DPYGKPVDMWACGV-ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 239
Query: 261 FIEKCIV--PASLRLPALELLKDPFL 284
            I K +   PA  R+ A E LK P++
Sbjct: 240 LINKMLTINPAK-RITASEALKHPWI 264

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG+G + TVYKG  ++    VA  ++ +E    +P    R   EV LLK LKH NI+  +
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVTLH 66
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPI 151
           +  +  T +++ ++ E +    L+QY     N ++M  +K +  Q+LRGL Y H     +
Sbjct: 67  D--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--V 121
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE--LYEEEYNE 207
           +HRDLK  N+ +N   GE+K+ D GLA     PT    + + T  +  P+  L   +Y+ 
Sbjct: 122 LHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYST 180
Query: 208 LVDIYSFGMCILEMVT 223
            +D++  G    EM T
Sbjct: 181 QIDMWGVGCIFYEMAT 196

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 85
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 143
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVN-EDXELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 199
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 260 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 297

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 118/248 (47%), Gaps = 22/248 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQV-NIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           E +G GA+  V      + G +VA  ++ N  DV+ +    +R   E+ +LK  KH+NII
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN---AKRTLRELKILKHFKHDNII 117
Query: 90  KFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
              +           +++ ++ +L  S  L Q     + + ++ ++ +  Q+LRGL Y+H
Sbjct: 118 AIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH 176
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------QQPTARSVIGTPEFMAPE 199
           S    +IHRDLK  N+ VN  N E+KIGD G+A  +       Q      + T  + APE
Sbjct: 177 SAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 200 LY--EEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
           L     EY + +D++S G    EM+     +P     +  Q+   V     PA +  V  
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 293
Query: 256 PQVKQFIE 263
            +V+ +I+
Sbjct: 294 ERVRAYIQ 301

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 91
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 149
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVN-EDXELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 205
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 266 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 303

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-- 199
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
           L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 85
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 143
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVN-EDXELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 199
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 260 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 297

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G    V+K   +  G+ +A   +++E     P    ++  E+ +L       I+ FY
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++  D   +I M  E    GSL Q  KK   +  + +   +  +++GL YL   +  I+
Sbjct: 71  GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M+PE L    Y+   DI
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 212 YSFGMCILEMVTCEYP 227
           +S G+ ++EM    YP
Sbjct: 187 WSMGLSLVEMAVGRYP 202

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LGKGAF  V +      G E A   +N + +  S    ++L  E  + + LKH NI++
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL--SARDHQKLEREARICRLLKHPNIVR 67
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            ++S  ++      ++ +L T G L +     +        +  +QIL  ++  H H   
Sbjct: 68  LHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN--HCHLNG 123
Query: 151 IIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE-LYEEEY 205
           I+HRDLK +N+ +        VK+ D GLAI +Q  Q       GTP +++PE L ++ Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIE 263
            + VD+++ G+ IL ++   YP    ++  ++Y+++ +G    P+       P+ K  I 
Sbjct: 184 GKPVDMWACGV-ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 264 KCIV--PASLRLPALELLKDPFL 284
           K +   PA  R+ A E LK P++
Sbjct: 243 KMLTINPAK-RITASEALKHPWI 264

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKH 78
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 136
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 137 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 192
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 252
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 253 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 290

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 100
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 158
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 214
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 275 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 312

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--KPFQSIIHAKRTYRELRLLKHMKH 92
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 150
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 206
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 267 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 304

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G    V+K   +  G+ +A   +++E     P    ++  E+ +L       I+ FY
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++  D   +I M  E    GSL Q  KK   +  + +   +  +++GL YL   +  I+
Sbjct: 71  GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M+PE L    Y+   DI
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 212 YSFGMCILEMVTCEYP 227
           +S G+ ++EM    YP
Sbjct: 187 WSMGLSLVEMAVGRYP 202

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 127/278 (45%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKSQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GL            + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDSELKILDFGLCRHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 99
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 157
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 213
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 274 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 311

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 136/270 (50%), Gaps = 18/270 (6%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHE 86
           R  + +GKG F  V      + G EVA   V I D  Q +   L++L+ EV ++K L H 
Sbjct: 10  RLLKTIGKGNFAKVKLARHILTGKEVA---VKIIDKTQLNSSSLQKLFREVRIMKVLNHP 66
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NI+K +   V +T +T+ ++ E  + G +  Y   H  +  K  +   RQI+  + Y   
Sbjct: 67  NIVKLFE--VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQY--C 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-GTPEFMAPELYE-EE 204
           H   I+HRDLK +N+ ++ +   +KI D G +             G+P + APEL++ ++
Sbjct: 123 HQKFIVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 181
Query: 205 YNE-LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQF 261
           Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  +S   +  +K+F
Sbjct: 182 YDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 240
Query: 262 IEKCIVPASLRLPALELLKDPFLVTDNPKD 291
           +   I+  S R    +++KD ++   +  D
Sbjct: 241 L---ILNPSKRGTLEQIMKDRWMNVGHEDD 267

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 92
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 150
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 206
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 267 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 304

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 118/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 58  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 116
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 117 QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 174
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T  ++ GTPE++APE 
Sbjct: 175 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGATW-TLCGTPEYLAPEI 230
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 274

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 92
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 150
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 206
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 267 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 304

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 118/248 (47%), Gaps = 22/248 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQV-NIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           E +G GA+  V      + G +VA  ++ N  DV+ +    +R   E+ +LK  KH+NII
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNA---KRTLRELKILKHFKHDNII 116
Query: 90  KFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
              +           +++ ++ +L  S  L Q     + + ++ ++ +  Q+LRGL Y+H
Sbjct: 117 AIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH 175
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------QQPTARSVIGTPEFMAPE 199
           S    +IHRDLK  N+ VN  N E+KIGD G+A  +       Q      + T  + APE
Sbjct: 176 SAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 200 LY--EEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
           L     EY + +D++S G    EM+     +P     +  Q+   V     PA +  V  
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292
Query: 256 PQVKQFIE 263
            +V+ +I+
Sbjct: 293 ERVRAYIQ 300

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GXVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 140
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 196
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 257 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 294

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F S  L+ +        + +  IK++  Q+L+GL + HSH
Sbjct: 69  KLLD--VIHTENKLYLVFE-FLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 126 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT 202

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 103
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 161
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 217
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 277
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 278 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 315

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 86
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 144
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 200
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 261 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 298

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 17  FSEKDPSC---RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
           ++ +DP+    R+ +Y   LGKG F +V    Y    +  G  VA  Q+        PDQ
Sbjct: 12  YACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQ 67
Query: 70  LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMK 128
                 E+ +LK+L  + I+K+         +++ ++ E   SG LR + ++H+  +D  
Sbjct: 68  QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS 127
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
            +  ++ QI +G+ YL S     +HRDL   NI V  +   VKI D GLA ++       
Sbjct: 128 RLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYY 184
Query: 189 VIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           V+  P      + APE L +  ++   D++SFG+ + E+ T
Sbjct: 185 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 91
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 149
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 205
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 266 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 303

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 140
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 196
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 257 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 294

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 25  RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           R+ +Y   LGKG F +V    Y    +  G  VA  Q+        PDQ      E+ +L
Sbjct: 11  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREIQIL 66
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILR 139
           K+L  + I+K+         +++ ++ E   SG LR + ++H+  +D   +  ++ QI +
Sbjct: 67  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 126
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----- 194
           G+ YL S     +HRDL   NI V  +   VKI D GLA ++       V+  P      
Sbjct: 127 GMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 183
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           + APE L +  ++   D++SFG+ + E+ T
Sbjct: 184 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 140
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 196
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 257 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 294

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G    V+K   +  G+ +A   +++E     P    ++  E+ +L       I+ FY
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++  D   +I M  E    GSL Q  KK   +  + +   +  +++GL YL   +  I+
Sbjct: 98  GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 154
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M+PE L    Y+   DI
Sbjct: 155 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 213
Query: 212 YSFGMCILEMVTCEYP 227
           +S G+ ++EM    YP
Sbjct: 214 WSMGLSLVEMAVGRYP 229

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 103
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 161
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA-RHTDDEMXGYVATRWYRAPEIM 217
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 277
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 278 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 315

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G    V+K   +  G+ +A   +++E     P    ++  E+ +L       I+ FY
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++  D   +I M  E    GSL Q  KK   +  + +   +  +++GL YL   +  I+
Sbjct: 71  GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M+PE L    Y+   DI
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 212 YSFGMCILEMVTCEYP 227
           +S G+ ++EM    YP
Sbjct: 187 WSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G    V+K   +  G+ +A   +++E     P    ++  E+ +L       I+ FY
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++  D   +I M  E    GSL Q  KK   +  + +   +  +++GL YL   +  I+
Sbjct: 71  GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M+PE L    Y+   DI
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 212 YSFGMCILEMVTCEYP 227
           +S G+ ++EM    YP
Sbjct: 187 WSMGLSLVEMAVGRYP 202

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 85
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 143
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 199
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 260 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 297

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 76
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 134
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 190
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 288

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 87
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 145
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 201
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 299

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 77
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 135
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 191
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 252 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 289

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G  VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKH 76
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 134
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA       A   + T  + APE+ 
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMA-GFVATRWYRAPEIM 190
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 251 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 288

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 67
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F S  L+ +        + +  IK++  Q+L+GL + HSH
Sbjct: 68  KLLD--VIHTENKLYLVFE-FLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 125 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 182 YYSTAVDIWSLGCIFAEMVT 201

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 77
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 135
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 191
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 252 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 289

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G  VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA       A   + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMA-GFVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 85
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 143
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 199
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 260 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 297

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 79
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 137
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 138 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 193
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 253
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 254 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 291

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G  VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA       A   + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMA-GFVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 115/231 (49%), Gaps = 13/231 (5%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSE 76
           +++ P     R  + +GKG F  V      + G EVA   V I D  Q +   L++L+ E
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVA---VKIIDKTQLNSSSLQKLFRE 63
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
           V + K L H NI+K +   V +T +T+ ++ E  + G +  Y   H     K  +   RQ
Sbjct: 64  VRIXKVLNHPNIVKLFE--VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ 121
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-GTPEF 195
           I+  + Y   H   I+HRDLK +N+ ++ +   +KI D G +             G P +
Sbjct: 122 IVSAVQY--CHQKFIVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAPPY 178
Query: 196 MAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
            APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRG 228

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 72
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 73  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEE 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE  L  +
Sbjct: 130 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 186
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 187 YYSTAVDIWSLGCIFAEMVT 206

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 86
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 144
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 200
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 261 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 298

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 29/213 (13%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLY-SEVHLLKSLKHEN 87
           + E+LGKG F    K      G EV    + ++++++  ++ +R +  EV +++ L+H N
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETG-EV----MVMKELIRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHS 146
           ++KF      D  + +N ITE    G+LR   K            ++A+ I  G+ YLHS
Sbjct: 69  VLKFIGVLYKD--KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA------------RSVI 190
            N  IIHRDL   N  V   N  V + D GLA +M     QP               +V+
Sbjct: 127 MN--IIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 191 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 222
           G P +MAPE+     Y+E VD++SFG+ + E++
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 67
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 68  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK +N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 125 R--VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 182 YYSTAVDIWSLGCIFAEMVT 201

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 132/268 (49%), Gaps = 18/268 (6%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG+G+F  V          +VA   ++   +++  D   R+  E+  LK L+H +IIK
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            Y+  V  T   I M+ E +  G L  Y  + K +     + + +QI+  + Y H H   
Sbjct: 74  LYD--VITTPTDIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK-- 128
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEEY--NE 207
           I+HRDLK +N+ ++ +N  VKI D GL+ +M      ++  G+P + APE+   +     
Sbjct: 129 IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASLSKVTDPQVKQFIEKC 265
            VD++S G+ +  M+    P+++   P  ++KKV S   + P  LS    P  +  I + 
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIP-NLFKKVNSCVYVMPDFLS----PGAQSLIRRM 242
Query: 266 IVPASL-RLPALELLKDPFLVTDNPKDL 292
           IV   + R+   E+ +DP+   + P  L
Sbjct: 243 IVADPMQRITIQEIRRDPWFNVNLPDYL 270

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 66
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 67  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK +N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 124 R--VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 181 YYSTAVDIWSLGCIFAEMVT 200

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 9/213 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G+F  V+      +G   A   +  E V++   Q+E    E  +L  + H  II+ +
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            ++ D   + I MI +    G L    +K +       K +A ++   L YLHS +  II
Sbjct: 73  GTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--II 128
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           +RDLK +NI ++  NG +KI D G A  +   T   + GTP+++APE+   + YN+ +D 
Sbjct: 129 YRDLKPENILLD-KNGHIKITDFGFAKYVPDVTY-XLCGTPDYIAPEVVSTKPYNKSIDW 186
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +SFG+ I EM+    P+ +  N  + Y+K+ + 
Sbjct: 187 WSFGILIYEMLAGYTPFYDS-NTMKTYEKILNA 218

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLAGTPEYLAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 66  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEE 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE  L  +
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 179
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT 199

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLXGTPEYLAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 84
           RY+ +  +G GA+ TVYK  D   G  VA   V + +  +  P    R  + +  L++ +
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 85  HENIIKFYNS-WVDDTNRTINMITELF--TSGSLRQYRKKHKNVDMKA--IKNWARQILR 139
           H N+++  +      T+R I  +T +F      LR Y  K     + A  IK+  RQ LR
Sbjct: 65  HPNVVRLMDVCATSRTDREIK-VTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAP 198
           GL +LH++   I+HRDLK +NI V  + G VK+ D GLA I   Q     V+ T  + AP
Sbjct: 124 GLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRAP 180
Query: 199 E-LYEEEYNELVDIYSFGMCILEM 221
           E L +  Y   VD++S G    EM
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 128/260 (49%), Gaps = 11/260 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   +      +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 20  LGKGKFGNVYLARERQSKFILAL-KVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 79  GYFHDATR--VYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR--VI 134
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+NGE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 135 HRDIKPENLLL-GSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 193
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-AS 270
           +S G+   E +    P+ E     + Y+++ S ++      VT+   +  I + +   AS
Sbjct: 194 WSLGVLCYEFLVGMPPF-EAHTYQETYRRI-SRVEFTFPDFVTE-GARDLISRLLKHNAS 250
Query: 271 LRLPALELLKDPFLVTDNPK 290
            RL   E+L+ P++  ++ K
Sbjct: 251 QRLTLAEVLEHPWIKANSSK 270

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 132/262 (50%), Gaps = 15/262 (5%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   +      +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 20  LGKGKFGNVYLARERQSKFILAL-KVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 79  GYFHDATR--VYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR--VI 134
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE-YNELV 209
           HRD+K +N+ + G+NGE+KI D G ++    P++R  ++ GT +++ PE+ E   ++E V
Sbjct: 135 HRDIKPENLLL-GSNGELKIADFGWSV--HAPSSRRDTLCGTLDYLPPEMIEGRMHDEKV 191
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP- 268
           D++S G+   E +    P+ E     + Y+++ S ++      VT+   +  I + +   
Sbjct: 192 DLWSLGVLCYEFLVGMPPF-EAHTYQETYRRI-SRVEFTFPDFVTE-GARDLISRLLKHN 248
Query: 269 ASLRLPALELLKDPFLVTDNPK 290
           AS RL   E+L+ P++  ++ K
Sbjct: 249 ASQRLTLAEVLEHPWIKANSSK 270

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDAGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDYGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 72
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 73  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 130 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 186
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 187 YYSTAVDIWSLGCIFAEMVT 206

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 69  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 126 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT 202

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 69
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 70  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 127 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 183
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 184 YYSTAVDIWSLGCIFAEMVT 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 67
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 68  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 125 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 182 YYSTAVDIWSLGCIFAEMVT 201

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/212 (34%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE-RLYSEVHL 79
           S    RY+ +  +G GA+ TVYK  D   G  VA   V + +       L      EV L
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 80  LKSLK---HENIIKFYNS-WVDDTNRTINMITELF--TSGSLRQYRKKHKNVDMKA--IK 131
           L+ L+   H N+++  +      T+R I  +T +F      LR Y  K     + A  IK
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIK-VTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVI 190
           +  RQ LRGL +LH++   I+HRDLK +NI V  + G VK+ D GLA I   Q     V+
Sbjct: 124 DLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVV 180
Query: 191 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 221
            T  + APE L +  Y   VD++S G    EM
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 64
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 65  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 122 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 179 YYSTAVDIWSLGCIFAEMVT 198

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 66  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 69  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 126 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 67
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 68  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 125 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 182 YYSTAVDIWSLGCIFAEMVT 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 66  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT 199

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDRGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 84
           RY+ +  +G GA+ TVYK  D   G  VA   V + +  +  P    R  + +  L++ +
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 85  HENIIKFYNS-WVDDTNRTINMITELF--TSGSLRQYRKKHKNVDMKA--IKNWARQILR 139
           H N+++  +      T+R I  +T +F      LR Y  K     + A  IK+  RQ LR
Sbjct: 65  HPNVVRLMDVCATSRTDREIK-VTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAP 198
           GL +LH++   I+HRDLK +NI V  + G VK+ D GLA I   Q     V+ T  + AP
Sbjct: 124 GLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRAP 180
Query: 199 E-LYEEEYNELVDIYSFGMCILEM 221
           E L +  Y   VD++S G    EM
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 66
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 67  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 124 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 180
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 181 YYSTAVDIWSLGCIFAEMVT 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 69
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 70  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 127 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 183
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 184 YYSTAVDIWSLGCIFAEMVT 203

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 66  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT 199

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 25  RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           R+ +Y   LGKG F +V    Y    +  G  VA  Q+        PDQ      E+ +L
Sbjct: 7   RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREIQIL 62
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILR 139
           K+L  + I+K+           + ++ E   SG LR + ++H+  +D   +  ++ QI +
Sbjct: 63  KALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 122
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----- 194
           G+ YL S     +HRDL   NI V  +   VKI D GLA ++       V+  P      
Sbjct: 123 GMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIF 179
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           + APE L +  ++   D++SFG+ + E+ T
Sbjct: 180 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 64
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 65  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 122 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 179 YYSTAVDIWSLGCIFAEMVT 198

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 64
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 65  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 122 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 179 YYSTAVDIWSLGCIFAEMVT 198

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 66
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 67  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 124 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 181 YYSTAVDIWSLGCIFAEMVT 200

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYMPGGDMFSHLRRIGRFSEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIKVADFGFAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+ +        + +  IK++  Q+L+GL + HSH
Sbjct: 66  KLLD--VIHTENKLYLVFE-FLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK +N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 123 R--VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT 199

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 66  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT 199

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 66  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT 199

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 66
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 67  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 124 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 181 YYSTAVDIWSLGCIFAEMVT 200

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYMPGGDMFSHLRRIGRFSEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIKVADFGFAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 66  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 64
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 65  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 122 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 179 YYSTAVDIWSLGCIFAEMVT 198

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 38  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 96
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 97  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 155 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 210
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 84
           RY+ +  +G GA+ TVYK  D   G  VA   V + +  +  P    R  + +  L++ +
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 85  HENIIKFYNS-WVDDTNRTINMITELF--TSGSLRQYRKKHKNVDMKA--IKNWARQILR 139
           H N+++  +      T+R I  +T +F      LR Y  K     + A  IK+  RQ LR
Sbjct: 65  HPNVVRLMDVCATSRTDREIK-VTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAP 198
           GL +LH++   I+HRDLK +NI V  + G VK+ D GLA I   Q     V+ T  + AP
Sbjct: 124 GLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRAP 180
Query: 199 E-LYEEEYNELVDIYSFGMCILEM 221
           E L +  Y   VD++S G    EM
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 66  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT 199

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADEPIQIYEKIVSG 253

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 58  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 116
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 117 QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT 174
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 175 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 230
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 274

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 100/198 (50%), Gaps = 7/198 (3%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++ +   +A  +V  +  ++      +L  E+ +   L+H NI++ Y
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMAL-KVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
           N + D   + I ++ E    G L +  +KH   D +    +  ++   LHY H     +I
Sbjct: 81  NYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VI 136
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDI 211
           HRD+K +N+ + G  GE+KI D G ++       R + GT +++ PE+ E + ++E VD+
Sbjct: 137 HRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDL 195
Query: 212 YSFGMCILEMVTCEYPYN 229
           +  G+   E +    P++
Sbjct: 196 WCAGVLCYEFLVGMPPFD 213

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIKVADFGFAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 66  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 64
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 65  KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 122 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 179 YYSTAVDIWSLGCIFAEMVT 198

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 24  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 82
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 83  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 140
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 141 FEYLHSLD--LIYRDLKPENLLID-EQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 196
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 240

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLIID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 IISKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 100/198 (50%), Gaps = 7/198 (3%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++ +   +A  +V  +  ++      +L  E+ +   L+H NI++ Y
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMAL-KVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 81
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
           N + D   + I ++ E    G L +  +KH   D +    +  ++   LHY H     +I
Sbjct: 82  NYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VI 137
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDI 211
           HRD+K +N+ + G  GE+KI D G ++       R + GT +++ PE+ E + ++E VD+
Sbjct: 138 HRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDL 196
Query: 212 YSFGMCILEMVTCEYPYN 229
           +  G+   E +    P++
Sbjct: 197 WCAGVLCYEFLVGMPPFD 214

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 32  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 90
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 91  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT 148
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 149 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 204
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 205 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 248

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDGGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G  VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 99
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 157
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 213
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 274 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 311

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E F    L+ +        + +  IK++  Q+L+GL + HSH
Sbjct: 69  KLLD--VIHTENKLYLVFE-FLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 126 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT 202

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G  VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 100
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 158
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA-RHTDDEMXGXVATRWYRAPEIM 214
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 275 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 312

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G  VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 100
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 158
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 214
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 275 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 312

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G  VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKH 76
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 134
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 190
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 251 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 288

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G  VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 16/215 (7%)
Query: 19  EKDPSCRYGRYDEI---LGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQS-PDQLERL 73
           EKD  CR  +  E    +G+GA+  V+K  D  +G   VA  +V ++   +  P    R 
Sbjct: 2   EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 74  YSEVHLLKSLKHENIIKFYNS-WVDDTNRTINMITELF--TSGSLRQYRKK--HKNVDMK 128
            + +  L++ +H N+++ ++   V  T+R   + T +F      L  Y  K     V  +
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTAR 187
            IK+   Q+LRGL +LHSH   ++HRDLK  NI V  ++G++K+ D GLA +   Q    
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALT 177
Query: 188 SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 221
           SV+ T  + APE L +  Y   VD++S G    EM
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G  VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 90
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 148
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 149 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 204
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 264
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 265 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 302

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L+++    ++K  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+ D++N  + M+ E    G +  + ++         + +A QI+    YLHS +  +I
Sbjct: 109 FSFKDNSN--LYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LI 164
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           +RDLK +N+ ++   G +K+ D G A  ++  T   + GTPE++APE +  + YN+ VD 
Sbjct: 165 YRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW-XLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 223 WALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G  VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 86
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 144
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 200
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 261 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 298

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I +M    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYQMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L+++    ++K  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+ D++N  + M+ E    G +  + ++         + +A QI+    YLHS +  +I
Sbjct: 108 YSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LI 163
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           +RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE +  + YN+ VD 
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 222 WALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L+++    ++K  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+ D++N  + M+ E    G +  + ++         + +A QI+    YLHS +  +I
Sbjct: 108 YSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LI 163
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           +RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE +  + YN+ VD 
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 222 WALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L+++    ++K  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+ D++N  + M+ E    G +  + ++         + +A QI+    YLHS +  +I
Sbjct: 108 YSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LI 163
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           +RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE +  + YN+ VD 
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 222 WALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 129/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 42  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 100
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 101 GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 156
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 157 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 215
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 216 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 272
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 273 QRPMLREVLEHPWITANSSKPSNCQ 297

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 16/215 (7%)
Query: 19  EKDPSCRYGRYDEI---LGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQS-PDQLERL 73
           EKD  CR  +  E    +G+GA+  V+K  D  +G   VA  +V ++   +  P    R 
Sbjct: 2   EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 74  YSEVHLLKSLKHENIIKFYNS-WVDDTNRTINMITELF--TSGSLRQYRKK--HKNVDMK 128
            + +  L++ +H N+++ ++   V  T+R   + T +F      L  Y  K     V  +
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTAR 187
            IK+   Q+LRGL +LHSH   ++HRDLK  NI V  ++G++K+ D GLA +   Q    
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALT 177
Query: 188 SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 221
           SV+ T  + APE L +  Y   VD++S G    EM
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 127/278 (45%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI   GLA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILGFGLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 16/215 (7%)
Query: 19  EKDPSCRYGRYDEI---LGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQS-PDQLERL 73
           EKD  CR  +  E    +G+GA+  V+K  D  +G   VA  +V ++   +  P    R 
Sbjct: 2   EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 74  YSEVHLLKSLKHENIIKFYNS-WVDDTNRTINMITELF--TSGSLRQYRKK--HKNVDMK 128
            + +  L++ +H N+++ ++   V  T+R   + T +F      L  Y  K     V  +
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTAR 187
            IK+   Q+LRGL +LHSH   ++HRDLK  NI V  ++G++K+ D GLA +   Q    
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALT 177
Query: 188 SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 221
           SV+ T  + APE L +  Y   VD++S G    EM
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G  VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 76
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCAKLTD-DHVQFLIYQILRGL 134
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  + APE+ 
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIM 190
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 251 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 288

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L+++    ++K  
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+ D++N  + M+ E    G +  + ++         + +A QI+    YLHS +  +I
Sbjct: 129 FSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LI 184
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           +RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE +  + YN+ VD 
Sbjct: 185 YRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEIILSKGYNKAVDW 242
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 243 WALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 274

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 129/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 16  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 75  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 130
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 131 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 190 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 246
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 247 QRPMLREVLEHPWITANSSKPSNCQ 271

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 118/241 (48%), Gaps = 16/241 (6%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G GA+ +V   +D     +VA  +++     QS     R Y E+ LLK LKHEN+I   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLS--RPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 93  NSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           + +   T+      + ++T L   G+      K + +  + ++    Q+LRGL Y+HS  
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYN 206
             IIHRDLK  N+ VN  + E++I D GLA    +      + T  + APE+      YN
Sbjct: 152 --IIHRDLKPSNVAVN-EDSELRILDFGLARQADEEMT-GYVATRWYRAPEIMLNWMHYN 207
Query: 207 ELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
           + VDI+S G  + E++  +  +P ++  +  +   +V     P  L+K++    + +I+ 
Sbjct: 208 QTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQS 267
Query: 265 C 265
Sbjct: 268 L 268

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 97/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 70  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEP 127
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T  +
Sbjct: 128 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-T 183
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 184 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 239

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 97/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 85  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T  +
Sbjct: 143 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-T 198
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L+++    ++K  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+ D++N  + M+ E    G +  + ++         + +A QI+    YLHS +  +I
Sbjct: 109 FSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LI 164
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           +RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE +  + YN+ VD 
Sbjct: 165 YRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 223 WALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 129/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 33  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 91
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 92  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 147
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 148 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 206
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 207 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 263
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 264 QRPMLREVLEHPWITANSSKPSNCQ 288

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 129/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 19  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 78  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 133
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 134 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDL 192
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 193 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 249
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 250 QRPMLREVLEHPWITANSSKPSNCQ 274

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L+++    ++K  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+ D++N  + M+ E    G +  + ++         + +A QI+    YLHS +  +I
Sbjct: 109 FSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LI 164
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           +RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE +  + YN+ VD 
Sbjct: 165 YRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 223 WALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L+++    ++K  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+ D++N  + M+ E    G +  + ++         + +A QI+    YLHS +  +I
Sbjct: 101 FSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LI 156
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           +RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE +  + YN+ VD 
Sbjct: 157 YRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEIILSKGYNKAVDW 214
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 215 WALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 246

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L+++    ++K  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+ D++N  + M+ E    G +  + ++         + +A QI+    YLHS +  +I
Sbjct: 109 FSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LI 164
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           +RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE +  + YN+ VD 
Sbjct: 165 YRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 223 WALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 129/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 21  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 80  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 135
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 136 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 194
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 195 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 251
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 252 QRPMLREVLEHPWITANSSKPSNCQ 276

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 129/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 19  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 78  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 133
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 134 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 192
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 193 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 249
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 250 QRPMLREVLEHPWITANSSKPSNCQ 274

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 128/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 21  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G + +  +K    D +    +  ++   L Y HS    +I
Sbjct: 80  GYFHDATR--VYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR--VI 135
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 136 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 194
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 195 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 251
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 252 QRPMLREVLEHPWITANSSKPSNCQ 276

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 133/267 (49%), Gaps = 15/267 (5%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 17  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 76  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 131
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE-YNELV 209
           HRD+K +N+ + G+ GE+KI D G ++    P++R  ++ GT +++ PE+ E   ++E V
Sbjct: 132 HRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRDTLCGTLDYLPPEMIEGRMHDEKV 188
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPA 269
           D++S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +   
Sbjct: 189 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHN 245
Query: 270 SLRLPAL-ELLKDPFLVTDNPKDLVCD 295
             + P L E+L+ P++  ++ K   C 
Sbjct: 246 PSQRPMLREVLEHPWITANSSKPSNCQ 272

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 116/225 (51%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE +APE 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEALAPEI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L+++    ++K  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+ D++N  + M+ E    G +  + ++         + +A QI+    YLHS +  +I
Sbjct: 101 FSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD--LI 156
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           +RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++APE +  + YN+ VD 
Sbjct: 157 YRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPEIILSKGYNKAVDW 214
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 215 WALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 246

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 97/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           ++E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  EIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D GLA  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIKVTDFGLAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 21  DPSCRYGRYDEI---LGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL 73
           DP+  + RY +    LG+G F  V    Y   ++  G  VA   +  +     P      
Sbjct: 24  DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGW 80
Query: 74  YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
             E+ +L++L HE+IIK+     D    ++ ++ E    GSLR Y  +H ++ +  +  +
Sbjct: 81  KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLF 139
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSV 189
           A+QI  G+ YLH+ +   IHRDL   N+ ++ N+  VKIGD GLA  +    +    R  
Sbjct: 140 AQQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVRED 196
Query: 190 IGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
             +P F  APE L E ++    D++SFG+ + E++T
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 116/225 (51%), Gaps = 11/225 (4%)
Query: 23  SCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           + +  ++D I  LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRIL 95
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +++    ++K   S+ D++N  + M+ E    G +  + ++         + +A QI+  
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 199
             YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GTPE++AP  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGTPEYLAPAI 209
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 31  EILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
           ++LG GAF TVYKG    +G    I VA   + I +    P        E  ++ S+ H 
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 100
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLH 145
           ++++     +   + TI ++T+L   G L +Y  +HK N+  + + NW  QI +G+ YL 
Sbjct: 101 HLVRLLGVCL---SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 157
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPE-L 200
                ++HRDL   N+ V   N  VKI D GLA +++    +  A       ++MA E +
Sbjct: 158 ERR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 201 YEEEYNELVDIYSFGMCILEMVT 223
           +  ++    D++S+G+ I E++T
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMT 237

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYAPGGEMFSHLRRIGRFXEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 106/211 (50%), Gaps = 8/211 (3%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 16  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 75  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 130
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 131 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
           +S G+   E +  + P+ E     + YK+++
Sbjct: 190 WSLGVLCYEFLVGKPPF-EANTYQETYKRIS 219

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 128/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 16  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 75  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 130
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++         + GT +++ PE+ E   ++E VD+
Sbjct: 131 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 190 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 246
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 247 QRPMLREVLEHPWITANSSKPSNCQ 271

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 106/211 (50%), Gaps = 8/211 (3%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 15  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 73
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 74  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 129
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 130 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 188
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
           +S G+   E +  + P+ E     + YK+++
Sbjct: 189 WSLGVLCYEFLVGKPPF-EANTYQETYKRIS 218

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 132/267 (49%), Gaps = 15/267 (5%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 42  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 100
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 101 GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 156
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPELYEEE-YNELV 209
           HRD+K +N+ + G+ GE+KI D G ++    P++R   + GT +++ PE+ E   ++E V
Sbjct: 157 HRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRDDLCGTLDYLPPEMIEGRMHDEKV 213
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPA 269
           D++S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +   
Sbjct: 214 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHN 270
Query: 270 SLRLPAL-ELLKDPFLVTDNPKDLVCD 295
             + P L E+L+ P++  ++ K   C 
Sbjct: 271 PSQRPMLREVLEHPWITANSSKPSNCQ 297

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 106/211 (50%), Gaps = 8/211 (3%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 20  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 79  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 134
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 135 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 193
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
           +S G+   E +  + P+ E     + YK+++
Sbjct: 194 WSLGVLCYEFLVGKPPF-EANTYQETYKRIS 223

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 128/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 21  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 80  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 135
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE  E   ++E VD+
Sbjct: 136 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKVDL 194
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 195 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 251
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 252 QRPXLREVLEHPWITANSSKPSNCQ 276

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSL 83
           RY R  + LG+G +  VYK  D V    VA  ++ +E   +  P    R   EV LLK L
Sbjct: 35  RYRRITK-LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---EVSLLKEL 90
Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
           +H NII+  +  V   N  +++I E +    L++Y  K+ +V M+ IK++  Q++ G+++
Sbjct: 91  QHRNIIELKS--VIHHNHRLHLIFE-YAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIVMQQPTARSV--IGTPEFMA 197
            HS     +HRDLK  N+ ++ ++      +KIGD GLA     P  +    I T  +  
Sbjct: 148 CHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRP 205
Query: 198 PE--LYEEEYNELVDIYSFGMCILEMV 222
           PE  L    Y+  VDI+S      EM+
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 127/265 (47%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 21  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G + +  +K    D +    +  ++   L Y HS    +I
Sbjct: 80  GYFHDATR--VYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR--VI 135
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++         + GT +++ PE+ E   ++E VD+
Sbjct: 136 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVDL 194
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 195 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 251
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 252 QRPMLREVLEHPWITANSSKPSNCQ 276

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 85  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   
Sbjct: 143 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-X 198
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 128/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 18  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 76
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 77  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 132
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++         + GT +++ PE+ E   ++E VD+
Sbjct: 133 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDL 191
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 192 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 248
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 249 QRPMLREVLEHPWITANSSKPSNCQ 273

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E      L+++        + +  IK++  Q+L+GL + HSH
Sbjct: 69  KLLD--VIHTENKLYLVFE-HVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 126 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT 202

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 106/211 (50%), Gaps = 8/211 (3%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 19  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 78  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 133
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 134 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 192
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
           +S G+   E +  + P+ E     + YK+++
Sbjct: 193 WSLGVLCYEFLVGKPPF-EANTYQETYKRIS 222

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 128/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 16  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 75  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 130
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++         + GT +++ PE+ E   ++E VD+
Sbjct: 131 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 190 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 246
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 247 QRPMLREVLEHPWITANSSKPSNCQ 271

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 128/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 21  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 80  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 135
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++         + GT +++ PE+ E   ++E VD+
Sbjct: 136 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDL 194
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 195 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 251
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 252 QRPMLREVLEHPWITANSSKPSNCQ 276

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 128/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 17  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 76  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 131
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++         + GT +++ PE+ E   ++E VD+
Sbjct: 132 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDL 190
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 191 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 247
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 248 QRPMLREVLEHPWITANSSKPSNCQ 272

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 110/213 (51%), Gaps = 9/213 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G+F  V     +  G   A   ++ + V++   Q+E   +E  + +++    ++K  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKL-KQIEHTLNEKRIQQAVNFPFLVKLE 108
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+ D++N  + M+ E    G +  + ++         + +A QI+    YLHS +  +I
Sbjct: 109 FSFKDNSN--LYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LI 164
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           +RDLK +N+ ++   G +K+ D G A  ++  T   + GTPE++APE +  + YN+ VD 
Sbjct: 165 YRDLKPENLLID-QQGYIKVADFGFAKRVKGRTW-XLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 223 WALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 31  EILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
           ++LG GAF TVYKG      E   I VA   + I +    P        E  ++ S+ H 
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 77
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLH 145
           ++++     +   + TI ++T+L   G L +Y  +HK N+  + + NW  QI +G+ YL 
Sbjct: 78  HLVRLLGVCL---SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 134
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPE-L 200
                ++HRDL   N+ V   N  VKI D GLA +++    +  A       ++MA E +
Sbjct: 135 ERR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 201 YEEEYNELVDIYSFGMCILEMVT 223
           +  ++    D++S+G+ I E++T
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 20/216 (9%)
Query: 21  DPSCRYGRYDEI---LGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL 73
           DP+  + RY +    LG+G F  V    Y   ++  G  VA   +  +     P      
Sbjct: 7   DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---CGPQHRSGW 63
Query: 74  YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
             E+ +L++L HE+IIK+     D   +++ ++ E    GSLR Y  +H ++ +  +  +
Sbjct: 64  KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLF 122
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSV 189
           A+QI  G+ YLHS +   IHR+L   N+ ++ N+  VKIGD GLA  + +       R  
Sbjct: 123 AQQICEGMAYLHSQH--YIHRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVRED 179
Query: 190 IGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
             +P F  APE L E ++    D++SFG+ + E++T
Sbjct: 180 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 118/239 (49%), Gaps = 16/239 (6%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G GA+ +V   +D     +VA  +++     QS     R Y E+ LLK LKHEN+I   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLS--RPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 93  NSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           + +   T+      + ++T L   G+      K + +  + ++    Q+LRGL Y+HS  
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYN 206
             IIHRDLK  N+ VN  + E++I D GLA    +      + T  + APE+      YN
Sbjct: 152 --IIHRDLKPSNVAVN-EDSELRILDFGLARQADEEMT-GYVATRWYRAPEIMLNWMHYN 207
Query: 207 ELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263
           + VDI+S G  + E++  +  +P ++  +  +   +V     P  L+K++    + +I+
Sbjct: 208 QTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFXEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 134/277 (48%), Gaps = 24/277 (8%)
Query: 26  YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHL 79
           Y +YD  +++G+G    V +      G E A   + +     SP+QLE +      E H+
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 80  LKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
           L+ +  H +II   +S+  +++  + ++ +L   G L  Y  +   +  K  ++  R +L
Sbjct: 153 LRQVAGHPHIITLIDSY--ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMA 197
             + +LH++N  I+HRDLK +NI ++ +N ++++ D G +  ++     R + GTP ++A
Sbjct: 211 EAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267
Query: 198 PELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
           PE+ +         Y + VD+++ G+ +  ++    P+   +    + + +  G    S 
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSS 326
Query: 251 SKVTD--PQVKQFIEKCI-VPASLRLPALELLKDPFL 284
            +  D    VK  I + + V    RL A + L+ PF 
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 128/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 16  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 75  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 130
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++         + GT +++ PE+ E   ++E VD+
Sbjct: 131 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 190 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 246
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 247 QRPMLREVLEHPWITANSSKPSNCQ 271

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFXEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 109/213 (51%), Gaps = 12/213 (5%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 19  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 78  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 133
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPELYEEE-YNELV 209
           HRD+K +N+ + G+ GE+KI D G ++    P++R   + GT +++ PE+ E   ++E V
Sbjct: 134 HRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRDDLCGTLDYLPPEMIEGRMHDEKV 190
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
           D++S G+   E +  + P+ E     + YK+++
Sbjct: 191 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 222

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 85  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVPGGEMFSHLRRIGRFXEP 142
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   
Sbjct: 143 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-X 198
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 8/211 (3%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 16  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 75  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 130
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++         + GT +++ PE+ E   ++E VD+
Sbjct: 131 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
           +S G+   E +  + P+ E     + YK+++
Sbjct: 190 WSLGVLCYEFLVGKPPF-EANTYQETYKRIS 219

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIQVTDFGFAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 8/211 (3%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 16  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 75  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 130
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++         + GT +++ PE+ E   ++E VD+
Sbjct: 131 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
           +S G+   E +  + P+ E     + YK+++
Sbjct: 190 WSLGVLCYEFLVGKPPF-EANTYQETYKRIS 219

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 106/211 (50%), Gaps = 8/211 (3%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 13  LGKGKFGNVYLAREKQRKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 71
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 72  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 127
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 128 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 186
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
           +S G+   E +  + P+ E     + YK+++
Sbjct: 187 WSLGVLCYEFLVGKPPF-EANTYQETYKRIS 216

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 8/211 (3%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 16  LGKGKFGNVYLAREKNSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 75  GYFHDSTR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK--VI 130
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 131 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
           +S G+   E +  + P+ E       YK+++
Sbjct: 190 WSLGVLCYEFLVGKPPF-EANTYQDTYKRIS 219

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    + K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 85  QIEHTLNEKRILQAVNFPFLTKLEFSFKDNSN--LYMVMEYAPGGEMFSHLRRIGRFSEP 142
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   
Sbjct: 143 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW-X 198
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    + K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 85  QIEHTLNEKRILQAVNFPFLTKLEFSFKDNSN--LYMVMEYAPGGEMFSHLRRIGRFSEP 142
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   
Sbjct: 143 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW-X 198
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 132/277 (47%), Gaps = 16/277 (5%)
Query: 29  YD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLK 84
           YD  E LG G F  V K  ++  G+E A   +       S   + R  +  EV +L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H N+I  ++ + + T+  + +I EL + G L  +  + +++  +   ++ +QIL G++YL
Sbjct: 74  HHNVITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 145 HSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPEL 200
           H+    I H DLK +NI +   N     +K+ D GLA  ++     +++ GTPEF+APE+
Sbjct: 132 HTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 201 YEEEYNEL-VDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
              E   L  D++S G+    +++   P+  + K          S          T    
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 259 KQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 293
           K FI K +V  +  RL   E L+ P++   DN + +V
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 8/211 (3%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 19  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 78  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 133
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G ++         + GT +++ PE+ E   ++E VD+
Sbjct: 134 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDL 192
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
           +S G+   E +  + P+ E     + YK+++
Sbjct: 193 WSLGVLCYEFLVGKPPF-EANTYQETYKRIS 222

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 97/177 (54%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           ++E   +E  +L+++    ++K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 84  EIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D GLA  ++  T   
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIQVTDFGLAKRVKGRTW-X 197
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 132/277 (47%), Gaps = 16/277 (5%)
Query: 29  YD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLK 84
           YD  E LG G F  V K  ++  G+E A   +       S   + R  +  EV +L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H N+I  ++ + + T+  + +I EL + G L  +  + +++  +   ++ +QIL G++YL
Sbjct: 74  HHNVITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 145 HSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPEL 200
           H+    I H DLK +NI +   N     +K+ D GLA  ++     +++ GTPEF+APE+
Sbjct: 132 HTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 201 YEEEYNEL-VDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
              E   L  D++S G+    +++   P+  + K          S          T    
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 259 KQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 293
           K FI K +V  +  RL   E L+ P++   DN + +V
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +++ G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 64
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 147
           K  +  V  T   + ++ E      L+ +        + +  IK++  Q+L+GL + HSH
Sbjct: 65  KLLD--VIHTENKLYLVFE-HVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E 203
              ++HRDLK  N+ +N   G +K+ D GLA     P  T    + T  + APE+    +
Sbjct: 122 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 204 EYNELVDIYSFGMCILEMVT 223
            Y+  VDI+S G    EMVT
Sbjct: 179 YYSTAVDIWSLGCIFAEMVT 198

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 129/265 (48%), Gaps = 11/265 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 18  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 76
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 77  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 132
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI + G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 133 HRDIKPENLLL-GSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 191
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
           +S G+   E +  + P+ E     + YK++ S ++      VT+   +  I + +     
Sbjct: 192 WSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GARDLISRLLKHNPS 248
Query: 272 RLPAL-ELLKDPFLVTDNPKDLVCD 295
           + P L E+L+ P++  ++ K   C 
Sbjct: 249 QRPMLREVLEHPWITANSSKPSNCQ 273

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           ILG+G F  VYKG    DG  VA  ++  E       Q +   +EV ++    H N+++ 
Sbjct: 45  ILGRGGFGKVYKG-RLADGTLVAVKRLKEERXQGGELQFQ---TEVEMISMAVHRNLLRL 100
Query: 92  YNSWVDDTNRTINMITELFTSGS----LRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
               +  T R   ++     +GS    LR+  +    +D    +  A    RGL YLH H
Sbjct: 101 RGFCMTPTERL--LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 158
Query: 148 -NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPE-LYE 202
            +P IIHRD+K  NI ++    E  +GD GLA +M         +V GT   +APE L  
Sbjct: 159 CDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLST 217
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYN 229
            + +E  D++ +G+ +LE++T +  ++
Sbjct: 218 GKSSEKTDVFGYGVMLLELITGQRAFD 244

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 8/177 (4%)
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
           Q+E   +E  +L+++    + K   S+ D++N  + M+ E    G +  + ++       
Sbjct: 85  QIEHTLNEKRILQAVNFPFLTKLEFSFKDNSN--LYMVMEYAPGGEMFSHLRRIGRFXEP 142
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
             + +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   
Sbjct: 143 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW-X 198
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           + GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 20/216 (9%)
Query: 21  DPSCRYGRYDEI---LGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL 73
           DP+  + RY +    LG+G F  V    Y   ++  G  VA   +  +     P      
Sbjct: 7   DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---CGPQHRSGW 63
Query: 74  YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
             E+ +L++L HE+IIK+     D   +++ ++ E    GSLR Y  +H ++ +  +  +
Sbjct: 64  KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLF 122
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSV 189
           A+QI  G+ YLH+ +   IHR+L   N+ ++ N+  VKIGD GLA  + +       R  
Sbjct: 123 AQQICEGMAYLHAQH--YIHRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVRED 179
Query: 190 IGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
             +P F  APE L E ++    D++SFG+ + E++T
Sbjct: 180 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 118/239 (49%), Gaps = 16/239 (6%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G GA+ +V   +D     +VA  +++     QS     R Y E+ LLK LKHEN+I   
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLS--RPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 93  NSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           + +   T+      + ++T L   G+      K + +  + ++    Q+LRGL Y+HS  
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG 143
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYN 206
             IIHRDLK  N+ VN  + E++I D GLA    +      + T  + APE+      YN
Sbjct: 144 --IIHRDLKPSNVAVN-EDCELRILDFGLARQADEEMT-GYVATRWYRAPEIMLNWMHYN 199
Query: 207 ELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263
           + VDI+S G  + E++  +  +P ++  +  +   +V     P  L+K++    + +I+
Sbjct: 200 QTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 258

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 12/219 (5%)
Query: 17  FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LY 74
           F ++D    Y   +E LG G F  V K   +  G E A   +    +  S   + R  + 
Sbjct: 5   FRQEDVEDHYEMGEE-LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE 63
Query: 75  SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 134
            EV++L+ ++H NII  ++ + + T+  + +I EL + G L  +  + +++       + 
Sbjct: 64  REVNILREIRHPNIITLHDIFENKTD--VVLILELVSGGELFDFLAEKESLTEDEATQFL 121
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVI 190
           +QIL G+HYLHS    I H DLK +NI +   N  N  +K+ D G+A  ++     +++ 
Sbjct: 122 KQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 179
Query: 191 GTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 228
           GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G GA+  V    D   G +VA  +  +    QS    +R Y E+ LLK ++HEN+I   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 93  NSWVDDTNRTINMITELFT----SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           + +  D   T++  T+ +      G+      KH+ +    I+    Q+L+GL Y+H+  
Sbjct: 91  DVFTPD--ETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYN 206
             IIHRDLK  N+ VN  + E+KI D GLA          V+ T  + APE  L    Y 
Sbjct: 149 --IIHRDLKPGNLAVN-EDCELKILDFGLARQADSEMXGXVV-TRWYRAPEVILNWMRYT 204
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASL 250
           + VDI+S G  + EM+T +  +    +  Q+ +  KVT G  PA  
Sbjct: 205 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT-GTPPAEF 249

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 15/216 (6%)
Query: 21  DPSCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEV 77
           D   R  RY+++  LG+G F TVYK  D+     VA  ++ +    ++ D + R    E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA-IKNWARQ 136
            LL+ L H NII   +++   +N  I+++ + F    L    K +  V   + IK +   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSN--ISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IGTPE 194
            L+GL YLH H   I+HRDLK +N+ ++  NG +K+ D GLA     P       + T  
Sbjct: 121 TLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYXHQVVTRW 177
Query: 195 FMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 228
           + APEL      Y   VD+++ G CIL  +    P+
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVG-CILAELLLRVPF 212

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 93
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGL--SYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELY-E 202
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A S +GT ++++PEL  E
Sbjct: 152 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +  ++  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 209 KSASKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 265
Query: 263 EKCIV 267
           EK +V
Sbjct: 266 EKLLV 270

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 106/211 (50%), Gaps = 8/211 (3%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 19  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 78  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 133
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI + G ++        ++ GT +++ PE+ E   ++E VD+
Sbjct: 134 HRDIKPENLLL-GSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 192
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
           +S G+   E +  + P+ E     + YK+++
Sbjct: 193 WSLGVLCYEFLVGKPPF-EANTYQETYKRIS 222

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG GAF  V+   +   G+E     +N +D  Q P  +E++ +E+ +LKSL H NIIK +
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTIN-KDRSQVP--MEQIEAEIEVLKSLDHPNIIKIF 86
Query: 93  NSWVDDTNRTINMIT----ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
             + D  N  I M T    EL       Q R   K +    +    +Q++  L Y HS +
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARG--KALSEGYVAELMKQMMNALAYFHSQH 144
Query: 149 PPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEY 205
             ++H+DLK +NI       +  +KI D GLA + +    + +  GT  +MAPE+++ + 
Sbjct: 145 --VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDV 202
Query: 206 NELVDIYSFGMCILEMVTCEYPYN 229
               DI+S G+ +  ++T   P+ 
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFT 226

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 8/211 (3%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     +A  +V  +  ++      +L  EV +   L+H NI++ Y
Sbjct: 17  LGKGKFGNVYLAREKQSKFILAL-KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
             + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    +I
Sbjct: 76  GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 131
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
           HRD+K +N+ + G+ GE+KI D G +         ++ GT +++ PE+ E   ++E VD+
Sbjct: 132 HRDIKPENLLL-GSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVDL 190
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
           +S G+   E +  + P+ E     + YK+++
Sbjct: 191 WSLGVLCYEFLVGKPPF-EANTYQETYKRIS 220

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G + TV+K  +      VA  +V ++D  +  P    R   E+ LLK LKH+NI+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIV 64
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHN 148
           + ++  V  +++ + ++ E F    L++Y    + ++D + +K++  Q+L+GL + HS N
Sbjct: 65  RLHD--VLHSDKKLTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPELY--EEE 204
             ++HRDLK  N+ +N  NGE+K+ D GLA     P     + + T  +  P++    + 
Sbjct: 122 --VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 205 YNELVDIYSFGMCILEMVTCEYP 227
           Y+  +D++S G    E+     P
Sbjct: 179 YSTSIDMWSAGCIFAELANAARP 201

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 18/278 (6%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G  VA  +++     QS    +R Y E+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +    +      + ++T L     L    K  K  D   ++    QILRGL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
            Y+HS +  IIHRDLK  N+ VN  + E+KI D  LA           + T  + APE+ 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFYLARHTDDEMT-GYVATRWYRAPEIM 194
Query: 202 EE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
                YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L K++   
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 258 VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 295
            + +I+       +    + +  +P  V    K LV D
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 132/277 (47%), Gaps = 16/277 (5%)
Query: 29  YD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLK 84
           YD  E LG G F  V K  ++  G+E A   +       S   + R  +  EV +L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H N+I  ++ + + T+  + +I EL + G L  +  + +++  +   ++ +QIL G++YL
Sbjct: 74  HHNVITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 145 HSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPEL 200
           H+    I H DLK +NI +   N     +K+ D GLA  ++     +++ GTPEF+APE+
Sbjct: 132 HT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 201 YEEEYNEL-VDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
              E   L  D++S G+    +++   P+  + K          S          T    
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 259 KQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 293
           K FI K +V  +  RL   E L+ P++   DN + +V
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 132/277 (47%), Gaps = 16/277 (5%)
Query: 29  YD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLK 84
           YD  E LG G F  V K  ++  G+E A   +       S   + R  +  EV +L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H N+I  ++ + + T+  + +I EL + G L  +  + +++  +   ++ +QIL G++YL
Sbjct: 74  HHNVITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 145 HSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPEL 200
           H+    I H DLK +NI +   N     +K+ D GLA  ++     +++ GTPEF+APE+
Sbjct: 132 HT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 201 YEEEYNEL-VDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
              E   L  D++S G+    +++   P+  + K          S          T    
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 259 KQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 293
           K FI K +V  +  RL   E L+ P++   DN + +V
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 132/278 (47%), Gaps = 18/278 (6%)
Query: 29  YD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLK 84
           YD  E LG G F  V K  ++  G+E A   +       S   + R  +  EV +L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 85  HENIIKFYNSWVDDTNRT-INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
           H N+I  ++ +    NRT + +I EL + G L  +  + +++  +   ++ +QIL G++Y
Sbjct: 74  HHNVITLHDVY---ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 199
           LH+    I H DLK +NI +   N     +K+ D GLA  ++     +++ GTPEF+APE
Sbjct: 131 LHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 200 LYEEEYNEL-VDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
           +   E   L  D++S G+    +++   P+  + K          S          T   
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 258 VKQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 293
            K FI K +V  +  RL   E L+ P++   DN + +V
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K   +  G E A   +    +  S   + R  +  EV++L+ ++H NI
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  ++ + + T+  + +I EL + G L  +  + +++       + +QIL G+HYLHS  
Sbjct: 71  ITLHDIFENKTD--VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 128
Query: 149 PPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N  N  +K+ D G+A  ++     +++ GTPEF+APE+   E
Sbjct: 129 --IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPF 211

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 119/246 (48%), Gaps = 18/246 (7%)
Query: 75  SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 134
           +E+ +LK L H  IIK  N + D  +  I  + EL   G L      +K +     K + 
Sbjct: 203 TEIEILKKLNHPCIIKIKN-FFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYF 259
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-ARSVIG 191
            Q+L  + YLH +   IIHRDLK +N+ ++    +  +KI D G + ++ + +  R++ G
Sbjct: 260 YQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 317
Query: 192 TPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--- 244
           TP ++APE+        YN  VD +S G+ +   ++   P++E +    +  ++TSG   
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 377
Query: 245 IKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN--- 301
             P   ++V++  +    +  +V    R    E L+ P+L  ++ K    D L   N   
Sbjct: 378 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENEST 437
Query: 302 LVPEVM 307
            +P+V+
Sbjct: 438 ALPQVL 443

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K   +  G E A   +    +  S   + R  +  EV++L+ ++H NI
Sbjct: 32  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  ++ + + T+  + +I EL + G L  +  + +++       + +QIL G+HYLHS  
Sbjct: 92  ITLHDIFENKTD--VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 149
Query: 149 PPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N  N  +K+ D G+A  ++     +++ GTPEF+APE+   E
Sbjct: 150 --IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 207
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 208 PLGLEADMWSIGVITYILLSGASPF 232

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 117/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 94
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 95  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A S +GT ++++PEL  E
Sbjct: 153 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 210 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 266
Query: 263 EKCIV 267
           EK +V
Sbjct: 267 EKLLV 271

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 130/293 (44%), Gaps = 24/293 (8%)
Query: 15  GEFSEKDPSCRYGRYD----EILGKGAFKTVYKG-FDEVDGIEVAWNQVNIE-DVMQSPD 68
           GE   +  +C  G  D    E LG G+F  V +G +D   G  V+     ++ DV+  P+
Sbjct: 4   GEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDM 127
            ++    EV+ + SL H N+I+ Y   +      + M+TEL   GSL    +KH+ +  +
Sbjct: 64  AMDDFIREVNAMHSLDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLL 120
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
             +  +A Q+  G+ YL S     IHRDL   N+ +   +  VKIGD GL   + Q    
Sbjct: 121 GTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH 177
Query: 188 SVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
            V+         + APE L    ++   D + FG+ + EM T         N +QI  K+
Sbjct: 178 XVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
Query: 242 TSGIKPASLSKVTD-PQ-VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDL 292
               +   L +  D PQ +   + +C        P    L+D FL+   P D+
Sbjct: 238 DK--EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD-FLLEAQPTDM 287

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 134/292 (45%), Gaps = 22/292 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLKHENI 88
           LG GA   V   F+     +VA   ++         +  D    + +E+ +LK L H  I
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           IK  N + D  +  I  + EL   G L      +K +     K +  Q+L  + YLH + 
Sbjct: 84  IKIKN-FFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 140
Query: 149 PPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY---- 201
             IIHRDLK +N+ ++    +  +KI D G + ++ + +  R++ GTP ++APE+     
Sbjct: 141 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG 198
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQV 258
              YN  VD +S G+ +   ++   P++E +    +  ++TSG     P   ++V++  +
Sbjct: 199 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 258
Query: 259 KQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN---LVPEVM 307
               +  +V    R    E L+ P+L  ++ K    D L   N    +P+V+
Sbjct: 259 DLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVL 310

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 134/292 (45%), Gaps = 22/292 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLKHENI 88
           LG GA   V   F+     +VA   ++         +  D    + +E+ +LK L H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           IK  N + D  +  I  + EL   G L      +K +     K +  Q+L  + YLH + 
Sbjct: 78  IKIKN-FFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 149 PPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY---- 201
             IIHRDLK +N+ ++    +  +KI D G + ++ + +  R++ GTP ++APE+     
Sbjct: 135 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG 192
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQV 258
              YN  VD +S G+ +   ++   P++E +    +  ++TSG     P   ++V++  +
Sbjct: 193 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252
Query: 259 KQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN---LVPEVM 307
               +  +V    R    E L+ P+L  ++ K    D L   N    +P+V+
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVL 304

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 120/250 (48%), Gaps = 24/250 (9%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 38  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 96
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 97  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 155 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-----PASLSKVTDPQ 257
           +   +  D+++ G CI+  +    P     N   I++K+   IK     PA+      P+
Sbjct: 212 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI---IKLEYDFPAAFF----PK 263
Query: 258 VKQFIEKCIV 267
            +  +EK +V
Sbjct: 264 ARDLVEKLLV 273

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 103/232 (44%), Gaps = 20/232 (8%)
Query: 23  SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
           +C      E LG G F  V +   +  G +VA  Q   E    SP   ER   E+ ++K 
Sbjct: 13  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKK 69
Query: 83  LKHENIIKFYNSWVDDTNRTIN------MITELFTSGSLRQYRKKHKN---VDMKAIKNW 133
           L H N++      V D  + +       +  E    G LR+Y  + +N   +    I+  
Sbjct: 70  LNHPNVVSARE--VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 127
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV--KIGDLGLAIVMQQ-PTARSVI 190
              I   L YLH +   IIHRDLK +NI +      +  KI DLG A  + Q       +
Sbjct: 128 LSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 185
Query: 191 GTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
           GT +++APEL E++ Y   VD +SFG    E +T   P+     P Q + KV
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 237

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 103/232 (44%), Gaps = 20/232 (8%)
Query: 23  SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
           +C      E LG G F  V +   +  G +VA  Q   E    SP   ER   E+ ++K 
Sbjct: 12  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKK 68
Query: 83  LKHENIIKFYNSWVDDTNRTIN------MITELFTSGSLRQYRKKHKN---VDMKAIKNW 133
           L H N++      V D  + +       +  E    G LR+Y  + +N   +    I+  
Sbjct: 69  LNHPNVVSARE--VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV--KIGDLGLAIVMQQ-PTARSVI 190
              I   L YLH +   IIHRDLK +NI +      +  KI DLG A  + Q       +
Sbjct: 127 LSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184
Query: 191 GTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
           GT +++APEL E++ Y   VD +SFG    E +T   P+     P Q + KV
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 134/292 (45%), Gaps = 22/292 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLKHENI 88
           LG GA   V   F+     +VA   ++         +  D    + +E+ +LK L H  I
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           IK  N + D  +  I  + EL   G L      +K +     K +  Q+L  + YLH + 
Sbjct: 77  IKIKN-FFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 133
Query: 149 PPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY---- 201
             IIHRDLK +N+ ++    +  +KI D G + ++ + +  R++ GTP ++APE+     
Sbjct: 134 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG 191
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQV 258
              YN  VD +S G+ +   ++   P++E +    +  ++TSG     P   ++V++  +
Sbjct: 192 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 251
Query: 259 KQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN---LVPEVM 307
               +  +V    R    E L+ P+L  ++ K    D L   N    +P+V+
Sbjct: 252 DLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVL 303

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 127/267 (47%), Gaps = 15/267 (5%)
Query: 29  YD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL--ERLYSEVHLLKSLK 84
           YD  E LG G F  V K  ++  G+E A   +       S   +  E +  EV +L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H NII  ++ + + T+  + +I EL + G L  +  + +++  +   ++ +QIL G++YL
Sbjct: 74  HPNIITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 145 HSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPEL 200
           H+    I H DLK +NI +   N     +K+ D GLA  ++     +++ GTPEF+APE+
Sbjct: 132 HTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 201 YEEEYNEL-VDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
              E   L  D++S G+    +++   P+  + K          S          T    
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 259 KQFIEKCIVPASL-RLPALELLKDPFL 284
           K FI K +V  +  RL   E L+ P++
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 111/226 (49%), Gaps = 15/226 (6%)
Query: 75  SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 134
           +E+ +LK L H  IIK  N + D  +  I  + EL   G L      +K +     K + 
Sbjct: 189 TEIEILKKLNHPCIIKIKN-FFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-ARSVIG 191
            Q+L  + YLH +   IIHRDLK +N+ ++    +  +KI D G + ++ + +  R++ G
Sbjct: 246 YQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 303
Query: 192 TPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--- 244
           TP ++APE+        YN  VD +S G+ +   ++   P++E +    +  ++TSG   
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363
Query: 245 IKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPK 290
             P   ++V++  +    +  +V    R    E L+ P+L  ++ K
Sbjct: 364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 134/292 (45%), Gaps = 22/292 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLKHENI 88
           LG GA   V   F+     +VA   ++         +  D    + +E+ +LK L H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           IK  N + D  +  I  + EL   G L      +K +     K +  Q+L  + YLH + 
Sbjct: 78  IKIKN-FFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 149 PPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY---- 201
             IIHRDLK +N+ ++    +  +KI D G + ++ + +  R++ GTP ++APE+     
Sbjct: 135 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG 192
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQV 258
              YN  VD +S G+ +   ++   P++E +    +  ++TSG     P   ++V++  +
Sbjct: 193 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252
Query: 259 KQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN---LVPEVM 307
               +  +V    R    E L+ P+L  ++ K    D L   N    +P+V+
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVL 304

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 19/283 (6%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLKHENI 88
           LG GA   V   F+     +VA   ++         +  D    + +E+ +LK L H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           IK  N + D  +  I  + EL   G L      +K +     K +  Q+L  + YLH + 
Sbjct: 78  IKIKN-FFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 149 PPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY---- 201
             IIHRDLK +N+ ++    +  +KI D G + ++ + +  R++ GTP ++APE+     
Sbjct: 135 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG 192
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQV 258
              YN  VD +S G+ +   ++   P++E +    +  ++TSG     P   ++V++  +
Sbjct: 193 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252
Query: 259 KQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
               +  +V    R    E L+ P+L  ++ K    D L   N
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEEN 295

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           ILG+G F  VYKG    DG  VA  ++  E       Q +   +EV ++    H N+++ 
Sbjct: 37  ILGRGGFGKVYKG-RLADGXLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHRNLLRL 92
Query: 92  YNSWVDDTNRTINMITELFTSGS----LRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
               +  T R   ++     +GS    LR+  +    +D    +  A    RGL YLH H
Sbjct: 93  RGFCMTPTERL--LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 150
Query: 148 -NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPE-LYE 202
            +P IIHRD+K  NI ++    E  +GD GLA +M         +V G    +APE L  
Sbjct: 151 CDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLST 209
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYN 229
            + +E  D++ +G+ +LE++T +  ++
Sbjct: 210 GKSSEKTDVFGYGVMLLELITGQRAFD 236

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 129/293 (44%), Gaps = 24/293 (8%)
Query: 15  GEFSEKDPSCRYGRYD----EILGKGAFKTVYKG-FDEVDGIEVAWNQVNIE-DVMQSPD 68
           GE   +  +C  G  D    E LG G+F  V +G +D   G  V+     ++ DV+  P+
Sbjct: 4   GEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDM 127
            ++    EV+ + SL H N+I+ Y   +      + M+TEL   GSL    +KH+ +  +
Sbjct: 64  AMDDFIREVNAMHSLDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLL 120
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
             +  +A Q+  G+ YL S     IHRDL   N+ +      VKIGD GL   + Q    
Sbjct: 121 GTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDH 177
Query: 188 SVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
            V+         + APE L    ++   D + FG+ + EM T         N +QI  K+
Sbjct: 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
Query: 242 TSGIKPASLSKVTD-PQ-VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDL 292
               +   L +  D PQ +   + +C        P    L+D FL+   P D+
Sbjct: 238 DK--EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD-FLLEAQPTDM 287

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 51/268 (19%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E++G G F  V+K    +DG      +V   +        E+   EV  L  L H NI+ 
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN--------EKAEREVKALAKLDHVNIVH 69
Query: 91  FYNSW---------VDDT------------------NRTINMITELFTSGSLRQY--RKK 121
           +   W          DD+                   + + +  E    G+L Q+  +++
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 122 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181
            + +D         QI +G+ Y+HS    +IHRDLK  NIF+  +  +VKIGD GL   +
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIHS--KKLIHRDLKPSNIFLV-DTKQVKIGDFGLVTSL 186
Query: 182 QQPTARS-VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQIY 238
           +    R+   GT  +M+PE +  ++Y + VD+Y+ G+ + E++  C+  +   K     +
Sbjct: 187 KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----FF 242
Query: 239 KKVTSGIKPASLSKVTDPQVKQFIEKCI 266
             +  GI    +S + D + K  ++K +
Sbjct: 243 TDLRDGI----ISDIFDKKEKTLLQKLL 266

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 117/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 91
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 92  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A + +GT ++++PEL  E
Sbjct: 150 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 207 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 263
Query: 263 EKCIV 267
           EK +V
Sbjct: 264 EKLLV 268

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 115/245 (46%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 93
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELY-E 202
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 152 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I+ K+          +   P+ +  +
Sbjct: 209 KSAXKSSDLWALG-CIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPEKFFPKARDLV 265
Query: 263 EKCIV 267
           EK +V
Sbjct: 266 EKLLV 270

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 117/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 90
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 91  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A S +GT ++++PEL  E
Sbjct: 149 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 206 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 262
Query: 263 EKCIV 267
           EK +V
Sbjct: 263 EKLLV 267

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 122/255 (47%), Gaps = 38/255 (14%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E++G G F  V+K    +DG         I+ V  + ++ ER   EV  L  L H NI+ 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYV-----IKRVKYNNEKAER---EVKALAKLDHVNIVH 68
Query: 91  FYNSW----------VDDTNRT----INMITELFTSGSLRQY--RKKHKNVDMKAIKNWA 134
           +   W            +++R+    + +  E    G+L Q+  +++ + +D        
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTP 193
            QI +G+ Y+HS    +I+RDLK  NIF+  +  +VKIGD GL   ++    R    GT 
Sbjct: 129 EQITKGVDYIHS--KKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRXRSKGTL 185
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQIYKKVTSGIKPASLS 251
            +M+PE +  ++Y + VD+Y+ G+ + E++  C+  +   K     +  +  GI    +S
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----FFTDLRDGI----IS 237
Query: 252 KVTDPQVKQFIEKCI 266
            + D + K  ++K +
Sbjct: 238 DIFDKKEKTLLQKLL 252

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 129/263 (49%), Gaps = 20/263 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           EILG G F  V+K  +   G+++A   +    +       E + +E+ ++  L H N+I+
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK----EEVKNEISVMNQLDHANLIQ 150
Query: 91  FYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
            Y+++  ++   I ++ E    G L  R   + +   ++  I  + +QI  G+   H H 
Sbjct: 151 LYDAF--ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL-FMKQICEGIR--HMHQ 205
Query: 149 PPIIHRDLKCDNIF-VNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYEEEYN 206
             I+H DLK +NI  VN +  ++KI D GLA   +      V  GTPEF+APE+   ++ 
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265
Query: 207 EL-VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKPASLSKVTDPQVKQFI 262
               D++S G+    +++   P+    N A+    + +    ++      +++ + K+FI
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPF-LGDNDAETLNNILACRWDLEDEEFQDISE-EAKEFI 323
Query: 263 EKCIVP-ASLRLPALELLKDPFL 284
            K ++   S R+ A E LK P+L
Sbjct: 324 SKLLIKEKSWRISASEALKHPWL 346

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 115/245 (46%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 93
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 152 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I+ K+          +   P+ +  +
Sbjct: 209 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPEKFFPKARDLV 265
Query: 263 EKCIV 267
           EK +V
Sbjct: 266 EKLLV 270

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 86/154 (55%), Gaps = 10/154 (6%)
Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           E+ +L++L HE+I+K+     D   +++ ++ E    GSLR Y  +H  V +  +  +A+
Sbjct: 61  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-CVGLAQLLLFAQ 119
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIG 191
           QI  G+ YLH+ +   IHR L   N+ ++ N+  VKIGD GLA  + +       R    
Sbjct: 120 QICEGMAYLHAQH--YIHRALAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGD 176
Query: 192 TPEF-MAPELYEE-EYNELVDIYSFGMCILEMVT 223
           +P F  APE  +E ++    D++SFG+ + E++T
Sbjct: 177 SPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 86/154 (55%), Gaps = 10/154 (6%)
Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           E+ +L++L HE+I+K+     D   +++ ++ E    GSLR Y  +H  V +  +  +A+
Sbjct: 60  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-CVGLAQLLLFAQ 118
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIG 191
           QI  G+ YLH+ +   IHR L   N+ ++ N+  VKIGD GLA  + +       R    
Sbjct: 119 QICEGMAYLHAQH--YIHRALAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGD 175
Query: 192 TPEF-MAPELYEE-EYNELVDIYSFGMCILEMVT 223
           +P F  APE  +E ++    D++SFG+ + E++T
Sbjct: 176 SPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 93
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 152 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 209 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 265
Query: 263 EKCIV 267
           EK +V
Sbjct: 266 EKLLV 270

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 94
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 95  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 153 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 210 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 266
Query: 263 EKCIV 267
           EK +V
Sbjct: 267 EKLLV 271

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 112/220 (50%), Gaps = 14/220 (6%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD-QLERLYSEVHLLKSLKHEN 87
           + E+LG GAF  V+     + G   A     ++ + +SP  +   L +E+ +LK +KHEN
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFA-----LKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           I+   + +   T+  + M  +L + G L     +      K      +Q+L  + YLH +
Sbjct: 68  IVTLEDIYESTTHYYLVM--QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 148 NPPIIHRDLKCDNIF--VNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEE 204
              I+HRDLK +N+       N ++ I D GL+ + Q     +  GTP ++APE L ++ 
Sbjct: 126 G--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKP 183
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           Y++ VD +S G+ I  ++ C YP    +  +++++K+  G
Sbjct: 184 YSKAVDCWSIGV-ITYILLCGYPPFYEETESKLFEKIKEG 222

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 127/288 (44%), Gaps = 30/288 (10%)
Query: 23  SCRYGRYD----EILGKGAFKTVYKG-FDEVDGIEVAWNQVNIE----DVMQSPDQLERL 73
           +C  G  D    E LG G+F  V +G +D   G  V+   V ++    DV+  P+ ++  
Sbjct: 6   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS---VAVKCLKPDVLSQPEAMDDF 62
Query: 74  YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKN 132
             EV+ + SL H N+I+ Y   +      + M+TEL   GSL    +KH+ +  +  +  
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 119
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
           +A Q+  G+ YL S     IHRDL   N+ +      VKIGD GL   + Q     V+  
Sbjct: 120 YAVQVAEGMGYLESKR--FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQE 176
Query: 193 PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
                  + APE L    ++   D + FG+ + EM T         N +QI  K+    +
Sbjct: 177 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--E 234
Query: 247 PASLSKVTD-PQ-VKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDL 292
              L +  D PQ +   + +C        P    L+D FL+   P D+
Sbjct: 235 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD-FLLEAQPTDM 281

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 23  SCRYGRYD----EILGKGAFKTVYKG-FDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSE 76
           +C  G  D    E LG G+F  V +G +D   G  V+     ++ DV+  P+ ++    E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWAR 135
           V+ + SL H N+I+ Y   +      + M+TEL   GSL    +KH+ +  +  +  +A 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 118
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE- 194
           Q+  G+ YL S     IHRDL   N+ +      VKIGD GL   + Q     V+     
Sbjct: 119 QVAEGMGYLESKR--FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 175
Query: 195 ----FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
               + APE L    ++   D + FG+ + EM T         N +QI  K+
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G + TV+K  +      VA  +V ++D  +  P    R   E+ LLK LKH+NI+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIV 64
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHN 148
           + ++  V  +++ + ++ E F    L++Y    + ++D + +K++  Q+L+GL + HS N
Sbjct: 65  RLHD--VLHSDKKLTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPELY--EEE 204
             ++HRDLK  N+ +N  NGE+K+ + GLA     P     + + T  +  P++    + 
Sbjct: 122 --VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 205 YNELVDIYSFGMCILEMVTCEYP 227
           Y+  +D++S G    E+     P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRP 201

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENI 88
           E +GKG +  V++G         +W   N+   + S    +  + E  L  +  L+HENI
Sbjct: 43  ECVGKGRYGEVWRG---------SWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENI 93
Query: 89  IKFYNSWVDDTNR----TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           + F  S  D T+R     + +IT     GSL  Y +    +D  +       I  GL +L
Sbjct: 94  LGFIAS--DMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHL 150
Query: 145 H------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGT 192
           H         P I HRDLK  NI V   NG+  I DLGLA++  Q T +        +GT
Sbjct: 151 HIEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 209
Query: 193 PEFMAPELYEEEYN-------ELVDIYSFGMCILEMV 222
             +MAPE+ +E          + VDI++FG+ + E+ 
Sbjct: 210 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 41/100 (41%), Positives = 63/100 (63%), Gaps = 6/100 (6%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 190
           +  QI+ GL +LH  N  II+RDLK +N+ ++ ++G V+I DLGLA+ ++  Q   +   
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 191 GTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYN 229
           GTP FMAPEL   EEY+  VD ++ G+ + EM+    P+ 
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 13  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 71
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 72  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 130 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 187 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 243
Query: 263 EKCIV 267
           EK +V
Sbjct: 244 EKLLV 248

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 93
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 152 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 209 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 265
Query: 263 EKCIV 267
           EK +V
Sbjct: 266 EKLLV 270

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 91
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 92  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 150 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 207 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 263
Query: 263 EKCIV 267
           EK +V
Sbjct: 264 EKLLV 268

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 41/100 (41%), Positives = 63/100 (63%), Gaps = 6/100 (6%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 190
           +  QI+ GL +LH  N  II+RDLK +N+ ++ ++G V+I DLGLA+ ++  Q   +   
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 191 GTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYN 229
           GTP FMAPEL   EEY+  VD ++ G+ + EM+    P+ 
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 91
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 92  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 150 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 207 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 263
Query: 263 EKCIV 267
           EK +V
Sbjct: 264 EKLLV 268

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 93
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 152 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 209 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 265
Query: 263 EKCIV 267
           EK +V
Sbjct: 266 EKLLV 270

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 41/100 (41%), Positives = 63/100 (63%), Gaps = 6/100 (6%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 190
           +  QI+ GL +LH  N  II+RDLK +N+ ++ ++G V+I DLGLA+ ++  Q   +   
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 191 GTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYN 229
           GTP FMAPEL   EEY+  VD ++ G+ + EM+    P+ 
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 8/202 (3%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           ++LGKG+F  V+    +      A   +  +DV+   D +E    E  +L SL  E+   
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVL-SLAWEHPFL 80
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            +      T   +  + E    G L  + +     D+     +A +I+ GL +LHS    
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG-- 138
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNE 207
           I++RDLK DNI ++  +G +KI D G+    ++         GTP+++APE L  ++YN 
Sbjct: 139 IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNH 197
Query: 208 LVDIYSFGMCILEMVTCEYPYN 229
            VD +SFG+ + EM+  + P++
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFH 219

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 10  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 68
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 69  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 127 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 184 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 240
Query: 263 EKCIV 267
           EK +V
Sbjct: 241 EKLLV 245

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 135/282 (47%), Gaps = 26/282 (9%)
Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVN---IEDVMQSPDQLERLYSEVHLLK 81
           +Y   +  +G+G++  V     +   I  A  ++    +EDV       +R   E+ ++K
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-------DRFKQEIEIMK 61
Query: 82  SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA-IKNWARQILRG 140
           SL H NII+ Y ++ D+T+  I ++ EL T G L + R  HK V  ++      + +L  
Sbjct: 62  SLDHPNIIRLYETFEDNTD--IYLVMELCTGGELFE-RVVHKRVFRESDAARIMKDVLSA 118
Query: 141 LHYLHSHNPPIIHRDLKCDN--IFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMA 197
           + Y H  N  + HRDLK +N     +  +  +K+ D GLA   +     R+ +GTP +++
Sbjct: 119 VAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 198 PELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTD 255
           P++ E  Y    D +S G+ ++ ++ C YP        ++  K+  G    P        
Sbjct: 177 PQVLEGLYGPECDEWSAGV-MMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVS 235
Query: 256 PQVKQFIEKCIVPA-SLRLPALELLKDPFL---VTDNPKDLV 293
           PQ +  I + +  +   R+ +L+ L+  +    ++ +P++L+
Sbjct: 236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNLL 277

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 135/282 (47%), Gaps = 26/282 (9%)
Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVN---IEDVMQSPDQLERLYSEVHLLK 81
           +Y   +  +G+G++  V     +   I  A  ++    +EDV       +R   E+ ++K
Sbjct: 26  QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-------DRFKQEIEIMK 78
Query: 82  SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA-IKNWARQILRG 140
           SL H NII+ Y ++ D+T+  I ++ EL T G L + R  HK V  ++      + +L  
Sbjct: 79  SLDHPNIIRLYETFEDNTD--IYLVMELCTGGELFE-RVVHKRVFRESDAARIMKDVLSA 135
Query: 141 LHYLHSHNPPIIHRDLKCDN--IFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMA 197
           + Y H  N  + HRDLK +N     +  +  +K+ D GLA   +     R+ +GTP +++
Sbjct: 136 VAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 193
Query: 198 PELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTD 255
           P++ E  Y    D +S G+ ++ ++ C YP        ++  K+  G    P        
Sbjct: 194 PQVLEGLYGPECDEWSAGV-MMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVS 252
Query: 256 PQVKQFIEKCIVPA-SLRLPALELLKDPFL---VTDNPKDLV 293
           PQ +  I + +  +   R+ +L+ L+  +    ++ +P++L+
Sbjct: 253 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNLL 294

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 41/100 (41%), Positives = 63/100 (63%), Gaps = 6/100 (6%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 190
           +  QI+ GL +LH  N  II+RDLK +N+ ++ ++G V+I DLGLA+ ++  Q   +   
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 191 GTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYN 229
           GTP FMAPEL   EEY+  VD ++ G+ + EM+    P+ 
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 23  SCRYGRYD----EILGKGAFKTVYKG-FDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSE 76
           +C  G  D    E LG G+F  V +G +D   G  V+     ++ DV+  P+ ++    E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWAR 135
           V+ + SL H N+I+ Y   +      + M+TEL   GSL    +KH+ +  +  +  +A 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 118
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE- 194
           Q+  G+ YL S     IHRDL   N+ +      VKIGD GL   + Q     V+     
Sbjct: 119 QVAEGMGYLESKR--FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 195 ----FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
               + APE L    ++   D + FG+ + EM T         N +QI  K+
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENI 88
           E +GKG +  V++G         +W   N+   + S    +  + E  L  +  L+HENI
Sbjct: 14  ECVGKGRYGEVWRG---------SWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENI 64
Query: 89  IKFYNSWVDDTNR----TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           + F  S  D T+R     + +IT     GSL  Y +    +D  +       I  GL +L
Sbjct: 65  LGFIAS--DMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHL 121
Query: 145 H------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGT 192
           H         P I HRDLK  NI V   NG+  I DLGLA++  Q T +        +GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 193 PEFMAPELYEEEYN-------ELVDIYSFGMCILEMV 222
             +MAPE+ +E          + VDI++FG+ + E+ 
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 139/289 (48%), Gaps = 19/289 (6%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           Y ++LGKG F  V    ++  G   A   +  E V+ + D++    +E  +L++ +H  +
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
                 +   T+  +  + E    G L  +  + +    +  + +  +I+  L YLHS +
Sbjct: 68  TAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EY 205
             +++RD+K +N+ ++  +G +KI D GL    +    T ++  GTPE++APE+ E+ +Y
Sbjct: 126 --VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
              VD +  G+ + EM+    P+   ++  ++++ +   ++     +   P+ K  +   
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEEIRFPRTLSPEAKSLLAGL 239
Query: 266 IVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
           +      RL      A E+++  F ++ N +D+V   L LP   P+V +
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPPFKPQVTS 287

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 8/202 (3%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           ++LGKG+F  V+    +      A   +  +DV+   D +E    E  +L SL  E+   
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVL-SLAWEHPFL 81
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            +      T   +  + E    G L  + +     D+     +A +I+ GL +LHS    
Sbjct: 82  THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG-- 139
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNE 207
           I++RDLK DNI ++  +G +KI D G+    ++         GTP+++APE L  ++YN 
Sbjct: 140 IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNH 198
Query: 208 LVDIYSFGMCILEMVTCEYPYN 229
            VD +SFG+ + EM+  + P++
Sbjct: 199 SVDWWSFGVLLYEMLIGQSPFH 220

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 139/289 (48%), Gaps = 19/289 (6%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           Y ++LGKG F  V    ++  G   A   +  E V+ + D++    +E  +L++ +H  +
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
                 +   T+  +  + E    G L  +  + +    +  + +  +I+  L YLHS +
Sbjct: 68  TAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EY 205
             +++RD+K +N+ ++  +G +KI D GL    +    T ++  GTPE++APE+ E+ +Y
Sbjct: 126 --VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
              VD +  G+ + EM+    P+   ++  ++++ +   ++     +   P+ K  +   
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEEIRFPRTLSPEAKSLLAGL 239
Query: 266 IVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
           +      RL      A E+++  F ++ N +D+V   L LP   P+V +
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPPFKPQVTS 287

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 12  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 70
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 71  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 129 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 186 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 242
Query: 263 EKCIV 267
           EK +V
Sbjct: 243 EKLLV 247

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 115/235 (48%), Gaps = 20/235 (8%)
Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
           E +  E+   +SL+H NI++F    +  T+  I  I E  + G L +             
Sbjct: 61  ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI--IMEYASGGELYERICNAGRFSEDEA 118
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLA---IVMQQPTA 186
           + + +Q+L G+ Y HS    I HRDLK +N  ++G+    +KI D G +   ++  QP  
Sbjct: 119 RFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 174
Query: 187 RSVIGTPEFMAPE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +S +GTP ++APE L  +EY+ ++ D++S G+ +  M+   YP+ + + P   Y+K    
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQR 233
Query: 245 IKPASLSKVTD----PQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLV 293
           I     S   D    P+    I +  V  PA+ R+   E+    + + + P DL+
Sbjct: 234 ILSVKYSIPDDIRISPECCHLISRIFVADPAT-RISIPEIKTHSWFLKNLPADLM 287

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++H N+
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YLHS  
Sbjct: 77  ITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE+   E
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 139/289 (48%), Gaps = 19/289 (6%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           Y ++LGKG F  V    ++  G   A   +  E V+ + D++    +E  +L++ +H  +
Sbjct: 12  YLKLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNTRHPFL 70
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
                 +   T+  +  + E    G L  +  + +    +  + +  +I+  L YLHS +
Sbjct: 71  TAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 128
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EY 205
             +++RD+K +N+ ++  +G +KI D GL    +    T ++  GTPE++APE+ E+ +Y
Sbjct: 129 --VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 185
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
              VD +  G+ + EM+    P+   ++  ++++ +   ++     +   P+ K  +   
Sbjct: 186 GRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEEIRFPRTLSPEAKSLLAGL 242
Query: 266 IVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
           +      RL      A E+++  F ++ N +D+V   L LP   P+V +
Sbjct: 243 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPPFKPQVTS 290

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENI 88
           E +GKG +  V++G         +W   N+   + S    +  + E  L  +  L+HENI
Sbjct: 14  ECVGKGRYGEVWRG---------SWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENI 64
Query: 89  IKFYNSWVDDTNR----TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           + F  S  D T+R     + +IT     GSL  Y +    +D  +       I  GL +L
Sbjct: 65  LGFIAS--DMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHL 121
Query: 145 H------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGT 192
           H         P I HRDLK  NI V   NG+  I DLGLA++  Q T +        +GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 193 PEFMAPELYEEEYN-------ELVDIYSFGMCILEMV 222
             +MAPE+ +E          + VDI++FG+ + E+ 
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 69
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 70  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 128 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 185 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 241
Query: 263 EKCIV 267
           EK +V
Sbjct: 242 EKLLV 246

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 82  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 139 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 196 RIYTHQSDVWSYGVTVWELMT 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 29  YD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLK 84
           YD  E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H N+I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YL
Sbjct: 73  HPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 145 HSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPEL 200
           HS    I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE+
Sbjct: 131 HSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 201 YEEEYNEL-VDIYSFGMCILEMVTCEYPY 228
              E   L  D++S G+    +++   P+
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 80  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 137 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 23  SCRYGRYD----EILGKGAFKTVYKG-FDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSE 76
           +C  G  D    E LG G+F  V +G +D   G  V+     ++ DV+  P+ ++    E
Sbjct: 6   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWAR 135
           V+ + SL H N+I+ Y   +      + M+TEL   GSL    +KH+ +  +  +  +A 
Sbjct: 66  VNAMHSLDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 122
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE- 194
           Q+  G+ YL S     IHRDL   N+ +      VKIGD GL   + Q     V+     
Sbjct: 123 QVAEGMGYLESKR--FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 195 ----FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
               + APE L    ++   D + FG+ + EM T         N +QI  K+
Sbjct: 180 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 231

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 83  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 140 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 197 RIYTHQSDVWSYGVTVWELMT 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YLHS  
Sbjct: 77  ITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE+   E
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 83  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 140 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 197 RIYTHQSDVWSYGVTVWELMT 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 104
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 105 CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 161
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 162 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 218
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 219 RIYTHQSDVWSYGVTVWELMT 239

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 80  CRLLGICL---TSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 137 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 83  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 140 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 197 RIYTHQSDVWSYGVTVWELMT 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 85
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 86  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 142
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 143 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 199
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 200 RIYTHQSDVWSYGVTVWELMT 220

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 89
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 90  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 146
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 147 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 203
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 204 RIYTHQSDVWSYGVTVWELMT 224

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 17  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 75
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 76  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 134 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 191 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 247
Query: 263 EKCIV 267
           EK +V
Sbjct: 248 EKLLV 252

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 115/245 (46%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 40  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 98
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y  + DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 99  FVKLYFCFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 157 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 214 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 270
Query: 263 EKCIV 267
           EK +V
Sbjct: 271 EKLLV 275

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 87  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 144 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 201 RIYTHQSDVWSYGVTVWELMT 221

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 80  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 137 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YLHS  
Sbjct: 77  ITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE+   E
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +LGKG+F  V     KG +E+  I++    V I+D     D +E    E  +L  L    
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQD-----DDVECTMVEKRVLALLDKPP 80
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +   +S     +R +  + E    G L  + ++           +A +I  GL +LH  
Sbjct: 81  FLTQLHSCFQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-EE 204
              II+RDLK DN+ ++ + G +KI D G+    +M   T R   GTP+++APE+   + 
Sbjct: 140 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQP 196
Query: 205 YNELVDIYSFGMCILEMVTCEYPYN 229
           Y + VD +++G+ + EM+  + P++
Sbjct: 197 YGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YLHS  
Sbjct: 76  ITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 149 PPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE+   E
Sbjct: 134 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPF 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++H N+
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YLHS  
Sbjct: 77  ITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE+   E
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YLHS  
Sbjct: 77  ITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE+   E
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++GKG+F  V     + + +  A   +  + +++  ++   +     LLK++KH  ++ 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            + S+   T   +  + +    G L  + ++ +       + +A +I   L YLHS N  
Sbjct: 104 LHFSF--QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN-- 159
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNE 207
           I++RDLK +NI ++ + G + + D GL    +    T  +  GTPE++APE L+++ Y+ 
Sbjct: 160 IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266
            VD +  G  + EM+    P+   +N A++Y  + +  KP  L        +  +E  +
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILN--KPLQLKPNITNSARHLLEGLL 274

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 73
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 74  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 131 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 188 RIYTHQSDVWSYGVTVWELMT 208

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 23  SCRYGRYD----EILGKGAFKTVYKG-FDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSE 76
           +C  G  D    E LG G+F  V +G +D   G  V+     ++ DV+  P+ ++    E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWAR 135
           V+ + SL H N+I+ Y   +      + M+TEL   GSL    +KH+ +  +  +  +A 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 118
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE- 194
           Q+  G+ YL S     IHRDL   N+ +      VKIGD GL   + Q     V+     
Sbjct: 119 QVAEGMGYLESKR--FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 195 ----FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
               + APE L    ++   D + FG+ + EM T         N +QI  K+
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YLHS  
Sbjct: 77  ITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE+   E
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YLHS  
Sbjct: 77  ITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE+   E
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YLHS  
Sbjct: 77  ITLHEVYENKTD--VILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE+   E
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YLHS  
Sbjct: 76  ITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 149 PPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE+   E
Sbjct: 134 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPF 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YLHS  
Sbjct: 77  ITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE+   E
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 90
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 91  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 149 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 206 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 262
Query: 263 EKCIV 267
           EK +V
Sbjct: 263 EKLLV 267

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 112/233 (48%), Gaps = 12/233 (5%)
Query: 3   CGSGFTKSETEEGEFSEKDPSCRYG----RYDEILGKGAFKTVYKGFDEVDGIEVAWNQV 58
            GS    S  EE E S   P  R       Y ++LGKG F  V    ++  G   A  ++
Sbjct: 122 SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYA-MKI 180
Query: 59  NIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY 118
             ++V+ + D++    +E  +L++ +H  +     S+   T+  +  + E    G L  +
Sbjct: 181 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYANGGELFFH 238
Query: 119 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
             + +       + +  +I+  L YLHS    +++RDLK +N+ ++  +G +KI D GL 
Sbjct: 239 LSRERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLD-KDGHIKITDFGLC 296
Query: 179 I--VMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY 228
              +    T ++  GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+
Sbjct: 297 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 69  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 123 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEIXINKMLNHENVVK 68
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 69  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 123 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 64  MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
           +Q    +E++Y E+ +LK L H N++K      D     + M+ EL   G + +     K
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-PTLK 132
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
            +     + + + +++G+ YLH     IIHRD+K  N+ V G +G +KI D G++   + 
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLV-GEDGHIKIADFGVSNEFKG 189
Query: 184 PTA--RSVIGTPEFMAPELYEEEY----NELVDIYSFGMCILEMVTCEYPY 228
             A   + +GTP FMAPE   E       + +D+++ G+ +   V  + P+
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 138/289 (47%), Gaps = 19/289 (6%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           Y ++LGKG F  V    ++  G   A   +  E V+ + D++    +E  +L++ +H  +
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
                 +   T+  +  + E    G L  +  + +    +  + +  +I+  L YLHS +
Sbjct: 68  TAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EY 205
             +++RD+K +N+ ++  +G +KI D GL    +    T +   GTPE++APE+ E+ +Y
Sbjct: 126 --VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
              VD +  G+ + EM+    P+   ++  ++++ +   ++     +   P+ K  +   
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEEIRFPRTLSPEAKSLLAGL 239
Query: 266 IVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
           +      RL      A E+++  F ++ N +D+V   L LP   P+V +
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPPFKPQVTS 287

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 138/289 (47%), Gaps = 19/289 (6%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           Y ++LGKG F  V    ++  G   A   +  E V+ + D++    +E  +L++ +H  +
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
                 +   T+  +  + E    G L  +  + +    +  + +  +I+  L YLHS +
Sbjct: 68  TAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EY 205
             +++RD+K +N+ ++  +G +KI D GL    +    T +   GTPE++APE+ E+ +Y
Sbjct: 126 --VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
              VD +  G+ + EM+    P+   ++  ++++ +   ++     +   P+ K  +   
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEEIRFPRTLSPEAKSLLAGL 239
Query: 266 IVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
           +      RL      A E+++  F ++ N +D+V   L LP   P+V +
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPPFKPQVTS 287

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 112/233 (48%), Gaps = 12/233 (5%)
Query: 3   CGSGFTKSETEEGEFSEKDPSCRYG----RYDEILGKGAFKTVYKGFDEVDGIEVAWNQV 58
            GS    S  EE E S   P  R       Y ++LGKG F  V    ++  G   A  ++
Sbjct: 125 SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYA-MKI 183
Query: 59  NIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY 118
             ++V+ + D++    +E  +L++ +H  +     S+   T+  +  + E    G L  +
Sbjct: 184 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYANGGELFFH 241
Query: 119 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
             + +       + +  +I+  L YLHS    +++RDLK +N+ ++  +G +KI D GL 
Sbjct: 242 LSRERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLD-KDGHIKITDFGLC 299
Query: 179 I--VMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY 228
              +    T ++  GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+
Sbjct: 300 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 142/299 (47%), Gaps = 21/299 (7%)
Query: 21  DPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 78
           DP      +D  ++LGKG F  V    ++  G   A   +  E V+ + D++    +E  
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESR 62
Query: 79  LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
           +L++ +H  +     ++   T+  +  + E    G L  +  + +    +  + +  +I+
Sbjct: 63  VLQNTRHPFLTALKYAF--QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 120
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFM 196
             L YLHS +  +++RD+K +N+ ++  +G +KI D GL    +    T +   GTPE++
Sbjct: 121 SALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKXFCGTPEYL 177
Query: 197 APELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
           APE+ E+ +Y   VD +  G+ + EM+    P+   ++  ++++ +   ++     +   
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEEIRFPRTLS 234
Query: 256 PQVKQFIEKCIVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
           P+ K  +   +      RL      A E+++  F ++ N +D+V   L LP   P+V +
Sbjct: 235 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPPFKPQVTS 292

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
           E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YLHS  
Sbjct: 77  ITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 204
             I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE+   E
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 205 YNEL-VDIYSFGMCILEMVTCEYPY 228
              L  D++S G+    +++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 70  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 124 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 138/289 (47%), Gaps = 19/289 (6%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           Y ++LGKG F  V    ++  G   A   +  E V+ + D++    +E  +L++ +H  +
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
                 +   T+  +  + E    G L  +  + +    +  + +  +I+  L YLHS +
Sbjct: 68  TAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EY 205
             +++RD+K +N+ ++  +G +KI D GL    +    T +   GTPE++APE+ E+ +Y
Sbjct: 126 --VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
              VD +  G+ + EM+    P+   ++  ++++ +   ++     +   P+ K  +   
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEEIRFPRTLSPEAKSLLAGL 239
Query: 266 IVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
           +      RL      A E+++  F ++ N +D+V   L LP   P+V +
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPPFKPQVTS 287

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEIXINKMLNHENVVK 68
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 69  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 123 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEIXINKMLNHENVVK 69
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 70  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 124 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 76
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI  G++YL   
Sbjct: 77  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR 133
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 134 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 190
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 191 RIYTHQSDVWSYGVTVWELMT 211

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 70  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 124 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 70  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 124 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 49/231 (21%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG+G F  V++  ++VD    A  ++ + +   + +++ R   EV  L  L+H  I++++
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKLEHPGIVRYF 69
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA-IKNWAR---------------- 135
           N+W++         TE     S + Y      +  K  +K+W                  
Sbjct: 70  NAWLEKNT------TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 136 --QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---------- 183
             QI   + +LHS    ++HRDLK  NIF   ++  VK+GD GL   M Q          
Sbjct: 124 FLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 184 --PTARSV--IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYN 229
               AR    +GT  +M+PE ++   Y+  VDI+S G+ + E++   YP++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFS 228

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I ++ +  SP   + +  E +++ S+ + ++
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIMELREATSPKANKEILDEAYVMASVDNPHV 113
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 114 CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 170
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 171 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 227
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 228 RIYTHQSDVWSYGVTVWELMT 248

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 70  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 124 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 137/292 (46%), Gaps = 26/292 (8%)
Query: 9   KSETEEGEFSEKDPSCRYG----RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
           K  ++EG     + S R G     +  +LGKG+F  V     +  G ++   +V  +DV+
Sbjct: 3   KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETG-DLYAVKVLKKDVI 61
Query: 65  QSPDQLERLYSEVHLLK-SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
              D +E   +E  +L  +  H  + + +  +   T   +  + E    G L  + +K +
Sbjct: 62  LQDDDVECTMTEKRILSLARNHPFLTQLFCCF--QTPDRLFFVMEFVNGGDLMFHIQKSR 119
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VM 181
             D    + +A +I+  L +LH     II+RDLK DN+ ++ + G  K+ D G+    + 
Sbjct: 120 RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIC 176
Query: 182 QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
              T  +  GTP+++APE+ +E  Y   VD ++ G+ + EM+    P+ E +N   +++ 
Sbjct: 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEA 235
Query: 241 VTSG--IKPASLSKVTDPQVKQFIEKCIVPASLRLPAL------ELLKDPFL 284
           + +   + P  L +     +K F+ K     ++RL +L       +L+ PF 
Sbjct: 236 ILNDEVVYPTWLHEDATGILKSFMTK---NPTMRLGSLTQGGEHAILRHPFF 284

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 115/245 (46%), Gaps = 14/245 (5%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F T     +     E A   +    +++  +++  +  E  ++  L H  
Sbjct: 33  KFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 91
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD      +      +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 92  FVKLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEE 203
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A   +GT ++++PEL  E
Sbjct: 150 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 204 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G CI+  +    P     N   I++K+          +   P+ +  +
Sbjct: 207 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 263
Query: 263 EKCIV 267
           EK +V
Sbjct: 264 EKLLV 268

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 68  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 122 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 69  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 123 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 70  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 124 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 69  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 123 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 69  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 123 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 69  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 123 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 27  ERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 80
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 81  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 137
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 138 --YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 194
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 195 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 228

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 69  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 123 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 28  ERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 81
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 82  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 138
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 139 --YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 195
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 196 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 229

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 69  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 123 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 83
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +I +L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 84  CRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 141 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 198 RIYTHQSDVWSYGVTVWELMT 218

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 69  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 123 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEY 217

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 21  ERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 74
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 75  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 131
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 132 --YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 188
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 189 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 222

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 70  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 124 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 25  ERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 79  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 136 --YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 192
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 226

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 125/269 (46%), Gaps = 18/269 (6%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKF 91
           LG+GA+  V K      G  +A  +  I   + S +Q +RL  ++ + ++++     + F
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKR--IRATVNSQEQ-KRLLMDLDISMRTVDCPFTVTF 115
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRK---KHKNVDMKAIKNWARQILRGLHYLHSHN 148
           Y +   + +  I M  EL  +   + Y++   K + +    +   A  I++ L +LHS  
Sbjct: 116 YGALFREGDVWICM--ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-K 172
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG------TPEFMAPELYE 202
             +IHRD+K  N+ +N   G+VK+ D G++  +    A+++         PE + PEL +
Sbjct: 173 LSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           + Y+   DI+S G+ ++E+    +PY+    P Q  K+V     P   +     +   F 
Sbjct: 232 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 291
Query: 263 EKCIVPASLRLPAL-ELLKDPFLVTDNPK 290
            +C+   S   P   EL++ PF      K
Sbjct: 292 SQCLKKNSKERPTYPELMQHPFFTLHESK 320

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 19  ERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 73  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 130 --YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 19  ERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 73  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 130 --YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 69  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 123 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +I +L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 82  CRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 139 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 196 RIYTHQSDVWSYGVTVWELMT 216

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 20  ERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 73
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 74  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 130
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 131 --YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 187
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 188 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 221

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 93/167 (55%), Gaps = 10/167 (5%)
Query: 68  DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
           +++  ++ E+ +++ L+H  ++  + S+ D+ +  + M+ +L   G LR + +++ +   
Sbjct: 57  NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED--MFMVVDLLLGGDLRYHLQQNVHFKE 114
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA- 186
           + +K +  +++  L YL   N  IIHRD+K DNI ++  +G V I D  +A ++ + T  
Sbjct: 115 ETVKLFICELVMALDYLQ--NQRIIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQI 171
Query: 187 RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYN 229
            ++ GT  +MAPE++       Y+  VD +S G+   E++    PY+
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 29  YD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLK 84
           YD  E LG G F  V K  ++  G++ A   +       S   + R  +  EV +LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H N+I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++YL
Sbjct: 73  HPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 145 HSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPEL 200
           HS    I H DLK +NI +   N     +KI D GLA  +      +++ GTP F+APE+
Sbjct: 131 HSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEI 188
Query: 201 YEEEYNEL-VDIYSFGMCILEMVTCEYPY 228
              E   L  D++S G+    +++   P+
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 80
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +I +L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 81  CRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 138 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 195 RIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +I +L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 80  CRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 137 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +I +L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 83  CRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 140 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 197 RIYTHQSDVWSYGVTVWELMT 217

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 11  RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 61
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y      +   I ++TE  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 62  HEKLVQLYAV---VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 118
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 119 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPE 175
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 176 AALY-GRFTIKSDVWSFGILLTELTT 200

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 80
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +I +L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 81  CRLLGICL---TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 138 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 195 RIYTHQSDVWSYGVTVWELMT 215

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 82  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D G A ++    ++  A       ++MA E +  
Sbjct: 139 R--LVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 196 RIYTHQSDVWSYGVTVWELMT 216

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 113/226 (50%), Gaps = 18/226 (7%)
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +SL+H NI++F    +  T+  I M  E  + G L +             + + +Q++ G
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVM--EYASGGELFERICNAGRFSEDEARFFFQQLISG 127
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLA---IVMQQPTARSVIGTPEFM 196
           + Y H+    + HRDLK +N  ++G+    +KI D G +   ++  QP  +S +GTP ++
Sbjct: 128 VSYAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP--KSAVGTPAYI 183
Query: 197 APE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASLSK 252
           APE L ++EY+ ++ D++S G+ +  M+   YP+ + + P    K +     ++ A    
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY 243
Query: 253 V-TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 295
           V   P+ +  I +  V  PA  R+   E+    + + + P DL+ D
Sbjct: 244 VHISPECRHLISRIFVADPAK-RISIPEIRNHEWFLKNLPADLMND 288

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 24  ERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 77
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 78  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 134
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 135 --YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 191
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 192 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 225

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 80  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D G A ++    ++  A       ++MA E +  
Sbjct: 137 R--LVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++L  GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 80  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 137 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++L  GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 87  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 144 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 201 RIYTHQSDVWSYGVTVWELMT 221

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 25  ERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 79  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 136 --YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 192
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 226

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 19  ERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 73  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 130 --YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 14  ERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 67
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 68  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 124
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 125 --YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 181
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 182 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 215

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           Y ++LGKG F  V    ++  G   A   +  E V+ + D++    +E  +L++ +H  +
Sbjct: 14  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKE-VIVAKDEVAHTLTENRVLQNSRHPFL 72
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
                S+   T+  +  + E    G L  +  + +       + +  +I+  L YLHS  
Sbjct: 73  TALKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 130
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EY 205
             +++RDLK +N+ ++  +G +KI D GL    +    T +   GTPE++APE+ E+ +Y
Sbjct: 131 N-VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY 188
Query: 206 NELVDIYSFGMCILEMVTCEYPY 228
              VD +  G+ + EM+    P+
Sbjct: 189 GRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D V+ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++T L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 108 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 164
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 165 -VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 223 KGYTKSIDIWSVGCILAEMLS 243

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 87  CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D G A ++    ++  A       ++MA E +  
Sbjct: 144 R--LVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 201 RIYTHQSDVWSYGVTVWELMT 221

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 29  ERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 82
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 83  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 139
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 140 --YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 196
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 197 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 230

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           Y ++LGKG F  V    ++  G   A   +  E V+ + D++    +E  +L++ +H  +
Sbjct: 12  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKE-VIVAKDEVAHTLTENRVLQNSRHPFL 70
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
                S+   T+  +  + E    G L  +  + +       + +  +I+  L YLHS  
Sbjct: 71  TALKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 128
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EY 205
             +++RDLK +N+ ++  +G +KI D GL    +    T +   GTPE++APE+ E+ +Y
Sbjct: 129 N-VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY 186
Query: 206 NELVDIYSFGMCILEMVTCEYPY 228
              VD +  G+ + EM+    P+
Sbjct: 187 GRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           Y ++LGKG F  V    ++  G   A   +  E V+ + D++    +E  +L++ +H  +
Sbjct: 13  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKE-VIVAKDEVAHTLTENRVLQNSRHPFL 71
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
                S+   T+  +  + E    G L  +  + +       + +  +I+  L YLHS  
Sbjct: 72  TALKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 129
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EY 205
             +++RDLK +N+ ++  +G +KI D GL    +    T +   GTPE++APE+ E+ +Y
Sbjct: 130 N-VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY 187
Query: 206 NELVDIYSFGMCILEMVTCEYPY 228
              VD +  G+ + EM+    P+
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D V+ + VA  +++     +     +R   E+ +L + +HENII   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 146
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 147 -VLHRDLKPSNLLLN-TTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 205 KGYTKSIDIWSVGCILAEMLS 225

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 121/241 (50%), Gaps = 31/241 (12%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E++GKG F  VY G     G EVA   ++IE    + DQL+    EV   +  +HEN++ 
Sbjct: 39  ELIGKGRFGQVYHG--RWHG-EVAIRLIDIER--DNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNP 149
           F  + +   +  I  IT L    +L    +  K V D+   +  A++I++G+ YLH+   
Sbjct: 94  FMGACMSPPHLAI--ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG- 150
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGL---AIVMQ----QPTARSVIGTPEFMAPELYE 202
            I+H+DLK  N+F   +NG+V I D GL   + V+Q    +   R   G    +APE+  
Sbjct: 151 -ILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 203 E----------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
           +           +++  D+++ G    E+   E+P+      A I+ ++ +G+KP +LS+
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-QMGTGMKP-NLSQ 265
Query: 253 V 253
           +
Sbjct: 266 I 266

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA   V    + V    VA   V I D+ ++ D  E +  E+ + K L HEN++K
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 69  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 123 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 16/199 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  D   G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 27  EKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIR---EISLLKELHHPNIV 82
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHN 148
              +  V  + R + ++ E F    L++   ++K  +    IK +  Q+LRG+ + H H 
Sbjct: 83  SLID--VIHSERCLTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IGTPEFMAPELY--EEE 204
             I+HRDLK  N+ +N ++G +K+ D GLA     P       + T  + AP++    ++
Sbjct: 140 --ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKK 196
Query: 205 YNELVDIYSFGMCILEMVT 223
           Y+  VDI+S G    EM+T
Sbjct: 197 YSTSVDIWSIGCIFAEMIT 215

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 16/199 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  D   G  VA  ++ ++   +  P    R   E+ LLK L H NI+
Sbjct: 27  EKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIR---EISLLKELHHPNIV 82
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHN 148
              +  V  + R + ++ E F    L++   ++K  +    IK +  Q+LRG+ + H H 
Sbjct: 83  SLID--VIHSERCLTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IGTPEFMAPELY--EEE 204
             I+HRDLK  N+ +N ++G +K+ D GLA     P       + T  + AP++    ++
Sbjct: 140 --ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKK 196
Query: 205 YNELVDIYSFGMCILEMVT 223
           Y+  VDI+S G    EM+T
Sbjct: 197 YSTSVDIWSIGCIFAEMIT 215

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 124/269 (46%), Gaps = 18/269 (6%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKF 91
           LG+GA+  V K      G  +A  +  I   + S +Q +RL  ++ + ++++     + F
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKR--IRATVNSQEQ-KRLLMDLDISMRTVDCPFTVTF 71
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRK---KHKNVDMKAIKNWARQILRGLHYLHSHN 148
           Y +   + +  I M  EL  +   + Y++   K + +    +   A  I++ L +LHS  
Sbjct: 72  YGALFREGDVWICM--ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-K 128
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG------TPEFMAPELYE 202
             +IHRD+K  N+ +N   G+VK+ D G++  +    A+ +         PE + PEL +
Sbjct: 129 LSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           + Y+   DI+S G+ ++E+    +PY+    P Q  K+V     P   +     +   F 
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247
Query: 263 EKCIVPASLRLPAL-ELLKDPFLVTDNPK 290
            +C+   S   P   EL++ PF      K
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFFTLHESK 276

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 270 RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 320
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y    ++    I ++TE  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 321 HEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 378 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 435 AALY-GRFTIKSDVWSFGILLTELTT 459

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 84/177 (47%), Gaps = 23/177 (12%)
Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---------NVD 126
           E+ LL+ LKH N+I     ++   +R + ++ + +    L    K H+          + 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQ 183
              +K+   QIL G+HYLH++   ++HRDLK  NI V G     G VKI D+G A +   
Sbjct: 127 RGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 184 PTA-----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKN 233
           P         V+ T  + APEL      Y + +DI++ G    E++T E P   C+ 
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQ 240

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 114/255 (44%), Gaps = 14/255 (5%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G++  V+K   + DG   A  + ++       D+  +L       K  +H   ++  
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 93  NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
            +W  +    + + TEL    SL+Q+      ++    +  + R  L  L +LHS    +
Sbjct: 124 QAW--EEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--L 178
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-GTPEFMAPELYEEEYNELVD 210
           +H D+K  NIF+ G  G  K+GD GL + +    A  V  G P +MAPEL +  Y    D
Sbjct: 179 VHLDVKPANIFL-GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAAD 237
Query: 211 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-A 269
           ++S G+ ILE V C     E  +  + ++++  G  P   +     +++  +   + P  
Sbjct: 238 VFSLGLTILE-VACNM---ELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDP 293
Query: 270 SLRLPALELLKDPFL 284
            LR  A  LL  P L
Sbjct: 294 KLRATAEALLALPVL 308

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 14  RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 64
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y      +   I ++TE  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 65  HEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 121
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 122 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 178
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 179 AALY-GRFTIKSDVWSFGILLTELTT 203

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 82/169 (48%), Gaps = 23/169 (13%)
Query: 75  SEVHLLKSLKHENIIKFYNSWVDDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKN 132
           +E++    ++HENI+ F  + +  T     + +IT+   +GSL  Y K    +D K++  
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLK 138
Query: 133 WARQILRGLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 185
            A   + GL +LH+        P I HRDLK  NI V   NG   I DLGLA+     T 
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTN 197
Query: 186 -----ARSVIGTPEFMAPELYEEEYNE-------LVDIYSFGMCILEMV 222
                  + +GT  +M PE+ +E  N        + D+YSFG+ + E+ 
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 12  RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 62
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y      +   I ++TE  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 63  HEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 119
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 120 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 176
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 177 AALY-GRFTIKSDVWSFGILLTELTT 201

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 10  RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 60
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y      +   I ++TE  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 61  HEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 117
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 118 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 174
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 175 AALY-GRFTIKSDVWSFGILLTELTT 199

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G F  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 73
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V    +   A QI   + YL   N  
Sbjct: 74  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 129
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 130 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 239
              D+++FG+ + E+ T         +P+Q+Y+
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 21  RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 71
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y      +   I ++TE  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 72  HEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 129 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 186 AALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 125/277 (45%), Gaps = 27/277 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY ++  +G GA   V   FD V GI VA  +++     Q+    +R Y E+ LLK + H
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS--RPFQNQTHAKRAYRELVLLKCVNH 80
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +     H  +D + +     Q+L G+
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGI 137
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +  + + + TP      + 
Sbjct: 138 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTASTNFMMTPYVVTRYYR 190
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + E+V     +    +  Q  K +   G   A      
Sbjct: 191 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL 250
Query: 255 DPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD 291
            P V+ ++E    PA   +   EL  D    +++ +D
Sbjct: 251 QPTVRNYVENR--PAYPGIAFEELFPDWIFPSESERD 285

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V I D+ ++ D  E +  E+ +   L HEN++K
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINAMLNHENVVK 69
Query: 91  FYNSWVDDTNRTINMITELF----TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           FY       +R    I  LF    + G L    +    +     + +  Q++ G+ YLH 
Sbjct: 70  FYG------HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE 202
               I HRD+K +N+ ++  +  +KI D GLA V +      ++    GT  ++APEL +
Sbjct: 124 IG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 203 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
             E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D V+ + VA  +++     +     +R   E+ +L + +HENII   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 146
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 147 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 205 KGYTKSIDIWSVGCILAEMLS 225

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 187 RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 237
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y    ++    I ++TE  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 238 HEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 295 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 352 AALY-GRFTIKSDVWSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 187 RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 237
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y    ++    I ++TE  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 238 HEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 295 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 352 AALY-GRFTIKSDVWSFGILLTELTT 376

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 28/225 (12%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           LG G F  V+ G          WN   +V I+ +       E    E  ++K LKH+ ++
Sbjct: 17  LGNGQFGEVWMG---------TWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLV 67
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQILRGLHYLHSH 147
           + Y      +   I ++TE    GSL  + K  +   +K   + + A Q+  G+ Y+   
Sbjct: 68  QLYAV---VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 124
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE--LYE 202
           N   IHRDL+  NI V GN    KI D GLA +++  + TAR     P ++ APE  LY 
Sbjct: 125 N--YIHRDLRSANILV-GNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG 181
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
             +    D++SFG+ + E+VT    PY    N  ++ ++V  G +
Sbjct: 182 R-FTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYR 224

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 15  ERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 68
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 69  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 125
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHR+L+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 126 --YIHRNLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 182
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 183 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +I +L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 82  CRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D G A ++    ++  A       ++MA E +  
Sbjct: 139 R--LVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 196 RIYTHQSDVWSYGVTVWELMT 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 111/230 (48%), Gaps = 19/230 (8%)
Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +LGKG+F  V     KG DE+  +++    V I+D     D +E    E  +L       
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-----DDVECTMVEKRVLALPGKPP 402
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +   +S     +R +  + E    G L  + ++           +A +I  GL +L S 
Sbjct: 403 FLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-EE 204
              II+RDLK DN+ ++ + G +KI D G+    +    T +   GTP+++APE+   + 
Sbjct: 462 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 518
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSK 252
           Y + VD ++FG+ + EM+  + P+ E ++  ++++ +       P S+SK
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSK 567

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +I +L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 82  CRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D G A ++    ++  A       ++MA E +  
Sbjct: 139 R--LVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 196 RIYTHQSDVWSYGVTVWELMT 216

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D V+ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 144
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 145 -VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 203 KGYTKSIDIWSVGCILAEMLS 223

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 113/226 (50%), Gaps = 18/226 (7%)
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +SL+H NI++F    +  T+  I M  E  + G L +             + + +Q++ G
Sbjct: 69  RSLRHPNIVRFKEVILTPTHLAIVM--EYASGGELFERICNAGRFSEDEARFFFQQLISG 126
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLA---IVMQQPTARSVIGTPEFM 196
           + Y H+    + HRDLK +N  ++G+    +KI D G +   ++  QP  +S +GTP ++
Sbjct: 127 VSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYI 182
Query: 197 APE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASLSK 252
           APE L ++EY+ ++ D++S G+ +  M+   YP+ + + P    K +     ++ A    
Sbjct: 183 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY 242
Query: 253 V-TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 295
           V   P+ +  I +  V  PA  R+   E+    + + + P DL+ D
Sbjct: 243 VHISPECRHLISRIFVADPAK-RISIPEIRNHEWFLKNLPADLMND 287

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 113/226 (50%), Gaps = 18/226 (7%)
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +SL+H NI++F    +  T+  I M  E  + G L +             + + +Q++ G
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVM--EYASGGELFERICNAGRFSEDEARFFFQQLISG 127
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLA---IVMQQPTARSVIGTPEFM 196
           + Y H+    + HRDLK +N  ++G+    +KI D G +   ++  QP  +S +GTP ++
Sbjct: 128 VSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYI 183
Query: 197 APE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASLSK 252
           APE L ++EY+ ++ D++S G+ +  M+   YP+ + + P    K +     ++ A    
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY 243
Query: 253 V-TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 295
           V   P+ +  I +  V  PA  R+   E+    + + + P DL+ D
Sbjct: 244 VHISPECRHLISRIFVADPAK-RISIPEIRNHEWFLKNLPADLMND 288

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D V+ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 144
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 145 -VLHRDLKPSNLLLN-TTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 203 KGYTKSIDIWSVGCILAEMLS 223

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++L  GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +I +L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 87  CRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +  
Sbjct: 144 R--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 201 RIYTHQSDVWSYGVTVWELMT 221

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D V+ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 89
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 146
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 147 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 205 KGYTKSIDIWSVGCILAEMLS 225

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENI 88
           ++LG GAF TVYKG    +G +V    V I+++ +  SP   + +  E +++ S+ + ++
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 83
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 147
            +     +     T+ +I +L   G L  Y ++HK N+  + + NW  QI +G++YL   
Sbjct: 84  CRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              ++HRDL   N+ V      VKI D G A ++    ++  A       ++MA E +  
Sbjct: 141 R--LVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 203 EEYNELVDIYSFGMCILEMVT 223
             Y    D++S+G+ + E++T
Sbjct: 198 RIYTHQSDVWSYGVTVWELMT 218

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 115/237 (48%), Gaps = 13/237 (5%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G GA+ +V    D+  G +VA  +++     QS    +R Y E+ LLK ++HEN+I   
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS--RPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--KAIKNWARQILRGLHYLHSHNPP 150
           + +   ++   N          ++   +K   ++   + I+    Q+L+GL Y+HS    
Sbjct: 108 DVFTPASSLR-NFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG-- 164
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYNEL 208
           ++HRDLK  N+ VN  + E+KI D GLA          V+ T  + APE  L    YN+ 
Sbjct: 165 VVHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGYVV-TRWYRAPEVILSWMHYNQT 222
Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASLSKVTDPQVKQFIE 263
           VDI+S G  + EM+T +  +       Q+ +  KVT       + K+ D   K +I+
Sbjct: 223 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 279

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D V+ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 144
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 145 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 203 KGYTKSIDIWSVGCILAEMLS 223

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 109/217 (50%), Gaps = 12/217 (5%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           + E LG GAF  V    ++  G   A   +  + +      +E   +E+ +L+ +KHENI
Sbjct: 26  FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIE---NEIAVLRKIKHENI 82
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +   +  + ++   + ++ +L + G L     +      K      RQ+L  ++YLH   
Sbjct: 83  VALED--IYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMG 140
Query: 149 PPIIHRDLKCDNIFVNGNNGEVK--IGDLGLAIVMQQPTARSVI-GTPEFMAPE-LYEEE 204
             I+HRDLK +N+     + E K  I D GL+ +  +    S   GTP ++APE L ++ 
Sbjct: 141 --IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKP 198
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
           Y++ VD +S G+ I  ++ C YP    +N +++++++
Sbjct: 199 YSKAVDCWSIGV-IAYILLCGYPPFYDENDSKLFEQI 234

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHE 86
           ++G+G++  V     K  D +  + V   ++  +D     + ++ + +E H+  ++  H 
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-----EDIDWVQTEKHVFEQASNHP 113
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            ++  ++ +   T   +  + E    G L  + ++ + +  +  + ++ +I   L+YLH 
Sbjct: 114 FLVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-E 203
               II+RDLK DN+ ++ + G +K+ D G+     +P  T  +  GTP ++APE+   E
Sbjct: 172 RG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
           +Y   VD ++ G+ + EM+    P++      NP Q                  D   + 
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDYLFQV 273
Query: 261 FIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 296
            +EK I +P SL + A  +LK  FL  D  + L C P
Sbjct: 274 ILEKQIRIPRSLSVKAASVLKS-FLNKDPKERLGCHP 309

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 111/233 (47%), Gaps = 24/233 (10%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERL 73
           S +D    +   +  LG+GA   VY    KG  +   ++V    V+ + V          
Sbjct: 46  SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--------- 96
Query: 74  YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
            +E+ +L  L H NIIK     + +T   I+++ EL T G L     +      +   + 
Sbjct: 97  -TEIGVLLRLSHPNIIKLKE--IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA 153
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLA-IVMQQPTARSVI 190
            +QIL  + YLH +   I+HRDLK +N+       +  +KI D GL+ IV  Q   ++V 
Sbjct: 154 VKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC 211
Query: 191 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKV 241
           GTP + APE+     Y   VD++S G+ I  ++ C + P+ + +    +++++
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGI-ITYILLCGFEPFYDERGDQFMFRRI 263

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D V+ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 95
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 152
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 153 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 210
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 211 KGYTKSIDIWSVGCILAEMLS 231

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D V+ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 144
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 145 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 203 KGYTKSIDIWSVGCILAEMLS 223

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 122/253 (48%), Gaps = 24/253 (9%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD--QLERL-YSEVHLLKSLKHENI 88
           ++G+G++  V K  ++  G  VA     I+  ++S D   ++++   E+ LLK L+HEN+
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVA-----IKKFLESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +      V    +   ++ E      L         +D + ++ +  QI+ G+ + HSHN
Sbjct: 87  VNLLE--VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY--EEE 204
             IIHRD+K +NI V+  +G VK+ D G A  +  P       + T  + APEL   + +
Sbjct: 145 --IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
           Y + VD+++ G  + EM   E  +    +  Q+Y  +        L  +  P+ ++   K
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM------CLGNLI-PRHQELFNK 254
Query: 265 CIVPASLRLPALE 277
             V A +RLP ++
Sbjct: 255 NPVFAGVRLPEIK 267

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K ++
Sbjct: 21  RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIR 71
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y      +   I ++TE  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 72  HEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 129 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 186 AALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY ++  +G+GA+  V   +D V    VA  +++     +     +R   E+ +L   +H
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKIS---PFEHQTYCQRTLREIQILLRFRH 100
Query: 86  ENIIKFYNSWVDDT---NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           EN+I   +     T    R + ++ +L  +   +  + +  + D   I  +  QILRGL 
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSND--HICYFLYQILRGLK 158
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMA 197
           Y+HS N  ++HRDLK  N+ +N    ++KI D GLA +       +      + T  + A
Sbjct: 159 YIHSAN--VLHRDLKPSNLLIN-TTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRA 215
Query: 198 PE--LYEEEYNELVDIYSFGMCILEMVT 223
           PE  L  + Y + +DI+S G  + EM++
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D V+ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 164
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 165 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 223 KGYTKSIDIWSVGCILAEMLS 243

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D V+ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 144
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 145 -VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 203 KGYTKSIDIWSVGCILAEMLS 223

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 111/230 (48%), Gaps = 19/230 (8%)
Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +LGKG+F  V     KG DE+  +++    V I+D     D +E    E  +L       
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-----DDVECTMVEKRVLALPGKPP 81
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +   +S     +R +  + E    G L  + ++           +A +I  GL +L S 
Sbjct: 82  FLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-EE 204
              II+RDLK DN+ ++ + G +KI D G+    +    T +   GTP+++APE+   + 
Sbjct: 141 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 197
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSK 252
           Y + VD ++FG+ + EM+  + P+ E ++  ++++ +       P S+SK
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSK 246

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV+ L  +KHENI++F  +    T+  +++  IT     GSL  + K +  V    + + 
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHI 126
Query: 134 ARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185
           A  + RGL YLH         H P I HRD+K  N+ +  NN    I D GLA+  +   
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGK 185
Query: 186 A----RSVIGTPEFMAPELYEEEYN------ELVDIYSFGMCILEMVT 223
           +       +GT  +MAPE+ E   N        +D+Y+ G+ + E+ +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G    V+ G+           +V ++ + Q     +   +E +L+K L+H+ +++
Sbjct: 19  ERLGAGQAGEVWMGYYN------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K    + +   K  + A QI  G+ ++   N
Sbjct: 73  LYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA +++  + TAR     P ++ APE +    
Sbjct: 130 --YIHRDLRAANILVS-DTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGT 186
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
           +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 115/239 (48%), Gaps = 17/239 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G GA+ +V    D+  G +VA  +++     QS    +R Y E+ LLK ++HEN+I   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS--RPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK----AIKNWARQILRGLHYLHSHN 148
           + +   +  ++    + +      Q     K + +K     I+    Q+L+GL Y+HS  
Sbjct: 90  DVFTPAS--SLRNFYDFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG 146
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYN 206
             ++HRDLK  N+ VN  + E+KI D GLA          V+ T  + APE  L    YN
Sbjct: 147 --VVHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGYVV-TRWYRAPEVILSWMHYN 202
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASLSKVTDPQVKQFIE 263
           + VDI+S G  + EM+T +  +       Q+ +  KVT       + K+ D   K +I+
Sbjct: 203 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 261

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 21  RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 71
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y      +   I ++ E  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 72  HEKLVQLYAV---VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 129 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPE 185
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 186 AALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 109/228 (47%), Gaps = 14/228 (6%)
Query: 27  GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           G+Y   ++LG+G++  V +  D       A   +  + + + P+    +  E+ LL+ L+
Sbjct: 5   GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHY 143
           H+N+I+  +   ++  + + M+ E    G          K   +     +  Q++ GL Y
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPE 199
           LHS    I+H+D+K  N+ +    G +KI  LG+A  +       T R+  G+P F  PE
Sbjct: 125 LHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 200 LYE--EEYNEL-VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +    + ++   VDI+S G+ +  + T  YP+ E  N  ++++ +  G
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKG 228

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 18  RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 68
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y      +   I ++TE    GSL  + K    K + +  + + + QI  G+ 
Sbjct: 69  HEKLVQLYAV---VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMA 125
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 126 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPE 182
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 183 AALY-GRFTIKSDVWSFGILLTELTT 207

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 18  RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 68
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y      +   I ++TE    GSL  + K    K + +  + + + QI  G+ 
Sbjct: 69  HEKLVQLYAV---VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMA 125
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 126 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 182
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 183 AALY-GRFTIKSDVWSFGILLTELTT 207

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D ++ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 148
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 149 -VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLS 227

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 73
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V    +   A QI   + YL   N  
Sbjct: 74  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 129
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 130 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 239
              D+++FG+ + E+ T         +P+Q+Y+
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 21  RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 71
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y      +   I ++TE  + G L  + K    K + +  + + A QI  G+ 
Sbjct: 72  HEKLVQLYAV---VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 129 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 186 AALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D ++ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 148
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 149 -VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLS 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D ++ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 149
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 150 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 207
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 208 KGYTKSIDIWSVGCILAEMLS 228

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D ++ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 93
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 150
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 151 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 208
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 209 KGYTKSIDIWSVGCILAEMLS 229

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D ++ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 84
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 141
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 142 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 199
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 200 KGYTKSIDIWSVGCILAEMLS 220

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D ++ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 148
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 149 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLS 227

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D ++ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 148
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 149 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLS 227

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 21  RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 71
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y      +   I ++ E  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 72  HEKLVQLYAV---VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 129 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 186 AALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           +LG+GA+  V     +  G  VA  ++   D    P    R   E+ +LK  KHENII  
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFD---KPLFALRTLREIKILKHFKHENIITI 74
Query: 92  YNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +N    D+    N   +I EL  +   R    +  + D   I+ +  Q LR +  LH  N
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD--HIQYFIYQTLRAVKVLHGSN 132
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------------QQPTARSVIGTPEFM 196
             +IHRDLK  N+ +N +N ++K+ D GLA ++            QQ      + T  + 
Sbjct: 133 --VIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYR 189
Query: 197 APE--LYEEEYNELVDIYSFGMCILEMVTCEYP 227
           APE  L   +Y+  +D++S G CIL  +    P
Sbjct: 190 APEVMLTSAKYSRAMDVWSCG-CILAELFLRRP 221

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D ++ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 148
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 149 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 206
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLS 227

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D ++ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 149
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 150 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 207
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 208 KGYTKSIDIWSVGCILAEMLS 228

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 21  RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 71
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y      +   I ++ E  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 72  HEKLVQLYAV---VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 129 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 186 AALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D ++ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 142
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 143 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 201 KGYTKSIDIWSVGCILAEMLS 221

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           +LG+GA+  V     +  G  VA  ++   D    P    R   E+ +LK  KHENII  
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFD---KPLFALRTLREIKILKHFKHENIITI 74
Query: 92  YNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +N    D+    N   +I EL  +   R    +  + D   I+ +  Q LR +  LH  N
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD--HIQYFIYQTLRAVKVLHGSN 132
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------------QQPTARSVIGTPEFM 196
             +IHRDLK  N+ +N +N ++K+ D GLA ++            QQ      + T  + 
Sbjct: 133 --VIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYR 189
Query: 197 APE--LYEEEYNELVDIYSFGMCILEMVTCEYP 227
           APE  L   +Y+  +D++S G CIL  +    P
Sbjct: 190 APEVMLTSAKYSRAMDVWSCG-CILAELFLRRP 221

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHE 86
           ++G+G++  V     K  D +  ++V   ++  +D     + ++ + +E H+  ++  H 
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNHP 70
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            ++  ++ +   T   +  + E    G L  + ++ + +  +  + ++ +I   L+YLH 
Sbjct: 71  FLVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-E 203
               II+RDLK DN+ ++ + G +K+ D G+     +P  T     GTP ++APE+   E
Sbjct: 129 RG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
           +Y   VD ++ G+ + EM+    P++      NP Q                  D   + 
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDYLFQV 230
Query: 261 FIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 296
            +EK I +P SL + A  +LK  FL  D  + L C P
Sbjct: 231 ILEKQIRIPRSLSVKAASVLKS-FLNKDPKERLGCHP 266

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D ++ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIHSAN- 142
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 143 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 201 KGYTKSIDIWSVGCILAEMLS 221

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +   G   A  ++ +E   +  P    R   E+ +LK LKH NI+
Sbjct: 8   EKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIV 63
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           K Y+  V  T + + ++ E       +        ++    K++  Q+L G+ Y H    
Sbjct: 64  KLYD--VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IGTPEFMAPELY--EEEY 205
            ++HRDLK  N+ +N   GE+KI D GLA     P  +    I T  + AP++    ++Y
Sbjct: 121 -VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 206 NELVDIYSFGMCILEMV 222
           +  +DI+S G    EMV
Sbjct: 179 STTIDIWSVGCIFAEMV 195

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHE 86
           ++G+G++  V     K  D +  ++V   ++  +D     + ++ + +E H+  ++  H 
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNHP 66
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            ++  ++ +   T   +  + E    G L  + ++ + +  +  + ++ +I   L+YLH 
Sbjct: 67  FLVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-E 203
               II+RDLK DN+ ++ + G +K+ D G+     +P  T     GTP ++APE+   E
Sbjct: 125 RG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
           +Y   VD ++ G+ + EM+    P++      NP Q                  D   + 
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDYLFQV 226
Query: 261 FIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 296
            +EK I +P SL + A  +LK  FL  D  + L C P
Sbjct: 227 ILEKQIRIPRSLSVKAASVLKS-FLNKDPKERLGCHP 262

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           +LG+GA+  V     +  G  VA  ++   D    P    R   E+ +LK  KHENII  
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFD---KPLFALRTLREIKILKHFKHENIITI 74
Query: 92  YNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +N    D+    N   +I EL  +   R    +  + D   I+ +  Q LR +  LH  N
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD--HIQYFIYQTLRAVKVLHGSN 132
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------------QQPTARSVIGTPEFM 196
             +IHRDLK  N+ +N +N ++K+ D GLA ++            QQ      + T  + 
Sbjct: 133 --VIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 197 APE--LYEEEYNELVDIYSFGMCILEMVTCEYP 227
           APE  L   +Y+  +D++S G CIL  +    P
Sbjct: 190 APEVMLTSAKYSRAMDVWSCG-CILAELFLRRP 221

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 124/266 (46%), Gaps = 18/266 (6%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG GAF  V++  +   G   A   V    +       E +  E+  +  L+H  ++ 
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFV----MTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 91  FYNSWVDDTNRTINMITELFTSGSL-RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
            ++++ DD    + MI E  + G L  +   +H  +       + RQ+ +GL ++H +N 
Sbjct: 219 LHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 275
Query: 150 PIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPELYE-EEYN 206
             +H DLK +NI F    + E+K+ D GL   +  + + +   GT EF APE+ E +   
Sbjct: 276 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKPASLSKVTDPQVKQFIE 263
              D++S G+    +++   P+   +N  +  + V S    +  ++ S +++   K FI 
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMDDSAFSGISE-DGKDFIR 392
Query: 264 KCIVP-ASLRLPALELLKDPFLVTDN 288
           K ++   + R+   + L+ P+L   N
Sbjct: 393 KLLLADPNTRMTIHQALEHPWLTPGN 418

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 188 RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLR 238
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y    ++    I ++TE  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 239 HEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 295
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GL  +++  + TAR     P ++ APE
Sbjct: 296 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPE 352
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 353 AALY-GRFTIKSDVWSFGILLTELTT 377

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 124/266 (46%), Gaps = 18/266 (6%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG GAF  V++  +   G   A   V    +       E +  E+  +  L+H  ++ 
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFV----MTPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 91  FYNSWVDDTNRTINMITELFTSGSL-RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
            ++++ DD    + MI E  + G L  +   +H  +       + RQ+ +GL ++H +N 
Sbjct: 113 LHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 169
Query: 150 PIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPELYE-EEYN 206
             +H DLK +NI F    + E+K+ D GL   +  + + +   GT EF APE+ E +   
Sbjct: 170 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKPASLSKVTDPQVKQFIE 263
              D++S G+    +++   P+   +N  +  + V S    +  ++ S +++   K FI 
Sbjct: 229 YYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMDDSAFSGISE-DGKDFIR 286
Query: 264 KCIVP-ASLRLPALELLKDPFLVTDN 288
           K ++   + R+   + L+ P+L   N
Sbjct: 287 KLLLADPNTRMTIHQALEHPWLTPGN 312

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 33  LGKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           +G+G F  VYKG+     + V    A   +  E++ Q  DQ      E+ ++   +HEN+
Sbjct: 33  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ------EIKVMAKCQHENL 86
Query: 89  IKF--YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW------ARQILRG 140
           ++   ++S  DD    + ++     +GSL     +   +D     +W      A+    G
Sbjct: 87  VELLGFSSDGDD----LCLVYVYMPNGSLLD---RLSCLDGTPPLSWHMRCKIAQGAANG 139
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV----MQQPTARSVIGTPEFM 196
           +++LH ++   IHRD+K  NI ++      KI D GLA       Q      ++GT  +M
Sbjct: 140 INFLHENHH--IHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYM 196
Query: 197 APELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 234
           APE    E     DIYSFG+ +LE++T     +E + P
Sbjct: 197 APEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 234

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 33  LGKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           +G+G F  VYKG+     + V    A   +  E++ Q  DQ      E+ ++   +HEN+
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ------EIKVMAKCQHENL 92
Query: 89  IKF--YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW------ARQILRG 140
           ++   ++S  DD    + ++     +GSL     +   +D     +W      A+    G
Sbjct: 93  VELLGFSSDGDD----LCLVYVYMPNGSLLD---RLSCLDGTPPLSWHMRCKIAQGAANG 145
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV----MQQPTARSVIGTPEFM 196
           +++LH ++   IHRD+K  NI ++      KI D GLA       Q      ++GT  +M
Sbjct: 146 INFLHENHH--IHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYM 202
Query: 197 APELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 234
           APE    E     DIYSFG+ +LE++T     +E + P
Sbjct: 203 APEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 33  LGKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           +G+G F  VYKG+     + V    A   +  E++ Q  DQ      E+ ++   +HEN+
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ------EIKVMAKCQHENL 92
Query: 89  IKF--YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW------ARQILRG 140
           ++   ++S  DD    + ++     +GSL     +   +D     +W      A+    G
Sbjct: 93  VELLGFSSDGDD----LCLVYVYMPNGSLLD---RLSCLDGTPPLSWHMRCKIAQGAANG 145
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV----MQQPTARSVIGTPEFM 196
           +++LH ++   IHRD+K  NI ++      KI D GLA       Q      ++GT  +M
Sbjct: 146 INFLHENHH--IHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYM 202
Query: 197 APELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 234
           APE    E     DIYSFG+ +LE++T     +E + P
Sbjct: 203 APEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 187 RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 237
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y    ++    I ++ E  + GSL  + K    K + +  + + A QI  G+ 
Sbjct: 238 HEKLVQLYAVVSEEP---IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 295 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 352 AALY-GRFTIKSDVWSFGILLTELTT 376

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +   G   A  ++ +E   +  P    R   E+ +LK LKH NI+
Sbjct: 8   EKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIV 63
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           K Y+  V  T + + ++ E       +        ++    K++  Q+L G+ Y H    
Sbjct: 64  KLYD--VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IGTPEFMAPELY--EEEY 205
            ++HRDLK  N+ +N   GE+KI D GLA     P  +    + T  + AP++    ++Y
Sbjct: 121 -VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 206 NELVDIYSFGMCILEMV 222
           +  +DI+S G    EMV
Sbjct: 179 STTIDIWSVGCIFAEMV 195

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
           E +G+G +  VYK  +   G   A  ++ +E   +  P    R   E+ +LK LKH NI+
Sbjct: 8   EKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIV 63
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           K Y+  V  T + + ++ E       +        ++    K++  Q+L G+ Y H    
Sbjct: 64  KLYD--VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IGTPEFMAPELY--EEEY 205
            ++HRDLK  N+ +N   GE+KI D GLA     P  +    + T  + AP++    ++Y
Sbjct: 121 -VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 206 NELVDIYSFGMCILEMV 222
           +  +DI+S G    EMV
Sbjct: 179 STTIDIWSVGCIFAEMV 195

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--- 89
           +G+GA+  V   +D ++ + VA  +++     +     +R   E+ +L   +HENII   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               +   +  + + ++ +L  +   +  + +H + D   I  +  QILRGL Y+HS N 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSND--HICYFLYQILRGLKYIHSAN- 148
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYE 202
            ++HRDLK  N+ +N    ++KI D GLA V       +      + T  + APE  L  
Sbjct: 149 -VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 203 EEYNELVDIYSFGMCILEMVT 223
           + Y + +DI+S G  + EM++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLS 227

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 25/218 (11%)
Query: 21  DPSCRYGRYD---------EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE 71
           DPS  Y +++           LG G +  VY+G  +   + VA   +  ED M+    +E
Sbjct: 4   DPSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VE 58
Query: 72  RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKA 129
               E  ++K +KH N+++     V        +ITE  T G+L  Y ++   + V+   
Sbjct: 59  EFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 116
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
           +   A QI   + YL   N   IHRDL   N  V G N  VK+ D GL+ +M   T  + 
Sbjct: 117 LLYMATQISSAMEYLEKKN--FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAH 173
Query: 190 IGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
            G     ++ APE L   +++   D+++FG+ + E+ T
Sbjct: 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 31  EILGKGAFKTVY--KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           ++LG+G+F  V+  K     D  ++   +V  +  ++  D++ R   E  +L  + H  I
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDILVEVNHPFI 88
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +K + ++   T   + +I +    G L     K      + +K +  ++   L +LHS  
Sbjct: 89  VKLHYAF--QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 146
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEEE-Y 205
             II+RDLK +NI ++   G +K+ D GL+   +  +  A S  GT E+MAPE+     +
Sbjct: 147 --IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 206 NELVDIYSFGMCILEMVTCEYPYN 229
            +  D +SFG+ + EM+T   P+ 
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 45/223 (20%)
Query: 31  EILGKGAFKTVYKG-FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           E++G+G +  VYKG  DE       ++  N ++ +   +        ++ +  ++H+NI 
Sbjct: 19  ELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKN--------IYRVPLMEHDNIA 70
Query: 90  KFYNSWVDDTNRTIN------MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
           +F    V D   T +      ++ E + +GSL +Y   H + D  +    A  + RGL Y
Sbjct: 71  RFI---VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-DWVSSCRLAHSVTRGLAY 126
Query: 144 LHS-------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----------QQPTA 186
           LH+       + P I HRDL   N+ V  N+G   I D GL++ +          +   A
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 187 RSVIGTPEFMAPELYEEEYN--------ELVDIYSFGMCILEM 221
            S +GT  +MAPE+ E   N        + VD+Y+ G+   E+
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 100/217 (46%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 2   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 60
Query: 76  EVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++  +     L  +  +   +  +  +++
Sbjct: 61  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERMEPVQDLFDFITERGALQEELARSF 119
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 120 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 177
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 73
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +I E  T G+L  Y ++   + V    +   A QI   + YL   N  
Sbjct: 74  G--VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 129
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 130 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 239
              D+++FG+ + E+ T         +P+Q+Y+
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 80
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V+   +   A QI   + YL   N  
Sbjct: 81  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 136
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 137 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 112/226 (49%), Gaps = 18/226 (7%)
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +SL+H NI++F    +  T+  I M  E  + G L +             + + +Q++ G
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVM--EYASGGELFERICNAGRFSEDEARFFFQQLISG 127
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLA---IVMQQPTARSVIGTPEFM 196
           + Y H+    + HRDLK +N  ++G+    +KI   G +   ++  QP  +S +GTP ++
Sbjct: 128 VSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP--KSTVGTPAYI 183
Query: 197 APE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASLSK 252
           APE L ++EY+ ++ D++S G+ +  M+   YP+ + + P    K +     ++ A    
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY 243
Query: 253 V-TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 295
           V   P+ +  I +  V  PA  R+   E+    + + + P DL+ D
Sbjct: 244 VHISPECRHLISRIFVADPAK-RISIPEIRNHEWFLKNLPADLMND 288

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 95/189 (50%), Gaps = 13/189 (6%)
Query: 56  NQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL 115
            +V ++ +      +E   +E +++K+L+H+ ++K +      T   I +ITE    GSL
Sbjct: 40  TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV---VTKEPIYIITEFMAKGSL 96
Query: 116 RQYRKKHKNVD--MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173
             + K  +     +  + +++ QI  G+ ++   N   IHRDL+  NI V+ +    KI 
Sbjct: 97  LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLV-CKIA 153
Query: 174 DLGLAIVMQ--QPTARSVIGTP-EFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY 228
           D GLA V++  + TAR     P ++ APE      +    D++SFG+ ++E+VT    PY
Sbjct: 154 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 213
Query: 229 NECKNPAQI 237
               NP  I
Sbjct: 214 PGMSNPEVI 222

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHE 86
           ++G+G++  V     K  D +  ++V   ++  +D     + ++ + +E H+  ++  H 
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNHP 81
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            ++  ++ +   T   +  + E    G L  + ++ + +  +  + ++ +I   L+YLH 
Sbjct: 82  FLVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 139
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-E 203
               II+RDLK DN+ ++ + G +K+ D G+     +P  T     GTP ++APE+   E
Sbjct: 140 RG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 196
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
           +Y   VD ++ G+ + EM+    P++      NP Q                  D   + 
Sbjct: 197 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDYLFQV 241
Query: 261 FIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 296
            +EK I +P S+ + A  +LK  FL  D  + L C P
Sbjct: 242 ILEKQIRIPRSMSVKAASVLK-SFLNKDPKERLGCLP 277

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 80
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V+   +   A QI   + YL   N  
Sbjct: 81  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 136
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 137 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 76
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V+   +   A QI   + YL   N  
Sbjct: 77  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 132
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 133 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS 191
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 77
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V+   +   A QI   + YL   N  
Sbjct: 78  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 133
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 134 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS 192
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 95/189 (50%), Gaps = 13/189 (6%)
Query: 56  NQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL 115
            +V ++ +      +E   +E +++K+L+H+ ++K +      T   I +ITE    GSL
Sbjct: 213 TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV---VTKEPIYIITEFMAKGSL 269
Query: 116 RQYRKKHKNVD--MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173
             + K  +     +  + +++ QI  G+ ++   N   IHRDL+  NI V+ +    KI 
Sbjct: 270 LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIA 326
Query: 174 DLGLAIVMQ--QPTARSVIGTP-EFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY 228
           D GLA V++  + TAR     P ++ APE      +    D++SFG+ ++E+VT    PY
Sbjct: 327 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386
Query: 229 NECKNPAQI 237
               NP  I
Sbjct: 387 PGMSNPEVI 395

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG+G+F  V++  D+  G + A  +V +E V ++         E+     L    I+  Y
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLE-VFRA--------EELMACAGLTSPRIVPLY 151
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            +  +     +N+  EL   GSL Q  K+   +       +  Q L GL YLHS    I+
Sbjct: 152 GAVREGP--WVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR--IL 207
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARSVIGTPEFMAPE-LYEEE 204
           H D+K DN+ ++ +     + D G A+ +Q         T   + GT   MAPE +    
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNE 230
            +  VD++S    +L M+   +P+ +
Sbjct: 268 CDAKVDVWSSCCMMLHMLNGCHPWTQ 293

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 112/249 (44%), Gaps = 22/249 (8%)
Query: 79  LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
           LL+  +H NII   +  V D  + + ++TEL   G L     + K    +        I 
Sbjct: 69  LLRYGQHPNIITLKD--VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 193
           + + YLH+    ++HRDLK  NI     +GN   ++I D G A   Q      ++ TP  
Sbjct: 127 KTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFA--KQLRAENGLLMTPCY 182
Query: 194 --EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSG---I 245
              F+APE+ E + Y+   DI+S G+ +  M+T   P+    +  P +I  ++ SG   +
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242
Query: 246 KPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVT-DNPKDLVCDPLRLPNLV 303
                + V+D   K  + K + V    RL A  +L+ P++V  D       +    P+LV
Sbjct: 243 SGGYWNSVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLV 301
Query: 304 PEVMNLAHS 312
              M   +S
Sbjct: 302 KGAMAATYS 310

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 31  EILGKGAFKTVY--KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           ++LG+G+F  V+  +     D   +   +V  +  ++  D++ R   E  +L  + H  +
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRV-RTKMERDILADVNHPFV 92
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +K + ++   T   + +I +    G L     K      + +K +  ++  GL +LHS  
Sbjct: 93  VKLHYAF--QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLG 150
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEEE-Y 205
             II+RDLK +NI ++   G +K+ D GL+   +  +  A S  GT E+MAPE+   + +
Sbjct: 151 --IIYRDLKPENILLD-EEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGH 207
Query: 206 NELVDIYSFGMCILEMVTCEYPYN 229
           +   D +S+G+ + EM+T   P+ 
Sbjct: 208 SHSADWWSYGVLMFEMLTGSLPFQ 231

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 31  EILGKGAFKTVY--KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           ++LG+G+F  V+  K     D  ++   +V  +  ++  D++ R   E  +L  + H  I
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDILVEVNHPFI 89
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +K + ++   T   + +I +    G L     K      + +K +  ++   L +LHS  
Sbjct: 90  VKLHYAF--QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 147
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEEE-Y 205
             II+RDLK +NI ++   G +K+ D GL+   +  +  A S  GT E+MAPE+     +
Sbjct: 148 --IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 204
Query: 206 NELVDIYSFGMCILEMVTCEYPYN 229
            +  D +SFG+ + EM+T   P+ 
Sbjct: 205 TQSADWWSFGVLMFEMLTGTLPFQ 228

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R +  LG+G F  V+ G          WN   +V I+ +       E    E  ++K L+
Sbjct: 21  RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 71
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
           HE +++ Y      +   I ++ E  + G L  + K    K + +  + + A QI  G+ 
Sbjct: 72  HEKLVQLYAV---VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
           Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P ++ APE
Sbjct: 129 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
             LY   +    D++SFG+ + E+ T
Sbjct: 186 AALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 80
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V+   +   A QI   + YL   N  
Sbjct: 81  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 136
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 137 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 31  EILGKGAFKTVY--KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           ++LG+G+F  V+  K     D  ++   +V  +  ++  D++ R   E  +L  + H  I
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDILVEVNHPFI 88
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +K + ++   T   + +I +    G L     K      + +K +  ++   L +LHS  
Sbjct: 89  VKLHYAF--QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 146
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEEE-Y 205
             II+RDLK +NI ++   G +K+ D GL+   +  +  A S  GT E+MAPE+     +
Sbjct: 147 --IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 206 NELVDIYSFGMCILEMVTCEYPYN 229
            +  D +SFG+ + EM+T   P+ 
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 73/142 (51%), Gaps = 5/142 (3%)
Query: 94  SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153
           S+   T   ++ I +L   G L  +  +H       ++ +A +I+ GL   H HN  +++
Sbjct: 258 SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMHNRFVVY 315
Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDI 211
           RDLK  NI ++  +G V+I DLGLA    +    + +GT  +MAPE+ ++   Y+   D 
Sbjct: 316 RDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 212 YSFGMCILEMVTCEYPYNECKN 233
           +S G  + +++    P+ + K 
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G F  V+ G+           +V ++ +      ++    E +L+K+L+H+ +++ Y
Sbjct: 21  LGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 74
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPP 150
              V      I +ITE    GSL  + K  +   V +  + +++ QI  G+ Y+   N  
Sbjct: 75  A--VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 130
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPELYEEE-YN 206
            IHRDL+  N+ V+  +   KI D GLA V++  + TAR     P ++ APE      + 
Sbjct: 131 YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 207 ELVDIYSFGMCILEMVT 223
              D++SFG+ + E+VT
Sbjct: 190 IKSDVWSFGILLYEIVT 206

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 73/142 (51%), Gaps = 5/142 (3%)
Query: 94  SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153
           S+   T   ++ I +L   G L  +  +H       ++ +A +I+ GL   H HN  +++
Sbjct: 258 SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMHNRFVVY 315
Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDI 211
           RDLK  NI ++  +G V+I DLGLA    +    + +GT  +MAPE+ ++   Y+   D 
Sbjct: 316 RDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 212 YSFGMCILEMVTCEYPYNECKN 233
           +S G  + +++    P+ + K 
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 73/142 (51%), Gaps = 5/142 (3%)
Query: 94  SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153
           S+   T   ++ I +L   G L  +  +H       ++ +A +I+ GL   H HN  +++
Sbjct: 258 SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMHNRFVVY 315
Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDI 211
           RDLK  NI ++  +G V+I DLGLA    +    + +GT  +MAPE+ ++   Y+   D 
Sbjct: 316 RDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 212 YSFGMCILEMVTCEYPYNECKN 233
           +S G  + +++    P+ + K 
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 73/142 (51%), Gaps = 5/142 (3%)
Query: 94  SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153
           S+   T   ++ I +L   G L  +  +H       ++ +A +I+ GL   H HN  +++
Sbjct: 257 SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMHNRFVVY 314
Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDI 211
           RDLK  NI ++  +G V+I DLGLA    +    + +GT  +MAPE+ ++   Y+   D 
Sbjct: 315 RDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 373
Query: 212 YSFGMCILEMVTCEYPYNECKN 233
           +S G  + +++    P+ + K 
Sbjct: 374 FSLGCMLFKLLRGHSPFRQHKT 395

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V+   +   A QI   + YL   N  
Sbjct: 76  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 77
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V+   +   A QI   + YL   N  
Sbjct: 78  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 133
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 134 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 77
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V+   +   A QI   + YL   N  
Sbjct: 78  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 133
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 134 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 80
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V    +   A QI   + YL   N  
Sbjct: 81  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 136
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 137 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 17  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 75
Query: 76  EVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 76  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 134
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 135 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 192
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 193 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 89
Query: 76  EVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 90  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 149 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 206
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 88
Query: 76  EVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 89  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 148 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 205
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V+   +   A QI   + YL   N  
Sbjct: 76  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG+G+F  V++  D+  G + A  +V +E V ++         E+     L    I+  Y
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLE-VFRA--------EELMACAGLTSPRIVPLY 132
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            +  +     +N+  EL   GSL Q  K+   +       +  Q L GL YLHS    I+
Sbjct: 133 GAVREGP--WVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR--IL 188
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARSVIGTPEFMAPE-LYEEE 204
           H D+K DN+ ++ +     + D G A+ +Q         T   + GT   MAPE +    
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNE 230
            +  VD++S    +L M+   +P+ +
Sbjct: 249 CDAKVDVWSSCCMMLHMLNGCHPWTQ 274

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 21/219 (9%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G F  V+ G+           +V ++ +      ++    E +L+K+L+H+ +++ Y
Sbjct: 20  LGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 73
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPP 150
              V      I +ITE    GSL  + K  +   V +  + +++ QI  G+ Y+   N  
Sbjct: 74  A--VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 129
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPELYEEE-YN 206
            IHRDL+  N+ V+  +   KI D GLA V++  + TAR     P ++ APE      + 
Sbjct: 130 YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 188
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245
              +++SFG+ + E+VT    Y +   P +    V S +
Sbjct: 189 IKSNVWSFGILLYEIVT----YGKIPYPGRTNADVMSAL 223

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V    +   A QI   + YL   N  
Sbjct: 76  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 18  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 76
Query: 76  EVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 77  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 136 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 193
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 17  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 75
Query: 76  EVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 76  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 134
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 135 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 192
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 193 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 17/238 (7%)
Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLYSE 76
           +E  PSC      +++G G F  VYKG  +   G +     +       +  Q      E
Sbjct: 39  TEIHPSCV--TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 96
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWAR 135
             ++    H NII+     V    + + +ITE   +G+L ++ R+K     +  +    R
Sbjct: 97  AGIMGQFSHHNIIRLEG--VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 154
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPE 194
            I  G+ YL + N   +HRDL   NI VN +N   K+ D GL+ V++  P A       +
Sbjct: 155 GIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 195 ----FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
               + APE +   ++    D++SFG+ + E++T  E PY E  N  ++ K +  G +
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFR 268

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 89
Query: 76  EVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 90  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 149 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 206
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 88
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V+   +   A QI   + YL   N  
Sbjct: 89  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 144
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 145 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 203
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 204 IKSDVWAFGVLLWEIAT 220

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V    +   A QI   + YL   N  
Sbjct: 76  G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 88
Query: 76  EVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 89  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 148 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 205
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 88
Query: 76  EVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 89  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 148 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 205
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 18  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 76
Query: 76  EVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 77  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 136 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 193
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 37  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 95
Query: 76  EVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 96  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 154
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 155 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 212
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 45  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 103
Query: 76  EVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 104 EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 162
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 163 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 220
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 89
Query: 76  EVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 90  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 149 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 206
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 89
Query: 76  EVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 90  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 149 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 206
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 18  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 76
Query: 76  EVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 77  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 136 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 193
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 88
Query: 76  EVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 89  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 148 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 205
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 45  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 103
Query: 76  EVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 104 EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 162
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 163 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 220
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +GKG F  V++G  +  G EVA   V I    +         +E++    L+HENI+ 
Sbjct: 48  ESIGKGRFGEVWRG--KWRGEEVA---VKIFSSREERSWFRE--AEIYQTVMLRHENILG 100
Query: 91  FYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--- 145
           F  +   D  T   + ++++    GSL  Y  ++  V ++ +   A     GL +LH   
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEI 159
Query: 146 ---SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFM 196
                 P I HRDLK  NI V   NG   I DLGLA+     T          +GT  +M
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 197 APELYEEEYN-------ELVDIYSFGMCILEMV 222
           APE+ ++  N       +  DIY+ G+   E+ 
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 50  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 108
Query: 76  EVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 109 EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 167
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 168 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 225
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 226 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 262

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 9/182 (4%)
Query: 116 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175
           +Q   K + +    +   A  I++ L +LHS    +IHRD+K  N+ +N   G+VK  D 
Sbjct: 124 KQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINAL-GQVKXCDF 181
Query: 176 GLAIVMQQPTARSVIG------TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYN 229
           G++  +    A+ +         PE + PEL ++ Y+   DI+S G+  +E+    +PY+
Sbjct: 182 GISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYD 241
Query: 230 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDN 288
               P Q  K+V     P   +     +   F  +C+   S   P   EL + PF     
Sbjct: 242 SWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFFTLHE 301
Query: 289 PK 290
            K
Sbjct: 302 SK 303

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +GKG F  V++G  +  G EVA   V I    +         +E++    L+HENI+ 
Sbjct: 35  ESIGKGRFGEVWRG--KWRGEEVA---VKIFSSREERSWFRE--AEIYQTVMLRHENILG 87
Query: 91  FYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--- 145
           F  +   D  T   + ++++    GSL  Y  ++  V ++ +   A     GL +LH   
Sbjct: 88  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEI 146
Query: 146 ---SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFM 196
                 P I HRDLK  NI V   NG   I DLGLA+     T          +GT  +M
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 205
Query: 197 APELYEEEYN-------ELVDIYSFGMCILEMV 222
           APE+ ++  N       +  DIY+ G+   E+ 
Sbjct: 206 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 120/262 (45%), Gaps = 11/262 (4%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LGKG F  VY   ++     VA  +V  +  ++      +L  E+ +   L H NI++ Y
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVAL-KVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLY 89
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
           N + D   R I +I E    G L +  +K    D +       ++   L Y H     +I
Sbjct: 90  NYFYD--RRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK--VI 145
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDI 211
           HRD+K +N+ + G  GE+KI D G ++       +++ GT +++ PE+ E   +NE VD+
Sbjct: 146 HRDIKPENL-LLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDL 204
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIVPAS 270
           +  G+   E++    P+    +     + V   +K PAS+       + + +       S
Sbjct: 205 WCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRHN---PS 261
Query: 271 LRLPALELLKDPFLVTDNPKDL 292
            RLP  ++   P++  ++ + L
Sbjct: 262 ERLPLAQVSAHPWVRANSRRVL 283

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +GKG F  V++G  +  G EVA   V I    +         +E++    L+HENI+ 
Sbjct: 10  ESIGKGRFGEVWRG--KWRGEEVA---VKIFSSREERSWFRE--AEIYQTVMLRHENILG 62
Query: 91  FYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--- 145
           F  +   D  T   + ++++    GSL  Y  ++  V ++ +   A     GL +LH   
Sbjct: 63  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEI 121
Query: 146 ---SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFM 196
                 P I HRDLK  NI V   NG   I DLGLA+     T          +GT  +M
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 180
Query: 197 APELYEEEYN-------ELVDIYSFGMCILEMV 222
           APE+ ++  N       +  DIY+ G+   E+ 
Sbjct: 181 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 111/249 (44%), Gaps = 25/249 (10%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY ++  +G GA   V   FD V GI VA  +++     Q+    +R Y E+ LLK + H
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS--RPFQNQTHAKRAYRELVLLKCVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +     H  +D + +     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV-----MQQPTARSVIGTPEFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA       M  P     + T  + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTACTNFMMTP----YVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y   VDI+S G  + E+V     +    +  Q  K +   G   A      
Sbjct: 193 APEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL 252
Query: 255 DPQVKQFIE 263
            P V+ ++E
Sbjct: 253 QPTVRNYVE 261

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 61
Query: 76  EVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 62  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 120
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 121 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 178
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +GKG F  V++G  +  G EVA   V I    +         +E++    L+HENI+ 
Sbjct: 15  ESIGKGRFGEVWRG--KWRGEEVA---VKIFSSREERSWFRE--AEIYQTVMLRHENILG 67
Query: 91  FYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--- 145
           F  +   D  T   + ++++    GSL  Y  ++  V ++ +   A     GL +LH   
Sbjct: 68  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEI 126
Query: 146 ---SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFM 196
                 P I HRDLK  NI V   NG   I DLGLA+     T          +GT  +M
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 185
Query: 197 APELYEEEYN-------ELVDIYSFGMCILEMV 222
           APE+ ++  N       +  DIY+ G+   E+ 
Sbjct: 186 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +GKG F  V++G  +  G EVA   V I    +         +E++    L+HENI+ 
Sbjct: 12  ESIGKGRFGEVWRG--KWRGEEVA---VKIFSSREERSWFRE--AEIYQTVMLRHENILG 64
Query: 91  FYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--- 145
           F  +   D  T   + ++++    GSL  Y  ++  V ++ +   A     GL +LH   
Sbjct: 65  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEI 123
Query: 146 ---SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFM 196
                 P I HRDLK  NI V   NG   I DLGLA+     T          +GT  +M
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 182
Query: 197 APELYEEEYN-------ELVDIYSFGMCILEMV 222
           APE+ ++  N       +  DIY+ G+   E+ 
Sbjct: 183 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 61
Query: 76  EVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 62  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 120
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 121 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 178
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +GKG F  V++G  +  G EVA   V I    +         +E++    L+HENI+ 
Sbjct: 9   ESIGKGRFGEVWRG--KWRGEEVA---VKIFSSREERSWFRE--AEIYQTVMLRHENILG 61
Query: 91  FYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--- 145
           F  +   D  T   + ++++    GSL  Y  ++  V ++ +   A     GL +LH   
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEI 120
Query: 146 ---SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFM 196
                 P I HRDLK  NI V   NG   I DLGLA+     T          +GT  +M
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 197 APELYEEEYN-------ELVDIYSFGMCILEMV 222
           APE+ ++  N       +  DIY+ G+   E+ 
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 122/276 (44%), Gaps = 25/276 (9%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
            +ILG+GA   V++G  +  G   A    N    ++  D   R   E  +LK L H+NI+
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR---EFEVLKKLNHKNIV 70
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW---ARQILRGLHYLHS 146
           K +    + T R   +I E    GSL    ++  N        +    R ++ G+++L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 147 HNPPIIHRDLKCDNIF-VNGNNGE--VKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYE 202
           +   I+HR++K  NI  V G +G+   K+ D G A  ++      S+ GT E++ P++YE
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 203 ---------EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASL 250
                    ++Y   VD++S G+      T   P+   + P    ++  K+ +G    ++
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 251 SKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLV 285
           S V   +         +P S  L   L++L  P L 
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 104/204 (50%), Gaps = 15/204 (7%)
Query: 28  RYDEILGKGAFKTVYKG--FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           R  ++LG G F TV+KG    E + I++      IED        + +   +  + SL H
Sbjct: 34  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIED-KSGRQSFQAVTDHMLAIGSLDH 92
Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYL 144
            +I++           ++ ++T+    GSL  + ++H+  +  + + NW  QI +G++YL
Sbjct: 93  AHIVRLLGLC---PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 149
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTP-EFMAPE- 199
             H   ++HR+L   N+ +  +  +V++ D G+A ++    +    S   TP ++MA E 
Sbjct: 150 EEHG--MVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 200 LYEEEYNELVDIYSFGMCILEMVT 223
           ++  +Y    D++S+G+ + E++T
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 61
Query: 76  EVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 62  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 120
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 121 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 178
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 2   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 60
Query: 76  EVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 61  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 119
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 120 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 177
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+    E     V +     + + L  L SE+ ++K + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y                R   + +  K + 
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T 
Sbjct: 161 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTT 217
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 218 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 25  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 83
Query: 76  EVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 84  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 142
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 143 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 200
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 201 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 237

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKF 91
           LGKGA+  V+K  D   G  VA  +  I D  Q+    +R + E+ +L  L  HENI+  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKK--IFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA-RQILRGLHYLHSHNPP 150
            N    D +R + ++ +   +      R    N+     K +   Q+++ + YLHS    
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG-- 129
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----------------------QQPTAR 187
           ++HRD+K  NI +N     VK+ D GL+                           QP   
Sbjct: 130 LLHRDMKPSNILLNA-ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 188 SVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYP 227
             + T  + APE  L   +Y + +D++S G CIL  + C  P
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILCGKP 229

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 111/226 (49%), Gaps = 18/226 (7%)
Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +SL+H NI++F    +  T+  I M  E  + G L +             + + +Q++ G
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVM--EYASGGELFERICNAGRFSEDEARFFFQQLISG 127
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLA---IVMQQPTARSVIGTPEFM 196
           + Y H+    + HRDLK +N  ++G+    +KI   G +   ++  QP  +  +GTP ++
Sbjct: 128 VSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP--KDTVGTPAYI 183
Query: 197 APE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASLSK 252
           APE L ++EY+ ++ D++S G+ +  M+   YP+ + + P    K +     ++ A    
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY 243
Query: 253 V-TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 295
           V   P+ +  I +  V  PA  R+   E+    + + + P DL+ D
Sbjct: 244 VHISPECRHLISRIFVADPAK-RISIPEIRNHEWFLKNLPADLMND 288

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 110/233 (47%), Gaps = 35/233 (15%)
Query: 30  DEILGKGAF----KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
           D+ LG+G+F    K V+K  ++   +++      I   M++  Q      E+  LK  + 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKI------ISKRMEANTQ-----KEITALKLCEG 64
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H NI+K +  + D  +  + M  EL   G L +  KK K+          R+++  +   
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVM--ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS-- 120
Query: 145 HSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP----EFMAP 198
           H H+  ++HRDLK +N+      +N E+KI D G A +  +P     + TP     + AP
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLHYAAP 178
Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNE------CKNPAQIYKKVTSG 244
           EL  +  Y+E  D++S G+ +  M++ + P+        C +  +I KK+  G
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +ILG+GA   V++G  +  G   A    N    ++  D   R   E  +LK L H+NI+K
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR---EFEVLKKLNHKNIVK 71
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW---ARQILRGLHYLHSH 147
            +    + T R   +I E    GSL    ++  N        +    R ++ G+++L  +
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 148 NPPIIHRDLKCDNIF-VNGNNGE--VKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYE- 202
              I+HR++K  NI  V G +G+   K+ D G A  ++       + GT E++ P++YE 
Sbjct: 132 G--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYER 189
Query: 203 --------EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLS 251
                   ++Y   VD++S G+      T   P+   + P    ++  K+ +G    ++S
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 252 KVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLV 285
            V   +         +P S  L   L++L  P L 
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+    E     V +     +   L  L SE+ ++K + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y                R   + +  K + 
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T 
Sbjct: 161 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDXXKKTT 217
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 218 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 104/204 (50%), Gaps = 15/204 (7%)
Query: 28  RYDEILGKGAFKTVYKG--FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           R  ++LG G F TV+KG    E + I++      IED        + +   +  + SL H
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIED-KSGRQSFQAVTDHMLAIGSLDH 74
Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYL 144
            +I++           ++ ++T+    GSL  + ++H+  +  + + NW  QI +G++YL
Sbjct: 75  AHIVRLLGL---CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTP-EFMAPE- 199
             H   ++HR+L   N+ +  +  +V++ D G+A ++    +    S   TP ++MA E 
Sbjct: 132 EEHG--MVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 200 LYEEEYNELVDIYSFGMCILEMVT 223
           ++  +Y    D++S+G+ + E++T
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+    E     V +     +   L  L SE+ ++K + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y                R   + +  K + 
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T 
Sbjct: 161 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDXXKKTT 217
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 218 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 108/218 (49%), Gaps = 19/218 (8%)
Query: 79  LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
           +LKS     I++ + +++ +T+  I M  EL  + + +  ++    +  + +      I+
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTDVFIAM--ELMGTCAEKLKKRMQGPIPERILGKMTVAIV 134
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFM 196
           + L+YL   +  +IHRD+K  NI ++   G++K+ D G++  +V  +   RS  G   +M
Sbjct: 135 KALYYLKEKHG-VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSA-GCAAYM 191
Query: 197 APELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKP 247
           APE  +       +Y+   D++S G+ ++E+ T ++PY  CK   ++  KV      + P
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251
Query: 248 ASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFL 284
             +    D Q   F++ C+     + P   +LL+  F+
Sbjct: 252 GHMGFSGDFQ--SFVKDCLTKDHRKRPKYNKLLEHSFI 287

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 76
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +I E  T G+L  Y ++   + V+   +   A QI   + YL   N  
Sbjct: 77  G--VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 132
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 133 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 191
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYS 75
           EK+P     +   +LG G F +VY G    D + VA   V    I D  + P+   R+  
Sbjct: 1   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 59
Query: 76  EVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           EV LLK +      +I+  + W +  +  + ++        L  +  +   +  +  +++
Sbjct: 60  EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 118
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+L  +   H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT 
Sbjct: 119 FWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 176
Query: 194 EFMAPEL--YEEEYNELVDIYSFGMCILEMVTCEYPY 228
            +  PE   Y   +     ++S G+ + +MV  + P+
Sbjct: 177 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 213

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 126/275 (45%), Gaps = 24/275 (8%)
Query: 26  YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLK 81
           Y  YD  E LG GAF  V++       +E A  +V +   + +P  L++  + +E+ ++ 
Sbjct: 50  YDYYDILEELGSGAFGVVHRC------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMN 103
Query: 82  SLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILR 139
            L H  +I  ++++ D       +I E  + G L  R   + +K  + + I N+ RQ   
Sbjct: 104 QLHHPKLINLHDAFEDKYEMV--LILEFLSGGELFDRIAAEDYKMSEAEVI-NYMRQACE 160
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQ-QPTARSVIGTPEFMA 197
           GL ++H H+  I+H D+K +NI         VKI D GLA  +      +    T EF A
Sbjct: 161 GLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAA 218
Query: 198 PELYEEE-YNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSGIKPASLSKVT 254
           PE+ + E      D+++ G+    +++   P+   +     Q  K+        + S V+
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278
Query: 255 DPQVKQFIEKCIVPASL-RLPALELLKDPFLVTDN 288
            P+ K FI+  +      RL   + L+ P+L  D+
Sbjct: 279 -PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 134/310 (43%), Gaps = 57/310 (18%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  V++    V+  EVA     I+ V+Q      R   E+ +++ +KH N++ 
Sbjct: 46  KVIGNGSFGVVFQA-KLVESDEVA-----IKKVLQDKRFKNR---ELQIMRIVKHPNVVD 96
Query: 91  ----FYNSWVDDTNRTINMITELFTSG---SLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY++        +N++ E        + R Y K  + + M  IK +  Q+LR L Y
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++  +G +K+ D G A  ++  +P   S I +  + APEL 
Sbjct: 157 IHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV-SXICSRYYRAPELI 213
Query: 202 --EEEYNELVDIYSFGMCILEMVTCE--------------------YPYNE---CKNPAQ 236
                Y   +DI+S G  + E++  +                     P  E     NP  
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273
Query: 237 IYKKVTSGIKPASLSKV----TDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPKD 291
           +  K    I+P   SKV    T P     I + +    S RL A+E L  PF       +
Sbjct: 274 MEHKFPQ-IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF-----DE 327
Query: 292 LVCDPLRLPN 301
           L     R+PN
Sbjct: 328 LRTGEARMPN 337

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 80
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +I E  T G+L  Y ++   + V+   +   A QI   + YL   N  
Sbjct: 81  G--VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 136
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 137 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G    V+   D      VA  ++    V+  P  ++    E+ +++ L H+NI+K +
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKI----VLTDPQSVKHALREIKIIRRLDHDNIVKVF 74
Query: 93  -------NSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKA--IKNWAR----QIL 138
                  +   DD    +  +TEL +   +++Y +    NV  +   ++  AR    Q+L
Sbjct: 75  EILGPSGSQLTDD----VGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVIGTP 193
           RGL Y+HS N  ++HRDLK  N+F+N  +  +KIGD GLA +M      +      + T 
Sbjct: 131 RGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 194 EFMAPELY--EEEYNELVDIYSFGMCILEMVT 223
            + +P L      Y + +D+++ G    EM+T
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 40/240 (16%)
Query: 20  KDPSCRYGRYDEILGK----GAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERL 73
           +DP   + R + +LGK    G F  V K           +  V ++ + +  SP +L  L
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL 73
Query: 74  YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD------- 126
            SE ++LK + H ++IK Y +   D    + +I E    GSLR + ++ + V        
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 127 -----------------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
                            M  + ++A QI +G+ YL   +  ++HRDL   NI V     +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS--LVHRDLAARNILV-AEGRK 188
Query: 170 VKIGDLGLAIVMQQPTA---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC 224
           +KI D GL+  + +  +   RS    P ++MA E L++  Y    D++SFG+ + E+VT 
Sbjct: 189 MKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 26  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQGKAFKNR---ELQIMRKLDHCNIVR 77
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +   +   R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 138 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRYYRAPELI 194
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 321
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V+   +   A QI   + YL   N  
Sbjct: 322 G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 377
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHR+L   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 378 FIHRNLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 436
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 437 IKSDVWAFGVLLWEIAT 453

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 40/240 (16%)
Query: 20  KDPSCRYGRYDEILGK----GAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERL 73
           +DP   + R + +LGK    G F  V K           +  V ++ + +  SP +L  L
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL 73
Query: 74  YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD------- 126
            SE ++LK + H ++IK Y +   D    + +I E    GSLR + ++ + V        
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 127 -----------------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
                            M  + ++A QI +G+ YL      ++HRDL   NI V     +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILV-AEGRK 188
Query: 170 VKIGDLGLAIVMQQPTA---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC 224
           +KI D GL+  + +  +   RS    P ++MA E L++  Y    D++SFG+ + E+VT 
Sbjct: 189 MKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+    E     V +     +   L  L SE+ ++K + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y                R   + +  K + 
Sbjct: 103 IITLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T 
Sbjct: 161 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTT 217
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 218 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 40/240 (16%)
Query: 20  KDPSCRYGRYDEILGK----GAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERL 73
           +DP   + R + +LGK    G F  V K           +  V ++ + +  SP +L  L
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL 73
Query: 74  YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD------- 126
            SE ++LK + H ++IK Y +   D    + +I E    GSLR + ++ + V        
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 127 -----------------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
                            M  + ++A QI +G+ YL      ++HRDL   NI V     +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILV-AEGRK 188
Query: 170 VKIGDLGLAIVMQQPTA---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC 224
           +KI D GL+  + +  +   RS    P ++MA E L++  Y    D++SFG+ + E+VT 
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           + + G+G F TV  G ++  G+ VA     I+ V+Q P    R    +  L  L H NI+
Sbjct: 28  ERMAGQGTFGTVQLGKEKSTGMSVA-----IKKVIQDPRFRNRELQIMQDLAVLHHPNIV 82
Query: 90  KFYNSWV-----DDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRG 140
           +  + +      D  +  +N++ E +   +L    R Y ++        IK +  Q++R 
Sbjct: 83  QLQSYFYTLGERDRRDIYLNVVME-YVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
           +  LH  +  + HRD+K  N+ VN  +G +K+ D G A  +   +P   + I +  + AP
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV-AYICSRYYRAP 200
Query: 199 ELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
           EL    + Y   VDI+S G    EM+  E  +    +  Q+++ V
Sbjct: 201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 282
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +ITE  T G+L  Y ++   + V    +   A QI   + YL   N  
Sbjct: 283 G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 338
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHR+L   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 339 FIHRNLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 398 IKSDVWAFGVLLWEIAT 414

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           EI  +G F  V+K     D + V    +  +   QS    ER   E+     +KHEN+++
Sbjct: 21  EIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQS----ER---EIFSTPGMKHENLLQ 73
Query: 91  FYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--- 145
           F  +    +N  + +  IT     GSL  Y K +  +    + + A  + RGL YLH   
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI-ITWNELCHVAETMSRGLSYLHEDV 132
Query: 146 ------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTA--RSVIGTPEF 195
                  H P I HRD K  N+ +  +   V + D GLA+  +  +P       +GT  +
Sbjct: 133 PWCRGEGHKPSIAHRDFKSKNVLLKSDLTAV-LADFGLAVRFEPGKPPGDTHGQVGTRRY 191
Query: 196 MAPELYEEEYN------ELVDIYSFGMCILEMVT 223
           MAPE+ E   N        +D+Y+ G+ + E+V+
Sbjct: 192 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+    E     V +     +   L  L SE+ ++K + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y                R   + +  K + 
Sbjct: 103 IIHLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T 
Sbjct: 161 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTT 217
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 218 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 106/260 (40%), Gaps = 54/260 (20%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKF 91
           +G+G++  V    +       A   +N   + Q +P  +ER+ +EV L+K L H NI + 
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 92  Y-------------------------NSWVDDTNRTINM------------ITELFTSGS 114
           Y                         N ++DD+     M              E   +GS
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 115 LRQYRKKHKNVDM-KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKI 172
           +  +R+    V   K I N  RQI   LHYL  HN  I HRD+K +N   + N   E+K+
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYL--HNQGICHRDIKPENFLFSTNKSFEIKL 211
Query: 173 GDLGLAIVMQQPT------ARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEMVT 223
            D GL+    +          +  GTP F+APE+     E Y    D +S G+ +  ++ 
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 224 CEYPY---NECKNPAQIYKK 240
              P+   N+    +Q+  K
Sbjct: 272 GAVPFPGVNDADTISQVLNK 291

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           + ++LG GAF  V    D+     VA   +  E +      +E   +E+ +L  +KH NI
Sbjct: 22  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME---NEIAVLHKIKHPNI 78
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +   + +  ++   + +I +L + G L     +      +       Q+L  + YLH  +
Sbjct: 79  VALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--D 134
Query: 149 PPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE-LYEE 203
             I+HRDLK +N+       + ++ I D GL+  M+ P +   +  GTP ++APE L ++
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
            Y++ VD +S G+ I  ++ C YP    +N A++++++
Sbjct: 194 PYSKAVDCWSIGV-IAYILLCGYPPFYDENDAKLFEQI 230

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYSEVHLLKSLK--HE 86
           +LG G F +VY G    D + VA   V    I D  + P+   R+  EV LLK +     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPMEVVLLKKVSSGFS 69
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            +I+  + W +  +  + ++        L  +  +   +  +  +++  Q+L  +   H 
Sbjct: 70  GVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HC 126
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YEEE 204
           HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y   
Sbjct: 127 HNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRY 186
Query: 205 YNELVDIYSFGMCILEMVTCEYPY 228
           +     ++S G+ + +MV  + P+
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +I E  T G+L  Y ++   + V    +   A QI   + YL   N  
Sbjct: 76  G--VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 33/276 (11%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQLERL----YSEVHLLKS 82
           EILG+G    V +   +    E A   V I DV      S ++++ L      EV +L+ 
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYA---VKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 83  LK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +  H NII+  +++  +TN    ++ +L   G L  Y  +   +  K  +   R +L  +
Sbjct: 80  VSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPEL 200
             LH  N  I+HRDLK +NI ++ ++  +K+ D G +  +      RSV GTP ++APE+
Sbjct: 138 CALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEI 194
Query: 201 YE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---- 249
            E         Y + VD++S G+ +  ++    P+   K    +   ++   +  S    
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 254
Query: 250 -LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 284
             S      V +F+   +V    R  A E L  PF 
Sbjct: 255 DYSDTVKDLVSRFL---VVQPQKRYTAEEALAHPFF 287

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 64  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 115
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 176 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPELI 232
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 233 FGATDYTSSIDVWSAGCVLAELL 255

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 60  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 111
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 172 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRYYRAPELI 228
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELL 251

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 21/221 (9%)
Query: 79  LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
           LL+  +H NII   +  V D  + + ++TEL   G L     + K    +        I 
Sbjct: 69  LLRYGQHPNIITLKD--VYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 193
           + + YLH+    ++HRDLK  NI     +GN   ++I D G A   Q      ++ TP  
Sbjct: 127 KTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFA--KQLRAENGLLXTPCY 182
Query: 194 --EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSG---I 245
              F+APE+ E + Y+   DI+S G+ +   +T   P+    +  P +I  ++ SG   +
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSL 242
Query: 246 KPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLV 285
                + V+D   K  + K + V    RL A  +L+ P++V
Sbjct: 243 SGGYWNSVSD-TAKDLVSKXLHVDPHQRLTAALVLRHPWIV 282

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+    E     V +     +   L  L SE+ ++K + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y                R   + +  K + 
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T 
Sbjct: 161 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKNTT 217
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 218 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY+G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        +I E  T G+L  Y ++   + V    +   A QI   + YL   N  
Sbjct: 76  G--VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L   +++
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 207 ELVDIYSFGMCILEMVT 223
              D+++FG+ + E+ T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
           R  ++LG GAF TVYKG    DG    I VA   + +     SP   + +  E +++  +
Sbjct: 20  RKVKVLGSGAFGTVYKGIWIPDGENVKIPVA---IKVLRENTSPKANKEILDEAYVMAGV 76
Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLH 142
               + +     +     T+ ++T+L   G L  + R+    +  + + NW  QI +G+ 
Sbjct: 77  GSPYVSRLLGICL---TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTP---EFMAP 198
           YL      ++HRDL   N+ V   N  VKI D GLA ++    T     G     ++MA 
Sbjct: 134 YLEDVR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 190
Query: 199 E-LYEEEYNELVDIYSFGMCILEMVT 223
           E +    +    D++S+G+ + E++T
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 54  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 105
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 166 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPELI 222
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 223 FGATDYTSSIDVWSAGCVLAELL 245

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYSEVHLLKSLK--HE 86
           +LG G F +VY G    D + VA   V    I D  + P+   R+  EV LLK +     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPMEVVLLKKVSSGFS 69
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            +I+  + W +  +  + ++        L  +  +   +  +  +++  Q+L  +   H 
Sbjct: 70  GVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HC 126
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YEEE 204
           HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y   
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRY 186
Query: 205 YNELVDIYSFGMCILEMVTCEYPY 228
           +     ++S G+ + +MV  + P+
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 4   GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV 63
           GS  T      G+  ++     Y    +++G G+F  VY+     D  E+    V I+ V
Sbjct: 8   GSKVTTVVATPGQGPDRPQEVSYTD-TKVIGNGSFGVVYQA-KLCDSGEL----VAIKKV 61
Query: 64  MQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTSGSLR--- 116
           +Q      R   E+ +++ L H NI++    FY+S        +N++ +       R   
Sbjct: 62  LQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 118
Query: 117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
            Y +  + + +  +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G
Sbjct: 119 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG 176
Query: 177 LA--IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 222
            A  +V  +P   S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 177 SAKQLVRGEPNV-SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 60  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 111
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 172 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPELI 228
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELL 251

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 26  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQGKAFKNR---ELQIMRKLDHCNIVR 77
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 138 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPELI 194
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 62  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 113
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 174 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPELI 230
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 231 FGATDYTSSIDVWSAGCVLAELL 253

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 26  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQGKAFKNR---ELQIMRKLDHCNIVR 77
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 138 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPELI 194
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 4   GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV 63
           GS  T      G+  ++     Y    +++G G+F  VY+     D  E+    V I+ V
Sbjct: 19  GSKVTTVVATPGQGPDRPQEVSYTD-TKVIGNGSFGVVYQA-KLCDSGEL----VAIKKV 72
Query: 64  MQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTSGSLR--- 116
           +Q      R   E+ +++ L H NI++    FY+S        +N++ +       R   
Sbjct: 73  LQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 129
Query: 117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
            Y +  + + +  +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G
Sbjct: 130 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG 187
Query: 177 LA--IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 222
            A  +V  +P   S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 188 SAKQLVRGEPNV-SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 4   GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV 63
           GS  T      G+  ++     Y    +++G G+F  VY+     D  E+    V I+ V
Sbjct: 13  GSKVTTVVATPGQGPDRPQEVSYTD-TKVIGNGSFGVVYQA-KLCDSGEL----VAIKKV 66
Query: 64  MQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTSGSLR--- 116
           +Q      R   E+ +++ L H NI++    FY+S        +N++ +       R   
Sbjct: 67  LQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 123
Query: 117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
            Y +  + + +  +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G
Sbjct: 124 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG 181
Query: 177 LA--IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 222
            A  +V  +P   S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 182 SAKQLVRGEPNV-SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYSEVHLLKSLK--HE 86
           +LG G F +VY G    D + VA   V    I D  + P+   R+  EV LLK +     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPMEVVLLKKVSSGFS 69
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            +I+  + W +  +  + ++        L  +  +   +  +  +++  Q+L  +   H 
Sbjct: 70  GVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HC 126
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YEEE 204
           HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y   
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRY 186
Query: 205 YNELVDIYSFGMCILEMVTCEYPY 228
           +     ++S G+ + +MV  + P+
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 4   GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV 63
           GS  T      G+  ++     Y    +++G G+F  VY+     D  E+    V I+ V
Sbjct: 4   GSKVTTVVATPGQGPDRPQEVSYTD-TKVIGNGSFGVVYQA-KLCDSGEL----VAIKKV 57
Query: 64  MQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTSGSLR--- 116
           +Q      R   E+ +++ L H NI++    FY+S        +N++ +       R   
Sbjct: 58  LQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 114
Query: 117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
            Y +  + + +  +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G
Sbjct: 115 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG 172
Query: 177 LA--IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 222
            A  +V  +P   S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 173 SAKQLVRGEPNV-SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 4   GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV 63
           GS  T      G+  ++     Y    +++G G+F  VY+     D  E+    V I+ V
Sbjct: 12  GSKVTTVVATPGQGPDRPQEVSYTD-TKVIGNGSFGVVYQA-KLCDSGEL----VAIKKV 65
Query: 64  MQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTSGSLR--- 116
           +Q      R   E+ +++ L H NI++    FY+S        +N++ +       R   
Sbjct: 66  LQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 122
Query: 117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
            Y +  + + +  +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G
Sbjct: 123 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG 180
Query: 177 LA--IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 222
            A  +V  +P   S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 181 SAKQLVRGEPNV-SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 4   GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV 63
           GS  T      G+  ++     Y    +++G G+F  VY+     D  E+    V I+ V
Sbjct: 12  GSKVTTVVATPGQGPDRPQEVSYTD-TKVIGNGSFGVVYQA-KLCDSGEL----VAIKKV 65
Query: 64  MQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTSGSLR--- 116
           +Q      R   E+ +++ L H NI++    FY+S        +N++ +       R   
Sbjct: 66  LQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 122
Query: 117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
            Y +  + + +  +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G
Sbjct: 123 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG 180
Query: 177 LA--IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 222
            A  +V  +P   S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 181 SAKQLVRGEPNV-SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 27  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 78
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 139 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRYYRAPELI 195
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 196 FGATDYTSSIDVWSAGCVLAELL 218

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+    E     V +     +   L  L SE+ ++K + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y                R   + +  K + 
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           +   Q+ RG+ YL S     IHRDL   N+ V  NN  ++I D GLA     I   + T 
Sbjct: 161 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMRIADFGLARDINNIDYYKKTT 217
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 218 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+     V    V +     +   L  L SE+ ++K + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y +  +                 +  K + 
Sbjct: 96  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T 
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDXXKKTT 210
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 211 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 26  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 138 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRYYRAPELI 194
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 31  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 82
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 143 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPELI 199
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 200 FGATDYTSSIDVWSAGCVLAELL 222

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 26  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 138 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPELI 194
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           + ++LG GAF  V    D+     VA   +  E +      +E   +E+ +L  +KH NI
Sbjct: 22  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME---NEIAVLHKIKHPNI 78
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +   + +  ++   + +I +L + G L     +      +       Q+L  + YLH  +
Sbjct: 79  VALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--D 134
Query: 149 PPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE-LYEE 203
             I+HRDLK +N+       + ++ I D GL+  M+ P +   +  GTP ++APE L ++
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
            Y++ VD +S G+ I  ++ C YP    +N A++++++
Sbjct: 194 PYSKAVDCWSIGV-IAYILLCGYPPFYDENDAKLFEQI 230

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 105 KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 156
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 217 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPELI 273
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 274 FGATDYTSSIDVWSAGCVLAELL 296

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 123/288 (42%), Gaps = 43/288 (14%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           E +G G F +V+K    +DG   A  +    +   +   + L  +Y+   L +   H ++
Sbjct: 13  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ---HSHV 69
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV----DMKAIKNWARQILRGLHYL 144
           ++++++W +D +  I    E    GSL     ++  +        +K+   Q+ RGL Y+
Sbjct: 70  VRYFSAWAEDDHMLIQ--NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 127
Query: 145 HSHNPPIIHRDLKCDNIFVN------------------GNNGEVKIGDLGLAIVMQQPTA 186
           HS +  ++H D+K  NIF++                   N    KIGDLG    +  P  
Sbjct: 128 HSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 185
Query: 187 RSVIGTPEFMAPELYEEEYNEL--VDIYSFGMCILEMVTCE-YPYNECKNPAQIYKKVTS 243
               G   F+A E+ +E Y  L   DI++  + ++     E  P N        + ++  
Sbjct: 186 EE--GDSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEPLPRN-----GDQWHEIRQ 238
Query: 244 GIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDNPK 290
           G  P  + +V   +  + ++  I P   R P A+ L+K   L++ + K
Sbjct: 239 GRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 285

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 26  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 138 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRYYRAPELI 194
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           + ++LG GAF  V    D+     VA   +  E +      +E   +E+ +L  +KH NI
Sbjct: 22  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME---NEIAVLHKIKHPNI 78
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +   + +  ++   + +I +L + G L     +      +       Q+L  + YLH  +
Sbjct: 79  VALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--D 134
Query: 149 PPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE-LYEE 203
             I+HRDLK +N+       + ++ I D GL+  M+ P +   +  GTP ++APE L ++
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
            Y++ VD +S G+ I  ++ C YP    +N A++++++
Sbjct: 194 PYSKAVDCWSIGV-IAYILLCGYPPFYDENDAKLFEQI 230

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 113/243 (46%), Gaps = 15/243 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENI 88
           D ++GKG+F  V K +D V   E  W  V I+ +      L +   EV LL+ + KH+  
Sbjct: 40  DSLIGKGSFGQVVKAYDRV---EQEW--VAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 94
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYL 144
           +K+Y   +       N +  +F   S   Y        + V +   + +A+Q+   L +L
Sbjct: 95  MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 154
Query: 145 HSHNPPIIHRDLKCDNIFV-NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYE 202
            +    IIH DLK +NI + N     +KI D G +  + Q   +  I +  + +PE L  
Sbjct: 155 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX-IQSRFYRSPEVLLG 213
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV-TSGIKPASLSKVTDPQVKQF 261
             Y+  +D++S G  ++EM T E  ++      Q+ K V   GI PA +     P+ ++F
Sbjct: 214 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA-PKARKF 272
Query: 262 IEK 264
            EK
Sbjct: 273 FEK 275

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 113/243 (46%), Gaps = 15/243 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENI 88
           D ++GKG+F  V K +D V   E  W  V I+ +      L +   EV LL+ + KH+  
Sbjct: 59  DSLIGKGSFGQVVKAYDRV---EQEW--VAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYL 144
           +K+Y   +       N +  +F   S   Y        + V +   + +A+Q+   L +L
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 145 HSHNPPIIHRDLKCDNIFV-NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYE 202
            +    IIH DLK +NI + N     +KI D G +  + Q   +  I +  + +PE L  
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX-IQSRFYRSPEVLLG 232
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV-TSGIKPASLSKVTDPQVKQF 261
             Y+  +D++S G  ++EM T E  ++      Q+ K V   GI PA +     P+ ++F
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA-PKARKF 291
Query: 262 IEK 264
            EK
Sbjct: 292 FEK 294

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 127/302 (42%), Gaps = 47/302 (15%)
Query: 26  YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
           Y    E+LG+GA+  V       +G E A   +      Q+     R++ EV  L   + 
Sbjct: 14  YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIE----KQAGHSRSRVFREVETLYQCQG 69
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           ++NI++    + DDT     ++ E    GS+  + +K K+ + +      R +   L +L
Sbjct: 70  NKNILELIEFFEDDTR--FYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFL 127
Query: 145 HSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQ---------QPTARSVIGTP 193
           H+    I HRDLK +NI          VKI D  L   M+          P   +  G+ 
Sbjct: 128 HTKG--IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 194 EFMAPELYE------EEYNELVDIYSFGMCILEMVT------------CEYPYNE----C 231
           E+MAPE+ E        Y++  D++S G+ +  M++            C +   E    C
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVC 245
Query: 232 KNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288
           +N  ++++ +  G    P         + K  I K +V  A  RL A ++L+ P++    
Sbjct: 246 QN--KLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQA 303
Query: 289 PK 290
           P+
Sbjct: 304 PE 305

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 110/251 (43%), Gaps = 43/251 (17%)
Query: 4   GSGFTKSETEEGEFSEKDPSCRYGRYDEILGK----GAFKTVYK----GFDEVDGIEVAW 55
           G+G ++ E  E      DP     R   +LGK    GAF  V      G D+     V  
Sbjct: 1   GAGVSEYELPE------DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK 54
Query: 56  NQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGS 114
             V +     +   L  L SE+ ++K + KH+NII    +   D    + +I E  + G+
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGN 112
Query: 115 LRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
           LR+Y +  +                 +  K + + A Q+ RG+ YL S     IHRDL  
Sbjct: 113 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 170
Query: 159 DNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIY 212
            N+ V  +N  +KI D GLA     I   + T    +   ++MAPE L++  Y    D++
Sbjct: 171 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVW 228
Query: 213 SFGMCILEMVT 223
           SFG+ + E+ T
Sbjct: 229 SFGVLLWEIFT 239

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 34  GKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           G+G F  VYKG+     + V    A   +  E++ Q  DQ      E+ +    +HEN++
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ------EIKVXAKCQHENLV 84
Query: 90  KF--YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW------ARQILRGL 141
           +   ++S  DD    + ++     +GSL     +   +D     +W      A+    G+
Sbjct: 85  ELLGFSSDGDD----LCLVYVYXPNGSLLD---RLSCLDGTPPLSWHXRCKIAQGAANGI 137
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV----MQQPTARSVIGTPEFMA 197
           ++LH ++   IHRD+K  NI ++      KI D GLA       Q      ++GT  + A
Sbjct: 138 NFLHENHH--IHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXA 194
Query: 198 PELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 234
           PE    E     DIYSFG+ +LE++T     +E + P
Sbjct: 195 PEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 231

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+G F  V      G D+    E     V +     +   L  L SE+ ++K + KH+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y                R   + +  K + 
Sbjct: 149 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T 
Sbjct: 207 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTT 263
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 264 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 121/261 (46%), Gaps = 31/261 (11%)
Query: 3   CGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNI 60
           C +G T S ++  E   K+ +   G     LG GAF  VY+G  +V G+  + +  QV +
Sbjct: 28  CFAGKTSSISDLKEVPRKNITLIRG-----LGHGAFGEVYEG--QVSGMPNDPSPLQVAV 80
Query: 61  E---DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 117
           +   +V    D+L+ L  E  ++  L H+NI++     +    R I  + EL   G L+ 
Sbjct: 81  KTLPEVCSEQDELDFLM-EALIISKLNHQNIVRCIGVSLQSLPRFI--LLELMAGGDLKS 137
Query: 118 YRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNG 168
           + ++ +       ++ M  + + AR I  G  YL  ++   IHRD+   N  +   G   
Sbjct: 138 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGR 195
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTP----EFMAPELYEEE-YNELVDIYSFGMCILEMVT 223
             KIGD G+A  + + +     G      ++M PE + E  +    D +SFG+ + E+ +
Sbjct: 196 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255
Query: 224 CEYPYNECKNPAQIYKKVTSG 244
             Y     K+  ++ + VTSG
Sbjct: 256 LGYMPYPSKSNQEVLEFVTSG 276

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+     V    V +     +   L  L SE+ ++K + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y +  +                 +  K + 
Sbjct: 96  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T 
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 210
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 211 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+     V    V +     +   L  L SE+ ++K + KH+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y +  +                 +  K + 
Sbjct: 81  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T 
Sbjct: 139 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 195
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 196 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG+G+F  V++  D+  G + A  +V +E       ++E L +       L    I+  Y
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVA----CAGLSSPRIVPLY 130
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            +  +     +N+  EL   GSL Q  K+   +       +  Q L GL YLH+    I+
Sbjct: 131 GAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--IL 186
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARSVIGTPEFMAPE-LYEEE 204
           H D+K DN+ ++ +     + D G A+ +Q         T   + GT   MAPE +  + 
Sbjct: 187 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 246
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNE 230
            +  VDI+S    +L M+   +P+ +
Sbjct: 247 CDAKVDIWSSCCMMLHMLNGCHPWTQ 272

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G G+F  VY+     D  E+    V I+ V+Q      R   E+ +++ L H NI++
Sbjct: 26  KVIGNGSFGVVYQA-KLCDSGEL----VAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 91  ----FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHY 143
               FY+S        +N++ +       R    Y +  + + +  +K +  Q+ R L Y
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY 201
           +HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   S I +  + APEL 
Sbjct: 138 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRYYRAPELI 194
Query: 202 --EEEYNELVDIYSFGMCILEMV 222
               +Y   +D++S G  + E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 18/229 (7%)
Query: 16  EFS-EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLY 74
           EF+ E D SC   + ++++G G F  V  G  ++ G    +  +       +  Q     
Sbjct: 25  EFAKEIDISCV--KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL 82
Query: 75  SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNW 133
           SE  ++    H N+I         T   + +ITE   +GSL  + R+      +  +   
Sbjct: 83  SEASIMGQFDHPNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 140
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSV 189
            R I  G+ YL   N   +HRDL   NI VN +N   K+ D GL+  ++     PT  S 
Sbjct: 141 LRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSA 197
Query: 190 IGTP---EFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKN 233
           +G      + APE  +  ++    D++S+G+ + E+++  E PY +  N
Sbjct: 198 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 246

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+G F  V      G D+    E     V +     +   L  L SE+ ++K + KH+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y                R   + +  K + 
Sbjct: 95  IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T 
Sbjct: 153 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTT 209
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 210 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+     V    V +     +   L  L SE+ ++K + KH+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y +  +                 +  K + 
Sbjct: 85  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T 
Sbjct: 143 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 199
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 200 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 120/287 (41%), Gaps = 41/287 (14%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           E +G G F +V+K    +DG   A  +    +   +   + L  +Y+   L +   H ++
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ---HSHV 73
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV----DMKAIKNWARQILRGLHYL 144
           ++++++W +D +  I    E    GSL     ++  +        +K+   Q+ RGL Y+
Sbjct: 74  VRYFSAWAEDDHMLIQ--NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 145 HSHNPPIIHRDLKCDNIFVN------------------GNNGEVKIGDLGLAIVMQQPTA 186
           HS +  ++H D+K  NIF++                   N    KIGDLG    +  P  
Sbjct: 132 HSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 187 RSVIGTPEFMAPELYEEEYNEL--VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
               G   F+A E+ +E Y  L   DI++  +     V C             + ++  G
Sbjct: 190 EE--GDSRFLANEVLQENYTHLPKADIFALALT----VVCAAGAEPLPRNGDQWHEIRQG 243
Query: 245 IKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDNPK 290
             P  + +V   +  + ++  I P   R P A+ L+K   L++ + K
Sbjct: 244 RLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 40/276 (14%)
Query: 31  EILGKGAFKT-VYKG-FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHEN 87
           ++LG GA  T VY+G FD  D        V ++ ++  P+       EV LL+ S +H N
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRD--------VAVKRIL--PECFSFADREVQLLRESDEHPN 79
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLH 145
           +I+++ +   + +R    I     + +L++Y  +K   ++ ++ I    +Q   GL +LH
Sbjct: 80  VIRYFCT---EKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLH 135
Query: 146 SHNPPIIHRDLKCDNIFVNGNN--GEVK--IGDLG----LAIVMQQPTARS-VIGTPEFM 196
           S N  I+HRDLK  NI ++  N  G++K  I D G    LA+     + RS V GT  ++
Sbjct: 136 SLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 197 APELYEEEYNE----LVDIYSFGMCILEMVTCE--YPYNEC-KNPAQIYKKVTSGIKPAS 249
           APE+  E+  E     VDI+S G C+   V  E  +P+ +  +  A I     S +    
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGKSLQRQANILLGACS-LDCLH 251
Query: 250 LSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 284
             K  D   ++ IEK I     + P A  +LK PF 
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 116/273 (42%), Gaps = 31/273 (11%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVA-----------WNQVNIEDVMQSPDQLERLYSE 76
           R   +LGKG F TV+ G    D ++VA           W+ ++  D +  P ++  L+  
Sbjct: 34  RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLS--DSVTCPLEVALLWK- 90
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
             +     H  +I+  + W +     + ++     +  L  Y  +   +     + +  Q
Sbjct: 91  --VGAGGGHPGVIRLLD-WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ 147
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 196
           ++  + + HS    ++HRD+K +NI ++   G  K+ D G   ++         GT  + 
Sbjct: 148 VVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYS 205
Query: 197 APE-LYEEEYNEL-VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
            PE +   +Y+ L   ++S G+ + +MV  + P+   +   +          PA +S   
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF-----PAHVS--- 257
Query: 255 DPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVT 286
            P     I +C+ P     P+L E+L DP++ T
Sbjct: 258 -PDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+     V    V +     +   L  L SE+ ++K + KH+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y +  +                 +  K + 
Sbjct: 89  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T 
Sbjct: 147 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 203
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 204 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 113/243 (46%), Gaps = 15/243 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENI 88
           D ++GKG+F  V K +D V   E  W  V I+ +      L +   EV LL+ + KH+  
Sbjct: 59  DSLIGKGSFGQVVKAYDRV---EQEW--VAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYL 144
           +K+Y   +       N +  +F   S   Y        + V +   + +A+Q+   L +L
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 145 HSHNPPIIHRDLKCDNIFV-NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYE 202
            +    IIH DLK +NI + N     +KI D G +  + Q   +  I +  + +PE L  
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQX-IQSRFYRSPEVLLG 232
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV-TSGIKPASLSKVTDPQVKQF 261
             Y+  +D++S G  ++EM T E  ++      Q+ K V   GI PA +     P+ ++F
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA-PKARKF 291
Query: 262 IEK 264
            EK
Sbjct: 292 FEK 294

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 31/261 (11%)
Query: 3   CGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNI 60
           C +G T S ++  E   K+ +   G     LG GAF  VY+G  +V G+  + +  QV +
Sbjct: 13  CFAGKTSSISDLKEVPRKNITLIRG-----LGHGAFGEVYEG--QVSGMPNDPSPLQVAV 65
Query: 61  E---DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 117
           +   +V    D+L+ L  E  ++    H+NI++     +    R I M  EL   G L+ 
Sbjct: 66  KTLPEVCSEQDELDFLM-EALIISKFNHQNIVRCIGVSLQSLPRFILM--ELMAGGDLKS 122
Query: 118 YRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNG 168
           + ++ +       ++ M  + + AR I  G  YL  ++   IHRD+   N  +   G   
Sbjct: 123 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGR 180
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTP----EFMAPELYEEE-YNELVDIYSFGMCILEMVT 223
             KIGD G+A  + + +     G      ++M PE + E  +    D +SFG+ + E+ +
Sbjct: 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
Query: 224 CEYPYNECKNPAQIYKKVTSG 244
             Y     K+  ++ + VTSG
Sbjct: 241 LGYMPYPSKSNQEVLEFVTSG 261

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+     V    V +     +   L  L SE+ ++K + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y +  +                 +  K + 
Sbjct: 96  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T 
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 210
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 211 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 120/287 (41%), Gaps = 41/287 (14%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           E +G G F +V+K    +DG   A  +    +   +   + L  +Y+   L +   H ++
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ---HSHV 71
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV----DMKAIKNWARQILRGLHYL 144
           ++++++W +D +  I    E    GSL     ++  +        +K+   Q+ RGL Y+
Sbjct: 72  VRYFSAWAEDDHMLIQ--NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 145 HSHNPPIIHRDLKCDNIFVN------------------GNNGEVKIGDLGLAIVMQQPTA 186
           HS +  ++H D+K  NIF++                   N    KIGDLG    +  P  
Sbjct: 130 HSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 187
Query: 187 RSVIGTPEFMAPELYEEEYNEL--VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
               G   F+A E+ +E Y  L   DI++  +     V C             + ++  G
Sbjct: 188 EE--GDSRFLANEVLQENYTHLPKADIFALALT----VVCAAGAEPLPRNGDQWHEIRQG 241
Query: 245 IKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDNPK 290
             P  + +V   +  + ++  I P   R P A+ L+K   L++ + K
Sbjct: 242 RLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 287

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+G F  V      G D+    E     V +     +   L  L SE+ ++K + KH+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y                R   + +  K + 
Sbjct: 92  IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T 
Sbjct: 150 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTT 206
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 207 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 33/276 (11%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQLERL----YSEVHLLKS 82
           EILG+G    V +   +    E A   V I DV      S ++++ L      EV +L+ 
Sbjct: 10  EILGRGVSSVVRRCIHKPTCKEYA---VKIIDVTGGGSFSAEEVQELREATLKEVDILRK 66
Query: 83  LK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +  H NII+  +++  +TN    ++ +L   G L  Y  +   +  K  +   R +L  +
Sbjct: 67  VSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 124
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPEL 200
             LH  N  I+HRDLK +NI ++ ++  +K+ D G +  +      R V GTP ++APE+
Sbjct: 125 CALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 201 YE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---- 249
            E         Y + VD++S G+ +  ++    P+   K    +   ++   +  S    
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 241
Query: 250 -LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 284
             S      V +F+   +V    R  A E L  PF 
Sbjct: 242 DYSDTVKDLVSRFL---VVQPQKRYTAEEALAHPFF 274

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 120/287 (41%), Gaps = 41/287 (14%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           E +G G F +V+K    +DG   A  +    +   +   + L  +Y+   L +   H ++
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ---HSHV 71
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV----DMKAIKNWARQILRGLHYL 144
           ++++++W +D +  I    E    GSL     ++  +        +K+   Q+ RGL Y+
Sbjct: 72  VRYFSAWAEDDHMLIQ--NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 145 HSHNPPIIHRDLKCDNIFVN------------------GNNGEVKIGDLGLAIVMQQPTA 186
           HS +  ++H D+K  NIF++                   N    KIGDLG    +  P  
Sbjct: 130 HSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 187
Query: 187 RSVIGTPEFMAPELYEEEYNEL--VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
               G   F+A E+ +E Y  L   DI++  +     V C             + ++  G
Sbjct: 188 EE--GDSRFLANEVLQENYTHLPKADIFALALT----VVCAAGAEPLPRNGDQWHEIRQG 241
Query: 245 IKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDNPK 290
             P  + +V   +  + ++  I P   R P A+ L+K   L++ + K
Sbjct: 242 RLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 287

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 33/276 (11%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQLERL----YSEVHLLKS 82
           EILG+G    V +   +    E A   V I DV      S ++++ L      EV +L+ 
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYA---VKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 83  LK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +  H NII+  +++  +TN    ++ +L   G L  Y  +   +  K  +   R +L  +
Sbjct: 80  VSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPEL 200
             LH  N  I+HRDLK +NI ++ ++  +K+ D G +  +      R V GTP ++APE+
Sbjct: 138 CALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 201 YE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---- 249
            E         Y + VD++S G+ +  ++    P+   K    +   ++   +  S    
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 254
Query: 250 -LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 284
             S      V +F+   +V    R  A E L  PF 
Sbjct: 255 DYSDTVKDLVSRFL---VVQPQKRYTAEEALAHPFF 287

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+     V    V +     +   L  L SE+ ++K + KH+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y +  +                 +  K + 
Sbjct: 137 IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T 
Sbjct: 195 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 251
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 252 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+G F  V      G D+    E     V +     +   L  L SE+ ++K + KH+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y                R   + +  K + 
Sbjct: 90  IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T 
Sbjct: 148 SCTYQLARGMEYLASQK--CIHRDLTARNVLVTENN-VMKIADFGLARDINNIDYYKKTT 204
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 205 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+    E     V +     +   L  L SE+ ++K + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKAIK 131
           II    +   D    + +I    + G+LR+Y                R   + +  K + 
Sbjct: 103 IINLLGACTQDG--PLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T 
Sbjct: 161 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTT 217
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 218 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 33  LGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           +G+G F  V++G     E   + VA   +       S    E+   E   ++   H +I+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 148
           K        T   + +I EL T G LR + +  K ++D+ ++  +A Q+   L YL S  
Sbjct: 75  KLIGV---ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 131
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEE 204
              +HRD+   N+ V+ N+  VK+GD GL+  M+  T           ++MAPE +    
Sbjct: 132 --FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRR 188
Query: 205 YNELVDIYSFGMCILEMV 222
           +    D++ FG+C+ E++
Sbjct: 189 FTSASDVWMFGVCMWEIL 206

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 139/292 (47%), Gaps = 35/292 (11%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERL-YSEVHLLKS 82
           +Y++I  +G+G++  V+K  +   G  VA     I+  ++S D   ++++   E+ +LK 
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVA-----IKKFLESEDDPVIKKIALREIRMLKQ 58
Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           LKH N++      V    R ++++ E      L +  +  + V    +K+   Q L+ ++
Sbjct: 59  LKHPNLVNLLE--VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPEL 200
           + H HN   IHRD+K +NI +   +  +K+ D G A ++  P+      + T  + +PEL
Sbjct: 117 FCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173
Query: 201 Y--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY-------------KKVTSGI 245
              + +Y   VD+++ G    E+++    +    +  Q+Y             ++V S  
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 246 KPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPL 297
           +  S  K+ DP+  + +E  +   ++  PAL LLK   L  D  + L C+ L
Sbjct: 234 QYFSGVKIPDPEDMEPLE--LKFPNISYPALGLLKG-CLHMDPTERLTCEQL 282

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           + ++LG GAF  V    D+     VA   +  + +      +E   +E+ +L  +KH NI
Sbjct: 22  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME---NEIAVLHKIKHPNI 78
Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +   + +  ++   + +I +L + G L     +      +       Q+L  + YLH  +
Sbjct: 79  VALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--D 134
Query: 149 PPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE-LYEE 203
             I+HRDLK +N+       + ++ I D GL+  M+ P +   +  GTP ++APE L ++
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
            Y++ VD +S G+ I  ++ C YP    +N A++++++
Sbjct: 194 PYSKAVDCWSIGV-IAYILLCGYPPFYDENDAKLFEQI 230

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 31/261 (11%)
Query: 3   CGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNI 60
           C +G T S ++  E   K+ +   G     LG GAF  VY+G  +V G+  + +  QV +
Sbjct: 28  CFAGKTSSISDLKEVPRKNITLIRG-----LGHGAFGEVYEG--QVSGMPNDPSPLQVAV 80
Query: 61  E---DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 117
           +   +V    D+L+ L  E  ++    H+NI++     +    R I M  EL   G L+ 
Sbjct: 81  KTLPEVCSEQDELDFLM-EALIISKFNHQNIVRCIGVSLQSLPRFILM--ELMAGGDLKS 137
Query: 118 YRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNG 168
           + ++ +       ++ M  + + AR I  G  YL  ++   IHRD+   N  +   G   
Sbjct: 138 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGR 195
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTP----EFMAPELYEEE-YNELVDIYSFGMCILEMVT 223
             KIGD G+A  + + +     G      ++M PE + E  +    D +SFG+ + E+ +
Sbjct: 196 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255
Query: 224 CEYPYNECKNPAQIYKKVTSG 244
             Y     K+  ++ + VTSG
Sbjct: 256 LGYMPYPSKSNQEVLEFVTSG 276

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 31/261 (11%)
Query: 3   CGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNI 60
           C +G T S ++  E   K+ +   G     LG GAF  VY+G  +V G+  + +  QV +
Sbjct: 5   CFAGKTSSISDLKEVPRKNITLIRG-----LGHGAFGEVYEG--QVSGMPNDPSPLQVAV 57
Query: 61  E---DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 117
           +   +V    D+L+ L  E  ++    H+NI++     +    R I  + EL   G L+ 
Sbjct: 58  KTLPEVCSEQDELDFLM-EALIISKFNHQNIVRCIGVSLQSLPRFI--LLELMAGGDLKS 114
Query: 118 YRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNG 168
           + ++ +       ++ M  + + AR I  G  YL  ++   IHRD+   N  +   G   
Sbjct: 115 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGR 172
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTP----EFMAPELYEEE-YNELVDIYSFGMCILEMVT 223
             KIGD G+A  + + +     G      ++M PE + E  +    D +SFG+ + E+ +
Sbjct: 173 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232
Query: 224 CEYPYNECKNPAQIYKKVTSG 244
             Y     K+  ++ + VTSG
Sbjct: 233 LGYMPYPSKSNQEVLEFVTSG 253

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 36/216 (16%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLY-SEVHLLKSLKHENII 89
           E +GKG +  V++G    + + V         +  S D+      +E++    L+H+NI+
Sbjct: 14  ECVGKGRYGEVWRGLWHGESVAV--------KIFSSRDEQSWFRETEIYNTVLLRHDNIL 65
Query: 90  KFYNSWVDDTNRT----INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
            F  S  D T+R     + +IT     GSL  + ++       A++  A     GL +LH
Sbjct: 66  GFIAS--DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRL-AVSAACGLAHLH 122
Query: 146 ------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTP 193
                    P I HRD K  N+ V  +N +  I DLGLA++  Q +          +GT 
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVK-SNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTK 181
Query: 194 EFMAPELYEE-------EYNELVDIYSFGMCILEMV 222
            +MAPE+ +E       E  +  DI++FG+ + E+ 
Sbjct: 182 RYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G+G+F  V++  D+  G + A  +V +E       ++E L +       L    I+  Y
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVA----CAGLSSPRIVPLY 116
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            +  +     +N+  EL   GSL Q  K+   +       +  Q L GL YLH+    I+
Sbjct: 117 GAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--IL 172
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARSVIGTPEFMAPE-LYEEE 204
           H D+K DN+ ++ +     + D G A+ +Q         T   + GT   MAPE +  + 
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNE 230
            +  VDI+S    +L M+   +P+ +
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHPWTQ 258

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 31/261 (11%)
Query: 3   CGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNI 60
           C +G T S ++  E   K+ +   G     LG GAF  VY+G  +V G+  + +  QV +
Sbjct: 13  CFAGKTSSISDLKEVPRKNITLIRG-----LGHGAFGEVYEG--QVSGMPNDPSPLQVAV 65
Query: 61  E---DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 117
           +   +V    D+L+ L  E  ++    H+NI++     +    R I  + EL   G L+ 
Sbjct: 66  KTLPEVCSEQDELDFLM-EALIISKFNHQNIVRCIGVSLQSLPRFI--LLELMAGGDLKS 122
Query: 118 YRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNG 168
           + ++ +       ++ M  + + AR I  G  YL  ++   IHRD+   N  +   G   
Sbjct: 123 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGR 180
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTP----EFMAPELYEEE-YNELVDIYSFGMCILEMVT 223
             KIGD G+A  + + +     G      ++M PE + E  +    D +SFG+ + E+ +
Sbjct: 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
Query: 224 CEYPYNECKNPAQIYKKVTSG 244
             Y     K+  ++ + VTSG
Sbjct: 241 LGYMPYPSKSNQEVLEFVTSG 261

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+    E     V +     +   L  L SE+ ++K + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKAIK 131
           II    +   D    + +I    + G+LR+Y                R   + +  K + 
Sbjct: 103 IINLLGACTQDG--PLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T 
Sbjct: 161 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTT 217
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 218 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 33  LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
           LG+GAF  V      G D+     V    V +     +   L  L SE+ ++K + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIK 131
           II    +   D    + +I E  + G+LR+Y +  +                 +  K + 
Sbjct: 96  IINLLGACTQDG--PLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
           + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T 
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 210
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
              +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 211 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 31/261 (11%)
Query: 3   CGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNI 60
           C +G T S ++  E   K+ +   G     LG GAF  VY+G  +V G+  + +  QV +
Sbjct: 28  CFAGKTSSISDLKEVPRKNITLIRG-----LGHGAFGEVYEG--QVSGMPNDPSPLQVAV 80
Query: 61  E---DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 117
           +   +V    D+L+ L  E  ++    H+NI++     +    R I  + EL   G L+ 
Sbjct: 81  KTLPEVYSEQDELDFLM-EALIISKFNHQNIVRCIGVSLQSLPRFI--LLELMAGGDLKS 137
Query: 118 YRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNG 168
           + ++ +       ++ M  + + AR I  G  YL  ++   IHRD+   N  +   G   
Sbjct: 138 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGR 195
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTP----EFMAPELYEEE-YNELVDIYSFGMCILEMVT 223
             KIGD G+A  + + +     G      ++M PE + E  +    D +SFG+ + E+ +
Sbjct: 196 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255
Query: 224 CEYPYNECKNPAQIYKKVTSG 244
             Y     K+  ++ + VTSG
Sbjct: 256 LGYMPYPSKSNQEVLEFVTSG 276

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 14/230 (6%)
Query: 22  PSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
           PS    RY+  EILG G    V+   D  D  +VA  +V   D+ + P    R   E   
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAV-KVLRADLARDPSFYLRFRREAQN 65
Query: 80  LKSLKHENIIKFYNSWVDDT--NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
             +L H  I+  Y++   +T       ++ E     +LR        +  K         
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGT 192
            + L++  SH   IIHRD+K  NI ++  N  VK+ D G+A  +           +VIGT
Sbjct: 126 CQALNF--SHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 193 PEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
            ++++PE    +  +   D+YS G  + E++T E P+      +  Y+ V
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHV 232

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 31/261 (11%)
Query: 3   CGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNI 60
           C +G T S ++  E   K+ +   G     LG GAF  VY+G  +V G+  + +  QV +
Sbjct: 30  CFAGKTSSISDLKEVPRKNITLIRG-----LGHGAFGEVYEG--QVSGMPNDPSPLQVAV 82
Query: 61  E---DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 117
           +   +V    D+L+ L  E  ++    H+NI++     +    R I  + EL   G L+ 
Sbjct: 83  KTLPEVCSEQDELDFLM-EALIISKFNHQNIVRCIGVSLQSLPRFI--LLELMAGGDLKS 139
Query: 118 YRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNG 168
           + ++ +       ++ M  + + AR I  G  YL  ++   IHRD+   N  +   G   
Sbjct: 140 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGR 197
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTP----EFMAPELYEEE-YNELVDIYSFGMCILEMVT 223
             KIGD G+A  + + +     G      ++M PE + E  +    D +SFG+ + E+ +
Sbjct: 198 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257
Query: 224 CEYPYNECKNPAQIYKKVTSG 244
             Y     K+  ++ + VTSG
Sbjct: 258 LGYMPYPSKSNQEVLEFVTSG 278

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G+G+F  V++  D+  G + A  +V +E       ++E L +       L    I+  Y
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVA----CAGLSSPRIVPLY 132
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            +  +     +N+  EL   GSL Q  K+   +       +  Q L GL YLH+    I+
Sbjct: 133 GAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--IL 188
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARSVIGTPEFMAPE-LYEEE 204
           H D+K DN+ ++ +     + D G A+ +Q         T   + GT   MAPE +  + 
Sbjct: 189 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 248
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNE 230
            +  VDI+S    +L M+   +P+ +
Sbjct: 249 CDAKVDIWSSCCMMLHMLNGCHPWTQ 274

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 33  LGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           +G+G F  V++G     E   + VA   +       S    E+   E   ++   H +I+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 148
           K        T   + +I EL T G LR + +  K ++D+ ++  +A Q+   L YL S  
Sbjct: 75  KLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 131
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEE 204
              +HRD+   N+ V+ N+  VK+GD GL+  M+  T           ++MAPE +    
Sbjct: 132 --FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 205 YNELVDIYSFGMCILEMV 222
           +    D++ FG+C+ E++
Sbjct: 189 FTSASDVWMFGVCMWEIL 206

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 33  LGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           +G+G F  V++G     E   + VA   +       S    E+   E   ++   H +I+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 148
           K        T   + +I EL T G LR + +  K ++D+ ++  +A Q+   L YL S  
Sbjct: 77  KLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 133
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEE 204
              +HRD+   N+ V+ N+  VK+GD GL+  M+  T           ++MAPE +    
Sbjct: 134 --FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 190
Query: 205 YNELVDIYSFGMCILEMV 222
           +    D++ FG+C+ E++
Sbjct: 191 FTSASDVWMFGVCMWEIL 208

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 29/280 (10%)
Query: 14  EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQ 69
           EGE+S+K  +         LG GAF  V+   D+    EV    +  E V++       +
Sbjct: 19  EGEYSQKYSTMS------PLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPK 72
Query: 70  LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSG-SLRQYRKKHKNVDMK 128
           L ++  E+ +L  ++H NIIK  +  + +      ++ E   SG  L  +  +H  +D  
Sbjct: 73  LGKVTLEIAILSRVEHANIIKVLD--IFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP 130
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-R 187
                 RQ++  + YL   +  IIHRD+K +NI +   +  +K+ D G A  +++     
Sbjct: 131 LASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKLFY 187
Query: 188 SVIGTPEFMAPE-LYEEEY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245
           +  GT E+ APE L    Y    ++++S G+ +  +V  E P+ E +      + V + I
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAI 241
Query: 246 KPASLSKVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFL 284
            P  L      ++   +   + P   R   LE L+ DP++
Sbjct: 242 HPPYL---VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 21/221 (9%)
Query: 79  LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
           LL+  +H NII   +  V D  + + ++TEL   G L     + K    +        I 
Sbjct: 74  LLRYGQHPNIITLKD--VYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG 131
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 193
           + + YLHS    ++HRDLK  NI     +GN   ++I D G A   Q      ++ TP  
Sbjct: 132 KTVEYLHSQG--VVHRDLKPSNILYVDESGNPECLRICDFGFA--KQLRAENGLLMTPCY 187
Query: 194 --EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSG---I 245
              F+APE+ + + Y+E  DI+S G+ +  M+    P+       P +I  ++ SG   +
Sbjct: 188 TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTL 247
Query: 246 KPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLV 285
              + + V++   K  + K + V    RL A ++L+ P++ 
Sbjct: 248 SGGNWNTVSE-TAKDLVSKMLHVDPHQRLTAKQVLQHPWVT 287

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 33  LGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           +G+G F  V++G     E   + VA   +       S    E+   E   ++   H +I+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 148
           K        T   + +I EL T G LR + +  K ++D+ ++  +A Q+   L YL S  
Sbjct: 72  KLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 128
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEE 204
              +HRD+   N+ V+ N+  VK+GD GL+  M+  T           ++MAPE +    
Sbjct: 129 --FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 205 YNELVDIYSFGMCILEMV 222
           +    D++ FG+C+ E++
Sbjct: 186 FTSASDVWMFGVCMWEIL 203

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 33  LGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           +G+G F  V++G     E   + VA   +       S    E+   E   ++   H +I+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 148
           K        T   + +I EL T G LR + +  K ++D+ ++  +A Q+   L YL S  
Sbjct: 78  KLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 134
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEE 204
              +HRD+   N+ V+ N+  VK+GD GL+  M+  T           ++MAPE +    
Sbjct: 135 --FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 191
Query: 205 YNELVDIYSFGMCILEMV 222
           +    D++ FG+C+ E++
Sbjct: 192 FTSASDVWMFGVCMWEIL 209

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 14/230 (6%)
Query: 22  PSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
           PS    RY+  EILG G    V+   D  D  +VA  +V   D+ + P    R   E   
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAV-KVLRADLARDPSFYLRFRREAQN 65
Query: 80  LKSLKHENIIKFYNSWVDDT--NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
             +L H  I+  Y++   +T       ++ E     +LR        +  K         
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGT 192
            + L++  SH   IIHRD+K  NI ++  N  VK+ D G+A  +           +VIGT
Sbjct: 126 CQALNF--SHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 193 PEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
            ++++PE    +  +   D+YS G  + E++T E P+      +  Y+ V
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 14/230 (6%)
Query: 22  PSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
           PS    RY+  EILG G    V+   D  D  +VA  +V   D+ + P    R   E   
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAV-KVLRADLARDPSFYLRFRREAQN 65
Query: 80  LKSLKHENIIKFYNSWVDDT--NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
             +L H  I+  Y++   +T       ++ E     +LR        +  K         
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGT 192
            + L++  SH   IIHRD+K  NI ++  N  VK+ D G+A  +           +VIGT
Sbjct: 126 CQALNF--SHQNGIIHRDVKPANILISATNA-VKVVDFGIARAIADSGNSVXQTAAVIGT 182
Query: 193 PEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
            ++++PE    +  +   D+YS G  + E++T E P+      +  Y+ V
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 109/231 (47%), Gaps = 26/231 (11%)
Query: 33  LGKGAFKTVYKGFDEVDGI--EVAWNQVNIE---DVMQSPDQLERLYSEVHLLKSLKHEN 87
           LG GAF  VY+G  +V G+  + +  QV ++   +V    D+L+ L  E  ++  L H+N
Sbjct: 39  LGHGAFGEVYEG--QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM-EALIISKLNHQN 95
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRG 140
           I++     +    R I  + EL   G L+ + ++ +       ++ M  + + AR I  G
Sbjct: 96  IVRCIGVSLQSLPRFI--LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP----E 194
             YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G      +
Sbjct: 154 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 195 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 33  LGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           +G+G F  V++G     E   + VA   +       S    E+   E   ++   H +I+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 148
           K        T   + +I EL T G LR + +  K ++D+ ++  +A Q+   L YL S  
Sbjct: 80  KLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEE 204
              +HRD+   N+ V+ N+  VK+GD GL+  M+  T           ++MAPE +    
Sbjct: 137 --FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 205 YNELVDIYSFGMCILEMV 222
           +    D++ FG+C+ E++
Sbjct: 194 FTSASDVWMFGVCMWEIL 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 33  LGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           +G+G F  V++G     E   + VA   +       S    E+   E   ++   H +I+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 148
           K        T   + +I EL T G LR + +  K ++D+ ++  +A Q+   L YL S  
Sbjct: 103 KLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 159
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEE 204
              +HRD+   N+ V+ N+  VK+GD GL+  M+  T           ++MAPE +    
Sbjct: 160 --FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 216
Query: 205 YNELVDIYSFGMCILEMV 222
           +    D++ FG+C+ E++
Sbjct: 217 FTSASDVWMFGVCMWEIL 234

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 33  LGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           +G+G F  V++G     E   + VA   +       S    E+   E   ++   H +I+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 148
           K        T   + +I EL T G LR + +  K ++D+ ++  +A Q+   L YL S  
Sbjct: 75  KLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 131
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEE 204
              +HRD+   N+ V+ N+  VK+GD GL+  M+  T           ++MAPE +    
Sbjct: 132 --FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 205 YNELVDIYSFGMCILEMV 222
           +    D++ FG+C+ E++
Sbjct: 189 FTSASDVWMFGVCMWEIL 206

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 79  LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
           LL+  +H NII   +  V D  + + ++TEL   G L     + K    +        I 
Sbjct: 74  LLRYGQHPNIITLKD--VYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG 131
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 193
           + + YLHS    ++HRDLK  NI     +GN   ++I D G A   Q      ++ TP  
Sbjct: 132 KTVEYLHSQG--VVHRDLKPSNILYVDESGNPECLRICDFGFA--KQLRAENGLLMTPCY 187
Query: 194 --EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSG---I 245
              F+APE+ + + Y+E  DI+S G+ +  M+    P+       P +I  ++ SG   +
Sbjct: 188 TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTL 247
Query: 246 KPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFL 284
              + + V++   K  + K + V    RL A ++L+ P++
Sbjct: 248 SGGNWNTVSE-TAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 127/292 (43%), Gaps = 36/292 (12%)
Query: 16  EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
           EF+ K+    Y + +E++G G F  V +G  +  G + +   +       +  Q     S
Sbjct: 8   EFA-KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLS 66
Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWA 134
           E  ++   +H NII+     V   +  + ++TE   +G+L  + R       +  +    
Sbjct: 67  EASIMGQFEHPNIIRLEG--VVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGML 124
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVI 190
           R I  G+ YL   +   +HRDL   NI VN +N   K+ D GL+  +++    PT  S +
Sbjct: 125 RGIASGMRYLAEMS--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEENSSDPTETSSL 181
Query: 191 GTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKN------------ 233
           G      + APE +   ++    D +S+G+ + E+++  E PY +  N            
Sbjct: 182 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYR 241
Query: 234 -------PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE 277
                  P  +++ +    +    ++   PQV   ++K I  PASL++ A E
Sbjct: 242 LPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARE 293

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HE 86
           R   +L +G F  VY+  D   G E A  ++    +    ++   +  EV  +K L  H 
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALKRL----LSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 87  NIIKFYNSWV-----DDTNRTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQIL 138
           NI++F ++        DT +   ++      G L ++ KK ++   +    +     Q  
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-------PTARSVI- 190
           R + ++H   PPIIHRDLK +N+ ++ N G +K+ D G A  +            R+++ 
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 191 ------GTPEFMAPELYEEEYN----ELVDIYSFGMCILEMV 222
                  TP +  PE+ +   N    E  DI++ G CIL ++
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLL 246

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 30  DEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
           + ILG+G F  VY+G     + + I VA      +  +   D  E+  SE  ++K+L H 
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL---DNKEKFMSEAVIMKNLDHP 85
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLH 145
           +I+K      ++      +I EL+  G L  Y +++KN + +  +  ++ QI + + YL 
Sbjct: 86  HIVKLIGIIEEEPTW---IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 142
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LY 201
           S N   +HRD+   NI V      VK+GD GL+  ++       SV   P ++M+PE + 
Sbjct: 143 SIN--CVHRDIAVRNILVASPEC-VKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 199
Query: 202 EEEYNELVDIYSFGMCILEMVT 223
              +    D++ F +C+ E+++
Sbjct: 200 FRRFTTASDVWMFAVCMWEILS 221

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 17/172 (9%)
Query: 70  LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD--M 127
           +E   +E +++K+L+H+ ++K +      T   I +ITE    GSL  + K  +     +
Sbjct: 221 VEAFLAEANVMKTLQHDKLVKLHAV---VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL 277
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
             + +++ QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA V     A+
Sbjct: 278 PKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARV----GAK 330
Query: 188 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
             I   ++ APE      +    D++SFG+ ++E+VT    PY    NP  I
Sbjct: 331 FPI---KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 379

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 127/292 (43%), Gaps = 36/292 (12%)
Query: 16  EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
           EF+ K+    Y + +E++G G F  V +G  +  G + +   +       +  Q     S
Sbjct: 6   EFA-KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLS 64
Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWA 134
           E  ++   +H NII+     V   +  + ++TE   +G+L  + R       +  +    
Sbjct: 65  EASIMGQFEHPNIIRLEG--VVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGML 122
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVI 190
           R I  G+ YL   +   +HRDL   NI VN +N   K+ D GL+  +++    PT  S +
Sbjct: 123 RGIASGMRYLAEMS--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEENSSDPTYTSSL 179
Query: 191 GTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKN------------ 233
           G      + APE +   ++    D +S+G+ + E+++  E PY +  N            
Sbjct: 180 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYR 239
Query: 234 -------PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE 277
                  P  +++ +    +    ++   PQV   ++K I  PASL++ A E
Sbjct: 240 LPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARE 291

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 105/239 (43%), Gaps = 17/239 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G +  VY G  +   + VA   +  ED M+    +E    E  ++K +KH N+++  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 94
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              V        ++TE    G+L  Y ++   + V    +   A QI   + YL   N  
Sbjct: 95  G--VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN-- 150
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
            IHRDL   N  V G N  VK+ D GL+ +M   T  +  G     ++ APE L    ++
Sbjct: 151 FIHRDLAARNCLV-GENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFS 209
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
              D+++FG+ + E+ T         + +Q+Y  +  G +     +   P+V + +  C
Sbjct: 210 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYR-MEQPEGCPPKVYELMRAC 267

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 119/261 (45%), Gaps = 31/261 (11%)
Query: 3   CGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNI 60
           C +G T S ++  E   K+ +   G     LG GAF  VY+G  +V G+  + +  QV +
Sbjct: 54  CFAGKTSSISDLKEVPRKNITLIRG-----LGHGAFGEVYEG--QVSGMPNDPSPLQVAV 106
Query: 61  E---DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 117
           +   +V    D+L+ L  E  ++    H+NI++     +    R I  + EL   G L+ 
Sbjct: 107 KTLPEVCSEQDELDFLM-EALIISKFNHQNIVRCIGVSLQSLPRFI--LLELMAGGDLKS 163
Query: 118 YRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNG 168
           + ++ +       ++ M  + + AR I  G  YL  ++   IHRD+   N  +   G   
Sbjct: 164 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGR 221
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTP----EFMAPELYEEE-YNELVDIYSFGMCILEMVT 223
             KIGD G+A  + +       G      ++M PE + E  +    D +SFG+ + E+ +
Sbjct: 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
Query: 224 CEYPYNECKNPAQIYKKVTSG 244
             Y     K+  ++ + VTSG
Sbjct: 282 LGYMPYPSKSNQEVLEFVTSG 302

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 14/225 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+++G G F  V  G  ++   +     +    V  +  Q      E  ++    H NII
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           +     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL    
Sbjct: 110 RLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GLA V++       T R       + +PE +  
Sbjct: 168 --YVHRDLAARNILIN-SNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
            ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 30  DEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
           + ILG+G F  VY+G     + + I VA      +  +   D  E+  SE  ++K+L H 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL---DNKEKFMSEAVIMKNLDHP 73
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLH 145
           +I+K      ++      +I EL+  G L  Y +++KN + +  +  ++ QI + + YL 
Sbjct: 74  HIVKLIGIIEEEPTW---IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LY 201
           S N   +HRD+   NI V      VK+GD GL+  ++       SV   P ++M+PE + 
Sbjct: 131 SIN--CVHRDIAVRNILVASPEC-VKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 187
Query: 202 EEEYNELVDIYSFGMCILEMVT 223
              +    D++ F +C+ E+++
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 30  DEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
           + ILG+G F  VY+G     + + I VA      +  +   D  E+  SE  ++K+L H 
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL---DNKEKFMSEAVIMKNLDHP 69
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLH 145
           +I+K      ++      +I EL+  G L  Y +++KN + +  +  ++ QI + + YL 
Sbjct: 70  HIVKLIGIIEEEPTW---IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 126
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LY 201
           S N   +HRD+   NI V      VK+GD GL+  ++       SV   P ++M+PE + 
Sbjct: 127 SIN--CVHRDIAVRNILVASPEC-VKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 183
Query: 202 EEEYNELVDIYSFGMCILEMVT 223
              +    D++ F +C+ E+++
Sbjct: 184 FRRFTTASDVWMFAVCMWEILS 205

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 119/261 (45%), Gaps = 31/261 (11%)
Query: 3   CGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNI 60
           C +G T S ++  E   K+ +   G     LG GAF  VY+G  +V G+  + +  QV +
Sbjct: 31  CFAGKTSSISDLKEVPRKNITLIRG-----LGHGAFGEVYEG--QVSGMPNDPSPLQVAV 83
Query: 61  E---DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 117
           +   +V    D+L+ L  E  ++    H+NI++     +    R I  + EL   G L+ 
Sbjct: 84  KTLPEVCSEQDELDFLM-EALIISKFNHQNIVRCIGVSLQSLPRFI--LLELMAGGDLKS 140
Query: 118 YRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNG 168
           + ++ +       ++ M  + + AR I  G  YL  ++   IHRD+   N  +   G   
Sbjct: 141 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGR 198
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTP----EFMAPELYEEE-YNELVDIYSFGMCILEMVT 223
             KIGD G+A  + +       G      ++M PE + E  +    D +SFG+ + E+ +
Sbjct: 199 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258
Query: 224 CEYPYNECKNPAQIYKKVTSG 244
             Y     K+  ++ + VTSG
Sbjct: 259 LGYMPYPSKSNQEVLEFVTSG 279

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKA 129
           E+   E   ++   H +I+K        T   + +I EL T G LR + +  K ++D+ +
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFSLDLAS 492
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
           +  +A Q+   L YL S     +HRD+   N+ V+ N+  VK+GD GL+  M+  T    
Sbjct: 493 LILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKA 549
Query: 190 IGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMV 222
                  ++MAPE +    +    D++ FG+C+ E++
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 123/267 (46%), Gaps = 20/267 (7%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G+GA+ +V K   +  G  +A  +  I   +   +Q + L     +++S     I++FY
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKR--IRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD----MKAIKNWARQILRGLHYLHSHN 148
            +   + +  I M  EL ++   + Y+  +  +D     + +       ++ L++L   N
Sbjct: 88  GALFREGDCWICM--ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK-EN 144
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYE----- 202
             IIHRD+K  NI ++  +G +K+ D G++  +    A++   G   +MAPE  +     
Sbjct: 145 LKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVK 259
           + Y+   D++S G+ + E+ T  +PY +  +      +V  G  P    S  +   P   
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFI 263
Query: 260 QFIEKCIVPASLRLPAL-ELLKDPFLV 285
            F+  C+     + P   ELLK PF++
Sbjct: 264 NFVNLCLTKDESKRPKYKELLKHPFIL 290

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 108/231 (46%), Gaps = 26/231 (11%)
Query: 33  LGKGAFKTVYKGFDEVDGI--EVAWNQVNIE---DVMQSPDQLERLYSEVHLLKSLKHEN 87
           LG GAF  VY+G  +V G+  + +  QV ++   +V    D+L+ L  E  ++    H+N
Sbjct: 39  LGHGAFGEVYEG--QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM-EALIISKFNHQN 95
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRG 140
           I++     +    R I  + EL   G L+ + ++ +       ++ M  + + AR I  G
Sbjct: 96  IVRCIGVSLQSLPRFI--LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP----E 194
             YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G      +
Sbjct: 154 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK 211
Query: 195 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 108/231 (46%), Gaps = 26/231 (11%)
Query: 33  LGKGAFKTVYKGFDEVDGI--EVAWNQVNIE---DVMQSPDQLERLYSEVHLLKSLKHEN 87
           LG GAF  VY+G  +V G+  + +  QV ++   +V    D+L+ L  E  ++    H+N
Sbjct: 39  LGHGAFGEVYEG--QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM-EALIISKFNHQN 95
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRG 140
           I++     +    R I  + EL   G L+ + ++ +       ++ M  + + AR I  G
Sbjct: 96  IVRCIGVSLQSLPRFI--LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP----E 194
             YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G      +
Sbjct: 154 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 195 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 108/231 (46%), Gaps = 26/231 (11%)
Query: 33  LGKGAFKTVYKGFDEVDGI--EVAWNQVNIE---DVMQSPDQLERLYSEVHLLKSLKHEN 87
           LG GAF  VY+G  +V G+  + +  QV ++   +V    D+L+ L  E  ++    H+N
Sbjct: 45  LGHGAFGEVYEG--QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM-EALIISKFNHQN 101
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRG 140
           I++     +    R I  + EL   G L+ + ++ +       ++ M  + + AR I  G
Sbjct: 102 IVRCIGVSLQSLPRFI--LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 159
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP----E 194
             YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G      +
Sbjct: 160 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 217
Query: 195 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 268

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 113/249 (45%), Gaps = 25/249 (10%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKVVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL    +L Q  +    +D + +     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM--ELDHERMSYLLYQMLVGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDATLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G+ + EM+     +    +  Q  K +   G       K  
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 255 DPQVKQFIE 263
            P V+ ++E
Sbjct: 253 QPTVRTYVE 261

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKXVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME---LDHERMSYLLYQMLXGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDXTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKL 274

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 14/225 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+++G G F  V  G  ++   +     +    V  +  Q      E  ++    H NII
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           +     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL    
Sbjct: 110 RLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GL+ V++       T R       + +PE +  
Sbjct: 168 --FVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
            ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 14/225 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+++G G F  V  G  ++   +     +    V  +  Q      E  ++    H NII
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           +     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL    
Sbjct: 110 RLEG--VVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GL+ V++       T R       + +PE +  
Sbjct: 168 A--VHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
            ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME---LDHERMSYLLYQMLXGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDXTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKL 274

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           LG G F  V  G          W     V ++ + +     +  + E   +  L H  ++
Sbjct: 16  LGSGQFGVVKLG---------KWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           KFY   V      I ++TE  ++G L  Y + H K ++   +      +  G+ +L SH 
Sbjct: 67  KFYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPELYEE-E 204
              IHRDL   N  V+  +  VK+ D G+   +      S +GT    ++ APE++   +
Sbjct: 125 --FIHRDLAARNCLVD-RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK 181
Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           Y+   D+++FG+ + E+ +  + PY+   N +++  KV+ G
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQG 221

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 75
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME---LDHERMSYLLYQMLXGI 132
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 133 KHLHSAG--IIHRDLKPSNIVVK-SDXTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 185
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKL 267

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 33  LGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           +G+G F  V++G     E   + VA   +       S    E+   E   ++   H +I+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 148
           K        T   + +I EL T G LR + +  K ++D+ ++  +A Q+   L YL S  
Sbjct: 75  KLIGV---ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 131
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEE 204
              +HRD+   N+ V+  +  VK+GD GL+  M+  T           ++MAPE +    
Sbjct: 132 --FVHRDIAARNVLVSATDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 205 YNELVDIYSFGMCILEMV 222
           +    D++ FG+C+ E++
Sbjct: 189 FTSASDVWMFGVCMWEIL 206

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TPE     + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPEVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMV 222
           APE +    Y E VDI+S G  + EM+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 120
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 177
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 178 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 230
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMV 222
           APE +    Y E VDI+S G  + EMV
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 17/225 (7%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 78
           E D SC   + ++++G G F  V  G  ++ G    +  +       +  Q     SE  
Sbjct: 3   EIDISCV--KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS 60
Query: 79  LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQI 137
           ++    H N+I      V   +  + +ITE   +GSL  + R+      +  +    R I
Sbjct: 61  IMGQFDHPNVIHLEG--VVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 118
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIGTP 193
             G+ YL   N   +HR L   NI VN +N   K+ D GL+  ++     PT  S +G  
Sbjct: 119 AAGMKYLADMN--YVHRALAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 175
Query: 194 ---EFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKN 233
               + APE  +  ++    D++S+G+ + E+++  E PY +  N
Sbjct: 176 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 220

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 114/250 (45%), Gaps = 15/250 (6%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           R   +LGKG F  V        G   A  ++  + + +   +   L +E  +L+ +    
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-NEKQILEKVNSRF 245
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWARQILRGLHYLH 145
           ++    ++  +T   + ++  L   G L+   Y              +A +I  GL  LH
Sbjct: 246 VVSL--AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEFMAPELYE-E 203
                I++RDLK +NI ++ ++G ++I DLGLA+ V +  T +  +GT  +MAPE+ + E
Sbjct: 304 RER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQF 261
            Y    D ++ G  + EM+  + P+ + K   +  ++V   +K  P   S+   PQ +  
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEVPEEYSERFSPQARSL 419
Query: 262 IEK--CIVPA 269
             +  C  PA
Sbjct: 420 CSQLLCKDPA 429

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 108/231 (46%), Gaps = 26/231 (11%)
Query: 33  LGKGAFKTVYKGFDEVDGI--EVAWNQVNIE---DVMQSPDQLERLYSEVHLLKSLKHEN 87
           LG GAF  VY+G  +V G+  + +  QV ++   +V    D+L+ L  E  ++    H+N
Sbjct: 65  LGHGAFGEVYEG--QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM-EALIISKFNHQN 121
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRG 140
           I++     +    R I  + EL   G L+ + ++ +       ++ M  + + AR I  G
Sbjct: 122 IVRCIGVSLQSLPRFI--LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 179
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP----E 194
             YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G      +
Sbjct: 180 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 237
Query: 195 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
           +M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 288

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 14/225 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+++G G F  V  G  ++   +     +    V  +  Q      E  ++    H NII
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           +     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL    
Sbjct: 110 RLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GL+ V++       T R       + +PE +  
Sbjct: 168 --YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
            ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 117/251 (46%), Gaps = 29/251 (11%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S +  PE     + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMEPEVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PASLSK 252
           APE +    Y E VDI+S G CI+  + C       ++    + KV   +    PA + K
Sbjct: 193 APEVILGMGYKENVDIWSVG-CIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKK 251
Query: 253 VTDPQVKQFIE 263
           +  P V+ ++E
Sbjct: 252 L-QPTVRNYVE 261

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 113/249 (45%), Gaps = 25/249 (10%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKVVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL    +L Q  +    +D + +     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM--ELDHERMSYLLYQMLVGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDATLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G+ + EM+     +    +  Q  K +   G       K  
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 255 DPQVKQFIE 263
            P V+ ++E
Sbjct: 253 QPTVRTYVE 261

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 14/225 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+++G G F  V  G  ++   +     +    V  +  Q      E  ++    H NII
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           +     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL    
Sbjct: 110 RLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GL+ V++       T R       + +PE +  
Sbjct: 168 --YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
            ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 14/225 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+++G G F  V  G  ++   +     +    V  +  Q      E  ++    H NII
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           +     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL    
Sbjct: 110 RLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GL+ V++       T R       + +PE +  
Sbjct: 168 --YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
            ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 14/225 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+++G G F  V  G  ++   +     +    V  +  Q      E  ++    H NII
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           +     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL    
Sbjct: 110 RLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GL  V++       T R       + +PE +  
Sbjct: 168 --YVHRDLAARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
            ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 14/225 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+++G G F  V  G  ++   +     +    V  +  Q      E  ++    H NII
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           +     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL    
Sbjct: 98  RLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 155
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GL+ V++       T R       + +PE +  
Sbjct: 156 --YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 212
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
            ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 213 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 256

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 14/225 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+++G G F  V  G  ++   +     +    V  +  Q      E  ++    H NII
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           +     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL    
Sbjct: 110 RLEG--VVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GL+ V++       T R       + +PE +  
Sbjct: 168 --YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
            ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 125/280 (44%), Gaps = 40/280 (14%)
Query: 31  EILGKGAFKTVY-----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           ++LG GA+  V+      G D   G   A   +    ++Q     E   +E  +L+ ++ 
Sbjct: 60  KVLGTGAYGKVFLVRKISGHD--TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
              +   + +   T   +++I +    G L  +  + +      ++ +  +I+  L +LH
Sbjct: 118 SPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELY- 201
                II+RD+K +NI ++ +NG V + D GL+   +  +   A    GT E+MAP++  
Sbjct: 177 KLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233
Query: 202 --EEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDP 256
             +  +++ VD +S G+ + E++T   P+    E  + A+I +++     P        P
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY-------P 286
Query: 257 QVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP 296
           Q    + K ++    RL    L+KDP       K L C P
Sbjct: 287 QEMSALAKDLIQ---RL----LMKDP------KKRLGCGP 313

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 14/225 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+++G G F  V  G  ++   +     +    V  +  Q      E  ++    H NII
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           +     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL    
Sbjct: 110 RLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GL+ V++       T R       + +PE +  
Sbjct: 168 --YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
            ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 114/250 (45%), Gaps = 15/250 (6%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           R   +LGKG F  V        G   A  ++  + + +   +   L +E  +L+ +    
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-NEKQILEKVNSRF 245
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWARQILRGLHYLH 145
           ++    ++  +T   + ++  L   G L+   Y              +A +I  GL  LH
Sbjct: 246 VVSL--AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEFMAPELYE-E 203
                I++RDLK +NI ++ ++G ++I DLGLA+ V +  T +  +GT  +MAPE+ + E
Sbjct: 304 RER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQF 261
            Y    D ++ G  + EM+  + P+ + K   +  ++V   +K  P   S+   PQ +  
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEVPEEYSERFSPQARSL 419
Query: 262 IEK--CIVPA 269
             +  C  PA
Sbjct: 420 CSQLLCKDPA 429

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 14/225 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+++G G F  V  G  ++   +     +    V  +  Q      E  ++    H NII
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           +     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL    
Sbjct: 108 RLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 165
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GL+ V++       T R       + +PE +  
Sbjct: 166 --YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 222
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
            ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 223 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 266

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 14/225 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+++G G F  V  G  ++   +     +    V  +  Q      E  ++    H NII
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           +     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL    
Sbjct: 81  RLEG--VVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GL+ V++       T R       + +PE +  
Sbjct: 139 --YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
            ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 196 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 239

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 14/225 (6%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+++G G F  V  G  ++   +     +    V  +  Q      E  ++    H NII
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 148
           +     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL    
Sbjct: 81  RLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GL+ V++       T R       + +PE +  
Sbjct: 139 --YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
            ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 196 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 239

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKXVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME---LDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDXTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKL 274

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 75
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 132
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 133 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 185
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKL 267

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +LGKG +  V++   +V G       A   +    ++++        +E ++L+ +KH  
Sbjct: 24  VLGKGGYGKVFQ-VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           I+    ++   T   + +I E  + G L    ++           +  +I   L +LH  
Sbjct: 83  IVDLIYAF--QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEE 204
              II+RDLK +NI +N + G VK+ D GL    +       +  GT E+MAPE L    
Sbjct: 141 G--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG 197
Query: 205 YNELVDIYSFGMCILEMVTCEYPYN 229
           +N  VD +S G  + +M+T   P+ 
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 120
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 177
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 178 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 230
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKL 312

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 76
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 133
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 134 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 186
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 246
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 247 QPTVRNYVENRPKYAGLTFPKL 268

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 76
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 133
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 134 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 186
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 246
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 247 QPTVRNYVENRPKYAGLTFPKL 268

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKXVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDXTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKL 274

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 24  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 81
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 138
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 139 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 191
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 192 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 251
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 252 QPTVRNYVENRPKYAGLTFPKL 273

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 83
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 140
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 141 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 193
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 253
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 254 QPTVRNYVENRPKYAGLTFPKL 275

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKL 274

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 12/169 (7%)
Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKA 129
           E+   E   ++   H +I+K        T   + +I EL T G LR + +  K ++D+ +
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFSLDLAS 492
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
           +  +A Q+   L YL S     +HRD+   N+ V+  +  VK+GD GL+  M+  T    
Sbjct: 493 LILYAYQLSTALAYLESKR--FVHRDIAARNVLVSATDC-VKLGDFGLSRYMEDSTYYKA 549
Query: 190 IGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY-PYNECKN 233
                  ++MAPE +    +    D++ FG+C+ E++     P+   KN
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 83
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 140
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 141 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 193
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 253
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 254 QPTVRNYVENRPKYAGLTFPKL 275

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 25/262 (9%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +         + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G       K  
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 255 DPQVKQFIEKCIVPASLRLPAL 276
            P V+ ++E     A L  P L
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKL 274

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKVVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL    +L Q  +    +D + +     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM--ELDHERMSYLLYQMLVGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDATLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EM+     +    +  Q  K +   G       K  
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 255 DPQVKQFIE 263
            P V+ ++E
Sbjct: 253 QPTVRTYVE 261

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +LGKG +  V++   +V G       A   +    ++++        +E ++L+ +KH  
Sbjct: 24  VLGKGGYGKVFQ-VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           I+    ++   T   + +I E  + G L    ++           +  +I   L +LH  
Sbjct: 83  IVDLIYAF--QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEE 204
              II+RDLK +NI +N + G VK+ D GL    +          GT E+MAPE L    
Sbjct: 141 G--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSG 197
Query: 205 YNELVDIYSFGMCILEMVTCEYPYN 229
           +N  VD +S G  + +M+T   P+ 
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 34/215 (15%)
Query: 33  LGKGAFKTV-----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHE 86
           LG+GAF  V     Y    E D I VA     ++ +  + D   +  + E  LL +L+HE
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVA-----VKTLKDASDNARKDFHREAELLTNLQHE 75
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-------------KNVDMKAIKNW 133
           +I+KFY   V+     + M+ E    G L ++ + H               +    + + 
Sbjct: 76  HIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
           A+QI  G+ YL S +   +HRDL   N  V G N  VKIGD G++  +       V G  
Sbjct: 134 AQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGMSRDVYSTDYYRVGGHT 190
Query: 194 ----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
                +M PE +   ++    D++S G+ + E+ T
Sbjct: 191 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 17/240 (7%)
Query: 16  EFS-EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLY 74
           EF+ E D SC   + ++++G G F  V  G  +V G       +       +  Q     
Sbjct: 21  EFAKEIDASCI--KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL 78
Query: 75  SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNW 133
           SE  ++    H NII      V    + + +ITE   +GSL  + RK      +  +   
Sbjct: 79  SEASIMGQFDHPNIIHLEG--VVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGM 136
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARS 188
            R I  G+ YL   +   +HRDL   NI VN +N   K+ D G++ V++       T R 
Sbjct: 137 LRGIGSGMKYLSDMSA--VHRDLAARNILVN-SNLVCKVSDFGMSRVLEDDPEAAYTTRG 193
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
                 + APE +   ++    D++S+G+ + E+++  E PY +  N   + K +  G +
Sbjct: 194 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYR 252

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 28/221 (12%)
Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHL 79
           D   +Y +  +I G+G F  V+K      G +VA  +V +E+  +  P    R   E+ +
Sbjct: 15  DEVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKI 70
Query: 80  LKSLKHENI---IKFYNSWVDDTNRTINMITELF------TSGSLRQYRKKHKNVDMKAI 130
           L+ LKHEN+   I+   +     NR    I  +F       +G L     K     +  I
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEI 127
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPT 185
           K   + +L GL+Y+H +   I+HRD+K  N+ +   +G +K+ D GLA         QP 
Sbjct: 128 KRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPN 184
Query: 186 A-RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 223
              + + T  +  PEL   E +Y   +D++  G  + EM T
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL    +L Q  +    +D + +     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDATLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EM+     +    +  Q  K +   G       K  
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 255 DPQVKQFIE 263
            P V+ ++E
Sbjct: 253 QPTVRTYVE 261

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKVVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL    +L Q  +    +D + +     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDATLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EM+     +    +  Q  K +   G       K  
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 255 DPQVKQFIE 263
            P V+ ++E
Sbjct: 253 QPTVRTYVE 261

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 14/218 (6%)
Query: 22  PSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
           PS    RY+  EILG G    V+   D     +VA  +V   D+ + P    R   E   
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAV-KVLRADLARDPSFYLRFRREAQN 65
Query: 80  LKSLKHENIIKFYNSWVDDT--NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
             +L H  I+  Y++   +T       ++ E     +LR        +  K         
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGT 192
            + L++  SH   IIHRD+K  NI ++  N  VK+ D G+A  +           +VIGT
Sbjct: 126 CQALNF--SHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 193 PEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN 229
            ++++PE    +  +   D+YS G  + E++T E P+ 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
           + ++ IK   + +L    Y+H+    I HRD+K  NI ++ N G VK+ D G +  M   
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNE-KNICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDK 205
Query: 185 TARSVIGTPEFMAPELY--EEEYN-ELVDIYSFGMCILEMVTCEYPY 228
             +   GT EFM PE +  E  YN   VDI+S G+C+  M     P+
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 28/221 (12%)
Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHL 79
           D   +Y +  +I G+G F  V+K      G +VA  +V +E+  +  P    R   E+ +
Sbjct: 14  DEVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKI 69
Query: 80  LKSLKHENI---IKFYNSWVDDTNRTINMITELF------TSGSLRQYRKKHKNVDMKAI 130
           L+ LKHEN+   I+   +     NR    I  +F       +G L     K     +  I
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEI 126
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPT 185
           K   + +L GL+Y+H +   I+HRD+K  N+ +   +G +K+ D GLA         QP 
Sbjct: 127 KRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPN 183
Query: 186 A-RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 223
              + + T  +  PEL   E +Y   +D++  G  + EM T
Sbjct: 184 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 28/221 (12%)
Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHL 79
           D   +Y +  +I G+G F  V+K      G +VA  +V +E+  +  P    R   E+ +
Sbjct: 15  DEVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKI 70
Query: 80  LKSLKHENI---IKFYNSWVDDTNRTINMITELF------TSGSLRQYRKKHKNVDMKAI 130
           L+ LKHEN+   I+   +     NR    I  +F       +G L     K     +  I
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEI 127
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPT 185
           K   + +L GL+Y+H +   I+HRD+K  N+ +   +G +K+ D GLA         QP 
Sbjct: 128 KRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPN 184
Query: 186 A-RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 223
              + + T  +  PEL   E +Y   +D++  G  + EM T
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/263 (22%), Positives = 108/263 (41%), Gaps = 79/263 (30%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G+G F  V++  ++VD    A  ++ + +   + +++ R   EV  L  L+H  I++++
Sbjct: 14  MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKLEHPGIVRYF 70
Query: 93  NS----------------WVDDTN------------------RTINMITELFTSGSLRQY 118
           N+                W+ D +                  R ++  +   T G L+  
Sbjct: 71  NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130
Query: 119 RKK-HKNVDMKA-----IKNWAR------------------QILRGLHYLHSHNPPIIHR 154
             K +  + M+      +K+W                    QI   + +LHS    ++HR
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHR 188
Query: 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------------PTARSVIGTPEFMAPE- 199
           DLK  NIF   ++  VK+GD GL   M Q               T    +GT  +M+PE 
Sbjct: 189 DLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQ 247
Query: 200 LYEEEYNELVDIYSFGMCILEMV 222
           ++   Y+  VDI+S G+ + E++
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELL 270

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 26  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 81
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 82  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 140
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ YL S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 141 VAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEXXSVHNKTGAK 197
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 14/230 (6%)
Query: 22  PSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
           PS    RY+  EILG G    V+   D     +VA  +V   D+ + P    R   E   
Sbjct: 24  PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAV-KVLRADLARDPSFYLRFRREAQN 82
Query: 80  LKSLKHENIIKFYNSWVDDT--NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
             +L H  I+  Y++   +T       ++ E     +LR        +  K         
Sbjct: 83  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 142
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGT 192
            + L++  SH   IIHRD+K  NI ++  N  VK+ D G+A  +           +VIGT
Sbjct: 143 CQALNF--SHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGT 199
Query: 193 PEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
            ++++PE    +  +   D+YS G  + E++T E P+      +  Y+ V
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 249

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 28/221 (12%)
Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHL 79
           D   +Y +  +I G+G F  V+K      G +VA  +V +E+  +  P    R   E+ +
Sbjct: 15  DEVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKI 70
Query: 80  LKSLKHENI---IKFYNSWVDDTNRTINMITELF------TSGSLRQYRKKHKNVDMKAI 130
           L+ LKHEN+   I+   +     NR    I  +F       +G L     K     +  I
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK---FTLSEI 127
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPT 185
           K   + +L GL+Y+H +   I+HRD+K  N+ +   +G +K+ D GLA         QP 
Sbjct: 128 KRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPN 184
Query: 186 A-RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 223
              + + T  +  PEL   E +Y   +D++  G  + EM T
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 113/250 (45%), Gaps = 27/250 (10%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 30  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 87
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 144
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 145 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 197
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASLSKV 253
           APE +    Y E VD++S G CI+  + C       ++    + KV    G       K 
Sbjct: 198 APEVILGMGYKENVDLWSVG-CIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 256
Query: 254 TDPQVKQFIE 263
             P V+ ++E
Sbjct: 257 LQPTVRTYVE 266

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 17/240 (7%)
Query: 16  EFS-EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLY 74
           EF+ E D SC   + ++++G G F  V  G  +V G       +       +  Q     
Sbjct: 6   EFAKEIDASCI--KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL 63
Query: 75  SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNW 133
           SE  ++    H NII      V    + + +ITE   +GSL  + RK      +  +   
Sbjct: 64  SEASIMGQFDHPNIIHLEG--VVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGM 121
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARS 188
            R I  G+ YL   +   +HRDL   NI VN +N   K+ D G++ V++       T R 
Sbjct: 122 LRGIGSGMKYLSDMS--YVHRDLAARNILVN-SNLVCKVSDFGMSRVLEDDPEAAYTTRG 178
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
                 + APE +   ++    D++S+G+ + E+++  E PY +  N   + K +  G +
Sbjct: 179 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYR 237

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 113/250 (45%), Gaps = 27/250 (10%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S +  PE     + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMEPEVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASLSKV 253
           APE +    Y E VD++S G CI+  + C       ++    + KV    G       K 
Sbjct: 193 APEVILGMGYKENVDLWSVG-CIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 254 TDPQVKQFIE 263
             P V+ ++E
Sbjct: 252 LQPTVRTYVE 261

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 14/218 (6%)
Query: 22  PSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
           PS    RY+  EILG G    V+   D     +VA  +V   D+ + P    R   E   
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAV-KVLRADLARDPSFYLRFRREAQN 65
Query: 80  LKSLKHENIIKFYNSWVDDT--NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
             +L H  I+  Y +   +T       ++ E     +LR        +  K         
Sbjct: 66  AAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGT 192
            + L++  SH   IIHRD+K  NI ++  N  VK+ D G+A  +           +VIGT
Sbjct: 126 CQALNF--SHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 193 PEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN 229
            ++++PE    +  +   D+YS G  + E++T E P+ 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMV 222
           APE +    Y E VDI+S G  + EM+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 102/233 (43%), Gaps = 54/233 (23%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK-- 90
           LG G+F  V + FD   G   A     ++ V+Q P    R   E+ ++K L H NIIK  
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFA-----LKKVLQDPRYKNR---ELDIMKVLDHVNIIKLV 66
Query: 91  --FY----------------------NSWVDD----------TNRTINMITELFTSG--- 113
             FY                      N+ V++           N+ +N+I E        
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 114 SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173
            L+ + +  +++ M  I  +  Q+ R + ++HS    I HRD+K  N+ VN  +  +K+ 
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLC 184
Query: 174 DLGLA--IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 222
           D G A  ++  +P+  + I +  + APEL     EY   +D++S G    E++
Sbjct: 185 DFGSAKKLIPSEPSV-AXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 16/236 (6%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 78
           E D SC   + ++++G G F  V  G  +V G       +       +  Q     SE  
Sbjct: 4   EIDASCI--KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEAS 61
Query: 79  LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQI 137
           ++    H NII      V    + + +ITE   +GSL  + RK      +  +    R I
Sbjct: 62  IMGQFDHPNIIHLEG--VVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGI 119
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGT 192
             G+ YL   +   +HRDL   NI VN +N   K+ D G++ V++       T R     
Sbjct: 120 GSGMKYLSDMS--YVHRDLAARNILVN-SNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 176
Query: 193 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
             + APE +   ++    D++S+G+ + E+++  E PY +  N   + K +  G +
Sbjct: 177 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYR 231

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 83
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 140
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 141 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 193
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMV 222
           APE +    Y E VDI+S G  + EM+
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMI 220

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 113/250 (45%), Gaps = 27/250 (10%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 76
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 133
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 134 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 186
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASLSKV 253
           APE +    Y E VD++S G CI+  + C       ++    + KV    G       K 
Sbjct: 187 APEVILGMGYKENVDLWSVG-CIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 254 TDPQVKQFIE 263
             P V+ ++E
Sbjct: 246 LQPTVRTYVE 255

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 107/256 (41%), Gaps = 35/256 (13%)
Query: 30  DEILGKGAFKTVYKG--FDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
           D ++GKG F  VY G   D+    I+ A   ++    MQ   Q+E    E  L++ L H 
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ---QVEAFLREGLLMRGLNHP 82
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 145
           N++      +       +++      G L Q+ R   +N  +K + ++  Q+ RG+ YL 
Sbjct: 83  NVLALIGIMLPPEGLP-HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------IVMQQPTARSVIGTPEFM 196
                 +HRDL   N  ++  +  VK+ D GLA          V Q   AR  +      
Sbjct: 142 EQK--FVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 197 APELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-------PAS 249
           + + Y   +    D++SFG+ + E++T   P     +P  +   +  G +       P S
Sbjct: 199 SLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDS 256
Query: 250 LSKV------TDPQVK 259
           L +V       DP V+
Sbjct: 257 LYQVMQQCWEADPAVR 272

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EM+     +    +  Q  K +   G       K  
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 255 DPQVKQFIE 263
            P V+ ++E
Sbjct: 253 QPTVRTYVE 261

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 21/239 (8%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           + ++G G F  V  G  ++ G       +    V  +  Q      E  ++    H NII
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHN 148
                 V   ++ + ++TE   +GSL  + KK+     +  +    R I  G+ YL    
Sbjct: 87  HLEG--VVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMG 144
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYE 202
              +HRDL   NI +N +N   K+ D GL+ V++       T R       + APE +  
Sbjct: 145 --YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK-------PASLSKV 253
            ++    D++S+G+ + E+V+  E PY E  N   + K V  G +       PA+L ++
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSYGERPYWEMTN-QDVIKAVEEGYRLPSPMDCPAALYQL 259

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL    +L Q  +    +D + +     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
           APE +    Y E VDI+S G  + EM+     +    +  Q  K +   G       K  
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 255 DPQVKQFIE 263
            P V+ ++E
Sbjct: 253 QPTVRTYVE 261

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 45  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 100
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 101 IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 159
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ YL S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 160 VAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 216
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 217 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 46  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 101
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 102 IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 160
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ YL S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 161 VAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 217
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 218 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 19  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 74
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 75  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 133
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ YL S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 134 VAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 190
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 191 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 120/275 (43%), Gaps = 47/275 (17%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           ++G G F  VYKG    DG +VA  +   E    S   +E   +E+  L   +H +++  
Sbjct: 46  LIGHGVFGKVYKGVLR-DGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSL 100
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI------LRGLHYLH 145
              + D+ N  I +I +   +G+L+++        M    +W +++       RGLHYLH
Sbjct: 101 IG-FCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSM--SWEQRLEICIGAARGLHYLH 156
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI----VMQQPTARSVIGTPEFMAPELY 201
           +    IIHRD+K  NI ++  N   KI D G++     + Q      V GT  ++ PE +
Sbjct: 157 TR--AIIHRDVKSINILLD-ENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYF 213
Query: 202 -EEEYNELVDIYSFGMCIL---------------EMVTCEYPYNECKNPAQIYKKV---- 241
            +    E  D+YSFG+ +                EMV       E  N  Q+ + V    
Sbjct: 214 IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273
Query: 242 TSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
              I+P SL K  D  V     KC+  +S   P++
Sbjct: 274 ADKIRPESLRKFGDTAV-----KCLALSSEDRPSM 303

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 27  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 82
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 141
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ YL S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 142 VAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 25  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 80
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 81  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 139
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ YL S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 140 VAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 196
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 24  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 79
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 80  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ YL S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 139 VAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 195
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 26  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 81
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 82  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 140
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ YL S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 141 VAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 197
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 22  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 77
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ YL S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 137 VAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 27  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 82
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 141
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ YL S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 142 VAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 120/275 (43%), Gaps = 47/275 (17%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           ++G G F  VYKG    DG +VA  +   E    S   +E   +E+  L   +H +++  
Sbjct: 46  LIGHGVFGKVYKGVLR-DGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSL 100
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI------LRGLHYLH 145
              + D+ N  I +I +   +G+L+++        M    +W +++       RGLHYLH
Sbjct: 101 IG-FCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSM--SWEQRLEICIGAARGLHYLH 156
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI----VMQQPTARSVIGTPEFMAPELY 201
           +    IIHRD+K  NI ++  N   KI D G++     + Q      V GT  ++ PE +
Sbjct: 157 TR--AIIHRDVKSINILLD-ENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYF 213
Query: 202 -EEEYNELVDIYSFGMCIL---------------EMVTCEYPYNECKNPAQIYKKV---- 241
            +    E  D+YSFG+ +                EMV       E  N  Q+ + V    
Sbjct: 214 IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273
Query: 242 TSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
              I+P SL K  D  V     KC+  +S   P++
Sbjct: 274 ADKIRPESLRKFGDTAV-----KCLALSSEDRPSM 303

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +++     Q+    +R Y E+ L+K + H
Sbjct: 27  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 84
Query: 86  ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +    + + ++ EL  +   +  + +   +D + +     Q+L G+
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 141
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S +  P      + 
Sbjct: 142 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMVPFVVTRYYR 194
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMV 222
           APE +    Y E VDI+S G  + EM+
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMI 221

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 86  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 141
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 200
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ +L S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 201 VAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 133/279 (47%), Gaps = 34/279 (12%)
Query: 17  FSEKDPSCRYGRYD----EILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPD 68
           F+ K    R  R D    +++G+GAF  V     K  D+V  +++    +N  ++++   
Sbjct: 62  FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI----LNKWEMLKRA- 116
Query: 69  QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDM 127
           +      E  +L +   + I   + ++ DD N  + ++ + +  G L     K ++ +  
Sbjct: 117 ETACFREERDVLVNGDSKWITTLHYAFQDDNN--LYLVMDYYVGGDLLTLLSKFEDRLPE 174
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTA 186
           +  + +  +++  +  +H  +   +HRD+K DNI ++  NG +++ D G  + +M+  T 
Sbjct: 175 EMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTV 231
Query: 187 RS--VIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
           +S   +GTP++++PE+ +        Y    D +S G+C+ EM+  E P+   ++  + Y
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETY 290
Query: 239 KKVTSGIK----PASLSKVTDPQVKQFIEKCIVPASLRL 273
            K+ +  +    P  ++ V++   K  I + I     RL
Sbjct: 291 GKIMNHKERFQFPTQVTDVSE-NAKDLIRRLICSREHRL 328

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/206 (21%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           +++G+GAF  V     +      A   ++  ++++  D     + E  ++       +++
Sbjct: 81  KVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDS-AFFWEERDIMAFANSPWVVQ 139
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            + ++ DD  + + M+ E    G L      + +V  K  K +  +++  L  +HS    
Sbjct: 140 LFCAFQDD--KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG-- 194
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYEEE--- 204
           +IHRD+K DN+ ++  +G +K+ D G  + M +       + +GTP++++PE+ + +   
Sbjct: 195 LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGD 253
Query: 205 --YNELVDIYSFGMCILEMVTCEYPY 228
             Y    D +S G+ + EM+  + P+
Sbjct: 254 GYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 102/241 (42%), Gaps = 17/241 (7%)
Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 78
           E D SC   + + ++G G F  V  G  ++ G       +    V  +  Q      E  
Sbjct: 39  ELDASCI--KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEAS 96
Query: 79  LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQI 137
           ++    H N++      V    + + ++ E   +G+L  + +KH     +  +    R I
Sbjct: 97  IMGQFDHPNVVHLEG--VVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGI 154
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---- 193
             G+ YL       +HRDL   NI VN +N   K+ D GL+ V++         T     
Sbjct: 155 AAGMRYLADMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIP 211
Query: 194 -EFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK-PAS 249
             + APE  +  ++    D++S+G+ + E+++  E PY +  N   + K +  G + PA 
Sbjct: 212 VRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPAP 270
Query: 250 L 250
           +
Sbjct: 271 M 271

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 87/191 (45%), Gaps = 28/191 (14%)
Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------------- 122
           E  LL +L+HE+I+KFY   V      + M+ E    G L ++ + H             
Sbjct: 67  EAELLTNLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 123 ---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179
                + +  + + A QI  G+ YL S +   +HRDL   N  V G N  VKIGD G++ 
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSR 181
Query: 180 VMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKN 233
            +       V G       +M PE +   ++    D++SFG+ + E+ T  + P+ +  N
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
Query: 234 PAQIYKKVTSG 244
             ++ + +T G
Sbjct: 242 -TEVIECITQG 251

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 27  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 82
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 141
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ +L S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 142 VAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 25  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 80
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 81  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 139
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ +L S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 140 VAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAK 196
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 28  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 83
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 84  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 142
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ +L S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 143 VAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAK 199
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 32  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 87
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 88  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 146
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ +L S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 147 VAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAK 203
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 204 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 27  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 82
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 141
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ +L S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 142 VAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 22  PSCRYGRYDEILGKGAFKTVYKG-FDEVDG--IEVAWNQVN-IEDVMQSPDQLERLYSEV 77
           PS     ++E++G+G F  VY G   + DG  I  A   +N I D+     ++ +  +E 
Sbjct: 28  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEG 83
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
            ++K   H N++      +      + ++      G LR + R +  N  +K +  +  Q
Sbjct: 84  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 142
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP--- 193
           + +G+ +L S     +HRDL   N  ++     VK+ D GLA  M      SV       
Sbjct: 143 VAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMLDKEFDSVHNKTGAK 199
Query: 194 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
              ++MA E L  +++    D++SFG+ + E++T   P
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 117/257 (45%), Gaps = 28/257 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + +GKG F  V  G  +  G +VA   +  +   Q+        +E  ++  L+H N+++
Sbjct: 27  QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQ 78
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV-DMKAIKNWARQILRGLHYLHSHN 148
                V++    + ++TE    GSL  Y R + ++V     +  ++  +   + YL  +N
Sbjct: 79  LLGVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEY 205
              +HRDL   N+ V+ +N   K+ D GL       Q T +  +   ++ APE L E+++
Sbjct: 138 --FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKF 191
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQVKQFI 262
           +   D++SFG+ + E+    Y +     P    K V   ++        D   P V + +
Sbjct: 192 STKSDVWSFGILLWEI----YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 247
Query: 263 EKCI-VPASLRLPALEL 278
           + C  + A++R   L+L
Sbjct: 248 KNCWHLDAAMRPSFLQL 264

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 106/230 (46%), Gaps = 28/230 (12%)
Query: 7   FTKSETEEGEFSEKDPSCRYG--------RYDEILGKGAFKTVYKGFDEVDGIEVAWNQV 58
             K +  EG  + +D   R G        +  + +GKG F  V  G  +  G +VA   +
Sbjct: 167 LIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCI 224
Query: 59  NIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY 118
             +   Q+        +E  ++  L+H N+++     V++    + ++TE    GSL  Y
Sbjct: 225 KNDATAQA------FLAEASVMTQLRHSNLVQLLGVIVEEKG-GLYIVTEYMAKGSLVDY 277
Query: 119 -RKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
            R + ++V     +  ++  +   + YL  +N   +HRDL   N+ V+ +N   K+ D G
Sbjct: 278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VAKVSDFG 334
Query: 177 LA--IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           L       Q T +  +   ++ APE L E++++   D++SFG+ + E+ +
Sbjct: 335 LTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 117/256 (45%), Gaps = 26/256 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + +GKG F  V  G  +  G +VA   +  +   Q+        +E  ++  L+H N+++
Sbjct: 12  QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQ 63
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV-DMKAIKNWARQILRGLHYLHSHN 148
                V++    + ++TE    GSL  Y R + ++V     +  ++  +   + YL  +N
Sbjct: 64  LLGVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 122
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-EFMAPE-LYEEEYN 206
              +HRDL   N+ V+ +N   K+ D GL    +  + +     P ++ APE L E++++
Sbjct: 123 --FVHRDLAARNVLVSEDN-VAKVSDFGL--TKEASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQVKQFIE 263
              D++SFG+ + E+    Y +     P    K V   ++        D   P V + ++
Sbjct: 178 TKSDVWSFGILLWEI----YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 233
Query: 264 KCI-VPASLRLPALEL 278
            C  + A++R   L+L
Sbjct: 234 NCWHLDAAMRPSFLQL 249

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQP-TARSVIG 191
           +QIL G++YLH +N  I+H DLK  NI ++     G++KI D G++  +      R ++G
Sbjct: 138 KQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG 195
Query: 192 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPY 228
           TPE++APE+   +      D+++ G+    ++T   P+
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           +++ + ++ DD  R + M+ E    G L      + +V  K  + +  +++  L  +HS 
Sbjct: 131 VVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM 187
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYEEE 204
               IHRD+K DN+ ++  +G +K+ D G  + M +       + +GTP++++PE+ + +
Sbjct: 188 G--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244
Query: 205 -----YNELVDIYSFGMCILEMVTCEYPY 228
                Y    D +S G+ + EM+  + P+
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           +++ + ++ DD  R + M+ E    G L      + +V  K  + +  +++  L  +HS 
Sbjct: 136 VVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM 192
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYEEE 204
               IHRD+K DN+ ++  +G +K+ D G  + M +       + +GTP++++PE+ + +
Sbjct: 193 G--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 249
Query: 205 -----YNELVDIYSFGMCILEMVTCEYPY 228
                Y    D +S G+ + EM+  + P+
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+ LG G F TV KG+ ++  +        +++    P   + L +E ++++ L +  I+
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 90  KFYN-----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           +        SW+        ++ E+   G L +Y +++++V  K I     Q+  G+ YL
Sbjct: 434 RMIGICEAESWM--------LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 485
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE 199
              N   +HRDL   N+ +   +   KI D GL+  ++       A++    P ++ APE
Sbjct: 486 EESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 542
Query: 200 -LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKN 233
            +   +++   D++SFG+ + E  +  + PY   K 
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           +++ + ++ DD  R + M+ E    G L      + +V  K  + +  +++  L  +HS 
Sbjct: 136 VVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM 192
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYEEE 204
               IHRD+K DN+ ++  +G +K+ D G  + M +       + +GTP++++PE+ + +
Sbjct: 193 G--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 249
Query: 205 -----YNELVDIYSFGMCILEMVTCEYPY 228
                Y    D +S G+ + EM+  + P+
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 115/257 (44%), Gaps = 28/257 (10%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + +GKG F  V  G  +  G +VA   +  +   Q+        +E  ++  L+H N+++
Sbjct: 18  QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQ 69
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV-DMKAIKNWARQILRGLHYLHSHN 148
                V++    + ++TE    GSL  Y R + ++V     +  ++  +   + YL  +N
Sbjct: 70  LLGVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 128
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEY 205
              +HRDL   N+ V+ +N   K+ D GL       Q T +  +   ++ APE L E  +
Sbjct: 129 --FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREAAF 182
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQVKQFI 262
           +   D++SFG+ + E+    Y +     P    K V   ++        D   P V + +
Sbjct: 183 STKSDVWSFGILLWEI----YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 238
Query: 263 EKCI-VPASLRLPALEL 278
           + C  + A++R   L+L
Sbjct: 239 KNCWHLDAAMRPSFLQL 255

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+ LG G F TV KG+ ++  +        +++    P   + L +E ++++ L +  I+
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 90  KFYN-----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           +        SW+        ++ E+   G L +Y +++++V  K I     Q+  G+ YL
Sbjct: 435 RMIGICEAESWM--------LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 486
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE 199
              N   +HRDL   N+ +   +   KI D GL+  ++       A++    P ++ APE
Sbjct: 487 EESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 543
Query: 200 -LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKN 233
            +   +++   D++SFG+ + E  +  + PY   K 
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 579

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 71/139 (51%), Gaps = 14/139 (10%)
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS--VIGTPEFMAPELYEE 203
           H    +HRD+K DN+ ++  NG +++ D G  + M    T +S   +GTP++++PE+ + 
Sbjct: 208 HQLHYVHRDIKPDNVLLD-VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 266
Query: 204 ------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-SKVTD- 255
                 +Y    D +S G+C+ EM+  E P+   ++  + Y K+ +  +     S VTD 
Sbjct: 267 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHEERFQFPSHVTDV 325
Query: 256 -PQVKQFIEKCIVPASLRL 273
             + K  I++ I     RL
Sbjct: 326 SEEAKDLIQRLICSRERRL 344

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQV--NIED-----VMQSPDQLERLYSEVHLLKSL 83
             +  G++  V  G D  +GI VA  +V   + D     ++      +R+  E+ LL   
Sbjct: 28  RFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 84  KHENIIKFYNSWV---DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
            H NI+   + +V   +     + ++TEL  +   +    +   +  + I+ +   IL G
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS----VIGTPEFM 196
           LH LH     ++HRDL   NI +  NN ++ I D  LA   ++ TA +     +    + 
Sbjct: 147 LHVLHE--AGVVHRDLHPGNILLADNN-DITICDFNLA---REDTADANKTHYVTHRWYR 200
Query: 197 APELYEE--EYNELVDIYSFGMCILEM 221
           APEL  +   + +LVD++S G  + EM
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 71/139 (51%), Gaps = 14/139 (10%)
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS--VIGTPEFMAPELYEE 203
           H    +HRD+K DN+ ++  NG +++ D G  + M    T +S   +GTP++++PE+ + 
Sbjct: 192 HQLHYVHRDIKPDNVLLD-VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 250
Query: 204 ------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-SKVTD- 255
                 +Y    D +S G+C+ EM+  E P+   ++  + Y K+ +  +     S VTD 
Sbjct: 251 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHEERFQFPSHVTDV 309
Query: 256 -PQVKQFIEKCIVPASLRL 273
             + K  I++ I     RL
Sbjct: 310 SEEAKDLIQRLICSRERRL 328

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQV--NIED-----VMQSPDQLERLYSEVHLLKSL 83
             +  G++  V  G D  +GI VA  +V   + D     ++      +R+  E+ LL   
Sbjct: 28  RFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 84  KHENIIKFYNSWV---DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
            H NI+   + +V   +     + ++TEL  +   +    +   +  + I+ +   IL G
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS----VIGTPEFM 196
           LH LH     ++HRDL   NI +  NN ++ I D  LA   ++ TA +     +    + 
Sbjct: 147 LHVLHE--AGVVHRDLHPGNILLADNN-DITICDFNLA---REDTADANKTHYVTHRWYR 200
Query: 197 APELYEE--EYNELVDIYSFGMCILEM 221
           APEL  +   + +LVD++S G  + EM
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 20  KDPSCRYGRYDEILGKGAFKTVYKG--FDEVDGIEVAWNQV-NIEDVMQSPDQLERLYSE 76
           K+ S    R+ E LG+  F  VYKG  F    G +     +  ++D  + P + E    E
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHE 62
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNV----DMKA 129
             L   L+H N++      V   ++ ++MI    + G L ++   R  H +V    D + 
Sbjct: 63  AMLRARLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 130 IK---------NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
           +K         +   QI  G+ YL SH+  ++H+DL   N+ V  +   VKI DLGL   
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY-DKLNVKISDLGLFRE 177
Query: 181 MQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           +       ++G       +MAPE +   +++   DI+S+G+ + E+ +
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 109/260 (41%), Gaps = 39/260 (15%)
Query: 33  LGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           LG+GAF  V+         E D + VA     +++  +S  Q      E  LL  L+H++
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQ--DFQREAELLTMLQHQH 81
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------KNVDMKAIKN 132
           I++F+   V    R + M+ E    G L ++ + H                 + +  +  
Sbjct: 82  IVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 139
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
            A Q+  G+ YL   +   +HRDL   N  V G    VKIGD G++  +       V G 
Sbjct: 140 VASQVAAGMVYLAGLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRVGGR 196
Query: 193 P----EFMAPE--LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 245
                 +M PE  LY +   E  D++SFG+ + E+ T  + P+ +  N   I   +T G 
Sbjct: 197 TMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-DCITQG- 253
Query: 246 KPASLSKVTDPQVKQFIEKC 265
           +     +   P+V   +  C
Sbjct: 254 RELERPRACPPEVYAIMRGC 273

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 20  KDPSCRYGRYDEILGKGAFKTVYKG--FDEVDGIEVAWNQV-NIEDVMQSPDQLERLYSE 76
           K+ S    R+ E LG+  F  VYKG  F    G +     +  ++D  + P + E    E
Sbjct: 21  KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHE 79
Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNV----DMKA 129
             L   L+H N++      V   ++ ++MI    + G L ++   R  H +V    D + 
Sbjct: 80  AMLRARLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 130 IK---------NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
           +K         +   QI  G+ YL SH+  ++H+DL   N+ V  +   VKI DLGL   
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY-DKLNVKISDLGLFRE 194
Query: 181 MQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
           +       ++G       +MAPE +   +++   DI+S+G+ + E+ +
Sbjct: 195 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 109/260 (41%), Gaps = 39/260 (15%)
Query: 33  LGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           LG+GAF  V+         E D + VA     +++  +S  Q      E  LL  L+H++
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQ--DFQREAELLTMLQHQH 75
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------KNVDMKAIKN 132
           I++F+   V    R + M+ E    G L ++ + H                 + +  +  
Sbjct: 76  IVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 133
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
            A Q+  G+ YL   +   +HRDL   N  V G    VKIGD G++  +       V G 
Sbjct: 134 VASQVAAGMVYLAGLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRVGGR 190
Query: 193 P----EFMAPE--LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 245
                 +M PE  LY +   E  D++SFG+ + E+ T  + P+ +  N   I   +T G 
Sbjct: 191 TMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-DCITQG- 247
Query: 246 KPASLSKVTDPQVKQFIEKC 265
           +     +   P+V   +  C
Sbjct: 248 RELERPRACPPEVYAIMRGC 267

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 109/260 (41%), Gaps = 39/260 (15%)
Query: 33  LGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           LG+GAF  V+         E D + VA     +++  +S  Q      E  LL  L+H++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQ--DFQREAELLTMLQHQH 104
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------KNVDMKAIKN 132
           I++F+   V    R + M+ E    G L ++ + H                 + +  +  
Sbjct: 105 IVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
            A Q+  G+ YL   +   +HRDL   N  V G    VKIGD G++  +       V G 
Sbjct: 163 VASQVAAGMVYLAGLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRVGGR 219
Query: 193 P----EFMAPE--LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 245
                 +M PE  LY +   E  D++SFG+ + E+ T  + P+ +  N   I   +T G 
Sbjct: 220 TMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-DCITQG- 276
Query: 246 KPASLSKVTDPQVKQFIEKC 265
           +     +   P+V   +  C
Sbjct: 277 RELERPRACPPEVYAIMRGC 296

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 12/135 (8%)
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILR----GLHYLHSHNPPIIHRD 155
            R + +I E    G L  + +  +  D    +  A +I+R     + +LHSHN  I HRD
Sbjct: 79  KRCLLIIMECMEGGEL--FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRD 134
Query: 156 LKCDNIFVNGN--NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIY 212
           +K +N+       +  +K+ D G A    Q   ++   TP ++APE L  E+Y++  D++
Sbjct: 135 VKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMW 194
Query: 213 SFGMCILEMVTCEYP 227
           S G+ I+ ++ C +P
Sbjct: 195 SLGV-IMYILLCGFP 208

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 12/135 (8%)
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILR----GLHYLHSHNPPIIHRD 155
            R + +I E    G L  + +  +  D    +  A +I+R     + +LHSHN  I HRD
Sbjct: 98  KRCLLIIMECMEGGEL--FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRD 153
Query: 156 LKCDNIFVNGN--NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIY 212
           +K +N+       +  +K+ D G A    Q   ++   TP ++APE L  E+Y++  D++
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMW 213
Query: 213 SFGMCILEMVTCEYP 227
           S G+ I+ ++ C +P
Sbjct: 214 SLGV-IMYILLCGFP 227

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+ LG G F TV KG+ ++  +        +++    P   + L +E ++++ L +  I+
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 90  KFYN-----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           +        SW+        ++ E+   G L +Y +++++V  K I     Q+  G+ YL
Sbjct: 90  RMIGICEAESWM--------LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 141
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE 199
              N   +HRDL   N+ +   +   KI D GL+  ++       A++    P ++ APE
Sbjct: 142 EESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 198
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECK 232
            +   +++   D++SFG+ + E  +  + PY   K
Sbjct: 199 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 233

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+ LG G F TV KG+ ++  +        +++    P   + L +E ++++ L +  I+
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 90  KFYN-----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           +        SW+        ++ E+   G L +Y +++++V  K I     Q+  G+ YL
Sbjct: 92  RMIGICEAESWM--------LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 143
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE 199
              N   +HRDL   N+ +   +   KI D GL+  ++       A++    P ++ APE
Sbjct: 144 EESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECK 232
            +   +++   D++SFG+ + E  +  + PY   K
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 235

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+ LG G F TV KG+ ++  +        +++    P   + L +E ++++ L +  I+
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 90  KFYN-----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           +        SW+        ++ E+   G L +Y +++++V  K I     Q+  G+ YL
Sbjct: 92  RMIGICEAESWM--------LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 143
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE 199
              N   +HRDL   N+ +   +   KI D GL+  ++       A++    P ++ APE
Sbjct: 144 EESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECK 232
            +   +++   D++SFG+ + E  +  + PY   K
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 235

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 37/221 (16%)
Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           ++G+G++  VY  +D+     VA  +VN   ED++      +R+  E+ +L  LK + II
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC----KRILREITILNRLKSDYII 88
Query: 90  KFYNSWV-DDTNRTINMITELFTSGS-LRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           + Y+  + DD  +   +   L  + S L++  K    +  + IK     +L G +++H  
Sbjct: 89  RLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES 148
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE------------- 194
              IIHRDLK  N  +N  +  VK+ D GLA  +      +++   E             
Sbjct: 149 G--IIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 195 -----------FMAPE--LYEEEYNELVDIYSFGMCILEMV 222
                      + APE  L +E Y + +DI+S G    E++
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+ LG G F TV KG+ ++  +        +++    P   + L +E ++++ L +  I+
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 90  KFYN-----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           +        SW+        ++ E+   G L +Y +++++V  K I     Q+  G+ YL
Sbjct: 76  RMIGICEAESWM--------LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 127
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE 199
              N   +HRDL   N+ +   +   KI D GL+  ++       A++    P ++ APE
Sbjct: 128 EESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE 184
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECK 232
            +   +++   D++SFG+ + E  +  + PY   K
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 219

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 45/310 (14%)
Query: 26  YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE-RLYSEVHLLKSLK 84
           Y   +++LG+GA   V    + +   E A     ++ + + P  +  R++ EV +L   +
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYA-----VKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
               +     + ++ +R   ++ E    GS+  +  K ++ +        + +   L +L
Sbjct: 69  GHRNVLELIEFFEEEDR-FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 145 HSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQ---------QPTARSVIGTP 193
           H  N  I HRDLK +NI     N    VKI D GL   ++          P   +  G+ 
Sbjct: 128 H--NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 194 EFMAPELYE---EE---YNELVDIYSFGMCILEMVTCEYP--YNECKN----------PA 235
           E+MAPE+ E   EE   Y++  D++S G+ IL ++   YP     C +          PA
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGV-ILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 236 ---QIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289
               +++ +  G    P           K  I K +V  A  RL A ++L+ P++    P
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304
Query: 290 KDLVCDPLRL 299
           ++ +  P+ L
Sbjct: 305 ENTLPTPMVL 314

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+ LG G F TV KG+ ++  +        +++    P   + L +E ++++ L +  I+
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 90  KFYN-----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           +        SW+        ++ E+   G L +Y +++++V  K I     Q+  G+ YL
Sbjct: 76  RMIGICEAESWM--------LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 127
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE 199
              N   +HRDL   N+ +   +   KI D GL+  ++       A++    P ++ APE
Sbjct: 128 EESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 184
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECK 232
            +   +++   D++SFG+ + E  +  + PY   K
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 219

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+ LG G F TV KG+ ++  +        +++    P   + L +E ++++ L +  I+
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 90  KFYN-----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           +        SW+        ++ E+   G L +Y +++++V  K I     Q+  G+ YL
Sbjct: 70  RMIGICEAESWM--------LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 121
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE 199
              N   +HRDL   N+ +   +   KI D GL+  ++       A++    P ++ APE
Sbjct: 122 EESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 178
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECK 232
            +   +++   D++SFG+ + E  +  + PY   K
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 213

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+ LG G F TV KG+ ++  +        +++    P   + L +E ++++ L +  I+
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 90  KFYN-----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           +        SW+        ++ E+   G L +Y +++++V  K I     Q+  G+ YL
Sbjct: 82  RMIGICEAESWM--------LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE 199
              N   +HRDL   N+ +   +   KI D GL+  ++       A++    P ++ APE
Sbjct: 134 EESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECK 232
            +   +++   D++SFG+ + E  +  + PY   K
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           D+ LG G F TV KG+ ++  +        +++    P   + L +E ++++ L +  I+
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 90  KFYN-----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           +        SW+        ++ E+   G L +Y +++++V  K I     Q+  G+ YL
Sbjct: 72  RMIGICEAESWM--------LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 123
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE 199
              N   +HRDL   N+ +   +   KI D GL+  ++       A++    P ++ APE
Sbjct: 124 EESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECK 232
            +   +++   D++SFG+ + E  +  + PY   K
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 202
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 231
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPY 228
             +     ++S G+ + +MV  + P+
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 109/247 (44%), Gaps = 47/247 (19%)
Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY+   ++G G++  V + +D+++   VA  +  I  V +     +R+  E+ +L  L H
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK--ILRVFEDLIDCKRILREIAILNRLNH 111
Query: 86  ENIIKFYNSWV-DDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           ++++K  +  +  D  +   + ++ E+  S   + +R      ++  IK     +L G+ 
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELH-IKTLLYNLLVGVK 170
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----------------- 185
           Y+HS    I+HRDLK  N  VN  +  VK+ D GLA  +  P                  
Sbjct: 171 YVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 186 ---------ARSVIG---TPEFMAPE--LYEEEYNELVDIYSFGMCI----LEMVTCEYP 227
                     R + G   T  + APE  L +E Y E +D++S G CI    L M+     
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKENVA 286
Query: 228 YNECKNP 234
           Y+  + P
Sbjct: 287 YHADRGP 293

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKF 91
           LG+G +  V+      + I +  N+  +  +++ P +  ++  E+ +L++L+   NII  
Sbjct: 45  LGRGKYSEVF------EAINITNNEKVVVKILK-PVKKNKIKREIKILENLRGGPNIITL 97
Query: 92  YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
            +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS    I
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMG--I 152
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EEEYNEL 208
           +HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    + Y+  
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 212
Query: 209 VDIYSFGMCILEMVTCEYPY 228
           +D++S G  +  M+  + P+
Sbjct: 213 LDMWSLGCMLASMIFRKEPF 232

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/264 (21%), Positives = 118/264 (44%), Gaps = 34/264 (12%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAW-NQVNIEDVMQSPDQLER-----LYSEVHLLKSLK 84
           +++G+GAF        EV  +++    QV    +M   D L+R        E  +L +  
Sbjct: 67  KVIGRGAFS-------EVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD 119
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHY 143
              I + + ++ D+    + ++ E +  G L     K  + +  +  + +  +I+  +  
Sbjct: 120 RRWITQLHFAFQDENY--LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSV--IGTPEFMAPEL 200
           +H      +HRD+K DNI ++   G +++ D G  + ++   T RS+  +GTP++++PE+
Sbjct: 178 VHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 201 YEEEYNELV--------DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
            +               D ++ G+   EM   + P+    + A+ Y K+    +  SL  
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY-ADSTAETYGKIVHYKEHLSLPL 293
Query: 253 VTD---PQVKQFIEKCIVPASLRL 273
           V +    + + FI++ + P   RL
Sbjct: 294 VDEGVPEEARDFIQRLLCPPETRL 317

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 107/241 (44%), Gaps = 24/241 (9%)
Query: 32  ILGKGA--FKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           ++GKG     TV     +  G  V   ++N+E    S + +  L  E+H+ K   H NI+
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIV 73
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH 147
            +  +++ D    + ++T     GS +     H    ++  AI    + +L+ L Y+H  
Sbjct: 74  PYRATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM 131
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDL--GLAIVMQQPTARSVIGTPEF-------MAP 198
               +HR +K  +I ++  +G+V +  L   L+++      R V   P++       ++P
Sbjct: 132 G--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 188
Query: 199 ELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
           E+ ++    Y+   DIYS G+   E+     P+ +      + +K+ +G  P  L   T 
Sbjct: 189 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLLDTSTI 247
Query: 256 P 256
           P
Sbjct: 248 P 248

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 98/257 (38%), Gaps = 40/257 (15%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +G+G F  V+ G    D   VA   V        PD   +   E  +LK   H NI++
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVA---VKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
                V    + I ++ EL   G    + R +   + +K +         G+ YL S   
Sbjct: 177 LIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEEE 204
             IHRDL   N  V   N  +KI D G++         +  G  +    + APE L    
Sbjct: 234 -CIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
           Y+   D++SFG+ + E                     T  +  +    +++ Q ++F+EK
Sbjct: 292 YSSESDVWSFGILLWE---------------------TFSLGASPYPNLSNQQTREFVEK 330
Query: 265 CIVPASLRLPALELLKD 281
                  RLP  EL  D
Sbjct: 331 -----GGRLPCPELCPD 342

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 107/241 (44%), Gaps = 24/241 (9%)
Query: 32  ILGKGA--FKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           ++GKG     TV     +  G  V   ++N+E    S + +  L  E+H+ K   H NI+
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIV 89
Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH 147
            +  +++ D    + ++T     GS +     H    ++  AI    + +L+ L Y+H  
Sbjct: 90  PYRATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM 147
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDL--GLAIVMQQPTARSVIGTPEF-------MAP 198
               +HR +K  +I ++  +G+V +  L   L+++      R V   P++       ++P
Sbjct: 148 G--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 199 ELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
           E+ ++    Y+   DIYS G+   E+     P+ +      + +K+ +G  P  L   T 
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLLDTSTI 263
Query: 256 P 256
           P
Sbjct: 264 P 264

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 99/259 (38%), Gaps = 44/259 (16%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +G+G F  V+ G    D   VA   V        PD   +   E  +LK   H NI++
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVA---VKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
                V    + I ++ EL   G    + R +   + +K +         G+ YL S   
Sbjct: 177 LIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA------IVMQQPTARSVIGTPEFMAPE-LYE 202
             IHRDL   N  V   N  +KI D G++      +       R V    ++ APE L  
Sbjct: 234 -CIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEALNY 289
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
             Y+   D++SFG+ + E                     T  +  +    +++ Q ++F+
Sbjct: 290 GRYSSESDVWSFGILLWE---------------------TFSLGASPYPNLSNQQTREFV 328
Query: 263 EKCIVPASLRLPALELLKD 281
           EK       RLP  EL  D
Sbjct: 329 EK-----GGRLPCPELCPD 342

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/207 (20%), Positives = 86/207 (41%), Gaps = 13/207 (6%)
Query: 80  LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQI 137
           L+   H N++    +          +IT     GSL     +  N  VD      +A  +
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTARSVIGTPEFM 196
            RG+ +LH+  P I    L   ++ ++ +    + + D+  +   Q P     +  P ++
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF--QSP---GRMYAPAWV 175
Query: 197 APELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
           APE      E+      D++SF + + E+VT E P+ +  N     K    G++P ++  
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-TIPP 234
Query: 253 VTDPQVKQFIEKCIVPASLRLPALELL 279
              P V + ++ C+     + P  +++
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMI 261

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK----------- 81
           LG G F TV+   D V+   VA   V  + V       E    E+ LL+           
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-----EAAEDEIKLLQRVNDADNTKED 81
Query: 82  SLKHENIIKFYNSWVDDTNRTIN--MITELFTSGSLRQYRK-KHKNVDMKAIKNWARQIL 138
           S+   +I+K  + +       ++  M+ E+     L   +K +H+ + +  +K  ++Q+L
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVN-----GNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
            GL Y+H     IIH D+K +N+ +       N  ++KI DLG A    +    S I T 
Sbjct: 142 LGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS-IQTR 199
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 228
           E+ +PE L    +    DI+S    I E++T ++ +
Sbjct: 200 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY+  +++GKG+F  V K +D      VA   V  E          +   E+ +L+ L+ 
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH-----RQAAEEIRILEHLRK 152
Query: 86  E------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQIL 138
           +      N+I    ++    +  I M  EL +       +K K +   +  ++ +A  IL
Sbjct: 153 QDKDNTMNVIHMLENFTFRNH--ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 196
           + L  LH +   IIH DLK +NI +   G +G +K+ D G +    Q    + I +  + 
Sbjct: 211 QCLDALHKNR--IIHCDLKPENILLKQQGRSG-IKVIDFGSSCYEHQ-RVYTXIQSRFYR 266
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
           APE +    Y   +D++S G CIL  +   YP
Sbjct: 267 APEVILGARYGMPIDMWSLG-CILAELLTGYP 297

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK----------- 81
           LG G F TV+   D V+   VA   V  + V     +      E+ LL+           
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE-----DEIKLLQRVNDADNTKED 81
Query: 82  SLKHENIIKFYNSWVDDTNRTIN--MITELFTSGSLRQYRK-KHKNVDMKAIKNWARQIL 138
           S+   +I+K  + +       ++  M+ E+     L   +K +H+ + +  +K  ++Q+L
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVN-----GNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
            GL Y+H     IIH D+K +N+ +       N  ++KI DLG A    +    S I T 
Sbjct: 142 LGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS-IQTR 199
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 228
           E+ +PE L    +    DI+S    I E++T ++ +
Sbjct: 200 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY+  +++GKG+F  V K +D      VA   V  E          +   E+ +L+ L+ 
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH-----RQAAEEIRILEHLRK 152
Query: 86  E------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQIL 138
           +      N+I    ++    +  I M  EL +       +K K +   +  ++ +A  IL
Sbjct: 153 QDKDNTMNVIHMLENFTFRNH--ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 196
           + L  LH +   IIH DLK +NI +   G +G +K+ D G +    Q    + I +  + 
Sbjct: 211 QCLDALHKNR--IIHCDLKPENILLKQQGRSG-IKVIDFGSSCYEHQ-RVYTXIQSRFYR 266
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
           APE +    Y   +D++S G CIL  +   YP
Sbjct: 267 APEVILGARYGMPIDMWSLG-CILAELLTGYP 297

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVN-IEDVMQSPDQLERLYSE-----VHLLKS 82
           ++E LG+G F  ++KG     G    + Q++  E +++  D+  R YSE       ++  
Sbjct: 12  FNESLGQGTFTKIFKGVRREVG---DYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 83  LKHENIIKFYNSWV-DDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRG 140
           L H++++  Y   V  D N    ++ E    GSL  Y KK+KN +++      A+Q+   
Sbjct: 69  LSHKHLVLNYGVCVCGDENI---LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125
Query: 141 LHYLHSHNPPIIHRDLKCDNIFV-------NGNNGEVKIGDLGLAI-VMQQPTARSVIGT 192
           +H+L  +   +IH ++   NI +        GN   +K+ D G++I V+ +   +  I  
Sbjct: 126 MHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI-- 181
Query: 193 PEFMAPELYE--EEYNELVDIYSFGMCILEMVT 223
             ++ PE  E  +  N   D +SFG  + E+ +
Sbjct: 182 -PWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 76/155 (49%), Gaps = 26/155 (16%)
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
           + M+ + +++ Q+ RG+ +L S     IHRDL   NI ++ NN  VKI D GL       
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSRK--CIHRDLAARNILLSENN-VVKICDFGL------- 245
Query: 185 TARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNE 230
            AR +   P++            MAPE ++++ Y+   D++S+G+ + E+ +    PY  
Sbjct: 246 -ARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPG 304
Query: 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
            +       ++  G++  +  + + P++ Q +  C
Sbjct: 305 VQMDEDFCSRLREGMRMRA-PEYSTPEIYQIMLDC 338

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NIIK  ++  D  ++T  ++ E   +   +Q  +   + D   I+ +  ++L+ L Y HS
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFD---IRFYMYELLKALDYCHS 150
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++    ++++ D GLA         +V + +  F  PEL    +
Sbjct: 151 KG--IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQ 208
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+    P+
Sbjct: 209 MYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q R+   + D   I+ +  +IL+ L Y HS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLRQTLTDYD---IRFYMYEILKALDYCHS 149
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 150 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 74/310 (23%), Positives = 132/310 (42%), Gaps = 45/310 (14%)
Query: 26  YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE-RLYSEVHLLKSLK 84
           Y   +++LG+GA   V    + +   E A     ++ + + P  +  R++ EV +L   +
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYA-----VKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
               +     + ++ +R   ++ E    GS+  +  K ++ +        + +   L +L
Sbjct: 69  GHRNVLELIEFFEEEDR-FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 145 HSHNPPIIHRDLKCDNIFVNGNN--GEVKIG--DLGLAIVM-------QQPTARSVIGTP 193
           H  N  I HRDLK +NI     N    VKI   DLG  I +         P   +  G+ 
Sbjct: 128 H--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 194 EFMAPELYE---EE---YNELVDIYSFGMCILEMVTCEYP--YNECKN----------PA 235
           E+MAPE+ E   EE   Y++  D++S G+ IL ++   YP     C +          PA
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGV-ILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 236 ---QIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289
               +++ +  G    P           K  I K +V  A  RL A ++L+ P++    P
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304
Query: 290 KDLVCDPLRL 299
           ++ +  P+ L
Sbjct: 305 ENTLPTPMVL 314

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NIIK  ++  D  ++T  ++ E   +   +Q  +   + D   I+ +  ++L+ L Y HS
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFD---IRFYMYELLKALDYCHS 155
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++    ++++ D GLA         +V + +  F  PEL    +
Sbjct: 156 KG--IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQ 213
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+    P+
Sbjct: 214 MYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY+  +++GKG F  V K +D      VA   V  E          +   E+ +L+ L+ 
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFH-----RQAAEEIRILEHLRK 152
Query: 86  E------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQIL 138
           +      N+I    ++    +  I M  EL +       +K K +   +  ++ +A  IL
Sbjct: 153 QDKDNTMNVIHMLENFTFRNH--ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 196
           + L  LH +   IIH DLK +NI +   G +G +K+ D G +    Q      I +  + 
Sbjct: 211 QCLDALHKNR--IIHCDLKPENILLKQQGRSG-IKVIDFGSSCYEHQ-RVYXXIQSRFYR 266
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
           APE +    Y   +D++S G CIL  +   YP
Sbjct: 267 APEVILGARYGMPIDMWSLG-CILAELLTGYP 297

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 124/273 (45%), Gaps = 29/273 (10%)
Query: 26  YGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
           Y +Y   E LG+G F  V++  +           V +    +  DQ+  +  E+ +L   
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQV-LVKKEISILNIA 58
Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSG--SLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +H NI+  + S+  ++   + MI E F SG     +       ++ + I ++  Q+   L
Sbjct: 59  RHRNILHLHESF--ESMEELVMIFE-FISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 142 HYLHSHNPPIIHRDLKCDN-IFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPE 199
            +LHSHN  I H D++ +N I+    +  +KI + G A  ++     R +   PE+ APE
Sbjct: 116 QFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173
Query: 200 LYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS------K 252
           +++ +  +   D++S G  +  +++   P+      A+  +++   I  A  +      K
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPF-----LAETNQQIIENIMNAEYTFDEEAFK 228
Query: 253 VTDPQVKQFIEKCIVPA-SLRLPALELLKDPFL 284
               +   F+++ +V     R+ A E L+ P+L
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVN-IEDVMQSPDQLERLYSE-----VHLLKS 82
           ++E LG+G F  ++KG     G    + Q++  E +++  D+  R YSE       ++  
Sbjct: 12  FNESLGQGTFTKIFKGVRREVG---DYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 83  LKHENIIKFYN-SWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRG 140
           L H++++  Y   +  D N    ++ E    GSL  Y KK+KN +++      A+Q+   
Sbjct: 69  LSHKHLVLNYGVCFCGDENI---LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA 125
Query: 141 LHYLHSHNPPIIHRDLKCDNIFV-------NGNNGEVKIGDLGLAI-VMQQPTARSVIGT 192
           +H+L  +   +IH ++   NI +        GN   +K+ D G++I V+ +   +  I  
Sbjct: 126 MHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI-- 181
Query: 193 PEFMAPELYE--EEYNELVDIYSFGMCILEMVT 223
             ++ PE  E  +  N   D +SFG  + E+ +
Sbjct: 182 -PWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE- 86
           ++ +++G+G F  V K   + DG+ +      +++   S D       E+ +L  L H  
Sbjct: 18  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHP 76
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK---AIKN----------- 132
           NII    +   +    + +  E    G+L  + +K + ++     AI N           
Sbjct: 77  NIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 133 --WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
             +A  + RG+ YL       IHRDL   NI V G N   KI D GL+   +    +++ 
Sbjct: 135 LHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMG 191
Query: 191 GTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNP-AQIYKKVTSGIK 246
             P  +MA E L    Y    D++S+G+ + E+V+    PY  C    A++Y+K+  G +
Sbjct: 192 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYR 249

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTIN----MITELFTSGSLRQYRKKHKNVDMKAIKNW 133
             L  + H +I++ +N +V+ T+R  +    ++ E     SL+  R K + + +     +
Sbjct: 131 QFLAEVVHPSIVQIFN-FVEHTDRHGDPVGYIVMEYVGGQSLK--RSKGQKLPVAEAIAY 187
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             +IL  L YLHS    +++ DLK +NI +     ++K+ DLG   V +  +   + GTP
Sbjct: 188 LLEILPALSYLHSIG--LVYNDLKPENIMLTEE--QLKLIDLG--AVSRINSFGYLYGTP 241
Query: 194 EFMAPELYEEEYNELVDIYSFGMCILEMVTCEYP 227
            F APE+         DIY+ G   L  +T + P
Sbjct: 242 GFQAPEIVRTGPTVATDIYTVGRT-LAALTLDLP 274

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE- 86
           ++ +++G+G F  V K   + DG+ +      +++   S D       E+ +L  L H  
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHP 86
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK---AIKN----------- 132
           NII    +   +    + +  E    G+L  + +K + ++     AI N           
Sbjct: 87  NIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 133 --WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
             +A  + RG+ YL       IHRDL   NI V G N   KI D GL+   +    +++ 
Sbjct: 145 LHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMG 201
Query: 191 GTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNP-AQIYKKVTSGIK 246
             P  +MA E L    Y    D++S+G+ + E+V+    PY  C    A++Y+K+  G +
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYR 259

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHS 149
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 150 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 40/225 (17%)
Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLKHENI 88
            ++G+G++  VY  +D+     VA  +VN   ED++      +R+  E+ +L  LK + I
Sbjct: 34  HLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDC----KRILREITILNRLKSDYI 89
Query: 89  IKFYNSWV-DDTNRTINMITELFTSGS-LRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           I+ ++  + +D  +   +   L  + S L++  K    +  + +K     +L G  ++H 
Sbjct: 90  IRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHE 149
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ------------------------ 182
               IIHRDLK  N  +N  +  VKI D GLA  +                         
Sbjct: 150 SG--IIHRDLKPANCLLN-QDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 183 ---QPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMV 222
              +    S + T  + APE  L +E Y   +DI+S G    E++
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHS 149
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 150 MG--IMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHS 149
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 150 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHS 148
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 149 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS
Sbjct: 98  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHS 154
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 155 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHS 149
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 150 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHS 149
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 150 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHS 149
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 150 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHS 149
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 150 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHS 149
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 150 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHS 147
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 148 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHS 148
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 149 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y HS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHS 149
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EE 203
               I+HRD+K  N+ ++  + ++++ D GLA         +V + +  F  PEL    +
Sbjct: 150 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
            Y+  +D++S G  +  M+  + P+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE- 86
           ++ +++G+G F  V K   + DG+ +      +++   S D       E+ +L  L H  
Sbjct: 25  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHP 83
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK---AIKN----------- 132
           NII    +   +    + +  E    G+L  + +K + ++     AI N           
Sbjct: 84  NIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 133 --WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
             +A  + RG+ YL       IHR+L   NI V G N   KI D GL+   +    +++ 
Sbjct: 142 LHFAADVARGMDYLSQKQ--FIHRNLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMG 198
Query: 191 GTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNP-AQIYKKVTSGIK 246
             P  +MA E L    Y    D++S+G+ + E+V+    PY  C    A++Y+K+  G +
Sbjct: 199 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYR 256

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 107/239 (44%), Gaps = 54/239 (22%)
Query: 30  DEILGKGAFKTV-YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHEN 87
           ++ILG G+  TV ++G     G  VA  ++ I       D  +    E+ LL +S  H N
Sbjct: 20  EKILGYGSSGTVVFQG--SFQGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPN 70
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--------NWARQILR 139
           +I++Y S  + T+R + +  EL       Q   + KNV  + +K        +  RQI  
Sbjct: 71  VIRYYCS--ETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVN------------GNNGEVKIGDLGLAIVMQ--QPT 185
           G+ +LHS    IIHRDLK  NI V+              N  + I D GL   +   Q +
Sbjct: 127 GVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 186 ARSVI----GTPEFMAPELYEEEYN--------ELVDIYSFGMCILEMVTC--EYPYNE 230
            R+ +    GT  + APEL EE  N          +DI+S G C+   +    ++P+ +
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHPFGD 242

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/192 (21%), Positives = 75/192 (39%), Gaps = 11/192 (5%)
Query: 80  LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQI 137
           L+   H N++    +          +IT     GSL     +  N  VD      +A   
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDX 120
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMA 197
            RG  +LH+  P I    L   ++ ++  +   +I    +    Q P        P ++A
Sbjct: 121 ARGXAFLHTLEPLIPRHALNSRSVXID-EDXTARISXADVKFSFQSPGRXY---APAWVA 176
Query: 198 PELYEEEYNEL----VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253
           PE  +++  +      D +SF + + E+VT E P+ +  N     K    G++P ++   
Sbjct: 177 PEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRP-TIPPG 235
Query: 254 TDPQVKQFIEKC 265
             P V +  + C
Sbjct: 236 ISPHVSKLXKIC 247

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 27  GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           GRY  I  LG G F TV+  +D + G +     V ++ V  +    E    E+ LLKS++
Sbjct: 21  GRYHVIRKLGWGHFSTVWLSWD-IQGKKF----VAMKVVKSAEHYTETALDEIRLLKSVR 75
Query: 85  H--------ENIIKFYNSW-VDDTNRT-INMITELFTSGSLRQYRKK-HKNVDMKAIKNW 133
           +        E +++  + + +   N T I M+ E+     L+   K  ++ + +  +K  
Sbjct: 76  NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI 135
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171
            +Q+L+GL YLH+    IIH D+K +NI ++ N   ++
Sbjct: 136 IQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIR 172

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 27  GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           GRY  I  LG G F TV+  +D + G +     V ++ V  +    E    E+ LLKS++
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWD-IQGKKF----VAMKVVKSAEHYTETALDEIRLLKSVR 91
Query: 85  H--------ENIIKFYNSW-VDDTNRT-INMITELFTSGSLRQYRKK-HKNVDMKAIKNW 133
           +        E +++  + + +   N T I M+ E+     L+   K  ++ + +  +K  
Sbjct: 92  NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171
            +Q+L+GL YLH+    IIH D+K +NI ++ N   ++
Sbjct: 152 IQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIR 188

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NI+K  +   D  ++T ++I E   +   +       + D   I+ +  ++L+ L Y HS
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 143
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYE--E 203
               I+HRD+K  N+ ++    ++++ D GLA         +V + +  F  PEL    +
Sbjct: 144 QG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
           +Y+  +D++S G     M+  + P+
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NI+K  +   D  ++T ++I E   +   +       + D   I+ +  ++L+ L Y HS
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 145
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYE--E 203
               I+HRD+K  N+ ++    ++++ D GLA         +V + +  F  PEL    +
Sbjct: 146 QG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 203
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
           +Y+  +D++S G     M+  + P+
Sbjct: 204 DYDYSLDMWSLGCMFAGMIFRKEPF 228

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NI+K  +   D  ++T ++I E   +   +       + D   I+ +  ++L+ L Y HS
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 144
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYE--E 203
               I+HRD+K  N+ ++    ++++ D GLA         +V + +  F  PEL    +
Sbjct: 145 QG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
           +Y+  +D++S G     M+  + P+
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/185 (23%), Positives = 81/185 (43%), Gaps = 20/185 (10%)
Query: 67  PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN--MITELFTSGSLRQYRKKHKN 124
           P+Q+++        + LK+  + K++ S + D N      MI + F S   + Y    K 
Sbjct: 93  PEQIQKWIR----TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR 148
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN-GEVKIGDLGLAIV--- 180
              K +   + +IL  L Y+H H    +H D+K  N+ +N  N  +V + D GLA     
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 181 ------MQQPTARSVIGTPEFMAPELYEEEY-NELVDIYSFGMCILEMVTCEYPYNE-CK 232
                  ++   R   GT EF + + +     +   D+   G C+++ +T   P+ +  K
Sbjct: 207 EGVHKEYKEDPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266
Query: 233 NPAQI 237
           +P  +
Sbjct: 267 DPKYV 271

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NI+K  +   D  ++T ++I E   +   +       + D   I+ +  ++L+ L Y HS
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 143
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYE--E 203
               I+HRD+K  N+ ++    ++++ D GLA         +V + +  F  PEL    +
Sbjct: 144 QG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
           +Y+  +D++S G     M+  + P+
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/185 (23%), Positives = 81/185 (43%), Gaps = 20/185 (10%)
Query: 67  PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN--MITELFTSGSLRQYRKKHKN 124
           P+Q+++        + LK+  + K++ S + D N      MI + F S   + Y    K 
Sbjct: 93  PEQIQKWIR----TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR 148
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN-GEVKIGDLGLAIV--- 180
              K +   + +IL  L Y+H H    +H D+K  N+ +N  N  +V + D GLA     
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 181 ------MQQPTARSVIGTPEFMAPELYEEEY-NELVDIYSFGMCILEMVTCEYPYNE-CK 232
                  ++   R   GT EF + + +     +   D+   G C+++ +T   P+ +  K
Sbjct: 207 EGVHKEYKEDPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266
Query: 233 NPAQI 237
           +P  +
Sbjct: 267 DPKYV 271

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NI+K  +   D  ++T ++I E   +   +       + D   I+ +  ++L+ L Y HS
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 143
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYE--E 203
               I+HRD+K  N+ ++    ++++ D GLA         +V + +  F  PEL    +
Sbjct: 144 QG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
           +Y+  +D++S G     M+  + P+
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NI+K  +   D  ++T ++I E   +   +       + D   I+ +  ++L+ L Y HS
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 164
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYE--E 203
               I+HRD+K  N+ ++    ++++ D GLA         +V + +  F  PEL    +
Sbjct: 165 QG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 222
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
           +Y+  +D++S G     M+  + P+
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPF 247

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NI+K  +   D  ++T ++I E   +   +       + D   I+ +  ++L+ L Y HS
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 144
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYE--E 203
               I+HRD+K  N+ ++    ++++ D GLA         +V + +  F  PEL    +
Sbjct: 145 QG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
           +Y+  +D++S G     M+  + P+
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 104/235 (44%), Gaps = 50/235 (21%)
Query: 30  DEILGKGAFKTV-YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHEN 87
           ++ILG G+  TV ++G     G  VA  ++ I       D  +    E+ LL +S  H N
Sbjct: 38  EKILGYGSSGTVVFQG--SFQGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPN 88
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--------NWARQILR 139
           +I++Y S  + T+R + +  EL       Q   + KNV  + +K        +  RQI  
Sbjct: 89  VIRYYCS--ETTDRFLYIALELCNLNL--QDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVN------------GNNGEVKIGDLGLAIVMQ--QPT 185
           G+ +LHS    IIHRDLK  NI V+              N  + I D GL   +   Q  
Sbjct: 145 GVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 186 ARSVI----GTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTC--EYPYNE 230
            R  +    GT  + APEL EE         +DI+S G C+   +    ++P+ +
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMG-CVFYYILSKGKHPFGD 256

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NI+K  +   D  ++T ++I E   +   +       + D   I+ +  ++L+ L Y HS
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 143
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYE--E 203
               I+HRD+K  N+ ++    ++++ D GLA         +V + +  F  PEL    +
Sbjct: 144 QG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
           +Y+  +D++S G     M+  + P+
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NI+K  +   D  ++T ++I E   +   +       + D   I+ +  ++L+ L Y HS
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 143
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYE--E 203
               I+HRD+K  N+ ++    ++++ D GLA         +V + +  F  PEL    +
Sbjct: 144 QG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
           +Y+  +D++S G     M+  + P+
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           NI+K  +   D  ++T ++I E   +   +       + D   I+ +  ++L+ L Y HS
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 143
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYE--E 203
               I+HRD+K  N+ ++    ++++ D GLA         +V + +  F  PEL    +
Sbjct: 144 QG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
           +Y+  +D++S G     M+  + P+
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 104/235 (44%), Gaps = 50/235 (21%)
Query: 30  DEILGKGAFKTV-YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHEN 87
           ++ILG G+  TV ++G     G  VA  ++ I       D  +    E+ LL +S  H N
Sbjct: 38  EKILGYGSSGTVVFQG--SFQGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPN 88
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--------NWARQILR 139
           +I++Y S  + T+R + +  EL       Q   + KNV  + +K        +  RQI  
Sbjct: 89  VIRYYCS--ETTDRFLYIALELCNLNL--QDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVN------------GNNGEVKIGDLGLAIVMQ--QPT 185
           G+ +LHS    IIHRDLK  NI V+              N  + I D GL   +   Q  
Sbjct: 145 GVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 186 ARSVI----GTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTC--EYPYNE 230
            R  +    GT  + APEL EE         +DI+S G C+   +    ++P+ +
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMG-CVFYYILSKGKHPFGD 256

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 105/239 (43%), Gaps = 54/239 (22%)
Query: 30  DEILGKGAFKTV-YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHEN 87
           ++ILG G+  TV ++G     G  VA  ++ I       D  +    E+ LL +S  H N
Sbjct: 20  EKILGYGSSGTVVFQG--SFQGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPN 70
Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--------NWARQILR 139
           +I++Y S  + T+R + +  EL       Q   + KNV  + +K        +  RQI  
Sbjct: 71  VIRYYCS--ETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVN------------GNNGEVKIGDLGLAIVMQ--QPT 185
           G+ +LHS    IIHRDLK  NI V+              N  + I D GL   +   Q  
Sbjct: 127 GVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 184
Query: 186 ARSVI----GTPEFMAPELYEEEYN--------ELVDIYSFGMCILEMVTC--EYPYNE 230
            R  +    GT  + APEL EE  N          +DI+S G C+   +    ++P+ +
Sbjct: 185 FRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHPFGD 242

>pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 82/185 (44%), Gaps = 20/185 (10%)
Query: 67  PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN--MITELFTSGSLRQYRKKHKN 124
           P+Q+++        + LK+  + K++ S + D N      MI + F S   + Y    K 
Sbjct: 93  PEQIQKWIRT----RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR 148
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN-GEVKIGDLGLAI---- 179
              K +   + +IL  L Y+H H    +H D+K  N+ +N  N  +V + D GLA     
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 180 --VMQQPTA---RSVIGTPEFMAPELYEEEY-NELVDIYSFGMCILEMVTCEYPYNE-CK 232
             V +   A   R   GT EF + + +     +   D+   G C+++ +T   P+ +  K
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266
Query: 233 NPAQI 237
           +P  +
Sbjct: 267 DPKYV 271

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	394
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-159
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-70
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-69
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-68
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-68
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-68
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-65
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-64
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-64
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-62
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-62
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-60
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-60
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-60
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-59
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-58
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-58
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-57
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-51
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-51
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-50
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-50
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-49
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-49
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-49
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-49
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-49
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-48
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-48
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-48
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-48
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-48
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-47
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-47
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-46
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-46
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-45
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-45
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-44
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-44
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-44
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-44
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-43
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-43
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-43
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-43
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-43
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-42
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-42
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-42
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-42
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-41
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-41
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-41
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-41
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-41
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-40
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-40
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-39
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-39
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-38
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-38
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-38
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-38
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-38
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-38
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-37
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-37
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-37
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-37
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-37
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-37
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-36
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-36
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-36
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-36
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-36
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-36
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-36
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-36
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-35
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-35
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-35
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-35
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-35
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-35
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-35
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-35
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-34
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-34
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-34
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-34
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-34
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-33
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-33
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-33
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-33
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-33
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-33
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-33
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-32
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-32
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-32
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-32
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-31
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-31
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-31
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-31
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-31
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-31
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-31
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-31
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-31
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-31
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-30
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-30
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-30
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-30
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-30
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-29
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-29
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-29
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-29
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-29
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-29
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-29
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-29
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-29
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-29
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-29
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-28
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-28
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-28
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-28
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-28
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-28
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-28
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-28
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-27
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-27
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-27
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-27
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-27
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-26
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-26
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-26
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-26
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-26
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-26
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-25
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-25
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-24
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-23
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-22
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-22
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-22
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-22
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-22
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-21
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-20
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-20
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-20
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-19
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-18
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-14
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-13
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  447 bits (1152), Expect = e-159
 Identities = 136/281 (48%), Positives = 188/281 (66%), Gaps = 5/281 (1%)

Query: 10  SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
            E  E +        R+ ++D  +G+G+FKTVYKG D    +EVAW ++       +  +
Sbjct: 11  IEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSE 68

Query: 70  LERLYSEVHLLKSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHKNVDM 127
            +R   E  +LK L+H NI++FY+SW       + I ++TEL TSG+L+ Y K+ K + +
Sbjct: 69  RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI 128

Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
           K +++W RQIL+GL +LH+  PPIIHRDLKCDNIF+ G  G VKIGDLGLA + +   A+
Sbjct: 129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188

Query: 188 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
           +VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+LEM T EYPY+EC+N AQIY++VTSG+KP
Sbjct: 189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 248

Query: 248 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD 287
           AS  KV  P+VK+ IE CI      R    +LL   F   +
Sbjct: 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  222 bits (567), Expect = 9e-70
 Identities = 70/293 (23%), Positives = 133/293 (45%), Gaps = 16/293 (5%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + +G+G+F          DG +    ++NI     S  + E    EV +L ++KH NI++
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKHPNIVQ 87

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--KAIKNWARQILRGLHYLHSHN 148
           +  S+ ++ +  + ++ +    G L +     K V      I +W  QI   L ++H   
Sbjct: 88  YRESFEENGS--LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-Y 205
             I+HRD+K  NIF+   +G V++GD G+A V+      AR+ IGTP +++PE+ E + Y
Sbjct: 146 --ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202

Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
           N   DI++ G  + E+ T ++ + E  +   +  K+ SG     +S      ++  + + 
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQL 260

Query: 266 IVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPM 317
                  R     +L+  F +    +  +   L       +  +   S+P P 
Sbjct: 261 FKRNPRDRPSVNSILEKGF-IAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPA 312

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  218 bits (558), Expect = 3e-69
 Identities = 72/267 (26%), Positives = 133/267 (49%), Gaps = 18/267 (6%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             +G G++    K   + DG  + W +++      +  + + L SEV+LL+ LKH NI++
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVR 69

Query: 91  FYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           +Y+  +D TN T+ ++ E    G L     +  K+ + +D + +     Q+   L   H 
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129

Query: 147 HNPP---IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY 201
            +     ++HRDLK  N+F++G    VK+GD GLA ++   T  A++ +GTP +M+PE  
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188

Query: 202 EEE-YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
               YNE  DI+S G C+L E+     P+    +  ++  K+  G K   +      ++ 
Sbjct: 189 NRMSYNEKSDIWSLG-CLLYELCALMPPFTA-FSQKELAGKIREG-KFRRIPYRYSDELN 245

Query: 260 QFIEKCIVP-ASLRLPALELLKDPFLV 285
           + I + +      R    E+L++P ++
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLIL 272

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  217 bits (554), Expect = 4e-68
 Identities = 78/289 (26%), Positives = 133/289 (46%), Gaps = 17/289 (5%)

Query: 8   TKSETEEGEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
                 +              +   + +G+G F  VY+    +DG+ VA  +V I D+M 
Sbjct: 13  VPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM- 71

Query: 66  SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKK 121
                     E+ LLK L H N+IK+Y S+++D    +N++ EL  +G L    + ++K+
Sbjct: 72  DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQ 129

Query: 122 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181
            + +  + +  +  Q+   L ++HS    ++HRD+K  N+F+    G VK+GDLGL    
Sbjct: 130 KRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFF 186

Query: 182 QQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYN-ECKNPAQI 237
              T  A S++GTP +M+PE   E  YN   DI+S G  + EM   + P+  +  N   +
Sbjct: 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 246

Query: 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 285
            KK+     P   S     +++Q +  CI P    R     +      +
Sbjct: 247 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  216 bits (552), Expect = 5e-68
 Identities = 65/284 (22%), Positives = 116/284 (40%), Gaps = 19/284 (6%)

Query: 8   TKSETEEGEFSEKDPSCRYG-RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
                +   +    P   +   +  +  LG G++  V+K   + DG   A  +       
Sbjct: 37  ASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF-- 94

Query: 65  QSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH- 122
           + P    R  +EV   + + +H   ++   +W +     + + TE     SL+Q+ +   
Sbjct: 95  RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI--LYLQTE-LCGPSLQQHCEAWG 151

Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
            ++    +  + R  L  L +LHS    ++H D+K  NIF+ G  G  K+GD GL + + 
Sbjct: 152 ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL-GPRGRCKLGDFGLLVELG 208

Query: 183 QPT-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
                    G P +MAPEL +  Y    D++S G+ ILE+       +  +   Q+ +  
Sbjct: 209 TAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY 268

Query: 242 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
                 A LS     +++  +   + P   LR  A  LL  P L
Sbjct: 269 LPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  215 bits (550), Expect = 8e-68
 Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 29/299 (9%)

Query: 10  SETEEGEFSEKDPSCRYGRYD----EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
             TEEG+         Y   +     +LGKG +  VY G D  + + +A  ++   D   
Sbjct: 3   RSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--- 59

Query: 66  SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKN 124
                + L+ E+ L K LKH+NI+++  S+ ++    I +  E    GSL    R K   
Sbjct: 60  -SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG--FIKIFMEQVPGGSLSALLRSKWGP 116

Query: 125 VDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IV 180
           +      I  + +QIL GL YLH +   I+HRD+K DN+ +N  +G +KI D G +  + 
Sbjct: 117 LKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174

Query: 181 MQQPTARSVIGTPEFMAPE---LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237
              P   +  GT ++MAPE        Y +  DI+S G  I+EM T + P+ E   P   
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA 234

Query: 238 YKKVTSGIK----PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
             KV         P S+S     + K FI KC  P    R  A +LL D FL   + K 
Sbjct: 235 MFKVGMFKVHPEIPESMS----AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  208 bits (532), Expect = 3e-65
 Identities = 73/275 (26%), Positives = 118/275 (42%), Gaps = 26/275 (9%)

Query: 4   GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVA---WNQVNI 60
           GS F KS       +E +       Y++ +GKG F  V+KG    D   VA       + 
Sbjct: 5   GSEFPKSRLPTLADNEIE-------YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57

Query: 61  EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-R 119
           E   +  ++ +    EV ++ +L H NI+K Y       +    M+ E    G L     
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL----MHNPPRMVMEFVPCGDLYHRLL 113

Query: 120 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDL 175
            K   +           I  G+ Y+ + NPPI+HRDL+  NIF+   +       K+ D 
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 176 GLAIVMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECK 232
           GL+      +   ++G  ++MAPE    E   Y E  D YSF M +  ++T E P++E  
Sbjct: 174 GLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

Query: 233 NP--AQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
                 I      G++P ++ +   P+++  IE C
Sbjct: 233 YGKIKFINMIREEGLRP-TIPEDCPPRLRNVIELC 266

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  207 bits (528), Expect = 1e-64
 Identities = 66/284 (23%), Positives = 114/284 (40%), Gaps = 39/284 (13%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            + EI  +G G F  V+K    +DG      +V   +        E+   EV  L  L H
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDH 63

Query: 86  ENIIKFYNSWVDD--------------TNRTINMITELFTSGSLRQYRKKHKNVDM--KA 129
            NI+ +   W                   + + +  E    G+L Q+ +K +   +    
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-S 188
                 QI +G+ Y+HS    +I+RDLK  NIF+  +  +VKIGD GL   ++    R  
Sbjct: 124 ALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 189 VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
             GT  +M+PE    + Y + VD+Y+ G+ + E++       E       +  +  GI  
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRDGIIS 237

Query: 248 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
                    + K  ++K +      R    E+L+   +   +P+
Sbjct: 238 DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  207 bits (528), Expect = 3e-64
 Identities = 73/243 (30%), Positives = 124/243 (51%), Gaps = 14/243 (5%)

Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
             E +G G+F TV++   E  G +VA   +  +D     +++     EV ++K L+H NI
Sbjct: 41  IKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNI 96

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLH 145
           + F  +     N +I  +TE  + GSL +        + +D +   + A  + +G++YLH
Sbjct: 97  VLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE- 202
           + NPPI+HR+LK  N+ V+     VK+ D GL+ +      +++S  GTPE+MAPE+   
Sbjct: 155 NRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213

Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           E  NE  D+YSFG+ + E+ T + P+        +        +   + +  +PQV   I
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL-EIPRNLNPQVAAII 272

Query: 263 EKC 265
           E C
Sbjct: 273 EGC 275

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  202 bits (516), Expect = 1e-62
 Identities = 65/292 (22%), Positives = 122/292 (41%), Gaps = 42/292 (14%)

Query: 25  RY-GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 81
           RY   ++ I  LG+G F  V++  ++VD    A  ++ + +        E++  EV  L 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALA 58

Query: 82  SLKHENIIKFYNSWVDDTN----------RTINMITELFTSGSLRQY---RKKHKNVDMK 128
            L+H  I++++N+W++               + +  +L    +L+ +   R   +  +  
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR- 187
              +   QI   + +LHS    ++HRDLK  NIF    +  VK+GD GL   M Q     
Sbjct: 119 VCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 188 -------------SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKN 233
                          +GT  +M+PE      Y+  VDI+S G+ + E++   YP++    
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQME 232

Query: 234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
             +    V +  K   L     P     ++  + P    R  A+ ++++   
Sbjct: 233 RVRTLTDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  203 bits (518), Expect = 1e-62
 Identities = 66/305 (21%), Positives = 116/305 (38%), Gaps = 30/305 (9%)

Query: 1   MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI 60
            +   G   +E  +    E      +  +   +G+G+F  V++  D+  G + A  +V +
Sbjct: 34  TEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL 93

Query: 61  EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
           E              E+     L    I+  Y +  +     +N+  EL   GSL Q  K
Sbjct: 94  EVFRVE---------ELVACAGLSSPRIVPLYGAVREGP--WVNIFMELLEGGSLGQLIK 142

Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
           +   +       +  Q L GL YLH+    I+H D+K DN+ ++ +     + D G A+ 
Sbjct: 143 QMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALC 200

Query: 181 MQQ-------PTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 232
           +Q         T   + GT   MAPE+   +  +  VDI+S    +L M+   +P+ +  
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260

Query: 233 NPAQIYKKVTSGI----KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD 287
                 K  +        P S +    P   Q I++ +      R  A+EL +       
Sbjct: 261 RGPLCLKIASEPPPIREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316

Query: 288 NPKDL 292
               L
Sbjct: 317 EVGGL 321

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  201 bits (514), Expect = 3e-62
 Identities = 67/243 (27%), Positives = 115/243 (47%), Gaps = 20/243 (8%)

Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
            +E++G+GAF  V K   +    +VA     I+  ++S  + +    E+  L  + H NI
Sbjct: 12  VEEVVGRGAFGVVCKA--KWRAKDVA-----IK-QIESESERKAFIVELRQLSRVNHPNI 63

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLH 145
           +K Y +        + ++ E    GSL       +           +W  Q  +G+ YLH
Sbjct: 64  VKLYGA----CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119

Query: 146 SHNP-PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E 203
           S  P  +IHRDLK  N+ +      +KI D G A  +Q     +  G+  +MAPE++E  
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-HMTNNKGSAAWMAPEVFEGS 178

Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVTDPQVKQFI 262
            Y+E  D++S+G+ + E++T   P++E   PA  I   V +G +P  L K     ++  +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIESLM 237

Query: 263 EKC 265
            +C
Sbjct: 238 TRC 240

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  200 bits (511), Expect = 6e-62
 Identities = 87/298 (29%), Positives = 132/298 (44%), Gaps = 47/298 (15%)

Query: 23  SCRYG-RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
           S RY   ++EI  LG+GAF  V K  + +D    A  ++       + ++L  + SEV L
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVML 55

Query: 80  LKSLKHENIIKFYNSWVDDTNR-----------TINMITELFTSGSLRQY-RKKHKNVDM 127
           L SL H+ ++++Y +W++  N            T+ +  E   +G+L      ++ N   
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115

Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
                  RQIL  L Y+HS    IIHRDLK  NIF++  +  VKIGD GLA  + +    
Sbjct: 116 DEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDI 172

Query: 188 ----------------SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYN 229
                           S IGT  ++A E+ +    YNE +D+YS G+   EM+   YP++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFS 229

Query: 230 ECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
                  I KK+ S     P           K+ I   I    + R  A  LL   +L
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  196 bits (500), Expect = 1e-60
 Identities = 69/244 (28%), Positives = 106/244 (43%), Gaps = 15/244 (6%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           EI+G G F  VY+      G EVA      +        +E +  E  L   LKH NII 
Sbjct: 13  EIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP- 149
                + + N  +  + E    G L +     + +    + NWA QI RG++YLH     
Sbjct: 71  LRGVCLKEPNLCL--VMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 150 PIIHRDLKCDNIFVN-------GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE 202
           PIIHRDLK  NI +         +N  +KI D GLA    + T  S  G   +MAPE+  
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIR 187

Query: 203 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
              +++  D++S+G+ + E++T E P+      A  Y    + +    +         + 
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL-PIPSTCPEPFAKL 246

Query: 262 IEKC 265
           +E C
Sbjct: 247 MEDC 250

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  196 bits (500), Expect = 2e-60
 Identities = 58/281 (20%), Positives = 115/281 (40%), Gaps = 39/281 (13%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENII 89
           E +G G F +V+K    +DG   A  +             +    EV+    L +H +++
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL--AGSVDEQNALREVYAHAVLGQHSHVV 74

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGLHYLH 145
           +++++W +D +  + +  E    GSL     ++  +        +K+   Q+ RGL Y+H
Sbjct: 75  RYFSAWAEDDH--MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 146 SHNPPIIHRDLKCDNIFVNGNN------------------GEVKIGDLGLAIVMQQPTAR 187
           S +  ++H D+K  NIF++  +                     KIGDLG    +  P  +
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--Q 188

Query: 188 SVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245
              G   F+A E+ +E   +    DI++  + ++     E            + ++  G 
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQGR 244

Query: 246 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 285
            P  + +V   +  + ++  I P    R  A+ L+K   L+
Sbjct: 245 LP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  194 bits (496), Expect = 4e-60
 Identities = 47/243 (19%), Positives = 94/243 (38%), Gaps = 15/243 (6%)

Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           +   L +     ++KG     G ++    + + D   S  +      E   L+   H N+
Sbjct: 14  FLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNV 69

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHS 146
           +    +          +IT     GSL        +  VD      +A  + RG+ +LH+
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-- 204
             P I    L   ++ ++  +   +I    +    Q P     +  P ++APE  +++  
Sbjct: 130 LEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPG---RMYAPAWVAPEALQKKPE 185

Query: 205 --YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
                  D++SF + + E+VT E P+ +  N     K    G++P ++     P V + +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-TIPPGISPHVSKLM 244

Query: 263 EKC 265
           + C
Sbjct: 245 KIC 247

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  194 bits (495), Expect = 3e-59
 Identities = 65/253 (25%), Positives = 116/253 (45%), Gaps = 30/253 (11%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E++GKG F  VY G     G EVA   ++IE    + DQL+    EV   +  +HEN++ 
Sbjct: 39  ELIGKGRFGQVYHGR--WHG-EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVL 93

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           F  + +   +  I  IT L    +L    R     +D+   +  A++I++G+ YLH+   
Sbjct: 94  FMGACMSPPHLAI--ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG- 150

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------QQPTARSVIGTPEFMAPEL-- 200
            I+H+DLK  N+F +  NG+V I D GL  +        ++   R   G    +APE+  
Sbjct: 151 -ILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 201 --------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
                    +  +++  D+++ G    E+   E+P+   +    I  ++ +G+KP     
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQI 266

Query: 253 VTDPQVKQFIEKC 265
               ++   +  C
Sbjct: 267 GMGKEISDILLFC 279

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  191 bits (488), Expect = 4e-58
 Identities = 61/279 (21%), Positives = 115/279 (41%), Gaps = 29/279 (10%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENI 88
           + +G G    V++  +E      A   VN+E+       L+   +E+  L  L+   + I
Sbjct: 15  KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I+ Y+  + D    I M+ E   +  L  + KK K++D    K++ + +L  +H +H H 
Sbjct: 72  IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPEL---- 200
             I+H DLK  N  +   +G +K+ D G+A  MQ  T      S +GT  +M PE     
Sbjct: 129 --IVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 201 --------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
                    + + +   D++S G  +  M   + P+ +  N       +           
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244

Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
           + +  ++  ++ C+      R+   ELL  P++      
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  189 bits (483), Expect = 6e-58
 Identities = 79/248 (31%), Positives = 128/248 (51%), Gaps = 23/248 (9%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + +G G+F TVYKG  +  G +VA   +N+     +P QL+   +EV +L+  +H NI+ 
Sbjct: 30  QRIGSGSFGTVYKG--KWHG-DVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILL 84

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           F   +       I  +T+     SL  +        +MK + + ARQ  RG+ YLH+ + 
Sbjct: 85  FM-GYSTAPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS- 140

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYEEE- 204
            IIHRDLK +NIF+   +  VKIGD GLA    +         + G+  +MAPE+   + 
Sbjct: 141 -IIHRDLKSNNIFL-HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 205 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQV 258
              Y+   D+Y+FG+ + E++T + PY+   N  QI + V  G     LSKV      ++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258

Query: 259 KQFIEKCI 266
           K+ + +C+
Sbjct: 259 KRLMAECL 266

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  189 bits (481), Expect = 2e-57
 Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 31/274 (11%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENI 88
           + +G G    V++  +E      A   VN+E+       L+   +E+  L  L+   + I
Sbjct: 34  KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 90

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I+ Y+  + D    I M+ E   +  L  + KK K++D    K++ + +L  +H +H H 
Sbjct: 91  IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEEE 204
             I+H DLK  N  +   +G +K+ D G+A  MQ  T      S +GT  +M PE  ++ 
Sbjct: 148 --IVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 205 ------------YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
                        +   D++S G CIL  M   + P+ +  N       +          
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262

Query: 252 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
            + +  ++  ++ C+      R+   ELL  P++
Sbjct: 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  190 bits (485), Expect = 4e-57
 Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 31/280 (11%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENI 88
           + +G G    V++  +E      A   VN+E+       L+   +E+  L  L+   + I
Sbjct: 62  KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I+ Y+  + D    I M+ E   +  L  + KK K++D    K++ + +L  +H +H H 
Sbjct: 119 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEEE 204
             I+H DLK  N  +   +G +K+ D G+A  MQ  T      S +G   +M PE  ++ 
Sbjct: 176 --IVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 205 ------------YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
                        +   D++S G CIL  M   + P+ +  N       +          
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290

Query: 252 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
            + +  ++  ++ C+      R+   ELL  P++      
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  174 bits (443), Expect = 2e-51
 Identities = 72/293 (24%), Positives = 118/293 (40%), Gaps = 50/293 (17%)

Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
             + +GKG +  V+ G  +  G +VA       +        E    E++    ++HENI
Sbjct: 41  MVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEAS--WFRET---EIYQTVLMRHENI 93

Query: 89  IKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           + F  + +  T     +  IT+   +GSL  Y K    +D K++   A   + GL +LH+
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHT 152

Query: 147 ------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGTPE 194
                   P I HRDLK  NI V   NG   I DLGLA+     T        + +GT  
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211

Query: 195 FMAPELYEE-------EYNELVDIYSFGMCILEMVTC----------EYPYNECKNPAQI 237
           +M PE+ +E       +   + D+YSFG+ + E+             + PY++       
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271

Query: 238 YKKVTSG---------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
           Y+ +                  S     Q+ + + +C     + RL AL + K
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  172 bits (438), Expect = 5e-51
 Identities = 88/298 (29%), Positives = 145/298 (48%), Gaps = 24/298 (8%)

Query: 8   TKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP 67
            +S     +  + DP   + + ++I GKG+F  V+KG D      VA   +++E   ++ 
Sbjct: 6   VQSGLPGMQNLKADPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLE---EAE 61

Query: 68  DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
           D++E +  E+ +L       + K+Y S++ DT   I M  E    GS      +   +D 
Sbjct: 62  DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM--EYLGGGSALDLL-EPGPLDE 118

Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
             I    R+IL+GL YLHS     IHRD+K  N+ ++  +GEVK+ D G+A  +     +
Sbjct: 119 TQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIK 175

Query: 188 --SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA----QIYKK 240
             + +GTP +MAPE+ ++  Y+   DI+S G+  +E+   E P++E  +P      I K 
Sbjct: 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKN 234

Query: 241 VTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPL 297
                 P +L       +K+F+E C     S R  A ELLK  F++ +  K      L
Sbjct: 235 -----NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTEL 287

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  172 bits (438), Expect = 1e-50
 Identities = 86/312 (27%), Positives = 144/312 (46%), Gaps = 26/312 (8%)

Query: 17  FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
           F + DP   +    EI G G+F  VY   D  +   VA  +++     QS ++ + +  E
Sbjct: 47  FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKE 104

Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWAR 135
           V  L+ L+H N I++   ++ +    + M  E +  GS         K +    I     
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWLVM--E-YCLGSASDLLEVHKKPLQEVEIAAVTH 161

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
             L+GL YLHSHN  +IHRD+K  NI ++   G VK+GD G A +M    A S +GTP +
Sbjct: 162 GALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYW 216

Query: 196 MAPE----LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ----IYKKVTSGIKP 247
           MAPE    + E +Y+  VD++S G+  +E+   + P     N       I +  +  ++ 
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQS 275

Query: 248 ASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPE 305
              S       + F++ C       R  +  LLK  F++ + P  ++ D + R  + V E
Sbjct: 276 GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRE 331

Query: 306 VMNLAHSEPHPM 317
           + NL + +   +
Sbjct: 332 LDNLQYRKMKKI 343

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  169 bits (430), Expect = 6e-50
 Identities = 88/276 (31%), Positives = 140/276 (50%), Gaps = 25/276 (9%)

Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
           S  DP  +Y R+++I G+GA  TVY   D   G EVA  Q+N++       + E + +E+
Sbjct: 14  SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEI 68

Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
            +++  K+ NI+ + +S++      + M  E    GSL         +D   I    R+ 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVM--EYLAGGSLTDVV-TETCMDEGQIAAVCREC 125

Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEF 195
           L+ L +LHS+   +IHRD+K DNI +   +G VK+ D G    I  +Q    +++GTP +
Sbjct: 126 LQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 196 MAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGI----KPAS 249
           MAPE+   + Y   VDI+S G+  +EM+  E PY   +NP + +Y   T+G      P  
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEK 241

Query: 250 LSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFL 284
           LS       + F+ +C  +    R  A ELL+  FL
Sbjct: 242 LS----AIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  170 bits (432), Expect = 7e-50
 Identities = 73/293 (24%), Positives = 114/293 (38%), Gaps = 50/293 (17%)

Query: 29  YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
             E +GKG F  V++G  +  G EVA    +  +        E    E++    L+HENI
Sbjct: 46  LQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERS--WFREA---EIYQTVMLRHENI 98

Query: 89  IKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
           + F  +   D      +  +++    GSL  Y  ++  V ++ +   A     GL +LH 
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHM 157

Query: 147 ------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPE 194
                   P I HRDLK  NI V   NG   I DLGLA+     T          +GT  
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 195 FMAPELYEE-------EYNELVDIYSFGMCILEMVTC----------EYPYNECKNP--- 234
           +MAPE+ ++       E  +  DIY+ G+   E+             + PY +       
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276

Query: 235 -AQIYKKVTSG-----IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
             ++ K V        I     S      + + + +C     + RL AL + K
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  169 bits (429), Expect = 1e-49
 Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 25/276 (9%)

Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
            + DP      Y +I G+G+   V    ++  G +VA   +++        + E L++EV
Sbjct: 39  DQGDPRLLLDSYVKI-GEGSTGIVCLAREKHSGRQVAVKMMDLR----KQQRRELLFNEV 93

Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
            +++  +H N+++ Y S++      + M  E    G+L         ++ + I      +
Sbjct: 94  VIMRDYQHFNVVEMYKSYLVGEELWVLM--EFLQGGALTDIV-SQVRLNEEQIATVCEAV 150

Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEF 195
           L+ L YLH+    +IHRD+K D+I +   +G VK+ D G    I    P  +S++GTP +
Sbjct: 151 LQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYW 207

Query: 196 MAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGI----KPAS 249
           MAPE+     Y   VDI+S G+ ++EMV  E PY    +P Q + +   S          
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHK 266

Query: 250 LSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFL 284
           +S    P ++ F+E+  +     R  A ELL  PFL
Sbjct: 267 VS----PVLRDFLERMLVRDPQERATAQELLDHPFL 298

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  167 bits (426), Expect = 2e-49
 Identities = 78/301 (25%), Positives = 137/301 (45%), Gaps = 26/301 (8%)

Query: 8   TKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP 67
            KS   E    + DP+  +    E+ G GAF  VYK  ++  G   A   +  +    S 
Sbjct: 3   RKSREYEHVRRDLDPNEVWEIVGEL-GDGAFGKVYKAKNKETGALAAAKVIETK----SE 57

Query: 68  DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVD 126
           ++LE    E+ +L +  H  I+K   ++  D    I +  E    G++     +  + + 
Sbjct: 58  EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI--EFCPGGAVDAIMLELDRGLT 115

Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQP 184
              I+   RQ+L  L++LHS    IIHRDLK  N+ +    G++++ D G++   +    
Sbjct: 116 EPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQ 172

Query: 185 TARSVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-I 237
              S IGTP +MAPE      + +  Y+   DI+S G+ ++EM   E P++E  NP + +
Sbjct: 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVL 231

Query: 238 YKKVTSGIKPASLSKVTD--PQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVC 294
            K   S   P +L   +    + + F++         R  A +LL+ PF+ +      + 
Sbjct: 232 LKIAKSD--PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289

Query: 295 D 295
           +
Sbjct: 290 E 290

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  167 bits (424), Expect = 4e-49
 Identities = 75/291 (25%), Positives = 116/291 (39%), Gaps = 50/291 (17%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +GKG +  V++G     G  VA    +  D        E    E++    L+HENI+ 
Sbjct: 14  ECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKS--WFRET---ELYNTVMLRHENILG 66

Query: 91  FYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-- 146
           F  S +   + +  +  IT     GSL  Y +    +D  +       I  GL +LH   
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEI 125

Query: 147 ----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGTPEFM 196
                 P I HRDLK  NI V   NG+  I DLGLA++  Q T +        +GT  +M
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 197 APELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG----- 244
           APE+ +E       +  + VDI++FG+ + E+          ++    +  V        
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 245 --------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
                         I     S  T   + + +++C     S RL AL + K
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  166 bits (423), Expect = 9e-49
 Identities = 79/288 (27%), Positives = 136/288 (47%), Gaps = 27/288 (9%)

Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
             K P   +   +++ G+G++ +VYK   +  G  VA  QV +E        L+ +  E+
Sbjct: 23  LTKQPEEVFDVLEKL-GEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEI 75

Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQ 136
            +++     +++K+Y S+  +T+  I M  E   +GS+    R ++K +    I    + 
Sbjct: 76  SIMQQCDSPHVVKYYGSYFKNTDLWIVM--EYCGAGSVSDIIRLRNKTLTEDEIATILQS 133

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 194
            L+GL YLH      IHRD+K  NI +N   G  K+ D G+A  +        +VIGTP 
Sbjct: 134 TLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPF 190

Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ----IYKKVTSGIK-PA 248
           +MAPE + E  YN + DI+S G+  +EM   + PY +  +P +    I        + P 
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTNPPPTFRKPE 249

Query: 249 SLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCD 295
             S         F+++C +     R  A +LL+ PF+ +     ++ D
Sbjct: 250 LWS----DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRD 293

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  166 bits (423), Expect = 9e-49
 Identities = 61/274 (22%), Positives = 111/274 (40%), Gaps = 28/274 (10%)

Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
            +ILG+GA   V++G  +  G   A   + + + +     ++    E  +LK L H+NI+
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRGLHYLHS 146
           K +    + T R   +I E    GSL    ++  N             R ++ G+++L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 147 HNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE 202
           +   I+HR++K  NI            K+ D G A  ++      S+ GT E++ P++YE
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 203 ---------EEYNELVDIYSFGMCIL-EMVTCE---YPYNECKNPAQIYKKVTSGIKPAS 249
                    ++Y   VD++S G        T      P+   +   ++  K+ +G    +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 250 LSKVTDPQ--VKQFIEKCIVPASLRLPALELLKD 281
           +S V   +     +     V  SL      LL  
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  165 bits (421), Expect = 1e-48
 Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 42/303 (13%)

Query: 11  ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
             +            Y   + I G GA   V   +      +VA  ++N+E   +    +
Sbjct: 2   SEDSSALPWSINRDDYELQEVI-GSGATAVVQAAYCAPKKEKVAIKRINLE---KCQTSM 57

Query: 71  ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--------QYRKKH 122
           + L  E+  +    H NI+ +Y S+V      + M  +L + GS+         +   K 
Sbjct: 58  DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM--KLLSGGSVLDIIKHIVAKGEHKS 115

Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---- 178
             +D   I    R++L GL YLH +    IHRD+K  NI +   +G V+I D G++    
Sbjct: 116 GVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFGVSAFLA 172

Query: 179 ---IVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC-- 231
               + +    ++ +GTP +MAPE+ E+   Y+   DI+SFG+  +E+ T   PY++   
Sbjct: 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232

Query: 232 ---------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKD 281
                     +P  +   V          K      ++ I  C       R  A ELL+ 
Sbjct: 233 MKVLMLTLQNDPPSLETGVQDKEMLKKYGKS----FRKMISLCLQKDPEKRPTAAELLRH 288

Query: 282 PFL 284
            F 
Sbjct: 289 KFF 291

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  165 bits (419), Expect = 2e-48
 Identities = 83/289 (28%), Positives = 136/289 (47%), Gaps = 26/289 (8%)

Query: 20  KDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
            DP     RY     LGKG F   ++  D       A   V  + ++  P Q E++  E+
Sbjct: 9   VDPR-SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQREKMSMEI 66

Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
            + +SL H++++ F+  + D+    + ++ EL    SL +  K+ K +     + + RQI
Sbjct: 67  SIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124

Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEF 195
           + G  YLH +   +IHRDLK  N+F+N  + EVKIGD GLA  ++    R   + GTP +
Sbjct: 125 VLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181

Query: 196 MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSK 252
           +APE L ++ ++  VD++S G CI+  +    P  E     + Y ++       P  ++ 
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN- 239

Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
              P     I+K +    + R    ELL D F  +         P RLP
Sbjct: 240 ---PVAASLIQKMLQTDPTARPTINELLNDEFFTSG------YIPARLP 279

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  165 bits (419), Expect = 4e-48
 Identities = 82/310 (26%), Positives = 140/310 (45%), Gaps = 34/310 (10%)

Query: 9   KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD 68
           +S  E    + +DP+  +   + + G G +  VYKG     G   A   +++       D
Sbjct: 9   RSLDEIDLSALRDPAGIFELVELV-GNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----D 62

Query: 69  QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN----MITELFTSGSLRQYRKKHK 123
           + E +  E+++LK    H NI  +Y +++      ++    ++ E   +GS+    K  K
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122

Query: 124 NVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181
              +K   I    R+ILRGL +LH H   +IHRD+K  N+ +   N EVK+ D G++  +
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQL 179

Query: 182 QQPTAR--SVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKN 233
            +   R  + IGTP +MAPE        +  Y+   D++S G+  +EM     P  +  +
Sbjct: 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MH 238

Query: 234 PA----QIYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDN 288
           P      I +     +K    SK    + + FIE C +   S R    +L+K PF+    
Sbjct: 239 PMRALFLIPRNPAPRLKSKKWSK----KFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294

Query: 289 PKDLVCDPLR 298
            +  V   L+
Sbjct: 295 NERQVRIQLK 304

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  164 bits (417), Expect = 7e-48
 Identities = 55/276 (19%), Positives = 92/276 (33%), Gaps = 33/276 (11%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+G F  V       DG   A  ++            E    E  + +   H NI++
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILC----HEQQDREEAQREADMHRLFNHPNILR 90

Query: 91  FYNSWVDDTNRT--INMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYL 144
                + +        ++   F  G+L       + K   +    I      I RGL  +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----------VIGTP 193
           H+      HRDLK  NI +  + G+  + DLG           S              T 
Sbjct: 151 HA--KGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 194 EFMAPELYEEE----YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYK-KVTSGIKP 247
            + APEL+  +     +E  D++S G C+L  M+  E PY+            V + +  
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266

Query: 248 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDP 282
               + +   + Q +   +      R     LL   
Sbjct: 267 PQSPRHS-SALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  166 bits (422), Expect = 7e-48
 Identities = 65/290 (22%), Positives = 118/290 (40%), Gaps = 31/290 (10%)

Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
            +ILG+GA   V++G  +  G   A   + + + +     ++    E  +LK L H+NI+
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRGLHYLHS 146
           K +    + T R   +I E    GSL    ++  N             R ++ G+++L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 147 HNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE 202
           +   I+HR++K  NI            K+ D G A  ++      S+ GT E++ P++YE
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 203 ---------EEYNELVDIYSFGMCIL-EMVTCE---YPYNECKNPAQIYKKVTSGIKPAS 249
                    ++Y   VD++S G        T      P+   +   ++  K+ +G    +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 250 LSKVTDPQVKQFIEKCIVPASLRLPA-LELLKDPFLVTDNPKDLVCDPLR 298
           +S V   +         +P S  L   L++L  P L       L  D  +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA----NILEADQEK 293

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  163 bits (414), Expect = 1e-47
 Identities = 65/253 (25%), Positives = 98/253 (38%), Gaps = 27/253 (10%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E+LGKG F    K      G  +       E +    +       EV +++ L+H N++K
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMV----MKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           F      D    +N ITE    G+LR   +            ++A+ I  G+ YLHS N 
Sbjct: 72  FIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN- 128

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----------------PTARSVIGTP 193
            IIHRDL   N  V  N   V + D GLA +M                      +V+G P
Sbjct: 129 -IIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
            +MAPE +    Y+E VD++SFG+ + E++       +       +     G        
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246

Query: 253 VTDPQVKQFIEKC 265
              P       +C
Sbjct: 247 NCPPSFFPITVRC 259

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  163 bits (414), Expect = 3e-47
 Identities = 81/282 (28%), Positives = 134/282 (47%), Gaps = 25/282 (8%)

Query: 27  GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            RY     LGKG F   ++  D       A   V  + ++  P Q E++  E+ + +SL 
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQREKMSMEISIHRSLA 99

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H++++ F+  + D+    + ++ EL    SL +  K+ K +     + + RQI+ G  YL
Sbjct: 100 HQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE-LY 201
           H +   +IHRDLK  N+F+N  + EVKIGD GLA  ++    R   + GTP ++APE L 
Sbjct: 158 HRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214

Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVK 259
           ++ ++  VD++S G CI+  +    P  E     + Y ++       P  ++    P   
Sbjct: 215 KKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAA 269

Query: 260 QFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
             I+K +    + R    ELL D F  +         P RLP
Sbjct: 270 SLIQKMLQTDPTARPTINELLNDEFFTSG------YIPARLP 305

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  162 bits (412), Expect = 2e-46
 Identities = 71/395 (17%), Positives = 128/395 (32%), Gaps = 73/395 (18%)

Query: 5   SGFTKSETEEGEFSEKDPSCRYGRYDEILGKGA--FKTVYKGFDEVDGIEVAWNQVNIED 62
               ++   +G  S       Y     I GKG     TV     +  G  V   ++N+E 
Sbjct: 6   HHHMENLYFQGMSSFLPEGGCYELLTVI-GKGFEDLMTVNLARYKPTGEYVTVRRINLEA 64

Query: 63  VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 122
              S + +  L  E+H+ K   H NI+ +  +++ D    + ++T     GS +     H
Sbjct: 65  --CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTH 120

Query: 123 KNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
               M   AI    + +L+ L Y+H      +HR +K  +I ++  +G+V +  L   + 
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLS 177

Query: 181 MQQPTAR---------SVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPY 228
           M     R           +    +++PE+ ++    Y+   DIYS G+   E+     P+
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

Query: 229 ---------------------------NECKNPAQIYKKVTSGIKPASLSKVTDPQV--- 258
                                       E    +       SG+  +  +    P     
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297

Query: 259 -------------KQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 304
                          F+E+C       R  A  LL   F      +        LP L+ 
Sbjct: 298 PSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEA----LPELLR 353

Query: 305 EVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTW 339
            V  + + E      D +       +  +     W
Sbjct: 354 PVTPITNFEGSQSQ-DHSGIFGLVTNLEELEVDDW 387

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  159 bits (403), Expect = 7e-46
 Identities = 56/272 (20%), Positives = 124/272 (45%), Gaps = 19/272 (6%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENII 89
             +G G    V+K      G  +A  Q+       + ++ +R+  ++  +LKS     I+
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVLKSHDCPYIV 87

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           + + +++ +T+  + +  EL  + + +  ++    +  + +      I++ L+YL   + 
Sbjct: 88  QCFGTFITNTD--VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH- 144

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE------LYE 202
            +IHRD+K  NI ++   G++K+ D G++  +    A+    G   +MAPE        +
Sbjct: 145 GVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203

Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD--PQVKQ 260
            +Y+   D++S G+ ++E+ T ++PY  CK   ++  KV    +P  L          + 
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQS 262

Query: 261 FIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291
           F++ C+      R    +LL+  F+      +
Sbjct: 263 FVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  165 bits (418), Expect = 2e-45
 Identities = 89/371 (23%), Positives = 134/371 (36%), Gaps = 39/371 (10%)

Query: 22  PSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
           P+   G ++  E LG G F  V +   +  G +VA   +       SP   ER   E+ +
Sbjct: 9   PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQI 65

Query: 80  LKSLKHENIIKFYNSWVDDTNRTIN------MITELFTSGSLRQYRKKHKNVDM---KAI 130
           +K L H N++      V D  + +       +  E    G LR+Y  + +N        I
Sbjct: 66  MKKLNHPNVVSARE--VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123

Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNI--FVNGNNGEVKIGDLGLAIVMQQPT-AR 187
           +     I   L YLH +   IIHRDLK +NI           KI DLG A  + Q     
Sbjct: 124 RTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181

Query: 188 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
             +GT +++APEL E ++Y   VD +SFG    E +T   P+     P Q + KV     
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241

Query: 247 PASLSKVTDPQVKQFIEKCIVPASL---------RLPALELLKDP-----FLVTDNPKDL 292
              +         +F      P  L         R     L+             N    
Sbjct: 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301

Query: 293 VCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENN 352
                 L   +  VMN+     H   +  N    +  S  + +TG   +  E Q L + +
Sbjct: 302 QALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTG---IPEEEQELLQAS 358

Query: 353 EFTLRGEKNDD 363
              L   +   
Sbjct: 359 GLALNSAQPLT 369

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  156 bits (396), Expect = 4e-45
 Identities = 64/281 (22%), Positives = 125/281 (44%), Gaps = 17/281 (6%)

Query: 27  GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
             ++    LGKG F  VY   ++     +A   +    + ++     +L  EV +   L+
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-GVEHQLRREVEIQSHLR 67

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H NI++ Y  + D T   + +I E    G++ +  +K    D +    +  ++   L Y 
Sbjct: 68  HPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE- 203
           HS    +IHRD+K +N+ + G+ GE+KI D G ++         + GT +++ PE+ E  
Sbjct: 126 HSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGR 182

Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQF 261
            ++E VD++S G+   E +    P  E     + YK+++      P  ++       +  
Sbjct: 183 MHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEFTFPDFVT----EGARDL 237

Query: 262 IEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
           I + +    S R    E+L+ P++  ++ K   C      +
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  156 bits (395), Expect = 1e-44
 Identities = 52/272 (19%), Positives = 105/272 (38%), Gaps = 28/272 (10%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
           +    A+        + +  E+     + +  + SP  ++    ++  +     +N +  
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 92  YNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
                      I M  +L    +L+ +   R   ++ +     +   QI   + +LHS  
Sbjct: 127 LQPSSPKVYLYIQM--QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--------------SVIGTPE 194
             ++HRDLK  NIF    +  VK+GD GL   M Q                    +GT  
Sbjct: 185 --LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241

Query: 195 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253
           +M+PE      Y+  VDI+S G+ + E++   Y ++      +I   V +   P   ++ 
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIITDVRNLKFPLLFTQ- 297

Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
             PQ    ++  + P  + R  A +++++   
Sbjct: 298 KYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  155 bits (393), Expect = 3e-44
 Identities = 66/311 (21%), Positives = 138/311 (44%), Gaps = 32/311 (10%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENII 89
             +G+GA+ +V K   +  G  +A  ++          + ++L  ++  +++S     I+
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIV 84

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGLHYLH 145
           +FY +   + +    +  EL ++   + Y+  +  +D     + +       ++ L++L 
Sbjct: 85  QFYGALFREGD--CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 146 S-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPE---- 199
                 IIHRD+K  NI ++  +G +K+ D G++  +    A++   G   +MAPE    
Sbjct: 143 ENLK--IIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 199

Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD--- 255
               + Y+   D++S G+ + E+ T  +PY +  +      +V  G  P  LS   +   
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREF 258

Query: 256 -PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSE 313
            P    F+  C+    S R    ELLK PF++    +      + +   V ++++   + 
Sbjct: 259 SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA-----VEVACYVCKILDQMPAT 313

Query: 314 P-HPMDIDLNH 323
           P  PM +D +H
Sbjct: 314 PSSPMYVDHHH 324

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  154 bits (390), Expect = 8e-44
 Identities = 68/294 (23%), Positives = 118/294 (40%), Gaps = 50/294 (17%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +  E+  +G F  V+K   ++    VA   V I   +Q     +    EV+ L  +KHEN
Sbjct: 27  QLLEVKARGRFGCVWKA--QLLNEYVA---VKIFP-IQDKQSWQNE-YEVYSLPGMKHEN 79

Query: 88  IIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
           I++F  +    T+  +++  IT     GSL  + K +  V    + + A  + RGL YLH
Sbjct: 80  ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLH 138

Query: 146 S--------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTP 193
                    H P I HRD+K  N+ +  NN    I D GLA+              +GT 
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197

Query: 194 EFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI---------- 237
            +MAPE+      ++ +    +D+Y+ G+ + E+ +     +   +   +          
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257

Query: 238 ----------YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
                     +KK    ++           + + IE+C    A  RL A  + +
Sbjct: 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  155 bits (392), Expect = 9e-44
 Identities = 71/333 (21%), Positives = 130/333 (39%), Gaps = 61/333 (18%)

Query: 5   SGFTKSETEEGEFSEKDPSCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIED 62
             F   + + GE  + D       +++I  LG G    V+K   +  G+ +A   +++E 
Sbjct: 18  EAFLTQKQKVGELKDDD-------FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 70

Query: 63  VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 122
               P    ++  E+ +L       I+ FY ++  D    I++  E    GSL Q  KK 
Sbjct: 71  ---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKA 125

Query: 123 KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181
             +  + +   +  +++GL YL   H   I+HRD+K  NI VN + GE+K+ D G++  +
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQL 182

Query: 182 QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
               A S +GT  +M+PE L    Y+   DI+S G+ ++EM    YP             
Sbjct: 183 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242

Query: 241 VTSGIKPASLSKVTD-----------------------------------------PQVK 259
                  A+ +                                              + +
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302

Query: 260 QFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291
            F+ KC++   + R    +L+   F+   + ++
Sbjct: 303 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  152 bits (387), Expect = 1e-43
 Identities = 63/274 (22%), Positives = 120/274 (43%), Gaps = 22/274 (8%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENII 89
             LG+GA+  V K      G  +A  ++       +  + +RL  ++   ++++     +
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDCPFTV 69

Query: 90  KFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
            FY +   + +  + +  E     SL    +Q   K + +    +   A  I++ L +LH
Sbjct: 70  TFYGALFREGD--VWICME-LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 146 S-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE---- 199
           S  +  +IHRD+K  N+ +N   G+VK+ D G++  +    A+    G   +MAPE    
Sbjct: 127 SKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183

Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
            L ++ Y+   DI+S G+ ++E+    +PY+    P Q  K+V     P   +     + 
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEF 243

Query: 259 KQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291
             F  +C+   +  R    EL++ PF      K 
Sbjct: 244 VDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  151 bits (385), Expect = 2e-43
 Identities = 70/276 (25%), Positives = 131/276 (47%), Gaps = 22/276 (7%)

Query: 25  RYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
           +   +    +LGKG+F  VY+      G+EVA   ++ +  M     ++R+ +EV +   
Sbjct: 9   KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA-MYKAGMVQRVQNEVKIHCQ 67

Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGL 141
           LKH +I++ YN + D     + ++ E+  +G + +Y + + K       +++  QI+ G+
Sbjct: 68  LKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE 199
            YLHSH   I+HRDL   N+ +   N  +KI D GLA  ++ P  +  ++ GTP +++PE
Sbjct: 126 LYLHSHG--ILHRDLTLSNLLL-TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182

Query: 200 -LYEEEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTD 255
                 +    D++S G C+   ++    P+ +         KV       P+ LS    
Sbjct: 183 IATRSAHGLESDVWSLG-CMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPSFLS---- 236

Query: 256 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
            + K  I + +    + RL    +L  PF+  ++  
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  156 bits (395), Expect = 4e-43
 Identities = 79/280 (28%), Positives = 127/280 (45%), Gaps = 14/280 (5%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
            +LGKG+F  V    D++ G E A   ++    ++     E L  EV LLK L H NI+K
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMK 90

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            Y  + D       ++ E++T G L       K           RQ+L G+ Y+H +   
Sbjct: 91  LYEFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-- 146

Query: 151 IIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYNE 207
           I+HRDLK +N+   +   +  ++I D GL+   +     +  IGT  ++APE+    Y+E
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 206

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEK 264
             D++S G  IL ++    P     N   I KKV  G    +     KV++   K  I K
Sbjct: 207 KCDVWSTG-VILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE-SAKDLIRK 264

Query: 265 CIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 303
            +    S+R+ A + L   ++ T   + +  D   L N +
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAI 304

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  154 bits (392), Expect = 4e-43
 Identities = 69/300 (23%), Positives = 115/300 (38%), Gaps = 31/300 (10%)

Query: 8   TKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP 67
            + + +E           +    ++LG GA  T+       D  +VA  ++  E      
Sbjct: 8   EQDDGDEETSVVIVGKISFCP-KDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF---- 61

Query: 68  DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV 125
              +R   EV LL+   +H N+I+++ +  D       +  EL  + +L++Y  +K    
Sbjct: 62  SFADR---EVQLLRESDEHPNVIRYFCTEKDRQF--QYIAIEL-CAATLQEYVEQKDFAH 115

Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIVM 181
                    +Q   GL +LHS N  I+HRDLK  NI ++  N        I D GL   +
Sbjct: 116 LGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173

Query: 182 QQP-----TARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEY-PYNEC 231
                       V GT  ++APE+  E+        VDI+S G     +++    P+ + 
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233

Query: 232 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
                        +      K  D   ++ IEK I      R  A  +LK PF  +   +
Sbjct: 234 LQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  153 bits (389), Expect = 8e-43
 Identities = 76/301 (25%), Positives = 131/301 (43%), Gaps = 24/301 (7%)

Query: 7   FTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVN----IED 62
           F     ++     K     Y    + LG GA   V   F+     +VA   ++       
Sbjct: 118 FFDLTVDDQSVYPKALRDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG 176

Query: 63  VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 122
             +  D    + +E+ +LK L H  IIK  N   D  +    ++ EL   G L      +
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAED--YYIVLELMEGGELFDKVVGN 233

Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIV 180
           K +     K +  Q+L  + YLH +   IIHRDLK +N+ +     +  +KI D G + +
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291

Query: 181 MQQPTA-RSVIGTPEFMAPE----LYEEEYNELVDIYSFGMCILEMVTCEY-PYNECKNP 234
           + + +  R++ GTP ++APE    +    YN  VD +S G  IL +    Y P++E +  
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEHRTQ 350

Query: 235 AQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
             +  ++TSG     P   ++V++      ++K +V     R    E L+ P+L  ++ K
Sbjct: 351 VSLKDQITSGKYNFIPEVWAEVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409

Query: 291 D 291
            
Sbjct: 410 R 410

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  151 bits (383), Expect = 1e-42
 Identities = 63/315 (20%), Positives = 113/315 (35%), Gaps = 42/315 (13%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 89
            +L +G F  VY+  D   G E A  ++         ++   +  EV  +K L  H NI+
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLS----NEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 90  KFYNSWVD-----DTNRTINMITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRGL 141
           +F ++        DT +   ++      G L ++ KK ++        +     Q  R +
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV------------ 189
            ++H   PPIIHRDLK +N+ +  N G +K+ D G A  +      S             
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLL-SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 190 --IGTPEFMAPELYE----EEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVT 242
               TP +  PE+ +        E  DI++ G CIL  +   ++P+ +     +I     
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED-GAKLRIVNGKY 266

Query: 243 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
           S     +            I   +      RL   E++     +          P  +  
Sbjct: 267 SIPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP--ITE 320

Query: 302 LVPEVMNLAHSEPHP 316
           L+ +      +    
Sbjct: 321 LLEQNGGYGSATLSR 335

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  149 bits (378), Expect = 2e-42
 Identities = 65/279 (23%), Positives = 128/279 (45%), Gaps = 17/279 (6%)

Query: 18  SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
                      +D    LGKG F  VY   ++ +   +A   +    + +      +L  
Sbjct: 5   EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-GVEHQLRR 63

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           E+ +   L+H NI++ YN + D     I ++ E    G L +  +KH   D +    +  
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKR--IYLMLEFAPRGELYKELQKHGRFDEQRSATFME 121

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
           ++   LHY H     +IHRD+K +N+ + G  GE+KI D G ++       R++ GT ++
Sbjct: 122 ELADALHYCHERK--VIHRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRTMCGTLDY 178

Query: 196 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSK 252
           + PE+ E + ++E VD++  G+   E +    P+ +  +  + ++++ +  +K P  LS 
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFLS- 236

Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
                 K  I K +      RLP   +++ P++  ++ +
Sbjct: 237 ---DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  152 bits (386), Expect = 8e-42
 Identities = 81/280 (28%), Positives = 125/280 (44%), Gaps = 15/280 (5%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
            +LGKG+F  V K  D +   E A   +N             +  EV LLK L H NI+K
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMK 85

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            +    D ++    ++ EL+T G L     K K           +Q+  G+ Y+H HN  
Sbjct: 86  LFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141

Query: 151 IIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYNE 207
           I+HRDLK +NI   +   + ++KI D GL+   QQ    +  IGT  ++APE+    Y+E
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEK 264
             D++S G  IL ++    P    KN   I K+V +G           ++D   K  I K
Sbjct: 202 KCDVWSAG-VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD-DAKDLIRK 259

Query: 265 CIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 303
            +    SLR+ A + L+ P++   + +      L      
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESA 299

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  147 bits (373), Expect = 9e-42
 Identities = 83/281 (29%), Positives = 130/281 (46%), Gaps = 16/281 (5%)

Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
            +   + RY     +LGKG+F  V K  D +   E A   +N             +  EV
Sbjct: 16  FQGTFAERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREV 72

Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
            LLK L H NI+K +    D ++    ++ EL+T G L     K K           +Q+
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130

Query: 138 LRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIGTPE 194
             G+ Y+H HN  I+HRDLK +NI   +   + ++KI D GL+   QQ T  +  IGT  
Sbjct: 131 FSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188

Query: 195 FMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLS 251
           ++APE+    Y+E  D++S G  IL ++    P    KN   I K+V +G          
Sbjct: 189 YIAPEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247

Query: 252 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
            ++D   K  I K +    SLR+ A + L+ P++   + ++
Sbjct: 248 TISD-DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  146 bits (372), Expect = 1e-41
 Identities = 63/277 (22%), Positives = 119/277 (42%), Gaps = 29/277 (10%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVN---IEDVMQSPDQLERLYSEVHLLKS 82
            Y     +G+G++  V     +   I  A  ++    +EDV       +R   E+ ++KS
Sbjct: 10  YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-------DRFKQEIEIMKS 62

Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           L H NII+ Y ++ D+T+  I ++ EL T G L +     +           + +L  + 
Sbjct: 63  LDHPNIIRLYETFEDNTD--IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA 120

Query: 143 YLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 199
           Y H  N  + HRDLK +N     +  +  +K+ D GLA   +     R+ +GTP +++P+
Sbjct: 121 YCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178

Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVT 254
           + E  Y    D +S G  ++ ++ C YP         +++  K+  G           V+
Sbjct: 179 VLEGLYGPECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVS 235

Query: 255 DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
             Q +  I + +      R+ +L+ L+  +       
Sbjct: 236 P-QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  147 bits (372), Expect = 3e-41
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 23/297 (7%)

Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVN----IEDVMQSPDQLERLYSEVHLLKSLKH 85
            + LG GA   V   F+     +VA   ++         +  D    + +E+ +LK L H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
             IIK  N + D  +    ++ EL   G L      +K +     K +  Q+L  + YLH
Sbjct: 75  PCIIKIKN-FFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 146 SHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE--- 199
            +   IIHRDLK +N+ +     +  +KI D G + ++ + +  R++ GTP ++APE   
Sbjct: 132 ENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189

Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSGI---KPASLSKVT 254
            +    YN  VD +S G  IL +    Y P++E +    +  ++TSG     P   ++V+
Sbjct: 190 SVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248

Query: 255 DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLA 310
           +      ++K +V     R    E L+ P+L  ++ K    D L   N    +  + 
Sbjct: 249 EK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVL 304

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  151 bits (382), Expect = 3e-41
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 15/281 (5%)

Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
            + LG GA+  V    D+V  +E A   +    V  S     +L  EV +LK L H NI+
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV--STSSNSKLLEEVAVLKLLDHPNIM 99

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           K Y+ + D  N    ++ E +  G L          +        +Q+L G+ YLH HN 
Sbjct: 100 KLYDFFEDKRN--YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN- 156

Query: 150 PIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYN 206
            I+HRDLK +N+   +   +  +KI D GL+ V +     +  +GT  ++APE+  ++Y+
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYD 215

Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIE 263
           E  D++S G  IL ++   YP    +   +I +KV  G           V++   K  I+
Sbjct: 216 EKCDVWSIG-VILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE-GAKDLIK 273

Query: 264 KCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 303
           + +   +  R+ A + L+ P++     K      L      
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANA 314

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  151 bits (382), Expect = 3e-41
 Identities = 80/294 (27%), Positives = 127/294 (43%), Gaps = 22/294 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVA---------WNQVNIEDVMQSPDQLERLYSEVHLLK 81
             LG GA+  V    ++    E A               +D        E +Y+E+ LLK
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 82  SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           SL H NIIK ++ + D       ++TE +  G L +        D     N  +QIL G+
Sbjct: 102 SLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159

Query: 142 HYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAP 198
            YLH HN  I+HRD+K +NI   N  +   +KI D GL+    +    R  +GT  ++AP
Sbjct: 160 CYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217

Query: 199 ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTD 255
           E+ +++YNE  D++S G  I+ ++ C YP    +N   I KKV  G           ++ 
Sbjct: 218 EVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNIS- 275

Query: 256 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
            + K+ I+  +    + R  A E L   ++          D   L   +  +  
Sbjct: 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRK 329

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  144 bits (365), Expect = 2e-40
 Identities = 62/281 (22%), Positives = 123/281 (43%), Gaps = 26/281 (9%)

Query: 17  FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
           + +      +  +   LG GAF  V+   +   G+E     +   +  +S   +E++ +E
Sbjct: 15  YFQGTIDDLF-IFKRKLGSGAFGDVHLVEERSSGLERV---IKTINKDRSQVPMEQIEAE 70

Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKN 132
           + +LKSL H NIIK +  + D  N  + ++ E    G L       + + K +    +  
Sbjct: 71  IEVLKSLDHPNIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128

Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSV 189
             +Q++  L Y HS +  ++H+DLK +NI F +   +  +KI D GLA + +      + 
Sbjct: 129 LMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA 186

Query: 190 IGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---- 245
            GT  +MAPE+++ +     DI+S G  ++  +          +  ++ +K T       
Sbjct: 187 AGTALYMAPEVFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA 245

Query: 246 -KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
            +   L+    PQ    +++ +      R  A ++L   + 
Sbjct: 246 VECRPLT----PQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  142 bits (361), Expect = 6e-40
 Identities = 72/276 (26%), Positives = 132/276 (47%), Gaps = 22/276 (7%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            YD  E LGKGAF  V +   +  G+E A   +N + +  S    ++L  E  + + L+H
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQH 64

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
            NI++ ++S  +++     ++ +L T G L +     +        +  +QIL  + Y H
Sbjct: 65  PNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122

Query: 146 SHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPE-LY 201
           S+   I+HR+LK +N+ +        VK+ D GLAI +          GTP +++PE L 
Sbjct: 123 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180

Query: 202 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 256
           ++ Y++ VDI++ G  IL ++   YP  ++E  +  ++Y ++ +G           VT  
Sbjct: 181 KDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTP- 236

Query: 257 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
           + K  I+  +      R+ A + LK P++       
Sbjct: 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  142 bits (361), Expect = 2e-39
 Identities = 72/294 (24%), Positives = 126/294 (42%), Gaps = 28/294 (9%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-LERLYSEVHLLKSLK 84
            Y+  E++GKG F  V +  +   G + A   V++     SP    E L  E  +   LK
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDM--KAIKNWARQILRG 140
           H +I++   ++  D    + M+ E      L     ++             ++ RQIL  
Sbjct: 85  HPHIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142

Query: 141 LHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFM 196
           L Y H +N  IIHRD+K   +   +  N+  VK+G  G+AI + +    A   +GTP FM
Sbjct: 143 LRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200

Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASL 250
           APE +  E Y + VD++  G  IL ++       Y       ++++ +  G     P   
Sbjct: 201 APEVVKREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQW 256

Query: 251 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK-DLVCDPLRLPNL 302
           S +++   K  + + ++   + R+   E L  P+L   +     +  P  +  L
Sbjct: 257 SHISE-SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQL 309

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  142 bits (359), Expect = 5e-39
 Identities = 39/297 (13%), Positives = 81/297 (27%), Gaps = 55/297 (18%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVA------------------------WNQVNIEDVMQS 66
            +LG+       +  D+  G                               +      + 
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 67  PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS------GSLRQYRK 120
                R      L+K  + + +I+      D    +   +     S        L  +  
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
            HK++   A      Q++R L  LH +   ++H  L+  +I ++   G V +      + 
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQ-RGGVFLTGFEHLVR 255

Query: 181 MQQPTARSVIGTPEFMAPELYEEE------------YNELVDIYSFGMCILEMVTCEYPY 228
                      +  F  PEL                     D ++ G+ I  +   + P 
Sbjct: 256 DGARV--VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313

Query: 229 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
            +        + +    K           V+  +E  +      RL  L+ ++ P  
Sbjct: 314 TK-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEY 363

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  140 bits (355), Expect = 1e-38
 Identities = 58/317 (18%), Positives = 117/317 (36%), Gaps = 46/317 (14%)

Query: 18  SEKDPSCRYGRYD--EILGKGAFKTVY-----------KGFDEVDGIEVAWNQVNIEDVM 64
             K+       Y     L +G F  +            K +++    +      +  D +
Sbjct: 22  YVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKI 81

Query: 65  QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 124
               + +   +E+ ++  +K+E  +       +     + +I E   + S+ ++ +    
Sbjct: 82  SIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFV 139

Query: 125 VDMKA--------IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
           +D           IK   + +L    Y+H+    I HRD+K  NI +   NG VK+ D G
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILM-DKNGRVKLSDFG 197

Query: 177 LAIVMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKN 233
            +  M     +   GT EFM PE +  E       VDI+S G+C+  M     P++   +
Sbjct: 198 ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257

Query: 234 PAQIYKKVTSG-----------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA 275
             +++  + +                   K    +     +   F++  +    + R+ +
Sbjct: 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317

Query: 276 LELLKDPFLVTDNPKDL 292
            + LK  +L   N +DL
Sbjct: 318 EDALKHEWLADTNIEDL 334

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  140 bits (356), Expect = 2e-38
 Identities = 73/274 (26%), Positives = 133/274 (48%), Gaps = 22/274 (8%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            YD  E LGKGAF  V +   +  G+E A   +N + +  S    ++L  E  + + L+H
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQH 87

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
            NI++ ++S  +++     ++ +L T G L +     +        +  +QIL  + Y H
Sbjct: 88  PNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145

Query: 146 SHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LY 201
           S+   I+HR+LK +N+   +      VK+ D GLAI +    A     GTP +++PE L 
Sbjct: 146 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 203

Query: 202 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 256
           ++ Y++ VDI++ G  IL ++   YP  ++E  +  ++Y ++ +G           VT  
Sbjct: 204 KDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTP- 259

Query: 257 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 289
           + K  I+  +      R+ A + LK P++     
Sbjct: 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  141 bits (357), Expect = 2e-38
 Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 25/295 (8%)

Query: 7   FTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS 66
           + K   +  E  +      Y    E LG GAF  V++  ++  G       +N       
Sbjct: 34  WKKYVPQPVEVKQGSVYDYY-DILEELGSGAFGVVHRCVEKATGRVFVAKFINT----PY 88

Query: 67  PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKN 124
           P     + +E+ ++  L H  +I  ++++ D     + +I E  + G L  R   + +K 
Sbjct: 89  PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKM 146

Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQ 183
            + + I N+ RQ   GL ++H H+  I+H D+K +NI         VKI D GLA  +  
Sbjct: 147 SEAEVI-NYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203

Query: 184 PTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYK 239
               +    T EF APE +  E      D+++ G  +  ++         E  +  +  +
Sbjct: 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQ 260

Query: 240 KVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
            V          + S V+  + K FI+  +      RL   + L+ P+L  D+  
Sbjct: 261 NVKRCDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  141 bits (357), Expect = 2e-38
 Identities = 42/337 (12%), Positives = 91/337 (27%), Gaps = 57/337 (16%)

Query: 27  GRY-----DEILGKGAFKTVYKGFDEVDGIEVA------WNQVNIEDV------------ 63
            R        +LG+       +  D+  G            +     +            
Sbjct: 75  ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134

Query: 64  ---MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS-------- 112
              +++  Q +     +     +K     K     +D+ +  +     L+          
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194

Query: 113 -GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171
              L  +   HK++   A      Q++R L  LH +   ++H  L+  +I +    G V 
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVL-DQRGGVF 251

Query: 172 IGDLGLAIVMQQPT---ARSVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMV 222
           +      +                PE  A  +               D ++ G+ I  + 
Sbjct: 252 LTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311

Query: 223 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 281
             + P  +        + +    K           V+  +E  +      RL  L+ ++ 
Sbjct: 312 CADLPNTD-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMET 364

Query: 282 PFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMD 318
           P    +  +  +   L L     E      + P    
Sbjct: 365 PEY--EQLRTELSAALPLYQTDGEPTREGGAPPSGTS 399

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  139 bits (351), Expect = 4e-38
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 43/225 (19%)

Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLY---SEVHLLKSLKHE 86
            E++G+G +  VYKG   +D   VA        V        + +     ++ +  ++H+
Sbjct: 18  LELIGRGRYGAVYKG--SLDERPVA--------VKVFSFANRQNFINEKNIYRVPLMEHD 67

Query: 87  NIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
           NI +F       T        ++ E + +GSL +Y   H   D  +    A  + RGL Y
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAY 126

Query: 144 LHS-------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----------QQPTA 186
           LH+       + P I HRDL   N+ V  N+G   I D GL++ +          +   A
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185

Query: 187 RSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT 223
            S +GT  +MAPE+ E        E   + VD+Y+ G+   E+  
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  137 bits (348), Expect = 6e-38
 Identities = 68/286 (23%), Positives = 125/286 (43%), Gaps = 23/286 (8%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            +   E+LG GAF  V+     + G   A   +      +       L +E+ +LK +KH
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD----SSLENEIAVLKKIKH 65

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
           ENI+   + +   T+    ++ +L + G L     +      K      +Q+L  + YLH
Sbjct: 66  ENIVTLEDIYESTTH--YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH 123

Query: 146 SHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYE 202
            +   I+HRDLK +N+       N ++ I D GL+ + Q     +  GTP ++APE L +
Sbjct: 124 ENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQ 181

Query: 203 EEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQ 257
           + Y++ VD +S G  I  ++ C YP  Y E    +++++K+  G    +      +++  
Sbjct: 182 KPYSKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKEGYYEFESPFWDDISE-S 237

Query: 258 VKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
            K FI   +    + R    + L  P++  +        P     +
Sbjct: 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQI 283

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  137 bits (347), Expect = 1e-37
 Identities = 74/290 (25%), Positives = 132/290 (45%), Gaps = 23/290 (7%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSL 83
            YD  E LG G F  V K  ++  G+E A   +       S   + R  +  EV +L+ +
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
            H N+I  ++ + + T+  + +I EL + G L  +  + +++  +   ++ +QIL G++Y
Sbjct: 73  LHHNVITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 144 LHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 199
           LH+    I H DLK +NI +   N     +K+ D GLA  ++     +++ GTPEF+APE
Sbjct: 131 LHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 253
            +  E      D++S G  I  ++         +     +    +TS          S  
Sbjct: 189 IVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITSVSYDFDEEFFSHT 245

Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
           ++   K FI K +V     RL   E L+ P++   + +  +     + NL
Sbjct: 246 SE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNL 294

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  138 bits (350), Expect = 1e-37
 Identities = 69/279 (24%), Positives = 129/279 (46%), Gaps = 24/279 (8%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           EILG G F  V+K  +   G+++A   +      +     E + +E+ ++  L H N+I+
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKT----RGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 91  FYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
            Y+++    +  I ++ E    G L  R   + +   ++  I  + +QI  G+ ++H   
Sbjct: 151 LYDAFESKND--IVLVMEYVDGGELFDRIIDESYNLTELDTI-LFMKQICEGIRHMHQMY 207

Query: 149 PPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LYEEEY 205
             I+H DLK +NI  VN +  ++KI D GLA   +     +   GTPEF+APE +  +  
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265

Query: 206 NELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQ 260
           +   D++S G+ I  M+         +  N A+    + +     +      +++ + K+
Sbjct: 266 SFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAETLNNILACRWDLEDEEFQDISE-EAKE 321

Query: 261 FIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
           FI K ++   S R+ A E LK P+L        +    +
Sbjct: 322 FISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  137 bits (347), Expect = 2e-37
 Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 63/320 (19%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLK 84
           +Y     +G+G++  V    +       A   +N   + Q +P  +ER+ +EV L+K L 
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA---------- 134
           H NI + Y  + D+    I ++ EL   G L        +                    
Sbjct: 87  HPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 135 ------------------------------RQILRGLHYLHSHNPPIIHRDLKCDNI-FV 163
                                         RQI   LHYLH+    I HRD+K +N  F 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFS 202

Query: 164 NGNNGEVKIGDLGLAIVMQQPTA------RSVIGTPEFMAPEL---YEEEYNELVDIYSF 214
              + E+K+ D GL+    +          +  GTP F+APE+     E Y    D +S 
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262

Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVP-AS 270
           G  +L ++          N A    +V +     +  + + ++    +  +   +     
Sbjct: 263 G-VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSP-LARDLLSNLLNRNVD 320

Query: 271 LRLPALELLKDPFLVTDNPK 290
            R  A+  L+ P++   + K
Sbjct: 321 ERFDAMRALQHPWISQFSDK 340

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  137 bits (346), Expect = 3e-37
 Identities = 74/290 (25%), Positives = 133/290 (45%), Gaps = 23/290 (7%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL--ERLYSEVHLLKSL 83
            YD  E LG G F  V K  ++  G+E A   +       S   +  E +  EV +L+ +
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
            H NII  ++ + + T+  + +I EL + G L  +  + +++  +   ++ +QIL G++Y
Sbjct: 73  LHPNIITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 144 LHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 199
           LH+    I H DLK +NI +   N     +K+ D GLA  ++     +++ GTPEF+APE
Sbjct: 131 LHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 253
            +  E      D++S G  I  ++         +     +    +T+          S+ 
Sbjct: 189 IVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITAVSYDFDEEFFSQT 245

Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
           ++   K FI K +V     RL   E L+ P++   + +  +     + NL
Sbjct: 246 SE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNL 294

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  137 bits (345), Expect = 5e-37
 Identities = 46/308 (14%), Positives = 88/308 (28%), Gaps = 47/308 (15%)

Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
           S      R  +  E L  G    V+   D     + A  +V       S  +LERL+   
Sbjct: 55  SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFAL-KVFTMGAENSRSELERLHEAT 113

Query: 78  HLLKSLKHEN------------------------IIKFYNSWVDDTNRTINMITELFTS- 112
                L  E+                          +      D       ++    +  
Sbjct: 114 FAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVD 173

Query: 113 -----GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167
                 +L        +  + A+     Q++R    L S    ++H     DN+F+   +
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFI-MPD 230

Query: 168 GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVT 223
           G + +GD+      +  T       P   AP  +       +   ++ +  G+ I  +  
Sbjct: 231 GRLMLGDVSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288

Query: 224 CEYPYNEC-KNPAQIYKKVTSGIK-----PASLSKVTDPQVKQFIEKCIVP-ASLRLPAL 276
              P+          +K+ +  +                 VK  I + +      RL  L
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348

Query: 277 ELLKDPFL 284
           E ++ P  
Sbjct: 349 EAMETPEF 356

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  134 bits (339), Expect = 7e-37
 Identities = 69/280 (24%), Positives = 128/280 (45%), Gaps = 23/280 (8%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSL 83
            Y+  E LG G F  V K   +  G E A   +    +  S   + R  +  EV++L+ +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
           +H NII  ++ + + T+  + +I EL + G L  +  + +++       + +QIL G+HY
Sbjct: 66  RHPNIITLHDIFENKTD--VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123

Query: 144 LHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 199
           LHS    I H DLK +NI +   N  N  +K+ D G+A  ++     +++ GTPEF+APE
Sbjct: 124 LHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181

Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 253
            +  E      D++S G  I  ++         E     +    +++          S  
Sbjct: 182 IVNYEPLGLEADMWSIG-VITYILLSGASPFLGE--TKQETLTNISAVNYDFDEEYFSNT 238

Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
           ++   K FI + +V     R+   + L+  ++     +++
Sbjct: 239 SE-LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  137 bits (348), Expect = 1e-36
 Identities = 73/289 (25%), Positives = 134/289 (46%), Gaps = 24/289 (8%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            Y   E LGKGAF  V +    + G E A   +N + +  S    ++L  E  + + LKH
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKH 69

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
            NI++ ++S  ++ +    +I +L T G L +     +        +  +QIL  + + H
Sbjct: 70  PNIVRLHDSISEEGH--HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127

Query: 146 SHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE-L 200
                ++HR+LK +N+   +      VK+ D GLAI ++          GTP +++PE L
Sbjct: 128 QMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185

Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTD 255
            ++ Y + VD+++ G  IL ++   YP  ++E  +  ++Y+++ +G           VT 
Sbjct: 186 RKDPYGKPVDLWACG-VILYILLVGYPPFWDE--DQHRLYQQIKAGAYDFPSPEWDTVTP 242

Query: 256 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP-KDLVCDPLRLPNL 302
            + K  I K +    S R+ A E LK P++   +     +     +  L
Sbjct: 243 -EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCL 290

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  134 bits (340), Expect = 1e-36
 Identities = 55/276 (19%), Positives = 114/276 (41%), Gaps = 27/276 (9%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           +Y   E LG+G F  V++  +              + V         +  E+ +L   +H
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYM-----AKFVKVKGTDQVLVKKEISILNIARH 60

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--KAIKNWARQILRGLHY 143
            NI+  + S+       + MI E  +   + + R      ++  + I ++  Q+   L +
Sbjct: 61  RNILHLHESFESMEE--LVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQF 117

Query: 144 LHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-L 200
           LHSHN  I H D++ +NI +    +  +KI + G A  ++     R +   PE+ APE  
Sbjct: 118 LHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175

Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTD 255
             +  +   D++S G  ++ ++         E     QI + + +        +  +++ 
Sbjct: 176 QHDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISI 232

Query: 256 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
            +   F+++ +V     R+ A E L+ P+L     +
Sbjct: 233 -EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  135 bits (341), Expect = 1e-36
 Identities = 78/296 (26%), Positives = 142/296 (47%), Gaps = 23/296 (7%)

Query: 18  SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLY 74
           S  D     G Y   + +GKG F  V      + G EVA   + I D  Q +P  L++L+
Sbjct: 6   SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVA---IKIIDKTQLNPTSLQKLF 62

Query: 75  SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 134
            EV ++K L H NI+K +   V +T +T+ +I E  + G +  Y   H  +  K  ++  
Sbjct: 63  REVRIMKILNHPNIVKLFE--VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF 120

Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTP 193
           RQI+  + Y H     I+HRDLK +N+ +   +  +KI D G +          +  G P
Sbjct: 121 RQIVSAVQYCHQKR--IVHRDLKAENLLL-DADMNIKIADFGFSNEFTVGGKLDAFCGAP 177

Query: 194 EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPAS 249
            + APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYRIPFY 236

Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 304
           +S       +  +++ +V     R    +++KD ++   + +D +  P   P L  
Sbjct: 237 MS----TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL-KPFVEPELDI 287

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  135 bits (341), Expect = 2e-36
 Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 29/298 (9%)

Query: 8   TKSETEEGEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
           T S   +      +       ++    LG+GA   VY+   +      A   +       
Sbjct: 34  TASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK- 92

Query: 66  SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
                + + +E+ +L  L H NIIK    +   T   I+++ EL T G L     +    
Sbjct: 93  -----KIVRTEIGVLLRLSHPNIIKLKEIFETPTE--ISLVLELVTGGELFDRIVEKGYY 145

Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 183
             +   +  +QIL  + YLH +   I+HRDLK +N+ +     +  +KI D GL+ +++ 
Sbjct: 146 SERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203

Query: 184 PTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFG--MCILEMVTCEYP--YNECKNPAQI 237
               ++V GTP + APE L    Y   VD++S G    IL    C +   Y+E +    +
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYIL---LCGFEPFYDE-RGDQFM 259

Query: 238 YKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
           ++++ +           +V+    K  + K IV     RL   + L+ P++       
Sbjct: 260 FRRILNCEYYFISPWWDEVSL-NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  135 bits (340), Expect = 2e-36
 Identities = 50/276 (18%), Positives = 101/276 (36%), Gaps = 33/276 (11%)

Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENI 88
             +LG+GAF  VY+             +  ++    + P +       +  LK       
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN-----WARQILRGLHY 143
           +KFY++ +        ++ EL++ G+L      +KN   K +       +A ++L  +  
Sbjct: 130 MKFYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187

Query: 144 LHSHNPPIIHRDLKCDNIFVNG----------NNGEVKIGDLGLAIVMQQP----TARSV 189
           +H     IIH D+K DN  +             +  + + DLG +I M+         + 
Sbjct: 188 VHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 190 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248
             T  F   E L  + +N  +D +     +  M+   Y   + +      + +   +   
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHL 305

Query: 249 SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPF 283
            +         +F    + +P    LP+L+LL+   
Sbjct: 306 DMW-------NEFFHVMLNIPDCHHLPSLDLLRQKL 334

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  133 bits (338), Expect = 3e-36
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 23/279 (8%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL--ERLYSEVHLLKSL 83
            YD  E LG G F  V K  ++  G++ A   +       S   +  E +  EV +LK +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
           +H N+I  +  + + T+  + +I EL   G L  +  + +++  +    + +QIL G++Y
Sbjct: 72  QHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129

Query: 144 LHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 199
           LHS    I H DLK +NI +   N     +KI D GLA  +      +++ GTPEF+APE
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187

Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 253
            +  E      D++S G  I  ++         +     +    V++     +    S  
Sbjct: 188 IVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFSNT 244

Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
           +    K FI + +V     R+   + L+ P++   + + 
Sbjct: 245 SA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  132 bits (335), Expect = 5e-36
 Identities = 70/308 (22%), Positives = 124/308 (40%), Gaps = 36/308 (11%)

Query: 8   TKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVA--------WNQVN 59
           T+     G  S       Y    EILG+G    V +   +    E A            +
Sbjct: 1   TRDAALPGSHSTHGFYENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59

Query: 60  IEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY 118
            E+V +  +   +   EV +L+ +  H NII+  +++  +T     ++ +L   G L  Y
Sbjct: 60  AEEVQELREATLK---EVDILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDY 114

Query: 119 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
             +   +  K  +   R +L  +  LH  N  I+HRDLK +NI ++ ++  +K+ D G +
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFS 171

Query: 179 IVMQQPTA-RSVIGTPEFMAPE-------LYEEEYNELVDIYSFGMCILEMVTCEYP--Y 228
             +      R V GTP ++APE            Y + VD++S G  I+  +    P  +
Sbjct: 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTLLAGSPPFW 230

Query: 229 NECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
           +       + + + SG            +D  VK  + + +V     R  A E L  PF 
Sbjct: 231 HR--KQMLMLRMIMSGNYQFGSPEWDDYSDT-VKDLVSRFLVVQPQKRYTAEEALAHPFF 287

Query: 285 VTDNPKDL 292
                +++
Sbjct: 288 QQYVVEEV 295

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  132 bits (335), Expect = 9e-36
 Identities = 66/327 (20%), Positives = 126/327 (38%), Gaps = 39/327 (11%)

Query: 7   FTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS 66
           F   E ++   ++      Y    ++LG G    V + F    G + A         ++ 
Sbjct: 16  FQGPEPKKYAVTDD-----YQLSKQVLGLGVNGKVLECFHRRTGQKCA---------LKL 61

Query: 67  PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN--RTINMITELFTSGSL--RQYRKK 121
                +   EV          +I+   + + +  +  R + +I E    G L  R   + 
Sbjct: 62  LYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG 121

Query: 122 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAI 179
            +    +      R I   + +LHSHN  I HRD+K +N+ + +   +  +K+ D G A 
Sbjct: 122 DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179

Query: 180 VMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKN--P 234
              Q   ++   TP ++APE L  E+Y++  D++S G  I+ ++ C +P  Y+       
Sbjct: 180 ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQAIS 238

Query: 235 AQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL-----V 285
             + +++  G         S+V++   KQ I   +    + RL   + +  P++     V
Sbjct: 239 PGMKRRIRLGQYGFPNPEWSEVSE-DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297

Query: 286 TDNPKDLVCDPLRLPNLVPEVMNLAHS 312
              P           +   EV     S
Sbjct: 298 PQTPLHTARVLQEDKDHWDEVKEEMTS 324

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  131 bits (332), Expect = 1e-35
 Identities = 61/309 (19%), Positives = 127/309 (41%), Gaps = 21/309 (6%)

Query: 25  RYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
             G+Y   ++LG+G++  V +  D       A   +  + + + P+    +  E+ LL+ 
Sbjct: 3   LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGL 141
           L+H+N+I+  +   ++  + + M+ E    G          K   +     +  Q++ GL
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMA 197
            YLHS    I+H+D+K  N+ +    G +KI  LG+A  +    A        G+P F  
Sbjct: 123 EYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 198 PELY--EEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSK 252
           PE+    + ++   VDI+S G+ +  + T  YP+    N  ++++ +  G    P     
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSYAIPGDCG- 237

Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAH 311
              P +   ++  +    + R    ++ +  +    +P      P+       +      
Sbjct: 238 ---PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMT 294

Query: 312 SEPHPMDID 320
             P+  D+ 
Sbjct: 295 VVPYLEDLH 303

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  136 bits (344), Expect = 1e-35
 Identities = 68/289 (23%), Positives = 122/289 (42%), Gaps = 26/289 (8%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            YD  E LG GAF  V++  +   G   A   V            E +  E+  +  L+H
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT----PHESDKETVRKEIQTMSVLRH 213

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSL-RQYRKKHKNVDMKAIKNWARQILRGLHYL 144
             ++  ++++ DD    + MI E  + G L  +   +H  +       + RQ+ +GL ++
Sbjct: 214 PTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271

Query: 145 HSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LY 201
           H +N   +H DLK +NI F    + E+K+ D GL   +    + +   GT EF APE   
Sbjct: 272 HENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329

Query: 202 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 256
            +      D++S G  +  ++         E  N  +  + V S       ++ S +++ 
Sbjct: 330 GKPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISE- 385

Query: 257 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN--PKDLVCDPLRLPNL 302
             K FI K ++   + R+   + L+ P+L   N   +D      R   +
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 434

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  130 bits (330), Expect = 2e-35
 Identities = 58/260 (22%), Positives = 113/260 (43%), Gaps = 35/260 (13%)

Query: 15  GEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVA------------------ 54
           G         +  +Y   + +GKG++  V   ++E D    A                  
Sbjct: 1   GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRR 60

Query: 55  ----WNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110
                 +      +Q    +E++Y E+ +LK L H N++K      D     + M+ EL 
Sbjct: 61  PPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELV 120

Query: 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170
             G + +        + +A   + + +++G+ YLH     IIHRD+K  N+ V G +G +
Sbjct: 121 NQGPVMEVPTLKPLSEDQARF-YFQDLIKGIEYLHYQK--IIHRDIKPSNLLV-GEDGHI 176

Query: 171 KIGDLGLAIVMQQPTA--RSVIGTPEFMAPEL---YEEEYN-ELVDIYSFGMCILEMVTC 224
           KI D G++   +   A   + +GTP FMAPE      + ++ + +D+++ G+ +   V  
Sbjct: 177 KIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

Query: 225 EYPYNECKNPAQIYKKVTSG 244
           + P+ + +    ++ K+ S 
Sbjct: 237 QCPFMD-ERIMCLHSKIKSQ 255

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  131 bits (332), Expect = 2e-35
 Identities = 64/282 (22%), Positives = 116/282 (41%), Gaps = 23/282 (8%)

Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            Y    + LG+G F  V +   +  G E A   +         D    +  E+ +L+  K
Sbjct: 29  FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAK 86

Query: 85  H-ENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILRGL 141
               +I  +  + + +   I +I E    G +      +  + V    +    +QIL G+
Sbjct: 87  SCPRVINLHEVYENTSE--IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144

Query: 142 HYLHSHNPPIIHRDLKCDNI-FVNGN-NGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAP 198
           +YLH +N  I+H DLK  NI   +    G++KI D G++  +      R ++GTPE++AP
Sbjct: 145 YYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202

Query: 199 E-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSK 252
           E L  +      D+++ G+ I  M+         E  +  + Y  ++         + S 
Sbjct: 203 EILNYDPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQETYLNISQVNVDYSEETFSS 259

Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLV 293
           V+      FI+  +V     R  A   L   +L   + ++L 
Sbjct: 260 VSQ-LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  131 bits (331), Expect = 2e-35
 Identities = 64/305 (20%), Positives = 114/305 (37%), Gaps = 29/305 (9%)

Query: 10  SETEEGEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP 67
             T       KD       Y    +LGKG F TV+ G    D ++VA   +    V+   
Sbjct: 14  PGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS 73

Query: 68  --DQLERLYSEVHLLKSL----KHENIIKFYNSWVDDTNRTINMITELFTSGS-LRQYRK 120
                     EV LL  +     H  +I+  +    +T     ++ E       L  Y  
Sbjct: 74  PLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD--WFETQEGFMLVLERPLPAQDLFDYIT 131

Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
           +   +     + +  Q++  + + HS    ++HRD+K +NI ++   G  K+ D G   +
Sbjct: 132 EKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGAL 189

Query: 181 MQQPTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
           +         GT  +  PE     +Y+     ++S G+ + +MV  + P+          
Sbjct: 190 LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER-------D 242

Query: 239 KKVTSGI--KPASLSKVTDPQVKQFIEKCIVPA-SLRLPALELLKDPFLVTDNPKDLVCD 295
           +++       PA +S    P     I +C+ P  S R    E+L DP++ T      +  
Sbjct: 243 QEILEAELHFPAHVS----PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNP 298

Query: 296 PLRLP 300
               P
Sbjct: 299 SKGGP 303

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  133 bits (336), Expect = 3e-35
 Identities = 68/319 (21%), Positives = 114/319 (35%), Gaps = 52/319 (16%)

Query: 10  SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
           S        E+         ++ILG G+  TV        G  VA  ++         D 
Sbjct: 1   SRIANIPNFEQSLKNLV-VSEKILGYGSSGTVVFQ-GSFQGRPVAVKRML-------IDF 51

Query: 70  LERLYSEVHLL-KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-------RQYRKK 121
            +    E+ LL +S  H N+I++Y S   D    + +  EL  + +L           + 
Sbjct: 52  CDIALMEIKLLTESDDHPNVIRYYCSETTDRF--LYIALEL-CNLNLQDLVESKNVSDEN 108

Query: 122 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------------GNNGE 169
            K        +  RQI  G+ +LHS    IIHRDLK  NI V+              N  
Sbjct: 109 LKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166

Query: 170 VKIGDLGLAIVMQ------QPTARSVIGTPEFMAPEL--------YEEEYNELVDIYSFG 215
           + I D GL   +       +    +  GT  + APEL         +      +DI+S G
Sbjct: 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226

Query: 216 MCILEMVTCEYP--YNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCIVP-ASL 271
                +++       ++    + I + + S  +   L   +   +    I + I      
Sbjct: 227 CVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK 286

Query: 272 RLPALELLKDPFLVTDNPK 290
           R  A+++L+ P     + K
Sbjct: 287 RPTAMKVLRHPLFWPKSKK 305

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  131 bits (331), Expect = 3e-35
 Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 35/253 (13%)

Query: 28  RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDV----MQSPDQLERLYSEVHL 79
           +Y   LGKG F +V         +  G  VA        V       PDQ      E+ +
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVA--------VKQLQHSGPDQQRDFQREIQI 77

Query: 80  LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQIL 138
           LK+L  + I+K+         +++ ++ E   SG LR + ++H+  +D   +  ++ QI 
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137

Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPE 194
           +G+ YL S     +HRDL   NI V  +   VKI D GLA ++         R    +P 
Sbjct: 138 KGMEYLGSRR--CVHRDLAARNILV-ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194

Query: 195 F-MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 251
           F  APE L +  ++   D++SFG+ + E+ T C+   +      ++              
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP------ 248

Query: 252 KVTDPQVKQFIEK 264
                ++ + +E+
Sbjct: 249 --ALSRLLELLEE 259

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  130 bits (329), Expect = 5e-35
 Identities = 58/300 (19%), Positives = 116/300 (38%), Gaps = 28/300 (9%)

Query: 18  SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERL 73
             K+      +Y    +LG G F +VY G    D + VA   V  + +          R+
Sbjct: 34  PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93

Query: 74  YSEVHLLKSLKHE--NIIKFYNSWVDDTNRTINMITELFT-SGSLRQYRKKHKNVDMKAI 130
             EV LLK +      +I+  +    +   +  +I E       L  +  +   +  +  
Sbjct: 94  PMEVVLLKKVSSGFSGVIRLLD--WFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151

Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
           +++  Q+L  + + H+    ++HRD+K +NI ++ N GE+K+ D G   +++        
Sbjct: 152 RSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 209

Query: 191 GTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--K 246
           GT  +  PE      Y+     ++S G+ + +MV  + P+          +++  G    
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQVFF 262

Query: 247 PASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLPNLVPE 305
              +S     + +  I  C+       P   E+   P++            + L +L P 
Sbjct: 263 RQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA-EIHLHSLSPG 317

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  131 bits (332), Expect = 7e-35
 Identities = 88/369 (23%), Positives = 148/369 (40%), Gaps = 71/369 (19%)

Query: 1   MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI 60
           +D  +   K    +G+  E+     Y    +++G G+F  V++        EVA     I
Sbjct: 18  LDDPNKVIKVLASDGKTGEQREI-AYTNC-KVIGNGSFGVVFQAKLVESD-EVA-----I 69

Query: 61  EDVMQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTS---G 113
           + V+Q          E+ +++ +KH N++     FY++        +N++ E        
Sbjct: 70  KKVLQDK---RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYR 126

Query: 114 SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173
           + R Y K  + + M  IK +  Q+LR L Y+HS    I HRD+K  N+ ++  +G +K+ 
Sbjct: 127 ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLI 184

Query: 174 DLGLA-IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE---- 225
           D G A I++      S I +  + APEL      Y   +DI+S G C++ E++  +    
Sbjct: 185 DFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQGQPLFP 243

Query: 226 ----------------YPYNE---CKNPAQIYKKVTSGIKPASLSKV----TDPQVKQFI 262
                            P  E     NP  +  K    I+P   SKV    T P     I
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDLI 302

Query: 263 EKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDID 320
            + +   P S RL A+E L  PF           D LR          + +    P   +
Sbjct: 303 SRLLEYTP-SARLTAIEALCHPFF----------DELRTGE-----ARMPNGRELPPLFN 346

Query: 321 LNHKKVSAD 329
              +++S  
Sbjct: 347 WTKEELSVR 355

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  129 bits (327), Expect = 1e-34
 Identities = 66/304 (21%), Positives = 122/304 (40%), Gaps = 32/304 (10%)

Query: 26  YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
               D+ LG+G+F    K   +      A   ++                E+  LK  + 
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-------KRMEANTQKEITALKLCEG 64

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H NI+K +  + D  +    ++ EL   G L +  KK K+          R+++  + ++
Sbjct: 65  HPNIVKLHEVFHDQLH--TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 145 HSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE- 199
           H     ++HRDLK +N+ F +  +N E+KI D G A +        ++   T  + APE 
Sbjct: 123 HDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180

Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYP-------YNECKNPAQIYKKVTSG---IKPAS 249
           L +  Y+E  D++S G  IL  +               C +  +I KK+  G    +  +
Sbjct: 181 LNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239

Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
              V+  + K  I+  +    + RL    L  + +L   +      +PL  P+++     
Sbjct: 240 WKNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS--NPLMTPDILGSSGA 296

Query: 309 LAHS 312
             H+
Sbjct: 297 AVHT 300

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  128 bits (325), Expect = 1e-34
 Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 26/270 (9%)

Query: 27  GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKS 82
            RY   + LG G   TVY   D +  I+VA   +        +  + L+R   EVH    
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSSQ 67

Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           L H+NI+   +   +D    + M  E     +L +Y + H  + +    N+  QIL G+ 
Sbjct: 68  LSHQNIVSMIDVDEEDDCYYLVM--EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPE 199
           + H     I+HRD+K  NI +  +N  +KI D G+A  + + +      V+GT ++ +PE
Sbjct: 126 HAHDMR--IVHRDIKPQNILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182

Query: 200 LYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQ 257
             + E  +E  DIYS G+ + EM+  E P+N  +    I  K +   + P   + V    
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQDSV-PNVTTDV-RKD 239

Query: 258 VKQFIEKCIVPASLRLP------ALELLKD 281
           + Q +   I+ A+ +          E+  D
Sbjct: 240 IPQSLSNVILRATEKDKANRYKTIQEMKDD 269

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  128 bits (323), Expect = 2e-34
 Identities = 68/248 (27%), Positives = 109/248 (43%), Gaps = 24/248 (9%)

Query: 28  RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
           ++ + LGKG F +V         +  G  VA  ++       + + L     E+ +LKSL
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSL 68

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLH 142
           +H+NI+K+         R + +I E    GSLR Y +KHK  +D   +  +  QI +G+ 
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--PEF-MA 197
           YL +     IHRDL   NI V  N   VKIGD GL   +   +   +       P F  A
Sbjct: 129 YLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185

Query: 198 PE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256
           PE L E +++   D++SFG+ + E+ T    Y E             G       ++   
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDK--QGQMIVF 239

Query: 257 QVKQFIEK 264
            + + ++ 
Sbjct: 240 HLIELLKN 247

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  130 bits (328), Expect = 3e-34
 Identities = 79/339 (23%), Positives = 134/339 (39%), Gaps = 66/339 (19%)

Query: 4   GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV 63
           GS  T      G+  ++     Y    +++G G+F  VY+      G  VA     I+ V
Sbjct: 34  GSKVTTVVATPGQGPDRPQEVSY-TDTKVIGNGSFGVVYQAKLCDSGELVA-----IKKV 87

Query: 64  MQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTS---GSLR 116
           +Q          E+ +++ L H NI++    FY+S        +N++ +          R
Sbjct: 88  LQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 144

Query: 117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
            Y +  + + +  +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G
Sbjct: 145 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG 202

Query: 177 LA-IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE------- 225
            A  +++     S I +  + APEL     +Y   +D++S G C+L E++  +       
Sbjct: 203 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG-CVLAELLLGQPIFPGDS 261

Query: 226 -------------YPYNE---CKNPAQIYKKVT-SGIKPASLSKV----TDPQVKQFIEK 264
                         P  E     NP   Y +     IK    +KV    T P+      +
Sbjct: 262 GVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 319

Query: 265 CIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
            +   P + RL  LE     F           D LR PN
Sbjct: 320 LLEYTP-TARLTPLEACAHSFF----------DELRDPN 347

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  128 bits (323), Expect = 4e-34
 Identities = 70/248 (28%), Positives = 111/248 (44%), Gaps = 24/248 (9%)

Query: 28  RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
           ++ + LGKG F +V         +  G  VA  ++       + + L     E+ +LKSL
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSL 99

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLH 142
           +H+NI+K+         R + +I E    GSLR Y +KHK  +D   +  +  QI +G+ 
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MA 197
           YL +     IHRDL   NI V  N   VKIGD GL  V+ Q       +    +P F  A
Sbjct: 160 YLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216

Query: 198 PE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256
           PE L E +++   D++SFG+ + E+ T    Y E             G       ++   
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDK--QGQMIVF 270

Query: 257 QVKQFIEK 264
            + + ++ 
Sbjct: 271 HLIELLKN 278

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  126 bits (319), Expect = 4e-34
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 17/275 (6%)

Query: 27  GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
             +D  + LG+GA+  V    + V    VA   V+++  +  P+ +++   E+ + K L 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLN 63

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           HEN++KFY            +  E  + G L    +    +     + +  Q++ G+ YL
Sbjct: 64  HENVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPE- 199
           H     I HRD+K +N+ ++     +KI D GLA V +      ++    GT  ++APE 
Sbjct: 122 HGIG--ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 200 LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
           L   E++ E VD++S G+ +  M+  E P+++  +  Q Y          +  K  D   
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238

Query: 259 KQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
              + K +V   S R+   ++ KD +      K  
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  128 bits (324), Expect = 5e-34
 Identities = 65/278 (23%), Positives = 124/278 (44%), Gaps = 30/278 (10%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL----ERLYSEVHLLK 81
           +YD  +++G+G    V +      G E A   + +     SP+QL    E    E H+L+
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154

Query: 82  SLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
            +  H +II   +S+   +   + ++ +L   G L  Y  +   +  K  ++  R +L  
Sbjct: 155 QVAGHPHIITLIDSYESSSF--MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 199
           + +LH++N  I+HRDLK +NI ++ +N ++++ D G +  ++     R + GTP ++APE
Sbjct: 213 VSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269

Query: 200 -------LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KP 247
                       Y + VD+++ G  IL  +    P  ++       + + +  G      
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACG-VILFTLLAGSPPFWHR--RQILMLRMIMEGQYQFSS 326

Query: 248 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
                 +   VK  I + +      RL A + L+ PF 
Sbjct: 327 PEWDDRSST-VKDLISRLLQVDPEARLTAEQALQHPFF 363

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  128 bits (324), Expect = 9e-34
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 30/220 (13%)

Query: 25  RYGRYDEILGKGAFKTVYKG--FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
            +      +G+G +  VYK    D  D  + A  Q+    +  S         E+ LL+ 
Sbjct: 21  LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRE 74

Query: 83  LKHENIIKFYNSWVDDTNRTINMITE--------LFTSGSLRQYRKKHKNVDMKAIKNWA 134
           LKH N+I     ++   +R + ++ +        +       +  KK   +    +K+  
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134

Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLAIVMQQPTARSVIG 191
            QIL G+HYLH++   ++HRDLK  NI V G     G VKI D+G A +   P       
Sbjct: 135 YQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192

Query: 192 TPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 223
            P  +     APEL      Y + +DI++ G CI  E++T
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIG-CIFAELLT 231

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  127 bits (320), Expect = 1e-33
 Identities = 68/304 (22%), Positives = 128/304 (42%), Gaps = 19/304 (6%)

Query: 27  GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
             +D  + LG+GA+  V    + V    VA   V+++  +  P+ +++   E+ + K L 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLN 63

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           HEN++KFY            +  E  + G L    +    +     + +  Q++ G+ YL
Sbjct: 64  HENVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPEL 200
           H     I HRD+K +N+ ++     +KI D GLA V +      ++    GT  ++APEL
Sbjct: 122 HGIG--ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 201 YE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIY-KKVTSGIKPASLSKVTDPQ 257
            +  E++ E VD++S G+ +  M+  E P+++  +  Q Y              K+ D  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSA 237

Query: 258 VKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHP 316
               + K +V   S R+   ++ KD +      K      +    +       +      
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSN 297

Query: 317 MDID 320
           +D  
Sbjct: 298 LDFS 301

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  127 bits (320), Expect = 1e-33
 Identities = 67/312 (21%), Positives = 123/312 (39%), Gaps = 30/312 (9%)

Query: 8   TKSETEEGEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVN----IE 61
              +  E E           +Y     LG GAF  V+   D+    EV    +     +E
Sbjct: 5   EPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE 64

Query: 62  DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGS-LRQYRK 120
           D      +L ++  E+ +L  ++H NIIK  +  + +      ++ E   SG  L  +  
Sbjct: 65  DCWIEDPKLGKVTLEIAILSRVEHANIIKVLD--IFENQGFFQLVMEKHGSGLDLFAFID 122

Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
           +H  +D        RQ++  + YL   +  IIHRD+K +NI +   +  +K+ D G A  
Sbjct: 123 RHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAE-DFTIKLIDFGSAAY 179

Query: 181 MQQ-PTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237
           +++     +  GT E+ APE+     Y    ++++S G+  L  +  E       NP   
Sbjct: 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGV-TLYTLVFEE------NPFCE 232

Query: 238 YKKVTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD-NPKDLV 293
            ++        P  +S     ++   +   + P    R    +L+ DP++    N  D  
Sbjct: 233 LEETVEAAIHPPYLVS----KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYT 288

Query: 294 CDPLRLPNLVPE 305
            + +   N    
Sbjct: 289 WEEVFRVNKPES 300

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  125 bits (316), Expect = 3e-33
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 17/206 (8%)

Query: 28  RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
           +    LG+G F  V        ++  G  VA   V        P        E+ +L++L
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVA---VKALKADAGPQHRSGWKQEIDILRTL 90

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
            HE+IIK+     D    ++ ++ E    GSLR Y  +H  + +  +  +A+QI  G+ Y
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAY 149

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MAP 198
           LH+ +   IHRDL   N+ +  N+  VKIGD GLA  + +       R    +P F  AP
Sbjct: 150 LHAQH--YIHRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206

Query: 199 E-LYEEEYNELVDIYSFGMCILEMVT 223
           E L E ++    D++SFG+ + E++T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  126 bits (319), Expect = 4e-33
 Identities = 58/281 (20%), Positives = 117/281 (41%), Gaps = 30/281 (10%)

Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL- 83
            Y    ++LG G    V + F++    + A     ++D         +   EV L     
Sbjct: 62  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--LQDC-------PKARREVELHWRAS 112

Query: 84  KHENIIKFYNSWVD--DTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILR 139
           +  +I++  + + +     + + ++ E    G L  R   +  +    +      + I  
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 140 GLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFM 196
            + YLHS N  I HRD+K +N+ + +   N  +K+ D G A       +  +   TP ++
Sbjct: 173 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 230

Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQ--IYKKVTSGI---KPA 248
           APE L  E+Y++  D++S G  I+ ++ C YP  Y+         +  ++  G       
Sbjct: 231 APEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289

Query: 249 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 288
             S+V++ +VK  I   +    + R+   E +  P+++   
Sbjct: 290 EWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  124 bits (314), Expect = 5e-33
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 28  RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
           +    LG+G F  V         +  G +VA   V         + +  L  E+ +L++L
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVA---VKSLKPESGGNHIADLKKEIEILRNL 80

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLH 142
            HENI+K+     +D    I +I E   SGSL++Y  K+K  +++K    +A QI +G+ 
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MA 197
           YL S     +HRDL   N+ V  +  +VKIGD GL   ++      T +    +P F  A
Sbjct: 141 YLGSRQ--YVHRDLAARNVLV-ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197

Query: 198 PE-LYEEEYNELVDIYSFGMCILEMVT 223
           PE L + ++    D++SFG+ + E++T
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  123 bits (312), Expect = 5e-33
 Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 21/284 (7%)

Query: 18  SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
           S+ D   + G Y   + LG G F  V  G  ++ G +VA   +N    ++S D + ++  
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKR 60

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           E+  LK  +H +IIK Y   V  T     M+ E  + G L  Y  KH  V+    +   +
Sbjct: 61  EIQNLKLFRHPHIIKLYQ--VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ 118

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPE 194
           QIL  + Y H H   ++HRDLK +N+ ++  +   KI D GL+ +M      R+  G+P 
Sbjct: 119 QILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPN 175

Query: 195 FMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSGI--KPAS 249
           + APE+     Y    VDI+S G+ IL  + C   P+++ ++   ++KK+  G+   P  
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGV-ILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEY 233

Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
           L+      V   +   +      R    ++ +  +   D P  L
Sbjct: 234 LN----RSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  125 bits (315), Expect = 5e-33
 Identities = 63/226 (27%), Positives = 107/226 (47%), Gaps = 21/226 (9%)

Query: 30  DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            ++LG GAF TVYKG      E   I VA   +       SP   + +  E +++ S+ +
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDN 76

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 144
            ++ +           T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL
Sbjct: 77  PHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGT--P-EFMAPE- 199
                 ++HRDL   N+ V      VKI D GLA ++  +       G   P ++MA E 
Sbjct: 134 EDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 200 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           +    Y    D++S+G+ + E++T    PY+     ++I   +  G
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  124 bits (313), Expect = 3e-32
 Identities = 58/221 (26%), Positives = 87/221 (39%), Gaps = 16/221 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +G+G F  V+ G    D   VA      E +   PD   +   E  +LK   H NI++
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLP--PDLKAKFLQEARILKQYSHPNIVR 176

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
                V    + I ++ EL   G    + R +   + +K +         G+ YL S   
Sbjct: 177 LIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC- 233

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEE 204
             IHRDL   N  V   N  +KI D G++         +  G  +      APE L    
Sbjct: 234 -CIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291

Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           Y+   D++SFG+ + E  +    PY    N  Q  + V  G
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKG 331

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  122 bits (308), Expect = 3e-32
 Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 25/213 (11%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLK 84
           +Y+  E +G+G + TV+K  +      VA  +V ++D  +  P    R   E+ LLK LK
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELK 59

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHY 143
           H+NI++ ++  V  +++ + ++ E F    L++Y        D + +K++  Q+L+GL +
Sbjct: 60  HKNIVRLHD--VLHSDKKLTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----AP 198
            HS N  ++HRDLK  N+ +N  NGE+K+ + GLA     P  R    + E +      P
Sbjct: 117 CHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPV-RCY--SAEVVTLWYRPP 170

Query: 199 ELY--EEEYNELVDIYSFGMCIL-EMVTCEYPY 228
           ++    + Y+  +D++S G CI  E+     P 
Sbjct: 171 DVLFGAKLYSTSIDMWSAG-CIFAELANAGRPL 202

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  123 bits (310), Expect = 3e-32
 Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 30/277 (10%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLK 84
            Y+  E +G G++    +   +   +E A   V I  + +S         E+  LL+  +
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNMEFA---VKI--IDKSKRDPTE---EIEILLRYGQ 74

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H NII   +  V D  + + ++TEL   G L     + K    +        I + + YL
Sbjct: 75  HPNIITLKD--VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132

Query: 145 HSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE 199
           H+    ++HRDLK  NI     +GN   ++I D G A  ++       +   T  F+APE
Sbjct: 133 HAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190

Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECK-NPAQIYKKVTSG---IKPASLSK 252
            L  + Y+   DI+S G  +L  +   Y    N     P +I  ++ SG   +     + 
Sbjct: 191 VLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249

Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 288
           V+D   K  + K +      RL A  +L+ P++V  +
Sbjct: 250 VSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  121 bits (307), Expect = 7e-32
 Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 34/221 (15%)

Query: 22  PSCRY-GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--- 75
           PS     RY     LG+G +  VYK  D V    VA  ++ +E       + E +     
Sbjct: 28  PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE------HEEEGVPGTAI 81

Query: 76  -EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 134
            EV LLK L+H NII+  +  V   N  +++I E +    L++Y  K+ +V M+ IK++ 
Sbjct: 82  REVSLLKELQHRNIIELKS--VIHHNHRLHLIFE-YAENDLKKYMDKNPDVSMRVIKSFL 138

Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQQPTARSVI 190
            Q++ G+++ HS     +HRDLK  N+ ++         +KIGD GLA     P  +   
Sbjct: 139 YQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-- 194

Query: 191 GTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 223
            T E +      PE+      Y+  VDI+S   CI  EM+ 
Sbjct: 195 -THEIITLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEMLM 233

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  122 bits (307), Expect = 1e-31
 Identities = 71/323 (21%), Positives = 131/323 (40%), Gaps = 38/323 (11%)

Query: 18  SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
            +        RYD  + +G G F       D++    VA   +     +      E +  
Sbjct: 11  LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-----ENVQR 65

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           E+   +SL+H NI++F    V  T   + +I E  + G L +             + + +
Sbjct: 66  EIINHRSLRHPNIVRFKE--VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ 123

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTA-RSVIGTP 193
           Q+L G+ Y HS    I HRDLK +N  ++G+    +KI D G +      +  +S +GTP
Sbjct: 124 QLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 181

Query: 194 EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-- 249
            ++APE+   +EY+ ++ D++S G+ +  M+   YP+ E     + Y+K    I      
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYS 240

Query: 250 ------LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
                 +S    P+    I +  V   + R+   E+    + + + P DL+ +       
Sbjct: 241 IPDDIRIS----PECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQF 296

Query: 303 ---------VPEVMNLAHSEPHP 316
                    +  +M +      P
Sbjct: 297 QEPEQPMQSLDTIMQIISEATIP 319

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (313), Expect = 3e-31
 Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 21/211 (9%)

Query: 27  GRY--DEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
           G+Y     +  G    +Y   D  V+G  V    +         +      +E   L  +
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNVNGRPVV---LKGLVHSGDAEAQAMAMAERQFLAEV 136

Query: 84  KHENIIKFYNSWVDDTNRTINMIT----ELFTSGSLRQYRKKHKNVDMKAIKNWARQILR 139
            H +I++ +N +V+ T+R  + +     E     SL++ + +   V  +AI  +  +IL 
Sbjct: 137 VHPSIVQIFN-FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA-EAI-AYLLEILP 193

Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE 199
            L YLHS    +++ DLK +NI +     ++K+ DLG    +       + GTP F APE
Sbjct: 194 ALSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAVSRINSFGY--LYGTPGFQAPE 247

Query: 200 LYEEEYNELVDIYSFGMCIL-EMVTCEYPYN 229
           +         DIY+ G   L  +       N
Sbjct: 248 IVRTGPTVATDIYTVG-RTLAALTLDLPTRN 277

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  120 bits (302), Expect = 3e-31
 Identities = 68/327 (20%), Positives = 131/327 (40%), Gaps = 52/327 (15%)

Query: 10  SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
           +++  G F +      Y   +++LG+GA   V    + +   E A   V I +      +
Sbjct: 3   TDSFSGRFEDV-----YQLQEDVLGEGAHARVQTCINLITSQEYA---VKIIEKQPGHIR 54

Query: 70  LERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
             R++ EV +L   + H N+++    + ++      ++ E    GS+  +  K ++ +  
Sbjct: 55  -SRVFREVEMLYQCQGHRNVLELIEFFEEEDR--FYLVFEKMRGGSILSHIHKRRHFNEL 111

Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ---- 182
                 + +   L +LH+    I HRDLK +NI   +      VKI D  L   ++    
Sbjct: 112 EASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169

Query: 183 -----QPTARSVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYP--YN 229
                 P   +  G+ E+MAPE           Y++  D++S G  IL ++   YP    
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYILLSGYPPFVG 228

Query: 230 ECK-------------NPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLR 272
            C                  +++ +  G         + ++    K  I K +V  A  R
Sbjct: 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC-AAKDLISKLLVRDAKQR 287

Query: 273 LPALELLKDPFLVTDNPKDLVCDPLRL 299
           L A ++L+ P++    P++ +  P+ L
Sbjct: 288 LSAAQVLQHPWVQGCAPENTLPTPMVL 314

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  120 bits (302), Expect = 3e-31
 Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 24/207 (11%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            Y   + LG+G + TVYKG  ++    VA  ++ +E    +P    R   EV LLK LKH
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKH 59

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYL 144
            NI+  ++  +  T +++ ++ E +    L+QY     N+ +M  +K +  Q+LRGL Y 
Sbjct: 60  ANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APE 199
           H     ++HRDLK  N+ +N   GE+K+ D GLA     PT        E +      P+
Sbjct: 117 HRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY---DNEVVTLWYRPPD 170

Query: 200 LY--EEEYNELVDIYSFGMCIL-EMVT 223
           +     +Y+  +D++  G CI  EM T
Sbjct: 171 ILLGSTDYSTQIDMWGVG-CIFYEMAT 196

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  119 bits (300), Expect = 3e-31
 Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 23/225 (10%)

Query: 30  DEILGKGAFKTVYKGF---DEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLK 84
            E LG G+F  V +G         + VA   V     DV+  P+ ++    EV+ + SL 
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVA---VKCLKPDVLSQPEAMDDFIREVNAMHSLD 79

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHY 143
           H N+I+ Y   V      + M+TEL   GSL    +KH+ +  +  +  +A Q+  G+ Y
Sbjct: 80  HRNLIRLYG--V-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAP 198
           L S     IHRDL   N+ +   +  VKIGD GL   +               P  + AP
Sbjct: 137 LESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193

Query: 199 E-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 241
           E L    ++   D + FG+ + EM T  + P+      +QI  K+
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKI 237

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  122 bits (307), Expect = 6e-31
 Identities = 80/287 (27%), Positives = 135/287 (47%), Gaps = 19/287 (6%)

Query: 18  SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
            + D   + G Y   + LG G F  V  G  E+ G +VA   +N    ++S D + ++  
Sbjct: 7   QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRR 65

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
           E+  LK  +H +IIK Y   V  T   I M+ E  + G L  Y  K+  +D K  +   +
Sbjct: 66  EIQNLKLFRHPHIIKLYQ--VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ 123

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPE 194
           QIL G+ Y H H   ++HRDLK +N+ ++  +   KI D GL+ +M      R+  G+P 
Sbjct: 124 QILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPN 180

Query: 195 FMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASL 250
           + APE+     Y    VDI+S G+ +  ++    P+++  +   ++KK+  GI   P  L
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYL 239

Query: 251 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDP 296
           +    P V   ++  +      R    ++ +  +   D PK L  + 
Sbjct: 240 N----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPED 282

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  119 bits (301), Expect = 7e-31
 Identities = 88/341 (25%), Positives = 151/341 (44%), Gaps = 29/341 (8%)

Query: 25  RYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIED--VMQSPDQLERLYSEVHLL 80
             G Y   E LG+G+F  V          +VA   +      +++  D   R+  E+  L
Sbjct: 7   HIGPYIIRETLGEGSFGKVKLATHYKTQQKVA---LKFISRQLLKKSDMHMRVEREISYL 63

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           K L+H +IIK Y+  V  T   I M+ E +  G L  Y  + K +     + + +QI+  
Sbjct: 64  KLLRHPHIIKLYD--VITTPTDIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPE 199
           + Y H H   I+HRDLK +N+ ++ +N  VKI D GL+ +M      ++  G+P + APE
Sbjct: 121 IEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177

Query: 200 LYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTD 255
           +   + Y    VD++S G+ +  M+    P+++ +    ++KKV S +   P  LS    
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLS---- 232

Query: 256 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEP 314
           P  +  I + IV     R+   E+ +DP+   + P  L        +     +     E 
Sbjct: 233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEA 292

Query: 315 HPMDIDLNHKKVSADSCAKSN--TGTWFLTLELQRLTENNE 353
                D   + + +D   ++N     + L  E Q + E  E
Sbjct: 293 MGFSEDYIVEALRSD---ENNEVKEAYNLLHENQVIQEKLE 330

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  119 bits (301), Expect = 7e-31
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 26/206 (12%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE----RLYSEVHLLKSLKHE 86
           + LG+G F TVYK  D+     VA  ++ +    ++ D +     R   E+ LL+ L H 
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKLLQELSHP 72

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLH 145
           NII   +++   +N  I+++ + F    L    K +  V     IK +    L+GL YLH
Sbjct: 73  NIIGLLDAFGHKSN--ISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APEL 200
            H   I+HRDLK +N+ ++  NG +K+ D GLA     P  R+   T + +     APEL
Sbjct: 130 QHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPN-RAY--THQVVTRWYRAPEL 183

Query: 201 Y--EEEYNELVDIYSFGMCIL-EMVT 223
                 Y   VD+++ G CIL E++ 
Sbjct: 184 LFGARMYGVGVDMWAVG-CILAELLL 208

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  118 bits (299), Expect = 8e-31
 Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 27/207 (13%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G + TVYKG ++  G+ VA  +V ++    +P    R   E+ L+K LKHENI++
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKELKHENIVR 67

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA------IKNWARQILRGLHYL 144
            Y+  V  T   + ++ E F    L++Y       +         +K +  Q+L+GL + 
Sbjct: 68  LYD--VIHTENKLTLVFE-FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APE 199
           H +   I+HRDLK  N+ +N   G++K+GD GLA     P       + E +     AP+
Sbjct: 125 HENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTF---SSEVVTLWYRAPD 178

Query: 200 LY--EEEYNELVDIYSFGMCIL-EMVT 223
           +      Y+  +DI+S G CIL EM+T
Sbjct: 179 VLMGSRTYSTSIDIWSCG-CILAEMIT 204

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  118 bits (298), Expect = 1e-30
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 30/206 (14%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHE 86
           E +G+G +  VYK  D    I VA  ++ ++       + E + S    E+ LLK L H 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRI-VALKRIRLD------AEDEGIPSTAIREISLLKELHHP 79

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLH 145
           NI+   +  V  + R + ++ E F    L++   ++K       IK +  Q+LRG+ + H
Sbjct: 80  NIVSLID--VIHSERCLTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APEL 200
            H   I+HRDLK  N+ +N ++G +K+ D GLA     P       T E +     AP++
Sbjct: 137 QHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSY---THEVVTLWYRAPDV 190

Query: 201 Y--EEEYNELVDIYSFGMCIL-EMVT 223
               ++Y+  VDI+S G CI  EM+T
Sbjct: 191 LMGSKKYSTSVDIWSIG-CIFAEMIT 215

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  117 bits (296), Expect = 1e-30
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 30/206 (14%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHE 86
           E +G+G +  VYK  +       A  ++ +E       + E + S    E+ +LK LKH 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGET-FALKKIRLE------KEDEGIPSTTIREISILKELKHS 60

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLH 145
           NI+K Y+  V  T + + ++ E      L++     +   +    K++  Q+L G+ Y H
Sbjct: 61  NIVKLYD--VIHTKKRLVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APEL 200
                ++HRDLK  N+ +N   GE+KI D GLA     P  R    T E +     AP++
Sbjct: 118 DRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPV-RKY--THEIVTLWYRAPDV 171

Query: 201 Y--EEEYNELVDIYSFGMCIL-EMVT 223
               ++Y+  +DI+S G CI  EMV 
Sbjct: 172 LMGSKKYSTTIDIWSVG-CIFAEMVN 196

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  117 bits (296), Expect = 3e-30
 Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 21/226 (9%)

Query: 30  DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            ++LG GAF TVYKG      E   I VA   +       SP   + +  E +++ S+ +
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDN 76

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 144
            ++ +           T+ +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL
Sbjct: 77  PHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG-TP-EFMAPE- 199
                 ++HRDL   N+ V      VKI D GLA  +  ++    +  G  P ++MA E 
Sbjct: 134 EDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 200 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           +    Y    D++S+G+ + E++T    PY+     ++I   +  G
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  117 bits (295), Expect = 3e-30
 Identities = 67/276 (24%), Positives = 110/276 (39%), Gaps = 33/276 (11%)

Query: 27  GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKS 82
            RY   EILG G    V+   D  D  +VA   V +   D+ + P    R   E     +
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAAA 68

Query: 83  LKHENIIKFYNSWVDDTNRT----INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
           L H  I+  Y++   +T       I M  E     +LR        +  K          
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVM--EYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126

Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-----SVIGTP 193
           + L++ H +   IIHRD+K  NI +      VK+ D G+A  +           +VIGT 
Sbjct: 127 QALNFSHQNG--IIHRDVKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 194 EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLS 251
           ++++PE    +  +   D+YS G  + E++T E P+    +P  + Y+ V     P S  
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPIPPS-- 240

Query: 252 KVTDPQVKQFIEKCIVPASLRLP------ALELLKD 281
                 +   ++  ++ A  + P      A E+  D
Sbjct: 241 -ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  116 bits (294), Expect = 4e-30
 Identities = 49/208 (23%), Positives = 97/208 (46%), Gaps = 25/208 (12%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLK 84
           +Y+    +G+G++  V+K  +   G  VA  +     D         R   E+ +LK LK
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLK 60

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHY 143
           H N++      V    R ++++ E +   ++     +++  V    +K+   Q L+ +++
Sbjct: 61  HPNLVNLLE--VFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----AP 198
            H HN   IHRD+K +NI +   +  +K+ D G A ++  P+        E       +P
Sbjct: 118 CHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYY---DDEVATRWYRSP 171

Query: 199 ELY--EEEYNELVDIYSFGMCIL-EMVT 223
           EL   + +Y   VD+++ G C+  E+++
Sbjct: 172 ELLVGDTQYGPPVDVWAIG-CVFAELLS 198

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  116 bits (293), Expect = 7e-30
 Identities = 49/209 (23%), Positives = 101/209 (48%), Gaps = 24/209 (11%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
            Y  +  LG+G +  V++  +  +  +V    +        P + +++  E+ +L++L+ 
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRG 89

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
             NII   +   D  +RT  ++ E   +   +Q  +   + D   I+ +  +IL+ L Y 
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYC 146

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPE-- 199
           HS    I+HRD+K  N+ ++  + ++++ D GLA      Q+   R  + +  F  PE  
Sbjct: 147 HSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--VASRYFKGPELL 202

Query: 200 LYEEEYNELVDIYSFGMCIL-EMVTCEYP 227
           +  + Y+  +D++S G C+L  M+  + P
Sbjct: 203 VDYQMYDYSLDMWSLG-CMLASMIFRKEP 230

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  116 bits (292), Expect = 1e-29
 Identities = 52/226 (23%), Positives = 108/226 (47%), Gaps = 21/226 (9%)

Query: 30  DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            ++LG G F TV+KG      E   I V    + + +        + +   +  + SL H
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVC---IKVIEDKSGRQSFQAVTDHMLAIGSLDH 74

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 144
            +I++           ++ ++T+    GSL  + ++H+  +  + + NW  QI +G++YL
Sbjct: 75  AHIVRLLGLC---PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTP-EFMAPE- 199
             H   ++HR+L   N+ +   + +V++ D G+A ++         S   TP ++MA E 
Sbjct: 132 EEHG--MVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188

Query: 200 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           ++  +Y    D++S+G+ + E++T    PY   +  A++   +  G
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-AEVPDLLEKG 233

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  116 bits (292), Expect = 1e-29
 Identities = 75/350 (21%), Positives = 125/350 (35%), Gaps = 79/350 (22%)

Query: 4   GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV 63
           GS  + +     +   +    R+ + + + G+G F TV  G ++  G+ VA     I+ V
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRF-QVERMAGQGTFGTVQLGKEKSTGMSVA-----IKKV 56

Query: 64  MQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRT-INMITELFTS---GSL 115
           +Q P    R    +  L  L H NI++    FY     D     +N++ E          
Sbjct: 57  IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCC 116

Query: 116 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175
           R Y ++        IK +  Q++R +  LH  +  + HRD+K  N+ VN  +G +K+ D 
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176

Query: 176 GLAIVMQQPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL-EMV 222
           G         A+ +  + E            APEL    + Y   VDI+S G CI  EM+
Sbjct: 177 GS--------AKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG-CIFAEMM 226

Query: 223 TCE--YPYNECKN------------PAQIYKKVTSG--------IKPASLSKV------- 253
             E  +  +                  ++ +K+            K    S V       
Sbjct: 227 LGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLK 286

Query: 254 TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
              +    +   +   P   R+   E L  P+           D L  P 
Sbjct: 287 DAKEAYDLLSALLQYLP-EERMKPYEALCHPYF----------DELHDPA 325

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  114 bits (288), Expect = 1e-29
 Identities = 46/241 (19%), Positives = 96/241 (39%), Gaps = 41/241 (17%)

Query: 28  RYDEILGKGAFKTVYKG-------FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
            ++E LG+G F  ++KG       + ++   EV    ++        +  E  +    ++
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA----HRNYSESFFEAASMM 66

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILR 139
             L H++++  Y   V        ++ E    GSL  Y KK+KN +++      A+Q+  
Sbjct: 67  SKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124

Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVN-------GNNGEVKIGDLGLAIVMQQPTARSVIGT 192
            +H+L  +   +IH ++   NI +        GN   +K+ D G+        + +V+  
Sbjct: 125 AMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI--------SITVLPK 174

Query: 193 PEF------MAPE--LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTS 243
                    + PE     +  N   D +SFG  + E+ +  + P +   +  +  +    
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYED 233

Query: 244 G 244
            
Sbjct: 234 R 234

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  114 bits (288), Expect = 2e-29
 Identities = 51/228 (22%), Positives = 101/228 (44%), Gaps = 26/228 (11%)

Query: 30  DEILGKGAFKTVYKGF--DEVDGIEVAWNQVNI----EDVMQSPDQLERLYSEVHLLKSL 83
           D+ LG G F TV KG+   +     VA     +     +    P   + L +E ++++ L
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVA-----VKILKNEAN-DPALKDELLAEANVMQQL 75

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
            +  I++     +     +  ++ E+   G L +Y +++++V  K I     Q+  G+ Y
Sbjct: 76  DNPYIVRMIG--IC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAP 198
           L   N   +HRDL   N+ +       KI D GL+  +   +   ++      P ++ AP
Sbjct: 133 LEESN--FVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189

Query: 199 E-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           E +   +++   D++SFG+ + E  +  + PY   K   ++   +  G
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKG 236

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  115 bits (289), Expect = 3e-29
 Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 26/219 (11%)

Query: 18  SEKDPSCRY-GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERL 73
             ++   +   +Y+   ++G+G++  V K  ++  G  VA  +    D  +       R 
Sbjct: 15  GTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR- 73

Query: 74  YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKN 132
             E+ LLK L+HEN++      V    +   ++ E F   ++    +   N +D + ++ 
Sbjct: 74  --EIKLLKQLRHENLVNLLE--VCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQK 128

Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
           +  QI+ G+ + HSHN  IIHRD+K +NI V+  +G VK+ D G A  +  P        
Sbjct: 129 YLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY---D 182

Query: 193 PEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 223
            E       APEL   + +Y + VD+++ G C++ EM  
Sbjct: 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFM 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  114 bits (287), Expect = 5e-29
 Identities = 66/308 (21%), Positives = 121/308 (39%), Gaps = 61/308 (19%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY   + LG G    V+   D      VA  ++ + D        +    E+ +++ L H
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV----KHALREIKIIRRLDH 67

Query: 86  ENIIKFYN------------SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
           +NI+K +                     ++ ++ E   +  L    ++   ++    + +
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEH-ARLF 125

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
             Q+LRGL Y+HS N  ++HRDLK  N+F+N  +  +KIGD GLA +M    +     + 
Sbjct: 126 MYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183

Query: 194 E-----FMAPE--LYEEEYNELVDIYSFGMCIL-EMVT---------------------- 223
                 + +P   L    Y + +D+++ G CI  EM+T                      
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 224 --CEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIV--PASLRLPAL 276
              E    E  +   +Y +         L+++      +   F+E+ +   P   RL A 
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD-RLTAE 301

Query: 277 ELLKDPFL 284
           E L  P++
Sbjct: 302 EALSHPYM 309

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  114 bits (288), Expect = 5e-29
 Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 29/216 (13%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            +    +LG+GA+  V     +  G  VA  ++        P    R   E+ +LK  KH
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKH 68

Query: 86  ENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           ENII  +N    D+    N   +I EL  +  L +        D   I+ +  Q LR + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDH-IQYFIYQTLRAVK 126

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFM---- 196
            LH  N  +IHRDLK  N+ +N  N ++K+ D GLA  I           G    M    
Sbjct: 127 VLHGSN--VIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 197 ------APE--LYEEEYNELVDIYSFGMCIL-EMVT 223
                 APE  L   +Y+  +D++S G CIL E+  
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFL 218

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  112 bits (283), Expect = 6e-29
 Identities = 57/224 (25%), Positives = 105/224 (46%), Gaps = 19/224 (8%)

Query: 30  DEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
           + ILG+G F  VY+G     + + I VA      +D     D  E+  SE  ++K+L H 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCT--LDNKEKFMSEAVIMKNLDHP 73

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 145
           +I+K     +        +I EL+  G L  Y  +   ++ +  +  ++ QI + + YL 
Sbjct: 74  HIVKLIG--II-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT--P-EFMAPE-LY 201
           S N   +HRD+   NI V  +   VK+GD GL+  ++         T  P ++M+PE + 
Sbjct: 131 SIN--CVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 187

Query: 202 EEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
              +    D++ F +C+ E+++  + P+   +N   +   +  G
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKG 230

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  116 bits (292), Expect = 7e-29
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 18/221 (8%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             LG G +  VY+G  +   + VA  +   ED M+    +E    E  ++K +KH N+++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAV-KTLKEDTME----VEEFLKEAAVMKEIKHPNLVQ 280

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 148
                V        +ITE  T G+L  Y ++   + V    +   A QI   + YL   N
Sbjct: 281 LLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 204
              IHR+L   N  V G N  VK+ D GL+ +M     TA +    P ++ APE L   +
Sbjct: 339 --FIHRNLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395

Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           ++   D+++FG+ + E+ T    PY      +Q+Y+ +   
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 435

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  116 bits (291), Expect = 8e-29
 Identities = 55/237 (23%), Positives = 98/237 (41%), Gaps = 44/237 (18%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY+   ++G G++  V + +D+++   VA  +  I  V +     +R+  E+ +L  L H
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK--ILRVFEDLIDCKRILREIAILNRLNH 111

Query: 86  ENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           ++++K  +       +    + ++ E+  S   ++  +    +    IK     +L G+ 
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVK 170

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------------------IVMQQ 183
           Y+HS    I+HRDLK  N  VN  +  VK+ D GLA                     M  
Sbjct: 171 YVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227

Query: 184 PTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVTCEYP 227
            T          +          APE  L +E Y E +D++S G CI  E++     
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKE 283

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  113 bits (284), Expect = 9e-29
 Identities = 69/212 (32%), Positives = 96/212 (45%), Gaps = 31/212 (14%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLK-- 84
             +G GA+ TVYK  D   G  VA   V +            L      EV LL+ L+  
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVREVALLRRLEAF 71

Query: 85  -HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQIL 138
            H N+++  +   +   D    + ++ E      LR Y  K     + A  IK+  RQ L
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 130

Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-- 196
           RGL +LH++   I+HRDLK +NI V  + G VK+ D GLA +     A     TP  +  
Sbjct: 131 RGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL----TPVVVTL 183

Query: 197 ---APE-LYEEEYNELVDIYSFGMCIL-EMVT 223
              APE L +  Y   VD++S G CI  EM  
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVG-CIFAEMFR 214

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  111 bits (281), Expect = 2e-28
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 19/223 (8%)

Query: 31  EILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
             +G+G F  V++G         + VA                E+   E   ++   H +
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTS--DSVREKFLQEALTMRQFDHPH 77

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHS 146
           I+K     V  T   + +I EL T G LR + +  K ++D+ ++  +A Q+   L YL S
Sbjct: 78  IVKLIG--V-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT--P-EFMAPE-LYE 202
                +HRD+   N+ V+ N+  VK+GD GL+  M+  T         P ++MAPE +  
Sbjct: 135 KR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191

Query: 203 EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
             +    D++ FG+C+ E++     P+   KN   +  ++ +G
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENG 233

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  113 bits (285), Expect = 2e-28
 Identities = 73/380 (19%), Positives = 137/380 (36%), Gaps = 107/380 (28%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG G+F  V + FD   G   A     ++ V+Q P        E+ ++K L H NIIK
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFA-----LKKVLQDP---RYKNRELDIMKVLDHVNIIK 64

Query: 91  ----FYNSWVDDTNRT--------------------------------INMITELFTS-- 112
               FY +  ++                                    +N+I E      
Sbjct: 65  LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124

Query: 113 -GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171
              L+ + +  +++ M  I  +  Q+ R + ++HS    I HRD+K  N+ VN  +  +K
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLK 182

Query: 172 IGDLGLAIVMQQPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL 219
           + D G         A+ +I + E            APEL     EY   +D++S G C+ 
Sbjct: 183 LCDFGS--------AKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVF 232

Query: 220 -EMVTCE--YPYNECKN------------PAQIYKKVTSG--------IKPASLSKV--- 253
            E++  +  +      +              +   ++           +K     K+   
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292

Query: 254 -TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVT-DNPKDL-VCDPLRLPNL----VP 304
            T       +E+ +   P  LR+   E +  PF     N  +  V +    P+     +P
Sbjct: 293 GTPSLAIDLLEQILRYEP-DLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIP 351

Query: 305 EVMNLAHSEPHPMDIDLNHK 324
           ++ N +  E   +  ++ ++
Sbjct: 352 QLFNFSPYELSIIPGNVLNR 371

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  111 bits (279), Expect = 2e-28
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 20/221 (9%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG G F  V  G  +    +VA   +  E  M   +  +    E   +  L H  ++K
Sbjct: 14  KELGSGQFGVVKLGKWK-GQYDVAVKMIK-EGSMSEDEFFQ----EAQTMMKLSHPKLVK 67

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
           FY   V      I ++TE  ++G L  Y R   K ++   +      +  G+ +L SH  
Sbjct: 68  FYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ- 124

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEE 204
             IHRDL   N  V+ +   VK+ D G+   +      S +GT +F     APE  +  +
Sbjct: 125 -FIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVSSVGT-KFPVKWSAPEVFHYFK 181

Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           Y+   D+++FG+ + E+ +  + PY+   N +++  KV+ G
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQG 221

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  111 bits (280), Expect = 3e-28
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 20/222 (9%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             LG G +  VY+G  +   + VA   +  ED M+     E    E  ++K +KH N+++
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEV----EEFLKEAAVMKEIKHPNLVQ 73

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 148
                V        +ITE  T G+L  Y ++   + V    +   A QI   + YL   N
Sbjct: 74  LLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEE 203
              IHRDL   N  V  N+  VK+ D GL+ +M   T  +  G  +F     APE L   
Sbjct: 132 --FIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGA-KFPIKWTAPESLAYN 187

Query: 204 EYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           +++   D+++FG+ + E+ T    PY      +Q+Y+ +   
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 228

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  111 bits (281), Expect = 3e-28
 Identities = 55/267 (20%), Positives = 97/267 (36%), Gaps = 30/267 (11%)

Query: 25  RYGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLL 80
           ++G Y    ++G+G    VY+  D V    VA   + +  E +   P    R+  E    
Sbjct: 32  QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVA---LKLMSETLSSDPVFRTRMQREARTA 88

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
             L+  +++  ++    D    ++M   L     L    ++   +         RQI   
Sbjct: 89  GRLQEPHVVPIHDFGEIDGQLYVDM--RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMA 197
           L   H+      HRD+K +NI V   +    + D G+A            + +GT  +MA
Sbjct: 147 LDAAHAAG--ATHRDVKPENILV-SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMA 203

Query: 198 PELYE-EEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
           PE +         DIY+   C+L E +T   PY +    + +   +   I   S      
Sbjct: 204 PERFSESHATYRADIYALT-CVLYECLTGSPPY-QGDQLSVMGAHINQAIPRPS---TVR 258

Query: 256 PQVKQFIEKCIVPASLRLPALELLKDP 282
           P +    +  I           + K+P
Sbjct: 259 PGIPVAFDAVIARG--------MAKNP 277

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  112 bits (283), Expect = 3e-28
 Identities = 63/319 (19%), Positives = 119/319 (37%), Gaps = 61/319 (19%)

Query: 1   MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVA------ 54
           M         +      + +     Y      +  G++  V  G D  +GI VA      
Sbjct: 2   MQAKGEAAMRDLIAELHAMQS---PY-TVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFN 56

Query: 55  -WNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN---SWVDDTNRTINMITELF 110
             +     +++      +R+  E+ LL    H NI+   +    + +     + ++TEL 
Sbjct: 57  TVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM 116

Query: 111 TSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
            +  L Q    +   +  + I+ +   IL GLH LH     ++HRDL   NI +  NN +
Sbjct: 117 RT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNN-D 172

Query: 170 VKIGDLGLAIVMQQPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMC 217
           + I D  L        AR                   APE  +  + + +LVD++S G C
Sbjct: 173 ITICDFNL--------ARE-DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG-C 222

Query: 218 IL-EMVTCE--YPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCI----- 266
           ++ EM   +  +  +   N  Q+  K+   +   K   +   + P  + ++   +     
Sbjct: 223 VMAEMFNRKALFRGSTFYN--QL-NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA 279

Query: 267 VPASLRLP-----ALELLK 280
              +  +P     AL+L+ 
Sbjct: 280 RAWTAVVPTADPVALDLIA 298

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  111 bits (280), Expect = 4e-28
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 38/228 (16%)

Query: 19  EKDPSCRY-GRYD--EILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLY 74
           EKD  CR   +Y+    +G+GA+  V+K  D    G  VA  +V ++         E + 
Sbjct: 2   EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT------GEEGMP 55

Query: 75  S----EVHLLKSLK---HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKN 124
                EV +L+ L+   H N+++ ++       D    + ++ E      L  Y  K   
Sbjct: 56  LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPE 114

Query: 125 V--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
                + IK+   Q+LRGL +LHSH   ++HRDLK  NI V  ++G++K+ D GLA +  
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYS 171

Query: 183 QPTARSVIGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 223
              A     T   +     APE L +  Y   VD++S G CI  EM  
Sbjct: 172 FQMAL----TSVVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  109 bits (276), Expect = 5e-28
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 20/221 (9%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + +G G F  V+ G+   +  +VA   +  E  M   D +E    E  ++  L H  +++
Sbjct: 14  QEIGSGQFGLVHLGYWL-NKDKVAIKTIR-EGAMSEEDFIE----EAEVMMKLSHPKLVQ 67

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNP 149
            Y   V      I ++TE    G L  Y +  +     + +      +  G+ YL     
Sbjct: 68  LYG--VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 124

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEE 204
            +IHRDL   N  V G N  +K+ D G+   +      S  GT +F     +PE      
Sbjct: 125 -VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSR 181

Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           Y+   D++SFG+ + E+ +  + PY    N +++ + +++G
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 221

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  113 bits (284), Expect = 5e-28
 Identities = 54/228 (23%), Positives = 98/228 (42%), Gaps = 39/228 (17%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            Y    ++G+G++  VY  +D+     VA  +  +  + +     +R+  E+ +L  LK 
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKK--VNRMFEDLIDCKRILREITILNRLKS 84

Query: 86  ENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           + II+ Y+  + D     +   ++ E+  S  L++  K    +  + IK     +L G +
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGEN 143

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--------------IVMQQPTARS 188
           ++H     IIHRDLK  N  +N  +  VK+ D GLA              +   +     
Sbjct: 144 FIHESG--IIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200

Query: 189 VIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 223
                + +          APE  L +E Y + +DI+S G CI  E++ 
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLN 247

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  112 bits (281), Expect = 6e-28
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 19/205 (9%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            Y     +G GA+ +V    D+  G +VA  +  +    QS    +R Y E+ LLK ++H
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK--LSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 86  ENIIKFYN----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   +    +          ++     +  L++          + I+    Q+L+GL
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGL 139

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-- 199
            Y+HS    ++HRDLK  N+ VN  + E+KI D GLA          V+ T  + APE  
Sbjct: 140 KYIHSAG--VVHRDLKPGNLAVNE-DCELKILDFGLARHADAEMTGYVV-TRWYRAPEVI 195

Query: 200 LYEEEYNELVDIYSFGMCIL-EMVT 223
           L    YN+ VDI+S G CI+ EM+T
Sbjct: 196 LSWMHYNQTVDIWSVG-CIMAEMLT 219

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  114 bits (287), Expect = 7e-28
 Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 19/224 (8%)

Query: 30  DEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
              +G+G F  V++G         + VA           S    E+   E   ++   H 
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHP 451

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLH 145
           +I+K        T   + +I EL T G LR + +  K  +D+ ++  +A Q+   L YL 
Sbjct: 452 HIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT--P-EFMAPE-LY 201
           S     +HRD+   N+ V+ N+  VK+GD GL+  M+  T         P ++MAPE + 
Sbjct: 509 SKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565

Query: 202 EEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
              +    D++ FG+C+ E++     P+   KN   +  ++ +G
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENG 608

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  111 bits (280), Expect = 9e-28
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 22/209 (10%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G+GA+  V   +D ++ + VA  +++     +     +R   E+ +L   +H
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRH 84

Query: 86  ENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           ENII   +     T   +    ++ +L  +  L +  K     +   I  +  QILRGL 
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDH-ICYFLYQILRGLK 142

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FMA 197
           Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V       +   T       + A
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199

Query: 198 PE--LYEEEYNELVDIYSFGMCIL-EMVT 223
           PE  L  + Y + +DI+S G CIL EM++
Sbjct: 200 PEIMLNSKGYTKSIDIWSVG-CILAEMLS 227

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  110 bits (277), Expect = 1e-27
 Identities = 69/284 (24%), Positives = 128/284 (45%), Gaps = 20/284 (7%)

Query: 1   MDCGSGFTKSETEEGEFSEKDPSCR-YGRYD----EILGKGAFKTVYKGFDEVDGIEVAW 55
           MD  +   +      + ++  P  R     D    +ILG+G+F TV    +     E A 
Sbjct: 1   MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAI 60

Query: 56  NQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL 115
             +    +++  +++  +  E  ++  L H   +K Y ++ DD    +        +G L
Sbjct: 61  KILEKRHIIKE-NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGEL 117

Query: 116 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175
            +Y +K  + D    + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D 
Sbjct: 118 LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDF 174

Query: 176 GLA----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 230
           G A       +Q  A S +GT ++++PE L E+   +  D+++ G  I ++V    P+  
Sbjct: 175 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-R 233

Query: 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRL 273
             N   I++K+          +   P+ +  +EK +V  A+ RL
Sbjct: 234 AGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRL 275

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  109 bits (275), Expect = 1e-27
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 20/221 (9%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG G F  V  G       +VA   +  E  M   + +E    E  ++ +L HE +++
Sbjct: 30  KELGTGQFGVVKYGKWR-GQYDVAIKMIK-EGSMSEDEFIE----EAKVMMNLSHEKLVQ 83

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
            Y   V    R I +ITE   +G L  Y R+       + +    + +   + YL S   
Sbjct: 84  LYG--VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 140

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEE 204
             +HRDL   N  VN     VK+ D GL+  +      S +G+ +F      PE L   +
Sbjct: 141 -FLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVLMYSK 197

Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           ++   DI++FG+ + E+ +  + PY    N ++  + +  G
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQG 237

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  109 bits (275), Expect = 1e-27
 Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 20/238 (8%)

Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
              PS     ++E++G+G F  VY G    ++   I  A   V   + +    ++ +  +
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFLT 75

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWA 134
           E  ++K   H N++         +  +  ++      G LR + R +  N  +K +  + 
Sbjct: 76  EGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134

Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 194
            Q+ +G+ YL S     +HRDL   N  ++     VK+ D GLA  M      SV     
Sbjct: 135 LQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTG 191

Query: 195 F------MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
                  MA E L  +++    D++SFG+ + E++T    PY +      I   +  G
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG 248

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  110 bits (278), Expect = 1e-27
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 28/222 (12%)

Query: 22  PSCRY-GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEV 77
           P C    +Y+    +G+G F  V+K      G +VA  +V +E+  +  P    R   E+
Sbjct: 11  PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EI 67

Query: 78  HLLKSLKHENIIKFY------NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAI 130
            +L+ LKHEN++          S  +    +I ++ + F    L            +  I
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD-FCEHDLAGLLSNVLVKFTLSEI 126

Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
           K   + +L GL+Y+H +   I+HRD+K  N+ +   +G +K+ D GLA            
Sbjct: 127 KRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPN 183

Query: 191 G-TPE-----FMAPELY--EEEYNELVDIYSFGMCIL-EMVT 223
             T       +  PEL   E +Y   +D++  G CI+ EM T
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWT 224

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  111 bits (280), Expect = 2e-27
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 20/221 (9%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             LG+G F  V+ G        VA         M      E    E  ++K L+HE +++
Sbjct: 190 VKLGQGCFGEVWMGTWN-GTTRVAIK-TLKPGTMSP----EAFLQEAQVMKKLRHEKLVQ 243

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 148
            Y      +   I ++TE  + GSL  + K    K + +  + + A QI  G+ Y+   N
Sbjct: 244 LYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 204
              +HRDL+  NI V  N    K+ D GLA +++    TAR     P ++ APE      
Sbjct: 301 --YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           +    D++SFG+ + E+ T    PY    N  ++  +V  G
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 397

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  112 bits (281), Expect = 2e-27
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 20/221 (9%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             LG+G F  V+ G        VA         M      E    E  ++K L+HE +++
Sbjct: 273 VKLGQGCFGEVWMGTWN-GTTRVAIK-TLKPGTMSP----EAFLQEAQVMKKLRHEKLVQ 326

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 148
            Y      +   I ++TE  + GSL  + K    K + +  + + A QI  G+ Y+   N
Sbjct: 327 LYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 204
              +HRDL+  NI V  N    K+ D GLA +++    TAR     P ++ APE      
Sbjct: 384 --YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440

Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           +    D++SFG+ + E+ T    PY    N  ++  +V  G
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 480

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  108 bits (271), Expect = 5e-27
 Identities = 52/229 (22%), Positives = 93/229 (40%), Gaps = 20/229 (8%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
             D ++GKG F  VY G         I+ A   ++    +    Q+E    E  L++ L 
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLN 80

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHY 143
           H N++      +       +++      G L Q+ R   +N  +K + ++  Q+ RG+ Y
Sbjct: 81  HPNVLALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEF----MA 197
           L       +HRDL   N  ++ +   VK+ D GLA  I+ ++  +              A
Sbjct: 140 LAEQK--FVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196

Query: 198 PE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
            E L    +    D++SFG+ + E++T    PY        +   +  G
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQG 244

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  108 bits (271), Expect = 7e-27
 Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 20/226 (8%)

Query: 30  DEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
           ++I+G G    V  G   V G   + VA   +          + + L SE  ++    H 
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYT-ERQRRDFL-SEASIMGQFDHP 110

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLH 145
           NII+     V    R   ++TE   +GSL  + + H     +  +    R +  G+ YL 
Sbjct: 111 NIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT--P-EFMAPE- 199
                 +HRDL   N+ V+ N    K+ D GL+ V++     A +  G   P  + APE 
Sbjct: 169 DLG--YVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225

Query: 200 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           +    ++   D++SFG+ + E++   E PY    N   +   V  G
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEG 270

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  107 bits (269), Expect = 8e-27
 Identities = 46/225 (20%), Positives = 94/225 (41%), Gaps = 20/225 (8%)

Query: 30  DEILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           D  LG G F +V +G        I+VA   + +          E +  E  ++  L +  
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 71

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHS 146
           I++     V      + ++ E+   G L ++   K + + +  +     Q+  G+ YL  
Sbjct: 72  IVRLIG--VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAPE-L 200
            N   +HRDL   N+ +   +   KI D GL+  +        +      P ++ APE +
Sbjct: 129 KN--FVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185

Query: 201 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
              +++   D++S+G+ + E ++  + PY + K   ++   +  G
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQG 229

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  107 bits (270), Expect = 9e-27
 Identities = 51/245 (20%), Positives = 96/245 (39%), Gaps = 43/245 (17%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI----EDVMQSPDQLERLYSEVHLLKSL 83
               +LGKG F +V +   ++   + ++ +V +     D++ +   +E    E   +K  
Sbjct: 26  TLGRMLGKGEFGSVREA--QLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEF 82

Query: 84  KHENIIKFY----NSWVDDTNRTINMITELFTSGSLRQYRKKHK------NVDMKAIKNW 133
            H ++ K       S          +I      G L  +    +      N+ ++ +  +
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
              I  G+ YL S N   IHRDL   N  +  +   V + D GL+        R +    
Sbjct: 143 MVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM-TVCVADFGLS--------RKIYSGD 191

Query: 194 EF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 239
            +            +A E L +  Y    D+++FG+ + E++T  + PY   +N A+IY 
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYN 250

Query: 240 KVTSG 244
            +  G
Sbjct: 251 YLIGG 255

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  108 bits (272), Expect = 9e-27
 Identities = 72/215 (33%), Positives = 104/215 (48%), Gaps = 38/215 (17%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA+ +V   FD   G+ VA     +    QS    +R Y E+ LLK +KH
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 86  ENIIKFYN----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   +    +   +    + ++T L  +  L     K + +    ++    QILRGL
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNI-VKCQKLTDDHVQFLIYQILRGL 145

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----- 196
            Y+HS +  IIHRDLK  N+ VN +  E+KI D GL        AR    T + M     
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGL--------ARH---TADEMTGYVA 191

Query: 197 -----APE--LYEEEYNELVDIYSFGMCIL-EMVT 223
                APE  L    YN+ VDI+S G CI+ E++T
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLT 225

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  108 bits (272), Expect = 1e-26
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 53/233 (22%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
           +Y+  + LGKGA+  V+K  D   G  VA  +  I D  Q+    +R + E+ +L  L  
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKK--IFDAFQNSTDAQRTFREIMILTELSG 67

Query: 85  HENIIKFYNSWVDDTNRTINMITEL--------FTSGSLRQYRKKHKNVDMKAIKNWARQ 136
           HENI+   N    D +R + ++ +           +  L      H        +    Q
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL---EPVH-------KQYVVYQ 117

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------------IVMQQ 183
           +++ + YLHS    ++HRD+K  NI +N     VK+ D GL+              +   
Sbjct: 118 LIKVIKYLHSGG--LLHRDMKPSNILLNA-ECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 184 PTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 223
               +       +          APE  L   +Y + +D++S G CIL E++ 
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILC 226

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  107 bits (270), Expect = 1e-26
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 21/227 (9%)

Query: 30  DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            +++G G F  VYKG          + VA   +          +++ L  E  ++    H
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYT-EKQRVDFL-GEAGIMGQFSH 105

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYL 144
            NII+     V    + + +ITE   +G+L ++ ++      +  +    R I  G+ YL
Sbjct: 106 HNIIRLEG--VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT--P-EFMAPE 199
            + N   +HRDL   NI VN N    K+ D GL+ V++       +  G   P  + APE
Sbjct: 164 ANMN--YVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220

Query: 200 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
            +   ++    D++SFG+ + E++T  E PY E  N  ++ K +  G
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDG 266

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  107 bits (269), Expect = 2e-26
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 26/209 (12%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D +    VA  +  +    Q+    +R Y E+ L+K + H
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKK--LSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 86  ENIIKFYNSWVDDTNRT----INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N +    +      + ++ EL  + +L Q  +    +D + +     Q+L G+
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGI 140

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FM 196
            +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP      + 
Sbjct: 141 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 193

Query: 197 APE-LYEEEYNELVDIYSFGMCIL-EMVT 223
           APE +    Y E VDI+S G CI+ EM+ 
Sbjct: 194 APEVILGMGYKENVDIWSVG-CIMGEMIK 221

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  107 bits (269), Expect = 3e-26
 Identities = 54/238 (22%), Positives = 100/238 (42%), Gaps = 20/238 (8%)

Query: 19  EKDPSCRYGRYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
              PS     ++E++G+G F  VY G    ++   I  A   V   + +    ++ +  +
Sbjct: 83  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFLT 139

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWA 134
           E  ++K   H N++         +  +  ++      G LR + R +  N  +K +  + 
Sbjct: 140 EGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198

Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 194
            Q+ +G+ +L S     +HRDL   N  ++     VK+ D GLA  M      SV     
Sbjct: 199 LQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTG 255

Query: 195 ------FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
                 +MA E L  +++    D++SFG+ + E++T    PY +      I   +  G
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG 312

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  107 bits (268), Expect = 4e-26
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 18/205 (8%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            Y ++  +G GA+  V    D   G +VA  +  +    QS    +R Y E+ LLK ++H
Sbjct: 26  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 86  ENIIKFYNSWVDDTNRT----INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           EN+I   + +  D          ++     +  L +   KH+ +    I+    Q+L+GL
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKL-MKHEKLGEDRIQFLVYQMLKGL 141

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-- 199
            Y+H+    IIHRDLK  N+ VN  + E+KI D GLA          V+ T  + APE  
Sbjct: 142 RYIHAAG--IIHRDLKPGNLAVNE-DCELKILDFGLARQADSEMTGYVV-TRWYRAPEVI 197

Query: 200 LYEEEYNELVDIYSFGMCIL-EMVT 223
           L    Y + VDI+S G CI+ EM+T
Sbjct: 198 LNWMRYTQTVDIWSVG-CIMAEMIT 221

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  105 bits (264), Expect = 5e-26
 Identities = 52/279 (18%), Positives = 107/279 (38%), Gaps = 47/279 (16%)

Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL- 83
            Y    ++LG G    V + F++    + A     ++D         +   EV L     
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--LQDC-------PKARREVELHWRAS 68

Query: 84  KHENIIKFYNSWVD--DTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILR 139
           +  +I++  + + +     + + ++ E    G L  R   +  +    +      + I  
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 140 GLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMA 197
            + YLHS N  I HRD+K +N+ + +   N  +K+ D G                    A
Sbjct: 129 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------A 167

Query: 198 PELYEEEYNELVDIYSFGMCILEMVTCEYP----YNECKNPAQIYKKVTSGI---KPASL 250
            E   E+Y++  D++S G  I+ ++ C YP     +       +  ++  G         
Sbjct: 168 KETTGEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226

Query: 251 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 288
           S+V++ +VK  I   +    + R+   E +  P+++   
Sbjct: 227 SEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  108 bits (272), Expect = 6e-26
 Identities = 45/225 (20%), Positives = 94/225 (41%), Gaps = 20/225 (8%)

Query: 30  DEILGKGAFKTVYKGFDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           D  LG G F +V +G   +    I+VA   + +          E +  E  ++  L +  
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 397

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHS 146
           I++            + ++ E+   G L ++    +  + +  +     Q+  G+ YL  
Sbjct: 398 IVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAPE-L 200
            N   +HR+L   N+ +  N    KI D GL+  +        +      P ++ APE +
Sbjct: 455 KN--FVHRNLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511

Query: 201 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
              +++   D++S+G+ + E ++  + PY + K P ++   +  G
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQG 555

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  107 bits (269), Expect = 6e-26
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 20/221 (9%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG G F  V+         +VA         M     L     E +++K+L+H+ ++K
Sbjct: 194 KKLGAGQFGEVWMATYN-KHTKVAVK-TMKPGSMSVEAFLA----EANVMKTLQHDKLVK 247

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHN 148
            +      T   I +ITE    GSL  + K  +     +  + +++ QI  G+ ++   N
Sbjct: 248 LHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+ +    KI D GLA V++    TAR     P ++ APE +    
Sbjct: 305 --YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361

Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
           +    D++SFG+ ++E+VT    PY    NP ++ + +  G
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERG 401

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  104 bits (262), Expect = 7e-26
 Identities = 49/219 (22%), Positives = 95/219 (43%), Gaps = 20/219 (9%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + +GKG F  V  G  +  G +VA   +   D        +   +E  ++  L+H N+++
Sbjct: 27  QTIGKGEFGDVMLG--DYRGNKVAVKCIK-NDATA-----QAFLAEASVMTQLRHSNLVQ 78

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 148
                + +    + ++TE    GSL  Y +      +    +  ++  +   + YL  +N
Sbjct: 79  LLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-EFMAPE-LYEEEYN 206
              +HRDL   N+ V+ +N   K+ D GL            +  P ++ APE L E++++
Sbjct: 138 --FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFS 192

Query: 207 ELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
              D++SFG+ + E+ +    PY        +  +V  G
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 230

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  105 bits (263), Expect = 8e-26
 Identities = 50/243 (20%), Positives = 102/243 (41%), Gaps = 40/243 (16%)

Query: 28  RYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
              +ILG+G F +V +G    ++   ++VA   + +++   S  ++E   SE   +K   
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFS 94

Query: 85  HENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHK------NVDMKAIKNWAR 135
           H N+I+     ++ +++ I    +I      G L  Y    +      ++ ++ +  +  
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
            I  G+ YL + N   +HRDL   N  +  +   V + D GL        ++ +     +
Sbjct: 155 DIALGMEYLSNRN--FLHRDLAARNCMLRDDM-TVCVADFGL--------SKKIYSGDYY 203

Query: 196 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 241
                       +A E L +  Y    D+++FG+ + E+ T    PY   +N  ++Y  +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYL 262

Query: 242 TSG 244
             G
Sbjct: 263 LHG 265

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  106 bits (266), Expect = 8e-26
 Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 20/226 (8%)

Query: 30  DEILGKGAFKTVYKG---FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
           D+++G G F  V  G         I VA   +          Q      E  ++    H 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYT--EKQRRDFLGEASIMGQFDHP 106

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLH 145
           NII+     V   ++ + ++TE   +GSL  + +KH     +  +    R I  G+ YL 
Sbjct: 107 NIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT--P-EFMAPE- 199
                 +HRDL   NI +N N    K+ D GL  V++     A +  G   P  + +PE 
Sbjct: 165 DMG--YVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221

Query: 200 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           +   ++    D++S+G+ + E+++  E PY E  N   + K V  G
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEG 266

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  107 bits (268), Expect = 1e-25
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 36/214 (16%)

Query: 28  RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           RY  +  +G GA   V   +D V    VA  +  +    Q+    +R Y E+ L+K + H
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK--LSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 86  ENIIKFYN----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
           +NII   N        +  + + ++ EL  + +L Q  +    +D + +     Q+L G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGI 177

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----- 196
            +LHS    IIHRDLK  NI V  +   +KI D GL        AR+  GT   M     
Sbjct: 178 KHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGL--------ART-AGTSFMMTPYVV 225

Query: 197 -----APE-LYEEEYNELVDIYSFGMCIL-EMVT 223
                APE +    Y E VDI+S G CI+ EMV 
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVG-CIMGEMVR 258

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  105 bits (264), Expect = 1e-25
 Identities = 63/239 (26%), Positives = 120/239 (50%), Gaps = 15/239 (6%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           LG G+F  V     +  G   A   ++ + V++   Q+E   +E  +L+++    ++K  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
            S+ D++N  + M+ E    G +  + ++         + +A QI+    YLHS +  +I
Sbjct: 108 FSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LI 163

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
           +RDLK +N+ ++   G +++ D G A  ++  T  ++ GTPE +APE +  + YN+ VD 
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKGYNKAVDW 221

Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQFIEKCIVP 268
           ++ G+ I EM     P+     P QIY+K+ SG ++ P+  S      +K  +   +  
Sbjct: 222 WALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHFS----SDLKDLLRNLLQV 275

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  105 bits (265), Expect = 1e-25
 Identities = 51/228 (22%), Positives = 116/228 (50%), Gaps = 20/228 (8%)

Query: 68  DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
           +++  ++ E+ +++ L+H  ++  + S+ D+ +  + M+ +L   G LR + +++ +   
Sbjct: 57  NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED--MFMVVDLLLGGDLRYHLQQNVHFKE 114

Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-A 186
           + +K +  +++  L YL +    IIHRD+K DNI ++  +G V I D  +A ++ + T  
Sbjct: 115 ETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQI 171

Query: 187 RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKK 240
            ++ GT  +MAPE++       Y+  VD +S G+   E++    PY      +  +I   
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231

Query: 241 VTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD-PFL 284
             + +   P++ S     ++   ++K + P    R   L  +++ P++
Sbjct: 232 FETTVVTYPSAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  103 bits (260), Expect = 3e-25
 Identities = 57/243 (23%), Positives = 94/243 (38%), Gaps = 40/243 (16%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
                LG+G+F  VY+G        VA   V  E   +          S  +     +E 
Sbjct: 28  TMSRELGQGSFGMVYEG--------VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 79

Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY----------RKKHKNVDM 127
            ++K     ++++     V    +   +I EL T G L+ Y                  +
Sbjct: 80  SVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137

Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
             +   A +I  G+ YL+++    +HRDL   N  V  +   VKIGD G+   + +    
Sbjct: 138 SKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYY 194

Query: 188 SVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241
              G        M+PE L +  +    D++SFG+ + E+ T  E PY    N  Q+ + V
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRFV 253

Query: 242 TSG 244
             G
Sbjct: 254 MEG 256

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  102 bits (257), Expect = 3e-25
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 20/221 (9%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E LG G F  V+ G+      +VA   +  +  M     L     E +L+K L+H+ +++
Sbjct: 19  ERLGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLA----EANLMKQLQHQRLVR 72

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHN 148
            Y      T   I +ITE   +GSL  + K      + +  + + A QI  G+ ++   N
Sbjct: 73  LYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 204
              IHRDL+  NI V+      KI D GLA +++    TAR     P ++ APE +    
Sbjct: 130 --YIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           +    D++SFG+ + E+VT    PY    NP ++ + +  G
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERG 226

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  104 bits (261), Expect = 8e-25
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 32/225 (14%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + +GKG F  V  G  +  G +VA   +   D        +   +E  ++  L+H N+++
Sbjct: 199 QTIGKGEFGDVMLG--DYRGNKVAVKCIK-NDATA-----QAFLAEASVMTQLRHSNLVQ 250

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 148
                + +    + ++TE    GSL  Y +      +    +  ++  +   + YL  +N
Sbjct: 251 LLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-------FMAPE-L 200
              +HRDL   N+ V+ +N   K+ D GL         +    T +       + APE L
Sbjct: 310 --FVHRDLAARNVLVSEDN-VAKVSDFGL--------TKEASSTQDTGKLPVKWTAPEAL 358

Query: 201 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
            E++++   D++SFG+ + E+ +    PY        +  +V  G
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 402

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  102 bits (256), Expect = 1e-24
 Identities = 56/237 (23%), Positives = 96/237 (40%), Gaps = 28/237 (11%)

Query: 28  RYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
                LG GAF  VY+G      ++   ++VA   +     + S         E  ++  
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISK 89

Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-------KNVDMKAIKNWAR 135
             H+NI++     V   +    ++ EL   G L+ + ++         ++ M  + + AR
Sbjct: 90  FNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
            I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G  
Sbjct: 148 DIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205

Query: 194 EF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
                 M PE   E  +    D +SFG+ + E+ +    PY    N  ++ + VTSG
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG 261

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  101 bits (254), Expect = 1e-24
 Identities = 61/256 (23%), Positives = 101/256 (39%), Gaps = 61/256 (23%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---------SPDQLERLYSEVH 78
                LG+GAF  V+            +N    +D M          +    +    E  
Sbjct: 18  VLKRELGEGAFGKVFLA--------ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE 69

Query: 79  LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------- 122
           LL +L+HE+I+KFY   V      + M+ E    G L ++ + H                
Sbjct: 70  LLTNLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
             + +  + + A QI  G+ YL S +   +HRDL   N  V  N   VKIGD G+     
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGM----- 179

Query: 183 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPY 228
              +R V  T  +            M PE +   ++    D++SFG+ + E+ T  + P+
Sbjct: 180 ---SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236

Query: 229 NECKNPAQIYKKVTSG 244
            +  N  ++ + +T G
Sbjct: 237 FQLSN-TEVIECITQG 251

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  101 bits (255), Expect = 1e-24
 Identities = 56/254 (22%), Positives = 102/254 (40%), Gaps = 53/254 (20%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLLK 81
           +  + LG+GAF  V +   +  GI+       +      E    S  +   L SE+ +L 
Sbjct: 30  KLGKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILI 85

Query: 82  SL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KN 124
            +  H N++    +        + +I E    G+L  Y +                    
Sbjct: 86  HIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144

Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
           + ++ +  ++ Q+ +G+ +L S     IHRDL   NI ++  N  VKI D GL       
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVKICDFGL------- 194

Query: 185 TARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNE 230
            AR +   P++            MAPE +++  Y    D++SFG+ + E+ +    PY  
Sbjct: 195 -ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

Query: 231 CKNPAQIYKKVTSG 244
            K   +  +++  G
Sbjct: 254 VKIDEEFCRRLKEG 267

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  101 bits (255), Expect = 1e-24
 Identities = 56/247 (22%), Positives = 95/247 (38%), Gaps = 44/247 (17%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---------SPDQLERLYSEVH 78
                LG+GAF  V+             N +  +D M          S    +    E  
Sbjct: 44  VLKWELGEGAFGKVFLA--------ECHNLLPEQDKMLVAVKALKEASESARQDFQREAE 95

Query: 79  LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------K 123
           LL  L+H++I++F+   V    R + M+ E    G L ++ + H                
Sbjct: 96  LLTMLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
            + +  +   A Q+  G+ YL   +   +HRDL   N  V      VKIGD G++  +  
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYS 210

Query: 184 PTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
                V G        M PE +   ++    D++SFG+ + E+ T  + P+ +  N  + 
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEA 269

Query: 238 YKKVTSG 244
              +T G
Sbjct: 270 IDCITQG 276

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 99.6 bits (249), Expect = 5e-24
 Identities = 54/244 (22%), Positives = 94/244 (38%), Gaps = 36/244 (14%)

Query: 28  RYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
           R+ E LG+  F  VYKG             VA   +  +         E    E  L   
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAE--GPLREEFRHEAMLRAR 68

Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVD 126
           L+H N++      V   ++ ++MI    + G L ++                      ++
Sbjct: 69  LQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
                +   QI  G+ YL SH+  ++H+DL   N+ V      VKI DLGL   +     
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-NVKISDLGLFREVYAADY 183

Query: 187 RSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 240
             ++G        MAPE +   +++   DI+S+G+ + E+ +    PY    N   + + 
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVEM 242

Query: 241 VTSG 244
           + + 
Sbjct: 243 IRNR 246

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  100 bits (252), Expect = 6e-24
 Identities = 56/237 (23%), Positives = 96/237 (40%), Gaps = 28/237 (11%)

Query: 28  RYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
                LG GAF  VY+G      ++   ++VA   +     + S         E  ++  
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISK 130

Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWAR 135
             H+NI++     V   +    ++ EL   G L+ + ++ +       ++ M  + + AR
Sbjct: 131 FNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
            I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + +       G  
Sbjct: 189 DIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246

Query: 194 EF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
                 M PE   E  +    D +SFG+ + E+ +    PY    N  ++ + VTSG
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG 302

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 56/260 (21%), Positives = 97/260 (37%), Gaps = 64/260 (24%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
            + + LG GAF  V +          A+  +  +  M              + E L SE+
Sbjct: 26  SFGKTLGAGAFGKVVEA--------TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 77

Query: 78  HLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-------------- 122
            +L  L  H NI+               +ITE    G L  + ++               
Sbjct: 78  KVLSYLGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 123 ----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
                 +D++ + +++ Q+ +G+ +L S N   IHRDL   NI +  +    KI D GL 
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL-THGRITKICDFGL- 191

Query: 179 IVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC- 224
                  AR +     +            MAPE ++   Y    D++S+G+ + E+ +  
Sbjct: 192 -------ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244

Query: 225 EYPYNECKNPAQIYKKVTSG 244
             PY      ++ YK +  G
Sbjct: 245 SSPYPGMPVDSKFYKMIKEG 264

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 53/276 (19%), Positives = 116/276 (42%), Gaps = 30/276 (10%)

Query: 16  EFSEKDPSCRYGRYD----EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSP 67
           +   K    R    D    +++G+GAF  V     K   +V  +++    ++  ++++  
Sbjct: 56  DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL----LSKFEMIKR- 110

Query: 68  DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
                 + E  ++       +++ + ++ DD    + M+ E    G L      +  V  
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYD-VPE 167

Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 184
           K  + +  +++  L  +HS     IHRD+K DN+ ++  +G +K+ D G  + M +    
Sbjct: 168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMV 224

Query: 185 TARSVIGTPEFMAPEL-----YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 239
              + +GTP++++PE+      +  Y    D +S G+ + EM+  + P+    +    Y 
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGTYS 283

Query: 240 KVTSGIKPASLSKVTD--PQVKQFIEKCIVPASLRL 273
           K+ +     +     D   + K  I   +    +RL
Sbjct: 284 KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRL 319

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 59/256 (23%), Positives = 104/256 (40%), Gaps = 60/256 (23%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
           ++ + LG GAF  V +          A+     + V++            D+ E L SE+
Sbjct: 49  QFGKTLGAGAFGKVVEA--------TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSEL 100

Query: 78  HLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKN--- 132
            ++  L +HENI+             + +ITE    G L  + R+K + ++         
Sbjct: 101 KIMSHLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 133 ----------WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
                     ++ Q+ +G+ +L S N   IHRD+   N+ +  N    KIGD GL     
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVAKIGDFGL----- 210

Query: 183 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPY 228
              AR ++    +            MAPE +++  Y    D++S+G+ + E+ +    PY
Sbjct: 211 ---ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

Query: 229 NECKNPAQIYKKVTSG 244
                 ++ YK V  G
Sbjct: 268 PGILVNSKFYKLVKDG 283

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 96.8 bits (242), Expect = 8e-23
 Identities = 67/241 (27%), Positives = 115/241 (47%), Gaps = 19/241 (7%)

Query: 33  LGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           LG G+F  V+    +       ++V    +  E V++   Q+E    E  +L  + H  I
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKV----LKKEIVVRL-KQVEHTNDERLMLSIVTHPFI 68

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           I+ + ++ D     I MI +    G L    +K +       K +A ++   L YLHS +
Sbjct: 69  IRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNE 207
             II+RDLK +NI ++  NG +KI D G A  +   T  ++ GTP+++APE +  + YN+
Sbjct: 127 --IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNK 182

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267
            +D +SFG+ I EM+    P+    N  + Y+K+ +           +  VK  + + I 
Sbjct: 183 SIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLIT 239

Query: 268 P 268
            
Sbjct: 240 R 240

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 49/265 (18%), Positives = 85/265 (32%), Gaps = 70/265 (26%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
            Y   +G+GAF  V++          A   +  E              S D       E 
Sbjct: 50  EYVRDIGEGAFGRVFQA--------RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA 101

Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--------------- 122
            L+    + NI+K          + + ++ E    G L ++ +                 
Sbjct: 102 ALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159

Query: 123 ---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173
                      +        ARQ+  G+ YL       +HRDL   N  V  N   VKI 
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIA 216

Query: 174 DLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILE 220
           D GL+        R++     +            M PE ++   Y    D++++G+ + E
Sbjct: 217 DFGLS--------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268

Query: 221 MVT-CEYPYNECKNPAQIYKKVTSG 244
           + +    PY    +  ++   V  G
Sbjct: 269 IFSYGLQPYYGMAH-EEVIYYVRDG 292

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 61/265 (23%), Positives = 102/265 (38%), Gaps = 70/265 (26%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
              + LG+G F  V K          A++                   SP +L  L SE 
Sbjct: 26  VLGKTLGEGEFGKVVKA--------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEF 77

Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--------------- 122
           ++LK + H ++IK Y       +  + +I E    GSLR + ++                
Sbjct: 78  NVLKQVNHPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135

Query: 123 ---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173
                    + + M  + ++A QI +G+ YL      ++HRDL   NI V     ++KI 
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGR-KMKIS 192

Query: 174 DLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILE 220
           D GL        +R V     +            MA E L++  Y    D++SFG+ + E
Sbjct: 193 DFGL--------SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244

Query: 221 MVTC-EYPYNECKNPAQIYKKVTSG 244
           +VT    PY       +++  + +G
Sbjct: 245 IVTLGGNPYPGIPP-ERLFNLLKTG 268

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 58/247 (23%), Positives = 105/247 (42%), Gaps = 26/247 (10%)

Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +LG+G F  V+    K   ++   +    +   +         +    E  +L  +    
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-----KGYQGAMVEKKILAKVHSRF 246

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHY 143
           I+    ++  +T   + ++  +   G +        + +          +  QI+ GL +
Sbjct: 247 IVSLAYAF--ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304

Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-L 200
           LH  N  II+RDLK +N+ ++ ++G V+I DLGLA  +   Q   +   GTP FMAPE L
Sbjct: 305 LHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
             EEY+  VD ++ G+ + EM+    P+    E     ++ ++V       +      P 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKFSPA 419

Query: 258 VKQFIEK 264
            K F E 
Sbjct: 420 SKDFCEA 426

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 60/261 (22%), Positives = 96/261 (36%), Gaps = 61/261 (23%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLLK 81
            + ++LG GAF  V        GI      + +      E    S  + E L SE+ ++ 
Sbjct: 48  EFGKVLGSGAFGKVMNA--TAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMT 103

Query: 82  SL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN-------- 132
            L  HENI+    +        I +I E    G L  Y +  +    +            
Sbjct: 104 QLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 133 ---------------WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177
                          +A Q+ +G+ +L   +   +HRDL   N+ V      VKI D GL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGK-VVKICDFGL 218

Query: 178 AIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC 224
                   AR ++    +            MAPE L+E  Y    D++S+G+ + E+ + 
Sbjct: 219 --------ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270

Query: 225 -EYPYNECKNPAQIYKKVTSG 244
              PY      A  YK + +G
Sbjct: 271 GVNPYPGIPVDANFYKLIQNG 291

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 34/227 (14%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
               ILG+G F  VYKG    DG  VA  ++  E       Q +   +EV ++    H N
Sbjct: 33  SNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHRN 88

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW-ARQ-----ILRGL 141
           +++     +  T R +  +     +GS+       +  + +   +W  RQ       RGL
Sbjct: 89  LLRLRGFCMTPTERLL--VYPYMANGSVASCL--RERPESQPPLDWPKRQRIALGSARGL 144

Query: 142 HYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEF 195
            YLH H +P IIHRD+K  NI ++    E  +GD GLA +M      +     V GT   
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM--DYKDTHVTTAVRGTIGH 201

Query: 196 MAPELYEEEY------NELVDIYSFGMCILEMVTCEYPYNECKNPAQ 236
           +AP     EY      +E  D++ +G+ +LE++T +  ++  +    
Sbjct: 202 IAP-----EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 64/311 (20%), Positives = 125/311 (40%), Gaps = 61/311 (19%)

Query: 2   DCGSGFTKSETEEGEFSEKD-------PSCRYGRYD----EILGKGAFKTVY----KGFD 46
           +C +   + E    E+ E            R  R D    +++G+GAF  V     K  D
Sbjct: 40  ECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD 99

Query: 47  EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106
           +V  +++       +  M    +      E  +L +   + I   + ++ DD N  + ++
Sbjct: 100 KVFAMKIL-----NKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN--LYLV 152

Query: 107 T------ELFTSGSLRQYRKKHKNVDMKAIKNWAR----QILRGLHYLHSHNPPIIHRDL 156
                  +L T   L ++  +            AR    +++  +  +H  +   +HRD+
Sbjct: 153 MDYYVGGDLLTL--LSKFEDRLPE-------EMARFYLAEMVIAIDSVHQLH--YVHRDI 201

Query: 157 KCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELYEEE------YNE 207
           K DNI ++  NG +++ D G     +      +   +GTP++++PE+ +        Y  
Sbjct: 202 KPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGP 260

Query: 208 LVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIK----PASLSKVTDPQVKQFI 262
             D +S G+C+ EM+  E P Y E  +  + Y K+ +  +    P  ++ V     K  I
Sbjct: 261 ECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERFQFPTQVTDV-SENAKDLI 317

Query: 263 EKCIVPASLRL 273
            + I     RL
Sbjct: 318 RRLICSREHRL 328

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 97.6 bits (243), Expect = 3e-22
 Identities = 41/170 (24%), Positives = 82/170 (48%), Gaps = 9/170 (5%)

Query: 99  TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
           T   ++ I +L   G L  +  +H       ++ +A +I+ GL ++H+    +++RDLK 
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKP 320

Query: 159 DNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGM 216
            NI ++  +G V+I DLGLA    +    + +GT  +MAPE       Y+   D +S G 
Sbjct: 321 ANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379

Query: 217 CILEMVTCEYPY--NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
            + +++    P+  ++ K+  +I +   +      L     P+++  +E 
Sbjct: 380 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLEG 427

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 94.9 bits (237), Expect = 3e-22
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 28/219 (12%)

Query: 17  FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYS 75
           F E+  S         +G+G F  VYKG+  V+   VA  ++     + +  +L++    
Sbjct: 27  FDERPIS----VGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTE-ELKQQFDQ 79

Query: 76  EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVD----MK 128
           E+ ++   +HEN+++      D  +    ++     +GSL            +      K
Sbjct: 80  EIKVMAKCQHENLVELLGFSSDGDDLC--LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137

Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTA 186
             +  A     G+++LH      IHRD+K  NI ++      KI D GLA        T 
Sbjct: 138 IAQGAAN----GINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTV 190

Query: 187 RS--VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT 223
            +  ++GT  +MAPE    E     DIYSFG+ +LE++T
Sbjct: 191 MTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 65/256 (25%), Positives = 105/256 (41%), Gaps = 57/256 (22%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--------EDVMQSPDQLERLYSEVHL 79
              + LG+GAF  V     E  GI+    +  +        +D  +    L  L SE+ +
Sbjct: 38  TLGKPLGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEM 93

Query: 80  LKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------- 122
           +K + KH+NII          +  + +I E  + G+LR+Y +                  
Sbjct: 94  MKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151

Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
           + +  K + +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GL     
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGL----- 203

Query: 183 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPY 228
              AR +     +            MAPE L++  Y    D++SFG+ + E+ T    PY
Sbjct: 204 ---ARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

Query: 229 NECKNPAQIYKKVTSG 244
                  +++K +  G
Sbjct: 261 PGIPV-EELFKLLKEG 275

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 95.5 bits (238), Expect = 4e-22
 Identities = 64/256 (25%), Positives = 104/256 (40%), Gaps = 57/256 (22%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--------EDVMQSPDQLERLYSEVHL 79
              + LG+G F  V     E  GI+    +  +        +D  +    L  L SE+ +
Sbjct: 84  TLGKPLGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEM 139

Query: 80  LKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------- 122
           +K + KH+NII          +  + +I E  + G+LR+Y +                  
Sbjct: 140 MKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
           + +  K + +   Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA    
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLA---- 250

Query: 183 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPY 228
               R +     +            MAPE L++  Y    D++SFG+ + E+ T    PY
Sbjct: 251 ----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

Query: 229 NECKNPAQIYKKVTSG 244
                  +++K +  G
Sbjct: 307 PGIPV-EELFKLLKEG 321

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 63/254 (24%), Positives = 102/254 (40%), Gaps = 53/254 (20%)

Query: 28  RYDEILGKGAFKTVYKG--FDEVDGIEVAWNQVNI----EDVMQSPDQLERLYSEVHLLK 81
              + LG+GAF  V                 +V +     D  +    L  L SE+ ++K
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMK 129

Query: 82  SL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KN 124
            + KH+NII          +  + +I E  + G+LR+Y +                  + 
Sbjct: 130 MIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187

Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
           +  K + + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA      
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLA------ 238

Query: 185 TARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNE 230
             R +     +            MAPE L++  Y    D++SFG+ + E+ T    PY  
Sbjct: 239 --RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 231 CKNPAQIYKKVTSG 244
                +++K +  G
Sbjct: 297 VPV-EELFKLLKEG 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 91.5 bits (228), Expect = 5e-21
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 33/208 (15%)

Query: 32  ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHENIIK 90
           ++G G F  VYKG    DG +VA  +   E       Q      +E+  L   +H +++ 
Sbjct: 46  LIGHGVFGKVYKGVLR-DGAKVALKRRTPESS-----QGIEEFETEIETLSFCRHPHLVS 99

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWAR--QIL----RGLH 142
                 +     +  I +   +G+L++  Y      + M    +W +  +I     RGLH
Sbjct: 100 LIGFCDERNEMIL--IYKYMENGNLKRHLYGSDLPTMSM----SWEQRLEICIGAARGLH 153

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFM 196
           YLH     IIHRD+K  NI ++ N    KI D G++    +       T   V GT  ++
Sbjct: 154 YLH--TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTV--VKGTLGYI 208

Query: 197 APELYEEEY-NELVDIYSFGMCILEMVT 223
            PE + +    E  D+YSFG+ + E++ 
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLC 236

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 52/302 (17%), Positives = 121/302 (40%), Gaps = 41/302 (13%)

Query: 2   DCGSGFTKSETEEGEFSEK-------DPSCRYGRYD----EILGKGAFKTVY----KGFD 46
           + G+     +    +F +            R  R D    +++G+GAF  V     K   
Sbjct: 27  ELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTG 86

Query: 47  EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106
           +V  +++       +  M    ++     E  +L +     I + + ++ D+    + ++
Sbjct: 87  QVYAMKIM-----NKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY--LYLV 139

Query: 107 TELFTSGSL-RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165
            E +  G L     K  + +  +  + +  +I+  +  +H      +HRD+K DNI ++ 
Sbjct: 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD- 196

Query: 166 NNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPEL--------YEEEYNELVDIYSF 214
             G +++ D G  + ++      +   +GTP++++PE+            Y    D ++ 
Sbjct: 197 RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256

Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVPASL 271
           G+   EM   + P+    + A+ Y K+      +    + +    + + FI++ + P   
Sbjct: 257 GVFAYEMFYGQTPF-YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPET 315

Query: 272 RL 273
           RL
Sbjct: 316 RL 317

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 38/124 (30%), Positives = 69/124 (55%), Gaps = 9/124 (7%)

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
           A +I   L YLHS N  I++RDLK +NI ++ + G + + D GL    +    T  +  G
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCG 201

Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PA 248
           TPE++APE L+++ Y+  VD +  G  + EM+    P+   +N A++Y  + +  ++   
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKP 260

Query: 249 SLSK 252
           +++ 
Sbjct: 261 NITN 264

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 92.2 bits (229), Expect = 2e-20
 Identities = 52/244 (21%), Positives = 103/244 (42%), Gaps = 23/244 (9%)

Query: 32  ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +LGKG F  V     +   ++   +    +   +             +E  +L+ +    
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----KGEAMALNEKQILEKVNSRF 245

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGLHYLH 145
           ++    ++  +T   + ++  L   G L+   Y              +A +I  GL  LH
Sbjct: 246 VVSLAYAY--ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPE-LYEE 203
                I++RDLK +NI ++ ++G ++I DLGLA+ + +  T +  +GT  +MAPE +  E
Sbjct: 304 RER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360

Query: 204 EYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
            Y    D ++ G  + EM+  + P+    +     ++ + V     P   S+   PQ + 
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSERFSPQARS 418

Query: 261 FIEK 264
              +
Sbjct: 419 LCSQ 422

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 14/228 (6%)

Query: 33  LGKGAFKTVY---KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           LGKG +  V+   K      G   A   +    ++++        +E ++L+ +KH  I+
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
               ++   T   + +I E  + G L    ++           +  +I   L +LH    
Sbjct: 85  DLIYAF--QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG- 141

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYN 206
            II+RDLK +NI +N + G VK+ D GL    +       +  GT E+MAPE L    +N
Sbjct: 142 -IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199

Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSK 252
             VD +S G  + +M+T   P+   +N  +   K+       P  L++
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYLTQ 246

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 31/239 (12%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-K 84
           ++ +++G+G F  V K   + DG  ++ A  ++  E   +          E+ +L  L  
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKD--DHRDFAGELEVLCKLGH 84

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW----------- 133
           H NII        +    + +  E    G+L  + +K + ++                  
Sbjct: 85  HPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 134 -----ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
                A  + RG+ YL       IHRDL   NI V  N    KI D GL+   +    ++
Sbjct: 143 QLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKT 199

Query: 189 VIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
           +   P  +MA E L    Y    D++S+G+ + E+V+    PY      A++Y+K+  G
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG 257

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 31/223 (13%)

Query: 27  GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            RY     LG G F TV+   D V+   VA     ++ V       E    E+ LL+ + 
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVA-----MKIVRGDKVYTEAAEDEIKLLQRVN 73

Query: 85  -----------HENIIKFYNS--WVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKA 129
                        +I+K  +           + M+ E+    +L    KK+++    +  
Sbjct: 74  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV-LGENLLALIKKYEHRGIPLIY 132

Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-----NGNNGEVKIGDLGLAIVMQQP 184
           +K  ++Q+L GL Y+H     IIH D+K +N+ +       N  ++KI DLG A    + 
Sbjct: 133 VKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE- 190

Query: 185 TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY 226
              + I T E+ +PE L    +    DI+S    I E++T ++
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.0 bits (221), Expect = 3e-20
 Identities = 30/262 (11%), Positives = 63/262 (24%), Gaps = 50/262 (19%)

Query: 27  GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           GRY      G       ++  D     +VA   V+    +   D L+   S    L  + 
Sbjct: 31  GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVD-PQGVLPDDVLQETLSRTLRLSRID 89

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
              + +  +         +    E    GSL++      +          + +       
Sbjct: 90  KPGVARVLDVVHTRAGGLVVA--EWIRGGSLQEVADTSPSPVGAI--RAMQSLAAAADAA 145

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE 204
           H     +         + V   +G+V +        M     +                 
Sbjct: 146 HRAG--VALSIDHPSRVRV-SIDGDVVLAYPA---TMPDANPQD---------------- 183

Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQI---YKKVTSGIKPASLSKVTDPQVKQF 261
                DI   G  +  ++   +P  E    + +    +         +     D      
Sbjct: 184 -----DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA---DIDRD---- 231

Query: 262 IEKCIVPASLRLPALELL-KDP 282
                +P  +   A   +  D 
Sbjct: 232 -----IPFQISAVAARSVQGDG 248

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 14/128 (10%)

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGT 192
           +I+  L +LH     II+RD+K +NI ++ +NG V + D GL+   +  +   A    GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223

Query: 193 PEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSG-I 245
            E+MAP++       +++ VD +S G+ + E++T   P+    E  + A+I +++     
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283

Query: 246 K-PASLSK 252
             P  +S 
Sbjct: 284 PYPQEMSA 291

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 88.4 bits (220), Expect = 7e-20
 Identities = 38/122 (31%), Positives = 63/122 (51%), Gaps = 9/122 (7%)

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
           ++   L +LHS    II+RDLK +NI ++   G +K+ D GL+   +  +  A S  GT 
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190

Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 250
           E+MAPE +    + +  D +SFG+ + EM+T   P+ + K+  +    +       P  L
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFL 249

Query: 251 SK 252
           S 
Sbjct: 250 SP 251

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 89.4 bits (222), Expect = 9e-20
 Identities = 61/264 (23%), Positives = 117/264 (44%), Gaps = 23/264 (8%)

Query: 2   DCGSGFTKSETEEGEFSEKDPSCRYGRYD----EILGKGAFKTVY----KGFDEVDGIEV 53
             GS    S  EE E S   P  R    +    ++LGKG F  V     K       +++
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI 180

Query: 54  AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSG 113
              +V +       D++    +E  +L++ +H  +     S+   T+  +  + E    G
Sbjct: 181 LKKEVIVAK-----DEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYANGG 233

Query: 114 SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173
            L  +  + +       + +  +I+  L YLHS    +++RDLK +N+ ++ + G +KI 
Sbjct: 234 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKIT 291

Query: 174 DLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 230
           D GL    +    T ++  GTPE++APE L + +Y   VD +  G+ + EM+    P+  
Sbjct: 292 DFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-Y 350

Query: 231 CKNPAQIYKKVTSG--IKPASLSK 252
            ++  ++++ +       P +L  
Sbjct: 351 NQDHEKLFELILMEEIRFPRTLGP 374

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 88.4 bits (220), Expect = 9e-20
 Identities = 53/229 (23%), Positives = 110/229 (48%), Gaps = 20/229 (8%)

Query: 33  LGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
           LGKG F  V     K       +++   +V I       D++    +E  +L++ +H  +
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVAHTVTESRVLQNTRHPFL 67

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
                ++   T+  +  + E    G L  +  + +    +  + +  +I+  L YLHS +
Sbjct: 68  TALKYAF--QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEY 205
             +++RD+K +N+ ++  +G +KI D GL    +    T ++  GTPE++APE L + +Y
Sbjct: 126 --VVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSK 252
              VD +  G+ + EM+    P+   ++  ++++ +    I+ P +LS 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPRTLSP 230

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
           + +I   L+YLH     II+RDLK DN+ ++   G +K+ D G+    +    T  +  G
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 172

Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
           TP ++APE L  E+Y   VD ++ G+ + EM+    P++   +     + 
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 25/210 (11%)

Query: 27  GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            RY   +++GKG+F  V K +D      VA     ++ V        +   E+ +L+ L+
Sbjct: 97  YRYEVLKVIGKGSFGQVVKAYDHKVHQHVA-----LKMVRNEKRFHRQAAEEIRILEHLR 151

Query: 85  HE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQ 136
            +      N+I          N    M  EL  S +L +  KK+K     +  ++ +A  
Sbjct: 152 KQDKDNTMNVIHMLE-NFTFRNHIC-MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
           IL+ L  LH +   IIH DLK +NI         +K+ D G +    Q    + I +  +
Sbjct: 209 ILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-TYIQSRFY 265

Query: 196 MAPE-LYEEEYNELVDIYSFGMCIL-EMVT 223
            APE +    Y   +D++S G CIL E++T
Sbjct: 266 RAPEVILGARYGMPIDMWSLG-CILAELLT 294

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 86.1 bits (214), Expect = 5e-19
 Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 13/154 (8%)

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
           +I+ GL +LHS    I++RDLK DNI ++  +G +KI D G+    ++      +  GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTP 182

Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 250
           +++APE L  ++YN  VD +SFG+ + EM+  + P+   ++  +++  +       P  L
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWL 241

Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKD-PF 283
            K     + +   +       RL     ++  P 
Sbjct: 242 EKEAKDLLVKLFVRE---PEKRLGVRGDIRQHPL 272

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 86.1 bits (214), Expect = 6e-19
 Identities = 36/122 (29%), Positives = 64/122 (52%), Gaps = 9/122 (7%)

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
           +I+  L +LH     II+RDLK DN+ ++   G  K+ D G+    +    T  +  GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188

Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 250
           +++APE L E  Y   VD ++ G+ + EM+    P+ E +N   +++ + +   + P  L
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWL 247

Query: 251 SK 252
            +
Sbjct: 248 HE 249

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 85.7 bits (213), Expect = 8e-19
 Identities = 38/122 (31%), Positives = 71/122 (58%), Gaps = 9/122 (7%)

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
           +I  GL +L S    II+RDLK DN+ ++ + G +KI D G+    +    T ++  GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTP 185

Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 250
           +++APE +  + Y + VD ++FG+ + EM+  + P+ E ++  ++++ +       P S+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM 244

Query: 251 SK 252
           SK
Sbjct: 245 SK 246

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 86.2 bits (214), Expect = 9e-19
 Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
           + +I   L+YLH     II+RDLK DN+ ++   G +K+ D G+    +    T  +  G
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 215

Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
           TP ++APE L  E+Y   VD ++ G+ + EM+    P++   +     + 
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 85.1 bits (210), Expect = 5e-18
 Identities = 39/124 (31%), Positives = 71/124 (57%), Gaps = 9/124 (7%)

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
           A +I  GL +L S    II+RDLK DN+ ++   G +KI D G+    +    T ++  G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTFCG 504

Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPA 248
           TP+++APE +  + Y + VD ++FG+ + EM+  + P+ E ++  ++++ +       P 
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPK 563

Query: 249 SLSK 252
           S+SK
Sbjct: 564 SMSK 567

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 23/210 (10%)

Query: 27  GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            RY+   ++GKG+F  V K +D V+   VA     I+ +      L +   EV LL+ + 
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVA-----IKIIKNKKAFLNQAQIEVRLLELMN 108

Query: 85  HE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQ 136
                    I+          N    ++ E+  S +L    +      V +   + +A+Q
Sbjct: 109 KHDTEMKYYIVHLKR-HFMFRNHLC-LVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
           +   L +L +    IIH DLK +NI   N     +KI D G +  + Q      I +  +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-QYIQSRFY 224

Query: 196 MAPE-LYEEEYNELVDIYSFGMCIL-EMVT 223
            +PE L    Y+  +D++S G CIL EM T
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLG-CILVEMHT 253

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 34/158 (21%), Positives = 67/158 (42%), Gaps = 9/158 (5%)

Query: 93  NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
           +S    ++  +   +                 + ++ +  ++ Q+ +G+ +L S     I
Sbjct: 158 SSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CI 215

Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTP---EFMAPE-LYEEEYNE 207
           HRDL   NI +      VKI D GLA  + + P            ++MAPE +++  Y  
Sbjct: 216 HRDLAARNILL-SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274

Query: 208 LVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
             D++SFG+ + E+ +    PY   K   +  +++  G
Sbjct: 275 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 40/206 (19%), Positives = 72/206 (34%), Gaps = 29/206 (14%)

Query: 30  DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLER--LYSEVHLLKSL-K 84
            + LG+GAF  V +   +  GI+       +   M  +     E   L SE+ +L  +  
Sbjct: 27  GKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
           H N++             + +I E    G+L  Y +  +N +    K    +  +G  Y+
Sbjct: 85  HLNVVNLL-GACTKPGGPLMVIVEFCKFGNLSTYLRSKRN-EFVPYKTKGARFRQGKDYV 142

Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE 204
            +     I  DLK     +  +      G +           +S+    E  APE   ++
Sbjct: 143 GA-----IPVDLKRRLDSITSSQSSASSGFVE---------EKSLSDVEEEEAPEDLYKD 188

Query: 205 YNELVDIYSF------GMCILEMVTC 224
           +  L  +  +      GM  L    C
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLASRKC 214

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 47/232 (20%), Positives = 90/232 (38%), Gaps = 47/232 (20%)

Query: 27  GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
             +     +G G F  V       +    A     ++ V            E  +LK ++
Sbjct: 35  NAFLVIRKMGDGTFGRVLLCQHIDNKKYYA-----VKVVRNIKKYTRSAKIEADILKKIQ 89

Query: 85  HE-----NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQI 137
           ++     NI+K++       +  + +I E     SL +   ++      ++ IK +  +I
Sbjct: 90  NDDINNNNIVKYHG-KFMYYDH-MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEI 146

Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVN------------------------GNNGEVKIG 173
           L+ L+YL   +  + H DLK +NI ++                          +  +K+ 
Sbjct: 147 LKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 174 DLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 223
           D G A         S+I T ++ APE +    ++   D++SFG C+L E+ T
Sbjct: 205 DFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFG-CVLAELYT 254

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 35/193 (18%), Positives = 68/193 (35%), Gaps = 39/193 (20%)

Query: 33  LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
           +G G F  +Y  F      + A + V +E       +   L+SE+   + +  ++ I   
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVE-----YQENGPLFSELKFYQRVAKKDCI--- 96

Query: 93  NSWVDDTNRTINMITELFTSG-------------------SLRQYRKKHKNVDMKAIKNW 133
             W++        I   + SG                    L++   ++       +   
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQQ 183
             ++L  L Y+H +    +H D+K  N+ +   N  +V + D GL+            Q+
Sbjct: 157 GIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214

Query: 184 PTARSVIGTPEFM 196
              +   GT EF 
Sbjct: 215 NPRKGHNGTIEFT 227

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 70.1 bits (172), Expect = 9e-14
 Identities = 46/185 (24%), Positives = 70/185 (37%), Gaps = 26/185 (14%)

Query: 27  GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            RY     +G G+F  +Y G D   G EVA   + +E V     QL     E  + K ++
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVA---IKLECVKTKHPQLHI---ESKIYKMMQ 62

Query: 85  H-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLH 142
               I        +       M+ EL    SL        +   +K +   A Q++  + 
Sbjct: 63  GGVGIPTIRWCGAEGDYNV--MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIE 119

Query: 143 YLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQP---------TARSVIG 191
           Y+HS N   IHRD+K DN  +        V I D GLA   +             +++ G
Sbjct: 120 YIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177

Query: 192 TPEFM 196
           T  + 
Sbjct: 178 TARYA 182

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 46/227 (20%), Positives = 89/227 (39%), Gaps = 41/227 (18%)

Query: 27  GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            RY     LG+G F  V +  D   G      QV ++ +       E    E+++LK +K
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKS----QVALKIIRNVGKYREAARLEINVLKKIK 74

Query: 85  HE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQ 136
            +        +   + W +     + +  EL    +  ++ K++      +  +++ A Q
Sbjct: 75  EKDKENKFLCVLMSD-WFNFHGH-MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQ 131

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NGEVKIGDLGLA 178
           +   L +LH +   + H DLK +NI    +                  N  +++ D G A
Sbjct: 132 LCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 179 IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 223
               +    +++ T  +  PE + E  + +  D++S G CIL E   
Sbjct: 190 TFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIG-CILFEYYR 234

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 43/228 (18%)

Query: 27  GRYD--EILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
            RY+  + LG+GAF  V +  D +  G  VA     ++ V       E   SE+ +L+ L
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVA-----VKIVKNVDRYCEAARSEIQVLEHL 68

Query: 84  KHE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWAR 135
                      ++    W +     I ++ EL    S   + K++  +   +  I+  A 
Sbjct: 69  NTTDPNSTFRCVQMLE-WFEHHGH-ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAY 125

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NGEVKIGDLGL 177
           QI + +++LHS+   + H DLK +NI    +                  N ++K+ D G 
Sbjct: 126 QICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183

Query: 178 AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 223
           A    +    +++ T  + APE +    +++  D++S G CIL E   
Sbjct: 184 ATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIG-CILIEYYL 229

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 36/158 (22%), Positives = 66/158 (41%), Gaps = 17/158 (10%)

Query: 27  GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            ++     +G G+F  +Y G +     EVA   + +E+V     QL     E  + + L+
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLLY---ESKIYRILQ 60

Query: 85  -HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLH 142
               I       V+       ++ +L    SL        + + +K +   A Q++  + 
Sbjct: 61  GGTGIPNVRWFGVEGDYNV--LVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVE 117

Query: 143 YLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLA 178
           ++HS +   +HRD+K DN  +       +V I D GLA
Sbjct: 118 FVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 36/160 (22%), Positives = 60/160 (37%), Gaps = 19/160 (11%)

Query: 27  GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
             +   + +G G F  +  G +      VA   + +E +     QL     E    K L 
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVA---IKLEPMKSRAPQLHL---EYRFYKQLG 62

Query: 85  H-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLH 142
             + I + Y            M+ EL    SL        +   +K +   A Q++  + 
Sbjct: 63  SGDGIPQVYYFGPCGKYNA--MVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRME 119

Query: 143 YLHSHNPPIIHRDLKCDNIFV----NGNNGEVKIGDLGLA 178
           Y+HS N  +I+RD+K +N  +    N     + I D  LA
Sbjct: 120 YVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 61.6 bits (150), Expect = 7e-11
 Identities = 31/160 (19%), Positives = 64/160 (40%), Gaps = 19/160 (11%)

Query: 27  GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
             Y     +G+G+F  +++G + ++  +VA   +  E       QL     E    K L 
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRD---EYRTYKLLA 63

Query: 85  H-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLH 142
               I   Y    +  +    ++ +L    SL        +   +K +   A+Q+L  + 
Sbjct: 64  GCTGIPNVYYFGQEGLHNV--LVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLA 178
            +H  +  +++RD+K DN  +   N +    + + D G+ 
Sbjct: 121 SIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 27/194 (13%), Positives = 59/194 (30%), Gaps = 38/194 (19%)

Query: 33  LGKGAFKTVYKGFDEVDGI--------EVA----------WNQVNIEDVMQSPDQLERLY 74
             +     +Y+                + +          +N+ N       P Q+ +  
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 75  SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKN 132
                L S     I       V        ++       SL+          +  +++  
Sbjct: 110 K----LYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLGR-SLQSALDVSPKHVLSERSVLQ 163

Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQ 182
            A ++L  L +LH +    +H ++  +NIFV+  +  +V +   G A         +   
Sbjct: 164 VACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221

Query: 183 QPTARSVIGTPEFM 196
           + +     G  EF+
Sbjct: 222 EGSRSPHEGDLEFI 235

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 63/264 (23%), Positives = 99/264 (37%), Gaps = 71/264 (26%)

Query: 27  GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           GRY  I  LG G F TV+  +D      VA   + +  V  +    E    E+ LLKS++
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVA---MKV--VKSAEHYTETALDEIRLLKSVR 91

Query: 85  --------HENIIKFYNS-WVDDTNRT-INMITELFTSGSLRQYRKKHKN--VDMKAIKN 132
                    E +++  +   +   N T I M+ E+     L ++  K     + +  +K 
Sbjct: 92  NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEV-LGHHLLKWIIKSNYQGLPLPCVKK 150

Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFV----------------------------- 163
             +Q+L+GL YLH+    IIH D+K +NI +                             
Sbjct: 151 IIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209

Query: 164 -------------------NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEE 203
                              N    +VKI DLG A  + +      I T ++ + E L   
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-TEDIQTRQYRSLEVLIGS 268

Query: 204 EYNELVDIYSFGMCILEMVTCEYP 227
            YN   DI+S      E+ T +Y 
Sbjct: 269 GYNTPADIWSTACMAFELATGDYL 292

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.9 bits (144), Expect = 3e-10
 Identities = 56/336 (16%), Positives = 99/336 (29%), Gaps = 80/336 (23%)

Query: 16  EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIED----VMQSPDQLE 71
            FS   P+ +  R ++I G+G F  V++     D   VA   + IE             E
Sbjct: 12  PFSHCLPTEKLQRCEKI-GEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFE 68

Query: 72  RLYSEVHLLKSL---------KHENIIKFYNSWV----------------DDTNRTINMI 106
            +  E+ + K L         + E  I   +                   + T  + N  
Sbjct: 69  EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128

Query: 107 TELFTSG-------------SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153
            + F                 L Q R K  ++     K+   Q+   L      +    H
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAE-ASLRFEH 185

Query: 154 RDLKCDNIFVNGNNG-------------------EVKIGDLGLAIVMQQPTARSVIGTPE 194
           RDL   N+ +   +                    +V I D  L+ + +      V+    
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI---VVFCDV 242

Query: 195 FMAPELYEEEYNELVDIYSFGMCILEMVTCEY-PYNECK-----NPAQIYKKVTSGIKPA 248
            M  +L+  + +   DIY            EY PY+            + +         
Sbjct: 243 SMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNT 302

Query: 249 SLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 284
              K    ++++F    +  +S    A +LL    L
Sbjct: 303 PAMKQIKRKIQEFHRTMLNFSS----ATDLLCQHSL 334

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 39/200 (19%), Positives = 67/200 (33%), Gaps = 36/200 (18%)

Query: 27  GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
             +     +G+G F  +Y   D      V  +   +  V   P     L++E+   +   
Sbjct: 35  AAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVE--PSDNGPLFTELKFYQRAA 91

Query: 85  HENIIKFYNSWVDDTNRTI----------------N-MITELFTSGSLRQYRKKHKNV-D 126
               I+ +          +                  MI + F S  L++  + +     
Sbjct: 92  KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFS 150

Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA------- 178
            K +   + +IL  L Y+H H    +H D+K  N+ +N  N  +V + D GLA       
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

Query: 179 --IVMQQPTARSVIGTPEFM 196
                     R   GT EF 
Sbjct: 209 VHKAYAADPKRCHDGTIEFT 228

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.6 bits (138), Expect = 5e-09
 Identities = 63/380 (16%), Positives = 111/380 (29%), Gaps = 106/380 (27%)

Query: 16  EFSEKDPSCRYGRYDEILG--KGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL 73
           E  E     +     +IL   + AF   +   D  D  +   ++  I+ ++ S D +   
Sbjct: 10  ETGEHQYQYK-----DILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT 64

Query: 74  YSEVHLLKSLKHENIIKFYNSWVDDTN------------RTINMITELFTSGSLRQYR-- 119
                 L S K E +++ +   V   N            R  +M+T ++     R Y   
Sbjct: 65  LRLFWTLLS-KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123

Query: 120 ---KKHKNV----DMKAIKNWARQILRGLHYLHSHNPPIIH---------------RDLK 157
               K+ NV        ++    + LR    +      +I                   K
Sbjct: 124 QVFAKY-NVSRLQPYLKLRQALLE-LRPAKNV------LIDGVLGSGKTWVALDVCLSYK 175

Query: 158 CDNIFVNG----NNGEVKIGDLGLAI-------VMQQPTARSVIGTPEFMAPELYEEEYN 206
                       N       +  L +       +    T+RS   +   +     + E  
Sbjct: 176 VQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR 235

Query: 207 ELVDIYSFGMC--ILEMV----TCEYPYNECKNPAQI-----YKKVTSGIKPASLSKV-- 253
            L+    +  C  +L  V            CK    I     +K+VT  +  A+ + +  
Sbjct: 236 RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK----ILLTTRFKQVTDFLSAATTTHISL 291

Query: 254 -------TDPQVKQFIEKCIVPASLRLPALELLKDPFLVT-------------DNPKDLV 293
                  T  +VK  + K +      LP   L  +P  ++             DN K + 
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351

Query: 294 CDPLR------LPNLVPEVM 307
           CD L       L  L P   
Sbjct: 352 CDKLTTIIESSLNVLEPAEY 371

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 5e-05
 Identities = 40/296 (13%), Positives = 84/296 (28%), Gaps = 98/296 (33%)

Query: 6   GFTKSETEE----------------------------GEFSEKDPSCRYGRYD------- 30
             T  E +                              E S +D    +  +        
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE-SIRDGLATWDNWKHVNCDKL 355

Query: 31  --------EILGKGAFKTVYKGF----DEVDGI-----EVAWNQVNIEDVMQSPDQL--- 70
                    +L    ++ ++            I      + W  V   DVM   ++L   
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSVFPPSAH-IPTILLSLIWFDVIKSDVMVVVNKLHKY 414

Query: 71  --------ERLYS--EVHLLKSLK-------HENIIKFYNSW--VDDTNRTINMITELFT 111
                   E   S   ++L   +K       H +I+  YN     D  +     + + F 
Sbjct: 415 SLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFY 474

Query: 112 S--GS-LRQYRKKHKNVDMKAIK---NWARQILRGLHYLHSHNPPIIH--RDLKC--DNI 161
           S  G  L+      +    + +     +  Q +R      + +  I++  + LK     I
Sbjct: 475 SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYI 534

Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-------FMAPE--LYEEEYNEL 208
             N    E  +  + L  + +     ++I +          MA +  ++EE + ++
Sbjct: 535 CDNDPKYERLVNAI-LDFLPK--IEENLICSKYTDLLRIALMAEDEAIFEEAHKQV 587

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	394
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.12
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.11
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.06
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.74
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.57
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.51
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.41
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.19
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.16
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.04
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.95
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.55
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.54
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.5
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.22
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.2
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.13
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.87
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.78
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.76
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.72
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.49
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.4
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.08
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.61
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.14
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.89

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-68  Score=504.55  Aligned_cols=268  Identities=50%  Similarity=0.942  Sum_probs=243.8

Q ss_pred             cccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEc
Q 016143           18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD   97 (394)
Q Consensus        18 ~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~   97 (394)
                      ....+.+||+++.+.||+|+||+||+|.++.++..||+|++.....  .....+++.+|+.+|++|+|||||+++++|.+
T Consensus        19 ~~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~   96 (290)
T 3fpq_A           19 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWES   96 (290)
T ss_dssp             EEECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             cCcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence            3445678999999999999999999999999999999999975543  45667889999999999999999999999865


Q ss_pred             C--CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143           98 D--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus        98 ~--~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                      .  ....++||||||+||+|.+++++.+.+++..++.|+.||+.||.|||+++++|+||||||+|||+++.+|.+||+||
T Consensus        97 ~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A           97 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             ccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeC
Confidence            3  34678999999999999999999999999999999999999999999998889999999999999856789999999


Q ss_pred             ceeeeecCCCCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          176 GLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       176 gla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      |+|+........+.+|||.|||||++.+.|+.++|||||||++|||+||+.||.+..+..+++..+..+..|..++...+
T Consensus       177 Gla~~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (290)
T 3fpq_A          177 GLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI  256 (290)
T ss_dssp             TGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred             cCCEeCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence            99987766667778999999999999989999999999999999999999999988888999999999887777788889


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      +++++||.+||. +|.+|||+.|+|+||||+..
T Consensus       257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            999999999998 99999999999999999853

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-64  Score=480.50  Aligned_cols=258  Identities=27%  Similarity=0.446  Sum_probs=229.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+|+.||+|+++...... .+..+.+.+|+.+|++|+|||||+++++|.++  ..+|+|
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~yiv  110 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFG  110 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEE
Confidence            488999999999999999999999999999997654322 23457789999999999999999999999654  579999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      ||||+||+|.+++++.+.+++..++.|+.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+|+.+...  
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTTT
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEc-CCCCEEEEEcCCceecCCCCC
Confidence            999999999999999999999999999999999999999999  99999999999998 7899999999999877533  


Q ss_pred             --CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          185 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       185 --~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                        ...+.+|||.|||||++.+ .|+.++|||||||++|+|+||++||.+ .+..+++..+..+..  .++...++++++|
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dl  264 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKARDL  264 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHHHHH
Confidence              3456789999999998875 599999999999999999999999987 677888888877643  3566788999999


Q ss_pred             HHHcCC-CCCCCCCHHH------HhcCCccccCCCCCcc
Q 016143          262 IEKCIV-PASLRLPALE------LLKDPFLVTDNPKDLV  293 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~e------lL~~p~~~~~~~~~~~  293 (394)
                      |.+||+ ||.+|+|+.|      +++||||+..+|..+.
T Consensus       265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  303 (311)
T ss_dssp             HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             HHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence            999998 9999999987      5899999999887764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.9e-64  Score=468.86  Aligned_cols=258  Identities=26%  Similarity=0.509  Sum_probs=211.5

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      ..|+| ++.+.||+|+||+||+|.++.+|+.||+|+++..... ..+..+++.+|+.+|++|+|||||+++++|.++  .
T Consensus        11 ~ig~Y-~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~   86 (275)
T 3hyh_A           11 HIGNY-QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--D   86 (275)
T ss_dssp             ---CC-EEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred             EeeCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--C
Confidence            34677 8889999999999999999999999999999765432 234456789999999999999999999998654  5


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .+|+||||| +|+|.+++.+.+.+++.+++.++.||+.||+|||++|  |+||||||+|||++ .++++||+|||+|+..
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~  162 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIM  162 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTCCEEECCSSCC---
T ss_pred             EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEEC-CCCCEEEeecCCCeec
Confidence            799999999 7899999999999999999999999999999999999  99999999999998 7899999999999866


Q ss_pred             cCC-CCcccccCCcccCccccccc-C-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          182 QQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       182 ~~~-~~~~~~gt~~y~aPE~l~~~-~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                      ... ...+.+||+.|||||++.+. | +.++|||||||++|+|+||+.||.+ .+..++++.+..+..  .++...++++
T Consensus       163 ~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~  239 (275)
T 3hyh_A          163 TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVY--TLPKFLSPGA  239 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTSCHHH
T ss_pred             CCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHH
Confidence            544 34567899999999988764 4 6899999999999999999999987 677888888887643  3567789999


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcCCccccCCCC
Q 016143          259 KQFIEKCIV-PASLRLPALELLKDPFLVTDNPK  290 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~  290 (394)
                      ++||++||+ +|.+|||+.|+|+||||+...++
T Consensus       240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p~  272 (275)
T 3hyh_A          240 AGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPE  272 (275)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCCG
T ss_pred             HHHHHHHccCChhHCcCHHHHHcCcccccCCCh
Confidence            999999998 99999999999999999876544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.8e-63  Score=479.03  Aligned_cols=257  Identities=29%  Similarity=0.533  Sum_probs=223.7

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      .||..+| ++.+.||+|+||+||+|.++.+|+.||||+++....    ...+.+.+|+.+|++|+|||||+++++|.++ 
T Consensus        70 ~dp~~~y-~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-  143 (346)
T 4fih_A           70 GDPRSYL-DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVG-  143 (346)
T ss_dssp             SCGGGTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----SSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-
T ss_pred             CChhHhc-EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-
Confidence            4455555 677889999999999999999999999999976543    2235678899999999999999999999765 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                       ..+|||||||+||+|.+++.+. ++++..++.|+.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+|+
T Consensus       144 -~~~~ivmEy~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~  218 (346)
T 4fih_A          144 -DELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCA  218 (346)
T ss_dssp             -TEEEEEECCCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCE
T ss_pred             -CEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEC-CCCCEEEecCcCce
Confidence             4799999999999999999874 5999999999999999999999999  99999999999998 78999999999998


Q ss_pred             eecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCC
Q 016143          180 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTD  255 (394)
Q Consensus       180 ~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-~~~~~~~~  255 (394)
                      .....  ...+.+|||.|||||++.+ .|+.++|||||||++|||++|++||.+ .+..+.+..+..+..+ ......++
T Consensus       219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s  297 (346)
T 4fih_A          219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVS  297 (346)
T ss_dssp             ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSC
T ss_pred             ecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCC
Confidence            77544  3567899999999998875 599999999999999999999999987 6677777777765433 22334578


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +++++||.+||. ||.+|||+.|+|+||||+...
T Consensus       298 ~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          298 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999998 999999999999999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.3e-63  Score=478.88  Aligned_cols=256  Identities=26%  Similarity=0.459  Sum_probs=219.8

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .+|| ++.+.||+|+||+||+|.++.+|+.||||+++....  .....+++.+|+.+|++|+|||||+++++|.++  ..
T Consensus        23 me~Y-~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~   97 (350)
T 4b9d_A           23 MEKY-VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEEN--GS   97 (350)
T ss_dssp             CCCE-EEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred             ccce-EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CE
Confidence            3577 788999999999999999999999999999976543  456678899999999999999999999999654  57


Q ss_pred             EEEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          103 INMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      +|||||||+||+|.+++...+  .+++.+++.|+.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+|+.
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~  174 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARV  174 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEEC-TTCCEEECSTTEESC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCCEEEccccccee
Confidence            999999999999999997553  4799999999999999999999999  99999999999998 789999999999987


Q ss_pred             ecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          181 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       181 ~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      ....  .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+ .+..+++..+..+..+. .+..++++
T Consensus       175 ~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~-~~~~~s~~  252 (350)
T 4b9d_A          175 LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPP-VSLHYSYD  252 (350)
T ss_dssp             CCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSCHH
T ss_pred             ecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCC-CCccCCHH
Confidence            6543  2345789999999998876 599999999999999999999999987 66777777777765443 45667899


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +++||.+||. ||.+|||+.|+|+||||+...
T Consensus       253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            9999999998 999999999999999998643

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.8e-62  Score=481.81  Aligned_cols=258  Identities=29%  Similarity=0.530  Sum_probs=224.9

Q ss_pred             ccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        19 ~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      ..||..+| ++.+.||+|+||+||+|.++.+|+.||||+++....    ...+.+.+|+.+|++|+|||||+++++|.++
T Consensus       146 ~~dp~~~y-~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  220 (423)
T 4fie_A          146 PGDPRSYL-DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVG  220 (423)
T ss_dssp             SSCGGGTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CCChhHhc-EeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence            34555555 777899999999999999999999999999976542    2345688999999999999999999999765


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                        ..+|||||||+||+|.++++.. ++++.+++.|++||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+|
T Consensus       221 --~~~~iVmEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~-~~g~vKl~DFGla  294 (423)
T 4fie_A          221 --DELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFC  294 (423)
T ss_dssp             --TEEEEEEECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEEC-TTCCEEECCCTTC
T ss_pred             --CEEEEEEeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEecCccc
Confidence              4799999999999999999765 5999999999999999999999999  99999999999998 7899999999999


Q ss_pred             eeecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCC
Q 016143          179 IVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVT  254 (394)
Q Consensus       179 ~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-~~~~~~~  254 (394)
                      +.+...  ...+.+||+.|||||++.+ .|+.++|||||||++|||++|++||.+ .+..+++..+..+..+ ......+
T Consensus       295 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~  373 (423)
T 4fie_A          295 AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKV  373 (423)
T ss_dssp             EECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSS
T ss_pred             eECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccC
Confidence            877544  3567899999999998875 599999999999999999999999987 6667777777665433 2334567


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ++++++||.+||. ||.+|+|+.|+|+||||+...
T Consensus       374 s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          374 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            8999999999998 999999999999999998753

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.4e-63  Score=469.96  Aligned_cols=262  Identities=23%  Similarity=0.328  Sum_probs=220.1

Q ss_pred             ccccceecccCceEEEEEEEc---cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      |++.+.||+|+||+||+|.+.   .+++.||+|+++......  ....++.+|+.+|++|+|||||+++++|.++  ..+
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~  101 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQTE--GKL  101 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEEET--TEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence            488999999999999999874   468899999997544321  2234577899999999999999999999654  579


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      |+|||||+||+|.+++++.+.+++.+++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+|+....
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTSCEEEESSEEEEC---
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEc-CCCCEEecccccceeccC
Confidence            999999999999999999999999999999999999999999999  99999999999998 789999999999986543


Q ss_pred             --CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          184 --PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       184 --~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                        ....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+..  .++...++++++
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~  255 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQS  255 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCcCCHHHHH
Confidence              34556789999999998875 599999999999999999999999987 677777888777643  356678999999


Q ss_pred             HHHHcCC-CCCCCCCH-----HHHhcCCccccCCCCCcccCCCC
Q 016143          261 FIEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLR  298 (394)
Q Consensus       261 li~~~L~-~p~~R~s~-----~elL~~p~~~~~~~~~~~~~~~~  298 (394)
                      ||++||+ +|.+|||+     +|+++||||+..++..+....+.
T Consensus       256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~  299 (304)
T 3ubd_A          256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIH  299 (304)
T ss_dssp             HHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             HHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCC
Confidence            9999998 99999984     79999999999887665444433

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.6e-61  Score=460.22  Aligned_cols=248  Identities=26%  Similarity=0.380  Sum_probs=210.6

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      ++++.+.||+|+||+||+|.++.+|+.||||+++....         ..+|+.+|+.|+|||||+++++|.++  ..+||
T Consensus        59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~--~~~~i  127 (336)
T 4g3f_A           59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREG--PWVNI  127 (336)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred             heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence            45777899999999999999999999999999975432         13599999999999999999998654  57999


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |||||+||+|.+++++.+.+++..++.|+.||+.||.|||+++  |+||||||+|||++.++.++||+|||+|+......
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9999999999999999889999999999999999999999999  99999999999998433379999999998765431


Q ss_pred             -------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCCH
Q 016143          186 -------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDP  256 (394)
Q Consensus       186 -------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-~~~~~~~~~  256 (394)
                             ....+|||.|||||++.+ .|+.++|||||||++|||+||++||.+.. ...++..+..+..+ ..++..+++
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~s~  284 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF-RGPLCLKIASEPPPIREIPPSCAP  284 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC-CSCCHHHHHHSCCGGGGSCTTSCH
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-HHHHHHHHHcCCCCchhcCccCCH
Confidence                   234679999999998875 59999999999999999999999998743 34444555554332 346677899


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHH-------------hcCCccccC
Q 016143          257 QVKQFIEKCIV-PASLRLPALEL-------------LKDPFLVTD  287 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~el-------------L~~p~~~~~  287 (394)
                      ++++||.+||+ +|.+|||+.|+             |+|||+...
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            99999999998 99999999997             578998754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9e-60  Score=447.00  Aligned_cols=252  Identities=23%  Similarity=0.425  Sum_probs=202.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC------
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN------  100 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~------  100 (394)
                      |++.+.||+|+||+||+|.++.+|+.||+|+++...   .....+++.+|+.+|++|+|||||+++++|.+.+.      
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            577899999999999999999999999999997543   45566789999999999999999999999976542      


Q ss_pred             ----ceEEEEEcccCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143          101 ----RTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus       101 ----~~~~lV~e~~~~gsL~~~i~~~~~---l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                          .++|+|||||++|+|.+++.....   .++..++.|+.||+.||+|||++|  |+||||||+|||++ .++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~-~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC-CCCcEEEc
Confidence                358999999999999999998765   455678999999999999999999  99999999999998 68899999


Q ss_pred             ccceeeeecCCC--------------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHH
Q 016143          174 DLGLAIVMQQPT--------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY  238 (394)
Q Consensus       174 Dfgla~~~~~~~--------------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~  238 (394)
                      |||+|+......              ..+.+||+.|||||++.+ .|+.++|||||||++|||++   ||....+.....
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~  237 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL  237 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence            999997664321              234579999999998875 59999999999999999996   886533333444


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       239 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ..+.....|+.+ ...++.+++||++||+ +|.+|||+.|+|+||||+..+
T Consensus       238 ~~~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          238 TDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHhcCCCCCCC-cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            555554433322 2235678899999998 999999999999999998754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-58  Score=452.67  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=214.3

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC----C
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----T   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~----~   99 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||||+++...  ......+++.+|+.+|+.|+|||||++++++...    +
T Consensus        54 ~~Y-~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           54 DEY-EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             SSE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred             CCe-EEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence            355 78899999999999999999999999999986432  3456677899999999999999999999987543    3


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ...+|||||||+ |+|.+++.+.+.+++..++.+++||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+|+
T Consensus       131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~-~~~~~Ki~DFGla~  206 (398)
T 4b99_A          131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMAR  206 (398)
T ss_dssp             CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCB
T ss_pred             CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccC-CCCCEEEeecceee
Confidence            467999999995 689999999999999999999999999999999999  99999999999998 78999999999997


Q ss_pred             eecCC------CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc--CCCCC-
Q 016143          180 VMQQP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPA-  248 (394)
Q Consensus       180 ~~~~~------~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~--~~~~~-  248 (394)
                      .+...      ...+.+||+.|||||++.+  .|+.++||||+||++|||++|++||.+.. ....+..+..  +..+. 
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-YVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-HHHHHHHHHHHHCCCCGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhcCCCChH
Confidence            65332      3456789999999998764  47899999999999999999999998744 4444443322  11110 


Q ss_pred             -----------------------C---CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          249 -----------------------S---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       249 -----------------------~---~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                             .   .....++++++||.+||. ||.+|+|+.|+|+||||+..
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence                                   0   012357899999999998 99999999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.2e-58  Score=469.54  Aligned_cols=268  Identities=21%  Similarity=0.348  Sum_probs=230.5

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccC--CHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      |++.++||+|+||+||+|.++.+|+.||+|++++.....  ......+...++.+++.++|||||+++++|.++  ..+|
T Consensus       191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--~~ly  268 (689)
T 3v5w_A          191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLS  268 (689)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--SEEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--CEEE
Confidence            488899999999999999999999999999997654321  223333344567788889999999999999655  5799


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      ||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|  |+||||||+|||++ .+|++||+|||+|+.....
T Consensus       269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld-~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEe-CCCCEEecccceeeecCCC
Confidence            99999999999999999999999999999999999999999999  99999999999998 7899999999999988877


Q ss_pred             CCcccccCCcccCccccc-c-cCCCcCcchhhhhHHHHHHhcCCCCCCC--CCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          185 TARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~-~-~~~~~~DIwSlG~il~elltg~~Pf~~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      ...+.+|||.|||||++. + .|+.++|||||||+||||++|.+||.+.  .+..++...+....  ..++...++++++
T Consensus       346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--~~~p~~~S~~a~d  423 (689)
T 3v5w_A          346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFSPELRS  423 (689)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--CCCCTTSCHHHHH
T ss_pred             CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--CCCCccCCHHHHH
Confidence            778889999999999885 3 5999999999999999999999999753  34556666666543  3456778999999


Q ss_pred             HHHHcCC-CCCCCCC-----HHHHhcCCccccCCCCCcccCCCCCCC
Q 016143          261 FIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPN  301 (394)
Q Consensus       261 li~~~L~-~p~~R~s-----~~elL~~p~~~~~~~~~~~~~~~~~p~  301 (394)
                      ||.+||. +|.+|++     +.|+++||||+..+|..+....+..|.
T Consensus       424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~  470 (689)
T 3v5w_A          424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL  470 (689)
T ss_dssp             HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSC
T ss_pred             HHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCc
Confidence            9999998 9999998     799999999999998776555444443

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-57  Score=427.82  Aligned_cols=243  Identities=31%  Similarity=0.494  Sum_probs=205.7

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|+||+||+|.+.   ..||||+++...  .+.+..+.|.+|+.+|++|+|||||++++++.+   ..++|||
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iVm  110 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAIVT  110 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESS---SEEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEEE
Confidence            67889999999999999764   359999986543  356778889999999999999999999997632   2478999


Q ss_pred             cccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      |||++|+|.+++... ..+++.++..|+.||+.||.|||+++  |+||||||+|||++ +++.+||+|||+|+.....  
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEE-TTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEEC-CCCcEEEeeccCceecccCCc
Confidence            999999999999765 56999999999999999999999999  99999999999999 7899999999999765432  


Q ss_pred             --CCcccccCCcccCcccccc----cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC---CCCCCCC
Q 016143          185 --TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTD  255 (394)
Q Consensus       185 --~~~~~~gt~~y~aPE~l~~----~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~---~~~~~~~  255 (394)
                        .....+||+.|||||++.+    .|+.++|||||||+||||+||+.||.+..+...+...+..+..++   ..+...+
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  267 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP  267 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence              2345689999999998753    489999999999999999999999998788888888887765443   3455678


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +++.+|+.+||. +|.+|||+.|++++
T Consensus       268 ~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          268 KAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999998 99999999987653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.1e-56  Score=436.78  Aligned_cols=251  Identities=18%  Similarity=0.348  Sum_probs=204.8

Q ss_pred             CcccccccceecccCceEEEEEEEc---cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcC
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD   98 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~   98 (394)
                      .++| ++.+.||+|+||+||+|.++   .+++.||+|.+....      ...++.+|+.+|+.+ +|||||+++++|.++
T Consensus        20 ~~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           20 SNVF-KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGTC-EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             cCcE-EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            3555 89999999999999999875   467899999885322      234578899999998 699999999998654


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                        ..+|+||||+++|+|.++++   .+++.+++.+++||+.||+|||++|  |+||||||+|||++.+.+.+||+|||+|
T Consensus        93 --~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           93 --DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             --TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             --CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence              57999999999999999984   4999999999999999999999999  9999999999999965689999999999


Q ss_pred             eeecCC------------------------------CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCC
Q 016143          179 IVMQQP------------------------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEY  226 (394)
Q Consensus       179 ~~~~~~------------------------------~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~  226 (394)
                      +.....                              ...+.+||+.|||||++.+  .|+.++||||+||++|||++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            765432                              1234579999999998764  48999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhc--C--------------------------------------------------CCCCCCCCCC
Q 016143          227 PYNECKNPAQIYKKVTS--G--------------------------------------------------IKPASLSKVT  254 (394)
Q Consensus       227 Pf~~~~~~~~~~~~i~~--~--------------------------------------------------~~~~~~~~~~  254 (394)
                      ||....+..+....+..  |                                                  ..........
T Consensus       246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            99766655443333211  0                                                  0000112346


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ++++++||++||+ ||.+|+|+.|+|+||||++.
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            7899999999998 99999999999999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.8e-57  Score=426.88  Aligned_cols=246  Identities=25%  Similarity=0.401  Sum_probs=209.8

Q ss_pred             cccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           28 RYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .+.+.||+|+||+||+|.+.     .++..||||.++..    +.+..++|.+|+.+|++|+|||||++++++.++  ..
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~~   89 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--DP   89 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--CE
Confidence            67899999999999999864     46889999998632    356678899999999999999999999998654  46


Q ss_pred             EEEEEcccCCCcHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 016143          103 INMITELFTSGSLRQYRKKH-------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE  169 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~  169 (394)
                      +++|||||++|+|.+++.++             ..+++.++..++.||+.||.|||+++  |+||||||+|||++ .++.
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~-~~~~  166 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENLL  166 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEEC-CCCc
Confidence            88999999999999999764             35999999999999999999999999  99999999999998 6889


Q ss_pred             EEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhc
Q 016143          170 VKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS  243 (394)
Q Consensus       170 ~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~  243 (394)
                      +||+|||+|+......    .....||+.|||||++. +.|+.++|||||||+||||+| |+.||.+ .+..++...+..
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~i~~  245 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIECITQ  245 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHc
Confidence            9999999997654332    23456999999999776 469999999999999999998 8999987 567778888887


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          244 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       244 ~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      +..+. .+...++++.+|+.+||. +|.+|||+.+++  +||+.
T Consensus       246 ~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~  286 (299)
T 4asz_A          246 GRVLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN  286 (299)
T ss_dssp             TCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             CCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence            76443 566788999999999998 999999999984  46654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.3e-56  Score=426.89  Aligned_cols=244  Identities=23%  Similarity=0.375  Sum_probs=203.7

Q ss_pred             ccccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           27 GRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +.+.+.||+|+||+||+|.+.     .++..||||+++..    +....++|.+|+.+|++|+|||||++++++.+.  .
T Consensus        43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~  116 (329)
T 4aoj_A           43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEG--R  116 (329)
T ss_dssp             EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--S
T ss_pred             eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence            356789999999999999864     46899999998632    456678899999999999999999999998544  4


Q ss_pred             eEEEEEcccCCCcHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 016143          102 TINMITELFTSGSLRQYRKKH---------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN  166 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~---------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~  166 (394)
                      .++||||||++|+|.+++.++               +.+++.++..|+.||+.||.|||+++  |+||||||+|||++ +
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~-~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG-Q  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-T
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC-C
Confidence            689999999999999999764               35899999999999999999999999  99999999999999 7


Q ss_pred             CCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHH
Q 016143          167 NGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK  240 (394)
Q Consensus       167 ~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~  240 (394)
                      ++.+||+|||+|+......    ....+||+.|||||++.+ .|+.++|||||||+||||+| |+.||.+ .+..+++..
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~  272 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTEAIDC  272 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence            8999999999998664332    234679999999997765 59999999999999999999 8999987 556777778


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       241 i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +..+..+ ..+..+++++.+|+.+||. +|.+|||+.|++.+
T Consensus       273 i~~g~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          273 ITQGREL-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHTCCC-CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHcCCCC-CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            8777544 3566788999999999998 99999999999874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5e-56  Score=422.63  Aligned_cols=245  Identities=23%  Similarity=0.317  Sum_probs=207.9

Q ss_pred             ccccceecccCceEEEEEEE-----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           27 GRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      .++.+.||+|+||+||+|..     ..+++.||||.++...   .....+.|.+|+.+|++|+|||||++++++.++  .
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--~  102 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--Q  102 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC--C
Confidence            37889999999999999985     3467899999986432   233457799999999999999999999998544  4


Q ss_pred             eEEEEEcccCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 016143          102 TINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG  165 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~----------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~  165 (394)
                      .+++|||||++|+|.+++...                ..+++..+..++.||+.||.|||+++  |+||||||+||||+ 
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~-  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY-  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEEC-
Confidence            678999999999999999653                35899999999999999999999999  99999999999998 


Q ss_pred             CCCcEEEcccceeeeecCC----CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHH
Q 016143          166 NNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK  239 (394)
Q Consensus       166 ~~~~~kl~Dfgla~~~~~~----~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~  239 (394)
                      +++.+||+|||+|+.....    .....+||+.|||||++. +.|+.++|||||||+||||+| |..||.+ .+..++..
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~~~~~~  258 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVVE  258 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCHHHHHH
Confidence            7889999999999765432    234567999999999775 569999999999999999998 8999987 56677888


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       240 ~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+..+..++ .+..+++++.+|+.+||. +|.+|||+.|++++
T Consensus       259 ~i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            888775443 466788999999999998 99999999999874

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.5e-55  Score=453.06  Aligned_cols=256  Identities=25%  Similarity=0.400  Sum_probs=223.1

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++....    ....+.+.+|+.+|+.|+|||||+++++|.++  ..+
T Consensus       157 ~~Y-~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~  229 (573)
T 3uto_A          157 DHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEM  229 (573)
T ss_dssp             GTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--SEE
T ss_pred             ccc-EEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEE
Confidence            455 78899999999999999999999999999987532    45567889999999999999999999999654  579


Q ss_pred             EEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-CCcEEEcccceeeee
Q 016143          104 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVM  181 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~-~~~~kl~Dfgla~~~  181 (394)
                      +||||||+||+|.+++.. .+.+++.+++.+++||+.||.|||+++  |+||||||+|||++.+ .+.+||+|||+|+.+
T Consensus       230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            999999999999999864 467999999999999999999999999  9999999999999842 479999999999887


Q ss_pred             cCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCHH
Q 016143          182 QQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQ  257 (394)
Q Consensus       182 ~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~  257 (394)
                      ... .....+||+.|||||++.+ .|+.++|||||||+||||++|..||.+ .+..+.+..+..+..  +......++++
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~  386 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISED  386 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred             cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            654 3456789999999998775 599999999999999999999999987 566777777766532  23344567899


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +++||++||. +|.+||++.|+|+||||+...+
T Consensus       387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            9999999998 9999999999999999997654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.7e-55  Score=426.30  Aligned_cols=249  Identities=24%  Similarity=0.364  Sum_probs=212.8

Q ss_pred             cccccccceecccCceEEEEEEEccC-----CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC-CCceeEeeeEEc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVD   97 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h-pnIv~~~~~~~~   97 (394)
                      .+| ++.+.||+|+||+||+|.+..+     ++.||+|.+....   .....+.+.+|+.+|++++| ||||++++++.+
T Consensus        64 ~~~-~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           64 DRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             HHe-EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            444 7889999999999999987654     4689999886432   35567789999999999965 899999998754


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI  161 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~----------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NI  161 (394)
                      + ...+++|||||++|+|.++++..                ..+++..+..++.||+.||.|||+++  |+||||||+||
T Consensus       140 ~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NI  216 (353)
T 4ase_A          140 P-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNI  216 (353)
T ss_dssp             T-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred             c-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccce
Confidence            3 34688999999999999999753                34899999999999999999999999  99999999999


Q ss_pred             EEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHH
Q 016143          162 FVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPA  235 (394)
Q Consensus       162 ll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~  235 (394)
                      |++ +++.+||+|||+|+......    ....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+.....
T Consensus       217 Ll~-~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          217 LLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeC-CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            998 78899999999998664432    23467999999999776 469999999999999999998 999998876667


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       236 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+...+..+..+. .+...++++.+++.+||. +|.+|||+.|+++|
T Consensus       296 ~~~~~i~~g~~~~-~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            7778888776543 566778999999999998 99999999999987

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.2e-53  Score=396.58  Aligned_cols=270  Identities=50%  Similarity=0.933  Sum_probs=242.0

Q ss_pred             CccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeE
Q 016143           16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW   95 (394)
Q Consensus        16 ~~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~   95 (394)
                      .....+..++|+++.+.||+|+||+||+|.+..++..||+|.+.....  .....+.+.+|+.++++++||||++++++|
T Consensus        17 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   94 (290)
T 1t4h_A           17 KAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSW   94 (290)
T ss_dssp             -CCEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhhhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence            344556678889999999999999999999999999999999875443  456678899999999999999999999988


Q ss_pred             EcC--CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143           96 VDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus        96 ~~~--~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                      .+.  ....+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++++|+||||||+||+++..++.+||+
T Consensus        95 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~  174 (290)
T 1t4h_A           95 ESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             EEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             ccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEe
Confidence            643  346789999999999999999998889999999999999999999999987899999999999998678899999


Q ss_pred             ccceeeeecCCCCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 016143          174 DLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       174 Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      |||++............||+.|+|||++.+.++.++|||||||++|+|++|+.||....+..++...+..+..+..++..
T Consensus       175 Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (290)
T 1t4h_A          175 DLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV  254 (290)
T ss_dssp             CTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred             eCCCcccccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence            99999776666666678999999999998889999999999999999999999999988889999999888777777778


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      .++++.++|.+||. +|.+||++.++|+||||+..
T Consensus       255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            88999999999998 99999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.5e-52  Score=399.68  Aligned_cols=254  Identities=26%  Similarity=0.498  Sum_probs=223.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+..+|+.||+|++.....  .....+++.+|+.+|+.++||||+++++++.+  ...+
T Consensus        15 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~   89 (328)
T 3fe3_A           15 GNY-RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTL   89 (328)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred             CCE-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEE
Confidence            455 889999999999999999999999999999875442  45677889999999999999999999998854  4578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+++|+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLD-ADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTCCGGGSS
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEc-CCCCEEEeeccCceecCC
Confidence            999999999999999998888999999999999999999999999  99999999999998 788999999999976544


Q ss_pred             C-CCcccccCCcccCccccccc-C-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          184 P-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       184 ~-~~~~~~gt~~y~aPE~l~~~-~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      . .....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+ .+..++...+..+...  ++...++++.+
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~  243 (328)
T 3fe3_A          167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDCEN  243 (328)
T ss_dssp             SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred             CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHH
Confidence            3 34567899999999987654 4 4799999999999999999999987 6677777777776433  45567899999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          261 FIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ||++||. +|.+|||+.|+|+||||+...
T Consensus       244 li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          244 LLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999998 999999999999999998654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.4e-53  Score=400.26  Aligned_cols=249  Identities=28%  Similarity=0.383  Sum_probs=194.0

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC--c
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--R  101 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~--~  101 (394)
                      .|.+.+.+.||+|+||+||+|.+  +|+.||||+++...     ........|+..+.+|+|||||++++++.++..  .
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence            45668899999999999999986  58999999986432     111223346777788999999999999876543  3


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~------~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                      .+++|||||++|+|.++++.. +++++.+..++.|++.||.|||++      .++|+||||||+|||++ .++++||+||
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DF  152 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADL  152 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCC
T ss_pred             EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeC
Confidence            689999999999999999875 499999999999999999999987      23499999999999998 7899999999


Q ss_pred             ceeeeecCCC------CcccccCCcccCcccccc-------cCCCcCcchhhhhHHHHHHhcCCCCCCC-----------
Q 016143          176 GLAIVMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNEC-----------  231 (394)
Q Consensus       176 gla~~~~~~~------~~~~~gt~~y~aPE~l~~-------~~~~~~DIwSlG~il~elltg~~Pf~~~-----------  231 (394)
                      |+|+......      ....+||+.|||||++.+       .|+.++|||||||+||||+||..||...           
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~  232 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence            9998765432      224579999999998864       3677999999999999999997765321           


Q ss_pred             ---CCHHHHHHHHhcCCCCCCCCCCC-----CHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          232 ---KNPAQIYKKVTSGIKPASLSKVT-----DPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       232 ---~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                         ....++.+.+......+.++...     ...+.+|+.+||. +|.+|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               13345555554443222333221     2467899999998 99999999998864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.4e-52  Score=401.19  Aligned_cols=264  Identities=23%  Similarity=0.441  Sum_probs=227.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.+|+.++||||++++++|.+.  ..+
T Consensus         5 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~   80 (337)
T 1o6l_A            5 NDF-DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRL   80 (337)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEE
T ss_pred             HHe-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEE
Confidence            344 78899999999999999999999999999997543211 23456788999999999999999999998654  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||++||+|..++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||++.....
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEEC-CCCCEEEeeccchhhccc
Confidence            999999999999999998888999999999999999999999999  99999999999998 788999999999975432


Q ss_pred             --CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          184 --PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       184 --~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                        ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+ .+...++..+..+.  ..++...++++++
T Consensus       158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~  234 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKS  234 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHH
T ss_pred             CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHH
Confidence              34556789999999998765 589999999999999999999999977 56677777776543  2356678899999


Q ss_pred             HHHHcCC-CCCCCC-----CHHHHhcCCccccCCCCCcccCCC
Q 016143          261 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL  297 (394)
Q Consensus       261 li~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~~~~~~  297 (394)
                      ||.+||. +|.+||     ++.++++||||+..++..+.....
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~  277 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL  277 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence            9999998 999999     899999999999988766554433

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.3e-52  Score=392.42  Aligned_cols=259  Identities=30%  Similarity=0.515  Sum_probs=221.6

Q ss_pred             ccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        19 ~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      ..++.++| ++.+.||+|+||+||+|.+..+|+.||+|.+.....    ...+.+.+|+.+++.++||||++++++|.+.
T Consensus        15 ~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (297)
T 3fxz_A           15 VGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVG   89 (297)
T ss_dssp             SSCGGGTB-CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cCChhhce-eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc----cHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence            34556666 788999999999999999999999999999875542    2245678899999999999999999998654


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                        ..+++||||+++|+|.+++... .+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++
T Consensus        90 --~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           90 --DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFC  163 (297)
T ss_dssp             --TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTC
T ss_pred             --CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEC-CCCCEEEeeCCCc
Confidence              4689999999999999999876 4999999999999999999999999  99999999999998 7889999999999


Q ss_pred             eeecCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          179 IVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       179 ~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      .......  .....||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...............+......+...+
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (297)
T 3fxz_A          164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS  243 (297)
T ss_dssp             EECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSC
T ss_pred             eecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Confidence            7765442  345679999999997765 5899999999999999999999999875544444444444444444556678


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +.+++||.+||. +|.+||++.|+|+||||+...
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            899999999998 999999999999999998654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.8e-52  Score=406.42  Aligned_cols=265  Identities=22%  Similarity=0.400  Sum_probs=224.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++...... .....+.+.+|..+|+.+ +||||++++++|.+.  ..
T Consensus        23 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~   98 (353)
T 3txo_A           23 DNF-EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DR   98 (353)
T ss_dssp             CCE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred             hhe-EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CE
Confidence            344 7889999999999999999999999999999754321 234456788899999998 799999999998654  57


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||++||+|..++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||++....
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEEC-CCCCEEEccccceeecc
Confidence            8999999999999999999889999999999999999999999999  99999999999998 78999999999997543


Q ss_pred             C--CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          183 Q--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       183 ~--~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      .  ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+ .+..+++..+..+..  .++...++.++
T Consensus       176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~  252 (353)
T 3txo_A          176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLHEDAT  252 (353)
T ss_dssp             C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred             cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence            2  23456789999999998765 599999999999999999999999987 667777777776533  34566789999


Q ss_pred             HHHHHcCC-CCCCCCCH------HHHhcCCccccCCCCCcccCCCC
Q 016143          260 QFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVCDPLR  298 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~------~elL~~p~~~~~~~~~~~~~~~~  298 (394)
                      +||++||. +|.+||++      .++++||||+..++..+....+.
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~  298 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIE  298 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCC
Confidence            99999998 99999998      89999999999887665444443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-51  Score=394.77  Aligned_cols=266  Identities=27%  Similarity=0.443  Sum_probs=227.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         6 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~   81 (318)
T 1fot_A            6 QDF-QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQI   81 (318)
T ss_dssp             GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEE
T ss_pred             HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--CEE
Confidence            344 78899999999999999999999999999987543211 23456788899999999999999999998654  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||++.....
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSS
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEc-CCCCEEEeecCcceecCC
Confidence            999999999999999999889999999999999999999999999  99999999999998 789999999999987654


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      . ....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+....+..+..+.  ..++...+++++++|
T Consensus       159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li  234 (318)
T 1fot_A          159 V-TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAE--LRFPPFFNEDVKDLL  234 (318)
T ss_dssp             C-BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             c-cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHH
Confidence            3 345689999999998765 589999999999999999999999987 55666666666653  235567789999999


Q ss_pred             HHcCC-CCCCCC-----CHHHHhcCCccccCCCCCcccCCCCCC
Q 016143          263 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP  300 (394)
Q Consensus       263 ~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~~~~~~~~p  300 (394)
                      ++||. +|.+|+     ++.++++||||+...+..+.......|
T Consensus       235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p  278 (318)
T 1fot_A          235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP  278 (318)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCS
T ss_pred             HHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCC
Confidence            99998 999999     899999999999888766554444433

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.7e-51  Score=399.27  Aligned_cols=264  Identities=26%  Similarity=0.408  Sum_probs=224.5

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC--HHHHHHHHHHHHHHHcCCCCCceeEeeeEEc
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVD   97 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~   97 (394)
                      .+..++| ++.+.||+|+||+||+|.++.+|..||+|++........  ....+.+.+|+.+|+.++||||++++++|.+
T Consensus         8 ~~~~~~y-~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A            8 QKVEDFY-DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             SCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CChhhce-EEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            3444455 889999999999999999999999999999986543221  1235678899999999999999999999854


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC---cEEEcc
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EVKIGD  174 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~---~~kl~D  174 (394)
                      .  ..+++||||++||+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++.+++   .+||+|
T Consensus        87 ~--~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           87 R--TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             S--SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             C--CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            4  578999999999999999998888999999999999999999999999  999999999999984332   799999


Q ss_pred             cceeeeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCC
Q 016143          175 LGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASL  250 (394)
Q Consensus       175 fgla~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~  250 (394)
                      ||++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+...  ...
T Consensus       163 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~  241 (361)
T 2yab_A          163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEF  241 (361)
T ss_dssp             CSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHH
T ss_pred             cCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCchh
Confidence            9999876554 3456789999999998775 589999999999999999999999987 5667777777765332  222


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      ....++++++||.+||. +|.+||++.|+|+||||+...+
T Consensus       242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence            34578899999999998 9999999999999999986543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.6e-51  Score=405.25  Aligned_cols=264  Identities=18%  Similarity=0.340  Sum_probs=223.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      |++.++||+|+||+||+|.++.+++.||+|+++.... ...+..+.+.+|..+|+++ +||||++++++|.++  ..+++
T Consensus        54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~-~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~~~l  130 (396)
T 4dc2_A           54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFF  130 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT-C----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CEEEE
Confidence            3788999999999999999999999999999976543 2344556688899999887 899999999998654  57899


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec--C
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--Q  183 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~--~  183 (394)
                      ||||+++|+|..++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+++...  .
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTT
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEC-CCCCEEEeecceeeecccCC
Confidence            9999999999999999889999999999999999999999999  99999999999998 78999999999997532  2


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC--------CCHHHHHHHHhcCCCCCCCCCCC
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~--------~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||...        .....++..+....  ..++...
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~  285 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSL  285 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--CCCCTTS
T ss_pred             CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--cCCCCcC
Confidence            34556789999999998765 5999999999999999999999999642        23345666666543  3356678


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCH------HHHhcCCccccCCCCCcccCCCC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVCDPLR  298 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~------~elL~~p~~~~~~~~~~~~~~~~  298 (394)
                      ++++++||++||. +|.+|+++      .|+++||||+..+|..+......
T Consensus       286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~  336 (396)
T 4dc2_A          286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV  336 (396)
T ss_dssp             CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSC
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCC
Confidence            8999999999998 99999985      79999999999887665544443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.8e-51  Score=397.64  Aligned_cols=266  Identities=23%  Similarity=0.396  Sum_probs=229.7

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.+|..||+|++....... ....+.+.+|+.+|+.++||||+++++++.+.  ..+
T Consensus        41 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~  116 (350)
T 1rdq_E           41 DQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNL  116 (350)
T ss_dssp             GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred             HHC-EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEE
Confidence            444 78899999999999999999999999999987543211 23456788999999999999999999998654  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||++.....
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEEC-CCCCEEEcccccceeccC
Confidence            999999999999999998888999999999999999999999999  99999999999998 788999999999987655


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      . ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+..+++..+..+..  .++...+++++++|
T Consensus       194 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li  269 (350)
T 1rdq_E          194 R-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLL  269 (350)
T ss_dssp             C-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHH
T ss_pred             C-cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHH
Confidence            4 345689999999997764 589999999999999999999999987 567778888877632  35567889999999


Q ss_pred             HHcCC-CCCCCCC-----HHHHhcCCccccCCCCCcccCCCCCC
Q 016143          263 EKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP  300 (394)
Q Consensus       263 ~~~L~-~p~~R~s-----~~elL~~p~~~~~~~~~~~~~~~~~p  300 (394)
                      .+||. +|.+||+     +.++++||||+..++..+.......|
T Consensus       270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p  313 (350)
T 1rdq_E          270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP  313 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred             HHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCC
Confidence            99998 9999998     99999999999888765544444333

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=7.5e-51  Score=393.84  Aligned_cols=262  Identities=18%  Similarity=0.353  Sum_probs=224.7

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++| ++.+.||+|+||+||+|.++.+++.||+|++..... ......+.+.+|+.+++++ +||||++++++|.++  ..
T Consensus         9 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~   84 (345)
T 3a8x_A            9 QDF-DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR   84 (345)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred             hhe-EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CE
Confidence            344 788999999999999999999999999999976543 3456677889999999988 899999999998654  57


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||++....
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCGGGCBCSC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEEecccccccc
Confidence            8999999999999999998888999999999999999999999999  99999999999998 78899999999997543


Q ss_pred             --CCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC--------CCHHHHHHHHhcCCCCCCCC
Q 016143          183 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLS  251 (394)
Q Consensus       183 --~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~--------~~~~~~~~~i~~~~~~~~~~  251 (394)
                        .......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||...        .+...++..+....  ..++
T Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p  239 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIP  239 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--CCCC
T ss_pred             CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--CCCC
Confidence              234456789999999998765 5899999999999999999999999642        23445566665543  3356


Q ss_pred             CCCCHHHHHHHHHcCC-CCCCCCCH------HHHhcCCccccCCCCCccc
Q 016143          252 KVTDPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVC  294 (394)
Q Consensus       252 ~~~~~~~~~li~~~L~-~p~~R~s~------~elL~~p~~~~~~~~~~~~  294 (394)
                      ...++++++||++||. +|.+||++      .++++||||+..++..+..
T Consensus       240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~  289 (345)
T 3a8x_A          240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ  289 (345)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHT
T ss_pred             CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHh
Confidence            6788999999999998 99999996      8999999999887655443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-51  Score=399.67  Aligned_cols=265  Identities=23%  Similarity=0.422  Sum_probs=227.0

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|..+++.+ +||||++++++|.+.  ..
T Consensus        17 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~~   92 (345)
T 1xjd_A           17 EDF-ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--EN   92 (345)
T ss_dssp             TTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred             HHe-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--CE
Confidence            444 78899999999999999999999999999997543211 22345677899999877 999999999998654  57


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||++....
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEEC-CCCCEEEeEChhhhhcc
Confidence            8999999999999999998888999999999999999999999999  99999999999998 78899999999997543


Q ss_pred             --CCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          183 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       183 --~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                        .......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+...++..+..+.  ..++...+++++
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~  246 (345)
T 1xjd_A          170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN--PFYPRWLEKEAK  246 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHH
T ss_pred             cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCC--CCCCcccCHHHH
Confidence              234556789999999998765 589999999999999999999999986 66677777776653  235567889999


Q ss_pred             HHHHHcCC-CCCCCCCHH-HHhcCCccccCCCCCcccCCCC
Q 016143          260 QFIEKCIV-PASLRLPAL-ELLKDPFLVTDNPKDLVCDPLR  298 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~-elL~~p~~~~~~~~~~~~~~~~  298 (394)
                      +||.+||. +|.+||++. ++++||||+..++..+......
T Consensus       247 ~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~  287 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEID  287 (345)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSC
T ss_pred             HHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCC
Confidence            99999998 999999998 9999999999887665444333

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.8e-51  Score=396.38  Aligned_cols=267  Identities=21%  Similarity=0.347  Sum_probs=227.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+..|..+|..+ +||||++++++|.+.  ..
T Consensus        20 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~   95 (353)
T 2i0e_A           20 TDF-NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR   95 (353)
T ss_dssp             TTE-EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--SE
T ss_pred             HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--CE
Confidence            344 78899999999999999999999999999997543221 23456788899999998 799999999998654  57


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||++....
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEc-CCCcEEEEeCCcccccc
Confidence            8999999999999999998888999999999999999999999999  99999999999998 78899999999997543


Q ss_pred             --CCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          183 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       183 --~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                        .......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+ .+..+++..+..+.  ..++...+++++
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~  249 (353)
T 2i0e_A          173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN--VAYPKSMSKEAV  249 (353)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHH
T ss_pred             cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHH
Confidence              234556789999999998764 589999999999999999999999976 66777777777653  235567889999


Q ss_pred             HHHHHcCC-CCCCCCC-----HHHHhcCCccccCCCCCcccCCCCCC
Q 016143          260 QFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP  300 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s-----~~elL~~p~~~~~~~~~~~~~~~~~p  300 (394)
                      +||.+||. +|.+||+     +.++++||||+..++..+....+..|
T Consensus       250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p  296 (353)
T 2i0e_A          250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP  296 (353)
T ss_dssp             HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCC
Confidence            99999998 9999995     69999999999888766544444333

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-50  Score=383.45  Aligned_cols=256  Identities=23%  Similarity=0.455  Sum_probs=212.8

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC----------------------HHHHHHHHHHHHHHH
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----------------------PDQLERLYSEVHLLK   81 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~----------------------~~~~~~~~~E~~~l~   81 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++........                      ....+.+.+|+.+|+
T Consensus        13 ~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           13 NQY-TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             TTE-EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             cce-EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            455 888999999999999999999999999999876542211                      123467889999999


Q ss_pred             cCCCCCceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 016143           82 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI  161 (394)
Q Consensus        82 ~L~hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NI  161 (394)
                      +++||||+++++++.+.....+++||||+++++|.+++.. +.+++..++.++.||+.||.|||+++  |+||||||+||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Ni  168 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNL  168 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHE
Confidence            9999999999999987667789999999999999886543 56999999999999999999999999  99999999999


Q ss_pred             EEeCCCCcEEEcccceeeeecCCC--CcccccCCcccCccccccc----CCCcCcchhhhhHHHHHHhcCCCCCCCCCHH
Q 016143          162 FVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPA  235 (394)
Q Consensus       162 ll~~~~~~~kl~Dfgla~~~~~~~--~~~~~gt~~y~aPE~l~~~----~~~~~DIwSlG~il~elltg~~Pf~~~~~~~  235 (394)
                      |++ .++.+||+|||++.......  .....||+.|+|||++.+.    ++.++|||||||++|+|++|+.||.. .+..
T Consensus       169 l~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~  246 (298)
T 2zv2_A          169 LVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIM  246 (298)
T ss_dssp             EEC-TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHH
T ss_pred             EEC-CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHH
Confidence            998 78899999999998765442  3456799999999988653    36789999999999999999999987 4555


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccc
Q 016143          236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  285 (394)
Q Consensus       236 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~  285 (394)
                      .+...+.............++++++||.+||. +|.+||++.|+|+||||+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            66666655543333344678999999999998 999999999999999996

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9e-51  Score=401.78  Aligned_cols=264  Identities=19%  Similarity=0.333  Sum_probs=220.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+++.||+|++....... ....+.+.+|+.+++.++||||++++++|.++  ..+++|
T Consensus        71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lV  147 (410)
T 3v8s_A           71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RYLYMV  147 (410)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred             cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEE
Confidence            378899999999999999999999999999987533211 11223477899999999999999999998654  579999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      |||++||+|.++++.. .+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||++....... 
T Consensus       148 ~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             ECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSE
T ss_pred             EeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeEC-CCCCEEEeccceeEeeccCCc
Confidence            9999999999999875 5999999999999999999999999  99999999999998 78999999999998765542 


Q ss_pred             --CcccccCCcccCccccccc-----CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCH
Q 016143          186 --ARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDP  256 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~~~-----~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~  256 (394)
                        ....+||+.|+|||++.+.     |+.++|||||||++|||++|+.||.+ .+....+..+..+..  ........++
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~  302 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISK  302 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCcccccH
Confidence              3467899999999987642     78899999999999999999999987 666777777765321  1112345789


Q ss_pred             HHHHHHHHcCC-CCCC--CCCHHHHhcCCccccCCCCCcccCCCC
Q 016143          257 QVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPKDLVCDPLR  298 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~--R~s~~elL~~p~~~~~~~~~~~~~~~~  298 (394)
                      ++++||.+||. +|.+  |+++.|+++||||+..++..+......
T Consensus       303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~  347 (410)
T 3v8s_A          303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTV  347 (410)
T ss_dssp             HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSC
T ss_pred             HHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccC
Confidence            99999999998 5666  899999999999999887655443333

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=396.32  Aligned_cols=264  Identities=21%  Similarity=0.403  Sum_probs=226.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.++..||+|++....... ....+.+.+|+.+|+.++||||++++++|.+.  ..+++|
T Consensus        17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lv   93 (384)
T 4fr4_A           17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--EDMFMV   93 (384)
T ss_dssp             EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEEEE
Confidence            488899999999999999999999999999987543211 23456788999999999999999999998654  478999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-C
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-T  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-~  185 (394)
                      |||+.||+|..++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||++...... .
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTCC
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEC-CCCCEEEeccceeeeccCCCc
Confidence            999999999999999989999999999999999999999999  99999999999998 7899999999999876544 4


Q ss_pred             CcccccCCcccCcccccc----cCCCcCcchhhhhHHHHHHhcCCCCCC--CCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          186 ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNE--CKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~----~~~~~~DIwSlG~il~elltg~~Pf~~--~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ....+||+.|+|||++..    .|+.++|||||||++|+|++|+.||..  ......++..+....  ..++..+++++.
T Consensus       171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~~~s~~~~  248 (384)
T 4fr4_A          171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWSQEMV  248 (384)
T ss_dssp             BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CCCCTTSCHHHH
T ss_pred             eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cCCCCcCCHHHH
Confidence            566789999999998753    488999999999999999999999974  244556666665543  335566789999


Q ss_pred             HHHHHcCC-CCCCCCC-HHHHhcCCccccCCCCCcccCCCC
Q 016143          260 QFIEKCIV-PASLRLP-ALELLKDPFLVTDNPKDLVCDPLR  298 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s-~~elL~~p~~~~~~~~~~~~~~~~  298 (394)
                      +||.+||. +|.+||+ +.++++||||...++..+....+.
T Consensus       249 ~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~  289 (384)
T 4fr4_A          249 SLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLI  289 (384)
T ss_dssp             HHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             HHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCC
Confidence            99999998 9999998 899999999999887665544443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.1e-50  Score=402.01  Aligned_cols=253  Identities=26%  Similarity=0.440  Sum_probs=219.5

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+|..||+|++.....  .....+.+.+|+.+|+.|+||||+++++++.++  ..+++|
T Consensus        13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lv   88 (444)
T 3soa_A           13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEE--GHHYLI   88 (444)
T ss_dssp             EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS--SEEEEE
T ss_pred             eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC--CEEEEE
Confidence            4788999999999999999999999999999876543  345567789999999999999999999998544  578999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+.||+|.+++...+.+++..+..++.||+.||.|||++|  |+||||||+|||++.  +++.+||+|||++......
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            999999999999999999999999999999999999999999  999999999999974  3578999999999776544


Q ss_pred             C--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCHHHH
Q 016143          185 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVK  259 (394)
Q Consensus       185 ~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~  259 (394)
                      .  .....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+..  +.......+++++
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  245 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPEAK  245 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            2  345689999999998876 599999999999999999999999987 566777777776643  2223346789999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          260 QFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      +||.+||. +|.+||++.|+|+||||+.
T Consensus       246 ~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          246 DLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            99999998 9999999999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.4e-51  Score=389.85  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=216.5

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.+++.||+|++.....   ....+.+.+|+.+++.++||||+++++++.+.  ...
T Consensus         7 ~~y-~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~   80 (323)
T 3tki_A            7 EDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQ   80 (323)
T ss_dssp             TCE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred             hhc-eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CeE
Confidence            455 889999999999999999999999999999875432   23346688899999999999999999988543  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+++|+|.+++.....+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEE
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEe-CCCCEEEEEeeccceecc
Confidence            899999999999999998888999999999999999999999999  99999999999998 788999999999976543


Q ss_pred             C----CCcccccCCcccCcccccc-cC-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          184 P----TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       184 ~----~~~~~~gt~~y~aPE~l~~-~~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      .    .....+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.........+................++.
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA  237 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHH
Confidence            2    2345679999999998765 33 6789999999999999999999987665545555555443333334557889


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCC
Q 016143          258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK  290 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~  290 (394)
                      +.+||.+||. +|.+||++.|+|+||||+....+
T Consensus       238 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  271 (323)
T 3tki_A          238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (323)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhhChhhcccccc
Confidence            9999999998 99999999999999999875443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-50  Score=388.59  Aligned_cols=263  Identities=24%  Similarity=0.348  Sum_probs=212.5

Q ss_pred             cccccccceecccCceEEEEEEEc---cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      ++| ++.+.||+|+||+||+|.+.   .+|+.||+|+++.............+.+|+.+|+.++||||+++++++.+.  
T Consensus        17 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--   93 (327)
T 3a62_A           17 ECF-ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG--   93 (327)
T ss_dssp             GGE-EEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--
T ss_pred             HHe-EEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--
Confidence            344 88899999999999999885   689999999997654433344556788899999999999999999998654  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ..+++||||+++++|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++..
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKE  170 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTSCEEECCCSCC--
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEEC-CCCcEEEEeCCcccc
Confidence            568899999999999999998888999999999999999999999999  99999999999998 788999999999975


Q ss_pred             ecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          181 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       181 ~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      ....  .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+....  ..++...+++
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~  247 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCK--LNLPPYLTQE  247 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTC--CCCCTTSCHH
T ss_pred             cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHH
Confidence            4332  3445679999999997764 589999999999999999999999987 55566666665543  2345667899


Q ss_pred             HHHHHHHcCC-CCCCCC-----CHHHHhcCCccccCCCCCcccC
Q 016143          258 VKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCD  295 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~~~~  295 (394)
                      +++||.+||. +|.+||     ++.++++||||+..++..+...
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~  291 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR  291 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTT
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhc
Confidence            9999999998 999999     8899999999998776655443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.7e-50  Score=377.72  Aligned_cols=256  Identities=23%  Similarity=0.405  Sum_probs=212.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      .+| ++.+.||+|+||+||+|.++.+|+.||+|++.....  .....+.+.+|+.++++++||||+++++++.++  ..+
T Consensus         2 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   76 (292)
T 3o0g_A            2 QKY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKL   76 (292)
T ss_dssp             CSE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred             CCc-eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEE
Confidence            345 788999999999999999999999999999976542  345567788999999999999999999998654  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+.++.+..+....+.+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.....
T Consensus        77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecCC
Confidence            999999986555555555678999999999999999999999999  99999999999998 788999999999987654


Q ss_pred             C--CCcccccCCcccCcccccc-c-CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC--C-CCC--------
Q 016143          184 P--TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I-KPA--------  248 (394)
Q Consensus       184 ~--~~~~~~gt~~y~aPE~l~~-~-~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~--~-~~~--------  248 (394)
                      .  ......||+.|+|||++.+ . ++.++|||||||++|+|++|..||....+.......+...  . ...        
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence            3  3345679999999997754 3 7999999999999999999988866556666655555321  0 000        


Q ss_pred             ----------------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          249 ----------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       249 ----------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                      ......++++++||++||. +|.+|||+.|+|+||||+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                            1122467899999999998 99999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.1e-50  Score=391.17  Aligned_cols=253  Identities=25%  Similarity=0.464  Sum_probs=220.0

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+|..||+|++.....  .....+.+.+|+.+++.|+||||+++++++.++  ..+++|
T Consensus        31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~lv  106 (362)
T 2bdw_A           31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYLV  106 (362)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred             eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEE
Confidence            4788999999999999999999999999999975443  456677899999999999999999999998654  578999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~--~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+.+|+|.+++.....+++..++.++.||+.||.|||+++  |+||||||+|||++.+  ++.+||+|||++......
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            999999999999998888999999999999999999999999  9999999999999732  346999999999876544


Q ss_pred             -CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCCHHHHH
Q 016143          185 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQ  260 (394)
Q Consensus       185 -~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~  260 (394)
                       ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+...  .......++++++
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  263 (362)
T 2bdw_A          185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS  263 (362)
T ss_dssp             CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred             cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence             3445689999999998776 599999999999999999999999987 5666777777665432  2222456889999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          261 FIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      ||.+||. +|.+||++.++|+||||..
T Consensus       264 li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          264 LIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            9999998 9999999999999999975

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-50  Score=385.12  Aligned_cols=259  Identities=25%  Similarity=0.400  Sum_probs=218.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC--HHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      ..+|++.+.||+|+||+||+|.++.+|..||+|++........  ....+.+.+|+.+|+.++||||++++++|.+.  .
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~   87 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--T   87 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--C
Confidence            3445889999999999999999999999999999976543221  12356788999999999999999999998654  5


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC----cEEEcccce
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGL  177 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~----~~kl~Dfgl  177 (394)
                      .+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++    .+||+|||+
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~-~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLL-DRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEES-CSSSSSCCEEECCCTT
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEe-cCCCCCCCEEEEECCC
Confidence            78999999999999999998888999999999999999999999999  99999999999998 455    799999999


Q ss_pred             eeeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCC
Q 016143          178 AIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKV  253 (394)
Q Consensus       178 a~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~  253 (394)
                      +...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.......+......  ......
T Consensus       165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          165 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             CEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             CeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHhcCCCcCcccccc
Confidence            9876543 3455679999999998764 589999999999999999999999987 4455555555443221  122345


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            67899999999998 999999999999999998654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-50  Score=394.20  Aligned_cols=265  Identities=24%  Similarity=0.405  Sum_probs=219.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHH-HHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~-l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      |++.+.||+|+||+||+|.++.++..||+|++....... ......+.+|..+ ++.++||||++++++|.+.  ..+|+
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--~~~~l  116 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYF  116 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECS--SEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--CEEEE
Confidence            478899999999999999999999999999998665432 3445567777776 5778999999999998654  57899


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec--C
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--Q  183 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~--~  183 (394)
                      ||||++||+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+++...  .
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCBCGGGBCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEeeCccccccccCC
Confidence            9999999999999999888999999999999999999999999  99999999999998 78999999999997532  2


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      ......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+..+++..+....  ..++...++++++||
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKP--LQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSC--CCCCSSSCHHHHHHH
T ss_pred             CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Confidence            34556789999999998765 589999999999999999999999987 66777777776652  335567889999999


Q ss_pred             HHcCC-CCCCCCCH----HHHhcCCccccCCCCCcccCCCCCC
Q 016143          263 EKCIV-PASLRLPA----LELLKDPFLVTDNPKDLVCDPLRLP  300 (394)
Q Consensus       263 ~~~L~-~p~~R~s~----~elL~~p~~~~~~~~~~~~~~~~~p  300 (394)
                      ++||. +|.+|+++    .++++||||+..+|..+....+..|
T Consensus       271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp  313 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPP  313 (373)
T ss_dssp             HHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred             HHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCC
Confidence            99998 99999987    6999999999988877655444333

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-50  Score=402.88  Aligned_cols=259  Identities=19%  Similarity=0.356  Sum_probs=218.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.++||+|+||+||+|.++.+++.||+|++....... ....+.+.+|+.++..++||||++++++|.+.  ..+++|
T Consensus        76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~~~lV  152 (437)
T 4aw2_A           76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDD--NNLYLV  152 (437)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS--SEEEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CEEEEE
Confidence            378899999999999999999999999999987533211 11223477899999999999999999998654  578999


Q ss_pred             EcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |||+++|+|.+++.+ .+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.......
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTS
T ss_pred             EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEc-CCCCEEEcchhhhhhcccCC
Confidence            999999999999987 467999999999999999999999999  99999999999998 78999999999997665442


Q ss_pred             ---CcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCC
Q 016143          186 ---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKV  253 (394)
Q Consensus       186 ---~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~---~~~~~~~~~  253 (394)
                         ....+||+.|+|||++.      +.|+.++|||||||++|||++|+.||.+ .+..+.+..+...   ...+.....
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~  308 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTD  308 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCCccccc
Confidence               23468999999999875      3589999999999999999999999987 5666666666542   112222344


Q ss_pred             CCHHHHHHHHHcCC-CCCC--CCCHHHHhcCCccccCCCCCc
Q 016143          254 TDPQVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~--R~s~~elL~~p~~~~~~~~~~  292 (394)
                      .++++++||++||. +|.+  |+++.|+++||||+..+|..+
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence            78999999999997 5555  899999999999999988876

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-50  Score=400.24  Aligned_cols=260  Identities=20%  Similarity=0.362  Sum_probs=219.0

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|..++..++||||++++++|.++  ..+++|
T Consensus        63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~~~lV  139 (412)
T 2vd5_A           63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQDE--NYLYLV  139 (412)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS--SEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEEEE
Confidence            47889999999999999999999999999998753321 122344578899999999999999999998654  579999


Q ss_pred             EcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |||++||+|.+++.+. ..+++..++.++.||+.||.|||+++  |+||||||+|||++ .+|++||+|||++.......
T Consensus       140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld-~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTS
T ss_pred             EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeec-CCCCEEEeechhheeccCCC
Confidence            9999999999999875 47999999999999999999999999  99999999999998 78999999999998765443


Q ss_pred             ---CcccccCCcccCccccc--------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC---CCCCCCC
Q 016143          186 ---ARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLS  251 (394)
Q Consensus       186 ---~~~~~gt~~y~aPE~l~--------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~---~~~~~~~  251 (394)
                         ....+||+.|+|||++.        +.|+.++|||||||++|||++|+.||.. .+..+.+..+...   ...+...
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~  295 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVD  295 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCC---
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCCCccc
Confidence               23468999999999875        3589999999999999999999999987 5566666666542   1222234


Q ss_pred             CCCCHHHHHHHHHcCCCCCCC---CCHHHHhcCCccccCCCCCcc
Q 016143          252 KVTDPQVKQFIEKCIVPASLR---LPALELLKDPFLVTDNPKDLV  293 (394)
Q Consensus       252 ~~~~~~~~~li~~~L~~p~~R---~s~~elL~~p~~~~~~~~~~~  293 (394)
                      ...++++++||++||.+|.+|   +++.|+++||||+..+|..+.
T Consensus       296 ~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             -CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred             cCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence            567899999999999988877   589999999999999887763

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-50  Score=385.66  Aligned_cols=255  Identities=22%  Similarity=0.350  Sum_probs=218.7

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      ..++| ++.+.||+|+||+||+|.++.++..||+|.+...     ....+.+.+|+.+|+.++||||+++++++.+.  .
T Consensus         3 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~   74 (321)
T 1tki_A            3 LYEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESM--E   74 (321)
T ss_dssp             CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--T
T ss_pred             hhhce-EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--C
Confidence            34566 8889999999999999999999999999998643     23456688999999999999999999998654  5


Q ss_pred             eEEEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-CCcEEEcccceee
Q 016143          102 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAI  179 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~-~~~~kl~Dfgla~  179 (394)
                      .+++||||+++|+|.+++.... .+++..++.++.||+.||.|||++|  |+||||||+|||++.. ++.+||+|||++.
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            7899999999999999998764 6999999999999999999999999  9999999999999842 6899999999998


Q ss_pred             eecCCC-CcccccCCcccCccccccc-CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCCC
Q 016143          180 VMQQPT-ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTD  255 (394)
Q Consensus       180 ~~~~~~-~~~~~gt~~y~aPE~l~~~-~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~~  255 (394)
                      ...... .....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+ .+..++...+..+....  ......+
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s  231 (321)
T 1tki_A          153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEIS  231 (321)
T ss_dssp             ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCC
Confidence            765443 3456799999999988764 79999999999999999999999987 55566666666553321  1224567


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      +++++||.+||. +|.+|||+.|+|+||||+..
T Consensus       232 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            899999999998 99999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.1e-50  Score=377.11  Aligned_cols=266  Identities=24%  Similarity=0.395  Sum_probs=214.9

Q ss_pred             CCCCCccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeE
Q 016143           12 TEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF   91 (394)
Q Consensus        12 ~~~~~~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~   91 (394)
                      +.+....+.+..++| ++.+.||+|+||+||+|.+..++..||+|.+.....   ....+.+.+|+.+|++++||||+++
T Consensus        10 ~~~~~~~~g~i~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~   85 (285)
T 3is5_A           10 GRENLYFQGTIDDLF-IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKI   85 (285)
T ss_dssp             ---CCEESSCHHHHE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             ccccCCCCCChhhhe-eecceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhH
Confidence            334444445555666 889999999999999999999999999999876542   2335678889999999999999999


Q ss_pred             eeeEEcCCCceEEEEEcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--
Q 016143           92 YNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--  165 (394)
Q Consensus        92 ~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--  165 (394)
                      ++++.+  ...+++||||+++|+|.+++..    ...+++..++.++.||+.||.|||+++  |+||||||+||+++.  
T Consensus        86 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~  161 (285)
T 3is5_A           86 FEVFED--YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTS  161 (285)
T ss_dssp             EEEEEC--SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSS
T ss_pred             HHheec--CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCC
Confidence            999854  3578999999999999998854    367999999999999999999999999  999999999999952  


Q ss_pred             CCCcEEEcccceeeeecCC-CCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 016143          166 NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG  244 (394)
Q Consensus       166 ~~~~~kl~Dfgla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~  244 (394)
                      .++.+||+|||++...... ......||+.|+|||++.+.++.++|||||||++|+|++|+.||.+ .+.......+...
T Consensus       162 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~-~~~~~~~~~~~~~  240 (285)
T 3is5_A          162 PHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYK  240 (285)
T ss_dssp             TTCCEEECCCCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC
T ss_pred             CCCCEEEEeeecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC-CCHHHHHhhhccC
Confidence            3578999999999765543 3445679999999999988899999999999999999999999987 4455555555443


Q ss_pred             CCC-CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          245 IKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       245 ~~~-~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      ... .......++++.+||.+||. +|.+||++.|+|+||||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          241 EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            222 22223467899999999998 9999999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2e-50  Score=403.81  Aligned_cols=262  Identities=23%  Similarity=0.413  Sum_probs=215.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+|..||+|++..... ........+.+|+.+|+.++||||+++++++.+.  ..+++|
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~lv  226 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFV  226 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEET--TEEEEE
T ss_pred             cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--CEEEEE
Confidence            4788999999999999999999999999999875432 2344556788999999999999999999998654  478999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC--
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--  183 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~--  183 (394)
                      |||+++|+|.+++...+.+++..++.++.||+.||.|||+ +|  |+||||||+|||++ .++.+||+|||++.....  
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEEC-SSSCEEECCCCCCCTTCC--
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEEC-CCCCEEEccCCCceeccCCC
Confidence            9999999999999988899999999999999999999998 88  99999999999998 688999999999975332  


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+ .+...+...+....  ..++...++++++||
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li  380 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLGPEAKSLL  380 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHH
Confidence            23456789999999998764 599999999999999999999999987 55666666666543  235566789999999


Q ss_pred             HHcCC-CCCCCC-----CHHHHhcCCccccCCCCCcccCCC
Q 016143          263 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL  297 (394)
Q Consensus       263 ~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~~~~~~  297 (394)
                      .+||. +|.+||     ++.|+|+||||+..++..+....+
T Consensus       381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~  421 (446)
T 4ejn_A          381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL  421 (446)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcC
Confidence            99998 999999     999999999999887765544333

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.9e-50  Score=381.30  Aligned_cols=260  Identities=25%  Similarity=0.413  Sum_probs=208.6

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      ....++| ++.+.||+|+||+||+|.+. +|+.||+|++.....  .....+.+.+|+.++++++||||+++++++.+  
T Consensus        17 q~l~~~y-~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--   90 (311)
T 3niz_A           17 QGLMEKY-QKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHS--   90 (311)
T ss_dssp             ECSSCEE-EEEEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred             cchHhhh-HhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--
Confidence            3445666 88899999999999999985 599999999875432  33455778899999999999999999998854  


Q ss_pred             CceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ...+++||||+++ +|.+++... ..+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a  166 (311)
T 3niz_A           91 ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLA  166 (311)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred             CCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEEC-CCCCEEEccCcCc
Confidence            4578899999975 777777654 45999999999999999999999999  99999999999998 6889999999999


Q ss_pred             eeecCC--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHh--cCCCCCCC--
Q 016143          179 IVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--SGIKPASL--  250 (394)
Q Consensus       179 ~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~--~~~~~~~~--  250 (394)
                      ......  ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+.....  ....+..+  
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ  246 (311)
T ss_dssp             EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred             eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence            876543  2345578999999998754  489999999999999999999999987555444333222  11111111  


Q ss_pred             -----------------------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          251 -----------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       251 -----------------------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                                             ....++++++||++||. +|.+|||+.|+|+||||+..++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                                   12356789999999998 9999999999999999997654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.1e-51  Score=393.59  Aligned_cols=256  Identities=28%  Similarity=0.471  Sum_probs=214.7

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .++| ++.+.||+|+||+||+|.+..+|..||+|++...... ..+...++.+|+.+|+.++||||+++++++.+.  ..
T Consensus         8 i~~Y-~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~   83 (336)
T 3h4j_B            8 IGPY-IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTP--TD   83 (336)
T ss_dssp             ETTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred             cCCE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CE
Confidence            3566 8899999999999999999999999999998743221 112235688999999999999999999998654  57


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||+ +|+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++....
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEEC-TTCCEEECCSSCTBTTT
T ss_pred             EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEc-CCCCEEEEEeccceecc
Confidence            89999999 7899999988888999999999999999999999999  99999999999998 78899999999997665


Q ss_pred             CC-CCcccccCCcccCccccccc-C-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          183 QP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       183 ~~-~~~~~~gt~~y~aPE~l~~~-~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      .. .....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+... ..+...+..+  ...++...+++++
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~i~~~--~~~~p~~~s~~~~  236 (336)
T 3h4j_B          160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-PNLFKKVNSC--VYVMPDFLSPGAQ  236 (336)
T ss_dssp             TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS-TTCBCCCCSS--CCCCCTTSCHHHH
T ss_pred             CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH-HHHHHHHHcC--CCCCcccCCHHHH
Confidence            44 34567899999999988764 4 6899999999999999999999976322 2222222222  2234566789999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          260 QFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +||++||. +|.+|||+.|+++||||+...+
T Consensus       237 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  267 (336)
T 3h4j_B          237 SLIRRMIVADPMQRITIQEIRRDPWFNVNLP  267 (336)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred             HHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence            99999998 9999999999999999987544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.6e-49  Score=385.32  Aligned_cols=257  Identities=23%  Similarity=0.387  Sum_probs=204.3

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .++| ++.+.||+|+||+||+|.++.+++.||+|++.....     ..+.+.+|+.+++.++||||+++++++.+.  ..
T Consensus        19 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~   90 (361)
T 3uc3_A           19 SDRY-DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----IDENVQREIINHRSLRHPNIVRFKEVILTP--TH   90 (361)
T ss_dssp             TTTE-EEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-----SCHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred             CCcE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC--CE
Confidence            4566 889999999999999999999999999999875432     225577899999999999999999998654  57


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC--cEEEcccceeee
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIV  180 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~--~~kl~Dfgla~~  180 (394)
                      +++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++  .+||+|||++..
T Consensus        91 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~-~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           91 LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLD-GSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEEC-SSSSCCEEECCCCCC--
T ss_pred             EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCceEEEeecCcccc
Confidence            8999999999999999998888999999999999999999999999  99999999999998 344  499999999974


Q ss_pred             ecC-CCCcccccCCcccCcccccc-cCCC-cCcchhhhhHHHHHHhcCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCC
Q 016143          181 MQQ-PTARSVIGTPEFMAPELYEE-EYNE-LVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       181 ~~~-~~~~~~~gt~~y~aPE~l~~-~~~~-~~DIwSlG~il~elltg~~Pf~~~~~---~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      ... ......+||+.|+|||++.+ .++. ++|||||||++|+|++|+.||.+...   .......+.............
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI  247 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC
T ss_pred             ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC
Confidence            432 23455679999999997754 4554 48999999999999999999976432   344445554443332233356


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK  290 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~  290 (394)
                      ++++++||++||. +|.+|||+.|+|+||||....+.
T Consensus       248 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  284 (361)
T 3uc3_A          248 SPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPA  284 (361)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCch
Confidence            8999999999998 99999999999999999765443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-48  Score=367.06  Aligned_cols=260  Identities=26%  Similarity=0.470  Sum_probs=222.4

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      ..++| ++.+.||+|+||+||+|.++.+|..||+|++.....  .....+.+.+|+.++++++||||+++++++.+.  .
T Consensus         4 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~   78 (284)
T 3kk8_A            4 FSDNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--S   78 (284)
T ss_dssp             TTTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred             hhhhh-hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--C
Confidence            34556 889999999999999999999999999999875543  456678899999999999999999999988543  5


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEcccceee
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAI  179 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--~~~~~kl~Dfgla~  179 (394)
                      ..++||||+++++|.+++.....+++..++.++.||+.||.|||+++  |+||||||+||+++.  .++.+||+|||++.
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            68899999999999999998888999999999999999999999999  999999999999973  23349999999997


Q ss_pred             eecCCC-CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCC
Q 016143          180 VMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD  255 (394)
Q Consensus       180 ~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~  255 (394)
                      ...... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+.......+..+..  +.......+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T 3kk8_A          157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVT  235 (284)
T ss_dssp             ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhcccC
Confidence            765543 345679999999998765 589999999999999999999999987 556666666665532  222334678


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +++.+||.+||. +|.+||++.|+|+||||+....
T Consensus       236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            999999999998 9999999999999999987543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-49  Score=386.46  Aligned_cols=254  Identities=24%  Similarity=0.382  Sum_probs=217.2

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      +|++.+.||+|+||+||+|.++.+|..||+|++....    ......+.+|+.+|+.|+||||+++++++.+.  ..+++
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~l  125 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMVL  125 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEEE
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--CEEEE
Confidence            4488899999999999999999999999999987432    34556788999999999999999999998654  57899


Q ss_pred             EEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEcccceeeeecC
Q 016143          106 ITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~-~~~~~kl~Dfgla~~~~~  183 (394)
                      ||||+.+|+|.+++.... .+++..++.++.||+.||.|||++|  |+||||||+|||++. .++.+||+|||++.....
T Consensus       126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999999999998654 6999999999999999999999999  999999999999973 347899999999987765


Q ss_pred             CC-CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCHHHH
Q 016143          184 PT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVK  259 (394)
Q Consensus       184 ~~-~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~  259 (394)
                      .. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.......+.....  +.......+++++
T Consensus       204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            43 344579999999998765 589999999999999999999999987 455555555554422  2333456789999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          260 QFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +||.+||. +|.+||++.++|+||||+...
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            99999998 999999999999999998754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.8e-49  Score=371.69  Aligned_cols=255  Identities=23%  Similarity=0.428  Sum_probs=216.2

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+..++..||+|++..... ........+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         9 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   84 (279)
T 3fdn_A            9 EDF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRV   84 (279)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred             ccE-EEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc-chhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CEE
Confidence            445 788999999999999999999999999999865432 1122346688999999999999999999998654  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+++++|.+++.....+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.....
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEEC-TTSCEEECSCCEESCC--
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEc-CCCCEEEEeccccccCCc
Confidence            899999999999999998888999999999999999999999999  99999999999998 788999999999976665


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+....  ..++...++.+++||
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li  238 (279)
T 3fdn_A          162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVE--FTFPDFVTEGARDLI  238 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTC--CCCCTTSCHHHHHHH
T ss_pred             ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCC--CCCCCcCCHHHHHHH
Confidence            55566789999999998765 478999999999999999999999986 55666666666543  234566789999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          263 EKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .+||. +|.+||++.|+|+||||+...
T Consensus       239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          239 SRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HHHhccChhhCCCHHHHhhCccccCCc
Confidence            99998 999999999999999998754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.9e-49  Score=387.33  Aligned_cols=256  Identities=24%  Similarity=0.395  Sum_probs=204.7

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~  102 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++...  .......+++.+|+.+|+.+. ||||+++++++..++...
T Consensus         9 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            9 RKY-ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             TTE-EEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             Cce-EEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc--ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            455 7889999999999999999999999999998533  234667788999999999997 999999999998777678


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||++ ++|.+++... .+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+...
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLN-AECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEESS
T ss_pred             EEEEecccC-cCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEc-CCCCEEecCCccccccc
Confidence            999999997 6899999874 6999999999999999999999999  99999999999998 78899999999997653


Q ss_pred             C-----------------------CCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHH
Q 016143          183 Q-----------------------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI  237 (394)
Q Consensus       183 ~-----------------------~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~  237 (394)
                      .                       ......+||+.|+|||++.+  .|+.++|||||||++|||++|++||.+.....++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            2                       12334679999999997754  5899999999999999999999999885544443


Q ss_pred             HHHHhcCCCCC--------------------------------------------CCCCCCCHHHHHHHHHcCC-CCCCC
Q 016143          238 YKKVTSGIKPA--------------------------------------------SLSKVTDPQVKQFIEKCIV-PASLR  272 (394)
Q Consensus       238 ~~~i~~~~~~~--------------------------------------------~~~~~~~~~~~~li~~~L~-~p~~R  272 (394)
                      ...+.....|.                                            ......++++++||++||. +|.+|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            33321110010                                            0112457899999999999 99999


Q ss_pred             CCHHHHhcCCccccC
Q 016143          273 LPALELLKDPFLVTD  287 (394)
Q Consensus       273 ~s~~elL~~p~~~~~  287 (394)
                      ||+.|+|+||||+..
T Consensus       321 ~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          321 ISANDALKHPFVSIF  335 (388)
T ss_dssp             CCHHHHTTSTTTTTT
T ss_pred             CCHHHHhCCHHHHHh
Confidence            999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.4e-49  Score=381.92  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=205.0

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      ..|++.+.||+|+||+||+|.++.+++.||+|++....      ..+.+.+|+.+|++++||||+++++++.+.  ..++
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  124 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TEIS  124 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecC--CeEE
Confidence            34588899999999999999999999999999986432      235677899999999999999999998654  5788


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEcccceeeeec
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--~~~~~kl~Dfgla~~~~  182 (394)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++.  .++.+||+|||++....
T Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            99999999999999998888999999999999999999999999  999999999999972  37899999999997665


Q ss_pred             CC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCHHH
Q 016143          183 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQV  258 (394)
Q Consensus       183 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~  258 (394)
                      .. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........++..+.....  +..+....+.++
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  282 (349)
T 2w4o_A          203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA  282 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence            44 2345679999999998765 5899999999999999999999999887777767777766533  223345678899


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          259 KQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ++||++||. +|.+||++.++|+||||....
T Consensus       283 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            999999998 999999999999999998654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3e-49  Score=401.29  Aligned_cols=259  Identities=29%  Similarity=0.427  Sum_probs=219.4

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC---------HHHHHHHHHHHHHHHcCCCCCceeEeeeE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS---------PDQLERLYSEVHLLKSLKHENIIKFYNSW   95 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~---------~~~~~~~~~E~~~l~~L~hpnIv~~~~~~   95 (394)
                      ..|++.+.||+|+||+||+|.++.++..||+|++........         ....+.+.+|+.+|++|+||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            334788999999999999999999999999999876543211         13356788999999999999999999998


Q ss_pred             EcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEc
Q 016143           96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIG  173 (394)
Q Consensus        96 ~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~--~~~kl~  173 (394)
                      .+  ...+++|||||++|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++.++  ..+||+
T Consensus       116 ~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          116 ED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             Ec--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEE
Confidence            64  4578999999999999999998888999999999999999999999999  99999999999998433  269999


Q ss_pred             ccceeeeecCC-CCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC--C
Q 016143          174 DLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--L  250 (394)
Q Consensus       174 Dfgla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~--~  250 (394)
                      |||++...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..++...+..+.....  .
T Consensus       192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~  270 (504)
T 3q5i_A          192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFND  270 (504)
T ss_dssp             CCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHH
T ss_pred             ECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCccc
Confidence            99999877654 3456789999999999988899999999999999999999999987 666777777777644322  1


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ....++++++||++||. +|.+|||+.|+|+||||+...
T Consensus       271 ~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            24578999999999998 999999999999999998754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-49  Score=400.18  Aligned_cols=256  Identities=28%  Similarity=0.490  Sum_probs=221.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++...... ..+..+.+.+|+.+|+.++||||+++++++.+.  ..+
T Consensus        16 ~~Y-~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~   91 (476)
T 2y94_A           16 GHY-ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SDI   91 (476)
T ss_dssp             TTE-EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred             cCE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence            444 8899999999999999999999999999999754321 123456788999999999999999999998654  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.....
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~-~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECCT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEe-cCCCeEEEeccchhhccc
Confidence            999999999999999998888999999999999999999999999  99999999999998 788999999999987655


Q ss_pred             C-CCcccccCCcccCccccccc-C-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          184 P-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       184 ~-~~~~~~gt~~y~aPE~l~~~-~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      . .....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+ .+...++..+..+...  .+...++++++
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~  245 (476)
T 2y94_A          169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFY--TPQYLNPSVIS  245 (476)
T ss_dssp             TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-SSSHHHHHHHHTTCCC--CCTTCCHHHHH
T ss_pred             cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCcC--CCccCCHHHHH
Confidence            4 34567899999999988764 4 6899999999999999999999987 4455667777766432  34567899999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          261 FIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      ||++||. +|.+||++.++++||||+...+
T Consensus       246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          246 LLKHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             HHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence            9999998 9999999999999999987543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7e-49  Score=385.50  Aligned_cols=262  Identities=22%  Similarity=0.403  Sum_probs=214.3

Q ss_pred             CCCcccccccceeccc--CceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           21 DPSCRYGRYDEILGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G--~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      .+.+..|++.+.||+|  +||+||+|.++.+|+.||+|++.....  ..+..+.+.+|+.+++.++||||++++++|.++
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   98 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   98 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence            3444445899999999  999999999999999999999976542  456678889999999999999999999998754


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccc
Q 016143           99 TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG  176 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfg  176 (394)
                        ..+++||||+++|+|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||
T Consensus        99 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~dfg  173 (389)
T 3gni_B           99 --NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLR  173 (389)
T ss_dssp             --TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCGG
T ss_pred             --CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccc
Confidence              4789999999999999999876  67999999999999999999999999  99999999999998 78899999999


Q ss_pred             eeeeecCC---------CCcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 016143          177 LAIVMQQP---------TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG  244 (394)
Q Consensus       177 la~~~~~~---------~~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~  244 (394)
                      ++......         .....+||+.|+|||++.+   .|+.++|||||||++|+|++|+.||.+......+...+...
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  253 (389)
T 3gni_B          174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT  253 (389)
T ss_dssp             GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred             cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            98644221         2233479999999998765   58999999999999999999999998755444433322111


Q ss_pred             CC-------------------------------------------CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          245 IK-------------------------------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       245 ~~-------------------------------------------~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..                                           ....+...++++++||++||+ +|.+|||+.|+|+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00                                           011344567899999999998 9999999999999


Q ss_pred             CCccccCCC
Q 016143          281 DPFLVTDNP  289 (394)
Q Consensus       281 ~p~~~~~~~  289 (394)
                      ||||+....
T Consensus       334 hp~f~~~~~  342 (389)
T 3gni_B          334 HSFFKQIKR  342 (389)
T ss_dssp             SGGGGGC--
T ss_pred             CHHHHHHhh
Confidence            999987643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.2e-49  Score=382.39  Aligned_cols=262  Identities=27%  Similarity=0.418  Sum_probs=206.1

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      ....++| ++.+.||+|+||+||+|.+..+|+.||+|++.....  .....+.+.+|+.+|++++||||+++++++.++ 
T Consensus        30 ~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-  105 (329)
T 3gbz_A           30 ATSIDRY-RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-  105 (329)
T ss_dssp             --CGGGE-EEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEET-
T ss_pred             ccchhhE-EEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecC-
Confidence            3344566 788999999999999999999999999999875432  234456778999999999999999999998654 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe----CCCCcEEEccc
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN----GNNGEVKIGDL  175 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~----~~~~~~kl~Df  175 (394)
                       ..+++||||+. |+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++    ...+.+||+||
T Consensus       106 -~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          106 -HRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             -TEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             -CEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcC
Confidence             57899999997 599999999989999999999999999999999999  99999999999995    24456999999


Q ss_pred             ceeeeecCC--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCC-CC
Q 016143          176 GLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP-AS  249 (394)
Q Consensus       176 gla~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~~~-~~  249 (394)
                      |++......  ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||........+...+.. +..+ ..
T Consensus       182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            999765433  3345678999999998765  4899999999999999999999999885555544444332 1111 11


Q ss_pred             CC-------------------------CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          250 LS-------------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       250 ~~-------------------------~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      ++                         ...++++++||++||. +|.+|||+.|+|+||||+..++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            10                         1156899999999998 9999999999999999998764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.7e-49  Score=405.97  Aligned_cols=265  Identities=23%  Similarity=0.364  Sum_probs=225.7

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      ..|++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.+|+.++||||++++++|.+.  ..++
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~  260 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALC  260 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--CEEE
Confidence            34578899999999999999999999999999997543321 22345678899999999999999999998654  5799


Q ss_pred             EEEcccCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          105 MITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~--l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +||||++||+|.+++...+.  +++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||++....
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld-~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEe-CCCCeEEEecccceecc
Confidence            99999999999999987643  999999999999999999999999  99999999999998 78999999999998765


Q ss_pred             CC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCC---CHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          183 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       183 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~---~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      .. .....+||+.|+|||++.+ .|+.++|||||||++|||++|..||....   ....+...+...  +..++...+++
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~s~~  415 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERFSPQ  415 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTSCHH
T ss_pred             cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccCCHH
Confidence            44 3345689999999998765 59999999999999999999999997643   456666666654  34456778899


Q ss_pred             HHHHHHHcCC-CCCCCC-----CHHHHhcCCccccCCCCCcccCCC
Q 016143          258 VKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL  297 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~~~~~~  297 (394)
                      +++||++||. +|.+||     ++.|+++||||+..++..+.....
T Consensus       416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~  461 (576)
T 2acx_A          416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGML  461 (576)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCC
Confidence            9999999998 999999     789999999999988765544333

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.7e-49  Score=373.96  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=204.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+ .+|+.||+|++.....  .....+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~y-~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   75 (288)
T 1ob3_A            2 EKY-HGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRL   75 (288)
T ss_dssp             CSE-EEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCE
T ss_pred             ccc-hhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeE
Confidence            355 7889999999999999998 6899999999875432  122345678899999999999999999998654  468


Q ss_pred             EEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+.+ +|.+++... +.+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++....
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFG  151 (288)
T ss_dssp             EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHC
T ss_pred             EEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEeECccccccC
Confidence            899999975 999988865 67999999999999999999999999  99999999999998 78899999999997654


Q ss_pred             CC--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-C-CCC---------
Q 016143          183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G-IKP---------  247 (394)
Q Consensus       183 ~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~-~~~---------  247 (394)
                      ..  ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+...... + ...         
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence            33  2344578999999998754  4899999999999999999999999875544443333221 0 000         


Q ss_pred             ---------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          248 ---------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       248 ---------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                     .......++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                           01123467899999999998 99999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-49  Score=385.48  Aligned_cols=256  Identities=25%  Similarity=0.434  Sum_probs=213.5

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC-HHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~-~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      .|++.+.||+|+||+||+|.++.+|+.||+|++........ ....+.+.+|+.+++.++||||++++++|.++  ..++
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~  102 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GMLY  102 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEE
Confidence            34888999999999999999999999999999875432211 12346788999999999999999999998654  5789


Q ss_pred             EEEcccCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEccccee
Q 016143          105 MITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLA  178 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~----~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~--~~~~kl~Dfgla  178 (394)
                      +||||+++++|.+++...    ..+++..++.++.||+.||.|||+++  |+||||||+|||++.+  .+.+||+|||++
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            999999999998877543    35899999999999999999999999  9999999999999732  234999999999


Q ss_pred             eeecCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC--CCCC
Q 016143          179 IVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKV  253 (394)
Q Consensus       179 ~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~--~~~~  253 (394)
                      .......  ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+  ....++..+..+.....  ....
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCCcccccc
Confidence            8776543  345679999999998765 589999999999999999999999976  34556666655533211  1245


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      .++++++||.+||. +|.+||++.++|+||||+..
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            67899999999998 99999999999999999863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.6e-50  Score=403.90  Aligned_cols=260  Identities=31%  Similarity=0.501  Sum_probs=222.4

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      ..++| ++.+.||+|+||+||+|.++.++..||+|++.......  .....+.+|+.+|++++||||+++++++.+  ..
T Consensus        20 ~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~   94 (486)
T 3mwu_A           20 FAERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILED--SS   94 (486)
T ss_dssp             HHHHE-EEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred             hhcce-EEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CC
Confidence            34555 88899999999999999999999999999987543222  234678899999999999999999999854  45


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEcccceee
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAI  179 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--~~~~~kl~Dfgla~  179 (394)
                      .+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++.  .++.+||+|||++.
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            78999999999999999988888999999999999999999999999  999999999999962  45689999999997


Q ss_pred             eecCC-CCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCCCH
Q 016143          180 VMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDP  256 (394)
Q Consensus       180 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~--~~~~~~  256 (394)
                      ..... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..++...+..+..+...  ....++
T Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~  251 (486)
T 3mwu_A          173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISD  251 (486)
T ss_dssp             TBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred             ECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCCCH
Confidence            65443 3455679999999999999999999999999999999999999987 5667777777766443322  245688


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      ++++||.+||. +|.+|||+.++|+||||+....
T Consensus       252 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            99999999998 9999999999999999987543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.3e-49  Score=380.12  Aligned_cols=255  Identities=24%  Similarity=0.414  Sum_probs=216.4

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC--CCceeEeeeEEcCCC
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTN  100 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h--pnIv~~~~~~~~~~~  100 (394)
                      .++.|++.+.||+|+||+||+|.+ .++..||+|++....  ......+.+.+|+.+|++++|  |||+++++++.++  
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--   81 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--   81 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC--
Confidence            466669999999999999999987 468999999987654  245667889999999999986  9999999988644  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ..+++||| +.+++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++  ++.+||+|||++..
T Consensus        82 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~--~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           82 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQ  156 (343)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSSCC
T ss_pred             CEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE--CCcEEEeecccccc
Confidence            57899999 458899999999999999999999999999999999999  99999999999997  57899999999976


Q ss_pred             ecCCC----CcccccCCcccCccccc------------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 016143          181 MQQPT----ARSVIGTPEFMAPELYE------------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG  244 (394)
Q Consensus       181 ~~~~~----~~~~~gt~~y~aPE~l~------------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~  244 (394)
                      .....    ....+||+.|+|||++.            ..++.++|||||||++|+|++|+.||....+.......+...
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  236 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  236 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence            64432    23567999999999874            357889999999999999999999998877766666666655


Q ss_pred             CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       245 ~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      .....++...++++.+||.+||. +|.+|||+.|+|+||||+..
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            55556777788899999999998 99999999999999999854

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.9e-49  Score=368.79  Aligned_cols=253  Identities=23%  Similarity=0.414  Sum_probs=218.6

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      ++|++.+.||+|+||+||+|.++.++..||+|++.....    ...+++.+|+.++++++||||+++++++.+.  ..++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~   82 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDN--TDIY   82 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CeEE
Confidence            345889999999999999999999999999999875432    2346788999999999999999999998643  5789


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE---eCCCCcEEEcccceeeee
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll---~~~~~~~kl~Dfgla~~~  181 (394)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+||++   + .++.+||+|||++...
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDS-PDSPLKLIDFGLAARF  159 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSS-TTCCEEECCCTTCEEC
T ss_pred             EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCC-CCCcEEEEecccceec
Confidence            99999999999999998888999999999999999999999999  9999999999999   5 6789999999999876


Q ss_pred             cCC-CCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCCCHHH
Q 016143          182 QQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQV  258 (394)
Q Consensus       182 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~  258 (394)
                      ... ......||+.|+|||++.+.++.++||||||+++|+|++|+.||.. .+..+....+..+.....  .....++.+
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T 3f3z_A          160 KPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSPQA  238 (277)
T ss_dssp             CTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred             cCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence            544 3455679999999999988899999999999999999999999987 455556666655533221  112567899


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          259 KQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      .++|.+||. +|.+||++.++|+||||+..
T Consensus       239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            999999998 99999999999999999864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3e-49  Score=382.14  Aligned_cols=250  Identities=24%  Similarity=0.408  Sum_probs=214.2

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++.....        ...+|+.++.++ +||||++++++|.+  ...
T Consensus        22 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~   90 (342)
T 2qr7_A           22 DGY-EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDD--GKY   90 (342)
T ss_dssp             HHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEEC--SSE
T ss_pred             ccE-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEc--CCE
Confidence            445 788999999999999999999999999999875432        134578888887 79999999999854  457


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC---CcEEEcccceee
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAI  179 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~---~~~kl~Dfgla~  179 (394)
                      +++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||+...+   +.+||+|||++.
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            8999999999999999999889999999999999999999999999  99999999999995333   359999999998


Q ss_pred             eecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC--CCHHHHHHHHhcCCCC--CCCCC
Q 016143          180 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKP--ASLSK  252 (394)
Q Consensus       180 ~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~--~~~~~~~~~i~~~~~~--~~~~~  252 (394)
                      .....  .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...  .+..++...+..+...  .....
T Consensus       169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  248 (342)
T 2qr7_A          169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN  248 (342)
T ss_dssp             ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred             cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence            76543  3445689999999998875 4899999999999999999999999763  4667788888776443  22345


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      ..++++++||++||. +|.+||++.++|+||||..
T Consensus       249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            678999999999998 9999999999999999965

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.1e-49  Score=399.36  Aligned_cols=254  Identities=27%  Similarity=0.453  Sum_probs=216.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.++..||+|++......  ....+.+.+|+.+|+.++||||++++++|.+.  ..+++|
T Consensus        39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv  114 (494)
T 3lij_A           39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK--RNYYLV  114 (494)
T ss_dssp             EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred             eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEE
Confidence            48889999999999999999999999999998765432  22346788999999999999999999998644  578999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~--~~~~kl~Dfgla~~~~~~  184 (394)
                      ||||.+|+|.+++.....+++..++.++.||+.||.|||++|  |+||||||+|||++..  ++.+||+|||++......
T Consensus       115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            999999999999988888999999999999999999999999  9999999999999732  456999999999877654


Q ss_pred             -CCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCCCHHHHHH
Q 016143          185 -TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQF  261 (394)
Q Consensus       185 -~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~~l  261 (394)
                       .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..++...+..+....  ......++.+++|
T Consensus       193 ~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  271 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL  271 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred             ccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence             3456689999999999988899999999999999999999999987 56677777777664332  2234578999999


Q ss_pred             HHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          262 IEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      |.+||. +|.+|||+.++|+||||+..
T Consensus       272 i~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          272 IKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHCCCChhhCccHHHHhcCcccccC
Confidence            999998 99999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.2e-49  Score=413.72  Aligned_cols=265  Identities=22%  Similarity=0.340  Sum_probs=229.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      |++.+.||+|+||+||+|.++.+++.||+|+++...... ....+.+..|..+|..+ +||||++++++|.+  ...+|+
T Consensus       343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~~~l  419 (674)
T 3pfq_A          343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF  419 (674)
T ss_dssp             EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSEEEE
T ss_pred             eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCEEEE
Confidence            367789999999999999999999999999997543211 23456788899999998 79999999998854  457999


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec--C
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--Q  183 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~--~  183 (394)
                      ||||+++|+|.+++.+.+.+++..++.|+.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+++...  .
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEEC-SSSCEEECCCTTCEECCCTT
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEc-CCCcEEEeecceeeccccCC
Confidence            9999999999999999888999999999999999999999999  99999999999998 78999999999998643  2


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      ......+||+.|+|||++.+ .|+.++|||||||+||||++|+.||.+ .+..+++..+....  ..++...++++++||
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~li  573 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN--VAYPKSMSKEAVAIC  573 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSC--CCCCTTSCHHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHH
Confidence            34556789999999998764 699999999999999999999999987 67778888887753  335667889999999


Q ss_pred             HHcCC-CCCCCCCH-----HHHhcCCccccCCCCCcccCCCCCC
Q 016143          263 EKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLRLP  300 (394)
Q Consensus       263 ~~~L~-~p~~R~s~-----~elL~~p~~~~~~~~~~~~~~~~~p  300 (394)
                      ++||. +|.+|+++     .|+++||||+..+|..+....+..|
T Consensus       574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp  617 (674)
T 3pfq_A          574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP  617 (674)
T ss_dssp             HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCS
T ss_pred             HHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCC
Confidence            99998 99999997     9999999999988877655544433

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.6e-49  Score=374.66  Aligned_cols=257  Identities=23%  Similarity=0.377  Sum_probs=207.0

Q ss_pred             Ccccccc-cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCC
Q 016143           23 SCRYGRY-DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN  100 (394)
Q Consensus        23 ~~ry~r~-~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~  100 (394)
                      .++| ++ .++||+|+||+||+|.+..+++.||+|++....    ....+++.+|+.+++++ +||||+++++++.++  
T Consensus        11 ~~~y-~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--   83 (316)
T 2ac3_A           11 EDVY-QLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--   83 (316)
T ss_dssp             TTSC-EECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--
T ss_pred             ceeE-EecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--
Confidence            4556 45 588999999999999999999999999987542    23346788999999985 799999999998654  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc---EEEcccce
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE---VKIGDLGL  177 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~---~kl~Dfgl  177 (394)
                      ..+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.   +||+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCE-HPNQVSPVKICDFDL  160 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEES-CSSSSCSEEECCTTC
T ss_pred             CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEc-cCCCcCceEEEEccC
Confidence            578999999999999999998888999999999999999999999999  99999999999998 4444   99999999


Q ss_pred             eeeecCC---------CCcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCC---------
Q 016143          178 AIVMQQP---------TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKN---------  233 (394)
Q Consensus       178 a~~~~~~---------~~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~---------  233 (394)
                      +......         .....+||+.|+|||++.      ..++.++|||||||++|+|++|+.||.....         
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            8654321         123456999999999875      3489999999999999999999999976432         


Q ss_pred             -----HHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          234 -----PAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       234 -----~~~~~~~i~~~~~~~~--~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                           ...+...+..+.....  .....++++++||++||. +|.+||++.|+|+||||+...+
T Consensus       241 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence                 2445566655533211  113467899999999998 9999999999999999987543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-48  Score=374.27  Aligned_cols=259  Identities=26%  Similarity=0.419  Sum_probs=220.1

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC--HHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      ...|++.+.||+|+||+||+|.++.+|..||+|.+........  ....+.+.+|+.++++++||||+++++++.+.  .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~   88 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR--T   88 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence            3445899999999999999999999999999999976543221  11356788999999999999999999998544  5


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC----cEEEcccce
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGL  177 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~----~~kl~Dfgl  177 (394)
                      .+++||||+++++|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+||+++ .++    .+||+|||+
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~-~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLL-DKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CTTSSSCCEEECCCTT
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEe-cCCCCcCCEEEccCcc
Confidence            78999999999999999999888999999999999999999999999  99999999999998 455    799999999


Q ss_pred             eeeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCC
Q 016143          178 AIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKV  253 (394)
Q Consensus       178 a~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~  253 (394)
                      +...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+....+......  ......
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~  244 (321)
T 2a2a_A          166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFSH  244 (321)
T ss_dssp             CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             ceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccccChhhhcc
Confidence            9876554 3445679999999998764 589999999999999999999999987 4556666666654322  122345


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .++.+++||.+||. +|.+||++.++|+||||....
T Consensus       245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             CCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            67899999999998 999999999999999998654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.6e-50  Score=402.79  Aligned_cols=259  Identities=30%  Similarity=0.490  Sum_probs=224.5

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.+|..||+|++...... .....+.+.+|+.+|++++||||++++++|.+  ...+
T Consensus        26 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~  101 (484)
T 3nyv_A           26 DRY-KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYF  101 (484)
T ss_dssp             HHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred             Cce-EEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEE
Confidence            445 8889999999999999999999999999998755432 23345778899999999999999999999865  4578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEcccceeeee
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~--~~~~~~kl~Dfgla~~~  181 (394)
                      ++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++  ..++.+||+|||++...
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            999999999999999999889999999999999999999999999  99999999999995  25689999999999766


Q ss_pred             cCC-CCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCCCHHH
Q 016143          182 QQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQV  258 (394)
Q Consensus       182 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~  258 (394)
                      ... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..++...+..+......  ....++++
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  258 (484)
T 3nyv_A          180 EASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSESA  258 (484)
T ss_dssp             CCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred             ccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence            544 3345679999999999998999999999999999999999999987 5667777777766443222  24568899


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          259 KQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      ++||++||. +|.+|||+.++|+||||+....
T Consensus       259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             HHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            999999998 9999999999999999987543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6e-49  Score=375.68  Aligned_cols=255  Identities=27%  Similarity=0.522  Sum_probs=198.8

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|.+.....   ....+.+.+|+.++++++||||+++++++.+  ...+
T Consensus         5 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~   78 (317)
T 2pmi_A            5 SQF-KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEE
T ss_pred             cce-eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeE
Confidence            445 788999999999999999999999999999875432   2233567889999999999999999998854  4578


Q ss_pred             EEEEcccCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143          104 NMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                      ++||||++ |+|.+++...      ..+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~  154 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCSS
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEc-CCCCEEECcCcc
Confidence            99999997 6999988754      35999999999999999999999999  99999999999998 788999999999


Q ss_pred             eeeecCC--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc--CCCCC---
Q 016143          178 AIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPA---  248 (394)
Q Consensus       178 a~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~--~~~~~---  248 (394)
                      +......  ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+... ......+..  +..+.   
T Consensus       155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  233 (317)
T 2pmi_A          155 ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQLKLIFDIMGTPNESLW  233 (317)
T ss_dssp             CEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCTTTC
T ss_pred             ceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhHh
Confidence            9876543  3345679999999998764  489999999999999999999999987444 333333321  11000   


Q ss_pred             ---------------------------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          249 ---------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       249 ---------------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                                                 ......++++++||.+||. +|.+|||+.|+|+||||+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence                                       0112467899999999998 9999999999999999987543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.6e-49  Score=386.85  Aligned_cols=254  Identities=24%  Similarity=0.419  Sum_probs=217.2

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC--CCCceeEeeeEEcCCCc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDTNR  101 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~--hpnIv~~~~~~~~~~~~  101 (394)
                      ++.|++.+.||+|+||+||+|.+.. +..||+|++.....  .....+.+.+|+.+|++|+  ||||+++++++..+  .
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~  129 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--Q  129 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--S
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--C
Confidence            4556889999999999999998865 99999999976542  4567788999999999996  59999999988654  4


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .+++||| +.+++|.+++.....+++..++.++.||+.||.|||+++  |+||||||+|||++  ++.+||+|||++...
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~--~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQM  204 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES--SSCEEECCCSSSCCC
T ss_pred             EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE--CCeEEEEecCccccc
Confidence            6999999 568899999999889999999999999999999999999  99999999999996  579999999999766


Q ss_pred             cCCC----CcccccCCcccCcccccc------------cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q 016143          182 QQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI  245 (394)
Q Consensus       182 ~~~~----~~~~~gt~~y~aPE~l~~------------~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~  245 (394)
                      ....    ....+||+.|+|||++.+            .|+.++|||||||++|+|++|+.||....+.......+....
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~  284 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  284 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence            4332    345679999999998754            588899999999999999999999988666666666666655


Q ss_pred             CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       246 ~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ....++...+.++++||.+||. +|.+||++.|+|+||||+..
T Consensus       285 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            4555667778899999999998 99999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.4e-48  Score=385.46  Aligned_cols=265  Identities=24%  Similarity=0.344  Sum_probs=210.0

Q ss_pred             ccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        19 ~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      .....++| ++.+.||+|+||+||+|.++.+|+.||+|++...  .......+++.+|+.+|+.++||||+++++++...
T Consensus        21 ~~~i~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           21 NVHVPDNY-IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD   97 (432)
T ss_dssp             GCCCCTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECST--TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             cceecCCE-EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch--hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            33444566 8899999999999999999999999999998643  23456678899999999999999999999988655


Q ss_pred             CC---ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143           99 TN---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus        99 ~~---~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                      ..   ..+++||||+. ++|.++++....+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+||
T Consensus        98 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~~kL~DF  173 (432)
T 3n9x_A           98 DLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN-QDCSVKVCDF  173 (432)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCC
T ss_pred             CCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEEC-CCCCEEEccC
Confidence            32   56899999986 699999999888999999999999999999999999  99999999999998 7889999999


Q ss_pred             ceeeeecCC------------------------CCcccccCCcccCcccc-c-ccCCCcCcchhhhhHHHHHHhcC----
Q 016143          176 GLAIVMQQP------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTCE----  225 (394)
Q Consensus       176 gla~~~~~~------------------------~~~~~~gt~~y~aPE~l-~-~~~~~~~DIwSlG~il~elltg~----  225 (394)
                      |+++.....                        .....+||+.|+|||++ . ..|+.++|||||||++|||++|.    
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            999866432                        13567899999999975 3 45999999999999999999843    


Q ss_pred             -------CCCCCCCC-----------------HHHHH-----------------------HHHhcCCCCCC-----CCCC
Q 016143          226 -------YPYNECKN-----------------PAQIY-----------------------KKVTSGIKPAS-----LSKV  253 (394)
Q Consensus       226 -------~Pf~~~~~-----------------~~~~~-----------------------~~i~~~~~~~~-----~~~~  253 (394)
                             ++|.+...                 ..++.                       ..+........     ....
T Consensus       254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (432)
T 3n9x_A          254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS  333 (432)
T ss_dssp             SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred             cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence                   44433210                 11111                       11111100000     0134


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK  290 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~  290 (394)
                      .++++++||++||. +|.+|||+.|+|+||||+.....
T Consensus       334 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          334 ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            68899999999998 99999999999999999986544

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.4e-49  Score=380.28  Aligned_cols=259  Identities=29%  Similarity=0.487  Sum_probs=217.6

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      .++..+| +..+.||+|+||+||+|.+..+|..||+|++..... ......+.+.+|+.+|++++||||+++++++.++ 
T Consensus        50 ~~~~~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-  126 (348)
T 1u5q_A           50 DDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-  126 (348)
T ss_dssp             SCHHHHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-
T ss_pred             cchhhhe-eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-
Confidence            3444555 777899999999999999999999999999875432 2345567899999999999999999999998654 


Q ss_pred             CceEEEEEcccCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 NRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~-~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                       ..+++||||+. |+|.+++. ....+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++
T Consensus       127 -~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a  201 (348)
T 1u5q_A          127 -HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSA  201 (348)
T ss_dssp             -TEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTC
T ss_pred             -CeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEeeccCc
Confidence             47889999997 57777775 4567999999999999999999999999  99999999999999 7889999999999


Q ss_pred             eeecCCCCcccccCCcccCccccc----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          179 IVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      ......  ....||+.|+|||++.    +.++.++|||||||++|||++|+.||........+ ..+..+..+......+
T Consensus       202 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  278 (348)
T 1u5q_A          202 SIMAPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNESPALQSGHW  278 (348)
T ss_dssp             BSSSSB--CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSCCCCCCCTTS
T ss_pred             eecCCC--CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCCCCCCCC
Confidence            765432  3467999999999773    46899999999999999999999999875444444 4444444454455677


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      ++.+++||.+||. +|.+||++.++|+||||....+
T Consensus       279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence            8999999999998 9999999999999999986543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.4e-48  Score=373.98  Aligned_cols=250  Identities=29%  Similarity=0.543  Sum_probs=214.1

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ...+.||+|+||+||+|.++.+|+.||+|++....    ....+.+.+|+.++++++||||+++++++...  ..+++||
T Consensus        48 ~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  121 (321)
T 2c30_A           48 DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG--EELWVLM  121 (321)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred             hccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEE
Confidence            55678999999999999999999999999987443    23456688999999999999999999998654  4688999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--C
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~  185 (394)
                      ||+++++|.+++... .+++..+..++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++......  .
T Consensus       122 e~~~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~  197 (321)
T 2c30_A          122 EFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPK  197 (321)
T ss_dssp             CCCCSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCC
T ss_pred             ecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCcEEEeeeeeeeecccCccc
Confidence            999999999998764 5999999999999999999999999  99999999999998 7889999999999776543  2


Q ss_pred             CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCCCHHHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIE  263 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~li~  263 (394)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..+....+.....+. ......++.++++|.
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  276 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE  276 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence            345679999999997765 589999999999999999999999987 55566666665554332 223346789999999


Q ss_pred             HcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          264 KCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       264 ~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +||. +|.+||++.++|+||||....
T Consensus       277 ~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          277 RMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHccCChhhCcCHHHHhcChhhccCC
Confidence            9998 999999999999999998643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-48  Score=392.48  Aligned_cols=260  Identities=23%  Similarity=0.386  Sum_probs=198.2

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC---C
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---N  100 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~---~  100 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++...  .......+++.+|+.+|+.|+||||+++++++....   .
T Consensus        53 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           53 DRY-EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             TTE-EECCC-------CEEEEEECC--CEEEEEEECST--TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             CCe-EEeeEeeecCCeEEEEEEECCCCcEEEEEEechh--hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            455 8899999999999999999999999999998543  234566788999999999999999999999886543   2


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ..+|+||||+ +++|.+++.....+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+|+.
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLART  205 (458)
T ss_dssp             CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBC
T ss_pred             ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEEC-CCCCEeecccccchh
Confidence            5789999998 5799999999888999999999999999999999999  99999999999998 788999999999976


Q ss_pred             ecCC-----------------------------CCcccccCCcccCcccc-c-ccCCCcCcchhhhhHHHHHHh------
Q 016143          181 MQQP-----------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVT------  223 (394)
Q Consensus       181 ~~~~-----------------------------~~~~~~gt~~y~aPE~l-~-~~~~~~~DIwSlG~il~ellt------  223 (394)
                      ....                             .....+||+.|+|||++ . ..|+.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            5422                             23345789999999965 3 459999999999999999999      


Q ss_pred             -----cCCCCCCCCC--------------------HHHHHHHHhc-CCC--------------------C-------CCC
Q 016143          224 -----CEYPYNECKN--------------------PAQIYKKVTS-GIK--------------------P-------ASL  250 (394)
Q Consensus       224 -----g~~Pf~~~~~--------------------~~~~~~~i~~-~~~--------------------~-------~~~  250 (394)
                           |+++|.+...                    ..++...+.. +..                    +       ...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 7777765321                    1111111100 000                    0       011


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCC
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK  290 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~  290 (394)
                      ....++++.+||++||. +|.+|||+.|+|+||||+.....
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~  406 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA  406 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence            23347899999999998 99999999999999999986544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.8e-49  Score=372.12  Aligned_cols=258  Identities=22%  Similarity=0.395  Sum_probs=209.5

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+..+|..||+|++....  ......+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         3 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~   77 (311)
T 4agu_A            3 EKY-EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRL   77 (311)
T ss_dssp             CCE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred             ccc-eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeE
Confidence            455 78899999999999999999999999999886443  3455567788999999999999999999998654  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+++++|..++...+.+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.....
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC-
T ss_pred             EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEc-CCCCEEEeeCCCchhccC
Confidence            899999999999999998888999999999999999999999999  99999999999998 788999999999987654


Q ss_pred             C--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc--C-------------
Q 016143          184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--G-------------  244 (394)
Q Consensus       184 ~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~--~-------------  244 (394)
                      .  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.............  .             
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence            3  2345679999999998754  5899999999999999999999999875544433322110  0             


Q ss_pred             ----CC---CCCC------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          245 ----IK---PASL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       245 ----~~---~~~~------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                          ..   +...      ....++++.+||.+||. +|.+|||+.|+|+||||+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence                00   0000      12467889999999998 9999999999999999997643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.9e-49  Score=377.90  Aligned_cols=281  Identities=22%  Similarity=0.320  Sum_probs=219.2

Q ss_pred             CCCCcCCCCCCCccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC
Q 016143            5 SGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK   84 (394)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~   84 (394)
                      +|++...++..-....+..++|....+.||+|+||+||+|.++.+|+.||+|++.....  .......+.+|+.+++.++
T Consensus         9 ~~~~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~   86 (327)
T 3lm5_A            9 SGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAK   86 (327)
T ss_dssp             -------CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTT
T ss_pred             ccccccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhcc
Confidence            34444333333333333445564444899999999999999999999999999875432  2334567889999999995


Q ss_pred             -CCCceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 016143           85 -HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI  161 (394)
Q Consensus        85 -hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NI  161 (394)
                       ||||+++++++.+  ...+++||||+.+|+|.+++...  ..+++..++.++.||+.||.|||++|  |+||||||+||
T Consensus        87 ~~~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NI  162 (327)
T 3lm5_A           87 SCPRVINLHEVYEN--TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNI  162 (327)
T ss_dssp             TCTTBCCEEEEEEC--SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGE
T ss_pred             CCCCEEEEEEEEEe--CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHE
Confidence             6999999999854  45789999999999999998654  67999999999999999999999999  99999999999


Q ss_pred             EEeC--CCCcEEEcccceeeeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHH
Q 016143          162 FVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI  237 (394)
Q Consensus       162 ll~~--~~~~~kl~Dfgla~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~  237 (394)
                      +++.  .++.+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||... +....
T Consensus       163 l~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~  241 (327)
T 3lm5_A          163 LLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE-DNQET  241 (327)
T ss_dssp             EESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHH
T ss_pred             EEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchHH
Confidence            9983  2689999999999876544 3345679999999998764 5899999999999999999999999874 44444


Q ss_pred             HHHHhcCC--CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCCCc
Q 016143          238 YKKVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       238 ~~~i~~~~--~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~~~  292 (394)
                      ...+....  .+.......++.+++||.+||. +|.+||++.++|+||||+..++..+
T Consensus       242 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          242 YLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             HHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence            44444332  2333445678899999999998 9999999999999999998776544

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.1e-48  Score=367.14  Aligned_cols=255  Identities=23%  Similarity=0.435  Sum_probs=220.1

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+..++..||+|++....... ....+.+.+|+.+++.++||||+++++++.+.  ..+
T Consensus        14 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   89 (284)
T 2vgo_A           14 DDF-DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--KRI   89 (284)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred             hhc-eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC--CEE
Confidence            444 88899999999999999999999999999987543211 12345688999999999999999999998654  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+++++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++.....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMG-YKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECSS
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEc-CCCCEEEecccccccCcc
Confidence            999999999999999998888999999999999999999999999  99999999999998 788999999999987766


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+....  ..++...+..++++|
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li  243 (284)
T 2vgo_A          167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNVD--LKFPPFLSDGSKDLI  243 (284)
T ss_dssp             SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTC--CCCCTTSCHHHHHHH
T ss_pred             cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC-CCHhHHHHHHhccc--cCCCCcCCHHHHHHH
Confidence            55566789999999998765 589999999999999999999999987 44555555555442  234566789999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          263 EKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .+||. +|.+||++.++|+||||+...
T Consensus       244 ~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          244 SKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             HHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             HHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            99998 999999999999999998654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.6e-49  Score=372.43  Aligned_cols=260  Identities=28%  Similarity=0.425  Sum_probs=205.8

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC-HHHHHHHHHHHHHHHcC---CCCCceeEeeeEEcC
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSL---KHENIIKFYNSWVDD   98 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~-~~~~~~~~~E~~~l~~L---~hpnIv~~~~~~~~~   98 (394)
                      .++| ++.+.||+|+||+||+|.+..+|+.||+|.+........ ......+.+|+.+++.+   +||||+++++++.+.
T Consensus         8 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            8 TSRY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             --CC-EEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             ccce-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3555 889999999999999999999999999999875442111 11123455677776666   499999999998765


Q ss_pred             CC---ceEEEEEcccCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143           99 TN---RTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus        99 ~~---~~~~lV~e~~~~gsL~~~i~~~~~--l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                      ..   ..+++||||+. ++|.+++.....  +++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEEC-TTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEEe
Confidence            42   25889999996 699999988754  999999999999999999999999  99999999999998 78899999


Q ss_pred             ccceeeeecCC-CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc--CCCC-C
Q 016143          174 DLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKP-A  248 (394)
Q Consensus       174 Dfgla~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~--~~~~-~  248 (394)
                      |||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+..... ....+..  +..+ .
T Consensus       163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPED  241 (308)
T ss_dssp             SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCCCTT
T ss_pred             eCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChh
Confidence            99999766544 345568999999999775 568999999999999999999999998744443 3333322  1111 1


Q ss_pred             CC----------------------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          249 SL----------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       249 ~~----------------------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .+                      ....++.+.+||.+||. +|.+|||+.|+|+||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            11                      12457899999999998 999999999999999998753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-48  Score=398.78  Aligned_cols=264  Identities=24%  Similarity=0.386  Sum_probs=224.0

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      .|++.++||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.+|++++||||++++++|.+.  ..+++
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~l  262 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TDLCL  262 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--CEEEE
Confidence            3477899999999999999999999999999997544321 23346788999999999999999999998654  57899


Q ss_pred             EEcccCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          106 ITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~----~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      ||||++||+|.+++...    ..+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||++...
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~-~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEe-CCCCEEEeecceeeec
Confidence            99999999999999864    36999999999999999999999999  99999999999998 7899999999999876


Q ss_pred             cCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCC---CHHHHHHHHhcCCCCCCCCCCCC
Q 016143          182 QQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       182 ~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~---~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      ....  ....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||....   +...+...+....  ..++...+
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~--~~~p~~~s  417 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYPDKFS  417 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--CCCCTTSC
T ss_pred             cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--cCCCcccC
Confidence            5443  344689999999998765 59999999999999999999999997642   4566777766553  23556788


Q ss_pred             HHHHHHHHHcCC-CCCCCCC-----HHHHhcCCccccCCCCCcccCCC
Q 016143          256 PQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPL  297 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s-----~~elL~~p~~~~~~~~~~~~~~~  297 (394)
                      +++++||++||. +|.+||+     +.++++||||+..++..+.....
T Consensus       418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~  465 (543)
T 3c4z_A          418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGML  465 (543)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCC
Confidence            999999999998 9999996     58999999999988765544333

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-48  Score=381.33  Aligned_cols=258  Identities=30%  Similarity=0.442  Sum_probs=208.8

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC-
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-  100 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~-  100 (394)
                      ..++| ++.+.||+|+||+||+|.+..+|+.||+|++....  ......+++.+|+.+|+.++||||+++++++..... 
T Consensus        23 ~~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           23 VRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   99 (367)
T ss_dssp             CBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             ecceE-EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence            34555 78899999999999999999999999999985432  345667889999999999999999999999865432 


Q ss_pred             ---ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143          101 ---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus       101 ---~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                         ..+++||||+ +++|.++++. ..+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||+
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~  174 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGL  174 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTT
T ss_pred             ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEc-CCCCEEEEeeec
Confidence               3568999999 8899999987 46999999999999999999999999  99999999999998 688999999999


Q ss_pred             eeeecCCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCC-------
Q 016143          178 AIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP-------  247 (394)
Q Consensus       178 a~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~~~-------  247 (394)
                      ++..... ....+||+.|+|||++.+  .|+.++|||||||++|+|++|+.||.+.....++...+.. +..+       
T Consensus       175 a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          175 ARQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             CEECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             ccccccc-cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            9876543 445679999999997764  5899999999999999999999999875444443332211 1100       


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          248 --------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       248 --------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                          ..+....++++.+||++||. +|.+|||+.++|+||||+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                                11223467899999999998 999999999999999998653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.1e-49  Score=394.13  Aligned_cols=254  Identities=28%  Similarity=0.391  Sum_probs=202.3

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC----
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~----   99 (394)
                      ++| ++.+.||+|+||+||+|.+..+|+.||+|++....  ......+++.+|+.+|+.++||||++++++|....    
T Consensus        62 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           62 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             TTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             CCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            445 77899999999999999999999999999987542  24566788999999999999999999999986543    


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ...+++||||+.+ +|.+.+..  .+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+|+
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~-~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR  212 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCCC-
T ss_pred             CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEe-CCCCEEEEEEEeee
Confidence            2568999999976 46666643  4999999999999999999999999  99999999999998 78899999999998


Q ss_pred             eecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCC--------
Q 016143          180 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA--------  248 (394)
Q Consensus       180 ~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~~~~--------  248 (394)
                      ..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++...+.. +..+.        
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             ecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence            76554 3456789999999997765 6999999999999999999999999885544443333221 10000        


Q ss_pred             ----------CC---------CCC-----------CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          249 ----------SL---------SKV-----------TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       249 ----------~~---------~~~-----------~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                                ..         +..           .++++++||++||. +|.+|||+.|+|+||||+.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence                      00         000           04678999999999 9999999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.8e-48  Score=364.10  Aligned_cols=259  Identities=29%  Similarity=0.446  Sum_probs=223.4

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      .....+.|++.+.||+|+||+||+|.++.+++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--   86 (294)
T 2rku_A           10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--   86 (294)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--
Confidence            33445556889999999999999999999999999999875443 345677889999999999999999999998854  


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ...+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++.
T Consensus        87 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~  163 (294)
T 2rku_A           87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLAT  163 (294)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEc-CCCCEEEEeccCce
Confidence            3578999999999999999998888999999999999999999999999  99999999999998 78899999999998


Q ss_pred             eecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          180 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       180 ~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      .....  ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+..+.+..+..+.  ..++...++
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~--~~~~~~~~~  240 (294)
T 2rku_A          164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNE--YSIPKHINP  240 (294)
T ss_dssp             ECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTC--CCCCTTSCH
T ss_pred             ecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhcc--CCCccccCH
Confidence            76533  3345679999999998765 488999999999999999999999977 44555555555543  234566789


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      .+.++|.+||. +|.+||++.++|+||||...
T Consensus       241 ~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          241 VAASLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence            99999999998 99999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.8e-48  Score=373.98  Aligned_cols=248  Identities=24%  Similarity=0.365  Sum_probs=194.8

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEEEEc
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      .+.||+|+||+||+|.++.+|+.||+|++...       ....+.+|+.+++.+. ||||+++++++.++  ..+++|||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e   86 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVME   86 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEEC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEEE
Confidence            37899999999999999999999999998632       2355678999999997 99999999998644  57889999


Q ss_pred             ccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEcccceeeeecCC--
Q 016143          109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       109 ~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~--~~~kl~Dfgla~~~~~~--  184 (394)
                      |+++|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++.++  ..+||+|||++......  
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  164 (325)
T 3kn6_A           87 LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ  164 (325)
T ss_dssp             CCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence            9999999999999999999999999999999999999999  99999999999998322  28999999999766443  


Q ss_pred             CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC------CCHHHHHHHHhcCCCCCC--CCCCCC
Q 016143          185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC------KNPAQIYKKVTSGIKPAS--LSKVTD  255 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~------~~~~~~~~~i~~~~~~~~--~~~~~~  255 (394)
                      .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...      ....++...+..+..+..  .....+
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS  244 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence            3345678999999998765 5899999999999999999999999753      234567777776643321  113467


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +++++||.+||. +|.+||++.++|+||||+...
T Consensus       245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             HHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            899999999998 999999999999999998653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-48  Score=363.49  Aligned_cols=254  Identities=26%  Similarity=0.406  Sum_probs=216.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+++.||+|++.....   ....+.+.+|+.+++.++||||+++++++.+.  ...++|
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   83 (276)
T 2yex_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLF   83 (276)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred             eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEEEEE
Confidence            3788999999999999999999999999999875542   34557788999999999999999999988654  578899


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      |||+++++|.+++.....+++..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......  
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEETTE
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEc-cCCCEEEeeCCCccccCCCcc
Confidence            999999999999988888999999999999999999999999  99999999999998 6889999999999765432  


Q ss_pred             --CCcccccCCcccCcccccc-cC-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          185 --TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       185 --~~~~~~gt~~y~aPE~l~~-~~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                        ......||+.|+|||++.+ .+ +.++||||||+++|+|++|+.||.........+..+.............++.+++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA  240 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHH
Confidence              2345679999999998765 33 6789999999999999999999987655444555554443322233456889999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          261 FIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +|.+||. +|.+||++.++++||||+...
T Consensus       241 li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          241 LLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            9999998 999999999999999998654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-48  Score=370.04  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=205.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      |++.+.||+|+||+||+|.++.+|+.||+|++....  .......+...|+..+.++ +||||++++++|.+.  ..+++
T Consensus        59 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~~l  134 (311)
T 3p1a_A           59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILYL  134 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC--CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred             eeeeheeccCCCeEEEEEEECCCCeEEEEEEecccc--cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEEEE
Confidence            477889999999999999999999999999875432  2344445555666655555 999999999998644  57899


Q ss_pred             EEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          106 ITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      ||||+ +++|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++......
T Consensus       135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLG-PRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-GGGCEEECCCTTCEECC--
T ss_pred             EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEccceeeeecccC
Confidence            99999 67888887664 46999999999999999999999999  99999999999998 6889999999999776544


Q ss_pred             C-CcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          185 T-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       185 ~-~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                      . .....||+.|+|||++.+.++.++|||||||++|||++|..||..    ......+..+..+..++...++++.+||.
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~  286 (311)
T 3p1a_A          211 GAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRSVLV  286 (311)
T ss_dssp             ----CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred             CCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCcccccCCCHHHHHHHH
Confidence            3 344569999999999988999999999999999999999777654    23344555555555556677899999999


Q ss_pred             HcCC-CCCCCCCHHHHhcCCcccc
Q 016143          264 KCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       264 ~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      +||. +|.+||++.|+|+||||+.
T Consensus       287 ~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          287 MMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHcCCChhhCcCHHHHHhCccccC
Confidence            9998 9999999999999999975

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.1e-49  Score=375.06  Aligned_cols=250  Identities=24%  Similarity=0.424  Sum_probs=206.3

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC------
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN------  100 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~------  100 (394)
                      |++.+.||+|+||+||+|.++.+|+.||+|++....   .....+.+.+|+.+|++|+||||++++++|.+...      
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            378899999999999999999999999999997543   34466789999999999999999999999865432      


Q ss_pred             -------------------------------------------------ceEEEEEcccCCCcHHHHHHhCCC---CCHH
Q 016143          101 -------------------------------------------------RTINMITELFTSGSLRQYRKKHKN---VDMK  128 (394)
Q Consensus       101 -------------------------------------------------~~~~lV~e~~~~gsL~~~i~~~~~---l~~~  128 (394)
                                                                       .++++||||+++++|.+++.....   .++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                             248999999999999999998654   5666


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC--------------CcccccCCc
Q 016143          129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--------------ARSVIGTPE  194 (394)
Q Consensus       129 ~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~--------------~~~~~gt~~  194 (394)
                      .++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.......              .....||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            79999999999999999999  99999999999998 78899999999998765431              234579999


Q ss_pred             ccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCC
Q 016143          195 FMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLR  272 (394)
Q Consensus       195 y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R  272 (394)
                      |+|||++.+ .++.++|||||||++|+|++|..|+.   ........+.....+. .....++++++||.+||. +|.+|
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R  317 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPL-LFTQKYPQEHMMVQDMLSPSPTER  317 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCc-ccccCChhHHHHHHHHccCCCCcC
Confidence            999998765 58999999999999999999877753   2334444444443332 122335788999999998 99999


Q ss_pred             CCHHHHhcCCcccc
Q 016143          273 LPALELLKDPFLVT  286 (394)
Q Consensus       273 ~s~~elL~~p~~~~  286 (394)
                      |++.|+|+||||+.
T Consensus       318 ps~~~~l~~~~f~~  331 (332)
T 3qd2_B          318 PEATDIIENAIFEN  331 (332)
T ss_dssp             CCHHHHHHSTTCCC
T ss_pred             CCHHHHhhchhhhc
Confidence            99999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-48  Score=379.91  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=206.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC-----
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD-----   98 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~-----   98 (394)
                      ++| ++.+.||+|+||+||+|.+..+|+.||+|++......        ..+|+.+|+.++||||++++++|...     
T Consensus         7 ~~y-~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            7 KKY-SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             TTE-EEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ceE-EEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            445 8899999999999999999999999999998644321        23599999999999999999988543     


Q ss_pred             -------------------------------CCceEEEEEcccCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHH
Q 016143           99 -------------------------------TNRTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHY  143 (394)
Q Consensus        99 -------------------------------~~~~~~lV~e~~~~gsL~~~i~----~~~~l~~~~~~~i~~qil~~L~~  143 (394)
                                                     ...++++||||+++ +|.+.+.    ....+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                           33468999999984 6666554    46779999999999999999999


Q ss_pred             HHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHH
Q 016143          144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILE  220 (394)
Q Consensus       144 LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~e  220 (394)
                      ||++|  |+||||||+||+++..++.+||+|||++...... ......||+.|+|||++.+  .|+.++|||||||++|+
T Consensus       157 LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          157 IHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             HHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             HHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence            99999  9999999999999866889999999999876544 3455679999999997754  48999999999999999


Q ss_pred             HHhcCCCCCCCCCHHHHHHHHhcCCCC------------------C--------CCCCCCCHHHHHHHHHcCC-CCCCCC
Q 016143          221 MVTCEYPYNECKNPAQIYKKVTSGIKP------------------A--------SLSKVTDPQVKQFIEKCIV-PASLRL  273 (394)
Q Consensus       221 lltg~~Pf~~~~~~~~~~~~i~~~~~~------------------~--------~~~~~~~~~~~~li~~~L~-~p~~R~  273 (394)
                      |++|+.||.+....+++...+.....|                  .        .++...++++++||.+||. +|.+||
T Consensus       235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (383)
T 3eb0_A          235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI  314 (383)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence            999999998855555554443311000                  0        0234567899999999999 999999


Q ss_pred             CHHHHhcCCccccC
Q 016143          274 PALELLKDPFLVTD  287 (394)
Q Consensus       274 s~~elL~~p~~~~~  287 (394)
                      |+.|+|+||||+..
T Consensus       315 t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          315 NPYEAMAHPFFDHL  328 (383)
T ss_dssp             CHHHHHTSGGGHHH
T ss_pred             CHHHHhcCHHHHHH
Confidence            99999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.6e-48  Score=375.96  Aligned_cols=260  Identities=24%  Similarity=0.395  Sum_probs=210.4

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      .+..++| ++.+.||+|+||+||+|.+..+|+.||+|++.....  .......+.+|+.+++.++||||+++++++.+..
T Consensus        13 ~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   89 (351)
T 3mi9_A           13 CDEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKA   89 (351)
T ss_dssp             SCBGGGE-EEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC--SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             cccccce-eEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc--cccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence            3455677 788999999999999999999999999999865542  2233456778999999999999999999987643


Q ss_pred             ------CceEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 016143          100 ------NRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI  172 (394)
Q Consensus       100 ------~~~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl  172 (394)
                            ...+++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||
T Consensus        90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~-~~~~~kl  165 (351)
T 3mi9_A           90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKL  165 (351)
T ss_dssp             -------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEE
T ss_pred             cccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCCEEE
Confidence                  4578999999975 66666655 467999999999999999999999999  99999999999998 7889999


Q ss_pred             cccceeeeecCC------CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-
Q 016143          173 GDLGLAIVMQQP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-  243 (394)
Q Consensus       173 ~Dfgla~~~~~~------~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-  243 (394)
                      +|||++......      ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.. .......+.. 
T Consensus       166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~  244 (351)
T 3mi9_A          166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLALISQL  244 (351)
T ss_dssp             CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHH
T ss_pred             ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHH
Confidence            999999766422      2344578999999997754  48999999999999999999999998744 3333333322 


Q ss_pred             --CCCCCCCCCC---------------------------CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          244 --GIKPASLSKV---------------------------TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       244 --~~~~~~~~~~---------------------------~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                        ...+..++..                           .++.+++||.+||. +|.+|||+.|+|+||||...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence              2222222211                           26789999999998 99999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.1e-48  Score=370.62  Aligned_cols=256  Identities=29%  Similarity=0.450  Sum_probs=221.9

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      ..+.|++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.  ..
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~  115 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DF  115 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--Ce
Confidence            34445888999999999999999999999999999875432 3456778899999999999999999999998654  57


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||+.+++|.+++.....+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++....
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEc-CCCCEEEeeccCceecc
Confidence            8999999999999999998888999999999999999999999999  99999999999998 78899999999998765


Q ss_pred             CC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          183 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       183 ~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      ..  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..+.+..+..+..  .++...++.+.
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~  269 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPVAA  269 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHH
T ss_pred             cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcCCC--CCCccCCHHHH
Confidence            33  3345679999999998765 488999999999999999999999977 445555555555432  34566789999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          260 QFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      +||.+||. +|.+||++.++|+||||...
T Consensus       270 ~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          270 SLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             HHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            99999998 99999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=380.79  Aligned_cols=255  Identities=25%  Similarity=0.378  Sum_probs=209.2

Q ss_pred             cccccc--cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           24 CRYGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        24 ~ry~r~--~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +.++++  .+.||+|+||+||+|.+..+|..||+|++....    ....+.+.+|+.+|++|+||||+++++++.+.  .
T Consensus        86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~  159 (373)
T 2x4f_A           86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESK--N  159 (373)
T ss_dssp             GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--S
T ss_pred             ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--C
Confidence            344455  468999999999999999999999999987532    35567889999999999999999999998654  5


Q ss_pred             eEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe-CCCCcEEEcccceee
Q 016143          102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAI  179 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~-~~~~~~kl~Dfgla~  179 (394)
                      .+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+|||++ ..++.+||+|||++.
T Consensus       160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~  237 (373)
T 2x4f_A          160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLAR  237 (373)
T ss_dssp             EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence            789999999999999988754 46999999999999999999999999  99999999999994 256799999999998


Q ss_pred             eecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCC
Q 016143          180 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD  255 (394)
Q Consensus       180 ~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~  255 (394)
                      ..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. +.......+.....  +.......+
T Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~  316 (373)
T 2x4f_A          238 RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-NDAETLNNILACRWDLEDEEFQDIS  316 (373)
T ss_dssp             ECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCSCSGGGTTSC
T ss_pred             ecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCChhhhccCC
Confidence            76554 3445679999999998765 5889999999999999999999999874 44445555544322  222234568


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      +++++||.+||. +|.+||++.|+|+||||+..
T Consensus       317 ~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          317 EEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            999999999998 99999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.8e-48  Score=366.11  Aligned_cols=258  Identities=22%  Similarity=0.450  Sum_probs=218.1

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+..++..||+|++............+.+.+|+.++++++||||+++++++.+.....+
T Consensus         5 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            5 GKY-LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             CCB-CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             cce-eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            556 8899999999999999999999999999999765433233456789999999999999999999999877666789


Q ss_pred             EEEEcccCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          104 NMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~--~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      ++||||+.++ |.+++..  ...+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-CCCcEEeecccccccc
Confidence            9999999876 7777765  356999999999999999999999999  99999999999998 7889999999999876


Q ss_pred             cCC----CCcccccCCcccCccccccc---CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          182 QQP----TARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       182 ~~~----~~~~~~gt~~y~aPE~l~~~---~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      ...    ......||+.|+|||++.+.   ++.++|||||||++|+|++|+.||.. .+...+...+..+..  .++...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~~  236 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGDC  236 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSSS
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCcc
Confidence            432    22345699999999987652   47799999999999999999999986 566667777766533  345667


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      ++.+.+||.+||. +|.+||++.++++||||+...+
T Consensus       237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            8999999999998 9999999999999999987644

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5e-49  Score=374.94  Aligned_cols=262  Identities=23%  Similarity=0.336  Sum_probs=214.6

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC-
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-  100 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~-  100 (394)
                      ..++| ++.+.||+|+||+||+|.+..+++.||+|++.... ........++.+|+.++++++||||+++++++..... 
T Consensus        10 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A           10 LSDRY-ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             ETTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT-TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ecCcE-EEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc-cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            34556 88999999999999999999999999999987543 3346677889999999999999999999998865543 


Q ss_pred             -ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 -~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                       ...++||||+++++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTSCEEECCCSCC-
T ss_pred             CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEc-CCCCEEEeeccCcc
Confidence             256899999999999999998888999999999999999999999999  99999999999998 68899999999997


Q ss_pred             eecCC-----CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC-CCCC
Q 016143          180 VMQQP-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSK  252 (394)
Q Consensus       180 ~~~~~-----~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~-~~~~  252 (394)
                      .....     ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+.....+. ....
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  244 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence            65433     2234569999999998765 589999999999999999999999987544444444444433221 2234


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ..++++.++|.+||. +|.+||++.++|.|+|++...
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            578899999999998 999999999999999998643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.2e-48  Score=367.79  Aligned_cols=252  Identities=24%  Similarity=0.402  Sum_probs=216.8

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+|+.||+|.+....    ....+.+.+|+.+++.++||||+++++++.+.  ..+++|
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   84 (304)
T 2jam_A           11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLEDIYEST--THYYLV   84 (304)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred             ceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCCeeehhhhcccC--CEEEEE
Confidence            488999999999999999999999999999987543    22335678899999999999999999988644  578999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE---eCCCCcEEEcccceeeeecC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll---~~~~~~~kl~Dfgla~~~~~  183 (394)
                      |||+++++|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+||++   + .++.+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~-~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPE-ENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSS-TTCCEEBCSCSTTCCCCC
T ss_pred             EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCC-CCCCEEEccCCcceecCC
Confidence            999999999999988888999999999999999999999999  9999999999999   5 678999999999976655


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQ  260 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~  260 (394)
                      .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...+...+..+..  +.......++++++
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  240 (304)
T 2jam_A          162 GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESAKD  240 (304)
T ss_dssp             BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred             CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence            55555679999999998765 589999999999999999999999987 556666677766543  23344567899999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          261 FIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ||.+||. +|.+||++.++|+||||+...
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          241 FICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            9999998 999999999999999998653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8e-48  Score=366.87  Aligned_cols=254  Identities=31%  Similarity=0.546  Sum_probs=207.2

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+  +|..||+|++....  ......+.+.+|+.+|++++||||+++++++.+.  ..+
T Consensus        37 ~~y-~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~  109 (309)
T 3p86_A           37 CDL-NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD--FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP--PNL  109 (309)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC--CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--TCC
T ss_pred             hHc-eeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--Cce
Confidence            444 7889999999999999976  58899999986543  2456678899999999999999999999988544  457


Q ss_pred             EEEEcccCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          104 NMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~---l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ++||||+++|+|.+++...+.   +++..++.++.||+.||.|||+++++|+||||||+||+++ .++.+||+|||++..
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC-TTCCEEECCCC----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe-CCCcEEECCCCCCcc
Confidence            889999999999999988754   9999999999999999999999988899999999999998 788999999999975


Q ss_pred             ecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          181 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       181 ~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      ....  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..+....+........++...+++
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNLNPQ  267 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCccCCHH
Confidence            5443  2345679999999998765 488999999999999999999999987 55666666665444455567788999


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhc--CCcccc
Q 016143          258 VKQFIEKCIV-PASLRLPALELLK--DPFLVT  286 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~--~p~~~~  286 (394)
                      +.+||++||. +|.+||++.++++  .++++.
T Consensus       268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            9999999998 9999999999987  455543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.8e-48  Score=375.37  Aligned_cols=252  Identities=24%  Similarity=0.462  Sum_probs=215.3

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCH----HHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCce
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP----DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++.+.||+|+||+||+|.++.+|+.||+|++.........    ...+.+.+|+.+++++ +||||++++++|..  ...
T Consensus        97 ~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~  174 (365)
T 2y7j_A           97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES--SSF  174 (365)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--SSE
T ss_pred             ccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--CCE
Confidence            6779999999999999999999999999998754322222    3356788999999999 79999999998854  357


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      .++||||+++++|.+++.....+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++....
T Consensus       175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~-~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEEecCcccccC
Confidence            8999999999999999998888999999999999999999999999  99999999999998 78899999999998765


Q ss_pred             CC-CCcccccCCcccCcccccc-------cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CC
Q 016143          183 QP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SK  252 (394)
Q Consensus       183 ~~-~~~~~~gt~~y~aPE~l~~-------~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~--~~  252 (394)
                      .. ......||+.|+|||++.+       .++.++|||||||++|+|++|..||.. .+.......+..+......  ..
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~  330 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEWD  330 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCHHHHS
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCcccc
Confidence            44 3456789999999998753       478899999999999999999999987 4556666666655332211  23


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccc
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  285 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~  285 (394)
                      ..++.+.++|.+||. +|.+||++.++|+||||+
T Consensus       331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            467889999999998 999999999999999997

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-48  Score=376.51  Aligned_cols=258  Identities=26%  Similarity=0.431  Sum_probs=209.7

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccC-CHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++| ++.+.||+|+||+||+|.+..++..||+|++....... .....+.+.+|+.++++++||||+++++++.+  ...
T Consensus        26 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~  102 (345)
T 3hko_A           26 KKY-HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQY  102 (345)
T ss_dssp             HHE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred             hhe-eecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCe
Confidence            444 88899999999999999999999999999987654321 34566789999999999999999999999854  457


Q ss_pred             EEEEEcccCCCcHHHHHHhC----------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 016143          103 INMITELFTSGSLRQYRKKH----------------------------------------KNVDMKAIKNWARQILRGLH  142 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~----------------------------------------~~l~~~~~~~i~~qil~~L~  142 (394)
                      +++||||+++|+|.+++...                                        ..+++..++.++.||+.||.
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            89999999999999998521                                        12467889999999999999


Q ss_pred             HHHhCCCCeEecCCCCCcEEEeCCCC--cEEEcccceeeeecCC------CCcccccCCcccCccccc---ccCCCcCcc
Q 016143          143 YLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYE---EEYNELVDI  211 (394)
Q Consensus       143 ~LH~~~~~ivHrDLkp~NIll~~~~~--~~kl~Dfgla~~~~~~------~~~~~~gt~~y~aPE~l~---~~~~~~~DI  211 (394)
                      |||+++  |+||||||+||+++ .++  .+||+|||++......      ......||+.|+|||++.   ..++.++||
T Consensus       183 ~LH~~~--ivH~Dlkp~NIll~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di  259 (345)
T 3hko_A          183 YLHNQG--ICHRDIKPENFLFS-TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA  259 (345)
T ss_dssp             HHHHTT--EECCCCCGGGEEES-CSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred             HHHHCC--ccccCCChhhEEEe-cCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence            999999  99999999999997 444  8999999999865432      134567999999999875   458899999


Q ss_pred             hhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       212 wSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      |||||++|+|++|+.||.+.... +....+.......  ......++++++||++||. +|.+||++.++|+||||+...
T Consensus       260 wslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          260 WSAGVLLHLLLMGAVPFPGVNDA-DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHHHHHHCCCCCCCCChH-HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            99999999999999999875544 4444444332221  1222367899999999998 999999999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.4e-48  Score=379.14  Aligned_cols=256  Identities=26%  Similarity=0.445  Sum_probs=215.7

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      ..|++.+.||+|+||+||+|.+..++..||+|++....   .....+.+.+|+.+++.++||||+++++++.++  ..++
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~  107 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEIS  107 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEEE
Confidence            33488899999999999999999999999999987542   456678899999999999999999999998654  5788


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~-~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||+. +  |+||||||+||+++ .++.+||+|||++.....
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHH
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEEC-CCCCEEEEECCCCccccc
Confidence            9999999999999999988899999999999999999999995 8  99999999999998 688999999999976655


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHH-------------------------
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-------------------------  237 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~-------------------------  237 (394)
                      .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||... +..++                         
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC-CHHHHHHHHC--------------------
T ss_pred             ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence            55556789999999998765 5899999999999999999999999763 32222                         


Q ss_pred             -----------------HHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          238 -----------------YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       238 -----------------~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                                       ...+.....+.......+.++++||++||. +|.+|||+.|+|+||||+....
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence                             222233333333344568899999999998 9999999999999999987543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.5e-49  Score=390.50  Aligned_cols=259  Identities=26%  Similarity=0.421  Sum_probs=208.8

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccC----CHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~----~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      ++| ++.+.||+|+||+||+|.+..+++.||+|++.......    .......+.+|+.+|++++||||+++++++..  
T Consensus       135 ~~y-~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--  211 (419)
T 3i6u_A          135 DEY-IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--  211 (419)
T ss_dssp             TTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred             ccE-EEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence            344 78899999999999999999999999999997654321    12233457889999999999999999998743  


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEcccce
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGL  177 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--~~~~~kl~Dfgl  177 (394)
                       ..+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++.  .++.+||+|||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeeccc
Confidence             247899999999999999998889999999999999999999999999  999999999999973  234699999999


Q ss_pred             eeeecCC-CCcccccCCcccCccccc----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC--CC
Q 016143          178 AIVMQQP-TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SL  250 (394)
Q Consensus       178 a~~~~~~-~~~~~~gt~~y~aPE~l~----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~--~~  250 (394)
                      +...... .....+||+.|+|||++.    ..|+.++|||||||++|+|++|..||........+...+..+....  ..
T Consensus       289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~  368 (419)
T 3i6u_A          289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  368 (419)
T ss_dssp             TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred             ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence            9766544 345678999999999874    3578899999999999999999999987655555566666553321  12


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ....++.+++||.+||. +|.+||++.|+|+||||+...
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence            24567899999999998 999999999999999998643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.8e-48  Score=380.37  Aligned_cols=254  Identities=20%  Similarity=0.333  Sum_probs=201.8

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHH-HcCCCCCceeEeeeEEc--CC
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWVD--DT   99 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l-~~L~hpnIv~~~~~~~~--~~   99 (394)
                      .+.|+...++||+|+||+||+|.++.+|+.||+|++...         ..+.+|+.++ +.++||||++++++|..  ..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            345644457899999999999999999999999998521         2456788887 45589999999998854  23


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEccc
Q 016143          100 NRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDL  175 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~--~~~~kl~Df  175 (394)
                      ...+++||||++||+|.+++...+  .+++..++.++.||+.||.|||+++  |+||||||+|||++..  ++.+||+||
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEec
Confidence            567999999999999999998754  5999999999999999999999999  9999999999999842  689999999


Q ss_pred             ceeeeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHH---HHHHHHhcCCC--CC
Q 016143          176 GLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIK--PA  248 (394)
Q Consensus       176 gla~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~---~~~~~i~~~~~--~~  248 (394)
                      |++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.......   .+...+..+..  +.
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  288 (400)
T ss_dssp             TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred             ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence            999866543 3456789999999998864 59999999999999999999999997633211   13334443322  22


Q ss_pred             CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       249 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ......++++++||++||. +|.+||++.++|+||||...
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            2234578999999999998 99999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.5e-47  Score=359.99  Aligned_cols=262  Identities=25%  Similarity=0.403  Sum_probs=219.7

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccC-C----HHHHHHHHHHHHHHHcCC-CCCceeEeeeE
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-S----PDQLERLYSEVHLLKSLK-HENIIKFYNSW   95 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~-~----~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~   95 (394)
                      ..++| ++.+.||+|+||+||+|.++.+|+.||+|++....... .    ....+.+.+|+.+++++. ||||+++++++
T Consensus        15 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           15 FYENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhcc-ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34555 78899999999999999999999999999987543211 1    234567889999999995 99999999988


Q ss_pred             EcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143           96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus        96 ~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                      .+  ...+++||||+++++|.+++.....+++..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+||
T Consensus        94 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~df  168 (298)
T 1phk_A           94 ET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDF  168 (298)
T ss_dssp             EC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCC
T ss_pred             cc--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEc-CCCcEEEecc
Confidence            54  4578999999999999999998888999999999999999999999999  99999999999998 7889999999


Q ss_pred             ceeeeecCC-CCcccccCCcccCccccc-------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q 016143          176 GLAIVMQQP-TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP  247 (394)
Q Consensus       176 gla~~~~~~-~~~~~~gt~~y~aPE~l~-------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~  247 (394)
                      |++...... ......||+.|+|||++.       ..++.++||||||+++|+|++|..||.. .+.......+..+...
T Consensus       169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~  247 (298)
T 1phk_A          169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQ  247 (298)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC
T ss_pred             cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCcc
Confidence            999876543 344567999999999874       3478899999999999999999999987 4555666666554332


Q ss_pred             CC--CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCC
Q 016143          248 AS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK  290 (394)
Q Consensus       248 ~~--~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~  290 (394)
                      ..  .....+..++++|.+||. +|.+||++.++|+||||+.....
T Consensus       248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            21  223467899999999998 99999999999999999876543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-48  Score=378.69  Aligned_cols=264  Identities=22%  Similarity=0.356  Sum_probs=218.3

Q ss_pred             cccccccceecccCceEEEEEEEc---cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~   99 (394)
                      ++| ++.+.||+|+||+||+|.+.   .+|+.||+|+++...........+.+.+|+.+|+.+ +||||+++++++.++ 
T Consensus        54 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-  131 (355)
T 1vzo_A           54 ENF-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  131 (355)
T ss_dssp             GGE-EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             cce-EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence            344 78899999999999999984   589999999987544322223334566799999999 699999999988654 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                       ..+++||||+++++|.+++.....+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.
T Consensus       132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          132 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSK  207 (355)
T ss_dssp             -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEE
T ss_pred             -ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCcEEEeeCCCCe
Confidence             478899999999999999998888999999999999999999999999  99999999999998 78899999999998


Q ss_pred             eecCC---CCcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCC---CCHHHHHHHHhcCCCCCCC
Q 016143          180 VMQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNEC---KNPAQIYKKVTSGIKPASL  250 (394)
Q Consensus       180 ~~~~~---~~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~---~~~~~~~~~i~~~~~~~~~  250 (394)
                      .....   .....+||+.|+|||++.+   .++.++|||||||++|+|++|+.||...   .....+...+....  ..+
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~  285 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPY  285 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--CCC
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC--CCC
Confidence            65432   2334679999999998864   3789999999999999999999999642   34455555555442  234


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCC-----CHHHHhcCCccccCCCCCcccC
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCD  295 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~~~~  295 (394)
                      +...++.+++||.+||. +|.+||     ++.++++||||+..++..+...
T Consensus       286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~  336 (355)
T 1vzo_A          286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAK  336 (355)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred             CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhc
Confidence            56678999999999998 999999     9999999999998776555433

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4e-48  Score=362.10  Aligned_cols=256  Identities=26%  Similarity=0.496  Sum_probs=193.1

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .++| ++.+.||+|+||+||+|.+..+|+.||+|.+...... .....+++.+|+.++++++||||+++++++.+.  ..
T Consensus        10 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~   85 (278)
T 3cok_A           10 IEDF-KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS--NY   85 (278)
T ss_dssp             GGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS--SE
T ss_pred             cccc-eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC--Ce
Confidence            3455 7889999999999999999999999999998744321 122346788999999999999999999998653  57


Q ss_pred             EEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      +++||||+++++|.+++... ..+++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++...
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLT-RNMNIKIADFGLATQL  162 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred             EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEEeecceeec
Confidence            89999999999999999876 56999999999999999999999999  99999999999998 7889999999999876


Q ss_pred             cCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          182 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       182 ~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                      ...  ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||....... ....+...  ....+...+.++
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~  239 (278)
T 3cok_A          163 KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-TLNKVVLA--DYEMPSFLSIEA  239 (278)
T ss_dssp             C----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSS--CCCCCTTSCHHH
T ss_pred             cCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-HHHHHhhc--ccCCccccCHHH
Confidence            533  2334679999999998765 58899999999999999999999997643322 22222211  223455678999


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          259 KQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +++|.+||. +|.+||++.++|+||||....
T Consensus       240 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            999999998 999999999999999998653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=367.06  Aligned_cols=260  Identities=29%  Similarity=0.528  Sum_probs=214.5

Q ss_pred             cccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEE
Q 016143           18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV   96 (394)
Q Consensus        18 ~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~   96 (394)
                      ...++.++| ++.+.||+|+||+||+|.+..+|+.||+|++.....     ..+.+.+|+.+++++ +||||+++++++.
T Consensus        18 ~l~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           18 ALRDPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             CCCCCTTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccCCCCcE-EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            334566777 889999999999999999999999999999875431     235678899999999 7999999999987


Q ss_pred             cCC----CceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE
Q 016143           97 DDT----NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV  170 (394)
Q Consensus        97 ~~~----~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~  170 (394)
                      ...    ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~~~  168 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEV  168 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEc-CCCCE
Confidence            643    46789999999999999999875  46999999999999999999999999  99999999999998 78899


Q ss_pred             EEcccceeeeecCC--CCcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 016143          171 KIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT  242 (394)
Q Consensus       171 kl~Dfgla~~~~~~--~~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~  242 (394)
                      ||+|||++......  ......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+. +.......+.
T Consensus       169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~  247 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIP  247 (326)
T ss_dssp             EECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHH
T ss_pred             EEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhh
Confidence            99999999765433  234567999999999874      35889999999999999999999999874 4444444555


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ....+......+++.+++||.+||. +|.+||++.++|+||||+..
T Consensus       248 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          248 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             HSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             cCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            5544544556678999999999998 99999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.4e-48  Score=362.51  Aligned_cols=259  Identities=27%  Similarity=0.479  Sum_probs=220.3

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|.+.....  .....+.+.+|+.++++++||||+++++++.+.....+
T Consensus         6 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            6 EDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             hhe-eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            455 788999999999999999999999999999875442  45667889999999999999999999999887777789


Q ss_pred             EEEEcccCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEecCCCCCcEEEeCCCCcEEEcccc
Q 016143          104 NMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLG  176 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~----~~l~~~~~~~i~~qil~~L~~LH~~~---~~ivHrDLkp~NIll~~~~~~~kl~Dfg  176 (394)
                      ++||||+++++|.+++...    ..+++..++.++.||+.||.|||+++   .+|+||||||+||+++ .++.+||+|||
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~dfg  161 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFG  161 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC-SSSCEEECCCC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecCc
Confidence            9999999999999998754    34999999999999999999999976   3499999999999998 78899999999


Q ss_pred             eeeeecCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 016143          177 LAIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       177 la~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      ++.......  .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...+...+..+..+ .++..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~  239 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYR  239 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC-CCCTT
T ss_pred             hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhcccc-cCCcc
Confidence            997654432  234579999999998765 588999999999999999999999987 4566677777766543 35566


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .++++.++|.+||. +|.+||++.++|+|+|+....
T Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            78999999999998 999999999999999998653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-48  Score=370.35  Aligned_cols=254  Identities=23%  Similarity=0.371  Sum_probs=209.9

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .+..|++.+.||+|+||+||+|.+..+|+.||+|++......   ...+.+.+|+.+|++++||||+++++++.+.....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            344558999999999999999999999999999998754432   23466788999999999999999999988777678


Q ss_pred             EEEEEcccCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE----eCCCCcEEEccc
Q 016143          103 INMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVKIGDL  175 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~---l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll----~~~~~~~kl~Df  175 (394)
                      +++||||+++++|.+++.....   +++..++.++.||+.||.|||+++  |+||||||+|||+    + .++.+||+||
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~Df  160 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDF  160 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTT-SCEEEEECCC
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCC-CCceEEEccC
Confidence            8999999999999999987543   999999999999999999999999  9999999999998    5 5678999999


Q ss_pred             ceeeeecCCC-CcccccCCcccCccccc---------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCC---HHHHHHHHh
Q 016143          176 GLAIVMQQPT-ARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVT  242 (394)
Q Consensus       176 gla~~~~~~~-~~~~~gt~~y~aPE~l~---------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~---~~~~~~~i~  242 (394)
                      |++....... .....||+.|+|||++.         ..++.++|||||||++|||++|+.||.....   ...+...+.
T Consensus       161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            9998765543 34567999999999874         4688999999999999999999999964332   233333333


Q ss_pred             cCCCCC-----------------------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCC
Q 016143          243 SGIKPA-----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  282 (394)
Q Consensus       243 ~~~~~~-----------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p  282 (394)
                      .+..+.                       .+....++.+.++|++||. +|.+||++.|+|+||
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            322211                       1122335678999999998 999999999999997

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.4e-47  Score=367.26  Aligned_cols=252  Identities=21%  Similarity=0.365  Sum_probs=209.7

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~  102 (394)
                      ++| ++.+.||+|+||+||+|.+..+++.||+|++...       ..+.+.+|+.++++++ ||||+++++++.+.....
T Consensus        36 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           36 DDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             Cce-EEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            444 7889999999999999999999999999998632       2356788999999997 999999999998766778


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      .++||||+.+++|.++++.   +++..++.++.||+.||.|||++|  |+||||||+|||++.++..+||+|||++....
T Consensus       108 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            9999999999999998854   899999999999999999999999  99999999999999555589999999998665


Q ss_pred             CC-CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-------------CCC
Q 016143          183 QP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------GIK  246 (394)
Q Consensus       183 ~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-------------~~~  246 (394)
                      .. ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||....+.......+..             ...
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            43 3455679999999998764  5899999999999999999999999665444332222211             100


Q ss_pred             ----------------------CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          247 ----------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       247 ----------------------~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                            ........++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence                                  011122267899999999998 999999999999999998754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.4e-49  Score=378.24  Aligned_cols=250  Identities=24%  Similarity=0.405  Sum_probs=210.9

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC----HHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~----~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      .++| ++.+.||+|+||+||+|.++.++..||+|.+........    ....+.+.+|+.+|++++||||++++++|.+ 
T Consensus        23 ~~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-  100 (335)
T 3dls_A           23 SQKY-STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-  100 (335)
T ss_dssp             HHHE-EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred             ccce-EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            3455 788999999999999999999999999999976543221    1133456779999999999999999999854 


Q ss_pred             CCceEEEEEcccCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143           99 TNRTINMITELFTSG-SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus        99 ~~~~~~lV~e~~~~g-sL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                       ...+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+
T Consensus       101 -~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~  176 (335)
T 3dls_A          101 -QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIA-EDFTIKLIDFGS  176 (335)
T ss_dssp             -SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTT
T ss_pred             -CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEc-CCCcEEEeeccc
Confidence             45788999999766 99999999989999999999999999999999999  99999999999998 688999999999


Q ss_pred             eeeecCCC-CcccccCCcccCccccccc-C-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          178 AIVMQQPT-ARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       178 a~~~~~~~-~~~~~gt~~y~aPE~l~~~-~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      +....... .....||+.|+|||++.+. + +.++|||||||++|+|++|..||.....       ....  ....+...
T Consensus       177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~--~~~~~~~~  247 (335)
T 3dls_A          177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVEA--AIHPPYLV  247 (335)
T ss_dssp             CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTTT--CCCCSSCC
T ss_pred             ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHhh--ccCCCccc
Confidence            98765543 4456799999999987653 4 7899999999999999999999975221       1111  12234457


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ++++++||.+||. +|.+||++.++|+||||+..
T Consensus       248 ~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            8999999999998 99999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.3e-47  Score=372.08  Aligned_cols=250  Identities=23%  Similarity=0.311  Sum_probs=206.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-----CCCceeEeeeEEcC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----HENIIKFYNSWVDD   98 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-----hpnIv~~~~~~~~~   98 (394)
                      +..|++.+.||+|+||+||+|.+..+++.||+|++..     .....+.+..|+.+++.+.     ||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~  108 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY  108 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence            3445889999999999999999999999999999863     2445567788999999996     99999999998654


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-----------
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-----------  165 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~-----------  165 (394)
                        ..+++||||+ +++|.+++....  .+++..++.++.||+.||.|||+++  |+||||||+|||++.           
T Consensus       109 --~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          109 --DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             --TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             --CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchh
Confidence              4789999999 999999998764  5999999999999999999999999  999999999999972           


Q ss_pred             -------------CCCcEEEcccceeeeecCCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC
Q 016143          166 -------------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC  231 (394)
Q Consensus       166 -------------~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~  231 (394)
                                   .++.+||+|||++...... .....||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTSC-CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccCCCCEEEEeccCceecCCC-CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                         3789999999999765443 345679999999997764 6999999999999999999999999874


Q ss_pred             CCHHHHHHHHhcCCCCC------------------------CCC--------------------CCCCHHHHHHHHHcCC
Q 016143          232 KNPAQIYKKVTSGIKPA------------------------SLS--------------------KVTDPQVKQFIEKCIV  267 (394)
Q Consensus       232 ~~~~~~~~~i~~~~~~~------------------------~~~--------------------~~~~~~~~~li~~~L~  267 (394)
                      . ..+....+.....+.                        .++                    ...++.+.+||.+||.
T Consensus       263 ~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          263 E-HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             S-HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             c-HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            3 343333332211110                        001                    1123678899999998


Q ss_pred             -CCCCCCCHHHHhcCCccc
Q 016143          268 -PASLRLPALELLKDPFLV  285 (394)
Q Consensus       268 -~p~~R~s~~elL~~p~~~  285 (394)
                       +|.+|||+.|+|+||||+
T Consensus       342 ~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          342 IDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SSGGGSCCHHHHTTSGGGC
T ss_pred             CChhhCCCHHHHhcCcccC
Confidence             999999999999999996

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.4e-48  Score=367.30  Aligned_cols=262  Identities=31%  Similarity=0.497  Sum_probs=222.5

Q ss_pred             ccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        19 ~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      .....++| ++.+.||+|+||+||+|.++.+++.||+|++.....  .....+.+.+|+.++++++||||+++++++.+.
T Consensus        17 ~~~~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (287)
T 2wei_A           17 QGTFAERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMKLFEILEDS   93 (287)
T ss_dssp             THHHHHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB--SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             HHHHhhcc-eeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence            33334555 888999999999999999999999999999875443  223456788999999999999999999988653


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEcccc
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLG  176 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~--~~~~kl~Dfg  176 (394)
                        ..+++||||+.+++|.+++.....+++..++.++.||+.||.|||+++  ++||||||+||+++.+  ++.+||+|||
T Consensus        94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A           94 --SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             --SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             --CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccC
Confidence              578999999999999999988888999999999999999999999999  9999999999999732  3479999999


Q ss_pred             eeeeecCC-CCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCC
Q 016143          177 LAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKV  253 (394)
Q Consensus       177 la~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~--~~~  253 (394)
                      ++...... ......||+.|+|||++.+.++.++||||||+++|+|++|..||.. .+..++...+..+..+...  ...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~  248 (287)
T 2wei_A          170 LSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRT  248 (287)
T ss_dssp             GGGTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGTT
T ss_pred             cceeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhhhh
Confidence            99765443 3345568999999999988899999999999999999999999987 5566677777666443322  245


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .++++.++|.+||. +|.+||++.++|+||||+...
T Consensus       249 ~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             cCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            68899999999998 999999999999999998653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.3e-48  Score=365.34  Aligned_cols=259  Identities=27%  Similarity=0.478  Sum_probs=212.3

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      .++.++| ++.+.||+|+||+||+|.+..++..||+|++....    ....+.+.+|+.+++.++||||+++++++.++ 
T Consensus        15 ~~~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   88 (302)
T 2j7t_A           15 LDPNEVW-EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYHD-   88 (302)
T ss_dssp             SCGGGTE-EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred             cCCccce-eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-
Confidence            4566666 88999999999999999999999999999986432    33457788999999999999999999998654 


Q ss_pred             CceEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 NRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                       ..+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++
T Consensus        89 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~  164 (302)
T 2j7t_A           89 -GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVS  164 (302)
T ss_dssp             --CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTSCEEECCCHHH
T ss_pred             -CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEC-CCCCEEEEECCCC
Confidence             468899999999999998876 466999999999999999999999999  99999999999998 6889999999997


Q ss_pred             eeecC--CCCcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CC
Q 016143          179 IVMQQ--PTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-AS  249 (394)
Q Consensus       179 ~~~~~--~~~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-~~  249 (394)
                      .....  .......||+.|+|||++.      ..++.++|||||||++|+|++|..||... +.......+.....+ ..
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~  243 (302)
T 2j7t_A          165 AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPTLL  243 (302)
T ss_dssp             HHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCS
T ss_pred             ccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHhccCCcccC
Confidence            53321  1233457999999999773      35789999999999999999999999874 444444444443322 23


Q ss_pred             CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       250 ~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      .+..++..+.++|.+||. +|.+||++.++++||||+....
T Consensus       244 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             CccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            345578899999999998 9999999999999999987643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.5e-48  Score=369.94  Aligned_cols=257  Identities=26%  Similarity=0.424  Sum_probs=210.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeecccc----CCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~----~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      |++.+.||+|+||+||+|.++.++..||+|++......    ........+.+|+.+|++++||||+++++++..+   .
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~   88 (322)
T 2ycf_A           12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE---D   88 (322)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred             eeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC---c
Confidence            48889999999999999999999999999998754321    1123345688899999999999999999987543   2


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEcccceeee
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIV  180 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~--~~~~kl~Dfgla~~  180 (394)
                      +++||||+++++|.+++.....+++..++.++.||+.||.|||+++  |+||||||+||+++.+  ++.+||+|||++..
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            7899999999999999998889999999999999999999999999  9999999999999832  22499999999987


Q ss_pred             ecCCC-CcccccCCcccCccccc----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCC
Q 016143          181 MQQPT-ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKV  253 (394)
Q Consensus       181 ~~~~~-~~~~~gt~~y~aPE~l~----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~  253 (394)
                      ..... .....||+.|+|||++.    ..++.++|||||||++|+|++|..||........+...+..+....  .....
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (322)
T 2ycf_A          167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  246 (322)
T ss_dssp             CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTT
T ss_pred             cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhh
Confidence            65442 23457999999999863    4588999999999999999999999987555444555555443221  12245


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .++.+.+||.+||. +|.+||++.++|+||||+...
T Consensus       247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             cCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence            67899999999998 999999999999999998643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.7e-48  Score=363.44  Aligned_cols=255  Identities=25%  Similarity=0.416  Sum_probs=210.4

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      ..|++.+.||+|+||+||+|.+..++..||+|.+..... ......+++.+|+.++++++||||+++++++.+  ...++
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~   87 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYY   87 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEE
Confidence            334889999999999999999999999999999865442 346677889999999999999999999998854  45789


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++......
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILID-SNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCSSSTTC---
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEEeCCCccccccc
Confidence            99999999999999999889999999999999999999999999  99999999999998 7889999999999765433


Q ss_pred             C---CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCCHHH
Q 016143          185 T---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQV  258 (394)
Q Consensus       185 ~---~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~  258 (394)
                      .   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+........+.+......  .......++.+
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL  244 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence            2   334579999999998765 48899999999999999999999998755444444444443221  22455678999


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcCCccc
Q 016143          259 KQFIEKCIV-PASLRLPALELLKDPFLV  285 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~p~~~  285 (394)
                      .++|.+||. +|.+||+..+.+.+.|..
T Consensus       245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          245 SNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            999999998 999999777777766654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-47  Score=379.88  Aligned_cols=252  Identities=20%  Similarity=0.312  Sum_probs=205.4

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC----CCc
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----TNR  101 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~----~~~  101 (394)
                      .|++.+.||+|+||+||+|.+..+|+.||||++.....        ...+|+.+|+.|+||||++++++|...    ...
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            35788999999999999999999999999999864321        123699999999999999999988542    234


Q ss_pred             eEEEEEcccCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143          102 TINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~----~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                      ++++||||+.+ +|.+++.    ....+++..++.++.||+.||.|||+++  |+||||||+|||++.+++.+||+|||+
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchh
Confidence            67899999975 5655543    3567999999999999999999999999  999999999999996667899999999


Q ss_pred             eeeecCC-CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC----------
Q 016143          178 AIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG----------  244 (394)
Q Consensus       178 a~~~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~----------  244 (394)
                      ++..... .....+||+.|+|||++.+  .|+.++|||||||++|||++|+.||.+....+++...+...          
T Consensus       204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          204 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             CEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             hhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            9876443 3455789999999997754  58999999999999999999999998865555554443310          


Q ss_pred             ----CCCCC------------CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          245 ----IKPAS------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       245 ----~~~~~------------~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                          .....            +....++++++||++||. +|.+||++.|+|+||||+...
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence                00001            223457899999999998 999999999999999997643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.5e-48  Score=370.71  Aligned_cols=255  Identities=26%  Similarity=0.422  Sum_probs=201.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.++..||+|++.....   ......+.+|+.+|+.++||||+++++++.++  ..+
T Consensus         2 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   75 (324)
T 3mtl_A            2 ETY-IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSL   75 (324)
T ss_dssp             CSE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCE
T ss_pred             Cce-EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEE
Confidence            355 788999999999999999999999999999864431   12222455799999999999999999998654  468


Q ss_pred             EEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+. |+|.+++...+ .+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++....
T Consensus        76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           76 TLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEEC-TTCCEEECSSSEEECC-
T ss_pred             EEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEEC-CCCCEEEccCccccccc
Confidence            89999997 58888887654 5999999999999999999999999  99999999999998 67899999999997654


Q ss_pred             CC--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc---CCCCCCCC----
Q 016143          183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKPASLS----  251 (394)
Q Consensus       183 ~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~---~~~~~~~~----  251 (394)
                      ..  ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+... .+....+..   ...+..++    
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHhchhhhc
Confidence            33  2345578999999998754  489999999999999999999999987443 333333322   11111111    


Q ss_pred             ---------------------CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          252 ---------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       252 ---------------------~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                                           ...++++++||.+||. +|.+|||+.|+|+||||.....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence                                 2357889999999998 9999999999999999987654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-47  Score=357.90  Aligned_cols=249  Identities=23%  Similarity=0.392  Sum_probs=207.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      |++.+.||+|+||+||+|.+..++..||+|.+.....  .......+.+|+..+..+ +||||+++++++.++  ..+++
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~~l   88 (289)
T 1x8b_A           13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHMLI   88 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEEEE
T ss_pred             hhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence            3788999999999999999999999999999875432  234556788999999999 999999999998654  47889


Q ss_pred             EEcccCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC----------------
Q 016143          106 ITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----------------  165 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~----~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~----------------  165 (394)
                      ||||+++++|.+++...    ..+++..++.++.||+.||.|||+++  |+||||||+||+++.                
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999999865    66999999999999999999999999  999999999999972                


Q ss_pred             --CCCcEEEcccceeeeecCCCCcccccCCcccCccccccc--CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHH
Q 016143          166 --NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV  241 (394)
Q Consensus       166 --~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i  241 (394)
                        ....+||+|||++.......  ...||+.|+|||++.+.  ++.++|||||||++|+|++|..|+...    .....+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~  240 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ--VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEI  240 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC--CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHH
T ss_pred             cCCceEEEEcccccccccCCcc--ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHH
Confidence              23479999999998765543  34599999999988754  557999999999999999999887542    223444


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ..+..+ .++...+++++++|.+||. +|.+||++.++|+||||+...
T Consensus       241 ~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          241 RQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HTTCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HcCCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            444333 3556778999999999998 999999999999999998653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.5e-48  Score=372.31  Aligned_cols=258  Identities=26%  Similarity=0.415  Sum_probs=211.6

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .++| ++.+.||+|+||+||+|.+..+|+.||+|++....  ......+.+.+|+.++++++||||+++++++.+.  ..
T Consensus        24 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~   98 (331)
T 4aaa_A           24 MEKY-ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--KR   98 (331)
T ss_dssp             GGGE-EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred             hhhh-eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--CE
Confidence            3555 78899999999999999999999999999986443  3455667788999999999999999999998654  57


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||+++++|..++.....+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++....
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCTTC----
T ss_pred             EEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEc-CCCcEEEEeCCCceeec
Confidence            8999999999999999888888999999999999999999999999  99999999999998 68899999999997654


Q ss_pred             CC--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc---------------
Q 016143          183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---------------  243 (394)
Q Consensus       183 ~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~---------------  243 (394)
                      ..  ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||........+...+..               
T Consensus       176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            33  2345679999999998765  5889999999999999999999999885555444433311               


Q ss_pred             ----CCCCCCC---------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          244 ----GIKPASL---------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       244 ----~~~~~~~---------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                          +.....+         ....++.+.+||.+||. +|.+||++.|+|+||||+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence                0000000         12357899999999998 999999999999999998653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.6e-48  Score=360.48  Aligned_cols=256  Identities=26%  Similarity=0.469  Sum_probs=211.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|.+...... ..+..+.+.+|+.+++.++||||+++++++.+.  ..+
T Consensus        11 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   86 (276)
T 2h6d_A           11 GHY-VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--TDF   86 (276)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred             ccE-EEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CeE
Confidence            344 8889999999999999999999999999998754321 123456788999999999999999999988554  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+++++|.+++...+.+++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++.....
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEEC-TTSCEEECCCCGGGCCCC
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEEC-CCCCEEEeecccccccCC
Confidence            999999999999999998888999999999999999999999999  99999999999998 688999999999976654


Q ss_pred             C-CCcccccCCcccCccccccc-C-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          184 P-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       184 ~-~~~~~~gt~~y~aPE~l~~~-~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      . ......||+.|+|||++.+. + +.++||||||+++|+|++|..||.. .+...+...+..+...  ++...+..+.+
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~  240 (276)
T 2h6d_A          164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVAT  240 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred             CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccc--CchhcCHHHHH
Confidence            3 23456799999999988764 3 5799999999999999999999977 5566677777665432  45567889999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          261 FIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +|.+||. +|.+||++.++++||||+...+
T Consensus       241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          241 LLMHMLQVDPLKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHHHccCChhhCCCHHHHHhChhhccCch
Confidence            9999998 9999999999999999987543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-47  Score=360.46  Aligned_cols=255  Identities=24%  Similarity=0.381  Sum_probs=201.8

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+..+|+.||+|.+....  ......+.+.++...++.++||||+++++++.++  ..+
T Consensus         7 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~~~   81 (290)
T 3fme_A            7 DDL-EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--GDV   81 (290)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SSE
T ss_pred             Hhh-hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--CCE
Confidence            344 88899999999999999999999999999986442  2234444555666678889999999999998654  468


Q ss_pred             EEEEcccCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          104 NMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~----~~~~l~~~~~~~i~~qil~~L~~LH~~-~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ++||||++ |+|.+++.    ....+++..++.++.||+.||.|||++ +  |+||||||+||+++ .++.+||+|||++
T Consensus        82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~  157 (290)
T 3fme_A           82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGIS  157 (290)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEEC-TTCCEEBCCC---
T ss_pred             EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecCCc
Confidence            89999997 48777665    356799999999999999999999998 8  99999999999998 6789999999999


Q ss_pred             eeecCCC-CcccccCCcccCccccc-----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 016143          179 IVMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK  252 (394)
Q Consensus       179 ~~~~~~~-~~~~~gt~~y~aPE~l~-----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  252 (394)
                      ....... .....||+.|+|||++.     ..++.++|||||||++|+|++|+.||..................+.....
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T 3fme_A          158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD  237 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred             ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence            7665443 33457999999999852     34788999999999999999999999876666666555555544444455


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ..++++.++|.+||. +|.+|||+.|+|+||||+..
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            678999999999998 99999999999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=358.78  Aligned_cols=250  Identities=32%  Similarity=0.518  Sum_probs=207.8

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEccc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF  110 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~~  110 (394)
                      .+||+|+||+||+|.+..++..||+|.+....    ....+.+.+|+.+++.++||||+++++++.+.  ..+++||||+
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~  101 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFMEQV  101 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEECC
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEEEEeC
Confidence            48999999999999999999999999987542    34456788999999999999999999998654  4788999999


Q ss_pred             CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--C
Q 016143          111 TSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T  185 (394)
Q Consensus       111 ~~gsL~~~i~~~~---~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~  185 (394)
                      ++++|.+++....   .+++..++.++.||+.||.|||+++  |+||||||+||+++..++.+||+|||++......  .
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~  179 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC  179 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence            9999999998752   4679999999999999999999999  9999999999999955889999999999766543  2


Q ss_pred             CcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      .....||+.|+|||++.+   .++.++||||||+++|+|++|+.||.....................++...++++.++|
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  259 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI  259 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence            345679999999998764   27899999999999999999999997655554333332222223345667889999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          263 EKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .+||. +|.+||++.++|+||||+...
T Consensus       260 ~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          260 LKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHccCChhhCCCHHHHhcChhhhhcc
Confidence            99998 999999999999999998654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.3e-47  Score=369.67  Aligned_cols=255  Identities=26%  Similarity=0.414  Sum_probs=210.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC---C
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---N  100 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~---~  100 (394)
                      ++| ++.+.||+|+||+||+|.+..++..||+|++...   ......+++.+|+.+|++++||||+++++++....   .
T Consensus        27 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  102 (364)
T 3qyz_A           27 PRY-TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM  102 (364)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             ccE-EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence            455 8899999999999999999999999999998642   24566678999999999999999999999886442   2


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ..+++||||+. ++|.++++.. .+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++..
T Consensus       103 ~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          103 KDVYIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARV  177 (364)
T ss_dssp             CCEEEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred             ceEEEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEEC-CCCCEEEEeCcceEe
Confidence            46899999997 5999999775 5999999999999999999999999  99999999999998 788999999999976


Q ss_pred             ecCCC-----CcccccCCcccCccccc-c-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-C--------
Q 016143          181 MQQPT-----ARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G--------  244 (394)
Q Consensus       181 ~~~~~-----~~~~~gt~~y~aPE~l~-~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~--------  244 (394)
                      .....     ....+||+.|+|||++. + .++.++|||||||++|+|++|+.||.+......+...+.. +        
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            65332     34458999999999764 3 4899999999999999999999999875443333222210 0        


Q ss_pred             --------------CCCC-----CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          245 --------------IKPA-----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       245 --------------~~~~-----~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                    ....     .+....++++.+||.+||. +|.+|||+.|+|+||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                          0000     0123457899999999998 99999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.9e-47  Score=358.24  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=214.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC--HHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      |++.+.||+|+||+||+|.++.+|..||+|.+........  ....+.+.+|+.++++++||||+++++++.+.  ..++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~   84 (283)
T 3bhy_A            7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--TDVV   84 (283)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred             hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--CeEE
Confidence            4888999999999999999999999999999876543221  12356788999999999999999999988654  5789


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC----cEEEcccceeee
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIV  180 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~----~~kl~Dfgla~~  180 (394)
                      +||||+++++|.+++.....+++..++.++.||+.||.|||+++  ++||||||+||+++ .++    .+||+|||++..
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLL-DKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES-CSSSSSCCEEECCCTTCEE
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEe-cCCCCCCceEEEeccccee
Confidence            99999999999999998888999999999999999999999999  99999999999998 444    899999999977


Q ss_pred             ecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCCH
Q 016143          181 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDP  256 (394)
Q Consensus       181 ~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~  256 (394)
                      .... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+......  .......++
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSNTSE  240 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhcccCCcchhcccCCH
Confidence            6543 3345679999999998764 589999999999999999999999987 4555566666554322  122245678


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .++++|++||. +|.+||++.++|+||||+...
T Consensus       241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            99999999998 999999999999999998653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.2e-48  Score=377.64  Aligned_cols=255  Identities=30%  Similarity=0.439  Sum_probs=193.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC----
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~----   99 (394)
                      ++| ++.+.||+|+||+||+|.+..+|+.||+|++....  ......+++.+|+.+|+.++||||+++++++....    
T Consensus        29 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           29 ERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             TTE-EEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             Cce-EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            555 78899999999999999999999999999986432  34566778999999999999999999999886431    


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ...+++|+||+ +++|.++++. +.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+++
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kL~DFG~a~  180 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLAR  180 (367)
T ss_dssp             CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECC-----
T ss_pred             CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEEC-CCCCEEEeeccccc
Confidence            24578999999 7899999876 56999999999999999999999999  99999999999998 78899999999997


Q ss_pred             eecCCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCC----------
Q 016143          180 VMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK----------  246 (394)
Q Consensus       180 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~~----------  246 (394)
                      ..... .....||+.|+|||++.+  .|+.++|||||||++|+|++|+.||.+.....++...+.. +..          
T Consensus       181 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          181 HTADE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             ccccc-CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            65443 345679999999997764  5899999999999999999999999875444333322211 100          


Q ss_pred             --------------CC---CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          247 --------------PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       247 --------------~~---~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                    ..   ......++++++||++||. +|.+|||+.++|+||||+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence                          00   0112357889999999998 99999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.3e-47  Score=360.47  Aligned_cols=262  Identities=31%  Similarity=0.550  Sum_probs=223.1

Q ss_pred             CCccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeee
Q 016143           15 GEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS   94 (394)
Q Consensus        15 ~~~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~   94 (394)
                      ......++..+| ++.+.||+|+||+||+|.+..++..||+|++.....   ....+.+.+|+.+++.++||||++++++
T Consensus        13 ~~~~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~   88 (303)
T 3a7i_A           13 MQNLKADPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGS   88 (303)
T ss_dssp             CTTCEECGGGTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhcCCCChHHHH-HHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            334445666666 788999999999999999999999999999875542   3346778899999999999999999999


Q ss_pred             EEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcc
Q 016143           95 WVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD  174 (394)
Q Consensus        95 ~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~D  174 (394)
                      +.++  ..+++||||+++++|.+++.. +.+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|
T Consensus        89 ~~~~--~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~D  162 (303)
T 3a7i_A           89 YLKD--TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLAD  162 (303)
T ss_dssp             EEET--TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECC
T ss_pred             EecC--CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEEC-CCCCEEEee
Confidence            8654  478999999999999999876 45999999999999999999999999  99999999999998 688999999


Q ss_pred             cceeeeecCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 016143          175 LGLAIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS  251 (394)
Q Consensus       175 fgla~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~  251 (394)
                      ||++.......  .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+.......+..+. +..+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~  240 (303)
T 3a7i_A          163 FGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKNN-PPTLE  240 (303)
T ss_dssp             CTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSC-CCCCC
T ss_pred             cccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC-cCHHHHHHHhhcCC-CCCCc
Confidence            99997765442  345679999999998765 588999999999999999999999987 44555555555543 33456


Q ss_pred             CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       252 ~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ...+..+.++|.+||. +|.+||++.++|+||||....
T Consensus       241 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          241 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            6778999999999998 999999999999999997643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.7e-47  Score=361.71  Aligned_cols=256  Identities=28%  Similarity=0.533  Sum_probs=209.7

Q ss_pred             CCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      .+..+| ++.+.||+|+||+||+|.+..+|..||+|.+....      ..+.+.+|+.+++.++||||+++++++.+.  
T Consensus        26 ~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   96 (314)
T 3com_A           26 QPEEVF-DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKN--   96 (314)
T ss_dssp             ----CE-EEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEET--
T ss_pred             cchhhh-hhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeC--
Confidence            344555 78899999999999999999999999999987432      235678899999999999999999988654  


Q ss_pred             ceEEEEEcccCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          101 RTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~-~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ..+++||||+.+++|.+++. ....+++..++.++.||+.||.|||++|  ++|+||||+||+++ .++.+||+|||++.
T Consensus        97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~  173 (314)
T 3com_A           97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAG  173 (314)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCE
T ss_pred             CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEEC-CCCCEEEeecccch
Confidence            47889999999999999997 4567999999999999999999999999  99999999999998 68899999999997


Q ss_pred             eecCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCCC
Q 016143          180 VMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTD  255 (394)
Q Consensus       180 ~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~-~~~~~~~~~  255 (394)
                      ......  .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ......+..... ....+..++
T Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  252 (314)
T 3com_A          174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-MRAIFMIPTNPPPTFRKPELWS  252 (314)
T ss_dssp             ECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHSCCCCCSSGGGSC
T ss_pred             hhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCCCcccCCcccCC
Confidence            765442  345679999999998765 589999999999999999999999987443 333333333322 222345568


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      ..+.++|.+||. +|.+||++.++|+||||+....
T Consensus       253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence            899999999998 9999999999999999987643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.6e-47  Score=376.64  Aligned_cols=252  Identities=26%  Similarity=0.397  Sum_probs=203.9

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC------CCCCceeEeeeEEcCC
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL------KHENIIKFYNSWVDDT   99 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L------~hpnIv~~~~~~~~~~   99 (394)
                      .|++.+.||+|+||+||+|.+..+++.||+|++...     ....+.+.+|+.+++.+      +|+||+++++++... 
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-  171 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-  171 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-
Confidence            348889999999999999999999999999998632     34456677888888777      577999999988654 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc--EEEccc
Q 016143          100 NRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDL  175 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~--~kl~Df  175 (394)
                       ..+++||||+. ++|.+++....  .+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.  +||+||
T Consensus       172 -~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~-~~~~~~vkL~DF  246 (429)
T 3kvw_A          172 -NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLK-QQGRSGIKVIDF  246 (429)
T ss_dssp             -TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEES-STTSCCEEECCC
T ss_pred             -CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-cCCCcceEEeec
Confidence             57899999995 69999988764  4999999999999999999999999  99999999999998 5665  999999


Q ss_pred             ceeeeecCCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCC-----
Q 016143          176 GLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA-----  248 (394)
Q Consensus       176 gla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~~~~-----  248 (394)
                      |++...... ....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.....++...+.. +..+.     
T Consensus       247 G~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~  325 (429)
T 3kvw_A          247 GSSCYEHQR-VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA  325 (429)
T ss_dssp             TTCEETTCC-CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ccceecCCc-ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence            999765443 345689999999997765 5999999999999999999999999875444433332211 00000     


Q ss_pred             --------------------------------------------------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHH
Q 016143          249 --------------------------------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALE  277 (394)
Q Consensus       249 --------------------------------------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~e  277 (394)
                                                                        .+....++++++||++||. +|.+|||+.|
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e  405 (429)
T 3kvw_A          326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ  405 (429)
T ss_dssp             BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence                                                              0112347889999999999 9999999999


Q ss_pred             HhcCCccccCCC
Q 016143          278 LLKDPFLVTDNP  289 (394)
Q Consensus       278 lL~~p~~~~~~~  289 (394)
                      +|+||||+...+
T Consensus       406 ~L~Hpw~~~~~~  417 (429)
T 3kvw_A          406 ALRHPWLRRRLP  417 (429)
T ss_dssp             HHTSTTTC----
T ss_pred             HhCChhhccCCC
Confidence            999999987643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-47  Score=368.74  Aligned_cols=259  Identities=25%  Similarity=0.383  Sum_probs=204.4

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC-HHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~-~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      .++| ++.+.||+|+||+||+|.+..+|+.||+|.+........ ....+.+.+|+.+++.++||||+++++++.+.  .
T Consensus         9 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~   85 (346)
T 1ua2_A            9 AKRY-EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--S   85 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--T
T ss_pred             hccc-EEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--C
Confidence            3455 788999999999999999999999999999875432111 12234678899999999999999999998543  5


Q ss_pred             eEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      .+++||||+++ +|..++... ..+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++..
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEc-CCCCEEEEeccccee
Confidence            67889999976 888888765 46999999999999999999999999  99999999999998 788999999999976


Q ss_pred             ecCC--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CC-CCCCC----
Q 016143          181 MQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI-KPASL----  250 (394)
Q Consensus       181 ~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~-~~~~~----  250 (394)
                      ....  ......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+......+...+.. +. .+..+    
T Consensus       162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            6433  3345679999999998754  3889999999999999999999999875444443333321 11 11111    


Q ss_pred             -------------------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          251 -------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       251 -------------------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                         ....++++++||++||. +|.+|||+.|+|+||||....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                               13346899999999998 999999999999999998653

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.6e-47  Score=372.58  Aligned_cols=252  Identities=25%  Similarity=0.352  Sum_probs=203.5

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC----Cce
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NRT  102 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~----~~~  102 (394)
                      |++.+.||+|+||+||+|.+..++. ||+|++......        ..+|+.+|+.++||||++++++|....    ..+
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            4888999999999999999876665 888887543321        125999999999999999999886532    345


Q ss_pred             EEEEEcccCCCcHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          103 INMITELFTSGSLRQYR---KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i---~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      +++||||+.++.+....   .....+++..++.++.||+.||.|||++|  |+||||||+|||++..++.+||+|||++.
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            88999999876444332   34567999999999999999999999999  99999999999998668899999999998


Q ss_pred             eecCC-CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC------------
Q 016143          180 VMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG------------  244 (394)
Q Consensus       180 ~~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~------------  244 (394)
                      ..... ......||+.|+|||++.+  .|+.++|||||||++|||++|+.||.+.....++...+...            
T Consensus       191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  270 (394)
T 4e7w_A          191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN  270 (394)
T ss_dssp             ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            76443 3456789999999997754  48999999999999999999999998855555544433210            


Q ss_pred             ------CCC--------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          245 ------IKP--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       245 ------~~~--------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                            ..+        ..++...++++++||.+||. +|.+||++.|+|+||||+....
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                  000        01233467899999999998 9999999999999999987644

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.7e-49  Score=383.49  Aligned_cols=249  Identities=16%  Similarity=0.184  Sum_probs=198.2

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHH---HHHHcCCCCCceeEe-------ee
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV---HLLKSLKHENIIKFY-------NS   94 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~---~~l~~L~hpnIv~~~-------~~   94 (394)
                      +.|++.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+   .+|++++||||++++       ++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC--CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc-cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            445889999999999999999999999999999975433 2345667889999   555666899999998       54


Q ss_pred             EEcCCC------------c---eEEEEEcccCCCcHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCCCeE
Q 016143           95 WVDDTN------------R---TINMITELFTSGSLRQYRKKHKNVDM-------KAIKNWARQILRGLHYLHSHNPPII  152 (394)
Q Consensus        95 ~~~~~~------------~---~~~lV~e~~~~gsL~~~i~~~~~l~~-------~~~~~i~~qil~~L~~LH~~~~~iv  152 (394)
                      +.+...            .   ..++||||+ +|+|.+++...+.+++       ..++.++.||+.||.|||+++  |+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv  228 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV  228 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence            433311            0   378999999 6899999987655655       888899999999999999999  99


Q ss_pred             ecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCcccccCCcccCcccccc------------cCCCcCcchhhhhHHHH
Q 016143          153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILE  220 (394)
Q Consensus       153 HrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~------------~~~~~~DIwSlG~il~e  220 (394)
                      ||||||+|||++ .++.+||+|||++..... .....+| +.|+|||++.+            .|+.++|||||||++||
T Consensus       229 HrDikp~NIll~-~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          229 HTYLRPVDIVLD-QRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CSCCCGGGEEEC-TTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEc-CCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            999999999998 678999999999986433 3345568 99999998764            48999999999999999


Q ss_pred             HHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          221 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       221 lltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      |++|+.||.+... ......+..      .....++++++||.+||. +|.+||++.++|+||||+..
T Consensus       306 lltg~~Pf~~~~~-~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          306 IWCADLPITKDAA-LGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHSSCCC-------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHHCCCCCccccc-ccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            9999999976322 222222211      124567899999999998 99999999999999999753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9.5e-48  Score=363.26  Aligned_cols=262  Identities=27%  Similarity=0.485  Sum_probs=191.5

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      .....|++.+.||+|+||+||+|.+..+++.||+|.+.....   ....+.+.+|+.++++++||||+++++++.+..  
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   86 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD--   86 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSS--
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--
Confidence            333445889999999999999999999999999998865432   344567889999999999999999999986554  


Q ss_pred             eEEEEEcccCCCcHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143          102 TINMITELFTSGSLRQYRKK--------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~--------~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                      .+++||||+++++|.+++..        ...+++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~  163 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIA  163 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEEC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEc-CCCCEEEE
Confidence            58899999999999999874        456999999999999999999999999  99999999999998 68899999


Q ss_pred             ccceeeeecCC-------CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 016143          174 DLGLAIVMQQP-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG  244 (394)
Q Consensus       174 Dfgla~~~~~~-------~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~  244 (394)
                      |||++......       ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||................
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  243 (303)
T 2vwi_A          164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND  243 (303)
T ss_dssp             CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred             eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence            99998654322       1234579999999998764  58999999999999999999999998755444444443332


Q ss_pred             CCC-------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCCC
Q 016143          245 IKP-------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD  291 (394)
Q Consensus       245 ~~~-------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~~  291 (394)
                      ...       .......+++++++|.+||. +|.+||++.++++||||+....+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  298 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE  298 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence            111       12334567899999999998 999999999999999998765443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.8e-47  Score=368.98  Aligned_cols=254  Identities=28%  Similarity=0.398  Sum_probs=199.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC----
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~----   99 (394)
                      ++| ++.+.||+|+||+||+|.+..+|..||+|++....  ......+++.+|+.+++.++||||+++++++....    
T Consensus        25 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           25 KRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhe-eEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            455 78899999999999999999999999999987432  34566778999999999999999999999886543    


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ...+++||||+. ++|.+++.  ..+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.
T Consensus       102 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          102 FQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR  175 (371)
T ss_dssp             CCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCC--
T ss_pred             ccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEEEeeccc
Confidence            237899999997 57888886  35999999999999999999999999  99999999999998 78899999999997


Q ss_pred             eecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC---------
Q 016143          180 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---------  248 (394)
Q Consensus       180 ~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~---------  248 (394)
                      ..... ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+... ...+..+.......         
T Consensus       176 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             ccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHHhh
Confidence            66544 3445679999999997765 589999999999999999999999987444 33444443321100         


Q ss_pred             -----------CC--------------CC------CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          249 -----------SL--------------SK------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       249 -----------~~--------------~~------~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                 .+              +.      ..++++++||++||. +|.+|||+.|+|+||||+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                       00              00      014678999999998 99999999999999999753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.9e-46  Score=362.55  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=209.2

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC---C
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD---T   99 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~---~   99 (394)
                      .++| ++.+.||+|+||+||+|.+..+|+.||+|.+...   .......++.+|+.++++++||||+++++++...   .
T Consensus        10 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   85 (353)
T 2b9h_A           10 SSDF-QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN   85 (353)
T ss_dssp             CTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred             ccce-EEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence            3455 8899999999999999999999999999998633   2456667888999999999999999999977543   2


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ...+++||||+. ++|.+++... .+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.
T Consensus        86 ~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           86 FNEVYIIQELMQ-TDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGLAR  160 (353)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred             cceEEEEEeccC-ccHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-CCCcEEEEeccccc
Confidence            357899999996 6999998874 5999999999999999999999999  99999999999998 68899999999997


Q ss_pred             eecCCC------------CcccccCCcccCccccc--ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-C
Q 016143          180 VMQQPT------------ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G  244 (394)
Q Consensus       180 ~~~~~~------------~~~~~gt~~y~aPE~l~--~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~  244 (394)
                      ......            .....||+.|+|||++.  ..++.++|||||||++|+|++|+.||.+.....++...... +
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            664321            22357899999999764  45889999999999999999999999875433333222211 0


Q ss_pred             CCC------------------------C----CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          245 IKP------------------------A----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       245 ~~~------------------------~----~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ..+                        .    ......++++++||.+||. +|.+||++.++|+||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            000                        0    0113567899999999998 999999999999999998754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-46  Score=355.35  Aligned_cols=251  Identities=32%  Similarity=0.493  Sum_probs=207.7

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC--------
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--------   98 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~--------   98 (394)
                      |++.+.||+|+||+||+|.+..+|+.||+|.+...     ....+.+.+|+.++++++||||++++++|.+.        
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             chhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            37889999999999999999999999999998642     45667899999999999999999999988653        


Q ss_pred             ---CCceEEEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcc
Q 016143           99 ---TNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD  174 (394)
Q Consensus        99 ---~~~~~~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~D  174 (394)
                         ....+++||||+++++|.+++.... .+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~-~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEc-CCCCEEEee
Confidence               2467899999999999999998654 5889999999999999999999999  99999999999998 788999999


Q ss_pred             cceeeeecCC----------------CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHH
Q 016143          175 LGLAIVMQQP----------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ  236 (394)
Q Consensus       175 fgla~~~~~~----------------~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~  236 (394)
                      ||++......                ......||+.|+|||++.+  .++.++|||||||++|+|++   ||....+...
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9999755421                2234569999999998764  58999999999999999998   6654344455


Q ss_pred             HHHHHhcC--CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          237 IYKKVTSG--IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       237 ~~~~i~~~--~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ....+...  ..+..++...++.++++|.+||. +|.+||++.++|+||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence            55665543  22445566677889999999998 999999999999999997643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.7e-47  Score=358.80  Aligned_cols=256  Identities=25%  Similarity=0.413  Sum_probs=205.5

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC----
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----   98 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~----   98 (394)
                      .++| ++.+.||+|+||+||+|.+..+|+.||+|.+...    .....+.+.+|+.++++++||||+++++++...    
T Consensus        10 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (320)
T 2i6l_A           10 GSRY-MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL   84 (320)
T ss_dssp             TTTE-EEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred             CCce-eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence            3555 8889999999999999999999999999998643    356678899999999999999999999987432    


Q ss_pred             --------CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE
Q 016143           99 --------TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV  170 (394)
Q Consensus        99 --------~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~  170 (394)
                              ....+++||||+. |+|.+++.. +.+++..++.++.||+.||.|||++|  |+||||||+||+++.+++.+
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             CC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEE
T ss_pred             ccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeE
Confidence                    3367899999997 699999875 45999999999999999999999999  99999999999998667899


Q ss_pred             EEcccceeeeecCC-----CCcccccCCcccCccccc--ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 016143          171 KIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS  243 (394)
Q Consensus       171 kl~Dfgla~~~~~~-----~~~~~~gt~~y~aPE~l~--~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~  243 (394)
                      ||+|||++......     ......||+.|+|||++.  ..++.++|||||||++|+|++|+.||.+... ......+..
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~~~  239 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-LEQMQLILE  239 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH
Confidence            99999999765432     233456899999999764  4588999999999999999999999987443 333333322


Q ss_pred             CCC------------------------C----CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          244 GIK------------------------P----ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       244 ~~~------------------------~----~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ...                        +    .......++++++||++||. +|.+||++.++|+||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            110                        0    01123467899999999998 999999999999999998653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=376.68  Aligned_cols=255  Identities=26%  Similarity=0.430  Sum_probs=191.4

Q ss_pred             ccccccceecccCceEEEEEEEc--cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      +|.-.+++||+|+||+||+|.++  .++..||+|++.....      ...+.+|+.+|+.|+||||++++++|.+.....
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            34323678999999999999965  5789999999864321      135778999999999999999999998777788


Q ss_pred             EEEEEcccCCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe---CCCCcE
Q 016143          103 INMITELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEV  170 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~---------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~---~~~~~~  170 (394)
                      +++||||+. ++|.+++...         ..+++..++.++.||+.||.|||+++  |+||||||+|||++   ..++.+
T Consensus        95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcE
Confidence            999999996 5888877532         24999999999999999999999999  99999999999993   256899


Q ss_pred             EEcccceeeeecCC-----CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCC---------H
Q 016143          171 KIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN---------P  234 (394)
Q Consensus       171 kl~Dfgla~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~---------~  234 (394)
                      ||+|||++......     .....+||+.|+|||++.+  .|+.++|||||||++|+|++|+.||.....         .
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            99999999766542     2345679999999998765  489999999999999999999999975332         1


Q ss_pred             HHHHHHHhc-CCCC-CCCC---------------------------------CCCCHHHHHHHHHcCC-CCCCCCCHHHH
Q 016143          235 AQIYKKVTS-GIKP-ASLS---------------------------------KVTDPQVKQFIEKCIV-PASLRLPALEL  278 (394)
Q Consensus       235 ~~~~~~i~~-~~~~-~~~~---------------------------------~~~~~~~~~li~~~L~-~p~~R~s~~el  278 (394)
                      .++...+.. +..+ ..+.                                 ...++.+.+||.+||. +|.+|||+.|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            222222211 1111 1110                                 1126788999999999 99999999999


Q ss_pred             hcCCccccCC
Q 016143          279 LKDPFLVTDN  288 (394)
Q Consensus       279 L~~p~~~~~~  288 (394)
                      |+||||....
T Consensus       332 L~hp~f~~~~  341 (405)
T 3rgf_A          332 MQDPYFLEDP  341 (405)
T ss_dssp             HTSGGGTSSS
T ss_pred             hcChhhccCC
Confidence            9999998754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-46  Score=357.88  Aligned_cols=256  Identities=24%  Similarity=0.419  Sum_probs=214.1

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC--CCCceeEeeeEEcCC
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDT   99 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~--hpnIv~~~~~~~~~~   99 (394)
                      ..++.|++.+.||+|+||+||+|.+. ++..||+|++.....  .....+.+.+|+.++++++  ||||+++++++.++ 
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-  100 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-  100 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEeecC-
Confidence            34555689999999999999999885 589999999875442  4567788999999999997  59999999988654 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                       ..+++||| +.+++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+||+++  ++.+||+|||++.
T Consensus       101 -~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~--~~~~kL~Dfg~~~  174 (313)
T 3cek_A          101 -QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIAN  174 (313)
T ss_dssp             -SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSSC
T ss_pred             -CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE--CCeEEEeeccccc
Confidence             47899999 568899999999889999999999999999999999999  99999999999997  4899999999997


Q ss_pred             eecCCC----CcccccCCcccCcccccc------------cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 016143          180 VMQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS  243 (394)
Q Consensus       180 ~~~~~~----~~~~~gt~~y~aPE~l~~------------~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~  243 (394)
                      ......    .....||+.|+|||++.+            .++.++|||||||++|+|++|..||....+.......+..
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  254 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence            654432    234579999999998754            5788999999999999999999999886666666666655


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          244 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       244 ~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ......++...+.++.++|.+||. +|.+||++.++|+||||+..
T Consensus       255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            544445666778999999999998 99999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.6e-47  Score=367.98  Aligned_cols=257  Identities=23%  Similarity=0.375  Sum_probs=217.6

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCH-------------HHHHHHHHHHHHHHcCCCCCceeEe
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-------------DQLERLYSEVHLLKSLKHENIIKFY   92 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~-------------~~~~~~~~E~~~l~~L~hpnIv~~~   92 (394)
                      .|++.+.||+|+||+||+|.+  +|..||+|.+.........             ...+.+.+|+.++++++||||++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            348889999999999999998  8999999998754432111             1227788999999999999999999


Q ss_pred             eeEEcCCCceEEEEEcccCCCcHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEE
Q 016143           93 NSWVDDTNRTINMITELFTSGSLRQY------RKK--HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFV  163 (394)
Q Consensus        93 ~~~~~~~~~~~~lV~e~~~~gsL~~~------i~~--~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll  163 (394)
                      +++.+.  ..+++||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ +|  |+||||||+||++
T Consensus       110 ~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~  185 (348)
T 2pml_X          110 GIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILM  185 (348)
T ss_dssp             EEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEE
T ss_pred             EEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEE
Confidence            998654  578999999999999998      666  5679999999999999999999999 88  9999999999999


Q ss_pred             eCCCCcEEEcccceeeeecCCCCcccccCCcccCccccccc--CCC-cCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHH
Q 016143          164 NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNE-LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK  240 (394)
Q Consensus       164 ~~~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~-~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~  240 (394)
                      + .++.+||+|||++............||+.|+|||++.+.  ++. ++|||||||++|+|++|..||........+...
T Consensus       186 ~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  264 (348)
T 2pml_X          186 D-KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN  264 (348)
T ss_dssp             C-TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred             c-CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            8 788999999999988766655667899999999988754  555 999999999999999999999886665677777


Q ss_pred             HhcCCCCCCC-----------------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          241 VTSGIKPASL-----------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       241 i~~~~~~~~~-----------------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +..+......                 ....++++.+||.+||. +|.+||++.|+|+||||+....
T Consensus       265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~  331 (348)
T 2pml_X          265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI  331 (348)
T ss_dssp             HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred             HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence            7665332211                 15578999999999998 9999999999999999987543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.4e-47  Score=365.22  Aligned_cols=268  Identities=20%  Similarity=0.304  Sum_probs=188.7

Q ss_pred             CCCCCCCccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCce
Q 016143           10 SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII   89 (394)
Q Consensus        10 ~~~~~~~~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv   89 (394)
                      +++..+........++|....++||+|+||+||+|.++.+|+.||+|++...     ....+   +....++.++||||+
T Consensus        14 ~~~~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~---e~~~~~~~~~h~~i~   85 (336)
T 3fhr_A           14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQ---EVDHHWQASGGPHIV   85 (336)
T ss_dssp             ------CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHH---HHHHHHHHTTSTTBC
T ss_pred             ccccCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHH---HHHHHHHhcCCCChH
Confidence            3455566666677788855567899999999999999999999999998632     22222   233446777999999


Q ss_pred             eEeeeEEcC--CCceEEEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 016143           90 KFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG  165 (394)
Q Consensus        90 ~~~~~~~~~--~~~~~~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~  165 (394)
                      ++++++...  ....+++||||+++|+|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+||+++.
T Consensus        86 ~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~  163 (336)
T 3fhr_A           86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTS  163 (336)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESC
T ss_pred             HHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEe
Confidence            999988652  2456899999999999999998764  6999999999999999999999999  999999999999973


Q ss_pred             --CCCcEEEcccceeeeecCCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHH---HHH
Q 016143          166 --NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IYK  239 (394)
Q Consensus       166 --~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~---~~~  239 (394)
                        .++.+||+|||++............||+.|+|||++.+ .++.++|||||||++|+|++|..||........   ...
T Consensus       164 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (336)
T 3fhr_A          164 KEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR  243 (336)
T ss_dssp             SSTTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred             cCCCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence              24569999999998777666667789999999998754 588999999999999999999999976332211   111


Q ss_pred             HHhcC--CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          240 KVTSG--IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       240 ~i~~~--~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      .+..+  ..+.......++++++||.+||. +|.+||++.|+|+||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          244 RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            22211  11222334578999999999998 99999999999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.9e-46  Score=366.23  Aligned_cols=253  Identities=28%  Similarity=0.406  Sum_probs=204.0

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc----e
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR----T  102 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~----~  102 (394)
                      |++.+.||+|+||+||+|.++.+|+.||+|++....  ......+++.+|+.+++.++||||+++++++......    .
T Consensus        44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            377899999999999999999999999999986432  3456678899999999999999999999998655432    2


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++||||+. ++|.+++.  ..+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++....
T Consensus       122 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHAD  195 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECSTTCC----
T ss_pred             EEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEEC-CCCCEEEEecCcccccc
Confidence            488999997 68888774  34999999999999999999999999  99999999999998 78899999999997654


Q ss_pred             CCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCC------------
Q 016143          183 QPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP------------  247 (394)
Q Consensus       183 ~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~~~------------  247 (394)
                      .. .....||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+...+.. +..+            
T Consensus       196 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  274 (371)
T 4exu_A          196 AE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  274 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred             cC-cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence            43 345678999999997765  5899999999999999999999999874443333332221 1000            


Q ss_pred             ---------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          248 ---------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       248 ---------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                     .......++++++||.+||. +|.+||++.|+|+||||+...
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                           00123457899999999998 999999999999999998643

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=362.43  Aligned_cols=246  Identities=27%  Similarity=0.433  Sum_probs=204.1

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+..++..||+|.+..    ......+.+.+|+.++++++||||+++++++.++  ..+
T Consensus        10 ~~~-~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~   82 (310)
T 3s95_A           10 SDL-IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRL   82 (310)
T ss_dssp             GGE-EEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred             hHe-eccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--Cee
Confidence            444 788999999999999999999999999998743    2466778899999999999999999999998654  578


Q ss_pred             EEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+++++|.++++. ...+++.++..++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR-ENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEC-TTSCEEECCCTTCEECC
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEEC-CCCCEEEeecccceecc
Confidence            899999999999999987 567999999999999999999999999  99999999999998 78899999999997664


Q ss_pred             CCCC----------------cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHH----HHHHHH
Q 016143          183 QPTA----------------RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA----QIYKKV  241 (394)
Q Consensus       183 ~~~~----------------~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~----~~~~~i  241 (394)
                      ....                ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.......    ......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~  239 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF  239 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence            3321                14579999999998765 58999999999999999999999986532110    001111


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccc
Q 016143          242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  285 (394)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~  285 (394)
                      ..    ...+...++.+.+++.+||. +|.+||++.++++  |++
T Consensus       240 ~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~  278 (310)
T 3s95_A          240 LD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE  278 (310)
T ss_dssp             HH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred             cc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHH
Confidence            11    11234566799999999998 9999999999987  454

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.6e-47  Score=366.81  Aligned_cols=258  Identities=24%  Similarity=0.325  Sum_probs=194.7

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC---
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---   99 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~---   99 (394)
                      .++| ++.+.||+|+||+||+|.++.+|..||+|++.....     ..++..+|+..++.++||||++++++|....   
T Consensus        22 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           22 MDRF-QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HTTE-EEC----------CEEEEETTTCCEEEEEEEECCTT-----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             ccce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-----ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            3555 788999999999999999999999999998864332     2234567888899999999999999986532   


Q ss_pred             --CceEEEEEcccCCCcHH---HHHHhCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCeEecCCCCCcEEEeCCCCcEEE
Q 016143          100 --NRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHYLH--SHNPPIIHRDLKCDNIFVNGNNGEVKI  172 (394)
Q Consensus       100 --~~~~~lV~e~~~~gsL~---~~i~~~~~l~~~~~~~i~~qil~~L~~LH--~~~~~ivHrDLkp~NIll~~~~~~~kl  172 (394)
                        ..++++||||+.++.+.   .+......+++..++.++.||+.||.|||  ++|  |+||||||+|||++..++.+||
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEE
T ss_pred             ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEE
Confidence              23588999999865333   23345677999999999999999999999  888  9999999999999954889999


Q ss_pred             cccceeeeecCCC-CcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--
Q 016143          173 GDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--  247 (394)
Q Consensus       173 ~Dfgla~~~~~~~-~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--  247 (394)
                      +|||++....... .....||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+...+.....+  
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR  253 (360)
T ss_dssp             CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence            9999998765443 345679999999997753  38999999999999999999999998744433333322210000  


Q ss_pred             ---------------------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          248 ---------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       248 ---------------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                                 .......++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence                                       01112246789999999999 999999999999999998753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1e-46  Score=360.33  Aligned_cols=262  Identities=20%  Similarity=0.348  Sum_probs=194.3

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCe---EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      +.++| ++.+.||+|+||+||+|.+..++.   .||+|++.....  .....+++.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           21 PEQQF-TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             C---C-EEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             ChhHe-EEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            33455 889999999999999999887775   899999865432  235567899999999999999999999998765


Q ss_pred             CCc----eEEEEEcccCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 016143           99 TNR----TINMITELFTSGSLRQYRKKHK------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG  168 (394)
Q Consensus        99 ~~~----~~~lV~e~~~~gsL~~~i~~~~------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~  168 (394)
                      ...    ..++||||+.+|+|.+++....      .+++..++.++.||+.||.|||++|  |+||||||+|||++ .++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~-~~~  174 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA-EDM  174 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTS
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc-CCC
Confidence            432    2488999999999999986542      5999999999999999999999999  99999999999998 688


Q ss_pred             cEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHh
Q 016143          169 EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT  242 (394)
Q Consensus       169 ~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~  242 (394)
                      .+||+|||++.......    .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+. +...+...+.
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~~~  253 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNYLI  253 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHH
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-ChHHHHHHHh
Confidence            99999999997654432    223457889999998765 58999999999999999999 99999874 4455556665


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCC-------HHHHhcCCccccCCCCC
Q 016143          243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-------ALELLKDPFLVTDNPKD  291 (394)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s-------~~elL~~p~~~~~~~~~  291 (394)
                      .+..+ ..+...++++.++|.+||. +|.+||+       ..+++.|||+.......
T Consensus       254 ~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p  309 (323)
T 3qup_A          254 GGNRL-KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP  309 (323)
T ss_dssp             TTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred             cCCCC-CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence            55433 3455677899999999998 9999999       77889999998765443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.5e-46  Score=364.44  Aligned_cols=246  Identities=26%  Similarity=0.426  Sum_probs=208.8

Q ss_pred             cccccceecccCceEEEEEEEc-------cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEc
Q 016143           26 YGRYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD   97 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~   97 (394)
                      .|++.+.||+|+||+||+|.+.       .++..||+|+++...   .....+.+.+|+.+|+.+ +||||+++++++.+
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3478899999999999999864       356789999986432   356678899999999999 89999999998854


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI  161 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~~----------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NI  161 (394)
                      .  ..+++||||+++|+|.+++....                .+++..++.++.||+.||.|||+++  |+||||||+||
T Consensus       159 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NI  234 (370)
T 2psq_A          159 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNV  234 (370)
T ss_dssp             S--SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGE
T ss_pred             C--CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhE
Confidence            4  46889999999999999998753                4899999999999999999999999  99999999999


Q ss_pred             EEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHH
Q 016143          162 FVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPA  235 (394)
Q Consensus       162 ll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~  235 (394)
                      |++ .++.+||+|||++.......    .....||+.|+|||++.+ .|+.++|||||||++|||++ |..||.+ .+..
T Consensus       235 ll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-~~~~  312 (370)
T 2psq_A          235 LVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVE  312 (370)
T ss_dssp             EEC-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGG
T ss_pred             EEC-CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-CCHH
Confidence            998 78899999999998665432    233457889999997754 58999999999999999999 9999987 4556


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       236 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +++..+..+..+ ..+...++++.++|.+||. +|.+||++.|++++
T Consensus       313 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          313 ELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GHHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            667777666543 3456678999999999998 99999999999874

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.4e-47  Score=366.76  Aligned_cols=251  Identities=25%  Similarity=0.399  Sum_probs=212.0

Q ss_pred             CCcccccccceecccCceEEEEEE-----EccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeE
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW   95 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~   95 (394)
                      +.++| ++.+.||+|+||+||+|.     +..+++.||+|.+....   .....+.+.+|+.+++++ +||||+++++++
T Consensus        20 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           20 PRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             CGGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccce-eeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            34555 889999999999999998     56677999999986432   355667899999999999 799999999988


Q ss_pred             EcCCCceEEEEEcccCCCcHHHHHHhCCC---------------------------------------------------
Q 016143           96 VDDTNRTINMITELFTSGSLRQYRKKHKN---------------------------------------------------  124 (394)
Q Consensus        96 ~~~~~~~~~lV~e~~~~gsL~~~i~~~~~---------------------------------------------------  124 (394)
                      .+.. ..+++||||+.+|+|.+++.....                                                   
T Consensus        96 ~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           96 TKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             CSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             ecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            6543 457899999999999999987643                                                   


Q ss_pred             ---------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC----
Q 016143          125 ---------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----  185 (394)
Q Consensus       125 ---------------l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~----  185 (394)
                                     +++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++.......    
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~  251 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVR  251 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCEE
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCcEEEEeccceeeecccccchh
Confidence                           899999999999999999999999  99999999999998 67899999999997654332    


Q ss_pred             CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          186 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       186 ~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                      .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+......+...+..+..+ ..+...++++.+++.
T Consensus       252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~  330 (359)
T 3vhe_A          252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTML  330 (359)
T ss_dssp             C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHH
T ss_pred             ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHHHHHHHH
Confidence            23456899999999775 458999999999999999998 999998866666666666665433 355667899999999


Q ss_pred             HcCC-CCCCCCCHHHHhcC
Q 016143          264 KCIV-PASLRLPALELLKD  281 (394)
Q Consensus       264 ~~L~-~p~~R~s~~elL~~  281 (394)
                      +||. +|.+||++.++++|
T Consensus       331 ~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          331 DCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhhCCCHHHHHHH
Confidence            9998 99999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=357.37  Aligned_cols=244  Identities=23%  Similarity=0.361  Sum_probs=205.9

Q ss_pred             ccccceecccCceEEEEEEEccCCe---EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      |++.+.||+|+||+||+|.+..++.   .||+|.+....   .....+.+.+|+.+|++++||||+++++++.+  ...+
T Consensus        51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~  125 (325)
T 3kul_A           51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRLA  125 (325)
T ss_dssp             EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--GGCC
T ss_pred             eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCcc
Confidence            4888999999999999999976554   59999986432   45667789999999999999999999998854  4567


Q ss_pred             EEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+++++|.+++... +.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++....
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVD-SNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECC
T ss_pred             EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEC-CCCCEEECCCCcccccc
Confidence            8999999999999999765 57999999999999999999999999  99999999999998 78899999999998765


Q ss_pred             CCC-----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          183 QPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       183 ~~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      ...     .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .+...+...+..+..+. .+...+
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~  280 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYRLP-APMGCP  280 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCCC-CCTTCC
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCCCC-CCCCcC
Confidence            432     22234678899999876 458999999999999999999 9999987 55666777776664332 455678


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +.+.++|.+||. +|.+||++.++++
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999998 9999999999887

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.2e-46  Score=356.88  Aligned_cols=259  Identities=28%  Similarity=0.442  Sum_probs=207.0

Q ss_pred             cccccccceecccCceEEEEEEEc-cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC---CCCCceeEeeeEEc--
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVD--   97 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L---~hpnIv~~~~~~~~--   97 (394)
                      ++| ++.+.||+|+||+||+|.+. .+|+.||+|++.......  .....+.+|+.+++.+   +||||+++++++..  
T Consensus        11 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A           11 QQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             hce-eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            444 88999999999999999995 678999999987654211  1122345666666655   89999999998862  


Q ss_pred             -CCCceEEEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcc
Q 016143           98 -DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD  174 (394)
Q Consensus        98 -~~~~~~~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~D  174 (394)
                       +....+++||||+. |+|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~-~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEc-CCCCEEEec
Confidence             24567899999997 69999998754  4999999999999999999999999  99999999999998 788999999


Q ss_pred             cceeeeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCC-----
Q 016143          175 LGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-----  246 (394)
Q Consensus       175 fgla~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~~-----  246 (394)
                      ||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.. +..     
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            9999765433 3345679999999997764 5899999999999999999999999875444333333211 000     


Q ss_pred             ------------------CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          247 ------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       247 ------------------~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                                        ...+....++.+++||.+||. +|.+||++.++|+||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                              011234567899999999998 9999999999999999987543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=8.9e-46  Score=347.75  Aligned_cols=251  Identities=26%  Similarity=0.440  Sum_probs=207.8

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHH---HHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL---ERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~---~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      .++| ++.+.||+|+||+||+|.+..+++.||+|.+............   +.+.+|+.++++++||||+++++++.+. 
T Consensus        18 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   95 (287)
T 4f0f_A           18 DNEI-EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-   95 (287)
T ss_dssp             STTE-EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-
T ss_pred             hccc-eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-
Confidence            3555 8899999999999999999999999999998765543333222   6788999999999999999999987433 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc-----EEEc
Q 016143          100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKIG  173 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~-----~kl~  173 (394)
                       .  ++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++++|+||||||+||+++ .++.     +||+
T Consensus        96 -~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~-~~~~~~~~~~kl~  171 (287)
T 4f0f_A           96 -P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ-SLDENAPVCAKVA  171 (287)
T ss_dssp             -T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES-CCCTTCSCCEEEC
T ss_pred             -C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe-ccCCCCceeEEeC
Confidence             2  5799999999998887655 469999999999999999999999987899999999999997 4554     9999


Q ss_pred             ccceeeeecCCCCcccccCCcccCccccc---ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCH-HHHHHHHhcCCCCCC
Q 016143          174 DLGLAIVMQQPTARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYKKVTSGIKPAS  249 (394)
Q Consensus       174 Dfgla~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~-~~~~~~i~~~~~~~~  249 (394)
                      |||++...... .....||+.|+|||++.   ..++.++|||||||++|+|++|+.||...... ......+........
T Consensus       172 Dfg~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 4f0f_A          172 DFGLSQQSVHS-VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT  250 (287)
T ss_dssp             CCTTCBCCSSC-EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred             CCCcccccccc-ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence            99999754443 34467999999999873   34788999999999999999999999765433 333444444444445


Q ss_pred             CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       250 ~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ++...++++.++|.+||. +|.+||++.++++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            667788999999999998 9999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.3e-46  Score=348.67  Aligned_cols=251  Identities=28%  Similarity=0.457  Sum_probs=196.3

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+.  |..||+|++............+.+.+|+.+++.++||||+++++++.++  ..+
T Consensus         7 ~~~-~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   81 (271)
T 3dtc_A            7 AEL-TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--PNL   81 (271)
T ss_dssp             TSE-EEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----C
T ss_pred             hhe-eeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--Cce
Confidence            445 78899999999999999874  8999999987654333334467788999999999999999999988544  467


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CeEecCCCCCcEEEeC-------CCCcEEEccc
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVNG-------NNGEVKIGDL  175 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~-~ivHrDLkp~NIll~~-------~~~~~kl~Df  175 (394)
                      ++||||+++++|.+++.. +.+++..++.++.||+.||.|||+++. +|+||||||+||+++.       .++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            899999999999999864 469999999999999999999999983 3889999999999974       2678999999


Q ss_pred             ceeeeecCCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          176 GLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       176 gla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      |++............||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+. +.......+.........+...
T Consensus       161 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3dtc_A          161 GLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALPIPSTC  239 (271)
T ss_dssp             CC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHTSCCCCCCCTTC
T ss_pred             CcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhhcCCCCCCCCccc
Confidence            9998776665556789999999998765 5899999999999999999999999874 4444444444444444566778


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++.+.++|.+||. +|.+||++.|++++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            8999999999998 99999999999874

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.4e-46  Score=346.75  Aligned_cols=247  Identities=19%  Similarity=0.309  Sum_probs=208.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+.  +..||+|++....  ......+.+.+|+.++++++||||+++++++.+.....+
T Consensus        10 ~~y-~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A           10 KQL-NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             GGC-EEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             HHh-HHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            444 78899999999999999974  8899999987543  245667789999999999999999999999877655678


Q ss_pred             EEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          104 NMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      ++||||+++|+|.+++....  .+++..++.++.||+.||.|||+++++++||||||+||+++ .++.++|+|||++...
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSF  163 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGSCCTT
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc-CCcceeEEeccceeee
Confidence            89999999999999999876  48999999999999999999999988899999999999998 7889999999887543


Q ss_pred             cCCCCcccccCCcccCccccccc-CC---CcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          182 QQPTARSVIGTPEFMAPELYEEE-YN---ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       182 ~~~~~~~~~gt~~y~aPE~l~~~-~~---~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      ..   ....||+.|+|||++.+. ++   .++|||||||++|+|++|+.||.+.............+ .....+...+++
T Consensus       164 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  239 (271)
T 3kmu_A          164 QS---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG-LRPTIPPGISPH  239 (271)
T ss_dssp             SC---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC-CCCCCCTTCCHH
T ss_pred             cc---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC-CCCCCCCCCCHH
Confidence            22   345689999999987653 33   37999999999999999999998754444434444444 344566778899


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          258 VKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +.++|.+||. +|.+||++.++++
T Consensus       240 ~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          240 VSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999998 9999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-46  Score=368.26  Aligned_cols=252  Identities=27%  Similarity=0.397  Sum_probs=200.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC--------CCCceeEeeeE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--------HENIIKFYNSW   95 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~--------hpnIv~~~~~~   95 (394)
                      ++| ++.+.||+|+||+||+|.+..+++.||+|++..     .....+.+.+|+.+|+.++        |+||++++++|
T Consensus        37 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           37 GRY-HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             CeE-EEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            444 888999999999999999999999999999863     2455677889999999995        78899999988


Q ss_pred             EcC--CCceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCC--
Q 016143           96 VDD--TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNG--  168 (394)
Q Consensus        96 ~~~--~~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~-~~~ivHrDLkp~NIll~~~~~--  168 (394)
                      ...  ....+++||||+ +++|.+++...  +.+++..++.++.||+.||.|||++ |  |+||||||+|||++ .++  
T Consensus       111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~-~~~~~  186 (397)
T 1wak_A          111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLS-VNEQY  186 (397)
T ss_dssp             EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEEC-CCHHH
T ss_pred             eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEe-ccchh
Confidence            632  456799999999 55665555443  5699999999999999999999998 8  99999999999998 343  


Q ss_pred             -----------------------------------------------cEEEcccceeeeecCCCCcccccCCcccCcccc
Q 016143          169 -----------------------------------------------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY  201 (394)
Q Consensus       169 -----------------------------------------------~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l  201 (394)
                                                                     .+||+|||++...... ....+||+.|+|||++
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhh
Confidence                                                           7999999999876544 3456799999999977


Q ss_pred             cc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCC-----HHHHHHHHhc--CCCCC-------------------------
Q 016143          202 EE-EYNELVDIYSFGMCILEMVTCEYPYNECKN-----PAQIYKKVTS--GIKPA-------------------------  248 (394)
Q Consensus       202 ~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~-----~~~~~~~i~~--~~~~~-------------------------  248 (394)
                      .+ .|+.++|||||||++|+|++|+.||.....     .......+..  +..|.                         
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            65 589999999999999999999999975332     1111111111  11000                         


Q ss_pred             -------------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          249 -------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       249 -------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                                   .++...++.+++||.+||. +|.+|||+.|+|+||||+.
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                         0111224578899999998 9999999999999999963

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.8e-46  Score=361.41  Aligned_cols=258  Identities=24%  Similarity=0.373  Sum_probs=201.2

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeecccc-------CCHHHHHHHHHHHHHHHcCCCCCceeEeeeE
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-------QSPDQLERLYSEVHLLKSLKHENIIKFYNSW   95 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~   95 (394)
                      .++| ++.+.||+|+||+||+|.+.. |..||+|.+......       ......+++.+|+.++++++||||+++++++
T Consensus        21 ~~~y-~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           21 QSPY-TVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TCSC-EEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             ccce-EEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            4555 889999999999999998854 999999998654321       2344567899999999999999999999988


Q ss_pred             EcC---CCceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEE
Q 016143           96 VDD---TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK  171 (394)
Q Consensus        96 ~~~---~~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~k  171 (394)
                      ...   ....+++||||+. |+|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~k  174 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA-DNNDIT  174 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEE
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc-CCCCEE
Confidence            653   3457899999997 5777777654 46999999999999999999999999  99999999999998 788999


Q ss_pred             EcccceeeeecCC-CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCC
Q 016143          172 IGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP  247 (394)
Q Consensus       172 l~Dfgla~~~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~~~  247 (394)
                      |+|||++...... ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+..... ....+.. ...+
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~  253 (362)
T 3pg1_A          175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLNKIVEVVGTP  253 (362)
T ss_dssp             ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCC
Confidence            9999999755443 3345679999999997764  58999999999999999999999998744333 3333221 0000


Q ss_pred             -----------------------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          248 -----------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       248 -----------------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                                   .......++.+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence                                         00123457889999999998 99999999999999999875

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.4e-46  Score=358.80  Aligned_cols=254  Identities=28%  Similarity=0.417  Sum_probs=205.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC---
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---  100 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~---  100 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++....  ......+++.+|+.+++.++||||+++++++.+...   
T Consensus        24 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           24 KTY-VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             ceE-EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence            445 78899999999999999999999999999986432  345567789999999999999999999999865432   


Q ss_pred             -ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 -~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                       ..+++||||+. ++|.+++..  .+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.
T Consensus       101 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          101 FYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLAR  174 (353)
T ss_dssp             CCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTCCEEECSTTCTT
T ss_pred             ceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeEC-CCCcEEEeeccccc
Confidence             23589999997 688887753  4999999999999999999999999  99999999999998 78899999999997


Q ss_pred             eecCCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc--CC----------
Q 016143          180 VMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GI----------  245 (394)
Q Consensus       180 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~--~~----------  245 (394)
                      ..... .....||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+...... ...+..  +.          
T Consensus       175 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          175 HADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             C---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHHHTTCS
T ss_pred             CCCCC-ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHHh
Confidence            65433 344678999999997764  588999999999999999999999987443333 222211  00          


Q ss_pred             -----------------CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          246 -----------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       246 -----------------~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                       .........++++++||.+||. +|.+||++.++|+||||+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                             0112234568899999999998 999999999999999998643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.5e-46  Score=352.68  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=211.4

Q ss_pred             CCcccccccceecccCceEEEEEEE-----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEE
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV   96 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~   96 (394)
                      ...+.|++.+.||+|+||+||+|.+     +.++..||+|++...   ......+.+.+|+.++++++||||+++++++.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN---ASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            3345568999999999999999987     345689999998643   24667788999999999999999999999885


Q ss_pred             cCCCceEEEEEcccCCCcHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 016143           97 DDTNRTINMITELFTSGSLRQYRKKHKN------------------------VDMKAIKNWARQILRGLHYLHSHNPPII  152 (394)
Q Consensus        97 ~~~~~~~~lV~e~~~~gsL~~~i~~~~~------------------------l~~~~~~~i~~qil~~L~~LH~~~~~iv  152 (394)
                      +.  ..+++||||+++++|.+++.....                        +++..++.++.||+.||.|||+++  |+
T Consensus        97 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iv  172 (314)
T 2ivs_A           97 QD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LV  172 (314)
T ss_dssp             SS--SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             cC--CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cc
Confidence            44  467889999999999999987643                        899999999999999999999999  99


Q ss_pred             ecCCCCCcEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCC
Q 016143          153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEY  226 (394)
Q Consensus       153 HrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~  226 (394)
                      ||||||+||+++ .++.+||+|||++.......    .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..
T Consensus       173 H~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          173 HRDLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             CCCCSGGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccchheEEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999 78899999999998665432    233457889999997764 58999999999999999999 999


Q ss_pred             CCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          227 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       227 Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ||.+ .+...+...+..+..+ ..+...++++.++|.+||. +|.+||++.+++++
T Consensus       252 p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          252 PYPG-IPPERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             SSTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCC-CCHHHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9977 4455666666665433 3456678999999999998 99999999999875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.9e-47  Score=370.22  Aligned_cols=254  Identities=15%  Similarity=0.159  Sum_probs=189.5

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHH---HHHHcCCCCCceeEe-------eeEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV---HLLKSLKHENIIKFY-------NSWV   96 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~---~~l~~L~hpnIv~~~-------~~~~   96 (394)
                      |++.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+   .+|+. +||||++++       +++.
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            5788999999999999999999999999999986542 2345666778885   45555 799988865       3333


Q ss_pred             cCCC---------------ceEEEEEcccCCCcHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCeEec
Q 016143           97 DDTN---------------RTINMITELFTSGSLRQYRKKH-KNVDMKAI------KNWARQILRGLHYLHSHNPPIIHR  154 (394)
Q Consensus        97 ~~~~---------------~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~------~~i~~qil~~L~~LH~~~~~ivHr  154 (394)
                      .+..               ..+++||||++ |+|.+++... ..+++...      ..++.||+.||.|||+++  |+||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHr  218 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHG  218 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccC
Confidence            2221               45899999998 8999999874 33455555      577799999999999999  9999


Q ss_pred             CCCCCcEEEeCCCCcEEEcccceeeeecCCCCcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCC
Q 016143          155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNEC  231 (394)
Q Consensus       155 DLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~  231 (394)
                      ||||+|||++ .++.+||+|||++........ ...||+.|+|||++.+   .|+.++|||||||++|+|++|+.||.+.
T Consensus       219 Dikp~NIll~-~~~~~kL~DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          219 HFTPDNLFIM-PDGRLMLGDVSALWKVGTRGP-ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             TCSGGGEEEC-TTSCEEECCGGGEEETTCEEE-GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             cCCHHHEEEC-CCCCEEEEecceeeecCCCcc-CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999998 788999999999986654332 4557799999998764   5899999999999999999999999764


Q ss_pred             CCHH-HHHHH---HhcCCCC--CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          232 KNPA-QIYKK---VTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       232 ~~~~-~~~~~---i~~~~~~--~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      .... ..+..   .......  .......++.+++||.+||. +|.+||++.++|+||||+..
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            2210 00000   0000011  11224568999999999998 99999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.8e-46  Score=351.84  Aligned_cols=252  Identities=27%  Similarity=0.410  Sum_probs=205.2

Q ss_pred             CCCcccccccceecccCceEEEEEE----EccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEE
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV   96 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~   96 (394)
                      +...+.|++.+.||+|+||+||+|.    +..++..||+|++...    .....+.+.+|+.++++++||||+++++++.
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3445666999999999999999998    6678999999998633    3566778999999999999999999999987


Q ss_pred             cCCCceEEEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143           97 DDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus        97 ~~~~~~~~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                      ......+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++  |+||||||+||+++ .++.+||+||
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Df  158 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF  158 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEc-CCCeEEEccC
Confidence            665566889999999999999998765 4999999999999999999999999  99999999999999 6789999999


Q ss_pred             ceeeeecCCC-----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCH---------------
Q 016143          176 GLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------------  234 (394)
Q Consensus       176 gla~~~~~~~-----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~---------------  234 (394)
                      |++.......     .....||+.|+|||++.+ .++.++|||||||++|+|++|..||......               
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  238 (295)
T ss_dssp             CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred             cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence            9997664432     223457788999997764 5899999999999999999999998642110               


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       235 ~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+...+..+.. ...+...++++.++|++||. +|.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          239 FHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            122233333322 23456678999999999998 9999999999886

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.9e-46  Score=357.51  Aligned_cols=257  Identities=22%  Similarity=0.382  Sum_probs=213.1

Q ss_pred             ccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCH--HHHHHHHHHHHHHHcCC--CCCceeEeee
Q 016143           19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLK--HENIIKFYNS   94 (394)
Q Consensus        19 ~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~--~~~~~~~~E~~~l~~L~--hpnIv~~~~~   94 (394)
                      +.++....|++.+.||+|+||+||+|.+..+|+.||+|.+.........  ...+++.+|+.++++++  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            3334444458999999999999999999999999999999765432100  12244667999999996  5999999998


Q ss_pred             EEcCCCceEEEEEcccCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143           95 WVDDTNRTINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus        95 ~~~~~~~~~~lV~e~~~~-gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                      +.+.  ..+++|+|++.+ ++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+++.+||+
T Consensus       117 ~~~~--~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          117 FERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EECS--SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecC--CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEe
Confidence            8644  578899999976 899999998888999999999999999999999999  99999999999998667899999


Q ss_pred             ccceeeeecCCCCcccccCCcccCcccccc-cC-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 016143          174 DLGLAIVMQQPTARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS  251 (394)
Q Consensus       174 Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~  251 (394)
                      |||++............||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||...   ..    +..+  ...++
T Consensus       193 Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~---~~----~~~~--~~~~~  263 (320)
T 3a99_A          193 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---EE----IIRG--QVFFR  263 (320)
T ss_dssp             CCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HH----HHHC--CCCCS
T ss_pred             eCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh---hh----hhcc--ccccc
Confidence            999998887766666789999999998764 34 67899999999999999999999652   11    2222  12244


Q ss_pred             CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       252 ~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ...++++.+||.+||. +|.+||++.++++||||+...
T Consensus       264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            5678999999999998 999999999999999998653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=363.67  Aligned_cols=252  Identities=23%  Similarity=0.352  Sum_probs=209.8

Q ss_pred             ccccceecccCceEEEEEE-----EccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           27 GRYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      +++.+.||+|+||+||+|.     +..++..||+|.+...   ........+.+|+.++++++||||+++++++.+.  .
T Consensus        73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~  147 (367)
T 3l9p_A           73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS--L  147 (367)
T ss_dssp             EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred             eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc---cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--C
Confidence            4788999999999999999     5567889999998532   2355666788999999999999999999988554  4


Q ss_pred             eEEEEEcccCCCcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEE
Q 016143          102 TINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKI  172 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~-------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--~~~~~kl  172 (394)
                      ..++||||+++|+|.+++...+       .+++..++.++.||+.||.|||++|  |+||||||+|||++.  ++..+||
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEE
Confidence            5688999999999999998653       4999999999999999999999999  999999999999982  2335999


Q ss_pred             cccceeeeecC----CCCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCC
Q 016143          173 GDLGLAIVMQQ----PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK  246 (394)
Q Consensus       173 ~Dfgla~~~~~----~~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~  246 (394)
                      +|||+++....    .......||+.|+|||++. ..++.++|||||||++|||++ |..||.. .+..++...+..+..
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGR  304 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCC
Confidence            99999964422    2233456899999999775 568999999999999999998 9999987 566777777777654


Q ss_pred             CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          247 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       247 ~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      +. .+...++.+.+|+.+||. +|.+||++.+++++.++...
T Consensus       305 ~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          305 MD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC-CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            32 455678899999999998 99999999999999877644

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5e-46  Score=356.18  Aligned_cols=245  Identities=28%  Similarity=0.354  Sum_probs=199.8

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC--Cc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--NR  101 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~--~~  101 (394)
                      ++| ++.+.||+|+||+||+|.+.  ++.||+|++....     .......+|+.+|++++||||+++++++.+..  ..
T Consensus        24 ~~y-~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           24 MPL-QLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             EEE-EEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             hhc-hhhheecccCceEEEEEEEC--CCEEEEEEeecCc-----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            445 88999999999999999865  8999999986432     33345566999999999999999999987654  34


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCeEecCCCCCcEEEeCCCCcEE
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH----------NPPIIHRDLKCDNIFVNGNNGEVK  171 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~----------~~~ivHrDLkp~NIll~~~~~~~k  171 (394)
                      .+++||||+++|+|.++++... +++..++.++.||+.||.|||++          +  |+||||||+|||++ .++.+|
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~-~~~~~k  171 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLK-NNLTAC  171 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEEC-TTCCEE
T ss_pred             eEEEEEecCCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEEC-CCCeEE
Confidence            5889999999999999998754 99999999999999999999999          8  99999999999998 788999


Q ss_pred             EcccceeeeecCCC----CcccccCCcccCcccccc------cCCCcCcchhhhhHHHHHHhcCCCCCCCC---------
Q 016143          172 IGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECK---------  232 (394)
Q Consensus       172 l~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~------~~~~~~DIwSlG~il~elltg~~Pf~~~~---------  232 (394)
                      |+|||++.......    .....||+.|+|||++.+      .++.++|||||||++|||+||+.||.+..         
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            99999997765432    234579999999998764      45678999999999999999999996532         


Q ss_pred             ------CHHHHHHHHhcCCCCCCCCCCC-----CHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          233 ------NPAQIYKKVTSGIKPASLSKVT-----DPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       233 ------~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                            ....+...+......+.++...     ++++.+||++||. +|.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                  3344444444433332222221     2459999999998 9999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2e-45  Score=347.62  Aligned_cols=256  Identities=26%  Similarity=0.407  Sum_probs=207.9

Q ss_pred             cccCCCcccccccceecccCceEEEEEE----EccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEee
Q 016143           18 SEKDPSCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN   93 (394)
Q Consensus        18 ~~~~~~~ry~r~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~   93 (394)
                      .......++|++.+.||+|+||+||+|.    +..+++.||+|.+....   .....+.+.+|+.+++.++||||+++++
T Consensus        14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~   90 (302)
T 4e5w_A           14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKG   90 (302)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeee
Confidence            3334445667899999999999999998    67789999999987543   2334567889999999999999999999


Q ss_pred             eEEcCCCceEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 016143           94 SWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI  172 (394)
Q Consensus        94 ~~~~~~~~~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl  172 (394)
                      ++.++....+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||
T Consensus        91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl  167 (302)
T 4e5w_A           91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKI  167 (302)
T ss_dssp             EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEE
T ss_pred             EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEc-CCCCEEE
Confidence            9987766778999999999999999954 456999999999999999999999999  99999999999998 6789999


Q ss_pred             cccceeeeecCCC-----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC--------------C
Q 016143          173 GDLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------------K  232 (394)
Q Consensus       173 ~Dfgla~~~~~~~-----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~--------------~  232 (394)
                      +|||++.......     .....||+.|+|||++.+ .++.++|||||||++|+|++|..|+...              .
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (302)
T 4e5w_A          168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM  247 (302)
T ss_dssp             CCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGG
T ss_pred             CcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccccc
Confidence            9999998765442     234568889999997764 5889999999999999999999886421              1


Q ss_pred             CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       233 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ....+...+..+. ....+...++++.++|.+||. +|.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          248 TVTRLVNTLKEGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHhccC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            2233344444443 233556678999999999998 9999999999886

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9e-46  Score=354.66  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=203.5

Q ss_pred             cccccceecccCceEEEEEEE-ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCC------ceeEeeeEEcC
Q 016143           26 YGRYDEILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN------IIKFYNSWVDD   98 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~-~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpn------Iv~~~~~~~~~   98 (394)
                      .|++.+.||+|+||+||+|.+ +.++..||+|++..     .....+.+.+|+.+++.++|++      |+++++++.+.
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-----CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            348899999999999999998 56899999999863     2455677889999999987664      99999988654


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC----------
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----------  166 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~----------  166 (394)
                        ..+++||||+ +++|.+++...+  .+++..++.++.||+.||.|||+++  |+||||||+|||++..          
T Consensus        90 --~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           90 --GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             --TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC---
T ss_pred             --CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCcc
Confidence              4789999999 899999998775  6899999999999999999999999  9999999999999732          


Q ss_pred             --------CCcEEEcccceeeeecCCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHH
Q 016143          167 --------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI  237 (394)
Q Consensus       167 --------~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~  237 (394)
                              ++.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|||++|..||..... .+.
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~  242 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH-HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS-KEH  242 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC-CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH-HHH
T ss_pred             ccccccccCCCceEeeCcccccCccc-cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-HHH
Confidence                    568999999999765443 345679999999997765 589999999999999999999999987443 332


Q ss_pred             HHHHhc--CCCCC----------------------------------------CCCCCCCHHHHHHHHHcCC-CCCCCCC
Q 016143          238 YKKVTS--GIKPA----------------------------------------SLSKVTDPQVKQFIEKCIV-PASLRLP  274 (394)
Q Consensus       238 ~~~i~~--~~~~~----------------------------------------~~~~~~~~~~~~li~~~L~-~p~~R~s  274 (394)
                      ...+..  +..|.                                        ......++++.+||.+||. +|.+|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            222211  11010                                        0011224678999999998 9999999


Q ss_pred             HHHHhcCCccccC
Q 016143          275 ALELLKDPFLVTD  287 (394)
Q Consensus       275 ~~elL~~p~~~~~  287 (394)
                      +.|+|+||||+..
T Consensus       323 ~~ell~hp~f~~~  335 (339)
T 1z57_A          323 LREALKHPFFDLL  335 (339)
T ss_dssp             HHHHTTSGGGGGG
T ss_pred             HHHHhcCHHHHHH
Confidence            9999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-45  Score=347.10  Aligned_cols=257  Identities=29%  Similarity=0.470  Sum_probs=202.6

Q ss_pred             CCCCccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEe
Q 016143           13 EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY   92 (394)
Q Consensus        13 ~~~~~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~   92 (394)
                      ........+..+..|++.+.||+|+||+||+|.+.   ..||+|+++...  ......+.+.+|+.++++++||||++++
T Consensus        12 ~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (289)
T 3og7_A           12 SRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFM   86 (289)
T ss_dssp             ------CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             CCCCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence            33344444444555589999999999999999754   359999986543  3466778899999999999999999999


Q ss_pred             eeEEcCCCceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEE
Q 016143           93 NSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK  171 (394)
Q Consensus        93 ~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~k  171 (394)
                      ++.. .  ..+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+|
T Consensus        87 ~~~~-~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~-~~~~~k  160 (289)
T 3og7_A           87 GYST-A--PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLH-EDNTVK  160 (289)
T ss_dssp             EEEC-S--SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTEEE
T ss_pred             eecc-C--CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCCCEE
Confidence            9542 2  3477899999999999999654 56999999999999999999999999  99999999999999 688999


Q ss_pred             EcccceeeeecCC----CCcccccCCcccCccccc----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 016143          172 IGDLGLAIVMQQP----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS  243 (394)
Q Consensus       172 l~Dfgla~~~~~~----~~~~~~gt~~y~aPE~l~----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~  243 (394)
                      |+|||++......    ......||+.|+|||++.    ..++.++|||||||++|+|++|+.||....+...+...+..
T Consensus       161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  240 (289)
T 3og7_A          161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR  240 (289)
T ss_dssp             ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred             EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence            9999999755432    234457999999999774    34788999999999999999999999988888888887776


Q ss_pred             CCCCCC---CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          244 GIKPAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       244 ~~~~~~---~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +..+..   +....++.+++||.+||. +|.+||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          241 GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            644333   344677899999999998 9999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.5e-45  Score=344.00  Aligned_cols=246  Identities=22%  Similarity=0.391  Sum_probs=204.6

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      ....|++.+.||+|+||+||+|.+. ++..||+|++.....     ..+.+.+|+.++++++||||+++++++.+  ...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~   93 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRP   93 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSS
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEEec--CCC
Confidence            3344588899999999999999875 678899999874432     22568889999999999999999998854  456


Q ss_pred             EEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      +++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++...
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTSCEEECSTTGGGGB
T ss_pred             eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEc-CCCCEEEccccccccc
Confidence            8899999999999999987 467999999999999999999999999  99999999999998 7889999999999755


Q ss_pred             cCC---CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          182 QQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       182 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      ...   ......+|+.|+|||++. ..++.++||||||+++|+|++ |+.||.. .+.......+..+... ..+...++
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~  248 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASE  248 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCH
T ss_pred             cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccCC-CCCCcCCH
Confidence            433   223345788999999876 468999999999999999998 9999987 5566666677666433 24556688


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+.++|.+||. +|.+||++.++++|
T Consensus       249 ~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          249 KVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHHH
Confidence            99999999998 99999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.4e-45  Score=355.76  Aligned_cols=254  Identities=20%  Similarity=0.328  Sum_probs=202.3

Q ss_pred             ccccccceecccCceEEEEEEEccCC-eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCC------ceeEeeeEEc
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN------IIKFYNSWVD   97 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpn------Iv~~~~~~~~   97 (394)
                      ..|++.+.||+|+||+||+|.+..++ ..||+|++..     .....+.+.+|+.+++.++|++      ++.+++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            33488899999999999999998777 7999999863     2455677888999999998766      8889988754


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe-----------
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-----------  164 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~-----------  164 (394)
                      .  ..+++||||+ +++|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+|||++           
T Consensus        94 ~--~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           94 H--GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             T--TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC
T ss_pred             C--CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccc
Confidence            4  4789999999 56666666654  36999999999999999999999999  99999999999993           


Q ss_pred             -------CCCCcEEEcccceeeeecCCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHH
Q 016143          165 -------GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ  236 (394)
Q Consensus       165 -------~~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~  236 (394)
                             ..++.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||........
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH-HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccccccCCCcEEEeecCcccccccc-ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                   15789999999999765443 345679999999997754 689999999999999999999999987444332


Q ss_pred             HHHHHhc--CCCCCC----------------------------------------CCCCCCHHHHHHHHHcCC-CCCCCC
Q 016143          237 IYKKVTS--GIKPAS----------------------------------------LSKVTDPQVKQFIEKCIV-PASLRL  273 (394)
Q Consensus       237 ~~~~i~~--~~~~~~----------------------------------------~~~~~~~~~~~li~~~L~-~p~~R~  273 (394)
                      + ..+..  +..|..                                        .....++++.+||.+||. +|.+||
T Consensus       248 ~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          248 L-VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             H-HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             H-HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            2 22211  111100                                        001113578899999998 999999


Q ss_pred             CHHHHhcCCccccCCCC
Q 016143          274 PALELLKDPFLVTDNPK  290 (394)
Q Consensus       274 s~~elL~~p~~~~~~~~  290 (394)
                      |+.|+|+||||+...+.
T Consensus       327 t~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          327 TLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             CHHHHTTSGGGGGCCHH
T ss_pred             CHHHHhcChhhcCCChh
Confidence            99999999999976543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-45  Score=362.05  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=202.2

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CC-----CceeEeeeEEc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HE-----NIIKFYNSWVD   97 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hp-----nIv~~~~~~~~   97 (394)
                      ++| ++.+.||+|+||+||+|.+..+++.||+|++..     .......+..|+.+++.++ |+     +|+++++++..
T Consensus        54 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           54 DRY-EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             eeE-EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            445 788999999999999999999999999999863     2345567788999998885 55     49999998865


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEcc
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGD  174 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~-~~~~~kl~D  174 (394)
                      .  ..+++||||+. ++|.+++...  +.+++..++.++.||+.||.|||++..+|+||||||+|||++. .++.+||+|
T Consensus       128 ~--~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          128 R--NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             T--TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             C--CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            4  57899999995 5999998876  4699999999999999999999964334999999999999952 467899999


Q ss_pred             cceeeeecCCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc--CCCCCC--
Q 016143          175 LGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPAS--  249 (394)
Q Consensus       175 fgla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~--~~~~~~--  249 (394)
                      ||++...... .....||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+..... ....+..  +..+..  
T Consensus       205 FG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  282 (382)
T 2vx3_A          205 FGSSCQLGQR-IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD-QMNKIVEVLGIPPAHIL  282 (382)
T ss_dssp             CTTCEETTCC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHH
T ss_pred             ccCceecccc-cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence            9999876543 345679999999997765 58999999999999999999999998744433 3333322  111100  


Q ss_pred             ------------CCC-------------------C---------------------------CCHHHHHHHHHcCC-CCC
Q 016143          250 ------------LSK-------------------V---------------------------TDPQVKQFIEKCIV-PAS  270 (394)
Q Consensus       250 ------------~~~-------------------~---------------------------~~~~~~~li~~~L~-~p~  270 (394)
                                  ++.                   .                           .++++++||.+||. +|.
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  362 (382)
T 2vx3_A          283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK  362 (382)
T ss_dssp             TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred             HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence                        000                   0                           01378999999998 999


Q ss_pred             CCCCHHHHhcCCccccC
Q 016143          271 LRLPALELLKDPFLVTD  287 (394)
Q Consensus       271 ~R~s~~elL~~p~~~~~  287 (394)
                      +|||+.|+|+||||+..
T Consensus       363 ~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          363 TRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TSCCHHHHTTSGGGCC-
T ss_pred             hCCCHHHHhcCcccccC
Confidence            99999999999999864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-45  Score=353.45  Aligned_cols=254  Identities=23%  Similarity=0.410  Sum_probs=187.4

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHH-HHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~-~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      .|++.+.||+|+||+||+|.++.+|+.||+|.+....   ......++..|+. +++.++||||+++++++.++  ..++
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~~   97 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDCW   97 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEEE
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--CceE
Confidence            3478899999999999999999999999999987542   2344455666666 77888999999999998654  4788


Q ss_pred             EEEcccCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          105 MITELFTSGSLRQYRKK-----HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~-----~~~l~~~~~~~i~~qil~~L~~LH~~-~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      +||||+.+ +|.+++..     ...+++..+..++.|++.||.|||++ +  |+||||||+||+++ .++.+||+|||++
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~  173 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNIKLCDFGIS  173 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEE-TTTEEEECCCSSS
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEc-CCCCEEEccCCCc
Confidence            99999975 88887763     56799999999999999999999998 8  99999999999998 7889999999999


Q ss_pred             eeecCCC-CcccccCCcccCccccc-----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC---CC
Q 016143          179 IVMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---AS  249 (394)
Q Consensus       179 ~~~~~~~-~~~~~gt~~y~aPE~l~-----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~---~~  249 (394)
                      ....... .....||+.|+|||++.     ..++.++|||||||++|+|++|+.||............+..+..+   ..
T Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred             eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence            7665443 23347999999999873     358899999999999999999999998744333333333333222   11


Q ss_pred             CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       250 ~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      .....++.+.+||.+||. +|.+||++.++|+||||....
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence            224578899999999998 999999999999999998643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-46  Score=353.93  Aligned_cols=251  Identities=22%  Similarity=0.401  Sum_probs=205.7

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCH--HHHHHHHHHHHHHHcC----CCCCceeEeeeEEc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSL----KHENIIKFYNSWVD   97 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~--~~~~~~~~E~~~l~~L----~hpnIv~~~~~~~~   97 (394)
                      ++| ++.+.||+|+||+||+|.+..+++.||+|++.........  .....+.+|+.+++++    +||||+++++++.+
T Consensus        31 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           31 AEY-RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             --C-EEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hce-EEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            444 8899999999999999999999999999998755432211  2234466799999998    89999999998855


Q ss_pred             CCCceEEEEEcc-cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccc
Q 016143           98 DTNRTINMITEL-FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG  176 (394)
Q Consensus        98 ~~~~~~~lV~e~-~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfg  176 (394)
                      .  ...++|+|| +.+++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+||+++..++.+||+|||
T Consensus       110 ~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg  185 (312)
T 2iwi_A          110 Q--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFG  185 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCS
T ss_pred             C--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcc
Confidence            4  457789999 789999999998888999999999999999999999999  99999999999998667899999999


Q ss_pred             eeeeecCCCCcccccCCcccCcccccc-cC-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          177 LAIVMQQPTARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       177 la~~~~~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      ++............||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||...   ..    +...  ...++...
T Consensus       186 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~----~~~~--~~~~~~~~  256 (312)
T 2iwi_A          186 SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---QE----ILEA--ELHFPAHV  256 (312)
T ss_dssp             SCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HH----HHHT--CCCCCTTS
T ss_pred             hhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---HH----Hhhh--ccCCcccC
Confidence            998887766667789999999998764 34 45899999999999999999999652   22    1111  22345567


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ++.++++|.+||. +|.+||++.|+|+||||+...
T Consensus       257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            8999999999998 999999999999999998653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.4e-45  Score=341.77  Aligned_cols=242  Identities=20%  Similarity=0.416  Sum_probs=206.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.+. ++..||+|.+.....     ..+.+.+|+.++++++||||+++++++.++  ..+++|
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   83 (269)
T 4hcu_A           12 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV   83 (269)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEEE
T ss_pred             ceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-----CHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CceEEE
Confidence            378899999999999999986 578899999874332     225688899999999999999999988543  468899


Q ss_pred             EcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      |||+++++|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++...... 
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGGCEEECCTTGGGGBCCHH
T ss_pred             EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEc-CCCCEEeccccccccccccc
Confidence            9999999999999765 45999999999999999999999999  99999999999998 6789999999999755433 


Q ss_pred             --CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          185 --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       185 --~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                        ......||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+.......+..+..+ ..+...++.+.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVYQ  238 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHH
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCHHHHH
Confidence              233445788999999876 468999999999999999999 9999987 5666777777766433 345567899999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcC
Q 016143          261 FIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++.+||. +|.+||++.+++++
T Consensus       239 li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          239 IMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCCcccCcCHHHHHHH
Confidence            9999998 99999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-45  Score=354.38  Aligned_cols=247  Identities=21%  Similarity=0.299  Sum_probs=208.8

Q ss_pred             cccccccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      ++| ++.+.||+|+||+||+|.+.     .++..||+|.+....   .....+.+.+|+.++++++||||+++++++.+ 
T Consensus        47 ~~~-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-  121 (343)
T 1luf_A           47 NNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCAV-  121 (343)
T ss_dssp             GGC-EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             HHC-eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-
Confidence            444 78899999999999999987     456899999986432   35667789999999999999999999998854 


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 016143           99 TNRTINMITELFTSGSLRQYRKKH------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHR  154 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~------------------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHr  154 (394)
                       ...+++||||+++|+|.+++...                        ..+++.+++.++.||+.||.|||+++  |+||
T Consensus       122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~  198 (343)
T 1luf_A          122 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR  198 (343)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred             -CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecC
Confidence             34678899999999999999874                        56999999999999999999999999  9999


Q ss_pred             CCCCCcEEEeCCCCcEEEcccceeeeecCC----CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCC
Q 016143          155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY  228 (394)
Q Consensus       155 DLkp~NIll~~~~~~~kl~Dfgla~~~~~~----~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf  228 (394)
                      ||||+||+++ .++.+||+|||++......    ......||+.|+|||++. ..++.++|||||||++|+|++ |..||
T Consensus       199 Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          199 DLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             CCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCcceEEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            9999999998 6889999999999655332    223456899999999776 468999999999999999999 99999


Q ss_pred             CCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          229 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       229 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+ .+..++...+..+..+ ..+...++.+.++|.+||. +|.+||++.+++++
T Consensus       278 ~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          278 YG-MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC-CChHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            87 5566666777666433 3456778999999999998 99999999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-45  Score=357.50  Aligned_cols=247  Identities=27%  Similarity=0.418  Sum_probs=210.7

Q ss_pred             cccccccceecccCceEEEEEEEcc-------CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW   95 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~   95 (394)
                      ++| ++.+.||+|+||+||+|.+..       .+..||+|++...   ......+++.+|+.+++++ +||||+++++++
T Consensus        69 ~~y-~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           69 DRL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhe-EeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            444 788999999999999998753       3468999998643   2456678899999999999 899999999988


Q ss_pred             EcCCCceEEEEEcccCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 016143           96 VDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD  159 (394)
Q Consensus        96 ~~~~~~~~~lV~e~~~~gsL~~~i~~~~----------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~  159 (394)
                      .++  ..+++||||+++|+|.+++....                .+++..++.++.||+.||.|||+++  |+||||||+
T Consensus       145 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~  220 (382)
T 3tt0_A          145 TQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAAR  220 (382)
T ss_dssp             CSS--SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred             ccC--CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcc
Confidence            544  46788999999999999998754                4999999999999999999999999  999999999


Q ss_pred             cEEEeCCCCcEEEcccceeeeecCC----CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCC
Q 016143          160 NIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKN  233 (394)
Q Consensus       160 NIll~~~~~~~kl~Dfgla~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~  233 (394)
                      |||++ .++.+||+|||++......    ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+ .+
T Consensus       221 NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~-~~  298 (382)
T 3tt0_A          221 NVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VP  298 (382)
T ss_dssp             GEEEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CC
T ss_pred             eEEEc-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CC
Confidence            99998 6889999999999766543    2233457889999997765 58999999999999999999 9999987 56


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       234 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..++...+..+..+. .+...++++.+||.+||. +|.+||++.+++++
T Consensus       299 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          299 VEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            777777777765433 455678999999999998 99999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-45  Score=361.18  Aligned_cols=245  Identities=22%  Similarity=0.358  Sum_probs=207.9

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      .+++.+.||+|+||+||+|.++.++..||+|.+...   ...+..+.+.+|+.+|++++||||+++++++.++  ..+++
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l  189 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYI  189 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT---SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS--SSCEE
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc---CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC--CCcEE
Confidence            347889999999999999999999999999998632   2355667789999999999999999999988543  46889


Q ss_pred             EEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          106 ITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      ||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++......
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~-~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVT-EKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECTTS
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEc-CCCcEEECcCCCceecCCC
Confidence            999999999999998654 5999999999999999999999999  99999999999998 7889999999999765443


Q ss_pred             CC----cccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          185 TA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       185 ~~----~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                      ..    ....+++.|+|||++. +.++.++|||||||++|||++ |..||.+ .+..+....+..+... ..+...++++
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l  344 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-LSNQQTREFVEKGGRL-PCPELCPDAV  344 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT-SCHHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHH
Confidence            21    1223577899999876 468999999999999999998 9999987 4556666666665433 3456678999


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhc
Q 016143          259 KQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .++|.+||. +|.+|||+.++++
T Consensus       345 ~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          345 FRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            999999998 9999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=355.01  Aligned_cols=248  Identities=24%  Similarity=0.378  Sum_probs=206.6

Q ss_pred             cccccccceecccCceEEEEEEE-----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD   97 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~   97 (394)
                      ++| ++.+.||+|+||+||+|.+     ..++..||+|.+....   .....+.+.+|+.+|+++ +||||+++++++.+
T Consensus        45 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           45 ENL-EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHc-eeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            444 7889999999999999997     3467789999987432   234557789999999999 89999999998855


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKHK-----------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR  154 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~~-----------------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHr  154 (394)
                      .  ..+++||||+++|+|.+++....                       .+++..++.++.||+.||.|||++|  |+||
T Consensus       121 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~  196 (344)
T 1rjb_A          121 S--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR  196 (344)
T ss_dssp             S--SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred             C--CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Confidence            4  46888999999999999998753                       2799999999999999999999999  9999


Q ss_pred             CCCCCcEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCC
Q 016143          155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY  228 (394)
Q Consensus       155 DLkp~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf  228 (394)
                      ||||+|||++ .++.+||+|||++.......    .....||+.|+|||++. +.++.++|||||||++|+|+| |..||
T Consensus       197 Dikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          197 DLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCChhhEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            9999999999 78899999999997664432    22345788999999775 468999999999999999998 99999


Q ss_pred             CCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          229 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       229 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+..........+..+..+ ..+...++++.++|.+||. +|.+||++.+++++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            8866666666666665433 3455678999999999998 99999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-45  Score=348.74  Aligned_cols=254  Identities=20%  Similarity=0.261  Sum_probs=202.6

Q ss_pred             ccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        19 ~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      .....++| ++.+.||+|+||+||+|.+..++..||+|++..... ......+.+.+|+.++++++||||+++++++.++
T Consensus        29 ~~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 2h34_A           29 EGTQFGPY-RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID  106 (309)
T ss_dssp             -----CCE-EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             CCcEeccE-EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence            33444666 888999999999999999999999999999865432 3455668899999999999999999999988654


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                        ..+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++
T Consensus       107 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~~  181 (309)
T 2h34_A          107 --GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVS-ADDFAYLVDFGIA  181 (309)
T ss_dssp             --TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSCCC-
T ss_pred             --CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEc-CCCCEEEecCccC
Confidence              578999999999999999998888999999999999999999999999  99999999999998 6789999999999


Q ss_pred             eeecCCC---CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCC
Q 016143          179 IVMQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKV  253 (394)
Q Consensus       179 ~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~-~~~~~~~  253 (394)
                      .......   .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+...+...+..... +...+..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~  260 (309)
T 2h34_A          182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPG  260 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS-CHHHHHHHHHHSCCCCGGGTSTT
T ss_pred             ccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC-chHHHHHHHhccCCCCccccCCC
Confidence            7655432   234579999999998765 588999999999999999999999986 334444445544332 3345566


Q ss_pred             CCHHHHHHHHHcCC-CCCCCC-CHHHHhc
Q 016143          254 TDPQVKQFIEKCIV-PASLRL-PALELLK  280 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~-s~~elL~  280 (394)
                      .++++.++|.+||. +|.+|| ++.+++.
T Consensus       261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          261 IPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             CCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            78899999999998 999999 6777665

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.8e-45  Score=348.03  Aligned_cols=255  Identities=21%  Similarity=0.384  Sum_probs=196.8

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++.....  .....+.+.++..+++.++||||+++++++.++  ..+
T Consensus        25 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~   99 (318)
T 2dyl_A           25 NDL-ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TDV   99 (318)
T ss_dssp             GGE-EEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred             ccc-cccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcE
Confidence            445 677899999999999999999999999999875431  233344455566678899999999999998654  478


Q ss_pred             EEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          104 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~-~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      ++||||+ ++.+..+... ...+++..++.++.||+.||.|||++ |  |+||||||+||+++ .++.+||+|||++...
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD-ERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEEC-TTSCEEECCCTTC---
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEEC-CCCCEEEEECCCchhc
Confidence            9999999 5667666654 56799999999999999999999995 8  99999999999998 7889999999999765


Q ss_pred             cCC-CCcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC-CCCCC
Q 016143          182 QQP-TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKV  253 (394)
Q Consensus       182 ~~~-~~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~-~~~~~  253 (394)
                      ... ......||+.|+|||++.      ..++.++|||||||++|+|++|+.||....+.......+..+..+. .....
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG  255 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence            443 334457999999999874      3588999999999999999999999988777766666666554332 12235


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      .++++.++|.+||. +|.+||++.++|+||||+..
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            78999999999998 99999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-45  Score=359.34  Aligned_cols=255  Identities=25%  Similarity=0.371  Sum_probs=203.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-----------CCCceeEe
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----------HENIIKFY   92 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-----------hpnIv~~~   92 (394)
                      ++| ++.+.||+|+||+||+|.+..+++.||+|++..     .....+.+.+|+.++++++           ||||++++
T Consensus        19 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           19 ARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CeE-EEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            455 889999999999999999999999999999863     2345567888999999886           89999999


Q ss_pred             eeEEcCC--CceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeC--
Q 016143           93 NSWVDDT--NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNG--  165 (394)
Q Consensus        93 ~~~~~~~--~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~-~~~ivHrDLkp~NIll~~--  165 (394)
                      +++....  ...+++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++ |  |+||||||+|||++.  
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccC
Confidence            9886542  34789999999 89999999874  4599999999999999999999998 9  999999999999952  


Q ss_pred             ---CCCcEEEcccceeeeecCCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCC-----HHH
Q 016143          166 ---NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN-----PAQ  236 (394)
Q Consensus       166 ---~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~-----~~~  236 (394)
                         ..+.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....     ...
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CCcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence               3448999999999776544 344579999999998765 589999999999999999999999975321     111


Q ss_pred             HHHHHhc--CCCC--------------------------------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCH
Q 016143          237 IYKKVTS--GIKP--------------------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPA  275 (394)
Q Consensus       237 ~~~~i~~--~~~~--------------------------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~  275 (394)
                      ....+..  +..|                                      ..++...++++++||++||. +|.+|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            1111111  1000                                      01122335688999999998 99999999


Q ss_pred             HHHhcCCccccCC
Q 016143          276 LELLKDPFLVTDN  288 (394)
Q Consensus       276 ~elL~~p~~~~~~  288 (394)
                      .|+|+||||+...
T Consensus       329 ~ell~hp~f~~~~  341 (373)
T 1q8y_A          329 GGLVNHPWLKDTL  341 (373)
T ss_dssp             HHHHTCGGGTTCT
T ss_pred             HHHhhChhhhccc
Confidence            9999999998753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=8.4e-45  Score=337.74  Aligned_cols=244  Identities=22%  Similarity=0.389  Sum_probs=205.5

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.++ ++..||+|.+.....     ..+.+.+|+.++++++||||+++++++.+  ...+
T Consensus         8 ~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~   78 (268)
T 3sxs_A            8 EEI-TLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVCSK--EYPI   78 (268)
T ss_dssp             GGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSE
T ss_pred             hhe-eeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCce
Confidence            344 88899999999999999775 678899999875432     22568889999999999999999998843  4568


Q ss_pred             EEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+++++|.+++...+ .+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD-RDLCVKVSDFGMTRYVL  155 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEEC-TTCCEEECCTTCEEECC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEEC-CCCCEEEccCccceecc
Confidence            89999999999999998754 4999999999999999999999999  99999999999998 78899999999998765


Q ss_pred             CCCC---cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          183 QPTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       183 ~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      ....   ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.. .+.......+..+... ..+...++.
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~  233 (268)
T 3sxs_A          156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL-YTNSEVVLKVSQGHRL-YRPHLASDT  233 (268)
T ss_dssp             TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTSCHH
T ss_pred             hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc-cChHHHHHHHHcCCCC-CCCCcChHH
Confidence            5432   23446778999998765 58999999999999999999 9999987 4555555666555432 234557889


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          258 VKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +.+++.+||. +|.+||++.+++++
T Consensus       234 l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          234 IYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999998 99999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.6e-46  Score=365.58  Aligned_cols=254  Identities=23%  Similarity=0.360  Sum_probs=207.6

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      ..++.|++.+.||+|+||+||+|.++.+|+.||+|++.....   ....+.+.+|+.+|++++||||+++++++.+....
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            345556899999999999999999999999999999875443   22346678899999999999999999998877766


Q ss_pred             eEEEEEcccCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE----eCCCCcEEEcc
Q 016143          102 TINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVKIGD  174 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~---~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll----~~~~~~~kl~D  174 (394)
                      .+++||||+++|+|.+++....   .+++..++.++.||+.||.|||+++  |+||||||+|||+    + .++.+||+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~D  159 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTD  159 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTT-SCEEEEECC
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCC-CceeEEEec
Confidence            8899999999999999998654   3999999999999999999999999  9999999999999    5 566799999


Q ss_pred             cceeeeecCC-CCcccccCCcccCccccc---------ccCCCcCcchhhhhHHHHHHhcCCCCCCCC---CHHHHHHHH
Q 016143          175 LGLAIVMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKV  241 (394)
Q Consensus       175 fgla~~~~~~-~~~~~~gt~~y~aPE~l~---------~~~~~~~DIwSlG~il~elltg~~Pf~~~~---~~~~~~~~i  241 (394)
                      ||++...... ......||+.|+|||++.         ..++.++|||||||++|||++|+.||....   ...++...+
T Consensus       160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             GGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             CCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            9999876544 344567999999999875         357889999999999999999999996422   223444444


Q ss_pred             hcCCCCC-----------------------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          242 TSGIKPA-----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       242 ~~~~~~~-----------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..+..+.                       .+....++.+.++|.+||. +|.+|+++.+++++
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            4433221                       1112234578999999998 99999999998653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.3e-45  Score=348.05  Aligned_cols=248  Identities=23%  Similarity=0.390  Sum_probs=208.3

Q ss_pred             cccccccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      ...|++.+.||+|+||+||+|.+.     .++..||+|.+....   .......+.+|+.+++.++||||+++++++.+.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            344488999999999999999876     467899999986432   355667799999999999999999999988543


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 016143           99 TNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG  168 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~----------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~  168 (394)
                        ...++||||+++|+|.+++...          ..+++..++.++.||+.||.|||++|  |+||||||+||+++ .++
T Consensus       101 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~-~~~  175 (322)
T 1p4o_A          101 --QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDF  175 (322)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTC
T ss_pred             --CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEc-CCC
Confidence              4678899999999999998753          35799999999999999999999999  99999999999998 788


Q ss_pred             cEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHh
Q 016143          169 EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT  242 (394)
Q Consensus       169 ~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~  242 (394)
                      .+||+|||++.......    .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.. .+..++...+.
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~  254 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVM  254 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHHHHH
Confidence            99999999997554332    223457899999998764 58999999999999999999 8999977 55666666666


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+..+ ..+...++.+.++|.+||. +|.+||++.+++++
T Consensus       255 ~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          255 EGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             TTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            65433 2455678899999999998 99999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.3e-45  Score=346.26  Aligned_cols=249  Identities=23%  Similarity=0.373  Sum_probs=210.4

Q ss_pred             CcccccccceecccCceEEEEEEE-----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEE
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV   96 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~   96 (394)
                      .++| ++.+.||+|+||+||+|.+     ..++..||+|.+....   .....+.+.+|+.+++++ +||||+++++++.
T Consensus        22 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           22 RNRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhhh-hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            3455 8889999999999999985     4578899999986432   345668899999999999 9999999999885


Q ss_pred             cCCCceEEEEEcccCCCcHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 016143           97 DDTNRTINMITELFTSGSLRQYRKKHK------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC  158 (394)
Q Consensus        97 ~~~~~~~~lV~e~~~~gsL~~~i~~~~------------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp  158 (394)
                      +.  ...++||||+++|+|.+++....                  .+++..++.++.||+.||.|||+++  |+||||||
T Consensus        98 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp  173 (313)
T 1t46_A           98 IG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA  173 (313)
T ss_dssp             SS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred             cC--CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCcc
Confidence            54  45788999999999999998764                  3899999999999999999999999  99999999


Q ss_pred             CcEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCC
Q 016143          159 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECK  232 (394)
Q Consensus       159 ~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~  232 (394)
                      +||+++ .++.+||+|||++.......    .....||+.|+|||++. ..++.++|||||||++|+|++ |..||....
T Consensus       174 ~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          174 RNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ceEEEc-CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            999998 78899999999997665443    22345788999999765 468999999999999999999 999998866


Q ss_pred             CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       233 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ........+..+..+ ..+...++++.++|.+||. +|.+||++.+++++
T Consensus       253 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          253 VDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHhccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            656666666655433 2345678999999999998 99999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.6e-45  Score=348.29  Aligned_cols=251  Identities=25%  Similarity=0.385  Sum_probs=211.2

Q ss_pred             CcccccccceecccCceEEEEEE----EccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      ..+.|++.+.||+|+||+||+|.    +..++..||+|++...    .....+.+.+|+.++++++||||+++++++..+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            34455899999999999999998    5778999999998643    356667899999999999999999999998877


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143           99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                      ....+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||+
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~  173 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADFGL  173 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCGGG
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEEC-CCCCEEEccccc
Confidence            778899999999999999999874 56999999999999999999999999  99999999999998 688999999999


Q ss_pred             eeeecCCC-----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCC--------------HHHH
Q 016143          178 AIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--------------PAQI  237 (394)
Q Consensus       178 a~~~~~~~-----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~--------------~~~~  237 (394)
                      +.......     .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.....              ...+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            98765432     233468889999998765 488999999999999999999999854221              1233


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       238 ~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ...+..+. ....+...++.+.++|.+||. +|.+||++.+++++
T Consensus       254 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          254 LELLEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            44444443 233456678999999999998 99999999999764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-44  Score=341.45  Aligned_cols=246  Identities=21%  Similarity=0.337  Sum_probs=206.0

Q ss_pred             cccccccc-eecccCceEEEEEE--EccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           24 CRYGRYDE-ILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        24 ~ry~r~~~-~LG~G~~g~Vy~a~--~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      .+| ++.+ .||+|+||+||+|.  +..++..||+|++....  ......+.+.+|+.+++.++||||+++++++. .  
T Consensus        16 ~~y-~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~--   89 (291)
T 1xbb_A           16 KLL-TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICE-A--   89 (291)
T ss_dssp             GGE-EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-S--
T ss_pred             hhh-hhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-C--
Confidence            445 6666 99999999999994  46678999999987543  23345678999999999999999999999883 2  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ..+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++..
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKA  166 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEE
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEe-CCCcEEEccCCccee
Confidence            357899999999999999999888999999999999999999999999  99999999999999 678999999999987


Q ss_pred             ecCCCC-----cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 016143          181 MQQPTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       181 ~~~~~~-----~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      ......     ....+|+.|+|||++.+ .++.++||||||+++|+|++ |+.||.. .+..++...+..+..+ ..+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~  244 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAG  244 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTT
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCC
Confidence            654321     22346789999998764 58899999999999999999 9999987 5566677777666433 35567


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .++.+.++|.+||. +|.+||++.++++
T Consensus       245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          245 CPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            78999999999998 9999999999886

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.4e-45  Score=349.94  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=207.0

Q ss_pred             CCCcccccccceecccCceEEEEEEEccCCeEE--EEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEc
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEV--AWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD   97 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~v--aiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~   97 (394)
                      -..++| ++.+.||+|+||+||+|.++.++..+  |+|.+....   .....+.+.+|+.+++++ +||||+++++++.+
T Consensus        22 ~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   97 (327)
T 1fvr_A           22 LDWNDI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   97 (327)
T ss_dssp             CCGGGC-EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             ccHHHc-cceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence            334555 88899999999999999999999866  888876322   234556788999999999 89999999999865


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI  161 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~~----------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NI  161 (394)
                      .  ..+++||||+++++|.+++...+                .+++..++.++.||+.||.|||+++  |+||||||+||
T Consensus        98 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NI  173 (327)
T 1fvr_A           98 R--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI  173 (327)
T ss_dssp             T--TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred             C--CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceE
Confidence            4  57899999999999999998764                6999999999999999999999999  99999999999


Q ss_pred             EEeCCCCcEEEcccceeeeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHH
Q 016143          162 FVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY  238 (394)
Q Consensus       162 ll~~~~~~~kl~Dfgla~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~  238 (394)
                      +++ .++.+||+|||++...... ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+ .+...+.
T Consensus       174 l~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~  251 (327)
T 1fvr_A          174 LVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELY  251 (327)
T ss_dssp             EEC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHH
T ss_pred             EEc-CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-CcHHHHH
Confidence            998 6789999999999744322 2233457889999998765 48999999999999999998 9999977 5667777


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       239 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..+..+..+ ..+...++++.++|.+||. +|.+||++.+++++
T Consensus       252 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          252 EKLPQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHGGGTCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            777766433 2445678999999999998 99999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.9e-44  Score=342.54  Aligned_cols=252  Identities=31%  Similarity=0.522  Sum_probs=202.4

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .++| ++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+.+|+.++++++||||+++++++.+.  ..
T Consensus        31 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~  106 (310)
T 2wqm_A           31 LANF-RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NE  106 (310)
T ss_dssp             GGGE-EEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred             ccce-EEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--Cc
Confidence            3444 888999999999999999999999999999875432 3456778899999999999999999999998754  47


Q ss_pred             EEEEEcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          103 INMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      +++||||+.+++|.+++..    ...+++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~-~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLG  183 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCC---
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEc-CCCCEEEEeccce
Confidence            8899999999999999874    456999999999999999999999999  99999999999998 7889999999999


Q ss_pred             eeecCCC--CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCCCCCCCCC
Q 016143          179 IVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC-KNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       179 ~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~-~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      .......  .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+. .+...+...+.....+.......
T Consensus       184 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (310)
T 2wqm_A          184 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY  263 (310)
T ss_dssp             ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTS
T ss_pred             eeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccccc
Confidence            7654432  334579999999997764 5889999999999999999999999753 34556666666655554445667


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +++++++|.+||. +|.+||++.+++++
T Consensus       264 ~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          264 SEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            8999999999998 99999999999873

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1e-44  Score=348.49  Aligned_cols=247  Identities=26%  Similarity=0.423  Sum_probs=208.6

Q ss_pred             ccccccceecccCceEEEEEEEc-------cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV   96 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~   96 (394)
                      ..|++.+.||+|+||+||+|.+.       .++..||+|++....   .....+.+.+|+.+++++ +||||+++++++.
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            34488999999999999999875       467889999986432   456678899999999999 8999999999885


Q ss_pred             cCCCceEEEEEcccCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCc
Q 016143           97 DDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN  160 (394)
Q Consensus        97 ~~~~~~~~lV~e~~~~gsL~~~i~~~~----------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~N  160 (394)
                      +  ...+++||||+++|+|.+++....                .+++..++.++.||+.||.|||+++  |+||||||+|
T Consensus       112 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~N  187 (334)
T 2pvf_A          112 Q--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARN  187 (334)
T ss_dssp             S--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred             c--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccce
Confidence            4  346889999999999999998754                3899999999999999999999999  9999999999


Q ss_pred             EEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCH
Q 016143          161 IFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNP  234 (394)
Q Consensus       161 Ill~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~  234 (394)
                      |+++ .++.+||+|||++.......    .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+ .+.
T Consensus       188 Ill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~  265 (334)
T 2pvf_A          188 VLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPV  265 (334)
T ss_dssp             EEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCH
T ss_pred             EEEc-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc-CCH
Confidence            9998 78899999999998765432    233457889999997754 58999999999999999999 9999977 566


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       235 ~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .++...+..+..+ ..+...++++.++|.+||. +|.+||++.+++++
T Consensus       266 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          266 EELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6777777666433 3455678999999999998 99999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.3e-45  Score=346.89  Aligned_cols=253  Identities=21%  Similarity=0.345  Sum_probs=200.9

Q ss_pred             CCcccccccceecccCceEEEEEEEcc---CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      ...+.|++.+.||+|+||+||+|.+..   ++..||+|.+....  ......+.+.+|+.++++++||||+++++++.+.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN--SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc--cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            334556889999999999999998765   56689999987543  2456678899999999999999999999998765


Q ss_pred             CCc---eEEEEEcccCCCcHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 016143           99 TNR---TINMITELFTSGSLRQYRKK------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE  169 (394)
Q Consensus        99 ~~~---~~~lV~e~~~~gsL~~~i~~------~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~  169 (394)
                      ...   ..++||||+++++|.+++..      ...+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLR-DDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEEC-TTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCc
Confidence            433   46899999999999999843      356999999999999999999999999  99999999999998 6889


Q ss_pred             EEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhc
Q 016143          170 VKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS  243 (394)
Q Consensus       170 ~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~  243 (394)
                      +||+|||++.......    .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.. .+...+...+..
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~  264 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG-VQNHEMYDYLLH  264 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHT
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc-CCHHHHHHHHHc
Confidence            9999999997654331    233457889999998765 58999999999999999999 8999977 444555666666


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          244 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       244 ~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +..+ ..+...++.+.++|.+||. +|.+||++.+++++
T Consensus       265 ~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          265 GHRL-KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TCCC-CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCC-CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5433 3455678899999999998 99999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.7e-45  Score=350.15  Aligned_cols=249  Identities=24%  Similarity=0.396  Sum_probs=210.9

Q ss_pred             cccccccceecccCceEEEEEEE-----ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD   97 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~   97 (394)
                      ++| ++.+.||+|+||+||+|.+     ..+++.||+|.+....   .....+.+.+|+.+++++ +||||+++++++..
T Consensus        27 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           27 DRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hhe-eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            444 8899999999999999985     4577899999986432   355667899999999999 79999999998764


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKHKN----------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI  161 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~~~----------------l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NI  161 (394)
                      . ...+++||||+++++|.+++.....                +++..++.++.||+.||.|||+++  |+||||||+||
T Consensus       103 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Ni  179 (316)
T 2xir_A          103 P-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNI  179 (316)
T ss_dssp             T-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred             C-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceE
Confidence            4 3468899999999999999987654                899999999999999999999999  99999999999


Q ss_pred             EEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHH
Q 016143          162 FVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPA  235 (394)
Q Consensus       162 ll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~  235 (394)
                      +++ .++.+||+|||++.......    .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.....
T Consensus       180 l~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          180 LLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             EEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             EEC-CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            998 67899999999997654432    223568899999997754 58999999999999999998 999998866666


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       236 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+...+..+..+ ..+...++.+.++|.+||. +|.+||++.++++|
T Consensus       259 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            666666665433 3455678999999999998 99999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.7e-45  Score=351.89  Aligned_cols=246  Identities=27%  Similarity=0.469  Sum_probs=198.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEE----EEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      ++| ++.+.||+|+||+||+|.+..++..+    |+|.+....   .....+++.+|+.++++++||||+++++++.+. 
T Consensus        15 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   89 (327)
T 3poz_A           15 TEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   89 (327)
T ss_dssp             GGE-EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred             HHc-ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence            444 88899999999999999998887765    666654322   234456788999999999999999999998754 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                        ..++|+||+.+|+|.+++... ..+++..++.|+.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++
T Consensus        90 --~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a  164 (327)
T 3poz_A           90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLA  164 (327)
T ss_dssp             --SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTHH
T ss_pred             --CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEEC-CCCCEEEccCcce
Confidence              367899999999999999874 56999999999999999999999999  99999999999998 6889999999999


Q ss_pred             eeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 016143          179 IVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK  252 (394)
Q Consensus       179 ~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  252 (394)
                      +......    .....||+.|+|||++.+ .++.++|||||||++|+|++ |+.||.+ .+...+...+..+... ..+.
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~  242 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPP  242 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCT
T ss_pred             eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHHHcCCCC-CCCc
Confidence            7664432    223456889999997764 58999999999999999999 9999976 4445566666655433 2455


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..+..+.+++.+||. +|.+||++.+++.+
T Consensus       243 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          243 ICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            678899999999998 99999999999876

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.2e-45  Score=341.86  Aligned_cols=246  Identities=25%  Similarity=0.437  Sum_probs=196.4

Q ss_pred             cccccccceecccCceEEEEEEEccC---CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      ++| ++.+.||+|+||+||+|.+..+   +..||+|.+...   ......+.+.+|+.++++++||||+++++++.+   
T Consensus        15 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---   87 (281)
T 1mp8_A           15 ERI-ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---   87 (281)
T ss_dssp             GGE-EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             HHe-EEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---
Confidence            444 8899999999999999998654   567999987532   245667889999999999999999999998732   


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          101 RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ..+++||||+++++|.+++...+ .+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSR  164 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC-----
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEEC-CCCCEEECcccccc
Confidence            35778999999999999998764 6999999999999999999999999  99999999999999 67899999999997


Q ss_pred             eecCCC---CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          180 VMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       180 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      ......   .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+. +..+....+..+..+ ..+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-~~~~~~~~i~~~~~~-~~~~~~  242 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERL-PMPPNC  242 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCTTC
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-CHHHHHHHHHcCCCC-CCCCCC
Confidence            665432   22345788999999876 458999999999999999997 99999874 344555566555432 355667


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++.+.+++.+||. +|.+||++.+++++
T Consensus       243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          243 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8999999999998 99999999998864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=340.04  Aligned_cols=249  Identities=19%  Similarity=0.343  Sum_probs=208.9

Q ss_pred             CcccccccceecccCceEEEEEEEc--cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      .++|+...+.||+|+||+||+|.+.  .++..||+|.+...   ......+.+.+|+.++++++||||+++++++..   
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   81 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---   81 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---
Confidence            3566555569999999999999853  57889999998753   245677889999999999999999999998832   


Q ss_pred             ceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ..+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSK  158 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCE
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEc-CCCCEEECccccee
Confidence            3488999999999999999754 46999999999999999999999999  99999999999998 68899999999998


Q ss_pred             eecCCC-----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 016143          180 VMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK  252 (394)
Q Consensus       180 ~~~~~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  252 (394)
                      ......     .....||+.|+|||++. ..++.++|||||||++|+|++ |+.||.... ..++...+..+..+ ..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~~~i~~~~~~-~~~~  236 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRM-ECPP  236 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHHHTTCCC-CCCT
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHhcCCcC-CCCC
Confidence            765432     22345789999999876 458999999999999999998 999998744 45556666665433 3556


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCC
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKDP  282 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~p  282 (394)
                      ..++++.++|.+||. +|.+||++.+++++.
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            778999999999998 999999999999863

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.8e-45  Score=344.50  Aligned_cols=242  Identities=21%  Similarity=0.362  Sum_probs=200.4

Q ss_pred             cccccceecccCceEEEEEEEccCC-------eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDG-------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      .|++.+.||+|+||+||+|.+..++       ..||+|.+....    ....+.+.+|+.++++++||||+++++++.+.
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            3488899999999999999998877       579999986432    34557789999999999999999999988654


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc--------
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--------  169 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~~-l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~--------  169 (394)
                        ...++||||+++++|.+++...+. +++..++.++.||+.||.|||+++  |+||||||+|||++ .++.        
T Consensus        85 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~~~~~~  159 (289)
T 4fvq_A           85 --DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLI-REEDRKTGNPPF  159 (289)
T ss_dssp             --TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-ECCBGGGTBCCE
T ss_pred             --CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEe-cCCcccccccce
Confidence              456789999999999999988765 999999999999999999999999  99999999999998 4555        


Q ss_pred             EEEcccceeeeecCCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q 016143          170 VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP  247 (394)
Q Consensus       170 ~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~  247 (394)
                      +||+|||++......  ....||+.|+|||++.+  .++.++|||||||++|+|++|..|+....+...........   
T Consensus       160 ~kl~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~---  234 (289)
T 4fvq_A          160 IKLSDPGISITVLPK--DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR---  234 (289)
T ss_dssp             EEECCCCSCTTTSCH--HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---
T ss_pred             eeeccCcccccccCc--cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc---
Confidence            999999998544322  33468999999998764  48999999999999999999655554445555555444432   


Q ss_pred             CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       248 ~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..++...++++.+++.+||. +|.+||++.+++++
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            22344456789999999998 99999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.1e-45  Score=349.11  Aligned_cols=250  Identities=26%  Similarity=0.415  Sum_probs=208.5

Q ss_pred             CcccccccceecccCceEEEEEE----EccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      .+||+++.+.||+|+||+||+|.    +..+++.||+|++...   ......+.+.+|+.+|++++||||+++++++.+.
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            47888999999999999998774    4558899999998743   2456678899999999999999999999999887


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ....+++||||+++++|.+++.... +++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFGLA  181 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGC
T ss_pred             CCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEc-CCCCEEECCcccc
Confidence            6778999999999999999998765 999999999999999999999999  99999999999998 7889999999999


Q ss_pred             eeecCCC-----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCH--------------HHHH
Q 016143          179 IVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--------------AQIY  238 (394)
Q Consensus       179 ~~~~~~~-----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~--------------~~~~  238 (394)
                      .......     .....||+.|+|||++.+ .++.++|||||||++|+|++|..||......              ..+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence            8765432     234468889999998765 5889999999999999999999999652111              1222


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       239 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+..+. ....+...++++.+||.+||. +|.+||++.++++
T Consensus       262 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          262 ELLERGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            3333333 333456678999999999998 9999999999985

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.8e-45  Score=355.26  Aligned_cols=244  Identities=23%  Similarity=0.404  Sum_probs=195.6

Q ss_pred             ccccceecccCceEEEEEEEc---cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      +++.+.||+|+||+||+|.++   .++..||+|.++...   .....+.+.+|+.+|++++||||+++++++.+.  ..+
T Consensus        47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  121 (373)
T 2qol_A           47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV  121 (373)
T ss_dssp             CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSC
T ss_pred             ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--Cce
Confidence            478899999999999999876   467789999986432   456677899999999999999999999988543  467


Q ss_pred             EEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+++|+|.+++...+ .+++.++..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++....
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC-------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEc-CCCCEEECcCccccccc
Confidence            88999999999999998764 6999999999999999999999999  99999999999998 78899999999997664


Q ss_pred             CCC-----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          183 QPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       183 ~~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      ...     .....+|+.|+|||++. ..++.++|||||||++|||++ |+.||.+ .+..++...+..+.... .+...+
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~  276 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKAVDEGYRLP-PPMDCP  276 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHHHHTTEECC-CCTTCB
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccc
Confidence            432     11234578899999776 468999999999999999998 9999987 45566667776654332 344567


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..+.+++.+||. +|.+||++.++++
T Consensus       277 ~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            899999999998 9999999999886

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.9e-45  Score=341.63  Aligned_cols=246  Identities=24%  Similarity=0.379  Sum_probs=209.5

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      ....|++.+.||+|+||+||+|.++.++..||+|.+...     ....+.+.+|+.++++++||||+++++++.+  ...
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~   83 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPP   83 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSS
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCC
Confidence            344458899999999999999999999999999998632     3356778899999999999999999998854  356


Q ss_pred             EEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          103 INMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      +++||||+++++|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++..
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEEC-GGGCEEECCCCGGGT
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEc-CCCCEEEccCcccee
Confidence            88999999999999999874  34999999999999999999999999  99999999999998 678999999999976


Q ss_pred             ecCCCC---cccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          181 MQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       181 ~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      ......   ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+..++...+.....+ ..+...+
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~  238 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCP  238 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCC
T ss_pred             ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-CCCCCCC
Confidence            654432   2345788999999776 458999999999999999999 9999976 4555666666655433 3455678


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +.+.+++.+||. +|.+||++.++++
T Consensus       239 ~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          239 EKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            999999999998 9999999999876

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=348.09  Aligned_cols=248  Identities=21%  Similarity=0.248  Sum_probs=201.4

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC--CCceE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TNRTI  103 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~--~~~~~  103 (394)
                      .|++.+.||+|+||+||+|.+..+|+.||+|.+...    .....+.+.+|+.+++.++||||+++++++..+  ....+
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            348899999999999999999999999999998643    356677899999999999999999999988643  34578


Q ss_pred             EEEEcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          104 NMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ++||||+.+|+|.+++..    ...+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLG-DEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEc-CCCCEEEEecCcch
Confidence            999999999999999876    467999999999999999999999999  99999999999998 78899999999986


Q ss_pred             eecCCC-----------CcccccCCcccCcccccc----cCCCcCcchhhhhHHHHHHhcCCCCCCCC-CHHHHHHHHhc
Q 016143          180 VMQQPT-----------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTS  243 (394)
Q Consensus       180 ~~~~~~-----------~~~~~gt~~y~aPE~l~~----~~~~~~DIwSlG~il~elltg~~Pf~~~~-~~~~~~~~i~~  243 (394)
                      ......           .....||+.|+|||++.+    .++.++|||||||++|+|++|+.||.... ........+..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  262 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN  262 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence            543221           123457999999998764    26899999999999999999999995310 00112222222


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          244 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       244 ~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .. ........++++.++|.+||. +|.+||++.+++++
T Consensus       263 ~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 QL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            22 222344568899999999998 99999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.7e-45  Score=349.74  Aligned_cols=242  Identities=21%  Similarity=0.264  Sum_probs=199.5

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      -|++.+.||+|+||+||+|.+..+|+.||+|.+.....      .+.+.+|+.+++.| +||||+++++++.+.  ...+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~   81 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KYNA   81 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEET--TEEE
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecC--CccE
Confidence            34889999999999999999999999999999865432      13477899999999 999999999988654  5789


Q ss_pred             EEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc-----EEEccccee
Q 016143          105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKIGDLGLA  178 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~-----~kl~Dfgla  178 (394)
                      +||||+ +++|.+++... +.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.     +||+|||++
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~-~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIG-RPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-CGGGTCTTSEEECCCTTC
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-cCCCCCCceEEEEEcccc
Confidence            999999 99999999874 67999999999999999999999999  99999999999998 5666     999999999


Q ss_pred             eeecCCC---------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC--CCHHHHHHHHhcCCC
Q 016143          179 IVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIK  246 (394)
Q Consensus       179 ~~~~~~~---------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~--~~~~~~~~~i~~~~~  246 (394)
                      .......         .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.  .+..+.+..+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            8764432         245679999999998765 5899999999999999999999999864  334444544433211


Q ss_pred             --C-CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          247 --P-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       247 --~-~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                        + ..+.... +++.+++.+||. +|.+||++.++++
T Consensus       238 ~~~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          238 ATPIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HSCHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              1 1112223 399999999998 9999999988776

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.8e-45  Score=339.76  Aligned_cols=243  Identities=27%  Similarity=0.486  Sum_probs=206.9

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEc---------
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD---------   97 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~---------   97 (394)
                      |++.+.||+|+||+||+|.+..+|+.||+|.+....        +.+.+|+.++++++||||+++++++..         
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             EEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             cceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            478899999999999999999999999999987432        245679999999999999999998754         


Q ss_pred             -----CCCceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE
Q 016143           98 -----DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV  170 (394)
Q Consensus        98 -----~~~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~  170 (394)
                           .....+++||||+++++|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEc-CCCCE
Confidence                 2245689999999999999999764  57999999999999999999999999  99999999999999 68899


Q ss_pred             EEcccceeeeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 016143          171 KIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA  248 (394)
Q Consensus       171 kl~Dfgla~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~  248 (394)
                      ||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||..   .......+..+.   
T Consensus       162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~---  235 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGI---  235 (284)
T ss_dssp             EECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTC---
T ss_pred             EECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhccc---
Confidence            99999999876554 3345679999999998765 589999999999999999999998843   234444454433   


Q ss_pred             CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       249 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                       ++...++.++++|.+||. +|.+||++.+++++.+.-..
T Consensus       236 -~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          236 -ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             -ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence             345577899999999998 99999999999999876543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=339.27  Aligned_cols=246  Identities=22%  Similarity=0.359  Sum_probs=205.3

Q ss_pred             cccceecccCceEEEEEEEccCCe---EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +..+.||+|+||+||+|.+..++.   .||+|.+...   ......+.+.+|+.++++++||||+++++++.+.+ ...+
T Consensus        24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~   99 (298)
T 3pls_A           24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLPH   99 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCE
T ss_pred             ccCceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCcE
Confidence            567999999999999998755544   7999987532   34567788999999999999999999999986544 3447


Q ss_pred             EEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +||||+.+++|.+++.. ...+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.....
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLD-ESFTVKVADFGLARDILD  176 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECCTTSSCTTTT
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEeCcCCCcccccC
Confidence            89999999999999987 456999999999999999999999999  99999999999998 788999999999975432


Q ss_pred             C------CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          184 P------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       184 ~------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      .      ......||+.|+|||.+.+ .++.++|||||||++|+|++|..||....+...+...+..+..+ ..+...++
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  255 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQPEYCPD  255 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CCCTTCCH
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CCCccchH
Confidence            2      2334568899999998765 58999999999999999999666655556666777777666433 34556788


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+.+++.+||. +|.+|||+.++++.
T Consensus       256 ~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          256 SLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999998 99999999998873

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=347.92  Aligned_cols=246  Identities=27%  Similarity=0.472  Sum_probs=198.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEE----EEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      ++| ++.+.||+|+||+||+|.+..++..|    |+|.+....   .....+.+.+|+.++++++||||+++++++.+. 
T Consensus        15 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-   89 (327)
T 3lzb_A           15 TEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   89 (327)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-
T ss_pred             hHc-eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-
Confidence            445 88899999999999999998888765    555543222   234556788999999999999999999998754 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                        ..++|++|+.+|+|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++
T Consensus        90 --~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kL~DfG~a  164 (327)
T 3lzb_A           90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLA  164 (327)
T ss_dssp             --SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTC-
T ss_pred             --CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEc-CCCCEEEccCcce
Confidence              367899999999999999874 56999999999999999999999999  99999999999998 6889999999999


Q ss_pred             eeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 016143          179 IVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK  252 (394)
Q Consensus       179 ~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  252 (394)
                      .......    .....||+.|+|||++.+ .|+.++|||||||++|+|++ |..||.+ .+...+...+..+... ..+.
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~  242 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPP  242 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCT
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CCCc
Confidence            7664332    223457889999997764 58999999999999999999 9999977 4455566666655433 2455


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..++++.++|.+||. +|.+||++.++++.
T Consensus       243 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          243 ICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            678899999999998 99999999999973

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.5e-44  Score=345.13  Aligned_cols=246  Identities=24%  Similarity=0.391  Sum_probs=206.9

Q ss_pred             ccccceecccCceEEEEEEEccCCe-----EEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCC
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGI-----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN  100 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~  100 (394)
                      |++.+.||+|+||+||+|.+..++.     .||+|.+....   .....+.+.+|+.+++.+ +||||+++++++.+.  
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--  122 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGACTHG--  122 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC--
Confidence            4788999999999999999877664     79999886432   355678899999999999 899999999988544  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 016143          101 RTINMITELFTSGSLRQYRKKH--------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN  166 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~--------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~  166 (394)
                      ..+++||||+++|+|.+++...              ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLT-N  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEE-G
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEEC-C
Confidence            4688899999999999998753              35899999999999999999999999  99999999999998 6


Q ss_pred             CCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHH
Q 016143          167 NGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK  240 (394)
Q Consensus       167 ~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~  240 (394)
                      ++.+||+|||++.......    .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+..........
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence            8899999999997654332    23345788999999775 468999999999999999998 99999886655555555


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       241 i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +..+..+ ..+...++.+.++|.+||. +|.+||++.+++++
T Consensus       280 ~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          280 VKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            5555332 3455678999999999998 99999999999873

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=8.8e-45  Score=342.80  Aligned_cols=254  Identities=23%  Similarity=0.380  Sum_probs=205.2

Q ss_pred             cccCCCcccccccceecccCceEEEEEEEccC---CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeee
Q 016143           18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS   94 (394)
Q Consensus        18 ~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~   94 (394)
                      ...++....|++.+.||+|+||+||+|.+..+   +..||+|.+...   ......+.+.+|+.++++++||||++++++
T Consensus        18 ~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   94 (298)
T 3f66_A           18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI   94 (298)
T ss_dssp             GBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             eecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence            34455566668999999999999999986543   346888887532   345677889999999999999999999998


Q ss_pred             EEcCCCceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143           95 WVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus        95 ~~~~~~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                      +.+. ....++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+
T Consensus        95 ~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~  170 (298)
T 3f66_A           95 CLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVA  170 (298)
T ss_dssp             ECCS-SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEEC
T ss_pred             EEcC-CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEC-CCCCEEEC
Confidence            6544 34678999999999999999864 45999999999999999999999999  99999999999998 78899999


Q ss_pred             ccceeeeecCC------CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCC
Q 016143          174 DLGLAIVMQQP------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI  245 (394)
Q Consensus       174 Dfgla~~~~~~------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~  245 (394)
                      |||++......      ......||+.|+|||++.+ .++.++||||||+++|+|++ |.+||.. .+.......+..+.
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~  249 (298)
T 3f66_A          171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGR  249 (298)
T ss_dssp             SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTC
T ss_pred             cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCC
Confidence            99999765432      2234567889999998764 58999999999999999999 5666655 44444555555543


Q ss_pred             CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       246 ~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .+ ..+...++.+.+++.+||. +|.+||++.++++
T Consensus       250 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          250 RL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            32 3355678899999999998 9999999999887

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.5e-44  Score=360.23  Aligned_cols=239  Identities=23%  Similarity=0.415  Sum_probs=201.7

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||+||+|.+.  |..||+|.++...      ..+.+.+|+.+|++++||||+++++++.+.. ..+++|
T Consensus       195 ~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~iv  265 (450)
T 1k9a_A          195 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIV  265 (450)
T ss_dssp             EEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SCEEEE
T ss_pred             eEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-CceEEE
Confidence            377899999999999999874  7899999986432      3466889999999999999999999876543 368899


Q ss_pred             EcccCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~--l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+++|+|.+++...+.  +++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++......
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTSCEEECCCTTCEECC--
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEC-CCCCEEEeeCCCccccccc
Confidence            999999999999987653  799999999999999999999999  99999999999998 7889999999999865443


Q ss_pred             CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      . ....+|+.|+|||++.+ .++.++|||||||++|||++ |+.||.+. +..++...+..+..+ ..+...++++.++|
T Consensus       343 ~-~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l~~li  419 (450)
T 1k9a_A          343 Q-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDGCPPAVYDVM  419 (450)
T ss_dssp             -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-CTTTHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred             c-cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHHHHH
Confidence            2 23367899999997764 58999999999999999998 99999874 344556667666543 34567789999999


Q ss_pred             HHcCC-CCCCCCCHHHHhc
Q 016143          263 EKCIV-PASLRLPALELLK  280 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~  280 (394)
                      .+||. +|.+||++.+++.
T Consensus       420 ~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          420 KNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHH
Confidence            99998 9999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.2e-44  Score=346.88  Aligned_cols=254  Identities=23%  Similarity=0.354  Sum_probs=207.5

Q ss_pred             ccccccceecccCceEEEEEE-----EccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC
Q 016143           25 RYGRYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT   99 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~   99 (394)
                      +.|++.+.||+|+||+||+|.     +..++..||+|.+...   .......++.+|+.++++++||||+++++++.+. 
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-  105 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-  105 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc---cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-
Confidence            334889999999999999998     5678889999998632   2355667889999999999999999999988554 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcE
Q 016143          100 NRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEV  170 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~-------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--~~~~~  170 (394)
                       ..+++||||+++++|.+++....       .+++..++.++.||+.||.|||+++  |+||||||+|||++.  ++..+
T Consensus       106 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          106 -LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred             -CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence             45788999999999999998763       4899999999999999999999999  999999999999982  34469


Q ss_pred             EEcccceeeeecCC----CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcC
Q 016143          171 KIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG  244 (394)
Q Consensus       171 kl~Dfgla~~~~~~----~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~  244 (394)
                      ||+|||++......    ......||+.|+|||++. +.++.++|||||||++|+|++ |..||.. .+...+...+..+
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~  261 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSG  261 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTT
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHHHHHHhcC
Confidence            99999999654332    223456899999999775 468999999999999999998 9999977 5566667777665


Q ss_pred             CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       245 ~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ..+ ..+...++.+.++|.+||. +|.+||++.+++++.|+...
T Consensus       262 ~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          262 GRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            433 3455678999999999998 99999999999999887644

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3e-44  Score=333.37  Aligned_cols=242  Identities=20%  Similarity=0.422  Sum_probs=205.9

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.+. ++..||+|.+.....     ..+.+.+|+.++++++||||+++++++.++  ..+++|
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   81 (267)
T 3t9t_A           10 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV   81 (267)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSCEEE
T ss_pred             eeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCeEEE
Confidence            478899999999999999986 678999999875432     225688899999999999999999988554  467889


Q ss_pred             EcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      |||+++++|.+++... ..+++..+..++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++...... 
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-GGGCEEECCTTGGGGBCCHH
T ss_pred             EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEC-CCCCEEEccccccccccccc
Confidence            9999999999999876 46999999999999999999999999  99999999999998 6789999999999755432 


Q ss_pred             --CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          185 --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       185 --~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                        ......||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+.......+..+..+ ..+...++.+.+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~  236 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVYQ  236 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHH
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcHHHHH
Confidence              223445788999999876 458899999999999999999 8999987 5566677777766433 345567899999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcC
Q 016143          261 FIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++.+||. +|.+||++.+++++
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          237 IMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999998 99999999999874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=345.21  Aligned_cols=246  Identities=24%  Similarity=0.380  Sum_probs=186.9

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEc------C
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD------D   98 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~------~   98 (394)
                      .|++.+.||+|+||+||+|.+..+|+.||+|.+...    .....+.+.+|+.+++++. ||||+++++++..      .
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            348899999999999999999999999999998543    3556678899999999996 9999999998852      3


Q ss_pred             CCceEEEEEcccCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143           99 TNRTINMITELFTSGSLRQYRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~---~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                      ....+++||||+. |+|.+++..   .+.+++..++.++.||+.||.|||+++++|+||||||+|||++ .++.+||+||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~~~kl~Df  182 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDF  182 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC-TTSCEEBCCC
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC-CCCCEEEecC
Confidence            4456899999995 789888765   4569999999999999999999999987899999999999998 6889999999


Q ss_pred             ceeeeecCCCC--------------cccccCCcccCccccc----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHH
Q 016143          176 GLAIVMQQPTA--------------RSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI  237 (394)
Q Consensus       176 gla~~~~~~~~--------------~~~~gt~~y~aPE~l~----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~  237 (394)
                      |++........              ....||+.|+|||++.    ..++.++|||||||++|+|++|+.||...... .+
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~  261 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-RI  261 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-Hh
Confidence            99976644211              1346999999999873    34788999999999999999999999763322 21


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCC
Q 016143          238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  282 (394)
Q Consensus       238 ~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p  282 (394)
                      .    .+..........++.+.+||.+||. +|.+||++.|++++-
T Consensus       262 ~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          262 V----NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             --------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             h----cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            1    1112222344566789999999998 999999999999873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.9e-44  Score=339.23  Aligned_cols=244  Identities=30%  Similarity=0.461  Sum_probs=193.7

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHc--CCCCCceeEeeeEEcC--C
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDD--T   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~--L~hpnIv~~~~~~~~~--~   99 (394)
                      .+.|++.+.||+|+||+||+|.+  +|..||+|++...       ....+.+|.+++..  ++||||+++++++.+.  .
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            33448899999999999999986  6999999998633       22445556666666  7999999999987643  3


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEecCCCCCcEEEeCCCCcEE
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNNGEVK  171 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH--------~~~~~ivHrDLkp~NIll~~~~~~~k  171 (394)
                      ...+++||||+++|+|.++++. ..+++..++.++.||+.||.|||        +++  |+||||||+|||++ .++.+|
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~-~~~~~k  153 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVK-KNGQCC  153 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEEC-TTSCEE
T ss_pred             CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEc-CCCCEE
Confidence            4568999999999999999965 46999999999999999999999        888  99999999999998 788999


Q ss_pred             EcccceeeeecCCC------CcccccCCcccCccccccc-------CCCcCcchhhhhHHHHHHhc----------CCCC
Q 016143          172 IGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTC----------EYPY  228 (394)
Q Consensus       172 l~Dfgla~~~~~~~------~~~~~gt~~y~aPE~l~~~-------~~~~~DIwSlG~il~elltg----------~~Pf  228 (394)
                      |+|||++.......      .....||+.|+|||++.+.       ++.++|||||||++|||++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999997665442      2334799999999987653       44689999999999999999          8898


Q ss_pred             CCCC----CHHHHHHHHhcCCCCCCCCC-----CCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          229 NECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       229 ~~~~----~~~~~~~~i~~~~~~~~~~~-----~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ....    ....+...+........++.     ..++++.+++.+||. +|.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            6532    22333333333222222221     234679999999998 9999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-44  Score=343.44  Aligned_cols=246  Identities=24%  Similarity=0.406  Sum_probs=200.9

Q ss_pred             cccccceecccCceEEEEEEEccCC----eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      .+++.+.||+|+||+||+|.++.++    ..||+|.+....   .......+.+|+.+++.++||||+++++++.+  ..
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~  119 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YK  119 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SS
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--CC
Confidence            3477899999999999999886553    469999986432   35566789999999999999999999998844  45


Q ss_pred             eEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      .+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++..
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC---
T ss_pred             CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEEC-CCCcEEECCCCcchh
Confidence            788999999999999999875 56999999999999999999999999  99999999999998 788999999999976


Q ss_pred             ecCCC-----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 016143          181 MQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       181 ~~~~~-----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      .....     .....+|+.|+|||++.+ .++.++|||||||++|+|++ |+.||.+ .+..++...+..+..+. .+..
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~~-~~~~  274 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGFRLP-TPMD  274 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-CCTT
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHCCCcCC-Cccc
Confidence            64432     122346889999998764 58999999999999999999 9999987 45566777777664333 3456


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .++.+.++|.+||. +|.+||++.+++++
T Consensus       275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          275 CPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78899999999998 99999999998874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.1e-44  Score=339.69  Aligned_cols=246  Identities=16%  Similarity=0.219  Sum_probs=202.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~  102 (394)
                      +..|++.+.||+|+||+||+|.+..+|..||+|++.....      .+.+.+|+.+++.+ +|+||+++++++.+  ...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~   80 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLH   80 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCC--Cce
Confidence            4445889999999999999999999999999999864332      23467799999999 79999999998754  457


Q ss_pred             EEEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc-----EEEcccc
Q 016143          103 INMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKIGDLG  176 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~-----~kl~Dfg  176 (394)
                      .++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.     +||+|||
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIG-RPNSKNANMIYVVDFG  156 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-CSSSTTTTCEEECCCT
T ss_pred             eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-cCCCCCCCeEEEEECc
Confidence            88999999 999999998754 5999999999999999999999999  99999999999997 4444     9999999


Q ss_pred             eeeeecCCC---------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCC--CHHHHHHHHhcC
Q 016143          177 LAIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSG  244 (394)
Q Consensus       177 la~~~~~~~---------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~--~~~~~~~~i~~~  244 (394)
                      ++.......         .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..  +..+.+..+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            998765432         234579999999998765 58999999999999999999999997632  344444444332


Q ss_pred             ---CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          245 ---IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       245 ---~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                         .....+....++++.+++.+||. +|.+||++.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence               11122334567899999999998 99999999998763

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=340.59  Aligned_cols=239  Identities=28%  Similarity=0.472  Sum_probs=192.7

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.+.  +..||+|.+..      ....+.+.+|+.++++++||||+++++++.+    ..++|
T Consensus        10 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~lv   77 (307)
T 2eva_A           10 IEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCLV   77 (307)
T ss_dssp             EEEEEEEECCSSSEEEEEEET--TEEEEEEECSS------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEEE
T ss_pred             eeeeeEeecCCCceEEEEEEC--CeeEEEEEecC------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEEE
Confidence            478899999999999999864  78999998752      2355778999999999999999999998742    26789


Q ss_pred             EcccCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHh---CCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          107 TELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHS---HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~---l~~~~~~~i~~qil~~L~~LH~---~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      |||+++|+|.+++.....   +++..+..++.||+.||.|||+   ++  |+||||||+||+++.++..+||+|||++..
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            999999999999987653   7899999999999999999999   67  999999999999984333489999999976


Q ss_pred             ecCCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCC-HHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          181 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN-PAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       181 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                      .... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ...+...+..+..+ ......++.+
T Consensus       156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l  233 (307)
T 2eva_A          156 IQTH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPI  233 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTCCHHH
T ss_pred             cccc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-CcccccCHHH
Confidence            5443 234469999999998765 589999999999999999999999976433 33444444444433 3455678999


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          259 KQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+++.+||. +|.+||++.+++++
T Consensus       234 ~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          234 ESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999998 99999999999873

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.6e-45  Score=350.57  Aligned_cols=245  Identities=22%  Similarity=0.403  Sum_probs=200.4

Q ss_pred             cccccceecccCceEEEEEEEccCCeE----EEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIE----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      .|++.+.||+|+||+||+|.+..++..    ||+|.+....   .....+.+.+|+.++++++||||+++++++.+   .
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~   87 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---S   87 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT---SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---S
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc---cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---C
Confidence            348889999999999999999888876    6666654322   12233456779999999999999999998742   3


Q ss_pred             eEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ..++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++..
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK-SPSQVQVADFGVADL  164 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEES-SSSCEEECSCSGGGG
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEEC-CCCeEEECCCCcccc
Confidence            578999999999999999875 56999999999999999999999999  99999999999998 688999999999976


Q ss_pred             ecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          181 MQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       181 ~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      .....    .....||+.|+|||++. +.++.++|||||||++|+|++ |..||.+. +...+...+..+..+ ..+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~  242 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKGERL-AQPQIC  242 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CTTHHHHHHHTTCBC-CCCTTB
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CCCCcC
Confidence            64332    23456788999999876 468999999999999999999 99999873 445555566555332 344556


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++++.+++.+||. +|.+||++.+++++
T Consensus       243 ~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          243 TIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7889999999998 99999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3e-44  Score=336.54  Aligned_cols=245  Identities=25%  Similarity=0.420  Sum_probs=200.9

Q ss_pred             cccccceecccCceEEEEEEEcc---CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .|++.+.||+|+||+||+|.+..   ++..||+|.+....   .....+++.+|+.+++.++||||+++++++.++   .
T Consensus        13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~   86 (281)
T 3cc6_A           13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---P   86 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS---S
T ss_pred             ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---C
Confidence            34888999999999999998653   34569999886432   356678899999999999999999999987432   3


Q ss_pred             EEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .++||||+++++|.+++... ..+++..+..++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++...
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVA-SPECVKLGDFGLSRYI  163 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-ETTEEEECCCCGGGCC
T ss_pred             CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEC-CCCcEEeCccCCCccc
Confidence            57899999999999999765 45999999999999999999999999  99999999999998 6789999999999765


Q ss_pred             cCCC---CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          182 QQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       182 ~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      ....   .....+|+.|+|||++.+ .++.++|||||||++|+|++ |+.||..... ......+..+..+ ..+...++
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~~  241 (281)
T 3cc6_A          164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRL-PKPDLCPP  241 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-GGHHHHHHHTCCC-CCCTTCCH
T ss_pred             ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-HHHHHHHhcCCCC-CCCCCCCH
Confidence            4432   233457889999998764 58999999999999999998 9999976433 3444455444322 24456789


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+.++|.+||. +|.+||++.+++++
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          242 VLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCchhCcCHHHHHHH
Confidence            99999999998 99999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.5e-44  Score=363.28  Aligned_cols=242  Identities=24%  Similarity=0.393  Sum_probs=207.0

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||+||+|.++.++..||+|.++...     ...+.+.+|+.+|++++||||+++++++.+.  ..+++|
T Consensus       222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv  294 (495)
T 1opk_A          222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII  294 (495)
T ss_dssp             EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEE
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEEecC--CcEEEE
Confidence            467899999999999999999999999999986432     2346788999999999999999999988544  467899


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+++|+|.+++...  ..+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+++.....
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTTCEECCTTC
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEC-CCCcEEEeecccceeccCC
Confidence            9999999999999864  45999999999999999999999999  99999999999998 6889999999999876544


Q ss_pred             C---CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          185 T---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       185 ~---~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      .   .....+|+.|+|||++. +.++.++|||||||++|||++ |..||.+ .+..++...+..+... ..+...++++.
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~  449 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCPEKVY  449 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred             ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence            2   22344678999999776 458999999999999999999 9999987 4455666666665433 34566789999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhc
Q 016143          260 QFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +||.+||. +|.+||++.++++
T Consensus       450 ~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          450 ELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCcChhHCcCHHHHHH
Confidence            99999998 9999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2e-44  Score=337.26  Aligned_cols=241  Identities=22%  Similarity=0.419  Sum_probs=196.5

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+  +|..||+|.+...      ...+.+.+|+.++++++||||+++++++.+.. ..+
T Consensus        21 ~~y-~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   90 (278)
T 1byg_A           21 KEL-KLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGL   90 (278)
T ss_dssp             GGE-EEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CC
T ss_pred             hhc-eEEeEEecCCCceEEEEEE--cCCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-Cce
Confidence            444 8889999999999999986  4889999998632      24467889999999999999999999875443 467


Q ss_pred             EEEEcccCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          104 NMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~--l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      ++||||+++++|.+++...+.  +++..++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC----
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEe-CCCcEEEeeccccccc
Confidence            899999999999999987643  899999999999999999999999  99999999999998 7889999999999755


Q ss_pred             cCCCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          182 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       182 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      .... ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...++.+.
T Consensus       168 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~  244 (278)
T 1byg_A          168 SSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPAVY  244 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCC-CCCTTCCHHHH
T ss_pred             cccc-cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCcccCCHHHH
Confidence            4432 23467899999998764 58999999999999999998 9999977 4445566666665433 34566789999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhc
Q 016143          260 QFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ++|.+||. +|.+||++.++++
T Consensus       245 ~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          245 EVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCChhhCCCHHHHHH
Confidence            99999998 9999999999886

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.2e-44  Score=355.69  Aligned_cols=249  Identities=26%  Similarity=0.340  Sum_probs=190.6

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCc
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~  101 (394)
                      .+.++...++||+|+||+||.+ ...+|+.||+|.+...       ..+.+.+|+.+|+++ +||||+++++++.+  ..
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~   82 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYYCSETT--DR   82 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-------GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SS
T ss_pred             hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-------HHHHHHHHHHHHHhccCCCCcCeEEEEEec--CC
Confidence            3455578899999999999875 4568999999998643       234577899999876 89999999998854  45


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC---------
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVD-------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG---------  165 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~-------~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~---------  165 (394)
                      .+++||||+. |+|.+++.......       +..++.++.||+.||.|||+++  |+||||||+|||++.         
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~  159 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQ  159 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCT
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccc
Confidence            7999999995 69999998765432       3345789999999999999999  999999999999973         


Q ss_pred             ---CCCcEEEcccceeeeecCCC------CcccccCCcccCcccccc--------cCCCcCcchhhhhHHHHHHh-cCCC
Q 016143          166 ---NNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYP  227 (394)
Q Consensus       166 ---~~~~~kl~Dfgla~~~~~~~------~~~~~gt~~y~aPE~l~~--------~~~~~~DIwSlG~il~ellt-g~~P  227 (394)
                         .++.+||+|||++.......      .....||+.|+|||++.+        .++.++|||||||++|||++ |..|
T Consensus       160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P  239 (434)
T 2rio_A          160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP  239 (434)
T ss_dssp             TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence               23589999999998765432      234579999999998753        47899999999999999999 9999


Q ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCC----CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          228 YNECKNPAQIYKKVTSGIKPASLSK----VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       228 f~~~~~~~~~~~~i~~~~~~~~~~~----~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      |.+......  ..+...........    ..+++++++|.+||. +|.+||++.++|+||||..
T Consensus       240 f~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          240 FGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             TCSTTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             CCCchhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            976544332  22222111111111    234789999999998 9999999999999999965

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.1e-44  Score=339.66  Aligned_cols=247  Identities=23%  Similarity=0.371  Sum_probs=201.2

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ..++.||+|+||+||+|.+  ++..||+|++.........+..+.+.+|+.++++++||||+++++++.+.  ..+++||
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~  109 (307)
T 2nru_A           34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG--DDLCLVY  109 (307)
T ss_dssp             TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEE
T ss_pred             ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC--CceEEEE
Confidence            4568999999999999985  68899999987544334456678899999999999999999999988544  4678899


Q ss_pred             cccCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          108 ELFTSGSLRQYRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       108 e~~~~gsL~~~i~~---~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++......
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD-EAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc-CCCcEEEeecccccccccc
Confidence            99999999999874   345999999999999999999999999  99999999999998 7889999999999766543


Q ss_pred             C----CcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHH---HHHHHHhcCCC---------CC
Q 016143          185 T----ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIK---------PA  248 (394)
Q Consensus       185 ~----~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~---~~~~~i~~~~~---------~~  248 (394)
                      .    .....||+.|+|||++.+.++.++||||||+++|+|++|..||.......   .+...+.....         ..
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence            2    23457999999999998889999999999999999999999997643322   22222222110         01


Q ss_pred             CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       249 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..+...+..+.+++.+||. +|.+||++.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1122234678999999998 99999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-44  Score=342.50  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=206.2

Q ss_pred             cCCCcccccccceecccCceEEEEEE----EccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeE
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW   95 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~   95 (394)
                      .....+.+++.+.||+|+||+||+|.    +..+|..||+|++...    .....+.+.+|+.++++++||||+++++++
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  111 (326)
T 2w1i_A           36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVC  111 (326)
T ss_dssp             -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            34456667899999999999999998    4678999999998643    345667899999999999999999999988


Q ss_pred             EcCCCceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcc
Q 016143           96 VDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD  174 (394)
Q Consensus        96 ~~~~~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~D  174 (394)
                      .......+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|
T Consensus       112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kL~D  188 (326)
T 2w1i_A          112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGD  188 (326)
T ss_dssp             CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECC
T ss_pred             EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEc-CCCcEEEec
Confidence            766656788999999999999999876 45999999999999999999999999  99999999999998 688999999


Q ss_pred             cceeeeecCCC-----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCH--------------
Q 016143          175 LGLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--------------  234 (394)
Q Consensus       175 fgla~~~~~~~-----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~--------------  234 (394)
                      ||++.......     .....+++.|+|||++.+ .++.++|||||||++|+|+||..||......              
T Consensus       189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  268 (326)
T 2w1i_A          189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI  268 (326)
T ss_dssp             CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred             CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence            99998765442     223457888999997764 5889999999999999999999998632100              


Q ss_pred             -HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          235 -AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       235 -~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                       ..+...+..+..+ ..+...++++.++|++||. +|.+||++.++++
T Consensus       269 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          269 VFHLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             1122333333222 3455678999999999998 9999999999885

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=352.64  Aligned_cols=257  Identities=18%  Similarity=0.219  Sum_probs=196.8

Q ss_pred             CCCcccccccceecccCceEEEEEEEcc---CCeEEEEEEeeeccccCCH--H-----HHHHHHHHHHHHHcCCCCCcee
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSP--D-----QLERLYSEVHLLKSLKHENIIK   90 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~--~-----~~~~~~~E~~~l~~L~hpnIv~   90 (394)
                      +..+..|++.+.||+|+||+||+|.+..   ++..||+|.+.........  .     ....+.+|+..++.++||||++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            3334445899999999999999999987   8889999998754310000  0     1123667899999999999999


Q ss_pred             EeeeEEcC--CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 016143           91 FYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG  168 (394)
Q Consensus        91 ~~~~~~~~--~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~  168 (394)
                      +++++.+.  ....+++||||+ +++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~  188 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLG-YKN  188 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-SSS
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEc-cCC
Confidence            99998762  356899999999 9999999998888999999999999999999999999  99999999999998 455


Q ss_pred             --cEEEcccceeeeecCC---------CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC-CCHH
Q 016143          169 --EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC-KNPA  235 (394)
Q Consensus       169 --~~kl~Dfgla~~~~~~---------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~-~~~~  235 (394)
                        .+||+|||++......         ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||... .+..
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999766322         1134579999999998776 4899999999999999999999999542 3333


Q ss_pred             HHHHHHhc--CCCCCC-----CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          236 QIYKKVTS--GIKPAS-----LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       236 ~~~~~i~~--~~~~~~-----~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ........  ...+..     .....+++++++|.+||. +|.+||++.++++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            22221111  111110     112567899999999998 99999999998873

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.7e-45  Score=349.53  Aligned_cols=250  Identities=23%  Similarity=0.363  Sum_probs=199.9

Q ss_pred             CCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      ...++| ++.+.||+|+||+||+|.+ .+|..||+|.+...    .....+.+.+|+.+++.++||||+++++++.+  .
T Consensus        36 ~~~~~y-~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~  107 (321)
T 2qkw_B           36 EATNNF-DHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDE--R  107 (321)
T ss_dssp             CCCCCC-SCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--T
T ss_pred             HHHhcc-CccceeecCCCeeEEEEEE-CCCCEEEEEEeccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--C
Confidence            344566 7889999999999999986 47899999987643    23456778999999999999999999998754  4


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccc
Q 016143          101 RTINMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG  176 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~----~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfg  176 (394)
                      ..+++||||+++|+|.+++....    .+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLD-ENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEEC-TTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEEC-CCCCEEEeecc
Confidence            56788999999999999987653    5999999999999999999999999  99999999999998 78899999999


Q ss_pred             eeeeecCC----CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCH-----HHHH-HHHhcCC
Q 016143          177 LAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP-----AQIY-KKVTSGI  245 (394)
Q Consensus       177 la~~~~~~----~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~-----~~~~-~~i~~~~  245 (394)
                      ++......    ......||+.|+|||++. +.++.++|||||||++|+|++|+.||......     .... .....+.
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            99765432    223456899999999775 56899999999999999999999999753221     1111 1111111


Q ss_pred             CC----C----CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          246 KP----A----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       246 ~~----~----~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..    .    ......+..+.+++.+||. +|.+||++.+++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            11    1    1112234578999999998 99999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.4e-44  Score=332.58  Aligned_cols=242  Identities=24%  Similarity=0.410  Sum_probs=204.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      .+| ++.+.||+|+||+||+|.+. ++..||+|.+....     ...+.+.+|+.+++.++||||+++++++.+   ...
T Consensus        13 ~~y-~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   82 (279)
T 1qpc_A           13 ETL-KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPI   82 (279)
T ss_dssp             GGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred             Hhh-hheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC---CCc
Confidence            445 88899999999999999875 67889999986432     124568889999999999999999998743   247


Q ss_pred             EEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          104 NMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      ++||||+++++|.+++....  .+++..+..++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++...
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLI  159 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEc-CCCCEEECCCcccccc
Confidence            78999999999999997653  6999999999999999999999999  99999999999998 7889999999999876


Q ss_pred             cCCC---CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          182 QQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       182 ~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      ....   .....+|+.|+|||++. +.++.++||||||+++|+|++ |+.||.+ .+..++...+..+..+ ..+...++
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~  237 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRM-VRPDNCPE  237 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCH
T ss_pred             cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHHhcccCC-CCcccccH
Confidence            5442   22345788999999876 458999999999999999999 9999987 4556666777666433 34556789


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ++.+++.+||. +|.+||++.++++
T Consensus       238 ~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          238 ELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHH
Confidence            99999999998 9999999999876

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.3e-44  Score=357.63  Aligned_cols=240  Identities=23%  Similarity=0.402  Sum_probs=203.7

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||+||+|.++ ++..||+|.++...     ...+.+.+|+.+|++|+||||+++++++.   ...+++|
T Consensus       190 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~lv  260 (454)
T 1qcf_A          190 LKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYII  260 (454)
T ss_dssp             EEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEE
T ss_pred             eEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccEEE
Confidence            378899999999999999885 57889999987432     23567899999999999999999999874   2357899


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+.+|+|.+++...  ..+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+++.....
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTCCEEECSTTGGGGBCCH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEC-CCCcEEEeeCCCceEcCCC
Confidence            9999999999999864  36899999999999999999999999  99999999999998 7889999999999765432


Q ss_pred             ---CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          185 ---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       185 ---~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                         ......+|+.|+|||++. +.++.++|||||||++|||+| |+.||.+ .+..++...+..+.... .+...++++.
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~  415 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRMP-RPENCPEELY  415 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHHTCCCC-CCTTSCHHHH
T ss_pred             ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHH
Confidence               123345678999999876 568999999999999999999 9999987 45566667776664433 3556789999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhc
Q 016143          260 QFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ++|.+||. +|.+||++.+++.
T Consensus       416 ~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          416 NIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHH
Confidence            99999998 9999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.1e-44  Score=352.74  Aligned_cols=252  Identities=17%  Similarity=0.221  Sum_probs=195.4

Q ss_pred             ccccccceecccCceEEEEEEEccC-----CeEEEEEEeeeccccCCHHH--------HHHHHHHHHHHHcCCCCCceeE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQ--------LERLYSEVHLLKSLKHENIIKF   91 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~--------~~~~~~E~~~l~~L~hpnIv~~   91 (394)
                      .-|++.+.||+|+||+||+|.+..+     ++.||+|.+...... ....        ......|+..++.++||||+++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            3448999999999999999998765     588999998643210 0001        1124457778888999999999


Q ss_pred             eeeEEcCC--CceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CC
Q 016143           92 YNSWVDDT--NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NN  167 (394)
Q Consensus        92 ~~~~~~~~--~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~-~~  167 (394)
                      ++++....  ..++++||||+ +++|.+++... +.+++..++.++.||+.||.|||+++  |+||||||+|||++. .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESSCT
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecCCC
Confidence            99987643  35689999999 99999999876 67999999999999999999999999  999999999999972 46


Q ss_pred             CcEEEcccceeeeecCCC---------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHH
Q 016143          168 GEVKIGDLGLAIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI  237 (394)
Q Consensus       168 ~~~kl~Dfgla~~~~~~~---------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~  237 (394)
                      +.+||+|||++.......         .....||+.|+|||++.+ .++.++|||||||++|||+||+.||.+.......
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            899999999997654321         134559999999998775 4899999999999999999999999853322222


Q ss_pred             HHHHhcCCC---C-----CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          238 YKKVTSGIK---P-----ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       238 ~~~i~~~~~---~-----~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .........   +     .-.....++++.+++..||. +|.+||++.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            211111000   0     00124567899999999998 9999999998876

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-43  Score=334.28  Aligned_cols=246  Identities=23%  Similarity=0.293  Sum_probs=199.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+..+|+.||+|++.....      .+.+.+|+.+++.++|++++..+..+.. .....
T Consensus         9 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~   80 (296)
T 3uzp_A            9 NRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYN   80 (296)
T ss_dssp             TTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEE
T ss_pred             cEE-EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccC-CCCce
Confidence            455 889999999999999999999999999999865432      1347789999999999988877766543 34578


Q ss_pred             EEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEcccceeee
Q 016143          104 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIV  180 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~--~~~~~~kl~Dfgla~~  180 (394)
                      ++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+++  |+||||||+|||++  ..++.+||+|||++..
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            9999999 9999999984 457999999999999999999999999  99999999999994  3678999999999987


Q ss_pred             ecCCC---------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCC--HHHHHHHHhcC---C
Q 016143          181 MQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSG---I  245 (394)
Q Consensus       181 ~~~~~---------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~--~~~~~~~i~~~---~  245 (394)
                      .....         .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....  ..+.+..+...   .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            65442         245679999999998765 589999999999999999999999976322  11222222211   1


Q ss_pred             CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       246 ~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ....+....++++.+++.+||. +|.+||++.++++
T Consensus       238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1112234567899999999998 9999999999886

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=360.94  Aligned_cols=246  Identities=27%  Similarity=0.325  Sum_probs=189.7

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      ++..++||+|+||+||. ....+|+.||||.+.....       ..+.+|+.+|+.+ +||||+++++++.+.  ..+++
T Consensus        26 y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~~~l   95 (432)
T 3p23_A           26 FCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDR--QFQYI   95 (432)
T ss_dssp             EEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEET--TEEEE
T ss_pred             EecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecC--CEEEE
Confidence            37789999999999764 3457899999999864322       2245699999999 799999999988544  57899


Q ss_pred             EEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC----CCCcEEEcccceeee
Q 016143          106 ITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDLGLAIV  180 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~----~~~~~kl~Dfgla~~  180 (394)
                      ||||+. |+|.+++.... .+++..+..++.||+.||.|||+++  |+||||||+|||++.    ....+||+|||++..
T Consensus        96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            999996 69999998764 4666678899999999999999999  999999999999952    223688999999976


Q ss_pred             ecCC-----CCcccccCCcccCccccc----ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCC--C
Q 016143          181 MQQP-----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP--A  248 (394)
Q Consensus       181 ~~~~-----~~~~~~gt~~y~aPE~l~----~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~--~  248 (394)
                      ....     .....+||+.|+|||++.    ..++.++|||||||++|||++ |..||..... .+.. .+......  .
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-~~~~-~~~~~~~~~~~  250 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-RQAN-ILLGACSLDCL  250 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-HHHH-HHTTCCCCTTS
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-HHHH-HHhccCCcccc
Confidence            6432     234467999999999886    346789999999999999999 9999976333 2222 22222111  1


Q ss_pred             CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       249 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ......+..+++||.+||. +|.+||++.++|+||||...
T Consensus       251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            1122335678999999998 99999999999999999764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.2e-44  Score=344.59  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=195.7

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .++| ++.+.||+|+||+||+|.+ .+|..||+|.+.....   ......+.+|+.+++.++||||+++++++.+.  ..
T Consensus        29 ~~~y-~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~  101 (326)
T 3uim_A           29 SDNF-SNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TE  101 (326)
T ss_dssp             TTSS-CSTTEEECCSSSEEEEECC-SSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS--SC
T ss_pred             hhcc-ccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC---chHHHHHHHHHHHHHhccCCCccceEEEEecC--Cc
Confidence            3455 7889999999999999975 4789999999875432   11223578899999999999999999988554  45


Q ss_pred             EEEEEcccCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143          103 INMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLHYLHSH---NPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~----~l~~~~~~~i~~qil~~L~~LH~~---~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                      .++||||+.+|+|.+++....    .+++..++.++.||+.||.|||++   +  |+||||||+|||++ .++.+||+||
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~-~~~~~kl~Df  178 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDF  178 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEEC-TTCCEEECCC
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEEC-CCCCEEeccC
Confidence            678999999999999998754    399999999999999999999999   8  99999999999998 7889999999


Q ss_pred             ceeeeecCCC---CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCC----CCCHHHHHHHHhcCCCC
Q 016143          176 GLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNE----CKNPAQIYKKVTSGIKP  247 (394)
Q Consensus       176 gla~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~----~~~~~~~~~~i~~~~~~  247 (394)
                      |++.......   .....||+.|+|||++. ..++.++|||||||++|+|++|+.||..    ..........+......
T Consensus       179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence            9998765432   23456999999999775 4689999999999999999999999952    01111111111111111


Q ss_pred             CC------------CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCC
Q 016143          248 AS------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  282 (394)
Q Consensus       248 ~~------------~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p  282 (394)
                      ..            .....+..+.+++.+||. +|.+|||+.++++|-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  306 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML  306 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence            11            111123678999999998 999999999999873

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.2e-44  Score=336.56  Aligned_cols=249  Identities=27%  Similarity=0.408  Sum_probs=198.0

Q ss_pred             cccccccceecccCceEEEEEEEcc-CC--eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEV-DG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~-~~--~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      ...|++.+.||+|+||+||+|.+.. ++  ..||+|.++.... ...+..+.+.+|+.++++++||||+++++++.++. 
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            3344889999999999999998643 33  3689999875432 23456778999999999999999999999886542 


Q ss_pred             ceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                        .++||||+.+++|.+++... ..+++..+..++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++.
T Consensus        95 --~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           95 --MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMR  169 (291)
T ss_dssp             --CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCE
T ss_pred             --ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEc-CCCCEEEccccccc
Confidence              67899999999999998764 56999999999999999999999999  99999999999998 67899999999997


Q ss_pred             eecCCC-----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 016143          180 VMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK  252 (394)
Q Consensus       180 ~~~~~~-----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  252 (394)
                      ......     .....+|+.|+|||++.+ .++.++||||||+++|+|++ |+.||.. .+..++...+.........+.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~  248 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPE  248 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCT
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHccCCCCCCCc
Confidence            765432     223457889999998765 58899999999999999999 9999987 456666666665544444556


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ..++++.++|.+||. +|.+||++.++++
T Consensus       249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          249 DCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            778999999999998 9999999999997

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.6e-43  Score=335.09  Aligned_cols=241  Identities=19%  Similarity=0.322  Sum_probs=192.8

Q ss_pred             CccccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHH-HcCCCCCceeEeee
Q 016143           16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNS   94 (394)
Q Consensus        16 ~~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l-~~L~hpnIv~~~~~   94 (394)
                      .....+..++|+...++||+|+||+||+|.++.+++.||+|.+...         ..+.+|+.++ +.++||||++++++
T Consensus         9 ~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~   79 (299)
T 3m2w_A            9 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDV   79 (299)
T ss_dssp             CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             cCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhh
Confidence            3445566677866668999999999999999999999999998531         3456788888 66699999999998


Q ss_pred             EEc--CCCceEEEEEcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CC
Q 016143           95 WVD--DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NG  168 (394)
Q Consensus        95 ~~~--~~~~~~~lV~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~--~~  168 (394)
                      +.+  .....+++||||+++|+|.+++....  .+++..++.++.||+.||.|||+++  |+||||||+||+++..  ++
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~  157 (299)
T 3m2w_A           80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA  157 (299)
T ss_dssp             EEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTC
T ss_pred             hhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCC
Confidence            864  33567899999999999999998764  6999999999999999999999999  9999999999999842  68


Q ss_pred             cEEEcccceeeeecCCCCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-
Q 016143          169 EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-  247 (394)
Q Consensus       169 ~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-  247 (394)
                      .+||+|||++.....                   ..|+.++|||||||++|+|++|..||...... ............ 
T Consensus       158 ~~kl~Dfg~a~~~~~-------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~  217 (299)
T 3m2w_A          158 ILKLTDFGFAKETTG-------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKTRIRMG  217 (299)
T ss_dssp             CEEECCCTTCEECTT-------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTT
T ss_pred             cEEEecccccccccc-------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcch-hhhHHHHHHHhhc
Confidence            899999998865332                   34678999999999999999999999763321 111111111111 


Q ss_pred             -CCCC----CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          248 -ASLS----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       248 -~~~~----~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                       ..++    ...++++++||.+||. +|.+||++.|+|+||||+..
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence             1111    4568899999999998 99999999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-43  Score=333.45  Aligned_cols=247  Identities=23%  Similarity=0.293  Sum_probs=197.1

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      ..++| ++.+.||+|+||+||+|.+..+++.||+|++.....      .+.+.+|+.+++.++|++++..+..+.. ...
T Consensus         7 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~   78 (296)
T 4hgt_A            7 VGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGD   78 (296)
T ss_dssp             ----C-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEE-ETT
T ss_pred             cCCce-EEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecC-CCC
Confidence            33555 889999999999999999999999999998764432      2347779999999999988887776644 345


Q ss_pred             eEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE---eCCCCcEEEcccce
Q 016143          102 TINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGL  177 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll---~~~~~~~kl~Dfgl  177 (394)
                      ..++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+++  |+||||||+|||+   + .++.+||+|||+
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~-~~~~~kL~Dfg~  154 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGK-KGNLVYIIDFGL  154 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGG-GTTCEEECCCTT
T ss_pred             ceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccC-CCCeEEEecCcc
Confidence            788999999 9999999985 456999999999999999999999999  9999999999999   5 678999999999


Q ss_pred             eeeecCCC---------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCH--HHHHHHHhcC-
Q 016143          178 AIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSG-  244 (394)
Q Consensus       178 a~~~~~~~---------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~--~~~~~~i~~~-  244 (394)
                      +.......         .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....  .+.+..+... 
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  234 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred             ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence            98765432         234579999999998765 5899999999999999999999999763321  1222222111 


Q ss_pred             --CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          245 --IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       245 --~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                        ..........++++.++|.+||. +|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence              11111234567899999999998 9999999999887

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.3e-43  Score=367.02  Aligned_cols=240  Identities=21%  Similarity=0.350  Sum_probs=202.5

Q ss_pred             ceecccCceEEEEEEE--ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEc
Q 016143           31 EILGKGAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      +.||+|+||+||+|.+  +.++..||+|+++...  ......+.+.+|+.+|++|+||||+++++++.++   .+++|||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~E  449 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVME  449 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEEE
Confidence            4799999999999954  5667899999986543  2345567899999999999999999999988432   4789999


Q ss_pred             ccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC---
Q 016143          109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---  185 (394)
Q Consensus       109 ~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~---  185 (394)
                      |+++|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+++......   
T Consensus       450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC-----
T ss_pred             ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEe-CCCCEEEEEcCCccccccCcccc
Confidence            9999999999999889999999999999999999999999  99999999999999 67899999999997654332   


Q ss_pred             --CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          186 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                        .....||+.|+|||++.+ .|+.++|||||||++|||++ |+.||.+ .+..++...+..+..+ ..+...++++.+|
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~l  604 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDL  604 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence              223457889999998765 69999999999999999998 9999987 5666777777776543 3456678999999


Q ss_pred             HHHcCC-CCCCCCCHHHHhc
Q 016143          262 IEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL~  280 (394)
                      |.+||. +|.+||++.++++
T Consensus       605 i~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          605 MNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHH
Confidence            999998 9999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-43  Score=336.88  Aligned_cols=244  Identities=29%  Similarity=0.462  Sum_probs=191.8

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC--CCCCceeEeeeEEcCCC--
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL--KHENIIKFYNSWVDDTN--  100 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L--~hpnIv~~~~~~~~~~~--  100 (394)
                      +.|++.+.||+|+||+||+|.+.  |..||+|++....       .....+|..++..+  +||||+++++++.+...  
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            34488999999999999999875  8999999985332       23344555666554  89999999999876643  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCeEecCCCCCcEEEeCCCCcEEE
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH--------NPPIIHRDLKCDNIFVNGNNGEVKI  172 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~--------~~~ivHrDLkp~NIll~~~~~~~kl  172 (394)
                      ..+++||||+++|+|.++++.. .+++..++.++.||+.||.|||++        +  |+||||||+|||++ .++.+||
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~kl  183 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVK-KNGTCCI  183 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEEC-TTSCEEE
T ss_pred             CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEEC-CCCCEEE
Confidence            5789999999999999999775 599999999999999999999998        7  99999999999998 7889999


Q ss_pred             cccceeeeecCCC------CcccccCCcccCccccccc-CCCc------CcchhhhhHHHHHHhc----------CCCCC
Q 016143          173 GDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE-YNEL------VDIYSFGMCILEMVTC----------EYPYN  229 (394)
Q Consensus       173 ~Dfgla~~~~~~~------~~~~~gt~~y~aPE~l~~~-~~~~------~DIwSlG~il~elltg----------~~Pf~  229 (394)
                      +|||++.......      .....||+.|+|||++.+. +...      +|||||||++|||+||          ..||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            9999997664432      2245799999999988754 3343      8999999999999999          77776


Q ss_pred             CCC----CHHHHHHHHhcCCCCCCCCC-----CCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          230 ECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       230 ~~~----~~~~~~~~i~~~~~~~~~~~-----~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ...    ....+...+........++.     ..++++.++|.+||. +|.+||++.+++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            532    22333333333222222222     234679999999998 99999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=347.01  Aligned_cols=247  Identities=17%  Similarity=0.269  Sum_probs=198.8

Q ss_pred             CCCcccccccceecccCceEEEEEEEccC--------CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCcee--
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVD--------GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK--   90 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~--------~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~--   90 (394)
                      +..++.|++.+.||+|+||+||+|.+..+        +..||+|.+...         +.+.+|+.++++++||||++  
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~  108 (352)
T 2jii_A           38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKW  108 (352)
T ss_dssp             CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHH
T ss_pred             cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhh
Confidence            44455568999999999999999999874        889999998633         34778999999999999998  


Q ss_pred             -------------EeeeEEcCCCceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecC
Q 016143           91 -------------FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD  155 (394)
Q Consensus        91 -------------~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrD  155 (394)
                                   +++++.. ....+++||||+ +++|.+++...  ..+++..++.++.||+.||.|||+++  |+|||
T Consensus       109 ~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~D  184 (352)
T 2jii_A          109 KKLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGN  184 (352)
T ss_dssp             HHHTTCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSC
T ss_pred             hhhccCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCC
Confidence                         4555543 346889999999 99999999986  77999999999999999999999999  99999


Q ss_pred             CCCCcEEEeCCCC--cEEEcccceeeeecCC---------CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh
Q 016143          156 LKCDNIFVNGNNG--EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT  223 (394)
Q Consensus       156 Lkp~NIll~~~~~--~~kl~Dfgla~~~~~~---------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt  223 (394)
                      |||+|||++ .++  .+||+|||++......         ......||+.|+|||++.+ .++.++|||||||++|+|++
T Consensus       185 ikp~NIl~~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  263 (352)
T 2jii_A          185 VTAENIFVD-PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY  263 (352)
T ss_dssp             CCGGGEEEE-TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEc-CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence            999999999 566  8999999999765432         1234579999999998776 58999999999999999999


Q ss_pred             cCCCCCCCC-CHHHHHHHHhcC-CCCCCC------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          224 CEYPYNECK-NPAQIYKKVTSG-IKPASL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       224 g~~Pf~~~~-~~~~~~~~i~~~-~~~~~~------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      |+.||.... +...+....... ..+..+      ....++++.+||.+||. +|.+||++.++++.
T Consensus       264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          264 GFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             SCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            999998754 444444333210 011111      12457999999999998 99999999998773

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-44  Score=347.47  Aligned_cols=251  Identities=22%  Similarity=0.383  Sum_probs=196.4

Q ss_pred             CCcccccccceecccCceEEEEEEEccC---CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      +....+++.+.||+|+||+||+|.+..+   +..||+|.++..   ......+++.+|+.++++++||||+++++++.+.
T Consensus        86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  162 (373)
T 3c1x_A           86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS  162 (373)
T ss_dssp             STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred             hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence            3344457789999999999999987543   346899987532   2346678899999999999999999999986544


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143           99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                      . ...++||||+++|+|.++++.. ..+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+
T Consensus       163 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DFG~  238 (373)
T 3c1x_A          163 E-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGL  238 (373)
T ss_dssp             S-SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC--
T ss_pred             C-CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEEC-CCCCEEEeeccc
Confidence            3 4677999999999999999875 45899999999999999999999999  99999999999998 788999999999


Q ss_pred             eeeecCCC------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCC
Q 016143          178 AIVMQQPT------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS  249 (394)
Q Consensus       178 a~~~~~~~------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~  249 (394)
                      +.......      .....+|+.|+|||++.+ .++.++|||||||++|||+| |.+||.... ..++...+..+..+ .
T Consensus       239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-~~~~~~~~~~~~~~-~  316 (373)
T 3c1x_A          239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRRL-L  316 (373)
T ss_dssp             -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-SSCHHHHHHTTCCC-C
T ss_pred             cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-HHHHHHHHHcCCCC-C
Confidence            97654321      223457889999997764 58999999999999999999 778887643 33444455555433 2


Q ss_pred             CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       250 ~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+...++.+.+++.+||. +|.+||++.+++++
T Consensus       317 ~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            455678899999999998 99999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.2e-43  Score=336.88  Aligned_cols=252  Identities=26%  Similarity=0.383  Sum_probs=191.1

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHH--HHHHHHcCCCCCceeEeeeEE---c
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--EVHLLKSLKHENIIKFYNSWV---D   97 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~--E~~~l~~L~hpnIv~~~~~~~---~   97 (394)
                      .++| ++.+.||+|+||+||+|.+  ++..||+|++....       ...+..  |+..+..++||||+++++.+.   .
T Consensus        12 ~~~y-~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A           12 LDNL-KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA   81 (336)
T ss_dssp             TTSE-EEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred             hHHh-heeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence            3455 8889999999999999975  68999999986432       122333  444455689999999997543   2


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCeEecCCCCCcEEEeCCCC
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH---------NPPIIHRDLKCDNIFVNGNNG  168 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~---------~~~ivHrDLkp~NIll~~~~~  168 (394)
                      .....+++||||+++|+|.++++... .++..+..++.||+.||.|||++         +  |+||||||+|||++ .++
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~-~~~  157 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVK-NDG  157 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEEC-TTS
T ss_pred             CCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEc-CCC
Confidence            34457889999999999999998765 59999999999999999999999         8  99999999999998 678


Q ss_pred             cEEEcccceeeeecCC----------CCcccccCCcccCcccccc--------cCCCcCcchhhhhHHHHHHhcCCCCCC
Q 016143          169 EVKIGDLGLAIVMQQP----------TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVTCEYPYNE  230 (394)
Q Consensus       169 ~~kl~Dfgla~~~~~~----------~~~~~~gt~~y~aPE~l~~--------~~~~~~DIwSlG~il~elltg~~Pf~~  230 (394)
                      .+||+|||++......          ......||+.|+|||++.+        .++.++|||||||++|||++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            9999999999766432          1224579999999998764        366789999999999999999777633


Q ss_pred             CCC-----------------HHHHHHHHhcCCCCCCCCCC------CCHHHHHHHHHcCC-CCCCCCCHHHH------hc
Q 016143          231 CKN-----------------PAQIYKKVTSGIKPASLSKV------TDPQVKQFIEKCIV-PASLRLPALEL------LK  280 (394)
Q Consensus       231 ~~~-----------------~~~~~~~i~~~~~~~~~~~~------~~~~~~~li~~~L~-~p~~R~s~~el------L~  280 (394)
                      ...                 ...+...+........++..      .++++.+||.+||. +|.+|||+.|+      +.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            211                 12222223222222223332      23479999999998 99999999999      44


Q ss_pred             CCccccCC
Q 016143          281 DPFLVTDN  288 (394)
Q Consensus       281 ~p~~~~~~  288 (394)
                      ++|-++..
T Consensus       318 ~~~~~~~~  325 (336)
T 3g2f_A          318 MIWERNKS  325 (336)
T ss_dssp             HCCCC---
T ss_pred             HHHHhccc
Confidence            67766543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.6e-44  Score=373.38  Aligned_cols=260  Identities=28%  Similarity=0.395  Sum_probs=206.1

Q ss_pred             cCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEc--
Q 016143           20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD--   97 (394)
Q Consensus        20 ~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~--   97 (394)
                      ....++| ++.+.||+|+||+||+|.+..+|..||+|++...   ......+++.+|+.++++++||||+++++++.+  
T Consensus        10 g~~~grY-~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~   85 (676)
T 3qa8_A           10 TQTCGPW-EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ   85 (676)
T ss_dssp             --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred             CCCCCCe-EEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence            3344666 8899999999999999999999999999988643   245667889999999999999999999998643  


Q ss_pred             --CCCceEEEEEcccCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC---c
Q 016143           98 --DTNRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---E  169 (394)
Q Consensus        98 --~~~~~~~lV~e~~~~gsL~~~i~~~~---~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~---~  169 (394)
                        ......++||||+++|+|.+++....   .+++..++.++.||+.||.|||++|  |+||||||+||+++. ++   .
T Consensus        86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~-~g~~~~  162 (676)
T 3qa8_A           86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQP-GPQRLI  162 (676)
T ss_dssp             CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEEC-CSSSCE
T ss_pred             cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeec-CCCcee
Confidence              12456789999999999999998754   5999999999999999999999999  999999999999983 44   3


Q ss_pred             EEEcccceeeeecCCC-CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHh-----
Q 016143          170 VKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-----  242 (394)
Q Consensus       170 ~kl~Dfgla~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~-----  242 (394)
                      +||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.....+.+....+.     
T Consensus       163 vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~  242 (676)
T 3qa8_A          163 HKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE  242 (676)
T ss_dssp             EEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred             EEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence            8999999998765543 345679999999998764 689999999999999999999999976433322111110     


Q ss_pred             --------cC--------CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          243 --------SG--------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       243 --------~~--------~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                              .+        ..+..+....++.+.+||.+||. +|.+||++.++|+||||+.
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence                    00        01112233356789999999998 9999999999999999976

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.4e-43  Score=353.21  Aligned_cols=240  Identities=25%  Similarity=0.394  Sum_probs=198.9

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||+||+|.+.. +..||+|.++....     ..+.+.+|+.+|++|+||||+++++++.+   ..+++|
T Consensus       186 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv  256 (452)
T 1fmk_A          186 LRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV  256 (452)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred             ceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEE
Confidence            4788999999999999999864 56799999864331     23568899999999999999999998743   357899


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+++|+|.+++...  ..+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++......
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC-----
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEC-CCCCEEECCCccceecCCC
Confidence            9999999999999753  56999999999999999999999999  99999999999998 6789999999999766443


Q ss_pred             C---CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          185 T---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       185 ~---~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      .   .....+|+.|+|||++. +.++.++|||||||++|||++ |+.||.+ .+..++...+..+..+. .+...++.+.
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~  411 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMP-CPPECPESLH  411 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTSCHHHH
T ss_pred             ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHH
Confidence            2   22345778999999765 568999999999999999999 9999987 55666777777765432 4556788999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhc
Q 016143          260 QFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ++|.+||. +|.+||++.++++
T Consensus       412 ~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          412 DLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHH
Confidence            99999998 9999999999886

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=345.25  Aligned_cols=239  Identities=21%  Similarity=0.309  Sum_probs=189.0

Q ss_pred             cccccccceecccCceEEEEE-----EEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC---CCCceeEeeeE
Q 016143           24 CRYGRYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSW   95 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a-----~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~---hpnIv~~~~~~   95 (394)
                      +..|++.+.||+|+||+||+|     .+..+++.||+|++....       ...+..|+.+++.++   |+||+++++++
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            444588899999999999999     467889999999986322       245677888888886   99999999998


Q ss_pred             EcCCCceEEEEEcccCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC----
Q 016143           96 VDDTNRTINMITELFTSGSLRQYRKK-----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----  166 (394)
Q Consensus        96 ~~~~~~~~~lV~e~~~~gsL~~~i~~-----~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~----  166 (394)
                      ...  ...++||||+++|+|.+++..     ...+++..++.++.||+.||.|||+++  |+||||||+|||++ .    
T Consensus       137 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~-~~~~~  211 (365)
T 3e7e_A          137 LFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILG-NGFLE  211 (365)
T ss_dssp             ECS--SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-GGGTC
T ss_pred             ecC--CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEec-ccccC
Confidence            655  457899999999999999974     456999999999999999999999999  99999999999998 4    


Q ss_pred             -------CCcEEEcccceeeeecC----CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCH
Q 016143          167 -------NGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP  234 (394)
Q Consensus       167 -------~~~~kl~Dfgla~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~  234 (394)
                             ++.+||+|||+|.....    ......+||+.|+|||++.+ .|+.++|||||||++|||+||+.||......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   78999999999976542    23345679999999998765 4899999999999999999999999642221


Q ss_pred             HHHHHHHhcCCCCCCCC-CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCC
Q 016143          235 AQIYKKVTSGIKPASLS-KVTDPQVKQFIEKCIV-PASLRLPALELLKDP  282 (394)
Q Consensus       235 ~~~~~~i~~~~~~~~~~-~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p  282 (394)
                      ..       .. ...+. ...+..+.+++.+||. +|.+|++..+.|.+.
T Consensus       292 ~~-------~~-~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          292 EC-------KP-EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             EE-------EE-CSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             ce-------ee-chhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence            00       00 01111 1235688999999998 888887766555543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.7e-43  Score=362.89  Aligned_cols=238  Identities=19%  Similarity=0.376  Sum_probs=197.6

Q ss_pred             eecccCceEEEEEEEc--cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           32 ILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        32 ~LG~G~~g~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      .||+|+||+||+|.++  .++..||+|.++...   .....+.+.+|+.+|++++||||+++++++.+   ..+++||||
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~E~  416 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEM  416 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEEEEEEC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeEEEEEe
Confidence            7999999999999875  456789999987542   23456778999999999999999999998864   248899999


Q ss_pred             cCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC---
Q 016143          110 FTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---  185 (394)
Q Consensus       110 ~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~---  185 (394)
                      +.+|+|.+++... ..+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+++......   
T Consensus       417 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLV-NRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             CTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCSTTTTCC------
T ss_pred             CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEc-CCCcEEEeeccCcccccCCCcee
Confidence            9999999999754 45999999999999999999999999  99999999999999 68899999999997654321   


Q ss_pred             --CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          186 --ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                        .....+|+.|+|||++. +.++.++|||||||++|||++ |+.||.+... .++...+..+..+ ..+...++++.++
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-~~~~~~i~~~~~~-~~p~~~~~~l~~l  571 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRM-ECPPECPPELYAL  571 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-HHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCCC-CCCCcCCHHHHHH
Confidence              11234678999999876 569999999999999999998 9999988544 5566777766543 3456678999999


Q ss_pred             HHHcCC-CCCCCCCHHHHhc
Q 016143          262 IEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL~  280 (394)
                      |.+||. +|.+||++.++++
T Consensus       572 i~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          572 MSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHH
Confidence            999998 9999999998753

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.2e-43  Score=335.46  Aligned_cols=244  Identities=28%  Similarity=0.449  Sum_probs=199.4

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHc--CCCCCceeEeeeEEcCCC--
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDDTN--  100 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~--L~hpnIv~~~~~~~~~~~--  100 (394)
                      +.|++.+.||+|+||+||+|.+  +|+.||+|.+...       ....+.+|+.+++.  ++||||+++++++.....  
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            3458899999999999999987  5899999998532       23557788888887  789999999999876543  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEecCCCCCcEEEeCCCCcEEE
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNNGEVKI  172 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH--------~~~~~ivHrDLkp~NIll~~~~~~~kl  172 (394)
                      ..+++||||+++|+|.+++.+. .+++..++.++.||+.||.|||        +++  |+||||||+||+++ .++.+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~-~~~~~kL  188 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK-KNGTCCI  188 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEEC-TTSCEEE
T ss_pred             ceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEEC-CCCCEEE
Confidence            2789999999999999999875 5999999999999999999999        888  99999999999998 6889999


Q ss_pred             cccceeeeecCCC------CcccccCCcccCccccccc-------CCCcCcchhhhhHHHHHHhc----------CCCCC
Q 016143          173 GDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTC----------EYPYN  229 (394)
Q Consensus       173 ~Dfgla~~~~~~~------~~~~~gt~~y~aPE~l~~~-------~~~~~DIwSlG~il~elltg----------~~Pf~  229 (394)
                      +|||++.......      .....||+.|+|||++.+.       ++.++|||||||++|+|+||          ..||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            9999997765442      2445799999999988653       23689999999999999999          88996


Q ss_pred             CCC----CHHHHHHHHhcCCCCCCCCC-----CCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          230 ECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       230 ~~~----~~~~~~~~i~~~~~~~~~~~-----~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ...    ....+...+........++.     ..+..+.+++.+||. +|.+||++.+++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            632    34555555544433333332     123578999999998 99999999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=337.84  Aligned_cols=245  Identities=27%  Similarity=0.449  Sum_probs=201.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+..   .||+|++.....  .....+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus        33 ~~~-~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~  104 (319)
T 2y4i_B           33 EQL-EIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMSP--PHL  104 (319)
T ss_dssp             SCE-ECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS--SCE
T ss_pred             HHe-EEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--Cce
Confidence            444 889999999999999998754   499999875432  223335577899999999999999999998654  458


Q ss_pred             EEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+++++|.+++...+ .+++..++.++.||+.||.|||+++  |+||||||+||+++  ++.+||+|||++....
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~--~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKVVITDFGLFSISG  180 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCCC---
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe--CCCEEEeecCCccccc
Confidence            89999999999999998765 6999999999999999999999999  99999999999997  5799999999986542


Q ss_pred             C-------CCCcccccCCcccCcccccc----------cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q 016143          183 Q-------PTARSVIGTPEFMAPELYEE----------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI  245 (394)
Q Consensus       183 ~-------~~~~~~~gt~~y~aPE~l~~----------~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~  245 (394)
                      .       .......||+.|+|||++.+          .++.++|||||||++|+|++|+.||.. .+.......+..+.
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~  259 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGM  259 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHTTC
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhccCC
Confidence            1       12334568999999998753          368899999999999999999999977 55666677777766


Q ss_pred             CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       246 ~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+.......+.++.+++.+||. +|.+||++.++++.
T Consensus       260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            5555555677899999999998 99999999999873

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=9.1e-43  Score=356.11  Aligned_cols=241  Identities=24%  Similarity=0.388  Sum_probs=203.4

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||+||+|.+.. +..||+|.++....     ..+.+.+|+.+|++|+||||+++++++.+   ..+++|
T Consensus       269 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv  339 (535)
T 2h8h_A          269 LRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV  339 (535)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred             hhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEe
Confidence            4788999999999999999864 56799999874331     23568899999999999999999998743   357899


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+.+|+|.+++...  ..+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++......
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCTTSTTTCCCH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEc-CCCcEEEcccccceecCCC
Confidence            9999999999999753  56999999999999999999999999  99999999999998 6789999999999765432


Q ss_pred             ---CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          185 ---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       185 ---~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                         ......+++.|+|||++. +.++.++|||||||+||||++ |+.||.+ ....++...+..+.... .+...+..+.
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~  494 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMP-CPPECPESLH  494 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCCHHHH
T ss_pred             ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHH
Confidence               122345788999999765 568999999999999999999 9999987 55566777777765432 4556788999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhcC
Q 016143          260 QFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +||.+||. +|.+||++.+++..
T Consensus       495 ~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          495 DLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHHH
Confidence            99999998 99999999998863

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.5e-43  Score=340.70  Aligned_cols=249  Identities=18%  Similarity=0.220  Sum_probs=192.1

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeecccc----CCHHHHHHHHHHHHHHHcCC---------CCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLK---------HENII   89 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~----~~~~~~~~~~~E~~~l~~L~---------hpnIv   89 (394)
                      .++| ++.+.||+|+||+||+|.+  +|+.||+|++......    ......+.+.+|+.+|+.|+         ||||+
T Consensus        19 ~~~y-~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           19 TEKL-QRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             HHHH-HTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccc-hheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            3555 7889999999999999987  6899999999865421    12234467888999998886         66666


Q ss_pred             eEeeeEEcC----------------------------CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 016143           90 KFYNSWVDD----------------------------TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL  141 (394)
Q Consensus        90 ~~~~~~~~~----------------------------~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L  141 (394)
                      ++.+.+...                            ....+++||||+++|++.+.+.+ +.+++..++.++.||+.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence            666554311                            24679999999999976666644 5689999999999999999


Q ss_pred             HHHH-hCCCCeEecCCCCCcEEEeCCCC--------------------cEEEcccceeeeecCCCCcccccCCcccCccc
Q 016143          142 HYLH-SHNPPIIHRDLKCDNIFVNGNNG--------------------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL  200 (394)
Q Consensus       142 ~~LH-~~~~~ivHrDLkp~NIll~~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~  200 (394)
                      .||| +++  |+||||||+|||++ .++                    .+||+|||+|+.....   ..+||+.|+|||+
T Consensus       175 ~~lH~~~~--ivHrDlKp~NILl~-~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~  248 (336)
T 2vuw_A          175 AVAEASLR--FEHRDLHWGNVLLK-KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDL  248 (336)
T ss_dssp             HHHHHHHC--CBCSCCCGGGEEEE-ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGG
T ss_pred             HHHHHhCC--EeECCCCHHHEEEe-ccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhh
Confidence            9999 999  99999999999998 454                    8999999999876643   4579999999999


Q ss_pred             ccccCCCcCcchhhhhH-HHHHHhcCCCCCCCCCHHHHHHHHhcCCC-C----CCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 016143          201 YEEEYNELVDIYSFGMC-ILEMVTCEYPYNECKNPAQIYKKVTSGIK-P----ASLSKVTDPQVKQFIEKCIVPASLRLP  274 (394)
Q Consensus       201 l~~~~~~~~DIwSlG~i-l~elltg~~Pf~~~~~~~~~~~~i~~~~~-~----~~~~~~~~~~~~~li~~~L~~p~~R~s  274 (394)
                      +.+..+.++||||||++ .+++++|..||.+......+...+..... .    .......++++++||++||..+    |
T Consensus       249 ~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----s  324 (336)
T 2vuw_A          249 FTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----S  324 (336)
T ss_dssp             GCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----S
T ss_pred             hcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----C
Confidence            98877899999998777 78889999999542111223333332211 1    1112235678999999999833    9


Q ss_pred             HHHHh-cCCccc
Q 016143          275 ALELL-KDPFLV  285 (394)
Q Consensus       275 ~~elL-~~p~~~  285 (394)
                      +.|+| +||||+
T Consensus       325 a~e~l~~Hp~f~  336 (336)
T 2vuw_A          325 ATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHCGGGC
T ss_pred             HHHHHhcCCCcC
Confidence            99999 999995

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7e-42  Score=344.74  Aligned_cols=246  Identities=20%  Similarity=0.296  Sum_probs=197.2

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ++| ++.+.||+|+||+||+|.+..+++.||||++......      ..+.+|+.+++.|+|++++..+..+.. .....
T Consensus         7 ~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~-~~~~~   78 (483)
T 3sv0_A            7 NKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGV-EGDYN   78 (483)
T ss_dssp             TTE-ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEE-ETTEE
T ss_pred             CcE-EEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEe-eCCEE
Confidence            344 8899999999999999999999999999987654321      236789999999987655554444433 34578


Q ss_pred             EEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEcccceeee
Q 016143          104 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIV  180 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~--~~~~~~kl~Dfgla~~  180 (394)
                      ++||||+ +++|.+++.. .+.+++..++.|+.||+.||.|||+++  |+||||||+||||+  ..++.+||+|||++..
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            8999999 9999999986 457999999999999999999999999  99999999999993  2678999999999987


Q ss_pred             ecCCCC---------cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCC--CHHHHHHHHhcCCC--
Q 016143          181 MQQPTA---------RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIK--  246 (394)
Q Consensus       181 ~~~~~~---------~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~--~~~~~~~~i~~~~~--  246 (394)
                      ......         ....||+.|+|||++.+ .++.++|||||||+||||++|+.||.+..  ...+.+..+.....  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            654321         25679999999997765 58999999999999999999999997743  23344443332111  


Q ss_pred             -CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          247 -PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       247 -~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                       ...+....++++.+||.+||. +|.+||++.++++
T Consensus       236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             112234567899999999998 9999999987665

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.2e-41  Score=355.43  Aligned_cols=243  Identities=25%  Similarity=0.425  Sum_probs=202.7

Q ss_pred             ccccceecccCceEEEEEEEccC---CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      +++.+.||+|+||+||+|.+..+   +..||+|.+...   ......+.+.+|+.+|++++||||+++++++.+   ..+
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~  465 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV  465 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---Cce
Confidence            36789999999999999998643   567999987532   245667889999999999999999999998732   347


Q ss_pred             EEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+++|+|.++++..+ .+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++....
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~-~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCCCCSCC
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEe-CCCCEEEEecCCCeecC
Confidence            89999999999999998654 6999999999999999999999999  99999999999999 68899999999997664


Q ss_pred             CCC---CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          183 QPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       183 ~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      ...   .....||+.|+|||++.+ .++.++|||||||++|||++ |..||.+ .+..+....+..+..+ ..+...++.
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~~~~  620 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPNCPPT  620 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHHTCCC-CCCTTCCHH
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCC-CCCccccHH
Confidence            432   223457889999997764 58999999999999999997 9999987 4556666666665433 345667899


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          258 VKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +.++|.+||. +|.+||++.++++
T Consensus       621 l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          621 LYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999998 9999999999886

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-43  Score=347.44  Aligned_cols=249  Identities=18%  Similarity=0.208  Sum_probs=189.3

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC-CCcee-------------
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIK-------------   90 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h-pnIv~-------------   90 (394)
                      +.+++.++||+|+||+||+|.+..+|+.||||++..... ......+.+.+|+.+++.++| +|+..             
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            445678999999999999999999999999998874332 223346778899999999987 32211             


Q ss_pred             --------EeeeEEcCC---CceEEEEEcccCCCcHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 016143           91 --------FYNSWVDDT---NRTINMITELFTSGSLRQYRKK-------HKNVDMKAIKNWARQILRGLHYLHSHNPPII  152 (394)
Q Consensus        91 --------~~~~~~~~~---~~~~~lV~e~~~~gsL~~~i~~-------~~~l~~~~~~~i~~qil~~L~~LH~~~~~iv  152 (394)
                              +...+....   ...++++|+++ +++|.++++.       ...+++..+..++.||+.||.|||+++  |+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ii  233 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV  233 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence                    111111111   23466777776 6899998852       234788899999999999999999999  99


Q ss_pred             ecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCcccccCCcccCcccc----------cc-cCCCcCcchhhhhHHHHH
Q 016143          153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----------EE-EYNELVDIYSFGMCILEM  221 (394)
Q Consensus       153 HrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l----------~~-~~~~~~DIwSlG~il~el  221 (394)
                      ||||||+|||++ .++.+||+|||+++..... ....+| +.|+|||++          .+ .|+.++|||||||++|||
T Consensus       234 HrDiKp~NILl~-~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          234 HTYLRPVDIVLD-QRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             CSCCCGGGEEEC-TTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEe-cCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            999999999998 7889999999999765544 445578 999999977          32 378899999999999999


Q ss_pred             HhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          222 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       222 ltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ++|+.||.... .......+...      ....++++++||.+||. +|.+||++.++|+||||+..
T Consensus       311 ltg~~Pf~~~~-~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          311 WCADLPNTDDA-ALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHSSCCCCTTG-GGSCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHCCCCCCCcc-hhhhHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            99999997632 22212222111      13457899999999998 99999999999999999864

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-42  Score=362.20  Aligned_cols=242  Identities=19%  Similarity=0.278  Sum_probs=198.6

Q ss_pred             cccccccceecccCceEEEEEEEcc-CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC--
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--  100 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~--  100 (394)
                      ++| ++.+.||+|+||+||+|.+.. +|+.||+|++...   ......+.+.+|+.+|++++||||+++++++.+...  
T Consensus        80 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           80 GQY-EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             TTE-EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             Cce-EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            445 889999999999999999976 7999999987643   245667788999999999999999999999875433  


Q ss_pred             -ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 -~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                       ...|+||||++|++|.+++..  .+++..++.++.||+.||.|||++|  |+||||||+|||++ . +.+||+|||++.
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~-~-~~~kl~DFG~a~  229 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLT-E-EQLKLIDLGAVS  229 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-S-SCEEECCCTTCE
T ss_pred             CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEe-C-CcEEEEecccch
Confidence             126899999999999998765  6999999999999999999999999  99999999999998 3 489999999998


Q ss_pred             eecCCCCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 016143          180 VMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK  259 (394)
Q Consensus       180 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  259 (394)
                      .....  ....||+.|+|||++.+.++.++|||||||++|+|++|..||.+...         ............++.+.
T Consensus       230 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l~  298 (681)
T 2pzi_A          230 RINSF--GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSYG  298 (681)
T ss_dssp             ETTCC--SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHHH
T ss_pred             hcccC--CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHHH
Confidence            76554  45679999999999888889999999999999999999999865210         01100000011246889


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          260 QFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                      ++|.+||. +|.+||++.+.+.|+|+..
T Consensus       299 ~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          299 RLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            99999998 9999999999999998753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.1e-41  Score=319.08  Aligned_cols=224  Identities=15%  Similarity=0.160  Sum_probs=182.9

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      +|| ++.+.||+|+||+||+|.+..+|+.||+|++.... ....+..+.+.+|+.++++++||||+++++++.++  ..+
T Consensus        31 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~  106 (286)
T 3uqc_A           31 GRY-RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG-VLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AGG  106 (286)
T ss_dssp             TTE-EEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTC-CSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred             CcE-EEEEEEcccCCeEEEEEEecCCCceEEEEEECccc-ccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--CcE
Confidence            555 88899999999999999999999999999987543 23466778899999999999999999999998654  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||++|++|.++++.+  ....++..++.||+.||.|||++|  |+||||||+|||++ .+|.+||+++|       
T Consensus       107 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~-~~g~~kl~~~~-------  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVS-IDGDVVLAYPA-------  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-TTSCEEECSCC-------
T ss_pred             EEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEc-CCCCEEEEecc-------
Confidence            9999999999999999653  466778999999999999999999  99999999999999 78899998543       


Q ss_pred             CCCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHH---HHHHhcCCC-CCCCCCCCCHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI---YKKVTSGIK-PASLSKVTDPQVK  259 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~---~~~i~~~~~-~~~~~~~~~~~~~  259 (394)
                                 |++|      ++.++|||||||++|+|+||+.||.+......+   .+.+..... +.......+++++
T Consensus       175 -----------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  237 (286)
T 3uqc_A          175 -----------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS  237 (286)
T ss_dssp             -----------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred             -----------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence                       4443      788999999999999999999999874322111   011111111 1123345778999


Q ss_pred             HHHHHcCC-CCCCCCCHHHHhcC
Q 016143          260 QFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       260 ~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++|.+||. +|.+| |+.|+++.
T Consensus       238 ~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          238 AVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHcccCCccC-CHHHHHHH
Confidence            99999998 99999 99999884

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=3.1e-35  Score=301.91  Aligned_cols=188  Identities=13%  Similarity=0.047  Sum_probs=136.2

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccC------CHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~------~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~  103 (394)
                      ..++.|+.|.+..+.....|+.||+|.+.......      .+...+++.+|+.+|+++ .|+||+++++++.++  ..+
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~  317 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSG  317 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEE
Confidence            44677888888888888899999999987543211      234456799999999999 699999999998544  579


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ||||||++|++|.+++++.+.+++.   .++.||+.||.|||++|  |+||||||+|||++ .+|++||+|||+|+....
T Consensus       318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~-~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVD-ARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEEC-TTSCEEECCCTTEESCC-
T ss_pred             EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEEC-CCCCEEEeecccCeeCCC
Confidence            9999999999999999999989875   47899999999999999  99999999999998 789999999999987654


Q ss_pred             C--CCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCC
Q 016143          184 P--TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEY  226 (394)
Q Consensus       184 ~--~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~  226 (394)
                      .  ...+.+||+.|||||++.+.+...+|+||+|+++++|.++..
T Consensus       392 ~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          392 DCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC-----------------CCCCTTHH
T ss_pred             CCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccc
Confidence            4  345678999999999999999999999999999887765533

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.6e-29  Score=258.06  Aligned_cols=184  Identities=19%  Similarity=0.211  Sum_probs=144.1

Q ss_pred             ccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC----HHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        29 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~----~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      -.++||+|+||+||+|.  ..+..+++|..........    ....+++.+|+.+|++++||||+++..++.++..  .+
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--~~  415 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--KR  415 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT--TE
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc--cE
Confidence            35789999999999993  5678899998754332211    1234568999999999999999954444344443  47


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      +||||+++++|.+++..        +..++.||+.||.|||+++  |+||||||+|||++ .  .+||+|||+++.....
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~-~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFD-K--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEES-S--SEEECCCTTCEECCCH
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEEC-C--eEEEEECccCEECCCc
Confidence            89999999999999876        6689999999999999999  99999999999998 3  9999999999877653


Q ss_pred             C---------CcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCC
Q 016143          185 T---------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYN  229 (394)
Q Consensus       185 ~---------~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~  229 (394)
                      .         ....+||+.|||||++..   .|+..+|+||..+-..+.+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2         235689999999998875   48889999999999999888887774

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=4.1e-26  Score=214.21  Aligned_cols=159  Identities=17%  Similarity=0.177  Sum_probs=123.2

Q ss_pred             cccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC-----H---------HHHHHHHHHHHHHHcCCCCCceeE
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-----P---------DQLERLYSEVHLLKSLKHENIIKF   91 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----~---------~~~~~~~~E~~~l~~L~hpnIv~~   91 (394)
                      ++++.+.||+|+||.||+|.+ .+|..||+|.++.......     .         .....+.+|+.+|++++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            345569999999999999999 8899999999864321110     0         24567889999999999  4 566


Q ss_pred             eeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEE
Q 016143           92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK  171 (394)
Q Consensus        92 ~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~k  171 (394)
                      ++.+..   ...++||||++|++|.+ +..      .....++.||+.||.|||++|  |+||||||+|||++  ++.+|
T Consensus       167 ~~~~~~---~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~--~~~vk  232 (282)
T 1zar_A          167 PKVYAW---EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS--EEGIW  232 (282)
T ss_dssp             CCEEEE---ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE--TTEEE
T ss_pred             CeEEec---cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE--CCcEE
Confidence            664422   23578999999999988 321      345679999999999999999  99999999999998  78999


Q ss_pred             EcccceeeeecCCCCcccccCCcccCcccccc-----------cCCCcCcchh
Q 016143          172 IGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-----------EYNELVDIYS  213 (394)
Q Consensus       172 l~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~DIwS  213 (394)
                      |+|||+|.           .+..++|||.+..           .|+..+|+|.
T Consensus       233 l~DFG~a~-----------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          233 IIDFPQSV-----------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             ECCCTTCE-----------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EEECCCCe-----------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            99999985           3556789997753           3566667665

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=8.6e-22  Score=182.26  Aligned_cols=144  Identities=16%  Similarity=0.196  Sum_probs=109.4

Q ss_pred             ccccccceecccCceEEEEEEEccCCeE--EEEEEeeeccccCC--------------------HHHHHHHHHHHHHHHc
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQS--------------------PDQLERLYSEVHLLKS   82 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~--vaiK~i~~~~~~~~--------------------~~~~~~~~~E~~~l~~   82 (394)
                      ..+.+.+.||+|+||+||+|.+..+|..  ||+|+++.......                    ......+.+|+.+|+.
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3456789999999999999998788999  99998754321100                    1122467889999999


Q ss_pred             CCCCCc--eeEeeeEEcCCCceEEEEEcccCC-C----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEec
Q 016143           83 LKHENI--IKFYNSWVDDTNRTINMITELFTS-G----SLRQYRKKHKNVDMKAIKNWARQILRGLHYLH-SHNPPIIHR  154 (394)
Q Consensus        83 L~hpnI--v~~~~~~~~~~~~~~~lV~e~~~~-g----sL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH-~~~~~ivHr  154 (394)
                      |.|+++  ..++..      ...++||||+.+ |    +|.++...   .++..+..++.||+.||.||| ++|  |+||
T Consensus       127 l~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHr  195 (258)
T 1zth_A          127 AKEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHA  195 (258)
T ss_dssp             HHHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECS
T ss_pred             HHhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence            988764  334432      134689999942 3    77776433   235578899999999999999 999  9999


Q ss_pred             CCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       155 DLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ||||+|||++ .  .++|+|||+|....
T Consensus       196 Dlkp~NILl~-~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          196 DLSEYNIMYI-D--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             SCSTTSEEES-S--SEEECCCTTCEETT
T ss_pred             CCCHHHEEEc-C--cEEEEECcccccCC
Confidence            9999999998 3  89999999997643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=8.7e-18  Score=162.85  Aligned_cols=141  Identities=15%  Similarity=0.150  Sum_probs=99.7

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccC-----------C---HHHH----HHHHHHHHHHHcCCCCCc
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-----------S---PDQL----ERLYSEVHLLKSLKHENI   88 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~-----------~---~~~~----~~~~~E~~~l~~L~hpnI   88 (394)
                      |++.+.||+|++|.||+|.+. +|+.||||+++......           .   ....    ....+|...|.+|.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            477889999999999999874 79999999876432110           0   0011    112357777777754443


Q ss_pred             e--eEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 016143           89 I--KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN  166 (394)
Q Consensus        89 v--~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~  166 (394)
                      .  ..++  ...    .++||||++|++|.++..      ......++.||+.+|.+||++|  ||||||||.|||++ +
T Consensus       176 ~vp~p~~--~~~----~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~-~  240 (397)
T 4gyi_A          176 PVPEPIA--QSR----HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIR-E  240 (397)
T ss_dssp             SCCCEEE--EET----TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-E
T ss_pred             CCCeeee--ccC----ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe-C
Confidence            2  2222  111    257999999999865432      2345678999999999999999  99999999999998 4


Q ss_pred             CC----------cEEEcccceeeeecC
Q 016143          167 NG----------EVKIGDLGLAIVMQQ  183 (394)
Q Consensus       167 ~~----------~~kl~Dfgla~~~~~  183 (394)
                      +|          .+.|+||+-+.....
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             CCCcccccccccceEEEEeCCcccCCC
Confidence            44          389999997755443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.31  E-value=8.2e-12  Score=114.77  Aligned_cols=137  Identities=15%  Similarity=0.062  Sum_probs=103.3

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      ++...++.|+.+.||++..  .+..+++|....... .   ....+.+|+.+|+.|. +.++.+++++..+  ....++|
T Consensus        17 ~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv   88 (263)
T 3tm0_A           17 RCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-G---TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLL   88 (263)
T ss_dssp             EEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-T---STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEE
T ss_pred             eeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-C---CHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEE
Confidence            6777888899999999964  367899998764211 1   1134778999999884 6778888887654  3578899


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN--------------------------------------  148 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~--------------------------------------  148 (394)
                      |||++|.+|.+...     +......++.++..+|..||+..                                      
T Consensus        89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999999987621     22334578899999999999811                                      


Q ss_pred             -------------------CCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          149 -------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       149 -------------------~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                                         +.++|+|++|.||+++ +++.+.|+||+.+
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~lIDwe~a  211 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRS  211 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE-TTEEEEECCCTTC
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE-CCcEEEEEEchhc
Confidence                               2389999999999998 4545679999876

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.12  E-value=1.9e-10  Score=104.95  Aligned_cols=133  Identities=13%  Similarity=0.013  Sum_probs=92.4

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCC--ceeEeeeEEcCCCceEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpn--Iv~~~~~~~~~~~~~~~l  105 (394)
                      .+..+.+.|..+.||++.. .+|..+++|.....       ....+.+|+.+++.|.+.+  +.+++.+..+.  ...++
T Consensus        23 ~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~   92 (264)
T 1nd4_A           23 DWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWL   92 (264)
T ss_dssp             EEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEE
T ss_pred             ceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEE
Confidence            3433334566699999854 56778999986532       1134667999999886444  45577765433  45789


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-------------------------------------  148 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~-------------------------------------  148 (394)
                      ||||++|.+|.  ..   ..+   ...++.++...|..||+..                                     
T Consensus        93 v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           93 LLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             EEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99999999884  11   122   2356777888888888753                                     


Q ss_pred             -------------------CCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          149 -------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       149 -------------------~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                                         +.++|+|++|.||+++ +++.+.|+||+.+.
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~liD~~~a~  213 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE-NGRFSGFIDCGRLG  213 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE-CCcEEEEEcchhcc
Confidence                               1299999999999998 45556799999773

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.11  E-value=2.1e-10  Score=110.48  Aligned_cols=144  Identities=15%  Similarity=0.168  Sum_probs=102.2

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEee--eccccCCHHHHHHHHHHHHHHHcCC--CCCceeEeeeEEcCCC-ceEE
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDTN-RTIN  104 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~--~~~~~~~~~~~~~~~~E~~~l~~L~--hpnIv~~~~~~~~~~~-~~~~  104 (394)
                      .+.|+.|.++.||++...  +..+++|+..  ....   ......+.+|+.+++.|.  +..+.+++.++.+... ...+
T Consensus        43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~---~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL---LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEECCC-CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC---CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            367899999999998653  4678888764  2221   112345778999999997  4557788876543321 3467


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-------------------------------------  147 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~-------------------------------------  147 (394)
                      +||||++|.++.+.  ....++..+...++.++...|..||+.                                     
T Consensus       118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            89999999887541  123478888999999999999999973                                     


Q ss_pred             -------------------CCCeEecCCCCCcEEEeCCCC-cEEEcccceeee
Q 016143          148 -------------------NPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIV  180 (394)
Q Consensus       148 -------------------~~~ivHrDLkp~NIll~~~~~-~~kl~Dfgla~~  180 (394)
                                         .+.++|+|+++.||+++.++. .+.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               134899999999999984433 369999998854

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.06  E-value=2.5e-10  Score=107.38  Aligned_cols=183  Identities=21%  Similarity=0.201  Sum_probs=121.4

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCC--ceeEeeeEEcCC-CceEEEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HEN--IIKFYNSWVDDT-NRTINMI  106 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpn--Iv~~~~~~~~~~-~~~~~lV  106 (394)
                      +.++.|....||++.     ..+++|+-.      .......+.+|+.+|+.|. +..  +.+++....+.. ....|+|
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPK------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEES------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecC------CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            568999999999863     357788743      1244567888999998884 333  334443321111 1234779


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN--------------------------------------  148 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~--------------------------------------  148 (394)
                      |++++|.+|.....  ..++..+...++.|+...|..||+..                                      
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999998876433  34778888889999999999998621                                      


Q ss_pred             ------------------CCeEecCCCCCcEEEeCC-CCcEEEcccceeeeecCCCCcccccCCcc---cCccccc---c
Q 016143          149 ------------------PPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTARSVIGTPEF---MAPELYE---E  203 (394)
Q Consensus       149 ------------------~~ivHrDLkp~NIll~~~-~~~~kl~Dfgla~~~~~~~~~~~~gt~~y---~aPE~l~---~  203 (394)
                                        +.++|+|++|.||+++.+ ++.+.|+||+.+.......  .......+   ..|+...   .
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHHHHHhhccccCHHHHHHHHH
Confidence                              237999999999999843 4567899999986543210  00001111   2333221   1


Q ss_pred             cCCC------------cCcchhhhhHHHHHHhcCCCC
Q 016143          204 EYNE------------LVDIYSFGMCILEMVTCEYPY  228 (394)
Q Consensus       204 ~~~~------------~~DIwSlG~il~elltg~~Pf  228 (394)
                      .|..            ..+.|+++.++|.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            2222            258999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.57  E-value=6.6e-07  Score=84.08  Aligned_cols=137  Identities=20%  Similarity=0.137  Sum_probs=92.8

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCC---CceeEeeeEEcCCCceEEEEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE---NIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hp---nIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +.++.|....||+.     |..+++|+-.      .......+.+|+.+|+.|.+.   .+.+.+.+.. ......++||
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~   92 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGY   92 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEE
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEE
Confidence            56788888899987     4567888632      234567788999999999753   2445555443 2334567999


Q ss_pred             cccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 016143          108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN---------------------------------------  148 (394)
Q Consensus       108 e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~---------------------------------------  148 (394)
                      ||++|.+|....-  ..++..+...++.|+...|..||+..                                       
T Consensus        93 e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           93 RKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             ECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             eccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            9999988876321  22455555556666666665555432                                       


Q ss_pred             -------------------CCeEecCCCCCcEEEeC--CCCc-EEEcccceeeee
Q 016143          149 -------------------PPIIHRDLKCDNIFVNG--NNGE-VKIGDLGLAIVM  181 (394)
Q Consensus       149 -------------------~~ivHrDLkp~NIll~~--~~~~-~kl~Dfgla~~~  181 (394)
                                         +.++|+|++|.||+++.  .++. +.|+||+.+...
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                               23699999999999984  1345 589999987543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.51  E-value=1.3e-06  Score=80.04  Aligned_cols=135  Identities=15%  Similarity=0.084  Sum_probs=93.6

Q ss_pred             ceecccCce-EEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEEEEc
Q 016143           31 EILGKGAFK-TVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        31 ~~LG~G~~g-~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      +.+..|..+ .||+......+..+.+|.-..       .....+.+|...|+.|. +-.+.+++.+..+.  ..-++|||
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme  100 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTT  100 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEE
Confidence            345555554 799987777778888887542       23456778999998884 33456677766544  46788999


Q ss_pred             ccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC---------------------------------------
Q 016143          109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP---------------------------------------  149 (394)
Q Consensus       109 ~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~---------------------------------------  149 (394)
                      +++|.++.+......    .....+..++...|.-||+..+                                       
T Consensus       101 ~l~G~~~~~~~~~~~----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          101 AIPGKTAFQVLEEYP----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CCCSEEHHHHHHHCG----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             eeCCccccccccCCH----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            999998887654421    2334556666666666664211                                       


Q ss_pred             -----------------CeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          150 -----------------PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       150 -----------------~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                                       .++|+|+.+.||+++ +++.+-|+||+.+.
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~-~~~~~~viDwe~a~  222 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD-EGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEE-CCeEEEEEECcccc
Confidence                             278999999999998 55566799998774

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.19  E-value=6.9e-06  Score=79.77  Aligned_cols=80  Identities=15%  Similarity=0.163  Sum_probs=48.1

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccc-cCC--HHHHHHHHHHHHHHHcCCC--CC-ceeEeeeEEcCCCceE
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV-MQS--PDQLERLYSEVHLLKSLKH--EN-IIKFYNSWVDDTNRTI  103 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~-~~~--~~~~~~~~~E~~~l~~L~h--pn-Iv~~~~~~~~~~~~~~  103 (394)
                      .+.||.|.++.||++....++..+++|....... ...  +...+++..|..+|+.+..  +. +.+++.+  +...  .
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~--~  110 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM--A  110 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT--T
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc--c
Confidence            3679999999999997666678899998642211 000  0123456778899887742  33 3455542  3333  3


Q ss_pred             EEEEcccCCC
Q 016143          104 NMITELFTSG  113 (394)
Q Consensus       104 ~lV~e~~~~g  113 (394)
                      ++|||++++.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            5799999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.04  E-value=6.9e-06  Score=78.47  Aligned_cols=82  Identities=5%  Similarity=-0.121  Sum_probs=50.1

Q ss_pred             cee-cccCceEEEEEEEc--c----CCeEEEEEEeeeccc--cCCHHHHHHHHHHHHHHHcCC-C--CCceeEeeeEEcC
Q 016143           31 EIL-GKGAFKTVYKGFDE--V----DGIEVAWNQVNIEDV--MQSPDQLERLYSEVHLLKSLK-H--ENIIKFYNSWVDD   98 (394)
Q Consensus        31 ~~L-G~G~~g~Vy~a~~~--~----~~~~vaiK~i~~~~~--~~~~~~~~~~~~E~~~l~~L~-h--pnIv~~~~~~~~~   98 (394)
                      +.| +.|....+|+....  .    ++..+++|.......  ...   ...+.+|+.+|+.|. +  -.+.+++.+..+.
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            567 78888999987543  1    266788887543220  000   134566888888874 2  3466677654332


Q ss_pred             C-CceEEEEEcccCCCcH
Q 016143           99 T-NRTINMITELFTSGSL  115 (394)
Q Consensus        99 ~-~~~~~lV~e~~~~gsL  115 (394)
                      . ....++||||++|.++
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence            1 1245679999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.95  E-value=6.4e-05  Score=70.82  Aligned_cols=29  Identities=24%  Similarity=0.437  Sum_probs=25.2

Q ss_pred             CCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       149 ~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      +.++|+|+++.||+++ .++.+.|+||+.+
T Consensus       222 ~~l~HgD~~~~Nil~~-~~~~~~lIDfe~a  250 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLG-ENEQIWVIDLDTV  250 (346)
T ss_dssp             CCEECSSCSTTSEEEC-GGGCEEECCCTTC
T ss_pred             CceecCCCCcccEEEe-CCCcEEEEehhhc
Confidence            3499999999999997 4578999999976

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.55  E-value=0.00053  Score=66.96  Aligned_cols=29  Identities=21%  Similarity=0.444  Sum_probs=24.8

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       150 ~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      .++|+|++|.||+++ .++ +.|+||+.+..
T Consensus       233 ~liHGDl~~~Nil~~-~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVT-QDS-TQVIDPEFSFY  261 (420)
T ss_dssp             EEECSCCSGGGEEEC-SSC-EEECCCTTCEE
T ss_pred             eEEecCCCCCcEEEe-CCC-CEEEeCccccc
Confidence            499999999999998 444 99999998854

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.54  E-value=0.00054  Score=64.32  Aligned_cols=74  Identities=15%  Similarity=0.043  Sum_probs=54.0

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC---CCCceeEeeeEEcCCCceEEEEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~---hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      +.|+.|.+..+|+...  ++..+++|.-...       ....+..|...|+.|.   ...+.+++.+..+  ....++||
T Consensus        42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvm  110 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND--EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLL  110 (312)
T ss_dssp             EEECCSSSSEEEEEES--SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEE
T ss_pred             EEeCCccceeeeEEEE--CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEE
Confidence            5689999999999864  4678888875421       2456778999888884   3567777776543  34688999


Q ss_pred             cccCCCcH
Q 016143          108 ELFTSGSL  115 (394)
Q Consensus       108 e~~~~gsL  115 (394)
                      ||++|..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.50  E-value=0.00071  Score=59.62  Aligned_cols=123  Identities=19%  Similarity=0.147  Sum_probs=82.4

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCCccc
Q 016143          112 SGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV  189 (394)
Q Consensus       112 ~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~L-H~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~~~~  189 (394)
                      ..+|.+.++.. .+++++++|.++.|.+.+|.-+ ++..  -..+=+.|..|++. .+|.|-+.+ +.+.          
T Consensus        32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVW-RDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEE-TTSCEEECC-C-------------
T ss_pred             cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEe-cCCceeccc-cccc----------
Confidence            34799988864 6799999999999999998876 3222  12344556899998 678877764 1110          


Q ss_pred             ccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCCC
Q 016143          190 IGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP  268 (394)
Q Consensus       190 ~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~  268 (394)
                      .....+.|||......+.+.=|||||+++|..+-...|-+                    -....++++.+||..|..+
T Consensus        98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e~--------------------eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKEN--------------------EERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCTT--------------------EEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCcc--------------------cchhhCHHHHHHHHHHHhc
Confidence            1233567888775555677889999999999997655432                    2345678999999888753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.22  E-value=0.002  Score=59.30  Aligned_cols=74  Identities=16%  Similarity=0.081  Sum_probs=48.6

Q ss_pred             cceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC---CCceeEeeeEEcCCCceEEEE
Q 016143           30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        30 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h---pnIv~~~~~~~~~~~~~~~lV  106 (394)
                      .+.+|.|..+.||+... .+|+.|.+|.-....    ......+..|+..|+.|.-   -.+.+++..  +.  .  ++|
T Consensus        20 v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~--~lv   88 (288)
T 3f7w_A           20 VAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA----PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--R--TLA   88 (288)
T ss_dssp             EEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC----CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--T--EEE
T ss_pred             EEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC----cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--c--eEE
Confidence            46789999999999864 578999999754221    1112345679999988842   134445542  22  2  468


Q ss_pred             EcccCCCc
Q 016143          107 TELFTSGS  114 (394)
Q Consensus       107 ~e~~~~gs  114 (394)
                      |||+.++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            89998654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.20  E-value=0.0011  Score=61.64  Aligned_cols=28  Identities=21%  Similarity=0.252  Sum_probs=23.9

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       151 ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ++|+|+.+.||+.  .++.+.++||..+..
T Consensus       175 l~HgDl~~~Nil~--~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFLD--TGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEEE--CSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEEE--CCCCEEEEecccccC
Confidence            7999999999995  466889999987743

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.13  E-value=0.0021  Score=60.47  Aligned_cols=32  Identities=22%  Similarity=0.242  Sum_probs=26.1

Q ss_pred             CeEecCCCCCcEEEeCC---CCcEEEcccceeeee
Q 016143          150 PIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVM  181 (394)
Q Consensus       150 ~ivHrDLkp~NIll~~~---~~~~kl~Dfgla~~~  181 (394)
                      .++|+|+.+.||+++.+   .+.+.|+||+.+..-
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            48999999999999832   268999999988543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.87  E-value=0.0042  Score=60.87  Aligned_cols=72  Identities=13%  Similarity=0.111  Sum_probs=46.1

Q ss_pred             ceecccCceEEEEEEEcc-------CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCc-eeEeeeEEcCCCce
Q 016143           31 EILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRT  102 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnI-v~~~~~~~~~~~~~  102 (394)
                      +.|+.|-...+|++....       ++..+++|+....   ..   .+.+.+|..+++.|...++ .++++.+  .+  .
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~~--g  148 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHLVAESVIFTLLSERHLGPKLYGIF--SG--G  148 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT--E
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC--C
Confidence            467778889999997542       2578888876321   11   1334579898888853333 5666644  32  2


Q ss_pred             EEEEEcccCCCc
Q 016143          103 INMITELFTSGS  114 (394)
Q Consensus       103 ~~lV~e~~~~gs  114 (394)
                        +|+||++|-+
T Consensus       149 --~v~e~l~G~~  158 (429)
T 1nw1_A          149 --RLEEYIPSRP  158 (429)
T ss_dssp             --EEECCCCEEE
T ss_pred             --EEEEEeCCcc
Confidence              6899998644

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.78  E-value=0.0069  Score=56.54  Aligned_cols=77  Identities=10%  Similarity=-0.019  Sum_probs=45.0

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCC--CceeEeee---EEcCCCceEEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNS---WVDDTNRTINM  105 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hp--nIv~~~~~---~~~~~~~~~~l  105 (394)
                      +.|+ |....||+... .+|..+++|.......  +.   +.+..|..+++.|...  .+.+++..   ......+..++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~--~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~  104 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW--TA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA  104 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS--CH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC--CH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence            4566 88889998753 3566788998752211  22   3455688888777421  23444432   00001245678


Q ss_pred             EEcccCCCc
Q 016143          106 ITELFTSGS  114 (394)
Q Consensus       106 V~e~~~~gs  114 (394)
                      ++++++|.+
T Consensus       105 l~~~i~G~~  113 (328)
T 1zyl_A          105 VFPSVGGRQ  113 (328)
T ss_dssp             EEECCCCEE
T ss_pred             EEEecCCCC
Confidence            999998754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.76  E-value=0.0038  Score=60.16  Aligned_cols=138  Identities=14%  Similarity=0.182  Sum_probs=79.3

Q ss_pred             ceecccCceEEEEEEEcc-------CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCce
Q 016143           31 EILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~  102 (394)
                      +.|..|-...+|++....       ++..+++|+...  ..   .....+.+|..+++.|. +.-..++++.+  ++  .
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~--g  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--IL---QGVDSLVLESVMFAILAERSLGPQLYGVF--PE--G  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--cc---chHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC--c
Confidence            456667788899987532       357888887421  11   12344557999998884 32235566644  33  2


Q ss_pred             EEEEEcccCCCcHHH--------------HHHh-C-------CCC--CHHHHHHHHHHHHH-------------------
Q 016143          103 INMITELFTSGSLRQ--------------YRKK-H-------KNV--DMKAIKNWARQILR-------------------  139 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~--------------~i~~-~-------~~l--~~~~~~~i~~qil~-------------------  139 (394)
                        +||||++|.+|..              .+.+ |       +..  -..++..|..|+-.                   
T Consensus       127 --~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  204 (379)
T 3feg_A          127 --RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD  204 (379)
T ss_dssp             --EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred             --cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence              6899999855421              1111 1       112  24567777766532                   


Q ss_pred             HHHH----HHhCC--CCeEecCCCCCcEEEeCC---CCcEEEcccceee
Q 016143          140 GLHY----LHSHN--PPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAI  179 (394)
Q Consensus       140 ~L~~----LH~~~--~~ivHrDLkp~NIll~~~---~~~~kl~Dfgla~  179 (394)
                      .+..    |.+.+  ..++|+|+.+.||+++.+   .+.+.++||..+.
T Consensus       205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            1222    22222  238999999999999843   3689999998774

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.72  E-value=0.0057  Score=56.95  Aligned_cols=140  Identities=14%  Similarity=0.123  Sum_probs=71.7

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCC--ceeEeeeE----EcCCCceEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNSW----VDDTNRTIN  104 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpn--Iv~~~~~~----~~~~~~~~~  104 (394)
                      +.|+.|....+|+.... +| .+++|......      ..+.+..|+.+++.|....  +.+++..-    ........+
T Consensus        28 ~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTT-KD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   99 (322)
T ss_dssp             EEECC---EEEEEEEES-SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             eccCCCcccceEEEEeC-Cc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence            55777888999998643 33 68888875321      1123455777777664212  23333210    000123567


Q ss_pred             EEEcccCCCcHH-----HH---------H-HhCCCC--------CHHHHHHH---------------HHHHHHHHHHHHh
Q 016143          105 MITELFTSGSLR-----QY---------R-KKHKNV--------DMKAIKNW---------------ARQILRGLHYLHS  146 (394)
Q Consensus       105 lV~e~~~~gsL~-----~~---------i-~~~~~l--------~~~~~~~i---------------~~qil~~L~~LH~  146 (394)
                      ++++|++|..+.     .+         + .....+        ....-...               ...+...+..+.+
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            899999886431     11         1 110111        11000000               0113334455542


Q ss_pred             C-----CCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          147 H-----NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       147 ~-----~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      .     ...++|+|+++.||+++ .++.+.|+||+.+.
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~-~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFL-GDELSGLIDFYFAC  216 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred             hCcccCCcccCCCCCCccCEEEe-CCceEEEecchhcc
Confidence            1     12389999999999998 44445799998763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.49  E-value=0.021  Score=56.36  Aligned_cols=74  Identities=18%  Similarity=0.144  Sum_probs=45.3

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCc-eeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnI-v~~~~~~~~~~~~~~~lV~e~  109 (394)
                      +.|+.|-...+|++.....+..+++|+.....    ..... ..+|..+++.|...++ .++++.+  .+  .  +|+||
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~----~~~id-R~~E~~vl~~L~~~gl~P~ll~~~--~~--G--~v~e~  182 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT----DEIIN-REREKKISCILYNKNIAKKIYVFF--TN--G--RIEEF  182 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C----CSCSC-HHHHHHHHHHHTTSSSBCCEEEEE--TT--E--EEEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh----hhhcC-HHHHHHHHHHHHhcCCCCCEEEEe--CC--e--EEEEe
Confidence            56777888999998765445788888764211    00111 1468888988865444 4566654  32  2  38999


Q ss_pred             cCCCcH
Q 016143          110 FTSGSL  115 (394)
Q Consensus       110 ~~~gsL  115 (394)
                      ++|-+|
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.40  E-value=0.0047  Score=58.95  Aligned_cols=73  Identities=14%  Similarity=0.129  Sum_probs=40.9

Q ss_pred             ceecccCceEEEEEEEcc--------CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCC-ceeEeeeEEcCCCc
Q 016143           31 EILGKGAFKTVYKGFDEV--------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDTNR  101 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~--------~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpn-Iv~~~~~~~~~~~~  101 (394)
                      +.|+.|....+|+.....        .+..+++|+.....     ........|..+++.|...+ ..+++..+  +  .
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~  109 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-----DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G  109 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-----cceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence            567778888999987543        13678888754211     11112346888888774333 34666543  2  2


Q ss_pred             eEEEEEcccCCCc
Q 016143          102 TINMITELFTSGS  114 (394)
Q Consensus       102 ~~~lV~e~~~~gs  114 (394)
                        ++|+||++|.+
T Consensus       110 --~~v~e~i~G~~  120 (369)
T 3c5i_A          110 --GRIEEWLYGDP  120 (369)
T ss_dssp             --EEEEECCCSEE
T ss_pred             --cEEEEEecCCc
Confidence              46899998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.08  E-value=0.047  Score=51.41  Aligned_cols=30  Identities=23%  Similarity=0.419  Sum_probs=25.7

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       150 ~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      .++|+|+.+.||+++ .++.+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~-~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVG-NEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEEC-GGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEe-CCCeEEEEECCCCee
Confidence            489999999999998 467899999987743

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.14  E-value=0.035  Score=54.82  Aligned_cols=64  Identities=17%  Similarity=0.104  Sum_probs=17.9

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEE------EEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAW------NQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV   96 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vai------K~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~   96 (394)
                      .+.+.||   ||.||+|.......+||+      |......  .+.+....+.+|..+++.++|||+++.+.+-.
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~--~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG--VSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCcccccccc--ccccccccccccccccccccccccCCCcceEE
Confidence            3456676   999999988665668888      5543222  12345567888999999999999999887543

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.89  E-value=3.6  Score=35.95  Aligned_cols=114  Identities=11%  Similarity=0.113  Sum_probs=71.5

Q ss_pred             CCCCceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCeEecCCCCCcEE
Q 016143           84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH-YLHSHNPPIIHRDLKCDNIF  162 (394)
Q Consensus        84 ~hpnIv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~-~LH~~~~~ivHrDLkp~NIl  162 (394)
                      .||++..-+    ..+.+.+.+.++.-+++.=+..+   ..++....++++.+|+.... +++  .  -+|--|+|+||+
T Consensus        48 ~~~~f~~~I----~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCIVRDI----DVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSSEEEE----EECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGGEE
T ss_pred             cCCCCCeEE----EEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCceEE
Confidence            678772222    23345666655554333333344   33778889999999888776 554  3  588999999999


Q ss_pred             EeCCCCcEEEcccceeeeecCCCCcccccCCcccCcccccccCCCcCcch-hhhhHHHHHHhcCCCCC
Q 016143          163 VNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIY-SFGMCILEMVTCEYPYN  229 (394)
Q Consensus       163 l~~~~~~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DIw-SlG~il~elltg~~Pf~  229 (394)
                      ++ .++.++|.-.|+-..               ++|.-+..     .|.| ++=|++..++.++..|.
T Consensus       117 f~-~~~~p~i~hRGi~~~---------------lpP~e~~e-----e~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          117 FN-RALEPFFLHVGVKES---------------LPPDEWDD-----ERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EC-TTCCEEESCCEETTT---------------BSSCSCCH-----HHHHHHHHHHHHHHTTCSSCHH
T ss_pred             Ee-CCCcEEEEEcCCccc---------------CCCCCCCH-----HHHHHHHHHHHHHHHcCCCCHH
Confidence            99 789999998875422               22221111     1222 44567777888877773

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	394
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-85
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-66
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-64
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-62
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-62
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-58
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-55
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-54
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-53
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-53
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-52
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-51
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-51
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-51
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-50
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-50
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-49
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-49
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-49
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-48
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-47
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-47
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-46
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-45
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-45
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-45
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-45
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-45
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-45
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-44
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-44
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-44
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-43
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-41
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-41
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-40
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-40
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-40
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-39
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-39
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-38
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-37
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-35
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-34
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  257 bits (659), Expect = 4e-85
 Identities = 134/263 (50%), Positives = 185/263 (70%), Gaps = 5/263 (1%)

Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
           R+ ++D  +G+G+FKTVYKG D    +EVAW ++    +  +  + +R   E  +LK L+
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQ 66

Query: 85  HENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           H NI++FY+SW       + I ++TEL TSG+L+ Y K+ K + +K +++W RQIL+GL 
Sbjct: 67  HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE 202
           +LH+  PPIIHRDLKCDNIF+ G  G VKIGDLGLA + +   A++VIGTPEFMAPE+YE
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE 186

Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           E+Y+E VD+Y+FGMC+LEM T EYPY+EC+N AQIY++VTSG+KPAS  KV  P+VK+ I
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246

Query: 263 EKCIVP-ASLRLPALELLKDPFL 284
           E CI      R    +LL   F 
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFF 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  210 bits (536), Expect = 4e-66
 Identities = 84/303 (27%), Positives = 140/303 (46%), Gaps = 16/303 (5%)

Query: 17  FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
           F + DP   +    EI G G+F  VY   D  +   VA  +++     QS ++ + +  E
Sbjct: 8   FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKE 65

Query: 77  VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
           V  L+ L+H N I++   ++ +      ++ E     +        K +    I      
Sbjct: 66  VRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG 123

Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 196
            L+GL YLHSHN  +IHRD+K  NI ++   G VK+GD G A +M    A S +GTP +M
Sbjct: 124 ALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYWM 178

Query: 197 APELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
           APE+     E +Y+  VD++S G+  +E+   + P     N       +     PA  S 
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSG 237

Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLA 310
                 + F++ C+      R  +  LLK  F++ + P  ++ D + R  + V E+ NL 
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQ 297

Query: 311 HSE 313
           + +
Sbjct: 298 YRK 300

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 1e-64
 Identities = 70/265 (26%), Positives = 130/265 (49%), Gaps = 16/265 (6%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             +G G++    K   + DG  + W +++   +  +  + + L SEV+LL+ LKH NI++
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVR 67

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYLHS 146
           +Y+  +D TN T+ ++ E    G L        K+ + +D + +     Q+   L   H 
Sbjct: 68  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127

Query: 147 HN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY 201
            +     ++HRDLK  N+F++G    VK+GD GLA ++   T  A++ +GTP +M+PE  
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186

Query: 202 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
               YNE  DI+S G  + E+     P+    +  ++  K+  G K   +      ++ +
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNE 244

Query: 261 FIEKCIVP-ASLRLPALELLKDPFL 284
            I + +      R    E+L++P +
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPLI 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-62
 Identities = 83/276 (30%), Positives = 136/276 (49%), Gaps = 15/276 (5%)

Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
           S  DP  +Y R+++I G+GA  TVY   D   G EVA  Q+N++       + E + +E+
Sbjct: 14  SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEI 68

Query: 78  HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
            +++  K+ NI+ + +S++      + ++ E    GSL     +    D   I    R+ 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCREC 125

Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEF 195
           L+ L +LHS+   +IHRD+K DNI +   +G VK+ D G    I  +Q    +++GTP +
Sbjct: 126 LQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 196 MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
           MAPE +  + Y   VDI+S G+  +EM+  E PY        +Y   T+G       +  
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242

Query: 255 DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 289
               + F+ +C+      R  A ELL+  FL    P
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 6e-62
 Identities = 59/260 (22%), Positives = 118/260 (45%), Gaps = 11/260 (4%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             LGKG F  VY   ++     +A   +     ++      +L  EV +   L+H NI++
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNILR 70

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            Y  + D T   + +I E    G++ +  +K    D +    +  ++   L Y HS    
Sbjct: 71  LYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-- 126

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 209
           +IHRD+K +N+ +  + GE+KI D G ++        ++ GT +++ PE +    ++E V
Sbjct: 127 VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 185

Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP- 268
           D++S G+   E +  + P+ E     + YK+++      +         +  I + +   
Sbjct: 186 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKHN 242

Query: 269 ASLRLPALELLKDPFLVTDN 288
            S R    E+L+ P++  ++
Sbjct: 243 PSQRPMLREVLEHPWITANS 262

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 1e-60
 Identities = 75/282 (26%), Positives = 132/282 (46%), Gaps = 20/282 (7%)

Query: 21  DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
           +P   +      LG GAF  VYK  ++   +  A   ++     +S ++LE    E+ +L
Sbjct: 9   NPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVID----TKSEEELEDYMVEIDIL 63

Query: 81  KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILR 139
            S  H NI+K  +++  + N  + ++ E    G++     +  + +    I+   +Q L 
Sbjct: 64  ASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD 121

Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMA 197
            L+YLH +   IIHRDLK  NI     +G++K+ D G++    +   R  S IGTP +MA
Sbjct: 122 ALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178

Query: 198 PELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
           PE+       +  Y+   D++S G+ ++EM   E P++E      + K   S     +  
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238

Query: 252 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
                  K F++KC+      R    +LL+ PF+  D+ K +
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 1e-58
 Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 50/304 (16%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             LG G    V+K   +  G+ +A   +++E     P    ++  E+ +L       I+ 
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVG 68

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
           FY ++  D    I++  E    GSL Q  KK   +  + +   +  +++GL YL   +  
Sbjct: 69  FYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-K 125

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 209
           I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M+PE L    Y+   
Sbjct: 126 IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184

Query: 210 DIYSFGMCILEMVTCEYPY----------------------------------------- 228
           DI+S G+ ++EM    YP                                          
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244

Query: 229 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD 287
                  ++   + +   P   S V   + + F+ KC++   + R    +L+   F+   
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304

Query: 288 NPKD 291
           + ++
Sbjct: 305 DAEE 308

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 3e-58
 Identities = 65/267 (24%), Positives = 120/267 (44%), Gaps = 15/267 (5%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG+GA+  V    + V    VA   V+++  +  P+ +++   E+ + K L HEN++K
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVK 67

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
           FY    +       +  E  + G L    +    +     + +  Q++ G+ YLH     
Sbjct: 68  FYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEEE-- 204
           I HRD+K +N+ ++     +KI D GLA V     ++     + GT  ++APEL +    
Sbjct: 124 ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
           + E VD++S G+ +  M+  E P+++  +  Q Y          +  K  D      + K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242

Query: 265 CIVP-ASLRLPALELLKDPFLVTDNPK 290
            +V   S R+   ++ KD +      K
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLKK 269

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-55
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 26/270 (9%)

Query: 26  YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
            G+    + +G G+F TVYKG       +VA   +N+     +P QL+   +EV +L+  
Sbjct: 7   DGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVT--APTPQQLQAFKNEVGVLRKT 61

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLH 142
           +H NI+ F           + ++T+     SL  +        +M  + + ARQ  +G+ 
Sbjct: 62  RHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAP 198
           YLH+ +  IIHRDLK +NIF++  +  VKIGD GLA V  + +       + G+  +MAP
Sbjct: 119 YLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 199 ELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
           E+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G     LSKV 
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235

Query: 255 D---PQVKQFIEKCIVP-ASLRLPALELLK 280
                 +K+ + +C+      R    ++L 
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILA 265

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  181 bits (460), Expect = 2e-54
 Identities = 62/273 (22%), Positives = 112/273 (41%), Gaps = 16/273 (5%)

Query: 26  YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
           Y  YD  E LG GAF  V++  ++  G       +N       P     + +E+ ++  L
Sbjct: 28  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQL 83

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLH 142
            H  +I  ++++ D     + +I E  + G L      +   +    + N+ RQ   GL 
Sbjct: 84  HHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPEL 200
           ++H H+  I+H D+K +NI         VKI D GLA  +      +    T EF APE+
Sbjct: 142 HMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 199

Query: 201 YE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQV 258
            + E      D+++ G+    +++   P+    +   +        +          P+ 
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259

Query: 259 KQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
           K FI+  +      RL   + L+ P+L  D+  
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  181 bits (459), Expect = 3e-54
 Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 20/301 (6%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
            YD  E LG GAF  V++  +   G   A   V            E +  E+  +  L+H
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRH 82

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYL 144
             ++  ++++ DD    + MI E  + G L +    +H  +       + RQ+ +GL ++
Sbjct: 83  PTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 145 HSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPELYE 202
           H +N   +H DLK +NI      + E+K+ D GL   +  + + +   GT EF APE+ E
Sbjct: 141 HENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198

Query: 203 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVK 259
            +      D++S G+    +++   P+   +N  +  + V S       S         K
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257

Query: 260 QFIEKCIVP-ASLRLPALELLKDPFLVTDNP--KDLVCDPLRLPNLVPEVMNLAHSEPHP 316
            FI K ++   + R+   + L+ P+L   N   +D      R   +   +     + P P
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEP 317

Query: 317 M 317
           +
Sbjct: 318 L 318

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-53
 Identities = 67/263 (25%), Positives = 123/263 (46%), Gaps = 15/263 (5%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           ++ +ILG+G+F TV    +     E A   +     +   +++  +  E  ++  L H  
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRH-IIKENKVPYVTRERDVMSRLDHPF 69

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
            +K Y ++ DD    +        +G L +Y +K  + D    + +  +I+  L YLH  
Sbjct: 70  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
              IIHRDLK +NI +N  +  ++I D G A V+    +Q  A S +GT ++++PE L E
Sbjct: 128 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
           +   +  D+++ G  I ++V    P+    N   I++K+          +   P+ +  +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKL--EYDFPEKFFPKARDLV 241

Query: 263 EKCIVP-ASLRLPALELLKDPFL 284
           EK +V  A+ RL   E+     L
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPL 264

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (452), Expect = 1e-53
 Identities = 60/290 (20%), Positives = 120/290 (41%), Gaps = 16/290 (5%)

Query: 20  KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
           +D    Y  + ++LG GAF  V    D+     VA   +  + +      +E    E+ +
Sbjct: 5   EDIRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMEN---EIAV 60

Query: 80  LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILR 139
           L  +KH NI+   + +    +  + +I +L + G L     +      +       Q+L 
Sbjct: 61  LHKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118

Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFM 196
            + YLH     I+HRDLK +N+       + ++ I D GL+ +    +   +  GTP ++
Sbjct: 119 AVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 176

Query: 197 AP-ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKV 253
           AP  L ++ Y++ VD +S G+    ++    P+ + +N A++++++        +     
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDD 235

Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
                K FI   +      R    + L+ P++  D   D          +
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 7e-52
 Identities = 57/268 (21%), Positives = 116/268 (43%), Gaps = 19/268 (7%)

Query: 26  YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
           Y +Y   E LG+G F  V++  +           V ++   Q       +  E+ +L   
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-----VLVKKEISILNIA 58

Query: 84  KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLH 142
           +H NI+  + S+       + MI E  +   + +        ++ + I ++  Q+   L 
Sbjct: 59  RHRNILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 143 YLHSHNPPIIHRDLKCDNIFV-NGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPEL 200
           +LHSHN  I H D++ +NI      +  +KI + G A  ++     R +   PE+ APE+
Sbjct: 117 FLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 201 YEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQ 257
           ++ +  +   D++S G  +  +++   P+   +   QI + + +          K    +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 258 VKQFIEKCIVP-ASLRLPALELLKDPFL 284
              F+++ +V     R+ A E L+ P+L
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWL 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  171 bits (433), Expect = 3e-51
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 25/278 (8%)

Query: 26  YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-----QSPDQLERLYSEVH 78
           Y  Y+  EILG+G    V +   +    E A   +++         +  +  E    EV 
Sbjct: 2   YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 79  LLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
           +L+ +  H NII+  +++  +T     ++ +L   G L  Y  +   +  K  +   R +
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119

Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFM 196
           L  +  LH  N  I+HRDLK +NI ++ ++  +K+ D G +  +      R V GTP ++
Sbjct: 120 LEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176

Query: 197 APELYEEE-------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249
           APE+ E         Y + VD++S G+ +  ++    P+   +    + + + SG     
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG 235

Query: 250 LSKVTD--PQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
             +  D    VK  + + +V     R  A E L  PF 
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 5e-51
 Identities = 71/296 (23%), Positives = 127/296 (42%), Gaps = 16/296 (5%)

Query: 17  FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLY 74
           F +++    Y    E LG G F  V K  ++  G++ A   +       S      E + 
Sbjct: 3   FRQENVDDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61

Query: 75  SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 134
            EV +LK ++H N+I  +  + + T+  + +I EL   G L  +  + +++  +    + 
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFL 119

Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTARS-VI 190
           +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +        + 
Sbjct: 120 KQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177

Query: 191 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 247
           GTPEF+APE+   E      D++S G+    +++   P+       +    V++      
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFE 236

Query: 248 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
                 T    K FI + +V     R+   + L+ P++   + +  +      P  
Sbjct: 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  171 bits (433), Expect = 6e-51
 Identities = 55/286 (19%), Positives = 108/286 (37%), Gaps = 19/286 (6%)

Query: 7   FTKSETEEG--EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
           FT  +  E   EF+++       + ++++G G F  V  G  ++ G    +  +      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65

Query: 65  QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 123
            +  Q     SE  ++    H N+I         T   + +ITE   +GSL  + R+   
Sbjct: 66  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP--VMIITEFMENGSLDSFLRQNDG 123

Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
              +  +    R I  G+ YL   N   +HRDL   NI VN +N   K+ D GL+  ++ 
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLED 180

Query: 184 PTARSV-------IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 235
            T+               + APE  +  ++    D++S+G+ + E+++            
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
            +   +    +           + Q +  C     + R    +++ 
Sbjct: 241 DVINAIEQDYRLPPPMDC-PSALHQLMLDCWQKDRNHRPKFGQIVN 285

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  169 bits (428), Expect = 5e-50
 Identities = 71/285 (24%), Positives = 129/285 (45%), Gaps = 18/285 (6%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             LG G+F  V+      +G   A   +  ++++    Q+E    E  +L  + H  II+
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
            + ++ D     I MI +    G L    +K +       K +A ++   L YLHS +  
Sbjct: 69  MWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-- 124

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 209
           II+RDLK +NI ++  NG +KI D G A  +   T  ++ GTP+++APE +  + YN+ +
Sbjct: 125 IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNKSI 182

Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-- 267
           D +SFG+ I EM+    P+ +  N  + Y+K+ +           +  VK  + + I   
Sbjct: 183 DWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRD 239

Query: 268 ----PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
                 +L+    ++   P+      + L+   +  P   P +  
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP-YEPPIQQ 283

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  167 bits (424), Expect = 6e-50
 Identities = 60/270 (22%), Positives = 106/270 (39%), Gaps = 16/270 (5%)

Query: 27  GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            RY+  EILG G    V+   D     +VA   +   D+ + P    R   E     +L 
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALN 65

Query: 85  HENIIKFYNSWVDDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           H  I+  Y++   +T       ++ E     +LR        +  K          + L+
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMA 197
           + H +   IIHRD+K  NI ++  N  VK+ D G+A  +           +VIGT ++++
Sbjct: 126 FSHQNG--IIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 198 PELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTD 255
           PE    +  +   D+YS G  + E++T E P+      +  Y+ V     P S   +   
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242

Query: 256 PQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
             +   + K +      R      ++   +
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 2e-49
 Identities = 54/254 (21%), Positives = 110/254 (43%), Gaps = 18/254 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + +GKG F  V  G  +  G +VA         +++    +   +E  ++  L+H N+++
Sbjct: 13  QTIGKGEFGDVMLG--DYRGNKVAVK------CIKNDATAQAFLAEASVMTQLRHSNLVQ 64

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
                V++    + ++TE    GSL  Y   +    +    +  ++  +   + YL  +N
Sbjct: 65  LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNE 207
              +HRDL   N+ V+  +   K+ D GL       T  +     ++ APE L E++++ 
Sbjct: 124 --FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEALREKKFST 179

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267
             D++SFG+ + E+ +             +  +V  G K  +      P V + ++ C  
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCWH 238

Query: 268 P-ASLRLPALELLK 280
             A++R   L+L +
Sbjct: 239 LDAAMRPSFLQLRE 252

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-49
 Identities = 50/267 (18%), Positives = 105/267 (39%), Gaps = 21/267 (7%)

Query: 27  GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV--MQSPDQLERLYSEVHLLKS 82
            +Y    +LG G F +VY G    D + VA   V  + +          R+  EV LLK 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 83  LK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           +      +I+  + +    +  + +         L  +  +   +  +  +++  Q+L  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLIL-ERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL 200
           + + H+    ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE 
Sbjct: 123 VRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEW 180

Query: 201 YEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
                 +     ++S G+ + +MV  + P+   +   +        +           + 
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------SSEC 231

Query: 259 KQFIEKCIVP-ASLRLPALELLKDPFL 284
           +  I  C+    S R    E+   P++
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 3e-49
 Identities = 60/285 (21%), Positives = 131/285 (45%), Gaps = 19/285 (6%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           ++LGKG F  V    ++  G   A   +  ++V+ + D++    +E  +L++ +H  +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
              ++       +  + E    G L  +  + +    +  + +  +I+  L YLHS +  
Sbjct: 70  LKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 125

Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE-EEYNE 207
           +++RD+K +N+ ++  +G +KI D GL    +    T ++  GTPE++APE+ E  +Y  
Sbjct: 126 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184

Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267
            VD +  G+ + EM+    P+   ++  ++++ +          +   P+ K  +   + 
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILME--EIRFPRTLSPEAKSLLAGLLK 241

Query: 268 ------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
                        A E+++  F ++ N +D+V   L  P   P+V
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP-FKPQV 285

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 5e-48
 Identities = 60/270 (22%), Positives = 113/270 (41%), Gaps = 23/270 (8%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           +  E LG G F  V+ G+      +VA     ++ + Q     +   +E +L+K L+H+ 
Sbjct: 16  KLVERLGAGQFGEVWMGYYN-GHTKVA-----VKSLKQGSMSPDAFLAEANLMKQLQHQR 69

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGLHYLH 145
           +++ Y     +    I +ITE   +GSL  + K    +   +  + + A QI  G+ ++ 
Sbjct: 70  LVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTPEFMAP-ELY 201
             N   IHRDL+  NI V+ +    KI D GLA ++   +           ++ AP  + 
Sbjct: 127 ERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
              +    D++SFG+ + E+VT            ++ + +  G +          ++ Q 
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQL 242

Query: 262 IEKCIVP-ASLRLPA---LELLKDPFLVTD 287
           +  C       R        +L+D F  T+
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVLEDFFTATE 272

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 1e-47
 Identities = 69/282 (24%), Positives = 129/282 (45%), Gaps = 16/282 (5%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENII 89
           ++LGKG+F  V+    +      A   +  +DV+   D +E    E  +L  + +H  + 
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
             + ++    N    M  E    G L  + +     D+     +A +I+ GL +LHS   
Sbjct: 67  HMFCTFQTKENLFFVM--EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE-LYEEEYN 206
            I++RDLK DNI ++  +G +KI D G+        A+  +  GTP+++APE L  ++YN
Sbjct: 124 -IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181

Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266
             VD +SFG+ + EM+  + P+   ++  +++  +          +  + + K  + K  
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLF 238

Query: 267 VP-ASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
           V     RL    ++ + P     N ++L    +  P   P+V
Sbjct: 239 VREPEKRLGVRGDIRQHPLFREINWEELERKEID-PPFRPKV 279

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-47
 Identities = 48/256 (18%), Positives = 99/256 (38%), Gaps = 18/256 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + +G G F  V+ G+   +  +VA   +      +     E    E  ++  L H  +++
Sbjct: 11  QEIGSGQFGLVHLGYWL-NKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
            Y   ++     I ++ E    G L  Y R +      + +      +  G+ YL     
Sbjct: 65  LYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPE-LYEEEY 205
            +IHRDL   N  V   N  +K+ D G+   +               ++ +PE      Y
Sbjct: 122 -VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
           +   D++SFG+ + E+ +      E ++ +++ + +++G +     ++    V Q +  C
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHC 238

Query: 266 IVP-ASLRLPALELLK 280
                  R     LL+
Sbjct: 239 WKERPEDRPAFSRLLR 254

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 4e-47
 Identities = 51/266 (19%), Positives = 107/266 (40%), Gaps = 21/266 (7%)

Query: 30  DEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           D+ LG G F TV KG+ ++      VA   +  E     P   + L +E ++++ L +  
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPY 69

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
           I++       ++     ++ E+   G L +Y +++++V  K I     Q+  G+ YL   
Sbjct: 70  IVRMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126

Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LY 201
           N   +HRDL   N+ +       KI D GL+  ++                ++ APE + 
Sbjct: 127 N--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
             +++   D++SFG+ + E  +           +++   +  G +    +     ++   
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDL 242

Query: 262 IEKCIVP-ASLRLPA---LELLKDPF 283
           +  C       R         L++ +
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNYY 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 4e-47
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 16/281 (5%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQ-VNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
           ++LG GAF TVYKG    +G +V     +       SP   + +  E +++ S+ + ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 148
           +     +  T +   +IT+L   G L  Y ++HK N+  + + NW  QI +G++YL    
Sbjct: 75  RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYEE 203
             ++HRDL   N+ V      VKI D GLA ++    ++  A       ++MA E +   
Sbjct: 132 --LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188

Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263
            Y    D++S+G+ + E++T      +    ++I   +  G +      +    V   + 
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQPPICTIDVYMIMV 247

Query: 264 KCIVP-ASLRLPALELLKDP-FLVTDNPKDLVCDPLRLPNL 302
           KC +  A  R    EL+ +   +  D  + LV       +L
Sbjct: 248 KCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 7e-47
 Identities = 69/301 (22%), Positives = 120/301 (39%), Gaps = 39/301 (12%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL-ERLYSEVHLLKSLKHENII 89
           + LG+G F TVYK  D+     VA  ++ +    ++ D +      E+ LL+ L H NII
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
              +++   +N  I+++ +   +      +     +    IK +    L+GL YLH H  
Sbjct: 64  GLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY--EEEY 205
            I+HRDLK +N+ ++  NG +K+ D GLA     P       + T  + APEL      Y
Sbjct: 121 -ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 206 NELVDIYSFGMCILEMVTCEYPY-------------------------NECKNPAQIYKK 240
              VD+++ G  + E++                               + C  P  +  K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 241 VTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRL 299
              GI    +       +   I+   +     R+ A + LK  +  ++ P        +L
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRPGP--TPGCQL 295

Query: 300 P 300
           P
Sbjct: 296 P 296

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  161 bits (407), Expect = 1e-46
 Identities = 58/284 (20%), Positives = 116/284 (40%), Gaps = 20/284 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENI 88
            I+G+G F  VY       G   A   ++ + +   Q           + L+ +     I
Sbjct: 10  RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69

Query: 89  IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
           +    ++       ++ I +L   G L  +  +H       ++ +A +I+ GL ++H+  
Sbjct: 70  VCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 127

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YN 206
             +++RDLK  NI ++  +G V+I DLGLA    +    + +GT  +MAPE+ ++   Y+
Sbjct: 128 --VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYD 184

Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266
              D +S G  + +++    P+ + K   +      +      L     P+++  +E  +
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244

Query: 267 V------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 304
                     L   A E+ + PF      + L    + L    P
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFF-----RSLDWQMVFLQKYPP 283

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 1e-45
 Identities = 45/267 (16%), Positives = 101/267 (37%), Gaps = 23/267 (8%)

Query: 30  DEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           D  LG G F +V +G   +    I+VA   + +          E +  E  ++  L +  
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 70

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHS 146
           I++            + ++ E+   G L ++   K + + +  +     Q+  G+ YL  
Sbjct: 71  IVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 127

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVIGTPEFMAPE-L 200
            N   +HRDL   N+ +  N    KI D GL+  +           +     ++ APE +
Sbjct: 128 KN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
              +++   D++S+G+ + E ++      +     ++   +  G +         P++  
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-ECPPECPPELYA 243

Query: 261 FIEKCIVPASLRLP----ALELLKDPF 283
            +  C +      P      + ++  +
Sbjct: 244 LMSDCWIYKWEDRPDFLTVEQRMRACY 270

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  156 bits (395), Expect = 1e-45
 Identities = 58/257 (22%), Positives = 103/257 (40%), Gaps = 18/257 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             LG G +  VY+G  +   + VA   +      +   ++E    E  ++K +KH N+++
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
                  +    I    E  T G+L  Y      + V    +   A QI   + YL   N
Sbjct: 78  LLGVCTREPPFYIIT--EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135

Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT---PEFMAP-ELYEEE 204
              IHRDL   N  V   N  VK+ D GL+ +M   T  +  G     ++ AP  L   +
Sbjct: 136 --FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192

Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
           ++   D+++FG+ + E+ T         + +Q+Y+ +    +          +V + +  
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP-EKVYELMRA 251

Query: 265 CIVP-ASLRLPALELLK 280
           C     S R    E+ +
Sbjct: 252 CWQWNPSDRPSFAEIHQ 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 2e-45
 Identities = 56/257 (21%), Positives = 106/257 (41%), Gaps = 13/257 (5%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
             +G+G F  V++G             +       S    E+   E   ++   H +I+K
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
                 ++    + +I EL T G LR + + +  ++D+ ++  +A Q+   L YL S   
Sbjct: 73  LIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPE-LYEEEY 205
             +HRD+   N+ V+  N  VK+GD GL+  M+  T           ++MAPE +    +
Sbjct: 129 -FVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
               D++ FG+C+ E++       +      +  ++ +G +   +     P +   + KC
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-PMPPNCPPTLYSLMTKC 245

Query: 266 IVP-ASLRLPALELLKD 281
                S R    EL   
Sbjct: 246 WAYDPSRRPRFTELKAQ 262

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-45
 Identities = 57/278 (20%), Positives = 112/278 (40%), Gaps = 14/278 (5%)

Query: 12  TEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE 71
            +  +     PS     ++E++G+G F  VY G    +  +     V   + +    ++ 
Sbjct: 14  VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 73

Query: 72  RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAI 130
           +  +E  ++K   H N++      +      + ++      G LR + + +  N  +K +
Sbjct: 74  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDL 132

Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-- 188
             +  Q+ +G+      +   +HRDL   N  ++     VK+ D GLA  M      S  
Sbjct: 133 IGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVH 189

Query: 189 ----VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243
                    ++MA E L  +++    D++SFG+ + E++T   P     N   I   +  
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249

Query: 244 GIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
           G +        DP + + + KC  P A +R    EL+ 
Sbjct: 250 GRRLLQPEYCPDP-LYEVMLKCWHPKAEMRPSFSELVS 286

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  156 bits (395), Expect = 6e-45
 Identities = 65/290 (22%), Positives = 129/290 (44%), Gaps = 20/290 (6%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           ++D  + LG G+F  V     +  G   A   ++ +  +    Q+E   +E  +L+++  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-VVKLKQIEHTLNEKRILQAVNF 100

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
             ++K   S+ D  N  + M+ E    G +  + ++         + +A QI+    YLH
Sbjct: 101 PFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEE 204
           S +  +I+RDLK +N+ ++   G +++ D G A  ++  T  ++ GTPE +APE +  + 
Sbjct: 159 SLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKG 214

Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
           YN+ VD ++ G+ I EM     P+     P QIY+K+ SG             +K  +  
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRN 271

Query: 265 CIV------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
            +         +L+    ++    +  T +   +    +  P  +P+   
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP-FIPKFKG 320

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 7e-45
 Identities = 66/261 (25%), Positives = 106/261 (40%), Gaps = 18/261 (6%)

Query: 31  EILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           E LG G+F  V +G  +      + VA   +   DV+  P+ ++    EV+ + SL H N
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-PDVLSQPEAMDDFIREVNAMHSLDHRN 72

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHS 146
           +I+ Y   +      + M+TEL   GSL    +KH+    +  +  +A Q+  G+ YL S
Sbjct: 73  LIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-L 200
                IHRDL   N+ +      VKIGD GL   + Q                + APE L
Sbjct: 130 KR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
               ++   D + FG+ + EM T         N +QI  K+    +     +     +  
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246

Query: 261 FIEKCIVP-ASLRLPALELLK 280
            + +C       R   + L  
Sbjct: 247 VMVQCWAHKPEDRPTFVALRD 267

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 8e-45
 Identities = 53/257 (20%), Positives = 99/257 (38%), Gaps = 18/257 (7%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           + LG G F  V  G       +VA   +    + +     +    E  ++ +L HE +++
Sbjct: 10  KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE-----DEFIEEAKVMMNLSHEKLVQ 63

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
            Y          I +ITE   +G L  Y R+       + +    + +   + YL S   
Sbjct: 64  LYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 120

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIGTPEFMAPELYE-EEY 205
             +HRDL   N  VN + G VK+ D GL+  +      S         +  PE+    ++
Sbjct: 121 -FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
           +   DI++FG+ + E+ +      E    ++  + +  G++      +   +V   +  C
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKVYTIMYSC 237

Query: 266 IVP-ASLRLPALELLKD 281
               A  R     LL +
Sbjct: 238 WHEKADERPTFKILLSN 254

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 1e-44
 Identities = 57/272 (20%), Positives = 107/272 (39%), Gaps = 22/272 (8%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
           R +  LG+G F  V+ G        VA   +    +       E    E  ++K L+HE 
Sbjct: 20  RLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-----EAFLQEAQVMKKLRHEK 73

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLH 145
           +++ Y      +   I ++TE  + GSL  +   +  K + +  + + A QI  G+ Y+ 
Sbjct: 74  LVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPE-LY 201
             N   +HRDL+  NI V   N   K+ D GLA +++       +      ++ APE   
Sbjct: 131 RMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
              +    D++SFG+ + E+ T            ++  +V  G +     +     +   
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHDL 246

Query: 262 IEKCIVP-ASLRLPALELLK--DPFLVTDNPK 290
           + +C       R     L    + +  +  P+
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-44
 Identities = 67/319 (21%), Positives = 117/319 (36%), Gaps = 53/319 (16%)

Query: 22  PSCR-YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 78
           P C    +Y+    +G+G F  V+K      G +VA  +V +E+  +          E+ 
Sbjct: 4   PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIK 61

Query: 79  LLKSLKHENIIKFYNSWVDDT------NRTINMITELFTSGSLRQYRKKHKNVDMKAIKN 132
           +L+ LKHEN++                  +I ++ +                  +  IK 
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121

Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------ 186
             + +L GL+Y+H +   I+HRD+K  N+ +   +G +K+ D GLA              
Sbjct: 122 VMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRY 178

Query: 187 RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY------ 238
            + + T  +  PE  L E +Y   +D++  G  + EM T            Q+       
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238

Query: 239 -----------------------KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
                                  K     +K    + V DP     I+K +V   + R+ 
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298

Query: 275 ALELLKDPFLVTD-NPKDL 292
           + + L   F  +D  P DL
Sbjct: 299 SDDALNHDFFWSDPMPSDL 317

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 2e-44
 Identities = 50/281 (17%), Positives = 108/281 (38%), Gaps = 28/281 (9%)

Query: 25  RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSL 83
            Y    ++LG G    V + F++    + A   +             +   EV    ++ 
Sbjct: 12  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRAS 62

Query: 84  KHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILR 139
           +  +I++  + + +     + + ++ E    G L      +  +    +      + I  
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122

Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFM 196
            + YLHS N  I HRD+K +N+       N  +K+ D G A       +  +   TP ++
Sbjct: 123 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 180

Query: 197 APELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------PAS 249
           APE+   E+Y++  D++S G+ +  ++    P+    +   I   + + I+      P  
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQYEFPNP 239

Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 289
                  +VK  I   +    + R+   E +  P+++    
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 5e-44
 Identities = 62/275 (22%), Positives = 111/275 (40%), Gaps = 23/275 (8%)

Query: 18  SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERL 73
           +E  PSC      +++G G F  VYKG  +       + VA   +       +  Q    
Sbjct: 2   TEIHPSCV--TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDF 56

Query: 74  YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKN 132
             E  ++    H NII+            I  ITE   +G+L ++ R+K     +  +  
Sbjct: 57  LGEAGIMGQFSHHNIIRLEGVISKYKPMMI--ITEYMENGALDKFLREKDGEFSVLQLVG 114

Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TAR 187
             R I  G+ YL + N   +HRDL   NI VN +N   K+ D GL+ V++       T  
Sbjct: 115 MLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTS 171

Query: 188 SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
                  + APE +   ++    D++SFG+ + E++T         +  ++ K +  G +
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231

Query: 247 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
             +        + Q + +C     + R    +++ 
Sbjct: 232 LPTPMDC-PSAIYQLMMQCWQQERARRPKFADIVS 265

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-43
 Identities = 71/348 (20%), Positives = 132/348 (37%), Gaps = 55/348 (15%)

Query: 5   SGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
           S  T      G+  ++     Y    +++G G+F  VY+      G  VA  +V  +   
Sbjct: 1   SKVTTVVATPGQGPDRPQEVSY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-- 57

Query: 65  QSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTSG---SLRQ 117
                      E+ +++ L H NI++    FY+S        +N++ +          R 
Sbjct: 58  ------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 111

Query: 118 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177
           Y +  + + +  +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G 
Sbjct: 112 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 169

Query: 178 AIVMQQPTA-RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 234
           A  + +     S I +  + APEL     +Y   +D++S G  + E++  +  +      
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229

Query: 235 AQIYKKVT----------------------SGIKPASLSKV----TDPQVKQFIEKCIVP 268
            Q+ + +                         IK    +KV    T P+      + +  
Sbjct: 230 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 289

Query: 269 -ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL--VPEVMNLAHSE 313
             + RL  LE     F       +L    ++LPN    P + N    E
Sbjct: 290 TPTARLTPLEACAHSFF-----DELRDPNVKLPNGRDTPALFNFTTQE 332

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 2e-43
 Identities = 58/273 (21%), Positives = 106/273 (38%), Gaps = 27/273 (9%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHE 86
           ++ +++G+G F  V K   + DG+ +    +       S D       E+ +L  L  H 
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAI 130
           NII    +        + +  E    G+L  + +K                   +  + +
Sbjct: 72  NIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
            ++A  + RG+ YL       IHRDL   NI V   N   KI D GL+   +    +++ 
Sbjct: 130 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 191 -GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248
                +MA E L    Y    D++S+G+ + E+V+           A++Y+K+  G +  
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246

Query: 249 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
                 D +V   + +C       R    ++L 
Sbjct: 247 KPLNC-DDEVYDLMRQCWREKPYERPSFAQILV 278

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 4e-43
 Identities = 63/283 (22%), Positives = 108/283 (38%), Gaps = 39/283 (13%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLYSEVHLLKSL-KHEN 87
           ++LG GAF  V               QV ++ + +  D    E L SE+ ++  L  HEN
Sbjct: 43  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 88  IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN----------------------- 124
           I+    +        I +I E    G L  Y +  +                        
Sbjct: 103 IVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
           +  + +  +A Q+ +G+ +L   +   +HRDL   N+ V  +   VKI D GLA  +   
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVT-HGKVVKICDFGLARDIMSD 217

Query: 185 ----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 238
                  +     ++MAPE L+E  Y    D++S+G+ + E+ +    PY      A  Y
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277

Query: 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
           K + +G K       T  ++   ++ C    +  R     L  
Sbjct: 278 KLIQNGFKMDQPFYAT-EEIYIIMQSCWAFDSRKRPSFPNLTS 319

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (369), Expect = 1e-41
 Identities = 54/280 (19%), Positives = 99/280 (35%), Gaps = 32/280 (11%)

Query: 27  GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            RY     +G G+F  +Y G D   G EVA     ++       +  +L+ E  + K ++
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQ 60

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
               I     W         M+ EL        +    +   +K +   A Q++  + Y+
Sbjct: 61  GGVGIPTIR-WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 145 HSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQP---------TARSVIGTP 193
           HS N   IHRD+K DN  +        V I D GLA   +             +++ GT 
Sbjct: 120 HSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 194 EFMAPELYE-EEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSG---IKP 247
            + +   +   E +   D+ S G  ++        +   +     Q Y++++        
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237

Query: 248 ASLSKVTDPQVKQFIEKCIVPASLRLP----ALELLKDPF 283
             L K    +   ++  C        P      +L ++ F
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-41
 Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 39/286 (13%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +G+G +  VYK  +++ G  VA  ++ ++   ++         E+ LLK L H NI+K
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65

Query: 91  FYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNP 149
             +    +    + ++ E       +         + +  IK++  Q+L+GL + HSH  
Sbjct: 66  LLDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY--EEEY 205
            ++HRDLK  N+ +N   G +K+ D GLA     P       + T  + APE+    + Y
Sbjct: 123 -VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------------ 247
           +  VDI+S G    EMVT    +       Q+++   +   P                  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240

Query: 248 --------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
                   + +    D   +  + + +    + R+ A   L  PF 
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (367), Expect = 2e-41
 Identities = 64/290 (22%), Positives = 110/290 (37%), Gaps = 41/290 (14%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           +Y   E +G+G +  VYK  +   G   A  ++ +E   +          E+ +LK LKH
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLE--KEDEGIPSTTIREISILKELKH 59

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
            NI+K Y+         + ++ E       +        ++    K++  Q+L G+ Y H
Sbjct: 60  SNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEE 203
                ++HRDLK  N+ +N   GE+KI D GLA     P  +    I T  + AP++   
Sbjct: 118 DRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 204 E--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK---------------------- 239
              Y+  +DI+S G    EMV     +       Q+ +                      
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 240 ----KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
                V   +   S  K  D      + K +    + R+ A + L+  + 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 3e-41
 Identities = 59/295 (20%), Positives = 125/295 (42%), Gaps = 27/295 (9%)

Query: 31  EILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE- 86
           ++LG GA+  V+          G   A   +    ++Q     E   +E  +L+ ++   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 87  NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
            ++  + ++  +T   + +  +    G L  +  + +      ++ +  +I+  L +LH 
Sbjct: 90  FLVTLHYAFQTETKLHLIL--DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147

Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV---MQQPTARSVIGTPEFMAPELY-- 201
               II+RD+K +NI ++ +NG V + D GL+      +   A    GT E+MAP++   
Sbjct: 148 LG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204

Query: 202 -EEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
            +  +++ VD +S G+ + E++T   P+    E  + A+I +++     P    +     
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSAL 262

Query: 258 VKQFIEKCIV------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
            K  I++ ++             A E+ +  F    N  DL    +  P   P +
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP-FKPVI 316

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 4e-41
 Identities = 66/298 (22%), Positives = 112/298 (37%), Gaps = 47/298 (15%)

Query: 27  GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            RY     +G+GA+  V   +D V+ + VA  +++  +        +R   E+ +L   +
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFR 64

Query: 85  HENIIKFYNSWVDDTNRTIN--MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
           HENII   +     T   +    +        L +  K    +    I  +  QILRGL 
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLK 123

Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVIGTPEFMA 197
           Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              + T  + A
Sbjct: 124 YIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180

Query: 198 PELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------- 247
           PE+      Y + +DI+S G  + EM++    +       Q+   +     P        
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240

Query: 248 --------------------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
                                 L    D +    ++K +      R+   + L  P+L
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 5e-41
 Identities = 80/313 (25%), Positives = 126/313 (40%), Gaps = 43/313 (13%)

Query: 5   SGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
           SGF + E  +  +  +     Y R  + +G GA+  V    D   G +VA  ++      
Sbjct: 2   SGFYRQEVTKTAWEVRA---VY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--F 55

Query: 65  QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS--GSLRQYRKKH 122
           QS    +R Y E+ LLK ++HEN+I   + +  D          L     G+      KH
Sbjct: 56  QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 115

Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
           + +    I+    Q+L+GL Y+H+      HRDLK  N+ VN  + E+KI D GLA    
Sbjct: 116 EKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVN-EDCELKILDFGLARQAD 172

Query: 183 QPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
                  + T  + APE+      Y + VDI+S G  + EM+T +  +    +  Q+ + 
Sbjct: 173 SEM-TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231

Query: 241 VTSGIKP----------------------------ASLSKVTDPQVKQFIEKCIVP-ASL 271
           +     P                            AS+     P     +EK +V  A  
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291

Query: 272 RLPALELLKDPFL 284
           R+ A E L  P+ 
Sbjct: 292 RVTAGEALAHPYF 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-40
 Identities = 61/291 (20%), Positives = 121/291 (41%), Gaps = 41/291 (14%)

Query: 28  RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
           +Y+  E +G+G + TV+K  +      VA  +V ++D             E+ LLK LKH
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKH 60

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
           +NI++ ++    D   T+    E       + +   + ++D + +K++  Q+L+GL + H
Sbjct: 61  KNIVRLHDVLHSDKKLTLVF--EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPELY-- 201
           S N  ++HRDLK  N+ +N  NGE+K+ + GLA     P       + T  +  P++   
Sbjct: 119 SRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---------------- 245
            + Y+  +D++S G    E+     P     +     K++   +                
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 246 -----------KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
                         ++    +   +  ++  +      R+ A E L+ P+ 
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 2e-40
 Identities = 69/291 (23%), Positives = 111/291 (38%), Gaps = 50/291 (17%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
           E +GKG F  V++G     G EVA    +  +     ++     +E++    L+HENI+ 
Sbjct: 9   ESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILG 61

Query: 91  FYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-- 146
           F  +   D      +  +++    GSL  Y  ++  V ++ +   A     GL +LH   
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEI 120

Query: 147 ----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFM 196
                 P I HRDLK  NI V   NG   I DLGLA+     T          +GT  +M
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 197 APELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG----- 244
           APE+ ++       E  +  DIY+ G+   E+          ++    Y  +        
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 245 --------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
                         I     S      + + + +C     + RL AL + K
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  143 bits (362), Expect = 2e-40
 Identities = 54/301 (17%), Positives = 117/301 (38%), Gaps = 53/301 (17%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 89
             LG+G +  V++  +  +  +V    +        P + +++  E+ +L++L+   NII
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNII 93

Query: 90  KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
              +   D  +RT  ++ E   +   +Q    ++ +    I+ +  +IL+ L Y HS   
Sbjct: 94  TLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG- 149

Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEE--YN 206
            I+HRD+K  N+ ++  + ++++ D GLA            + +  F  PEL  +   Y+
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208

Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT------------------------ 242
             +D++S G  +  M+  + P+    +      ++                         
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268

Query: 243 -----------SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
                           +    +  P+   F++K +      RL A E ++ P+      K
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF-YTVVK 327

Query: 291 D 291
           D
Sbjct: 328 D 328

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 73/298 (24%), Positives = 124/298 (41%), Gaps = 39/298 (13%)

Query: 23  SCRY-GRYD--EILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQS-PDQLERLYSEV 77
            CR   +Y+    +G+GA+  V+K  D +  G  VA  +V ++   +  P    R  + +
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 78  HLLKSLKHENIIKFYNSWVD---DTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNW 133
             L++ +H N+++ ++       D    + ++ E           +     V  + IK+ 
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGT 192
             Q+LRGL +LHSH   ++HRDLK  NI V  ++G++K+ D GLA I   Q    SV+ T
Sbjct: 122 MFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVT 178

Query: 193 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-- 249
             + APE L +  Y   VD++S G    EM   +  +    +  Q+ K +     P    
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 250 ----------------------LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
                                      D   K  + KC+    + R+ A   L  P+ 
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (355), Expect = 1e-39
 Identities = 49/288 (17%), Positives = 91/288 (31%), Gaps = 44/288 (15%)

Query: 28  RYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
            Y   +G+GAF  V++              VA   +  E    S D       E  L+  
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAE 72

Query: 83  LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN------------------ 124
             + NI+K            + ++ E    G L ++ +                      
Sbjct: 73  FDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 125 ------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
                 +        ARQ+  G+ YL       +HRDL   N  V   N  VKI D GL+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG-ENMVVKIADFGLS 187

Query: 179 IVMQQPTAR----SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKN 233
             +          +      +M PE ++   Y    D++++G+ + E+ +          
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
             ++   V  G    +  +    ++   +  C     + R     + +
Sbjct: 248 HEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-39
 Identities = 54/283 (19%), Positives = 108/283 (38%), Gaps = 38/283 (13%)

Query: 28  RYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
            + + LG GAF  V +            + VA   +          + E L SE+ +L  
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSY 82

Query: 83  LK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN----------------- 124
           L  H NI+    +          +ITE    G L  + ++ ++                 
Sbjct: 83  LGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 125 -VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
            +D++ + +++ Q+ +G+ +L S N   IHRDL   NI +  +    KI D GLA  ++ 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIKN 197

Query: 184 PTARSV----IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
            +   V        ++MAPE ++   Y    D++S+G+ + E+ +              +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
            K+          +    ++   ++ C       R    ++++
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  139 bits (351), Expect = 4e-39
 Identities = 37/260 (14%), Positives = 94/260 (36%), Gaps = 30/260 (11%)

Query: 27  GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
             Y     +G+G+F  +++G + ++  +VA   +  E       QL   Y    LL    
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRDEYRTYKLLAGCT 61

Query: 85  HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
               + ++            ++ +L             +   +K +   A+Q+L  +  +
Sbjct: 62  GIPNVYYF----GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117

Query: 145 HSHNPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQQP---------TARSVIG 191
           H  +  +++RD+K DN  +      N   + + D G+    + P           +++ G
Sbjct: 118 HEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 192 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTSGIKPA 248
           T  +M+   +   E +   D+ + G   +  +     +   +     Q Y+++    +  
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235

Query: 249 SLSKVTD---PQVKQFIEKC 265
            L ++      +  +++   
Sbjct: 236 PLRELCAGFPEEFYKYMHYA 255

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 7e-39
 Identities = 67/281 (23%), Positives = 116/281 (41%), Gaps = 39/281 (13%)

Query: 31  EILGKGAFKTVYKGFD-------EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
           + LG+GAF  V                 +VA   +  +    +   L  L SE+ ++K +
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMI 75

Query: 84  -KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVD 126
            KH+NII    +   D    + +I E  + G+LR+Y +  +                 + 
Sbjct: 76  GKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184
            K + + A Q+ RG+ YL S     IHRDL   N+ V  +   +KI D GLA  +     
Sbjct: 134 SKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 190

Query: 185 --TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
                +     ++MAPE L++  Y    D++SFG+ + E+ T            +++K +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 242 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 281
             G +    S  T  ++   +  C     S R    +L++D
Sbjct: 251 KEGHRMDKPSNCT-NELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-38
 Identities = 53/271 (19%), Positives = 105/271 (38%), Gaps = 24/271 (8%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKH 85
                LG+G+F  VY+G  +    +    +V I+  +   S  +     +E  ++K    
Sbjct: 23  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV----------DMKAIKNWAR 135
            ++++              +I EL T G L+ Y +  +             +  +   A 
Sbjct: 83  HHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIG 191
           +I  G+ YL+++    +HRDL   N  V   +  VKIGD G+   + +          + 
Sbjct: 141 EIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
              +M+PE L +  +    D++SFG+ + E+ T      +  +  Q+ + V  G      
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257

Query: 251 SKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
                  + + +  C      +R   LE++ 
Sbjct: 258 DNC-PDMLFELMRMCWQYNPKMRPSFLEIIS 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-37
 Identities = 56/278 (20%), Positives = 108/278 (38%), Gaps = 29/278 (10%)

Query: 28  RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKH 85
           +  + LG+GAF  V +              V ++      +  +   L SE+ +L  + H
Sbjct: 16  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75

Query: 86  ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN----------------VDMKA 129
              +             + +I E    G+L  Y +  +N                + ++ 
Sbjct: 76  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----T 185
           +  ++ Q+ +G+ +L S     IHRDL   NI ++     VKI D GLA  + +      
Sbjct: 136 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVR 192

Query: 186 ARSVIGTPEFMA-PELYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 243
                   ++MA   +++  Y    D++SFG+ + E+ +    PY   K   +  +++  
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252

Query: 244 GIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
           G +       T P++ Q +  C     S R    EL++
Sbjct: 253 GTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 1e-35
 Identities = 82/327 (25%), Positives = 135/327 (41%), Gaps = 45/327 (13%)

Query: 6   GFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
            F + E  +  +   +   RY +    +G GA+ +V   FD   G+ VA  +++     Q
Sbjct: 3   TFYRQELNKTIWEVPE---RY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQ 56

Query: 66  SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI--NMITELFTSGSLRQYRKKHK 123
           S    +R Y E+ LLK +KHEN+I   + +    +     ++       G+      K +
Sbjct: 57  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116

Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
            +    ++    QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA     
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDD 173

Query: 184 PTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
                 + T  + APE+      YN+ VDI+S G  + E++T    +    +  Q+   +
Sbjct: 174 EM-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232

Query: 242 TSGIKP----------------------------ASLSKVTDPQVKQFIEKCIVP-ASLR 272
                P                            A++    +P     +EK +V  +  R
Sbjct: 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292

Query: 273 LPALELLKDPFLVT-DNPKDL-VCDPL 297
           + A + L   +     +P D  V DP 
Sbjct: 293 ITAAQALAHAYFAQYHDPDDEPVADPY 319

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 7e-34
 Identities = 72/330 (21%), Positives = 128/330 (38%), Gaps = 62/330 (18%)

Query: 27  GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            RY   + +G GA   V   +D V    VA  +++     Q+    +R Y E+ L+K + 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVN 74

Query: 85  HENIIKFYNSWVDD----TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
           H+NII   N +         + + ++ EL  +   +  + +    D + +     Q+L G
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCG 131

Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPE 199
           + +LHS     IHRDLK  NI V  ++  +KI D GLA         +  + T  + APE
Sbjct: 132 IKHLHSAGI--IHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188

Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------- 247
            +    Y E VDI+S G  + EMV  +  +       Q  K +     P           
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248

Query: 248 ----------------------------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALEL 278
                                       +  +K+   Q +  + K +V   + R+   + 
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

Query: 279 LKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
           L+ P++      ++  DP  +    P++ +
Sbjct: 309 LQHPYI------NVWYDPAEVEAPPPQIYD 332

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (266), Expect = 1e-26
 Identities = 62/342 (18%), Positives = 118/342 (34%), Gaps = 77/342 (22%)

Query: 27  GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
            RY     LG G F TV+   D V+   VA   V  + V       E    E+ LL+ + 
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-----EAAEDEIKLLQRVN 67

Query: 85  HENIIK--------------FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
             +  K               +N    +    + +   L  +      + +H+ + +  +
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTA 186
           K  ++Q+L GL Y+H     IIH D+K +N+ +   +    +  + +A +          
Sbjct: 128 KQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186

Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY------NECKNPAQIYK 239
            + I T E+ +PE L    +    DI+S    I E++T ++ +      +  K+   I +
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246

Query: 240 KVTSGIKPAS---------------------------------------LSKVTDPQVKQ 260
            +    +  S                                        SK    ++  
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306

Query: 261 FIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
           F+   +      R  A  L+  P+L       L  + +R+P+
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLK----DTLGMEEIRVPD 344

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.0 bits (199), Expect = 1e-18
 Identities = 30/199 (15%), Positives = 61/199 (30%), Gaps = 22/199 (11%)

Query: 31  EILGKGAFKTVYKGFDEVDGIEVA-----WNQVNIEDVMQSPDQLE-RLYSEVHLLKSLK 84
           +++G+G    V+  + E    E           + + V +  D  +             +
Sbjct: 6   KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 85  HENIIKFYNSWVD---DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
              + K     V           ++ EL          K+   V ++        IL  +
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNA-VLMELI-------DAKELYRVRVENPDEVLDMILEEV 116

Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
              +     I+H DL   N+ V+     + I D   ++ + +   R ++          +
Sbjct: 117 AKFYHRG--IVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRNIITYF 172

Query: 202 EEEYNELVDIYSFGMCILE 220
              Y    DI S    IL+
Sbjct: 173 SRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	394
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.24
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.01
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.65
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.55
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.44
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.94

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-66  Score=481.38  Aligned_cols=263  Identities=51%  Similarity=0.960  Sum_probs=241.8

Q ss_pred             CCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC--
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--   98 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~--   98 (394)
                      ...|||+++.+.||+|+||+||+|.++.++..||+|.+.....  .....+++.+|+++|++|+|||||+++++|.+.  
T Consensus         5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   82 (270)
T d1t4ha_           5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   82 (270)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             CCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence            4568999999999999999999999999999999999875543  456678899999999999999999999998653  


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                      ....+++||||+++|+|.+++.+.+.+++..++.|+.||+.||.|||+++++|+||||||+|||++++++.+||+|||+|
T Consensus        83 ~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          83 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             cCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            34678999999999999999999889999999999999999999999998889999999999999756789999999999


Q ss_pred             eeecCCCCcccccCCcccCcccccccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          179 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                      +..........+||+.|||||++.+.|+.++|||||||++|||++|+.||.+..+..++++.+..+..+..++...++++
T Consensus       163 ~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (270)
T d1t4ha_         163 TLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  242 (270)
T ss_dssp             GGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             eeccCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHH
Confidence            87776667778899999999999999999999999999999999999999988889999999999888877888889999


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcCCccc
Q 016143          259 KQFIEKCIV-PASLRLPALELLKDPFLV  285 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~p~~~  285 (394)
                      ++||++||. +|.+|||+.|+|+||||+
T Consensus       243 ~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         243 KEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999998 999999999999999996

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-62  Score=457.33  Aligned_cols=260  Identities=30%  Similarity=0.515  Sum_probs=225.5

Q ss_pred             cccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEc
Q 016143           18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD   97 (394)
Q Consensus        18 ~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~   97 (394)
                      ...||..|| ++.+.||+|+||+||+|.++.+|+.||+|+++....    ...+.+.+|+.+|++++|||||+++++|.+
T Consensus        14 ~~~dp~~~Y-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   88 (293)
T d1yhwa1          14 SVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLV   88 (293)
T ss_dssp             BSSCTTTTB-CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCCCccccc-EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEE
Confidence            345777787 677899999999999999999999999999976542    224678899999999999999999999976


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                      +  ..+|+|||||+||+|.+++.++ .+++.+++.+++||+.||.|||++|  |+||||||+|||++ .+|++||+|||+
T Consensus        89 ~--~~~~ivmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~  162 (293)
T d1yhwa1          89 G--DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGF  162 (293)
T ss_dssp             T--TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTT
T ss_pred             C--CEEEEEEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEEC-CCCcEeeccchh
Confidence            5  4789999999999999988765 5999999999999999999999999  99999999999998 688999999999


Q ss_pred             eeeecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          178 AIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       178 a~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      |+.....  .....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+......+...+..+......+...
T Consensus       163 a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
T d1yhwa1         163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL  242 (293)
T ss_dssp             CEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGS
T ss_pred             heeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccC
Confidence            9876543  3456689999999998775 589999999999999999999999988555555665555555444556677


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus       243 s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence            8999999999998 999999999999999998643

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-62  Score=455.03  Aligned_cols=255  Identities=26%  Similarity=0.414  Sum_probs=218.1

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      .| ++.+.||+|+||+||+|.++.+|+.||+|+++....   .+..+++.+|+.+|++++|||||++++++.++  ..+|
T Consensus         6 dy-~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~   79 (271)
T d1nvra_           6 DW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQY   79 (271)
T ss_dssp             EE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred             ce-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ceeE
Confidence            44 788999999999999999999999999999976542   33456788999999999999999999999664  5789


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      +|||||++|+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+|+.....
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECEET
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEEC-CCCCEEEccchhheeeccC
Confidence            99999999999999998888999999999999999999999999  99999999999998 6789999999999876432


Q ss_pred             ----CCcccccCCcccCcccccc-cC-CCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          185 ----TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       185 ----~~~~~~gt~~y~aPE~l~~-~~-~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                          .....+||+.|||||++.+ .| +.++|||||||++|||+||++||....+....+..+.............++++
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  236 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP  236 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence                2455789999999998865 44 57899999999999999999999876666666666655544443445678999


Q ss_pred             HHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          259 KQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ++||.+||. +|.+|||+.|+|+||||+...
T Consensus       237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         237 LALLHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            999999998 999999999999999998654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-62  Score=452.27  Aligned_cols=253  Identities=23%  Similarity=0.434  Sum_probs=225.4

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      .| ++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.+|++++|||||++++++.++  ..++
T Consensus         7 dy-~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~   82 (263)
T d2j4za1           7 DF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVY   82 (263)
T ss_dssp             GE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred             He-EEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC-hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CEEE
Confidence            44 78899999999999999999999999999987543221 23456788999999999999999999998654  5789


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      +|||||++|+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|......
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCC
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceec-CCCCEeecccceeeecCCC
Confidence            99999999999999999889999999999999999999999999  99999999999998 6889999999999877776


Q ss_pred             CCcccccCCcccCccccccc-CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          185 TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~~~-~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                      .....+||+.|||||++.+. |+.++|||||||++|||++|+.||.+ .+..+++..+..+..  .++...++++++||.
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~  236 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLIS  236 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHH
T ss_pred             cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHH
Confidence            66778899999999988764 89999999999999999999999976 677788888877643  356678899999999


Q ss_pred             HcCC-CCCCCCCHHHHhcCCccccC
Q 016143          264 KCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       264 ~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      +||. +|.+|||+.|+|+||||+..
T Consensus       237 ~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHcCcCcCCc
Confidence            9998 99999999999999999753

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-61  Score=445.74  Aligned_cols=253  Identities=26%  Similarity=0.471  Sum_probs=210.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+|+.||+|.+.....  ++...+.+.+|+.+|++++|||||++++++.++....+|+|
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            3778999999999999999999999999999876543  45667889999999999999999999999988777789999


Q ss_pred             EcccCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          107 TELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~----~~~l~~~~~~~i~~qil~~L~~LH~~~---~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ||||++|+|.+++.+    .+.+++..++.++.||+.||.|||+++   .+|+||||||+|||++ .++.+||+|||+|+
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeecccee
Confidence            999999999999864    457999999999999999999999864   2499999999999998 68899999999997


Q ss_pred             eecCC--CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          180 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       180 ~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      .....  .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..++...+..+..+ .++...++
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~s~  240 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYSD  240 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSCH
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCH
Confidence            66543  3456789999999998865 599999999999999999999999986 6777888888776544 35667889


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcCCcc
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKDPFL  284 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~p~~  284 (394)
                      ++++||++||. +|.+|||+.|+|+|||+
T Consensus       241 ~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         241 ELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            99999999998 99999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-61  Score=450.64  Aligned_cols=259  Identities=28%  Similarity=0.506  Sum_probs=221.0

Q ss_pred             ccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        19 ~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      +.||...| ++.+.||+|+||+||+|.++.+|..||+|+++...    .+..+++.+|+.+|++|+|||||+++++|.++
T Consensus         7 ~~~p~d~Y-~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~   81 (288)
T d2jfla1           7 DLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYE   81 (288)
T ss_dssp             SSCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CCCcccCe-EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            45666766 88899999999999999999999999999987542    34556788999999999999999999998655


Q ss_pred             CCceEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143           99 TNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                        ..+++|||||++|+|.+++.+ .+.+++.+++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+
T Consensus        82 --~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG~  156 (288)
T d2jfla1          82 --NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGV  156 (288)
T ss_dssp             --TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred             --CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeEC-CCCCEEEEechh
Confidence              478999999999999999765 456999999999999999999999999  99999999999998 788999999999


Q ss_pred             eeeecCC--CCcccccCCcccCccccc------ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CC
Q 016143          178 AIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PA  248 (394)
Q Consensus       178 a~~~~~~--~~~~~~gt~~y~aPE~l~------~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~-~~  248 (394)
                      |......  .....+||+.|||||++.      ..|+.++|||||||++|||+||+.||.+. +..+++..+..+.. ..
T Consensus       157 a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-~~~~~~~~i~~~~~~~~  235 (288)
T d2jfla1         157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTL  235 (288)
T ss_dssp             CEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHHSCCCCC
T ss_pred             hhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHcCCCCCC
Confidence            9766443  234568999999999763      34889999999999999999999999874 44455555555432 33


Q ss_pred             CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       249 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      ..+...++++++||++||+ +|.+|||+.|+|+||||+...
T Consensus       236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~  276 (288)
T d2jfla1         236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS  276 (288)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred             CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            3455678999999999998 999999999999999998543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-60  Score=448.01  Aligned_cols=258  Identities=27%  Similarity=0.445  Sum_probs=224.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.+|++++|||||+++++|.++  ..+|+|
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~iv   86 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFG   86 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEEEE
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC-HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEEEE
Confidence            488999999999999999999999999999997544221 23456789999999999999999999998654  578999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      ||||+||+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ +++.+||+|||+|+.....  
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC----
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccC-CCceEEecccccceecccCCc
Confidence            999999999999999999999999999999999999999999  99999999999998 7889999999999876533  


Q ss_pred             --CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          185 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       185 --~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                        .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+..+++..+..+.  ..++...++++++|
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~l  240 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLE--YDFPEKFFPKARDL  240 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTC--CCCCTTCCHHHHHH
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCC--CCCCccCCHHHHHH
Confidence              2345689999999998875 589999999999999999999999987 67778888887763  23566788999999


Q ss_pred             HHHcCC-CCCCCCCHHH------HhcCCccccCCCCCcc
Q 016143          262 IEKCIV-PASLRLPALE------LLKDPFLVTDNPKDLV  293 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~e------lL~~p~~~~~~~~~~~  293 (394)
                      |++||+ +|.+|||++|      +++||||+..++..+.
T Consensus       241 i~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~  279 (288)
T d1uu3a_         241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  279 (288)
T ss_dssp             HHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             HHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence            999998 9999999987      5889999998877654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-60  Score=451.33  Aligned_cols=261  Identities=28%  Similarity=0.459  Sum_probs=225.6

Q ss_pred             cccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEc
Q 016143           18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD   97 (394)
Q Consensus        18 ~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~   97 (394)
                      ...||..+| +..+.||+|+||+||+|.++.+|+.||||+++.... ...+..+.+.+|+.+|++|+|||||+++++|.+
T Consensus         9 ~~~dp~~~y-~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   86 (309)
T d1u5ra_           9 FKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (309)
T ss_dssp             CCSCHHHHE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             cccCcHHhc-EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence            344666666 667889999999999999999999999999975442 335566789999999999999999999999876


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                      +  ..+++|||||.+|+|..++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ +++.+||+|||+
T Consensus        87 ~--~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG~  161 (309)
T d1u5ra_          87 E--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGS  161 (309)
T ss_dssp             T--TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTT
T ss_pred             C--CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEC-CCCCEEEeeccc
Confidence            5  578999999999999988888889999999999999999999999999  99999999999999 789999999999


Q ss_pred             eeeecCCCCcccccCCcccCccccc----ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 016143          178 AIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV  253 (394)
Q Consensus       178 a~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  253 (394)
                      |......  ...+||+.|||||++.    +.|+.++|||||||++|||++|..||.+. +..+....+..+..+...+..
T Consensus       162 a~~~~~~--~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~  238 (309)
T d1u5ra_         162 ASIMAPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGH  238 (309)
T ss_dssp             CBSSSSB--CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTT
T ss_pred             ccccCCC--CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCCCC
Confidence            9765443  4567999999999874    35899999999999999999999999874 445555555555555545667


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                      +++++++||.+||. +|.+|||+.|+|+||||....
T Consensus       239 ~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            88999999999998 999999999999999998643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-59  Score=443.38  Aligned_cols=266  Identities=25%  Similarity=0.395  Sum_probs=223.9

Q ss_pred             CCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC--HHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      +...|| ++.+.||+|+||+||+|.++.+|+.||+|+++.......  ....+.+.+|+.+|++|+|||||+++++|.++
T Consensus         7 ~i~d~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (293)
T d1jksa_           7 NVDDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   85 (293)
T ss_dssp             CGGGTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CcccCE-EEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            344455 889999999999999999999999999999976543222  23467789999999999999999999998654


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC---CcEEEccc
Q 016143           99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDL  175 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~---~~~kl~Df  175 (394)
                        ..+++|||||++|+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+||+++.++   ..+||+||
T Consensus        86 --~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          86 --TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             --SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             --CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecch
Confidence              578999999999999999999889999999999999999999999999  99999999999998332   25999999


Q ss_pred             ceeeeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCCC
Q 016143          176 GLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLS  251 (394)
Q Consensus       176 gla~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~  251 (394)
                      |+|...... ......||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+ .+..+.+..+..+...  ...+
T Consensus       162 G~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~  240 (293)
T d1jksa_         162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYF  240 (293)
T ss_dssp             TTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHH
T ss_pred             hhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhc
Confidence            999877544 4556789999999998875 599999999999999999999999987 6667777777665432  2233


Q ss_pred             CCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCCCCc
Q 016143          252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL  292 (394)
Q Consensus       252 ~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~~~~  292 (394)
                      ...++++++||++||. +|.+|||+.|+|+||||+..++...
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~  282 (293)
T d1jksa_         241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA  282 (293)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC------
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHh
Confidence            5678899999999999 9999999999999999997665543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-59  Score=450.89  Aligned_cols=262  Identities=23%  Similarity=0.431  Sum_probs=229.9

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|+++.+|+.||+|+++...... ....+++.+|+.+|++++||||++++++|.++  ..+|+|
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~iv   83 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFV   83 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEEEE
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc--cccccc
Confidence            378899999999999999999999999999997554322 23457788999999999999999999999654  579999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--  184 (394)
                      |||++||+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+|+.....  
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEec-CCCCEEEeecccccccccCCc
Confidence            999999999999999999999999999999999999999999  99999999999998 6899999999999865433  


Q ss_pred             CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 016143          185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE  263 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  263 (394)
                      .....+||+.|+|||++.+ .|+.++|||||||++|||++|++||.+ .+..+++..+..+.  ..++...++++++||.
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~  237 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCC--CCCCccCCHHHHHHHH
Confidence            4556789999999998875 599999999999999999999999987 67778888887764  3456778999999999


Q ss_pred             HcCC-CCCCCCC-----HHHHhcCCccccCCCCCcccCCC
Q 016143          264 KCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPL  297 (394)
Q Consensus       264 ~~L~-~p~~R~s-----~~elL~~p~~~~~~~~~~~~~~~  297 (394)
                      +||+ +|.+|++     +.|+++||||+..++..+....+
T Consensus       238 ~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~  277 (337)
T d1o6la_         238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL  277 (337)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             hhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCC
Confidence            9998 9999995     89999999999877665544433

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-59  Score=445.62  Aligned_cols=258  Identities=22%  Similarity=0.394  Sum_probs=207.0

Q ss_pred             CCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      |...+| ++.+.||+|+||+||+|.++.+|+.||+|++.....   ......+.+|+.+|++|+|||||+++++|.++  
T Consensus         6 di~d~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--   79 (307)
T d1a06a_           6 DIRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL---EGKEGSMENEIAVLHKIKHPNIVALDDIYESG--   79 (307)
T ss_dssp             CGGGTE-EEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred             CCccce-EEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence            334455 889999999999999999999999999999976543   22335678899999999999999999998654  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEccccee
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLA  178 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--~~~~~kl~Dfgla  178 (394)
                      ..+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+||++..  +++.+||+|||+|
T Consensus        80 ~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a  157 (307)
T d1a06a_          80 GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLS  157 (307)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred             CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEecccee
Confidence            578999999999999999999989999999999999999999999999  999999999999952  4689999999999


Q ss_pred             eeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCC
Q 016143          179 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVT  254 (394)
Q Consensus       179 ~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~  254 (394)
                      ...... .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+..++...+..+...  .......
T Consensus       158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~  236 (307)
T d1a06a_         158 KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDI  236 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred             EEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCC
Confidence            766544 3456789999999998875 599999999999999999999999987 5566777777765432  3344567


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus       237 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            8999999999999 99999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-60  Score=453.78  Aligned_cols=256  Identities=26%  Similarity=0.462  Sum_probs=215.1

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +| .+.+.||+|+||+||+|.++.+|+.||+|+++...   .+...+++.+|+.+|++++|||||+++++|.++  ..++
T Consensus         7 ~y-~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~   80 (322)
T d1s9ja_           7 DF-EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEIS   80 (322)
T ss_dssp             GE-EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SEEE
T ss_pred             CC-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence            45 67799999999999999999999999999987542   345567889999999999999999999999655  4689


Q ss_pred             EEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ ++  |+||||||+|||++ .+|.+||+|||+|+....
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHH
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeEC-CCCCEEEeeCCCccccCC
Confidence            999999999999999998899999999999999999999997 58  99999999999998 789999999999987766


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHH--------------------------
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ--------------------------  236 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~--------------------------  236 (394)
                      ....+.+||+.|||||++.+ .|+.++||||+||++|||++|+.||........                          
T Consensus       158 ~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence            66677899999999998775 699999999999999999999999976432211                          


Q ss_pred             ---------------HHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          237 ---------------IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       237 ---------------~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                                     ....+.....+.......++++++||.+||. +|.+|||+.|+|+||||+..++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence                           1111222222222234467899999999999 9999999999999999986543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.1e-59  Score=443.82  Aligned_cols=264  Identities=28%  Similarity=0.433  Sum_probs=229.9

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|+.+|++++|||||++++++.++  ..+|+|
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv   82 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIFMI   82 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEEEE
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeC--CeeeeE
Confidence            48889999999999999999999999999999754321 123457788999999999999999999998654  579999


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCCC
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA  186 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~~  186 (394)
                      ||||+||+|..++.....+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+|+..... .
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~-~  158 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV-T  158 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC-B
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEc-CCCCEEEecCccceEeccc-c
Confidence            999999999999999999999999999999999999999999  99999999999998 7899999999999876554 3


Q ss_pred             cccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHc
Q 016143          187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC  265 (394)
Q Consensus       187 ~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~  265 (394)
                      .+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+..  .++...+++++++|.+|
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~  235 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRL  235 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred             ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            45789999999998876 499999999999999999999999987 677777777776632  35567889999999999


Q ss_pred             CC-CCCCCC-----CHHHHhcCCccccCCCCCcccCCCCCC
Q 016143          266 IV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP  300 (394)
Q Consensus       266 L~-~p~~R~-----s~~elL~~p~~~~~~~~~~~~~~~~~p  300 (394)
                      |. +|.+|+     +++++|+||||+..++..+.......|
T Consensus       236 L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p  276 (316)
T d1fota_         236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP  276 (316)
T ss_dssp             TCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCS
T ss_pred             hhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcC
Confidence            98 899986     899999999999988766554444333

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-58  Score=445.86  Aligned_cols=266  Identities=23%  Similarity=0.396  Sum_probs=230.2

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      .+| ++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.+|+.++|||||+++++|.+.  ..+
T Consensus        41 d~y-~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~  116 (350)
T d1rdqe_          41 DQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNL  116 (350)
T ss_dssp             GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred             cCe-EEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHHcCCCcEeecccccccc--ccc
Confidence            455 77799999999999999999999999999987544321 23456789999999999999999999998654  578


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++||||+.+|+|..++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .+|.+||+|||+|+....
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSS
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccC-CCCCEEeeeceeeeeccc
Confidence            899999999999999999889999999999999999999999999  99999999999998 688999999999987765


Q ss_pred             CCCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       184 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                      . ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+...++..+..+..  ..+...++++++||
T Consensus       194 ~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li  269 (350)
T d1rdqe_         194 R-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLL  269 (350)
T ss_dssp             C-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHH
T ss_pred             c-cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHH
Confidence            4 345789999999998776 599999999999999999999999976 677777787777643  34566889999999


Q ss_pred             HHcCC-CCCCCC-----CHHHHhcCCccccCCCCCcccCCCCCC
Q 016143          263 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP  300 (394)
Q Consensus       263 ~~~L~-~p~~R~-----s~~elL~~p~~~~~~~~~~~~~~~~~p  300 (394)
                      ++||. +|.+|+     +++++|+||||+..++..+....+..|
T Consensus       270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p  313 (350)
T d1rdqe_         270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP  313 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred             HHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcC
Confidence            99998 898884     899999999999988766555444444

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.4e-58  Score=443.22  Aligned_cols=258  Identities=25%  Similarity=0.388  Sum_probs=222.5

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCc
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~  101 (394)
                      ..++| ++.+.||+|+||+||+|.++.+|+.||+|++...    .....+.+.+|+.+|++|+|||||+++++|.++  .
T Consensus        24 il~~Y-~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~   96 (350)
T d1koaa2          24 VLDHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--N   96 (350)
T ss_dssp             GGGTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--T
T ss_pred             CccCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence            34566 8889999999999999999999999999998643    245567889999999999999999999998654  5


Q ss_pred             eEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEcccceee
Q 016143          102 TINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAI  179 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~-~~~~~kl~Dfgla~  179 (394)
                      .+++|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++|  |+||||||+|||++. .++.+||+|||+|+
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~  174 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA  174 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchhe
Confidence            79999999999999999854 467999999999999999999999999  999999999999963 35799999999998


Q ss_pred             eecCCC-CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCC
Q 016143          180 VMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD  255 (394)
Q Consensus       180 ~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~  255 (394)
                      ...... .....||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+ .+..+++..+..+..  +.......+
T Consensus       175 ~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s  253 (350)
T d1koaa2         175 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGIS  253 (350)
T ss_dssp             ECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCC
T ss_pred             ecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCC
Confidence            776543 445789999999998875 589999999999999999999999986 566777777766532  222334578


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCCC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  289 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~~  289 (394)
                      +++++||.+||. +|.+|||+.|+|+||||+....
T Consensus       254 ~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            899999999998 9999999999999999987653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.9e-58  Score=446.16  Aligned_cols=263  Identities=22%  Similarity=0.375  Sum_probs=222.2

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeecccc--CCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .| ++.+.||+|+||+||+|.++.+|+.||+|++......  .......+..+|+.+++.++|||||+++++|.++  ..
T Consensus         5 dy-~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~~   81 (364)
T d1omwa3           5 DF-SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DK   81 (364)
T ss_dssp             TE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--SE
T ss_pred             hC-eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--CE
Confidence            44 8889999999999999999999999999998754321  1222233344568888889999999999998654  57


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +|+|||||+||+|.+++.++..+++..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+|+...
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEECS
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEc-CCCcEEEeeeceeeecC
Confidence            8999999999999999999999999999999999999999999999  99999999999998 78999999999999887


Q ss_pred             CCCCcccccCCcccCccccc-c-cCCCcCcchhhhhHHHHHHhcCCCCCCCC--CHHHHHHHHhcCCCCCCCCCCCCHHH
Q 016143          183 QPTARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLSKVTDPQV  258 (394)
Q Consensus       183 ~~~~~~~~gt~~y~aPE~l~-~-~~~~~~DIwSlG~il~elltg~~Pf~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (394)
                      .......+||+.|+|||++. + .|+.++|||||||++|||+||+.||.+..  +...+...+..  .+..++...++++
T Consensus       159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~  236 (364)
T d1omwa3         159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPEL  236 (364)
T ss_dssp             SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS--CCCCCCSSSCHHH
T ss_pred             CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--CCCCCCCCCCHHH
Confidence            77777788999999999875 3 48999999999999999999999997643  23333333322  2444566788999


Q ss_pred             HHHHHHcCC-CCCCCCC-----HHHHhcCCccccCCCCCcccC
Q 016143          259 KQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCD  295 (394)
Q Consensus       259 ~~li~~~L~-~p~~R~s-----~~elL~~p~~~~~~~~~~~~~  295 (394)
                      ++||.+||. +|.+||+     |+|+|+||||+..++..+...
T Consensus       237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~  279 (364)
T d1omwa3         237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQ  279 (364)
T ss_dssp             HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTT
T ss_pred             HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcC
Confidence            999999998 9999999     799999999998877654443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.3e-58  Score=440.46  Aligned_cols=252  Identities=23%  Similarity=0.373  Sum_probs=219.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      |++.+.||+|+||+||+|.++.+|+.||+|+++...    ....+.+.+|+.+|++|+|||||+++++|.++  ..+|+|
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~iv  104 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMVLI  104 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEE
Confidence            488999999999999999999999999999987542    34556788999999999999999999998654  578999


Q ss_pred             EcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~-~~~~~kl~Dfgla~~~~~~  184 (394)
                      ||||+||+|.+++...+ ++++.+++.++.||+.||.|||++|  |+||||||+|||++. .++.+||+|||+|......
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            99999999999876654 6999999999999999999999999  999999999999973 4689999999999887655


Q ss_pred             C-CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCHHHHH
Q 016143          185 T-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQ  260 (394)
Q Consensus       185 ~-~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~  260 (394)
                      . .....||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+.+..+..+..  +.......++++++
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            3 445689999999998875 499999999999999999999999987 555666666665432  33445667899999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          261 FIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ||++||. +|.+|||+.|+|+||||+..
T Consensus       262 li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         262 FIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            9999998 99999999999999999865

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-58  Score=435.44  Aligned_cols=258  Identities=24%  Similarity=0.423  Sum_probs=222.5

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHH-cCCCCCceeEeeeEEcCCCceEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWVDDTNRTINM  105 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~-~L~hpnIv~~~~~~~~~~~~~~~l  105 (394)
                      |.+.+.||+|+||+||+|.++.+|+.||+|+++...... .+..+.+..|..++. .++|||||+++++|.++  ..+||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~yi   80 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLFF   80 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--CceeE
Confidence            378899999999999999999999999999997543322 233455666777654 78999999999998654  57999


Q ss_pred             EEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC-
Q 016143          106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-  184 (394)
Q Consensus       106 V~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~-  184 (394)
                      ||||+++|+|.+++...+.+++.+++.++.||+.||.|||+++  |+||||||+|||++ .++++||+|||+++..... 
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTT
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeec-CCCceeccccchhhhccccc
Confidence            9999999999999999999999999999999999999999999  99999999999998 7899999999999765433 


Q ss_pred             -CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          185 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       185 -~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                       ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+ .+..+++..+..+.  ..++...++++++||
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dli  234 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN--PFYPRWLEKEAKDLL  234 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCccCCHHHHHHH
Confidence             3445689999999998765 699999999999999999999999987 67778888877663  345677899999999


Q ss_pred             HHcCC-CCCCCCCHH-HHhcCCccccCCCCCcc
Q 016143          263 EKCIV-PASLRLPAL-ELLKDPFLVTDNPKDLV  293 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~-elL~~p~~~~~~~~~~~  293 (394)
                      .+||. +|.+||++. ++++||||+..++..+.
T Consensus       235 ~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~  267 (320)
T d1xjda_         235 VKLFVREPEKRLGVRGDIRQHPLFREINWEELE  267 (320)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHH
T ss_pred             HHhcccCCCCCcCHHHHHHhCchhccCCHHHHH
Confidence            99998 999999995 89999999987655443

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5e-57  Score=421.59  Aligned_cols=257  Identities=25%  Similarity=0.415  Sum_probs=221.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCC-----HHHHHHHHHHHHHHHcCC-CCCceeEeeeEEc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-----PDQLERLYSEVHLLKSLK-HENIIKFYNSWVD   97 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~   97 (394)
                      .+| .+.+.||+|+||+||+|.++.+|+.||+|+++.......     ....+++.+|+.+|++|+ ||||++++++|.+
T Consensus         3 ~~y-~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           3 ENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             ccC-EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            345 788999999999999999999999999999976543221     234567889999999997 9999999999864


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                        +..+||||||+++|+|.++++..+.+++.+++.|+.||+.||+|||++|  |+||||||+||+++ .++.+||+|||+
T Consensus        82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~  156 (277)
T d1phka_          82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGF  156 (277)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTT
T ss_pred             --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEc-CCCCeEEccchh
Confidence              4579999999999999999999889999999999999999999999999  99999999999998 789999999999


Q ss_pred             eeeecCC-CCcccccCCcccCcccccc-------cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--C
Q 016143          178 AIVMQQP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P  247 (394)
Q Consensus       178 a~~~~~~-~~~~~~gt~~y~aPE~l~~-------~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~--~  247 (394)
                      +...... .....+||+.|+|||.+.+       .|+.++||||+||++|+|++|+.||.+ .+.......+..+..  +
T Consensus       157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~  235 (277)
T d1phka_         157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG  235 (277)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCC
T ss_pred             eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCC
Confidence            9876544 3455789999999997753       368899999999999999999999987 556666666666532  2


Q ss_pred             CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       248 ~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      .......++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            22334678999999999998 99999999999999999853

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-57  Score=430.27  Aligned_cols=256  Identities=21%  Similarity=0.352  Sum_probs=220.5

Q ss_pred             CCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        21 ~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      +..+|| ++.+.||+|+||+||+|.++.+|+.||+|+++...     .....+.+|+.+|+.++|||||+++++|.++  
T Consensus         2 ~~~~rY-~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--   73 (321)
T d1tkia_           2 ELYEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESM--   73 (321)
T ss_dssp             CCTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--
T ss_pred             CCccce-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--
Confidence            345677 78899999999999999999999999999997542     3345688999999999999999999999654  


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEccccee
Q 016143          101 RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLA  178 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~-~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~-~~~~~kl~Dfgla  178 (394)
                      ..+|+|||||+||+|.+++...+ .+++.+++.|+.||+.||.|||++|  |+||||||+|||++. +...+||+|||++
T Consensus        74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~  151 (321)
T d1tkia_          74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQA  151 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchh
Confidence            57999999999999999998765 6999999999999999999999999  999999999999973 2458999999999


Q ss_pred             eeecCCC-CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCC
Q 016143          179 IVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVT  254 (394)
Q Consensus       179 ~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~  254 (394)
                      ....... .....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+...  .......
T Consensus       152 ~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~  230 (321)
T d1tkia_         152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEI  230 (321)
T ss_dssp             EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             hccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCC
Confidence            8775543 455679999999997765 589999999999999999999999987 6667777777665332  2223457


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus       231 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            8899999999998 99999999999999999754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-57  Score=426.48  Aligned_cols=252  Identities=24%  Similarity=0.377  Sum_probs=204.8

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeeccccCC-HHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEcc
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL  109 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~-~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e~  109 (394)
                      ++||+|+||+||+|.++.+|+.||||+++....... ....+++.+|+.+|++++|||||+++++|.++  ..+++||||
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--~~~~ivmE~   81 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVFDF   81 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEEEEEC
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC--Cceeehhhh
Confidence            789999999999999999999999999876543222 12345688999999999999999999998554  468899999


Q ss_pred             cCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC--CCc
Q 016143          110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR  187 (394)
Q Consensus       110 ~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~--~~~  187 (394)
                      +.++++..+......+++..++.+++||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|......  ...
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~~~  158 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYT  158 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEec-CCCccccccCccccccCCCccccc
Confidence            999988888877788999999999999999999999999  99999999999998 7899999999999766543  344


Q ss_pred             ccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCC-CCC--------------
Q 016143          188 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-PAS--------------  249 (394)
Q Consensus       188 ~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~~-~~~--------------  249 (394)
                      ..+||+.|+|||++..  .|+.++|||||||++|||+||.+||.+..+.+++...... +.. ...              
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence            5689999999997653  4899999999999999999999999875544444333221 000 000              


Q ss_pred             ---------CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          250 ---------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       250 ---------~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                               .....++++++||++||+ ||.+||||.|+|+||||++.
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence                     012457899999999999 99999999999999999854

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-57  Score=421.08  Aligned_cols=250  Identities=21%  Similarity=0.387  Sum_probs=213.0

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCH--HHHHHHHHHHHHHHcCC--CCCceeEeeeEEcCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLK--HENIIKFYNSWVDDT   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~--~~~~~~~~E~~~l~~L~--hpnIv~~~~~~~~~~   99 (394)
                      +|| ++.+.||+|+||+||+|.++.+|+.||+|+++........  ....++.+|+.+|++++  |||||+++++|.++ 
T Consensus         4 ~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-   81 (273)
T d1xwsa_           4 SQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-   81 (273)
T ss_dssp             TTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred             CeE-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence            455 8999999999999999999999999999999765432211  12234667999999997  89999999998654 


Q ss_pred             CceEEEEEcccCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          100 NRTINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       100 ~~~~~lV~e~~~~-gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                       ..+++||||+.+ +++.+++.+...+++.+++.++.||+.||.|||++|  |+||||||+|||++.+++.+||+|||+|
T Consensus        82 -~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          82 -DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             -SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             -CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccc
Confidence             578899999975 688999998889999999999999999999999999  9999999999999866689999999999


Q ss_pred             eeecCCCCcccccCCcccCcccccc-c-CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          179 IVMQQPTARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~l~~-~-~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      ............||+.|+|||++.+ . ++.++|||||||++|||+||+.||...   .    .+..+  ...++...++
T Consensus       159 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~----~i~~~--~~~~~~~~s~  229 (273)
T d1xwsa_         159 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---E----EIIRG--QVFFRQRVSS  229 (273)
T ss_dssp             EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H----HHHHC--CCCCSSCCCH
T ss_pred             eecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---h----HHhhc--ccCCCCCCCH
Confidence            8877777777889999999998764 3 467899999999999999999999752   2    22333  2235566889


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      ++++||++||. +|.+|||+.|+|+||||+..
T Consensus       230 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            99999999998 99999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-56  Score=424.08  Aligned_cols=255  Identities=20%  Similarity=0.319  Sum_probs=207.5

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHc-CCCCCceeEeeeEEc--C
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVD--D   98 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~-L~hpnIv~~~~~~~~--~   98 (394)
                      ..+.|.-+.++||+|+||+||+|.++.+|+.||||+++..         ..+.+|+.++.+ ++|||||+++++|.+  .
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            3467754567899999999999999999999999998632         346679988654 589999999999865  3


Q ss_pred             CCceEEEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEcc
Q 016143           99 TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGD  174 (394)
Q Consensus        99 ~~~~~~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--~~~~~kl~D  174 (394)
                      ....+|+|||||+||+|.+++.+.  ..+++.+++.|+.||+.||.|||++|  |+||||||+|||++.  +.+.+||+|
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccc
Confidence            456799999999999999999875  36999999999999999999999999  999999999999973  346799999


Q ss_pred             cceeeeecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHH---HHHHHHhcCCC--C
Q 016143          175 LGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIK--P  247 (394)
Q Consensus       175 fgla~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~---~~~~~i~~~~~--~  247 (394)
                      ||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+.....   .+...+..+..  |
T Consensus       158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            9999876544 4456789999999998876 59999999999999999999999997643322   22222222211  1


Q ss_pred             CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       248 ~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                      .......++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            11122467899999999998 99999999999999999754

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=410.16  Aligned_cols=247  Identities=30%  Similarity=0.474  Sum_probs=208.2

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      .++| ++.+.||+|+||+||+|..+   ..||||+++....  +.+..+.+.+|+.+|++++|||||++++++.+   ..
T Consensus         7 ~~~~-~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~   77 (276)
T d1uwha_           7 DGQI-TVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQ   77 (276)
T ss_dssp             TTCC-CCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SS
T ss_pred             cccE-EEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cE
Confidence            3455 78899999999999999753   3699999875432  34567889999999999999999999997532   34


Q ss_pred             EEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      +++|||||++|+|.+++... ..+++..+..++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+|+..
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVK  154 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCSCC-
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEc-CCCCEEEccccceeec
Confidence            78999999999999999765 56999999999999999999999999  99999999999999 7899999999999765


Q ss_pred             cCC----CCcccccCCcccCcccccc----cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC---CC
Q 016143          182 QQP----TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SL  250 (394)
Q Consensus       182 ~~~----~~~~~~gt~~y~aPE~l~~----~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~---~~  250 (394)
                      ...    ......||+.|||||++.+    .|+.++|||||||+||||+||+.||.+..+..++...+..+..++   ..
T Consensus       155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~  234 (276)
T d1uwha_         155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV  234 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred             cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence            432    2345679999999998753    488999999999999999999999998888888888887765443   34


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +...++++++||.+||. +|.+|||+.|++++
T Consensus       235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            55678999999999998 99999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3e-55  Score=409.75  Aligned_cols=258  Identities=22%  Similarity=0.330  Sum_probs=211.6

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC--C
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--N  100 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~--~  100 (394)
                      .+|| ++.+.||+|+||+||+|.++.+|+.||+|+++... ..+++..+++.+|+.+|+.++||||+++++++.++.  .
T Consensus         6 ~drY-~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           6 SDRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             ccee-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhh-ccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            4666 88899999999999999999999999999997544 344667788999999999999999999999987654  3


Q ss_pred             ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeee
Q 016143          101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV  180 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~  180 (394)
                      ..+|+||||++|++|.+++...+.+++.+++.++.||+.||.|||++|  |+||||||+|||++ .++..+|+|||++..
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTCEE
T ss_pred             ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccC-ccccceeehhhhhhh
Confidence            468999999999999999999999999999999999999999999999  99999999999999 788999999999865


Q ss_pred             ecCC-----CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCC
Q 016143          181 MQQP-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKV  253 (394)
Q Consensus       181 ~~~~-----~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~-~~~~~~  253 (394)
                      ....     .....+||+.|||||++.+ .|+.++|||||||++|||+||++||.+..........+.....+ ......
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  240 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence            5432     2345679999999998875 58999999999999999999999998744444444455444333 334566


Q ss_pred             CCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccc
Q 016143          254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  285 (394)
Q Consensus       254 ~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~  285 (394)
                      .++++++||++||. +|.+||++.+.|.|+|.+
T Consensus       241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            78999999999998 999999655555566654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-55  Score=408.45  Aligned_cols=245  Identities=21%  Similarity=0.361  Sum_probs=207.2

Q ss_pred             ceecccCceEEEEEEEc--cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEEc
Q 016143           31 EILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      +.||+|+||+||+|.+.  .+++.||||+++...  .++...+++.+|+.+|++++|||||++++++.++   ..++|||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEEEEEE
Confidence            46999999999999764  456889999986443  2345667899999999999999999999987532   3679999


Q ss_pred             ccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC---
Q 016143          109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---  185 (394)
Q Consensus       109 ~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~---  185 (394)
                      |+++|+|.+++.+...+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+|+......   
T Consensus        88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEE
T ss_pred             cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccc-ccCcccccchhhhhhcccccccc
Confidence            9999999999999999999999999999999999999999  99999999999999 68899999999998765432   


Q ss_pred             --CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          186 --ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                        .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+ ..+...++++++|
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~~~~l  242 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDL  242 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHHHHH
Confidence              22356899999999775 458999999999999999998 8999987 5667788888877654 3566788999999


Q ss_pred             HHHcCC-CCCCCCCHHHH---hcCCccc
Q 016143          262 IEKCIV-PASLRLPALEL---LKDPFLV  285 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~el---L~~p~~~  285 (394)
                      |.+||. +|.+|||+.++   |+|+|+.
T Consensus       243 i~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         243 MNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            999998 99999999988   5676654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-55  Score=410.68  Aligned_cols=255  Identities=25%  Similarity=0.431  Sum_probs=206.3

Q ss_pred             ccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        25 ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      +| ++.+.||+|+||+||+|.++.+|+.||+|+++....  .+...+++.+|+.+|++++|||||+++++|.++  ..++
T Consensus         3 ~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~   77 (298)
T d1gz8a_           3 NF-QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLY   77 (298)
T ss_dssp             TE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEE
T ss_pred             CC-EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--ccee
Confidence            45 677999999999999999999999999999975432  233456788999999999999999999999765  5789


Q ss_pred             EEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +||||+.++.+...... ...+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+|.....
T Consensus        78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCC
T ss_pred             EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeec-ccCcceeccCCcceeccC
Confidence            99999976555544343 456999999999999999999999999  99999999999998 678999999999976654


Q ss_pred             C--CCcccccCCcccCcccccc-c-CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----------
Q 016143          184 P--TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS----------  249 (394)
Q Consensus       184 ~--~~~~~~gt~~y~aPE~l~~-~-~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~----------  249 (394)
                      .  ......||+.|+|||++.. . ++.++|||||||++|+|++|+.||.+......+.........+..          
T Consensus       155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence            3  3445689999999997654 3 578999999999999999999999885555555544332111100          


Q ss_pred             ----------------CCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          250 ----------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       250 ----------------~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                      .....++++++||++||. +|.+|||+.|+|+||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence                            012346789999999998 99999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.3e-55  Score=409.10  Aligned_cols=243  Identities=24%  Similarity=0.371  Sum_probs=211.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||+||+|.++.+|+.||||+++.+.     ...+++.+|+.+|++|+|||||+++++|.++  ..+++|
T Consensus        19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv   91 (287)
T d1opja_          19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII   91 (287)
T ss_dssp             EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEE
T ss_pred             eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccEeeC--CeeEEE
Confidence            378899999999999999999999999999986432     2346788999999999999999999998644  467889


Q ss_pred             EcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      ||||++|+|.+++...  ..+++..++.++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+|+.....
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCCTTTCCSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEEC-CCCcEEEccccceeecCCC
Confidence            9999999999998764  56899999999999999999999999  99999999999998 6889999999999876554


Q ss_pred             CC---cccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          185 TA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       185 ~~---~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                      ..   ....||+.|+|||++. +.|+.++|||||||++|||++|..||....+..+++..+..+..+. .+...++++++
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~  247 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-RPEGCPEKVYE  247 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHHHHH
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC-CCccchHHHHH
Confidence            32   2345899999999765 5699999999999999999998877777688888888888775543 55677899999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhc
Q 016143          261 FIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~  280 (394)
                      ||.+||. +|.+|||+.|+++
T Consensus       248 li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         248 LMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHH
Confidence            9999998 9999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.3e-54  Score=406.12  Aligned_cols=246  Identities=22%  Similarity=0.380  Sum_probs=199.3

Q ss_pred             cccccceecccCceEEEEEEEccCCe---EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      ++++.++||+|+||+||+|.++.+|.   .||+|.+...   ......+++.+|+.+|++|+|||||++++++.++  ..
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~  101 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--TP  101 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--CE
Confidence            34889999999999999999987765   5888876533   2456778899999999999999999999998544  46


Q ss_pred             EEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      +++|||||++|+|.+++... +.+++.++..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+|+..
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEEC-CCCcEEECCcccceEc
Confidence            88999999999999988875 46999999999999999999999999  99999999999998 7899999999999866


Q ss_pred             cCCC-------CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 016143          182 QQPT-------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK  252 (394)
Q Consensus       182 ~~~~-------~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  252 (394)
                      ....       .....||+.|||||.+. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+..++ .+.
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~-~~~  256 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYRLP-PPM  256 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-CCT
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCc
Confidence            5432       11245799999999876 469999999999999999998 8999987 55677778887775443 455


Q ss_pred             CCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          253 VTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       253 ~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ..++++.+|+.+||. +|.+|||+.|++++
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            678999999999998 99999999998875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.6e-54  Score=406.56  Aligned_cols=254  Identities=25%  Similarity=0.399  Sum_probs=208.1

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      .|| ++.+.||+|+||+||+|.++ +|+.||+|+++....  .....+++.+|+.+|++++|||||+++++|.++  ..+
T Consensus         2 ~~Y-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~   75 (286)
T d1ob3a_           2 EKY-HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRL   75 (286)
T ss_dssp             CSE-EEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCE
T ss_pred             CCc-eeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC--Cce
Confidence            467 67789999999999999985 889999999976542  233457788999999999999999999999765  457


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++++||+.++.+..+.+..+.+++..++.++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+|.....
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGI  152 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC
T ss_pred             eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEc-CCCCEEecccccceeccc
Confidence            889999999888888888888999999999999999999999999  99999999999998 689999999999976654


Q ss_pred             C--CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCC------------
Q 016143          184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK------------  246 (394)
Q Consensus       184 ~--~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~~------------  246 (394)
                      .  ......|++.|+|||.+.+  .++.++|||||||++|||++|+.||.+....+++...... +..            
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence            4  2344579999999997754  4789999999999999999999999875444443332210 000            


Q ss_pred             -------------CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCcccc
Q 016143          247 -------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  286 (394)
Q Consensus       247 -------------~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~  286 (394)
                                   ........++.+++||++||+ ||.+|||+.|+|+||||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                         011234467899999999999 9999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=408.06  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=206.2

Q ss_pred             cccccccceecccCceEEEEEEEccC-CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC---CCCCceeEeeeEEcC-
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDD-   98 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L---~hpnIv~~~~~~~~~-   98 (394)
                      ++| ++.+.||+|+||+||+|.+..+ ++.||+|+++......  .....+.+|+.+|+.|   +||||++++++|... 
T Consensus         7 ~~Y-~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           7 QQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CCE-EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            456 7889999999999999999765 6789999997654321  2223355677766655   899999999988642 


Q ss_pred             --CCceEEEEEcccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143           99 --TNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus        99 --~~~~~~lV~e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                        ....++++|||+.++++...... ...+++..++.++.||+.||+|||+++  |+||||||+|||++ ..+.+||+||
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl~df  160 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADF  160 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEc-CCCCeeecch
Confidence              34578999999998887655544 456999999999999999999999999  99999999999998 7889999999


Q ss_pred             ceeeeecCC-CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC--C------
Q 016143          176 GLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I------  245 (394)
Q Consensus       176 gla~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~--~------  245 (394)
                      |++...... ......||+.|+|||++. ..|+.++||||+||++|||++|++||.+.. ..+....+...  .      
T Consensus       161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhhCCCchhcc
Confidence            999765443 345678999999999775 469999999999999999999999998744 44443333210  0      


Q ss_pred             -----------------CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          246 -----------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       246 -----------------~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                       ....+....++.+++||++||. +|.+|||+.|+|+||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                             0011234567899999999998 999999999999999998653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=401.95  Aligned_cols=247  Identities=19%  Similarity=0.389  Sum_probs=209.7

Q ss_pred             cccce-ecccCceEEEEEEEcc--CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           28 RYDEI-LGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        28 r~~~~-LG~G~~g~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      .+.+. ||+|+||+||+|.++.  ++..||||.++..   ......+++.+|+.+|++++|||||++++++.++   .++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~   84 (285)
T d1u59a_          11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALM   84 (285)
T ss_dssp             EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEE
T ss_pred             EECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---eEE
Confidence            45564 9999999999998753  4568999998643   2456778899999999999999999999987543   478


Q ss_pred             EEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +||||+++|+|.+++... ..+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+|+....
T Consensus        85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTT
T ss_pred             EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeec-cCCceeeccchhhhcccc
Confidence            999999999999998654 56999999999999999999999999  99999999999999 688999999999987754


Q ss_pred             CC-----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          184 PT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       184 ~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      ..     .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.. ..++...+..+..++ .+...++
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-~~~~~~~i~~~~~~~-~p~~~~~  239 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRME-CPPECPP  239 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHHHTTCCCC-CCTTCCH
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCC-CCCcCCH
Confidence            32     23456899999999876 569999999999999999998 999998754 456777787776543 5667889


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHH---hcCCccc
Q 016143          257 QVKQFIEKCIV-PASLRLPALEL---LKDPFLV  285 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~el---L~~p~~~  285 (394)
                      ++.+||.+||. +|.+||++.++   |+|+|+.
T Consensus       240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999998 99999999877   6777764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-54  Score=411.14  Aligned_cols=245  Identities=24%  Similarity=0.382  Sum_probs=206.1

Q ss_pred             cccceecccCceEEEEEEEccCC-----eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCc
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR  101 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~  101 (394)
                      ++.+.||+|+||+||+|.+..++     ..||+|.+....   .......+.+|+.+|+++ +|||||++++++.++  .
T Consensus        40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~  114 (325)
T d1rjba_          40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTLS--G  114 (325)
T ss_dssp             EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred             EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--C
Confidence            78899999999999999986554     369999876432   234556788999999998 899999999998654  4


Q ss_pred             eEEEEEcccCCCcHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 016143          102 TINMITELFTSGSLRQYRKKHK-----------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC  158 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~-----------------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp  158 (394)
                      .+++|||||++|+|.+++....                       .+++..++.++.||+.||+|||+++  |+||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp  192 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAA  192 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCch
Confidence            6889999999999999997653                       4899999999999999999999999  99999999


Q ss_pred             CcEEEeCCCCcEEEcccceeeeecCCCC----cccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCC
Q 016143          159 DNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECK  232 (394)
Q Consensus       159 ~NIll~~~~~~~kl~Dfgla~~~~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~  232 (394)
                      +|||++ .++.+||+|||+|+.......    ....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+..
T Consensus       193 ~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         193 RNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            999999 789999999999976654432    3456899999999765 569999999999999999998 899998866


Q ss_pred             CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       233 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ....+.+.+..+..+ ..+...++++++||.+||+ +|.+|||++||++|
T Consensus       272 ~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         272 VDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            666677777666544 4566788999999999998 99999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=402.05  Aligned_cols=248  Identities=23%  Similarity=0.380  Sum_probs=211.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      .+| ++.+.||+|+||+||+|.++ ++..||||+++...     ...+.+.+|+.+|++++|||||++++++.+   ..+
T Consensus        13 ~~~-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~   82 (272)
T d1qpca_          13 ETL-KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPI   82 (272)
T ss_dssp             GGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred             HHe-EEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCe
Confidence            344 88899999999999999975 67899999986432     223568999999999999999999997643   246


Q ss_pred             EEEEcccCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~--~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      ++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+++  |+||||||+||||+ +++.+||+|||+|+..
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLI  159 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeee-cccceeeccccceEEc
Confidence            7899999999999977544  35999999999999999999999999  99999999999998 7899999999999877


Q ss_pred             cCCC---CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 016143          182 QQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ  257 (394)
Q Consensus       182 ~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (394)
                      ....   .....||+.|||||++. +.|+.++|||||||++|||+||..|+....+..++...+..+..+. .+...+++
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~  238 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCPEE  238 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHH
T ss_pred             cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CcccChHH
Confidence            5542   33457899999999876 4699999999999999999997666656677888888888776544 45667899


Q ss_pred             HHHHHHHcCC-CCCCCCCHHHHhc--CCccc
Q 016143          258 VKQFIEKCIV-PASLRLPALELLK--DPFLV  285 (394)
Q Consensus       258 ~~~li~~~L~-~p~~R~s~~elL~--~p~~~  285 (394)
                      +++|+.+||. +|.+|||++++++  ++||.
T Consensus       239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            9999999998 8999999999988  77775

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=406.65  Aligned_cols=262  Identities=23%  Similarity=0.376  Sum_probs=210.6

Q ss_pred             ccCCCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC
Q 016143           19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD   98 (394)
Q Consensus        19 ~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~   98 (394)
                      ..+..+|| ++.+.||+|+||+||+|.++.+|+.||||++.....  .....+++.+|+.+|++++||||+++++++...
T Consensus         5 ~~~~~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~   81 (318)
T d3blha1           5 FCDEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTK   81 (318)
T ss_dssp             TSCBGGGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             CCCccCCE-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence            34567898 788999999999999999999999999999876543  234456788999999999999999999988653


Q ss_pred             C------CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 016143           99 T------NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI  172 (394)
Q Consensus        99 ~------~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl  172 (394)
                      .      ...+++||||+.++++..+......+++..++.+++||+.||.|||+++  |+||||||+|||++ .++.+||
T Consensus        82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~-~~~~~kl  158 (318)
T d3blha1          82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKL  158 (318)
T ss_dssp             ---------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEE
T ss_pred             cccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeec-CCCcEEe
Confidence            2      3468999999998888777777778999999999999999999999999  99999999999998 7889999


Q ss_pred             cccceeeeecCC------CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-
Q 016143          173 GDLGLAIVMQQP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-  243 (394)
Q Consensus       173 ~Dfgla~~~~~~------~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-  243 (394)
                      +|||++......      .....+||+.|+|||++.+  .|+.++|||||||++|||++|+.||.+. +.......+.. 
T Consensus       159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~i~~~  237 (318)
T d3blha1         159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQL  237 (318)
T ss_dssp             CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHH
T ss_pred             eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-CHHHHHHHHHHh
Confidence            999999765432      2334679999999997653  5899999999999999999999999873 44433333322 


Q ss_pred             --CCCCCCCCC---------------------------CCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          244 --GIKPASLSK---------------------------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       244 --~~~~~~~~~---------------------------~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                        ...+.....                           ..++++++||.+||+ +|.+|||+.|+|+||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence              111111111                           126678899999999 99999999999999999853

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=409.70  Aligned_cols=258  Identities=29%  Similarity=0.425  Sum_probs=208.5

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC--
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--   99 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~--   99 (394)
                      ...|| ++.+.||+|+||+||+|.++.+|+.||||+++...  .+....+++.+|+.+|++|+|||||+++++|...+  
T Consensus        16 ~~~~Y-~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          16 VRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             CBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             cCCcE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence            45677 77899999999999999999999999999987432  34567788999999999999999999999986543  


Q ss_pred             --CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccce
Q 016143          100 --NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL  177 (394)
Q Consensus       100 --~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgl  177 (394)
                        ...+++||||+ +.+|..+++. +.+++..++.+++||+.||.|||++|  |+||||||+|||++ .++.+||+|||+
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~-~~~~~kl~Dfg~  167 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGL  167 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTT
T ss_pred             cccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcc-cccccccccccc
Confidence              23578999999 6788887765 46999999999999999999999999  99999999999998 789999999999


Q ss_pred             eeeecCCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-CC---------
Q 016143          178 AIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI---------  245 (394)
Q Consensus       178 a~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~~---------  245 (394)
                      |...... .....||+.|+|||++.+  .++.++||||+||++|+|++|++||.+......+...... +.         
T Consensus       168 a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         168 ARQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             CEECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             eeccCCc-cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            9876554 345679999999997754  4689999999999999999999999875444333222210 00         


Q ss_pred             ---------------C---CCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          246 ---------------K---PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       246 ---------------~---~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                     .   ........++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                           0   011234567899999999998 999999999999999998753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.7e-53  Score=405.82  Aligned_cols=252  Identities=21%  Similarity=0.380  Sum_probs=210.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~  102 (394)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|+++...       .+++.+|+.+|++++ ||||++++++|.......
T Consensus        35 d~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          35 DDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             cCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            455 88899999999999999999999999999986322       356788999999995 999999999998777778


Q ss_pred             EEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      +++|||||.+++|..+.   +.+++..++.+++||+.||.|||++|  |+||||||+|||++.+++.+||+|||+|....
T Consensus       107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceecc
Confidence            99999999999997763   46999999999999999999999999  99999999999999666679999999998765


Q ss_pred             CC-CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc--------------CC
Q 016143          183 QP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------------GI  245 (394)
Q Consensus       183 ~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~--------------~~  245 (394)
                      .. .....+||+.|+|||++.+  .|+.++||||+||++|+|++|+.||....+.......+..              ..
T Consensus       182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            44 4556789999999997654  4899999999999999999999999876554433222210              00


Q ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccCC
Q 016143          246 ---------------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  288 (394)
Q Consensus       246 ---------------------~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~~  288 (394)
                                           .+.......++++++||++||. +|.+|||++|+|+||||++..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                 0011123357899999999998 999999999999999998754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=396.42  Aligned_cols=243  Identities=19%  Similarity=0.370  Sum_probs=198.6

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +.+.+.||+|+||+||+|.++ ++..||||+++....     ..+++.+|+.++++++|||||++++++.++  ..+++|
T Consensus         7 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~lv   78 (263)
T d1sm2a_           7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV   78 (263)
T ss_dssp             EEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC-----cHHHHHHHHHHHHhcCCCCcccccceeccC--CceEEE
Confidence            378899999999999999875 678899999864321     235688999999999999999999998654  457889


Q ss_pred             EcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC
Q 016143          107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT  185 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~  185 (394)
                      |||+++|+|.+++... ..++++.+..++.||+.||.|||+++  |+||||||+|||++ +++.+||+|||+|+......
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEEC-GGGCEEECSCC---------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeec-CCCCeEecccchheeccCCC
Confidence            9999999999998765 56899999999999999999999999  99999999999999 68899999999997665442


Q ss_pred             ---CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          186 ---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       186 ---~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                         .....||+.|+|||++.+ .|+.++|||||||++|||+|+..|+....+..++...+..+..+. .+...++++.+|
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~~l  234 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVYQI  234 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-CCTTSCHHHHHH
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC-CccccCHHHHHH
Confidence               234578999999998774 699999999999999999995444444577788888888775543 456778999999


Q ss_pred             HHHcCC-CCCCCCCHHHHhcC
Q 016143          262 IEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL~~  281 (394)
                      +.+||. +|.+|||++|+|+|
T Consensus       235 i~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         235 MNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHHH
Confidence            999998 99999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-53  Score=395.52  Aligned_cols=256  Identities=23%  Similarity=0.402  Sum_probs=218.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      .|| ++.+.||+|+||+||+|.++.+|+.||||+++....  .....+++.+|+.+|+.++||||++++++|.+.  ..+
T Consensus         2 ~ry-~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~   76 (292)
T d1unla_           2 QKY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKL   76 (292)
T ss_dssp             CSE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred             CCC-EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeeccccccc--cce
Confidence            355 788999999999999999999999999999976542  345678899999999999999999999998655  468


Q ss_pred             EEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      ++|++++.+++|..++...+.+++..++.++.|++.||+|||++|  |+||||||+|||++ .++.+||+|||.|.....
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCS
T ss_pred             eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccc-cCCceeeeecchhhcccC
Confidence            889999999999999999999999999999999999999999999  99999999999998 678999999999987755


Q ss_pred             CC--CcccccCCcccCccccccc--CCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC--C------------
Q 016143          184 PT--ARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I------------  245 (394)
Q Consensus       184 ~~--~~~~~gt~~y~aPE~l~~~--~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~--~------------  245 (394)
                      ..  .....+++.|+|||++...  ++.++|||||||++|||++|+.||....+..+.+..+...  .            
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            42  3345678899999977643  6899999999999999999999987767777666655321  0            


Q ss_pred             -------------CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          246 -------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       246 -------------~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                   .........++++++||++||. +|.+||||+|+|+||||++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                         0111233457899999999998 99999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=407.76  Aligned_cols=251  Identities=22%  Similarity=0.339  Sum_probs=205.2

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC----CCce
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----TNRT  102 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~----~~~~  102 (394)
                      |+..++||+|+||+||+|.++.+|+.||||++......        ..+|+.+|++|+||||++++++|...    +..+
T Consensus        22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            46778999999999999999999999999999754321        23699999999999999999988543    3457


Q ss_pred             EEEEEcccCCCcHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          103 INMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~---i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      +++|||||.++.+..+   ......+++.+++.|++||+.||+|||++|  |+||||||+|||++.++..+||+|||++.
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchh
Confidence            8999999987644433   345567999999999999999999999999  99999999999998555689999999998


Q ss_pred             eecCC-CCcccccCCcccCccccc--ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhc-C-----------
Q 016143          180 VMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G-----------  244 (394)
Q Consensus       180 ~~~~~-~~~~~~gt~~y~aPE~l~--~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~-~-----------  244 (394)
                      ..... ...+.+||+.|+|||++.  ..|+.++||||+||++|||++|+.||......+++...+.. +           
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            76544 455678999999999654  35899999999999999999999999875554444433221 0           


Q ss_pred             ------CCC--------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          245 ------IKP--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       245 ------~~~--------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                            ..+        .......++++++||++||. ||.+|||+.|+|+||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence                  000        01123467899999999999 99999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-53  Score=388.66  Aligned_cols=241  Identities=22%  Similarity=0.407  Sum_probs=209.1

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT  107 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV~  107 (394)
                      ++.+.||+|+||+||+|.++ ++..||||.++....     ..+.+.+|+.++++++||||+++++++.++  ..+++||
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~iv~   78 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFIIT   78 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEEEEE
T ss_pred             EEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-----CHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEEE
Confidence            68899999999999999984 788999999875432     235688999999999999999999988544  4689999


Q ss_pred             cccCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCCC-
Q 016143          108 ELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-  185 (394)
Q Consensus       108 e~~~~gsL~~~i~~-~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~~-  185 (394)
                      ||+++|+|..++.. ...+++..+..++.||+.||.|||++|  |+||||||+||+++ +++.+||+|||+++...... 
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSSSSC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEc-CCCcEEECcchhheeccCCCc
Confidence            99999999999665 456999999999999999999999999  99999999999998 78899999999997654432 


Q ss_pred             --CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 016143          186 --ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF  261 (394)
Q Consensus       186 --~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  261 (394)
                        .....||+.|+|||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+ ..+...++++++|
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~l  233 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASEKVYTI  233 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC-CCHHHHHHHHHhCCCC-CCcccccHHHHHH
Confidence              23456899999999776 569999999999999999998 8999987 4567788888887644 3567788999999


Q ss_pred             HHHcCC-CCCCCCCHHHHhcC
Q 016143          262 IEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       262 i~~~L~-~p~~R~s~~elL~~  281 (394)
                      |++||+ +|.+|||+.++|+|
T Consensus       234 i~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         234 MYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHHH
Confidence            999998 89999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=404.71  Aligned_cols=257  Identities=26%  Similarity=0.395  Sum_probs=207.0

Q ss_pred             CCcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC-
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-  100 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~-  100 (394)
                      ...|| ++.+.||+|+||+||+|.++.+|+.||||++....   .....+++.+|+.+|++|+||||+++++++..+.. 
T Consensus         6 i~~rY-~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           6 VGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE   81 (345)
T ss_dssp             CCTTE-EEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             cCCCe-EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence            34566 88899999999999999999999999999986433   45667789999999999999999999999865432 


Q ss_pred             --ceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEccccee
Q 016143          101 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA  178 (394)
Q Consensus       101 --~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla  178 (394)
                        ..++++ +|+.+|+|.++++.+ ++++..++.++.||+.||+|||++|  |+||||||+|||++ +++.+||+|||+|
T Consensus        82 ~~~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a  156 (345)
T d1pmea_          82 QMKDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLA  156 (345)
T ss_dssp             TCCCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred             ccceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEEC-CCCCEEEcccCce
Confidence              235555 556699999999875 5999999999999999999999999  99999999999998 7889999999999


Q ss_pred             eeecCC-----CCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC----
Q 016143          179 IVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----  247 (394)
Q Consensus       179 ~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~----  247 (394)
                      ......     .....+||+.|+|||++..  .|+.++||||+||++|+|++|+.||.......+....+.....+    
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            765433     2345679999999998753  47899999999999999999999998754433333322110000    


Q ss_pred             ---------------------C---CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          248 ---------------------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       248 ---------------------~---~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                           .   ......++++++||.+||. ||.+|||+.|+|+||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                                 0   1123457899999999998 99999999999999999854

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=406.83  Aligned_cols=269  Identities=22%  Similarity=0.364  Sum_probs=220.9

Q ss_pred             cccccccceecccCceEEEEEEE---ccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC-CCceeEeeeEEcCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFD---EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDT   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~---~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h-pnIv~~~~~~~~~~   99 (394)
                      .+| ++.+.||+|+||+||+|.+   +.+|+.||+|+++...........+++.+|+.+|++++| |||+++++++.+. 
T Consensus        24 ~~y-~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-  101 (322)
T d1vzoa_          24 ENF-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  101 (322)
T ss_dssp             GGE-EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             hce-EEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence            344 7889999999999999987   457899999998765433333345667889999999976 8999999988655 


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                       ..++++|||+.+|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||+|.
T Consensus       102 -~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         102 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSK  177 (322)
T ss_dssp             -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEE
T ss_pred             -CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeec-CCCCEEEeeccchh
Confidence             478899999999999999999999999999999999999999999999  99999999999999 67899999999998


Q ss_pred             eecCC---CCcccccCCcccCcccccc---cCCCcCcchhhhhHHHHHHhcCCCCCCC---CCHHHHHHHHhcCCCCCCC
Q 016143          180 VMQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNEC---KNPAQIYKKVTSGIKPASL  250 (394)
Q Consensus       180 ~~~~~---~~~~~~gt~~y~aPE~l~~---~~~~~~DIwSlG~il~elltg~~Pf~~~---~~~~~~~~~i~~~~~~~~~  250 (394)
                      .....   ......||+.|+|||.+.+   .++.++|||||||+||+|++|+.||.+.   ....++........  ..+
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~--~~~  255 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPY  255 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--CCC
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--CCC
Confidence            76443   2345679999999997753   3678999999999999999999999664   23344444444442  335


Q ss_pred             CCCCCHHHHHHHHHcCC-CCCCCCC-----HHHHhcCCccccCCCCCcccCCCCCC
Q 016143          251 SKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP  300 (394)
Q Consensus       251 ~~~~~~~~~~li~~~L~-~p~~R~s-----~~elL~~p~~~~~~~~~~~~~~~~~p  300 (394)
                      +...++++++||++||. +|.+|+|     ++|+|+||||+..++..+....+..|
T Consensus       256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p  311 (322)
T d1vzoa_         256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP  311 (322)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred             cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcC
Confidence            56788999999999999 9999994     89999999999877665554444433

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=391.05  Aligned_cols=244  Identities=22%  Similarity=0.374  Sum_probs=203.0

Q ss_pred             cccceecccCceEEEEEEEccCC----eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      +..++||+|+||+||+|.++.++    ..||||.++...   .......+.+|+.+|++|+|||||++++++.+.  ..+
T Consensus        10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--~~~   84 (283)
T d1mqba_          10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KPM   84 (283)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred             EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC--Cce
Confidence            67899999999999999887655    579999986432   455667799999999999999999999988544  468


Q ss_pred             EEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeec
Q 016143          104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ  182 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~  182 (394)
                      ++||||+.+++|.+++... +.+++.++..++.||+.||+|||+++  |+||||||+||||+ .++.+||+|||+|+...
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC-----
T ss_pred             EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEEC-CCCeEEEcccchhhccc
Confidence            8999999999999987765 57999999999999999999999999  99999999999999 78999999999998664


Q ss_pred             CCC-----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          183 QPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       183 ~~~-----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      ...     .....||+.|||||++.+ .|+.++|||||||++|||++|..||....+..+++..+..+..++ .+...++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~  240 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-TPMDCPS  240 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-CCTTCBH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC-CchhhHH
Confidence            432     223468999999997765 599999999999999999997777666678888898888886554 4566789


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ++.++|.+||. +|.+||++.|+++
T Consensus       241 ~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         241 AIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999998 9999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=389.89  Aligned_cols=249  Identities=23%  Similarity=0.361  Sum_probs=207.0

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||+||+|.++.+ ..||||+++....     ..+.+.+|+.+|++++|||||++++++.+ +  .+++|
T Consensus        19 ~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~--~~~lv   89 (285)
T d1fmka3          19 LRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--PIYIV   89 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S--SCEEE
T ss_pred             EEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC-----CHHHHHHHHHHHHhcccCCEeEEEEEEec-C--CeEEE
Confidence            48999999999999999998654 6799999864331     23568899999999999999999998743 2  36789


Q ss_pred             EcccCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~--~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+++|+|..++..  .+.+++.+++.++.||+.||+|||+++  |+||||||+||||+ +++.+||+|||+|+.....
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~-~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC-----
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEEC-CCCcEEEcccchhhhccCC
Confidence            999999999988754  356999999999999999999999999  99999999999998 6889999999999766433


Q ss_pred             ---CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 016143          185 ---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ  260 (394)
Q Consensus       185 ---~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (394)
                         ......||+.|+|||.+. +.++.++|||||||++|||++|..||....+..+++..+..+..++ .+...++++++
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~  245 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHD  245 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHHHHH
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccCHHHHH
Confidence               223457999999999765 5699999999999999999997777766678888888888776544 56678899999


Q ss_pred             HHHHcCC-CCCCCCCHHHHhc--CCccccCC
Q 016143          261 FIEKCIV-PASLRLPALELLK--DPFLVTDN  288 (394)
Q Consensus       261 li~~~L~-~p~~R~s~~elL~--~p~~~~~~  288 (394)
                      ||.+||. +|++||++++++.  ++||....
T Consensus       246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         246 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            9999998 9999999999987  88887543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=388.30  Aligned_cols=246  Identities=24%  Similarity=0.425  Sum_probs=199.5

Q ss_pred             cccccccceecccCceEEEEEEEccC---CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN  100 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~  100 (394)
                      .+| ++.+.||+|+||+||+|.+..+   +..||+|.++..   ......+.+.+|+.+|++++|||||++++++.+   
T Consensus         7 ~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---   79 (273)
T d1mp8a_           7 ERI-ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---   79 (273)
T ss_dssp             GGE-EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             HHe-EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence            345 7889999999999999988654   456888887532   245667889999999999999999999998742   


Q ss_pred             ceEEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       101 ~~~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ..+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||+|+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~-~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSR  156 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC-----
T ss_pred             CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeec-CCCcEEEccchhhe
Confidence            3578999999999999987654 56999999999999999999999999  99999999999999 68899999999997


Q ss_pred             eecCC---CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          180 VMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       180 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      .....   ......||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+ .+..+++..+..+..+ ..+...
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~  234 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPNC  234 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTC
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCC
Confidence            66543   233456899999999876 469999999999999999998 8999977 5566777778777554 356678


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++++++||.+||. +|.+|||+.|++++
T Consensus       235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            8999999999998 99999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-52  Score=391.73  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=201.6

Q ss_pred             cccccccceecccCceEEEEEEEcc-----CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEc
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD   97 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~   97 (394)
                      .+| ++.+.||+|+||+||+|.+..     +++.||+|+++...   .....+.+.+|..++.++ +|+||+.+++++.+
T Consensus        13 ~~y-~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          13 DRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             GGE-EEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHE-EEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            455 788999999999999998754     45789999986432   345567788888888777 68999999998754


Q ss_pred             CCCceEEEEEcccCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 016143           98 DTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI  161 (394)
Q Consensus        98 ~~~~~~~lV~e~~~~gsL~~~i~~~----------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NI  161 (394)
                      + ...+++|||||++|+|.+++...                ..+++..++.++.||+.||.|||+++  |+||||||+||
T Consensus        89 ~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NI  165 (299)
T d1ywna1          89 P-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNI  165 (299)
T ss_dssp             T-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred             C-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccce
Confidence            4 34688999999999999999754                24899999999999999999999999  99999999999


Q ss_pred             EEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhc-CCCCCCCCCHH
Q 016143          162 FVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTC-EYPYNECKNPA  235 (394)
Q Consensus       162 ll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg-~~Pf~~~~~~~  235 (394)
                      |++ +++.+||+|||+|+......    .....||+.|||||++.+ .|+.++|||||||++|||+|| .+||.+.....
T Consensus       166 Ll~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         166 LLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             EEC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             eEC-CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            998 68899999999997654432    334679999999997765 589999999999999999986 57888766667


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       236 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+...+..+..+. .+...+++++++|.+||. +|.+|||+.|+++|
T Consensus       245 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         245 EFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7777777776543 566778999999999998 99999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-52  Score=393.89  Aligned_cols=244  Identities=27%  Similarity=0.457  Sum_probs=201.5

Q ss_pred             ccccceecccCceEEEEEEEccCCe----EEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      |++.++||+|+||+||+|.+..+|+    .||+|.++...   +.+..+++.+|+.+|++++|||||++++++.++   .
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~   84 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T   84 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence            4888999999999999999988876    57777765332   234567799999999999999999999998754   3


Q ss_pred             EEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      .++++||+.+|+|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+|+..
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~-~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCCSHHHHT
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeC-CCCCeEeeccccceec
Confidence            56788999999999887764 57999999999999999999999999  99999999999999 6889999999999766


Q ss_pred             cCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 016143          182 QQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD  255 (394)
Q Consensus       182 ~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (394)
                      ....    .....||+.|||||++. +.|+.++|||||||++|||+| |.+||.+ .+..++...+..+..++ .+...+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~~~~  239 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPICT  239 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCTTBC
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccC
Confidence            4432    23346899999999765 469999999999999999998 7899876 55566777787776543 456678


Q ss_pred             HHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          256 PQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       256 ~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      +++.+|+.+||. +|.+|||+.|++.|
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            999999999998 99999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-52  Score=398.82  Aligned_cols=256  Identities=29%  Similarity=0.412  Sum_probs=205.2

Q ss_pred             CcccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCC---
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---   99 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~---   99 (394)
                      ..|| ++.+.||+|+||+||+|.++.+|+.||||++....  .+....+++.+|+.+|++|+|||||+++++|....   
T Consensus        17 ~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          17 PERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             ETTE-EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred             CCCe-EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence            3566 78899999999999999999999999999987543  34566678999999999999999999999885432   


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ....+++++|+.+|+|.+++.. +++++..++.+++||+.||.|||++|  |+||||||+|||++ .++.+|++|||++.
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLAR  169 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC----
T ss_pred             cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccc-ccccccccccchhc
Confidence            2233455677789999999865 46999999999999999999999999  99999999999998 78999999999997


Q ss_pred             eecCCCCcccccCCcccCcccccc--cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcC-CCC---------
Q 016143          180 VMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKP---------  247 (394)
Q Consensus       180 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~-~~~---------  247 (394)
                      ..... .....||+.|+|||++.+  .++.++|||||||++|+|++|++||.+.. .......+... ..+         
T Consensus       170 ~~~~~-~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         170 HTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CCTGG-GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             ccCcc-cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCChHHhhhcc
Confidence            65443 345679999999997554  36899999999999999999999998743 33333333211 000         


Q ss_pred             -----------C--------CCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          248 -----------A--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       248 -----------~--------~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                                 .        ......++++++||++||. ||.+|||+.|+|+||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                       0        0113467899999999998 99999999999999999864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=397.37  Aligned_cols=255  Identities=27%  Similarity=0.374  Sum_probs=197.2

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcC----C
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----T   99 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~----~   99 (394)
                      .|| ++.++||+|+||+||+|.++.+|+.||||++....  .+.....++.+|+.+|++++||||++++++|...    .
T Consensus        17 ~~Y-~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          17 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             TTE-EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             CCe-EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh--cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            455 88899999999999999999999999999997543  2466777899999999999999999999998654    3


Q ss_pred             CceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       100 ~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ...+|+|||||.++.+.. +  ...+++..++.+++||+.||.|||++|  |+||||||+|||++ .++.+|++|||++.
T Consensus        94 ~~~~~iv~Ey~~~~l~~~-~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~-~~~~~kl~df~~~~  167 (355)
T d2b1pa1          94 FQDVYLVMELMDANLCQV-I--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR  167 (355)
T ss_dssp             CCEEEEEEECCSEEHHHH-H--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC--
T ss_pred             CceeEEEEeccchHHHHh-h--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccc-cccceeeechhhhh
Confidence            468999999997665543 3  356999999999999999999999999  99999999999998 68899999999987


Q ss_pred             eecCC-CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHh---------------
Q 016143          180 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT---------------  242 (394)
Q Consensus       180 ~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~---------------  242 (394)
                      ..... .....+||+.|+|||++.+ .++.++||||+||++|+|++|++||.+........+.+.               
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            66554 3456679999999998765 589999999999999999999999987443333222211               


Q ss_pred             ------cCCCCCC------------C------CCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcCCccccC
Q 016143          243 ------SGIKPAS------------L------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  287 (394)
Q Consensus       243 ------~~~~~~~------------~------~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~p~~~~~  287 (394)
                            ....+..            .      ....++++++||++||. +|.+||||+|+|+||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                  0100000            0      00124678999999999 99999999999999999863

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=382.53  Aligned_cols=247  Identities=26%  Similarity=0.400  Sum_probs=196.1

Q ss_pred             cccccceecccCceEEEEEEEccC---CeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCce
Q 016143           26 YGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        26 y~r~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~  102 (394)
                      -+++.+.||+|+||+||+|.+..+   ...||||+++.... ...+..+++.+|+.+|++++||||+++++++.++   .
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~   84 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---P   84 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---S
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---c
Confidence            358889999999999999986433   34799999875443 3345667899999999999999999999988542   4


Q ss_pred             EEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeee
Q 016143          103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM  181 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~  181 (394)
                      +++||||+++|+|.+++... +.+++..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||+++..
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~-~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEEC
T ss_pred             hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccc-cccceeeccchhhhhc
Confidence            67899999999999876654 56999999999999999999999999  99999999999999 6789999999999876


Q ss_pred             cCCC-----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 016143          182 QQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT  254 (394)
Q Consensus       182 ~~~~-----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  254 (394)
                      ....     .....||+.|+|||++.+ .++.++|||||||++|||+| |+.||.+ .+..++...+.........+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~  240 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDC  240 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCcccc
Confidence            5442     233457889999997765 58899999999999999998 8999987 56666666665543333456677


Q ss_pred             CHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          255 DPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       255 ~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ++.+++||.+||. +|.+|||+.++++
T Consensus       241 ~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         241 PQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8999999999998 9999999999863

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-51  Score=385.16  Aligned_cols=248  Identities=21%  Similarity=0.313  Sum_probs=209.5

Q ss_pred             CCcccccccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEE
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV   96 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~   96 (394)
                      |.+.| .+.+.||+|+||+||+|.++     .++..||||+++..   ...+..+++.+|+.+|++++||||+++++++.
T Consensus        11 p~~~~-~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_          11 PRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             CGGGC-EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CHHHc-EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh---cChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            55666 78899999999999999875     35689999998643   24566778999999999999999999999986


Q ss_pred             cCCCceEEEEEcccCCCcHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 016143           97 DDTNRTINMITELFTSGSLRQYRKKHK------------------------NVDMKAIKNWARQILRGLHYLHSHNPPII  152 (394)
Q Consensus        97 ~~~~~~~~lV~e~~~~gsL~~~i~~~~------------------------~l~~~~~~~i~~qil~~L~~LH~~~~~iv  152 (394)
                      +.  ..+++||||+++|+|.+++....                        .+++..+..++.||+.||+|||+++  |+
T Consensus        87 ~~--~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iv  162 (301)
T d1lufa_          87 VG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV  162 (301)
T ss_dssp             SS--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred             cC--CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eE
Confidence            54  45778999999999999986532                        3899999999999999999999999  99


Q ss_pred             ecCCCCCcEEEeCCCCcEEEcccceeeeecCC----CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcC-C
Q 016143          153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCE-Y  226 (394)
Q Consensus       153 HrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~-~  226 (394)
                      ||||||+|||++ .++.+||+|||+|+.....    ......||+.|+|||.+.+ .|+.++|||||||++|||++|. +
T Consensus       163 HrDlKp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         163 HRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             eeEEcccceEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            999999999999 6789999999999765433    2234578999999997765 6999999999999999999986 5


Q ss_pred             CCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          227 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       227 Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      ||.+ .+..++...+..+..+ ..+...++++.+||.+||. +|.+|||+.|+++
T Consensus       242 p~~~-~~~~e~~~~v~~~~~~-~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         242 PYYG-MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCC-CCHHHHHHHHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6765 6777888888887654 3566778999999999998 9999999999865

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-51  Score=387.19  Aligned_cols=244  Identities=25%  Similarity=0.397  Sum_probs=204.6

Q ss_pred             cccceecccCceEEEEEEEccCCeE--EEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeEEcCCCceEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      ++.+.||+|+||+||+|.++.+|..  ||||.++...   ..+..+.+.+|+.+|+++ +|||||++++++.++  ..++
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~   87 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY   87 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEE
T ss_pred             EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--CeeE
Confidence            6789999999999999999988875  6666664322   234567799999999999 799999999998754  4789


Q ss_pred             EEEcccCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 016143          105 MITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG  168 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~----------------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~  168 (394)
                      +||||+++|+|.+++...                ..+++..+..++.||+.||.|||+++  |+||||||+|||++ .++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~-~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc-CCC
Confidence            999999999999999754                56999999999999999999999999  99999999999998 678


Q ss_pred             cEEEcccceeeeecCCC-CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcC-CCCCCCCCHHHHHHHHhcCC
Q 016143          169 EVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE-YPYNECKNPAQIYKKVTSGI  245 (394)
Q Consensus       169 ~~kl~Dfgla~~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~-~Pf~~~~~~~~~~~~i~~~~  245 (394)
                      .+||+|||+|+...... .....||+.|+|||.+. +.|+.++|||||||++|||++|. +||.+ .+..+++..+.++.
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i~~~~  243 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY  243 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGGTC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhcC
Confidence            99999999997554433 33456899999999775 46999999999999999999976 45654 78888888888876


Q ss_pred             CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       246 ~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      .+. .+...++++++||.+||. +|.+|||+.|++++
T Consensus       244 ~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         244 RLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            554 456678999999999998 99999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=380.40  Aligned_cols=240  Identities=22%  Similarity=0.413  Sum_probs=199.1

Q ss_pred             ccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEEEE
Q 016143           27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        27 ~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      +++.+.||+|+||+||+|.++  |..||+|+++.+      ...+.+.+|+.+|++++||||+++++++.++. ..+++|
T Consensus         9 ~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv   79 (262)
T d1byga_           9 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIV   79 (262)
T ss_dssp             EEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEE
T ss_pred             eEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEEE
Confidence            378899999999999999874  789999998632      23467889999999999999999999886543 357899


Q ss_pred             EcccCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecCC
Q 016143          107 TELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP  184 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~--~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~~  184 (394)
                      |||+++|+|.+++....  .+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-------
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheec-CCCCEeecccccceecCCC
Confidence            99999999999987643  4999999999999999999999999  99999999999998 7899999999999765543


Q ss_pred             CCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 016143          185 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  262 (394)
Q Consensus       185 ~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  262 (394)
                       .....+|+.|+|||.+. +.++.++|||||||++|||+| |++||.. .+..++...+..+..++ ++...++++++||
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li  233 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYEVM  233 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHHHH
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHH
Confidence             33456899999999775 569999999999999999998 6888766 56778888888776654 5667889999999


Q ss_pred             HHcCC-CCCCCCCHHHHhcC
Q 016143          263 EKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       263 ~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++||. +|.+|||+.+++++
T Consensus       234 ~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         234 KNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcccCHhHCcCHHHHHHH
Confidence            99998 89999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=382.33  Aligned_cols=247  Identities=27%  Similarity=0.407  Sum_probs=206.3

Q ss_pred             CcccccccceecccCceEEEEEEEccCC-------eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeee
Q 016143           23 SCRYGRYDEILGKGAFKTVYKGFDEVDG-------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS   94 (394)
Q Consensus        23 ~~ry~r~~~~LG~G~~g~Vy~a~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~   94 (394)
                      .++| .+.+.||+|+||.||+|.+..++       ..||+|.++...   .......+.+|+..+.++ +|||||+++++
T Consensus        12 ~~~~-~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          12 RDRL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             GGGE-EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHHe-EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            3566 78899999999999999876554       479999986432   356667889999999888 89999999999


Q ss_pred             EEcCCCceEEEEEcccCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 016143           95 WVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC  158 (394)
Q Consensus        95 ~~~~~~~~~~lV~e~~~~gsL~~~i~~~~----------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp  158 (394)
                      +.++  ..+++||||+++|+|.+++....                .+++.+++.++.||+.||+|||+++  |+||||||
T Consensus        88 ~~~~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp  163 (299)
T d1fgka_          88 CTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA  163 (299)
T ss_dssp             ECSS--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred             cccC--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecc
Confidence            8654  46889999999999999997553                4899999999999999999999999  99999999


Q ss_pred             CcEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCCC
Q 016143          159 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECK  232 (394)
Q Consensus       159 ~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~~  232 (394)
                      +|||++ .++.+||+|||+++......    .....||+.|+|||.+. +.|+.++|||||||++|||++ |.+||.+ .
T Consensus       164 ~NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~  241 (299)
T d1fgka_         164 RNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-V  241 (299)
T ss_dssp             GGEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-C
T ss_pred             cceeec-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-C
Confidence            999998 78899999999998665442    33467899999999775 569999999999999999998 6888876 6


Q ss_pred             CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       233 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      +..+++..+..+..+. .+...++.+++||.+||+ +|.+|||+.|+|+
T Consensus       242 ~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         242 PVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             CHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            7778888888876554 566788999999999998 9999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=382.38  Aligned_cols=246  Identities=22%  Similarity=0.368  Sum_probs=205.8

Q ss_pred             cccceecccCceEEEEEEEccCC---eEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~~  104 (394)
                      .+.++||+|+||+||+|.+..++   ..||||.++..   .+....+++.+|+.+|++++|||||++++++.+.. ..++
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~  105 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPL  105 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-CceE
Confidence            45789999999999999986543   46999988632   35677888999999999999999999999876543 4688


Q ss_pred             EEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEcccceeeeecC
Q 016143          105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ  183 (394)
Q Consensus       105 lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~~~~~  183 (394)
                      +|||||++|+|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+|||++ +++.+||+|||+++....
T Consensus       106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSSGGGCCTTT
T ss_pred             EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeEC-CCCCEEEecccchhhccc
Confidence            999999999999988865 45888999999999999999999999  99999999999998 788999999999986644


Q ss_pred             CC------CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 016143          184 PT------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  256 (394)
Q Consensus       184 ~~------~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  256 (394)
                      ..      .....||+.|+|||.+. +.++.++|||||||++|||+||..||....+..++...+..+..+. .+...++
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~p~~~~~  261 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCPD  261 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-CCTTCCH
T ss_pred             cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-CcccCcH
Confidence            32      22356899999999765 5699999999999999999998888877677777788888876553 5567789


Q ss_pred             HHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          257 QVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       257 ~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                      ++.+||.+||. +|.+||++.|++++
T Consensus       262 ~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         262 PLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999998 99999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=377.33  Aligned_cols=256  Identities=22%  Similarity=0.365  Sum_probs=213.0

Q ss_pred             CCCCccccCCCcccccccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCC
Q 016143           13 EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN   87 (394)
Q Consensus        13 ~~~~~~~~~~~~ry~r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpn   87 (394)
                      -.++.++.++ .+| .+.+.||+|+||+||+|.+.     .++..||||+++...   .......+.+|+.++++++|||
T Consensus        10 ~~~~~~ei~~-~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~n   84 (308)
T d1p4oa_          10 YVPDEWEVAR-EKI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHH   84 (308)
T ss_dssp             CCCCTTBCCG-GGE-EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTT
T ss_pred             cCccceeecH-HHe-EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCC
Confidence            3344455553 455 68899999999999999875     346789999986432   4556678999999999999999


Q ss_pred             ceeEeeeEEcCCCceEEEEEcccCCCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCC
Q 016143           88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK  157 (394)
Q Consensus        88 Iv~~~~~~~~~~~~~~~lV~e~~~~gsL~~~i~~~----------~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLk  157 (394)
                      |+++++++..+  ..+++||||+++|+|.+++...          ..+++..+..++.||+.||.|||+++  |+|||||
T Consensus        85 Iv~~~~~~~~~--~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk  160 (308)
T d1p4oa_          85 VVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLA  160 (308)
T ss_dssp             BCCEEEEECSS--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCS
T ss_pred             EeeeeeEEecC--CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEc
Confidence            99999988544  4578899999999999987643          24789999999999999999999999  9999999


Q ss_pred             CCcEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcC-CCCCCC
Q 016143          158 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCE-YPYNEC  231 (394)
Q Consensus       158 p~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~-~Pf~~~  231 (394)
                      |+|||++ .++++||+|||+|+......    .....||+.|+|||.+.+ .++.++|||||||++|||+||. .||.+ 
T Consensus       161 ~~NiLld-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-  238 (308)
T d1p4oa_         161 ARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-  238 (308)
T ss_dssp             GGGEEEC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-
T ss_pred             CCceeec-CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-
Confidence            9999999 78899999999997664432    334568999999997764 5889999999999999999985 66755 


Q ss_pred             CCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          232 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       232 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .+..+++..+.++..+. .+...++.+.++|.+||+ +|.+|||+.++++
T Consensus       239 ~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         239 LSNEQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            77788888888776543 456678999999999998 9999999999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-50  Score=378.57  Aligned_cols=249  Identities=24%  Similarity=0.386  Sum_probs=209.5

Q ss_pred             CCcccccccceecccCceEEEEEEEc-----cCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcC-CCCCceeEeeeE
Q 016143           22 PSCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW   95 (394)
Q Consensus        22 ~~~ry~r~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L-~hpnIv~~~~~~   95 (394)
                      +..+| .+.+.||+|+||.||+|.+.     .++..||+|+++...   .......+.+|+.+++++ +|||||++++++
T Consensus        21 ~~~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          21 PRNRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             CGGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHe-EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            34566 78899999999999999863     567899999987433   356677899999999999 699999999998


Q ss_pred             EcCCCceEEEEEcccCCCcHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCC
Q 016143           96 VDDTNRTINMITELFTSGSLRQYRKKHK------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK  157 (394)
Q Consensus        96 ~~~~~~~~~lV~e~~~~gsL~~~i~~~~------------------~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLk  157 (394)
                      .+.  ..+++|||||++|+|.+++.+..                  .+++..+..++.||+.||+|||+++  ++|||||
T Consensus        97 ~~~--~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLK  172 (311)
T d1t46a_          97 TIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA  172 (311)
T ss_dssp             CSS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred             eeC--CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccc
Confidence            544  45788999999999999987643                  5899999999999999999999999  9999999


Q ss_pred             CCcEEEeCCCCcEEEcccceeeeecCCC----CcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHh-cCCCCCCC
Q 016143          158 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNEC  231 (394)
Q Consensus       158 p~NIll~~~~~~~kl~Dfgla~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~ellt-g~~Pf~~~  231 (394)
                      |+||+++ .++.+||+|||+++......    .....||+.|+|||.+. +.++.++|||||||++|||+| |.+||...
T Consensus       173 p~NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         173 ARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             GGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccccccc-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence            9999999 68899999999998665432    23467899999999776 468999999999999999998 66666665


Q ss_pred             CCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          232 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       232 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                      .....+.+.+..+..+. .+...++.+.+||.+||. +|.+|||+.++|+
T Consensus       252 ~~~~~~~~~i~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         252 PVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCC-CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            55556666666665443 456678999999999998 9999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=366.43  Aligned_cols=249  Identities=27%  Similarity=0.378  Sum_probs=192.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCC--c
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--R  101 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~--~  101 (394)
                      .|-+.+.+.||+|+||+||+|.+  +|+.||||+++...     ........|+..+..++|||||++++++.++..  .
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence            35567889999999999999985  68999999986432     111222245666678899999999999876543  3


Q ss_pred             eEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEecCCCCCcEEEeCCCCcEEEccc
Q 016143          102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDL  175 (394)
Q Consensus       102 ~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~------~~~ivHrDLkp~NIll~~~~~~~kl~Df  175 (394)
                      .+++||||+++|+|.+++++. +++++....++.|++.||.|||+.      ..+|+||||||+||||+ .++.+||+||
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DF  152 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADL  152 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCC
T ss_pred             EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-CCCCeEEEec
Confidence            689999999999999999876 599999999999999999999973      12399999999999998 7899999999


Q ss_pred             ceeeeecCCC------CcccccCCcccCccccccc-------CCCcCcchhhhhHHHHHHhcCCCCCCC-----------
Q 016143          176 GLAIVMQQPT------ARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTCEYPYNEC-----------  231 (394)
Q Consensus       176 gla~~~~~~~------~~~~~gt~~y~aPE~l~~~-------~~~~~DIwSlG~il~elltg~~Pf~~~-----------  231 (394)
                      |++.......      .....||+.|+|||++.+.       ++.++|||||||+||||+||..||...           
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            9998765432      2346799999999987653       567899999999999999998877421           


Q ss_pred             ---CCHHHHHHHHhcCCCCCCCCCCC-----CHHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 016143          232 ---KNPAQIYKKVTSGIKPASLSKVT-----DPQVKQFIEKCIV-PASLRLPALELLKD  281 (394)
Q Consensus       232 ---~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~li~~~L~-~p~~R~s~~elL~~  281 (394)
                         .....+...+......+.++...     ...+.+++.+||+ +|.+|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               23344444444433222222221     2358899999998 89999999998763

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.4e-48  Score=362.87  Aligned_cols=252  Identities=22%  Similarity=0.299  Sum_probs=195.4

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCceeEeeeEEcCCCceE
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI  103 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnIv~~~~~~~~~~~~~~  103 (394)
                      +|| ++.+.||+|+||+||+|.+..+|+.||||++......      +++..|+++++.++|+|++..+..+..+ ....
T Consensus         7 ~rY-~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~   78 (299)
T d1ckia_           7 NRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYN   78 (299)
T ss_dssp             TTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEE
T ss_pred             CEE-EEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEec-CCEE
Confidence            355 8899999999999999999999999999988754321      2467899999999888766665544333 3578


Q ss_pred             EEEEcccCCCcHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEcccceeee
Q 016143          104 NMITELFTSGSLRQYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIV  180 (394)
Q Consensus       104 ~lV~e~~~~gsL~~~i-~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~--~~~~~kl~Dfgla~~  180 (394)
                      ++||||+. ++|...+ ...+.+++..+..++.||+.||+|||++|  |+||||||+|||++.  .+..+||+|||+|+.
T Consensus        79 ~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          79 VMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             EEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCccee
Confidence            89999995 5555554 45567999999999999999999999999  999999999999862  345799999999987


Q ss_pred             ecCCC---------CcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCCCCHHHH--HHHHhc---CC
Q 016143          181 MQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI--YKKVTS---GI  245 (394)
Q Consensus       181 ~~~~~---------~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~~~~~~~--~~~i~~---~~  245 (394)
                      .....         .....||+.|||||++.+ .|+.++|||||||++|||+||+.||.........  +.....   ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  235 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence            65432         234579999999998776 5999999999999999999999999774433221  111111   11


Q ss_pred             CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHH---HHhcCCcccc
Q 016143          246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPAL---ELLKDPFLVT  286 (394)
Q Consensus       246 ~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~---elL~~p~~~~  286 (394)
                      .........++++.+||.+||. +|.+||++.   ++|+|+|.+.
T Consensus       236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            1222345678899999999998 999999987   4577776543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.8e-46  Score=352.86  Aligned_cols=245  Identities=17%  Similarity=0.253  Sum_probs=198.0

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC-CCceeEeeeEEcCCCce
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h-pnIv~~~~~~~~~~~~~  102 (394)
                      +|| ++.+.||+|+||+||+|.+..+|+.||+|++.....      ...+.+|++.++.|+| +||+.+++++.+  ...
T Consensus         5 ~~Y-~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~   75 (293)
T d1csna_           5 VHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLH   75 (293)
T ss_dssp             TTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTE
T ss_pred             Cce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCc
Confidence            355 899999999999999999999999999998764321      1236678999999975 899999998754  357


Q ss_pred             EEEEEcccCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC----CCCcEEEcccce
Q 016143          103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDLGL  177 (394)
Q Consensus       103 ~~lV~e~~~~gsL~~~i~~~-~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~----~~~~~kl~Dfgl  177 (394)
                      .++||||+ +++|.+++... ..+++..+..++.|++.||.|||++|  |+||||||+|||++.    ..+.+||+|||+
T Consensus        76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             cEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccce
Confidence            88999999 78999988765 46999999999999999999999999  999999999999963    357899999999


Q ss_pred             eeeecCC---------CCcccccCCcccCcccccc-cCCCcCcchhhhhHHHHHHhcCCCCCCC--CCHHHHHHHHhcC-
Q 016143          178 AIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSG-  244 (394)
Q Consensus       178 a~~~~~~---------~~~~~~gt~~y~aPE~l~~-~~~~~~DIwSlG~il~elltg~~Pf~~~--~~~~~~~~~i~~~-  244 (394)
                      |+.....         .....+||+.|||||++.+ .++.++|||||||++|||+||+.||.+.  .+....+..+... 
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            9876432         2335679999999998766 5999999999999999999999999753  3334444333221 


Q ss_pred             --CCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCHHHHhc
Q 016143          245 --IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  280 (394)
Q Consensus       245 --~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~elL~  280 (394)
                        ..+..+....++++.+++..|+. +|.+||+...+.+
T Consensus       233 ~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence              12223445577899999999997 9999999776543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-45  Score=356.88  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=194.6

Q ss_pred             cccccccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-----------CCCceeEe
Q 016143           24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----------HENIIKFY   92 (394)
Q Consensus        24 ~ry~r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-----------hpnIv~~~   92 (394)
                      +|| ++.+.||+|+||+||+|+++.+|+.||||+++..     ....+.+.+|+.+++.++           |+||++++
T Consensus        13 ~rY-~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          13 ARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CcE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            566 8999999999999999999999999999998743     334466788999988875           57899999


Q ss_pred             eeEEcCCCceEEEEEcccCCCcHHH-H--HHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCC
Q 016143           93 NSWVDDTNRTINMITELFTSGSLRQ-Y--RKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNG  168 (394)
Q Consensus        93 ~~~~~~~~~~~~lV~e~~~~gsL~~-~--i~~~~~l~~~~~~~i~~qil~~L~~LH~-~~~~ivHrDLkp~NIll~~~~~  168 (394)
                      +++........+++++++..+.... .  ......+++..++.++.||+.||.|||+ +|  |+||||||+|||++.++.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEET
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCc
Confidence            9887665556667777765544322 2  2334579999999999999999999998 78  999999999999973221


Q ss_pred             -----cEEEcccceeeeecCCCCcccccCCcccCccccc-ccCCCcCcchhhhhHHHHHHhcCCCCCCCCCH------HH
Q 016143          169 -----EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP------AQ  236 (394)
Q Consensus       169 -----~~kl~Dfgla~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DIwSlG~il~elltg~~Pf~~~~~~------~~  236 (394)
                           .++++|||.|...... ....+||+.|+|||++. ..|+.++||||+||++++|++|+.||......      ..
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ccccceeeEeecccccccccc-cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence                 4999999999766543 35567999999999765 46999999999999999999999999653211      11


Q ss_pred             HHHHHhc-CC--------------------CC------------------CCCCCCCCHHHHHHHHHcCC-CCCCCCCHH
Q 016143          237 IYKKVTS-GI--------------------KP------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPAL  276 (394)
Q Consensus       237 ~~~~i~~-~~--------------------~~------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~  276 (394)
                      +...+.. +.                    .+                  .......++++++||++||. ||.+|||+.
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            1111100 00                    00                  00111235688999999999 999999999


Q ss_pred             HHhcCCccccCC
Q 016143          277 ELLKDPFLVTDN  288 (394)
Q Consensus       277 elL~~p~~~~~~  288 (394)
                      |+|+||||++..
T Consensus       324 e~L~Hp~f~~~~  335 (362)
T d1q8ya_         324 GLVNHPWLKDTL  335 (362)
T ss_dssp             HHHTCGGGTTCT
T ss_pred             HHhcCcccCCCC
Confidence            999999999543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.4e-26  Score=202.75  Aligned_cols=170  Identities=18%  Similarity=0.190  Sum_probs=123.7

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeecccc-----C---------CHHHHHHHHHHHHHHHcCCCCCceeEee
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-----Q---------SPDQLERLYSEVHLLKSLKHENIIKFYN   93 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~-----~---------~~~~~~~~~~E~~~l~~L~hpnIv~~~~   93 (394)
                      -+++.||+|+||+||+|.+. +|+.||+|+++.....     .         ..........|...+.++.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            36789999999999999884 7999999987532210     0         0112234557899999999999999887


Q ss_pred             eEEcCCCceEEEEEcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEc
Q 016143           94 SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG  173 (394)
Q Consensus        94 ~~~~~~~~~~~lV~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~~~ivHrDLkp~NIll~~~~~~~kl~  173 (394)
                      +.  .    -+++|||+++..+.+       ++...+..++.||+.+|.|||++|  |+||||||+|||++ + +.++|+
T Consensus        82 ~~--~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~li  144 (191)
T d1zara2          82 WE--G----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWII  144 (191)
T ss_dssp             EE--T----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEEC
T ss_pred             ec--C----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeee-C-CCEEEE
Confidence            43  2    147999998876543       556667889999999999999999  99999999999998 4 469999


Q ss_pred             ccceeeeecCCCCcccccC-CcccCcccccccCCCcCcchhhhh
Q 016143          174 DLGLAIVMQQPTARSVIGT-PEFMAPELYEEEYNELVDIYSFGM  216 (394)
Q Consensus       174 Dfgla~~~~~~~~~~~~gt-~~y~aPE~l~~~~~~~~DIwSlG~  216 (394)
                      |||+|.....+........ ... -.+-+.+.|+..+|+||+.-
T Consensus       145 DFG~a~~~~~~~~~~~l~rd~~~-~~~~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         145 DFPQSVEVGEEGWREILERDVRN-IITYFSRTYRTEKDINSAID  187 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHHHHHH-HHHHHHHHHCCCCCHHHHHH
T ss_pred             ECCCcccCCCCCcHHHHHHHHHH-HHHHHcCCCCCcccHHHHHH
Confidence            9999977655433221100 000 01234467899999999643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.24  E-value=2.3e-06  Score=75.73  Aligned_cols=138  Identities=14%  Similarity=0.041  Sum_probs=84.3

Q ss_pred             cccceecccCceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCceEEEE
Q 016143           28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI  106 (394)
Q Consensus        28 r~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~~~lV  106 (394)
                      ++.+..+.++.+.||+..  .++..+.+|.......    .....+.+|...++.|. +--+.+++.+..+  ....++|
T Consensus        17 ~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~----~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv   88 (263)
T d1j7la_          17 RCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLL   88 (263)
T ss_dssp             EEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEE
T ss_pred             EEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc----cchhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEEE
Confidence            444444444557899874  4566778887653321    11234566888887774 3335566665433  3567889


Q ss_pred             EcccCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 016143          107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN--------------------------------------  148 (394)
Q Consensus       107 ~e~~~~gsL~~~i~~~~~l~~~~~~~i~~qil~~L~~LH~~~--------------------------------------  148 (394)
                      |++++|.++.......     .....++.++...+..||+..                                      
T Consensus        89 ~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          89 MSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             EEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            9999998886543211     112233444444555555321                                      


Q ss_pred             -------------------CCeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          149 -------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       149 -------------------~~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                                         +.++|+|+.|.||+++ +++..-|+||+.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~  212 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec-CCceEEEeechhcc
Confidence                               1278999999999998 55555699998773

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.01  E-value=1.2e-05  Score=75.83  Aligned_cols=80  Identities=15%  Similarity=0.164  Sum_probs=48.1

Q ss_pred             ceecccCceEEEEEEEccCCeEEEEEEeeecccc---CCHHHHHHHHHHHHHHHcCC-C--CCceeEeeeEEcCCCceEE
Q 016143           31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM---QSPDQLERLYSEVHLLKSLK-H--ENIIKFYNSWVDDTNRTIN  104 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~---~~~~~~~~~~~E~~~l~~L~-h--pnIv~~~~~~~~~~~~~~~  104 (394)
                      +.||.|....||+..+..+++.|++|+-...-..   ..+...++...|...|+.+. +  ..+.+++.  .++...  +
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~--~  107 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMA--V  107 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTT--E
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCC--E
Confidence            4689999999999988777888999975321100   01122345667888887763 2  34555665  344433  4


Q ss_pred             EEEcccCCCc
Q 016143          105 MITELFTSGS  114 (394)
Q Consensus       105 lV~e~~~~gs  114 (394)
                      +|||++.+..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            6899997654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.65  E-value=7.7e-05  Score=65.14  Aligned_cols=74  Identities=11%  Similarity=-0.056  Sum_probs=46.1

Q ss_pred             eecccC-ceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCC--CCceeEeeeEEcCCCceEEEEEc
Q 016143           32 ILGKGA-FKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITE  108 (394)
Q Consensus        32 ~LG~G~-~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~h--pnIv~~~~~~~~~~~~~~~lV~e  108 (394)
                      .+..|. -+.||+... ..+..+.+|......       ...+..|...|+.|..  -.+.+++.+..+  ....++||+
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~   86 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLG   86 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEE
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEE
Confidence            344555 368998864 456667788654322       1235668888877743  335556665443  346788999


Q ss_pred             ccCCCcH
Q 016143          109 LFTSGSL  115 (394)
Q Consensus       109 ~~~~gsL  115 (394)
                      +++|-++
T Consensus        87 ~i~G~~~   93 (255)
T d1nd4a_          87 EVPGQDL   93 (255)
T ss_dssp             CCSSEET
T ss_pred             eeecccc
Confidence            9988665

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.55  E-value=0.0019  Score=58.45  Aligned_cols=70  Identities=11%  Similarity=0.066  Sum_probs=40.8

Q ss_pred             ceEEEEEEEccCCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCCCCCc-----eeEeeeEEcCCCceEEEEEcccCC
Q 016143           38 FKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-----IKFYNSWVDDTNRTINMITELFTS  112 (394)
Q Consensus        38 ~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~hpnI-----v~~~~~~~~~~~~~~~lV~e~~~~  112 (394)
                      --.||++.. .+|..|++|+.+...  .+   .+++..|...+..|....+     +..-+--........+.++++..|
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~--~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPER--WT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTT--SC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCC--CC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            358999865 578889999875321  12   2446668888877742221     111110001123467788999876


Q ss_pred             C
Q 016143          113 G  113 (394)
Q Consensus       113 g  113 (394)
                      .
T Consensus       109 ~  109 (325)
T d1zyla1         109 R  109 (325)
T ss_dssp             E
T ss_pred             c
Confidence            3

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.44  E-value=0.0034  Score=58.33  Aligned_cols=73  Identities=14%  Similarity=0.104  Sum_probs=45.5

Q ss_pred             ceecccCceEEEEEEEcc-------CCeEEEEEEeeeccccCCHHHHHHHHHHHHHHHcCC-CCCceeEeeeEEcCCCce
Q 016143           31 EILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT  102 (394)
Q Consensus        31 ~~LG~G~~g~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~~E~~~l~~L~-hpnIv~~~~~~~~~~~~~  102 (394)
                      +.|+.|-.-.+|++....       ....|.+++....   ..  . ....+|..+++.+. +.-..++++++  ++   
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~--~-idr~~E~~i~~~ls~~gl~Pkll~~~--~~---  116 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET--E-SHLVAESVIFTLLSERHLGPKLYGIF--SG---  116 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC--H-HHHHHHHHHHHHHHHTTSSSCEEEEE--TT---
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---ch--h-hHHHHHHHHHHHHHhCCCCCeEEEEc--CC---
Confidence            567778888999987643       2356777665411   11  2 23456888988885 43334677755  32   


Q ss_pred             EEEEEcccCCCcH
Q 016143          103 INMITELFTSGSL  115 (394)
Q Consensus       103 ~~lV~e~~~~gsL  115 (394)
                       .+|+||++|.+|
T Consensus       117 -g~I~efi~g~~l  128 (395)
T d1nw1a_         117 -GRLEEYIPSRPL  128 (395)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -ceEEEEeccccC
Confidence             358999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.94  E-value=0.015  Score=51.70  Aligned_cols=29  Identities=31%  Similarity=0.355  Sum_probs=24.4

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEcccceee
Q 016143          150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI  179 (394)
Q Consensus       150 ~ivHrDLkp~NIll~~~~~~~kl~Dfgla~  179 (394)
                      ++||+|+.++||+++ .+...-|+||+.+.
T Consensus       184 giIHgDl~~dNvl~~-~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFL-GDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcc-cccceeEecccccc
Confidence            399999999999998 45556899999773